Citrus Sinensis ID: 038199

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350------
Protein Sequence
MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLDLIKMTGLKSLESSDGSNSSNRSRWYKETTPIMAKHEIQIATC
Secondary Structure (PSIPRED)
cHHHHHHHcccccccccHHHHHHHHHHHHHHcccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHccccccEEEEEEEEcccccEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEEccccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccHHHHcccccHHHHHHHHHHHHHHHccccccccccccHHHHHHHHcccccccccccccccccHHHcccccccccccccccccccccccccccccccccEEEccc
Secondary Structure Prediction (SSPRO)
ccccHHHcccccccEEcHHHHHHHHHccHHHccccccccEEccEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHEEEcccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccccEEEcccccHHHEEEEEEEHHHHcHccHHEEcccccccccccEEEEccccccHHHHHcccEEcccccHHHHHEEEEEEEccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccEEEccccccccccccccccccccccccccccccccccccEEEccc
Coil and Loop (DISEMBL)
MERFLQeigrekpvrftslqlnnftsnystrlgfggfgevykgqfpngVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMengsldgylfgKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIhydikpenvlldanfspkvadfglaklcdrnrshvtisgykgtpgysapeflsgnypithkcdvysFGMVLFEIVGRRrnaivgssesldwfpkhvWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWcvqdspedrppmSAVVKMLEGVvevlpppkpfryldlikmtglkslessdgsnssnrsrwykettpimaKHEIQIATC
Flexible Loop (DISEMBL)
merflqeigrekpvrftslqlnnFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVgssesldwfpkHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWcvqdspedrPPMSAVVKMLEGVVEVLPPPKPFRYLDLIKMTGlkslessdgsnssnrsrwykettpimakheiqiatc
Low Complexity Region (SEG)
MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLDLIKMTGLKslessdgsnssnrsrWYKETTPIMAKHEIQIATC
Disordered region (IsUnstruct)
*************VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQ**********AVVKMLEGVVEVLPPPKPFRYLDLIKMTG************************************
Disordered Region (DISOPRED)
MERFL**IGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNR*****AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRN******ESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRY*************************************EIQIA**
Disordered Region (DISEMBL)
MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLDLIKMTGLKS*************RWYKETTPIMAKHEIQIATC
Disordered Region (DISPRO)
*ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLDLI****************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLDLIKMTGLKSLESSDGSNSSNRSRWYKETTPIMAKHEIQIATC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	356	2.2.26 [Sep-21-2011]
O64477	828	G-type lectin S-receptor-	no	no	0.814	0.350	0.486	1e-69
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.918	0.398	0.423	4e-69
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.845	0.345	0.471	9e-69
Q9XID3	829	G-type lectin S-receptor-	no	no	0.845	0.363	0.461	1e-68
Q9FID5	806	Probable receptor-like pr	no	no	0.867	0.383	0.431	3e-67
Q3ECH2	892	Probable receptor-like pr	no	no	0.853	0.340	0.390	1e-64
Q9FID6	813	Probable receptor-like pr	no	no	0.887	0.388	0.398	1e-64
Q39203	797	G-type lectin S-receptor-	no	no	0.786	0.351	0.465	3e-63
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.808	0.278	0.433	4e-58
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.808	0.279	0.433	5e-58

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  263 bits (673), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 146/300 (48%), Positives = 190/300 (63%), Gaps = 10/300 (3%)

Query: 16  FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 75
           F+  +L N T N+S +LG GGFG V+KG  P+   IAVK L   + +  E+QF  EV TI
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRL-EGISQ-GEKQFRTEVVTI 540

Query: 76  GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF----GKKRAIEWEKLHEIAIGT 131
           G   H+NLVRL GFC +     LVY+YM NGSLD +LF     +K  + W+   +IA+GT
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A+GL YLH+EC+  IIH DIKPEN+LLD+ F PKVADFGLAKL  R+ S V ++  +GT 
Sbjct: 601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGTR 659

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
           GY APE++SG   IT K DVYS+GM+LFE+V  RRN     +E + +FP        K  
Sbjct: 660 GYLAPEWISG-VAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDG 718

Query: 252 LDATILACGIEEK--DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKP 309
              +++   +E    D E+  R C  A WC+QD    RP MS VV++LEGV+EV PPP P
Sbjct: 719 DIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  261 bits (668), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 143/338 (42%), Positives = 211/338 (62%), Gaps = 11/338 (3%)

Query: 2   ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG 61
           + FL+ +    P+RF    L + T+N+S +LG GGFG VY+G  P+G ++AVK L   +G
Sbjct: 470 DNFLENL-SGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKL-EGIG 527

Query: 62  RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA--- 118
           +  +++F AEV  IG  +H++LVRL GFC +     L YE++  GSL+ ++F KK     
Sbjct: 528 Q-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVL 586

Query: 119 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
           ++W+    IA+GTAKGL YLHE+C  RI+H DIKPEN+LLD NF+ KV+DFGLAKL  R 
Sbjct: 587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646

Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW 238
           +SHV  +  +GT GY APE+++ NY I+ K DVYS+GMVL E++G R+N     +     
Sbjct: 647 QSHV-FTTMRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCH 704

Query: 239 FPKHVWEEYEKSELDATILACGIEEKD--KEKAKRLCMAALWCVQDSPEDRPPMSAVVKM 296
           FP   +++ E+ +L   I+   ++  D   E+ +R    ALWC+Q+  + RP MS VV+M
Sbjct: 705 FPSFAFKKMEEGKL-MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQM 763

Query: 297 LEGVVEVLPPPKPFRYLDLIKMTGLKSLESSDGSNSSN 334
           LEGV  V+ PP        +  +  KS+    G+ +S+
Sbjct: 764 LEGVFPVVQPPSSSTMGSRLYSSFFKSISEDGGATTSS 801

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  260 bits (665), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 148/314 (47%), Positives = 195/314 (62%), Gaps = 13/314 (4%)

Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMA 70
           + PV FT   L N T+N+S  LG GGFG VYKG       +AVK L+R L    E +F+ 
Sbjct: 515 DSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSH-GEREFIT 573

Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---IEWEKLHEI 127
           EV TIG  +H+NLVRL G+C +     LVYEYM NGSLD ++F  ++    ++W    EI
Sbjct: 574 EVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEI 633

Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
           A+ TA+G+ Y HE+C+ RIIH DIKPEN+LLD NF PKV+DFGLAK+  R  SHV ++  
Sbjct: 634 AVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV-VTMI 692

Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY 247
           +GT GY APE++S N PIT K DVYS+GM+L EIVG RRN  +       ++P   ++E 
Sbjct: 693 RGTRGYLAPEWVS-NRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKEL 751

Query: 248 EK-SELDATI--LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV-EV 303
              + L A    L    EE++  KA ++   A WC+QD    RP M  VVK+LEG   E+
Sbjct: 752 TNGTSLKAVDKRLQGVAEEEEVVKALKV---AFWCIQDEVSMRPSMGEVVKLLEGTSDEI 808

Query: 304 LPPPKPFRYLDLIK 317
             PP P   L+LI+
Sbjct: 809 NLPPMPQTILELIE 822

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  260 bits (664), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 143/310 (46%), Positives = 185/310 (59%), Gaps = 9/310 (2%)

Query: 5   LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA 64
           L E     PV+FT  +L   T ++  +LG GGFG VY+G   N   +AVK L        
Sbjct: 463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGI--EQG 520

Query: 65  EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA--IEWE 122
           E+QF  EV TI  T+H+NLVRL GFC       LVYE+M NGSLD +LF    A  + WE
Sbjct: 521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWE 580

Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
               IA+GTAKG+ YLHEEC+  I+H DIKPEN+L+D NF+ KV+DFGLAKL +   +  
Sbjct: 581 YRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY 640

Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH 242
            +S  +GT GY APE+L+ N PIT K DVYS+GMVL E+V  +RN  V    +   F   
Sbjct: 641 NMSSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIW 699

Query: 243 VWEEYEKSELDATILACGIEEK---DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG 299
            +EE+EK    A IL   + E    D E+  R+   + WC+Q+ P  RP M  VV+MLEG
Sbjct: 700 AYEEFEKGNTKA-ILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG 758

Query: 300 VVEVLPPPKP 309
           + E+  P  P
Sbjct: 759 ITEIKNPLCP 768

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  255 bits (652), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 138/320 (43%), Positives = 201/320 (62%), Gaps = 11/320 (3%)

Query: 16  FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 75
           +T  +L   T ++S  +G GGFG VY G   NG K+AVKVL    G  + E F+ EV ++
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKG--SAEDFINEVASM 545

Query: 76  GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE-WEKLHEIAIGTAKG 134
            +T H+N+V L GFC +    A+VYE++ENGSLD ++   K   +    L+ IA+G A+G
Sbjct: 546 SQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTLYGIALGIARG 605

Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS 194
           L YLH  C+ RI+H+DIKP+N+LLD N  PKV+DFGLAKLC++  S +++   +GT GY 
Sbjct: 606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665

Query: 195 APEFLSGNYP-ITHKCDVYSFGMVLFEIVGRRRNAI---VGSSESLDWFPKHVWEEYEKS 250
           APE  S  Y  ++HK DVYSFGM++ +++G R   I   V S+ S  +FP  ++++ E  
Sbjct: 666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDG 725

Query: 251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP-PPKP 309
           E    I    I +++KE AK++ +  LWC+Q  P DRP M+ VV+M+EG ++ L  PPKP
Sbjct: 726 E-QTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP 784

Query: 310 FRYLDLIKMTGLKSLESSDG 329
             ++    +T   SL  SDG
Sbjct: 785 SMHISTEVITESSSL--SDG 802

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  247 bits (631), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 125/320 (39%), Positives = 205/320 (64%), Gaps = 16/320 (5%)

Query: 5   LQEIGREKPVR-FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI 63
           LQ++    P++ +T  ++   T +++  +G GGFG VY G   +   +AVKVL  + G  
Sbjct: 534 LQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTD 593

Query: 64  AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWE 122
            E+ F+ EV ++ +T H+N+V L GFC +    A++YE++ NGSLD ++  K    ++ +
Sbjct: 594 GED-FINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSSVNLDLK 652

Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L+ IA+G A+GL YLH  C+ RI+H+DIKP+NVLLD N  PKV+DFGLAKLC++  S +
Sbjct: 653 TLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESIL 712

Query: 183 TISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD---- 237
           ++   +GT GY APE +S  Y  ++HK DVYS+GM++ E++G R+      +   D    
Sbjct: 713 SLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSI 772

Query: 238 WFPKHVWEEYEKSEL-------DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPM 290
           +FP+ ++++ EK+ +       +  ++  GI  +++E A+++ +  LWC+Q SP DRPPM
Sbjct: 773 YFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPM 832

Query: 291 SAVVKMLEGVVEVLP-PPKP 309
           + VV+M+EG ++ L  PP+P
Sbjct: 833 NKVVEMMEGSLDALEVPPRP 852

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  247 bits (630), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 131/329 (39%), Positives = 205/329 (62%), Gaps = 13/329 (3%)

Query: 20  QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 79
           +L   T ++S  +G GGFG VY+G   NG  +AVKVL    G    + F+ EV ++ +T 
Sbjct: 490 ELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGN--GDDFINEVTSMSQTS 547

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIGTAKGLVYL 138
           H+N+V L GFC++    A++ E++E+GSLD ++   K        L+ IA+G A+GL YL
Sbjct: 548 HVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVTTLYGIALGIARGLEYL 607

Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
           H  C+ RI+H+DIKP+N+LLD NF PKVADFGLAKLC++  S +++   +GT GY APE 
Sbjct: 608 HYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEV 667

Query: 199 LSGNY-PITHKCDVYSFGMVLFEIVGRRRNA-IVGSSESLDWFPKHVWEEYEKSELDATI 256
           +S  Y  I+HK DVYS+GM++ +++G R        + S  +FP  ++++ E  +    I
Sbjct: 668 VSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGD-QTWI 726

Query: 257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP-PPKPFRYL-- 313
           +   I E+D +  K++ + +LWC++  P DRPPM+ VV+M+EG ++ L  PPKP R++  
Sbjct: 727 IGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKPSRHIST 786

Query: 314 DLIKMTGLKSLESSDGSNSSNRSRWYKET 342
           +L+    L+S   SDG  +  +++    T
Sbjct: 787 ELV----LESSSLSDGQEAEKQTQTLDST 811

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  242 bits (618), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 137/294 (46%), Positives = 182/294 (61%), Gaps = 14/294 (4%)

Query: 16  FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGT 74
           F+  +L + T+ +S ++G GGFG V+KG  P +   +AVK L R      E +F AEV T
Sbjct: 451 FSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGS--GESEFRAEVCT 508

Query: 75  IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAK 133
           IG   H+NLVRL GFC +     LVY+YM  GSL  YL     + + WE    IA+GTAK
Sbjct: 509 IGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAK 568

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ YLHE C+  IIH DIKPEN+LLD++++ KV+DFGLAKL  R+ S V ++  +GT GY
Sbjct: 569 GIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRV-LATMRGTWGY 627

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGS-------SESLDW-FPKHVWE 245
            APE++SG  PIT K DVYSFGM L E++G RRN IV S       +E   W FP     
Sbjct: 628 VAPEWISG-LPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAR 686

Query: 246 EYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG 299
           E  +  +D+ + +    E + E+  R+   A+WC+QD+ E RP M  VVKMLEG
Sbjct: 687 EIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  225 bits (574), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 128/295 (43%), Positives = 181/295 (61%), Gaps = 7/295 (2%)

Query: 12  KPVRFTSLQLNNFTSNY--STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFM 69
           KP  FT  +L + T ++  S +LG GGFG VYKG+  +G ++AVK+L+    R  + QF+
Sbjct: 677 KPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVG-SRQGKGQFV 735

Query: 70  AEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIA 128
           AE+  I    H NLV+LYG C++     LVYEY+ NGSLD  LFG+K   ++W   +EI 
Sbjct: 736 AEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLHLDWSTRYEIC 795

Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
           +G A+GLVYLHEE + RI+H D+K  N+LLD+   PKV+DFGLAKL D  ++H++ +   
Sbjct: 796 LGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHIS-TRVA 854

Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE 248
           GT GY APE+    + +T K DVY+FG+V  E+V  R N+     +   +  +  W  +E
Sbjct: 855 GTIGYLAPEYAMRGH-LTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHE 913

Query: 249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV 303
           K   +  ++   + E + E+ KR+   AL C Q S   RPPMS VV ML G VEV
Sbjct: 914 KGR-EVELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEV 967

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  225 bits (573), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 128/295 (43%), Positives = 178/295 (60%), Gaps = 7/295 (2%)

Query: 12  KPVRFTSLQLNNFTSNY--STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFM 69
           KP  FT  +L + T ++  S +LG GGFG VYKG   +G  +AVK+L+    R  + QF+
Sbjct: 678 KPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVG-SRQGKGQFV 736

Query: 70  AEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIA 128
           AE+  I    H NLV+LYG C +     LVYEY+ NGSLD  LFG K   ++W   +EI 
Sbjct: 737 AEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEIC 796

Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
           +G A+GLVYLHEE   RI+H D+K  N+LLD+   P+++DFGLAKL D  ++H++ +   
Sbjct: 797 LGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHIS-TRVA 855

Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE 248
           GT GY APE+    + +T K DVY+FG+V  E+V  R N+     E   +  +  W  +E
Sbjct: 856 GTIGYLAPEYAMRGH-LTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHE 914

Query: 249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV 303
           KS  D  ++   + + + E+AKR+   AL C Q S   RPPMS VV ML G VE+
Sbjct: 915 KSR-DIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEI 968

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	356
225429784	361	PREDICTED: G-type lectin S-receptor-like	0.994	0.980	0.736	1e-158
296081766	543	unnamed protein product [Vitis vinifera]	0.997	0.653	0.738	1e-158
359476316	361	PREDICTED: G-type lectin S-receptor-like	0.997	0.983	0.738	1e-158
449532913	358	PREDICTED: G-type lectin S-receptor-like	0.994	0.988	0.712	1e-150
449437068	436	PREDICTED: G-type lectin S-receptor-like	0.994	0.811	0.709	1e-149
449437352	452	PREDICTED: G-type lectin S-receptor-like	0.969	0.763	0.637	1e-141
449437350	363	PREDICTED: G-type lectin S-receptor-like	0.994	0.975	0.669	1e-141
449528245	486	PREDICTED: G-type lectin S-receptor-like	0.949	0.695	0.638	1e-138
449437348	452	PREDICTED: probable receptor-like protei	0.963	0.758	0.603	1e-125
225454761	491	PREDICTED: G-type lectin S-receptor-like	0.988	0.716	0.582	1e-115

>gi|225429784|ref|XP_002282725.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera]

 Score =  565 bits (1457), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 266/361 (73%), Positives = 306/361 (84%), Gaps = 7/361 (1%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 60
           ME+F QE+ REKPVRFT+ QL +FT NY+T LG GGFG VYKGQFPNGVKIAVKVLNR+ 
Sbjct: 1   MEKFFQELAREKPVRFTAQQLCSFTDNYTTTLGSGGFGMVYKGQFPNGVKIAVKVLNRSP 60

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
            R AEEQFMAEVGTIGRTYHINLVRLYGFC+DQ M+ALVYEY+ENGSLD YLF + + +E
Sbjct: 61  DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQFMSALVYEYLENGSLDKYLFSEAQEVE 120

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
           WEKLH IA+GTAKG+ YLHEEC +RIIHYDIKP N+LLDANF PKVADFGLAKLC+R+ +
Sbjct: 121 WEKLHHIAVGTAKGIAYLHEECVERIIHYDIKPGNILLDANFFPKVADFGLAKLCNRDGT 180

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
           H+T+SGY+GTPGYSAPEFL  N+PITHKCDVYSFGM+LFEIVGRRRNA VGS+ES+DWFP
Sbjct: 181 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKVGSNESMDWFP 240

Query: 241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
           KH WEEYEK +L A  +ACGIEEKD+EKA+R+ M ALWCVQDSP+ RPPMSAVVKMLEG 
Sbjct: 241 KHTWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPPMSAVVKMLEGG 300

Query: 301 VEVLPPPKPFRYLDLIKMTGLKSLESSDGSNSS------NRSRWYKETTPIMAKHEIQIA 354
           VEV+PPPKPF YL  + M   +    + G+NSS        S WYKETTPIMAK+EIQ+A
Sbjct: 301 VEVMPPPKPFHYLYSVGMNVFQQANET-GTNSSYATSEETSSIWYKETTPIMAKYEIQVA 359

Query: 355 T 355
           +
Sbjct: 360 S 360

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296081766|emb|CBI20771.3| unnamed protein product [Vitis vinifera]

 Score =  565 bits (1456), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 266/360 (73%), Positives = 304/360 (84%), Gaps = 5/360 (1%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 60
           MERF QEI +EKPVRFT+ QL +FT+NYST LG GGFG VYKGQF NGVKIAVKVLNR+ 
Sbjct: 59  MERFFQEIAKEKPVRFTAQQLCSFTANYSTTLGSGGFGVVYKGQFLNGVKIAVKVLNRSP 118

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
            R A EQFMAEVGTIGRTYH+NLVRLYGFCHDQ M+ALVYEY+ENGSLD YLF + R IE
Sbjct: 119 DRQAGEQFMAEVGTIGRTYHMNLVRLYGFCHDQFMSALVYEYLENGSLDKYLFSEAREIE 178

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
           WEKLH IA+GTAKG+ YLHEEC QRIIHYDIKP NVLLDANF PKVADFGLAKLC+R+ +
Sbjct: 179 WEKLHHIAVGTAKGIAYLHEECVQRIIHYDIKPGNVLLDANFFPKVADFGLAKLCNRDNT 238

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
           H+T+SGY+GTPGYSAPEFL  N+PITHKCDVYSFGM+LFEIVGRRRNA +GS+ES+DWFP
Sbjct: 239 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKIGSNESMDWFP 298

Query: 241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
           KHVWEEYEK +L A  +ACGIEEKD+EKA+R+ M ALWCVQDSP+ RP MSAVVKMLEG 
Sbjct: 299 KHVWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPLMSAVVKMLEGG 358

Query: 301 VEVLPPPKPFRYL-----DLIKMTGLKSLESSDGSNSSNRSRWYKETTPIMAKHEIQIAT 355
           VEV+PPPKPF YL     ++++        SS  ++    S WYKETTPIMAK+EIQ+A+
Sbjct: 359 VEVMPPPKPFHYLYSVGINVLQQANETGTSSSYATSKETNSIWYKETTPIMAKYEIQVAS 418

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359476316|ref|XP_003631817.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera]

 Score =  564 bits (1454), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 266/360 (73%), Positives = 304/360 (84%), Gaps = 5/360 (1%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 60
           MERF QEI +EKPVRFT+ QL +FT+NYST LG GGFG VYKGQF NGVKIAVKVLNR+ 
Sbjct: 1   MERFFQEIAKEKPVRFTAQQLCSFTANYSTTLGSGGFGVVYKGQFLNGVKIAVKVLNRSP 60

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
            R A EQFMAEVGTIGRTYH+NLVRLYGFCHDQ M+ALVYEY+ENGSLD YLF + R IE
Sbjct: 61  DRQAGEQFMAEVGTIGRTYHMNLVRLYGFCHDQFMSALVYEYLENGSLDKYLFSEAREIE 120

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
           WEKLH IA+GTAKG+ YLHEEC QRIIHYDIKP NVLLDANF PKVADFGLAKLC+R+ +
Sbjct: 121 WEKLHHIAVGTAKGIAYLHEECVQRIIHYDIKPGNVLLDANFFPKVADFGLAKLCNRDNT 180

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
           H+T+SGY+GTPGYSAPEFL  N+PITHKCDVYSFGM+LFEIVGRRRNA +GS+ES+DWFP
Sbjct: 181 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKIGSNESMDWFP 240

Query: 241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
           KHVWEEYEK +L A  +ACGIEEKD+EKA+R+ M ALWCVQDSP+ RP MSAVVKMLEG 
Sbjct: 241 KHVWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPLMSAVVKMLEGG 300

Query: 301 VEVLPPPKPFRYL-----DLIKMTGLKSLESSDGSNSSNRSRWYKETTPIMAKHEIQIAT 355
           VEV+PPPKPF YL     ++++        SS  ++    S WYKETTPIMAK+EIQ+A+
Sbjct: 301 VEVMPPPKPFHYLYSVGINVLQQANETGTSSSYATSKETNSIWYKETTPIMAKYEIQVAS 360

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449532913|ref|XP_004173422.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus]

 Score =  535 bits (1379), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 255/358 (71%), Positives = 296/358 (82%), Gaps = 4/358 (1%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 60
           ME+F++E+  E+PVRFT  QL  FTSNYST LG GGFG VYKGQFPNGVKIAVKVL RN 
Sbjct: 1   MEKFIREMAEERPVRFTPQQLYCFTSNYSTPLGSGGFGSVYKGQFPNGVKIAVKVLKRNA 60

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
            R AEEQFMAEVGTIGRTYHINLVRLYGFC+DQ+M ALV+EYMENGSLD YLFGK + I+
Sbjct: 61  DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDID 120

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
           W KLH++AIGTAKGL YLHEECQQRIIHYDIKP N+LLDANFSPKV DFGLAKLC+R+ +
Sbjct: 121 WRKLHDVAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDIT 180

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
           H++++GY+GTPGYSAPEFL  NYPITHKCDVYSFGMVLFEIVGR+RNA V  S + DW P
Sbjct: 181 HMSLTGYRGTPGYSAPEFLFFNYPITHKCDVYSFGMVLFEIVGRKRNAGVTDSGNPDWLP 240

Query: 241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
           +HVW+ YEK +L+   L CGIEE +KE+A R+C  ALWCVQDSP++RPPMS VV+MLEG 
Sbjct: 241 QHVWDNYEKGKLEELTLMCGIEEDNKERANRMCEVALWCVQDSPDNRPPMSTVVRMLEGG 300

Query: 301 VEVLPPPKPFRYL-DLIKMTGLKSLESSD--GSNSSNRSRWYKETTPIMAKHEIQIAT 355
           VE++PPPKPF YL    K    ++  SSD   SN  + S WYK+ TPIM K+EIQIA+
Sbjct: 301 VEIMPPPKPFLYLQSTAKRNAQQTSNSSDYSTSNEESGSVWYKD-TPIMKKYEIQIAS 357

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449437068|ref|XP_004136314.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus]

 Score =  535 bits (1378), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 254/358 (70%), Positives = 295/358 (82%), Gaps = 4/358 (1%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 60
           ME+F++E+  E+PVR T  QL  FTSNYST LG GGFG VYKGQFPNGVKIAVKVL RN 
Sbjct: 79  MEKFIREMAEERPVRLTPQQLYCFTSNYSTPLGSGGFGSVYKGQFPNGVKIAVKVLKRNA 138

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
            R AEEQFMAEVGTIGRTYHINLVRLYGFC+DQ+M ALV+EYMENGSLD YLFGK + I+
Sbjct: 139 DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDID 198

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
           W KLH++AIGTAKGL YLHEECQQRIIHYDIKP N+LLDANFSPKV DFGLAKLC+R+ +
Sbjct: 199 WRKLHDVAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDIT 258

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
           H++++GY+GTPGYSAPEFL  NYPITHKCDVYSFGMVLFEIVGR+RNA V  S + DW P
Sbjct: 259 HMSLTGYRGTPGYSAPEFLFFNYPITHKCDVYSFGMVLFEIVGRKRNAGVTDSGNPDWLP 318

Query: 241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
           +HVW+ YEK +L+   L CGIEE +KE+A R+C  ALWCVQDSP++RPPMS VV+MLEG 
Sbjct: 319 QHVWDNYEKGKLEELTLMCGIEEDNKERANRMCEVALWCVQDSPDNRPPMSTVVRMLEGG 378

Query: 301 VEVLPPPKPFRYL-DLIKMTGLKSLESSD--GSNSSNRSRWYKETTPIMAKHEIQIAT 355
           VE++PPPKPF YL    K    ++  SSD   SN  + S WYK+ TPIM K+EIQIA+
Sbjct: 379 VEIMPPPKPFLYLQSTAKRNAQQTSNSSDYSTSNEESGSVWYKD-TPIMKKYEIQIAS 435

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449437352|ref|XP_004136456.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus]

 Score =  507 bits (1306), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 237/372 (63%), Positives = 287/372 (77%), Gaps = 27/372 (7%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 60
           ME+F+QE+ +EKP+RFT+ QL  FT NYST LG G F  VYKG+FPNGVKIAVKVLNRN 
Sbjct: 90  MEKFIQELAKEKPIRFTAQQLYIFTRNYSTILGAGAFSTVYKGEFPNGVKIAVKVLNRNS 149

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
            + AE+QFMAEVGTIG+TYH +LVRLYGFC+DQ+M ALV+EYMENGSLD YLFGK + ++
Sbjct: 150 DKQAEQQFMAEVGTIGKTYHRHLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDVD 209

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
           W KLH++AIGTAKGL YLHEECQ+RIIHYDIKP N+LLDANFSPKV DFGLAKLC R+R+
Sbjct: 210 WGKLHDVAIGTAKGLTYLHEECQERIIHYDIKPANILLDANFSPKVCDFGLAKLCHRDRT 269

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
           H++++GY+GTPGYSAPEF   NYPITHKCDVYSFGM+LFEIVGR++NA V  S +LDWFP
Sbjct: 270 HISLTGYRGTPGYSAPEFFLNNYPITHKCDVYSFGMLLFEIVGRKKNATVTPSGNLDWFP 329

Query: 241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
           +HVW++Y+K EL+     CGIEEKDKE   R+C  ALWC+QDSP++RPPMS VVKMLEG 
Sbjct: 330 RHVWDKYKKRELEEISQICGIEEKDKESVSRMCKVALWCIQDSPDERPPMSVVVKMLEGD 389

Query: 301 VEVLPPPKPFRYLDLIKMTGLKSLESSDGSNSSN-----------------RSRWYKETT 343
           VE++ P  PF++          S  +  G+N  N                  S WYK+ T
Sbjct: 390 VEIMAPSNPFKF----------SNPTPVGNNKPNLLQSSSSSNYSTSSEEIHSSWYKKAT 439

Query: 344 PIMAKHEIQIAT 355
           PIM K+EI I +
Sbjct: 440 PIMKKYEIHIGS 451

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449437350|ref|XP_004136455.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Cucumis sativus]

 Score =  507 bits (1305), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 243/363 (66%), Positives = 290/363 (79%), Gaps = 9/363 (2%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 60
           ME+F ++I  EKPVRFT+ QL  FTSNYSTRLG GGFGEVYKG+FPNGV IAVKVL R  
Sbjct: 1   MEKFFRKIAEEKPVRFTADQLYTFTSNYSTRLGSGGFGEVYKGKFPNGVNIAVKVLKRGS 60

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
            + AEEQFMAEVG+I RTYHINLVRLYGFC+D  M+ALV+EY+ NGSLD YLFGK++ IE
Sbjct: 61  DKRAEEQFMAEVGSICRTYHINLVRLYGFCYDHFMSALVFEYLVNGSLDKYLFGKRKEIE 120

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
           W KLH+IAIGTAKGL YLHEECQQRIIHYDIKP N+LLDANFSPKV DFGLAKLC+R+ +
Sbjct: 121 WRKLHDIAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDST 180

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
           H++ SGY+GTPGYSAPEFL  NYP+THKCDVYSFGMVLFEI+GR+ NA    S + DWFP
Sbjct: 181 HISFSGYRGTPGYSAPEFLLVNYPLTHKCDVYSFGMVLFEIIGRKSNAGTTVSGNPDWFP 240

Query: 241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
           +HVW+ YE  +L+  I+ CGI E+D+E A R C  ALWCVQDSP+ RP MS VV+MLEG 
Sbjct: 241 QHVWDAYENGKLEELIIGCGIGEEDREMASRACEVALWCVQDSPDGRPTMSVVVRMLEGG 300

Query: 301 VEVLPPPKPFRYLDLIKMTG--------LKSLESSDGSNSSNRSRWYKETTPIMAKHEIQ 352
           VE++PP KPF+YL+ I+ TG          S  S   ++  + S+WYK+TT IM K+EIQ
Sbjct: 301 VEIMPPAKPFQYLNPIR-TGNSSTSSQQTGSNSSGSSTSRDSNSQWYKKTTTIMRKYEIQ 359

Query: 353 IAT 355
           +A+
Sbjct: 360 MAS 362

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449528245|ref|XP_004171116.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like, partial [Cucumis sativus]

 Score =  497 bits (1279), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 233/365 (63%), Positives = 281/365 (76%), Gaps = 27/365 (7%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 60
           ME+F+QE+ +EKP+RFT+ QL  FT NYST LG G F  VYKG+FPNGVKIAVKVLNRN 
Sbjct: 90  MEKFIQELAKEKPMRFTAQQLYIFTRNYSTILGAGAFSTVYKGEFPNGVKIAVKVLNRNS 149

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
            + AE+QFMAEVGTIG+TYH +LVRLYGFC+DQ+M ALV+EYMENGSLD YLFGK + ++
Sbjct: 150 DKQAEQQFMAEVGTIGKTYHRHLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDVD 209

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
           W KLH++AIGTAKGL YLHEECQ+RIIHYDIKP N+LLDANFSPKV DFGLAKLC R+R+
Sbjct: 210 WGKLHDVAIGTAKGLTYLHEECQERIIHYDIKPANILLDANFSPKVCDFGLAKLCHRDRT 269

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
           H++++G +GTPGYSAPEF   NYPITHKCDVYSFGM+LFEIVGR++NA V  S +LDWFP
Sbjct: 270 HISLTGCRGTPGYSAPEFFLNNYPITHKCDVYSFGMLLFEIVGRKKNATVTPSGNLDWFP 329

Query: 241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
           +HVW++Y+K EL+     CGIEEKDKE   R+C  ALWC+QDSP++RPPMS VVKMLEG 
Sbjct: 330 RHVWDKYKKRELEEISQICGIEEKDKESVSRMCKVALWCIQDSPDERPPMSVVVKMLEGD 389

Query: 301 VEVLPPPKPFRYLDLIKMTGLKSLESSDGSNSSN-----------------RSRWYKETT 343
           VE++ P  PF++          S  +  G+N  N                  S WYK+ T
Sbjct: 390 VEIMAPSNPFKF----------SNPTPVGNNKPNLLQSSSSSNYSTSSEEIHSSWYKKAT 439

Query: 344 PIMAK 348
           PIM K
Sbjct: 440 PIMKK 444

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449437348|ref|XP_004136454.1| PREDICTED: probable receptor-like protein kinase At5g39020-like [Cucumis sativus]

 Score =  453 bits (1165), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 216/358 (60%), Positives = 270/358 (75%), Gaps = 15/358 (4%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 60
           ME+ L+ I  E P+RFT+LQLN FTSNYSTRLG GGFG+VYKGQFPNG+KIAVK+L +N 
Sbjct: 93  MEKILRGIAEESPIRFTALQLNAFTSNYSTRLGSGGFGDVYKGQFPNGLKIAVKILKKNS 152

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK-KRAI 119
            + AE QFMAE+ TIGRT H NL+RLYGFC+D+ M+ALV E+MENGSLD +L+GK K  +
Sbjct: 153 NKKAENQFMAEIETIGRTRHRNLLRLYGFCYDETMSALVLEFMENGSLDRFLYGKTKNEL 212

Query: 120 EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179
           +WEKL EIAIGT +G+ Y+HEEC+++IIHYDIKP N+LLD NFSPK+ DFGLA LC+++ 
Sbjct: 213 DWEKLLEIAIGTGRGIAYMHEECERKIIHYDIKPANILLDENFSPKIGDFGLANLCNKDN 272

Query: 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF 239
           +H +++ Y+GTPGYSAPE L  N+P+T+KCDVYSFGMVLFE+VGRR+NA V    S+DWF
Sbjct: 273 THDSLTEYRGTPGYSAPELLRFNFPVTYKCDVYSFGMVLFEMVGRRKNAAVSPLGSIDWF 332

Query: 240 PKHVWEEYEKSELDATILACGIEEKDKEKAK--RLCMAALWCVQDSPEDRPPMSAVVKML 297
           P  VWE +EK EL        +EE  + K K  R+C+ ALWCVQDSPEDRPPMSAVV+ML
Sbjct: 333 PIQVWERFEKGELVNMSGDYDVEEDGERKMKVDRMCVVALWCVQDSPEDRPPMSAVVRML 392

Query: 298 EGVVEVLPPPKPFRYLDLIK------MTGLKSLESSDGSNSSNRSR------WYKETT 343
           EG VE++PPPKPF+Y+  I          + S + S GS SS          WYK  +
Sbjct: 393 EGSVEIMPPPKPFQYMFPIPTDSSTVTVAMDSEQMSFGSTSSYSMSKGTLPIWYKAAS 450

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225454761|ref|XP_002272528.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera]

 Score =  421 bits (1083), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 209/359 (58%), Positives = 258/359 (71%), Gaps = 7/359 (1%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL 60
           ME FL E+ REKP RF+  QL  FTS++S  LG GGFG VYKG+FPNG+ +AVKV+N N 
Sbjct: 136 MEIFLSEMEREKPTRFSPQQLARFTSDFSMVLGSGGFGVVYKGEFPNGLPVAVKVINSNS 195

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI- 119
            +   EQFMAEV +IGRTYHINLVRLYGFC D  M ALVYEY+ENGSLD  LFG+ +A  
Sbjct: 196 EKKVAEQFMAEVASIGRTYHINLVRLYGFCFDPTMRALVYEYVENGSLDRLLFGENKATN 255

Query: 120 -EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
            +W K  EIA+GTAKG+ YLHEEC+QRIIHYDIKP NVLLDA FSPK+ADFGLAKLC+R+
Sbjct: 256 DQWGKFEEIAVGTAKGIAYLHEECRQRIIHYDIKPANVLLDAVFSPKLADFGLAKLCNRD 315

Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW 238
            + V ++G++GTPGY+APE L   YP+T KCDVYSFGM+LFE+VGRRRN     SE+  W
Sbjct: 316 STQVPVTGFRGTPGYAAPE-LWKPYPVTCKCDVYSFGMLLFEMVGRRRNHDASLSETRQW 374

Query: 239 FPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            P+  WE +EK+EL   +  CGI+E + EKA R+CM A+WCVQ  PE RP M  VVKMLE
Sbjct: 375 LPRWTWEMFEKNELPEMLSLCGIKETNIEKAGRMCMVAMWCVQYLPEARPTMGKVVKMLE 434

Query: 299 GVVEVLPPPKPFR--YLDLIKMTGLKSLESSDGSNSSNRSRWYKETTPIMAKHEIQIAT 355
           G  E+ PPP PF+    +L+  +G  + E +D S S+  +       P     EI+I +
Sbjct: 435 GETEIPPPPYPFQRSMPNLVSSSG--NSEDTDPSESTRETSEPSYAAPGEGVLEIEIVS 491

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	356
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.839	0.374	0.445	7.2e-68
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.828	0.443	0.426	1.5e-67
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.831	0.439	0.432	1.3e-66
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.842	0.365	0.446	2.8e-66
TAIR|locus:2059103	828	AT2G19130 [Arabidopsis thalian	0.814	0.350	0.486	4.5e-66
TAIR|locus:2026155	829	AT1G34300 [Arabidopsis thalian	0.842	0.361	0.463	2.5e-65
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.825	0.441	0.430	2.5e-65
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.842	0.351	0.423	2.5e-65
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.820	0.457	0.435	1.1e-64
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.828	0.366	0.437	6e-64

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 689 (247.6 bits), Expect = 7.2e-68, P = 7.2e-68
 Identities = 138/310 (44%), Positives = 201/310 (64%)

Query:    15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVG 73
             RF+ +Q+   T ++   LG GGFG VYKG+ P+G + +AVK+L  +      E F+ E+ 
Sbjct:   448 RFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKILKES--NEDGEDFINEIA 505

Query:    74 TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTA 132
             ++ RT H N+V L GFC++    A++YE M NGSLD ++     A +EW+ L+ IA+G +
Sbjct:   506 SMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFISKNMSAKMEWKTLYNIAVGVS 565

Query:   133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
              GL YLH  C  RI+H+DIKP+N+L+D +  PK++DFGLAKLC  N S +++   +GT G
Sbjct:   566 HGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARGTIG 625

Query:   193 YSAPEFLSGNYP-ITHKCDVYSFGMVLFEIVGRR---RNAIVGSSESLDWFPKHVWEEYE 248
             Y APE  S N+  ++HK DVYS+GMV+ E++G R   R    GSS +  +FP  ++++ E
Sbjct:   626 YIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQNAGSSNTSMYFPDWIYKDLE 685

Query:   249 KSELDATILACGIEEKDKEK-AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP-P 306
             K E+  + LA  I E++ EK  K++ +  LWC+Q +P DRPPMS VV+MLEG +E L  P
Sbjct:   686 KGEI-MSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEGSLEALQIP 744

Query:   307 PKPFRYLDLI 316
             PKP   L  I
Sbjct:   745 PKPLLCLPAI 754

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 686 (246.5 bits), Expect = 1.5e-67, P = 1.5e-67
 Identities = 130/305 (42%), Positives = 205/305 (67%)

Query:    15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVG 73
             R++  ++   T++++  LG GGFG VYKG+  + G  +AVK+L  + G    E+F+ EV 
Sbjct:   320 RYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGN--GEEFINEVA 377

Query:    74 TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTA 132
             ++ RT H+N+V L GFC++++  A++YE+M NGSLD Y+       +EWE+L+++A+G +
Sbjct:   378 SMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISANMSTKMEWERLYDVAVGIS 437

Query:   133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
             +GL YLH  C  RI+H+DIKP+N+L+D N  PK++DFGLAKLC    S +++   +GT G
Sbjct:   438 RGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFG 497

Query:   193 YSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIV---GSSESLDWFPKHVWEEYE 248
             Y APE  S N+  ++HK DVYS+GMV+ E++G +    V   GS+    +FP+ V++++E
Sbjct:   498 YIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYKDFE 557

Query:   249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP-PP 307
             K E+   I    I +++++ AK+L + ALWC+Q +P DRPPM  V++MLEG +E L  PP
Sbjct:   558 KGEI-TRIFGDSITDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQVPP 616

Query:   308 KPFRY 312
              P  +
Sbjct:   617 NPLLF 621

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 677 (243.4 bits), Expect = 1.3e-66, P = 1.3e-66
 Identities = 132/305 (43%), Positives = 206/305 (67%)

Query:    13 PVR-FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAE 71
             P++ +T  Q+   T +++  +G GGFG VY+G   +G  +AVKVL  + G  +E+ F+ E
Sbjct:   332 PLKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSED-FINE 390

Query:    72 VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIG 130
             V ++ +T H+N+V L GFC +    A++YE++ENGSLD ++  K   I +   L+ IA+G
Sbjct:   391 VSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTSVILDLTALYGIALG 450

Query:   131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
              A+GL YLH  C+ RI+H+DIKP+NVLLD N SPKV+DFGLAKLC++  S +++   +GT
Sbjct:   451 VARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGT 510

Query:   191 PGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGSSE---SLDWFPKHVWEE 246
              GY APE +S  Y  ++HK DVYS+GM++FE++G R+    G +    S  +FP+ ++++
Sbjct:   511 IGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKD 570

Query:   247 YEKSEL-DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
              EK++  D   +  GI  +++E AK++ +  LWC+Q SP DRPPM+ VV+M+EG ++ L 
Sbjct:   571 LEKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALE 630

Query:   306 -PPKP 309
              PP+P
Sbjct:   631 VPPRP 635

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 674 (242.3 bits), Expect = 2.8e-66, P = 2.8e-66
 Identities = 139/311 (44%), Positives = 201/311 (64%)

Query:     2 ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG 61
             + FL+ +    P+RF    L + T+N+S +LG GGFG VY+G  P+G ++AVK L   +G
Sbjct:   470 DNFLENLSG-MPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLE-GIG 527

Query:    62 RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA--- 118
             +  +++F AEV  IG  +H++LVRL GFC +     L YE++  GSL+ ++F KK     
Sbjct:   528 Q-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVL 586

Query:   119 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
             ++W+    IA+GTAKGL YLHE+C  RI+H DIKPEN+LLD NF+ KV+DFGLAKL  R 
Sbjct:   587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646

Query:   179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW 238
             +SHV  +  +GT GY APE+++ NY I+ K DVYS+GMVL E++G R+N     +     
Sbjct:   647 QSHV-FTTMRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCH 704

Query:   239 FPKHVWEEYEKSELDATILACGIEEKD--KEKAKRLCMAALWCVQDSPEDRPPMSAVVKM 296
             FP   +++ E+ +L   I+   ++  D   E+ +R    ALWC+Q+  + RP MS VV+M
Sbjct:   705 FPSFAFKKMEEGKL-MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQM 763

Query:   297 LEGVVEVLPPP 307
             LEGV  V+ PP
Sbjct:   764 LEGVFPVVQPP 774

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)]

 Score = 672 (241.6 bits), Expect = 4.5e-66, P = 4.5e-66
 Identities = 146/300 (48%), Positives = 190/300 (63%)

Query:    16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 75
             F+  +L N T N+S +LG GGFG V+KG  P+   IAVK L   + +  E+QF  EV TI
Sbjct:   483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLE-GISQ-GEKQFRTEVVTI 540

Query:    76 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF----GKKRAIEWEKLHEIAIGT 131
             G   H+NLVRL GFC +     LVY+YM NGSLD +LF     +K  + W+   +IA+GT
Sbjct:   541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600

Query:   132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
             A+GL YLH+EC+  IIH DIKPEN+LLD+ F PKVADFGLAKL  R+ S V ++  +GT 
Sbjct:   601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGTR 659

Query:   192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
             GY APE++SG   IT K DVYS+GM+LFE+V  RRN     +E + +FP        K  
Sbjct:   660 GYLAPEWISG-VAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDG 718

Query:   252 LDATILACGIEEK--DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKP 309
                +++   +E    D E+  R C  A WC+QD    RP MS VV++LEGV+EV PPP P
Sbjct:   719 DIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)]

 Score = 665 (239.2 bits), Expect = 2.5e-65, P = 2.5e-65
 Identities = 144/311 (46%), Positives = 188/311 (60%)

Query:     5 LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA 64
             L E     PV+FT  +L   T ++  +LG GGFG VY+G   N   +AVK L   + +  
Sbjct:   463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLE-GIEQ-G 520

Query:    65 EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA--IEWE 122
             E+QF  EV TI  T+H+NLVRL GFC       LVYE+M NGSLD +LF    A  + WE
Sbjct:   521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWE 580

Query:   123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
                 IA+GTAKG+ YLHEEC+  I+H DIKPEN+L+D NF+ KV+DFGLAKL +   +  
Sbjct:   581 YRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY 640

Query:   183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH 242
              +S  +GT GY APE+L+ N PIT K DVYS+GMVL E+V  +RN  V    +   F   
Sbjct:   641 NMSSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIW 699

Query:   243 VWEEYEKSELDATILACGIEEK---DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG 299
              +EE+EK    A IL   + E    D E+  R+   + WC+Q+ P  RP M  VV+MLEG
Sbjct:   700 AYEEFEKGNTKA-ILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG 758

Query:   300 VVEVLPP--PK 308
             + E+  P  PK
Sbjct:   759 ITEIKNPLCPK 769

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 665 (239.2 bits), Expect = 2.5e-65, P = 2.5e-65
 Identities = 131/304 (43%), Positives = 201/304 (66%)

Query:    13 PVR-FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAE 71
             P++ ++  Q+ + T +++  +G GGFG VY+G   +G  +AVKVL  + G    E F+ E
Sbjct:   334 PLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGN--GEDFINE 391

Query:    72 VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIG 130
             V ++ +T H+N+V L GFC + +  A++YE+MENGSLD ++  KK + ++W +L+ IA+G
Sbjct:   392 VASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKKSSTMDWRELYGIALG 451

Query:   131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
              A+GL YLH  C+ RI+H+DIKP+NVLLD N SPKV+DFGLAKLC+R  S +++   +GT
Sbjct:   452 VARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILSLMDTRGT 511

Query:   191 PGYSAPEFLSGNYP-ITHKCDVYSFGMVLFEIVGRRRNAIVG---SSESLDWFPKHVWEE 246
              GY APE  S  Y  ++HK DVYS+GM++ +I+G R         SS S  +FP+ ++ +
Sbjct:   512 IGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPEWIYRD 571

Query:   247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP- 305
              EK+    +I    I  ++ E AK++ +  LWC+Q  P DRP M+ VV+M+EG ++ L  
Sbjct:   572 LEKAHNGKSI-ETAISNEEDEIAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEGNLDALEV 630

Query:   306 PPKP 309
             PP+P
Sbjct:   631 PPRP 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 665 (239.2 bits), Expect = 2.5e-65, P = 2.5e-65
 Identities = 132/312 (42%), Positives = 203/312 (65%)

Query:    15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN--GVKIAVKVLNRNLGRIAEEQFMAEV 72
             R++  ++   T+++   +G GGFG VYKG+ P+  G  IA+K+L  + G    E+F+ E+
Sbjct:   508 RYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKESKGN--GEEFINEL 565

Query:    73 GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGT 131
              ++ R  H+N+V L+GFC++    A++YE+M NGSLD ++       IEW+ L+ IA+G 
Sbjct:   566 VSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKFISENMSTKIEWKTLYNIAVGV 625

Query:   132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
             A+GL YLH  C  +I+H+DIKP+N+L+D +  PK++DFGLAKLC +  S +++   +GT 
Sbjct:   626 ARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDARGTV 685

Query:   192 GYSAPEFLSGNYP-ITHKCDVYSFGMVLFEIVGRRRNAIVGSS---ESLDWFPKHVWEEY 247
             GY APE  S NY  ++HK DVYS+GMV+ E++G  +   V +S   +S  +FP  V+E+ 
Sbjct:   686 GYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSSMYFPDWVYEDL 745

Query:   248 EKSELDATILACGIEEKDKEK-AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV-VEVLP 305
             E+ E    +    IEE+++EK  KR+ +  LWC+Q +P DRPPM  VV+MLEG  +E L 
Sbjct:   746 ERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGSRLEALQ 805

Query:   306 -PPKPFRYLDLI 316
              PPKP   L ++
Sbjct:   806 VPPKPLLNLHVV 817

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
 Identities = 131/301 (43%), Positives = 197/301 (65%)

Query:    15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT 74
             +++  ++   T  +S  LG GGFG VY G   +G K+AVK+L ++     E+ F+ EV +
Sbjct:   310 QYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKIL-KDFKSNGED-FINEVAS 367

Query:    75 IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAK 133
             + +T H+N+V L GFC++    A+VYE++ENGSLD +L  KK   ++   L+ IA+G A+
Sbjct:   368 MSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLSEKKSLNLDVSTLYRIALGVAR 427

Query:   134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
             GL YLH  C+ RI+H+DIKP+N+LLD  F PKV+DFGLAKLC++  S +++   +GT GY
Sbjct:   428 GLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIGY 487

Query:   194 SAPEFLSGNYP-ITHKCDVYSFGMVLFEIVGRRRNAI---VGSSESLDWFPKHVWEEYEK 249
              APE  SG Y  ++HK DVYS+GM++ E++G +   I     S+ S  +FP  +++  E 
Sbjct:   488 IAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGAKNKEIEETAASNSSSAYFPDWIYKNLEN 547

Query:   250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP-PPK 308
              E D       I  +DKE AK++ +  LWC+Q SP +RPPM+ +V+M+EG ++VL  PPK
Sbjct:   548 GE-DTWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSLDVLEVPPK 606

Query:   309 P 309
             P
Sbjct:   607 P 607

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 652 (234.6 bits), Expect = 6.0e-64, P = 6.0e-64
 Identities = 133/304 (43%), Positives = 197/304 (64%)

Query:    16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 75
             +T  +L   T ++S  +G GGFG VY G   NG K+AVKVL ++L   AE+ F+ EV ++
Sbjct:   488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVL-KDLKGSAED-FINEVASM 545

Query:    76 GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE-WEKLHEIAIGTAKG 134
              +T H+N+V L GFC +    A+VYE++ENGSLD ++   K   +    L+ IA+G A+G
Sbjct:   546 SQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTLYGIALGIARG 605

Query:   135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS 194
             L YLH  C+ RI+H+DIKP+N+LLD N  PKV+DFGLAKLC++  S +++   +GT GY 
Sbjct:   606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665

Query:   195 APEFLSGNYP-ITHKCDVYSFGMVLFEIVGRRRNAIV---GSSESLDWFPKHVWEEYEKS 250
             APE  S  Y  ++HK DVYSFGM++ +++G R   IV    S+ S  +FP  ++++ E  
Sbjct:   666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDG 725

Query:   251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP-PPKP 309
             E    I    I +++KE AK++ +  LWC+Q  P DRP M+ VV+M+EG ++ L  PPKP
Sbjct:   726 E-QTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP 784

Query:   310 FRYL 313
               ++
Sbjct:   785 SMHI 788

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00032335001 SubName- Full=Chromosome chr4 scaffold_6, whole genome shotgun sequence; (353 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	356
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-54
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-47
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-40
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-31
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-31
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-27
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-26
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-19
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-07
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	9e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	7e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (451), Expect = 3e-54
 Identities = 72/192 (37%), Positives = 109/192 (56%), Gaps = 7/192 (3%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG GGFG VY  +    G K+A+K++ +       E+ + E+  + +  H N+V+LYG  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
            D++   LV EY E GSL   L   +  +  +++  I +   +GL YLH      IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117

Query: 151 IKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           +KPEN+LLD+ N   K+ADFGL+KL   ++S   +    GTP Y APE L G    + K 
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 210 DVYSFGMVLFEI 221
           D++S G++L+E+
Sbjct: 176 DIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (407), Expect = 4e-47
 Identities = 76/197 (38%), Positives = 108/197 (54%), Gaps = 8/197 (4%)

Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +LG G FG VYK +    G  +AVK+L  R+     ++    E+  + R  H N+VRL  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              D+    LV EY E G L  YL  +   +  ++  +IA+   +GL YLH      IIH
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHS---NGIIH 121

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+KPEN+LLD N   K+ADFGLAK   ++ S +T   + GTP Y APE L G      K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT--TFVGTPWYMAPEVLLGGNGYGPK 179

Query: 209 CDVYSFGMVLFEIVGRR 225
            DV+S G++L+E++  +
Sbjct: 180 VDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  157 bits (400), Expect = 4e-46
 Identities = 65/199 (32%), Positives = 99/199 (49%), Gaps = 18/199 (9%)

Query: 32  LGFGGFGEVYKGQ-----FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FGEVYKG+         V++AVK L  +      E+F+ E   + +  H N+V+L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C ++    +V EYME G L  YL   +  +    L   A+  A+G+ YL     +  
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES---KNF 123

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG---YKGTPGYSAPE-FLSGN 202
           IH D+   N L+  N   K++DFGL++    +  +    G    +    + APE    G 
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPESLKEGK 179

Query: 203 YPITHKCDVYSFGMVLFEI 221
           +  T K DV+SFG++L+EI
Sbjct: 180 F--TSKSDVWSFGVLLWEI 196

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  154 bits (391), Expect = 8e-45
 Identities = 79/276 (28%), Positives = 121/276 (43%), Gaps = 34/276 (12%)

Query: 32  LGFGGFGEVYKGQ-----FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FGEVYKG          V++AVK L  +      E+F+ E   + +  H N+V+L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
            G C ++    +V EYM  G L  YL   + + +    L   A+  A+G+ YL     + 
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KN 123

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG---YKGTPGYSAPE-FLSG 201
            IH D+   N L+  N   K++DFGL++    +  +    G    +    + APE    G
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKEG 179

Query: 202 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI 261
            +  T K DV+SFG++L+EI         G        P   +     +E+   +     
Sbjct: 180 KF--TSKSDVWSFGVLLWEIFTL------GEE------P---YPGMSNAEVLEYLKKGYR 222

Query: 262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
             K       L    L C  + PEDRP  S +V++L
Sbjct: 223 LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  151 bits (383), Expect = 1e-43
 Identities = 68/192 (35%), Positives = 98/192 (51%), Gaps = 9/192 (4%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G FG+VY  +    G  +A+KV+ +   +   E+ + E+  + +  H N+VRLY   
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
            D+    LV EY E G L   L  + R  E E            L YLH    + I+H D
Sbjct: 67  EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-ARFYLRQILSALEYLH---SKGIVHRD 122

Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD 210
           +KPEN+LLD +   K+ADFGLA+  D      T   + GTP Y APE L G        D
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVLLGK-GYGKAVD 178

Query: 211 VYSFGMVLFEIV 222
           ++S G++L+E++
Sbjct: 179 IWSLGVILYELL 190

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (365), Expect = 5e-41
 Identities = 82/282 (29%), Positives = 123/282 (43%), Gaps = 46/282 (16%)

Query: 32  LGFGGFGEVYKG-----QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FGEVYKG           K+AVK L         E+F+ E   + +  H N+VRL
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       +V EYM  G L  +L      +  + L ++A+  AKG+ YL     +  
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KNF 123

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   N L+  N   K++DFGL++    +  +    G K    + APE L  +   T
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK-DGKFT 182

Query: 207 HKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWF--------PKHVWEE-YEKSELDAT 255
            K DV+SFG++L+EI   G +    + + E L+          P++  +E YE       
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYE------- 235

Query: 256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
           ++               C A        PEDRP  S +V+ L
Sbjct: 236 LM-------------LQCWAY------DPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  141 bits (359), Expect = 5e-40
 Identities = 85/285 (29%), Positives = 124/285 (43%), Gaps = 43/285 (15%)

Query: 32  LGFGGFGEVYKGQF----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           LG G FGEVYKG+         ++AVK L  +      + F+ E   + +  H N+VRL 
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL--------FGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           G C ++    LV EYME G L  YL          +K  +  + L   AI  AKG+ YL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS----- 194
               ++ +H D+   N L+  +   K++DFGL++    +  +      K T G       
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----RKKTGGKLPIRWM 174

Query: 195 APE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
           APE    G +  T K DV+SFG++L+EI             +L   P   +      E+ 
Sbjct: 175 APESLKDGIF--TSKSDVWSFGVLLWEIF------------TLGATP---YPGLSNEEVL 217

Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
             +       K +     L    L C Q  PEDRP  S +V+ LE
Sbjct: 218 EYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 2e-32
 Identities = 76/218 (34%), Positives = 114/218 (52%), Gaps = 23/218 (10%)

Query: 7   EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE 66
           EI RE      SL+L         +LG G FGEV+ G +    K+AVK L    G ++ E
Sbjct: 2   EIPRE------SLKLER-------KLGAGQFGEVWMGTWNGTTKVAVKTLKP--GTMSPE 46

Query: 67  QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLH 125
            F+ E   + +  H  LV+LY  C ++    +V EYM  GSL  +L  G+ + +   +L 
Sbjct: 47  AFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV 106

Query: 126 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185
           ++A   A+G+ YL     +  IH D+   N+L+  N   K+ADFGLA+L + +  +    
Sbjct: 107 DMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTARE 162

Query: 186 GYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
           G K    ++APE    G + I  K DV+SFG++L EIV
Sbjct: 163 GAKFPIKWTAPEAANYGRFTI--KSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  119 bits (301), Expect = 1e-31
 Identities = 76/239 (31%), Positives = 107/239 (44%), Gaps = 38/239 (15%)

Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMA---EVGTIGRTYHINLVRLY 87
           LG G FG VY       G  +AVK +   L   +EE+  A   E+  +    H N+VR Y
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVE--LSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 88  GFCHD-QHMTALVY-EYMENGSLDGYL--FGKKRAIEWEKLHEIAIGT-----AKGLVYL 138
           G   D +  T  ++ EY+  GSL   L  FGK        L E  I        +GL YL
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--------LPEPVIRKYTRQILEGLAYL 117

Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
           H      I+H DIK  N+L+D++   K+ADFG AK      +       +GTP + APE 
Sbjct: 118 HS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 199 LSGNYPITHKCDVYSFGMVLFEIV-GRR-----RNAI-----VGSSESLDWFPKHVWEE 246
           + G        D++S G  + E+  G+       N +     +GSS      P+H+ EE
Sbjct: 175 IRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEE 232

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  118 bits (298), Expect = 2e-31
 Identities = 78/271 (28%), Positives = 130/271 (47%), Gaps = 24/271 (8%)

Query: 28  YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
               +G G FG V+ G +    K+A+K +    G ++EE F+ E   + +  H  LV+LY
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C ++    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL       +I
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPIT 206
           H D+   N L+  N   KV+DFG+ +    +  + + +G K    +S+PE  S   Y  +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFSKY--S 179

Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++++E+           SE      K  +E    SE+  TI A     K +
Sbjct: 180 SKSDVWSFGVLMWEVF----------SEG-----KTPYENRSNSEVVETINAGFRLYKPR 224

Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
             ++ +      C ++ PEDRP  S ++  L
Sbjct: 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 2e-31
 Identities = 70/202 (34%), Positives = 101/202 (50%), Gaps = 14/202 (6%)

Query: 32  LGFGGFGEVYKGQF-PNG--VKI--AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G  VKI  A+KVL       A ++ + E   +    H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C    +  L+ + M  G L  Y+   K  I  + L    +  AKG+ YL E   +R+
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPI 205
           +H D+   NVL+      K+ DFGLAKL D +       G K    + A E  L   Y  
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY-- 188

Query: 206 THKCDVYSFGMVLFEIV--GRR 225
           THK DV+S+G+ ++E++  G +
Sbjct: 189 THKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 6e-31
 Identities = 66/191 (34%), Positives = 96/191 (50%), Gaps = 13/191 (6%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           +G G FG+V  G +  G K+AVK L  +    A + F+AE   +    H NLV+L G   
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
             +   +V EYM  GSL  YL  + RA I   +    A+   +G+ YL E   +  +H D
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127

Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD 210
           +   NVL+  +   KV+DFGLAK      +       K    ++APE L      + K D
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREK-KFSTKSD 181

Query: 211 VYSFGMVLFEI 221
           V+SFG++L+EI
Sbjct: 182 VWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (294), Expect = 1e-30
 Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 9/193 (4%)

Query: 30  TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
             LG G  G VYK +  P G   A+K ++ +      +Q + E+ T+       +V+ YG
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             + +   ++V EYM+ GSL   L  K   I    L  IA    KGL YLH   ++ IIH
Sbjct: 67  AFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIH 123

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            DIKP N+L+++    K+ADFG++K+ + N      + + GT  Y +PE     +Y   +
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLE-NTLDQCNT-FVGTVTYMSPERIQGESYS--Y 179

Query: 208 KCDVYSFGMVLFE 220
             D++S G+ L E
Sbjct: 180 AADIWSLGLTLLE 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 5e-30
 Identities = 71/199 (35%), Positives = 104/199 (52%), Gaps = 20/199 (10%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV++G + N   +AVK L    G +  + F+AE   + +  H  L++LY  C
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             +    +V E M+ GSL  YL G   RA++  +L ++A   A G+ YL     Q  IH 
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLSGNY 203
           D+   NVL+  N   KVADFGLA++   +        Y+   G      ++APE    N 
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDI-------YEAREGAKFPIKWTAPEAALYN- 179

Query: 204 PITHKCDVYSFGMVLFEIV 222
             + K DV+SFG++L EIV
Sbjct: 180 RFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  115 bits (289), Expect = 3e-29
 Identities = 87/277 (31%), Positives = 126/277 (45%), Gaps = 23/277 (8%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYH-INLVRLYG 88
           LG G FGEVY  +  +   +A+KVL + L       E+F+ E+  +    H  N+V+LY 
Sbjct: 8   LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 89  FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           F  D+    LV EY++ GSL+  L   G+K  +   +   I       L YLH    + I
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122

Query: 147 IHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTI----SGYKGTPGYSAPEFLSG 201
           IH DIKPEN+LLD +    K+ DFGLAKL     S  +I    S   GTPGY APE L G
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 202 NY--PITHKCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA 258
                 +   D++S G+ L+E++ G        +S +     K + E    S        
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP- 241

Query: 259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
               E   + A  L       +   P++R   S+ + 
Sbjct: 242 -SNPELISKAASDLLKK---LLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  110 bits (278), Expect = 2e-28
 Identities = 61/193 (31%), Positives = 99/193 (51%), Gaps = 13/193 (6%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 88
           ++G GGFGEVYK +    G ++A+KV+        +E+ + E+  + +  H N+V+ YG 
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE-KKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 89  -FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
               D+    +V E+   GSL   L    + +   ++  +     KGL YLH      II
Sbjct: 66  YLKKDELW--IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGII 120

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DIK  N+LL ++   K+ DFGL+      ++  T+    GTP + APE ++G  P  +
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGK-PYDY 176

Query: 208 KCDVYSFGMVLFE 220
           K D++S G+   E
Sbjct: 177 KADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 3e-28
 Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 13/193 (6%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FG V+ G++   + +A+K++    G ++E+ F+ E   + +  H NLV+LYG C 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            Q    +V EYM NG L  YL  +K  +  E L ++     + + YL        IH D+
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126

Query: 152 KPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
              N L+  +   KV+DFGLA+  L D+  S     G K    ++ PE F    +  + K
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ---GTKFPVKWAPPEVFDYSRF--SSK 181

Query: 209 CDVYSFGMVLFEI 221
            DV+SFG++++E+
Sbjct: 182 SDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  109 bits (275), Expect = 4e-28
 Identities = 67/197 (34%), Positives = 108/197 (54%), Gaps = 12/197 (6%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV++G + N V++A+K+L  +     ++ F  EV  + R  H +L+ L+  C
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD-FQKEVQALKRLRHKHLISLFAVC 71

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                  ++ E ME GSL  +L   + + +    L ++A   A+G+ YL E   Q  IH 
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHR 128

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLS-GNYPITH 207
           D+   N+L+  +   KVADFGLA+L    +  V +S  K  P  ++APE  S G +  + 
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLI---KEDVYLSSDKKIPYKWTAPEAASHGTF--ST 183

Query: 208 KCDVYSFGMVLFEIVGR 224
           K DV+SFG++L+E+   
Sbjct: 184 KSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  110 bits (277), Expect = 5e-28
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)

Query: 28  YSTRLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG+V   ++       G ++AVK LN +        F  E+  +    H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 83  LVRLYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C      +  L+ EY+ +GSL  YL   +  I  ++L   +    KG+ YL  
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-YSAPEFL 199
              QR IH D+   N+L+++    K++DFGLAK+   ++ +  +     +P  + APE L
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
                 +   DV+SFG+ L+E+
Sbjct: 185 R-TSKFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 4e-27
 Identities = 62/195 (31%), Positives = 100/195 (51%), Gaps = 10/195 (5%)

Query: 32  LGFGGFGEVYKG--QFPNG--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV +G  + P    + +A+K L           F+ E   +G+  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         ++ EYMENGSLD +L          +L  +  G A G+ YL E      +
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YV 128

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI-T 206
           H D+   N+L+++N   KV+DFGL++  + + +  T  G K    ++APE ++  Y   T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA--YRKFT 186

Query: 207 HKCDVYSFGMVLFEI 221
              DV+SFG+V++E+
Sbjct: 187 SASDVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 6e-27
 Identities = 79/276 (28%), Positives = 128/276 (46%), Gaps = 35/276 (12%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 89
           ++G G FG+VYKG      ++AVK     L    + +F+ E   I + Y H N+V+L G 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQE-AEILKQYDHPNIVKLIGV 60

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
           C  +    +V E +  GSL  +L  KK  +  +KL ++++  A G+ YL  +     IH 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLS-GNYPITH 207
           D+   N L+  N   K++DFG+++  +     V+  G K  P  ++APE L+ G Y  T 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-DGLKQIPIKWTAPEALNYGRY--TS 174

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
           + DV+S+G++L+E              SL   P       +  E         IE   + 
Sbjct: 175 ESDVWSYGILLWETF------------SLGDTPYPGMSNQQTRER--------IESGYRM 214

Query: 268 KAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLE 298
            A +LC   ++     C    PE+RP  S +   L+
Sbjct: 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  105 bits (263), Expect = 2e-26
 Identities = 72/196 (36%), Positives = 110/196 (56%), Gaps = 15/196 (7%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    K+A+K L +  G ++ E F+AE   + +  H  LVRLY   
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++    ++  I
Sbjct: 71  -TQEPIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKNYI 124

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPIT 206
           H D++  N+L+      K+ADFGLA+L + N  +    G K    ++APE ++ G + I 
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTI- 182

Query: 207 HKCDVYSFGMVLFEIV 222
            K DV+SFG++L EIV
Sbjct: 183 -KSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  105 bits (265), Expect = 2e-26
 Identities = 69/206 (33%), Positives = 93/206 (45%), Gaps = 24/206 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           RLG G  G V K +  N   I A+K +  +     ++Q + E+          +V+ YG 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 90  CHDQH--MTALVYEYMENGSLDGYL--FGKKRAIEWEK-LHEIAIGTAKGLVYLHEECQQ 144
             D+      +  EY E GSLD       K+     EK L +IA    KGL YLH    +
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---R 124

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG----YKGTPGYSAPEFLS 200
           +IIH DIKP N+LL           G  KLCD   S   ++     + GT  Y APE + 
Sbjct: 125 KIIHRDIKPSNILLTRK--------GQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ 176

Query: 201 G-NYPITHKCDVYSFGMVLFEIVGRR 225
           G  Y IT   DV+S G+ L E+   R
Sbjct: 177 GKPYSIT--SDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 3e-26
 Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 29/201 (14%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLY 87
           +G G FG VYKG     G  +A+K ++    +I EE     M E+  +    H N+V+  
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLE--KIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHE--IAIGTA---KGLVYLHE 140
           G         ++ EY ENGSL   +  FG           E  +A+      +GL YLHE
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGP--------FPESLVAVYVYQVLQGLAYLHE 117

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFL 199
              Q +IH DIK  N+L   +   K+ADFG+A KL   N      +   GTP + APE +
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVATKL---NDVSKDDASVVGTPYWMAPEVI 171

Query: 200 SGNYPITHKCDVYSFGMVLFE 220
             +   +   D++S G  + E
Sbjct: 172 EMS-GASTASDIWSLGCTVIE 191

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  104 bits (261), Expect = 5e-26
 Identities = 65/198 (32%), Positives = 105/198 (53%), Gaps = 15/198 (7%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G  G V K    P G  +AVK +   +    ++Q + E+  + +     +V  YG  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
           ++    ++  EYM+ GSLD  L   +  I    L +IA+   KGL YLHE  + +IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRD 126

Query: 151 IKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISG-YKGTPGYSAPEFLSGN-YPITH 207
           +KP N+L+++    K+ DFG++ +L +      +++  + GT  Y APE + GN Y +  
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVN------SLAKTFVGTSSYMAPERIQGNDYSV-- 178

Query: 208 KCDVYSFGMVLFEI-VGR 224
           K D++S G+ L E+  GR
Sbjct: 179 KSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  100 bits (251), Expect = 1e-24
 Identities = 66/194 (34%), Positives = 107/194 (55%), Gaps = 10/194 (5%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G + N  K+AVK L    G ++ + F+ E   +    H  LVRLY   
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             +    ++ EYM  GSL  +L   +   +   KL + +   A+G+ Y+    ++  IH 
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPITHK 208
           D++  NVL+  +   K+ADFGLA++ + N  +    G K    ++APE ++ G++ I  K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTI--K 184

Query: 209 CDVYSFGMVLFEIV 222
            DV+SFG++L+EIV
Sbjct: 185 SDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  100 bits (251), Expect = 1e-24
 Identities = 84/270 (31%), Positives = 131/270 (48%), Gaps = 26/270 (9%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    K+AVK L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 91  HDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L  G+ RA++   L ++A   A G+ Y+    +   IH 
Sbjct: 71  SEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+      K+ADFGLA+L + N  +    G K    ++APE  L G + I  K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 183

Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV+SFG++L E+V + R    G +       + V E+ E+         C I   +   
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYRMPCPQDCPISLHE--- 234

Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                   L C +  PE+RP    +   LE
Sbjct: 235 ------LMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 98.4 bits (246), Expect = 6e-24
 Identities = 70/204 (34%), Positives = 99/204 (48%), Gaps = 25/204 (12%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRL-Y 87
           LG G FG+V   +  + G   A+KVL   + + R   E  + E   + R  H  +V+L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
            F   +    LV EY   G L  +L     F ++RA  +    EI +     L YLH   
Sbjct: 61  AF-QTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLA----LEYLHS-- 111

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSG 201
              II+ D+KPEN+LLDA+   K+ DFGLAK L          + + GTP Y APE L G
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNTFCGTPEYLAPEVLLG 167

Query: 202 NYPITHKCDVYSFGMVLFE-IVGR 224
                   D +S G++L+E + G+
Sbjct: 168 K-GYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.4 bits (242), Expect = 2e-23
 Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)

Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV++G         V +A+K L         + F++E   +G+  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         ++ EYMENG+LD YL          +L  +  G A G+ YL +      +
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYV 129

Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D      T SG K    ++APE ++     T
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFT 188

Query: 207 HKCDVYSFGMVLFEIV 222
              DV+SFG+V++E++
Sbjct: 189 SASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 96.8 bits (242), Expect = 3e-23
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 25/201 (12%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 88
           +G G FG+VY  +   +G    +K ++  N+     E  + EV  + +  H N+++ Y  
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG-----TAKGLVYLHEECQ 143
           F     +  +V EY + G L   +  KK+  E +   E  I          L YLH    
Sbjct: 68  FEEKGKL-CIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKYLHS--- 121

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKL----CDRNRSHVTISGYKGTPGYSAPEFL 199
           ++I+H DIKP+N+ L +N   K+ DFG++K+     D  ++ V      GTP Y +PE  
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV------GTPYYLSPELC 175

Query: 200 SGNYPITHKCDVYSFGMVLFE 220
             N P  +K D++S G VL+E
Sbjct: 176 Q-NKPYNYKSDIWSLGCVLYE 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 96.1 bits (239), Expect = 5e-23
 Identities = 62/191 (32%), Positives = 102/191 (53%), Gaps = 9/191 (4%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FG V+ G++   +K+A+K +N   G ++EE F+ E   + +  H  LV+LYG C 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            Q    +V E+MENG L  YL  ++  +  + L  +     +G+ YL    +   IH D+
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDL 126

Query: 152 KPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCD 210
              N L+ +    KV+DFG+ +    +  + + SG K    +S PE F    Y  + K D
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY--SSKSD 183

Query: 211 VYSFGMVLFEI 221
           V+SFG++++E+
Sbjct: 184 VWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 95.9 bits (239), Expect = 6e-23
 Identities = 74/275 (26%), Positives = 118/275 (42%), Gaps = 29/275 (10%)

Query: 31  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           +LG G FG V +G++    G  + +AVK L  +      + F+ E   +    H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 87  YGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           YG      +  +V E    GSL D              L + A+  A G+ YL     +R
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYP 204
            IH D+   N+LL ++   K+ DFGL +   +N  H  +  +   P  + APE L     
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR-TRT 176

Query: 205 ITHKCDVYSFGMVLFEIVGRRRNAIVG--SSESLDWFPKHVWEEYEKSELDATILACGIE 262
            +H  DV+ FG+ L+E+         G   S+ L    K + +E E+             
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL----KKIDKEGERL------------ 220

Query: 263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
           E+ +   + +    L C   +P DRP  +A+ + L
Sbjct: 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 96.0 bits (239), Expect = 8e-23
 Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 48/291 (16%)

Query: 32  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V+ G+  +         +AVK L       A + F  E   +    H N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFG-------------KKRAIEWEKLHEIAIGTA 132
            YG C +     +V+EYME+G L+ +L                   +   +L +IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKG 189
            G+VYL     Q  +H D+   N L+  +   K+ DFG+++     D  R    + G+  
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR----VGGHTM 185

Query: 190 TP-GYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY 247
            P  +  PE  +   +  T + DV+SFG+VL+EI                 + K  W   
Sbjct: 186 LPIRWMPPESIMYRKF--TTESDVWSFGVVLWEIFT---------------YGKQPWYGL 228

Query: 248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
              E+   I    + ++ +     +    L C +  P+ R  +  + + L+
Sbjct: 229 SNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.1 bits (237), Expect = 1e-22
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLN------RNLGRIAEEQFMAEVGTIGRTYHINLV 84
           +G G FG+VY       G  +AVK +       + +  IA+E     +  +    H NLV
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADE-----MKVLELLKHPNLV 62

Query: 85  RLYGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-LHEIAIGTAKGLVYLHEEC 142
           + YG   H + +  +  EY   G+L+  L   +  I  E  +    +   +GL YLH   
Sbjct: 63  KYYGVEVHREKVY-IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHS-- 117

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN--RSHVTISGYKGTPGYSAPEFLS 200
              I+H DIKP N+ LD N   K+ DFG A     N       +    GTP Y APE ++
Sbjct: 118 -HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 201 GNYPITH--KCDVYSFGMVLFEIV-GRR 225
           G     H    D++S G V+ E+  G+R
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.6 bits (235), Expect = 2e-22
 Identities = 65/192 (33%), Positives = 101/192 (52%), Gaps = 11/192 (5%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FG V  G++     +A+K++    G ++E++F+ E   + +  H  LV+LYG C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            Q    +V EYM NG L  YL    +  +  +L E+     +G+ YL  E +Q  IH D+
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL--ESKQ-FIHRDL 126

Query: 152 KPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
              N L+D     KV+DFGL++  L D   S V   G K    +S PE L      + K 
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLL-YSKFSSKS 182

Query: 210 DVYSFGMVLFEI 221
           DV++FG++++E+
Sbjct: 183 DVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 94.3 bits (234), Expect = 2e-22
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 26/270 (9%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+   +    K+AVK +    G ++ E F+AE   +    H  LV+L+   
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             + +  ++ E+M  GSL  +L   +       KL + +   A+G+ ++    Q+  IH 
Sbjct: 71  TKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 126

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHK 208
           D++  N+L+ A+   K+ADFGLA++ + N  +    G K    ++APE +  N+   T K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFTIK 183

Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV+SFG++L EIV   R    G S         V    E+         C  E  +   
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALERGYRMPRPENCPEELYN--- 234

Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                   + C ++ PE+RP    +  +L+
Sbjct: 235 ------IMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 94.2 bits (235), Expect = 4e-22
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 43/221 (19%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR------TYHINLV 84
           +G G F  V   +      + A+K+L++   ++ +E+ +  V  I +        H  ++
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYV-KIEKEVLTRLNGHPGII 65

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIAIGTAKGLVYLH 139
           +LY    D+     V EY  NG L  Y+  +K     EK       EI +     L YLH
Sbjct: 66  KLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLA----LEYLH 119

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG------------- 186
               + IIH D+KPEN+LLD +   K+ DFG AK+ D N S  +  G             
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 187 -----YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
                + GT  Y +PE L+   P     D+++ G ++++++
Sbjct: 177 RRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQML 216

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 93.2 bits (231), Expect = 6e-22
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 11/198 (5%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 91  HDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 71  SEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 183

Query: 209 CDVYSFGMVLFEIVGRRR 226
            DV+SFG++L E+  + R
Sbjct: 184 SDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 93.6 bits (232), Expect = 9e-22
 Identities = 66/196 (33%), Positives = 102/196 (52%), Gaps = 10/196 (5%)

Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K+LN   G  A  +FM E   +    H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C    +  LV + M +G L  Y+   K  I  + L    +  AKG++YL E   +R+
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 130

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+ +    K+ DFGLA+L + +       G K    + A E +      T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFT 189

Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 190 HQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 11/195 (5%)

Query: 30  TRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
            ++G G  GEVYK      G ++A+K +   L +  +E  + E+  +    H N+V  Y 
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
                    +V EYM+ GSL   +      +   ++  +     +GL YLH    Q +IH
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIH 139

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITH 207
            DIK +N+LL  + S K+ADFG A    + +S   ++    GTP + APE +        
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---GTPYWMAPEVIKRK-DYGP 195

Query: 208 KCDVYSFGMVLFEIV 222
           K D++S G++  E+ 
Sbjct: 196 KVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 14/201 (6%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAV-KVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
            +G G FG V K +  +  KI V K ++  N+    ++Q ++EV  +    H N+VR Y 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 89  FCHD--QHMTALVYEYMENGSLDGYLFGKKRA----IEWEKLHEIAIGTAKGLVYLH--E 140
              D       +V EY E G L   L  K +     IE E +  I       L   H   
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
           +    ++H D+KP N+ LDAN + K+ DFGLAK+   + S      Y GTP Y +PE L+
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA--KTYVGTPYYMSPEQLN 183

Query: 201 GNYPITHKCDVYSFGMVLFEI 221
                  K D++S G +++E+
Sbjct: 184 HM-SYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 91.7 bits (227), Expect = 2e-21
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 11/198 (5%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    K+A+K L    G +  E F+ E   + +  H  LV LY   
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 91  HDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V E+M  GSL  +L  G  + ++  +L ++A   A G+ Y+    +   IH 
Sbjct: 71  SEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   K+ADFGLA+L + N  +    G K    ++APE  L G + I  K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 183

Query: 209 CDVYSFGMVLFEIVGRRR 226
            DV+SFG++L E+V + R
Sbjct: 184 SDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.9 bits (228), Expect = 2e-21
 Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 11/198 (5%)

Query: 32  LGFGGFGEVYKGQF-PNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV +G+    G +   +A+K L           F++E   +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         ++ E+MENG+LD +L          +L  +  G A G+ YL E      +
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYV 128

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS---GYKGTPGYSAPEFLSGNYP 204
           H D+   N+L+++N   KV+DFGL++  + + S  T +   G K    ++APE ++    
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-K 187

Query: 205 ITHKCDVYSFGMVLFEIV 222
            T   DV+S+G+V++E++
Sbjct: 188 FTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 90.4 bits (224), Expect = 5e-21
 Identities = 59/191 (30%), Positives = 103/191 (53%), Gaps = 9/191 (4%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FGEV+KG   +   +AVK    +L +  + +F++E   + +  H N+V+L G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            +    +V E +  G    +L  KK  ++ ++L + A+  A G+ YL     +  IH D+
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDL 119

Query: 152 KPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLS-GNYPITHKC 209
              N L+  N   K++DFG+++    +    + SG K  P  ++APE L+ G Y  + + 
Sbjct: 120 AARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRY--SSES 175

Query: 210 DVYSFGMVLFE 220
           DV+S+G++L+E
Sbjct: 176 DVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.6 bits (225), Expect = 6e-21
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 13/195 (6%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           LG G +G VYK +   +    A+K ++  ++ +   E  + E+  +    H N++     
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 90  CHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
             D +   +V EY   G L   +     K++ I  +++  I I   +GL  LHE   Q+I
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKI 124

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+K  N+LL AN   K+ D G++K+  +N +   I    GTP Y APE   G  P +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGR-PYS 179

Query: 207 HKCDVYSFGMVLFEI 221
           +K D++S G +L+E+
Sbjct: 180 YKSDIWSLGCLLYEM 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 90.0 bits (223), Expect = 1e-20
 Identities = 77/282 (27%), Positives = 130/282 (46%), Gaps = 38/282 (13%)

Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G+        + +A+K L           F++E   +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI--GTAKGLVYLHEECQQR 145
           G         +V EYMENGSLD +L  +K   ++  +  + +  G A G+ YL +     
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYLSD---MG 126

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
            +H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    ++APE ++    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-K 185

Query: 205 ITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEK 264
            T   DV+S+G+V++E+              + +  +  WE   +  + A      IEE 
Sbjct: 186 FTSASDVWSYGIVMWEV--------------MSYGERPYWEMSNQDVIKA------IEEG 225

Query: 265 DKEKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
            +  A   C AAL      C Q    +RP    +V +L+ ++
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 89.1 bits (221), Expect = 2e-20
 Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 9/193 (4%)

Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    R  +    L  +A   +  + YL    ++  IH
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L     ++   +G K    ++APE L+ N   + K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIK 185

Query: 209 CDVYSFGMVLFEI 221
            DV++FG++L+EI
Sbjct: 186 SDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 21/204 (10%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLY 87
           LG G FG+VYK Q    G+  A K++       +EE+   FM E+  +    H N+V LY
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLY 68

Query: 88  -GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
             + ++  +  L+ E+ + G+LD  +   +R +   ++  +     + L +LH     ++
Sbjct: 69  EAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKV 124

Query: 147 IHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFL----SG 201
           IH D+K  N+LL  +   K+ADFG+ AK     +   T   + GTP + APE +      
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACETFK 181

Query: 202 NYPITHKCDVYSFGMVLFEIVGRR 225
           + P  +K D++S G+ L E+    
Sbjct: 182 DNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 88.6 bits (220), Expect = 3e-20
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 23/203 (11%)

Query: 31  RLGFGGFGEVYKG--QFPNG--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            LG G FG V KG     +G  V++AVK L +      +++F+ E   + +  H  +VRL
Sbjct: 2   ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C  + +  LV E    G L  YL  K+R I    L E+A   A G+ YL     +  
Sbjct: 62  IGVCKGEPLM-LVMELAPLGPLLKYLK-KRREIPVSDLKELAHQVAMGMAYLES---KHF 116

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLS 200
           +H D+   NVLL      K++DFG+++       +     Y+ T        + APE   
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-----YRATTAGRWPLKWYAPE--C 169

Query: 201 GNYPI-THKCDVYSFGMVLFEIV 222
            NY   + K DV+S+G+ L+E  
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 88.3 bits (219), Expect = 4e-20
 Identities = 76/282 (26%), Positives = 118/282 (41%), Gaps = 38/282 (13%)

Query: 32  LGFGGFGEVYKGQFPNGVK--IAVK---VLNRNLGRIAEEQ------FMAEVGTIGRT-Y 79
           LG G FG VYK +  N  +  +A+K   V N   G+   E+       ++EV  I     
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFG----KKRAIEWEKLHEIAIGTAKGL 135
           H N+VR Y    +     +V + +E   L G  F     KK+    E++  I +     L
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPL-GEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
            YLH+E  +RI+H D+ P N++L  +    + DFGLAK         ++    GT  YS 
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTILYSC 181

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT 255
           PE +  N P   K DV++FG +L+++          S+  L    K V   YE       
Sbjct: 182 PEIVK-NEPYGEKADVWAFGCILYQMC--TLQPPFYSTNMLSLATKIVEAVYEPL----- 233

Query: 256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
                    +   ++ +      C+    E RP +  V  M+
Sbjct: 234 --------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.2 bits (219), Expect = 4e-20
 Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 14/198 (7%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G    VY     PN  K+A+K ++    + + ++   EV  + +  H N+V+ Y   
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQQR 145
                  LV  Y+  GSL   +   K +     L E  I T      KGL YLH      
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIM---KSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122

Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCD-RNRSHVTISGYKGTPGYSAPEFLSGNY 203
            IH DIK  N+LL  + S K+ADFG+ A L D  +R+      + GTP + APE +   +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 204 PITHKCDVYSFGMVLFEI 221
               K D++SFG+   E+
Sbjct: 183 GYDFKADIWSFGITAIEL 200

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 87.5 bits (217), Expect = 6e-20
 Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 12/196 (6%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVK----VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY+G    +G   AVK      +   G+ A +Q   E+  + +  H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G   ++    +  E +  GSL   L  K  +     +         GL YLH+   +  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHD---RNT 123

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H DIK  N+L+D N   K+ADFG+AK             +KG+P + APE ++      
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 207 HKCDVYSFGMVLFEIV 222
              D++S G  + E+ 
Sbjct: 181 LAADIWSLGCTVLEMA 196

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 87.3 bits (217), Expect = 6e-20
 Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 20/196 (10%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G +G VYK      G  +A+KV+      +  ++ + E+  + +     +V+ YG  
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVE-EDL--QEIIKEISILKQCDSPYIVKYYGSY 67

Query: 91  HDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAI---GTAKGLVYLHEECQQRI 146
                  +V EY   GS  D      K   E     EIA     T KGL YLH     + 
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKTLTE----EEIAAILYQTLKGLEYLH---SNKK 120

Query: 147 IHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           IH DIK  N+LL+     K+ADFG++ +L D      T+    GTP + APE +      
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI---GTPFWMAPEVIQEI-GY 176

Query: 206 THKCDVYSFGMVLFEI 221
            +K D++S G+   E+
Sbjct: 177 NNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 68/208 (32%), Positives = 97/208 (46%), Gaps = 25/208 (12%)

Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+G +         +++AVK L  +     E  F+ E   + +  H N+VR
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYL------FGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           L G   ++    ++ E M  G L  +L        +  ++  + L   A   AKG  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 140 EECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNRSHVTISGYKGTP-GYS 194
           E      IH DI   N LL     P    K+ADFG+A+   R  S+    G    P  + 
Sbjct: 134 E---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRA-SYYRKGGRAMLPIKWM 188

Query: 195 APE-FLSGNYPITHKCDVYSFGMVLFEI 221
            PE FL G +  T K DV+SFG++L+EI
Sbjct: 189 PPEAFLDGIF--TSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 2e-19
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 33/218 (15%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRI--AEEQF----MAEVGTIGRTYHINL 83
           +LG G +G VYK +    G  +A+K +     R+   EE      + E+  +    H N+
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI-----RLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
           V+L    H +    LV+EY +   L  YL  +   +    +  I     +GL Y H    
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEFLS 200
            RI+H D+KP+N+L++ +   K+ADFGLA+      R  +H  +     T  Y APE L 
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLWYRAPEILL 171

Query: 201 G----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
           G    +  +    D++S G +  E++   +    G SE
Sbjct: 172 GSKHYSTAV----DIWSVGCIFAEMI-TGKPLFPGDSE 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)

Query: 32  LGFGGFGEVYKG---QFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGR--TYHINL 83
           LG G FG VY+G       G    ++A+K +N N       +F+ E   +     +H+  
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV-- 71

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------RAIEWEKLHEIAIGTAKG 134
           VRL G       T +V E M  G L  YL  ++              +K  ++A   A G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY--KGTPG 192
           + YL     ++ +H D+   N ++  + + K+ DFG+ +        +  + Y  KG  G
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRD-------IYETDYYRKGGKG 181

Query: 193 -----YSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
                + APE L      T K DV+SFG+VL+E+ 
Sbjct: 182 LLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 72/267 (26%), Positives = 121/267 (45%), Gaps = 32/267 (11%)

Query: 28  YSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           Y   LG G  G VYK       +I AVKV+  ++    ++Q M+E+  + +     ++  
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG    ++  ++  E+M+ GSLD Y     R I    L  IA+   KGL YL      +I
Sbjct: 65  YGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYL---WSLKI 116

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+KP N+L++     K+ DFG++        +     Y GT  Y APE +SG     
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERISGEQYGI 172

Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEK-- 264
           H  DV+S G+   E+             +L  FP    ++ + S +   +L C ++E   
Sbjct: 173 HS-DVWSLGISFMEL-------------ALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218

Query: 265 ---DKEKAKRLCMAALWCVQDSPEDRP 288
                + +++       C++  P++RP
Sbjct: 219 VLPVGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 8/197 (4%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  R       +  + E+  +    H N+++L  
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +    LV+E+M+   L   +  ++R +    +        +GL + H      I+H
Sbjct: 66  VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+KPEN+L++     K+ADFGLA+           + Y  T  Y APE L G+   +  
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFG--SPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 209 CDVYSFGMVLFEIVGRR 225
            D++S G +  E++ RR
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 85.7 bits (212), Expect = 3e-19
 Identities = 82/284 (28%), Positives = 119/284 (41%), Gaps = 48/284 (16%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLN--RNLGRIAE---EQFMAEVGTIGRTYHINLVR 85
           LG G F   Y+ +    G  +AVK +   RN     E   E    E+  + R  H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 86  LYG-FCHDQHMTALVYEYMENGSLDGYL--FGK-KRAIEWEKLHEIAIGTAKGLVYLHEE 141
           + G  C D H    V E+M  GS+   L  +G  K A+      ++     +GL YLHE 
Sbjct: 68  MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHE- 121

Query: 142 CQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISG-----YKGTPGYSA 195
              +IIH D+K  N+L+D+     ++ADFG A    R  +  T +G       GT  + A
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAA---RLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT 255
           PE L G       CDV+S G V+ E+                   K  W   + S   A 
Sbjct: 177 PEVLRGE-QYGRSCDVWSVGCVIIEMAT----------------AKPPWNAEKHSNHLAL 219

Query: 256 I--LACGIEEKDKEKAKR--LCMAALWCVQDSPEDRPPMSAVVK 295
           I  +A         +     L    L C++  PEDRPP   ++K
Sbjct: 220 IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 86.0 bits (214), Expect = 3e-19
 Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 16/198 (8%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYG 88
           +LG G FG VY  +    G  +A+K + +      E   + EV ++ +   H N+V+L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              +      V+EYME          K +      +  I     +GL ++H   +    H
Sbjct: 66  VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFH 122

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL--SGNY--P 204
            D+KPEN+L+      K+ADFGLA+   R+R   T   Y  T  Y APE L  S +Y  P
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYT--DYVSTRWYRAPEILLRSTSYSSP 179

Query: 205 ITHKCDVYSFGMVLFEIV 222
           +    D+++ G ++ E+ 
Sbjct: 180 V----DIWALGCIMAELY 193

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.4 bits (219), Expect = 4e-19
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 35/276 (12%)

Query: 35  GGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ 93
           G  G  YKG+   NG++  VK +N ++  I      +E+  +G+  H N+V+L G C  +
Sbjct: 701 GKKGASYKGKSIKNGMQFVVKEIN-DVNSIPS----SEIADMGKLQHPNIVKLIGLCRSE 755

Query: 94  HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153
               L++EY+E  +L   L    R + WE+  +IAIG AK L +LH  C   ++  ++ P
Sbjct: 756 KGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811

Query: 154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           E +++D    P +       LC   +  +       +  Y APE       IT K D+Y 
Sbjct: 812 EKIIIDGKDEPHLRLSLPGLLCTDTKCFI-------SSAYVAPE-TRETKDITEKSDIYG 863

Query: 214 FGMVLFEIVGRR--RNAIVGSSESLDWFPKHVWEEYEKSE------LDATILA-CGIEEK 264
           FG++L E++  +   +A  G   S+       W  Y  S+      +D +I     + + 
Sbjct: 864 FGLILIELLTGKSPADAEFGVHGSI-----VEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918

Query: 265 DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
           +  +   L   AL C    P  RP  + V+K LE  
Sbjct: 919 EIVEVMNL---ALHCTATDPTARPCANDVLKTLESA 951

Length = 968

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.0 bits (210), Expect = 7e-19
 Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 14/201 (6%)

Query: 32  LGFGGFGEVYKGQF-PN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG+V    + P     G  +AVK L R  G+     +  E+  +   YH N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 87  YGFCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            G C +Q      L+ EY+  GSL  YL   K  +   +L   A    +G+ YLH    Q
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFLSGNY 203
             IH D+   NVLLD +   K+ DFGLAK       +  +     +P +  A E L    
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK-EN 185

Query: 204 PITHKCDVYSFGMVLFEIVGR 224
             ++  DV+SFG+ L+E++  
Sbjct: 186 KFSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +        F  E+  +    H N
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDN 66

Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    LV EY+  GSL  YL   +  ++  KL   A    KG+ YL  
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS-----A 195
              +R +H D+   N+L+++    K+ DFGL K+  +++ +  +      PG S     A
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR----EPGESPIFWYA 179

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEI 221
           PE L+ +   +   DV+SFG+VL+E+
Sbjct: 180 PESLTES-KFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 13/196 (6%)

Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY-GF 89
           LG G FG+VYK Q    GV  A KV++        E +M E+  +    H N+V+L   F
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ ++  L+ E+   G++D  +   +R +   ++  +   T + L YLHE    +IIH 
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHR 127

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNYPI 205
           D+K  N+L   +   K+ADFG++      R+      + GTP + APE +    S + P 
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 206 THKCDVYSFGMVLFEI 221
            +K DV+S G+ L E+
Sbjct: 186 DYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 30/213 (14%)

Query: 32  LGFGGFGEVYKGQFPN-------GVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHIN 82
           LG G FGEVY+G   +        +++AVK L +  G   +E+  F+ E   +    H N
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK--GATDQEKKEFLKEAHLMSNFNHPN 60

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA------IEWEKLHEIAIGTAKGLV 136
           +V+L G C       ++ E ME G L  YL   +        +  ++L +I +  AKG V
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 137 YLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           YL    Q   IH D+   N L+     DA+   K+ DFGLA+   ++  +    G    P
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS-DYYRKEGEGLLP 176

Query: 192 -GYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
             + APE  L G +  T + DV+SFG++++EI+
Sbjct: 177 VRWMAPESLLDGKF--TTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 58/192 (30%), Positives = 103/192 (53%), Gaps = 15/192 (7%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            +G G FG V +G++  G K+AVK +  +   +  + F+ E   + + +H NLVRL G  
Sbjct: 13  IIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
               +  +V E M  G+L  +L  + RA +   +L + ++  A+G+ YL     ++++H 
Sbjct: 69  LHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D+   N+L+  +   KV+DFGLA++       V  S  K    ++APE L      + K 
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV---GSMGVDNS--KLPVKWTAPEALKHK-KFSSKS 178

Query: 210 DVYSFGMVLFEI 221
           DV+S+G++L+E+
Sbjct: 179 DVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 19/198 (9%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           R+G G +G+VYK +    G  +A+KV+    G    E    E+  +    H N+V  +G 
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
              +    +V EY   GSL       +  +   ++  +   T KGL YLH   +   IH 
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHR 125

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK---GTPGYSAPEFLS----GN 202
           DIK  N+LL  +   K+ADFG++          TI+  K   GTP + APE  +    G 
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTA-----TIAKRKSFIGTPYWMAPEVAAVERKGG 180

Query: 203 YPITHKCDVYSFGMVLFE 220
           Y    KCD+++ G+   E
Sbjct: 181 Y--DGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.9 bits (205), Expect = 3e-18
 Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 11/194 (5%)

Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G FG V+K  +  +    A+K ++   + R   E+ + E   + +     ++R Y 
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
              D+    +V EY ENG L   L   + R +  +++    I    GL +LH    ++I+
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKIL 123

Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H DIK  N+ LDA  + K+ D G+AK L D      TI    GTP Y +PE L  + P  
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV---GTPYYLSPE-LCEDKPYN 179

Query: 207 HKCDVYSFGMVLFE 220
            K DV++ G+VL+E
Sbjct: 180 EKSDVWALGVVLYE 193

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 82.9 bits (205), Expect = 3e-18
 Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 13/201 (6%)

Query: 32  LGFGGFGEVYKGQF----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRL 86
           +G G FG VY G         +  AVK LNR       EQF+ E G I + + H N++ L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKE-GIIMKDFSHPNVLSL 61

Query: 87  YGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
            G C     + LV   YM++G L  ++  +      + L    +  AKG+ YL     ++
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKK 118

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTPGYSAPEFLSGNY 203
            +H D+   N +LD +F+ KVADFGLA+ + D+    V   +G K    + A E L    
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ-TQ 177

Query: 204 PITHKCDVYSFGMVLFEIVGR 224
             T K DV+SFG++L+E++ R
Sbjct: 178 KFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 12/197 (6%)

Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V+KG + P G    + +A+K +    GR   ++    +  +G   H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C    +  LV +    GSL  ++   + +++ ++L    +  AKG+ YL E    R+
Sbjct: 75  LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRM 130

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPI 205
           +H ++   N+LL ++   ++ADFG+A L   +      S +K    + A E  L G Y  
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY-- 188

Query: 206 THKCDVYSFGMVLFEIV 222
           TH+ DV+S+G+ ++E++
Sbjct: 189 THQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 5e-18
 Identities = 62/209 (29%), Positives = 90/209 (43%), Gaps = 43/209 (20%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLN-----RNLGRIAEE-QFMAEVGTIGRTYHINL 83
            +G G FGEVYK         +A+KV++       +  I +E QF+++     R+ +I  
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC----RSPYI-- 61

Query: 84  VRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVY 137
            + YG F     +  ++ EY   GS    L       +  KL E  I         GL Y
Sbjct: 62  TKYYGSFLKGSKL-WIIMEYCGGGSCLDLL-------KPGKLDETYIAFILREVLLGLEY 113

Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGY 193
           LHE   +  IH DIK  N+LL      K+ADFG    L     +  + V      GTP +
Sbjct: 114 LHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPFW 164

Query: 194 SAPEFLS-GNYPITHKCDVYSFGMVLFEI 221
            APE +    Y    K D++S G+   E+
Sbjct: 165 MAPEVIKQSGY--DEKADIWSLGITAIEL 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 82.1 bits (203), Expect = 7e-18
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 9/195 (4%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +  VYKG+    G  +A+K ++ +         + E+  +    H N+VRL+  
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 90  CHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
            H ++   LV+EYM+   L  Y+   G + A++   +        KG+ + HE    R++
Sbjct: 67  IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVL 122

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H D+KP+N+L++     K+ADFGLA+      +  T S    T  Y AP+ L G+   + 
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYST 180

Query: 208 KCDVYSFGMVLFEIV 222
             D++S G ++ E++
Sbjct: 181 SIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 34/209 (16%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           R+G G  G VYK    P G   A+KV+  N       Q   E+  +    H N+V+    
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK---- 136

Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           CHD         ++ E+M+ GSL+G     ++      L ++A     G+ YLH   ++ 
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF-----LADVARQILSGIAYLH---RRH 188

Query: 146 IIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLS- 200
           I+H DIKP N+L+++  + K+ADFG    LA+  D   S V      GT  Y +PE ++ 
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV------GTIAYMSPERINT 242

Query: 201 ----GNYPITHKCDVYSFGMVLFEI-VGR 224
               G Y   +  D++S G+ + E  +GR
Sbjct: 243 DLNHGAYD-GYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 22/200 (11%)

Query: 32  LGFGGFGEVYKGQF--PNGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+VY+G +  P   KI  AVK           E+F+ E   + +  H ++V+L 
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G   +  +  +V E    G L  YL   K +++   L   +   +  L YL     +R +
Sbjct: 74  GVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFV 129

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPEFLSGN 202
           H DI   NVL+ +    K+ DFGL++  +        S YK + G     + APE  S N
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDE------SYYKASKGKLPIKWMAPE--SIN 181

Query: 203 Y-PITHKCDVYSFGMVLFEI 221
           +   T   DV+ FG+ ++EI
Sbjct: 182 FRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 50/226 (22%)

Query: 31  RLGFGGFGEVYKGQF------PNGVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTY 79
            LG G FG+V K +            +AVK+L      ++L  +  E  M  +  IG+  
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE--MEMMKMIGK-- 74

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---------------L 124
           H N++ L G C  +    +V EY  +G+L  +L  ++   E+                 L
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSH 181
              A   A+G+ +L     ++ IH D+   NVL+  +   K+ADFGLA+     D  R  
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR-- 189

Query: 182 VTISGYKGTPG-----YSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
                 K T G     + APE L      TH+ DV+SFG++L+EI 
Sbjct: 190 ------KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 80.0 bits (197), Expect = 4e-17
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 22/203 (10%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVK--VLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRL 86
           LG G +G VY G    G  IAVK   L+ +    AE+++     EV  +    H+N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            G C D +  ++  E++  GS+   L  FG      + K  +  +    G+ YLH  C  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLHNNC-- 122

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS----GYKGTPGYSAPEFL- 199
            ++H DIK  NV+L  N   K+ DFG A+       H T S       GTP + APE + 
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 200 -SGNYPITHKCDVYSFGMVLFEI 221
            SG      K D++S G  +FE+
Sbjct: 182 ESGY---GRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 37/207 (17%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGFG V   +        A+K + +   +    +E   +E   +    H  +V+LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI---GTAK--------GLVY 137
              D+    ++ EY   G L            W  L +  +    TA+           Y
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL------------WTILRDRGLFDEYTARFYIACVVLAFEY 108

Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAP 196
           LH    + II+ D+KPEN+LLD+N   K+ DFG AK L    ++        GTP Y AP
Sbjct: 109 LHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC----GTPEYVAP 161

Query: 197 EFLSGN-YPITHKCDVYSFGMVLFEIV 222
           E +    Y      D +S G++L+E++
Sbjct: 162 EIILNKGY--DFSVDYWSLGILLYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 25/204 (12%)

Query: 35  GGFGEVY---KGQFPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRL-YG 88
           G +G V+   K     G   A+KV+ +   + +   +Q + E   + +     +V+L Y 
Sbjct: 4   GAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61

Query: 89  FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           F   +++  LV EY+  G L   L   G   +++ +            L YLH      I
Sbjct: 62  FQGKKNLY-LVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLH---SNGI 114

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKL------CDRNRSHVTISGYKGTPGYSAPEFLS 200
           IH D+KP+N+L+D+N   K+ DFGL+K+       + N          GTP Y APE + 
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 201 GNYPITHKCDVYSFGMVLFE-IVG 223
           G    +   D +S G +L+E +VG
Sbjct: 175 GQ-GHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 79.6 bits (196), Expect = 4e-17
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 9/207 (4%)

Query: 20  QLNNFTSNYSTRLGFGGFGEVYKG--QFPNG--VKIAVKVLNRNLGRIAEEQFMAEVGTI 75
           +L+N +      LG G FGE+ +G  + P+   + +A+  L           F+AE  T+
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60

Query: 76  GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 135
           G+  H N+VRL G     +   +V EYM NG+LD +L   +  +   +L  +  G A G+
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGM 120

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
            YL E      +H  +    VL++++   K++ F   +  D++ +  T    K    ++A
Sbjct: 121 KYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTTMSGKSPVLWAA 176

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE +  ++  +   DV+SFG+V++E++
Sbjct: 177 PEAIQYHH-FSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 12/198 (6%)

Query: 30  TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V K Q  P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 11  SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L   KR  E E L +++I   +GL YL E+ Q  I+H
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSIAVLRGLAYLREKHQ--IMH 127

Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 181

Query: 208 KCDVYSFGMVLFEI-VGR 224
           + D++S G+ L E+ +GR
Sbjct: 182 QSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.9 bits (194), Expect = 6e-17
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 15/192 (7%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 90
           +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G   
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++    +V EYM  GSL  YL  + R+ +  + L + ++   + + YL        +H 
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D+   NVL+  +   KV+DFGL K      +  T    K    ++APE L      + K 
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKS 180

Query: 210 DVYSFGMVLFEI 221
           DV+SFG++L+EI
Sbjct: 181 DVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.9 bits (194), Expect = 6e-17
 Identities = 55/193 (28%), Positives = 100/193 (51%), Gaps = 9/193 (4%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           R+G G FGEV+ G+   +   +AVK     L    + +F+ E   + +  H N+VRL G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
           C  +    +V E ++ G    +L  +   ++ ++L ++    A G+ YL  +     IH 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHR 118

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLS-GNYPITH 207
           D+   N L+      K++DFG+++  + +  + +  G K  P  ++APE L+ G Y  + 
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRY--SS 175

Query: 208 KCDVYSFGMVLFE 220
           + DV+SFG++L+E
Sbjct: 176 ESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 7e-17
 Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 32/204 (15%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HINLVRLYG 88
           +G G +G+VYK +    G  +A+K+++       EE+   E   + R Y  H N+   YG
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE--EEEIKEEYNIL-RKYSNHPNIATFYG 70

Query: 89  F--------CHDQHMTALVYEYMENGS---LDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 137
                      DQ    LV E    GS   L   L  K + ++ E +  I   T +GL Y
Sbjct: 71  AFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN--RSHVTISGYKGTPGYSA 195
           LHE    ++IH DIK +N+LL  N   K+ DFG++   D    R +  I    GTP + A
Sbjct: 129 LHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI----GTPYWMA 181

Query: 196 PEFLSGN----YPITHKCDVYSFG 215
           PE ++ +         + DV+S G
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLG 205

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.9 bits (195), Expect = 8e-17
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 18/200 (9%)

Query: 33  GFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL- 86
           G G FG+V   Q        A+K +N+   +  E+      + E   +    H  LV L 
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNK--QKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y F  +++M  LV + +  G L  Y   +K     E++          L YLH    + I
Sbjct: 67  YSFQDEENMY-LVVDLLLGGDLR-YHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGI 121

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKP+N+LLD      + DF +A     +    + S   GTPGY APE L      +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQG-YS 177

Query: 207 HKCDVYSFGMVLFE-IVGRR 225
              D +S G+  +E + G+R
Sbjct: 178 VAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 79.0 bits (195), Expect = 9e-17
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 41/219 (18%)

Query: 32  LGFGGFGEVYKGQF--PNGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+VYKG+   PN       +A+K L  N     +++F  E   +    H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF---------------GKKRAIEWEKLHEIAIG 130
           L G C  +  T +++EY+ +G L  +L                  K +++      IAI 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            A G+ YL        +H D+   N L+    + K++DFGL++        +  + Y   
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD-------IYSADYYRV 182

Query: 191 PGYS-------APE-FLSGNYPITHKCDVYSFGMVLFEI 221
              S        PE  L G +  T + D++SFG+VL+EI
Sbjct: 183 QSKSLLPVRWMPPEAILYGKF--TTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 9e-17
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 20/217 (9%)

Query: 29  STRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMA-EVGT---IGRTYHINL 83
              +G G +G VYK +  N  +  A+K +   L           E+     +    H N+
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 84  VRLYGFCHDQHMT-----ALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVY 137
           VRL   CH           LV+E+++   L  YL    K  +  E + ++     +G+ +
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           LH     RI+H D+KP+N+L+ ++   K+ADFGLA++     +  ++     T  Y APE
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV---VTLWYRAPE 176

Query: 198 FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
            L  +   T   D++S G +  E+  RRR    G+SE
Sbjct: 177 VLLQSSYAT-PVDMWSVGCIFAELF-RRRPLFRGTSE 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 79.1 bits (195), Expect = 9e-17
 Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 21/197 (10%)

Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-F 89
           LG G  G V K    P G  +A KV++        +Q + E+  +       +V  YG F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ ++  +  E+M+ GSLD  ++ K   I  E L +IA+   +GL YL+     RI+H 
Sbjct: 73  LNENNIC-MCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHR 128

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG----YKGTPGYSAPEFL-SGNYP 204
           DIKP N+L+++         G  KLCD   S   I+     + GT  Y +PE +  G Y 
Sbjct: 129 DIKPSNILVNSR--------GQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKY- 179

Query: 205 ITHKCDVYSFGMVLFEI 221
            T K DV+S G+ + E+
Sbjct: 180 -TVKSDVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 75/269 (27%), Positives = 119/269 (44%), Gaps = 27/269 (10%)

Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P+G    + +A+KVL  N    A ++ + E   +       + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       LV + M  G L  Y+   K  I  + L    +  AKG+ YL E    R+
Sbjct: 75  LGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+ +    K+ DFGLA+L D + +     G K    + A E +  +   T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL-HRRFT 189

Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP-KHVWEEYEKSELDATILACGIEEKD 265
           H+ DV+S+G+ ++E+       +   ++  D  P + + +  EK E       C I+   
Sbjct: 190 HQSDVWSYGVTVWEL-------MTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID--- 239

Query: 266 KEKAKRLCMAALWCVQDSPEDRPPMSAVV 294
                 + M  + C     E RP    +V
Sbjct: 240 ------VYMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 78/284 (27%), Positives = 136/284 (47%), Gaps = 34/284 (11%)

Query: 30  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 11  SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L  K   I  + L +++I   KGL YL E  + +I+H
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMH 127

Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 181

Query: 208 KCDVYSFGMVLFEI-VGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE--EK 264
           + D++S G+ L E+ +GR              +P       +  EL+  +  C +E    
Sbjct: 182 QSDIWSMGLSLVEMAIGR--------------YP---IPPPDAKELE-LMFGCPVEGDPA 223

Query: 265 DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPK 308
           + E + R            P+ RPPM A+ ++L+ +V   PPPK
Sbjct: 224 ESETSPRPRPPGRPLSSYGPDSRPPM-AIFELLDYIVNE-PPPK 265

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 20/210 (9%)

Query: 21  LNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGR 77
           L NF      ++G G F  VYK     +G  +A+K +     +   A +  + E+  + +
Sbjct: 1   LGNFK--IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQ 58

Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLD---GYLFGKKRAIEWEKLHEIAIGTAKG 134
             H N+++      + +   +V E  + G L     +   +KR I    + +  +     
Sbjct: 59  LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPG 192
           L ++H    +RI+H DIKP NV + A    K+ D GL     R  S  T + +   GTP 
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLG----RFFSSKTTAAHSLVGTPY 171

Query: 193 YSAPEFLSGN-YPITHKCDVYSFGMVLFEI 221
           Y +PE +  N Y    K D++S G +L+E+
Sbjct: 172 YMSPERIHENGY--NFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 87/269 (32%), Positives = 121/269 (44%), Gaps = 42/269 (15%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRL-Y 87
           LG GGFGEV   Q     K+ A K L+  R   R  E+  + E   + +     +V L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            F   +    LV   M  G L  ++       F + RAI +    +I  G    L +LH+
Sbjct: 61  AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA--QIICG----LEHLHQ 113

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
               RI++ D+KPENVLLD + + +++D GLA   +  +    I G  GTPGY APE L 
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLA--VEL-KGGKKIKGRAGTPGYMAPEVLQ 167

Query: 201 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG 260
           G        D ++ G  L+E++  R             F +   E+ EK EL    L   
Sbjct: 168 GEV-YDFSVDWFALGCTLYEMIAGRSP-----------FRQRK-EKVEKEELKRRTLEMA 214

Query: 261 IEEKDK--EKAKRLCMAALWCVQDSPEDR 287
           +E  DK   +AK LC A L   Q  PE R
Sbjct: 215 VEYPDKFSPEAKDLCEALL---QKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 30  TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVR 85
             +G G FG VY  +       +A+K ++ + G+ + E++   + EV  + +  H N + 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 86  LYGFCHDQHMTA-LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            Y  C+ +  TA LV EY   GS    L   K+ ++  ++  I  G  +GL YLH   + 
Sbjct: 80  -YKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----S 200
             IH DIK  N+LL    + K+ADFG A L     S V      GTP + APE +     
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDE 188

Query: 201 GNYPITHKCDVYSFGMVLFEIVGRR 225
           G Y    K DV+S G+   E+  R+
Sbjct: 189 GQY--DGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 72/299 (24%), Positives = 125/299 (41%), Gaps = 50/299 (16%)

Query: 30  TRLGFGGFGEVYKGQ------FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL 83
             LG G FG+V K              +AVK+L  N         ++E   + +  H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------------------RAIE 120
           ++LYG C       L+ EY + GSL  +L   +                       RA+ 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
              L   A   ++G+ YL E    +++H D+   NVL+      K++DFGL++      S
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
           +V  S  +    + A E L  ++  T + DV+SFG++L+EIV       +G +      P
Sbjct: 183 YVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIV------TLGGNPYPGIAP 235

Query: 241 KHVWEEYEKSELDATILACGIE-EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
           + ++           +L  G   E+ +  ++ +    L C +  P+ RP  + + K LE
Sbjct: 236 ERLF----------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 76.8 bits (189), Expect = 5e-16
 Identities = 85/271 (31%), Positives = 114/271 (42%), Gaps = 43/271 (15%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRL-Y 87
           LG GGFGEV   Q    G   A K LN  R   R   E  M E   + + +   +V L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK---GLVYLHEECQQ 144
            F   +    LV   M  G L  +++                 TA+   GL +LH   Q+
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QR 116

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
           RII+ D+KPENVLLD + + +++D GLA +L D         GY GTPG+ APE L G  
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK---TKGYAGTPGFMAPELLQGE- 172

Query: 204 PITHKCDVYSFGMVLFEIVG-----RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA 258
                 D ++ G+ L+E++      R R                  E+ E  EL   IL 
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARG-----------------EKVENKELKQRILN 215

Query: 259 CGIEEKDK--EKAKRLCMAALWCVQDSPEDR 287
             +   DK    +K  C A L      PE R
Sbjct: 216 DSVTYPDKFSPASKSFCEALL---AKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL E   +R+
Sbjct: 75  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRL 130

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPI 205
           +H D+   NVL+      K+ DFGLAKL   +       G K    + A E  L   Y  
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY-- 188

Query: 206 THKCDVYSFGMVLFEIV 222
           TH+ DV+S+G+ ++E++
Sbjct: 189 THQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.9 bits (189), Expect = 6e-16
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 32  LGFGGFGEV----YKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG+V    Y  +  N G ++AVK L    G         E+  +   YH N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 87  YGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            G C +       L+ E++ +GSL  YL   K  I  ++  + A+   KG+ YL     +
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPE-FLSGN 202
           + +H D+   NVL+++    K+ DFGL K  + ++ + T+     +P +  APE  +   
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 203 YPITHKCDVYSFGMVLFEIV 222
           + I    DV+SFG+ L+E++
Sbjct: 189 FYIA--SDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 76.2 bits (188), Expect = 9e-16
 Identities = 60/197 (30%), Positives = 87/197 (44%), Gaps = 17/197 (8%)

Query: 31  RLGFGGFGEVYK-GQFPNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           R+G G  G V+K      G  +A+K V  R L      Q + E+  +    H  +V+L  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 89  -FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
            F H      LV EYM    L   L  ++R +   ++        KG+ Y+H      I+
Sbjct: 67  VFPHGSGF-VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIM 121

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCD----RNRSHVTISGYKGTPGYSAPEFLSGNY 203
           H D+KP N+L+ A+   K+ADFGLA+L      R  SH        T  Y APE L G  
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-----ATRWYRAPELLYGAR 176

Query: 204 PITHKCDVYSFGMVLFE 220
                 D+++ G +  E
Sbjct: 177 KYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 76.7 bits (189), Expect = 9e-16
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 39/229 (17%)

Query: 83  LVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           +V  YG F  D  ++  + E+M+ GSLD  L  K   I    L +I+I   +GL YL E+
Sbjct: 61  IVGFYGAFYSDGEISICM-EHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREK 118

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLS 200
            +  I+H D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L 
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQ 171

Query: 201 GNYPITHKCDVYSFGMVLFEI-VGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC 259
           G +  T + D++S G+ L E+ +GR              +P       +  EL   +   
Sbjct: 172 GTH-YTVQSDIWSLGLSLVEMAIGR--------------YPI---PPPDAKEL-EAMFGR 212

Query: 260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPK 308
            + E + +++ R        V   P D P   A+ ++L+ +V   PPPK
Sbjct: 213 PVSEGEAKESHRP-------VSGHPPDSPRPMAIFELLDYIVNE-PPPK 253

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 74/295 (25%), Positives = 127/295 (43%), Gaps = 41/295 (13%)

Query: 32  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V+  +  N       + +AVK L ++    A + F  E   +    H ++V+
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRAIEWE----KLHEIAIG 130
            YG C D     +V+EYM++G L+ +L            G+ R  + E    ++  IA  
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            A G+VYL     Q  +H D+   N L+ AN   K+ DFG+++    +  +  + G+   
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRVGGHTML 187

Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS 250
           P    P         T + DV+SFG++L+EI                 + K  W +   +
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------YGKQPWFQLSNT 232

Query: 251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
           E+   I    + E+ +   K +    L C Q  P+ R  +  + K+L  + +  P
Sbjct: 233 EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 39/213 (18%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKV------------LNRNLGRIAEEQFMAEVGTIGRT 78
           LG G +  VYK +    G  +A+K             +N    R  E + + E+      
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR--EIKLLQEL------ 59

Query: 79  YHINLVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH--EIAIGTAKGL 135
            H N++ L   F H  ++  LV+E+ME   L+  +  K ++I           + T +GL
Sbjct: 60  KHPNIIGLLDVFGHKSNIN-LVFEFME-TDLEKVI--KDKSIVLTPADIKSYMLMTLRGL 115

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPG 192
            YLH      I+H D+KP N+L+ ++   K+ADFGLA+     +R  +H  +     T  
Sbjct: 116 EYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-----TRW 167

Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           Y APE L G        D++S G +  E++ R 
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 68/228 (29%), Positives = 102/228 (44%), Gaps = 43/228 (18%)

Query: 27  NYSTRLGFGGFGEVY------------KGQFPNGVK-----IAVKVLNRNLGRIAEEQFM 69
           N+  +LG G FGEV+            K    N        +AVKVL  +    A E F+
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 70  AEVGTIGRTYHINLVRLYGFC-HDQHMTALVYEYMENGSLDGYL----------FGKKRA 118
            EV  + R    N+ RL G C  D  +  ++ EYMENG L+ +L              ++
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPL-CMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 119 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
           + +  L  +A   A G+ YL        +H D+   N L+  N++ K+ADFG+     RN
Sbjct: 127 LSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGM----SRN 179

Query: 179 ---RSHVTISGYKGTP-GYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 221
                +  + G    P  + A E  L G +  T K DV++FG+ L+EI
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKF--TTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 61/203 (30%), Positives = 84/203 (41%), Gaps = 37/203 (18%)

Query: 35  GGFGEVYKGQ-FPNGVKIAVKVL--------NRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           G FG VY  +    G   A+KVL        N+     AE   M     + +     + +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-----MIQGESPYVAK 61

Query: 86  LYGFCHDQHMTALVYEYMENGSLD------GYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           LY     +    LV EY+  G         G L       +W K  +       G+  LH
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL-----PEDWAK--QYIAEVVLGVEDLH 114

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
              Q+ IIH DIKPEN+L+D     K+ DFGL++    N+  V      GTP Y APE +
Sbjct: 115 ---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETI 165

Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
            G        D +S G V+FE +
Sbjct: 166 LGV-GDDKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 67/227 (29%), Positives = 96/227 (42%), Gaps = 47/227 (20%)

Query: 30  TRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHIN--- 82
             +G G FGEV+  +  +  ++ A+KVL ++   I   Q     AE     R    +   
Sbjct: 7   KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD-MIKRNQIAHVRAE-----RDILADADS 60

Query: 83  --LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             +V+LY    D+    LV EYM  G L   L  K    E           A+ ++ L  
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETARFYIAELVLALDS 116

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-----------------LCDRNRSHVT 183
             +   IH DIKP+N+L+DA+   K+ADFGL K                 L  R+   V 
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 184 ISGYK----------GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
              +K          GTP Y APE L G      +CD +S G++L+E
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 16/198 (8%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYG 88
           ++G G F EV K Q    G   A+K + ++   + +   + E+  + R + H N++RL  
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 89  FCHDQHM--TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
              D+     ALV+E M+  +L   + G+KR +  +++        K L ++H   +  I
Sbjct: 66  VLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGI 121

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL--SGNYP 204
            H DIKPEN+L+  +   K+ADFG  +      S    + Y  T  Y APE L   G Y 
Sbjct: 122 FHRDIKPENILIKDDIL-KLADFGSCRGIY---SKPPYTEYISTRWYRAPECLLTDGYY- 176

Query: 205 ITHKCDVYSFGMVLFEIV 222
              K D+++ G V FEI+
Sbjct: 177 -GPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 40/211 (18%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH-INLVRLYGF 89
           +G G FG V K      G  +AVK +   +    +++ + ++  + R+     +V+ YG 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 90  CHDQHMTALVYEYMENGSLDG-----YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
              +    +  E M+  SLD      Y   K    E E L +IA+ T K L YL EE   
Sbjct: 72  LFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPE-EILGKIAVATVKALNYLKEEL-- 127

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY----------KGTPGYS 194
           +IIH D+KP N+LLD N + K+ DFG             ISG            G   Y 
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFG-------------ISGQLVDSIAKTRDAGCRPYM 174

Query: 195 APEFLSGN----YPITHKCDVYSFGMVLFEI 221
           APE +  +    Y +  + DV+S G+ L+E+
Sbjct: 175 APERIDPSARDGYDV--RSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 16/199 (8%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G +G VYK    P GV +A+K +   L      Q + E+  + +     +V  YG  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEW---EKLHEIAIGTAKGLVYLHEECQQRII 147
             +    +  EYM+ GSLD  L+    A E    + L  I     KGL +L EE    II
Sbjct: 69  FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI-- 205
           H D+KP NVL++ N   K+ DFG++     + +   I    G   Y APE +    P   
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPNQN 181

Query: 206 ---THKCDVYSFGMVLFEI 221
              T + DV+S G+ + E+
Sbjct: 182 PTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.9 bits (185), Expect = 3e-15
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 23/199 (11%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIA----EEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +   +G   A+K+L++   +I      E  + E   +    H  LV L
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLH--EIAIGTAKGLVYLHEECQ 143
           YG   D     LV EY+  G L  +L    R      + +  ++ +     L YLH    
Sbjct: 67  YGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEYLHSL-- 120

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
             I++ D+KPEN+LLD++   K+ DFG AK     R++ T+    GTP Y APE +  + 
Sbjct: 121 -DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTY-TLC---GTPEYLAPEIIL-SK 173

Query: 204 PITHKCDVYSFGMVLFEIV 222
                 D ++ G++++E++
Sbjct: 174 GYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 17/198 (8%)

Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            +G G +G V K +    G  +A+K       + ++ + A    + EV  + +  H N+V
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA----LREVKVLRQLRHENIV 63

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            L      +    LV+EY+E   L+  L      +  + +        + + Y H     
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
            IIH DIKPEN+L+  +   K+ DFG A+ L  R  S +T   Y  T  Y APE L G+ 
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVATRWYRAPELLVGDT 177

Query: 204 PITHKCDVYSFGMVLFEI 221
                 DV++ G ++ E+
Sbjct: 178 NYGKPVDVWAIGCIMAEL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 69/235 (29%), Positives = 105/235 (44%), Gaps = 49/235 (20%)

Query: 28  YSTRLGFGGFGEVY-----------KGQFPNGVK------IAVKVLNRNLGRIAEEQFMA 70
           +  +LG G FGEV+             QFP  V+      +AVK+L  +  + A   F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF----------------- 113
           EV  + R    N++RL G C D+    ++ EYMENG L+ +L                  
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 114 -GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
                AI +  L  +A+  A G+ YL        +H D+   N L+  N + K+ADFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 173 KLCDRNR---SHVTISGYKGTP-GYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
               RN     +  I G    P  + A E  L G +  T   DV++FG+ L+EI+
Sbjct: 186 ----RNLYAGDYYRIQGRAVLPIRWMAWECILMGKF--TTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 35/284 (12%)

Query: 30  TRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL 83
           T LG G FGEV+  +     +      + VK L +      + +F  E+    +  H N+
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKL------HEIAIGT--AKGL 135
           VRL G C +     ++ EY + G L  +L   K   E  K        ++A+ T  A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR-NRSHVTISGYKGTPGYS 194
            +L      R +H D+   N L+ +    KV+   L+K  D  N  +  +        + 
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWL 185

Query: 195 APEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           APE +  +   + K DV+SFG++++E+          +   L  F     EE   + L A
Sbjct: 186 APEAVQED-DFSTKSDVWSFGVLMWEVF---------TQGELP-FYGLSDEEV-LNRLQA 233

Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
             L   + E    +  +L M   W V  +P+DRP  S +V  L 
Sbjct: 234 GKLELPVPEGCPSRLYKL-MTRCWAV--NPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.8 bits (181), Expect = 4e-15
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 11/194 (5%)

Query: 32  LGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG V KG +      + +A+KVL     +   ++ M E   + +  +  +VR+ G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
            C  + +  LV E    G L+ +L GKK  I    + E+    + G+ YL     +  +H
Sbjct: 63  VCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVH 118

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI-SGYKGTPGYSAPEFLSGNY-PIT 206
            D+   NVLL      K++DFGL+K    + S+    S  K    + APE +  N+   +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--NFRKFS 176

Query: 207 HKCDVYSFGMVLFE 220
            + DV+S+G+ ++E
Sbjct: 177 SRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 23/201 (11%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 88
           LG G FG+VYK +    G   A KV+  ++   +  E +M E+  +    H  +V+L G 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYMVEIEILATCNHPYIVKLLGA 77

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           F  D  +  ++ E+   G++D  +    R +   ++  I     + L YLH     +IIH
Sbjct: 78  FYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIH 133

Query: 149 YDIKPENVLLDANFSPKVADFGLA----KLCDRNRSHVTISGYKGTPGYSAPEFL----S 200
            D+K  NVLL  +   K+ADFG++    K   R  S +      GTP + APE +     
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCETM 187

Query: 201 GNYPITHKCDVYSFGMVLFEI 221
            + P  +K D++S G+ L E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 44/224 (19%)

Query: 31  RLGFGGFGEV----------YKGQFPNG-----VKIAVKVLNRNLGRIAEEQFMAEVGTI 75
           +LG G FGEV          + G+         V +AVK+L  ++ + A   F+ E+  +
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 76  GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE-------------WE 122
            R  + N++RL G C       ++ EYMENG L+ +L   +R IE               
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANNIPSVSIA 129

Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN---R 179
            L  +A+  A G+ YL        +H D+   N L+  +++ K+ADFG++    RN    
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMS----RNLYSG 182

Query: 180 SHVTISGYKGTP-GYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 221
            +  I G    P  + A E  L G +  T   DV++FG+ L+E+
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKF--TTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 5e-15
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 29/206 (14%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLN--RNLGRIAEE--QFMAEVGTIGRTYHINLVRL 86
           LG G FG VY       G ++AVK +    +     +E      E+  +    H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYL--FGK-----KRAIEWEKLHEIAIGTAKGLVYLH 139
           YG   D    ++  EYM  GS+   L  +G       R    + L         G+ YLH
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE--------GVEYLH 121

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEF 198
                 I+H DIK  N+L D+  + K+ DFG +K      S  T +    GTP + +PE 
Sbjct: 122 S---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178

Query: 199 LSGNYPITH--KCDVYSFGMVLFEIV 222
           +SG     +  K DV+S G  + E++
Sbjct: 179 ISGE---GYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 73.3 bits (180), Expect = 7e-15
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 15/206 (7%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVK---VLNRNLGRIAEEQ------FMAEVGTIGRTYHI 81
           +G G +G VY       G  +AVK   +     GR    Q        +E+ T+    H+
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           N+V+  GF   +   ++  EY+  GS+ G         E + +        +GL YLH  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLAYLH-- 125

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
             + I+H D+K +N+L+DA+   K++DFG++K  D    +      +G+  + APE +  
Sbjct: 126 -SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184

Query: 202 NYP-ITHKCDVYSFGMVLFEIVGRRR 226
                + K D++S G V+ E+   RR
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 73.6 bits (181), Expect = 8e-15
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 34/208 (16%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH-INLVRLYGF 89
           LG G +G V K +  P G  +AVK +   +    +++ + ++    R+      V  YG 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 90  CHDQHMTALVYEYMENGSLDGY---LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
              +    +  E M+  SLD +   ++ K   I  + L +IA+   K L YLH   +  +
Sbjct: 69  LFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSV 125

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY----------KGTPGYSAP 196
           IH D+KP NVL++ N   K+ DFG             ISGY           G   Y AP
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFG-------------ISGYLVDSVAKTIDAGCKPYMAP 172

Query: 197 EFLSGNYPITH---KCDVYSFGMVLFEI 221
           E ++          K DV+S G+ + E+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 45/288 (15%)

Query: 32  LGFGGFGEVYKGQF--PNGV--KIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V +GQ    +G   K+AVK +          E+F++E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 87  YGFCHDQH------MTALVYEYMENGSLDGYLFGKKRA-----IEWEKLHEIAIGTAKGL 135
            G C +           ++  +M++G L  +L   +       +  + L +  +  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
            YL     +  IH D+   N +L  + +  VADFGL+K       +      K    + A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT 255
            E L+     T K DV++FG+ ++EI  R +    G             E Y+       
Sbjct: 184 IESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENH---------EIYD------- 226

Query: 256 ILACGIEEKDKEKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLE 298
            L  G   K  E     C+  L+     C +  P+DRP  + + ++LE
Sbjct: 227 YLRHGNRLKQPED----CLDELYDLMYSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 63/194 (32%), Positives = 92/194 (47%), Gaps = 13/194 (6%)

Query: 31  RLGFGGFGEVYKGQFPNGVK--IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           R+G G FGEVYKG   N  K  +A+K+++        E    E+  + +     + R YG
Sbjct: 11  RIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
                    ++ EY+  GS    L  K   +E   +  I     KGL YLH E   R IH
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE---RKIH 124

Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            DIK  NVLL      K+ADFG+A +L D   + +  + + GTP + APE +  +     
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIKQS-AYDF 180

Query: 208 KCDVYSFGMVLFEI 221
           K D++S G+   E+
Sbjct: 181 KADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 11/196 (5%)

Query: 30  TRLGFGGFGEVYKG--QFPNGVK-IAVKVL-NRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
             LG G FG V KG  +     K +AVK+L N N     +++ + E   + +  +  +VR
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           + G C  +    LV E  E G L+ +L  K + +  + + E+    + G+ YL E     
Sbjct: 61  MIGICEAESWM-LVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEE---TN 115

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYP 204
            +H D+   NVLL      K++DFGL+K    + ++     +   P  + APE ++  Y 
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN-YYK 174

Query: 205 ITHKCDVYSFGMVLFE 220
            + K DV+SFG++++E
Sbjct: 175 FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 39/225 (17%)

Query: 28  YSTRLGFGGFGEVY-------------------KGQFPNGVKIAVKVLNRNLGRIAEEQF 68
           +  +LG G FGEV+                    G  P  V +AVK+L  +  + A   F
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQP--VLVAVKMLREDANKNARNDF 66

Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL----------FGKKRA 118
           + E+  + R    N++RL   C       ++ EYMENG L+ +L                
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 119 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
           I +  L  +A   A G+ YL        +H D+   N L+  N++ K+ADFG+++     
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183

Query: 179 RSHVTISGYKGTP--GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             +  I G    P    S    L G +  T   DV++FG+ L+EI
Sbjct: 184 -DYYRIQGRAVLPIRWMSWESILLGKF--TTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 30/207 (14%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTY-----HINLVR 85
           LG G FG+V   +     ++ AVKVL +++  I ++  +    T  R       H  L +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDV--ILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 86  LYGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYL 138
           L      Q    L  V EY+  G L  ++     F + RA  +    EI +G    L +L
Sbjct: 61  L--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAA--EIVLG----LQFL 112

Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
           HE   + II+ D+K +NVLLD+    K+ADFG+ K        VT S + GTP Y APE 
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEI 167

Query: 199 LSGNYPITHKCDVYSFGMVLFE-IVGR 224
           LS   P     D ++ G++L+E + G+
Sbjct: 168 LSYQ-PYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 40/275 (14%)

Query: 32  LGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYG 88
           +G G FG++Y  K +  +     +K ++     + E E    EV  + +  H N+V  + 
Sbjct: 8   IGEGSFGKIYLAKAKSDSE-HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 89  FCHDQHMTALVYEYMENGSL-------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
              +     +V EY + G L        G LF + + + W    +I++G    L ++H+ 
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG----LKHIHD- 119

Query: 142 CQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
             ++I+H DIK +N+ L  N    K+ DFG+A+    N S        GTP Y +PE + 
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPE-IC 174

Query: 201 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG 260
            N P  +K D++S G VL+E+                   KH +E     +L   I    
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTL----------------KHPFEGNNLHQLVLKICQGY 218

Query: 261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
                   ++ L        + SP DRP +++++K
Sbjct: 219 FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 8e-14
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 11/195 (5%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI---NLVRLY 87
           +G G +G VY+G   P G  +A+K++N +           EV  + +       N+ + Y
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         ++ EY E GS+   +  K   I  + +  I       L Y+H   +  +I
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKYIH---KVGVI 123

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DIK  N+L+    + K+ DFG+A L ++N S    S + GTP + APE ++       
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--STFVGTPYWMAPEVITEGKYYDT 181

Query: 208 KCDVYSFGMVLFEIV 222
           K D++S G+ ++E+ 
Sbjct: 182 KADIWSLGITIYEMA 196

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 38/292 (13%)

Query: 32  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V+  +  N       + +AVK L ++    A + F  E   +    H ++V+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWE----------KLHEIAIGTAK 133
            YG C +     +V+EYM++G L+ +L   G    +  E          ++  IA   A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+VYL     Q  +H D+   N L+  N   K+ DFG+++    +  +  + G+   P  
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGHTMLPIR 187

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
             P         T + DV+S G+VL+EI                 + K  W +   +E+ 
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT---------------YGKQPWYQLSNNEVI 232

Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
             I    + ++ +   K +    L C Q  P  R  +  +  +L+ + +  P
Sbjct: 233 ECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 45/292 (15%)

Query: 32  LGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLY 87
           +G G FG+V +     +G+K+  A+K+L           F  E+  + +  +H N++ L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKLHEIAIGTA 132
           G C ++    +  EY   G+L  +L                G    +  ++L + A   A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
            G+ YL E   ++ IH D+   NVL+  N + K+ADFGL++        V +    G   
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRLP 181

Query: 193 YSAPEFLSGNYPI-THKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
                  S NY + T K DV+SFG++L+EIV        G + +         E YEK  
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---------ELYEK-- 230

Query: 252 LDATILACGIE-EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
                L  G   EK +     +      C +D P +RPP + +   L  ++E
Sbjct: 231 -----LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 79/287 (27%), Positives = 124/287 (43%), Gaps = 62/287 (21%)

Query: 32  LGFGGFGEVYKGQFPNGVK----IAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLV 84
           +G G FG VY   F   V+    +A+K ++ + G+ + E++   + EV  + R  H N +
Sbjct: 33  IGHGSFGAVY---FARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVKFLQRIKHPNSI 88

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
              G    +H   LV EY   GS    L   K+ ++  ++  I  G  +GL YLH     
Sbjct: 89  EYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SH 144

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----S 200
            +IH DIK  N+LL      K+ADFG A +     S V      GTP + APE +     
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILAMDE 198

Query: 201 GNYPITHKCDVYSFGMVLFEIVGRR-----RNAI-----VGSSESLDWFPKHVWEEYEKS 250
           G Y    K DV+S G+   E+  R+      NA+     +  +ES      + W +Y ++
Sbjct: 199 GQY--DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-LQSNEWSDYFRN 255

Query: 251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
            +D+                        C+Q  P+DRP    ++K +
Sbjct: 256 FVDS------------------------CLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 13/199 (6%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRL-Y 87
           LG GGFGEV   Q  N G   A K L+  R   +  E+  + E   + +     +V L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            F    H+  LV   M  G L  +++   +R +E E++   +     G+++LH      I
Sbjct: 61  AFESKTHL-CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           ++ D+KPENVLLD   + +++D GLA      +   TI+   GT GY APE L    P +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILK-EEPYS 172

Query: 207 HKCDVYSFGMVLFEIVGRR 225
           +  D ++ G  ++E+V  R
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 17/198 (8%)

Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQ---FMA--EVGTIGRTYHINLV 84
           +LG G +  VYKG+   NG  +A+KV+     R+ EE+   F A  E   +    H N+V
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVI-----RLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            L+   H +    LV+EY+    L  Y+      +  E +        +GL Y+H   Q+
Sbjct: 67  LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QR 122

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
            I+H D+KP+N+L+      K+ADFGLA+      SH T S    T  Y  P+ L G+  
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSH-TYSNEVVTLWYRPPDVLLGSTE 180

Query: 205 ITHKCDVYSFGMVLFEIV 222
            +   D++  G +  E++
Sbjct: 181 YSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.5 bits (170), Expect = 1e-13
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 13/200 (6%)

Query: 32  LGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY-G 88
           +G G FG V+  + +    + I  ++    + +        E   +    H N++  Y  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           F  D+ +  +V EY   G+L  Y+  +  ++  E    I     + L+ LH    + I+H
Sbjct: 68  FLEDKAL-MIVMEYAPGGTLAEYIQKRCNSLLDED--TILHFFVQILLALHHVHTKLILH 124

Query: 149 YDIKPENVLLDAN-FSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
            D+K +N+LLD +    K+ DFG++K L  +++++  +    GTP Y +PE   G  P  
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV----GTPCYISPELCEGK-PYN 179

Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K D+++ G VL+E+   +R
Sbjct: 180 QKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 17/220 (7%)

Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEE--QFMA--EVGTIGRTYHINLVR 85
           +LG G +  VYKG    NG  +A+KV++       EE   F A  E   +    H N+V 
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMK----TEEGVPFTAIREASLLKGLKHANIVL 67

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L+   H +     V+EYM    L  Y+      +    +        +GL Y+H    Q 
Sbjct: 68  LHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQH 123

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I+H D+KP+N+L+      K+ADFGLA+   ++    T S    T  Y  P+ L G    
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181

Query: 206 THKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWE 245
           +   D++  G +  E++ + + A  G S+  +   K +W 
Sbjct: 182 SSALDIWGAGCIFIEML-QGQPAFPGVSDVFEQLEK-IWT 219

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 39/190 (20%)

Query: 48  GVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTA----LVYE 101
           G ++AVK ++ R   R   E    EV  I R Y H N+V +Y      ++      +V E
Sbjct: 44  GRQVAVKKMDLRKQQR--RELLFNEV-VIMRDYQHPNIVEMY----SSYLVGDELWVVME 96

Query: 102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQQRIIHYDIKPENV 156
           ++E G+L          +   +++E  I T      K L +LH    Q +IH DIK +++
Sbjct: 97  FLEGGAL-------TDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSI 146

Query: 157 LLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVY 212
           LL ++   K++DFG    ++K   R +S V      GTP + APE +S   P   + D++
Sbjct: 147 LLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVIS-RLPYGTEVDIW 199

Query: 213 SFGMVLFEIV 222
           S G+++ E+V
Sbjct: 200 SLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 55/297 (18%)

Query: 32  LGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLY 87
           +G G FG+V K +   +G+++  A+K +     +     F  E+  + +  +H N++ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE----------------KLHEIAIGT 131
           G C  +    L  EY  +G+L  +L  K R +E +                +L   A   
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A+G+ YL +   ++ IH D+   N+L+  N+  K+ADFGL++        V +    G  
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173

Query: 192 GYSAPEFLSGNYPI-THKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS 250
                   S NY + T   DV+S+G++L+EIV        G + +         E YEK 
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------ELYEK- 223

Query: 251 ELDATILACGIEEKDKEKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVVE 302
                     + +  + +    C   ++     C ++ P +RP  + ++  L  ++E
Sbjct: 224 ----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 28/203 (13%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAE---VGTIGRTYHINLVR 85
           LG G FG+V   ++   G   A+K L +   + R   E  M E     T     H  LV 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 86  LYG-FCHDQHMTALVYEYMENGSLDGYL----FGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           L+  F  + H+   V EY   G L  ++    F + RA+ +      A     GL YLHE
Sbjct: 67  LFACFQTEDHV-CFVMEYAAGGDLMMHIHTDVFSEPRAVFY------AACVVLGLQYLHE 119

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFL 199
               +I++ D+K +N+LLD     K+ADFG   LC          S + GTP + APE L
Sbjct: 120 ---NKIVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTFCGTPEFLAPEVL 173

Query: 200 SG-NYPITHKCDVYSFGMVLFEI 221
           +  +Y  T   D +  G++++E+
Sbjct: 174 TETSY--TRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 64/273 (23%), Positives = 108/273 (39%), Gaps = 33/273 (12%)

Query: 32  LGFGGFGE--VYKGQFPNGVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRL 86
           LG G FGE  +Y+    + + +  +V   NL R++E++    + E+  +    H N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEV---NLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 87  YGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           Y    D +   +  EY   G+L D  +  K +  E E +          + Y+H+     
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-NYP 204
           I+H DIK  N+ L      K+ DFG++K+     S        GTP Y +PE   G  Y 
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQGVKY- 178

Query: 205 ITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEK 264
              K D+++ G VL+E++  +R                 ++      L   I+       
Sbjct: 179 -NFKSDIWALGCVLYELLTLKR----------------TFDATNPLNLVVKIVQGNYTPV 221

Query: 265 DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
               +  L       +Q  PE RP    V+   
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 16/200 (8%)

Query: 32  LGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLV 84
           LG G FG+V +       +    +K+AVK+L         E  M+E+  +     H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQ 143
            L G C       ++ EY   G L  +L  K+ + +  E L   +   AKG+ +L     
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---AS 159

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCD-RNRSHVTISGYKGTP-GYSAPEFLSG 201
           +  IH D+   NVLL      K+ DFGLA+  D  N S+  + G    P  + APE +  
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLAR--DIMNDSNYVVKGNARLPVKWMAPESIFN 217

Query: 202 NYPITHKCDVYSFGMVLFEI 221
               T + DV+S+G++L+EI
Sbjct: 218 CV-YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 64/202 (31%), Positives = 91/202 (45%), Gaps = 21/202 (10%)

Query: 32  LGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 87
           +G G FG VY       N V +AVK ++ +  +  E  +  + EV  + +  H N +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    +H   LV EY   GS    L   K+ ++  ++  I  G  +GL YLH      +I
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNY 203
           H DIK  N+LL      K+ADFG A       S V      GTP + APE +     G Y
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQY 197

Query: 204 PITHKCDVYSFGMVLFEIVGRR 225
               K DV+S G+   E+  R+
Sbjct: 198 --DGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)

Query: 32  LGFGGFGEVYKGQFPNGV---KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FG+V  G+  +G    ++ VK L  +     + +F+ E        H NL++  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRA----IEWEKLHEIAIGTAKGLVYLHEECQQ 144
            C +     LV E+   G L GYL   ++A     +   L  +A   A GL++LH   + 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLS--- 200
             IH D+   N LL A+ + K+ D+GL+    +   +VT       P  + APE +    
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT-PDQLWVPLRWIAPELVDEVH 178

Query: 201 GNYPI---THKCDVYSFGMVLFEI 221
           GN  +   T + +V+S G+ ++E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 39/213 (18%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINL 83
           ++G G +G VYK +    G  +A+K +     R+  E        + E+  +    H N+
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKI-----RLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK--------GL 135
           V+L    H ++   LV+E++ +  L       K+ ++   L  I +   K        GL
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDL-------KKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPG 192
            + H     R++H D+KP+N+L++   + K+ADFGLA+   +  R  +H  +     T  
Sbjct: 114 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLW 165

Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           Y APE L G    +   D++S G +  E+V RR
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 21/154 (13%)

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKG 134
           H N+VRL    H ++   LV+E++ +  L  Y+      G    +    L+++     +G
Sbjct: 57  HPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QG 111

Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTP 191
           + Y H     R++H D+KP+N+L+D   + K+ADFGLA+   +  R  +H  +     T 
Sbjct: 112 IAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-----TL 163

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            Y APE L G+   +   D++S G +  E+V RR
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 22/187 (11%)

Query: 48  GVKIAVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRLY--GFCHDQHMTALVYEYM 103
           G ++A+K+L  +      +  +F  E     R YH N+V L   G      + A V+EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61

Query: 104 ENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL--- 158
              +L   L   G   A E  +L    +     L   H    Q I+H D+KP+N+++   
Sbjct: 62  PGRTLREVLAADGALPAGETGRL---MLQVLDALACAHN---QGIVHRDLKPQNIMVSQT 115

Query: 159 DANFSPKVADFGLAKLC----DRNRSHVTISG-YKGTPGYSAPEFLSGNYPITHKCDVYS 213
                 KV DFG+  L     D + + +T +    GTP Y APE L G  P+T   D+Y+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE-PVTPNSDLYA 174

Query: 214 FGMVLFE 220
           +G++  E
Sbjct: 175 WGLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-----FMAEVGTIGRTYHINLVR 85
           +LG G +  VYKG+     K+   ++     R+  E+      + EV  +    H N+V 
Sbjct: 13  KLGEGTYATVYKGR----SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L+   H +    LV+EY++   L  YL     +I    +        +GL Y H   +++
Sbjct: 69  LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRK 124

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           ++H D+KP+N+L++     K+ADFGLA+   ++    T S    T  Y  P+ L G+   
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 206 THKCDVYSFGMVLFEIVGRR 225
           + + D++  G + +E+   R
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 48/289 (16%)

Query: 32  LGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V +GQ       +K+AVK +   +   +E E F++E   +    H N++RL 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 88  GFCHDQHMT------ALVYEYMENGSLDGYLFGKKRA-----IEWEKLHEIAIGTAKGLV 136
           G C     +       ++  +M++G L  +L   +       +  + L +     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
           YL     +  IH D+   N +L+ N +  VADFGL+K       +      K    + A 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG--SSESLDWFPKHVWEEYEKSELDA 254
           E L+ +   T K DV+SFG+ ++EI  R +    G  +SE  D+                
Sbjct: 184 ESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY---------------- 226

Query: 255 TILACGIEEKDKEKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLE 298
                 + + ++ K    C+  L+     C   +P+DRP    +   LE
Sbjct: 227 ------LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 32/228 (14%)

Query: 16  FTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKI--AVKVLNRNLGRIAEEQFMAEV 72
           +  L+ N+    +   +G G FG+V K +   +G+++  A+K +     +     F  E+
Sbjct: 1   YPVLEWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58

Query: 73  GTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 131
             + +  +H N++ L G C  +    L  EY  +G+L  +L  K R +E +    IA  T
Sbjct: 59  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANST 117

Query: 132 A----------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
           A                +G+ YL    Q++ IH D+   N+L+  N+  K+ADFGL++  
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-- 172

Query: 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIV 222
                 V +    G          S NY + T   DV+S+G++L+EIV
Sbjct: 173 ---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.4 bits (164), Expect = 9e-13
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 7/196 (3%)

Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +  V+KG+       +A+K +       A    + EV  +    H N+V L+  
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            H +    LV+EY+++  L  YL      +    +        +GL Y H+   ++I+H 
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHR 127

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D+KP+N+L++     K+ADFGLA+   ++    T S    T  Y  P+ L G+   +   
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185

Query: 210 DVYSFGMVLFEIVGRR 225
           D++  G +L+E+   R
Sbjct: 186 DMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 12/97 (12%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-HVT---ISGYK 188
           +GL YLH      I+H DIKP N+L+++N   K+ DFGLA++ + + S H+T   ++ Y 
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
               Y APE L G+   T   D++S G +  E++GRR
Sbjct: 170 ----YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 40/214 (18%)

Query: 31  RLGFGGFGEVYKGQ--FPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHIN 82
           ++G G +G VYK +    N   IA+K +     R+ +E        + E+  +    H N
Sbjct: 9   KIGEGTYGVVYKARDRVTNET-IALKKI-----RLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 83  LVRLYGFCHDQHMTALVYEYME-------NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 135
           +VRL    H +    LV+EY++       + S D   F K   +    L++I     +G+
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPD---FAKNPRLIKTYLYQIL----RGI 115

Query: 136 VYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAK---LCDRNRSHVTISGYKGTP 191
            Y H     R++H D+KP+N+L+D    + K+ADFGLA+   +  R  +H  +     T 
Sbjct: 116 AYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-----TL 167

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            Y APE L G+   +   D++S G +  E+V ++
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 43/227 (18%)

Query: 28  YSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 81
           Y   +G G FG V++ + P  +       +AVK+L        +  F  E   +    H 
Sbjct: 9   YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLDGYL---------------------FGKKRAIE 120
           N+V+L G C       L++EYM  G L+ +L                           + 
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
             +   IA   A G+ YL E   ++ +H D+   N L+  N   K+ADFGL+      R+
Sbjct: 129 CTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS------RN 179

Query: 181 HVTISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             +   YK +        +  PE +  N   T + DV+++G+VL+EI
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 50/225 (22%)

Query: 32  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 82

Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 + ++
Sbjct: 83  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H 
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH- 192

Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            I  YK T        + APE L      TH+ DV+SFG++L+EI
Sbjct: 193 -IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 50/225 (22%)

Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 79

Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA---------- 128
            H N++ L G C       ++ EY   G+L  YL  + R    E  ++IA          
Sbjct: 80  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDIARVPDEQMTFK 137

Query: 129 ------IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
                    A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  D N    
Sbjct: 138 DLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVN---- 188

Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            I  YK T        + APE L  +   TH+ DV+SFG++++EI
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 56/282 (19%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLY 87
           +G G FG VY  +   N   +A+K ++ + G+ + E++   + EV  + +  H N ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    +H   LV EY   GS    L   K+ ++  ++  +  G  +GL YLH      +I
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMI 137

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNY 203
           H D+K  N+LL      K+ DFG A +       V      GTP + APE +     G Y
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEGQY 191

Query: 204 PITHKCDVYSFGMVLFEIVGRR-----RNAI-----VGSSESLDWFPKHVWEEYEKSELD 253
               K DV+S G+   E+  R+      NA+     +  +ES      H W EY ++ +D
Sbjct: 192 --DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH-WSEYFRNFVD 248

Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
           +                        C+Q  P+DRP    ++K
Sbjct: 249 S------------------------CLQKIPQDRPTSEVLLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)

Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 11  SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E          +K+ ++A   A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TP 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 131 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 185

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 186 RWMSPESLKDGVFTTYS-DVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 61/195 (31%), Positives = 90/195 (46%), Gaps = 11/195 (5%)

Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTY-HINLVRLY 87
           +G G FG+V   +   +G   AVKVL +   L +  +   MAE   + +   H  LV L+
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
                      V +Y+  G L  +L  ++  +E  +    A   A  + YLH      II
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-PRARFYAAEVASAIGYLH---SLNII 118

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           + D+KPEN+LLD+     + DFGL K  +      T S + GTP Y APE L    P   
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE-PYDR 175

Query: 208 KCDVYSFGMVLFEIV 222
             D +  G VL+E++
Sbjct: 176 TVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 26/206 (12%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGF 89
           +G G +G+VYKG+    G   A+KV++  +    EE+   E+  + + ++H N+   YG 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 90  C-------HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEE 141
                   HD  +  LV E+   GS+   +   K  A++ + +  I     +GL +LH  
Sbjct: 82  FIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH-- 138

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN--RSHVTISGYKGTPGYSAPEFL 199
              ++IH DIK +NVLL  N   K+ DFG++   DR   R +  I    GTP + APE +
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----GTPYWMAPEVI 193

Query: 200 S----GNYPITHKCDVYSFGMVLFEI 221
           +     +    ++ D++S G+   E+
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.9 bits (160), Expect = 3e-12
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 23/199 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G FGEV+KG      K+ A+K+++        E    E+  + +     + + YG 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 90  CHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 143
                   ++ EY+  GS LD         +E   L E  I T      KGL YLH E  
Sbjct: 71  YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 120

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            + IH DIK  NVLL  +   K+ADFG+A +L D   + +  + + GTP + APE +  +
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIKQS 176

Query: 203 YPITHKCDVYSFGMVLFEI 221
                K D++S G+   E+
Sbjct: 177 -AYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 48/224 (21%)

Query: 32  LGFGGFGEVYKG-------QFPN-GVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V +          P+  V +AVK+L     +++L  +  E  + ++  IG+ 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKL--IGK- 76

Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK-----RAIEWEKLHE------- 126
            H N++ L G C  +    ++ EY   G+L  +L  ++        +  K+ E       
Sbjct: 77  -HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 127 ---IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A   A+G+ YL     +R IH D+   NVL+  +   K+ADFGLA      R    
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLA------RGVHD 186

Query: 184 ISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
           I  YK T        + APE L  +   TH+ DV+SFG++++EI
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 26/207 (12%)

Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINL 83
           ++G G +G VYKG+    G  +A+K +     R+  E+       + E+  +    H N+
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKI-----RLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           V L      +    L++E++    L  YL    K + ++ E +        +G+++ H  
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH-- 118

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEF 198
             +R++H D+KP+N+L+D     K+ADFGLA+   +  R  +H  +     T  Y APE 
Sbjct: 119 -SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYRAPEV 172

Query: 199 LSGNYPITHKCDVYSFGMVLFEIVGRR 225
           L G+   +   D++S G +  E+  ++
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 63/197 (31%), Positives = 91/197 (46%), Gaps = 15/197 (7%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTY-HINLVRLY 87
           +G G FG+V   +     K  AVKVL +   L +  ++  MAE   + +   H  LV L+
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYLHEECQQRI 146
                      V +Y+  G L  +L  ++   E   + +   I +A G  YLH      I
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS---LNI 117

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPI 205
           I+ D+KPEN+LLD+     + DFG   LC     H  T S + GTP Y APE L    P 
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFG---LCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ-PY 173

Query: 206 THKCDVYSFGMVLFEIV 222
               D +  G VL+E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 34/208 (16%)

Query: 30  TRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRL 86
           T++G GG+G+V+  +  +  +I A+K + ++L     E    + E   +  T    LV+L
Sbjct: 7   TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66

Query: 87  -YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE----- 140
            Y F  D+++  L  EY+  G     L           L E     A+   Y+ E     
Sbjct: 67  LYAFQDDEYLY-LAMEYVPGGDFRTLLNNLG------VLSE---DHAR--FYMAEMFEAV 114

Query: 141 -ECQQR-IIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPE 197
               +   IH D+KPEN L+DA+   K+ DFGL+K +     S V      G+P Y APE
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPE 168

Query: 198 FLSG-NYPITHKCDVYSFGMVLFE-IVG 223
            L G  Y      D +S G +L+E + G
Sbjct: 169 VLRGKGY--DFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 35/221 (15%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G GG GEVY    P    ++A+K +  +L    + +++F+ E        H  +V +Y 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKL-HEIAIGTAKG--LVYLHEECQ-- 143
            C D         Y+E  +L   L   K   + E L  E+A  T+ G  L   H+ C   
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLL---KSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 144 -----QRIIHYDIKPENVLLDANFSPKV-ADFGLAKLCDRNR---------------SHV 182
                + ++H D+KP+N+LL   F   V  D+G A                      S +
Sbjct: 127 EYVHSKGVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 183 TISG-YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           TI G   GTP Y APE L G  P +   D+Y+ G++L++++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 18/217 (8%)

Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNG--VKIAVKVLNRN--LGRIAEE 66
           ++P R   ++  +F  N+   LG G FG V    + N     +A+K   ++  + +   +
Sbjct: 19  KEPKRKNKMKYEDF--NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76

Query: 67  QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 126
              +E   +    H   V LYG   D+    LV E++  G    +L   KR       ++
Sbjct: 77  HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP-----ND 131

Query: 127 IAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185
           +    A  +V + E  Q   I++ D+KPEN+LLD +   K+ DFG AK+ D  R++    
Sbjct: 132 VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-TRTYTLC- 189

Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
              GTP Y APE L  N       D ++ G+ ++EI+
Sbjct: 190 ---GTPEYIAPEILL-NVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 25/210 (11%)

Query: 32  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V+  +  N       + +AVK L +     A + F  E   +    H ++VR
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIVR 71

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRA---IEWEKLHEIAIGT 131
            YG C +     +V+EYM +G L+ +L            G+  A   +   ++  IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A G+VYL        +H D+   N L+      K+ DFG+++    +  +  + G    P
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLP 187

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
               P         T + D++SFG+VL+EI
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.5 bits (159), Expect = 6e-12
 Identities = 54/160 (33%), Positives = 85/160 (53%), Gaps = 10/160 (6%)

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H  LV L+     +     V EY+  G L  ++  ++R +  E     +   +  L YLH
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLH 113

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
           E   + II+ D+K +NVLLD+    K+ D+G+ K  +  R   T S + GTP Y APE L
Sbjct: 114 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL 168

Query: 200 SG-NYPITHKCDVYSFGMVLFEIV-GRRRNAIVGSSESLD 237
            G +Y  +   D ++ G+++FE++ GR    IVGSS++ D
Sbjct: 169 RGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 20/203 (9%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGF 89
           +G G +G+VYKG+    G   A+KV++  +    EE+   E+  + + ++H N+   YG 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 90  CHDQHMTA------LVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEEC 142
              ++         LV E+   GS+   +   K   ++ E +  I     +GL +LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-- 200
           Q ++IH DIK +NVLL  N   K+ DFG++   DR         + GTP + APE ++  
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACD 186

Query: 201 GNYPITH--KCDVYSFGMVLFEI 221
            N   T+  K D++S G+   E+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 40/285 (14%)

Query: 32  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 84
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 135
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGY 193
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG     +
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 187

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
            APE L      T   D++SFG+VL+EI         G S           E+  K  +D
Sbjct: 188 MAPESLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSN----------EQVLKFVMD 236

Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                 G  ++     +R+      C Q +P+ RP    +V +L+
Sbjct: 237 G-----GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 64.9 bits (159), Expect = 8e-12
 Identities = 51/171 (29%), Positives = 73/171 (42%), Gaps = 36/171 (21%)

Query: 80  HINLVRLYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK---- 133
           H N+VRL      +   +  +V+EYM++  L G L             +      K    
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLD--------SPEVKFTESQIKCYMK 107

Query: 134 ----GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVT---IS 185
               GL YLH      I+H DIK  N+L++ +   K+ADFGLA     RN +  T   I 
Sbjct: 108 QLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163

Query: 186 GYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
               T  Y  PE L G   Y    + D++S G +L E+    +    GS+E
Sbjct: 164 ----TLWYRPPELLLGATRY--GPEVDMWSVGCILAELF-LGKPIFQGSTE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.5 bits (157), Expect = 8e-12
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 18/204 (8%)

Query: 32  LGFGGFGEVYKGQFPNGVKIA---VKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FG+V  G+   G+  A   VK L  +     +  F+ EV       H N+++  G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAI----EWEKLHEIAIGTAKGLVYLHEECQQ 144
            C +     LV E+   G L  YL   +  +    + + L  +A   A GL++LH   Q 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNY 203
             IH D+   N  L A+ S K+ D+GLA L      +         P  + APE +    
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 204 P------ITHKCDVYSFGMVLFEI 221
                   T K +++S G+ ++E+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 23/199 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVK--IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           R+G G FGEV+KG   N  +  +A+K+++        E    E+  + +     + + YG
Sbjct: 11  RIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 143
                    ++ EY+  GS    L    RA  ++   E  I T      KGL YLH E  
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGLDYLHSE-- 120

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            + IH DIK  NVLL      K+ADFG+A +L D   + +  + + GTP + APE +  +
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIQQS 176

Query: 203 YPITHKCDVYSFGMVLFEI 221
                K D++S G+   E+
Sbjct: 177 -AYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 64.6 bits (157), Expect = 9e-12
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 27/207 (13%)

Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLVRLYG- 88
           +G G +G+VYK     +G   AVK+L+       +E+  AE   +     H N+V+ YG 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 89  FCHDQHMTA----LVYEYMENGS----LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           F     +      LV E    GS    + G L   +R  E   +  I  G   GL +LH 
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE-AMISYILYGALLGLQHLH- 145

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCD-RNRSHVTISGYKGTPGYSAPEF 198
               RIIH D+K  N+LL      K+ DFG+ A+L   R R + ++    GTP + APE 
Sbjct: 146 --NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMAPEV 199

Query: 199 LSG----NYPITHKCDVYSFGMVLFEI 221
           ++     +Y    +CDV+S G+   E+
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 48/224 (21%)

Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L     +++L  +  E  M ++  IG+ 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM--IGK- 76

Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 77  -HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L   A   A+G+ YL     Q+ IH D+   NVL+  +   K+ADFGLA      R    
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA------RDVHN 186

Query: 184 ISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
           I  YK T        + APE L  +   TH+ DV+SFG++L+EI
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.7 bits (160), Expect = 9e-12
 Identities = 41/132 (31%), Positives = 67/132 (50%), Gaps = 1/132 (0%)

Query: 95  MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE 154
           M ALV +Y   G L   +  + +     + HE  +   + L+ +H    + +IH DIK  
Sbjct: 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172

Query: 155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSF 214
           N+LL +N   K+ DFG +K+     S      + GTP Y APE      P + K D++S 
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSL 231

Query: 215 GMVLFEIVGRRR 226
           G++L+E++  +R
Sbjct: 232 GVLLYELLTLKR 243

Length = 496

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 13/219 (5%)

Query: 11  EKPVR-FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEE 66
           EK VR    LQ+     +    +G G FGEV   +  +  K+ A+K+L++   + R    
Sbjct: 29  EKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSA 88

Query: 67  QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 126
            F  E   +       +V+L+    D     +V EYM  G L   +       +W K + 
Sbjct: 89  FFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY- 147

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
               TA+ ++ L       +IH D+KP+N+LLD +   K+ADFG     D     V    
Sbjct: 148 ----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMVRCDT 202

Query: 187 YKGTPGYSAPEFLS---GNYPITHKCDVYSFGMVLFEIV 222
             GTP Y +PE L    G+     +CD +S G+ LFE++
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 64.8 bits (158), Expect = 9e-12
 Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 10/142 (7%)

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
            Y F  D+    LV EY   G L   L  +      E + +  +  A+ ++ +H   Q  
Sbjct: 67  QYAF-QDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYL--AELVLAIHSVHQMG 122

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL---SGN 202
            +H DIKPENVL+D     K+ADFG A     N+  V      GTP Y APE L   +G+
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGD 181

Query: 203 YPITH--KCDVYSFGMVLFEIV 222
              T+  +CD +S G++ +E++
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 63/196 (32%), Positives = 89/196 (45%), Gaps = 13/196 (6%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTY-HINLVRLY 87
           +G G FG+V   +     K  AVKVL +   L +  E+  M+E   + +   H  LV L+
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
                      V +Y+  G L  Y   ++R     +    A   A  L YLH      I+
Sbjct: 63  FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIV 118

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPIT 206
           + D+KPEN+LLD+     + DFG   LC  N  H  T S + GTP Y APE L    P  
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFG---LCKENIEHNGTTSTFCGTPEYLAPEVLHKQ-PYD 174

Query: 207 HKCDVYSFGMVLFEIV 222
              D +  G VL+E++
Sbjct: 175 RTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 17/196 (8%)

Query: 32  LGFGGFGEVYKGQFPNGVK-IAVKVLN-RNLGRIAEEQFM-AEVGTIGRTYHINLVRLYG 88
           +G G FG V+  +        A+KV+    + R+ +EQ +  E   +    H  ++RL+ 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA-IGTAKGLVYLHEECQQRII 147
             HDQ    ++ EY+  G L  YL    R      L   + I  A  L YLH    + I+
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA--LEYLH---SKEIV 123

Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           + D+KPEN+LLD     K+ DFG AK L DR     T+    GTP Y APE +  +    
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---WTLC---GTPEYLAPEVI-QSKGHN 176

Query: 207 HKCDVYSFGMVLFEIV 222
              D ++ G++++E++
Sbjct: 177 KAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)

Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRL 86
           LG G FG V + Q      +  K+AVK+L  ++   ++ E+F+ E   +    H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 87  YGFCHDQH------MTALVYEYMENGSLDGYLFGKKRA-----IEWEKLHEIAIGTAKGL 135
            G            +  ++  +M++G L  +L   +       +  + L    I  A G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
            YL     +  IH D+   N +L+ N +  VADFGL+K       +      K    + A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            E L+ N   TH  DV++FG+ ++EI+ R
Sbjct: 184 LESLADNVYTTHS-DVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT--ISGYKGTP 191
           GL Y+H      ++H D+KP N+L++A+   K+ DFGLA+    N       ++ Y  T 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            Y APE +      T   DV+S G +L E++GR+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 20/215 (9%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVL----NRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           +G G +G VYK + P+ G  +A+K +    N +   ++  + +A +  +    H N+VRL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 87  YGFCH----DQHM-TALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHE 140
              C     D+     LV+E+++   L  YL       +  E + ++     +GL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
            C   I+H D+KPEN+L+ +    K+ADFGLA++       + ++    T  Y APE L 
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLL 180

Query: 201 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES 235
            +   T   D++S G +  E+  RR+    G+SE+
Sbjct: 181 QSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 24/201 (11%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVR 85
           R+G G +G+VYK +    G   AVK++    G     I +E FM     +    H N+V 
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM-----VKECKHCNIVA 70

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
            +G    +    +  EY   GSL   ++     +   ++  +   T +GL YLH + +  
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK-- 127

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK---GTPGYSAPEF--LS 200
            +H DIK  N+LL  N   K+ADFG+A      +   TI+  K   GTP + APE   + 
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 201 GNYPITHKCDVYSFGMVLFEI 221
            N      CD+++ G+   E+
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 18/198 (9%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIA----VKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           ++G G +G V+K +     +I     V++ + + G       + E+  +    H N+VRL
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELKHKNIVRL 64

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y   H      LV+EY +   L  Y       I+ E +        KGL + H      +
Sbjct: 65  YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNV 120

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
           +H D+KP+N+L++ N   K+ADFGLA+   +  R  S   +     T  Y  P+ L G  
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLFGAK 175

Query: 204 PITHKCDVYSFGMVLFEI 221
             +   D++S G +  E+
Sbjct: 176 LYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 78/251 (31%), Positives = 110/251 (43%), Gaps = 32/251 (12%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVL--NRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGFGEV   Q    G   A K L   R   R  E   + E   + +     +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 89  FCHDQHMTALVYEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
               +    LV   M  G L  ++       F + RA+ +      A     GL  LH+E
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY------AAEICCGLEDLHQE 121

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
              RI++ D+KPEN+LLD +   +++D GLA      +   TI G  GT GY APE +  
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVK- 174

Query: 202 NYPITHKCDVYSFGMVLFEIVG------RRRNAIVGSSESLDWFPKHVWEEY-EKSELDA 254
           N   T   D ++ G +L+E++       +R+  I    E ++   K V EEY EK   DA
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVQEEYSEKFSPDA 232

Query: 255 TILACGIEEKD 265
             L   +  KD
Sbjct: 233 RSLCKMLLCKD 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 23/202 (11%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI-NLVRLYGF 89
           +G G  G+VYK +F   G  +AVK + R   +   ++ + ++  + +++    +V+ YG+
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                   +  E M    LD  L   +  I  + L ++ +   K L YL E+    +IH 
Sbjct: 83  FITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHR 139

Query: 150 DIKPENVLLDANFSPKVADFGLA-KLCD---RNRSHVTISGYKGTPGYSAPEFLS----- 200
           D+KP N+LLDA+ + K+ DFG++ +L D   + RS        G   Y APE +      
Sbjct: 140 DVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-------AGCAAYMAPERIDPPDPN 192

Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
             Y I  + DV+S G+ L E+ 
Sbjct: 193 PKYDI--RADVWSLGISLVELA 212

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 22/199 (11%)

Query: 32  LGFGGFGEVYKGQFPNG-VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY-GF 89
           +G G FG     Q  N   K A+K +       A E    E   + +  H N+V     F
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 90  CHDQHMTALVYEYMENGSL-------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
             D H+  +V EY + G L        G LF +   ++W       +    G+ ++HE  
Sbjct: 68  EADGHLY-IVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHE-- 118

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            +R++H DIK +N+ L  N   K+ DFG A+L     ++     Y GTP Y  PE    N
Sbjct: 119 -KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWE-N 174

Query: 203 YPITHKCDVYSFGMVLFEI 221
            P  +K D++S G +L+E+
Sbjct: 175 MPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 15/200 (7%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-----FMAEVGTIGRTYHINLVR 85
           +LG G +  V+KG+     K+   ++     R+  E+      + EV  +    H N+V 
Sbjct: 13  KLGEGTYATVFKGR----SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L+   H      LV+EY++   L  Y+      +    +        +GL Y H   +++
Sbjct: 69  LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRK 124

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           ++H D+KP+N+L++     K+ADFGLA+   ++    T S    T  Y  P+ L G+   
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 206 THKCDVYSFGMVLFEIVGRR 225
           + + D++  G + FE+   R
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 30/219 (13%)

Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQ---FMA--EVGTIGRTYHINLV 84
           +LG G +  VYKG+    G  +A+K +     R+  E+   F A  E   +    H N+V
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEI-----RLEHEEGAPFTAIREASLLKDLKHANIV 66

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT---AKGLVYLHEE 141
            L+   H +    LV+EY++   L  Y+      +    +H + +      +GL Y H  
Sbjct: 67  TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGL---SMHNVRLFLFQLLRGLAYCH-- 120

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG---TPGYSAPEF 198
            Q+R++H D+KP+N+L+      K+ADFGLA    R +S V    Y     T  Y  P+ 
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLA----RAKS-VPSKTYSNEVVTLWYRPPDV 174

Query: 199 LSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD 237
           L G+   +   D++  G + +E+    R    GS++  D
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVED 212

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 65/238 (27%), Positives = 99/238 (41%), Gaps = 40/238 (16%)

Query: 25  TSNY--STRLGFGGFGEVYKG-QFPNGVKIAVK-VLNRNLGRIAEEQF----MAEVGTIG 76
             +Y    +LG G FGEVYK  Q   G  +A+K +L  N     ++ F    + E+  + 
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN----EKDGFPITALREIKILK 62

Query: 77  RTYHINLVRLYGFCHDQHMTA--------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
           +  H N+V L     ++   +        +V  YM++  L G L      +   ++    
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYM 121

Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
           +   +G+ YLHE     I+H DIK  N+L+D     K+ADFGLA+  D            
Sbjct: 122 LQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGP---PPNPKGG 175

Query: 189 GTPG------------YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
           G  G            Y  PE L G    T   D++  G V  E+   RR  + G S+
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF-TRRPILQGKSD 232

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 21/200 (10%)

Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTY-HINLVRLY 87
           LG G FG+V+  +        A+K L +++  + +  E  M E   +   + H  L  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
                +     V EY+  G L  ++     F   RA  +    EI  G    L +LH   
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAA--EIICG----LQFLH--- 113

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            + I++ D+K +N+LLD +   K+ADFG+ K  +          + GTP Y APE L G 
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 203 YPITHKCDVYSFGMVLFEIV 222
                  D +SFG++L+E++
Sbjct: 172 -KYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 25/202 (12%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G +G VY  +     V+IA+K +     R  +     E+       H N+V+  G  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGSD 74

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWE--KLHEIAIG-----TAKGLVYLHEECQ 143
            +     +  E +  GSL   L  K     W   K +E  I        +GL YLH+   
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSK-----WGPLKDNEQTIIFYTKQILEGLKYLHD--- 126

Query: 144 QRIIHYDIKPENVLLDANFSP--KVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLS 200
            +I+H DIK +NVL++  +S   K++DFG +K L   N    T   + GT  Y APE + 
Sbjct: 127 NQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTET---FTGTLQYMAPEVID 182

Query: 201 -GNYPITHKCDVYSFGMVLFEI 221
            G        D++S G  + E+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.9 bits (154), Expect = 4e-11
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 12/98 (12%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTP 191
           +GL YLH      +IH D+KP N+L+++N   K+ DFGLA+ +         ++ Y  T 
Sbjct: 114 RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170

Query: 192 GYSAPEFL--SGNY--PITHKCDVYSFGMVLFEIVGRR 225
            Y APE L  S  Y   I    D++S G +  E++ R+
Sbjct: 171 WYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 16/199 (8%)

Query: 30  TRLGFGGFGEVYKGQF-PNGVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTYHINL 83
           +++G G +G V+K +    G  +A+K       +  + +IA    + E+  + +  H NL
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA----LREIRMLKQLKHPNL 62

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
           V L      +    LV+EY ++  L+  L    R +    + +I   T + + + H   +
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLN-ELEKNPRGVPEHLIKKIIWQTLQAVNFCH---K 118

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
              IH D+KPEN+L+      K+ DFG A++        T   Y  T  Y APE L G+ 
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVATRWYRAPELLVGDT 176

Query: 204 PITHKCDVYSFGMVLFEIV 222
                 DV++ G V  E++
Sbjct: 177 QYGPPVDVWAIGCVFAELL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 43/213 (20%)

Query: 31  RLGFGGFGEVY-----KGQFPNGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 81
           RLG G FG VY     K      +K    I V  LN N       Q   E   + +  H 
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN----ETVQANQEAQLLSKLDHP 62

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLD---------GYLFGKKRAIEWEKLHEIAIGTA 132
            +V+ +    ++    ++ EY E   LD         G    + +  EW       I   
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLL 116

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL----CDRNRSHVTISGYK 188
            G+ Y+H   Q+RI+H D+K +N+ L  N   K+ DFG+++L    CD        + + 
Sbjct: 117 LGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD------LATTFT 166

Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
           GTP Y +PE L  +     K D++S G +L+E+
Sbjct: 167 GTPYYMSPEALK-HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 5/95 (5%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVT-ISGYKGT 190
           +GL Y+H      +IH D+KP N+L++ +   ++ DFG+A+ L      H   ++ Y  T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
             Y APE L      T   D++S G +  E++GRR
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 18/198 (9%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           +G G +G V K +    G  +A+K       ++ + +IA    M E+  + +  H NLV 
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA----MREIRMLKQLRHENLVN 64

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L      +    LV+E++++  LD  L      ++  ++ +      +G+ + H      
Sbjct: 65  LIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH---SHN 120

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
           IIH DIKPEN+L+  +   K+ DFG A+ L      +   + Y  T  Y APE L G+  
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---TDYVATRWYRAPELLVGDTK 177

Query: 205 ITHKCDVYSFGMVLFEIV 222
                D+++ G ++ E++
Sbjct: 178 YGRAVDIWAVGCLVTEML 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
           +GL Y+H      ++H D+KP N+LL+AN   K+ DFGLA+        +T   Y  T  
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMT--EYVVTRW 173

Query: 193 YSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRR 225
           Y APE L     Y  T   DV+S G +  E++GR+
Sbjct: 174 YRAPELLLNCSEY--TTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 13/196 (6%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE--EQFMAEVGTIG-RTYHINLVRLY 87
           LG G FG+V   +     +  A+K L +++    +  E  M E   +     H  L  L+
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 88  -GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
             F   +H+   V EY+  G L  ++    R  +  +    A     GL +LH   ++ I
Sbjct: 63  CTFQTKEHLF-FVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KKGI 117

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           I+ D+K +NVLLD +   K+ADFG+ K  + N      S + GTP Y APE L G     
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKA-STFCGTPDYIAPEILKGQ-KYN 174

Query: 207 HKCDVYSFGMVLFEIV 222
              D +SFG++L+E++
Sbjct: 175 ESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 76/256 (29%), Positives = 104/256 (40%), Gaps = 33/256 (12%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVL--NRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGFGEV   Q    G   A K L   R   R  E   + E   + +     +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 89  FCHDQHMTALVYEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
               +    LV   M  G L  ++       F ++RA+ +    EI  G    L  LH E
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA--EITCG----LEDLHRE 121

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
              RI++ D+KPEN+LLD     +++D GLA          TI G  GT GY APE +  
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVK- 174

Query: 202 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI 261
           N   T   D +  G +++E+       I G S       K   EE E+   +        
Sbjct: 175 NERYTFSPDWWGLGCLIYEM-------IEGKSPFRQRKEKVKREEVERRVKEDQEE---Y 224

Query: 262 EEKDKEKAKRLCMAAL 277
            EK  E A+ +C   L
Sbjct: 225 SEKFSEAARSICRQLL 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 18/102 (17%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
           K L Y+H      +IH D+KP N+LL+++   K+ADFGLA      RS   +      P 
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA------RSLSELEENPENPV 168

Query: 193 ---------YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
                    Y APE L G+   T   D++S G +L E++  +
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMAEVGTIGRTYHINL 83
           +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M  + + G    I +
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-V 60

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
              Y F H       + + M  G L  Y   +      +++   A     GL ++H    
Sbjct: 61  CMTYAF-HTPDKLCFILDLMNGGDLH-YHLSQHGVFSEKEMRFYATEIILGLEHMH---N 115

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
           + +++ D+KP N+LLD +   +++D GLA    + + H ++    GT GY APE L    
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGT 171

Query: 204 PITHKCDVYSFGMVLFEIV 222
                 D +S G +LF+++
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTI--GRTYHINLVRL 86
           +G G FGEV   +  +  +I A+K+LN+   L R     F  E   +  G    I  +  
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH- 67

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           Y F  + ++  LV +Y   G L   L  F  +   +  + +      A+ ++ +H   Q 
Sbjct: 68  YAFQDENYLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAIHSIHQL 121

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS---- 200
             +H DIKP+NVLLD N   ++ADFG     +++ + V  S   GTP Y +PE L     
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMED 180

Query: 201 --GNYPITHKCDVYSFGMVLFEIV 222
             G Y    +CD +S G+ ++E++
Sbjct: 181 GMGKY--GPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 15/197 (7%)

Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTY-HINLVRLY 87
           LG G FG+V   +    G   AVK L +++  I +  E  M E   +   + +  L  LY
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
                +     V E++  G L  ++  K R  +  +    A     GL +LH    + II
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SKGII 118

Query: 148 HYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           + D+K +NV+LD +   K+ADFG+ K  +   NR+    S + GTP Y APE L G    
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA----STFCGTPDYIAPEILQG-LKY 173

Query: 206 THKCDVYSFGMVLFEIV 222
           T   D +SFG++L+E++
Sbjct: 174 TFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 13/196 (6%)

Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTY-HINLVRLY 87
           +G G FG+V   +   +G   AVKVL +   L R  ++  MAE   + +   H  LV L+
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
                      V +++  G L  +L  ++R+    +    A   A  L YLH      I+
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHL-QRERSFPEPRARFYAAEIASALGYLH---SINIV 118

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPIT 206
           + D+KPEN+LLD+     + DFG   LC    +   T + + GTP Y APE +    P  
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFG---LCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ-PYD 174

Query: 207 HKCDVYSFGMVLFEIV 222
           +  D +  G VL+E++
Sbjct: 175 NTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 22/200 (11%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLY-G 88
           +G G +GEV   +   +G +  +K LN RN  R   +    E   + +  H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 89  FCHDQHMTALVYEYMENGSL-------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           +  +  +  +V  + E G L        G L  + + +EW       +  A  L YLHE+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYLHEK 121

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
               I+H D+K +NV L      KV D G+A++ +        S   GTP Y +PE  S 
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STLIGTPYYMSPELFS- 175

Query: 202 NYPITHKCDVYSFGMVLFEI 221
           N P  +K DV++ G  ++E+
Sbjct: 176 NKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 8/96 (8%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTP 191
           +GL Y+H      ++H D+KP N+LL+ N   K+ DFGLA++ D    H   ++ Y  T 
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 192 GYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRR 225
            Y APE +  S  Y  T   D++S G +L E++  R
Sbjct: 174 WYRAPEIMLNSKGY--TKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 37/97 (38%), Positives = 56/97 (57%), Gaps = 10/97 (10%)

Query: 126 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185
           EIAIG    L +LH    + II+ D+K +NV+LDA    K+ADFG+ K  +      T  
Sbjct: 109 EIAIG----LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTR 159

Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            + GTP Y APE ++   P     D ++FG++L+E++
Sbjct: 160 TFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)

Query: 17  TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNR-NLGRIAEEQFMAEVGT 74
           T L++     +    +G G FGEV   +  +  ++ A+K+L++  + + ++  F  E   
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 75  IGRTYHIN---LVRL-YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 130
           I    H N   +V+L Y F  D+++  +V EYM  G L   +       +W + +   + 
Sbjct: 96  I--MAHANSEWIVQLHYAFQDDKYLY-MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVV 152

Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            A  L  +H       IH D+KP+N+LLD +   K+ADFG     D N   V      GT
Sbjct: 153 LA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGT 206

Query: 191 PGYSAPEFL---SGNYPITHKCDVYSFGMVLFEIV 222
           P Y +PE L    G+     +CD +S G+ L+E++
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 18/200 (9%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVR-L 86
           ++G G F EVY+     +   +A+K +     +   A +  + E+  + +  H N+++ L
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68

Query: 87  YGFCHDQHMTALVYEYMENGSLDG---YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
             F  D  +  +V E  + G L     Y   +KR I    + +  +     + ++H    
Sbjct: 69  DSFIEDNELN-IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---S 124

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSG 201
           +R++H DIKP NV + A    K+ D GL +      S  T + +   GTP Y +PE +  
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPERIHE 180

Query: 202 NYPITHKCDVYSFGMVLFEI 221
           N     K D++S G +L+E+
Sbjct: 181 N-GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 16/199 (8%)

Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           ++G G F EVY+     +GV +A+K +     +   A    + E+  + +  H N+++ Y
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL--FGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
               + +   +V E  + G L   +  F K KR I  + + +  +     L ++H    +
Sbjct: 69  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SR 125

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSGN 202
           R++H DIKP NV + A    K+ D GL +      S  T + +   GTP Y +PE +  N
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 203 YPITHKCDVYSFGMVLFEI 221
                K D++S G +L+E+
Sbjct: 182 -GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 48/142 (33%), Positives = 77/142 (54%), Gaps = 10/142 (7%)

Query: 98  LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL 157
            V E++  G L  +   ++R +  E     +   +  L +LHE   + II+ D+K +NVL
Sbjct: 73  FVIEFVSGGDL-MFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVL 128

Query: 158 LDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGM 216
           LDA    K+ D+G+ K  +  R   T S + GTP Y APE L G +Y  +   D ++ G+
Sbjct: 129 LDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS--VDWWALGV 184

Query: 217 VLFEIV-GRRRNAIVGSSESLD 237
           ++FE++ GR    IVG S++ D
Sbjct: 185 LMFEMMAGRSPFDIVGMSDNPD 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRL- 86
           LG G FG+V   +     K  A+K+L + +  IA+++    + E   +  T H  L  L 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEV-IIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y F         V EY   G L  +L  ++R    ++           L YLH      +
Sbjct: 62  YSF-QTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALGYLHS---CDV 116

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
           ++ D+K EN++LD +   K+ DFGL K  + D      T+  + GTP Y APE L  N  
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLEDN-D 171

Query: 205 ITHKCDVYSFGMVLFEIV-GR 224
                D +  G+V++E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 54/182 (29%), Positives = 94/182 (51%), Gaps = 21/182 (11%)

Query: 47  NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYME 104
           +G ++AVK+++ R   R   E    EV  I R Y H N+V +Y          ++ E+++
Sbjct: 45  SGRQVAVKMMDLRKQQR--RELLFNEV-VIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101

Query: 105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164
            G+L   +  + R  E E++  +     + L YLH    Q +IH DIK +++LL  +   
Sbjct: 102 GGALTD-IVSQTRLNE-EQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRV 156

Query: 165 KVADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
           K++DFG    ++K   + +S V      GTP + APE +S   P   + D++S G+++ E
Sbjct: 157 KLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVIS-RTPYGTEVDIWSLGIMVIE 209

Query: 221 IV 222
           +V
Sbjct: 210 MV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 30/207 (14%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINL 83
           R+G G +G VY+ +   +G  +A+K +     R+  E+       + E+  +    H N+
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 84  VRLYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           V L      +H+ +  LV EY E   L   L          ++  + +   +GL YLHE 
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAP 196
               IIH D+K  N+LL      K+ADFGLA    R            TP      Y AP
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLA----RTYGLPAKP---MTPKVVTLWYRAP 177

Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIVG 223
           E L G    T   D+++ G +L E++ 
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 31/209 (14%)

Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLVRLYGF 89
           +G G +G+V+K     NG K AVK+L+  +  I EE   AE   +   + H N+V+ YG 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEE-IEAEYNILKALSDHPNVVKFYGM 83

Query: 90  CHDQHMTA-----LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIG-----TAKGLVYL 138
            + + +       LV E    GS+   + G  KR    E++ E  I         GL +L
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG---ERMEEPIIAYILHEALMGLQHL 140

Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCD-RNRSHVTISGYKGTPGYSAP 196
           H     + IH D+K  N+LL      K+ DFG+ A+L   R R + ++    GTP + AP
Sbjct: 141 HV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMAP 193

Query: 197 EFLSGNYPI----THKCDVYSFGMVLFEI 221
           E ++    +      +CDV+S G+   E+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 50/181 (27%), Positives = 92/181 (50%), Gaps = 19/181 (10%)

Query: 47  NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN 105
            G ++AVK ++ R   R   E    EV  +   +H N+V +Y          +V E++E 
Sbjct: 46  TGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103

Query: 106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165
           G+L   +   +  +  E++  + +   + L YLH    Q +IH DIK +++LL ++   K
Sbjct: 104 GALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIK 158

Query: 166 VADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
           ++DFG    ++K   + +S V      GTP + APE +S   P   + D++S G+++ E+
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLV------GTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEM 211

Query: 222 V 222
           +
Sbjct: 212 I 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 22/205 (10%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVL--------NRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +G G FG VY G    +G  +AVK +        +++  R   +    E+  +    H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G   D     +  EY+  GS+   L  +G   A E   +        KGL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH- 123

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG----YKGTPGYSAP 196
              + IIH DIK  N+L+D     K++DFG++K  + N      +G     +G+  + AP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 197 EFLSGNYPITHKCDVYSFGMVLFEI 221
           E +      T K D++S G ++ E+
Sbjct: 182 EVVKQTS-YTRKADIWSLGCLVVEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 12/197 (6%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FGEV   +  +  K+ A+K+L++   + R     F  E   +       +V+L+ 
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              D     +V EYM  G L   +       +W + +     TA+ ++ L        IH
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIH 165

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS---GNYPI 205
            D+KP+N+LLD +   K+ADFG     ++    V      GTP Y +PE L    G+   
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYY 224

Query: 206 THKCDVYSFGMVLFEIV 222
             +CD +S G+ L+E++
Sbjct: 225 GRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 29/219 (13%)

Query: 32  LGFGGFGEVYKGQ-FPNG--------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +G G +G+V+K +   NG        V++        L  I E   +  + T     H N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPN 65

Query: 83  LVRLYGFC------HDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGL 135
           +VRL+  C       +  +T LV+E+++   L  YL    +  +  E + ++     +GL
Sbjct: 66  VVRLFDVCTVSRTDRETKLT-LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
            +LH     R++H D+KP+N+L+ ++   K+ADFGLA++       + ++    T  Y A
Sbjct: 124 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRA 177

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
           PE L  +   T   D++S G +  E+  RR+    GSS+
Sbjct: 178 PEVLLQSSYAT-PVDLWSVGCIFAEMF-RRKPLFRGSSD 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 9e-10
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 28/204 (13%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEE--QFMAEVGTIGRTYHIN---LVR 85
           +G G FG+VY+ +  +  +I A+KVL++      +E    + E   + RT       +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 86  L-YGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           L + F  D  +  LV +YM  G L  +L     F + RA  +  + E+ +     L +LH
Sbjct: 61  LKFSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSEDRAKFY--IAELVLA----LEHLH 113

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPE 197
           +     I++ D+KPEN+LLDA     + DFGL+K  L D      T + + GT  Y APE
Sbjct: 114 K---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK----TTNTFCGTTEYLAPE 166

Query: 198 FLSGNYPITHKCDVYSFGMVLFEI 221
            L      T   D +S G+++FE+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 7/90 (7%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
           +GL YLH    QRIIH D+K EN+ ++      + D G A+            G  GT  
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTVE 221

Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            +APE L+ +     K D++S G+VLFE++
Sbjct: 222 TNAPEVLARD-KYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 9/144 (6%)

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           LV L+          LV EY+  G L  ++  ++R +  E     A      L +LHE  
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHE-- 114

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG- 201
            + II+ D+K +NVLLDA+   K+ D+G+ K  +      T S + GTP Y APE L G 
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE 171

Query: 202 NYPITHKCDVYSFGMVLFEIVGRR 225
            Y  +   D ++ G+++FE++  R
Sbjct: 172 EYGFS--VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 20/203 (9%)

Query: 32  LGFGGFGEVY----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HIN--- 82
           LG G +G+V+     G    G   A+KVL +    I ++   AE     R     +    
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKK--ATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 83  -LVRL-YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            LV L Y F  D  +  L+ +Y+  G L  +L+ ++         E+ +  A+ ++ L  
Sbjct: 66  FLVTLHYAFQTDTKLH-LILDYVNGGELFTHLYQREHF----TESEVRVYIAEIVLALDH 120

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
             Q  II+ DIK EN+LLD+     + DFGL+K           S + GT  Y APE + 
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIR 179

Query: 201 GNYPITHKC-DVYSFGMVLFEIV 222
           G      K  D +S G++ FE++
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 67/232 (28%), Positives = 97/232 (41%), Gaps = 48/232 (20%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV   Q  +   I A+K L R    + +EQ     AE   +    +  +V+LY
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
               D++   L+ EY+  G +   L  K    E E    IA  T   +  +H   +   I
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIH---KLGYI 123

Query: 148 HYDIKPENVLLDANFSPKVADFGLAK--------LCDRNRSHVTISGYK----------- 188
           H DIKP+N+LLDA    K++DFGL             R  SH   S +            
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183

Query: 189 -----------------GTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
                            GTP Y APE FL   Y    +CD +S G++++E++
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY--NKECDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 16/200 (8%)

Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRL- 86
           LG G FG+V    +   G   A+K+L + +  IA+++    + E   +  T H  L  L 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEV-IIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 87  YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           Y F  HD+     V EY   G L  +L  ++R    E+           L YLH    + 
Sbjct: 62  YAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH---SRD 115

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +++ DIK EN++LD +   K+ DFGL K    + +  T+  + GTP Y APE L  N   
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN-DY 172

Query: 206 THKCDVYSFGMVLFEIVGRR 225
               D +  G+V++E++  R
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRL-Y 87
           LG G FG+V    +   G   A+K+L + +    +E    + E   +  + H  L  L Y
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 88  GF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            F  HD+     V EY   G L  +L  ++R    ++           L YLH E  + +
Sbjct: 63  SFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLHSE--KNV 117

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           ++ D+K EN++LD +   K+ DFGL K  +  +   T+  + GTP Y APE L  N    
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDN-DYG 174

Query: 207 HKCDVYSFGMVLFEIVGRR 225
              D +  G+V++E++  R
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 40/216 (18%)

Query: 29  STRLGFGGFGEVYKGQFP-NGVKIAVK-VLNRNLGRIAEEQF----MAEVGTIGRTYHIN 82
             ++G G FGEV+K +       +A+K VL  N     +E F    + E+  +    H N
Sbjct: 17  LAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN----EKEGFPITALREIKILQLLKHEN 72

Query: 83  LVRLYGFCH--------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKG 134
           +V L   C          +    LV+E+ E+  L G L  K       ++ ++      G
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNG 131

Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA------KLCDRNRSHVTISGYK 188
           L Y+H   + +I+H D+K  N+L+  +   K+ADFGLA      K    NR     +   
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR----YTNRV 184

Query: 189 GTPGYSAPEFLSG--NY--PITHKCDVYSFGMVLFE 220
            T  Y  PE L G  +Y  PI    D++  G ++ E
Sbjct: 185 VTLWYRPPELLLGERDYGPPI----DMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 19/181 (10%)

Query: 47  NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN 105
           +G  +AVK ++ R   R   E    EV  +    H N+V +Y          +V E++E 
Sbjct: 44  SGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101

Query: 106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165
           G+L   +   +  +  E++  + +   K L  LH    Q +IH DIK +++LL  +   K
Sbjct: 102 GALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVK 156

Query: 166 VADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
           ++DFG    ++K   R +S V      GTP + APE +S   P   + D++S G+++ E+
Sbjct: 157 LSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEM 209

Query: 222 V 222
           V
Sbjct: 210 V 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 22/201 (10%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMAEVGTIGRTYHINL 83
           +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M  + + G    I +
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-V 60

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
              Y F H     + + + M  G L  Y   +       ++   A     GL ++H    
Sbjct: 61  CMSYAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEAEMRFYAAEIILGLEHMH---N 115

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNRSHVTISGYKGTPGYSAPEFLSG 201
           + +++ D+KP N+LLD +   +++D GLA  CD  + + H ++    GT GY APE L  
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV----GTHGYMAPEVLQK 169

Query: 202 NYPITHKCDVYSFGMVLFEIV 222
                   D +S G +LF+++
Sbjct: 170 GVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 26/202 (12%)

Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRL 86
           R+G G +G+VYK +  N G   A+KV+    G    E F     E+  +    H N+V  
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPG----EDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           +G    +    +  E+   GSL   ++     +   ++  ++  T +GL YLH + +   
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--- 127

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK---GTPGYSAPEFLS--- 200
           +H DIK  N+LL  N   K+ADFG++      +   TI+  K   GTP + APE  +   
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA-----QITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 201 -GNYPITHKCDVYSFGMVLFEI 221
            G Y     CD+++ G+   E+
Sbjct: 183 KGGY--NQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 41/128 (32%), Positives = 70/128 (54%), Gaps = 11/128 (8%)

Query: 98  LVYEYMENGSLDGYLFGKKRAIEWEKLHEI--AIGTAKGLVYLHEECQQRIIHYDIKPEN 155
            V EY+  G L   ++  ++   +++ H +  A   A GL +LH    + II+ D+K +N
Sbjct: 78  FVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDN 131

Query: 156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
           V+LD+    K+ADFG+ K  +     VT   + GTP Y APE ++   P     D ++FG
Sbjct: 132 VMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFG 188

Query: 216 MVLFEIVG 223
           ++L+E++ 
Sbjct: 189 VLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 37/230 (16%)

Query: 6   QEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL- 60
           +E+ +   E P R+TSL           ++G G +G V        G K+A+K L+R   
Sbjct: 4   EEVNKTVWELPERYTSL----------KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ 53

Query: 61  GRIAEEQFMAEVGTIGRTYHINLVRLYGF------CHDQHMTALVYEYMEN--GSLDGYL 112
             I  ++   E+  +    H N++ L           +     LV  YM+     + G+ 
Sbjct: 54  SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP 113

Query: 113 FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
             +      +K+  +      GL Y+H      IIH D+KP N+ ++ +   K+ DFGLA
Sbjct: 114 LSE------DKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA 164

Query: 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           +  D       ++GY  T  Y APE +          D++S G ++ E++
Sbjct: 165 RHAD-----AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 76/267 (28%), Positives = 109/267 (40%), Gaps = 63/267 (23%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG GGFGEV   Q    G   A K L +   RI + +        G    +N  R+    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKK--RIKKRK--------GEAMALNEKRILEKV 57

Query: 91  HDQHMTALVYEY------------MENGSLDGYL-------FGKKRAIEWEKLHEIAIGT 131
           + + + +L Y Y            M  G L  ++       F ++RAI +      A   
Sbjct: 58  NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY------AAEL 111

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
             GL  L  E   RI++ D+KPEN+LLD     +++D GLA          T+ G  GT 
Sbjct: 112 CCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTV 165

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-----RRRNAIVGSSESLDWFPKHVWEE 246
           GY APE ++ N   T   D +  G +++E++      R+R   V   E +D   K   EE
Sbjct: 166 GYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRRVKEDQEE 223

Query: 247 YEKSELDATILACGIEEKDKEKAKRLC 273
           Y               EK  E AK +C
Sbjct: 224 Y--------------SEKFSEDAKSIC 236

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLY 87
           LG G FG+V    +  +G   A+K+L + +  IA+++    + E   +  T H  L  L 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEV-IIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
                +     V EY+  G L  +L  ++R    ++           L YLH     +I+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAEIVSALDYLH---SGKIV 117

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           + D+K EN++LD +   K+ DFGL K  +      T+  + GTP Y APE L  N     
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDN-DYGR 174

Query: 208 KCDVYSFGMVLFEIVGRR 225
             D +  G+V++E++  R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 39/222 (17%)

Query: 28  YSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHIN 82
           +   LG   FG++YKG  +  G+  A  V  + L  I   Q    F  E   +   +H N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK----------------KRAIEWEKLHE 126
           +V L G    +    +++EY+  G L  +L  +                K +++      
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
           IAI  A G+ YL        +H D+   N+L+      K++D GL+      R   +   
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLS------REIYSADY 179

Query: 187 YKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVLFEI 221
           Y+  P       +  PE  + G +  +   D++SFG+VL+EI
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKF--SSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 41/131 (31%), Positives = 71/131 (54%), Gaps = 17/131 (12%)

Query: 98  LVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK 152
            V EY+  G L  ++     F + +A+ +    EI++G    L +LH    + II+ D+K
Sbjct: 78  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA--EISVG----LFFLHR---RGIIYRDLK 128

Query: 153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVY 212
            +NV+LD+    K+ADFG+ K  +     VT   + GTP Y APE ++   P     D +
Sbjct: 129 LDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWW 185

Query: 213 SFGMVLFEIVG 223
           ++G++L+E++ 
Sbjct: 186 AYGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.7 bits (134), Expect = 7e-09
 Identities = 60/201 (29%), Positives = 88/201 (43%), Gaps = 23/201 (11%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR--------IAEEQFMAEVGTIGRTYHIN 82
           LG GGFGEV   Q    G   A K L +   +        + E+Q + +V +    + +N
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS---QFVVN 64

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEE 141
           L   Y     +    LV   M  G L  +++       E E+    A     GL  LH E
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
                ++ D+KPEN+LLD     +++D GLA       S   I G  GT GY APE L+ 
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLN- 174

Query: 202 NYPITHKCDVYSFGMVLFEIV 222
           N   T   D +  G +++E++
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVL--NRNLGRIAEE--QFMAEVGTIGRTYHINLVRL 86
           LG G FG VY       G ++AVK +  +      ++E      E+  +    H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 87  YGFCHD--QHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           YG   D  +   ++  E+M  GS+   L  +G   A+      +      +G+ YLH   
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLH--- 123

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK----LCDRNRSHVTISGYKGTPGYSAPEF 198
              I+H DIK  N+L D+  + K+ DFG +K    +C    S   +    GTP + +PE 
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC---LSGTGMKSVTGTPYWMSPEV 180

Query: 199 LSGNYPITHKCDVYSFGMVLFEIVGRR 225
           +SG      K D++S G  + E++  +
Sbjct: 181 ISGE-GYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 8/90 (8%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
           +GL Y+H      ++H D+KP N+L++ N   K+ DFGLA++ D     +T  GY  T  
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD---PQMT--GYVSTRY 170

Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           Y APE +        + D++S G +  E++
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 47/230 (20%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV   Q  + G   A+K+L R    + +EQ     AE   +     + +V+++
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
               D+    L+ E++  G +   L  K    E E    IA  T   +  +H   Q   I
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH---QLGFI 123

Query: 148 HYDIKPENVLLDANFSPKVADFGL----------------------------------AK 173
           H DIKP+N+LLD+    K++DFGL                                  A+
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183

Query: 174 LCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
              RNR  +  S   GTP Y APE F+   Y     CD +S G++++E++
Sbjct: 184 TWKRNRRQLAFSTV-GTPDYIAPEVFMQTGY--NKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 55.2 bits (133), Expect = 9e-09
 Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 19/158 (12%)

Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL-------DGYLFGKKRAIEWEK 123
           EV  +    H N+V+      +     +V +Y E G L        G LF + + ++W  
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW-- 106

Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
                +     L ++H+   ++I+H DIK +N+ L  + + K+ DFG+A++   N +   
Sbjct: 107 ----FVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVEL 157

Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
                GTP Y +PE    N P  +K D+++ G VL+E+
Sbjct: 158 ARTCIGTPYYLSPEICE-NRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FGEV   +  N  K+ A+K+LN+   L R     F  E   +    +  +  L+ 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 89  FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
              D++   LV +Y   G L   L  F  +   +  + +      A+ ++ +    Q   
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAIDSVHQLHY 123

Query: 147 IHYDIKPENVLLDANFSPKVADFG-LAKLCDRNRSHVTISGYKGTPGYSAPEFLS----G 201
           +H DIKP+N+L+D N   ++ADFG   KL +      +++   GTP Y +PE L     G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEDG 181

Query: 202 NYPITHKCDVYSFGMVLFEIV 222
                 +CD +S G+ ++E++
Sbjct: 182 KGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 34/84 (40%), Positives = 46/84 (54%), Gaps = 4/84 (4%)

Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
           Y+H E    IIH DIK ENVL++      + DFG A     + S     G  GT   +AP
Sbjct: 275 YIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 197 EFLSGNYPITHKCDVYSFGMVLFE 220
           E L+G+ P T   D++S G+V+FE
Sbjct: 332 EVLAGD-PYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 34/234 (14%)

Query: 4   FLQEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRN 59
           + QE+ +   E P R+ +L          + +G G +G V        G+++AVK L+R 
Sbjct: 4   YRQELNKTIWEVPERYQNL----------SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 53

Query: 60  LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 116
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 54  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 109

Query: 117 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 110 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 166

Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           A+  D       ++GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 167 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
           TA+ L  L    +  +I+ D+KPEN+LLD      + DFGL KL  ++      + + GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGT 156

Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           P Y APE L G +  T   D ++ G++L+E++
Sbjct: 157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 15/197 (7%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAE--VGTIGRTYHINLVRL 86
           LG G FG+V   +     ++ AVKVL ++  L     E  M E  + ++ R  H  L +L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-HPFLTQL 61

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y           V E++  G L  +   K R  +  +    A      L++LH+   + I
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAAEITSALMFLHD---KGI 117

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPI 205
           I+ D+K +NVLLD     K+ADFG+ K  +   +  T S + GTP Y APE L    Y  
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 206 THKCDVYSFGMVLFEIV 222
           +   D ++ G++L+E++
Sbjct: 176 S--VDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 4/100 (4%)

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
           I     + L YLH    + IIH D+K EN+ LD   +  + DFG A   D +       G
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246

Query: 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 226
           + GT   ++PE L+ + P   K D++S G+VLFE+  +  
Sbjct: 247 WSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 26/157 (16%)

Query: 35  GGFGEVYKGQFPNGVKI-AVKV------LNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           G FG+VY G+  N  K+ AVKV      +N+N+      Q  AE   +  +    +V LY
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNM----VHQVQAERDALALSKSPFIVHLY 70

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
                 +   LV EY+  G +   L     F ++ A+++  + E+A+     L YLH   
Sbjct: 71  YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--ISEVALA----LDYLH--- 121

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179
           +  IIH D+KP+N+L+      K+ DFGL+K+   NR
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV-TLNR 157

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 59/259 (22%), Positives = 97/259 (37%), Gaps = 52/259 (20%)

Query: 32  LGFGGFGEVYKGQF-PNG----------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH 80
           LG G F  +YKG                V + +KVL  +  R +   F      + +  H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLA-FFETASLMSQLSH 60

Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            +LV+LYG C       +V EY++ G LD +L  +K  +      ++A   A  L YL +
Sbjct: 61  KHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS------ 194
              ++++H ++  +N+L+ A +          KL D              PG        
Sbjct: 120 ---KKLVHGNVCGKNILV-ARYGLNEGYVPFIKLSD--------------PGIPITVLSR 161

Query: 195 ----------APEFLSGNYP-ITHKCDVYSFGMVLFEIVGRRR---NAIVGSSESLDWFP 240
                     APE +      +T   D +SFG  L EI        + +  S +   +  
Sbjct: 162 EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD 221

Query: 241 KHVWEEYEKSELDATILAC 259
           +H     + +EL   I  C
Sbjct: 222 QHRLPMPDCAELANLINQC 240

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 29/206 (14%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAE--VGTIGRTYHINLVRL 86
           +G G FGEV   +  N  ++ A+K+LN+   L R     F  E  V   G    I  +  
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH- 67

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           Y F  + ++  LV +Y   G L   L  F  +   +  + +      A+ ++ +    Q 
Sbjct: 68  YAFQDENNLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVLAIDSVHQL 121

Query: 145 RIIHYDIKPENVLLDANFSPKVADFG--LAKLCDRN-RSHVTISGYKGTPGYSAPEFL-- 199
             +H DIKP+NVLLD N   ++ADFG  L  L D   +S+V +    GTP Y +PE L  
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV----GTPDYISPEILQA 177

Query: 200 ----SGNYPITHKCDVYSFGMVLFEI 221
                G Y    +CD +S G+ ++E+
Sbjct: 178 MEDGKGRY--GPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 38/210 (18%)

Query: 32  LGFGGFGEVY---KGQFPNGVKI-AVKVLN-----RNLGRIAEEQFMAEVGTIGRTYHIN 82
           LG GG+G+V+   K    +  KI A+KVL      RN    A  +  AE   +    H  
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVKHPF 61

Query: 83  LVRL-YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIAIGTAKGLV 136
           +V L Y F     +  L+ EY+  G L  +L  ++  I  E      L EI++     L 
Sbjct: 62  IVDLIYAFQTGGKLY-LILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLA----LE 114

Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYS 194
           +LH   QQ II+ D+KPEN+LLDA    K+ DFGL K  + +   +H     + GT  Y 
Sbjct: 115 HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT----FCGTIEYM 167

Query: 195 APEFL--SGNYPITHKCDVYSFGMVLFEIV 222
           APE L  SG+       D +S G ++++++
Sbjct: 168 APEILMRSGH---GKAVDWWSLGALMYDML 194

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLG--RIAEE--QFMAEVGTIGRTYHINLVRL 86
           LG G FGEVY       G ++AVK +  +      ++E      E+  +    H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 87  YGFC---HDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           YG C    ++   ++  EYM  GS+   L  +G   A+             +G+ YLH  
Sbjct: 70  YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLH-- 123

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAK----LCDRNRSHVTISGYKGTPGYSAPE 197
               I+H DIK  N+L D+  + K+ DFG +K    +C    S   I    GTP + +PE
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC---MSGTGIKSVTGTPYWMSPE 179

Query: 198 FLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            +SG      K DV+S    + E++  +
Sbjct: 180 VISGE-GYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 17/147 (11%)

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H ++++L G       T L+    +   L  YL  K+     + L  I     + + YLH
Sbjct: 142 HPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDIL-AIERSVLRAIQYLH 199

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC-----DRNRSHVTISGYKGTPGYS 194
           E    RIIH DIK EN+ ++      + DFG A  C     + N+ +    G+ GT   +
Sbjct: 200 E---NRIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDINANKYY----GWAGTIATN 250

Query: 195 APEFLSGNYPITHKCDVYSFGMVLFEI 221
           APE L+ + P     D++S G+VLFE+
Sbjct: 251 APELLARD-PYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 32/230 (13%)

Query: 4   FLQEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRN 59
           + QE+ +   E P R+  L+          ++G G +G V        G K+A+K L R 
Sbjct: 2   YRQEVNKTIWEVPDRYRDLK----------QVGSGAYGTVCSALDRRTGAKVAIKKLYRP 51

Query: 60  L-GRIAEEQFMAEVGTIGRTYHINLVRLYG-FCHDQHMTA-----LVYEYMENGSLDGYL 112
               +  ++   E+  +    H N++ L   F  D  +       LV  +M  G+  G L
Sbjct: 52  FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKL 109

Query: 113 FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
              ++  E +++  +     KGL Y+H      IIH D+KP N+ ++ +   K+ DFGLA
Sbjct: 110 MKHEKLSE-DRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165

Query: 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           +  D       ++GY  T  Y APE +      T   D++S G ++ E++
Sbjct: 166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 12/95 (12%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
           +GL Y+H      IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 180

Query: 193 YSAPE--FLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           Y APE      +Y      D++S G ++ E++  +
Sbjct: 181 YRAPEIMLNWMHY--NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 47/230 (20%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV   Q  +   I A+K+L R    + +EQ     AE   +       +V+++
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
               D+    L+ E++  G +   L  K    E      IA  T   +  +H   Q   I
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH---QLGFI 123

Query: 148 HYDIKPENVLLDANFSPKVADFGL----------------------------------AK 173
           H DIKP+N+LLDA    K++DFGL                                  A+
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183

Query: 174 LCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
              +NR  +  S   GTP Y APE F+   Y     CD +S G++++E++
Sbjct: 184 TWKKNRRQLAYSTV-GTPDYIAPEVFMQTGY--NKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 18/163 (11%)

Query: 71  EVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHE 126
           E+  +    H  +V+ YG   D  +    +  EYM  GS+   L  +G   A+      +
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRK 110

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK----LCDRNRSHV 182
                 +G+ YLH      I+H DIK  N+L D+  + K+ DFG +K    +C    S  
Sbjct: 111 YTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC---MSGT 164

Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            I    GTP + +PE +SG      K DV+S G  + E++  +
Sbjct: 165 GIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 42/211 (19%)

Query: 32  LGFGGFGEVY---KGQFPN-GVKIAVKVLNRNLGRI-------AEEQFMAEVGTIGRTYH 80
           LG G FG+V+   K   P+ G   A+KVL +   ++        E   +AEV       H
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------H 57

Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIAIGTAKGL 135
             +V+L+     +    L+ +++  G L   L   K  +  E+     L E+A+     L
Sbjct: 58  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALA----L 111

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGY 193
            +LH      II+ D+KPEN+LLD     K+ DFGL+K  +    +++     + GT  Y
Sbjct: 112 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY----SFCGTVEY 164

Query: 194 SAPEFLS--GNYPITHKCDVYSFGMVLFEIV 222
            APE ++  G+   T   D +SFG+++FE++
Sbjct: 165 MAPEVVNRRGH---TQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 30/204 (14%)

Query: 32  LGFGGFGEV----YKGQFPNGVKIAVKVL-NRNLGRIAEEQ-FMAEVGTIGRTYHINLVR 85
           LG G FG V    +KG    G   A+K L  R + ++ + Q    E   +    H  +V 
Sbjct: 26  LGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +     D++    + E++  G L  +L    R   +  K +   +  A    YLH    +
Sbjct: 83  MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--FEYLHS---K 137

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSGN 202
            II+ D+KPEN+LLD     KV DFG AK        V    +   GTP Y APE +   
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAK-------KVPDRTFTLCGTPEYLAPEVIQSK 190

Query: 203 YPITH--KCDVYSFGMVLFE-IVG 223
               H    D ++ G++L+E I G
Sbjct: 191 ---GHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 17/150 (11%)

Query: 32  LGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY----HINLV 84
           +G G FG+V   +        ++ VK L  N     + +F+ +    G  Y    H N++
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQ----GDPYRILQHPNIL 58

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           +  G C +     LV+EY E G L  YL      +R  +   L  +A   A G+ ++H  
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-- 116

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGL 171
            +   +H D+   N  L ++ + KV D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF----MAEVGTIGRTYH-INLV 84
           ++G G +G+VYK +    G  +A+K   +    + EE      + E+  +      I +V
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 85  RLYGFCHDQH-----MTALVYEYMEN---GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLV 136
           RL    H +         LV+EY+++     +D    G  R +  + +        KG+ 
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 137 YLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNRSHVTISGYKG---TPG 192
           + H   +  ++H D+KP+N+L+D      K+AD GL     R  S + +  Y     T  
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLG----RAFS-IPVKSYTHEIVTLW 176

Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
           Y APE L G+   +   D++S G +  E+  R++    G SE
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSE 217

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 41/125 (32%), Positives = 63/125 (50%), Gaps = 8/125 (6%)

Query: 98  LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL 157
           LV+EY+E   L+  L      +  EK+        K + + H   +  I+H DIKPEN+L
Sbjct: 77  LVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLL 132

Query: 158 LDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM 216
           +  N   K+ DFG A+ L + + ++ T   Y  T  Y +PE L G  P     D++S G 
Sbjct: 133 ISHNDVLKLCDFGFARNLSEGSNANYT--EYVATRWYRSPELLLGA-PYGKAVDMWSVGC 189

Query: 217 VLFEI 221
           +L E+
Sbjct: 190 ILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 22/204 (10%)

Query: 32  LGFGGFGEVYKG---------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           LG G F +++KG         +  +  ++ +KVL+++  R   E F      + +  H +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGEL-HKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKH 60

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE--WEKLHEIAIGTAKGLVYLHE 140
           LV  YG C     + +V EY++ GSLD YL   K  I   W KL E+A   A  L +L +
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW-KL-EVAKQLAWALHFLED 118

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG---YKGTPGYSAPE 197
              + + H ++  +NVLL      K  +    KL D   S   +      +  P +  PE
Sbjct: 119 ---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-WVPPE 174

Query: 198 FLSGNYPITHKCDVYSFGMVLFEI 221
            +     ++   D +SFG  L+EI
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 21/200 (10%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--------GRIAEEQFMAEVGTIGRTYHIN 82
           LG G FG+V   +     ++ A+KVL +++          + E++ +A         H  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK-----HPF 57

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           L  L+     +     V EY+  G L  +   + R  +  +    A      L++LH   
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLALMFLH--- 113

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           +  +I+ D+K +N+LLDA    K+ADFG+ K  +   + VT + + GTP Y APE L   
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ-E 170

Query: 203 YPITHKCDVYSFGMVLFEIV 222
                  D ++ G++++E++
Sbjct: 171 LEYGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.0 bits (123), Expect = 2e-07
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 26/150 (17%)

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
           + N ++LY          L+ +Y+++G L D  L  K+  +   ++ +I     + L  L
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKEGKLSEAEVKKIIRQLVEALNDL 125

Query: 139 HEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAP 196
           H   +  IIH DIK ENVL D A     + D+GL K        + T S Y GT  Y +P
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLDYFSP 175

Query: 197 EFLSGNYPITHKCDVYSF-----GMVLFEI 221
           E + G     H  D  SF     G++ +E+
Sbjct: 176 EKIKG-----HNYD-VSFDWWAVGVLTYEL 199

Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 54/233 (23%), Positives = 84/233 (36%), Gaps = 40/233 (17%)

Query: 15  RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRN---LGRIAEEQFMA 70
           R+   Q           LG G +G+V K      G  +A+K +           + Q + 
Sbjct: 9   RYI--QKGAH-------LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVG 59

Query: 71  EVG---TIGRT-------YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
             G   T  R         H N++ L     +     LV + M    L   +  K R  E
Sbjct: 60  MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTE 118

Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
            +    I +    GL  LH   +   +H D+ P N+ +++    K+ADFGLA+       
Sbjct: 119 SQV-KCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174

Query: 181 HVTISGYKG------------TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             T+S  +             T  Y APE L G        D++S G +  E+
Sbjct: 175 SDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227

Length = 335

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 41/231 (17%)

Query: 20  QLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVG 73
           ++N  T  +   LG   FG+VYKG             +A+K L         E+F  E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 74  TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK---------------KRA 118
              R  H N+V L G    +   ++++ Y  +  L  +L  +               K  
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 119 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
           +E      I    A G+ +L       ++H D+   NVL+    + K++D GL +     
Sbjct: 121 LEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR----- 172

Query: 179 RSHVTISGYKGTPGYS-------APE-FLSGNYPITHKCDVYSFGMVLFEI 221
              V  + Y    G S       +PE  + G + I    D++S+G+VL+E+
Sbjct: 173 --EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI--DSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 24/205 (11%)

Query: 32  LGFGGFGEVY----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HIN--- 82
           LG G +G+V+         +G   A+KVL +    I ++    E     R    HI    
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKK--ATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 83  -LVRL-YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            LV L Y F  D  +  L+ +Y+  G L  +L  ++R  E     E+ I + + ++ L  
Sbjct: 66  FLVTLHYAFQTDTKL-HLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEH 120

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEF 198
             +  II+ DIK EN+LLD+N    + DFGL+K    D      +     GT  Y AP+ 
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC---GTIEYMAPDI 177

Query: 199 LSGNYPITHKC-DVYSFGMVLFEIV 222
           + G      K  D +S G++++E++
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 50.5 bits (120), Expect = 4e-07
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 20/198 (10%)

Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G  G VY       G ++A+K +N    +  +E  + E+  +    + N+V     
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 82

Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 83  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH---SNQ 135

Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
           +IH DIK +N+LL  + S K+ DFG  A++        T+    GTP + APE ++    
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 191

Query: 205 ITHKCDVYSFGMVLFEIV 222
              K D++S G++  E+V
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 8/90 (8%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
           +GL Y+H      IIH D+KP NV ++ +   ++ DFGLA+  D       ++GY  T  
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRW 180

Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           Y APE +          D++S G ++ E++
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 20/198 (10%)

Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G  G VY       G ++A+K +N    +  +E  + E+  +    H N+V     
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYL-- 82

Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 83  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 135

Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
           +IH DIK +N+LL  + S K+ DFG  A++        T+    GTP + APE ++    
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 191

Query: 205 ITHKCDVYSFGMVLFEIV 222
              K D++S G++  E+V
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 29/212 (13%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQF----MAEVGTIGRTYHINLVRL 86
           +G G +G+VYK +  + G  +A+K +  +  +   E F    + E+  + +  H N+V L
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNL 71

Query: 87  Y----------GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLV 136
                       F  D+    LV+EYM++  L G L         + +        +GL 
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130

Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG---TPGY 193
           Y H   ++  +H DIK  N+LL+     K+ADFGLA+L +   S      Y     T  Y
Sbjct: 131 YCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP----YTNKVITLWY 183

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
             PE L G        DV+S G +L E+  ++
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 17/201 (8%)

Query: 35  GGFGEVYKG-----QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           G FG ++ G     +     ++ VK +  +   I     + E   +    H N++ +   
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 90  CHDQHMTALV-YEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           C +      V Y YM  G+L  +L           +A+  ++L  +AI  A G+ YLH  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
            ++ +IH DI   N ++D     K+ D  L++       H           + A E L  
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193

Query: 202 NYPITHKCDVYSFGMVLFEIV 222
               +   DV+SFG++L+E++
Sbjct: 194 KE-YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 5/159 (3%)

Query: 70  AEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE--KLHEI 127
           +E+  +    H  +V+ +          L+ EY   G L+  +  K+R  E    + +E+
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYEV 171

Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
            +   + ++ L E   ++++H D+K  N+ L      K+ DFG +K    + S    S +
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 226
            GTP Y APE L      + K D++S G++L+E++   R
Sbjct: 232 CGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 22/101 (21%)

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLC--------DRNRSH 181
           G+ YLH      ++H D+KP N+L+          K+ D GLA+L         D +   
Sbjct: 120 GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           VTI        Y APE L G    T   D+++ G +  E++
Sbjct: 177 VTI-------WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 32/197 (16%)

Query: 40  VYKGQFPNGVKIAVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF----CHDQ 93
           +YKG F N  ++ ++   +     ++  +    E+  + R    N++++YGF      D 
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 94  HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153
              +L+ EY   G L   L  K++ + ++   ++AI   KGL  L++        Y  KP
Sbjct: 95  PRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYK--------YTNKP 145

Query: 154 ------ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSGNY-P 204
                  + L+  N+  K+   GL K+       ++   +K      Y + + L+  +  
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKI-------LSSPPFKNVNFMVYFSYKMLNDIFSE 198

Query: 205 ITHKCDVYSFGMVLFEI 221
            T K D+YS G+VL+EI
Sbjct: 199 YTIKDDIYSLGVVLWEI 215

Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 10/103 (9%)

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TP 191
           G+ +LH      I+H D+K  N+LL+     K+ DFGLA+         T    +   T 
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT----QLVVTL 170

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
            Y APE L G    +   D++S G +  E++  ++    G SE
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELL-TKKPLFPGKSE 212

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 20/167 (11%)

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A+G+ +L     ++ IH D+   N+LL  N   K+ DFGLA+   ++  +V     +   
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK-HVWEEYEKS 250
            + APE +      T + DV+SFG++L+EI        +G+S     +P   + EE+ + 
Sbjct: 241 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFS------LGASP----YPGVQINEEFCQR 289

Query: 251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
             D T +     E    +  R+ +A   C Q  P++RP  SA+V++L
Sbjct: 290 LKDGTRMRA--PENATPEIYRIMLA---CWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 15/97 (15%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKG-- 189
           +GL Y+H      ++H D+KP NV ++  +   K+ DFGLA++ D + SH    GY    
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH---KGYLSEG 178

Query: 190 --TPGYSAPEFL--SGNYPITHKCDVYSFGMVLFEIV 222
             T  Y +P  L    NY  T   D+++ G +  E++
Sbjct: 179 LVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEML 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 48.6 bits (115), Expect = 2e-06
 Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 18/197 (9%)

Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 83

Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 84  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +IH DIK +N+LL  + S K+ DFG        +S    S   GTP + APE ++     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT-RKAY 193

Query: 206 THKCDVYSFGMVLFEIV 222
             K D++S G++  E++
Sbjct: 194 GPKVDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 47.8 bits (113), Expect = 3e-06
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 20/198 (10%)

Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G  G V+       G ++A+K +N    +  +E  + E+  +    + N+V     
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFL-- 82

Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
             D  +      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 83  --DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH---ANQ 135

Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
           +IH DIK +NVLL  + S K+ DFG  A++        T+    GTP + APE ++    
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 191

Query: 205 ITHKCDVYSFGMVLFEIV 222
              K D++S G++  E+V
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 32  LGFGGFGEVY---KGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTY--HIN--- 82
           LG G +G+V+   K    +  K+ A+KVL +    + ++    E     R    H+    
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQK--AALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 83  -LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
            LV L+     +    L+ +Y+  G +  +L+ +    E     E+   + + ++ L   
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEIILALEHL 121

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
            +  I++ DIK EN+LLD+     + DFGL+K         T S + GT  Y APE + G
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRG 180

Query: 202 NYPITHKCDVYSFGMVLFEIV 222
                   D +S G+++FE++
Sbjct: 181 KGGHGKAVDWWSLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 62/247 (25%), Positives = 92/247 (37%), Gaps = 68/247 (27%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVK------VLNRN-LGRI-AEEQFMAEVGTIGRTYHIN 82
           +G G FGEV   +  +   + A+K      VL RN    + AE   +AE           
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW------ 62

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-AKGLVYLHEE 141
           +V+LY    D+     V +Y+  G +   L   +  I  E L    I      +  +H  
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVH-- 118

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLA----------------------------- 172
            +   IH DIKP+N+L+D +   K+ DFGL                              
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 173 ------------KLCDRNRSHVTISGYKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVL 218
                       +   R           GTP Y APE L  +G    T  CD +S G++L
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY---TQLCDWWSVGVIL 234

Query: 219 FE-IVGR 224
           +E +VG+
Sbjct: 235 YEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 9/94 (9%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI--SGYKGT 190
           + L Y+H      + H D+KP+N+L +A+   K+ DFGLA++   N +   I  + Y  T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169

Query: 191 PGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIV 222
             Y APE L G++    T   D++S G +  E++
Sbjct: 170 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVL 202

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.4 bits (112), Expect = 6e-06
 Identities = 43/177 (24%), Positives = 81/177 (45%), Gaps = 23/177 (12%)

Query: 58  RNLGRIAEEQFMAEVGTIGRTYHINLVRL--------YGFCHDQHMTALVYEYMENGSLD 109
           +   R A  Q   E+  +GR  H N++++          +   Q     +Y +M + + D
Sbjct: 201 KAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD 259

Query: 110 GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF 169
                K R +  +    I       + Y+H+   +++IH DIK EN+ L+ +    + DF
Sbjct: 260 W----KDRPLLKQT-RAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDF 311

Query: 170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGR 224
           G A   ++ R      G+ GT   ++PE L+G+    IT   D++S G++L +++  
Sbjct: 312 GTAMPFEKEREAFDY-GWVGTVATNSPEILAGDGYCEIT---DIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 36/216 (16%)

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           GF  ++ ++ +  E  E    D Y    K+ +  E L   +   AKG+ +L     ++ I
Sbjct: 151 GFVEEKSLSDV--EEEEAEQEDLY----KKVLTLEDLICYSFQVAKGMEFL---ASRKCI 201

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H D+   N+LL  N   K+ DFGLA+   ++  +V     +    + APE +      T 
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTI 260

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK-HVWEEYEKSELDATILACGIEEKDK 266
           + DV+SFG++L+EI        +G+S     +P   + EE+             ++E  +
Sbjct: 261 QSDVWSFGVLLWEIFS------LGASP----YPGVKIDEEF----------CRRLKEGTR 300

Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKML 297
            +A       ++     C    P  RP  S +V+ L
Sbjct: 301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 66/255 (25%), Positives = 95/255 (37%), Gaps = 89/255 (34%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN-------LGRI-AEEQFMAEVGTIGRTYHIN 82
           +G G FGEV   Q  +  KI A+K L ++       L  + AE   +AE  +        
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW------ 62

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-----------IAIGT 131
           +V LY    D     L+ E++  G L   L      I+++   E           +AI  
Sbjct: 63  VVSLYYSFQDAQYLYLIMEFLPGGDLMTML------IKYDTFSEDVTRFYMAECVLAIEA 116

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA----KLCDRN--------- 178
              L +         IH DIKP+N+L+D     K++DFGL+    K  D           
Sbjct: 117 VHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167

Query: 179 ---------------------RSHVTISGYK-----------GTPGYSAPE-FLSGNYPI 205
                                 S   I+ +K           GTP Y APE FL   Y  
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-- 225

Query: 206 THKCDVYSFGMVLFE 220
             +CD +S G ++FE
Sbjct: 226 GQECDWWSLGAIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 62/240 (25%), Positives = 89/240 (37%), Gaps = 55/240 (22%)

Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FGEV    +       A+K L +   L R       AE   +    +  +VRLY 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              D+     V +Y+  G +   L   +  I  E L    I  A+    +    +   IH
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFPEDLARFYI--AELTCAVESVHKMGFIH 124

Query: 149 YDIKPENVLLDANFSPKVADFGL-----------------------------------AK 173
            DIKP+N+L+D +   K+ DFGL                                    +
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184

Query: 174 LCDR--------NRSHVTISGYK--GTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
             DR         R H     +   GTP Y APE  L   Y  T  CD +S G++L+E++
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY--TQLCDWWSVGVILYEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 60/240 (25%), Positives = 90/240 (37%), Gaps = 55/240 (22%)

Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FGEV    +       A+K L +   L R       AE   +    +  +V+LY 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              D+     V +Y+  G +   L   +  +  E L    I  A+  + +    +   IH
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYI--AELTLAIESVHKMGFIH 124

Query: 149 YDIKPENVLLDANFSPKVADFGL-----------------------------------AK 173
            DIKP+N+L+D +   K+ DFGL                                    +
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184

Query: 174 LCDR--------NRSHVTISGYK--GTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
             DR         + H     +   GTP Y APE  L   Y  T  CD +S G++LFE++
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY--TQLCDWWSVGVILFEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 66/247 (26%)

Query: 32  LGFGGFGEVY----KGQFPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G  G V+    KG    G   A+KVL++   + R   ++ + E   +    H  L  
Sbjct: 9   LGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK--------GLVY 137
           LY     +    LV +Y   G L        R ++ +    ++   A+         L Y
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELF-------RLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG----- 192
           LH      I++ D+KPEN+LL  +    ++DF L+K  D     V+ +  KG+       
Sbjct: 119 LH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 193 ----------------------YSAPEFLSGNYPITH--KCDVYSFGMVLFEIV------ 222
                                 Y APE +SG+    H    D ++ G++L+E++      
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGD---GHGSAVDWWTLGILLYEMLYGTTPF 232

Query: 223 -GRRRNA 228
            G  R+ 
Sbjct: 233 KGSNRDE 239

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 7/89 (7%)

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+    N     ++ Y  T  Y
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYY 188

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            APE + G        D++S G ++ E+V
Sbjct: 189 RAPEVILG-MGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 23/108 (21%)

Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-- 188
           T   L YLH      I+H D+KP+N+L+ +    K+ DFGL+K+   + +     G+   
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 189 -----------GTPGYSAPE-FLSGNY--PITHKCDVYSFGMVLFEIV 222
                      GTP Y APE  L   Y  P+    D ++ G++L+E +
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 7/89 (7%)

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      +   ++ Y  T  Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 183

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            APE + G        D++S G ++ E++
Sbjct: 184 RAPEVILG-MGYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 9/92 (9%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAK-LCDRNRSHVTISGYKGT 190
           + L Y+H    + I H D+KP+N+L+D N  + K+ DFG AK L    RS      Y  +
Sbjct: 181 RALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS----VSYICS 233

Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             Y APE + G    T   D++S G ++ E++
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 18/171 (10%)

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A+G+ +L     ++ IH D+   N+LL  N   K+ DFGLA+   ++  +V     +   
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
            + APE +      T + DV+SFG++L+EI        +G+S     +P    +E     
Sbjct: 240 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFS------LGASP----YPGVQIDEEFCRR 288

Query: 252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
           L         E    E    +    L C  ++PEDRP  S +V++L  +++
Sbjct: 289 LKEGTRMRAPEYATPE----IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.1 bits (104), Expect = 3e-05
 Identities = 39/145 (26%), Positives = 60/145 (41%), Gaps = 18/145 (12%)

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           N+V L+ +   +    LV ++ E G L  ++  K   I  E +   A      L  LH E
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSAPE 197
               I+  D+ P N+LLD     ++  F     +   CD       +        Y APE
Sbjct: 105 ---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE----AVENM-----YCAPE 152

Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T  CD +S G +LFE++
Sbjct: 153 -VGGISEETEACDWWSLGAILFELL 176

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 6/105 (5%)

Query: 118 AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177
           A++ E L   +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+   R
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-R 265

Query: 178 NRSHVTISGYKGTP-GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
           N S+  + G    P  + APE +  N   T + DV+S+G++L+EI
Sbjct: 266 NDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 7/89 (7%)

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      +   ++ Y  T  Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 184

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            APE + G        D++S G ++ E+V
Sbjct: 185 RAPEVILG-MGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 56/223 (25%), Positives = 88/223 (39%), Gaps = 41/223 (18%)

Query: 32  LGFGGFGEVYKGQFPNGVKI----AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G GGFG VY+ Q  +   I      K+ N        E  + E       Y I+ + L+
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLE-----NETIVMETLVYNNIYDIDKIALW 74

Query: 88  GFCHD-QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-------------------I 127
              H+  H+   + +Y   GS         R I  EKL E                   I
Sbjct: 75  KNIHNIDHLG--IPKYYGCGSFK-RCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNI 131

Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG- 186
                  L Y+HE     I H DIKPEN+++D N    + D+G+A     +  H+  S  
Sbjct: 132 MKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188

Query: 187 ----YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
               ++GT  Y+  +  +G   +T + D+ S G  + +  G +
Sbjct: 189 QKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIK 230

Length = 294

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 48/205 (23%), Positives = 84/205 (40%), Gaps = 15/205 (7%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-- 88
           ++G G +G VYK +  +G       L +  G         E+  +    H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY-----LHEECQ 143
             H      L+++Y E+       F +      +K  ++  G  K L+Y     +H    
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 144 QRIIHYDIKPENVLLDANFSP-----KVADFGLAKLCDRN-RSHVTISGYKGTPGYSAPE 197
             ++H D+KP N+L+     P     K+AD G A+L +   +    +     T  Y APE
Sbjct: 127 NWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            L G    T   D+++ G +  E++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 7/89 (7%)

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      +   ++ Y  T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            APE + G        D++S G ++ E++
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 44/226 (19%)

Query: 31  RLGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G FGEV+  K +          +  R L    + Q + EV  +    H N+VR   
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 89  FCHDQHMTAL--VYEYMENGSLDG------YLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
              ++    L  + E+ + G L         +FGK   IE   + +I       L Y H 
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK---IEEHAIVDITRQLLHALAYCHN 136

Query: 141 ----ECQQRIIHYDIKPENVLL---------------DANFSP--KVADFGLAK-LCDRN 178
                  +R++H D+KP+N+ L               + N  P  K+ DFGL+K +   +
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196

Query: 179 RSHVTISGYKGTPGYSAPEFL---SGNYPITHKCDVYSFGMVLFEI 221
            +H  +    GTP Y +PE L   + +Y    K D+++ G +++E+
Sbjct: 197 MAHSCV----GTPYYWSPELLLHETKSY--DDKSDMWALGCIIYEL 236

Length = 1021

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 13/204 (6%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-- 88
           ++G G +G VYK +  +G       L +  G         E+  +    H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY-----LHEECQ 143
             H      L+++Y E+       F +      +K  ++     K L+Y     +H    
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 144 QRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRN-RSHVTISGYKGTPGYSAPEF 198
             ++H D+KP N+L+          K+AD G A+L +   +    +     T  Y APE 
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186

Query: 199 LSGNYPITHKCDVYSFGMVLFEIV 222
           L G    T   D+++ G +  E++
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 21/182 (11%)

Query: 49  VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL 108
           +++ +KVL+ +   IA   F      + +  HI+L  ++G C       +V E++E+G L
Sbjct: 45  LRVVLKVLDPSHRDIAL-AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103

Query: 109 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 168
           D  L  +K  +       +A   A  L YL +   + ++H ++  +N+LL        A 
Sbjct: 104 DVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILL--------AR 152

Query: 169 FGLA-------KLCDRNRSHVTISGYKGTP--GYSAPEFLSGNYPITHKCDVYSFGMVLF 219
            GLA       KL D   S   +S  +      + APE + G   ++   D +SFG  L 
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212

Query: 220 EI 221
           EI
Sbjct: 213 EI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 10/93 (10%)

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD-RNRSHVTISGYKGT 190
           A+G+ +L     +  IH D+   NVLL      K+ DFGLA+  D  N S+  + G    
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR--DIMNDSNYVVKGNARL 276

Query: 191 P-GYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 221
           P  + APE      Y  T + DV+S+G++L+EI
Sbjct: 277 PVKWMAPESIFDCVY--TVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.8 bits (95), Expect = 9e-04
 Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 4/90 (4%)

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A+G+ +L     +  +H D+   NVLL      K+ DFGLA+    + ++V+        
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + APE +  N   T   DV+S+G++L+EI
Sbjct: 304 KWMAPESIFDNL-YTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 19/205 (9%)

Query: 25  TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
           T  Y+  L +    E     +   +K+ +KVL+ +  R     F      + +  H ++V
Sbjct: 9   TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIV 67

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            LYG C       +V E++E G LD ++  K   +      ++A   A  L YL +   +
Sbjct: 68  LLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---K 124

Query: 145 RIIHYDIKPENVLL-----DANFSP--KVADFGLA-KLCDRNRSHVTISGYKGTPGYSAP 196
            ++H ++  +N+LL     D    P  K++D G+   +  R      I        + AP
Sbjct: 125 DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP-------WIAP 177

Query: 197 EFLSGNYPITHKCDVYSFGMVLFEI 221
           E +  +  ++   D +SFG  L+EI
Sbjct: 178 ECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A G+ +L     +  +H D+   NVL+      K+ DFGLA+   R+ ++++  G    P
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTFLP 304

Query: 192 -GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             + APE +  N   T   DV+SFG++L+EI
Sbjct: 305 LKWMAPESIFNNL-YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	356
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
smart00090	237	RIO RIO-like kinase.	99.85
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.65
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.59
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.54
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.53
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
KOG1243	690	consensus Protein kinase [General function predict	99.52
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.47
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.41
KOG3087	229	consensus Serine/threonine protein kinase [General	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.37
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.31
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.21
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.2
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.13
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.11
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.0
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.0
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.92
PRK09902	216	hypothetical protein; Provisional	98.88
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.78
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.77
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.7
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.63
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.61
PF01636	239	APH: Phosphotransferase enzyme family This family	98.6
PLN02876	822	acyl-CoA dehydrogenase	98.54
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.53
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.5
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.44
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.37
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.36
PRK10593	297	hypothetical protein; Provisional	98.33
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.19
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.14
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.1
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.02
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.02
PRK05231	319	homoserine kinase; Provisional	97.99
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.99
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.85
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.78
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.72
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.66
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.59
KOG2270	520	consensus Serine/threonine protein kinase involved	97.52
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.45
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.29
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.23
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.21
PLN02236	344	choline kinase	97.12
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.9
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.89
PLN02756	418	S-methyl-5-thioribose kinase	96.84
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.77
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.65
PRK06148	1013	hypothetical protein; Provisional	96.62
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.59
PRK11768	325	serine/threonine protein kinase; Provisional	96.49
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.48
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.39
COG2334	331	Putative homoserine kinase type II (protein kinase	96.22
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.22
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	96.16
PRK12396	409	5-methylribose kinase; Reviewed	96.15

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-54  Score=392.22  Aligned_cols=287  Identities=41%  Similarity=0.665  Sum_probs=240.9

Q ss_pred             CcceecHHHHhhhhcccc--ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeece
Q 038199           12 KPVRFTSLQLNNFTSNYS--TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF   89 (356)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~--~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~   89 (356)
                      ....|++.++..+|.+|.  .+||+|+||+||+|...+|+.||||++....... ..+|.+|+.++.+++|||+++++|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            345689999999999998  6899999999999999888999999887654332 4569999999999999999999999


Q ss_pred             EecCC-eeeEEEeccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEc
Q 038199           90 CHDQH-MTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA  167 (356)
Q Consensus        90 ~~~~~-~~~lV~e~~~~~sL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~  167 (356)
                      |.+.+ ..+|||||+.+|+|.+.++.... .++|.++++|+.++|+||+|||..++.+||||||||+|||||++..+||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99998 59999999999999999977665 89999999999999999999999877789999999999999999999999


Q ss_pred             ccCCccccCCCCCeeeeccC-CCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH
Q 038199          168 DFGLAKLCDRNRSHVTISGY-KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       168 Dfgl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      |||+++.....  ....... .||.+|+|||++... ..+.|+|||||||+++||+||+.+...........+..+.+..
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            99999655431  1111112 799999999999865 7899999999999999999999887765533333355666677


Q ss_pred             HhhchhhHHHHhcCC-CchhH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          247 YEKSELDATILACGI-EEKDK-EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      +....+...+++... ..... .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus       297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            777766666665543 33332 577789999999999999999999999999965543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-54  Score=370.59  Aligned_cols=253  Identities=28%  Similarity=0.406  Sum_probs=217.8

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC-eeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-MTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-~~~lV~e  101 (356)
                      .+.+-.+.||+|..|+||++.++ +++.+|+|++..+.......++.+|+++++..+|||||.+||.|.+.. ...|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            35566788999999999999875 699999999977777788899999999999999999999999999988 5999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      ||++|||++++. ..+.+++..+.+|+.++++||.|||.  .++||||||||+|||++..|.|||+|||.+....+.   
T Consensus       159 YMDgGSLd~~~k-~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  159 YMDGGSLDDILK-RVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             hcCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            999999999983 34789999999999999999999995  289999999999999999999999999999887655   


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                       ...+++||..|||||.+.+. .|+.++||||||++++|+.+|+.|+.+.......|           -++...+.....
T Consensus       233 -~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~-----------~~Ll~~Iv~~pp  299 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI-----------FELLCAIVDEPP  299 (364)
T ss_pred             -hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH-----------HHHHHHHhcCCC
Confidence             23457899999999999988 89999999999999999999999987753322222           122233333344


Q ss_pred             CchhHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKE-KAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +..+.. ++.+++.++..||++||.+||+++++++
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            455554 8899999999999999999999999997

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-53  Score=381.79  Aligned_cols=269  Identities=30%  Similarity=0.460  Sum_probs=224.4

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC-
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-   94 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-   94 (356)
                      ..+++......+.+.||+|+||+||+|.+.....||||++.... .....+.|.+|+.+|++++|||||+++|++.+.. 
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            44556666667778899999999999999544449999997532 2233678999999999999999999999999887 


Q ss_pred             eeeEEEeccCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-ccccCCCCCcEEEcCCC-ceEEcccCC
Q 038199           95 MTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIHYDIKPENVLLDANF-SPKVADFGL  171 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~dikp~Nill~~~~-~~kl~Dfgl  171 (356)
                      .+++||||+++|+|.+++.. .+..+++..++.|+.||+.||.|||+   ++ ||||||||+|||++.++ ++||+|||+
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            78999999999999999977 47899999999999999999999999   77 99999999999999998 999999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccC-CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      ++......  ...+...||..|||||++.+ ...++.|+||||||+++|||+||+.||..-..               ..
T Consensus       191 sr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---------------~~  253 (362)
T KOG0192|consen  191 SREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---------------VQ  253 (362)
T ss_pred             ceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---------------HH
Confidence            98765432  22334679999999999984 23799999999999999999999998754322               11


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                      ..........++..+..++..+..++.+||+.||+.||++.+++..|+.+.....
T Consensus       254 ~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  254 VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            2223334455566666688999999999999999999999999999998876443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-53  Score=378.62  Aligned_cols=266  Identities=28%  Similarity=0.456  Sum_probs=233.2

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ...|++....+++.+.||+|-||+||.|.+.+...||+|.++..  ....+.|.+|+.+|++|+|+|||+++++|...+.
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p  275 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP  275 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence            56788899999999999999999999999977779999999875  3455789999999999999999999999999889


Q ss_pred             eeEEEeccCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           96 TALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ++|||||+..|+|.+++.. .+..+...+.+.++.|||+|++||++   +++|||||...||||++++.+||+||||++.
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccc
Confidence            9999999999999999975 46789999999999999999999999   9999999999999999999999999999995


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ..+.... ...+..-...|.|||.+... .++.|||||||||+||||+|-.               ..++..+...++.+
T Consensus       353 ~~d~~Y~-~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G---------------~~py~~msn~ev~~  415 (468)
T KOG0197|consen  353 IGDDEYT-ASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYG---------------RVPYPGMSNEEVLE  415 (468)
T ss_pred             cCCCcee-ecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccC---------------CCCCCCCCHHHHHH
Confidence            4433222 22333456789999999876 7999999999999999999943               22344556777788


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      .+..+.+.+.+..+|.++++++..||+.+|++|||++.+...|+.+...
T Consensus       416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            8888888999999999999999999999999999999999999877543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-51  Score=371.46  Aligned_cols=249  Identities=27%  Similarity=0.389  Sum_probs=213.2

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .+|+.++.||+|||+.||.++. .+|+.||+|++.+..  .....+.+.+|+++-++|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999976 789999999997632  3455578899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+|..++|..++. +.+++++..+..++.||+.||.|||+   .+|+|||||..|++++++.+|||+|||||..+.....
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999984 77899999999999999999999999   9999999999999999999999999999998875432


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                      .  ....+||+.|.|||++... ..+..+||||+|||+|.||.|++||....          ..+.+.      .+....
T Consensus       174 r--k~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~----------vkety~------~Ik~~~  234 (592)
T KOG0575|consen  174 R--KKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKT----------VKETYN------KIKLNE  234 (592)
T ss_pred             c--cceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccch----------HHHHHH------HHHhcC
Confidence            2  2346799999999999866 78999999999999999999999985432          112221      121111


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                       -..+...+.+..+||.++|+.||.+|||+++|+..
T Consensus       235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             12334667778899999999999999999999984

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-52  Score=359.33  Aligned_cols=258  Identities=26%  Similarity=0.337  Sum_probs=210.3

Q ss_pred             HHHhhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccccc------hhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLG------RIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      ....+..|-+.+.||+|+||.|-+|. -.+|+.||||+++....      ........+|+++|++|+|||||+++++|.
T Consensus       167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~  246 (475)
T KOG0615|consen  167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE  246 (475)
T ss_pred             cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence            34467788889999999999999995 45799999999975321      112234579999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC---CceEEcc
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVAD  168 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~D  168 (356)
                      +.+..|+||||++||.|.+.+ -.++.+.+..-..++.|++.|+.|||+   +||+||||||+|||+..+   -.+||+|
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~v-v~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKV-VANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             cCCceEEEEEEecCccHHHHH-HhccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecc
Confidence            999999999999999999988 456778888889999999999999999   999999999999999765   6799999


Q ss_pred             cCCccccCCCCCeeeeccCCCCCCCCCcccccCCC--CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH
Q 038199          169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       169 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      ||+|+..+..   ..+...|||+.|.|||++.+..  .+..+.|+||+||++|-+|+|.+||.....+      ....+.
T Consensus       323 FGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~------~sl~eQ  393 (475)
T KOG0615|consen  323 FGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD------PSLKEQ  393 (475)
T ss_pred             cchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC------ccHHHH
Confidence            9999977633   3456689999999999997652  3455889999999999999999998654332      112222


Q ss_pred             HhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +..+..      ...+..-...+.+..+++.+||..||++|||++|+++
T Consensus       394 I~~G~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  394 ILKGRY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HhcCcc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            222211      1123455667888999999999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-51  Score=341.08  Aligned_cols=260  Identities=25%  Similarity=0.374  Sum_probs=214.0

Q ss_pred             HHHhhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceE--ecCC
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFC--HDQH   94 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~--~~~~   94 (356)
                      ....-..|.+.++||.|+||+||++. ..+|+.+|.|.+.-+ ......+....|+.+|++|+||||++++++.  .+++
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            44555678899999999999999995 568999999998743 3455557789999999999999999999843  3445


Q ss_pred             eeeEEEeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CccccCCCCCcEEEcCCCceEEcccC
Q 038199           95 MTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      .++||||+|.+|+|..++..   ..+.+++.++++++.|++.||..+|+..++ -|+||||||.||+++.+|.|||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            58999999999999999853   467799999999999999999999983333 38999999999999999999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      +++.+......  ..+.+||+.||+||.+.+. +|+.+|||||+||++|||+..+.||..+.                --
T Consensus       174 L~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n----------------~~  234 (375)
T KOG0591|consen  174 LGRFLSSKTTF--AHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDN----------------LL  234 (375)
T ss_pred             hHhHhcchhHH--HHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCccccc----------------HH
Confidence            99988654332  3567899999999999988 89999999999999999999999986541                11


Q ss_pred             hhhHHHHhcCCCchh-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          251 ELDATILACGIEEKD-KEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      .+...+..+-.++.+ .-++.++..++..|+..||+.||+...++..+
T Consensus       235 ~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  235 SLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             HHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            233334444455444 77899999999999999999999855544443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-50  Score=348.99  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=201.6

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ..+|.+.++||.|+||+||+|+++ ++.+||||.+... ......+.+..|+.+|+.++|||||.+++++...+..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888899999999999999875 5899999998754 35667788999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC------CceEEcccCCccc
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN------FSPKVADFGLAKL  174 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~------~~~kl~Dfgl~~~  174 (356)
                      |||+||+|.+|++ ..+.+++.++..++.||+.||++||+   ++||||||||+|||++..      -.+||+|||+++.
T Consensus        89 EyC~gGDLs~yi~-~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIR-RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999994 45589999999999999999999999   999999999999999764      4689999999998


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      +.....   ....+|++-|||||++..+ .|+.|+|+||+|+++|++++|+.||........       ...+..     
T Consensus       165 L~~~~~---a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL-------~~~~~k-----  228 (429)
T KOG0595|consen  165 LQPGSM---AETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKEL-------LLYIKK-----  228 (429)
T ss_pred             CCchhH---HHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHH-------HHHHhc-----
Confidence            874433   3457899999999999866 799999999999999999999999864432211       000100     


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVV  294 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~  294 (356)
                        .....+..+......+.+++...++.+|.+|-+..+-.
T Consensus       229 --~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  229 --GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             --cccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence              11112233334444555666777777777776665543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-50  Score=344.48  Aligned_cols=246  Identities=24%  Similarity=0.310  Sum_probs=208.3

Q ss_pred             HHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      .....+|++.++||+|+||+||.++. .+++.||+|++++..  .....++.+.|..+|.+++||+||+++..|++.+.+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            34678899999999999999999965 469999999998643  233457889999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      |+|+||+.||.|...+ ++.+.+++..+..++.+|+.||.|||+   .+||||||||+|||+|.+|+++|+|||+++...
T Consensus       101 ylVld~~~GGeLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHL-QREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEEEeccCCccHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999999999 457789999999999999999999999   999999999999999999999999999998544


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ....  .....+||+.|||||++.+. .++.++|.||||+++|||++|..||.....                ....+.+
T Consensus       177 ~~~~--~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~----------------~~~~~~I  237 (357)
T KOG0598|consen  177 KDGD--ATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDV----------------KKMYDKI  237 (357)
T ss_pred             cCCC--ccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccH----------------HHHHHHH
Confidence            3322  23447899999999999988 899999999999999999999999865432                1222233


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCC
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRP  288 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  288 (356)
                      ........+.-.+.+.++++.+.|..||++|-
T Consensus       238 ~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  238 LKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             hcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            33333333444677899999999999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-49  Score=333.02  Aligned_cols=266  Identities=22%  Similarity=0.284  Sum_probs=209.8

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..|+-..++|+|+||+||+++++ +|+-||||.+... ......+-.++|+++|++++|+|+|.++.+|..+..+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35777789999999999999876 5999999998643 235556778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      ||+. ++.+-++.....++.+.+.+++.|++.|+.|+|+   +++|||||||+|||++.+|.+||||||+|+....+  .
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--g  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--G  155 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC--c
Confidence            9988 5555565677889999999999999999999999   99999999999999999999999999999987642  2


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc--------hhhhHHHHhhch-h
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF--------PKHVWEEYEKSE-L  252 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~-~  252 (356)
                      ...+.++.|.+|.|||.+.+...|....||||+||++.||++|...|-..+.-..-+.        .....+...... +
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            3456788999999999999977999999999999999999999877755444221110        011111111000 0


Q ss_pred             hHHHHh-----cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 DATILA-----CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 ~~~~~~-----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....+     ...+..-+....-+.+++..||+.||++|++.++++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            000001     0111222444567889999999999999999999876

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=360.43  Aligned_cols=272  Identities=25%  Similarity=0.435  Sum_probs=223.7

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ..|++......++++||+|+||+||+|+|..  .||||+++.+ .+....+.|++|+.++++.+|.||+-+.|++.+...
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            7799999999999999999999999999843  5999999854 345566889999999999999999999999998877


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                       .||+.+|+|.+|+.+++.....|...+.+.|+.||++|+.|||+   ++|||||||..||++.++++|||+|||++..-
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence             99999999999999998888899999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ..-..........|...|||||+++-  ..+|+..+||||||+|+|||+||..|+.....+..-|....-+       ..
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~-------l~  611 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGY-------LM  611 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccc-------cC
Confidence            43322223334558889999999863  2379999999999999999999999987444443333211100       00


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCC
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPP  306 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~  306 (356)
                      .     .......++++++.+|+..||..++++||.+.+|+..|+.+....|.
T Consensus       612 p-----d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk  659 (678)
T KOG0193|consen  612 P-----DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK  659 (678)
T ss_pred             c-----cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence            0     00112345677899999999999999999999999988887765443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-48  Score=340.33  Aligned_cols=257  Identities=26%  Similarity=0.339  Sum_probs=207.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC--eeeEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH--MTALV   99 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~--~~~lV   99 (356)
                      ..+|..++.||+|+||+||++.+. +|+..|||.+....... .+.+.+|+.+|++++|||||+++|......  .+++.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            566888999999999999999764 49999999887643233 677999999999999999999999754444  68899


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-CCceEEcccCCccccCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfgl~~~~~~~  178 (356)
                      |||+.+|+|.+++.+.+.++++..+..+..||++||+|||+   +|+||+||||+|||++. ++.+||+|||++......
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999997655589999999999999999999999   99999999999999999 799999999999876531


Q ss_pred             -CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          179 -RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       179 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                       ..........||+.|||||++.+......++|||||||++.||+||..||... .             ...........
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~-------------~~~~~~~~ig~  237 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F-------------EEAEALLLIGR  237 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c-------------chHHHHHHHhc
Confidence             11122334679999999999985323345999999999999999999887432 0             00011111112


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      ....+..+...+.+..+++.+|+..+|++|||++++++..
T Consensus       238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            2223456666788899999999999999999999999854

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.5e-48  Score=351.83  Aligned_cols=265  Identities=25%  Similarity=0.385  Sum_probs=208.3

Q ss_pred             HHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH   91 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~   91 (356)
                      |.+...+|++.++||+|+||.||+|.+      .+++.||||++...........+.+|+.+++++ +||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            456677899999999999999999963      235689999997654444556799999999999 8999999999887


Q ss_pred             cC-CeeeEEEeccCCCChhhhhhcC-------------------------------------------------------
Q 038199           92 DQ-HMTALVYEYMENGSLDGYLFGK-------------------------------------------------------  115 (356)
Q Consensus        92 ~~-~~~~lV~e~~~~~sL~~~l~~~-------------------------------------------------------  115 (356)
                      .. ...++||||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4578999999999999988532                                                       


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCC
Q 038199          116 ------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG  189 (356)
Q Consensus       116 ------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  189 (356)
                            ...+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.++|+|||+++...............+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                  1347888999999999999999999   9999999999999999999999999999986543222222223346


Q ss_pred             CCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHH
Q 038199          190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK  268 (356)
Q Consensus       190 t~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (356)
                      +..|+|||++.+. .++.++|||||||++|||++ |..||......      .         ..............+...
T Consensus       239 ~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~---------~~~~~~~~~~~~~~~~~~  302 (338)
T cd05102         239 PLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------E---------EFCQRLKDGTRMRAPENA  302 (338)
T ss_pred             CccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------H---------HHHHHHhcCCCCCCCCCC
Confidence            6789999999776 68999999999999999997 88887432211      0         011111111122223345


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       269 ~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      +..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            6779999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=356.58  Aligned_cols=274  Identities=31%  Similarity=0.423  Sum_probs=229.9

Q ss_pred             CCcceecHHHHhhhhccccccccccCceEEEEEEeC--CC--cE-EEEEEecc--ccchhhHHHHHHHHHHHccCCCCce
Q 038199           11 EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP--NG--VK-IAVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINL   83 (356)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~--~~-vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~ni   83 (356)
                      ..||..+.|++...+.++.++||+|+||.||+|++.  ++  .. ||||..+.  ........+|++|++++++++||||
T Consensus       144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV  223 (474)
T KOG0194|consen  144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV  223 (474)
T ss_pred             cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE
Confidence            578889999999999999999999999999999753  22  23 89999874  3456667889999999999999999


Q ss_pred             eeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc
Q 038199           84 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  163 (356)
Q Consensus        84 ~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~  163 (356)
                      +++||++.....+++|||+|.||+|.+++.+....++..+...++.+.+.||+|||+   ++++||||..+|+|++.++.
T Consensus       224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~  300 (474)
T KOG0194|consen  224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGV  300 (474)
T ss_pred             EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCe
Confidence            999999999999999999999999999997666679999999999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhh
Q 038199          164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKH  242 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~  242 (356)
                      +||+|||+++.......  ......-..+|+|||.+... .++.++|||||||++||+++ |..|+..            
T Consensus       301 vKISDFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g------------  365 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPG------------  365 (474)
T ss_pred             EEeCccccccCCcceee--ccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCC------------
Confidence            99999999876541111  11122356799999999877 89999999999999999998 5555422            


Q ss_pred             hHHHHhhchhhHHH-HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCC
Q 038199          243 VWEEYEKSELDATI-LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPP  306 (356)
Q Consensus       243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~  306 (356)
                          +....+...+ ..+.....+...+.++..++.+||..+|++||+|.++.+.|+.+.....+
T Consensus       366 ----~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  366 ----MKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ----CCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                2233444444 44445556667788899999999999999999999999999988766544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4e-49  Score=371.70  Aligned_cols=267  Identities=25%  Similarity=0.404  Sum_probs=229.1

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      .++.-....+.+.||+|.||.||+|+..      ....||||.++.+.......+|.+|++++..++|||||+++|+|.+
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            3444555667799999999999999753      2456999999987767678899999999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcC---------C----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGK---------K----RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD  159 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~---------~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~  159 (356)
                      ++..++|+|||..|+|..+|..+         +    .+++..+.+.|+.|||.|++||-+   +.+|||||...|+||+
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceec
Confidence            99999999999999999999532         1    238899999999999999999999   9999999999999999


Q ss_pred             CCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCcccc
Q 038199          160 ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDW  238 (356)
Q Consensus       160 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~  238 (356)
                      ++..|||+||||++..-..+.......-.-..+|||||.+..+ .||.+||||||||+|||+++ |.             
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~-------------  703 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGK-------------  703 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhcccc-------------
Confidence            9999999999999875443333322223346799999999876 79999999999999999998 44             


Q ss_pred             chhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          239 FPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                         .+|....+.++.+.+.++...+.+.++|.++++|+..||+.+|++||++++|..+|.......+
T Consensus       704 ---QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  704 ---QPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             ---CcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence               4456666778888888888889999999999999999999999999999999999998765543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-48  Score=348.03  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=210.9

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   97 (356)
                      ...+|.|++.||.|+|++|++|+. .++++|||||+.+..  .+...+-...|-++|.+| .||.|++++..|.|...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            567899999999999999999964 579999999987532  222234567888999999 7999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +|+||+++|+|.+++. +-+.|++..+..++.||+.||+|||+   +|||||||||+|||+|++++++|+|||.++.+..
T Consensus       151 FvLe~A~nGdll~~i~-K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIK-KYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EEEEecCCCcHHHHHH-HhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999999994 45789999999999999999999999   9999999999999999999999999999998753


Q ss_pred             CCCe---------ee--eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH
Q 038199          178 NRSH---------VT--ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       178 ~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      ....         ..  .++++||..|.+||++... ..+..+|+|+|||++|.|+.|.+||.....       .+.++.
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------yliFqk  298 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANE-------YLIFQK  298 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccH-------HHHHHH
Confidence            3221         11  1458899999999999987 789999999999999999999999866543       222222


Q ss_pred             HhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      +-.-         . -..++..+....+|+.+.|..||.+|++.++|.+.
T Consensus       299 I~~l---------~-y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  299 IQAL---------D-YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHh---------c-ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            2111         1 13445566778999999999999999999998874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=335.23  Aligned_cols=269  Identities=23%  Similarity=0.295  Sum_probs=218.5

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ..|.++...|++...||.|..++||+|. .+.++.||||+++-+....+.+.+.+|+..++.++||||++++..|..+..
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            4566788999999999999999999996 567899999999877666777899999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           96 TALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      +|+||.||.+||+.+++... ...+++..+..|+.++++||.|||.   +|.||||||+.||||+.+|.|||+|||.+..
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeee
Confidence            99999999999999999553 5679999999999999999999999   9999999999999999999999999998766


Q ss_pred             cCCCCCeeee--ccCCCCCCCCCccc-ccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          175 CDRNRSHVTI--SGYKGTPGYSAPEF-LSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       175 ~~~~~~~~~~--~~~~gt~~y~aPE~-~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      +.........  ....||++|||||+ .++-..|+.|+||||||++..||.+|..||..-.+-      .+....+.+..
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~p  249 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDP  249 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCC
Confidence            5443322222  45689999999999 444458999999999999999999999997543220      00011111100


Q ss_pred             hhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      - ........-+....+...+++++..||.+||.+|||++++++
T Consensus       250 p-~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  250 P-TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             C-CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0 000001112344566778999999999999999999999987

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-48  Score=341.49  Aligned_cols=269  Identities=22%  Similarity=0.294  Sum_probs=214.4

Q ss_pred             HhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCC-eee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQH-MTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~-~~~   97 (356)
                      +...+|++.++||.|.||.||+|+. .+|..||||.+++..-....-.-.+|+..|+++. ||||+++.+++.+.+ .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            4678999999999999999999974 4699999999987643333333468999999998 999999999999888 999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +|||||+. +|+.++..+++.|++..+..|+.||++||+|+|.   +|+.|||+||+|||+.....+||+|||+|+....
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence            99999965 9999998888999999999999999999999999   9999999999999999888999999999997654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cchhhhHHHHhhchh
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WFPKHVWEEYEKSEL  252 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~  252 (356)
                      ..   ..+.++.|.+|+|||++.....|+.+.|+||+|||++|+.+-+..|-..++...-     .++...++.|..+..
T Consensus       163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            33   3456778999999999887768999999999999999999987555333321110     111111222222211


Q ss_pred             hHHHHh--------cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          253 DATILA--------CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       253 ~~~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ......        ..+....++.+.+..+++.+|+..||++|||+++.++.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111111        11223345578889999999999999999999999985

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.4e-46  Score=344.95  Aligned_cols=264  Identities=25%  Similarity=0.360  Sum_probs=208.7

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceE
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC   90 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~   90 (356)
                      .+.+...+|.+.++||+|+||+||+|.+      .++..||||+++........+.+.+|+.+++.+ +||||+++++++
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            4566677899999999999999999963      246689999997554444556789999999999 899999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcCC------------------------------------------------------
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGKK------------------------------------------------------  116 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~~------------------------------------------------------  116 (356)
                      .+....++||||+++|+|.+++....                                                      
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            99999999999999999998884321                                                      


Q ss_pred             --------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199          117 --------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus       117 --------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                                          ..+++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                247889999999999999999999   999999999999999999999999999998665


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ............++..|+|||.+.+. .++.++|||||||++|||++ |..|+......      ...+.         .
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~---------~  329 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYK---------M  329 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHH---------H
Confidence            43322222223456789999999876 78999999999999999998 76676432211      01111         1


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      +........+...+.++.+++.+||+.||++||++.+|++.|++.
T Consensus       330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            111111122223456799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-46  Score=310.53  Aligned_cols=266  Identities=23%  Similarity=0.300  Sum_probs=212.7

Q ss_pred             hhccccccccccCceEEEEEE-eCCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .+|.-.++||+|.||+||+|+ ..+|+.||||.++.. ..+.......+|+..|+.++|+||+.++++|.+.+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468888999999999999996 567999999999753 222334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |++. +|+..+......++...+..|+.++++|++|||+   +.|+||||||.|+|++.+|.+||+|||+++.+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9976 9999997777889999999999999999999999   99999999999999999999999999999998766554


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc------ch---hhhHHHHhhchh
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW------FP---KHVWEEYEKSEL  252 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~------~~---~~~~~~~~~~~~  252 (356)
                      ...  .+-|.+|.|||.+.|...|+...|+||.||++.||+-| .|+.++.++..+.      +.   ...|..+..-..
T Consensus       158 ~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  158 QTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             ccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            332  25688999999999888999999999999999999965 5666665554221      00   111222221111


Q ss_pred             hHHHHh---cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          253 DATILA---CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       253 ~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ...+..   .......+..+.+..+++..++..||.+|+++.+.++.
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            111111   11111334566778999999999999999999999974

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=366.94  Aligned_cols=266  Identities=29%  Similarity=0.417  Sum_probs=227.5

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC--CCc----EEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP--NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      .++.....++...||+|.||.||.|...  +|.    .||||.+++..+......|.+|+.+|++++||||++++|++.+
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            3455677788899999999999999764  343    4999999988888888999999999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEE
Q 038199           93 QHMTALVYEYMENGSLDGYLFGK------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV  166 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl  166 (356)
                      ....+|++|||+||+|..+|...      ...++....+.++.|||+|+.||++   +++|||||..+|+||+....|||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEE
Confidence            99999999999999999999765      5679999999999999999999999   99999999999999999999999


Q ss_pred             cccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCC-cccccCCCCccccchhhhHH
Q 038199          167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR-RNAIVGSSESLDWFPKHVWE  245 (356)
Q Consensus       167 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~  245 (356)
                      +|||+|+.............-.-..+|||||.+... .++.|+|||||||++||++|.. .|+                .
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY----------------~  906 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPY----------------P  906 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCC----------------C
Confidence            999999954433332221112345689999999876 7999999999999999999944 343                3


Q ss_pred             HHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          246 EYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      ...+.++...+..+++.+.+..++..++++|.+||+.+|++||++..|++.+..+....
T Consensus       907 ~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  907 SRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             CcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            34455566666677788889999999999999999999999999999999988876543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=339.43  Aligned_cols=246  Identities=25%  Similarity=0.344  Sum_probs=209.2

Q ss_pred             hccccccccccCceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      .|+--++||+|+.|.||.|. ..+++.||||.+.... ....+-+.+|+.+|+..+|+|||.+++.|.-++.+|+||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            45666899999999999995 5578999999997532 344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      +||+|.+.+  ....+++.++..|+.++++||+|||.   ++|+|||||.+|||++.+|.+||+|||++..+.....  .
T Consensus       353 ~ggsLTDvV--t~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVV--TKTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhh--hcccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            999999988  44569999999999999999999999   9999999999999999999999999999987765544  2


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC--
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI--  261 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  261 (356)
                      ....+||+.|||||+.... .|..+.||||||++++||+-|++|+.....-               . ....+...+.  
T Consensus       426 R~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl---------------r-AlyLIa~ng~P~  488 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---------------R-ALYLIATNGTPK  488 (550)
T ss_pred             cccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChH---------------H-HHHHHhhcCCCC
Confidence            3456799999999999877 8999999999999999999999998654321               1 1111122222  


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      -......+..+.+++.+||+.|+++|+++.|+|+
T Consensus       489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            2345667889999999999999999999999997

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-46  Score=335.46  Aligned_cols=269  Identities=23%  Similarity=0.287  Sum_probs=210.3

Q ss_pred             HhhhhccccccccccCceEEEEEE-eCCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC--Cee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMT   96 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~   96 (356)
                      .....|+-.++||+|.||.||+|+ ..+|+.||+|.+.-+. .+....-..+|+.+|++|.||||+++.++..+.  ..+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            345567778999999999999996 5679999999997543 234445678999999999999999999999876  689


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      |||+|||+. +|.-++....-.|+..++..++.||+.||+|+|+   ++|+|||||.+|||||.+|.+||+||||++.+.
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999999988 9999886667789999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc------cchhhhHHHHhhc
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD------WFPKHVWEEYEKS  250 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~------~~~~~~~~~~~~~  250 (356)
                      ...... .++.+-|.+|.|||.+.|...|+.+.|+||.|||+.||++|++.+ .+..+..+      .+....-+.|...
T Consensus       270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~-~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL-QGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc-CCccHHHHHHHHHHHhCCCChhccccc
Confidence            544332 455667999999999999989999999999999999999997554 33333211      1111111111111


Q ss_pred             hhhHHHH-------hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          251 ELDATIL-------ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       251 ~~~~~~~-------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+.....       ...+.+.....+....+|+..+|..||.+|.|+.++++
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1111000       00011223345677889999999999999999999987

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-46  Score=337.13  Aligned_cols=253  Identities=25%  Similarity=0.375  Sum_probs=209.0

Q ss_pred             HHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc----hhhHHHHHHHHHHHccCC-CCceeeeeceEecC
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG----RIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQ   93 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~   93 (356)
                      ......|.+++.||+|+||+|+.|.+ .+++.||+|++++...    ....+.+.+|+.++++++ ||||++++.++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            45677899999999999999999965 4689999998876411    123456778999999998 99999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-CceEEcccCCc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLA  172 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfgl~  172 (356)
                      ...++||||+.||+|.+++.. .+++.+..+..++.|++.|++|+|+   ++|+||||||+|||++.+ +++||+|||++
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999999965 7889999999999999999999999   999999999999999999 99999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCC-CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      ....  .........+||+.|+|||++.+.. -...++||||+||+||.|++|..||......       ..+..     
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-------~l~~k-----  234 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-------NLYRK-----  234 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------HHHHH-----
Confidence            8774  1112335578999999999999875 3358999999999999999999998652211       11111     


Q ss_pred             hhHHHHhcCCCchhHHH-HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          252 LDATILACGIEEKDKEK-AKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          +..+. -..+... +.++..++.+||..||.+|+++.+|++
T Consensus       235 ----i~~~~-~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  235 ----IRKGE-FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ----HhcCC-ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                11111 1122222 788999999999999999999999995

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-45  Score=326.27  Aligned_cols=259  Identities=25%  Similarity=0.358  Sum_probs=210.0

Q ss_pred             HhhhhccccccccccCceEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      +....|++.+.||+|+||.||+|.+.    .+..||+|+++..........+.+|+.++++++||||+++++++..+...
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            45678999999999999999999652    36789999998654445556789999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999999986656689999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ..... ......++..|+|||.+.+. .++.++|||||||++||+++ |..||......                .....
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----------------~~~~~  220 (266)
T cd05064         159 SEAIY-TTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----------------DVIKA  220 (266)
T ss_pred             ccchh-cccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----------------HHHHH
Confidence            22111 11123356789999998776 78999999999999999875 88887432210                11111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      +......+.+..++..+.+++.+||+.+|++||++++|.+.|.++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         221 VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            122222234455677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.1e-45  Score=330.78  Aligned_cols=264  Identities=26%  Similarity=0.348  Sum_probs=203.6

Q ss_pred             hhhhccccccccccCceEEEEEEeCC-----------------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCcee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPN-----------------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV   84 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~   84 (356)
                      ...+|.+.++||+|+||.||+|.+.+                 +..||+|++...........+.+|+.++++++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            45688999999999999999997532                 3469999998654455556899999999999999999


Q ss_pred             eeeceEecCCeeeEEEeccCCCChhhhhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 038199           85 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKK------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRI  146 (356)
Q Consensus        85 ~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  146 (356)
                      ++++++.+....++||||+.+++|.+++....                  ..+++..+..++.||+.||.|||+   .++
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence            99999999999999999999999999884321                  347888999999999999999999   999


Q ss_pred             cccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCC-
Q 038199          147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR-  225 (356)
Q Consensus       147 vH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~-  225 (356)
                      +||||||+||+++.++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||+++. 
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccC
Confidence            99999999999999999999999999866444333223334567899999998766 6899999999999999999753 


Q ss_pred             -cccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          226 -RNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       226 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                       .|+......       ........  .............++.++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus       239 ~~p~~~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         239 EQPYGELTDE-------QVIENAGE--FFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCcCCHH-------HHHHHHHH--HhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence             444322110       00000000  00000000001122345577999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.9e-46  Score=341.58  Aligned_cols=265  Identities=23%  Similarity=0.337  Sum_probs=209.1

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceE
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC   90 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~   90 (356)
                      .|.+....|.+.+.||+|+||.||+|.+.      +++.||||++...........+.+|+++++.+ +|+||+++++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            45567778999999999999999998642      24579999997654444556789999999999 899999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcC-------------------------------------------------------
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGK-------------------------------------------------------  115 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~-------------------------------------------------------  115 (356)
                      ......++||||+.+|+|.+++...                                                       
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            9999999999999999999887432                                                       


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          116 --------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       116 --------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                                    ..++++..+++|+.||+.||.|||+   ++++||||||+||+++.++.++|+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                          1247889999999999999999999   99999999999999999999999999999865443322


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                      .......++..|+|||++.+. .++.++|||||||++|||++ |..||......               ...........
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---------------~~~~~~~~~~~  332 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---------------SKFYKMVKRGY  332 (374)
T ss_pred             eeccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCcccccc---------------HHHHHHHHccc
Confidence            222223456789999998766 68999999999999999997 88886432211               00111111111


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      ....+...+.++.+++.+||+.||++||++.+|++.|+++.
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         333 QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            11122224577999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.7e-45  Score=324.95  Aligned_cols=247  Identities=19%  Similarity=0.244  Sum_probs=200.2

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEec----CCeeeEEEecc
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHMTALVYEYM  103 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~----~~~~~lV~e~~  103 (356)
                      ..||+|++|.||+|.+ +|+.||||++.....  ....+.+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999988 788999999975422  1224678899999999999999999999876    35678999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      ++|+|.+++.. .+.+++.....++.|++.||.|||+  ..+++||||||+||++++++.+||+|||+++......    
T Consensus       105 ~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        105 TRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----  177 (283)
T ss_pred             CCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence            99999999843 4678999999999999999999997  2488999999999999999999999999988654322    


Q ss_pred             eccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH-HhcCC
Q 038199          184 ISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI-LACGI  261 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  261 (356)
                       ....|+..|+|||++.+. ..++.++|||||||++|||++|..||......                .....+ .....
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----------------~~~~~i~~~~~~  240 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----------------EIYDLIINKNNS  240 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhcCCC
Confidence             123578899999998752 26899999999999999999999998543211                111111 11122


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      ...+...+..+.+++.+||+.||++|||+++|++.|+.+.
T Consensus       241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            2333356778999999999999999999999999998764

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.1e-45  Score=339.07  Aligned_cols=266  Identities=24%  Similarity=0.326  Sum_probs=211.6

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceE
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFC   90 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~   90 (356)
                      -+++...+|.+.++||+|+||.||+|.+.      ++..||||++.........+.+.+|+++++++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            46667788899999999999999999752      234799999976544555578999999999996 99999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcC-------------------------------------------------------
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGK-------------------------------------------------------  115 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~-------------------------------------------------------  115 (356)
                      .+....++|||||++|+|.+++...                                                       
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            9999999999999999999887432                                                       


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCc
Q 038199          116 ----------------------------------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  155 (356)
Q Consensus       116 ----------------------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~N  155 (356)
                                                              ...+++..+..++.|++.||.|||+   .+++||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHh
Confidence                                                    1247888999999999999999999   999999999999


Q ss_pred             EEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCC
Q 038199          156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSE  234 (356)
Q Consensus       156 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~  234 (356)
                      |+++.++.++|+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..|+......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            99999999999999999865433322222233467789999999876 68999999999999999997 77776432111


Q ss_pred             ccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          235 SLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                            .         ..............+...+.++.+++.+||+.+|++||++.+|.+.|+.+..
T Consensus       347 ------~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 ------S---------TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ------H---------HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                  0         0111111111223334567789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-45  Score=321.05  Aligned_cols=259  Identities=27%  Similarity=0.423  Sum_probs=211.6

Q ss_pred             hhhhccccccccccCceEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      ...+|++.+.||+|+||+||+|.+..    ...||||++...........+.+|+.++++++||||+++++++.+....+
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            35678999999999999999997642    45799999876555555678899999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+.+++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++.....
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999999996656689999999999999999999999   9999999999999999999999999999987753


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ...........++..|+|||.+.+. .++.++||||||+++|+|++ |..|+.....                .......
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----------------~~~~~~~  221 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSN----------------QDVIKAV  221 (266)
T ss_pred             cccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCH----------------HHHHHHH
Confidence            3332222233456789999999876 68999999999999999998 8877633211                1111111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ......+.+...+..+.+++.+||+.+|++||++++|++.|.++
T Consensus       222 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         222 EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            12222223345567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=308.47  Aligned_cols=240  Identities=27%  Similarity=0.308  Sum_probs=204.0

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      ..-.+|++.+.||.|+||.|.+++.+ +|..||+|+++...  .-...++..+|-.+|+.+.||+++++++.+.+...++
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            44567788899999999999999765 69999999997542  2344467889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||.+||.|..++ ++.+++++..+..++.||+.||+|||+   .+|++|||||+|||+|.+|.+||+|||.++....
T Consensus       121 mvmeyv~GGElFS~L-rk~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYL-RKSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EEEeccCCccHHHHH-HhcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            999999999999999 456789999999999999999999999   9999999999999999999999999999997654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      .     +-..|||+.|+|||+++.. +++.++|.|||||++|||+.|..||.....       ...++.         +.
T Consensus       197 r-----T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~K---------I~  254 (355)
T KOG0616|consen  197 R-----TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEK---------IL  254 (355)
T ss_pred             c-----EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHH---------HH
Confidence            3     2335799999999999988 899999999999999999999999966543       112222         22


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCC
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDR  287 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  287 (356)
                      .+. -..+.-...++.+|+...|+.|-.+|
T Consensus       255 ~~~-v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  255 EGK-VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             hCc-ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            222 13455566778899999999999999

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-47  Score=332.79  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=211.6

Q ss_pred             hhhccccccccccCceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...|+-.+.||+|+||.||+|. ..+++.||+|++.-+..+...+.+.+|+.++.+++++||.++|+.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            4456667999999999999995 557999999999877666667789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      ||.||++.+.+ +.+..+.+..+.-++.+++.|+.|||+   ++.+|||||+.|||+..+|.|||+|||.+.........
T Consensus        92 y~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   92 YCGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HhcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999999998 445556888999999999999999999   99999999999999999999999999999876544333


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                      .  ..++||+.|||||++.+. .|+.|+||||||++.+||.+|.+|+..-.+.                ...-.+.....
T Consensus       168 r--~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~P  228 (467)
T KOG0201|consen  168 R--KTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAP  228 (467)
T ss_pred             c--ccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCC
Confidence            2  557899999999999966 8999999999999999999999987443221                11111122223


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +.....++..+.+++..||++||+.||++.++++
T Consensus       229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            3344467788999999999999999999999987

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.3e-45  Score=323.82  Aligned_cols=257  Identities=25%  Similarity=0.415  Sum_probs=210.2

Q ss_pred             hhhccccccccccCceEEEEEEeCC-C-----cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPN-G-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ..+|.+.+.||+|+||.||+|.... +     ..||+|.+...........+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            4578899999999999999997532 2     579999987654445556799999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC
Q 038199           97 ALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  161 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~  161 (356)
                      +++|||+++++|.+++....               ..+++..++.++.|++.||.|||+   .+++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence            99999999999999885421               468899999999999999999999   999999999999999999


Q ss_pred             CceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccch
Q 038199          162 FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFP  240 (356)
Q Consensus       162 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~  240 (356)
                      +.++|+|||++................++..|+|||.+.+. .++.++|||||||++|||++ |..|+.....       
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~-------  232 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-------  232 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            99999999999765433322222334567889999998766 68999999999999999998 8878643221       


Q ss_pred             hhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                               ......+........+..++.++.+++.+||+.||.+||++.+|++.|+.
T Consensus       233 ---------~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         233 ---------QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---------HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                     11122222333334455677889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.3e-46  Score=333.23  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=211.3

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .+|-+.+.||+|+||.||+|+- .+.+.||+|.+.+. ..+.....+.+|+++++.++||||+.++++|+....+|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            3577788999999999999964 47899999999753 345556789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.| +|..++ ..++.++++.+..++.+++.||.|||+   .+|+|||+||.|||++.+|++|++|||+++.+..  ..
T Consensus        82 ~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9987 999999 567899999999999999999999999   9999999999999999999999999999998764  33


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                      ...+..+||+-|||||...++ +|+..+|+||+||++||+++|++||...+          ..      .+...+.... 
T Consensus       155 ~vltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~s----------i~------~Lv~~I~~d~-  216 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARS----------IT------QLVKSILKDP-  216 (808)
T ss_pred             eeeeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHH----------HH------HHHHHHhcCC-
Confidence            455677899999999999977 89999999999999999999999984322          11      1122222222 


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...+...+..+.+++...|.+||.+|.+..+++.
T Consensus       217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            2334477888999999999999999999999876

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=349.91  Aligned_cols=267  Identities=25%  Similarity=0.419  Sum_probs=234.4

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      -..||......+.++||.|.||+|++|+++.    ...||||.++..-.+.....|..|+.+|-+++||||+++.|+...
T Consensus       622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            3467777788889999999999999998652    356999999988888888899999999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      .....||.|||++|+|+.+|..+.+++++.++..++.+|+.|+.||-+   +++|||||...|||++.+-.+|++|||++
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccce
Confidence            999999999999999999998888899999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhc
Q 038199          173 KLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       173 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      +...+.... ....+-+-..+|.|||.+.-. .+|.+||||||||++||.++ |.+|.                =++.+.
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPY----------------WdmSNQ  841 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPY----------------WDMSNQ  841 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcc----------------cccchH
Confidence            987554422 222223345799999999876 79999999999999999886 66553                244556


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      ++...+..+.+.+.+.++|..|..|++.||++|-.+||.+.+|+..|.++...
T Consensus       842 dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  842 DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            66677777888888899999999999999999999999999999999998765

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.1e-44  Score=316.27  Aligned_cols=253  Identities=27%  Similarity=0.434  Sum_probs=204.5

Q ss_pred             hhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..+|++.+.||+|+||.||++++.++..+|+|.+...  ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            3568889999999999999998877788999988654  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999999986555678999999999999999999999   99999999999999999999999999998765432221 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                      ......++..|+|||.+.+. .++.++||||||+++|||++ |+.|+......       .....         +.....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~~~~~---------i~~~~~  219 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------EVVEM---------ISRGFR  219 (256)
T ss_pred             ccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH---------HHCCCC
Confidence            11223356689999999866 68999999999999999999 77777443211       01111         111111


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ...+...+..+.+++.+||+.+|++||+++++++.|.
T Consensus       220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1122234567899999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.3e-46  Score=325.73  Aligned_cols=251  Identities=33%  Similarity=0.513  Sum_probs=200.2

Q ss_pred             cccccccccCceEEEEEEeC-----CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           27 NYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        27 ~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ++.+.||.|.||.||+|.+.     .+..|+||+++........+.+.+|++.+++++||||++++|++.+....++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46788999999999999764     3678999999765555567889999999999999999999999998888999999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          102 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+.+|+|.+++... ...+++.++..|+.||+.||.|||+   .+++|+||+++||+++.++.+||+|||++........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            99999999999766 6789999999999999999999999   9999999999999999999999999999987643333


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      ........+...|+|||.+.+. .++.++||||||+++|||++ |+.|+...                ....+...+...
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~----------------~~~~~~~~~~~~  221 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDY----------------DNEEIIEKLKQG  221 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTS----------------CHHHHHHHHHTT
T ss_pred             cccccccccccccccccccccc-ccccccccccccccccccccccccccccc----------------cccccccccccc
Confidence            3333344577789999999876 58999999999999999999 56664322                112222222333


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      .....+..++..+.+++.+||..+|++||++.+|++.|
T Consensus       222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            33344455677899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.4e-44  Score=327.27  Aligned_cols=262  Identities=25%  Similarity=0.353  Sum_probs=210.0

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      +...+|+..+.||+|+||+||+|.+. +++    .||+|++..........++.+|+.+++.++||||+++++++... .
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            35667899999999999999999753 333    48999987654445567899999999999999999999999765 4


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++|++|+.+|+|.+++......+++..++.++.||+.||+|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence            679999999999999997666679999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      .............++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....                .....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----------------~~~~~  222 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----------------SEISS  222 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----------------HHHHH
Confidence            544333333333456789999999876 78999999999999999998 8887643211                01111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      ..........+..++.++..++.+||..+|++||++.+++..|..+...
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            1111222223334556789999999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-44  Score=317.46  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=210.8

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      |++....|++.++||+|+||.||+|...++..||+|.+...  ....+.+.+|+.++++++|+||+++++++.+....++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            45667889999999999999999998777888999988754  2345688999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||||+.+++|.+++... ...+++.++..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            99999999999998543 4568999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||......                .....+
T Consensus       156 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----------------~~~~~~  217 (261)
T cd05072         156 NEYT-AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----------------DVMSAL  217 (261)
T ss_pred             Ccee-ccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----------------HHHHHH
Confidence            3221 12233467789999998766 68899999999999999998 88776432110                011111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ......+.....+.++.+++.+|++.+|++||+++++.+.|+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11111222234567799999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-45  Score=335.09  Aligned_cols=249  Identities=26%  Similarity=0.336  Sum_probs=213.4

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .-|++++-||.|+.|.|.+|++ .+|+..|||++...  ........+.+|+.+|+.+.|||++.+|++++++..+|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4588999999999999999976 47999999999753  33444567889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||++||-|.+++ ...+++++..+..++.||+.|+.|+|.   .+|+|||+||+|+|+|..+.+||+|||+|..-.... 
T Consensus        92 Eyv~gGELFdyl-v~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-  166 (786)
T KOG0588|consen   92 EYVPGGELFDYL-VRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-  166 (786)
T ss_pred             EecCCchhHHHH-HhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence            999999999999 456789999999999999999999999   999999999999999999999999999997644332 


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                        .....||++.|.|||++.|......++||||.|||||.||||..||..+..                ..+...+.. +
T Consensus       167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----------------r~LLlKV~~-G  227 (786)
T KOG0588|consen  167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----------------RVLLLKVQR-G  227 (786)
T ss_pred             --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----------------HHHHHHHHc-C
Confidence              234578999999999999987778999999999999999999999973321                111222222 2


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .-.++.+.+.+..+|+.+|+..||++|.|+++|++.
T Consensus       228 ~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  228 VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            234567778889999999999999999999999984

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.5e-44  Score=329.39  Aligned_cols=265  Identities=25%  Similarity=0.378  Sum_probs=207.2

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH   91 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~   91 (356)
                      |++...+|++.+.||+|+||.||+|...      +++.||+|++.........+.+..|+.++.++ +|+||+++++++.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            4556678999999999999999999531      35789999987544344446788899999999 7999999999886


Q ss_pred             c-CCeeeEEEeccCCCChhhhhhcC-------------------------------------------------------
Q 038199           92 D-QHMTALVYEYMENGSLDGYLFGK-------------------------------------------------------  115 (356)
Q Consensus        92 ~-~~~~~lV~e~~~~~sL~~~l~~~-------------------------------------------------------  115 (356)
                      . +...++||||+++++|.+++...                                                       
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 45678999999999999888432                                                       


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCC
Q 038199          116 -----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT  190 (356)
Q Consensus       116 -----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt  190 (356)
                           ...+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.++|+|||++................++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                 1268999999999999999999999   99999999999999999999999999999876433222222234467


Q ss_pred             CCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHH
Q 038199          191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKA  269 (356)
Q Consensus       191 ~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (356)
                      ..|+|||++.+. .++.++|||||||++|||++ |..|+......      ..         .............+...+
T Consensus       239 ~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------~~---------~~~~~~~~~~~~~~~~~~  302 (337)
T cd05054         239 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------EE---------FCRRLKEGTRMRAPEYAT  302 (337)
T ss_pred             ccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------HH---------HHHHHhccCCCCCCccCC
Confidence            789999998876 78999999999999999998 88776432111      00         011111111122233455


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          270 KRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       270 ~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .++.+++.+||+.+|++||++++|++.|+.+..
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            779999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-44  Score=328.22  Aligned_cols=247  Identities=23%  Similarity=0.246  Sum_probs=201.4

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ....|++.+.||+|+||.||+|++. +++.||||++....  .....+.+.+|+.++++++||||+++++++.++...++
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            3467889999999999999999765 58999999987531  12334578899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||+.+++|.+++. ....+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||++......
T Consensus        96 v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         96 LLEFVVGGELFTHLR-KAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEcCCCCChHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            999999999999884 34678999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .     ....||+.|+|||++.+. .++.++|||||||++|||++|..||.....       ...++...         .
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~---------~  229 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKIL---------A  229 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHh---------c
Confidence            2     124589999999999877 689999999999999999999999854321       11111111         1


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      . ....+...+.++.+++.+||+.||.+||+     +++++.
T Consensus       230 ~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        230 G-RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             C-CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1 11122234567889999999999999997     577765

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6e-45  Score=326.78  Aligned_cols=257  Identities=23%  Similarity=0.295  Sum_probs=206.1

Q ss_pred             HHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      -+...+|++.+.||+|+||.||+|+- .+|..||+|++++..  .....++.+.|-++|....+|+||++|..|.+.+++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            34667888999999999999999964 469999999998642  233346788999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ||||||++||++..+| .+.+.+++..+..++.+++.||..+|.   .|+|||||||+|+|||..|++||+||||+..+.
T Consensus       217 YLiMEylPGGD~mTLL-~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLL-MRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEEEecCCccHHHHH-HhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhh
Confidence            9999999999999999 466789999999999999999999999   999999999999999999999999999986432


Q ss_pred             C----------------------CCCe-----ee------------------eccCCCCCCCCCcccccCCCCCCccccc
Q 038199          177 R----------------------NRSH-----VT------------------ISGYKGTPGYSAPEFLSGNYPITHKCDV  211 (356)
Q Consensus       177 ~----------------------~~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Dv  211 (356)
                      .                      ....     ..                  .-+.+||+-|+|||++.+. .|+..+|.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDw  371 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDW  371 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccH
Confidence            1                      0000     00                  0134699999999999988 79999999


Q ss_pred             hhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC--
Q 038199          212 YSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP--  289 (356)
Q Consensus       212 ~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps--  289 (356)
                      ||||||+||||.|.+||....+.       -.|..+..   ...   ....+.....+.+..+||.+|+. ||++|-.  
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~-------~T~rkI~n---wr~---~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~  437 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQ-------ETYRKIVN---WRE---TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSK  437 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHH---Hhh---hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence            99999999999999999665432       12222211   111   11222333344778899999999 9999975  


Q ss_pred             -HHHHHH
Q 038199          290 -MSAVVK  295 (356)
Q Consensus       290 -~~~v~~  295 (356)
                       ++||-+
T Consensus       438 G~~EIK~  444 (550)
T KOG0605|consen  438 GAEEIKK  444 (550)
T ss_pred             cHHHHhc
Confidence             555554

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.3e-44  Score=319.65  Aligned_cols=260  Identities=23%  Similarity=0.361  Sum_probs=206.4

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      |++...+|++.+.||+|+||.||+|.+.      ++..||||++..........++.+|+.+++.++||||+++++++.+
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4566788999999999999999999642      2567999998654333445678999999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKK---------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  163 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~  163 (356)
                      +...++||||+.+++|.+++....         ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCC
Confidence            999999999999999999885321         246788999999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhh
Q 038199          164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKH  242 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~  242 (356)
                      ++|+|||++................++..|+|||.+.+. .++.++|||||||++|||++ |..|+.....         
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---------  227 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---------  227 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence            999999998765433322222223457789999999876 68999999999999999999 5666533211         


Q ss_pred             hHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          243 VWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                             ...............+...+..+.+++.+||+.||++||++.++++.|+
T Consensus       228 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         228 -------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                   1111111222222333445677999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-44  Score=319.31  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=208.7

Q ss_pred             hhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ...+|++.+.||+|+||.||+|...      +++.||||++...........+.+|++++++++|+||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            4567899999999999999999753      2578999999765444456789999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           96 TALVYEYMENGSLDGYLFGK-------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      .++||||+++++|.+++...             ...+++..+..++.|++.|+.|||+   .+++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCC
Confidence            99999999999999998543             2357899999999999999999999   9999999999999999999


Q ss_pred             ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchh
Q 038199          163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPK  241 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~  241 (356)
                      .++|+|||++................++..|+|||++.+. .++.++||||||+++|||++ |..|+......       
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------  231 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------  231 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------
Confidence            9999999998754332221112223457789999999876 68999999999999999998 88886432211       


Q ss_pred             hhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          242 HVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                               ..............+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus       232 ---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         232 ---------EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ---------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                     1111122222223334566789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1e-44  Score=323.78  Aligned_cols=266  Identities=21%  Similarity=0.266  Sum_probs=202.0

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|.+.++||+|+||+||+|... +++.||+|++...........+.+|+.++++++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999764 68999999987543333445678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.+ +|.+++......+++..+..++.||+.||+|||+   ++++||||||+||+++.++.+||+|||+++.......  
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence            975 8998886666678999999999999999999999   9999999999999999999999999999876432221  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cchhhhHHHHhhch----hh
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WFPKHVWEEYEKSE----LD  253 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~----~~  253 (356)
                      ......++..|+|||.+.+...++.++|||||||++|+|++|+.||........-     .......+.+....    ..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            1223457899999999876556899999999999999999999988544321100     00000001111000    00


Q ss_pred             HHHHhcCCC----chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILACGIE----EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ....+....    ...+..+.+..+++.+||+.||.+|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000000    001123466889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-44  Score=314.63  Aligned_cols=261  Identities=21%  Similarity=0.252  Sum_probs=215.4

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      .....+....+++.++||+|.-|+||+++.. ++..+|+||+.+..  ......+...|-++|+.++||.++.+|+.+..
T Consensus        69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            3456667778888999999999999999875 47999999998642  23334577889999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           93 QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                      ..+.|+|||||.||+|..+++++ ++.+++..+..++.+++.||+|||.   .|||+|||||+||||-++|++.|+||.|
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDL  225 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDL  225 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccc
Confidence            99999999999999999999765 5679999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCC---------------------------------CCC---------------------eeeeccCCCCCCCCCcc
Q 038199          172 AKLCDR---------------------------------NRS---------------------HVTISGYKGTPGYSAPE  197 (356)
Q Consensus       172 ~~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE  197 (356)
                      +..+..                                 ...                     .....+++||..|+|||
T Consensus       226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence            764311                                 000                     00112467999999999


Q ss_pred             cccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHH
Q 038199          198 FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAAL  277 (356)
Q Consensus       198 ~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  277 (356)
                      ++.|. ..+.+.|.|+|||++||||.|..||.....               +..+.+.+.....-+..+..+..+.+||+
T Consensus       306 vI~G~-GHgsAVDWWtfGIflYEmLyG~TPFKG~~~---------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr  369 (459)
T KOG0610|consen  306 VIRGE-GHGSAVDWWTFGIFLYEMLYGTTPFKGSNN---------------KETLRNIVGQPLKFPEEPEVSSAAKDLIR  369 (459)
T ss_pred             eeecC-CCCchhhHHHHHHHHHHHHhCCCCcCCCCc---------------hhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence            99988 689999999999999999999999976554               23333444333333344477788999999


Q ss_pred             hcccCCCCCCCC----HHHHHH
Q 038199          278 WCVQDSPEDRPP----MSAVVK  295 (356)
Q Consensus       278 ~cl~~~p~~Rps----~~~v~~  295 (356)
                      +.|.+||.+|-.    +.||-+
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HHhccChhhhhccccchHHhhc
Confidence            999999999998    666665

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.3e-44  Score=320.04  Aligned_cols=251  Identities=25%  Similarity=0.315  Sum_probs=201.3

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|...+.||+|+||+||+|.+ .+|+.||+|++....  .......+.+|+.++++++|+||+.+++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            467789999999999999975 479999999986432  12223467889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          102 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+.+++|..++... ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999998877443 3468999999999999999999999   999999999999999999999999999998654322 


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                        ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.......       ..+..     .... ...
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-------~~~~~-----~~~~-~~~  220 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-------KREEV-----DRRV-KED  220 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcch-------hHHHH-----HHHh-hcc
Confidence              12335689999999999876 78999999999999999999999986543210       00111     1111 111


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      ........+.++.+++.+||+.||.+||+     ++++++
T Consensus       221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            12233445678899999999999999997     777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.3e-44  Score=314.30  Aligned_cols=254  Identities=25%  Similarity=0.426  Sum_probs=206.0

Q ss_pred             hhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...+|++.+.||+|+||+||+|++.++..+|||.+...  ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            34678999999999999999998877778999988754  2334678999999999999999999999999889999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.+++|.+++......+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++........
T Consensus        80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            999999999986555579999999999999999999999   99999999999999999999999999998765433221


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                       ......++..|+|||.+.+. .++.++||||||+++|+|++ |..|+......                ..........
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----------------~~~~~~~~~~  218 (256)
T cd05113         157 -SSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----------------ETVEKVSQGL  218 (256)
T ss_pred             -ecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----------------HHHHHHhcCC
Confidence             22223456789999999866 68899999999999999998 88776432210                1111111222


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ....+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            22223334678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.5e-44  Score=327.91  Aligned_cols=242  Identities=24%  Similarity=0.314  Sum_probs=196.8

Q ss_pred             ccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCC
Q 038199           30 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +.||+|+||.||++.. .+|+.||||++....  .......+.+|+.++++++||||+++++++.+....++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 469999999997532  2233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeecc
Q 038199          107 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG  186 (356)
Q Consensus       107 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  186 (356)
                      +|.+++. ....+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++.......  ....
T Consensus        81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~  154 (323)
T cd05571          81 ELFFHLS-RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccc
Confidence            9998884 45678999999999999999999999   9999999999999999999999999999875322211  1233


Q ss_pred             CCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhH
Q 038199          187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK  266 (356)
Q Consensus       187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (356)
                      ..||..|+|||++.+. .++.++|||||||++|||++|..||......       ....         ..... ....+.
T Consensus       155 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~---------~~~~~-~~~~p~  216 (323)
T cd05571         155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFE---------LILME-EIRFPR  216 (323)
T ss_pred             eecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHH---------HHHcC-CCCCCC
Confidence            5689999999999876 7899999999999999999999998543211       0011         11111 112233


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          267 EKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       267 ~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      ..+.++.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            4567789999999999999999     7888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.5e-44  Score=312.80  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=200.0

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCCh
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      ++||+|+||.||+|.+. +++.||+|.+...........+.+|++++++++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999764 68999999887554455567899999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCC
Q 038199          109 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK  188 (356)
Q Consensus       109 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  188 (356)
                      .+++......+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            99986555678999999999999999999999   999999999999999999999999999987644321111111112


Q ss_pred             CCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHH
Q 038199          189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE  267 (356)
Q Consensus       189 gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (356)
                      ++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....                ...............+..
T Consensus       158 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~  220 (252)
T cd05084         158 IPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSN----------------QQTREAIEQGVRLPCPEL  220 (252)
T ss_pred             CceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCH----------------HHHHHHHHcCCCCCCccc
Confidence            34569999998776 68999999999999999998 7666533211                111111111222233345


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          268 KAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       268 ~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      .+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            5678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-44  Score=314.66  Aligned_cols=258  Identities=32%  Similarity=0.442  Sum_probs=208.6

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      |++...+|++.+.||+|++|.||+|.+.+++.||+|.+...  ....+.+.+|+.++++++||||+++++++......++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG--TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC--cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            35667789999999999999999998767788999998754  2334678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||||+.+++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            99999999999998544 3578999999999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .... .......+..|+|||.+.+. .++.++||||||+++|||++ |+.|+.....       .....         .+
T Consensus       156 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~---------~~  217 (261)
T cd05068         156 DIYE-AREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-------AEVLQ---------QV  217 (261)
T ss_pred             Cccc-ccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHH---------HH
Confidence            2211 11112234579999998876 68999999999999999999 8777643211       11111         11


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      ........+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         218 DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1111122334456789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.1e-44  Score=325.00  Aligned_cols=269  Identities=26%  Similarity=0.365  Sum_probs=214.6

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeee
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLY   87 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~   87 (356)
                      +.|++...+|++.+.||+|+||.||+|...        ++..||+|++...........+.+|+.+++++ +||||++++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            568888899999999999999999999642        12368999987654455567899999999999 799999999


Q ss_pred             ceEecCCeeeEEEeccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCC
Q 038199           88 GFCHDQHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK  152 (356)
Q Consensus        88 ~~~~~~~~~~lV~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dik  152 (356)
                      +++.+....++||||+.+++|.+++...               ...+++.++..++.|++.||.|||+   .+++|||||
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlk  161 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLA  161 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccc
Confidence            9999999999999999999999998542               2358889999999999999999999   999999999


Q ss_pred             CCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccC
Q 038199          153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVG  231 (356)
Q Consensus       153 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~  231 (356)
                      |+||+++.++.++|+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |..|+...
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999865433222222223345679999999876 68899999999999999998 66665322


Q ss_pred             CCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          232 SSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                      ..                ......+........+...+.++.+++.+||+.+|.+||++.++++.|..+.....
T Consensus       241 ~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         241 PV----------------EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             CH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence            11                11111111222223334556789999999999999999999999999998876544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-45  Score=334.11  Aligned_cols=246  Identities=26%  Similarity=0.313  Sum_probs=207.7

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCC-CCceeeeeceEecCCe
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHM   95 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~   95 (356)
                      -+.-..++|.++||+|+||+|+++..+ +++.||||+++++.  ...+.+..+.|.+++.... ||.++.++.+|..+++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            456678899999999999999999875 58899999998763  4555678899999998885 9999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      +|+||||+.||++....  +.+.+++..+..+++.|+.||.|||+   ++|||||||.+|||||.+|++||+|||+++..
T Consensus       444 l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccccc
Confidence            99999999999955433  56789999999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      -...  ..+..++||+.|+|||++.+. .|+.+.|.|||||++||||.|..||..+..+               +.+...
T Consensus       519 m~~g--~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------e~FdsI  580 (694)
T KOG0694|consen  519 MGQG--DRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------EVFDSI  580 (694)
T ss_pred             CCCC--CccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHH
Confidence            3222  245668999999999999988 8999999999999999999999998655432               111111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPM  290 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  290 (356)
                      +..  ....+.-.+.+...++.++|.+||++|-.+
T Consensus       581 ~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 VND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            111  134556677889999999999999999865

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.6e-44  Score=317.75  Aligned_cols=257  Identities=22%  Similarity=0.355  Sum_probs=206.4

Q ss_pred             hhhccccccccccCceEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      -.++++.++||+|+||+||+|.+     ..++.||+|.+...........+.+|+.+++.++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            35678899999999999999974     2467899999975444445567899999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC
Q 038199           98 LVYEYMENGSLDGYLFGK----------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  161 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~  161 (356)
                      +||||+.+++|.+++...                ...+++.++..++.|++.||.|||+   ++++||||||+||+++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence            999999999999988422                2347899999999999999999999   999999999999999999


Q ss_pred             CceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccch
Q 038199          162 FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFP  240 (356)
Q Consensus       162 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~  240 (356)
                      +.++|+|||++................++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....       
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------  232 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------  232 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            99999999999876443332223334467789999998766 68999999999999999998 7777633211       


Q ss_pred             hhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                               ......+........+...+..+.+++.+||+.||++||++.+|.+.|.+
T Consensus       233 ---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 ---------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                     11111222222223334556789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.8e-44  Score=325.10  Aligned_cols=268  Identities=24%  Similarity=0.347  Sum_probs=207.6

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +...+|++.+.||+|+||.||++.+. ++..||+|++...........+.+|++++++++||||+++++++.++...++|
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            45678999999999999999999765 68899999997654445567899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+++++|.+++. ....+++..+..++.|++.||.|||+  ..+++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          82 MEHMDGGSLDQVLK-EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             eecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            99999999999984 34578999999999999999999998  1369999999999999999999999999987654321


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-cchhhhH--------------
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-WFPKHVW--------------  244 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-~~~~~~~--------------  244 (356)
                          .....|+..|+|||++.+. .++.++|||||||++|||++|+.|+......... .+.....              
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence                2234689999999999876 6899999999999999999999998543211000 0000000              


Q ss_pred             ---------------HHHhhchhhHHHHhcCCCc-hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          245 ---------------EEYEKSELDATILACGIEE-KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       245 ---------------~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                                     ...........+.....+. ....++.++.+++.+||+.||++|||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                           0000000001111111111 112356789999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=323.19  Aligned_cols=244  Identities=24%  Similarity=0.250  Sum_probs=199.8

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|++.+.||+|+||+||+|... +++.||+|++....  .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            5788999999999999999764 68999999986431  12334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.+++|.+++. ..+.+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--  155 (291)
T cd05612          82 YVPGGELFSYLR-NSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--  155 (291)
T ss_pred             CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence            999999999984 44578999999999999999999999   999999999999999999999999999988654321  


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                         ....|+..|+|||++.+. .++.++|||||||++|+|++|..||......       ..+...         .... 
T Consensus       156 ---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~~~~~i---------~~~~-  214 (291)
T cd05612         156 ---WTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------GIYEKI---------LAGK-  214 (291)
T ss_pred             ---ccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHH---------HhCC-
Confidence               224589999999999876 6899999999999999999999998543211       111111         1111 


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      ...+...+..+.+++.+||+.||.+||+     ++++++
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            1222334567899999999999999995     777775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-45  Score=326.60  Aligned_cols=251  Identities=25%  Similarity=0.337  Sum_probs=216.5

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe-eeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM-TALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~-~~lV~  100 (356)
                      ..|...+++|+|+||.+++++++ +++.|++|.+.-. ..+.......+|+.++++++||||+.+.+.+..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888999999999999999765 5889999998743 334444578899999999999999999999998877 99999


Q ss_pred             eccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          101 EYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      +||+||+|.+.+...+ ..++++.+..|+.|++.|+.|||+   ..|+|||||+.||++..++.|+|+|||+++......
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999997655 679999999999999999999998   999999999999999999999999999999887654


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      .  ......||+.|++||.+.+. +|+.|+|||||||++|||++-+.+|.....                ..+...+...
T Consensus       161 ~--~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m----------------~~Li~ki~~~  221 (426)
T KOG0589|consen  161 S--LASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNM----------------SELILKINRG  221 (426)
T ss_pred             h--hhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccch----------------HHHHHHHhhc
Confidence            2  23446799999999999988 899999999999999999999887754332                2223333444


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ...+.+..++.++..++..|+..+|..||++.+++..
T Consensus       222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            4567788899999999999999999999999999985

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8e-44  Score=318.76  Aligned_cols=264  Identities=25%  Similarity=0.357  Sum_probs=211.9

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceE
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC   90 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~   90 (356)
                      .+.+...+|++.+.||+|+||.||++...      +...+|+|.+...........+.+|+++++++ +|+||+++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            35667788999999999999999999753      24689999987654445556789999999999 799999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhc---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCc
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFG---------------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  155 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~---------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~N  155 (356)
                      ..+...++||||+.+++|..++..               ....+++..++.++.|++.||.|||+   .+++||||||+|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceee
Confidence            999999999999999999999853               23568999999999999999999999   999999999999


Q ss_pred             EEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCC
Q 038199          156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSE  234 (356)
Q Consensus       156 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~  234 (356)
                      |+++.++.++|+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..|+..... 
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~-  240 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-  240 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCH-
Confidence            99999999999999999876543322222233456789999998766 68999999999999999998 7777532211 


Q ss_pred             ccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          235 SLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                                     ...............+...+.++.+++.+||..||++|||+.++++.|+++.
T Consensus       241 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 ---------------EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ---------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                           0111111122222333445677999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.9e-44  Score=318.53  Aligned_cols=259  Identities=22%  Similarity=0.323  Sum_probs=208.2

Q ss_pred             HhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      +...+|.+.+.||+|+||.||+|.+.      .++.||||+++........+.+..|+.++++++||||+++++++....
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            34567888999999999999999753      257899999986544444567899999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc
Q 038199           95 MTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD  159 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~  159 (356)
                      ..++++||+.+++|.+++...               ...+++..+..++.|++.||.|||+   .+++||||||+||+++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVF  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEec
Confidence            999999999999999987421               2358889999999999999999999   9999999999999999


Q ss_pred             CCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCcccc
Q 038199          160 ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDW  238 (356)
Q Consensus       160 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~  238 (356)
                      +++.+||+|||+++...............+++.|+|||.+.+. .++.++||||||+++|||++ |..|+.....     
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----  232 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----  232 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            9999999999998865443332222334467899999998766 68999999999999999998 6656532211     


Q ss_pred             chhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          239 FPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                                 ......+........+..++..+.+++.+||+.+|.+||++++|+..|+.
T Consensus       233 -----------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 -----------QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                       11222222333333445567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-43  Score=315.57  Aligned_cols=261  Identities=23%  Similarity=0.313  Sum_probs=205.4

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ...+|.+.+.||+|+||+||+|.+. +++    .+++|++..........++..|+..++++.||||+++++++.. ...
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            3467788899999999999999763 444    4788887654333444678889999999999999999998764 456


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++|+||+.+++|.+++......+++..+..|+.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            88999999999999997666789999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ............++..|+|||.+.+. .++.++||||||+++||+++ |..|+......                .....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----------------~~~~~  223 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----------------EVPDL  223 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHH
Confidence            33322222334577789999999766 68999999999999999998 88776432110                01111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      +..+.....+..++.++..++.+||..||++||++.++++.|..+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         224 LEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             HHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            111111222223456688899999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.2e-44  Score=330.61  Aligned_cols=266  Identities=24%  Similarity=0.341  Sum_probs=211.1

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeece
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF   89 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~   89 (356)
                      ..|++....+.+.++||+|+||.||+|.+.      +++.||||++...........+.+|+.++.++. ||||++++++
T Consensus        30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            458888888999999999999999999753      356899999986544444567899999999997 9999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhcCC-----------------------------------------------------
Q 038199           90 CHDQHMTALVYEYMENGSLDGYLFGKK-----------------------------------------------------  116 (356)
Q Consensus        90 ~~~~~~~~lV~e~~~~~sL~~~l~~~~-----------------------------------------------------  116 (356)
                      +......++||||+.+|+|.+++....                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999889999999999999999885321                                                     


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCC
Q 038199          117 --------------------------------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK  152 (356)
Q Consensus       117 --------------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dik  152 (356)
                                                                  ..+++..+..++.|++.||.|||+   .+++|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCC
Confidence                                                        236778889999999999999999   999999999


Q ss_pred             CCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccC
Q 038199          153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVG  231 (356)
Q Consensus       153 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~  231 (356)
                      |+||++++++.++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..|+...
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999865432221112223467889999999876 68999999999999999998 77776432


Q ss_pred             CCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          232 SSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      ...               ......+........+...+.++.+++.+||+.+|.+||++++|++.|+.+.
T Consensus       346 ~~~---------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         346 PMN---------------EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             Cch---------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            210               0011111111122223345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.8e-44  Score=320.43  Aligned_cols=266  Identities=22%  Similarity=0.250  Sum_probs=199.9

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+|++.++||+|+||+||+|... +++.||||++...........+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            357899999999999999999765 6899999998754333334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+. ++|.+++......++...+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........ 
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence            996 58887776666779999999999999999999999   9999999999999999999999999999875432221 


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhh-------HHHHhhchhhH
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHV-------WEEYEKSELDA  254 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~  254 (356)
                       ......|+..|+|||++.+...++.++|||||||++|+|++|..||......... +....       ...+.......
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ-LERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhCCCChhhccchhhcc
Confidence             1233458899999999876556889999999999999999999998643221000 00000       00000000000


Q ss_pred             HHHh----cCCCchh------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          255 TILA----CGIEEKD------KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       255 ~~~~----~~~~~~~------~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ....    ...+...      ...+..+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000    0000000      012356789999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.6e-45  Score=316.35  Aligned_cols=253  Identities=21%  Similarity=0.378  Sum_probs=214.6

Q ss_pred             HHhhhhccccccccccCceEEEEEE-eCCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      --..++|+|.+.||+|.||.|-+|. +..|+.||||.++++.  .+++.-++.+|+++|+.|+||||+.+|.+|++++..
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            3467899999999999999999995 5679999999998653  456667899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      .|||||..+|.|++|+ ...+.+++..+..++.||..|+.|+|.   ++++|||||.+|||+|+++++||+|||++..+.
T Consensus       129 vivMEYaS~GeLYDYi-Ser~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYI-SERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEEEecCCccHHHHH-HHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999999999 456789999999999999999999999   999999999999999999999999999998876


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ...   ....++|++-|.+||++.|.+.-.+..|.|||||+||-|+.|..||.....                ..+...+
T Consensus       205 ~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----------------k~lvrQI  265 (668)
T KOG0611|consen  205 DKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----------------KRLVRQI  265 (668)
T ss_pred             ccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----------------HHHHHHh
Confidence            544   335588999999999999986567889999999999999999999854321                1111111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      ..+..  ..+..+.+..-||.+||..||++|.|+.+|...-
T Consensus       266 s~GaY--rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  266 SRGAY--REPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             hcccc--cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            11111  1233455678899999999999999999998753

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-43  Score=311.52  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=203.7

Q ss_pred             hhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..+|++.+.||+|+||.||++.+.++..+|+|++...  ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            3468899999999999999998877778999998653  23345788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||+++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            99999999986555679999999999999999999999   99999999999999999999999999998765432211 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                      ......++..|+|||.+.+. .++.++||||||+++|+|++ |..|+......                ...........
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~~~~~~~  219 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----------------EVVESVSAGYR  219 (256)
T ss_pred             ccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----------------HHHHHHHcCCc
Confidence            11122245579999998876 68899999999999999999 67776432211                11111111111


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      ...+...+.++.+++.+||+.+|++||++.++++.|
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            223334677899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-43  Score=321.20  Aligned_cols=242  Identities=25%  Similarity=0.314  Sum_probs=195.5

Q ss_pred             ccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCC
Q 038199           30 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +.||+|+||.||++.. .+|+.||+|++....  .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4799999999999975 468999999997532  2233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeecc
Q 038199          107 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG  186 (356)
Q Consensus       107 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  186 (356)
                      +|..++. ....+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  154 (323)
T cd05595          81 ELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence            9988873 45578999999999999999999999   9999999999999999999999999999875322211  1233


Q ss_pred             CCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhH
Q 038199          187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK  266 (356)
Q Consensus       187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (356)
                      ..||..|+|||++.+. .++.++|||||||++|||++|..||......       ......         ... ....+.
T Consensus       155 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~---------~~~-~~~~p~  216 (323)
T cd05595         155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELI---------LME-EIRFPR  216 (323)
T ss_pred             ccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHH---------hcC-CCCCCC
Confidence            5689999999999876 7899999999999999999999998543221       001111         000 111233


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          267 EKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       267 ~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      ..+.++.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            4567789999999999999998     7888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.6e-43  Score=311.41  Aligned_cols=257  Identities=30%  Similarity=0.452  Sum_probs=208.2

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      |++...+|++.++||+|+||.||+|...+++.||+|.+....  .....+.+|+.++++++|+|++++++++. ....++
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence            467889999999999999999999988788999999987542  34467899999999999999999999875 456899


Q ss_pred             EEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||||+.+++|.+++... ...+++.++..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            99999999999988543 4578999999999999999999999   9999999999999999999999999999976653


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .... ......++..|+|||.+.+. .++.++||||||+++||+++ |..||......       .         .....
T Consensus       155 ~~~~-~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~---------~~~~~  216 (260)
T cd05067         155 NEYT-AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------E---------VIQNL  216 (260)
T ss_pred             CCcc-cccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------H---------HHHHH
Confidence            2221 11233456789999998766 68899999999999999999 88887432211       0         11111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      ......+.....+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         217 ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1111122233455679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=317.40  Aligned_cols=261  Identities=23%  Similarity=0.286  Sum_probs=204.8

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-------------chhhHHHHHHHHHHHccCCCCceeeee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-------------GRIAEEQFMAEVGTIGRTYHINLVRLY   87 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~ni~~~~   87 (356)
                      ...+|++.+.||+|.||.|-+|... +++.||||++.+..             .....+...+|+.+|++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3457899999999999999999754 69999999996531             011224788999999999999999999


Q ss_pred             ceEec--CCeeeEEEeccCCCChhhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCce
Q 038199           88 GFCHD--QHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  164 (356)
Q Consensus        88 ~~~~~--~~~~~lV~e~~~~~sL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~  164 (356)
                      .+..+  .+.+|||+|||..|.+...-  ..+. +++.++++++.+++.||+|||.   +|||||||||+|+|++++|+|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence            99875  46789999999988876432  3455 9999999999999999999999   999999999999999999999


Q ss_pred             EEcccCCccccCCCCCee---eeccCCCCCCCCCcccccC---CCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc
Q 038199          165 KVADFGLAKLCDRNRSHV---TISGYKGTPGYSAPEFLSG---NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW  238 (356)
Q Consensus       165 kl~Dfgl~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~  238 (356)
                      ||+|||.+..+.......   ....-.||+.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||...       
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-------  322 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-------  322 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-------
Confidence            999999998764332221   1223579999999998876   224578999999999999999999998543       


Q ss_pred             chhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          239 FPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                         ...+.+...     +.....-+..++...++.+||.++|.+||++|.+..+|.....-...
T Consensus       323 ---~~~~l~~KI-----vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  323 ---FELELFDKI-----VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ---hHHHHHHHH-----hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence               222222221     11111122333566789999999999999999999999887654433

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-44  Score=325.79  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=203.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|++.++||+|+||.||+|.+. +++.||||++.....  ......+..|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            5888999999999999999765 589999999975321  2234568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |++|++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....    
T Consensus        82 ~~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          82 YVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            999999999984 44578999999999999999999999   9999999999999999999999999999976543    


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                       ......||..|+|||++.+. .++.++|||||||++|||++|..||......       ..+.......  ........
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~--~~~~~~~~  222 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-------ETWENLKYWK--ETLQRPVY  222 (333)
T ss_pred             -ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHH-------HHHHHHHhcc--ccccCCCC
Confidence             22335689999999999877 7899999999999999999999998543221       1111111000  00000000


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .......+.++.+++.+||..+|.+||+++++++.
T Consensus       223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            11112456788999999999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-43  Score=312.33  Aligned_cols=258  Identities=28%  Similarity=0.418  Sum_probs=208.4

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ++....|.+.++||+|+||.||+|.+. +++.||+|++..+  ......+.+|+++++.++|+||+++++++......++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            455677889999999999999999754 5889999998754  3345678999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||||+.+++|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.++|+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            99999999999998543 3568999999999999999999999   9999999999999999999999999999986643


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .... ......++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....       ...+..         .
T Consensus       157 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~---------~  218 (263)
T cd05052         157 DTYT-AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYEL---------L  218 (263)
T ss_pred             ceee-ccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHH---------H
Confidence            3221 11222346689999998776 68899999999999999998 7777633211       011111         1


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11112233344567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.6e-43  Score=316.11  Aligned_cols=262  Identities=24%  Similarity=0.385  Sum_probs=208.7

Q ss_pred             HhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      ++.+.|.+.+.||+|+||+||++..      .++..+|+|.+... .......+.+|+.++++++||||+++++++....
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            4567889999999999999999964      13456899988653 2344567999999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           95 MTALVYEYMENGSLDGYLFGKK------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      ..++||||+.+++|.+++....            ..+++.+++.++.|++.||+|||+   .+++||||||+||++++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCC
Confidence            9999999999999999885322            348999999999999999999999   9999999999999999999


Q ss_pred             ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchh
Q 038199          163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPK  241 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~  241 (356)
                      .++|+|||++................++..|+|||.+.+. .++.++||||||+++|+|++ |..|+......       
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------  229 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------  229 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence            9999999999865433222222223457789999999876 68999999999999999998 77776432210       


Q ss_pred             hhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          242 HVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                               .....+........+...+.++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       230 ---------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         230 ---------EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             ---------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                     01111112222222334556799999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.5e-43  Score=313.40  Aligned_cols=261  Identities=27%  Similarity=0.384  Sum_probs=208.9

Q ss_pred             HhhhhccccccccccCceEEEEEEe-CCCc----EEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      +...+|++.++||+|+||+||+|.+ .+++    .||+|++...........+.+|+.+++.++||||+++++++... .
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            4567888999999999999999975 3444    48999987654455567789999999999999999999998764 4


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .+++++++++|+|.+++......+++..++.++.|++.||.|||+   .+++||||||+||++++++.++|+|||+++..
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            679999999999999996656679999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      .............++..|+|||.+.+. .++.++|||||||++|||++ |..|+.....                .....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----------------~~~~~  222 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----------------REIPD  222 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----------------HHHHH
Confidence            543332222223456789999998766 68999999999999999998 7777643211                11111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .+........+...+.++.+++.+||+.||++||++.++++.|..+..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         223 LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            111222223334566789999999999999999999999999877644

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.7e-44  Score=317.50  Aligned_cols=264  Identities=23%  Similarity=0.364  Sum_probs=208.4

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      |++...+|++.++||+|+||.||+|...      .+..||+|.+...........+.+|+.+++.++||||+++++++.+
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            5677889999999999999999999642      2458999998755434444578899999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGK---------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  163 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~  163 (356)
                      ....++||||+.+|+|.+++...         ...+++..+..++.|++.||.|||+   ++++||||||+||+++.++.
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~  157 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCc
Confidence            99999999999999999998532         1345778899999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhh
Q 038199          164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKH  242 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~  242 (356)
                      ++|+|||+++...............++..|+|||.+.+. .++.++|||||||++|||++ |..|+.....         
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---------  227 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------  227 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---------
Confidence            999999998765432222211222356789999998876 68999999999999999998 5666532111         


Q ss_pred             hHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          243 VWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                             ...............+...+..+.+++.+||+.||++||++.++++.|.+...
T Consensus       228 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         228 -------EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             -------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence                   11111222222222333446789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.1e-44  Score=326.62  Aligned_cols=251  Identities=23%  Similarity=0.260  Sum_probs=203.6

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCC--CcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPN--GVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      ..+....|++.+.||+|+||.||+|.+.+  +..||+|++....  .....+.+.+|+.+++.++||||+++++++.+..
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            44566789999999999999999997543  4689999986431  2233457889999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+.+|+|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.++|+|||++..
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            9999999999999999984 45679999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      .....     ....||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..+...       
T Consensus       181 ~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i-------  240 (340)
T PTZ00426        181 VDTRT-----YTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKI-------  240 (340)
T ss_pred             cCCCc-----ceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHH-------
Confidence            54321     234689999999999876 6899999999999999999999998543211       111111       


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVKM  296 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~  296 (356)
                        .... ...+...+..+.+++.+||+.||++|+     +++++++.
T Consensus       241 --~~~~-~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        241 --LEGI-IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --hcCC-CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              1111 112233456688999999999999995     88888764

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-43  Score=320.04  Aligned_cols=268  Identities=25%  Similarity=0.348  Sum_probs=212.4

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeee
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRL   86 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~   86 (356)
                      .+.+++...+|.+.+.||+|+||.||++.+.        +...+|+|.+...........+..|+.+++++ +||||+++
T Consensus        10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            3456777789999999999999999999642        23569999998654445556788999999999 79999999


Q ss_pred             eceEecCCeeeEEEeccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCC
Q 038199           87 YGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI  151 (356)
Q Consensus        87 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~di  151 (356)
                      ++++.+....++||||+.+++|.+++....               ..+++.+++.++.|++.||+|||+   .+++||||
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dl  166 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDL  166 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccc
Confidence            999999999999999999999999985432               358999999999999999999999   99999999


Q ss_pred             CCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCccccc
Q 038199          152 KPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIV  230 (356)
Q Consensus       152 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~  230 (356)
                      ||+||+++.++.++|+|||++................++..|+|||.+.+. .++.++|||||||++|||++ |..|+..
T Consensus       167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            999999999999999999998765432221111222345689999998876 68999999999999999998 6666532


Q ss_pred             CCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          231 GSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      ...                ...............+...+.++.+++.+||+.+|++||++.+|++.|..+...
T Consensus       246 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         246 VPV----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             CCH----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            110                111111222222233445567899999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.2e-43  Score=317.27  Aligned_cols=264  Identities=24%  Similarity=0.336  Sum_probs=210.7

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceE
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC   90 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~   90 (356)
                      .+++...+|.+.+.||+|+||.||++..      ..+..||||++.........+.+.+|+.+++++ +||||+++++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            4667788999999999999999999963      135579999987654445556799999999999 799999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEccc
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  169 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df  169 (356)
                      ......++||||+.+++|.+++.... ..+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.++|+||
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCC
Confidence            99999999999999999999985433 348999999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHh
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYE  248 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  248 (356)
                      |++................++..|+|||.+.+. .++.++|||||||++|||++ |..|+......      .       
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~-------  251 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------S-------  251 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------H-------
Confidence            999866543322222233467789999998876 68999999999999999998 87776432110      0       


Q ss_pred             hchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                        ..............+...+.++.+++.+||+.+|++||++.+|++.|++.
T Consensus       252 --~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         252 --KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              01111111111222233456799999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-43  Score=316.00  Aligned_cols=258  Identities=26%  Similarity=0.386  Sum_probs=205.9

Q ss_pred             hccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      .|.+.+.||+|+||.||+|...      ....+|+|.+..........++.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3678899999999999999642      2357999988765444555789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCc
Q 038199           99 VYEYMENGSLDGYLFGK-----------------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  155 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~N  155 (356)
                      |+||+.+++|.+++...                       ...+++.+++.++.|++.||+|||+   .+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            99999999999987431                       1358899999999999999999999   999999999999


Q ss_pred             EEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCC
Q 038199          156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSE  234 (356)
Q Consensus       156 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~  234 (356)
                      |++++++.++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..|+..... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence            99999999999999999765433222222233467789999998766 68999999999999999998 8877643211 


Q ss_pred             ccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          235 SLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                            ...++.         .........+...+.++.+++.+||+.+|++||+++++++.|+++..
T Consensus       236 ------~~~~~~---------~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ------ERLFNL---------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ------HHHHHH---------HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                  111111         11111122234456789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-44  Score=321.42  Aligned_cols=242  Identities=22%  Similarity=0.275  Sum_probs=194.0

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCCh
Q 038199           32 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        32 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      ||+|+||.||+|.+. +++.||+|++....  .......+..|+.++++++||||+++++++.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999764 58899999986431  233446788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCC
Q 038199          109 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK  188 (356)
Q Consensus       109 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  188 (356)
                      .+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.......  ......
T Consensus        81 ~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  154 (312)
T cd05585          81 FHHLQ-REGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC  154 (312)
T ss_pred             HHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence            99884 35679999999999999999999999   9999999999999999999999999999875432221  123456


Q ss_pred             CCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHH
Q 038199          189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK  268 (356)
Q Consensus       189 gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (356)
                      ||..|+|||++.+. .++.++|||||||++|||++|..||......       ..+.         ..... ....+...
T Consensus       155 gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~---------~~~~~-~~~~~~~~  216 (312)
T cd05585         155 GTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYR---------KILQE-PLRFPDGF  216 (312)
T ss_pred             CCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHH---------HHHcC-CCCCCCcC
Confidence            89999999999876 7899999999999999999999998543210       0011         11111 11223345


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          269 AKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       269 ~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      +.++.+++.+||+.||.+||++..+.+.|
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            67789999999999999998654443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-45  Score=330.11  Aligned_cols=264  Identities=24%  Similarity=0.366  Sum_probs=226.8

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC---CC--cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP---NG--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~---~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      +.+++.-...++.++||.|-||.||.|.+.   .|  -.||||+-+.+-...+.+.|++|+.++++++||||++++|+|.
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~  461 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV  461 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence            345666677778899999999999999652   23  3588998887666677889999999999999999999999997


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                      +. ..|+|||+++-|.|..|++.+...++..+...++.||+.||.|||+   ..+|||||...|||+....-|||+|||+
T Consensus       462 e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  462 EQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             cc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccch
Confidence            65 5799999999999999998888899999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhc
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      +++..+....... ...-...|||||.+.-. .++.++|||.|||.+||++. |..||.                +..+.
T Consensus       538 SR~~ed~~yYkaS-~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfq----------------gvkNs  599 (974)
T KOG4257|consen  538 SRYLEDDAYYKAS-RGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQ----------------GVKNS  599 (974)
T ss_pred             hhhccccchhhcc-ccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccc----------------ccccc
Confidence            9998765443322 23346689999999876 79999999999999999986 666653                34455


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ++...+..+.+.+.+++++..|+.++.+||..+|.+||.+.++...|..+..
T Consensus       600 DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  600 DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            5666667788889999999999999999999999999999999998876543

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-43  Score=325.37  Aligned_cols=251  Identities=25%  Similarity=0.366  Sum_probs=199.4

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...|++.++||+|+||+||+|.+. +++.||||++...........+.+|+++++.++|+||+++++++.+....++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            456778899999999999999764 6899999999765445556789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++++|...     ....+..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||+++........
T Consensus       153 ~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        153 FMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             cCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            9999998653     245677888999999999999999   99999999999999999999999999999865432211


Q ss_pred             eeeccCCCCCCCCCcccccCC----CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          182 VTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                        .....||..|+|||++...    ...+.++|||||||++|||++|+.||......  .|      ...     .....
T Consensus       225 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~------~~~-----~~~~~  289 (353)
T PLN00034        225 --CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DW------ASL-----MCAIC  289 (353)
T ss_pred             --ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cH------HHH-----HHHHh
Confidence              1234689999999987432    13456899999999999999999998633221  11      000     00011


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ...........+.++.+++.+||+.||++||++.++++.
T Consensus       290 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111223334566789999999999999999999999973

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-45  Score=327.34  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=205.1

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      |++-...+.-.+-||+|+.|.||+|++ .++.||||+++.        .-..++.-|++|+||||+.+.|+|...-.+||
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCI  189 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCI  189 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhh--------hhhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence            444333333346699999999999999 567899997753        12347888999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      |||||..|-|...| +.+..++......|..+||.|+.|||.   +.|||||||.-||||..+..|||+|||.++.....
T Consensus       190 iMEfCa~GqL~~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVL-KAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             eeeccccccHHHHH-hccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            99999999999998 567789999999999999999999999   99999999999999999999999999999877655


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .+.   -.+.||..|||||++++. +.++|.|||||||||||||||..|+..-....+-|-         .+      ..
T Consensus       266 STk---MSFaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG---------VG------sN  326 (904)
T KOG4721|consen  266 STK---MSFAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG---------VG------SN  326 (904)
T ss_pred             hhh---hhhhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEEe---------cc------CC
Confidence            333   347899999999999987 899999999999999999999988644322111110         00      01


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      ..-.+.+..+++-+.-|+++||+..|..||++.+|+..|+-
T Consensus       327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            11134556677889999999999999999999999998875

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7e-44  Score=324.66  Aligned_cols=267  Identities=24%  Similarity=0.339  Sum_probs=205.8

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +...+|++.++||+|+||.||++.+. ++..+|+|++...........+.+|++++++++||||+++++++.+....++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            55678999999999999999999765 58899999987654445557899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+.+++|.+++. ....+++..+..++.|++.||.|||+  ..+++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          82 MEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             EecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            99999999999984 34568999999999999999999997  2479999999999999999999999999987553221


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch------hh-----------
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP------KH-----------  242 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~------~~-----------  242 (356)
                          .....|+..|+|||.+.+. .++.++|||||||++|+|++|+.|+............      ..           
T Consensus       159 ----~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         159 ----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ----cccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence                1234689999999999876 6899999999999999999999998643221100000      00           


Q ss_pred             ---hHHHHh--------hchhhHHHHhcCCCchh-HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          243 ---VWEEYE--------KSELDATILACGIEEKD-KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       243 ---~~~~~~--------~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                         ......        .......+.....+..+ ...+.++.+++.+||+.||++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence               000000        00000001111111111 124567899999999999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-43  Score=336.94  Aligned_cols=251  Identities=19%  Similarity=0.227  Sum_probs=203.8

Q ss_pred             hhccccccccccCceEEEEEEeC-C-CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-N-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..|.+.+.||+|+||.||+|... + ++.||+|.+..+. ......+..|+.+++.++||||+++++++...+..++|||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            34888999999999999999643 4 6789999775432 3334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199          102 YMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       102 ~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      |++||+|.+++..   ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999988743   24568999999999999999999999   99999999999999999999999999999876544


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .........+||+.|+|||++.+. .++.++|||||||++|||++|..||.....                .........
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----------------~~~~~~~~~  285 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQ----------------REIMQQVLY  285 (478)
T ss_pred             cccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHh
Confidence            332233445699999999999876 789999999999999999999999743221                111111112


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +.....+...+.++.+++.+||+.||++||++++++.
T Consensus       286 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        286 GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            2222233445678999999999999999999999875

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-43  Score=318.44  Aligned_cols=267  Identities=25%  Similarity=0.363  Sum_probs=212.8

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeee
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLY   87 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~   87 (356)
                      +.+++...+|.+.+.||+|+||.||+|...        ++..||+|++...........+.+|+.+++.+ +||||++++
T Consensus         8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101           8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhee
Confidence            346788999999999999999999999631        24579999987654445557799999999999 799999999


Q ss_pred             ceEecCCeeeEEEeccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCC
Q 038199           88 GFCHDQHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK  152 (356)
Q Consensus        88 ~~~~~~~~~~lV~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dik  152 (356)
                      +++......++||||+.+++|.+++...               ...+++.++..++.|++.||.|||+   .+++|||||
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlk  164 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLA  164 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccc
Confidence            9999999999999999999999998543               1357889999999999999999999   999999999


Q ss_pred             CCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccC
Q 038199          153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVG  231 (356)
Q Consensus       153 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~  231 (356)
                      |+||+++.++.++|+|||+++...............++..|+|||++.+. .++.++||||||+++|+|++ |..|+...
T Consensus       165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999876543322222233456789999999776 68999999999999999998 55554221


Q ss_pred             CCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          232 SSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      ..                ......+........+...+..+..++.+||+.+|++||++.+|++.|.++...
T Consensus       244 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         244 PV----------------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             CH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            10                111111111222223345567899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.5e-43  Score=319.99  Aligned_cols=245  Identities=26%  Similarity=0.328  Sum_probs=194.0

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHH---ccCCCCceeeeeceEecCCeeeEE
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTI---GRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      |++.+.||+|+||.||+|.+. +++.||||+++...  .....+.+.+|.+++   +.++||||+++++++.+....++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567899999999999999754 68999999997532  122334566666554   567899999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+.+++|...+  ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~E~~~~~~L~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999887  34579999999999999999999999   999999999999999999999999999987532221


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      .  ......|+..|+|||.+.+. .++.++|||||||++|||++|..||......                .....+...
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~----------------~~~~~i~~~  216 (324)
T cd05589         156 D--RTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----------------EVFDSIVND  216 (324)
T ss_pred             C--cccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhC
Confidence            1  22345689999999999876 6899999999999999999999997543211                001111111


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                       ....+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       217 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         217 -EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence             1122334567789999999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.3e-43  Score=314.50  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=209.2

Q ss_pred             hhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ....|.+.+.||+|+||.||+|...      ++..+++|.+.... ....+.+.+|+.++++++|+||+++++++.+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            3456888899999999999999642      35668999886532 3334678899999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC
Q 038199           96 TALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA  160 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~  160 (356)
                      .++||||+++++|.+++...               ...+++..++.++.||+.||+|||+   ++++||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEcc
Confidence            99999999999999998542               2348999999999999999999999   99999999999999999


Q ss_pred             CCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccc
Q 038199          161 NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWF  239 (356)
Q Consensus       161 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~  239 (356)
                      ++.++|+|||++................++..|+|||.+.+. .++.++||||||+++|||++ |..|+......     
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----  232 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-----  232 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence            999999999999765433322222334467889999998876 68899999999999999999 88886443221     


Q ss_pred             hhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          240 PKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                        ..+         ...............+..+.+++.+||+.+|++||++++|++.|+.+...
T Consensus       233 --~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         233 --EVI---------ECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             --HHH---------HHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence              011         11122222223344567899999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-43  Score=314.10  Aligned_cols=274  Identities=22%  Similarity=0.347  Sum_probs=208.6

Q ss_pred             hhhhccccccccccCceEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC--C
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--H   94 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~   94 (356)
                      +...|++.+.||+|+||.||++.+     .++..||+|.+...........+.+|+.++++++|||++++++++.+.  .
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            456778899999999999999974     247889999987654455557899999999999999999999998775  5


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||++|++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||+++.
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccc
Confidence            6889999999999999986555678999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCee-eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          175 CDRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       175 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ........ ......++..|+|||.+.+. .++.++||||||+++|||++++.|................ .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  236 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTH-GQMTVTRLV  236 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccc-ccccHHHHH
Confidence            65433321 12234567789999998766 6889999999999999999987654221110000000000 000000001


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      .........+....++..+.+++.+||+.+|++||+++++++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111112222334667899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.5e-44  Score=317.64  Aligned_cols=265  Identities=21%  Similarity=0.244  Sum_probs=200.5

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|++.+.||+|+||+||+|.+. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            5889999999999999999875 58899999987532 233446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.++++..+. .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......... 
T Consensus        82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  156 (287)
T cd07848          82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-  156 (287)
T ss_pred             CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-
Confidence            9987776554 445679999999999999999999999   99999999999999999999999999999875433221 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc--------chhhhHHHHhhch-hh
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW--------FPKHVWEEYEKSE-LD  253 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~-~~  253 (356)
                      ......|+..|+|||++.+. .++.++|||||||++|||++|+.||..........        .+...+..+.... ..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             cccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            12234689999999999876 68999999999999999999998885433211000        0000000000000 00


Q ss_pred             HHHHhcCC------CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILACGI------EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........      .......+.++.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000      0001124567999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-43  Score=336.79  Aligned_cols=258  Identities=24%  Similarity=0.316  Sum_probs=208.2

Q ss_pred             HHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCC--
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH--   94 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~--   94 (356)
                      .+....+|.+.+.||+|+||+||+|.. .+|+.||||++... ........+.+|+.++..++|+|+++++..+....  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            344567999999999999999999965 46999999998653 23445567889999999999999999988765332  


Q ss_pred             ------eeeEEEeccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceE
Q 038199           95 ------MTALVYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK  165 (356)
Q Consensus        95 ------~~~lV~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~k  165 (356)
                            ..++||||+.+|+|.+++...   ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEE
Confidence                  367999999999999988542   4578999999999999999999999   9999999999999999999999


Q ss_pred             EcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHH
Q 038199          166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWE  245 (356)
Q Consensus       166 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~  245 (356)
                      |+|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||++|+.||.....            
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------------  250 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENM------------  250 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------------
Confidence            9999999876543333233446799999999999876 689999999999999999999999753221            


Q ss_pred             HHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          246 EYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                          ...............+...+.++.+++.+||+.||.+||++.++++.
T Consensus       251 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        251 ----EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                01111122222333445567789999999999999999999999863

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-43  Score=323.50  Aligned_cols=265  Identities=25%  Similarity=0.371  Sum_probs=205.2

Q ss_pred             HHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH   91 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~   91 (356)
                      |++...+|.+.+.||+|+||+||+|.+      .+++.||||++...........+.+|+.++.++ +||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            456677899999999999999999963      247889999997654344456788999999999 6899999999876


Q ss_pred             cC-CeeeEEEeccCCCChhhhhhcCC------------------------------------------------------
Q 038199           92 DQ-HMTALVYEYMENGSLDGYLFGKK------------------------------------------------------  116 (356)
Q Consensus        92 ~~-~~~~lV~e~~~~~sL~~~l~~~~------------------------------------------------------  116 (356)
                      .. ...++||||+++|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            54 56789999999999999885321                                                      


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeee
Q 038199          117 ------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI  184 (356)
Q Consensus       117 ------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  184 (356)
                                  ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                        236888999999999999999999   99999999999999999999999999998765332222222


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      ....++..|+|||.+.+. .++.++||||||+++|+|++ |..|+......      .         .............
T Consensus       239 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~---------~~~~~~~~~~~~~  302 (343)
T cd05103         239 GDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------E---------EFCRRLKEGTRMR  302 (343)
T ss_pred             CCCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------H---------HHHHHHhccCCCC
Confidence            223456789999998766 68999999999999999997 77776432111      0         0111111111112


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .+...+.++.+++.+||+.+|++||++.+|++.|+.+..
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            222234578999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.1e-43  Score=309.16  Aligned_cols=257  Identities=28%  Similarity=0.425  Sum_probs=205.6

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      .+...+|++.++||+|+||+||+|.+.+...||+|.+....  ...+.+.+|++++++++||||+++++.+.+ ...++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv   78 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   78 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence            35567899999999999999999987666679999987532  334678999999999999999999998754 557899


Q ss_pred             EeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199          100 YEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      |||+.+++|.+++... ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999999999543 3468999999999999999999999   99999999999999999999999999999766433


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ... ......++..|+|||...+. .++.++||||||+++|+|++ |..|+.....       .         .......
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-------~---------~~~~~~~  217 (262)
T cd05071         156 EYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------R---------EVLDQVE  217 (262)
T ss_pred             ccc-cccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-------H---------HHHHHHh
Confidence            221 11233466789999998766 68999999999999999999 6666533211       0         1111111


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ...........+..+.+++.+|++.+|++||+++++++.|+..
T Consensus       218 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         218 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            1112233445677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.2e-43  Score=320.48  Aligned_cols=253  Identities=21%  Similarity=0.244  Sum_probs=200.0

Q ss_pred             hccccccccccCceEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCee
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~   96 (356)
                      .|++.++||+|+||+||+++.    .+++.||+|++....   .....+.+..|+.+++.+ +||||+.+++++.+....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            378899999999999999964    258899999986431   123345688899999999 599999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+.+++|.+++. ....+++..+..++.||+.||.|||+   .+++||||||+|||++.++.++|+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999884 34578999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ..... ......||..|+|||++.+...++.++|||||||++|||++|..||........   ..         .+...+
T Consensus       157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~---------~~~~~~  223 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QS---------EVSRRI  223 (332)
T ss_pred             ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HH---------HHHHHH
Confidence            33222 122356899999999998764578999999999999999999999854322111   00         011111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      .. .....+...+..+.+++.+||+.||++||     +++++++
T Consensus       224 ~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         224 LK-CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             hc-CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11 11222334566788999999999999999     6677775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-43  Score=310.78  Aligned_cols=257  Identities=30%  Similarity=0.437  Sum_probs=210.0

Q ss_pred             HhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .....|++.++||.|+||.||+|.+.+++.+|+|++.... ......+..|+.+++.++|+||+++++++.+....++||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            3456789999999999999999988778999999987642 234567899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          101 EYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       101 e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      ||+++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999999553 4568999999999999999999999   999999999999999999999999999997654322


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      ..  .....++..|+|||.+.+. .++.++||||||+++++|++ |..|+.....                .........
T Consensus       159 ~~--~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----------------~~~~~~~~~  219 (261)
T cd05148         159 YL--SSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----------------HEVYDQITA  219 (261)
T ss_pred             cc--ccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----------------HHHHHHHHh
Confidence            11  1233466789999998766 68899999999999999998 7777643221                111111112


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ......+...+..+.+++.+||+.||++|||++++++.|+.+
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            222333445667899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.6e-43  Score=308.45  Aligned_cols=257  Identities=30%  Similarity=0.431  Sum_probs=206.3

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      |++...+|++.++||+|+||.||+|...++..+|+|.+....  ...+.+.+|+.++++++|+|++++++++.. ...++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI   77 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence            456677899999999999999999988778889999987542  334678999999999999999999998754 45789


Q ss_pred             EEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||||+.+++|.+++... ...+++.++..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            99999999999998543 3568999999999999999999999   9999999999999999999999999999976543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .... ......++..|+|||.+.+. .++.++|+||||+++|+|++ |..|+.....                .......
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----------------~~~~~~~  216 (260)
T cd05070         155 NEYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNN----------------REVLEQV  216 (260)
T ss_pred             cccc-cccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----------------HHHHHHH
Confidence            3211 11223456789999998765 68899999999999999999 7777643211                0111111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      ......+.+...+..+.+++.+|+..+|++|||+.++.+.|+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         217 ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1111222334556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-43  Score=321.36  Aligned_cols=243  Identities=25%  Similarity=0.306  Sum_probs=196.6

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +.||+|+||.||++... +++.||+|++....  .......+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999754 68999999997532  2234457888999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeecc
Q 038199          107 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG  186 (356)
Q Consensus       107 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  186 (356)
                      +|..++. ....+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            9988873 45679999999999999999999999   999999999999999999999999999987533221  12233


Q ss_pred             CCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhH
Q 038199          187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK  266 (356)
Q Consensus       187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (356)
                      ..||..|+|||++.+. .++.++|||||||++|+|++|..||......                ........ .....+.
T Consensus       155 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~----------------~~~~~~~~-~~~~~p~  216 (328)
T cd05593         155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILM-EDIKFPR  216 (328)
T ss_pred             ccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHH----------------HHHHHhcc-CCccCCC
Confidence            5689999999999876 6899999999999999999999998543211                00001110 1112233


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038199          267 EKAKRLCMAALWCVQDSPEDRP-----PMSAVVKM  296 (356)
Q Consensus       267 ~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~  296 (356)
                      ..+.++.+++.+||+.||++||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            4567789999999999999997     88888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.5e-43  Score=309.85  Aligned_cols=260  Identities=28%  Similarity=0.446  Sum_probs=209.1

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CC---cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NG---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      +....|+..+.||+|+||.||+|... ++   ..+|+|.+.........+.+..|++++++++|||++++++++.+....
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            44567888999999999999999764 33   379999987654445567799999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+.+++|.+++......+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999999986656789999999999999999999999   999999999999999999999999999988664


Q ss_pred             CCCCeeee-ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          177 RNRSHVTI-SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       177 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ........ .....+..|+|||++.+. .++.++|||||||++|||++ |..|+.....                .....
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----------------~~~~~  221 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSN----------------HEVMK  221 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----------------HHHHH
Confidence            33222111 112234579999998766 68999999999999999997 8888743221                01111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      .+......+.....+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       222 ~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         222 AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111112223334567799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-43  Score=311.71  Aligned_cols=260  Identities=25%  Similarity=0.361  Sum_probs=208.5

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      |++...+|++.+.||+|+||.||+|...      ++..||+|.+...........+.+|+.+++.++||||+++++++..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4567788999999999999999999653      2478999998765444555678899999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGK---------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  163 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~  163 (356)
                      ....++||||+.+++|.+++...         ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCC
Confidence            99999999999999999998532         1247889999999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhh
Q 038199          164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKH  242 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~  242 (356)
                      ++|+|||+++...............++..|+|||.+.+. .++.++||||||+++||+++ |..|+.....         
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~---------  227 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---------  227 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCH---------
Confidence            999999998765433222222233467889999998766 68999999999999999998 7777633221         


Q ss_pred             hHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          243 VWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                             ...............+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       228 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         228 -------EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                   1111111122222233345778999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.8e-43  Score=310.50  Aligned_cols=258  Identities=26%  Similarity=0.415  Sum_probs=206.5

Q ss_pred             hhhccccccccccCceEEEEEEeCC-C---cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPN-G---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ..+|.+.+.||+|+||.||+|.... +   ..||||++..........+|..|+.++++++||||+++++++.++...++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            4568899999999999999997642 3   36999998765445556789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||+.+++|.+++......+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999999986666779999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CCeeeeccCC---CCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          179 RSHVTISGYK---GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       179 ~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ..........   .+..|+|||.+.+. .++.++||||||+++||+++ |..|+......                ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----------------~~~~  222 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----------------DVIN  222 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----------------HHHH
Confidence            2221111111   24579999999766 68999999999999999886 88776432210                0111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      .+......+.+...+..+.+++.+||..+|++||++.+|+..|+++
T Consensus       223 ~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         223 AIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111111222334567789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-43  Score=324.54  Aligned_cols=261  Identities=22%  Similarity=0.250  Sum_probs=198.4

Q ss_pred             HhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +....|.+.++||+|+||.||++.+ .+++.||+|+...       ..+.+|++++++++||||+++++++..+...++|
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            3446799999999999999999965 4689999996542       3467899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      +|++. ++|..++. ....+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.++|+|||++.......
T Consensus       162 ~e~~~-~~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        162 LPRYK-TDLYCYLA-AKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EecCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            99995 58888773 34578999999999999999999999   999999999999999999999999999987543221


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch----hhhHHHH--------
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP----KHVWEEY--------  247 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~----~~~~~~~--------  247 (356)
                      .. ......||+.|+|||++.+. .++.++|||||||++|||++|..|+............    .......        
T Consensus       237 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        237 AN-KYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             cc-ccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            11 22345699999999999876 7899999999999999999999887543221110000    0000000        


Q ss_pred             --hhchhhHHH---Hhc------CC--CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 --EKSELDATI---LAC------GI--EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 --~~~~~~~~~---~~~------~~--~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                        .........   ...      ..  .......+.++.+++.+||+.||.+|||++++++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence              000000000   000      00  0112245678999999999999999999999996

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.6e-43  Score=310.38  Aligned_cols=259  Identities=26%  Similarity=0.425  Sum_probs=208.1

Q ss_pred             hhhhccccccccccCceEEEEEEeC-C---CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-N---GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      ...+|++.+.||+|+||.||+|.+. +   +..+|+|.+.........+.+..|+.++++++||||+++++++.++...+
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            3467889999999999999999753 2   33799999876544455678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+++++|.+++......+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999996666678999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          178 NRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       178 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ...... .....++..|+|||.+.+. .++.++|+||||+++||+++ |..|+......                .....
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----------------~~~~~  221 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----------------DVIKA  221 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----------------HHHHH
Confidence            332211 1222345689999999876 68999999999999999886 88886432211                01111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      +......+.....+..+.+++.+|++.+|.+||++.++++.|.++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         222 IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            111111222334567789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.5e-43  Score=311.30  Aligned_cols=262  Identities=23%  Similarity=0.316  Sum_probs=211.0

Q ss_pred             HhhhhccccccccccCceEEEEEEeCC-----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec-CC
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QH   94 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~-~~   94 (356)
                      +...+|.+.+.||+|+||.||+|.+..     +..|++|++...........+.+|+.++++++||||+++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            456788999999999999999997654     688999998766555666788999999999999999999998766 56


Q ss_pred             eeeEEEeccCCCChhhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEc
Q 038199           95 MTALVYEYMENGSLDGYLFGKK-------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA  167 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~  167 (356)
                      ..+++++|+.+++|.+++....       ..+++.++..++.|++.||+|||+   .+++||||||+||++++++.++|+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEEC
Confidence            7889999999999999985431       468999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHH
Q 038199          168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       168 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      |||+++.+.............++..|+|||++.+. .++.++||||||+++||+++ |..|+......            
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------  226 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------------  226 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------------
Confidence            99999866443332222334467789999999766 68999999999999999999 88887432110            


Q ss_pred             HhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                          .................++.++.+++.+||+.+|++||++.++++.|..+..
T Consensus       227 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         227 ----EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ----HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                0111111111122233456779999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.6e-43  Score=313.17  Aligned_cols=273  Identities=24%  Similarity=0.369  Sum_probs=204.4

Q ss_pred             hhhccccccccccCceEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec--CCe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHM   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~--~~~   95 (356)
                      ...|.+.+.||+|+||.||++..     .+++.||+|.+... .......+.+|++++++++||||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            45788899999999999999964     25789999998754 23445678999999999999999999998753  346


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            789999999999999996555679999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCeeee-ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSHVTI-SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ......... ....++..|+|||.+.+. .++.++||||||+++|||++|..++......-................+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            443322111 112234569999998766 689999999999999999998765432211000000000000000000111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ........+.....+.++.+++.+||..+|++|||+.+|++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1111222223344567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-43  Score=322.85  Aligned_cols=253  Identities=23%  Similarity=0.240  Sum_probs=202.9

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|++.++||+|+||+||++... +|+.||+|+++...  .......+..|+.+++.++|+||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            5888999999999999999764 68999999997542  12344568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            999999999996666789999999999999999999999   99999999999999999999999999999876543322


Q ss_pred             eeeccCCCCCCCCCcccccC-----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          182 VTISGYKGTPGYSAPEFLSG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                       ......||..|+|||++..     ...++.++|||||||++|||++|..||......       ..+..+...      
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~------  224 (330)
T cd05601         159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNF------  224 (330)
T ss_pred             -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcC------
Confidence             2233468999999999863     235788999999999999999999998544321       011111000      


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ......+.....+.++.+++.+|++ +|.+||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0000011222356778899999998 9999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.2e-43  Score=304.63  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=200.9

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCChh
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLD  109 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL~  109 (356)
                      ++||+|+||.||+|...+++.+|+|++...........+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            47999999999999877889999999876654555567899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCC
Q 038199          110 GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG  189 (356)
Q Consensus       110 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  189 (356)
                      +++......+++..+..++.|++.+|.|||+   .+++||||||+||+++.++.++|+|||++......... ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence            9986556678999999999999999999999   99999999999999999999999999998754322111 1112234


Q ss_pred             CCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHH
Q 038199          190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK  268 (356)
Q Consensus       190 t~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (356)
                      +..|+|||++.+. .++.++||||||+++|++++ |..||......       .         .............+...
T Consensus       157 ~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~---------~~~~~~~~~~~~~~~~~  219 (250)
T cd05085         157 PIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------Q---------AREQVEKGYRMSCPQKC  219 (250)
T ss_pred             cccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------H---------HHHHHHcCCCCCCCCCC
Confidence            5679999998766 68899999999999999998 87776432110       0         01111111112223345


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       269 ~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      +..+.+++.+|++.+|++||++.++++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.7e-43  Score=307.39  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=200.6

Q ss_pred             cccccCceEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCC
Q 038199           31 RLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  107 (356)
Q Consensus        31 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~s  107 (356)
                      .||+|+||.||+|.+.   ++..||+|++.........+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999653   3567999999765445555779999999999999999999998854 46799999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee-ecc
Q 038199          108 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISG  186 (356)
Q Consensus       108 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~  186 (356)
                      |.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........... ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            999986666789999999999999999999999   9999999999999999999999999999986543322211 111


Q ss_pred             CCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ..++..|+|||.+.+. .++.++||||||+++||+++ |..|+.....                ......+..+.....+
T Consensus       158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~  220 (257)
T cd05115         158 GKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----------------PEVMSFIEQGKRLDCP  220 (257)
T ss_pred             CCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----------------HHHHHHHHCCCCCCCC
Confidence            2245789999998766 68899999999999999996 8887643221                1122222222333344


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ...+.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            55677899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.9e-43  Score=316.94  Aligned_cols=242  Identities=24%  Similarity=0.268  Sum_probs=194.6

Q ss_pred             ccccccCceEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           30 TRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ++||+|+||.||+++.    .+++.||||++....   .......+..|+.+++.++||||+++++++.++...++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999964    357899999987531   122335678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.+++|.+++. ....+.+..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLE-REGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            99999999884 35578899999999999999999999   9999999999999999999999999999875432221  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                      ......|+..|+|||++.+. .++.++|||||||++|||++|..||......       .....         +... ..
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~---------~~~~-~~  217 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDK---------ILKG-KL  217 (323)
T ss_pred             cccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHH---------HHcC-CC
Confidence            12235689999999999876 6889999999999999999999998543210       00111         1111 11


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            22334456789999999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.9e-43  Score=311.21  Aligned_cols=258  Identities=28%  Similarity=0.386  Sum_probs=204.4

Q ss_pred             HhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      +....|.+.+.||+|+||.||+|.+.      .+..||+|.+...........+..|+.++++++|+||+++++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            34567888999999999999999764      357899998875544555567999999999999999999999999988


Q ss_pred             eeeEEEeccCCCChhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC---ceE
Q 038199           95 MTALVYEYMENGSLDGYLFGKK------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPK  165 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~k  165 (356)
                      ..++||||+.|++|.+++....      ..+++..++.++.||+.||+|||+   .+++||||||+||+++.++   .++
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceE
Confidence            9999999999999999985432      258999999999999999999999   9999999999999998654   599


Q ss_pred             EcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhH
Q 038199          166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVW  244 (356)
Q Consensus       166 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  244 (356)
                      |+|||+++................+..|+|||++.+. .++.++|||||||++|||++ |..||......          
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----------  228 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----------  228 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence            9999999866332222111122235679999999766 68999999999999999997 87776432211          


Q ss_pred             HHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          245 EEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                            .....+........+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 ------EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                  111112222222334455678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.4e-43  Score=313.15  Aligned_cols=270  Identities=25%  Similarity=0.338  Sum_probs=204.3

Q ss_pred             hccccccccccCceEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC--Ceee
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTA   97 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~~   97 (356)
                      .|.+.+.||+|+||+||++.+     .+++.||+|++...........+.+|++++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            348899999999999988643     357889999997654344556788999999999999999999987653  4678


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+.+++|.+++..  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            99999999999999843  469999999999999999999999   9999999999999999999999999999986654


Q ss_pred             CCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ...... .....++..|+|||.+.+. .++.++||||||+++|||++|..|+........... ................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMTVVRLIELL  237 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cccccccchhhhhhhh
Confidence            322211 1122356679999998766 689999999999999999999988654322110000 0000000011111111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      ........+...+..+.+++.+||+.+|++||++++|++.|+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111112223345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-43  Score=307.84  Aligned_cols=258  Identities=30%  Similarity=0.473  Sum_probs=208.9

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      |++....|++.++||+|+||+||+|.+.+++.||||.+...  ....+.+.+|+.++++++|+||+++++++.+....++
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG--TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC--ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            45677889999999999999999998877888999998754  2345678999999999999999999999999889999


Q ss_pred             EEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||||+++++|.+++.... ..+++.++..++.|++.|+.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            999999999999985543 578999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .... ......++..|+|||.+.+. .++.++|+||||++++++++ |+.|+.....       .....         ..
T Consensus       156 ~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~---------~~  217 (261)
T cd05034         156 DEYT-AREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REVLE---------QV  217 (261)
T ss_pred             hhhh-hhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH---------HH
Confidence            2111 11122345689999999866 68999999999999999998 8877643211       01111         11


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      ........+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         218 ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1111122233346789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.7e-43  Score=315.53  Aligned_cols=265  Identities=26%  Similarity=0.369  Sum_probs=209.6

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeec
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG   88 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~   88 (356)
                      .+++...+|.+.++||+|+||.||+++..        ....+|+|++...........+..|+.+++++ +||||+++++
T Consensus         6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            35666788999999999999999999642        24579999987654445566788999999999 5999999999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCC
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP  153 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp  153 (356)
                      ++.+....++||||+.+++|.+++...               ...+++.++..++.|++.||.|||+   .+++||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp  162 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAA  162 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccc
Confidence            999999999999999999999998542               2458999999999999999999999   9999999999


Q ss_pred             CcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCC
Q 038199          154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGS  232 (356)
Q Consensus       154 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~  232 (356)
                      +||+++.++.++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|+|++ |..|+....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999865432221111122345679999998776 68999999999999999999 666653221


Q ss_pred             CCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          233 SESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .                ...............+...+.++.+++.+||+.+|++||++.++++.|.++..
T Consensus       242 ~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         242 V----------------EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             H----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            1                11111111222222334456678899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.7e-43  Score=313.08  Aligned_cols=258  Identities=24%  Similarity=0.374  Sum_probs=205.8

Q ss_pred             hhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ...+|++.+.||+|+||.||+|...      ++..||+|++...........+.+|+.++++++||||+++++++.+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4567889999999999999999753      4678999998765444555679999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCC
Q 038199           96 TALVYEYMENGSLDGYLFGK---------------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  154 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~---------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~  154 (356)
                      .++||||+.+++|.+++...                     ...+++..++.++.|++.||.|||+   .+++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence            99999999999999998532                     1247888999999999999999999   99999999999


Q ss_pred             cEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCC
Q 038199          155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSS  233 (356)
Q Consensus       155 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~  233 (356)
                      ||+++.++.++|+|||++.................+..|+|||.+.+. .++.++|||||||++|||++ |..|+.....
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999998765433222222223356679999998776 68999999999999999997 6666532211


Q ss_pred             CccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          234 ESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                                      .+....+........+...+.++.+++.+||+.+|++||++.++++.|++
T Consensus       239 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 ----------------EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                            01111222222222333456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.5e-42  Score=313.74  Aligned_cols=242  Identities=25%  Similarity=0.328  Sum_probs=191.8

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||+||+|.+. +++.||||+++...  .....+.+..|..++... +||||+++++++..+...++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999764 58899999997542  123334556677777654 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQ-SSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99998884 34579999999999999999999999   999999999999999999999999999997643322  1223


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||++.+. .++.++|||||||++|||++|..||......       .....         +. ...+..+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------~~~~~---------i~-~~~~~~~  216 (316)
T cd05592         155 TFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------ELFDS---------IL-NDRPHFP  216 (316)
T ss_pred             cccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------HHHHH---------HH-cCCCCCC
Confidence            35689999999999876 6899999999999999999999998543211       00111         11 1112233


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMS-AVVK  295 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~-~v~~  295 (356)
                      ...+.++.+++.+||+.||++||++. ++++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            44566788999999999999999875 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=292.60  Aligned_cols=264  Identities=23%  Similarity=0.276  Sum_probs=208.0

Q ss_pred             HhhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC-----C
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----H   94 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-----~   94 (356)
                      +++.+|.+.+.||+|||+-||+++ ..+++.||+|++.-.. ..+.+..++|++.-++++|||+++++++...+     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            478899999999999999999997 5579999999986542 46667899999999999999999999987644     3


Q ss_pred             eeeEEEeccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           95 MTALVYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                      ..|++++|+..|+|.+.+...   +..+++.+++.|+.+|++||++||+.. .+++||||||.|||+.+++.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence            589999999999999988653   447999999999999999999999821 2499999999999999999999999999


Q ss_pred             ccccCCCCCeee-------eccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh
Q 038199          172 AKLCDRNRSHVT-------ISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH  242 (356)
Q Consensus       172 ~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~  242 (356)
                      +....-.-....       ......|..|.|||.+.-  ....++++|||||||++|+|+.|..||...-          
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~----------  245 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY----------  245 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh----------
Confidence            875432111100       112346889999998753  3368999999999999999999998874321          


Q ss_pred             hHHHHhhchhhHHHHh--cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          243 VWEEYEKSELDATILA--CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       243 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                        +  ..+.+...+..  ...+.. ..++..+.+++++|++.||.+||++.+++..+..+.
T Consensus       246 --~--~GgSlaLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  246 --Q--QGGSLALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --h--cCCeEEEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence              1  11111111111  112222 238889999999999999999999999999987653

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-43  Score=313.82  Aligned_cols=265  Identities=23%  Similarity=0.340  Sum_probs=202.4

Q ss_pred             HhhhhccccccccccCceEEEEEEeCC---------------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFPN---------------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR   85 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~   85 (356)
                      +...+|.+.++||+|+||.||++....               ...||+|++...........+.+|++++++++|+|+++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            345689999999999999999996532               23589999976554555567999999999999999999


Q ss_pred             eeceEecCCeeeEEEeccCCCChhhhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCC
Q 038199           86 LYGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  154 (356)
Q Consensus        86 ~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~  154 (356)
                      +++++......++||||+.+++|.+++....           ..+++..++.++.|++.||.|||+   .+++||||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChh
Confidence            9999999999999999999999999884321           247889999999999999999999   99999999999


Q ss_pred             cEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhC--CcccccCC
Q 038199          155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR--RRNAIVGS  232 (356)
Q Consensus       155 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg--~~p~~~~~  232 (356)
                      ||+++.++.+||+|||++................++..|+|||.+.+. .++.++||||||+++++|+++  ..|+....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            999999999999999999765433222222233456789999998766 689999999999999999984  34443221


Q ss_pred             CCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          233 SESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ..       ........  .................+..+.+++.+||..+|++||++++|++.|.
T Consensus       238 ~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         238 DE-------QVIENTGE--FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             hH-------HHHHHHHH--hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            10       00000000  00000000011122234568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=325.43  Aligned_cols=253  Identities=27%  Similarity=0.339  Sum_probs=203.4

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|.+.+.||+|+||+||+|... +++.||||++....  .......+..|+.++..++||||+++++++.++...++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            6888999999999999999765 69999999997532  12344578899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC--
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR--  179 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~--  179 (356)
                      |+.+++|.+++... ..+++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            99999999998543 689999999999999999999999   999999999999999999999999999998654332  


Q ss_pred             -------------------------CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCC
Q 038199          180 -------------------------SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE  234 (356)
Q Consensus       180 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~  234 (356)
                                               .........||..|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                     00112235689999999999877 7899999999999999999999998654321


Q ss_pred             ccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 038199          235 SLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP-MSAVVKM  296 (356)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~v~~~  296 (356)
                             ..+..+...      ......+.....+.++.+++.+|+. ||.+||+ ++++++.
T Consensus       237 -------~~~~~i~~~------~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 -------ETYNKIINW------KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             -------HHHHHHhcc------CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                   011111100      0001111112256778999999997 9999999 9999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=304.48  Aligned_cols=249  Identities=33%  Similarity=0.476  Sum_probs=206.3

Q ss_pred             ccccccCceEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      ++||+|+||.||+|....    +..||+|++.........+.+.+|++.++.++|+|++++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            579999999999997643    8899999998765444567899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199          106 GSLDGYLFGK--------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       106 ~sL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ++|.+++...        ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999655        4789999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ...........++..|+|||.+.+. .++.++||||||+++++|++ |..|+.....                .......
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~~~~~  220 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----------------EEVLEYL  220 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCH----------------HHHHHHH
Confidence            4322223345578899999998876 68999999999999999999 5777644311                1111112


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ........+...+.++.+++.+||+.+|++||++.++++.|+
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            222233344555788999999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=304.98  Aligned_cols=253  Identities=28%  Similarity=0.425  Sum_probs=207.5

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ++...+|++.+.||+|+||.||+|.. .|+.||+|.+.....  ..+++.+|+.+++.++|+||+++++++.+....++|
T Consensus         2 ~~~~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           2 AINSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             ccChhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            45677899999999999999999987 578899999986532  457899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199          100 YEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      |||+++++|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||.++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999985443 369999999999999999999999   99999999999999999999999999999866322


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ..     ...++..|+|||.+... .++.++||||||+++|++++ |..|+......                .......
T Consensus       156 ~~-----~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~~~  213 (256)
T cd05039         156 QD-----SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPHVE  213 (256)
T ss_pred             cc-----cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH----------------HHHHHHh
Confidence            11     22356689999998766 68899999999999999997 88776432211                1111111


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      .......+...+..+.+++.+||..+|++||+++++++.|+.+
T Consensus       214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         214 KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            1112222334567899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.7e-42  Score=306.81  Aligned_cols=255  Identities=25%  Similarity=0.355  Sum_probs=198.0

Q ss_pred             ccccccccccCceEEEEEEeCC-Cc--EEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC------Ce
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPN-GV--KIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HM   95 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------~~   95 (356)
                      +.++++||+|+||.||+|.+.. +.  .+|+|.++... .....+.+..|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3578999999999999997643 33  68999887542 234456789999999999999999999987432      24


Q ss_pred             eeEEEeccCCCChhhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           96 TALVYEYMENGSLDGYLFG-----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      .++||||+.+++|.+++..     ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999887632     23458999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhh
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      +++...............++..|+|||.+.+. .++.++||||||+++|||++ |..||.....       ...++    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~----  225 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYD----  225 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH----
Confidence            99876543322111223456789999999876 68999999999999999999 6666633211       11111    


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                           .+............+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       226 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         226 -----YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -----HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 1112222222334567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.4e-43  Score=325.41  Aligned_cols=259  Identities=23%  Similarity=0.248  Sum_probs=204.3

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ..+....|++.++||+|+||.||+++.. +++.||+|++....  .......+..|+.+++.++||||+++++++.+...
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3456678999999999999999999764 68999999996421  12333457889999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||++||+|.+++.  +..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus       118 ~~lv~Ey~~gg~L~~~l~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999999999883  3468899999999999999999999   99999999999999999999999999999765


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCC---CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNY---PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ...... ......||+.|+|||++.+..   .++.++|||||||++|||++|..||......       ..+..+.... 
T Consensus       193 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~-  263 (370)
T cd05596         193 DANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMDHK-  263 (370)
T ss_pred             cCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCC-
Confidence            432211 123356999999999986532   4788999999999999999999998643321       1111111100 


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPED--RPPMSAVVKM  296 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~  296 (356)
                           .....+.....+.++.+++.+||+.+|.+  |++++++++.
T Consensus       264 -----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 -----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                 00011122235678889999999999988  9999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-42  Score=305.18  Aligned_cols=256  Identities=28%  Similarity=0.417  Sum_probs=204.6

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ++...+|.+.++||+|+||.||+|.+..+..+|+|.+...  ....+.+.+|++++++++|+|++++++++.. ...++|
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05069           2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV   78 (260)
T ss_pred             cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC--CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence            4556789999999999999999998766678999988654  2334678899999999999999999998754 567899


Q ss_pred             EeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199          100 YEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      |||+.+++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            9999999999998543 3458999999999999999999999   99999999999999999999999999999765433


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ... ......++..|+|||...+. ..+.++||||||+++|||++ |..|+.....       ....         ....
T Consensus       156 ~~~-~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~---------~~~~  217 (260)
T cd05069         156 EYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVN-------REVL---------EQVE  217 (260)
T ss_pred             ccc-ccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHH---------HHHH
Confidence            221 11223466789999998766 68999999999999999999 7777643211       0011         1111


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      .......+...+..+.+++.+||..||++||++++|++.|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         218 RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            111222334567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.9e-42  Score=305.65  Aligned_cols=257  Identities=21%  Similarity=0.366  Sum_probs=207.3

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .+|++.+.||+|+||.||+|... +++.||||.+...  ........+.+|+++++.++||||+++++++.+....++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            36889999999999999999754 6899999987532  22344467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199          101 EYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       101 e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||+++++|.+++..   ....++...+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988742   24568999999999999999999999   9999999999999999999999999999886543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ....  .....|+..|+|||.+.+. .++.++|+||||+++|||++|+.|+........              .....+.
T Consensus       159 ~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--------------~~~~~~~  221 (267)
T cd08228         159 KTTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF--------------SLCQKIE  221 (267)
T ss_pred             hhHH--HhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHH--------------HHHHHHh
Confidence            2211  1234588899999998876 688999999999999999999999754322100              0111111


Q ss_pred             hcCCCc-hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          258 ACGIEE-KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       258 ~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ....+. .....+..+.+++.+||..+|++||++.+|++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            111222 2234567899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.8e-43  Score=324.43  Aligned_cols=254  Identities=21%  Similarity=0.242  Sum_probs=195.9

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|++.+.||+|+||+||+|.. .+++.||||++....  .......+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            477889999999999999965 468999999996531  22334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |++||+|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.+++++|+|||++..+......
T Consensus        82 ~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLI-RMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999884 34578999999999999999999999   99999999999999999999999999997643210000


Q ss_pred             ---------------------------------------------eeeccCCCCCCCCCcccccCCCCCCccccchhhHH
Q 038199          182 ---------------------------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM  216 (356)
Q Consensus       182 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGv  216 (356)
                                                                   .......||..|+|||++.+. .++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~  236 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGV  236 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhh
Confidence                                                         001234699999999999876 6899999999999


Q ss_pred             HHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHh--cccCCCCCCCCHHHHH
Q 038199          217 VLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALW--CVQDSPEDRPPMSAVV  294 (356)
Q Consensus       217 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~Rps~~~v~  294 (356)
                      ++|||++|..||........       .......      ......+.....+.++.+++.+  |+..+|..||++++++
T Consensus       237 il~elltG~~Pf~~~~~~~~-------~~~i~~~------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTET-------QLKVINW------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHH-------HHHHHcc------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            99999999999865332100       0000000      0000011112245567777777  5566777799999998


Q ss_pred             HH
Q 038199          295 KM  296 (356)
Q Consensus       295 ~~  296 (356)
                      +.
T Consensus       304 ~h  305 (381)
T cd05626         304 AH  305 (381)
T ss_pred             cC
Confidence            74

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.8e-42  Score=303.56  Aligned_cols=258  Identities=23%  Similarity=0.363  Sum_probs=209.1

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ..|++.+.||+|+||.||+|... +|+.||+|.++..  ......+.+.+|++++++++|+|++++++.+.+....++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            46889999999999999999765 7999999988632  22334567899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199          101 EYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       101 e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||+++++|.+++..   .+..+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998843   24568999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ....  .....++..|+|||.+.+. .++.++|+||||+++|+|++|..|+........              .......
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~  221 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--------------SLCKKIE  221 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHH--------------HHHhhhh
Confidence            3221  1224578899999998766 689999999999999999999988754321100              0011111


Q ss_pred             hcCCCchhH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          258 ACGIEEKDK-EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       258 ~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      .+.....+. ..+..+.+++.+||..+|++||++.+|++.|..+.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            111222222 56678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.1e-43  Score=321.31  Aligned_cols=266  Identities=19%  Similarity=0.247  Sum_probs=196.5

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC-----Ceee
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMTA   97 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-----~~~~   97 (356)
                      +|++.++||+|+||.||+|... +|+.||||++.... ......++.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788999999999999999754 68999999987432 223345788999999999999999999988543     2479


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+. ++|.+++. ....+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 58988883 45579999999999999999999999   9999999999999999999999999999976533


Q ss_pred             CCCe-eeeccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCcccccCCCCcc-cc-------chhhhHHHH
Q 038199          178 NRSH-VTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL-DW-------FPKHVWEEY  247 (356)
Q Consensus       178 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~-~~-------~~~~~~~~~  247 (356)
                      .... .......||..|+|||++.+. ..++.++|||||||++|||++|+.||........ ..       .....+..+
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            2211 122345689999999998652 3688999999999999999999988854322100 00       000000111


Q ss_pred             hhchhhHHH---HhcCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATI---LACGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~---~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .........   .....   ....+..+..+.+++.+||+.||++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            111000000   00000   0111123466889999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=308.07  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=209.7

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ...+|.+.+.||+|+||+||+|.+. +|+    .+|+|++...........+.+|+.++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            4567888999999999999999753 333    5899998766545556788999999999999999999999987 678


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+.+++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||+++...
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999999997666679999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ............++..|+|||.+... .++.++|+||||+++||+++ |..|+.....                ......
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----------------~~~~~~  223 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----------------VEIPDL  223 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----------------HHHHHH
Confidence            43332222223345689999998765 68899999999999999998 8888743221                111112


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      +........+...+..+..++.+||..+|.+||++.++++.|+.+..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         224 LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            22222222333355678899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-42  Score=304.67  Aligned_cols=257  Identities=27%  Similarity=0.426  Sum_probs=207.8

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      |++...+|.+.++||+|+||.||++...++..+|+|.+...  ....+.+.+|+.++++++|+||+++++++.+ ...++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            56778899999999999999999998767788999988754  3345678999999999999999999999887 67899


Q ss_pred             EEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||||+++++|.+++... ...+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            99999999999998653 4568999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .... ......++..|+|||++.+. .++.++|+||||+++|++++ |..|+......       ....         ..
T Consensus       155 ~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~---------~~  216 (260)
T cd05073         155 NEYT-AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIR---------AL  216 (260)
T ss_pred             CCcc-cccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------HHHH---------HH
Confidence            2221 12223456789999999866 68899999999999999999 77776432210       0111         11


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      ......+.....+.++.+++.+|++.+|++||++.++++.|+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         217 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1111122234456779999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-42  Score=306.05  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=201.3

Q ss_pred             ccccccccccCceEEEEEEeC-C---CcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCe-----
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-N---GVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM-----   95 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~-----   95 (356)
                      |.+.+.||+|+||.||+|... +   +..||+|++..+. .....+.+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567899999999999999753 2   4789999987542 23445679999999999999999999998866543     


Q ss_pred             -eeEEEeccCCCChhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEccc
Q 038199           96 -TALVYEYMENGSLDGYLFGK-----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  169 (356)
Q Consensus        96 -~~lV~e~~~~~sL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df  169 (356)
                       .++||||+.+++|..++...     ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999887432     2468999999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHh
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYE  248 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  248 (356)
                      |+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....               
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---------------  221 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---------------  221 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCH---------------
Confidence            999866443322222223356789999998766 68999999999999999999 7666633211               


Q ss_pred             hchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                       ...............+...+.++.+++.+||+.||++||++.+|++.|+.+
T Consensus       222 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         222 -HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -HHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             111111122222233445667899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-43  Score=301.36  Aligned_cols=266  Identities=20%  Similarity=0.232  Sum_probs=203.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccch-hhHHHHHHHHHHHccCCCCceeeeeceEecC--CeeeEEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALVY  100 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~~lV~  100 (356)
                      .|+...+|++|+||.||+|+++ +++.||+|.++.+... .----..+|+.+|.+.+|||||.+-.+....  +..|+||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            4566788999999999999764 6999999999764311 1113467999999999999999999887643  5689999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |||+. +|..+++...+++...++..+..|++.|++|||.   ..|+|||||++|+|++..|.+|++|||+|+.++.+..
T Consensus       157 e~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  157 EYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK  232 (419)
T ss_pred             HHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence            99988 9999998888899999999999999999999999   9999999999999999999999999999999886633


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc-c----cch---hhhHHHHhhchh
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL-D----WFP---KHVWEEYEKSEL  252 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~-~----~~~---~~~~~~~~~~~~  252 (356)
                        ..+..+-|.+|.|||.+.+...|+.+.|+||+|||+.||+++++.|...+.... +    .+.   ...|..+..-..
T Consensus       233 --~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  233 --PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             --cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence              234455689999999999988999999999999999999998765544333211 0    000   111222221111


Q ss_pred             hHHH------HhcCCCch-hHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          253 DATI------LACGIEEK-DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       253 ~~~~------~~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ...+      ........ .......-++++..+|..||.+|.|+++.++.
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            1100      00000000 01144667889999999999999999998873

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-42  Score=311.09  Aligned_cols=264  Identities=27%  Similarity=0.355  Sum_probs=205.2

Q ss_pred             hhhhccccccccccCceEEEEEEeCC-----------------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCcee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPN-----------------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV   84 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~   84 (356)
                      ...+|.+.+.||+|+||.||+|.+..                 +..||+|++.........+.+.+|++++++++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            34678999999999999999996532                 2458999998665555667899999999999999999


Q ss_pred             eeeceEecCCeeeEEEeccCCCChhhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCC
Q 038199           85 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKK----------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  154 (356)
Q Consensus        85 ~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~  154 (356)
                      ++++++.++...++|||++.+++|.+++....          ..+++..++.++.|++.||.|||+   .+++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence            99999999999999999999999999985432          268999999999999999999999   99999999999


Q ss_pred             cEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh--CCcccccCC
Q 038199          155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG--RRRNAIVGS  232 (356)
Q Consensus       155 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt--g~~p~~~~~  232 (356)
                      ||+++.++.++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++  |..|+....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999998765433322223334567789999998766 68999999999999999998  445543221


Q ss_pred             CCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          233 SESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      .       ...+......  ............+...+.++.+++.+||+.||++||++.+|++.|+
T Consensus       239 ~-------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 D-------QQVIENAGHF--FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             h-------HHHHHHHHhc--cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1       1111111100  0000000011122344578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=332.82  Aligned_cols=264  Identities=23%  Similarity=0.293  Sum_probs=212.3

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCC-cEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeec-eEec---
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNG-VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYG-FCHD---   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~-~~~~---   92 (356)
                      .++..++.++.+.|.+|||+.||+|.+.++ ..||+|++-.. .+......++|+++|++|+ |+|||.+++ ....   
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            566778889999999999999999976554 99999998765 5777788999999999997 999999999 3321   


Q ss_pred             ---CCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcc
Q 038199           93 ---QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  168 (356)
Q Consensus        93 ---~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D  168 (356)
                         ..+.+|.||||.||+|-++++.+ ...|++.++++|+.++++|+.+||. ++.+|||||||-+||||+.+|..||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCc
Confidence               23567999999999999999754 3459999999999999999999998 346799999999999999999999999


Q ss_pred             cCCccccCCCCC-eeee------ccCCCCCCCCCccccc--CCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc
Q 038199          169 FGLAKLCDRNRS-HVTI------SGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF  239 (356)
Q Consensus       169 fgl~~~~~~~~~-~~~~------~~~~gt~~y~aPE~~~--~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~  239 (356)
                      ||.+........ ....      ...--|+.|+|||++.  ++...++|+|||+|||+||-|+....||...+.-     
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----  264 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----  264 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence            999875432221 1110      0122588999999863  3337999999999999999999999998654321     


Q ss_pred             hhhhHHHHhhchhhHHHHhcCC-CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          240 PKHVWEEYEKSELDATILACGI-EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                                     .+..+.. -+..+.++..+..||..||+.||.+||++-+|+..+..+....
T Consensus       265 ---------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  265 ---------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ---------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                           1111111 1233688999999999999999999999999999998877654

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-42  Score=314.59  Aligned_cols=238  Identities=27%  Similarity=0.338  Sum_probs=187.5

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHH-HHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVG-TIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      ++||+|+||+||+|++. +++.||+|++....  .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999764 68999999986532  1122334555554 57889999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|...+. ....+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05603          81 GELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTS  154 (321)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccc
Confidence            99988774 45678999999999999999999999   9999999999999999999999999999875322211  123


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||.+.+. .++.++|||||||++|||++|..||......       ...+.         +... ....+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~---------i~~~-~~~~~  216 (321)
T cd05603         155 TFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------QMYDN---------ILHK-PLQLP  216 (321)
T ss_pred             cccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHH-------HHHHH---------HhcC-CCCCC
Confidence            35689999999999876 6899999999999999999999998543210       01111         1111 11222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMS  291 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~  291 (356)
                      ...+..+.+++.+||+.||.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            34556788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-42  Score=302.51  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=200.7

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCChh
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLD  109 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL~  109 (356)
                      ++||+|+||.||++.+.+++.||+|.+...........+.+|+++++++.|+||+++++++.+....++||||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999876699999999876544445578999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCC
Q 038199          110 GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG  189 (356)
Q Consensus       110 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  189 (356)
                      +++......+++..+..++.|++.+|.|||+   .+++||||+|+||+++.++.++|+|||++................+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            9986556678999999999999999999999   9999999999999999999999999999876543222111112234


Q ss_pred             CCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHH
Q 038199          190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK  268 (356)
Q Consensus       190 t~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (356)
                      +..|+|||.+.+. .++.++|+||||+++|||++ |..|+......                .....+........+...
T Consensus       158 ~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~  220 (251)
T cd05041         158 PIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----------------QTRERIESGYRMPAPQLC  220 (251)
T ss_pred             eeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHH----------------HHHHHHhcCCCCCCCccC
Confidence            5679999998766 68999999999999999999 66665332210                111111111112223345


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       269 ~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      +..+.+++.+||+.+|++||++.+|++.|.
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-42  Score=310.94  Aligned_cols=264  Identities=25%  Similarity=0.339  Sum_probs=202.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-----------------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-----------------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR   85 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~   85 (356)
                      ..+|++.++||+|+||+||++.+.                 ++..+|+|++...........+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            456899999999999999998532                 244699999976544555678999999999999999999


Q ss_pred             eeceEecCCeeeEEEeccCCCChhhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCc
Q 038199           86 LYGFCHDQHMTALVYEYMENGSLDGYLFGKK----------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN  155 (356)
Q Consensus        86 ~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~N  155 (356)
                      +++++.+....++||||+.+++|.+++....          ..+++.++..++.|++.||+|||+   .+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence            9999999999999999999999999885421          247788999999999999999999   999999999999


Q ss_pred             EEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh--CCcccccCCC
Q 038199          156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG--RRRNAIVGSS  233 (356)
Q Consensus       156 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt--g~~p~~~~~~  233 (356)
                      |+++.++.++|+|||+++...............++..|++||...+. .++.++|||||||++|||++  |..|+.....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            99999999999999999865433222222223346789999988766 68999999999999999998  5556543221


Q ss_pred             CccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          234 ESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      ..       ......  ............+.+..++..+.+++.+||+.||.+||++.+|++.|++
T Consensus       240 ~~-------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 EQ-------VIENTG--EFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HH-------HHHHHH--HHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            10       000000  0000000000111223355779999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.7e-42  Score=303.79  Aligned_cols=253  Identities=29%  Similarity=0.418  Sum_probs=196.9

Q ss_pred             ccccccCceEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe-cCCeeeEEEeccC
Q 038199           30 TRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH-DQHMTALVYEYME  104 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~-~~~~~~lV~e~~~  104 (356)
                      +.||+|+||.||+|.+.    ++..+|+|.+.........+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999752    245799999865433445578899999999999999999999775 4556789999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee--
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV--  182 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~--  182 (356)
                      +++|.+++.......++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.........  
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            999999996555667888899999999999999999   999999999999999999999999999987654322111  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                      ......++..|+|||.+.+. .++.++||||||+++|||++|+.|.......               ......+......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---------------~~~~~~~~~~~~~  221 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---------------FDITVYLLQGRRL  221 (262)
T ss_pred             ccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---------------HHHHHHHhcCCCC
Confidence            11233467789999998766 6899999999999999999976543322110               0111111122222


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      ..+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            223334567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-42  Score=308.04  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=203.1

Q ss_pred             hhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      +..++.+.++||+|+||.||++...      ++..+|+|.+... .......+.+|+++++.++|+||+++++++.+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            3456778899999999999999532      3567999988643 34455689999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC
Q 038199           96 TALVYEYMENGSLDGYLFGKK--------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  161 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~  161 (356)
                      .++||||+.+++|.+++....              ..+++.++..++.|++.||+|||+   .+++||||||+||+++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCC
Confidence            999999999999999885432              358999999999999999999999   999999999999999999


Q ss_pred             CceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccch
Q 038199          162 FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFP  240 (356)
Q Consensus       162 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~  240 (356)
                      +.++|+|||++................++..|+|||.+.+. .++.++|||||||++|||++ |..||......      
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------  231 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------  231 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------
Confidence            99999999998765432222212223356789999998876 68999999999999999998 77776432211      


Q ss_pred             hhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                                ..............+...+..+.+++.+||+.||.+||++++|++.|+
T Consensus       232 ----------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         232 ----------EAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ----------HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                      011111121122223345677999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.5e-42  Score=303.23  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=198.5

Q ss_pred             ccccccCceEEEEEEe---CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQF---PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||.||+|.+   .+++.+|+|+++... .....+.+..|+.+++.+.||||+++++++.+ +..++||||+.+
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            3699999999999964   357889999987543 23345678999999999999999999998864 466899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee-e
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-I  184 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~  184 (356)
                      ++|.+++. ....+++..+..++.|++.||+|||+   ++++||||||+||+++.++.++|+|||++........... .
T Consensus        80 ~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          80 GPLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            99999984 34578999999999999999999999   9999999999999999999999999999987654433211 1


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      ....++..|+|||.+... .++.++|+||||+++|||++ |..||.....                ......+......+
T Consensus       156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----------------~~~~~~i~~~~~~~  218 (257)
T cd05116         156 THGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----------------NEVTQMIESGERME  218 (257)
T ss_pred             CCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHCCCCCC
Confidence            222345789999998765 68899999999999999998 8888743221                11112222222233


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      .+...+.++.+++.+||+.||++||++.+|.+.|+..
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            3445667899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-42  Score=309.25  Aligned_cols=273  Identities=24%  Similarity=0.367  Sum_probs=210.4

Q ss_pred             hhhccccccccccCceEEEEEEeC-----CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec--CCe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHM   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~--~~~   95 (356)
                      ..+|++.++||+|+||.||+|.+.     +++.||||++...........+.+|+++++.+.|+||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            457788899999999999999753     3789999999865433346789999999999999999999999887  567


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++++|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            899999999999999996655579999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ........ .....++..|+|||.+.+. .++.++||||||++++||++|..|+.........+....... ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  237 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ-MIVTRLLE  237 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc-ccHHHHHH
Confidence            53322211 1123456679999998766 688999999999999999999988654332211111100000 00011111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      .+........+..++.++.+++.+||+.+|++||++.+|+++|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111122222344557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8e-43  Score=316.30  Aligned_cols=243  Identities=24%  Similarity=0.301  Sum_probs=194.2

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      ++||+|+||.||+|+.. +++.||||++....  .......+..|.+++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            47999999999999764 58899999997532  223345677899998876 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|...+. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05591          81 GDLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT  154 (321)
T ss_pred             CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence            99998884 44678999999999999999999999   9999999999999999999999999999875432221  123


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||++.+. .++.++|||||||++|||++|+.||......       ......         .... ...+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~~~~~i---------~~~~-~~~p  216 (321)
T cd05591         155 TFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNED-------DLFESI---------LHDD-VLYP  216 (321)
T ss_pred             ccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHH-------HHHHHH---------HcCC-CCCC
Confidence            35689999999999876 7899999999999999999999998543321       111111         1111 1122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-------CHHHHHHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRP-------PMSAVVKM  296 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rp-------s~~~v~~~  296 (356)
                      ...+.++.+++.+||+.||++||       +++++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            23456788999999999999999       77777753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.6e-43  Score=316.60  Aligned_cols=237  Identities=27%  Similarity=0.316  Sum_probs=190.7

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||+||+|.+. +++.||||++....  .......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999764 58999999987532  223345677888888876 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........  ...
T Consensus        81 g~L~~~i~-~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (320)
T cd05590          81 GDLMFHIQ-KSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS  154 (320)
T ss_pred             chHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence            99998884 34679999999999999999999999   9999999999999999999999999999875432211  123


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|+.||......       ...+.+         .... ...+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i---------~~~~-~~~~  216 (320)
T cd05590         155 TFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAI---------LNDE-VVYP  216 (320)
T ss_pred             ccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHH---------hcCC-CCCC
Confidence            35689999999999876 6899999999999999999999998543211       111111         1111 1122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPM  290 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~  290 (356)
                      ...+.++.+++.+||+.||++||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            2356678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-42  Score=315.65  Aligned_cols=242  Identities=25%  Similarity=0.305  Sum_probs=194.1

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCC-CceeeeeceEecCCeeeEEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYH-INLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h-~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .|++.+.||+|+||.||+|... +++.||||++....  .....+.+..|.+++..+.| ++|+.+++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999764 58899999997532  23344678889999999975 56888999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+++++|..++. ....+++..+..++.||+.||.|||+   ++++||||||+|||++.++.++|+|||++........
T Consensus        81 E~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999998884 34578999999999999999999999   9999999999999999999999999999875322211


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                        ......||..|+|||++.+. .++.++|||||||++|||++|+.||......       .....         +.. .
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~---------i~~-~  216 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQS---------IME-H  216 (324)
T ss_pred             --ceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHH---------HHc-C
Confidence              12335689999999999876 6899999999999999999999998543211       01111         111 1


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPM  290 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  290 (356)
                      ....+...+.++.+++.+||+.||.+|++.
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            112233456678899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.3e-43  Score=316.19  Aligned_cols=239  Identities=24%  Similarity=0.263  Sum_probs=192.8

Q ss_pred             ccccccCceEEEEEEe----CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccC
Q 038199           30 TRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~  104 (356)
                      +.||+|+||.||++..    .+|+.||+|++.... .......+..|++++++++||||+++++++.+....++||||+.
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999964    358899999997532 22234567789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeee
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI  184 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  184 (356)
                      +++|.+++. ....+++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++........  ..
T Consensus        82 ~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~  155 (318)
T cd05582          82 GGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA  155 (318)
T ss_pred             CCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence            999999883 34579999999999999999999999   9999999999999999999999999999876543321  12


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCch
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEK  264 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (356)
                      ....|+..|+|||.+.+. .++.++|||||||++|||++|+.||......       ...         ..+... ....
T Consensus       156 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~---------~~i~~~-~~~~  217 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETM---------TMILKA-KLGM  217 (318)
T ss_pred             ecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHH-------HHH---------HHHHcC-CCCC
Confidence            335689999999999876 6789999999999999999999997543210       000         111111 1122


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 038199          265 DKEKAKRLCMAALWCVQDSPEDRPPMSA  292 (356)
Q Consensus       265 ~~~~~~~l~~l~~~cl~~~p~~Rps~~~  292 (356)
                      +...+.++.+++.+||+.||++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            3345677899999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-42  Score=312.77  Aligned_cols=267  Identities=21%  Similarity=0.274  Sum_probs=203.4

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+|.+.++||+|+||+||+|... +++.||+|++...........+.+|+.++++++||||+++++++..+...++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            356889999999999999999764 5889999998754433444567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.+ +|..++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            9975 8888876666678999999999999999999999   99999999999999999999999999998764332211


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc--------hhhhHHHHhhchhh
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF--------PKHVWEEYEKSELD  253 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~  253 (356)
                        .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...........        ....|..+......
T Consensus       161 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         161 --YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             --cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence              12345788999999987655688999999999999999999998855432110000        00011111100000


Q ss_pred             HHHHhcCCC-----chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILACGIE-----EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .........     ...+..+.++.+++.+||+.||.+|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000000     111234567889999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=308.87  Aligned_cols=251  Identities=25%  Similarity=0.299  Sum_probs=201.5

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|+..++||+|+||+||++... +++.||+|++....  .......+.+|+.+++.++||||+++++++.++...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            5788899999999999999754 68999999986532  12223457789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          102 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+.+++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            99999999887543 3569999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                         .....|+..|+|||.+.+. .++.++|||||||++|||++|..||......       ...+.     ....+. ..
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-------~~~~~-----~~~~~~-~~  220 (285)
T cd05605         158 ---IRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-------VKREE-----VERRVK-ED  220 (285)
T ss_pred             ---cccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchh-------hHHHH-----HHHHhh-hc
Confidence               1234689999999999866 6899999999999999999999998643221       00111     111111 11


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      ....+...+..+.+++.+||+.||++||     +++++++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            1223345677899999999999999999     7888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=318.84  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=217.9

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      .++-.....|.++||+|-||.|.+++..++..||||.++.+........|.+|+++|.+++||||+.++|+|..++.+++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            44455566788999999999999999877899999999987766667899999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      |+||+++|+|..++.....+ ..-.....|+.||+.|++||.+   .++|||||.+.|+|++.++++||+|||+++-+-.
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccccccc
Confidence            99999999999999665333 3556677899999999999999   9999999999999999999999999999997665


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh--CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG--RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      +.........+-..+|||+|.+.-+ .++.++|||+||+++||+++  ...|+                +.+..+...+.
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py----------------~~lt~e~vven  752 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPY----------------SQLTDEQVVEN  752 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCch----------------hhhhHHHHHHh
Confidence            5555555555677899999998766 79999999999999999875  34443                33333322222


Q ss_pred             H----H---hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          256 I----L---ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       256 ~----~---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      .    .   .......++-++..+++++.+||+.+-++||+++++...|...
T Consensus       753 ~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  753 AGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1    1   1123456677889999999999999999999999999988653

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-42  Score=305.75  Aligned_cols=261  Identities=23%  Similarity=0.317  Sum_probs=208.1

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ++...+|.+.++||+|+||.||+|.+.+    ...||||...........+.+.+|+.++++++||||+++++++.+. .
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~   80 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P   80 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence            3456778999999999999999997532    3468999887655455567899999999999999999999988764 5


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++++|.+++......+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence            689999999999999996655679999999999999999999999   99999999999999999999999999998766


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ....... .....++..|+|||.+.+. .++.++||||||++++|+++ |..||......                ....
T Consensus       158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----------------~~~~  219 (270)
T cd05056         158 EDESYYK-ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----------------DVIG  219 (270)
T ss_pred             cccccee-cCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHH
Confidence            4432211 1222345689999998766 68999999999999999986 88887543221                0001


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ..........+...+..+.+++.+|+..+|++|||+.++++.|+.+..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         220 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111111122334456789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.1e-42  Score=318.74  Aligned_cols=254  Identities=21%  Similarity=0.269  Sum_probs=194.0

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|++.+.||+|+||+||+|... +++.||||++....  .......+..|+.++..++|+||+++++.+.+....++|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            5788999999999999999754 68999999997531  12333568889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |++||+|.+++. ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.++|+|||+++........
T Consensus        82 ~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          82 FLPGGDMMTLLM-KKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             CCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            999999999984 35679999999999999999999999   99999999999999999999999999998754321100


Q ss_pred             ---------------------------------eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCccc
Q 038199          182 ---------------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNA  228 (356)
Q Consensus       182 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~  228 (356)
                                                       ......+||..|+|||++.+. .++.++|||||||++|||++|..||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                             001234699999999999876 7899999999999999999999998


Q ss_pred             ccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhccc--CCCCCCCCHHHHHHH
Q 038199          229 IVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQ--DSPEDRPPMSAVVKM  296 (356)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~~p~~Rps~~~v~~~  296 (356)
                      ......       ..+........     ....+. ....+.++.+++.+++.  .++..||++++|++.
T Consensus       237 ~~~~~~-------~~~~~i~~~~~-----~~~~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         237 CSETPQ-------ETYKKVMNWKE-----TLIFPP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCHH-------HHHHHHHcCcC-----cccCCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            543211       11111110000     000111 11133456666666443  344467899999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.6e-42  Score=311.91  Aligned_cols=258  Identities=24%  Similarity=0.373  Sum_probs=202.1

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCc--EEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGV--KIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   97 (356)
                      ....|++.+.||+|+||.||+|.+. ++.  .+|+|.+...........+.+|++++.++ +|+||+++++++.+....+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            3457788999999999999999764 454  45777776544445556788999999999 8999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           98 LVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      +||||+++++|.+++...               ...+++.+++.++.|++.||+|||+   .+++||||||+||+++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCC
Confidence            999999999999998532               1358899999999999999999999   9999999999999999999


Q ss_pred             ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchh
Q 038199          163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPK  241 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~  241 (356)
                      .++|+|||++.......   ......++..|+|||.+.+. .++.++|||||||++|||+| |..||......       
T Consensus       162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------  230 (303)
T cd05088         162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------  230 (303)
T ss_pred             cEEeCccccCcccchhh---hcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChH-------
Confidence            99999999986422111   11112245679999998766 68899999999999999998 88887432211       


Q ss_pred             hhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          242 HVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                               ..............+...+..+.+++.+||+.+|++||++++++..|..+..
T Consensus       231 ---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         231 ---------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             ---------HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                     0111111111122223345678999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.8e-42  Score=301.00  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=205.8

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .|.+.+.||+|++|.||+|... +++.|++|.+... ........+.+|++++++++|||++++++++.+....++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            3678899999999999999764 6899999998642 2345567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          103 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       103 ~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      +.+++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999998654 5679999999999999999999999   99999999999999999999999999998866543222


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                        .....|+..|+|||++.+. .++.++|+||||+++++|++|..|+......                ...........
T Consensus       158 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~  218 (256)
T cd08529         158 --ANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQG----------------ALILKIIRGVF  218 (256)
T ss_pred             --hhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcCCC
Confidence              1234578899999999876 6889999999999999999999987543210                11111122222


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +......+..+.+++.+||+.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            3333356778999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.6e-42  Score=307.92  Aligned_cols=247  Identities=26%  Similarity=0.347  Sum_probs=194.9

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCCh
Q 038199           32 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        32 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      ||+|+||+||+++.. +|+.||+|++.....  ......+..|++++++++||||+++++++.++...++||||+.|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999764 699999999864321  12234566799999999999999999999999999999999999999


Q ss_pred             hhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccC
Q 038199          109 DGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY  187 (356)
Q Consensus       109 ~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  187 (356)
                      .+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........   ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence            8887443 3468999999999999999999999   9999999999999999999999999999876643321   2234


Q ss_pred             CCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHH
Q 038199          188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE  267 (356)
Q Consensus       188 ~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (356)
                      .|+..|+|||++.+. .++.++|||||||++|||++|..|+.......       .     ...................
T Consensus       155 ~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-------~-----~~~~~~~~~~~~~~~~~~~  221 (277)
T cd05607         155 AGTNGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-------A-----KEELKRRTLEDEVKFEHQN  221 (277)
T ss_pred             CCCCCccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-------h-----HHHHHHHhhcccccccccc
Confidence            689999999999877 58999999999999999999999975432210       0     0011111111111112234


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          268 KAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       268 ~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      .+.++.+++.+||+.||++||++.++++.+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            567789999999999999999998776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.3e-42  Score=307.37  Aligned_cols=245  Identities=28%  Similarity=0.357  Sum_probs=194.8

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCCh
Q 038199           32 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        32 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      ||+|+||+||++.+. +++.||+|++.....  ....+.+..|+.++++++|+||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999754 689999999865321  12335678899999999999999999999999999999999999999


Q ss_pred             hhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          109 DGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       109 ~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ..++..   .+..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            887643   34579999999999999999999999   99999999999999999999999999999765433221  23


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||.+.+. .++.++||||||+++|||++|+.||........       .     .......... ....+
T Consensus       156 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-------~-----~~~~~~~~~~-~~~~~  221 (280)
T cd05608         156 GYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-------N-----KELKQRILND-SVTYP  221 (280)
T ss_pred             ccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-------H-----HHHHHhhccc-CCCCc
Confidence            35689999999999876 789999999999999999999999865332100       0     0001111111 11223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      ...+..+.+++.+||+.||++||     +++++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            34667789999999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-43  Score=300.39  Aligned_cols=279  Identities=21%  Similarity=0.266  Sum_probs=214.1

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEec-----CCee
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-----QHMT   96 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~-----~~~~   96 (356)
                      .+|...+.||+|+||.|..+.+ .+|+.||||.+.+.. .....++..+|+.+|+.++|+||+.+++++..     -...
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            3444478899999999999965 479999999997433 35666889999999999999999999999865     3567


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      |+|+|+| +.+|...+ +.++.++...+..+++|+++||.|+|+   .+++||||||+|++++.+..+|++|||+++...
T Consensus       102 YiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             EEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecc
Confidence            9999999 55999988 455569999999999999999999999   999999999999999999999999999999886


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCc-cc----cch---hhhHHHHh
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES-LD----WFP---KHVWEEYE  248 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~-~~----~~~---~~~~~~~~  248 (356)
                      ........+.++.|.+|.|||.+.....|+.+.||||.||++.||++|+..|.....-. ..    .++   ......+.
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            54333445677889999999998777689999999999999999999987664432211 00    011   11111222


Q ss_pred             hchhhHHHHhcC-CC-----chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhccccCCCCC
Q 038199          249 KSELDATILACG-IE-----EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK--MLEGVVEVLPPP  307 (356)
Q Consensus       249 ~~~~~~~~~~~~-~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~~~~~~~~  307 (356)
                      ...+...+...+ .+     ...++......+++.+||..||.+|+|+++.++  .|....+....|
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            222222222211 11     122345677889999999999999999999998  466666554333

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.9e-43  Score=318.22  Aligned_cols=244  Identities=24%  Similarity=0.319  Sum_probs=195.4

Q ss_pred             ccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCC
Q 038199           30 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +.||+|+||.||++.. .+|+.||+|++....  .......+..|+++++.++||||+++++++.+....++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 468999999997532  2233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeecc
Q 038199          107 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG  186 (356)
Q Consensus       107 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  186 (356)
                      +|..++. ....+++..+..++.||+.||.|||+  ..+++||||||+|||++.++.+||+|||+++.......  ....
T Consensus        81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  155 (325)
T cd05594          81 ELFFHLS-RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT  155 (325)
T ss_pred             cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence            9998873 45679999999999999999999996  26999999999999999999999999999875432211  1223


Q ss_pred             CCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhH
Q 038199          187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK  266 (356)
Q Consensus       187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (356)
                      ..||..|+|||++.+. .++.++|||||||++|||++|..||......       ....         ..... ....+.
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~---------~i~~~-~~~~p~  217 (325)
T cd05594         156 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFE---------LILME-EIRFPR  217 (325)
T ss_pred             ccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHH-------HHHH---------HHhcC-CCCCCC
Confidence            5689999999999876 7899999999999999999999998543211       0011         11111 111223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038199          267 EKAKRLCMAALWCVQDSPEDRP-----PMSAVVKM  296 (356)
Q Consensus       267 ~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~  296 (356)
                      ..+.++.+++.+||+.||++|+     ++.++++.
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            3566789999999999999996     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.2e-42  Score=309.02  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=202.8

Q ss_pred             hhccccccccccCceEEEEEEeC-CC--cEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NG--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ..|.+.+.||+|+||.||+|... ++  ..+++|.++........+.+.+|+.+++++ +||||+++++++.+....++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            36788999999999999999764 33  347888887533344556789999999999 799999999999999999999


Q ss_pred             EeccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCce
Q 038199          100 YEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  164 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~  164 (356)
                      +||+++++|.+++....               ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            99999999999985421               358899999999999999999999   999999999999999999999


Q ss_pred             EEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhh
Q 038199          165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHV  243 (356)
Q Consensus       165 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~  243 (356)
                      ||+|||++.......   .......+..|+|||++.+. .++.++|||||||++|||++ |..||......       ..
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~~  227 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------EL  227 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HH
Confidence            999999986432111   11112235579999998766 68999999999999999997 88887432211       01


Q ss_pred             HHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          244 WEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      +         ...........+...+..+.+++.+||+.+|.+||+++++++.|+.+....
T Consensus       228 ~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         228 Y---------EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             H---------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1         111111122233345677999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.1e-42  Score=302.26  Aligned_cols=250  Identities=23%  Similarity=0.304  Sum_probs=204.9

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      +|++.++||+|+||.||++... +++.||+|.++........+.+..|+.+++.++|+|++++++.+.++...++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999764 689999999865433455677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          104 ENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       104 ~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      ++++|.+++.. ....++...+..++.|++.||.|||+   .+++|+||||+||++++++.++++|||++......... 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence            99999988754 34568999999999999999999999   99999999999999999999999999998766433221 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                       .....|+..|+|||++.+. .++.++|+||||+++|+|++|..||......                ............
T Consensus       157 -~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~  218 (255)
T cd08219         157 -ACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWK----------------NLILKVCQGSYK  218 (255)
T ss_pred             -cccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHH----------------HHHHHHhcCCCC
Confidence             1234588899999999876 6899999999999999999999997542210                011111122222


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ..+...+..+.+++.+||+.||++||++.+|+..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            3334456678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-42  Score=314.32  Aligned_cols=241  Identities=26%  Similarity=0.315  Sum_probs=192.1

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      ++||+|+||.||+|++. +|+.||+|++.....  ......+..|..++... +||||+++++++.+....++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999765 689999999975421  23345667788888764 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....+++..+..++.|++.||+|||+   ++++||||||+||+++.++.++|+|||+++.......  ...
T Consensus        81 g~L~~~i~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05620          81 GDLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS  154 (316)
T ss_pred             CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence            99998884 34678999999999999999999999   9999999999999999999999999999874322111  223


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||++.+. .++.++|||||||++|||++|..||......       ..++..         .. .....+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~---------~~-~~~~~~  216 (316)
T cd05620         155 TFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESI---------RV-DTPHYP  216 (316)
T ss_pred             ccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHH---------Hh-CCCCCC
Confidence            45689999999999876 7899999999999999999999998543211       111111         10 111222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMS-AVV  294 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~-~v~  294 (356)
                      ...+.++.+++.+||+.||++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            33556788999999999999999984 565

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1e-42  Score=316.53  Aligned_cols=249  Identities=23%  Similarity=0.293  Sum_probs=194.9

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      ++||+|+||.||++.+. +++.||||+++...  .....+.+..|..+++++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999764 68999999997532  223345688899999998 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ..+.+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||+++.......  ...
T Consensus        81 g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (329)
T cd05588          81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTS  154 (329)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccc
Confidence            99988874 44679999999999999999999999   9999999999999999999999999999874322111  123


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--cchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--WFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      ...||..|+|||++.+. .++.++|+|||||++|+|++|+.||.........  ......++         ..... ...
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~~~~~-~~~  223 (329)
T cd05588         155 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ---------VILEK-QIR  223 (329)
T ss_pred             cccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH---------HHHcC-CCC
Confidence            35689999999999876 6899999999999999999999998643221100  00011111         11111 112


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPP------MSAVVK  295 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps------~~~v~~  295 (356)
                      .+...+.++.+++.+||+.||.+||+      ++++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            23345567899999999999999998      556654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-42  Score=315.45  Aligned_cols=242  Identities=26%  Similarity=0.297  Sum_probs=189.4

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHH-HHHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEV-GTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~-~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||+||+|.+. +++.||+|++.....  ......+..|. .+++.++||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999765 588999999875321  12223344444 456788999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....++...+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||+++.......  ...
T Consensus        81 ~~L~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~  154 (325)
T cd05602          81 GELFYHLQ-RERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS  154 (325)
T ss_pred             CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence            99999884 35678899999999999999999999   9999999999999999999999999999875432221  123


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||++.+. .++.++|||||||++|+|++|..||......       ..+..         +.... ....
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~---------i~~~~-~~~~  216 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDN---------ILNKP-LQLK  216 (325)
T ss_pred             cccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHH---------HHhCC-cCCC
Confidence            45689999999999876 7899999999999999999999998533211       01111         11111 1122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +..+..+.+++.+||+.||.+||++.+.+.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            345677899999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.9e-42  Score=302.51  Aligned_cols=252  Identities=29%  Similarity=0.483  Sum_probs=202.9

Q ss_pred             hhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..+|++.+.||+|+||.||++.+.++..+|+|.+...  ......+.+|++++++++|||++++++++......++||||
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            4578889999999999999998767889999988754  23345789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.+++|.+++......+++..+..++.|++.+++|||+   .+++|+||||+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            99999999986556678999999999999999999999   99999999999999999999999999998765432211 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                      ......++.+|+|||.+.+. .++.++||||||+++|||++ |..|+......                ...........
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~~~~  219 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----------------EVVETINAGFR  219 (256)
T ss_pred             ccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----------------HHHHHHhCCCC
Confidence            11222356689999998866 68899999999999999998 77776432210                01111111111


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      ...+...+..+.+++.+||+.+|++||+++++++.|
T Consensus       220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            111223457799999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.2e-42  Score=303.44  Aligned_cols=258  Identities=23%  Similarity=0.392  Sum_probs=207.7

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ..|++.+.||+|+||.||++.. .+++.+|||.+...  .......++.+|+.+++.++||||+++++++.+....++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3678899999999999999975 57899999987642  12334467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199          101 EYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       101 e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||+.+++|.+++..   ....+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998743   24568999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ....  .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+........              .......
T Consensus       159 ~~~~--~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~  221 (267)
T cd08229         159 KTTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--------------SLCKKIE  221 (267)
T ss_pred             CCcc--cccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHH--------------HHhhhhh
Confidence            3221  1234588899999999776 688999999999999999999998754322100              0001111


Q ss_pred             hcCCCc-hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          258 ACGIEE-KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       258 ~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      ....+. .....+..+.+++.+||..+|++|||+.+|++.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            111111 22346678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.7e-42  Score=302.87  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=201.8

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe-cCCeeeE
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH-DQHMTAL   98 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~-~~~~~~l   98 (356)
                      .+...+|.+.+.||+|+||.||++.. .|..||+|.+..+   ...+.+.+|+.++++++|+|++++++++. ++...++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           2 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             CccHHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            35567889999999999999999977 4778999998754   23457889999999999999999999764 4567899


Q ss_pred             EEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||||+++++|.+++.... ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            999999999999986543 358999999999999999999999   9999999999999999999999999999875433


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ..     ....++..|+|||++.+. .++.++||||||+++|+|++ |+.|+.....           ..     ....+
T Consensus       155 ~~-----~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------~~-----~~~~~  212 (256)
T cd05082         155 TQ-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------KD-----VVPRV  212 (256)
T ss_pred             cC-----CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------HH-----HHHHH
Confidence            22     122345689999998766 68899999999999999998 8777642211           00     01111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ............+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            11111222334567799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-42  Score=300.88  Aligned_cols=250  Identities=27%  Similarity=0.411  Sum_probs=198.3

Q ss_pred             ccccccCceEEEEEEeC-C---CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-N---GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      ++||+|+||.||+|.+. .   +..+|+|.+.........+.+.+|+.+++.+.|+|++++++++.. ...++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            57999999999999653 2   378999999865444456789999999999999999999998764 457999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee-e
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-I  184 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~  184 (356)
                      ++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.......... .
T Consensus        80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            999999943 3479999999999999999999999   9999999999999999999999999999987644332211 1


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      ....++..|+|||.+.+. .++.++||||||+++|++++ |..|+......                .....+.......
T Consensus       156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~  218 (257)
T cd05060         156 TAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----------------EVIAMLESGERLP  218 (257)
T ss_pred             cCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHH----------------HHHHHHHcCCcCC
Confidence            112235679999998766 68999999999999999998 88887432210                1111111111222


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      .+...+..+.+++.+||..+|++||++.+|++.|+++.
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            33445677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-43  Score=285.64  Aligned_cols=252  Identities=26%  Similarity=0.325  Sum_probs=209.8

Q ss_pred             HHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      .+...++++++.||+|-||.||+|+. +++--||+||+.+..  ......++.+|+++-+.|+||||+++|++|.+....
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            34556788999999999999999975 468889999997542  233346799999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           97 ALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      |+++||..+|+|...+.. ...++++.....+..|++.||.|+|.   ++++||||||+|+|++..+.+|++|||.+...
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            999999999999999954 45679999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ..  .  .....+||.-|.+||...+. ..+...|+|++|++.||++.|.+||...+.                .+....
T Consensus       175 p~--~--kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~----------------~etYkr  233 (281)
T KOG0580|consen  175 PS--N--KRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSH----------------SETYKR  233 (281)
T ss_pred             CC--C--CceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhh----------------HHHHHH
Confidence            31  1  22346799999999999988 789999999999999999999999854331                222222


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      +.... -..+...+....++|.+|+.++|.+|.+..++++.
T Consensus       234 I~k~~-~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  234 IRKVD-LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHcc-ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            22211 12335667788999999999999999999999863

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-43  Score=321.95  Aligned_cols=252  Identities=22%  Similarity=0.259  Sum_probs=197.5

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|++.++||+|+||+||+|+.. +++.||||++....  .......+.+|+.+++.++||||+++++++.++...++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            5788999999999999999764 68999999997531  12334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.+|+|.+++.. ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.++|+|||++.........
T Consensus        82 ~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          82 YLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            9999999999843 4579999999999999999999999   99999999999999999999999999998754321110


Q ss_pred             e------------------------------------eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCC
Q 038199          182 V------------------------------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR  225 (356)
Q Consensus       182 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~  225 (356)
                      .                                    .....+||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCC
Confidence            0                                    00124589999999999876 7899999999999999999999


Q ss_pred             cccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 038199          226 RNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP---MSAVVK  295 (356)
Q Consensus       226 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~v~~  295 (356)
                      .||......       .........      ......+.....+.++.+++.+|+. +|.+|++   ++++++
T Consensus       237 ~Pf~~~~~~-------~~~~~i~~~------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQ-------ETYRKIINW------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHH-------HHHHHHHcC------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            998543221       000000000      0000001111345678889999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-43  Score=322.76  Aligned_cols=253  Identities=22%  Similarity=0.247  Sum_probs=196.2

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|.+.++||+|+||+||++.. .+++.||||++....  .....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            578899999999999999965 468999999986431  12334578899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |++|++|.+++. ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||+++.+......
T Consensus        82 ~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          82 FLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             CCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            999999999884 45678999999999999999999999   99999999999999999999999999998643211000


Q ss_pred             ------------e---------------------------------eeccCCCCCCCCCcccccCCCCCCccccchhhHH
Q 038199          182 ------------V---------------------------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM  216 (356)
Q Consensus       182 ------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGv  216 (356)
                                  .                                 ......||..|+|||++.+. .++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGv  236 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGA  236 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecch
Confidence                        0                                 00124689999999999876 7899999999999


Q ss_pred             HHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCC---CCHHHH
Q 038199          217 VLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDR---PPMSAV  293 (356)
Q Consensus       217 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---ps~~~v  293 (356)
                      ++|||++|..||......       ..+..+....     ..... +.....+.++.+++.+|+. +|.+|   +++.++
T Consensus       237 il~elltG~~Pf~~~~~~-------~~~~~i~~~~-----~~~~~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         237 IMFECLIGWPPFCSENSH-------ETYRKIINWR-----ETLYF-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             hhhhhhcCCCCCCCCCHH-------HHHHHHHccC-----CccCC-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            999999999998543221       0111110000     00000 1111245678889999997 66665   599998


Q ss_pred             HHH
Q 038199          294 VKM  296 (356)
Q Consensus       294 ~~~  296 (356)
                      ++.
T Consensus       303 l~h  305 (377)
T cd05629         303 KSH  305 (377)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-42  Score=315.69  Aligned_cols=244  Identities=24%  Similarity=0.308  Sum_probs=191.3

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||.||+|... +++.||+|++....  .......+..|..++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999764 68899999997532  223345677898888876 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.......  ...
T Consensus        81 ~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (329)
T cd05618          81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS  154 (329)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence            99988873 45679999999999999999999999   9999999999999999999999999999875322211  123


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--cchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--WFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      ...||..|+|||++.+. .++.++|||||||++|||++|..||.........  ......++.         ... ....
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------i~~-~~~~  223 (329)
T cd05618         155 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV---------ILE-KQIR  223 (329)
T ss_pred             cccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH---------Hhc-CCCC
Confidence            35689999999999876 7899999999999999999999998532211100  000111111         111 1112


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCCH
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPPM  290 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~  290 (356)
                      .+...+..+.+++.+||+.||++||++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            333456678899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-42  Score=313.94  Aligned_cols=242  Identities=24%  Similarity=0.312  Sum_probs=194.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      +|++.+.||+|+||.||+|... +++.||||++....  .......+..|..++..+ +|++|+.+++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999765 58899999997542  123334577788888877 5899999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+++|+|.+++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            9999999998884 34578999999999999999999999   9999999999999999999999999999875432211


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                        ......||+.|+|||++.+. .++.++|||||||++|||++|..||......       ...         ..+... 
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~---------~~i~~~-  216 (323)
T cd05616         157 --TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELF---------QSIMEH-  216 (323)
T ss_pred             --ccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHH---------HHHHhC-
Confidence              12335689999999999876 7899999999999999999999998543211       001         111111 


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPM  290 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  290 (356)
                      ....+...+.++.+++.+||+.||++|++.
T Consensus       217 ~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            112233456778999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.4e-42  Score=311.74  Aligned_cols=238  Identities=27%  Similarity=0.328  Sum_probs=188.1

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHH-HHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVG-TIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||+||+|.+. +|+.||||++....  ......++..|.. +++.++||||+++++++.+....++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999764 69999999986431  1122234455544 56789999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||++........  ...
T Consensus        81 g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (323)
T cd05575          81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTS  154 (323)
T ss_pred             CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccc
Confidence            99998884 45678999999999999999999999   9999999999999999999999999999875322211  223


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||++.+. .++.++|||||||++|||++|..||......       ..+..         +.... ....
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~---------i~~~~-~~~~  216 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------EMYDN---------ILNKP-LRLK  216 (323)
T ss_pred             cccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHH-------HHHHH---------HHcCC-CCCC
Confidence            35689999999999876 6899999999999999999999997543210       01111         11111 1222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMS  291 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~  291 (356)
                      +..+..+.+++.+||+.||.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            34467789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.1e-42  Score=313.06  Aligned_cols=242  Identities=27%  Similarity=0.328  Sum_probs=194.5

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||+||+|.+. +++.||||++....  .......+..|..+++.+ +||||+++++++.+....++||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999765 58899999997532  223345677899999887 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.......  ...
T Consensus        81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (318)
T cd05570          81 GDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS  154 (318)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence            99998884 34579999999999999999999999   9999999999999999999999999999875322211  122


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...|+..|+|||++.+. .++.++|||||||++|+|++|+.||......       .....         +... ....+
T Consensus       155 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~---------i~~~-~~~~~  216 (318)
T cd05570         155 TFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQS---------ILED-EVRYP  216 (318)
T ss_pred             ceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHH---------HHcC-CCCCC
Confidence            34689999999999876 7899999999999999999999998543211       01111         1111 11223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPM-----SAVVK  295 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~-----~~v~~  295 (356)
                      ...+..+.+++.+||+.||.+||++     .++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            3456778999999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.8e-42  Score=320.75  Aligned_cols=253  Identities=22%  Similarity=0.266  Sum_probs=195.4

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|++.+.||+|+||+||+|+.. +++.||||++....  .......+.+|+++++.++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            5888999999999999999754 68999999986431  12234568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC-
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~-  180 (356)
                      |+++++|.+++. ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.++|+|||++..+..... 
T Consensus        82 ~~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          82 YIPGGDMMSLLI-RLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            999999999984 34578999999999999999999999   9999999999999999999999999999753311000 


Q ss_pred             ----------------------------------------eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHH
Q 038199          181 ----------------------------------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE  220 (356)
Q Consensus       181 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~e  220 (356)
                                                              ........||+.|+|||++.+. .++.++|||||||++||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye  236 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYE  236 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeee
Confidence                                                    0001134699999999999876 68999999999999999


Q ss_pred             HHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCC---CHHHHHHH
Q 038199          221 IVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRP---PMSAVVKM  296 (356)
Q Consensus       221 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp---s~~~v~~~  296 (356)
                      |++|..||.......       .........      .....+.....+.++.+++.+|+ .+|.+|+   ++.++++.
T Consensus       237 ll~G~~Pf~~~~~~~-------~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAE-------TQLKVINWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHH-------HHHHHhccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999986543210       000000000      00000111234456777777765 5999999   88888874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.9e-42  Score=311.76  Aligned_cols=242  Identities=24%  Similarity=0.320  Sum_probs=192.1

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||+||+|.+. +++.||||++....  .......+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999764 58899999997542  123334567788888764 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........  ...
T Consensus        81 g~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05619          81 GDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC  154 (316)
T ss_pred             CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence            99999884 34578999999999999999999999   9999999999999999999999999999875322211  123


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||++.+. .++.++|||||||++|||++|..||......       .....         +.. ..+..+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~---------i~~-~~~~~~  216 (316)
T cd05619         155 TFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQS---------IRM-DNPCYP  216 (316)
T ss_pred             eecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHH---------HHh-CCCCCC
Confidence            35689999999999876 6899999999999999999999998543211       01111         111 111222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMS-AVVK  295 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~-~v~~  295 (356)
                      ...+.++.+++.+||+.||++||++. ++.+
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            33556788999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.6e-42  Score=300.47  Aligned_cols=249  Identities=28%  Similarity=0.427  Sum_probs=200.0

Q ss_pred             ccccccCceEEEEEEeCC--C--cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFPN--G--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      ++||+|++|.||+|.+.+  +  ..||||.+.........+.+.+|+.++++++||||+++++.+.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            479999999999997532  3  36999999876443556789999999999999999999999988 888999999999


Q ss_pred             CChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee-
Q 038199          106 GSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-  183 (356)
Q Consensus       106 ~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-  183 (356)
                      ++|.+.+.... ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........... 
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999986544 578999999999999999999999   9999999999999999999999999999987654332211 


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                      .....++..|+|||.+.+. .++.++||||||+++|||++ |..|+......       .......        ......
T Consensus       157 ~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~--------~~~~~~  220 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKID--------KEGERL  220 (257)
T ss_pred             ccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHH--------hcCCcC
Confidence            1234577899999998866 68999999999999999998 88887432211       0011110        011112


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            223345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=313.14  Aligned_cols=256  Identities=21%  Similarity=0.217  Sum_probs=197.9

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|++.+.||+|+||+||++... +++.||+|++...  ........+.+|..++..++|+||+.+++++.++...++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            6889999999999999999764 5899999998642  122334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.|++|.+++......+++..+..++.||+.||+|||+   ++++||||||+|||++.++.++|+|||++.........
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            999999999996556789999999999999999999999   99999999999999999999999999998765433221


Q ss_pred             eeeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          182 VTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                       ......||+.|+|||++.+    ...++.++|||||||++|+|++|+.||......       ..+.......     .
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~-----~  225 (331)
T cd05597         159 -QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHK-----E  225 (331)
T ss_pred             -cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCC-----C
Confidence             1122458999999999863    225788999999999999999999998543211       0011110000     0


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCC--CCCCCHHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSP--EDRPPMSAVVKM  296 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p--~~Rps~~~v~~~  296 (356)
                      ....+......+..+.+++.+|+..++  ..||+++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         226 HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            011122223356678888888775433  347899998875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.2e-42  Score=318.76  Aligned_cols=257  Identities=24%  Similarity=0.261  Sum_probs=201.5

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ..+....|++.++||+|+||.||++++. +++.||+|++....  .......+.+|+.+++.++||||+++++++.++..
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3445678999999999999999999765 58899999986421  22334567889999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++|+|.+++.  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus       118 ~~lv~Ey~~gg~L~~~l~--~~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            999999999999999984  3468999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCC---CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNY---PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ..... .......||..|+|||++.+..   .++.++|||||||++|||++|..||......       ..+..      
T Consensus       193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~~~------  258 (370)
T cd05621         193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTYSK------  258 (370)
T ss_pred             ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHHHH------
Confidence            43222 1223456999999999986542   3788999999999999999999998543221       00111      


Q ss_pred             hHHHHhc--CCCchhHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038199          253 DATILAC--GIEEKDKEKAKRLCMAALWCVQDSPED--RPPMSAVVKM  296 (356)
Q Consensus       253 ~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~  296 (356)
                        .....  ...+.....+..+.+++.+|+..++.+  |++++++++.
T Consensus       259 --i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         259 --IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              11100  001122234667888899999765544  8899999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.1e-42  Score=302.42  Aligned_cols=254  Identities=25%  Similarity=0.330  Sum_probs=192.6

Q ss_pred             ccccccCceEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCC
Q 038199           30 TRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +.||+|+||.||+|.+.   ++..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46999999999999653   356799998876544445567889999999999999999999999998999999999999


Q ss_pred             ChhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          107 SLDGYLFGK----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       107 sL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +|.+++...    ....++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            999998542    2346778888999999999999999   999999999999999999999999999987544332222


Q ss_pred             eeccCCCCCCCCCcccccCCC------CCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          183 TISGYKGTPGYSAPEFLSGNY------PITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~------~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ......++..|+|||++.+..      .++.++|+||||+++|||++ |..||.......       .......    ..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~----~~  226 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-------VLTYTVR----EQ  226 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHhh----cc
Confidence            222345778899999986421      35789999999999999996 888874432210       0000000    00


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ......+......+..+.+++.+|+ .+|++|||+++|+..|+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0000111112234556788999998 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.3e-42  Score=309.07  Aligned_cols=261  Identities=27%  Similarity=0.406  Sum_probs=205.5

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ...+|+..+.||+|+||.||+|.+. +|.    .+|+|++...........+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            3456778899999999999999753 444    57899887654444455789999999999999999999998765 46


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++|+||+.+|+|.+++......+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccccc
Confidence            78999999999999986666679999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ............++..|+|||.+.+. .++.++||||||+++|||++ |..|+......                .....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~----------------~~~~~  223 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR----------------EIPDL  223 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHH
Confidence            43332222334457789999998766 68999999999999999997 77776432110                00111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      .............+..+..++.+||..+|++||+++++++.|..+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         224 LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            111111222233456789999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6e-42  Score=306.17  Aligned_cols=261  Identities=24%  Similarity=0.363  Sum_probs=191.9

Q ss_pred             hccccccccccCceEEEEEEe-C-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccC---CCCceeeeeceEe-----cC
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-P-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRT---YHINLVRLYGFCH-----DQ   93 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~ni~~~~~~~~-----~~   93 (356)
                      +|++.+.||+|+||+||+|++ . +++.||+|++..... ......+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            688999999999999999975 3 478899999865322 22224556677776665   6999999999885     34


Q ss_pred             CeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           94 HMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ...++||||+. ++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56889999996 5898888543 3568999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhh-------HH
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHV-------WE  245 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~-------~~  245 (356)
                      +......   ......|+..|+|||.+.+. .++.++|||||||++|||++|..||........  +....       .+
T Consensus       158 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~~~i~~~~~~~~~~  231 (290)
T cd07862         158 RIYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGEE  231 (290)
T ss_pred             EeccCCc---ccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChh
Confidence            7654331   22334689999999999766 689999999999999999999988865432110  00000       00


Q ss_pred             HHhhc-hhhHHHHh-cC---CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          246 EYEKS-ELDATILA-CG---IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       246 ~~~~~-~~~~~~~~-~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+... ........ ..   .....+..+..+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000 00000000 00   00011234566789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=319.61  Aligned_cols=264  Identities=26%  Similarity=0.406  Sum_probs=227.6

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      .-|+++.-+++...+||.|-||.||.|.|+. .-.||||.++.+  ....++|..|+.+|+.++|||+|+++|+|..+-.
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            5689999999999999999999999998865 778999999876  4556789999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           96 TALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      +|||.|||..|+|.+|+..++ ..++....++++.||+.|++||..   +++|||||...|+|+.++..||++||||++.
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            999999999999999997665 457888999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      +...... ...+..-...|.|||.+.-+ .++.|+|||+|||+|||+.|-...               ++..++...+..
T Consensus       415 MtgDTYT-AHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMs---------------PYPGidlSqVY~  477 (1157)
T KOG4278|consen  415 MTGDTYT-AHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYG  477 (1157)
T ss_pred             hcCCcee-cccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCC---------------CCCCccHHHHHH
Confidence            7654333 22334456689999998766 799999999999999999984322               233344555556


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .+..+.+.+.+..++..+++|++.||+.+|.+||++.++.+.++.+..
T Consensus       478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            666677778888999999999999999999999999999999887653

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-42  Score=299.35  Aligned_cols=268  Identities=23%  Similarity=0.285  Sum_probs=202.2

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCc-eeeeeceEecCC-----
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQH-----   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-i~~~~~~~~~~~-----   94 (356)
                      ...|+..++||+|+||+||+|+. .+|+.||+|++.-... +..-....+|+.+++.++|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45567778899999999999975 4699999999976533 233345789999999999999 999999998877     


Q ss_pred             -eeeEEEeccCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           95 -MTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        95 -~~~lV~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                       .+++|+||++. +|..++....   ..++...+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence             78899999965 9999997655   468889999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cchh---h
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WFPK---H  242 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~~~---~  242 (356)
                      +++.+.-+..  ..+..++|.+|.|||++.+...|+...||||+||++.||++++..|...+....-     .+..   .
T Consensus       166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            9997653322  2344568999999999998878999999999999999999977655443331100     0000   0


Q ss_pred             hHHHHhhchhhHHHHhcC--CCch---hHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          243 VWEEYEKSELDATILACG--IEEK---DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .|+...............  ....   .+....+..+++.+||+.+|.+|.|++..++.
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            011111000000000000  0011   11122478899999999999999999999874

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.5e-42  Score=320.45  Aligned_cols=250  Identities=23%  Similarity=0.274  Sum_probs=193.7

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|++.++||+|+||+||+|.. .+++.||+|++....  .......+.+|+.++++++||||+++++.+.++...++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            478889999999999999975 468999999987531  12334578899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC-
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~-  180 (356)
                      |+++|+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.++|+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            9999999998843 4578999999999999999999999   9999999999999999999999999999753311000 


Q ss_pred             --------------------------------------------eeeeccCCCCCCCCCcccccCCCCCCccccchhhHH
Q 038199          181 --------------------------------------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM  216 (356)
Q Consensus       181 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGv  216 (356)
                                                                  ........||..|+|||++.+. .++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGv  236 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGV  236 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechH
Confidence                                                        0001124689999999999876 7899999999999


Q ss_pred             HHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH--hcCCCchhHHHHHHHHHHHHhcccCCCCCCCC---HH
Q 038199          217 VLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL--ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP---MS  291 (356)
Q Consensus       217 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~  291 (356)
                      ++|||++|..||......          +..     .....  .....+.....+.+..+++.+++ .+|.+|++   ++
T Consensus       237 il~elltG~~Pf~~~~~~----------~~~-----~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPL----------ETQ-----MKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             HHHHHHhCCCCCCCCCHH----------HHH-----HHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            999999999998643221          000     00000  00011111234556777777765 59999997   77


Q ss_pred             HHHH
Q 038199          292 AVVK  295 (356)
Q Consensus       292 ~v~~  295 (356)
                      ++++
T Consensus       301 ei~~  304 (382)
T cd05625         301 EIKA  304 (382)
T ss_pred             HHhc
Confidence            7765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-41  Score=302.27  Aligned_cols=251  Identities=25%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      +|++.++||+|+||.||+|.+ .+++.||+|++..+........+.+|++++++++||||+++++.+......++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577889999999999999965 4689999999876544445567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      ++++|..+.     .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......    
T Consensus        82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----  149 (279)
T cd06619          82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----  149 (279)
T ss_pred             CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence            999997543     57888999999999999999999   999999999999999999999999999997654321    


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+....................        .......
T Consensus       150 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~  220 (279)
T cd06619         150 AKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV--------DEDPPVL  220 (279)
T ss_pred             ccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh--------ccCCCCC
Confidence            2235689999999999876 689999999999999999999999854322111100000000000        0000111


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .....+.++.+++.+||+.+|++||+++++++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            122345678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=299.64  Aligned_cols=253  Identities=23%  Similarity=0.286  Sum_probs=202.6

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc----hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG----RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ..|++.+.||+|++|.||.+.. .+++.||+|++.....    ......+.+|++++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            3588899999999999999975 4689999999864321    1223568899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      |+||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLK-AYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999884 34568999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          179 RSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       179 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ..... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.|+......          ..     ......
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------~~-----~~~~~~  221 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----------AA-----IFKIAT  221 (263)
T ss_pred             ccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchH----------HH-----HHHHhc
Confidence            21111 1234578899999999876 6899999999999999999999887432210          00     011111


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .......+...+..+.+++.+||..+|.+||++.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            112223344566788999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-41  Score=310.09  Aligned_cols=256  Identities=21%  Similarity=0.227  Sum_probs=198.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|++.++||+|+||+||+++.. +++.||+|++...  ........+..|..++..++|+||+.+++++.+.+..++|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            6889999999999999999764 5889999998642  122333568889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.||+|.+++......+++..+..++.|++.||+|||+   ++|+||||||+||+++.++.+||+|||++.........
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            999999999996656789999999999999999999999   99999999999999999999999999999765433221


Q ss_pred             eeeccCCCCCCCCCcccccCC----CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          182 VTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                       ......||..|+|||++.+.    ..++.++|||||||++|||++|+.||......       ..+.......     .
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~-----~  225 (331)
T cd05624         159 -QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHE-----E  225 (331)
T ss_pred             -eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCC-----C
Confidence             12235689999999988642    25788999999999999999999998543210       0111110000     0


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPED--RPPMSAVVKM  296 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~  296 (356)
                      ....+......+.++.+++.+|+..++.+  |++++++++.
T Consensus       226 ~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         226 RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            00112222334667888999998866544  4578877753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.2e-42  Score=335.90  Aligned_cols=262  Identities=22%  Similarity=0.341  Sum_probs=204.3

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .+|++.++||+|+||.||+|.+. +|+.||||++..+..  ....+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999764 589999999975432  334467999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199          101 EYMENGSLDGYLFGK----------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus       101 e~~~~~sL~~~l~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      ||++|++|.+++...          ...+++..++.++.||+.||+|||+   .+++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988531          2346678889999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCe----------------eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCC
Q 038199          171 LAKLCDRNRSH----------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE  234 (356)
Q Consensus       171 l~~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~  234 (356)
                      ++.........                .......||+.|+|||.+.+. .++.++|||||||++|||+||..||......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            99865211100                001124689999999999876 6899999999999999999999998542211


Q ss_pred             ccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhccccC
Q 038199          235 SLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRP-PMSAVVKMLEGVVEV  303 (356)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~v~~~L~~~~~~  303 (356)
                      ..      ....        ..............+..+.+++.+|+..||++|| +++++.+.|+.....
T Consensus       238 ki------~~~~--------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        238 KI------SYRD--------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh------hhhh--------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00      0000        0000000011124456788999999999999996 677788878776543

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1e-41  Score=301.32  Aligned_cols=249  Identities=27%  Similarity=0.435  Sum_probs=197.9

Q ss_pred             ccccccCceEEEEEEeCC-------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           30 TRLGFGGFGEVYKGQFPN-------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +.||+|+||.||+|+..+       ++.+|||.+...........+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999997532       2679999887654344566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-----ceEEcccCC
Q 038199          103 MENGSLDGYLFGK------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-----SPKVADFGL  171 (356)
Q Consensus       103 ~~~~sL~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-----~~kl~Dfgl  171 (356)
                      +++++|.+++...      ...+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998542      2347899999999999999999999   9999999999999998877     899999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhc
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      +................++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....                .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----------------~  220 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNN----------------Q  220 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCH----------------H
Confidence            8765433222222223456789999999876 68999999999999999998 8877642211                0


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      .....+............+..+.+++.+||..+|++||++++|++.|.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         221 EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            011111112222333456678999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3e-42  Score=318.09  Aligned_cols=263  Identities=22%  Similarity=0.255  Sum_probs=203.8

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      +....+....|++.+.||+|+||.||++.+. +++.||+|++....  .......+.+|..+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445666789999999999999999999765 68999999986421  22333567889999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ....++||||++|++|.+++.  ...++...+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999999884  3468999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCC---CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNY---PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      ......... ......||+.|+|||++.+..   .++.++|||||||++|||++|..||......       ..+..+..
T Consensus       190 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~  261 (371)
T cd05622         190 MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMN  261 (371)
T ss_pred             eEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------HHHHHHHc
Confidence            866432211 123456999999999987532   3788999999999999999999998543221       01111110


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHH
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPED--RPPMSAVVKML  297 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~L  297 (356)
                      ..      .....+.....+..+.+++.+|+..++.+  |++++++++..
T Consensus       262 ~~------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         262 HK------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CC------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            00      00001122345677889999999844433  77888888753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=301.08  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=195.1

Q ss_pred             ccccccCceEEEEEEeC-CCc--EEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGV--KIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||.||+|.+. ++.  .+|+|.+.........+.+.+|+++++++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            46999999999999764 343  57888887543344556789999999999 799999999999999999999999999


Q ss_pred             CChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199          106 GSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus       106 ~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      ++|.+++....               ..+++.++..++.|++.||+|||+   .+++||||||+||++++++.++|+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999985321               247899999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhh
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      ++........   ......+..|+|||++.+. .++.++||||||+++|||++ |..||......               
T Consensus       158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---------------  218 (270)
T cd05047         158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------------  218 (270)
T ss_pred             Cccccchhhh---ccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHH---------------
Confidence            9863221111   1112235679999998766 68999999999999999997 88887432110               


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                       ..................+.++.+++.+||+.+|.+||++.+++..|..+.
T Consensus       219 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         219 -ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence             011111111112223345567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.2e-42  Score=310.37  Aligned_cols=245  Identities=24%  Similarity=0.286  Sum_probs=192.7

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||+||+|... +++.||+|++....  .....+.+..|..++.++ +||||+.+++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999764 68899999997542  123345688899999888 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....+++..+..++.||+.||+|||+   ++++||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (327)
T cd05617          81 GDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS  154 (327)
T ss_pred             CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence            99998874 34579999999999999999999999   9999999999999999999999999999875322211  123


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||++.+. .++.++|||||||++|||++|..||...............+.         ..... ....+
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~-~~~~p  223 (327)
T cd05617         155 TFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ---------VILEK-PIRIP  223 (327)
T ss_pred             cccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH---------HHHhC-CCCCC
Confidence            35689999999999876 789999999999999999999999854322111100011111         11111 11223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMS  291 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~  291 (356)
                      ...+..+.+++.+||+.||++|+++.
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            34556788999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.3e-42  Score=308.84  Aligned_cols=267  Identities=22%  Similarity=0.270  Sum_probs=202.4

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+|.+.++||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++.+....++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            356889999999999999999764 6889999998754333444567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.+ +|..++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        85 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          85 YLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            9974 8988886666779999999999999999999999   99999999999999999999999999998764332211


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----c---chhhhHHHHhhc-hh
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----W---FPKHVWEEYEKS-EL  252 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~---~~~~~~~~~~~~-~~  252 (356)
                        .....++..|+|||.+.+...++.++||||||+++|+|++|+.||.........     .   .....|..+... ..
T Consensus       161 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         161 --YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             --ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence              122346889999999876556889999999999999999999888544321100     0   000001110000 00


Q ss_pred             hHHHHhcCC----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 DATILACGI----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 ~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .........    .......+..+.+++.+||+.||.+|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000    0011234567889999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.3e-42  Score=301.94  Aligned_cols=256  Identities=23%  Similarity=0.298  Sum_probs=201.2

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++.+......++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            45789999999999999999975 468999999987542 2334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.+++|.+++. ....+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++........ 
T Consensus        87 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          87 YCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            999999999884 34578999999999999999999999   9999999999999999999999999999986543221 


Q ss_pred             eeeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          182 VTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                       ......|+..|+|||.+.+  ...++.++|+|||||++|||++|+.|+.........       ..+....     ...
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-------~~~~~~~-----~~~  228 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLMSKSN-----FQP  228 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-------eeeecCC-----CCC
Confidence             1123457889999998742  225788999999999999999999887433211000       0000000     000


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      .........+..+.+++.+||+.+|++||++++|++.|
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            01111223456789999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-41  Score=319.60  Aligned_cols=263  Identities=21%  Similarity=0.251  Sum_probs=198.7

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ....|.+.++||+|+||.||++.+. .++.||||....       ..+.+|++++++++|+||+++++++..+...++||
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            4557889999999999999999765 488999996432       23568999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |++. ++|..++......+++.+++.|+.|++.||.|||+   .+|+||||||+|||++.++.++|+|||+++.......
T Consensus       240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            9995 58888886556689999999999999999999999   9999999999999999999999999999986543322


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc-ccchhhhHHHHhhchh-------
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL-DWFPKHVWEEYEKSEL-------  252 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~-------  252 (356)
                      ........||..|+|||++.+. .++.++|||||||++|||++|..++........ .-+.......+.....       
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            2222345699999999999876 689999999999999999998876544332111 0011111111110000       


Q ss_pred             ------hHHHH----hcCCC-------chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          253 ------DATIL----ACGIE-------EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       253 ------~~~~~----~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                            .....    .....       ........++.+++.+||+.||.+|||+.|+++.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                  00000    00000       0001223468899999999999999999999973

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.5e-42  Score=301.89  Aligned_cols=254  Identities=24%  Similarity=0.335  Sum_probs=189.7

Q ss_pred             ccccccCceEEEEEEeCC---CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCC
Q 038199           30 TRLGFGGFGEVYKGQFPN---GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +.||+|+||+||+|...+   ...+|+|.+...........+.+|+.+++.++|+||+++++.+.+....++||||+.++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            469999999999996433   45788888765444445567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          107 SLDGYLFGKK----RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       107 sL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +|.+++....    ...++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999985432    235678899999999999999999   999999999999999999999999999987543322211


Q ss_pred             eeccCCCCCCCCCcccccC------CCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          183 TISGYKGTPGYSAPEFLSG------NYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~------~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ......++..|+|||++..      ...++.++|||||||++|||++ |..|+......      ..........     
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-----  226 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-----  226 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-----
Confidence            1222345678999998742      1256889999999999999999 56665332110      0000000000     


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ......+..+...+..+.+++..|+ .||++||++++|++.|.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0001112223345666778888888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-41  Score=298.38  Aligned_cols=241  Identities=22%  Similarity=0.311  Sum_probs=188.4

Q ss_pred             ccccccCceEEEEEEeCC-------------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           30 TRLGFGGFGEVYKGQFPN-------------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      +.||+|+||.||+|....             ...+|+|++.... ......+..|+.+++.++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            479999999999997422             2358999876542 23345788899999999999999999999999899


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc-------eEEccc
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-------PKVADF  169 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~-------~kl~Df  169 (356)
                      ++||||+++++|..++......+++..+..++.||+.||+|||+   ++++||||||+||+++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            99999999999999886666779999999999999999999999   99999999999999987664       899999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHh
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYE  248 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  248 (356)
                      |++......      ....++..|+|||.+.+...++.++|||||||++|||++ |..|+.......             
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------------  217 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------------  217 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------------
Confidence            998654321      123478899999988744468999999999999999984 666653221100             


Q ss_pred             hchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                         ..... ... .......+.++.+++.+||+.||.+||++.+|++.|+
T Consensus       218 ---~~~~~-~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         218 ---KERFY-EGQ-CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ---HHHHH-hcC-ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence               00000 000 0111122456889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.8e-42  Score=310.38  Aligned_cols=242  Identities=24%  Similarity=0.310  Sum_probs=193.9

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      +|++.+.||+|+||+||+|... +|+.||+|++....  .....+.+..|..+++.+. |++|+.+++++.+....++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788899999999999999754 68999999997542  1233456788999998885 678889999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||++|++|.+++. ....+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQ-QVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            9999999999883 44679999999999999999999999   9999999999999999999999999999875432211


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                        ......||..|+|||++.+. .++.++|||||||++|||++|..||......       ....         .+....
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~---------~i~~~~  217 (323)
T cd05615         157 --TTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQ---------SIMEHN  217 (323)
T ss_pred             --cccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHH---------HHHhCC
Confidence              12335689999999999876 6899999999999999999999998543211       0111         111111


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPM  290 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  290 (356)
                       ...+...+.++.+++.+||+.+|.+|++.
T Consensus       218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             12233456678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.3e-42  Score=309.85  Aligned_cols=241  Identities=25%  Similarity=0.304  Sum_probs=189.2

Q ss_pred             ccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHH-HHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVG-TIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||+||+|.. .+|+.||+|++....  .......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4799999999999975 468999999986532  1223344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....+++..+..++.||+.||.|||+   .+++||||||+|||++.++.++|+|||+++.......  ...
T Consensus        81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (325)
T cd05604          81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT  154 (325)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence            99988873 45679999999999999999999999   9999999999999999999999999999875322211  123


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||++.+. .++.++|||||||++|||++|..||......       ..+...         .... ....
T Consensus       155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~---------~~~~-~~~~  216 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNI---------LHKP-LVLR  216 (325)
T ss_pred             cccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHH---------HcCC-ccCC
Confidence            35689999999999876 6899999999999999999999998543211       011111         1111 1112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMSAVV  294 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~  294 (356)
                      +..+..+.+++.+|++.||.+||++.+.+
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            23556788999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-41  Score=299.59  Aligned_cols=252  Identities=23%  Similarity=0.315  Sum_probs=202.0

Q ss_pred             hccccccccccCceEEEEEEeCCCcEEEEEEeccccc-----hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-----RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +|+..+.||+|+||+||+|...+++.+|+|.+.....     ......+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999877899999998864321     22335688999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      +||+++++|.+++. ....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILN-RFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999984 34578999999999999999999999   999999999999999999999999999987653211


Q ss_pred             C----eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          180 S----HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       180 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      .    ........|+..|+|||.+.+. .++.++||||||+++|+|++|..||......          ......    .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------~~~~~~----~  221 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRL----------AAMFYI----G  221 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChH----------HHHHHh----h
Confidence            1    1112234588999999999876 6889999999999999999999988532210          000000    0


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ......+..+...+.++.+++.+||+.+|++||++.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         222 AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0001122334456677899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-41  Score=315.29  Aligned_cols=265  Identities=22%  Similarity=0.316  Sum_probs=198.5

Q ss_pred             ccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC-----eeeE
Q 038199           26 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----MTAL   98 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-----~~~l   98 (356)
                      |.+.++||+|+||+||++.. .+|+.||||++.... ......++.+|+.+++.++|+||+++++++....     ..++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            67789999999999999975 469999999986532 2234467889999999999999999999998766     7899


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||+. ++|.+.+. ....+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        82 v~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          82 VTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             Eeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            999996 47877773 45679999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cchhhhHHHHhh--ch
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WFPKHVWEEYEK--SE  251 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~--~~  251 (356)
                      ... ......++..|+|||.+.+...++.++|||||||++|||++|+.||.........     .+.....+.+..  ..
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         157 ESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             ccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            221 1233457889999999987646789999999999999999999998543321100     000000000000  00


Q ss_pred             hhHHHHhcCC-Cc-------hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          252 LDATILACGI-EE-------KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       252 ~~~~~~~~~~-~~-------~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ....+..... ..       .....+.++.+++.+||+.||++|||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0111111110 00       111235678899999999999999999999873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-41  Score=302.54  Aligned_cols=266  Identities=25%  Similarity=0.317  Sum_probs=208.0

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +...+|++.++||+|+||+||++... +++.||+|++...........+.+|+++++.++||||+++++.+.+....++|
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            45678999999999999999999754 68999999987654445567899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+++++|.+++. ..+.+++..+..++.|++.+|.|||+  ..+++||||+|+||+++.++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          82 MEFMDCGSLDRIYK-KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             EecCCCCCHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            99999999998884 34578999999999999999999996  2589999999999999999999999999986543221


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      .    ....|+..|+|||++.+. .++.++|+|||||++|+|++|..||..........   ....... ..........
T Consensus       159 ~----~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~  229 (284)
T cd06620         159 A----DTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ---DDPMGIL-DLLQQIVQEP  229 (284)
T ss_pred             c----CccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh---hhhhHHH-HHHHHHhhcc
Confidence            1    234689999999998766 78899999999999999999999986543321100   0000000 0011111111


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      .........+.++.+++.+|++.||++||+++++++...
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            111111235677999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.2e-41  Score=295.17  Aligned_cols=251  Identities=23%  Similarity=0.306  Sum_probs=205.7

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|++.+.||.|+||.||.++. .+++.+++|.+... ........+.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478899999999999999965 46899999988643 2345556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          103 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       103 ~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      +++++|.+++... ...+++.++..++.|++.+|.|||+   .+++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999998654 4568999999999999999999999   9999999999999999999999999999876643332 


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                       ......|+..|+|||.+.+. .++.++||||||+++|+|++|..|+......                ........+..
T Consensus       157 -~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~~~~~  218 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPL----------------NLVVKIVQGNY  218 (256)
T ss_pred             -cccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHcCCC
Confidence             22335689999999998876 5788999999999999999999887432210                11111112222


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      .......+.++.+++.+||+.+|++||+++++++.+
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            333345667899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.6e-41  Score=303.00  Aligned_cols=249  Identities=20%  Similarity=0.289  Sum_probs=201.6

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++|+|++++++.+......++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            5888899999999999999975 4689999999875432 3346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++.  ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......... 
T Consensus        99 ~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-  172 (296)
T cd06654          99 LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (296)
T ss_pred             cCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence            99999999883  3468999999999999999999999   99999999999999999999999999998764332211 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                       .....|+..|+|||.+.+. .++.++|||||||++|+|++|+.||.......      ...... .       ......
T Consensus       173 -~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~-~-------~~~~~~  236 (296)
T cd06654         173 -RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIA-T-------NGTPEL  236 (296)
T ss_pred             -cCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHh-c-------CCCCCC
Confidence             1224588899999998866 67899999999999999999999985432210      000000 0       000011


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+...+..+.+++.+||..+|++||++++|++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            123345677899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=319.42  Aligned_cols=256  Identities=27%  Similarity=0.387  Sum_probs=217.3

Q ss_pred             HhhhhccccccccccCceEEEEEEeC--CCc--EEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP--NGV--KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      |-+...++.++||+|+||.|++|.|.  +|+  .||||.+..+.-....+.|.+|+.+|.+|+|+|++++||+..+ ...
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence            34556677899999999999999874  354  5899999877655577899999999999999999999999988 667


Q ss_pred             eEEEeccCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           97 ALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .+|+|++..|||.+.|.. ....|.......++.||+.|+.||.+   +++|||||...|+++...-.|||+||||.+.+
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceecc
Confidence            899999999999999966 35678999999999999999999999   99999999999999999999999999999988


Q ss_pred             CCCCCeeeecc-CCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhC-CcccccCCCCccccchhhhHHHHhhchhh
Q 038199          176 DRNRSHVTISG-YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR-RRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       176 ~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ........+.. ..-...|+|||.++.. .++.++|||+|||++|||+|+ ..||                .......+.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW----------------~G~~g~qIL  325 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPW----------------VGCRGIQIL  325 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCC----------------CCCCHHHHH
Confidence            77666555443 3356689999999877 899999999999999999994 3454                333444555


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      ..++.+.+...++.+++++++++..||..+|++||++..|.+.+
T Consensus       326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            55556666677888999999999999999999999999998543

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-41  Score=297.08  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=205.1

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...|++.++||+|+||.||+|... +++.||+|.+...   ...+++.+|++++++++||||+++++++.+....++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE---EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH---HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            357889999999999999999875 4889999998764   226789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.+++|.+++......+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.........
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            999999999996667789999999999999999999999   99999999999999999999999999998876543321


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                        .....++..|+|||.+.+. .++.++||||||+++|+|++|..|+........       ......       .....
T Consensus       156 --~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~~~~~-------~~~~~  218 (256)
T cd06612         156 --RNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IFMIPN-------KPPPT  218 (256)
T ss_pred             --cccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hhhhcc-------CCCCC
Confidence              1224478899999998876 689999999999999999999988754322100       000000       00011


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...+...+.++.+++.+||+.||++||++++|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            1223345677999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-41  Score=313.31  Aligned_cols=195  Identities=25%  Similarity=0.356  Sum_probs=167.2

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +....|.+.+.||+|+||.||+|... +++.||+|+....       ....|+.++++++||||+++++++.+....++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            34567999999999999999999764 5789999975432       234689999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      ||++. ++|.+++......+++..+..|+.||+.||.|||+   .+|+||||||+||+++.++.++|+|||+++......
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            99995 58888886667789999999999999999999999   999999999999999999999999999987533221


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCccccc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIV  230 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~  230 (356)
                         ......||..|+|||++.+. .++.++|||||||++|||+++..++..
T Consensus       212 ---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~  258 (357)
T PHA03209        212 ---AFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFE  258 (357)
T ss_pred             ---ccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCcccc
Confidence               12234689999999999876 689999999999999999997766543

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.8e-41  Score=296.30  Aligned_cols=251  Identities=31%  Similarity=0.485  Sum_probs=202.8

Q ss_pred             ccccccccccCceEEEEEEeCC-C----cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPN-G----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      +++.+.||.|+||.||++.+.. +    ..||+|++...........+..|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3578899999999999997643 3    8899999976644445678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          101 EYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |++++++|.+++...... +++.++..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998554434 9999999999999999999999   999999999999999999999999999998765442


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .... ....++..|+|||.+.+. .++.++|+||||+++++|++ |..|+.....                .........
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----------------~~~~~~~~~  219 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----------------EEVLEYLKK  219 (258)
T ss_pred             cccc-ccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHhc
Confidence            2211 123367899999998655 68999999999999999998 5666532111                111111222


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      ..........+.++.+++.+|+..+|++|||+.++++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      220 GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            222333444677899999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.6e-42  Score=317.54  Aligned_cols=267  Identities=21%  Similarity=0.236  Sum_probs=202.8

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      ...+...+|.+.++||+|+||.||++...   .++.||+|.+...      ....+|++++++++||||+++++++....
T Consensus        86 ~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         86 PASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             cchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            34455678999999999999999999642   3678999988653      23467999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++|||++. ++|..++ .....+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.++|+|||++..
T Consensus       160 ~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            9999999995 5888888 445689999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh------
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE------  248 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  248 (356)
                      ..............||..|+|||++.+. .++.++|||||||++|||++|+.||....................      
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            6544333333346799999999999876 689999999999999999999999865443221000000000000      


Q ss_pred             -h---chhhHHH---HhcCCC-----ch--hHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          249 -K---SELDATI---LACGIE-----EK--DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       249 -~---~~~~~~~---~~~~~~-----~~--~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                       .   .......   .....+     ..  ....+.++.+++.+||..||++||++.+++..
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0   0000000   000000     00  01234568889999999999999999999974

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=299.12  Aligned_cols=247  Identities=24%  Similarity=0.304  Sum_probs=203.6

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      +|++.+.||.|+||.||+|... +++.||+|++...........+.+|+.+++.++|+|++++++++.+....++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            6788999999999999999764 689999999876544445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      .+++|.+++..  ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||+++.......  .
T Consensus        82 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~  154 (274)
T cd06609          82 GGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--K  154 (274)
T ss_pred             CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--c
Confidence            99999999843  388999999999999999999999   9999999999999999999999999999987654321  2


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      .....++..|+|||.+.+. .++.++||||||+++|+|++|..|+......                ...........+.
T Consensus       155 ~~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----------------~~~~~~~~~~~~~  217 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPM----------------RVLFLIPKNNPPS  217 (274)
T ss_pred             cccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchH----------------HHHHHhhhcCCCC
Confidence            2334578899999999876 5899999999999999999999987533210                0001111111122


Q ss_pred             hhHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          264 KDKE-KAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       264 ~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .... .+.++.+++.+||..+|++||+++++++
T Consensus       218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            2222 5677999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-41  Score=308.41  Aligned_cols=256  Identities=19%  Similarity=0.207  Sum_probs=198.2

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|++.++||+|+||+||++... +++.||+|++....  .......+..|..++..++|+||+++++++.+....++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            6888999999999999999765 58889999986421  12233458889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.+|+|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            999999999996656789999999999999999999999   99999999999999999999999999998754332221


Q ss_pred             eeeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          182 VTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                       ......||..|+|||++.+    ...++.++|||||||++|||++|+.||......       ..........     .
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~-----~  225 (332)
T cd05623         159 -QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHK-----E  225 (332)
T ss_pred             -eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCC-----c
Confidence             1223569999999999862    235788999999999999999999998543211       0111110000     0


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPED--RPPMSAVVKM  296 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~  296 (356)
                      ....+......+.++.+++.+|+..++++  |++++++++.
T Consensus       226 ~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            00112222345677888899988654444  6889988875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-41  Score=299.24  Aligned_cols=254  Identities=32%  Similarity=0.498  Sum_probs=199.0

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhH-HHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      |++.+.||+|+||+||++... +++.||+|++......... ....+|+.++++++||||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            678999999999999999765 5779999999865322222 23456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      .+++|.+++. ....+++..+..++.|++.||.+||+   .+++|+||||+||+++.++.++|+|||.+.....  ....
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNEN  154 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSE
T ss_pred             cccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cccc
Confidence            9999999995 46788999999999999999999999   9999999999999999999999999999976421  1223


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      .....++..|+|||.+.....++.++||||||+++++|++|..|+......       ...................   
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~---  224 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-------DQLEIIEKILKRPLPSSSQ---  224 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-------HHHHHHHHHHHTHHHHHTT---
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccch-------hhhhhhhhccccccccccc---
Confidence            344668999999999983337899999999999999999999887543110       0000111100000111100   


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........+.+++.+||+.||++||++.++++
T Consensus       225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01111267999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-42  Score=305.79  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=216.9

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ...-|.+.+-||+|-|+.|-+|++ -+|+.||||++.+. .......++.+|++.|+.++|||||++|.+......+|+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            456788999999999999999964 58999999999753 3456667899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE-cCCCceEEcccCCccccCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL-DANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill-~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      .|+-++|+|.+|+-+....+++..+.+++.||+.|+.|+|.   ..+|||||||+||.+ ..-|-|||.|||++..+..+
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999999998888999999999999999999999999   999999999999988 45689999999999877655


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      ..   ....+|+..|-|||++.|.....++.|||||||+||.|++|+.||....                ..+...++++
T Consensus       173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLTmImD  233 (864)
T KOG4717|consen  173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLTMIMD  233 (864)
T ss_pred             ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------chhhhhhhhc
Confidence            43   3457899999999999988556778999999999999999999985533                2333444555


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +.. ..+...+.+.++||.+||..||.+|.+.++|..
T Consensus       234 CKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  234 CKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            554 245567889999999999999999999999986

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.3e-41  Score=305.23  Aligned_cols=197  Identities=22%  Similarity=0.325  Sum_probs=161.6

Q ss_pred             cccccccCceEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec--CCeeeEEEecc
Q 038199           29 STRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYM  103 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~--~~~~~lV~e~~  103 (356)
                      +++||+|+||+||+|...   +++.||+|.+...   .....+.+|+.++++++||||+++++++..  ....++||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            578999999999999753   4688999998753   223457789999999999999999998854  45678999999


Q ss_pred             CCCChhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE----cCCCceEEcccCC
Q 038199          104 ENGSLDGYLFGK--------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGL  171 (356)
Q Consensus       104 ~~~sL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill----~~~~~~kl~Dfgl  171 (356)
                      .+ +|..++...        ...+++..+..++.||+.||.|||+   .+++||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            65 887776321        2358999999999999999999999   999999999999999    4567899999999


Q ss_pred             ccccCCCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCC
Q 038199          172 AKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGS  232 (356)
Q Consensus       172 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~  232 (356)
                      ++........ .......||..|+|||++.+...++.++||||+||++|||++|+.||....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            9876533221 122345689999999999875468999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2e-41  Score=305.46  Aligned_cols=264  Identities=25%  Similarity=0.343  Sum_probs=202.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      .|++.++||+|+||.||++.+. ++..+|+|.+..........++.+|++++++++||||+++++++.+....++||||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            5788999999999999999754 688999999876544445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      ++++|.+++.. ...+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.++|+|||++.......    
T Consensus        82 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----  154 (308)
T cd06615          82 DGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----  154 (308)
T ss_pred             CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence            99999999843 4678999999999999999999997  2589999999999999999999999999987543221    


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-cchhhhHH-----------------
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-WFPKHVWE-----------------  245 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~-----------------  245 (356)
                      .....|+..|+|||.+.+. .++.++|+||||+++|+|++|+.|+......... ++......                 
T Consensus       155 ~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            1234688999999998766 6889999999999999999999987533211100 00000000                 


Q ss_pred             --HHhhchhhHHHHhcCCCch-hHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          246 --EYEKSELDATILACGIEEK-DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       246 --~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                        ................+.. ...++.++.+++.+||..+|++||++++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0000000000000000110 11255679999999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-41  Score=300.73  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=204.0

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      +|++.+.||+|+||.||++.+. +++.||+|.+...........+.+|+.++++++||||+++++.+......++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            6889999999999999999765 689999999876544455578899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          104 ENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       104 ~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      ++++|..++...  ...+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-  158 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence            999999988543  3479999999999999999999996  25999999999999999999999999999876533221 


Q ss_pred             eeeccCCCCCCCCCcccccCCC-----CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          182 VTISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                         ....++..|+|||.+.+..     .++.++|+|||||++|+|++|..||......       .....      ....
T Consensus       159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~------~~~~  222 (286)
T cd06622         159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-------NIFAQ------LSAI  222 (286)
T ss_pred             ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-------hHHHH------HHHH
Confidence               2235788999999985431     3588999999999999999999997543211       00000      0111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........+..++.++.+++.+||+.+|++||++++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            122223344557788999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=306.33  Aligned_cols=255  Identities=25%  Similarity=0.309  Sum_probs=211.1

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCC-CCceeeeeceEecCCe
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHM   95 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~   95 (356)
                      +-....|++.+.||.|.||.||++..+ +|+.+|+|++.+...  ....+.+.+|+.+|+++. ||||+.+++++++...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            345567899999999999999999765 599999999975432  234468999999999998 9999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC----CCceEEcccCC
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----NFSPKVADFGL  171 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~----~~~~kl~Dfgl  171 (356)
                      .++|||+|.||.|.+.+...  .+++..+..++.|++.++.|||+   .|++||||||+|+|+..    ++.++++|||+
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999998555  49999999999999999999999   99999999999999953    35799999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      +.....   .......+||+.|+|||++.+. .++..+||||+||++|.|++|..||........       ...+....
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-------~~~i~~~~  254 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-------FLAILRGD  254 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-------HHHHHcCC
Confidence            998765   2234557899999999999876 799999999999999999999999866543211       11111111


Q ss_pred             hhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .      ....+.-...+..+.+++..++..||.+|+|+.++++.
T Consensus       255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1      11123334557788999999999999999999999984

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.1e-41  Score=296.78  Aligned_cols=248  Identities=26%  Similarity=0.431  Sum_probs=200.2

Q ss_pred             hhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...+|++.+.||+|+||.||++.. +++.||+|.+...   ...+.+.+|+.++++++|||++++++++.... .++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e   78 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVME   78 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEE
Confidence            346789999999999999999975 6788999998754   23467889999999999999999999987654 689999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          102 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+.+++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++....... 
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            99999999998654 3468999999999999999999999   999999999999999999999999999987543221 


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                          .....+..|+|||.+.+. .++.++|+||||+++|+|++ |..|+......                .........
T Consensus       155 ----~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~~  213 (254)
T cd05083         155 ----DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK----------------EVKECVEKG  213 (254)
T ss_pred             ----CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----------------HHHHHHhCC
Confidence                122345679999998766 68999999999999999998 87776433211                011111112


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      .........+..+.+++.+||+.+|++||++++|++.|+.
T Consensus       214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            2222234456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=309.21  Aligned_cols=242  Identities=24%  Similarity=0.265  Sum_probs=187.6

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC---CCCceeeeeceEecCCeeeEEEeccCC
Q 038199           32 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT---YHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        32 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l---~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      ||+|+||+||+|+.. +++.||||++....  .......+..|..++...   +||||+.+++++.+....++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999764 68999999986431  112223455666676655   699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|..++. ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.++|+|||++........  ...
T Consensus        81 g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~  154 (330)
T cd05586          81 GELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN  154 (330)
T ss_pred             ChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence            99998884 45679999999999999999999999   9999999999999999999999999999875432221  123


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...||..|+|||++.+...++.++|||||||++|+|++|..||......       ..+..+         .........
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i---------~~~~~~~~~  218 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNI---------AFGKVRFPK  218 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHH---------HcCCCCCCC
Confidence            4568999999999876546899999999999999999999997543211       111111         111111111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC----CHHHHHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRP----PMSAVVK  295 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rp----s~~~v~~  295 (356)
                      ...+.++.+++.+||+.||.+||    ++.++++
T Consensus       219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            23456788999999999999998    4566555

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-41  Score=299.65  Aligned_cols=241  Identities=22%  Similarity=0.318  Sum_probs=187.7

Q ss_pred             ccccccCceEEEEEEeCC-------------------------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCcee
Q 038199           30 TRLGFGGFGEVYKGQFPN-------------------------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV   84 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~   84 (356)
                      .+||+|+||.||+|.+..                         ...||+|++.... ......+.+|+.++++++||||+
T Consensus         1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCee
Confidence            369999999999996411                         1358899886532 23335688899999999999999


Q ss_pred             eeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC--
Q 038199           85 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF--  162 (356)
Q Consensus        85 ~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~--  162 (356)
                      ++++++.+....++||||+++++|..++......+++..+..++.|++.||+|||+   ++++||||||+||+++..+  
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999999986656789999999999999999999999   9999999999999997643  


Q ss_pred             -----ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHH-hCCcccccCCCCcc
Q 038199          163 -----SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV-GRRRNAIVGSSESL  236 (356)
Q Consensus       163 -----~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ell-tg~~p~~~~~~~~~  236 (356)
                           .++++|||++......      ....++..|+|||.+.+...++.++||||||+++|||+ +|..|+....... 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                 3899999987643221      11246788999999876546899999999999999995 6777764332210 


Q ss_pred             ccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          237 DWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                                     .........  ..+.....++.+++.+||+.+|++||++++|++.|+
T Consensus       230 ---------------~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 ---------------KERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ---------------HHHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                           000011110  111122346889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-41  Score=319.13  Aligned_cols=261  Identities=20%  Similarity=0.240  Sum_probs=191.4

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC--------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--------   93 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--------   93 (356)
                      ...|.+.++||+|+||.||+|.. .+++.||||++..+.     ....+|+.+++.++||||+++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            45789999999999999999976 468999999886432     2245799999999999999998876432        


Q ss_pred             CeeeEEEeccCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-ceEEccc
Q 038199           94 HMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADF  169 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Df  169 (356)
                      ..+++||||+.+ +|.+++.   .....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246789999975 7766653   235679999999999999999999999   9999999999999998664 7999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cchhhhH
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WFPKHVW  244 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~~~~~~  244 (356)
                      |+++.......   .....||..|+|||++.+...++.++|||||||++|||++|..||.........     .+.....
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99986643322   123468999999999876556899999999999999999999888654321100     0000000


Q ss_pred             HHHhhc--hhhHHHHhcCC-----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          245 EEYEKS--ELDATILACGI-----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       245 ~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +.+...  .......+...     ...+...+.++.+++.+||+.||.+|||+.++++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            000000  00000000000     0011123567899999999999999999999986

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.3e-41  Score=296.88  Aligned_cols=249  Identities=24%  Similarity=0.305  Sum_probs=205.6

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|+..++||+|+||.||+|.+. +++.||||++...........+.+|+.+++.+.||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777899999999999999764 58899999987554445557899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++.  ..++++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        84 ~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-  157 (277)
T cd06640          84 LGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-  157 (277)
T ss_pred             CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-
Confidence            99999999884  3578999999999999999999999   99999999999999999999999999999765433211 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                       .....++..|+|||.+.+. .++.++|+||||+++|||++|..|+......                ...........+
T Consensus       158 -~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----------------~~~~~~~~~~~~  219 (277)
T cd06640         158 -RNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPM----------------RVLFLIPKNNPP  219 (277)
T ss_pred             -cccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChH----------------hHhhhhhcCCCC
Confidence             1224578899999999876 6899999999999999999999887532211                000111112223


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ......+..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            4455677889999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.5e-42  Score=299.79  Aligned_cols=241  Identities=25%  Similarity=0.324  Sum_probs=189.6

Q ss_pred             ccccccCceEEEEEEeCC--------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           30 TRLGFGGFGEVYKGQFPN--------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ++||+|+||.||+|....        ...+|+|.+.... ....+.+..|+.+++.++|||++++++++......++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            479999999999996532        2348888876432 2334678899999999999999999999999889999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc--------eEEcccCCcc
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--------PKVADFGLAK  173 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~--------~kl~Dfgl~~  173 (356)
                      |+++|+|..++......+++..++.++.||+.||.|||+   .+++||||||+||+++.++.        ++++|||++.
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999997666679999999999999999999999   99999999999999987765        6999999886


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCc-ccccCCCCccccchhhhHHHHhhchh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR-NAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      .....      ....++..|+|||++.+...++.++||||||+++|||++|.. |+......                ..
T Consensus       157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~----------------~~  214 (258)
T cd05078         157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ----------------KK  214 (258)
T ss_pred             ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH----------------HH
Confidence            54322      223578899999999865467899999999999999999954 33211110                00


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      .....  .....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       215 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         215 LQFYE--DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHH--ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00000  011122233467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.7e-41  Score=299.20  Aligned_cols=250  Identities=24%  Similarity=0.336  Sum_probs=199.8

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccC
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~  104 (356)
                      |++.+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+++++.++|||++++++++......++||||+.
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            678899999999999999764 58889999986532 3445678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeee
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI  184 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  184 (356)
                      +++|..++.....++++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........  ..
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~  160 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RR  160 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--cc
Confidence            999998886556789999999999999999999999   9999999999999999999999999999876533221  12


Q ss_pred             ccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh-c
Q 038199          185 SGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA-C  259 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  259 (356)
                      ....++..|+|||++..    ...++.++|||||||++|||++|..|+......          +..     ...... .
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----------~~~-----~~~~~~~~  225 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----------RVL-----LKIAKSEP  225 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----------HHH-----HHHhhcCC
Confidence            23458899999998742    225778999999999999999999886432210          000     000000 0


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .....+...+.++.+++.+||+.+|.+||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         226 PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111233456789999999999999999999998863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.3e-41  Score=299.92  Aligned_cols=251  Identities=26%  Similarity=0.307  Sum_probs=198.1

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|+..+.||+|+||+||+|.+ .+++.||+|.+.....  ......+.+|++++++++|+|++.+++.+.+++..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            466778999999999999975 4689999999865321  2223457789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          102 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+.+++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999999887543 3479999999999999999999999   9999999999999999999999999999876432221


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                         .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||.......       ..+.     ....+... 
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-------~~~~-----~~~~~~~~-  220 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-------KREE-----VDRRVLET-  220 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH-----HHHhhhcc-
Confidence               1234689999999999876 68999999999999999999999985432210       0000     11111111 


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      ........+..+.+++.+||+.||++||+     +.+++.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            11223345567889999999999999999     556655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.8e-41  Score=307.60  Aligned_cols=263  Identities=22%  Similarity=0.266  Sum_probs=196.0

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC-----
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----   94 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-----   94 (356)
                      ...+|.+.+.||+|+||.||++... +|+.||||++.... .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578899999999999999999764 68999999997532 2344467889999999999999999999986443     


Q ss_pred             -eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           95 -MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        95 -~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                       ..++||||+++ +|...+.   ..++...+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             46899999976 6665552   358899999999999999999999   999999999999999999999999999997


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch------hhhHHHH
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP------KHVWEEY  247 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~------~~~~~~~  247 (356)
                      ......   ......||..|+|||++.+. .++.++|||||||++|+|++|..||....... .|..      ....+..
T Consensus       172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         172 TACTNF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccCc---cCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHH
Confidence            543221   12334689999999999876 78999999999999999999999986442210 0000      0000000


Q ss_pred             h--hchhhHHHHhcCC------------------CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          248 E--KSELDATILACGI------------------EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       248 ~--~~~~~~~~~~~~~------------------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .  .............                  .......+..+.+++.+||+.||++|||++++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0  0000000000000                  00111234678899999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.9e-41  Score=296.07  Aligned_cols=250  Identities=24%  Similarity=0.305  Sum_probs=201.1

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccch--------hhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR--------IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      +|.+.+.||+|+||.||+|... +++.||+|.+......        ...+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788999999999999999754 5889999988643211        122568899999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||+++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999999843 4678999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCCee----eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          176 DRNRSHV----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       176 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      .......    ......|+..|+|||.+.+. .++.++|+||||+++|+|++|..||......          ...    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~----  221 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----------QAI----  221 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHH----------HHH----
Confidence            5221111    11224578899999999876 6789999999999999999999987532110          000    


Q ss_pred             hhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                        ........+..+...+..+.+++.+||+.||.+||++.+|++
T Consensus       222 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         222 --FKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --HHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              011111223344456778999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.8e-41  Score=301.09  Aligned_cols=251  Identities=26%  Similarity=0.307  Sum_probs=199.0

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|...+.||+|+||+||++.+. +++.||+|.+.....  ......+..|+.++++++|+|++.+++.+.+....++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            4677889999999999999754 689999998865321  2223457789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          102 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+.|++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999888543 3469999999999999999999999   9999999999999999999999999999875432221


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                         .....|+..|+|||.+.+. .++.++||||||+++|+|++|..||.......       .++...     ... ...
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-------~~~~~~-----~~~-~~~  220 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-------KREEVE-----RLV-KEV  220 (285)
T ss_pred             ---ccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccc-------hHHHHH-----hhh-hhh
Confidence               1234689999999999876 68999999999999999999999986432210       000000     000 000


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      ........+.++.+++.+||+.||++|||     ++++++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            01122334567889999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.9e-41  Score=295.60  Aligned_cols=254  Identities=22%  Similarity=0.326  Sum_probs=188.1

Q ss_pred             ccccccCceEEEEEEeCC---CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCC
Q 038199           30 TRLGFGGFGEVYKGQFPN---GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +.||+|+||.||+|...+   ...+++|.+.........+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            469999999999996433   33566777665444445678999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          107 SLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       107 sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      +|.+++...   ....++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999998543   2346777889999999999999999   9999999999999999999999999999764322111112


Q ss_pred             eccCCCCCCCCCcccccCC------CCCCccccchhhHHHHHHHHhC-CcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          184 ISGYKGTPGYSAPEFLSGN------YPITHKCDVYSFGMVLFEIVGR-RRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~------~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .....++..|+|||++...      ..++.++||||||+++|||+++ ..|+.....       ............    
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~~~----  226 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKDQQ----  226 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhhcc----
Confidence            2234578899999987531      1357899999999999999975 445432211       001111100000    


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      .....+.........+.+++..|| .+|++||++++|++.|.
T Consensus       227 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         227 VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            000111222235567888999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-41  Score=333.72  Aligned_cols=263  Identities=21%  Similarity=0.297  Sum_probs=204.7

Q ss_pred             ceecHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           14 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      ..+..+++....|.+.++||+|+||+||+|.+. +++.||+|++... ........+..|+.++++++||||+++++++.
T Consensus         3 ~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~   82 (1021)
T PTZ00266          3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL   82 (1021)
T ss_pred             ccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            345667777889999999999999999999764 5889999998743 23445567899999999999999999999886


Q ss_pred             c--CCeeeEEEeccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCccccCCCCCcEEEcC--
Q 038199           92 D--QHMTALVYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQ----QRIIHYDIKPENVLLDA--  160 (356)
Q Consensus        92 ~--~~~~~lV~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~----~~ivH~dikp~Nill~~--  160 (356)
                      +  ...+||||||+.+++|.+++...   ...+++..++.|+.||+.||.|||+...    .+||||||||+||||+.  
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            4  35689999999999999988542   3579999999999999999999998221    35999999999999954  


Q ss_pred             ---------------CCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhC
Q 038199          161 ---------------NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGR  224 (356)
Q Consensus       161 ---------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg  224 (356)
                                     .+.+||+|||++........   .....||+.|+|||++.+. ..++.++|||||||++|||++|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                           23589999999986543221   2235689999999998643 2578999999999999999999


Q ss_pred             CcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          225 RRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       225 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..||......      ..         +...+.... .......+.++.+||..||+.+|.+||++.+++.
T Consensus       240 k~PF~~~~~~------~q---------li~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        240 KTPFHKANNF------SQ---------LISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCcCCcH------HH---------HHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9998543221      00         001111111 1111234677999999999999999999999985

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-41  Score=302.90  Aligned_cols=265  Identities=22%  Similarity=0.278  Sum_probs=199.9

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|++.+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999764 68999999986432 122234677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.+ +|.+++......+++..+..++.||++||.|||+   .+++||||||+||+++.++.++|+|||+++.......  
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            975 8888775556779999999999999999999999   9999999999999999999999999999876543221  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc---------hhhhHHHHhhchhh
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF---------PKHVWEEYEKSELD  253 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~  253 (356)
                      ......++..|+|||.+.+...++.++|||||||++|+|++|+.|+..+........         ....|.........
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            112345788999999987754578999999999999999999988755433211000         00000000000000


Q ss_pred             HHHHh----cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILA----CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....    .......+..+.++.+++.+||+.||.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000    0000112234577889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=311.41  Aligned_cols=242  Identities=27%  Similarity=0.370  Sum_probs=202.1

Q ss_pred             cccccccCceEEEEEE-eCCCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           29 STRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      .+-||-|+||.||.|+ ..+.+.||||.++-.  .+...+..+..|+..|+++.|||++.+-|||......|+|||||-|
T Consensus        31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG  110 (948)
T KOG0577|consen   31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG  110 (948)
T ss_pred             HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence            4679999999999996 467899999998632  2345567899999999999999999999999999999999999965


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                       |-.+++....+++-+..+..|..+.++||+|||+   .+.||||||..|||+++.|.|||+|||.+....+      ..
T Consensus       111 -SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An  180 (948)
T KOG0577|consen  111 -SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN  180 (948)
T ss_pred             -cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence             8899998788999999999999999999999999   9999999999999999999999999999876543      34


Q ss_pred             cCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          186 GYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      +++||+.|||||++..  .+.|+-++||||||++..||.-.++|.+.-..               -..+..........-
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---------------MSALYHIAQNesPtL  245 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------------MSALYHIAQNESPTL  245 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---------------HHHHHHHHhcCCCCC
Confidence            5779999999999853  34789999999999999999999888643211               111122222222223


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....+..+++++..||++-|.+|||.+++++
T Consensus       246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            34567788999999999999999999999876

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.6e-41  Score=300.05  Aligned_cols=249  Identities=26%  Similarity=0.323  Sum_probs=202.8

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|...+.||+|+||.||+|.+ .+++.||+|.+.........+.+.+|+.++++++||||+++++++......++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            4567778899999999999965 468899999987554444556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++.  ...+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++........  
T Consensus        84 ~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06642          84 LGGGSALDLLK--PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             cCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence            99999999883  4578999999999999999999999   9999999999999999999999999999876543221  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                      ......|+..|+|||.+.+. .++.++||||||+++|||++|..|+.......                ..........+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----------------~~~~~~~~~~~  219 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMR----------------VLFLIPKNSPP  219 (277)
T ss_pred             hhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhh----------------HHhhhhcCCCC
Confidence            11224578899999999876 68899999999999999999998864322110                00011111112


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ......+.++.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            2333456778999999999999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.3e-41  Score=298.82  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=201.2

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...|++.++||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|||++++++.+..+...++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            356899999999999999999764 58999999987542 3445678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++++|..++......+++..+..++.|++.+|.|||+   .+++||||||+||+++.++.++|+|||++........ 
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-  165 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-  165 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence            999999998876556779999999999999999999999   9999999999999999999999999999875432211 


Q ss_pred             eeeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          182 VTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                       ......++..|+|||.+.+    ...++.++|+|||||++|||++|..|+......          +.     . ....
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------~~-----~-~~~~  228 (292)
T cd06644         166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------RV-----L-LKIA  228 (292)
T ss_pred             -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----------HH-----H-HHHh
Confidence             1123457889999998852    224688999999999999999999887432210          00     0 0001


Q ss_pred             hcC--CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          258 ACG--IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       258 ~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...  ....+...+.++.+++.+||+.+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         229 KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            110  11123345567899999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.5e-42  Score=314.09  Aligned_cols=252  Identities=22%  Similarity=0.280  Sum_probs=194.0

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|++.+.||+|+||+||++... +++.||+|++....  .......+..|+.++..++||||+++++.+.+....++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5788899999999999999764 68999999996421  22334578889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |++|++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          82 FLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             CCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            999999999984 45679999999999999999999999   99999999999999999999999999998754321100


Q ss_pred             ---------------------------------eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCccc
Q 038199          182 ---------------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNA  228 (356)
Q Consensus       182 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~  228 (356)
                                                       .......||..|+|||++.+. .++.++|||||||++|||++|..||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCC
Confidence                                             001134699999999999876 7899999999999999999999998


Q ss_pred             ccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 038199          229 IVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP---MSAVVK  295 (356)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~v~~  295 (356)
                      ......       ..+.......     .....+. ....+.++.+++.+++ .||.+|++   +.++++
T Consensus       237 ~~~~~~-------~~~~~i~~~~-----~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         237 CSETPQ-------ETYRKVMNWK-----ETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCHH-------HHHHHHHcCC-----CceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            543221       1111110000     0000011 1123456777887766 49999996   455554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.3e-40  Score=292.17  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=201.1

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEec-CCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~-~~~~~lV~e  101 (356)
                      .|++.+.||+|++|.||++... +++.||+|.+.... .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999754 58899999986432 23445678899999999999999999998764 446789999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          102 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+++++|.+++... ...+++.++..++.|++.|+++||+   .+++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999988543 4568999999999999999999999   9999999999999999999999999999876643322


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                        ......++..|+|||.+.+. .++.++|+||||+++++|++|..|+......      .          .........
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~----------~~~~~~~~~  218 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMN------S----------LVYRIIEGK  218 (257)
T ss_pred             --ccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------H----------HHHHHHhcC
Confidence              12234578899999999876 6889999999999999999999886432110      0          011111222


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+..+...+..+.+++.+|++.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            23344556778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.5e-41  Score=296.62  Aligned_cols=251  Identities=25%  Similarity=0.343  Sum_probs=197.0

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecC------C
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ------H   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~------~   94 (356)
                      ...|++.+.||+|+||.||+|... +++.||+|++...  ......+.+|+.+++++ +|+|++++++++...      .
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            356788899999999999999764 5889999998754  23346788999999998 699999999998753      4


Q ss_pred             eeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           95 MTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+   ++++|+||||+||++++++.++|+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            578999999999999998653 3568999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      .......  ......|+..|+|||++.+    ...++.++|||||||++|||++|..|+......       ......  
T Consensus       160 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~~~~--  228 (272)
T cd06637         160 QLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLI--  228 (272)
T ss_pred             ecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHHHH--
Confidence            6533221  1233568889999999853    225788999999999999999999887432211       000000  


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                            .............+..+.+++.+||+.+|.+||+++++++
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 ------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ------hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                  0011111122234567899999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.2e-41  Score=298.76  Aligned_cols=265  Identities=21%  Similarity=0.269  Sum_probs=198.5

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .|++.+.||+|++|.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999764 68999999986432 223346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          103 MENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       103 ~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      +. ++|.+++...  +..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 5888877443  3679999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc--------chhhhHHHHhhchh
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW--------FPKHVWEEYEKSEL  252 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~  252 (356)
                        ......++..|+|||.+.+...++.++||||||+++++|++|+.|+.........+        .....|........
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence              11233568899999998765467899999999999999999998876432211000        00000100000000


Q ss_pred             hHHHHhc----CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 DATILAC----GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 ~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .......    .........+.++.+++.+||+.||++|||+.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000    000111224567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.7e-41  Score=304.20  Aligned_cols=260  Identities=20%  Similarity=0.290  Sum_probs=188.3

Q ss_pred             cccccccCceEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec--CCeeeEEEecc
Q 038199           29 STRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYM  103 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~--~~~~~lV~e~~  103 (356)
                      +.+||+|+||+||+|...   +++.||+|.+...   .....+.+|+.++++++||||+++++++..  ....++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            468999999999999754   4578999998753   223457889999999999999999998853  45778999999


Q ss_pred             CCCChhhhhhc--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE----cCCCceEEcccCC
Q 038199          104 ENGSLDGYLFG--------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGL  171 (356)
Q Consensus       104 ~~~sL~~~l~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill----~~~~~~kl~Dfgl  171 (356)
                      .+ +|.+++..        ....+++..+..++.|++.||.|||+   .+++||||||+||++    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            65 77766532        12358899999999999999999999   999999999999999    5667899999999


Q ss_pred             ccccCCCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch----------
Q 038199          172 AKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP----------  240 (356)
Q Consensus       172 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~----------  240 (356)
                      ++........ .......||..|+|||++.+...++.++|||||||++|||+||..||...........+          
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            9876543222 12233568999999999877546899999999999999999999988654322110000          


Q ss_pred             -------hhhHHHHhhchh----hHHHHhcC---------CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          241 -------KHVWEEYEKSEL----DATILACG---------IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       241 -------~~~~~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                             ...|..+.....    ........         ...........+.+++.+||+.||.+|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                   001111100000    00000000         00001112345788999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.2e-41  Score=293.02  Aligned_cols=249  Identities=21%  Similarity=0.346  Sum_probs=204.0

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|++.++||+|+||.||++.. .+|+.||+|.+... ........+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478899999999999999965 46899999998643 2234456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          103 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       103 ~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      +.+++|.+++... ...+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999999988543 3468999999999999999999999   99999999999999999999999999999765432211


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                        .....|+..|+|||.+.+. ..+.++|+||||+++++|++|..|+......                ........+..
T Consensus       158 --~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~~~~~  218 (256)
T cd08218         158 --ARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----------------NLVLKIIRGSY  218 (256)
T ss_pred             --hhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHH----------------HHHHHHhcCCC
Confidence              1223478899999998876 6889999999999999999999887543211                11111122223


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +..+...+.++.+++.+||+.+|++||++.+|++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            3344556778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=292.96  Aligned_cols=254  Identities=24%  Similarity=0.339  Sum_probs=203.6

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|++.++||+|+||.||+|... +++.+|+|++..... ...+.+.+|+.++++++||||+++++.+.+....+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            56888999999999999999764 588999999975432 2457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.+++|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........  
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence            99999999886555789999999999999999999999   9999999999999999999999999999876543221  


Q ss_pred             eeccCCCCCCCCCcccccCC--CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          183 TISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                      ......++..|+|||.+.+.  ..++.++|+||||+++|+|++|..|+......       ..........     ....
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~~~~~~~~~~-----~~~~  224 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------RALFLISKSN-----FPPP  224 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcc-----CCCc
Confidence            11234578899999998643  25788999999999999999999887542210       0000000000     0011


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........+.++.+++.+||..+|.+||++++|+.
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11223456678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=313.12  Aligned_cols=258  Identities=25%  Similarity=0.330  Sum_probs=211.0

Q ss_pred             HHHHhhhhccccc-----cccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           18 SLQLNNFTSNYST-----RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        18 ~~~~~~~~~~~~~-----~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      ..+.....|+..+     +||+|.||+||.|++. +...+|||-+.... .....-+..|+.+-+.|+|.|||+++|.+.
T Consensus       564 ane~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~s  642 (1226)
T KOG4279|consen  564 ANEKIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVS  642 (1226)
T ss_pred             cccceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccC
Confidence            3455556666642     4999999999999764 57789999887432 233456889999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc-CCCceEEcc
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKKRAI--EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVAD  168 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~kl~D  168 (356)
                      ++++.-|.||.++||||.+++...=+++  ++.+.-.+..||++||.|||.   +.|||||||-+|||++ -.|.+||+|
T Consensus       643 enGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISD  719 (1226)
T KOG4279|consen  643 ENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISD  719 (1226)
T ss_pred             CCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecc
Confidence            9999999999999999999997666677  889999999999999999999   9999999999999996 468999999


Q ss_pred             cCCccccCCCCCeeeeccCCCCCCCCCcccccC-CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       169 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      ||.++++..-..  .+..+.||..|||||++.. ...|..++|||||||.+.||.||++||-.-.....         .+
T Consensus       720 FGTsKRLAginP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------AM  788 (1226)
T KOG4279|consen  720 FGTSKRLAGINP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------AM  788 (1226)
T ss_pred             cccchhhccCCc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------hh
Confidence            999987653322  2345779999999999864 44799999999999999999999999855333211         11


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..     .-.-..-++.+.+.+.+...++.+|+.++|.+||++++++.
T Consensus       789 Fk-----VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  789 FK-----VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             hh-----hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            11     11122346778889999999999999999999999999987

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.2e-41  Score=294.90  Aligned_cols=254  Identities=21%  Similarity=0.309  Sum_probs=199.3

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...|.+.++||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++.++||||+++++.+.+....++|||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            34788899999999999999975 468999999987542 2334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++++|.+++. ..+.+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........ 
T Consensus        87 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          87 FCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             ccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence            999999999884 44579999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             eeeccCCCCCCCCCccccc--CCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          182 VTISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                       ......|+..|+|||.+.  ....++.++|+|||||++|+|++|..|+........      .+. .......     .
T Consensus       162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~-~~~~~~~-----~  228 (267)
T cd06645         162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFL-MTKSNFQ-----P  228 (267)
T ss_pred             -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHh-hhccCCC-----C
Confidence             123346899999999874  222578899999999999999999988754322100      000 0000000     0


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .........+..+.+++.+||..+|++||++++|++
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         229 PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            000011123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-42  Score=296.80  Aligned_cols=260  Identities=23%  Similarity=0.274  Sum_probs=196.5

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC-----eee
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----MTA   97 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-----~~~   97 (356)
                      -.|.-.+++|.|+||.||+|... +++.||||..-.+...     -.+|+.+|+++.|||||++..+|....     +..
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            34556789999999999999754 5899999988665332     246999999999999999998886432     445


Q ss_pred             EEEeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-CceEEcccCCcc
Q 038199           98 LVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAK  173 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfgl~~  173 (356)
                      +||||++. +|.+.+..   .+..++...+.-+..||++||.|||+   .+|+||||||.|+|+|.+ |.+||+|||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999976 99988853   36789999999999999999999999   999999999999999976 999999999999


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc-----ccchhhhHHHHh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL-----DWFPKHVWEEYE  248 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~  248 (356)
                      ....+....   ++.-|..|+|||.+.|...|+.+.||||.|||+.||+-|+.-|...+....     +.++....+.+.
T Consensus       175 ~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  175 VLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             eeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            876554432   233577899999999988999999999999999999999876654333210     011111111111


Q ss_pred             hchhh-------HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          249 KSELD-------ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       249 ~~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....       ......+........+.+..+++.++|..+|.+|.++.+++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            10000       000001111134456778999999999999999999999886

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-41  Score=297.00  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=202.7

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|++.++||.|+||.||++.+. +++.+|+|++.... ....+.+..|+.++++++|||++++++.+.+....++||||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            46889999999999999999764 68999999987542 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........  
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence            99999999986666789999999999999999999999   9999999999999999999999999999875433221  


Q ss_pred             eeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          183 TISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      ......++..|+|||.+..    ...++.++|+||||+++|+|++|..|+......          .      .......
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----------~------~~~~~~~  222 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----------R------VLLKILK  222 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----------H------HHHHHhc
Confidence            1123458889999998752    224678999999999999999999887432211          0      0001111


Q ss_pred             cC--CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          259 CG--IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       259 ~~--~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ..  ....+...+.++.+++.+||+.+|.+||++.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         223 SEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            11  111233456678999999999999999999999873

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.5e-41  Score=293.93  Aligned_cols=239  Identities=25%  Similarity=0.350  Sum_probs=188.0

Q ss_pred             ccccccCceEEEEEEeCC-C----------cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           30 TRLGFGGFGEVYKGQFPN-G----------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      +.||+|+||.||+|.+.+ +          ..+++|++....  .....+.+|+.++++++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH--RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch--hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            479999999999997653 3          257888776542  225788999999999999999999999988 77899


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-------ceEEcccCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-------SPKVADFGL  171 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-------~~kl~Dfgl  171 (356)
                      ||||+.+++|.+++......+++..+..++.||+.||.|||+   ++++||||||+||+++.++       .++|+|||+
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999996555579999999999999999999999   9999999999999999887       799999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhC-CcccccCCCCccccchhhhHHHHhh
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGR-RRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      +......      ....++..|+|||++.+. ..++.++||||||+++|+|++| ..|+.......        +..   
T Consensus       155 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--------~~~---  217 (259)
T cd05037         155 PITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--------KER---  217 (259)
T ss_pred             ccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--------HHH---
Confidence            8765431      123467789999998765 3578999999999999999995 55543322110        000   


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                           ..........  .....+.+++.+||..+|.+||++.+|++.|+
T Consensus       218 -----~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         218 -----FYQDQHRLPM--PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -----HHhcCCCCCC--CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 0000000001  11167889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-41  Score=311.32  Aligned_cols=205  Identities=26%  Similarity=0.392  Sum_probs=173.8

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-C-----Cceeeeec
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-H-----INLVRLYG   88 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~ni~~~~~   88 (356)
                      +...+....+|++.+.||+|+||.|.+|. ..+++.||||++++.  ..-..+...|+.+|..|+ |     -|+|++++
T Consensus       178 ~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d  255 (586)
T KOG0667|consen  178 LVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD  255 (586)
T ss_pred             EEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence            33445566689999999999999999995 567999999999886  344467788999999986 3     38999999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC--CceE
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN--FSPK  165 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~--~~~k  165 (356)
                      +|...+++|||+|.+.. +|++++... -.+++...+..++.||+.||.+||.   .+|||+||||+||||.+.  ..+|
T Consensus       256 ~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  256 YFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             ccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCcee
Confidence            99999999999999955 999999654 3579999999999999999999999   999999999999999654  3799


Q ss_pred             EcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCC
Q 038199          166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSS  233 (356)
Q Consensus       166 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~  233 (356)
                      |+|||.++......     ..+.-+..|.|||++.|. +|+.+.||||||||+.||++|. |..++..
T Consensus       332 VIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~-PLfpG~n  392 (586)
T KOG0667|consen  332 VIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGE-PLFPGDN  392 (586)
T ss_pred             EEecccccccCCcc-----eeeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCc-cccCCCC
Confidence            99999998654432     234567789999999988 8999999999999999999994 4445444

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-40  Score=305.40  Aligned_cols=263  Identities=21%  Similarity=0.253  Sum_probs=195.5

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecC------C
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------H   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------~   94 (356)
                      ..+|.+.+.||+|+||+||+|.. .+++.||||++..... ......+.+|+.++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            46788999999999999999975 4688999999875422 23345678899999999999999999987543      3


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..+++++++ +++|.+++  ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~~~~~-~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          94 EVYLVTNLM-GADLNNIV--KCQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             cEEEEeecC-CCCHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcccee
Confidence            468999998 77998877  34579999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--c------chhhhHHH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--W------FPKHVWEE  246 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--~------~~~~~~~~  246 (356)
                      ....     .....||..|+|||++.+...++.++|||||||++|+|++|..||........-  +      ........
T Consensus       168 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         168 ADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             cCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            5432     233468999999999877546899999999999999999999887543211000  0      00000000


Q ss_pred             HhhchhhHHHHhcC-CCch-----hHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          247 YEKSELDATILACG-IEEK-----DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       247 ~~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .............. .+..     .......+.+++.+||+.||.+|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000000000 0000     01123457899999999999999999999963

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.6e-41  Score=296.07  Aligned_cols=257  Identities=24%  Similarity=0.329  Sum_probs=200.8

Q ss_pred             hhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ....|...+.||+|+||+||+|...      +.+.|++|.+.........+.+.+|++++++++|+||+++++++.+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            3467788899999999999999753      2467999988754333345679999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEc
Q 038199           96 TALVYEYMENGSLDGYLFGKK--------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA  167 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~  167 (356)
                      .++||||+++++|.+++....        ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEc
Confidence            999999999999999985432        168999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHH
Q 038199          168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       168 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      |||++........ .......++..|+|||.+.+. ..+.++||||||+++|+|++ |..|+......       .....
T Consensus       160 ~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~~~~~  230 (275)
T cd05046         160 LLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------EVLNR  230 (275)
T ss_pred             ccccccccCcccc-cccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchH-------HHHHH
Confidence            9999875432211 112223456789999998766 67899999999999999998 56665321110       00111


Q ss_pred             HhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ....        ..........+..+.+++.+||+.+|++||++.++++.|.
T Consensus       231 ~~~~--------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 LQAG--------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHcC--------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1100        0001122345567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-40  Score=297.19  Aligned_cols=261  Identities=24%  Similarity=0.341  Sum_probs=191.1

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccC---CCCceeeeeceEec-----CC
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRT---YHINLVRLYGFCHD-----QH   94 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~ni~~~~~~~~~-----~~   94 (356)
                      +|++.+.||+|+||+||+|.+. +++.||+|.+..... ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999764 689999999874321 12223456677777665   69999999998864     34


Q ss_pred             eeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           95 MTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ..++|||++.+ +|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999975 888887543 3468999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh-------hHHH
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH-------VWEE  246 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~-------~~~~  246 (356)
                      .......   .....|+..|+|||++.+. .++.++|||||||++|+|++|..||........  +...       ....
T Consensus       157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~  230 (288)
T cd07863         157 IYSCQMA---LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDD  230 (288)
T ss_pred             cccCccc---CCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhh
Confidence            6543221   1234578899999999766 689999999999999999999888754322100  0000       0000


Q ss_pred             Hhhc-hhhHHHHh-c---CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          247 YEKS-ELDATILA-C---GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       247 ~~~~-~~~~~~~~-~---~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +... ........ .   ......+..+..+.+++.+||+.||++|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000 00000000 0   000111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.2e-40  Score=298.53  Aligned_cols=248  Identities=21%  Similarity=0.292  Sum_probs=201.2

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|++.+.||.|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|||++++++++......++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4588899999999999999965 468999999987543 23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.+++|..++.  ...+++.++..++.|++.|+.|||+   .+++||||||+||+++.++.++|+|||++......... 
T Consensus        98 ~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655          98 LAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             cCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence            99999999883  3468999999999999999999999   99999999999999999999999999998765432211 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh-cCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA-CGI  261 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  261 (356)
                       .....++..|+|||.+.+. .++.++|||||||++|+|++|..||......          ...     ...... ...
T Consensus       172 -~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----------~~~-----~~~~~~~~~~  234 (296)
T cd06655         172 -RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----------RAL-----YLIATNGTPE  234 (296)
T ss_pred             -CCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------HHH-----HHHHhcCCcc
Confidence             1234588899999998866 6889999999999999999999987543221          000     000000 001


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...+...+..+.+++.+||..||++||++.+|++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            1123345567889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-40  Score=291.75  Aligned_cols=249  Identities=25%  Similarity=0.321  Sum_probs=201.4

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc----chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +|...+.||+|+||.||+|... +++.|++|.+....    .....+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677899999999999999765 78999999886432    123446789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      +||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            999999999999843 4568999999999999999999999   999999999999999999999999999987654332


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                         ......|+..|++||.+.....++.++|+||||+++|+|++|..|+......      ...+.         .....
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~---------~~~~~  218 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFK---------IGRSK  218 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHH---------HHhcc
Confidence               1233558889999999876533789999999999999999999987543210      00000         00101


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+..+......+.+++.+||+.+|++||++++++.
T Consensus       219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            112233345677899999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=295.36  Aligned_cols=248  Identities=24%  Similarity=0.353  Sum_probs=201.0

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCC---CCceeeeeceEecCCeeeEEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .|++.+.||+|+||.||+|.+ .+++.||+|++..........++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467789999999999999975 4689999999876544455567889999999986   999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+++++|.+++..  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            99999999998843  478999999999999999999999   9999999999999999999999999999887654332


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                      .  .....|+..|+|||.+.+...++.++|+||||+++|+|++|..|+........       ....         ....
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~~~---------~~~~  218 (277)
T cd06917         157 K--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------MMLI---------PKSK  218 (277)
T ss_pred             c--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------hhcc---------ccCC
Confidence            1  22345888999999987654678999999999999999999999854321100       0000         0000


Q ss_pred             CCchhH-HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDK-EKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+.... ..+.++.+++.+||+.||++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111111 25567899999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-40  Score=302.50  Aligned_cols=266  Identities=17%  Similarity=0.182  Sum_probs=195.3

Q ss_pred             ccccccccc--CceEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           27 NYSTRLGFG--GFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        27 ~~~~~iG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ++.++||+|  +||+||++.. .+|+.||+|++..... ....+.+..|+.+++.++||||+++++++.++...++||||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            357889999  7899999975 4799999999975432 33345677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          103 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       103 ~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+++.||+...........
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999998543 3568999999999999999999999   99999999999999999999999999865433211110


Q ss_pred             e-----eeccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCcccccCCCCcccc------ch------hhh
Q 038199          182 V-----TISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW------FP------KHV  243 (356)
Q Consensus       182 ~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~------~~------~~~  243 (356)
                      .     ......++..|+|||++.+. ..++.++|||||||++|||++|..||..........      .+      ...
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence            0     01123467789999998753 258899999999999999999999985432211000      00      000


Q ss_pred             HHHHhhch--------hhH---------HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          244 WEEYEKSE--------LDA---------TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       244 ~~~~~~~~--------~~~---------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+......        ...         ........+.....+..+.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00000000        000         00000001122334567899999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=286.21  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=206.4

Q ss_pred             hhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ....|.+-+.||+|.|+.||++- -++|+.+|+|.++.. .+....+.+.+|+++-+.|+||||+++.+.+......++|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            45567888999999999999995 457999999998743 3445667899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc---CCCceEEcccCCccccC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCD  176 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~---~~~~~kl~Dfgl~~~~~  176 (356)
                      +|+++|++|-.-+-. ..-+++..+.-+..||+.+|.|.|.   ++|||||+||.|+++.   ...-+||+|||++....
T Consensus        89 Fe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999998654422 2457888889999999999999999   9999999999999994   34569999999998877


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .   .....+..||++|||||++... +++..+|||+.||++|-||.|..||-..+.       ...++.+..+...-  
T Consensus       165 ~---g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~-------~rlye~I~~g~yd~--  231 (355)
T KOG0033|consen  165 D---GEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYEQIKAGAYDY--  231 (355)
T ss_pred             C---ccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccH-------HHHHHHHhccccCC--
Confidence            2   2344667899999999999877 899999999999999999999999854322       23344443332210  


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          ..+.-....++..+|+.+||..||.+|.|+.|.++
T Consensus       232 ----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 ----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                11233455677889999999999999999999876

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-40  Score=291.97  Aligned_cols=255  Identities=24%  Similarity=0.330  Sum_probs=204.9

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      +|++.+.||.|+||+||+|... ++..+|+|++...........+.+|+.+++.++|+|++++++.+......++|||++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            6889999999999999999754 688999999975543445678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          104 ENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       104 ~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      ++++|.+++...  ...+++..+..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||++.........
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999998543  2568999999999999999999999   99999999999999999999999999998776543322


Q ss_pred             e--eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          182 V--TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       182 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      .  ......|+..|+|||.+.....++.++|+||||+++|+|++|..|+.......      ...... ..      ...
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~-~~------~~~  225 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTL-QN------DPP  225 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHh-cC------CCC
Confidence            1  11234588899999998765467899999999999999999999985432210      000000 00      000


Q ss_pred             CCCch--hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 GIEEK--DKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ~~~~~--~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....  ....+..+.+++.+||..||++||++++|++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11111  1255678899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-40  Score=298.56  Aligned_cols=248  Identities=21%  Similarity=0.282  Sum_probs=201.4

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|++.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.+++.++|+|++++++++......++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            7788899999999999999975 479999999987543 23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++.  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......... 
T Consensus        98 ~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-  171 (297)
T cd06656          98 LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (297)
T ss_pred             cCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence            99999999883  3568999999999999999999999   99999999999999999999999999998765432211 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH-hcCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL-ACGI  261 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  261 (356)
                       .....++..|+|||.+.+. .++.++|+||||+++|++++|..||.........               ..... ....
T Consensus       172 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---------------~~~~~~~~~~  234 (297)
T cd06656         172 -RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---------------YLIATNGTPE  234 (297)
T ss_pred             -cCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---------------eeeccCCCCC
Confidence             1234578899999999876 6889999999999999999999988543221100               00000 0001


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...+...+..+.+++.+||+.+|++||++++|++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1123345566889999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.6e-41  Score=294.33  Aligned_cols=253  Identities=27%  Similarity=0.399  Sum_probs=205.5

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      +|++.++||+|+||.||++.+. +++.+|+|++..........++.+|++++++++||||+++++.+......++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5778899999999999999765 689999999987654555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      .+++|.+++......++...+..++.|++.||.|||+  ..+++|+||||+||+++.++.++|+|||.+.........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--  157 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--  157 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence            9999999996555789999999999999999999997  379999999999999999999999999998765432211  


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                        ...++..|+|||.+.+. .++.++||||||+++|+|++|..|+........     ...+.      .........+.
T Consensus       158 --~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~------~~~~~~~~~~~  223 (265)
T cd06605         158 --TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-----GIFEL------LQYIVNEPPPR  223 (265)
T ss_pred             --cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccc-----cHHHH------HHHHhcCCCCC
Confidence              15578899999999876 789999999999999999999998754422100     00010      11111111122


Q ss_pred             hhHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          264 KDKE-KAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       264 ~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .... .+.++.+++.+||..+|++||++.+++.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            2222 6777999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.6e-40  Score=291.19  Aligned_cols=252  Identities=26%  Similarity=0.382  Sum_probs=204.0

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEec--CCeeeEEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVY  100 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~--~~~~~lV~  100 (356)
                      +|++.+.||.|+||.||++.. .+++.||+|++... ......+++..|+.++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999965 46889999998643 334455678899999999999999999998764  45678999


Q ss_pred             eccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199          101 EYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEEC--QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus       101 e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||..+  ..+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998543   567999999999999999999999211  189999999999999999999999999999876


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ......  .....++..|+|||.+.+. .++.++|+||||+++++|++|..|+.....                ......
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------------~~~~~~  221 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQ----------------LQLASK  221 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCH----------------HHHHHH
Confidence            543321  2234588999999999876 688999999999999999999988754321                111122


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ......+..+...+..+.+++.+|++.+|++||++++|++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         222 IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            2233334445567788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-40  Score=295.27  Aligned_cols=265  Identities=22%  Similarity=0.275  Sum_probs=201.8

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|++.+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|+.++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788999999999999999764 68999999987542 233456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      + +++|.+++......+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 999999986666789999999999999999999999   9999999999999999999999999999887654322 1


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch---------hhhHHHHhhch-h
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP---------KHVWEEYEKSE-L  252 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~-~  252 (356)
                      ......|+..|+|||.+.+...++.++||||||++++||++|..++...... ..+..         ...|....... .
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchh
Confidence            1223458889999999876546789999999999999999996665332211 00000         00000000000 0


Q ss_pred             hHHHHhcC----CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 DATILACG----IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 ~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........    .....++.+..+.+++.+||+.+|.+||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000000    00011234578999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-40  Score=293.56  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=197.2

Q ss_pred             ccccccccccCceEEEEEEeC----CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC------
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------   94 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~------   94 (356)
                      |.+.+.||+|+||.||+|.+.    +++.||||++..+. .....+++.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999642    47899999987543 2344567889999999999999999999886532      


Q ss_pred             eeeEEEeccCCCChhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEccc
Q 038199           95 MTALVYEYMENGSLDGYLFGK-----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  169 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df  169 (356)
                      ..+++++|+.+++|..++...     ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence            246889999999998876321     2357899999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHh
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYE  248 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  248 (356)
                      |+++...............++..|++||.+.+. .++.++||||||+++|+|++ |..|+......       ....   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------~~~~---  226 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------EIYN---  226 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-------HHHH---
Confidence            998865433222222223456789999998766 68899999999999999999 66665322110       0011   


Q ss_pred             hchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                            ..............+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       227 ------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         227 ------YLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------HHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  1111111122234556899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3e-40  Score=291.54  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=195.2

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEecccc----chhhHHHHHHHHHHHccCCCCceeeeeceEecC--Cee
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMT   96 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~   96 (356)
                      ..|+..+.||+|+||.||+|.. .+++.||+|++....    .......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3578889999999999999975 468999999886431    123345688999999999999999999988753  567


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++++||+.+++|.+++.. ...+++...+.++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            899999999999998843 4568999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ..... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||.....          ....     ...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----------~~~~-----~~~  221 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEA----------MAAI-----FKI  221 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccch----------HHHH-----HHH
Confidence            22111 112234578899999999876 689999999999999999999988743211          0000     111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ......+..+......+..++ +||..+|++||++++|++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         222 ATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             hcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            111112233344556677777 688889999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.3e-41  Score=307.01  Aligned_cols=262  Identities=21%  Similarity=0.244  Sum_probs=196.3

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC------
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------   93 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------   93 (356)
                      ...+|.+.+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578899999999999999999754 68999999987543 233446788999999999999999999988643      


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ...++||||+++ +|...+.   ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            346899999976 6666652   358899999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch---------hhhH
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP---------KHVW  244 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~---------~~~~  244 (356)
                      ......   ......||..|+|||++.+. .++.++|||||||++|+|++|+.||........ +..         ...+
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  242 (355)
T cd07874         168 TAGTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cCCCcc---ccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence            654322   12335689999999999876 789999999999999999999999854321100 000         0000


Q ss_pred             HHHhhchhhHHHHhc---------------C---CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          245 EEYEKSELDATILAC---------------G---IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       245 ~~~~~~~~~~~~~~~---------------~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .... ..........               .   ..........++.+++.+||+.||++|||+.++++.
T Consensus       243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             Hhhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0000 0000000000               0   001112234678899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-40  Score=296.94  Aligned_cols=262  Identities=25%  Similarity=0.310  Sum_probs=202.6

Q ss_pred             ceecHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEe
Q 038199           14 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH   91 (356)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~   91 (356)
                      +.+.+..-...+|++.+.||+|+||.||++... +++.+|+|++...  ......+.+|+.+++++ +||||+++++++.
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            455666667788999999999999999999764 5889999988643  22335678899999999 6999999999874


Q ss_pred             -----cCCeeeEEEeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc
Q 038199           92 -----DQHMTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  163 (356)
Q Consensus        92 -----~~~~~~lV~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~  163 (356)
                           ++...++||||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCC
Confidence                 34578999999999999988742   34578999999999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCC----CCCCccccchhhHHHHHHHHhCCcccccCCCCccccc
Q 038199          164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF  239 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~  239 (356)
                      ++|+|||++........  ......|+..|+|||++...    ..++.++|||||||++|||++|+.|+......     
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-----  235 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-----  235 (286)
T ss_pred             EEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----
Confidence            99999999876543221  12234589999999987532    24788999999999999999999887543211     


Q ss_pred             hhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          240 PKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                           ......  ...  .......+...+..+.+++.+||+.||++||++.+|++.
T Consensus       236 -----~~~~~~--~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         236 -----RALFKI--PRN--PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -----HHHhhc--ccc--CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                 000000  000  000011122235578999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-41  Score=299.13  Aligned_cols=266  Identities=23%  Similarity=0.315  Sum_probs=197.2

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|++.+.||+|++|.||+|... +++.||||.+...........+.+|++++++++|+||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56888999999999999999765 68999999987543333334577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.+ +|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.......  
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            975 9998886656688999999999999999999999   9999999999999999999999999999875432211  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc---------hhhhHHHHhhch-h
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF---------PKHVWEEYEKSE-L  252 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~---------~~~~~~~~~~~~-~  252 (356)
                      ......++..|+|||.+.+...++.++||||||+++|+|++|..||...........         ....|....... .
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            112234678899999987654688999999999999999999988743321100000         000000000000 0


Q ss_pred             hHHHHhcCCCc----hhHHH--HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 DATILACGIEE----KDKEK--AKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 ~~~~~~~~~~~----~~~~~--~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...........    .....  ..++.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000000000    00011  256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-40  Score=294.72  Aligned_cols=265  Identities=21%  Similarity=0.304  Sum_probs=200.1

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.++++++|||++++++++......++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            5888999999999999999765 589999998864321 22335678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|..++ .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........  
T Consensus        82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--  155 (286)
T cd07847          82 CDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--  155 (286)
T ss_pred             cCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence            9998888776 344579999999999999999999999   9999999999999999999999999999987654322  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchh--------hhHHHHhhchhhH
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK--------HVWEEYEKSELDA  254 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~  254 (356)
                      ......++..|+|||.+.+...++.++||||||+++|+|++|..||.........+...        ...+.+.......
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            11234578899999998765467899999999999999999998885433211000000        0000000000000


Q ss_pred             H-HHhcCC-----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          255 T-ILACGI-----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       255 ~-~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      . ......     .......+..+.+++.+||+.+|++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0 000000     0011234577899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-40  Score=293.52  Aligned_cols=256  Identities=22%  Similarity=0.308  Sum_probs=199.4

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccccc---------hhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG---------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      .|...+.||+|+||.||+|.. .+|+.||+|.+.....         ....+.+..|+.++++++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            577889999999999999965 4689999998753211         112246788999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            999999999999999998443 678999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCC-CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ..............|+..|+|||.+.+.. .++.++|+||||+++|++++|..|+......      ....+.. ...  
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~--  228 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLG-NKR--  228 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhh-ccc--
Confidence            54332222223356888999999987652 4789999999999999999999987432110      0000000 000  


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                        .............+..+.+++.+||+.+|++||++++|++
T Consensus       229 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 --SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             --cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence              0000011122345678999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.4e-40  Score=306.79  Aligned_cols=262  Identities=19%  Similarity=0.232  Sum_probs=196.0

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC------
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------   93 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------   93 (356)
                      ...+|.+.+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4568899999999999999999754 58999999997542 234446788999999999999999999987543      


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ...++||||+.+ +|...+.   ..+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357899999965 7777662   358899999999999999999999   999999999999999999999999999997


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch---------hhhH
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP---------KHVW  244 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~---------~~~~  244 (356)
                      ......   ......||..|+|||++.+. .++.++|||||||++|+|++|+.||........ +..         ...+
T Consensus       175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  249 (364)
T cd07875         175 TAGTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccCCCC---cccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence            654322   12334689999999999876 789999999999999999999999854332100 000         0000


Q ss_pred             HHHhhchhhHHHHhcC------------------CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          245 EEYEKSELDATILACG------------------IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       245 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ...... .........                  ...........+.+++.+||+.||.+|||++++++.
T Consensus       250 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000 000000000                  000111124568899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.2e-41  Score=300.04  Aligned_cols=265  Identities=23%  Similarity=0.332  Sum_probs=200.0

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|++.++||+|+||.||+|.+. +++.||+|++..... ....+.+.+|+++++.++||||+++++++.++...++||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5788899999999999999765 589999998764322 22345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|..+.. ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........  
T Consensus        82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--  155 (286)
T cd07846          82 VDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--  155 (286)
T ss_pred             CCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence            99988887763 34568999999999999999999999   9999999999999999999999999999876543321  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--------cchhhhHHHHhhchhhH
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--------WFPKHVWEEYEKSELDA  254 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~  254 (356)
                      ......++..|+|||++.+...++.++||||||+++|||++|..|+.........        .+...............
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            1223457889999999876545788999999999999999998877533221000        00000000000000000


Q ss_pred             HH-HhcC-----CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          255 TI-LACG-----IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       255 ~~-~~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .. ....     .....+..+..+.+++.+||+.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00 0000     00012234677999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.6e-40  Score=288.42  Aligned_cols=248  Identities=22%  Similarity=0.357  Sum_probs=200.9

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .|++.+.||+|+||.||++.. .+++.+|||++... ........+.+|++++++++|||++++++.+..+...++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999965 46899999998653 2334456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-CceEEcccCCccccCCCCC
Q 038199          103 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       103 ~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfgl~~~~~~~~~  180 (356)
                      +++++|.+++... ...+++..+..++.|++.+|.|||+   ++++|+||+|+||+++.+ +.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999654 3468999999999999999999999   999999999999999855 4689999999987643322


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                      .   ....++..|+|||.+.+. ..+.++||||||+++|+|++|..|+......      .          .........
T Consensus       158 ~---~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~----------~~~~~~~~~  217 (256)
T cd08220         158 A---YTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLP------A----------LVLKIMSGT  217 (256)
T ss_pred             c---cccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchH------H----------HHHHHHhcC
Confidence            1   224578899999999876 6889999999999999999999887443211      0          001111111


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ....+...+.++.+++.+||+.+|++|||+.++++
T Consensus       218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            22233345677999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.7e-40  Score=291.27  Aligned_cols=247  Identities=22%  Similarity=0.289  Sum_probs=195.7

Q ss_pred             cccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCC
Q 038199           29 STRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  107 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~s  107 (356)
                      ...||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.++++++|+||+++++++..+...++|+||+.+++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   91 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS   91 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence            467999999999999754 68889999887542 3345678999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-CCceEEcccCCccccCCCCCeeee
Q 038199          108 LDGYLFGKKRAI--EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTI  184 (356)
Q Consensus       108 L~~~l~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~  184 (356)
                      |.+++......+  ++..+..++.|++.||.|||+   .+++||||||+||+++. ++.++|+|||++........  ..
T Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~  166 (268)
T cd06624          92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CT  166 (268)
T ss_pred             HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--cc
Confidence            999986544555  888999999999999999999   99999999999999976 67999999999876543221  11


Q ss_pred             ccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          185 SGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      ....|+..|+|||.+.+. ..++.++||||||+++|+|++|..|+.........              ..........+.
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~~  232 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--------------MFKVGMFKIHPE  232 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--------------HhhhhhhccCCC
Confidence            223578899999998653 24788999999999999999999887432211000              000001111122


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+.....++.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            34456677999999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.4e-40  Score=290.90  Aligned_cols=252  Identities=26%  Similarity=0.391  Sum_probs=200.0

Q ss_pred             hccccccccccCceEEEEEEeCC--CcEEEEEEecccc---------chhhHHHHHHHHHHHcc-CCCCceeeeeceEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFPN--GVKIAVKVLNRNL---------GRIAEEQFMAEVGTIGR-TYHINLVRLYGFCHD   92 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~ni~~~~~~~~~   92 (356)
                      .|++.+.||+|+||.||+|.+..  ++.+|+|.+....         ......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37888999999999999997643  7889999875321         12333567788888875 689999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEccc
Q 038199           93 QHMTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  169 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df  169 (356)
                      +...++||||+++++|.+++..   ....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999988743   34579999999999999999999995  267999999999999999999999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      |++.......   ......|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+......       ..      
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~~------  221 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNML-------SL------  221 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHH-------HH------
Confidence            9998655432   22345688999999999876 6899999999999999999999887433211       00      


Q ss_pred             chhhHHHHhcCCCc-hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          250 SELDATILACGIEE-KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       250 ~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                         ..........+ .....+..+.+++.+||+.||++||++.++..+++
T Consensus       222 ---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         222 ---ATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ---HHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence               00111111111 11234567999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.1e-40  Score=289.88  Aligned_cols=251  Identities=22%  Similarity=0.259  Sum_probs=197.3

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEecccc----chhhHHHHHHHHHHHccCCCCceeeeeceEecC--Cee
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMT   96 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~   96 (356)
                      ..|++.++||+|+||.||.|.. .+++.||||.+....    .......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4578899999999999999975 468999999885321    123345788999999999999999999988764  467


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            899999999999998843 3568899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ..... .......|+..|+|||.+.+. .++.++||||||+++|||++|+.||.....          ..     .....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~----------~~-----~~~~~  221 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEA----------MA-----AIFKI  221 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccch----------HH-----HHHHH
Confidence            22111 112234588899999998876 689999999999999999999988743211          00     01111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ......+..+......+.+++.+|+. +|++||++++|++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         222 ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            11112233445566778889999985 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.8e-40  Score=290.98  Aligned_cols=254  Identities=26%  Similarity=0.368  Sum_probs=202.3

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccccc-----hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-----RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      .|+..+.||+|++|.||++.. .+++.||+|++.....     ....+.+.+|+.++++++|+||+++++++.+....++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            367789999999999999975 5789999999864321     1234678999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-ceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfgl~~~~~~  177 (356)
                      ||||+.+++|.+++. ....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++ .++|+|||++.....
T Consensus        81 v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999884 34578999999999999999999999   9999999999999998775 599999999877654


Q ss_pred             CCCee--eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          178 NRSHV--TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       178 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      .....  ......|+..|+|||.+.+. .++.++|+||||+++++|++|..|+........       ...     ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-------~~~-----~~~~  223 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-------LAL-----IFKI  223 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-------HHH-----HHHH
Confidence            32111  11224578899999998766 688999999999999999999988754322100       000     0011


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .........+...+.++.+++.+||..+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            1112223445567788999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-41  Score=279.27  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=205.1

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc----ch---hhHHHHHHHHHHHccC-CCCceeeeeceEec
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----GR---IAEEQFMAEVGTIGRT-YHINLVRLYGFCHD   92 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~---~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~   92 (356)
                      ....|.-.+.||.|..++|.++.+ .+|+++|+|++....    ++   .-.+.-.+|+.+|+++ .||||+++.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            344566678999999999999965 479999999985321    11   2224566899999998 59999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      +...|+|+|.|+.|.|.+++ ...-.+++.....|+.|++.|++|||.   ++||||||||+|||++++.+++|+|||++
T Consensus        95 ~sF~FlVFdl~prGELFDyL-ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYL-TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             cchhhhhhhhcccchHHHHh-hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecccee
Confidence            99999999999999999999 456789999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCccccc-----CCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLS-----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      +....+..   ....+||++|+|||.+.     +.+.|+...|+|++||++|.||.|..||-            +-.   
T Consensus       171 ~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw------------HRk---  232 (411)
T KOG0599|consen  171 CQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW------------HRK---  232 (411)
T ss_pred             eccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh------------HHH---
Confidence            98765543   34568999999999874     33478999999999999999999998861            111   


Q ss_pred             hhchhhHHHHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       ..-+.+.+..+...   +.=.+.+....+++.+||+.||.+|.|++|++.
T Consensus       233 -QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 -QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             -HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence             11122333344332   223456778889999999999999999999987

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-40  Score=315.24  Aligned_cols=264  Identities=16%  Similarity=0.208  Sum_probs=188.3

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC------CCceeeeeceEec
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY------HINLVRLYGFCHD   92 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~ni~~~~~~~~~   92 (356)
                      ++...+|.+.++||+|+||+||+|.+. +++.||||+++...  .....+..|+.+++.++      |.+++.+++++..
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            345678999999999999999999754 68899999996431  22234455666666554      4568889888875


Q ss_pred             C-CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC---------
Q 038199           93 Q-HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---------  162 (356)
Q Consensus        93 ~-~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---------  162 (356)
                      . ...|+||+++ |++|.+++. ....+++..+..|+.||+.||.|||+  ..+||||||||+|||++.++         
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIM-KHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccc
Confidence            4 5788999998 678888774 34679999999999999999999997  14999999999999998765         


Q ss_pred             -------ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCc
Q 038199          163 -------SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES  235 (356)
Q Consensus       163 -------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~  235 (356)
                             .+||+|||++......     .....||..|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             ccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   4999999987643221     2335689999999999876 78999999999999999999999986533211


Q ss_pred             cc--------cchhhhHHHHhhchhhHHHHh-----------------cCCCchhHHHHHHHHHHHHhcccCCCCCCCCH
Q 038199          236 LD--------WFPKHVWEEYEKSELDATILA-----------------CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPM  290 (356)
Q Consensus       236 ~~--------~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  290 (356)
                      ..        .++..................                 .............+.+|+.+||+.||++|||+
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            00        000000000000000000000                 00000011123567899999999999999999


Q ss_pred             HHHHH
Q 038199          291 SAVVK  295 (356)
Q Consensus       291 ~~v~~  295 (356)
                      +++++
T Consensus       433 ~e~L~  437 (467)
T PTZ00284        433 RQMTT  437 (467)
T ss_pred             HHHhc
Confidence            99997

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.1e-40  Score=291.31  Aligned_cols=249  Identities=24%  Similarity=0.319  Sum_probs=202.8

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|.+.++||+|+||.||+|.+ .+++.||||++...........+.+|+.++++++||||+++++++.++...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            4577889999999999999975 468999999986543344456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++.  ...+++..+..++.|++.++.|||+   .+++|+||+|+||+++.++.++|+|||++........  
T Consensus        84 ~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06641          84 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence            99999999883  4568999999999999999999999   9999999999999999999999999999876543221  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                      ......++..|+|||.+.+. .++.++|+|||||++|+|++|..|+......                .....+.....+
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~  219 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPM----------------KVLFLIPKNNPP  219 (277)
T ss_pred             hhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchH----------------HHHHHHhcCCCC
Confidence            11224578899999998765 6789999999999999999999887432110                001111112222


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ......+.++.+++.+||+.+|.+||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            3334556778999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.6e-40  Score=294.75  Aligned_cols=244  Identities=25%  Similarity=0.309  Sum_probs=199.4

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|++.+.||+|+||.||++.+. +++.||+|++....  .....+.+.+|++++++++||||+++++++.++...++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            5788999999999999999764 68999999986532  12334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.+++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......   
T Consensus        82 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          82 YVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence            9999999999843 4679999999999999999999999   99999999999999999999999999998876443   


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                        .....|+..|+|||.+.+. ..+.++||||||+++|+|++|..|+.....       ...+..         ... ..
T Consensus       155 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~---------~~~-~~  214 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEK---------ILE-GK  214 (290)
T ss_pred             --CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH---------Hhc-CC
Confidence              1234588999999998766 678999999999999999999998754321       001111         111 11


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      ...+...+..+.+++.+||..||.+|+     +++++++
T Consensus       215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            122334467889999999999999999     6666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.2e-40  Score=293.80  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=198.5

Q ss_pred             HhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEec------
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD------   92 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~------   92 (356)
                      .....|++.+.||+|+||.||+|.+ .+++.+|+|++...  .....++..|+.+++++ +|+|++++++++..      
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            3556888899999999999999976 46899999998654  33446788999999998 69999999999853      


Q ss_pred             CCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           93 QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                      ....++||||+.+++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||+
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence            45789999999999999988543 3568899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      +........  ......|+..|+|||.+..    ...++.++|+|||||++|||++|..||......          ...
T Consensus       168 ~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----------~~~  235 (282)
T cd06636         168 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----------RAL  235 (282)
T ss_pred             hhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH----------hhh
Confidence            875532211  1123458889999998752    225788999999999999999999887432211          000


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                           ................+..+.+++.+||+.||.+||++.+|++
T Consensus       236 -----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 -----FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -----hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                 0001111111122345678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.9e-40  Score=292.67  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=193.8

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHH-HccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|++.+.||+|+||.||++.+. +|+.||+|+++..........+..|+.. ++.++||||+++++++......++||||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            5788899999999999999764 6999999998765433344556666665 5667899999999999999999999999


Q ss_pred             cCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199          103 MENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       103 ~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ++ ++|.+++..   ....+++..+..++.|++.||.|||+   + +++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            96 588777643   24578999999999999999999998   6 9999999999999999999999999998765432


Q ss_pred             CCeeeeccCCCCCCCCCcccccCC---CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ..   .....++..|+|||.+.+.   ..++.++|+||||+++|+|++|..|+......         ++..     ...
T Consensus       158 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~-----~~~  220 (283)
T cd06617         158 VA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------FQQL-----KQV  220 (283)
T ss_pred             cc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---------HHHH-----HHH
Confidence            21   1224578899999988642   24688999999999999999999887432111         0111     011


Q ss_pred             HHhcCCCc-hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIEE-KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       ....... .....+.++.+++.+||..+|++||+++++++
T Consensus       221 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         221 -VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             1111111 11235678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.8e-40  Score=296.72  Aligned_cols=256  Identities=20%  Similarity=0.254  Sum_probs=200.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|.+.+.||+|+||.||++... +++.||+|.+.....  ......+.+|+++++.++||||+++++.+.++...++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999765 588999999875421  2234568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |++|++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++........
T Consensus        82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          82 YVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            9999999999843 4578999999999999999999999   99999999999999999999999999998642111100


Q ss_pred             -------------eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh
Q 038199          182 -------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE  248 (356)
Q Consensus       182 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  248 (356)
                                   .......++..|+|||.+.+. .++.++|+||||+++|||++|..|+......       .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~~~~~~~  229 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQVI  229 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH
Confidence                         001123578889999998766 6899999999999999999999987532211       0011100


Q ss_pred             hchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      ..       ....+......+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       230 ~~-------~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SD-------DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hc-------ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            00       001111222456778999999999999999998777776665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=294.35  Aligned_cols=272  Identities=29%  Similarity=0.413  Sum_probs=213.6

Q ss_pred             hhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHcc--CCCCceeeeeceEecCC----e
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--TYHINLVRLYGFCHDQH----M   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~~~~~~~~~~----~   95 (356)
                      +..-.++.+.||+|.||+||+|.+ +++.||||+++.    .....|..|-++.+.  ++|+||+++++.-....    .
T Consensus       208 ~l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  208 ELDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             cCCchhhHHHhhcCccceeehhhc-cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            445567789999999999999998 568999999974    556778888888776  57999999999876554    7


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCccccCCCCCcEEEcCCCceEEccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC------QQRIIHYDIKPENVLLDANFSPKVADF  169 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------~~~ivH~dikp~Nill~~~~~~kl~Df  169 (356)
                      ++||++|.+.|||.+++  ....++|....+|+..+++||+|||+..      +.+|+|||||++||||..|++..|+||
T Consensus       283 ywLVt~fh~kGsL~dyL--~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYL--KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             eeEEeeeccCCcHHHHH--HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            89999999999999999  5668999999999999999999999733      467999999999999999999999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCC-----ccccchhhHHHHHHHHhCCcccccCCCCccccchhhhH
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT-----HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVW  244 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~  244 (356)
                      |++..+..........+.+||.+|||||++.+..++.     .+.||||+|.|+|||+++.....++..+...    .++
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq----lpf  436 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ----LPF  436 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc----Cch
Confidence            9999988766666666688999999999998765444     4799999999999999987655443333221    122


Q ss_pred             H-HHh----hchhhHHHHhcCCCchhH------HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          245 E-EYE----KSELDATILACGIEEKDK------EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       245 ~-~~~----~~~~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      + .+.    -+++.+.+......+..+      ....-+.+.+..||..||+.|-|+.=+-+++..+....
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            2 111    122222222222222222      34567889999999999999999999999888776543

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3e-40  Score=296.35  Aligned_cols=262  Identities=22%  Similarity=0.276  Sum_probs=198.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccch----hhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +|++.+.||+|+||.||+|... +++.||||.+......    .....+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999764 6899999999754321    2234577899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+ +++|.+++......+++..+..++.||+.||.|||+   .+++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 889999985444479999999999999999999999   999999999999999999999999999998765432


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc---------
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS---------  250 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  250 (356)
                      ..  .....++..|+|||.+.+...++.++|||||||+++||++|..++.......  .+.. ........         
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         157 RK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGK-IFEALGTPTEENWPGVT  231 (298)
T ss_pred             cc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHH-HHHHcCCCchhhhhhcc
Confidence            21  1223467789999998665467899999999999999999965553322110  0000 00000000         


Q ss_pred             hhhHHHHhc-----CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          251 ELDATILAC-----GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       251 ~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .........     .........+..+.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000000000     000111334677899999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-39  Score=291.04  Aligned_cols=258  Identities=26%  Similarity=0.368  Sum_probs=200.2

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC--CeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~~lV~e  101 (356)
                      +|++.++||.|++|.||++.+. +++.||+|.+..........++.+|++++++++||||+++++++.+.  ...++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5778899999999999999764 68999999987654445567899999999999999999999988653  46899999


Q ss_pred             ccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199          102 YMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       102 ~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      |+++++|.+++..   ....++...+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999987642   34568999999999999999999999   99999999999999999999999999998754322


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      ..    ....++..|+|||.+.+. .++.++||||||+++|+|++|..|+.........  ............ ....  
T Consensus       159 ~~----~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~-~~~~--  228 (287)
T cd06621         159 LA----GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG--PIELLSYIVNMP-NPEL--  228 (287)
T ss_pred             cc----ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC--hHHHHHHHhcCC-chhh--
Confidence            21    123478899999998766 6899999999999999999999998655321100  000000000000 0000  


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..........+..+.+++.+||..+|++|||+.+|++
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0001111234567899999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.3e-40  Score=290.90  Aligned_cols=248  Identities=24%  Similarity=0.258  Sum_probs=202.9

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|++.+.||+|+||.||+|... +++.||+|++....  .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            3788999999999999999764 68999999997532  22345689999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.|++|.+++... ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998443 689999999999999999999999   999999999999999999999999999987654332  


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                       ......|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+........        ..     ...... ...
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------~~-----~~~~~~-~~~  218 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR--------DQ-----IRAKQE-TAD  218 (258)
T ss_pred             -cccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHH--------HH-----HHHHhc-ccc
Confidence             12334588899999999876 589999999999999999999999865543210        00     001111 022


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPM--SAVV  294 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~--~~v~  294 (356)
                      ...+...+..+.+++.+||+.||.+||++  ++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            33444566889999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=297.58  Aligned_cols=252  Identities=22%  Similarity=0.259  Sum_probs=200.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccch--hhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR--IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      +|++.+.||+|+||+||+|... +++.||+|.+......  .....+..|+++++.++|+||+++++.+.+....++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5788899999999999999764 5899999999754322  244678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          102 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+.+++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999998543 4579999999999999999999999   9999999999999999999999999999875432211


Q ss_pred             ee---------------------------eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCC
Q 038199          181 HV---------------------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSS  233 (356)
Q Consensus       181 ~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~  233 (356)
                      ..                           ......|+..|+|||++.+. .++.++||||||+++|+|++|..|+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           01123578899999999876 689999999999999999999999754322


Q ss_pred             CccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 038199          234 ESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP----MSAVVK  295 (356)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps----~~~v~~  295 (356)
                      .       ..+.        ...............+..+.+++.+||..||++||+    +++++.
T Consensus       238 ~-------~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 D-------ETFS--------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             H-------HHHH--------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            1       0010        011111111112225778999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-39  Score=286.97  Aligned_cols=252  Identities=26%  Similarity=0.377  Sum_probs=201.5

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999754 689999999875432 23557899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            999999999843 4568999999999999999999999   999999999999999999999999999988765433221


Q ss_pred             e--eccCCCCCCCCCcccccCCC--CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          183 T--ISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       183 ~--~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .  .....++..|+|||.+.+..  ..+.++||||||++++++++|+.||......         +...      .....
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---------~~~~------~~~~~  221 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---------FQIM------FHVGA  221 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---------HHHH------HHHhc
Confidence            1  12345788999999987652  3789999999999999999999998543211         0000      00000


Q ss_pred             cCCCchh--HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          259 CGIEEKD--KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       259 ~~~~~~~--~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...+..+  ...+..+.+++.+||+.+|.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111111  223667889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.4e-40  Score=293.74  Aligned_cols=264  Identities=22%  Similarity=0.282  Sum_probs=196.5

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|.+.+.||+|+||.||+|.. .+|+.||+|++...........+.+|+.+++.++|+||+++++++.++...++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            4688899999999999999975 468899999987543333334678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +. ++|.+.+......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++........ 
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  159 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-  159 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence            96 57776665555678899999999999999999999   99999999999999999999999999998754332211 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh--hchh--------
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE--KSEL--------  252 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~--------  252 (356)
                       .....++..|+|||.+.+...++.++||||||+++|+|++|..||.........  ....+....  ....        
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHHHHHHcCCCChhhhhhhhhcc
Confidence             122347889999999876545788999999999999999999988543321000  000000000  0000        


Q ss_pred             --hHHHHhcCCCch------hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 --DATILACGIEEK------DKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 --~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                        ............      ....+..+.+++.+|+..||.+|||+++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence              000000000000      0012456789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-39  Score=293.13  Aligned_cols=249  Identities=25%  Similarity=0.337  Sum_probs=198.0

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ..|.+.+.||+|+||+||+|... +++.||+|++....  .......+.+|+++++.++|||++++++++.+....++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999764 68999999986322  2233457889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+.| +|.+++......+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            99975 7777775556679999999999999999999999   99999999999999999999999999998754322  


Q ss_pred             eeeeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          181 HVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                          ....++..|+|||++.+  ...++.++||||||+++|||++|..|+......      .....         ....
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~---------~~~~  229 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH---------IAQN  229 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHH---------HhcC
Confidence                22457889999998742  235788999999999999999999887432210      00000         0000


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      ..........+..+.+++.+||+.+|++||++.+|+...
T Consensus       230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            011111234567799999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.2e-40  Score=295.28  Aligned_cols=250  Identities=21%  Similarity=0.318  Sum_probs=198.1

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|.....||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++|+|++++++.+...+..++||||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            3444457799999999999975 468899999986532 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++.  ...+++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++......... 
T Consensus       101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-  174 (292)
T cd06658         101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-  174 (292)
T ss_pred             CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-
Confidence            99999999873  3468999999999999999999999   99999999999999999999999999998755332211 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                       .....|+..|+|||.+.+. .++.++||||||+++|||++|..|+......          .....  ... ... ...
T Consensus       175 -~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----------~~~~~--~~~-~~~-~~~  238 (292)
T cd06658         175 -RKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----------QAMRR--IRD-NLP-PRV  238 (292)
T ss_pred             -CceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHH--HHh-cCC-Ccc
Confidence             1224578899999998766 6889999999999999999999987543211          00000  000 000 011


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ......+..+..++.+||..||.+|||++++++.
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1122345678899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-40  Score=289.86  Aligned_cols=252  Identities=25%  Similarity=0.371  Sum_probs=198.8

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCC------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQH------   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~------   94 (356)
                      ..+|++.+.||+|+||.||+|... +++.+++|++....  ...+.+.+|+.+++++ .|+||+++++++.+..      
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            468899999999999999999764 58899999987642  3446789999999999 6999999999997544      


Q ss_pred             eeeEEEeccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           95 MTALVYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                      ..++||||+++++|.+++...   +..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999988542   4679999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCC----CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      +........  ......|+..|+|||.+...    ..++.++||||||+++++|++|..||......      .... ..
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~-~~  230 (275)
T cd06608         160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALF-KI  230 (275)
T ss_pred             ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHH-Hh
Confidence            876543221  12334588899999987532    24678999999999999999999998532110      0000 00


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ....       ..........+.++.+++.+||..||++|||+.++++
T Consensus       231 ~~~~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRNP-------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hccC-------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0000       0001112335678999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.1e-39  Score=290.23  Aligned_cols=262  Identities=24%  Similarity=0.297  Sum_probs=194.7

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecC--CeeeEEEe
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQ--HMTALVYE  101 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~--~~~~lV~e  101 (356)
                      |++.++||+|+||.||+|... +++.||+|++..............|+.+++++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567899999999999999754 689999999876433333334567899999885 99999999999987  88999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.+ +|.+.+......+++..+..++.|++.||.|||+   .+++||||+|+||+++. +.++|+|||++.........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            9975 8887775555689999999999999999999999   99999999999999999 99999999999865433221


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc-ccch-------hhhHHHHhhchhh
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL-DWFP-------KHVWEEYEKSELD  253 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~-~~~~-------~~~~~~~~~~~~~  253 (356)
                         ....++..|+|||.+.....++.++|||||||++|||++|..|+........ .+..       .............
T Consensus       156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence               2245788999999875443578899999999999999999888744322100 0000       0000000000000


Q ss_pred             HHHHh----cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILA----CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....    ..........+..+.+++.+||+.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000    0001112345788999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=295.40  Aligned_cols=266  Identities=20%  Similarity=0.277  Sum_probs=200.5

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|++.++||+|+||.||+|.+. +++.||+|+++... .....+.+.+|++++++++|+||+++++++.++...++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6889999999999999999765 58899999886532 233446789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      ++++.+..+. .....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++......... 
T Consensus        82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-  156 (288)
T cd07833          82 VERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-  156 (288)
T ss_pred             CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-
Confidence            9987776555 445668999999999999999999999   99999999999999999999999999998876544321 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch--------hhhHHHHhhc-hhh
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP--------KHVWEEYEKS-ELD  253 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~-~~~  253 (356)
                      ......++..|+|||++.+...++.++||||||+++|+|++|..|+........-+..        ......+... ...
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            1223557889999999886646789999999999999999999887543221100000        0000000000 000


Q ss_pred             H-HHHhcCC-----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 A-TILACGI-----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~-~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      . .......     ...+...+.++.+++.+||..+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0 0000000     0011123678999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.9e-40  Score=294.93  Aligned_cols=266  Identities=19%  Similarity=0.203  Sum_probs=199.6

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecC--CeeeEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALV   99 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~~lV   99 (356)
                      ..|++.+.||+|+||.||+|.+. +++.+|+|.++.... ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999865 588999999874321 22234567899999999999999999998877  889999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+.+ +|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999975 9998886655679999999999999999999999   999999999999999999999999999998765432


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----c---chhhhHHHHhhch
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----W---FPKHVWEEYEKSE  251 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~---~~~~~~~~~~~~~  251 (356)
                      ..  .....++..|+|||.+.+...++.++|+||||+++|+|++|..|+.........     .   .....|..+..-.
T Consensus       161 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 KP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             cc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            11  123457889999999876545789999999999999999999887643321100     0   0000011110000


Q ss_pred             hhH------HHHhcCCCchhHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          252 LDA------TILACGIEEKDKE-KAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       252 ~~~------~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...      ............. .+..+.+++.+||+.+|++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            000      0000000001111 3566889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=290.24  Aligned_cols=249  Identities=23%  Similarity=0.325  Sum_probs=210.0

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      -|.+..+||+|+||.||+|.++ .|+.+|||.+..   +.+..++..|+.++++...|++|++||.+.....+|+|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            4567899999999999999665 699999999876   467788999999999999999999999999988999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      ..|++.+.+..+++++++..+..++...+.||+|||.   ..-+|||||..|||++.+|++||+|||.+..+.+...+. 
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR-  186 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR-  186 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh-
Confidence            9999999998889999999999999999999999999   888999999999999999999999999998766544333 


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                       ....||+.|||||++..- .|..++||||||+...||..|++|+..-.+          ...+    +.-...+.+.-.
T Consensus       187 -NTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHP----------MRAI----FMIPT~PPPTF~  250 (502)
T KOG0574|consen  187 -NTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHP----------MRAI----FMIPTKPPPTFK  250 (502)
T ss_pred             -CccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccc----------ccee----EeccCCCCCCCC
Confidence             335699999999999865 789999999999999999999988633111          1000    000011222234


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .+...+.++-+++++||-++|++|-|+-++++.
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            567778899999999999999999999888763

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-39  Score=288.98  Aligned_cols=244  Identities=23%  Similarity=0.256  Sum_probs=188.4

Q ss_pred             cccccCceEEEEEEeC-CCcEEEEEEeccccch--hhHHHHHHHHHHHc---cCCCCceeeeeceEecCCeeeEEEeccC
Q 038199           31 RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR--IAEEQFMAEVGTIG---RTYHINLVRLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        31 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~---~l~h~ni~~~~~~~~~~~~~~lV~e~~~  104 (356)
                      .||+|+||.||++... +++.||+|.+......  .....+.+|..+++   ...|||++.+++++...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999764 6899999988653211  11223444444433   3479999999999999899999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeee
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI  184 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  184 (356)
                      +++|.+++. ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......    .
T Consensus        81 ~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            999998884 44579999999999999999999999   999999999999999999999999999987554322    1


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCch
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEK  264 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (356)
                      ....|+..|+|||.+.+...++.++|||||||++|+|++|..||........        ...     .... .......
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------~~~-----~~~~-~~~~~~~  218 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------HEI-----DRMT-LTVNVEL  218 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--------HHH-----HHHh-hcCCcCC
Confidence            2345899999999986543678999999999999999999999854322110        000     0000 0111223


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038199          265 DKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVKM  296 (356)
Q Consensus       265 ~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~  296 (356)
                      +...+.++.+++.+||+.||++||     +++++++.
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            345677899999999999999999     58888773

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-39  Score=290.57  Aligned_cols=251  Identities=21%  Similarity=0.288  Sum_probs=201.4

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+|.+.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++++++|||++++++.+......++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            36888999999999999999965 468899999986432 2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++++|.+++.  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.........
T Consensus        97 ~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             cCCCCcHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            999999999983  3468899999999999999999999   99999999999999999999999999998765433221


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                        .....|+..|+|||.+.+. .++.++|+||||+++|++++|..||..........      ... .       .....
T Consensus       172 --~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~-~-------~~~~~  234 (293)
T cd06647         172 --RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIA-T-------NGTPE  234 (293)
T ss_pred             --cccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehh-c-------CCCCC
Confidence              1224578899999998766 68899999999999999999999985433211000      000 0       00000


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .......+..+.+++.+||..+|++||++.+++..
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11122345678899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-39  Score=291.42  Aligned_cols=254  Identities=24%  Similarity=0.324  Sum_probs=197.6

Q ss_pred             HhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecC-----
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ-----   93 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~-----   93 (356)
                      -....|.+.+.||+|+||.||++.. .+++.+|+|++...  ......+.+|+.+++++ +|||++++++++...     
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            3467789999999999999999976 46899999998653  23345678899999998 799999999998753     


Q ss_pred             CeeeEEEeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           94 HMTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      ...++||||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecc
Confidence            357999999999999998743   34678999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCC----CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY----PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      ++.........  .....|+..|+|||.+....    .++.++|||||||++|||++|+.|+......       .....
T Consensus       174 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------~~~~~  244 (291)
T cd06639         174 VSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------KTLFK  244 (291)
T ss_pred             cchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------HHHHH
Confidence            98765432211  12245788999999875431    3688999999999999999999887532210       00000


Q ss_pred             HhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +....       .............+.+++.+||+.+|++||++.++++
T Consensus       245 ~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         245 IPRNP-------PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HhcCC-------CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00000       0001112334567899999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.7e-39  Score=291.13  Aligned_cols=252  Identities=26%  Similarity=0.342  Sum_probs=199.9

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|...+.||+|+||.||++... ++..||+|++....  .......+..|++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667889999999999999754 68999999986432  22334578899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.| +|.+.+......+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......   
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            9975 7877775556779999999999999999999999   99999999999999999999999999998654322   


Q ss_pred             eeeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          182 VTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                         ....|+..|+|||.+..  ...++.++|||||||++|||++|..|+......               ..........
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---------------~~~~~~~~~~  240 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---------------SALYHIAQNE  240 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---------------HHHHHHHhcc
Confidence               22457889999998742  225788999999999999999999887432110               0000111111


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      .........+..+.+++.+||+.+|.+||++.+|++.+....
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            112223345567899999999999999999999998665543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=294.86  Aligned_cols=248  Identities=27%  Similarity=0.334  Sum_probs=205.6

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ...++..-++||+||||.||-++.+ +|+.||.|.+.+..  ......-..+|-.+|++++.+.||.+-..|+.++.+|+
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            3455666799999999999999754 69999999886432  12222346789999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      |+..|+||+|.-++... +..+++..+..++.+|+.||++||.   ..||+||+||+|||+|+.|+++|+|+|++..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            99999999999888554 4579999999999999999999999   9999999999999999999999999999987764


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ..   .+.+.+||.+|||||++.+. .|+...|.|||||++|||+.|..||...            .+....+++.+.+.
T Consensus       340 g~---~~~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~------------KeKvk~eEvdrr~~  403 (591)
T KOG0986|consen  340 GK---PIRGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQR------------KEKVKREEVDRRTL  403 (591)
T ss_pred             CC---ccccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhh------------hhhhhHHHHHHHHh
Confidence            43   33445799999999999988 5999999999999999999999998432            23334445555554


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCC
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP  289 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  289 (356)
                      ... ...+..++++..++....|.+||++|-.
T Consensus       404 ~~~-~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  404 EDP-EEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             cch-hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            433 2345677888889999999999999953

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-39  Score=291.61  Aligned_cols=266  Identities=20%  Similarity=0.238  Sum_probs=191.1

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC-C---CcEEEEEEeccccchhhH----------HHHHHHHHHHccCCCCce
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP-N---GVKIAVKVLNRNLGRIAE----------EQFMAEVGTIGRTYHINL   83 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~ni   83 (356)
                      ..++...+|.+.++||+|+||+||+|... +   +..+|+|+..........          .....+...+..+.|+|+
T Consensus         6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            34567788999999999999999999754 3   456777765432111100          112334455667789999


Q ss_pred             eeeeceEecCC----eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc
Q 038199           84 VRLYGFCHDQH----MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD  159 (356)
Q Consensus        84 ~~~~~~~~~~~----~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~  159 (356)
                      +.+++++....    ..+++++++.. ++.+.+. .....++..+..|+.|++.||.|||+   .+++||||||+|||++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~  160 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVD  160 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhcc-CHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEc
Confidence            99999776543    44678888744 6766663 23446788899999999999999999   9999999999999999


Q ss_pred             CCCceEEcccCCccccCCCCCe-----eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCC
Q 038199          160 ANFSPKVADFGLAKLCDRNRSH-----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE  234 (356)
Q Consensus       160 ~~~~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~  234 (356)
                      .++.++|+|||+++.+......     .......||..|+|||++.+. .++.++|||||||++|||++|..||......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            9999999999999876432211     111234699999999999876 6899999999999999999999998654321


Q ss_pred             ccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          235 SLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ...  ....     .......+....  ......+..+.+++..|+..+|++||+++++++.|+
T Consensus       240 ~~~--~~~~-----~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        240 GNL--IHAA-----KCDFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHH--HHHh-----HHHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            110  0000     000111111111  112234677999999999999999999999998763

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.8e-40  Score=294.33  Aligned_cols=246  Identities=22%  Similarity=0.336  Sum_probs=196.7

Q ss_pred             ccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCC
Q 038199           28 YSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        28 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      ...+||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++|||++++++++..+...++||||++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            3567999999999999754 68999999986432 233467889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeecc
Q 038199          107 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG  186 (356)
Q Consensus       107 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  186 (356)
                      +|..++  ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........  ...
T Consensus       104 ~L~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~  176 (297)
T cd06659         104 ALTDIV--SQTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKS  176 (297)
T ss_pred             CHHHHH--hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccc
Confidence            999887  33568999999999999999999999   99999999999999999999999999998755432211  123


Q ss_pred             CCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhH
Q 038199          187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK  266 (356)
Q Consensus       187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (356)
                      ..|+..|+|||++.+. .++.++||||||+++|||++|..|+.......       ....+...       .........
T Consensus       177 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~-------~~~~~~~~~  241 (297)
T cd06659         177 LVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDS-------PPPKLKNAH  241 (297)
T ss_pred             eecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcc-------CCCCccccC
Confidence            4588999999999876 68999999999999999999999885432210       00000000       000011122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       267 ~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ..+..+.+++.+||+.+|++||+++++++.
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            345678899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.9e-39  Score=282.17  Aligned_cols=247  Identities=28%  Similarity=0.440  Sum_probs=202.8

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      +|++.+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++++......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            3678899999999999999765 689999999976532 35578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      ++++|.+++......+++..+..++.|++.||.+||+   .+++||||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            9999999986555689999999999999999999999   9999999999999999999999999999887654432   


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      .....++..|+|||.+.+. ..+.++|+||||+++++|++|..|+......          ....      .........
T Consensus       154 ~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~~------~~~~~~~~~  216 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPM----------KALF------KIATNGPPG  216 (253)
T ss_pred             ccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchH----------HHHH------HHHhcCCCC
Confidence            2234578899999999876 5889999999999999999999887543211          0000      000011111


Q ss_pred             h--hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          264 K--DKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       264 ~--~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .  ....+..+.+++.+||+.||++|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1  1222677999999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.3e-39  Score=284.23  Aligned_cols=252  Identities=28%  Similarity=0.381  Sum_probs=206.1

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      .|++.+.||+|++|.||+|... +++.||||++...........+..|+..+++++|+|++++++++......++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            4778899999999999999765 599999999876543345678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      ++++|.+++.. ...+++..+..++.|++.|+.|||+  ..+++||||+|+||+++.++.++|+|||++.......... 
T Consensus        82 ~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-  157 (264)
T cd06623          82 DGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-  157 (264)
T ss_pred             CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence            99999999843 3779999999999999999999996  3899999999999999999999999999988764333221 


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                       ....++..|+|||.+.+. .++.++|+||||+++|+|++|..|+.......        +.     .............
T Consensus       158 -~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--------~~-----~~~~~~~~~~~~~  222 (264)
T cd06623         158 -NTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPS--------FF-----ELMQAICDGPPPS  222 (264)
T ss_pred             -cceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccC--------HH-----HHHHHHhcCCCCC
Confidence             234578899999998876 78899999999999999999999875543200        00     0011111112223


Q ss_pred             hhHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          264 KDKE-KAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       264 ~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .... .+..+.+++.+||..+|++||++.++++
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            3333 6778999999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-39  Score=289.47  Aligned_cols=264  Identities=22%  Similarity=0.274  Sum_probs=197.0

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      |+..+.||.|+||.||+|... +++.||||.+.... .......+.+|++++++++||||+++++++.+....++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            678899999999999999764 68999999886432 2223357889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          104 ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       104 ~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      . ++|.+++... ...+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++......... 
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-  156 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-  156 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence            6 5888887543 4678999999999999999999999   99999999999999999999999999998765432211 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cc---hhhhHHHHhhchhhH
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WF---PKHVWEEYEKSELDA  254 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~---~~~~~~~~~~~~~~~  254 (356)
                       .....++..|+|||.+.+...++.++||||||+++|+|+||+.|+.........     .+   ....|..........
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence             122346788999998876545688999999999999999999988544321100     00   000000000000000


Q ss_pred             HHHhcCC----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          255 TILACGI----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       255 ~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .......    ....+..+.++.+++.+||+.||++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000000    0011223466889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-39  Score=290.49  Aligned_cols=265  Identities=23%  Similarity=0.314  Sum_probs=200.1

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      .|++.++||+|++|.||+|++. +|+.||||++...........+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            3778899999999999999865 689999999876543444567788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          104 ENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       104 ~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      .+ +|.+++....  ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||++.........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            76 8888775433  568999999999999999999999   99999999999999999999999999998755432211


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc--------chhhhHHHHhhchhh
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW--------FPKHVWEEYEKSELD  253 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~  253 (356)
                        .....++..|++||.+.+...++.++||||||+++|+|++|..|+.........-        .....|+.+......
T Consensus       157 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         157 --FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             --cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence              1223468899999998765467899999999999999999998876543211000        000001111100000


Q ss_pred             HHHHh----cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILA----CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....    .......+..+..+.+++.+|++.||.+||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000    0000112234677889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.9e-39  Score=287.44  Aligned_cols=250  Identities=24%  Similarity=0.329  Sum_probs=202.2

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...|++.+.||+|++|.||+|.+. +++.||+|++.....  ....+..|++++++++|+|++++++.+......++|+|
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            345777899999999999999775 688999999976432  45678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++++|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.........
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence            999999999996544489999999999999999999999   99999999999999999999999999998755432211


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC-
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG-  260 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  260 (356)
                        .....++..|++||.+.+. .++.++|+||||+++|+|++|..|+......          ....     ....... 
T Consensus       173 --~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----------~~~~-----~~~~~~~~  234 (286)
T cd06614         173 --RNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----------RALF-----LITTKGIP  234 (286)
T ss_pred             --hccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHH----------HHHH-----HHHhcCCC
Confidence              1223478899999998766 6899999999999999999999887432211          0000     0000000 


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........+..+.+++.+||+.+|.+||++.+|++
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11122235678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-39  Score=284.91  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=200.0

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|.+.+.||+|+||.||+|... +|..+|+|.+.... .....+.+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999764 58899999986531 223446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-ceEEcccCCccccCCCCC
Q 038199          103 MENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       103 ~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfgl~~~~~~~~~  180 (356)
                      +.+++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++ .++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            9999999988543 3358999999999999999999999   9999999999999998885 469999999876643322


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                      .  .....|+..|+|||.+.+. .++.++|+||||+++++|++|..|+......      ....          ......
T Consensus       158 ~--~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~----------~~~~~~  218 (257)
T cd08225         158 L--AYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVL----------KICQGY  218 (257)
T ss_pred             c--ccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH----------HHhccc
Confidence            1  1224588899999998766 6889999999999999999999887432110      0000          111112


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........+.++.+++.+||..+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         219 FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            22233445667999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-40  Score=299.14  Aligned_cols=273  Identities=22%  Similarity=0.306  Sum_probs=200.8

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC-----eee
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----MTA   97 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-----~~~   97 (356)
                      .+|++.++||+|+||.||+|.+ .+|+.||||++...........+..|+.++++++|+||+++++++....     ..+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            5788999999999999999965 4689999999864333344567889999999999999999999876543     578


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +|+||+.+ +|.+++  ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        85 lv~e~~~~-~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          85 IVQELMET-DLYKLI--KTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEehhccc-CHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            99999965 888777  44579999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCee-eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc-cc----chhhhHHHHh---
Q 038199          178 NRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL-DW----FPKHVWEEYE---  248 (356)
Q Consensus       178 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~-~~----~~~~~~~~~~---  248 (356)
                      ..... ......|+..|+|||.+.+...++.++|||||||++|+|++|+.|+........ ..    +.....+.+.   
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            22211 112346889999999876554688999999999999999999988743221000 00    0000000000   


Q ss_pred             hchhhHHHHhcCC-C-----chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhcccc
Q 038199          249 KSELDATILACGI-E-----EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM--LEGVVE  302 (356)
Q Consensus       249 ~~~~~~~~~~~~~-~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~--L~~~~~  302 (356)
                      ............. .     ...+..+.++.+++.+||+.+|++||++.++++.  ++....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            0000000000000 0     0112345778999999999999999999999985  555543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-39  Score=290.75  Aligned_cols=255  Identities=25%  Similarity=0.340  Sum_probs=196.0

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .++++.++||+|+||.||++.+. +++.||+|.+...........+.+|+.++.++. |+||+++++++.+....+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            45667789999999999999764 689999999875433445567889999999996 9999999999999889999999


Q ss_pred             ccCCCChhhhhh----cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199          102 YMENGSLDGYLF----GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       102 ~~~~~sL~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      |+.. +|.++..    .....+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9864 6655432    124679999999999999999999997  24999999999999999999999999999876543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCC--CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ....   ....|+..|+|||.+.+.  ..++.++||||||+++|+|++|+.||.....         ..+.......  .
T Consensus       161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~~~~--~  226 (288)
T cd06616         161 SIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---------VFDQLTQVVK--G  226 (288)
T ss_pred             CCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---------HHHHHhhhcC--C
Confidence            3221   223578899999998755  3578999999999999999999998743221         0111000000  0


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .............+.++.+++.+||+.+|++||++++|++
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000011112346678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-41  Score=282.64  Aligned_cols=250  Identities=24%  Similarity=0.293  Sum_probs=206.4

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      -..++.+.++||+|.||.|.+++-+ +++.||+|++++..  ......+-..|-++|+..+||.+..+-..|...+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3456778899999999999999754 79999999998653  23333566789999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||..||.|.-.+ ++.+.+++.....+...|+.||.|||+   ++||+||||.+|.|+|.+|++||+|||+++.-...
T Consensus       246 VMeyanGGeLf~HL-srer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  246 VMEYANGGELFFHL-SRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEccCceEeeeh-hhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            99999999999888 456789999999999999999999999   99999999999999999999999999999864322


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                        ......++||+.|+|||++..+ .|.++.|.|.+||++|||++|+.||.....+       ..++.+...+       
T Consensus       322 --g~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-------kLFeLIl~ed-------  384 (516)
T KOG0690|consen  322 --GDTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-------KLFELILMED-------  384 (516)
T ss_pred             --cceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchh-------HHHHHHHhhh-------
Confidence              2344668999999999999988 8999999999999999999999998654432       1122221111       


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                         -..+...+.+...|+.-.|.+||.+|-     .++||.+
T Consensus       385 ---~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  385 ---LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             ---ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence               134555667788899999999999994     4555554

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.4e-39  Score=284.08  Aligned_cols=243  Identities=25%  Similarity=0.354  Sum_probs=195.6

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCCh
Q 038199           32 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        32 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      ||.|+||.||++... +++.||+|++....  .....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999764 58999999987542  223446799999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCC
Q 038199          109 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK  188 (356)
Q Consensus       109 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  188 (356)
                      .+++.+ ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......   ......
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            999843 4568999999999999999999999   999999999999999999999999999998765432   112245


Q ss_pred             CCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHH
Q 038199          189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK  268 (356)
Q Consensus       189 gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (356)
                      ++..|++||.+.+. .++.++|+||||+++|+|++|..|+.....+..     ..+        ............+...
T Consensus       154 ~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~--------~~~~~~~~~~~~~~~~  219 (262)
T cd05572         154 GTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-----EIY--------NDILKGNGKLEFPNYI  219 (262)
T ss_pred             CCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-----HHH--------HHHhccCCCCCCCccc
Confidence            78899999998765 688999999999999999999998865432100     000        0011001112223334


Q ss_pred             HHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          269 AKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       269 ~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      +.++.+++.+||+.+|++||+     ++++++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            678999999999999999999     677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=289.39  Aligned_cols=265  Identities=22%  Similarity=0.259  Sum_probs=198.7

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC--CeeeEEEe
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALVYE  101 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~~lV~e  101 (356)
                      |++.++||+|+||.||+|... +++.+|+|++.... .......+.+|+.++++++|+|++++++++.+.  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999765 58999999997653 223345688999999999999999999999988  88999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++ +|.+++......+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9975 8988885555689999999999999999999999   99999999999999999999999999999876544321


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-cc-------hhhhHHHHhhchhh
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-WF-------PKHVWEEYEKSELD  253 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-~~-------~~~~~~~~~~~~~~  253 (356)
                       ......++..|+|||.+.+...++.++||||||+++|||++|..|+......... ..       ....|.........
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         157 -DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             -cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence             1222346788999998876546789999999999999999999887543321000 00       00000000000000


Q ss_pred             HHHHh-c----CCCchhHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILA-C----GIEEKDKE-KAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~-~----~~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..... .    ........ ++..+.+++.+||+.+|.+||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00000 0    00001111 2677899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=291.69  Aligned_cols=267  Identities=20%  Similarity=0.272  Sum_probs=196.4

Q ss_pred             hccccccccccCceEEEEEEeC---CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecC--Ceee
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTA   97 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~~   97 (356)
                      +|.+.++||+|+||.||+|...   +++.||+|.+....  .......+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999764   47899999997632  112235678899999999999999999999988  7899


Q ss_pred             EEEeccCCCChhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC----CCceEEccc
Q 038199           98 LVYEYMENGSLDGYLFGK----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----NFSPKVADF  169 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~----~~~~kl~Df  169 (356)
                      +||||+++ +|.+++...    ...+++..+..++.|++.||.|||+   .+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 666665321    2378999999999999999999999   99999999999999999    899999999


Q ss_pred             CCccccCCCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch--hhh---
Q 038199          170 GLAKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP--KHV---  243 (356)
Q Consensus       170 gl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~--~~~---  243 (356)
                      |++......... .......++..|+|||.+.+...++.++||||||+++++|++|..|+...........+  ...   
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            998876443321 12223457889999998876546789999999999999999999988654433210000  000   


Q ss_pred             ------------HHHHhhc-hhhHHHHhcC---CC--chh------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          244 ------------WEEYEKS-ELDATILACG---IE--EKD------KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       244 ------------~~~~~~~-~~~~~~~~~~---~~--~~~------~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                                  |...... ..........   ..  ...      .....++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                        0000000 0000000000   00  000      023456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.8e-39  Score=281.88  Aligned_cols=247  Identities=26%  Similarity=0.355  Sum_probs=204.6

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|++.++||+|+||.||++.. .+++.+|+|++.... .......+.+|+.++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999965 468899999987532 334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          103 MENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       103 ~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      +++++|.+++...   ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            9999999988542   3578999999999999999999999   999999999999999999999999999998765441


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                          .....++..|++||.+.+. .++.++|+||||+++|+|++|..|+......                .........
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~~  216 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----------------DLRYKVQRG  216 (256)
T ss_pred             ----cccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhcC
Confidence                1224578899999999776 6888999999999999999999887543211                111122223


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+......+.++.+++.+|++.+|++||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            334444567788999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.2e-39  Score=288.84  Aligned_cols=269  Identities=22%  Similarity=0.239  Sum_probs=199.7

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC--
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH--   94 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~--   94 (356)
                      ++.....|++.+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++++++|||++++++++.+..  
T Consensus         2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            3456678899999999999999999765 58999999987532 2233356788999999999999999999987654  


Q ss_pred             --------eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEE
Q 038199           95 --------MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV  166 (356)
Q Consensus        95 --------~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl  166 (356)
                              ..++|+||+++ +|..++......+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence                    78999999976 7777775555679999999999999999999999   99999999999999999999999


Q ss_pred             cccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH
Q 038199          167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       167 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      +|||++......... ......++..|+|||.+.+...++.++|||||||++|+|++|+.|+........  + ......
T Consensus       158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~-~~~~~~  233 (302)
T cd07864         158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--L-ELISRL  233 (302)
T ss_pred             CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHH
Confidence            999999866443221 111233577899999886554578899999999999999999988754322100  0 000000


Q ss_pred             -----------HhhchhhHHH-----HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          247 -----------YEKSELDATI-----LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       247 -----------~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                                 +.........     ............+..+.+++.+||+.+|++||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                       0000000000     000000011123567899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.9e-39  Score=280.54  Aligned_cols=252  Identities=25%  Similarity=0.337  Sum_probs=204.6

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecC--CeeeEEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALVY  100 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~~lV~  100 (356)
                      .|...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|+.++++++||||+++++++.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667899999999999999765 689999999875421 23457889999999999999999999999988  8899999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |++.+++|.+++... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            999999999998543 489999999999999999999999   9999999999999999999999999999887665433


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                      ........++..|+|||.+.+. ..+.++||||||+++++|++|..|+......     ....+.         ......
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~---------~~~~~~  221 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYK---------IGSSGE  221 (260)
T ss_pred             cccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHh---------ccccCC
Confidence            1112334588899999998876 5899999999999999999999987654310     000000         000111


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ....+...+..+.+++.+|+..+|++||++.++++
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            22333445778999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=304.48  Aligned_cols=271  Identities=25%  Similarity=0.369  Sum_probs=207.0

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC------Ce
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HM   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------~~   95 (356)
                      +..|...+.||+|+||.||+|+++ +|+.||||+++.-......++..+|++++++|+|+|||+++++=.+.      ..
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            467778899999999999999865 69999999998765667778999999999999999999999976544      35


Q ss_pred             eeEEEeccCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc--CCC--ceEEccc
Q 038199           96 TALVYEYMENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANF--SPKVADF  169 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~--~~~--~~kl~Df  169 (356)
                      ..+|||||.||||+..+++-  ...+++...+.++..++.||.|||.   ++||||||||.||++-  .+|  ..||+||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecc
Confidence            68999999999999999653  4679999999999999999999999   9999999999999993  333  5799999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      |.|+..++..   ...+..||..|.+||....+..|+..+|.|||||++|+..||..||.+........  ...|.....
T Consensus       169 G~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~--~~~~~~~tk  243 (732)
T KOG4250|consen  169 GAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK--EIMWHIITK  243 (732)
T ss_pred             cccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc--hhhhhhhcc
Confidence            9999887665   44567899999999999854489999999999999999999999998865542100  111111111


Q ss_pred             chhhHHH-----Hh------cC---CCchhHHHHHHHHHHHHhcccCCCCCCC--CHHHHHHHHhccc
Q 038199          250 SELDATI-----LA------CG---IEEKDKEKAKRLCMAALWCVQDSPEDRP--PMSAVVKMLEGVV  301 (356)
Q Consensus       250 ~~~~~~~-----~~------~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rp--s~~~v~~~L~~~~  301 (356)
                      ......+     ..      ..   .....+.....+-..+-.+|..+|.+|.  ...+....+..+.
T Consensus       244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            1000000     00      00   1112234445556667778888888888  6555555544433

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-40  Score=294.35  Aligned_cols=255  Identities=20%  Similarity=0.246  Sum_probs=203.6

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCCCcEEEEEEec-cccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~   97 (356)
                      .++...|++.++||+||-+.||++...+.+-||+|.+. .........-|.+|+.+|.+|+ |.+|+.++++-..++++|
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            35677899999999999999999987776777777664 3344666788999999999996 999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +|||+-+. +|..+|.+...-++.-.+..+..|++.++.++|.   .||||.||||.|+|+-. |.+||+|||++.....
T Consensus       437 mvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  437 MVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             EEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            99999744 9999997665555544899999999999999999   99999999999999965 4999999999998877


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCC----------CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      ..........+||..||+||.+...          ...++++|||||||+||+|+.|+.||..-..         .|..+
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~aKl  582 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QIAKL  582 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HHHHH
Confidence            6666666778999999999987532          1367899999999999999999999743211         12221


Q ss_pred             hhchhhHHHHhc---CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILAC---GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .     +...++   .++..+.  ..++.++++.||..||.+||+..++++
T Consensus       583 ~-----aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 H-----AITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             H-----hhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            1     111111   1111122  223899999999999999999999997

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.4e-39  Score=290.34  Aligned_cols=268  Identities=23%  Similarity=0.259  Sum_probs=197.7

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecC--CeeeE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTAL   98 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~~l   98 (356)
                      ...|++.+.||+|+||.||+|.+. +|+.||+|++..... ......+.+|+.++++++|+|++++++++.+.  ...++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            457889999999999999999764 699999999864321 12223567899999999999999999998755  56899


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||+.+ +|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999965 8888886556789999999999999999999999   99999999999999999999999999999876533


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cch---hhhHHHHhhc
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WFP---KHVWEEYEKS  250 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~~---~~~~~~~~~~  250 (356)
                      ...  .....++..|+|||.+.+...++.++||||||+++|||++|..|+.........     ...   ...|......
T Consensus       162 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         162 AKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             cCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            211  122335778999999876546889999999999999999999888543221100     000   0000000000


Q ss_pred             hhhHHH-Hh-cCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          251 ELDATI-LA-CGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       251 ~~~~~~-~~-~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ...... .. ...   .......+..+.+++.+||+.||++|||+++++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000 00 000   00011235678899999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.8e-39  Score=280.93  Aligned_cols=249  Identities=25%  Similarity=0.400  Sum_probs=204.9

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|.+.+.||.|+||.||++.+. +++.||+|++.... .......+..|+++++.++|+|++++++.+......++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999764 68999999987542 234556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          103 MENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       103 ~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      +++++|.+++...   ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999998654   3789999999999999999999999   999999999999999999999999999998765443


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      .  ......|+..|+|||.+.+. .++.++|+||+|+++++|++|..|+......                .........
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~~  218 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLL----------------ELALKILKG  218 (258)
T ss_pred             c--eecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHH----------------HHHHHHhcC
Confidence            1  12234588899999998776 6889999999999999999999887443211                111111112


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....+...+..+.+++.+||..+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            222333356678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9e-40  Score=312.09  Aligned_cols=270  Identities=19%  Similarity=0.261  Sum_probs=187.6

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC--CCcEEEEEEec--------------c--ccchhhHHHHHHHHHHHccCCCC
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP--NGVKIAVKVLN--------------R--NLGRIAEEQFMAEVGTIGRTYHI   81 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~--------------~--~~~~~~~~~~~~E~~~l~~l~h~   81 (356)
                      +.....|.+.++||+|+||+||++..+  .+...++|.+.              .  .........+.+|+.++++++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            334568999999999999999998653  23223322111              0  01122345688999999999999


Q ss_pred             ceeeeeceEecCCeeeEEEeccCCCChhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEE
Q 038199           82 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL  157 (356)
Q Consensus        82 ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nil  157 (356)
                      ||+++++++.+....++|++++.+ +|..++...    ........+..|+.||+.||.|||+   ++|+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence            999999999999999999999954 777666332    2234566788999999999999999   99999999999999


Q ss_pred             EcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCc-c
Q 038199          158 LDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES-L  236 (356)
Q Consensus       158 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~-~  236 (356)
                      ++.++.+||+|||+++.+...... ......||..|+|||++.+. .++.++|||||||++|||++|..++....... .
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            999999999999999876543222 12235699999999999876 78999999999999999999875443322111 0


Q ss_pred             ccchhhh------HHHHhh--chhhHHHHhc-------CCCch--hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          237 DWFPKHV------WEEYEK--SELDATILAC-------GIEEK--DKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       237 ~~~~~~~------~~~~~~--~~~~~~~~~~-------~~~~~--~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+....      .+.+..  ......+...       ..+..  ....+.++.+++.+||+.||.+|||+.|+++
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000000      000000  0000000000       00000  0112345777899999999999999999987

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=287.63  Aligned_cols=263  Identities=22%  Similarity=0.291  Sum_probs=197.1

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEEecc
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      |.+.+.||+|+||+||+|... +++.||||.+.............+|+..+++++ |+|++++++++.++...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            578899999999999999865 588999999876543333345567999999998 999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          104 ENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       104 ~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                       +++|.+++.... ..+++..+..++.|++.+|.|||+   .+++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             779988885543 578999999999999999999999   9999999999999999999999999999876543221  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cchhhhHHHHhhch----hh
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WFPKHVWEEYEKSE----LD  253 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~----~~  253 (356)
                       .....++..|+|||.+.+...++.++|+||||++++||++|..|+.........     ++.......+....    ..
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence             122457889999998865546789999999999999999998877443221100     00000000000000    00


Q ss_pred             HHHHhcCC----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILACGI----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........    ....+..+.++.+++.+||+.+|++||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000    0011122467999999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.9e-40  Score=319.21  Aligned_cols=250  Identities=28%  Similarity=0.399  Sum_probs=194.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe------------
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH------------   91 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~------------   91 (356)
                      +|+..+.||+||||.||+++++ +|+.||||+|....+......+.+|+.++++|+|||||+++..+.            
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~  559 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV  559 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence            4455688999999999999876 899999999987656666678999999999999999999983110            


Q ss_pred             ------------------------------------------------------------------c-------------
Q 038199           92 ------------------------------------------------------------------D-------------   92 (356)
Q Consensus        92 ------------------------------------------------------------------~-------------   92 (356)
                                                                                        +             
T Consensus       560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~  639 (1351)
T KOG1035|consen  560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS  639 (1351)
T ss_pred             ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence                                                                              0             


Q ss_pred             --------------------C--------CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038199           93 --------------------Q--------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ  144 (356)
Q Consensus        93 --------------------~--------~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~  144 (356)
                                          +        ..+||=||||+..+|.+++......-....+++++.+|+.||.|+|+   +
T Consensus       640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~  716 (1351)
T KOG1035|consen  640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---Q  716 (1351)
T ss_pred             cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---C
Confidence                                0        23578899999977777774332222578899999999999999999   9


Q ss_pred             CccccCCCCCcEEEcCCCceEEcccCCccccC----------------CCCCeeeeccCCCCCCCCCcccccCCC--CCC
Q 038199          145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCD----------------RNRSHVTISGYKGTPGYSAPEFLSGNY--PIT  206 (356)
Q Consensus       145 ~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  206 (356)
                      |+|||||||.||++++++.|||+|||++....                ........++..||.-|+|||++.+..  .|+
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999999999999999998721                011111345678999999999998765  599


Q ss_pred             ccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCch---hHHHHHHHHHHHHhcccCC
Q 038199          207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEK---DKEKAKRLCMAALWCVQDS  283 (356)
Q Consensus       207 ~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~  283 (356)
                      .|.|+||||||++||+.   ||.               ..+++......+..+.++..   ..+....-..+|.++++.|
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~---------------TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd  858 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFG---------------TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHD  858 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCC---------------chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCC
Confidence            99999999999999993   322               22333344444444444444   3444455678999999999


Q ss_pred             CCCCCCHHHHHH
Q 038199          284 PEDRPPMSAVVK  295 (356)
Q Consensus       284 p~~Rps~~~v~~  295 (356)
                      |.+|||+.+++.
T Consensus       859 P~kRPtA~eLL~  870 (1351)
T KOG1035|consen  859 PSKRPTATELLN  870 (1351)
T ss_pred             CccCCCHHHHhh
Confidence            999999999986

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-38  Score=284.59  Aligned_cols=247  Identities=22%  Similarity=0.322  Sum_probs=197.0

Q ss_pred             ccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccC
Q 038199           26 SNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~  104 (356)
                      +.-.++||+|++|.||++.. .+++.+++|++.... ....+.+.+|+.+++.++|||++++++++......++|+||+.
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            34457899999999999975 468899999886432 2334568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeee
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI  184 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  184 (356)
                      +++|.+++..  .++++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++.........  .
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~  172 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--R  172 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--c
Confidence            9999998844  678999999999999999999999   99999999999999999999999999988754332211  1


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCch
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEK  264 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (356)
                      ....|+..|+|||.+.+. .++.++||||||+++|+|++|..|+......       .........       .......
T Consensus       173 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~~~~-------~~~~~~~  237 (285)
T cd06648         173 KSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRIRDN-------LPPKLKN  237 (285)
T ss_pred             ccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHhc-------CCCCCcc
Confidence            234588899999998876 6889999999999999999999987542210       000000000       0001111


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          265 DKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       265 ~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ....+..+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            2235567999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.3e-38  Score=282.91  Aligned_cols=243  Identities=23%  Similarity=0.271  Sum_probs=188.2

Q ss_pred             cccccCceEEEEEEe-CCCcEEEEEEeccccch--hhHHHHHHHH---HHHccCCCCceeeeeceEecCCeeeEEEeccC
Q 038199           31 RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR--IAEEQFMAEV---GTIGRTYHINLVRLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        31 ~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~---~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~  104 (356)
                      .||+|+||.||+|.. .+++.||+|.+......  .....+..|.   ..++...||||+.+++++.+....++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999975 46899999988653211  1112233443   34444579999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeee
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI  184 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  184 (356)
                      |++|..++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......    .
T Consensus        81 g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            999998884 45679999999999999999999999   999999999999999999999999999987554322    1


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCch
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEK  264 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (356)
                      ....|+..|+|||.+.+...++.++||||+|+++|+|++|+.||........             ....... .......
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-------------~~~~~~~-~~~~~~~  218 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------------HEIDRMT-LTMAVEL  218 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-------------HHHHHHh-hccCCCC
Confidence            2346899999999987554688999999999999999999999854322110             0000000 1111223


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          265 DKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       265 ~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      +...+.++.+++.+|+..+|.+||     ++.++++
T Consensus       219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            334567899999999999999999     8999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.9e-39  Score=289.43  Aligned_cols=268  Identities=23%  Similarity=0.293  Sum_probs=194.9

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC-------
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-------   94 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-------   94 (356)
                      .+|++.++||+|+||.||+|... +++.||||.+.... .......+.+|+.++++++||||+++++++....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            36889999999999999999764 68999999886432 2222345678999999999999999999887543       


Q ss_pred             -eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           95 -MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        95 -~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                       ..++||||+.+ +|.+.+......+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence             34999999965 8888886555679999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCe--eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--------cchhhh
Q 038199          174 LCDRNRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--------WFPKHV  243 (356)
Q Consensus       174 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~  243 (356)
                      ........  .......++..|+|||.+.+...++.++||||||+++|||++|..|+.........        ..+...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            66433221  11223457889999999876545788999999999999999999887543321000        000000


Q ss_pred             HHHHhhchhhHHH-HhcCCC-c-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          244 WEEYEKSELDATI-LACGIE-E-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       244 ~~~~~~~~~~~~~-~~~~~~-~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +............ ...... .     ........+.+++.+||+.||++||+++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000000000000 000000 0     00012345678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.9e-39  Score=283.70  Aligned_cols=247  Identities=24%  Similarity=0.323  Sum_probs=195.5

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCCh
Q 038199           32 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        32 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      ||+|+||.||++.+. +|+.+|+|++.....  ......+.+|++++++++||||+++++.+..+...++||||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            699999999999875 599999999875421  23446788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC------ee
Q 038199          109 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS------HV  182 (356)
Q Consensus       109 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~------~~  182 (356)
                      .+++.+. ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++........      ..
T Consensus        81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            9998543 479999999999999999999999   9999999999999999999999999999876543321      11


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                      ......++..|+|||...+. ..+.++||||||+++++|++|..|+......       ........        .....
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~--------~~~~~  220 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------EIFQNILN--------GKIEW  220 (265)
T ss_pred             cccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhc--------CCcCC
Confidence            22334578899999998776 5889999999999999999999887543211       00111100        00001


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ......+..+.+++.+||+.+|++||++..+.+.|+
T Consensus       221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            111113678899999999999999999966666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=281.02  Aligned_cols=251  Identities=23%  Similarity=0.269  Sum_probs=198.9

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEecccc----chhhHHHHHHHHHHHccCCCCceeeeeceEecC--Cee
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMT   96 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~   96 (356)
                      ..|.+.+.||+|+||.||+|.+ .+++.||+|++....    .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3578899999999999999975 469999999875321    223446788999999999999999999998764  457


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            899999999999998843 3468999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ..... .......++..|+|||.+.+. .++.++|+|||||++++|++|..||.....          .     ......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~-----~~~~~~  221 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEA----------M-----AAIFKI  221 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCH----------H-----HHHHHH
Confidence            32111 111234588899999999876 688999999999999999999998743211          0     111111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ......+..+......+.+++.+||+ +|..||++.+++.
T Consensus       222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            11222234456677889999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=309.39  Aligned_cols=253  Identities=28%  Similarity=0.417  Sum_probs=222.5

Q ss_pred             cccccccCceEEEEEEe-CCC----cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           29 STRLGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      .++||+|+||+||+|.+ +.|    -+||||++........-+++.+|+.+|.+++|||++++++++.... +-||++|+
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            58899999999999965 443    4689999987766666789999999999999999999999998776 78999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      ++|+|.++++..+..+.....+.|..||++|+.|||.   +.+|||||...||||..-..+|+.|||+++..........
T Consensus       780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~  856 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS  856 (1177)
T ss_pred             ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence            9999999998888899999999999999999999999   9999999999999999999999999999998776655555


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                      .....-.+.|||-|.+... .++.++|||||||.+||++| |..                ++..+...++...+..+.+.
T Consensus       857 ~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~----------------Py~gi~~~eI~dlle~geRL  919 (1177)
T KOG1025|consen  857 APGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAK----------------PYDGIPAEEIPDLLEKGERL  919 (1177)
T ss_pred             ccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCC----------------ccCCCCHHHhhHHHhccccC
Confidence            5444556789999998866 79999999999999999998 444                45556677777888888888


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      +.++.++.+++.++.+||..|+..||+++++...+.+...
T Consensus       920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            8999999999999999999999999999999998877544

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2e-39  Score=290.48  Aligned_cols=262  Identities=20%  Similarity=0.251  Sum_probs=194.0

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccch-hhHHHHHHHHHHHccCC-CCceeeeeceEecCCe-----e
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHM-----T   96 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~-----~   96 (356)
                      .|++.+.||+|+||.||+|.+. +++.||||++...... .....+.+|+.+++++. ||||+++++++.....     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5788899999999999999764 6899999988654322 22356888999999995 6999999999876655     7


Q ss_pred             eEEEeccCCCChhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-CCceEEcccCC
Q 038199           97 ALVYEYMENGSLDGYLFGK----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGL  171 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfgl  171 (356)
                      ++||||+++ +|.+++...    ...+++..+..++.||+.||.|||+   ++++||||+|+||+++. ++.++|+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999986 888887542    2468999999999999999999999   99999999999999998 88999999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh--
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK--  249 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  249 (356)
                      +..+......  .....+++.|+|||.+.+...++.++|+||||+++|+|++|..|+..........   ........  
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~  232 (295)
T cd07837         158 GRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL---HIFKLLGTPT  232 (295)
T ss_pred             ceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHhCCCC
Confidence            8765432211  1123467889999988765467899999999999999999998875432211000   00000000  


Q ss_pred             c-------hhhHHHHhcC-C----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 S-------ELDATILACG-I----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 ~-------~~~~~~~~~~-~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .       .......... .    ....+..+.++.+++.+||..||.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0       0000000000 0    0111235677899999999999999999999885

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=287.13  Aligned_cols=264  Identities=23%  Similarity=0.315  Sum_probs=196.8

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      |++.+.||.|++|+||+|.+. +|+.||+|++..+.. ......+.+|+++++.++|||++++++++.+....++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999754 699999999875421 223356888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          104 ENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       104 ~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      + ++|.+++.... ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence            5 58998885433 468999999999999999999999   99999999999999999999999999998765432211 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc--------chhhhHHHHhhc-hhh
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW--------FPKHVWEEYEKS-ELD  253 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~-~~~  253 (356)
                       .....++..|+|||++.+...++.++|+||||+++|+|++|..||..........        .....|...... ...
T Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence             1223468899999988765457889999999999999999998875432210000        000000000000 000


Q ss_pred             HHHHh---cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILA---CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....   .......+..+..+.+++.+||+.+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000   0001112234467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.7e-39  Score=286.03  Aligned_cols=266  Identities=22%  Similarity=0.252  Sum_probs=195.2

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .+|++.+.||+|++|+||+|... +|+.||+|.+.... .....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            36888999999999999999764 68999999886432 22334578899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-CCceEEcccCCccccCCCC
Q 038199          102 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |+++ +|.+++... ...+++..+..++.||+.||.|||+   ++++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9965 787777443 3346889999999999999999999   99999999999999985 5679999999997654321


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc-----h---hhhHHHHhhch
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF-----P---KHVWEEYEKSE  251 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~-----~---~~~~~~~~~~~  251 (356)
                      .  ......++..|+|||.+.+...++.++||||||+++|+|+||..|+...........     .   ...|.......
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence            1  112235688999999987654678999999999999999999988854322100000     0   00000000000


Q ss_pred             hhHHHHhcCCC----chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          252 LDATILACGIE----EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       252 ~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...........    ...+..+.++.+++.+|++.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000000000    011234566889999999999999999999986

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=278.19  Aligned_cols=248  Identities=25%  Similarity=0.339  Sum_probs=203.1

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +|.+.+.||+|++|.||++... +++.|++|.+.... .....+.+.+|++++++++|+|++++++++.+....++|||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999764 58899999987542 224557899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            999999999843 3679999999999999999999999   99999999999999999999999999999876543322 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                       .....++..|+|||...+. ..+.++||||||+++++|++|..|+......      ...+.          .......
T Consensus       156 -~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~----------~~~~~~~  217 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFR----------IVQDDHP  217 (254)
T ss_pred             -ccccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH----------HhccCCC
Confidence             1234578899999998776 5789999999999999999999887532210      00010          0111222


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+...+..+.+++.+||..+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            333445678999999999999999999999884

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.7e-39  Score=287.86  Aligned_cols=258  Identities=22%  Similarity=0.347  Sum_probs=198.4

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCee
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMT   96 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~   96 (356)
                      +.+....|++.++||+|+||.||+|.+. +++.||||.+...........+..|+.++.+.. ||||+++++++.+....
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            3445567889999999999999999875 489999999975433333455667777776664 99999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+. ++|.+++......+++..+..++.|++.||.|||+  ..+++||||+|+||++++++.++|+|||++....
T Consensus        90 ~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          90 FICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             EEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99999985 47887775556689999999999999999999996  1589999999999999999999999999987654


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCC---CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      .....   ....++..|+|||.+.+.   ..++.++||||||+++|+|++|+.|+......         .+..     .
T Consensus       167 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~~~~-----~  229 (296)
T cd06618         167 DSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---------FEVL-----T  229 (296)
T ss_pred             CCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---------HHHH-----H
Confidence            32221   223477899999998754   24788999999999999999999987432111         0000     0


Q ss_pred             HHHHhc-CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          254 ATILAC-GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       254 ~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ...... ........++.++.+++.+||+.||++||+++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         230 KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            001000 0111112356679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-40  Score=299.41  Aligned_cols=245  Identities=25%  Similarity=0.384  Sum_probs=198.0

Q ss_pred             cccccccccCceEEEEEEe-CCCcEEEEEEec---cccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe--eeEEE
Q 038199           27 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLN---RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM--TALVY  100 (356)
Q Consensus        27 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~---~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~--~~lV~  100 (356)
                      .+..+||+|+|-+||+|.+ .+|.+||.--++   ........++|..|+++|+.|+||||+++|+.+.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            7889999999999999954 468888854332   22234555899999999999999999999999886654  67899


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-CceEEcccCCccccCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfgl~~~~~~~~  179 (356)
                      |++..|+|..|+ ++.+.++...+..|+.||+.||.|||+. ..+|+|||||.+||+|+.+ |.|||+|+|||.......
T Consensus       123 EL~TSGtLr~Y~-kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYR-KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHH-HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            999999999999 4557889999999999999999999984 4689999999999999765 899999999999876555


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      ...    ..||+.|||||+...  .|++..||||||+.++||.|+..|+..               ......+...+..+
T Consensus       201 aks----vIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsE---------------C~n~AQIYKKV~SG  259 (632)
T KOG0584|consen  201 AKS----VIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSE---------------CTNPAQIYKKVTSG  259 (632)
T ss_pred             cce----eccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhh---------------hCCHHHHHHHHHcC
Confidence            443    469999999999973  689999999999999999999987532               12233344444443


Q ss_pred             CCCchh-HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 GIEEKD-KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ~~~~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+... .-...++..+|.+|+.. .++|||+.++++
T Consensus       260 iKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  260 IKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             CCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            332211 11235689999999999 999999999997

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1e-38  Score=283.53  Aligned_cols=244  Identities=28%  Similarity=0.352  Sum_probs=191.7

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCCh
Q 038199           32 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        32 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      ||+|+||+||++... +|+.||+|++....  .......+..|++++++++|||++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            799999999999654 68999999986432  122334567899999999999999999999999999999999999999


Q ss_pred             hhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccC
Q 038199          109 DGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY  187 (356)
Q Consensus       109 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~  187 (356)
                      .+++.... ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            99885443 469999999999999999999999   999999999999999999999999999987654321   11234


Q ss_pred             CCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHH
Q 038199          188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE  267 (356)
Q Consensus       188 ~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (356)
                      .++..|+|||.+.+. .++.++||||||+++++|++|+.||........       .......     ... .....+..
T Consensus       155 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~-----~~~-~~~~~~~~  220 (277)
T cd05577         155 AGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-------KEELKRR-----TLE-MAVEYPDK  220 (277)
T ss_pred             cCCCCcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-------HHHHHhc-----ccc-ccccCCcc
Confidence            578899999998876 588999999999999999999999854332100       0111110     000 01122233


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          268 KAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       268 ~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      .+..+.+++.+||+.+|++||     ++.+++.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            467789999999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=314.66  Aligned_cols=263  Identities=29%  Similarity=0.384  Sum_probs=219.9

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC----C----CcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeec
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP----N----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG   88 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~   88 (356)
                      .|++......+.+.||+|.||.|++|...    .    ...||||.++........+.+..|+++++.+ .|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            57777777788889999999999999642    1    4579999998776667778999999999999 5999999999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCC
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP  153 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp  153 (356)
                      ++..+...++|+||+..|+|.+++....               ..++....+.++.||+.|++||++   .++|||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhh
Confidence            9999999999999999999999996544               348999999999999999999999   9999999999


Q ss_pred             CcEEEcCCCceEEcccCCccccCCCCCeeeeccCC--CCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccC
Q 038199          154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG  231 (356)
Q Consensus       154 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  231 (356)
                      .|||+..+..+|++|||+++........... ...  -...|||||.+... .++.++|||||||++||++|...+..++
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~-~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDR-VFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccC-cccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            9999999999999999999965544333321 112  24569999999985 8999999999999999999954332221


Q ss_pred             CCCccccchhhhHHHHh-hchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          232 SSESLDWFPKHVWEEYE-KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                                     +. ..++...+..+.+...+..+..+++++++.||+.+|++||++.++.+.++..
T Consensus       525 ---------------~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  525 ---------------IPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ---------------CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                           11 2233445667777788888899999999999999999999999999999874

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-38  Score=287.00  Aligned_cols=266  Identities=17%  Similarity=0.140  Sum_probs=196.9

Q ss_pred             ccccccccccCceEEEEEEeCCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccC
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~  104 (356)
                      +.+++.+|.|+++.||++.. +++.||||++... ......+.+.+|+++++.++|+||+++++++.+....+++|||+.
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            44566666676666666655 7899999998754 344566789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe--
Q 038199          105 NGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH--  181 (356)
Q Consensus       105 ~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~--  181 (356)
                      +++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||.+.........  
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999998643 4568999999999999999999999   99999999999999999999999999988755322111  


Q ss_pred             ---eeeccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCcccccCCCCccc----------cchhhhHHHH
Q 038199          182 ---VTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD----------WFPKHVWEEY  247 (356)
Q Consensus       182 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~----------~~~~~~~~~~  247 (356)
                         .......++..|+|||.+.+. ..++.++|+|||||++|||++|..||.........          ++........
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence               111224467789999998753 25788999999999999999999998653221100          0000000000


Q ss_pred             h--hc-----hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 E--KS-----ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~--~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .  ..     ....................++.+++.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0  00     000000001111223445678899999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.6e-39  Score=294.45  Aligned_cols=269  Identities=22%  Similarity=0.254  Sum_probs=199.2

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccC-CCCceeeeeceEecC--Cee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ--HMT   96 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~--~~~   96 (356)
                      ...+|++.++||+|+||.||+|.+. +|+.+|+|++.... .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567889999999999999999764 68899999885421 223345677899999999 999999999988643  468


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+.+ +|..++..  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYMET-DLHAVIRA--NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEeccccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            999999975 99888843  378999999999999999999999   999999999999999999999999999998664


Q ss_pred             CCCCe---eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cc---hhhhHH
Q 038199          177 RNRSH---VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WF---PKHVWE  245 (356)
Q Consensus       177 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~---~~~~~~  245 (356)
                      .....   .......|+..|+|||.+.+...++.++||||||+++|+|++|+.|+.........     ..   ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            43221   12233568899999998876546789999999999999999999887543221100     00   000000


Q ss_pred             HHhhchhhHHHHh------cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          246 EYEKSELDATILA------CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       246 ~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .+...........      .......+..+.++.+++.+||+.||++||++.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000000000000      00011112246778999999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.1e-38  Score=285.77  Aligned_cols=249  Identities=25%  Similarity=0.334  Sum_probs=197.4

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .+|...+.||+|+||.||+|... +++.+|+|.+...  .......++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34667788999999999999764 5889999988642  12333457889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+. ++|.+.+......+++.++..++.|++.|+.|||+   .+++||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 58877775556678999999999999999999999   99999999999999999999999999998754322  


Q ss_pred             eeeeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          181 HVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                          ....++..|+|||.+.+  ....+.++|||||||++|+|++|..|+......                ........
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~~~~~  228 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYHIAQ  228 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH----------------HHHHHHhh
Confidence                22357889999998742  225788999999999999999999886432110                00001111


Q ss_pred             cCC-CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          259 CGI-EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       259 ~~~-~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ... .......+..+.+++.+||+.+|++||+++++++...
T Consensus       229 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            111 1123346677899999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-38  Score=326.52  Aligned_cols=261  Identities=27%  Similarity=0.423  Sum_probs=197.9

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      .+...+.||+|+||.||+|.. .+++.||||++.....     ....|++.+++++||||+++++++.+....++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            345567899999999999976 4789999999864321     1234688999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      ++|+|.+++.    .++|..+..|+.|++.||+|||..+..+++||||||+||+++.++.+++. ||........     
T Consensus       766 ~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----  835 (968)
T PLN00113        766 EGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----  835 (968)
T ss_pred             CCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----
Confidence            9999999983    48999999999999999999996445899999999999999998887775 6554332111     


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC--C
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG--I  261 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  261 (356)
                       ....++..|+|||++.+. .++.++|||||||++|||+||+.|+......... ...+...............+..  .
T Consensus       836 -~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        836 -TKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGS-IVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             -CCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCc-HHHHHHHhcCccchhheeCccccCC
Confidence             123578899999999876 7899999999999999999999998543221111 1111111111111111111111  1


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      .........++.+++.+||+.||++||+|++|++.|+++...
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            123445667888999999999999999999999999987553

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.9e-39  Score=291.43  Aligned_cols=268  Identities=19%  Similarity=0.269  Sum_probs=199.9

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEec----CCeee
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHMTA   97 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~----~~~~~   97 (356)
                      ..|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888999999999999999754 699999999875422 2334667889999999999999999998763    35679


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+. ++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        85 lv~e~~~-~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          85 VVMDLME-SDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEehhh-hhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            9999995 58988884 34569999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCe--eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--------cchhhhHHHH
Q 038199          178 NRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--------WFPKHVWEEY  247 (356)
Q Consensus       178 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~  247 (356)
                      ....  .......|+..|+|||.+.+...++.++||||||+++|||++|+.||........-        ..+...++..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            2221  11223468889999999876446889999999999999999999988543221000        0000001101


Q ss_pred             hhchhhHHHHhcC----C--CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          248 EKSELDATILACG----I--EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       248 ~~~~~~~~~~~~~----~--~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .............    .  ....+..+.++.+++.+||+.+|.+||++++++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1111111110000    0  01113356789999999999999999999999883

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.3e-38  Score=290.88  Aligned_cols=261  Identities=21%  Similarity=0.259  Sum_probs=196.2

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC------
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------   93 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------   93 (356)
                      ...+|+..+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4677999999999999999999754 68999999986432 233445678899999999999999999988643      


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ...++||||+.+ +|.+.+..   .++...+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            356899999965 88887732   28999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc------h---hhhH
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF------P---KHVW  244 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~------~---~~~~  244 (356)
                      .......   .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||........ +.      .   ....
T Consensus       167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  241 (353)
T cd07850         167 TAGTSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFM  241 (353)
T ss_pred             eCCCCCC---CCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence            6543321   1224578899999999876 789999999999999999999988854322100 00      0   0000


Q ss_pred             HHHhhchhhHHHHhcC---------------C----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          245 EEYEKSELDATILACG---------------I----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       245 ~~~~~~~~~~~~~~~~---------------~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .... ...........               .    .......+..+.+++.+||+.||++||+++++++
T Consensus       242 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         242 SRLQ-PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHhh-hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000 00000000000               0    0001234667889999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=278.88  Aligned_cols=245  Identities=23%  Similarity=0.271  Sum_probs=189.5

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHH-ccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTI-GRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l-~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.||+|+||.||+|... +++.||+|++.....  ......+..|..++ ...+|+|++++++++.+++..++|+||+.+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999764 689999999864311  11122344554444 445899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|.+++. ....+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.....      ..
T Consensus        82 ~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIK-TLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999984 34578999999999999999999999   9999999999999999999999999999875432      12


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...++..|+|||.+.+. .++.++||||||+++|+|++|..|+.....       ...+........      .......
T Consensus       152 ~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~------~~~~~~~  217 (260)
T cd05611         152 KFVGTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETP-------DAVFDNILSRRI------NWPEEVK  217 (260)
T ss_pred             cCCCCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhccc------CCCCccc
Confidence            24578899999999877 589999999999999999999999854321       111111111100      0111222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ..++.++.+++.+||+.+|++||++.++.+.|.
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            345678999999999999999998876666553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.5e-38  Score=284.39  Aligned_cols=246  Identities=22%  Similarity=0.316  Sum_probs=195.9

Q ss_pred             cccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           27 NYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        27 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +...+||+|+||.||++... +++.||||++.... ......+.+|+.+++.++|+|++++++.+...+..++||||+++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            33478999999999999764 68999999886432 34456789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      ++|.+++  ....+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++.........  ..
T Consensus       102 ~~L~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~  174 (292)
T cd06657         102 GALTDIV--THTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RK  174 (292)
T ss_pred             CcHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--cc
Confidence            9999887  34468999999999999999999999   99999999999999999999999999998755432211  12


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ...|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+.......       .......      ... ......
T Consensus       175 ~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-------~~~~~~~------~~~-~~~~~~  239 (292)
T cd06657         175 SLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRD------NLP-PKLKNL  239 (292)
T ss_pred             ccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHh------hCC-cccCCc
Confidence            34578899999998765 67899999999999999999999875432110       0000000      000 001112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...+..+.+++.+||+.+|.+||++.++++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            234567889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.5e-38  Score=284.17  Aligned_cols=246  Identities=26%  Similarity=0.356  Sum_probs=194.1

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      |...++||+|+||+||+|... +++.||+|++....  .......+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999754 68999999986432  223335688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.+ +|.+++......+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....     
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            965 7877776566789999999999999999999999   9999999999999999999999999999864321     


Q ss_pred             eeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          183 TISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                       .....|+..|+|||.+..  ...++.++||||||+++|+|++|..|+.......      ...         .......
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~---------~~~~~~~  237 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY---------HIAQNDS  237 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHH---------HHHhcCC
Confidence             123458889999999842  2357889999999999999999998874432110      000         0000001


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ........+..+.+++.+||+.+|.+||++.+++..
T Consensus       238 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111122344568899999999999999999999963

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-41  Score=325.34  Aligned_cols=255  Identities=27%  Similarity=0.331  Sum_probs=210.8

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ..+|.-+.+||.|.||.||-|.+ .+|+-.|+|-+.-... ......+.+|+.++..+.|||+|++||+=.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            34455568899999999999964 5799999998764322 333367889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |||+||+|.+++ ..++..++....-+..|++.|+.|||+   .|||||||||.||+++.+|.+|++|||.+........
T Consensus      1314 EyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            999999999998 445567777777789999999999999   9999999999999999999999999999988765421


Q ss_pred             --eeeeccCCCCCCCCCcccccCCC--CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          181 --HVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       181 --~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                        ........||+.|||||++.+..  +-..++||||+|||++||.||+.||..-..               +-.+...+
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------------e~aIMy~V 1454 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------------EWAIMYHV 1454 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------------hhHHHhHH
Confidence              12234567999999999997642  457799999999999999999999855332               12334445


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ..+..+..+...+.+-.+++.+||..||++|.++.++++.
T Consensus      1455 ~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            5666777888899999999999999999999999888763

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-39  Score=284.81  Aligned_cols=264  Identities=21%  Similarity=0.309  Sum_probs=200.9

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      |++.+.||+|++|.||+|... +++.+++|.+..... ......+.+|+.++++++|+||+++++++.++...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999764 689999999875432 234567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      .+ +|..++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            76 8888886656789999999999999999999999   999999999999999999999999999987765433  11


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc-----ch---hhhHHHHhhc-hhhH
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW-----FP---KHVWEEYEKS-ELDA  254 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~-----~~---~~~~~~~~~~-~~~~  254 (356)
                      .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||..........     ..   ...|...... ....
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            2234578889999998765468999999999999999999998874433210000     00   0000000000 0000


Q ss_pred             HHHh----cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          255 TILA----CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       255 ~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ....    .......+..+.++.+++.+||+.||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000    0001122346788999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-38  Score=291.23  Aligned_cols=270  Identities=20%  Similarity=0.249  Sum_probs=199.5

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC-----Cee
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMT   96 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-----~~~   96 (356)
                      .+|.+.+.||+|+||+||+|.. .+++.||||.+.... .......+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4688899999999999999975 468999999986432 223345678899999999999999999988644     347


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          85 YIVYELMD-TDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEeCCC-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            99999995 58888874 45679999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----c---chhhhHHHHh
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----W---FPKHVWEEYE  248 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~---~~~~~~~~~~  248 (356)
                      ...  .......++..|+|||.+.+...++.++||||||+++|+|++|..||.........     .   .....+....
T Consensus       160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         160 EKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             CCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            332  11223457889999998865435889999999999999999999887432210000     0   0000000000


Q ss_pred             hchhhHHHHhcCC------CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhcc
Q 038199          249 KSELDATILACGI------EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM--LEGV  300 (356)
Q Consensus       249 ~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~--L~~~  300 (356)
                      .............      ....+..+.++.+++.+||+.+|++||+++++++.  +..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            0000100100000      01122456778999999999999999999999985  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-38  Score=282.99  Aligned_cols=249  Identities=23%  Similarity=0.327  Sum_probs=201.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .|.+.+.||+|+||.||+|... +++.||+|++....  .......+..|..+++++. ||||+++++++.+.+..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            5788999999999999999764 69999999987531  2334467889999999998 999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |++.+++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          82 EYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            99999999999843 4579999999999999999999999   9999999999999999999999999999886643322


Q ss_pred             e------------------eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh
Q 038199          181 H------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH  242 (356)
Q Consensus       181 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~  242 (356)
                      .                  .......++..|+|||.+.+. ..+.++|+||||++++++++|..|+......       .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~  229 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------L  229 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHH-------H
Confidence            1                  111234578899999998766 6889999999999999999999887543310       0


Q ss_pred             hHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 038199          243 VWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPM----SAVVK  295 (356)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~----~~v~~  295 (356)
                      ....        ..  ......+...+..+.+++.+||+.+|++||++    +++++
T Consensus       230 ~~~~--------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 TFQK--------IL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHH--------HH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            0000        00  11122333446779999999999999999999    76664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.5e-38  Score=288.62  Aligned_cols=266  Identities=18%  Similarity=0.202  Sum_probs=196.0

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchh-------------hHHHHHHHHHHHccCCCCceeeeec
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRI-------------AEEQFMAEVGTIGRTYHINLVRLYG   88 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~ni~~~~~   88 (356)
                      ...+.+.+.||+|+||+||+|.+. +++.||||++.......             ....+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            333456788999999999999754 68999999986432111             0124778999999999999999999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcc
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  168 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D  168 (356)
                      ++......++||||+. ++|.+++. ....+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECC
Confidence            9999999999999996 58988884 45578999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCC------------eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc
Q 038199          169 FGLAKLCDRNRS------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL  236 (356)
Q Consensus       169 fgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~  236 (356)
                      ||++........            ........++..|+|||.+.+...++.++|+||||+++|+|++|..|+........
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999876541110            11112234678899999987654578999999999999999999988754432100


Q ss_pred             ccchhhhHHHHhhch---hhHH--------HH---hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          237 DWFPKHVWEEYEKSE---LDAT--------IL---ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       237 ~~~~~~~~~~~~~~~---~~~~--------~~---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                        + ....+......   ....        ..   ...........+.++.+++.+||+.+|++||++++++..
T Consensus       243 --~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        243 --L-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             --H-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence              0 00000000000   0000        00   000001112335678899999999999999999999973

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.1e-38  Score=283.03  Aligned_cols=256  Identities=22%  Similarity=0.243  Sum_probs=200.9

Q ss_pred             ccccccccccCceEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeee
Q 038199           26 SNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   97 (356)
                      |++.+.||+|++|.||++..    .+++.||||++....   .....+.+..|+.++.++ +||||+++++++..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            67889999999999999964    257889999986421   123345688999999999 5999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+.+++|.+++. ....+++..+..++.|++.+|.|||+   .+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          82 LILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEecCCCCcHHHHHh-hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            9999999999999884 34578999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCC-CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ..... .....|+..|+|||.+.+.. ..+.++|+||||+++|||++|..|+.......       ....+.     ...
T Consensus       158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~~-----~~~  224 (288)
T cd05583         158 EEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-------SQSEIS-----RRI  224 (288)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-------hHHHHH-----HHH
Confidence            32211 12345788999999986542 36889999999999999999999975432210       001111     111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      .. .....+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       225 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         225 LK-SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             Hc-cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            11 1123334456778999999999999999999988887765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.2e-38  Score=282.14  Aligned_cols=252  Identities=23%  Similarity=0.262  Sum_probs=196.3

Q ss_pred             ccccccccccCceEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeee
Q 038199           26 SNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   97 (356)
                      |++.+.||+|+||.||++..    .+|+.||+|++....   .....+++.+|+.+++++ +|+||+.+++++..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            67889999999999999975    368899999987532   123346788999999999 5999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          82 LILDYINGGELFTHLS-QRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            9999999999999984 34578999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .... ......|+..|+|||.+.+. ..++.++||||||+++|+|++|..|+........       ...+     ....
T Consensus       158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~~~-----~~~~  224 (290)
T cd05613         158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-------QAEI-----SRRI  224 (290)
T ss_pred             cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-------HHHH-----HHHh
Confidence            2211 11234588899999998653 2467899999999999999999998754221100       0000     0111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      .. ...+.+...+..+.+++.+||+.||++||     ++++++.
T Consensus       225 ~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         225 LK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             hc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            11 11223344567789999999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.3e-38  Score=277.51  Aligned_cols=248  Identities=23%  Similarity=0.322  Sum_probs=196.7

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccc----cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +|.+.++||+|+||+||++.+. .+..+++|+++..    .......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5888999999999999999764 3555667766532    1223334677899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199          100 YEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      |||+.+++|.+++..   ....+++..++.++.|++.||.|||+   .+++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988753   34679999999999999999999999   99999999999999975 579999999987654


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ....  ......|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+.....          ..      .....
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----------~~------~~~~~  217 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNF----------LS------VVLRI  217 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HH------HHHHH
Confidence            3222  12234578899999998765 678899999999999999999988742211          00      11111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....+..+...+.++.+++.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         218 VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            222333445567788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-40  Score=298.95  Aligned_cols=268  Identities=22%  Similarity=0.340  Sum_probs=214.4

Q ss_pred             hhhcCCcceecHHHHhh-hhccccccccccCceEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCcee
Q 038199            7 EIGREKPVRFTSLQLNN-FTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV   84 (356)
Q Consensus         7 ~~~~~~~~~~~~~~~~~-~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~   84 (356)
                      ...+++|....+-+++. .-|++..-||-|+||.||+|..+. +-.-|-|+|... ++...+.|+-|+++|+...||+|+
T Consensus        14 ~~eKkk~~ehv~rdlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~iv   92 (1187)
T KOG0579|consen   14 QAEKKKPYEHVYRDLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIV   92 (1187)
T ss_pred             hhhhhccHHHHhccCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHH
Confidence            44667776666666654 446899999999999999997764 555677888643 356668899999999999999999


Q ss_pred             eeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCce
Q 038199           85 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  164 (356)
Q Consensus        85 ~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~  164 (356)
                      ++++.|...+.+|++.|||.||.++..+..-+..+++.++.-+++|++.||.|||+   ++|||||||..|||+..+|.+
T Consensus        93 kLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdi  169 (1187)
T KOG0579|consen   93 KLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDI  169 (1187)
T ss_pred             HHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcE
Confidence            99999999999999999999999999987778899999999999999999999999   999999999999999999999


Q ss_pred             EEcccCCccccCCCCCeeeeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch
Q 038199          165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP  240 (356)
Q Consensus       165 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~  240 (356)
                      +|+|||.+.....  ......++.||+.|||||+...    ..+|..++||||||+.|.||..+.+|-..-.        
T Consensus       170 rLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------  239 (1187)
T KOG0579|consen  170 RLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------  239 (1187)
T ss_pred             eeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------
Confidence            9999999864321  1222356789999999998642    2378999999999999999999987632111        


Q ss_pred             hhhHHHHhhchhhHHHHh-cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          241 KHVWEEYEKSELDATILA-CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                           .+  ..+...... .+....+...+..+.+++..||.+||..||++.++++
T Consensus       240 -----pM--RVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  240 -----PM--RVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -----hH--HHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                 00  011111111 1122344556778999999999999999999999987

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-39  Score=292.95  Aligned_cols=264  Identities=23%  Similarity=0.324  Sum_probs=217.0

Q ss_pred             hcCCcceec-HHHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceee
Q 038199            9 GREKPVRFT-SLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVR   85 (356)
Q Consensus         9 ~~~~~~~~~-~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~   85 (356)
                      .+++|...+ ..+....-|.+.+.||+|.|++|.+|.+ .++..||||.+.+... ......+.+|+++|+.+.||||++
T Consensus        40 ~~~~~~s~~~~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvk  119 (596)
T KOG0586|consen   40 EDKSPASLETDDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVK  119 (596)
T ss_pred             cccCcccccccccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceee
Confidence            455566665 5566677788999999999999999975 4699999999986532 333356889999999999999999


Q ss_pred             eeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceE
Q 038199           86 LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK  165 (356)
Q Consensus        86 ~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~k  165 (356)
                      ++.+......+++||||+.+|.+.+++. ..+.+.+..+..++.|+..|++|||+   +.|||||||++||||+.+.++|
T Consensus       120 l~~v~~t~~~lylV~eya~~ge~~~yl~-~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnik  195 (596)
T KOG0586|consen  120 LFSVIETEATLYLVMEYASGGELFDYLV-KHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIK  195 (596)
T ss_pred             eeeeeeecceeEEEEEeccCchhHHHHH-hcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhccccccccee
Confidence            9999999999999999999999999994 44556669999999999999999999   9999999999999999999999


Q ss_pred             EcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHH
Q 038199          166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWE  245 (356)
Q Consensus       166 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~  245 (356)
                      |+|||++..+....   ....++|++.|.|||++.+....++.+|+||+|+++|.|+.|..||....-...         
T Consensus       196 IaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L---------  263 (596)
T KOG0586|consen  196 IADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL---------  263 (596)
T ss_pred             eeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc---------
Confidence            99999998876332   345688999999999999887788999999999999999999999865432211         


Q ss_pred             HHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          246 EYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                             ...+..+. -..+.-...+..++++++|-++|.+|++++++.+.
T Consensus       264 -------r~rvl~gk-~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  264 -------RPRVLRGK-YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -------cchheeee-ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                   11111111 12233345567889999999999999999999873

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.8e-38  Score=284.51  Aligned_cols=264  Identities=19%  Similarity=0.226  Sum_probs=193.1

Q ss_pred             ccccccc--CceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccC
Q 038199           29 STRLGFG--GFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        29 ~~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~  104 (356)
                      ...||+|  +||+||++.+. +|+.||+|++.... .....+.+.+|+.+++.++||||+++++++..+...++|+||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3467777  99999999764 69999999987532 23344678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          105 NGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       105 ~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      +++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++++||+.+...........
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999988543 3468999999999999999999999   9999999999999999999999999976543221111100


Q ss_pred             -----eccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCcccccCCCCccc---------------cchhh
Q 038199          184 -----ISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD---------------WFPKH  242 (356)
Q Consensus       184 -----~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~---------------~~~~~  242 (356)
                           .....++..|+|||++.+. ..++.++|||||||++|||++|..|+.........               +.+..
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                 0112346679999998754 25789999999999999999999998543221000               00000


Q ss_pred             h------HHHHhhchhhHH---------HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          243 V------WEEYEKSELDAT---------ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       243 ~------~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .      ............         ............++..+.+++.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0      000000000000         0000111223456778999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=266.61  Aligned_cols=252  Identities=22%  Similarity=0.328  Sum_probs=204.2

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...++..-||.|+.|+|+++++. +|...|||.+.+.-.....+++...++++.+-+ .|+||+.+|+|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            34455677999999999999875 589999999987765666678888888887765 9999999999999988899999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      .|. -.++.++.+-.+++++..+-++...++.||.||..  +++|+|||+||+|||+|+.|.+||+|||++-.+.+....
T Consensus       172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence            994 47888886678889999999999999999999998  589999999999999999999999999999877654433


Q ss_pred             eeeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          182 VTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                         +...|-+.|||||.+..  ...|..++||||||+.++||.||+.|+..-..+         ++.      ...+.+.
T Consensus       249 ---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------Fe~------ltkvln~  310 (391)
T KOG0983|consen  249 ---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------FEV------LTKVLNE  310 (391)
T ss_pred             ---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---------HHH------HHHHHhc
Confidence               23457889999999864  346889999999999999999999997553332         111      1111111


Q ss_pred             --CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          260 --GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       260 --~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                        +..+....++..+.+++..||++|+.+||.+.++++.
T Consensus       311 ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence              1112223378889999999999999999999999873

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.3e-38  Score=285.73  Aligned_cols=269  Identities=23%  Similarity=0.260  Sum_probs=195.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecC-------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-------   93 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-------   93 (356)
                      ...|++.++||+|+||.||+|.+. +++.||||++..... ......+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467899999999999999999764 689999998864321 22234577899999999999999999987543       


Q ss_pred             -CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           94 -HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        94 -~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                       ...++|+||+.+ +|...+......+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346899999965 7777775556689999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCee---------eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc-----
Q 038199          173 KLCDRNRSHV---------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW-----  238 (356)
Q Consensus       173 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~-----  238 (356)
                      ..........         ......++..|+|||.+.+...++.++||||||+++|||++|..|+..........     
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            7654322111         11223567889999988765467899999999999999999998875433211000     


Q ss_pred             ---chhhhHHHHhhchhhH--HHHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          239 ---FPKHVWEEYEKSELDA--TILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       239 ---~~~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                         .....+..+.......  ........   .........+.+++.+||+.||++|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence               0000000000000000  00000000   001122367889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-38  Score=286.85  Aligned_cols=269  Identities=20%  Similarity=0.241  Sum_probs=199.3

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC-----
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----   94 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-----   94 (356)
                      ...+|.+.+.||+|+||.||++.. .+++.||||++.... .......+.+|+.++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            356788999999999999999964 469999999986432 2333456889999999999999999999987543     


Q ss_pred             -eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           95 -MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        95 -~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                       ..++|||++ +++|.+++.  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence             358999999 779988873  4578999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--------cchhhhHH
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--------WFPKHVWE  245 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~  245 (356)
                      .....     .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.........        ..+.....
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            65332     123457889999999876445789999999999999999999988643221000        00000001


Q ss_pred             HHhhchhhHHHHhcC--C----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhccc
Q 038199          246 EYEKSELDATILACG--I----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK--MLEGVV  301 (356)
Q Consensus       246 ~~~~~~~~~~~~~~~--~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~~  301 (356)
                      .+.............  .    .......+..+.+++.+|++.||++||++.+++.  .++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            111111111110000  0    0011234556889999999999999999999995  344443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=280.85  Aligned_cols=274  Identities=26%  Similarity=0.368  Sum_probs=202.9

Q ss_pred             hhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHcc--CCCCceeeeeceEecC----Ce
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--TYHINLVRLYGFCHDQ----HM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~~~~~~~~~----~~   95 (356)
                      ...+..+.+.||+|.||+||+|+| .|+.||||++..    .++..+.+|.++.+.  |+|+||+.+++.-..+    ..
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            456678889999999999999999 678999999975    445678889888886  4899999999876543    36


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-----QQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      ++||.+|.+.|||.+||  ...+++....++++..++.||++||...     +..|.|||||+.|||+..+|...|+|+|
T Consensus       284 LwLvTdYHe~GSL~DyL--~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYL--NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEeeecccCCcHHHHH--hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            89999999999999999  4478999999999999999999999632     4569999999999999999999999999


Q ss_pred             CccccCCCCCeee--eccCCCCCCCCCcccccCCC-----CCCccccchhhHHHHHHHHhCCcccccCCCCccccch---
Q 038199          171 LAKLCDRNRSHVT--ISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP---  240 (356)
Q Consensus       171 l~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~---  240 (356)
                      |+...........  ....+||.+|||||++...-     .--..+||||||+|+||+..+..-.+....-...+..   
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            9988765533322  23467999999999986431     1234699999999999998542211110000000000   


Q ss_pred             -hhhHHHHhhchhhHHHHhcCC-CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          241 -KHVWEEYEKSELDATILACGI-EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       241 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                       ...++.+....-.+.+.+... ..........+.++++.||..||.-|-|+=.|-+.|.++..
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence             111222222222222222111 12334566788999999999999999999999998887764

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.7e-38  Score=284.82  Aligned_cols=273  Identities=20%  Similarity=0.262  Sum_probs=204.6

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCC-----eee
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-----MTA   97 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-----~~~   97 (356)
                      +|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788999999999999999765 589999999876432 334467899999999999999999999988765     789


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+.+ +|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~~-~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELMET-DLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchhh-hHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            99999974 8888884 34589999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cch---hhhHHHHh
Q 038199          178 NRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WFP---KHVWEEYE  248 (356)
Q Consensus       178 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~~---~~~~~~~~  248 (356)
                      .... .......++..|+|||.+.+...++.++|+||||+++|+|++|..||.........     ...   ...+....
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            4311 11233457889999999987656899999999999999999999887543321100     000   00000000


Q ss_pred             hchhhHHHHhcC------CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhcccc
Q 038199          249 KSELDATILACG------IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM--LEGVVE  302 (356)
Q Consensus       249 ~~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~--L~~~~~  302 (356)
                      .......+....      .....+..+..+.+++.+||+.+|++||++++++..  ++....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            111111111000      001112346778999999999999999999999983  555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=276.24  Aligned_cols=259  Identities=23%  Similarity=0.327  Sum_probs=192.6

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEeccccch-hhHHHHHHHHHHHccC---CCCceeeeeceEecCCe-----
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRT---YHINLVRLYGFCHDQHM-----   95 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~ni~~~~~~~~~~~~-----   95 (356)
                      |++.++||+|+||.||+|++. +++.||+|++...... .....+.+|+.+++++   .|||++++++++.+...     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567899999999999999875 4899999999743221 2224566777777665   59999999999987776     


Q ss_pred             eeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           96 TALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      .+++||++.+ +|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 8888875433 368999999999999999999999   9999999999999999999999999999877


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH-------
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY-------  247 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------  247 (356)
                      .......   ....++..|+|||.+.+. .++.++|+||||+++|+|++|..|+........  . ....+..       
T Consensus       157 ~~~~~~~---~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~  229 (287)
T cd07838         157 YSFEMAL---TSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--L-DKIFDVIGLPSEEE  229 (287)
T ss_pred             ccCCccc---ccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--H-HHHHHHcCCCChHh
Confidence            6433221   223478899999999876 689999999999999999999887754322100  0 0000000       


Q ss_pred             -hhchh--hHHHHhc---CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 -EKSEL--DATILAC---GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 -~~~~~--~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       .....  .......   ......+..+..+.+++.+||+.||++||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence             00000  0000000   001112345677889999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.6e-38  Score=287.03  Aligned_cols=266  Identities=21%  Similarity=0.219  Sum_probs=193.7

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC--------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--------   93 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--------   93 (356)
                      ..+|.+.+.||.|+||.||+|.. .+|+.||+|.+.... ....+.+.+|++++++++||||+++++++...        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            36788999999999999999975 468999999986542 23446788999999999999999999876543        


Q ss_pred             ------CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-CCceEE
Q 038199           94 ------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKV  166 (356)
Q Consensus        94 ------~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl  166 (356)
                            ...++||||+. ++|.+++.  ...+++..+..++.||+.||.|||+   .+++||||||+||+++. ++.++|
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence                  35789999997 48988773  3468999999999999999999999   99999999999999974 567899


Q ss_pred             cccCCccccCCCCCee-eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--cch---
Q 038199          167 ADFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--WFP---  240 (356)
Q Consensus       167 ~Dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--~~~---  240 (356)
                      +|||++.......... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.........  ...   
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999987653322111 1122357889999998765446888999999999999999999998543221000  000   


Q ss_pred             ---hhhHHHHhhchhhHHHHhcCCC-----chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          241 ---KHVWEEYEKSELDATILACGIE-----EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       241 ---~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                         ......................     ...+..+.++.+++.+||+.||.+||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence               0000000000000000000000     011234567889999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-38  Score=278.31  Aligned_cols=264  Identities=24%  Similarity=0.283  Sum_probs=199.6

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      |++.++||+|++|.||+|... +++.||+|++.... .....+.+..|+.++++++|+|++++++++.+....++|||++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566789999999999999765 59999999987643 2333467888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      .+ +|.+++......+++..+..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||++........  .
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            74 9999996554689999999999999999999999   9999999999999999999999999999876543322  1


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--------cchhhhHHHHhhchhhHH
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--------WFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~  255 (356)
                      .....++..|+|||.+.+...++.++||||||+++|||++|..|+.........        ......|..+........
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            122345778999999876546889999999999999999998887543321000        000001111111000000


Q ss_pred             HHhcC----CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACG----IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....    .....+..+..+.+++.+||..||++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000    00111223667999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-37  Score=284.33  Aligned_cols=269  Identities=20%  Similarity=0.252  Sum_probs=197.2

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~------   94 (356)
                      ...|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            357888899999999999999754 68999999987532 2233356889999999999999999999987542      


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++|+||+.. +|..++   ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            45899999964 777655   3468999999999999999999999   9999999999999999999999999999875


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc--------chhhhHHH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW--------FPKHVWEE  246 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~  246 (356)
                      .....     ....++..|+|||.+.+...++.++|||||||++|||++|+.||........-.        ......+.
T Consensus       167 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         167 ADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            43221     234578899999998764467899999999999999999999986432110000        00000000


Q ss_pred             HhhchhhHHHHhcC-CC-----chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhccccC
Q 038199          247 YEKSELDATILACG-IE-----EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK--MLEGVVEV  303 (356)
Q Consensus       247 ~~~~~~~~~~~~~~-~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~~~~  303 (356)
                      +............. ..     ...+..+..+.+++.+||+.||++||++++++.  .++.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            00000000000000 00     001124466889999999999999999999996  36665443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-37  Score=274.47  Aligned_cols=242  Identities=22%  Similarity=0.241  Sum_probs=187.4

Q ss_pred             hhccccccc--cccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEE
Q 038199           24 FTSNYSTRL--GFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        24 ~~~~~~~~i--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ..|.+.+.+  |+|+||.||++.. .+++.+|+|++.......      .|+.....+ +|||++++++.+......++|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            455666665  9999999999975 468899999986531111      122222222 699999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-ceEEcccCCccccCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRN  178 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfgl~~~~~~~  178 (356)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++ .++|+|||++......
T Consensus        88 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         88 MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            9999999999998443 489999999999999999999999   9999999999999999988 9999999998765432


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .      ...++..|+|||++.+. .++.++||||||+++|+|++|..|+.........      ...+.     ...  
T Consensus       164 ~------~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~------~~~~~-----~~~--  223 (267)
T PHA03390        164 S------CYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD------LESLL-----KRQ--  223 (267)
T ss_pred             c------cCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh------HHHHH-----Hhh--
Confidence            1      23578899999999876 6889999999999999999999998633221100      01111     011  


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPP-MSAVVK  295 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~v~~  295 (356)
                      ..........+..+.+++.+||+.+|.+||+ ++++++
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            1111233356778999999999999999996 688874

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.8e-37  Score=280.68  Aligned_cols=264  Identities=21%  Similarity=0.269  Sum_probs=196.8

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEec-CCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~-~~~~~l   98 (356)
                      ...+|++.+.||.|+||.||+|... +++.||||++.... .......+..|+++++.++||||+++++++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            4567889999999999999999754 79999999876432 22344678899999999999999999999865 567889


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      |+||+ +++|.+++.  ...++...+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......
T Consensus        88 v~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          88 VTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             Eeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            99999 568988873  4568889999999999999999999   99999999999999999999999999998754321


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc-----ccch---hhhHHHHhhc
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL-----DWFP---KHVWEEYEKS  250 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~-----~~~~---~~~~~~~~~~  250 (356)
                           .....++..|+|||.+.+...++.++||||||+++|+|++|..|+........     .++.   ....+.....
T Consensus       162 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         162 -----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             -----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence                 12345788999999886644689999999999999999999988744321100     0000   0000000000


Q ss_pred             hhhHHHHhcCC-C-----chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          251 ELDATILACGI-E-----EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       251 ~~~~~~~~~~~-~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ........... .     ...+..+..+.+++.+||+.+|++||++++++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00011100000 0     1112345789999999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.9e-38  Score=284.61  Aligned_cols=266  Identities=21%  Similarity=0.246  Sum_probs=193.7

Q ss_pred             hccccccccccCceEEEEEEeC-C--CcEEEEEEeccccc-hhhHHHHHHHHHHHccC-CCCceeeeeceEec----CCe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-N--GVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD----QHM   95 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~----~~~   95 (356)
                      .|++.+.||+|+||.||++... .  ++.||+|++..... ......+.+|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999764 4  78999999875322 22345688899999999 59999999987542    245


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .+++++++. ++|.+.+. ....+++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            678899985 58988873 45679999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCCe--eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--------cchhhhHH
Q 038199          176 DRNRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--------WFPKHVWE  245 (356)
Q Consensus       176 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~  245 (356)
                      ......  .......|+..|+|||.+.+...++.++|+||||+++|+|++|..|+........-        ..+...+.
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            432221  11233568999999998876546899999999999999999999887543321000        00000000


Q ss_pred             HHhhchhhHHHHh---cC---CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          246 EYEKSELDATILA---CG---IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       246 ~~~~~~~~~~~~~---~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+...........   ..   .....+..+..+.+++.+|++.||.+|||+++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1100000000000   00   00011123567899999999999999999999886

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-38  Score=286.64  Aligned_cols=262  Identities=20%  Similarity=0.268  Sum_probs=197.2

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCe-----
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM-----   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~-----   95 (356)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++|||++++++++.....     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            446888999999999999999765 58899999986532 22334567789999999999999999998876554     


Q ss_pred             -eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           96 -TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        96 -~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                       .++|+||+ +++|.+++.  ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++..
T Consensus        94 ~~~lv~e~~-~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             cEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence             89999999 669999884  3579999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc--------ccchhhhHHH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL--------DWFPKHVWEE  246 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~  246 (356)
                      ....     .....++..|+|||.+.+...++.++||||||+++|+|++|+.||........        .......+..
T Consensus       168 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         168 TDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             cccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            5432     23345788999999986544678999999999999999999998854322100        0000001111


Q ss_pred             HhhchhhHHHHhcCC---C---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          247 YEKSELDATILACGI---E---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~---~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +..............   .   ......+.++.+++.+||+.+|++|||+.+|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            111111111110000   0   011123678999999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-37  Score=282.07  Aligned_cols=264  Identities=19%  Similarity=0.245  Sum_probs=195.3

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC------
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------   93 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------   93 (356)
                      ...+|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.++++++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            457788899999999999999965 468999999987542 223346688899999999999999999988643      


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ...+++++++ +++|.+++.  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccc
Confidence            3467888887 779988873  3469999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc--------ccchhhhHH
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL--------DWFPKHVWE  245 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~  245 (356)
                      .....     .....++..|+|||.+.+...++.++|||||||++|+|++|+.|+........        ...+.....
T Consensus       169 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         169 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             ccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            54322     12345788999999987644678899999999999999999988743322100        000000011


Q ss_pred             HHhhchhhHHHHhc-CCCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          246 EYEKSELDATILAC-GIEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       246 ~~~~~~~~~~~~~~-~~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .+............ ..+.     .....+.++.+++.+|++.||.+||++.+++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            11100000000000 0000     001235568899999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=270.21  Aligned_cols=237  Identities=30%  Similarity=0.344  Sum_probs=192.4

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCCh
Q 038199           32 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        32 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      ||+|+||.||++... +++.||+|++.....  ....+.+..|+.++++++|+||+++++.+.++...++|||++.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999764 589999999875422  22446789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCC
Q 038199          109 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK  188 (356)
Q Consensus       109 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~  188 (356)
                      .+++. ....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        81 ~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (250)
T cd05123          81 FSHLS-KEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC  154 (250)
T ss_pred             HHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence            99984 34478999999999999999999999   9999999999999999999999999999876543321  123345


Q ss_pred             CCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHH
Q 038199          189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK  268 (356)
Q Consensus       189 gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (356)
                      ++..|+|||.+.+. ..+.++|+||||+++|++++|..|+......                ........ .....+...
T Consensus       155 ~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~-~~~~~~~~~  216 (250)
T cd05123         155 GTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----------------EIYEKILK-DPLRFPEFL  216 (250)
T ss_pred             CCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHhc-CCCCCCCCC
Confidence            78899999999876 5788999999999999999999887443210                00111111 112233334


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHH
Q 038199          269 AKRLCMAALWCVQDSPEDRPPMSA  292 (356)
Q Consensus       269 ~~~l~~l~~~cl~~~p~~Rps~~~  292 (356)
                      +..+.+++.+||..||++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            678899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=268.08  Aligned_cols=258  Identities=25%  Similarity=0.322  Sum_probs=200.2

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   97 (356)
                      ++.....+-...||.|+||+|++-.++ .|+..|||.++....+....++..|.++..+- +.||||++||.+..+.-.|
T Consensus        60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence            333333344577999999999999764 69999999998766667778899998887776 5999999999999999999


Q ss_pred             EEEeccCCCChhhhhh----cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           98 LVYEYMENGSLDGYLF----GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      +.||+|+- ||+.+..    ..+..+++..+-.|....+.||.||-.  ...|||||+||+|||++..|.+||+|||++-
T Consensus       140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcG  216 (361)
T KOG1006|consen  140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICG  216 (361)
T ss_pred             eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchH
Confidence            99999954 8876652    235679999999999999999999997  4889999999999999999999999999987


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCC-CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      .+...-...   ...|-..|||||.+.... .+..+|||||||++++|+.||.-|.             ..|.......-
T Consensus       217 qLv~SiAkT---~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPy-------------r~w~svfeql~  280 (361)
T KOG1006|consen  217 QLVDSIAKT---VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPY-------------RKWDSVFEQLC  280 (361)
T ss_pred             hHHHHHHhh---hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCc-------------chHHHHHHHHH
Confidence            665433222   234666899999997554 4899999999999999999999664             23333221111


Q ss_pred             hHHHHhcCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          253 DATILACGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       253 ~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .-.....++   ......++..+..++.-|+.+|-.+||.++++.+.
T Consensus       281 ~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  281 QVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            111111111   12234578889999999999999999999999873

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.8e-38  Score=266.13  Aligned_cols=271  Identities=21%  Similarity=0.222  Sum_probs=199.4

Q ss_pred             hhhccccccccccCceEEEEEEe-C-C---CcEEEEEEeccccch-hhHHHHHHHHHHHccCCCCceeeeeceEec-CCe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-P-N---GVKIAVKVLNRNLGR-IAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHM   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~-~---~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~-~~~   95 (356)
                      -..|+..+.||+|.||.||+|.- . +   .+.||||.++..... ..-....+|+.+++.++|||++.+..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            45788899999999999999942 2 2   347999998753211 222457889999999999999999999887 778


Q ss_pred             eeEEEeccCCCChhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC----CceEEc
Q 038199           96 TALVYEYMENGSLDGYLFG----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN----FSPKVA  167 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~----~~~kl~  167 (356)
                      .++++||.+. +|...+.-    ..+.++...+..|+.||+.|+.|||+   +=|+||||||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence            8999999988 88777732    24579999999999999999999999   999999999999999877    899999


Q ss_pred             ccCCccccCCCCCee-eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch------
Q 038199          168 DFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP------  240 (356)
Q Consensus       168 Dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~------  240 (356)
                      |+|+++.+.+.-... .....+-|.+|.|||.+.|...||.+.||||.||++.||+|..+.|.........-.+      
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999987664443 2334557899999999999889999999999999999999887655443222111000      


Q ss_pred             -----------hhhHHHHhhchhh-----HHHHhcCCCchh-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          241 -----------KHVWEEYEKSELD-----ATILACGIEEKD-------KEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       241 -----------~~~~~~~~~~~~~-----~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                                 ...|..+.+-...     .+-.........       ...+....+|+.++|+.||-+|.|+++.++..
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence                       0011111111111     000000000000       00123367899999999999999999998854

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-38  Score=302.34  Aligned_cols=260  Identities=25%  Similarity=0.260  Sum_probs=208.7

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      .-.-+...+|.+.++||+|+||.|.+++.+ +++.||.|++++-  ........|..|-.+|..-..+.|+.++..|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            445567889999999999999999999875 5999999998752  1233346789999999999999999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      .++|+||||++||+|-.++.+.. .+++..+..++..|+.||.-||+   .|+|||||||+|||+|..|++||+|||.+-
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHH
Confidence            99999999999999999996555 89999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      .+..... ......+|||-|++||++..    .+.|++.+|.||+||++|||+.|..||..++          ..+.+..
T Consensus       224 km~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----------lveTY~K  292 (1317)
T KOG0612|consen  224 KMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----------LVETYGK  292 (1317)
T ss_pred             hcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----------HHHHHHH
Confidence            7764332 23345679999999999852    2468999999999999999999999985432          2333322


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP---MSAVVK  295 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~v~~  295 (356)
                      .--.  -....+| .....+.+..+||.+.+. +|+.|-.   ++++..
T Consensus       293 Im~h--k~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  293 IMNH--KESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             Hhch--hhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            2111  1111222 234467778888877664 6777776   777765

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=282.39  Aligned_cols=239  Identities=25%  Similarity=0.349  Sum_probs=195.7

Q ss_pred             cccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCC
Q 038199           29 STRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      .++||+|-||+||-|.++ +|+.||||++.+- ......+++++|+.+|.+++||.||.+-..|+..+..|+|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            588999999999999764 7999999999753 23445578999999999999999999999999999999999999775


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC---CceEEcccCCccccCCCCCeee
Q 038199          107 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       107 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      -|+=++....+.+++.....++.||+.||.|||-   ++|+|.||||+|||+.+.   ..+||+|||.++..+....   
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh---
Confidence            5555555567889999999999999999999999   999999999999999654   3699999999998875443   


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc------cchhhhHHHHhhchhhHHHH
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD------WFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ..+.+||+.|+|||+++++ .|++.-|+||.||++|.-|+|.-||..+...+..      .++..+|.            
T Consensus       723 RrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~------------  789 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWS------------  789 (888)
T ss_pred             hhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchh------------
Confidence            3456799999999999987 8999999999999999999999998765442211      12222222            


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                               +.+....++|...|+..-.+|-+.+.-+.
T Consensus       790 ---------eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  790 ---------EISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ---------hcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence                     23344667777788888888888776554

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=259.37  Aligned_cols=249  Identities=23%  Similarity=0.265  Sum_probs=194.6

Q ss_pred             hhhcccc-ccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecC----Ce
Q 038199           23 NFTSNYS-TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQ----HM   95 (356)
Q Consensus        23 ~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~----~~   95 (356)
                      ..+|.+. ++||-|-.|.|-.+.++ +++.+|+|++...      ...++|+++--.. .|||||.++++|.+.    ..
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            3456554 78999999999999654 7999999998542      2346677665555 499999999998753    45


Q ss_pred             eeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---CCceEEcccCC
Q 038199           96 TALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGL  171 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfgl  171 (356)
                      +.+|||.++||.|...++.+ ...+++.++..|..||..|+.|||+   .+|.||||||+|+|...   +..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence            67899999999999988655 4579999999999999999999999   99999999999999954   45799999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      ++......   .....+-|+.|.|||++... .|...+|+||+||++|-||+|.+||........            ...
T Consensus       211 AK~t~~~~---~L~TPc~TPyYvaPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~hg~ai------------spg  274 (400)
T KOG0604|consen  211 AKETQEPG---DLMTPCFTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPG  274 (400)
T ss_pred             ccccCCCc---cccCCcccccccCHHHhCch-hcCCCCCccchhHHHHHhhcCCCcccccCCccC------------Chh
Confidence            98655322   23345679999999999876 799999999999999999999999865433111            112


Q ss_pred             hhHHHHhcCCCc---hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          252 LDATILACGIEE---KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       252 ~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ....+..+....   .=...++...++++.+|..+|.+|-|+.++++.
T Consensus       275 Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  275 MKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             HHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            222333333221   122356677889999999999999999999874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=273.36  Aligned_cols=245  Identities=26%  Similarity=0.306  Sum_probs=202.2

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCC-CCceeeeeceEecCCe
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHM   95 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~   95 (356)
                      -+...+++|..+||+|+||.|-+|+-+ +.+.||||+++++.  +..+.+.-+.|-++|.... -|.++.+..+|..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            345667899999999999999999654 57789999998764  3344456678888998874 6789999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      +|+||||+.||+|.-.+ ++-+.+.+..+..++..|+-||-+||+   +||++||||.+||+++.+|++||+|||+++.-
T Consensus       425 LyFVMEyvnGGDLMyhi-QQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHI-QQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eeeEEEEecCchhhhHH-HHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999999888 345678899999999999999999999   99999999999999999999999999999853


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      -  .....+..++||+.|+|||++.-+ +|+...|.|||||+||||+.|+.||.....+                ++-..
T Consensus       501 i--~~~~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----------------elF~a  561 (683)
T KOG0696|consen  501 I--FDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQA  561 (683)
T ss_pred             c--cCCcceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHH
Confidence            2  222334568999999999999877 8999999999999999999999998655432                11111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCC
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRP  288 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  288 (356)
                      +.. .--..+...+.+...+....|.+.|.+|-
T Consensus       562 I~e-hnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  562 IME-HNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHH-ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            111 11245667788888999999999999994

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=271.56  Aligned_cols=278  Identities=27%  Similarity=0.343  Sum_probs=211.1

Q ss_pred             HhhhhcCCcceecHHHHhhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccccchhhH------HHHHHHHHHHcc
Q 038199            5 LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE------EQFMAEVGTIGR   77 (356)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~   77 (356)
                      |+.+.-+..-.|..--..+.+|.+...||+|||+.||+|. ...++.||||+-..+....+.      ++..+|.++-+.
T Consensus       444 LKRi~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKe  523 (775)
T KOG1151|consen  444 LKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKE  523 (775)
T ss_pred             HHhhcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhc
Confidence            3334344444555555678899999999999999999994 556889999975433222222      357789999999


Q ss_pred             CCCCceeeeeceEe-cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcE
Q 038199           78 TYHINLVRLYGFCH-DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV  156 (356)
Q Consensus        78 l~h~ni~~~~~~~~-~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Ni  156 (356)
                      |.||.||++|+++. +.+.+|-|+|||+|.+|+-|+ +..+.+++..+..|+.||+.||.||... +.+|||.||||.||
T Consensus       524 LDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNI  601 (775)
T KOG1151|consen  524 LDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNI  601 (775)
T ss_pred             cCcceeeeeeeeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccE
Confidence            99999999999986 667889999999999999888 5678899999999999999999999973 47899999999999


Q ss_pred             EEcC---CCceEEcccCCccccCCCCCee-----eeccCCCCCCCCCccccc-C--CCCCCccccchhhHHHHHHHHhCC
Q 038199          157 LLDA---NFSPKVADFGLAKLCDRNRSHV-----TISGYKGTPGYSAPEFLS-G--NYPITHKCDVYSFGMVLFEIVGRR  225 (356)
Q Consensus       157 ll~~---~~~~kl~Dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-~--~~~~~~~~Dv~slGvvl~elltg~  225 (356)
                      |+..   -|.+||.|||+++.+.......     ......||.+|++||++. +  .+..+.|.||||.||++|..+-|+
T Consensus       602 LLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGr  681 (775)
T KOG1151|consen  602 LLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGR  681 (775)
T ss_pred             EEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccC
Confidence            9943   4789999999999986544332     234467999999999874 2  346899999999999999999999


Q ss_pred             cccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          226 RNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       226 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .||+......         ..+....+.. ...-.+ +..+-.+.+...+|++||...-++|.+..++..
T Consensus       682 KPFGhnqsQQ---------dILqeNTIlk-AtEVqF-P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  682 KPFGHNQSQQ---------DILQENTILK-ATEVQF-PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             CCCCCchhHH---------HHHhhhchhc-ceeccC-CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            9997654321         0111111000 000111 223445667888999999999999988777764

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=237.04  Aligned_cols=262  Identities=20%  Similarity=0.244  Sum_probs=202.4

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      |.=.++||+|.||+||+|+.. +++-||+|.+.-+. .+..-....+|+-+++.++|.||++++++...+..+-+|+|||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            444578999999999999765 58899999987542 2334457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      +. +|..+..+.++.++.+.+..++.|+++||.+.|+   +++.|||+||.|.+++.+|.+||+|||+++.++-+-.  .
T Consensus        84 dq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr--c  157 (292)
T KOG0662|consen   84 DQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--C  157 (292)
T ss_pred             hH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--e
Confidence            65 9999998889999999999999999999999999   9999999999999999999999999999998764432  2


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch------hhhHHHHhhchhhHHHH
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP------KHVWEEYEKSELDATIL  257 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~  257 (356)
                      ....+-|.+|.+|.++.+..-|+...|+||.||++.|+.....|..++..-..+...      ....+.|....  ....
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t--~lpd  235 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT--KLPD  235 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc--cCCC
Confidence            233456899999999998878999999999999999999888887776552211000      00000010000  0000


Q ss_pred             hcCCCc---------hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          258 ACGIEE---------KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       258 ~~~~~~---------~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ....+.         .-+.....=++++...+.-+|.+|.++++.++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            000111         11333445567888888999999999998875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=282.54  Aligned_cols=240  Identities=23%  Similarity=0.270  Sum_probs=194.2

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ...|++...+|.|+|+.|-.+.. .+++.+++|++....     .+-.+|+.++... +||||+++.+.+.++...++||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            45788888899999999999964 578999999997642     1234467666665 6999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE-cCCCceEEcccCCccccCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL-DANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill-~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |.+.|+-|.+.+. ..+.+. ..+..|+.+|+.|+.|||+   +|+|||||||+|||+ ++.++++|+|||.++..... 
T Consensus       396 e~l~g~ell~ri~-~~~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIR-SKPEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHH-hcchhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            9999988877662 233333 7888999999999999999   999999999999999 68899999999999876544 


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                          ....+-|..|.|||+.... .+++++|+||||++||+||+|+.|+.....+               .++...+.. 
T Consensus       470 ----~~tp~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------------~ei~~~i~~-  528 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------------IEIHTRIQM-  528 (612)
T ss_pred             ----hcccchhhcccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCccccCCch---------------HHHHHhhcC-
Confidence                1223457789999999865 8999999999999999999999998665432               112222211 


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                        +......+....+|+.+||+.||.+||+++++...
T Consensus       529 --~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  529 --PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             --CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence              22336677888999999999999999999999874

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-36  Score=262.48  Aligned_cols=220  Identities=21%  Similarity=0.161  Sum_probs=174.5

Q ss_pred             cCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCChhhhhh
Q 038199           35 GGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF  113 (356)
Q Consensus        35 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~  113 (356)
                      |.||.||++.+ .+++.||+|++....      .+.+|...+....||||+++++++.+....++||||+.|++|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            89999999976 468999999987531      22344555555679999999999999999999999999999999884


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCC
Q 038199          114 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY  193 (356)
Q Consensus       114 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y  193 (356)
                      . ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++++|||.+.......     ....++..|
T Consensus        78 ~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y  148 (237)
T cd05576          78 K-FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY  148 (237)
T ss_pred             H-hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence            3 3468999999999999999999999   999999999999999999999999999876554321     223456789


Q ss_pred             CCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHH
Q 038199          194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLC  273 (356)
Q Consensus       194 ~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  273 (356)
                      +|||.+.+. .++.++|+||+|+++|||++|..++......            ..         .......+...+..+.
T Consensus       149 ~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~---------~~~~~~~~~~~~~~~~  206 (237)
T cd05576         149 CAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG------------IN---------THTTLNIPEWVSEEAR  206 (237)
T ss_pred             cCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cc---------cccccCCcccCCHHHH
Confidence            999998765 6789999999999999999998764321110            00         0000112233456788


Q ss_pred             HHHHhcccCCCCCCCCHH
Q 038199          274 MAALWCVQDSPEDRPPMS  291 (356)
Q Consensus       274 ~l~~~cl~~~p~~Rps~~  291 (356)
                      +++.+|++.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.2e-36  Score=296.26  Aligned_cols=146  Identities=29%  Similarity=0.353  Sum_probs=130.6

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ..|.+.++||+|+||+||+|.+. +++.||||++....  .......+..|+.+++.++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56888999999999999999765 68999999987432  2233467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ||+.|++|.+++.. ...+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.++|+|||+++
T Consensus        84 Ey~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999843 4568999999999999999999999   999999999999999999999999999876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=267.37  Aligned_cols=266  Identities=21%  Similarity=0.279  Sum_probs=228.3

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceE
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC   90 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~   90 (356)
                      ....+...++++...+-+|.||.||.|.+.      +.+.|-+|.++.+.++.....+..|.-.+..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            456667778888899999999999999543      34567789998887777788899999999999999999999987


Q ss_pred             ec-CCeeeEEEeccCCCChhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           91 HD-QHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        91 ~~-~~~~~lV~e~~~~~sL~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      .+ ...+++++.+..-|+|..++..       ..+.++-.+...++.|++.|++|||.   .++||.||...|+++|+.-
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhe
Confidence            64 5678999999999999999962       13457888999999999999999999   9999999999999999999


Q ss_pred             ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh
Q 038199          163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH  242 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~  242 (356)
                      .|||+|=.+++..-+.+...-..+.-....||+||.+... .|+.++|||||||++|||+|..               ..
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg---------------~~  497 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLG---------------KL  497 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcC---------------CC
Confidence            9999999999987665555544455567899999999877 7999999999999999999833               23


Q ss_pred             hHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          243 VWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      ++..++..++...+.++.+...+.++|++++.++..||...|++||++++++.-|....
T Consensus       498 PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  498 PYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             CccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            34556667777888888888999999999999999999999999999999999987653

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=256.34  Aligned_cols=265  Identities=22%  Similarity=0.326  Sum_probs=200.9

Q ss_pred             hccc-cccccccCceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNY-STRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~-~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      -|++ ++.||+|+++.|--+. ..+|.+||||++.+. ......+..+|++++.+.+ |+||+.++++|+++...|+|||
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE  156 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE  156 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence            3444 5889999999999995 578999999999875 4677788999999999985 9999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC---ceEEcccCCccccC--
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCD--  176 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~kl~Dfgl~~~~~--  176 (356)
                      -+.||+|...++ ....+++..+.++...|+.||.+||.   +||.||||||+|||....+   -|||+||.+..-..  
T Consensus       157 Km~GGplLshI~-~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  157 KMRGGPLLSHIQ-KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             cccCchHHHHHH-HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            999999999884 45689999999999999999999999   9999999999999996654   48999998764322  


Q ss_pred             CC---CCeeeeccCCCCCCCCCccccc---C-CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          177 RN---RSHVTISGYKGTPGYSAPEFLS---G-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       177 ~~---~~~~~~~~~~gt~~y~aPE~~~---~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      ..   .........+|+..|||||+..   + ...|..++|.||||||+|-||+|..||..--...=.|-..-+...-. 
T Consensus       233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ-  311 (463)
T KOG0607|consen  233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ-  311 (463)
T ss_pred             CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH-
Confidence            11   1112234567999999999753   2 23688999999999999999999999876444333332111111110 


Q ss_pred             chhhHHHHhcCCC--chh-HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 SELDATILACGIE--EKD-KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 ~~~~~~~~~~~~~--~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+-+.+..+..+  +.. ...+.+..+++...+..++.+|-++.+++.
T Consensus       312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            1111112222222  111 223556667888888999999999998887

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-38  Score=257.67  Aligned_cols=274  Identities=23%  Similarity=0.305  Sum_probs=202.2

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEec-cccchhhHHHHHHHHHHHccCCCCceeeeeceEecC------
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------   93 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------   93 (356)
                      +..+|+=..+||+|.||+||+|+.+ +|+.||+|++- .+..+.--....+|+.+|..++|+|++.++.+|...      
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3345555688999999999999765 48888887542 121222234568899999999999999999988532      


Q ss_pred             --CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           94 --HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        94 --~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                        ..+++|+++|+. +|.-++......++..++.+++.+++.||.|+|+   ..|+|||+|+.|+|++.+|++||+|||+
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence              357899999987 9999886667889999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCe--eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cc---hh
Q 038199          172 AKLCDRNRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WF---PK  241 (356)
Q Consensus       172 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~---~~  241 (356)
                      ++.+......  ...++.+-|.+|.+||.+.|...++.+.|||..||++.||.||..-+........-     .+   ..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9876533222  22344556999999999999889999999999999999999987655443332110     01   11


Q ss_pred             hhHHHHhhchhhHHHHhcCCC----chhHHH------HHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          242 HVWEEYEKSELDATILACGIE----EKDKEK------AKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~------~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      -.|....+-.+...+...+.+    ...++.      ..+..+++..++..||.+|+++++++...--
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F  318 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF  318 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence            123333332222222111111    111111      2367789999999999999999999875433

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=260.74  Aligned_cols=270  Identities=19%  Similarity=0.247  Sum_probs=204.3

Q ss_pred             ceecHHHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCC--CCc----eeee
Q 038199           14 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HIN----LVRL   86 (356)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~n----i~~~   86 (356)
                      .-|..++....+|.+.+.+|+|.||.|-.+.+ ..+..||||++++.  ....+..+-|++++.++.  -|+    ++.+
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            34577888899999999999999999999954 45889999999864  455567888999999993  333    8888


Q ss_pred             eceEecCCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-----
Q 038199           87 YGFCHDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-----  160 (356)
Q Consensus        87 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-----  160 (356)
                      .+||...+..|+|+|.+ |.|+.+++..+ -.+++..++..++.|++.++++||+   .+++|-||||+|||+.+     
T Consensus       157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEE
Confidence            99999999999999999 77999999553 3579999999999999999999999   99999999999999922     


Q ss_pred             ---------------CCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCC
Q 038199          161 ---------------NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR  225 (356)
Q Consensus       161 ---------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~  225 (356)
                                     +-.++++|||.++.-....     ...+.|-.|.|||++.+- +++..+||||+||+|.||.||.
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccc
Confidence                           2348999999998654433     234468899999999987 8999999999999999999998


Q ss_pred             cccccCCCCc-----cccchhhhHHHHhhchhh--------------------HHHHhcC----CCchhHHHHHHHHHHH
Q 038199          226 RNAIVGSSES-----LDWFPKHVWEEYEKSELD--------------------ATILACG----IEEKDKEKAKRLCMAA  276 (356)
Q Consensus       226 ~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~--------------------~~~~~~~----~~~~~~~~~~~l~~l~  276 (356)
                      ..|..-....     +..+++.+...+......                    .....+.    ..........+|++|+
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            7664433211     011111111111111000                    0000000    0011123456799999


Q ss_pred             HhcccCCCCCCCCHHHHHH
Q 038199          277 LWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       277 ~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+||..||.+|+|+.|++.
T Consensus       387 ~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHccCccccccHHHHhc
Confidence            9999999999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.8e-35  Score=252.82  Aligned_cols=237  Identities=30%  Similarity=0.405  Sum_probs=191.3

Q ss_pred             CceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCChhhhhhc
Q 038199           36 GFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFG  114 (356)
Q Consensus        36 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~  114 (356)
                      +||.||+|... +|+.+|+|++.........+.+.+|++.+++++|+|++++++++......++++|++.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999875 58999999997653333267899999999999999999999999999999999999999999998843


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCC
Q 038199          115 KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS  194 (356)
Q Consensus       115 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~  194 (356)
                      . ..+++..+..++.+++.++.+||+   .+++|+||+|+||+++.++.++|+|||.+.......   ......++..|+
T Consensus        81 ~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 R-GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             c-cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            3 338999999999999999999999   999999999999999999999999999998765432   223345788999


Q ss_pred             CcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHH--HHHHH
Q 038199          195 APEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE--KAKRL  272 (356)
Q Consensus       195 aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l  272 (356)
                      +||.+.+. .++.++||||||++++++++|..|+......               ..................  .+.++
T Consensus       154 ~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~  217 (244)
T smart00220      154 APEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQL---------------LELFKKIGKPKPPFPPPEWKISPEA  217 (244)
T ss_pred             CHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHHHhccCCCCccccccCCHHH
Confidence            99998765 6788999999999999999999887542110               011111111111111111  56789


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHH
Q 038199          273 CMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       273 ~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            99999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=279.69  Aligned_cols=252  Identities=24%  Similarity=0.332  Sum_probs=204.8

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEe-----cCC
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH-----DQH   94 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~-----~~~   94 (356)
                      -..+++|.+.||+|.+|.||+++. ++++-.|+|+...+  ....+++..|.++++.+ .|||++.++|+|.     .++
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~--~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT--EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC--ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            456789999999999999999975 47888999988765  34446788899999998 5999999999986     357


Q ss_pred             eeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           95 MTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      .+|||||||.|||..+++..- +..+.|..+..|+..++.|+.+||.   ..++|||||-.|||++.++.|||+|||++.
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSA  171 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeee
Confidence            899999999999999999543 5689999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCC----CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      ..+......  ....||+.|||||++...    ..|+..+|+||||++..||--|.+|+..-          ++...+. 
T Consensus       172 QldsT~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm----------HPmraLF-  238 (953)
T KOG0587|consen  172 QLDSTVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM----------HPMRALF-  238 (953)
T ss_pred             eeecccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc----------chhhhhc-
Confidence            776443332  346799999999998532    25788999999999999999999886321          1111111 


Q ss_pred             chhhHHHHh-cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 SELDATILA-CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 ~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          ..... .+....+....+++.++|..||.+|.++||++.++++
T Consensus       239 ----~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 ----LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ----cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                01111 1112235667889999999999999999999999886

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=246.48  Aligned_cols=281  Identities=19%  Similarity=0.214  Sum_probs=236.3

Q ss_pred             HhhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeE
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~l   98 (356)
                      +....|.++++||+|+||+.+.|+ .-+++.||||..+..   ....++..|.+..+.|. .++|..+|.+...+.+..|
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            466789999999999999999996 568999999998763   45568999999999985 8999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-----CceEEcccCCcc
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-----FSPKVADFGLAK  173 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-----~~~kl~Dfgl~~  173 (356)
                      |+|++ |.||+++..-+++.|+..++..++.|++.-++|+|+   +.+|+|||||+|+||...     ..+.++|||+++
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            99999 889999998889999999999999999999999999   999999999999999644     358999999999


Q ss_pred             ccCCCCCeeee-----ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh
Q 038199          174 LCDRNRSHVTI-----SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE  248 (356)
Q Consensus       174 ~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  248 (356)
                      .+.++.+...+     .+..||.+||+...+.|. +.+++.|+-|||-|++++|.|..||..-..+..    ...++.+.
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn----K~kYeKIG  252 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN----KEKYEKIG  252 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcch----HHHHHHhc
Confidence            98877665442     346699999999999988 789999999999999999999999866444322    22222222


Q ss_pred             hchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCCCCCcccchhhhh
Q 038199          249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLDLIKM  318 (356)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~~~~~~~~~~~~  318 (356)
                      .     .-....+.+.+.++|.++..-+...-+.+-.+-|+++.+...+..+.+.........+.|....
T Consensus       253 e-----~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln  317 (449)
T KOG1165|consen  253 E-----TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN  317 (449)
T ss_pred             c-----ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence            1     1223344566778899999999999999999999999999999999888877776666666555

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=250.49  Aligned_cols=256  Identities=25%  Similarity=0.295  Sum_probs=203.3

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccC-CCCceeeeeceEec
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD   92 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~   92 (356)
                      ..+.+.-.++.+.++||+|+|+.|-+++++ +.+-||+|++++..-  ..+.+=...|-.+..+. +||.+|-+..+|..
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            456677788899999999999999999864 688999999976431  23333455677777776 59999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ...+++|.||++||+|.-.+ .+.++++++.+..+...|+.||.|||+   +||++||||.+|||+|..|++||.|+|++
T Consensus       323 esrlffvieyv~ggdlmfhm-qrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             cceEEEEEEEecCcceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchh
Confidence            99999999999999998766 456789999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      +.-....  ..+..++||+.|.|||++++. .|....|.|+|||+++||+.|+.||..-..++.+.    ..+.+    +
T Consensus       399 ke~l~~g--d~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~----ntedy----l  467 (593)
T KOG0695|consen  399 KEGLGPG--DTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM----NTEDY----L  467 (593)
T ss_pred             hcCCCCC--cccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCccc----chhHH----H
Confidence            8643322  234568999999999999988 89999999999999999999999998754432211    01111    1


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCC
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRP  288 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  288 (356)
                      -..++...+ ..+...+-....+++..|++||.+|-
T Consensus       468 fqvilekqi-riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  468 FQVILEKQI-RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHhhhcc-cccceeehhhHHHHHHhhcCCcHHhc
Confidence            111111111 23445555677788889999999994

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3e-34  Score=275.91  Aligned_cols=258  Identities=18%  Similarity=0.175  Sum_probs=165.8

Q ss_pred             hhhhccccccccccCceEEEEEEeC-C----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeece------E
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-N----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF------C   90 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~------~   90 (356)
                      ....|.+.++||+|+||.||+|.+. +    +..||||++....   ..+.+..+  .++...+.++..++..      .
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4567889999999999999999764 4    7899999876431   11112222  1122222233222221      2


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHhhcCCCCccccCC
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGKKRA-------------------IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI  151 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~~~~-------------------~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~di  151 (356)
                      .+....++||||+.+++|.+++......                   .....+..++.|++.||.|||+   ++|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcC
Confidence            4556789999999999999988543211                   1234466899999999999999   99999999


Q ss_pred             CCCcEEEcC-CCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCC---------------------CCCccc
Q 038199          152 KPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY---------------------PITHKC  209 (356)
Q Consensus       152 kp~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~  209 (356)
                      ||+|||++. ++.+||+|||+++........ ......+++.|+|||.+....                     .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999985 579999999999765432221 123356899999999653211                     234567


Q ss_pred             cchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc-----hhhHHHHhcCCCc------hhHHHHHHHHHHHHh
Q 038199          210 DVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS-----ELDATILACGIEE------KDKEKAKRLCMAALW  278 (356)
Q Consensus       210 Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~------~~~~~~~~l~~l~~~  278 (356)
                      |||||||++|||+++..+....   ..     .....+...     .............      ..........+|+.+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~---~~-----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN---LI-----QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH---HH-----HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence            9999999999999876442111   00     000000000     0000000000000      000112345589999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 038199          279 CVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       279 cl~~~p~~Rps~~~v~~~  296 (356)
                      ||+.||++|||++++++.
T Consensus       433 mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        433 MMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HccCCcccCCCHHHHhCC
Confidence            999999999999999973

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=267.26  Aligned_cols=241  Identities=24%  Similarity=0.312  Sum_probs=198.2

Q ss_pred             hccccccccccCceEEEEEEeCCC-cEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFPNG-VKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+...-||-||||.|=+++..+. ..+|+|.+++..  .....++...|-++|...+.|.||++|-.|.+..+.|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            344456699999999999987443 348999887532  34445788899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      -|-||.|...+ +..+.++..+...++..+++|++|||+   ++||+|||||+|++++.+|-+||.|||+++........
T Consensus       501 aClGGElWTiL-rdRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  501 ACLGGELWTIL-RDRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             hhcCchhhhhh-hhcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence            99999999998 566789999999999999999999999   99999999999999999999999999999988766544


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC-
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG-  260 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  260 (356)
                      ..   ++||+.|.|||++.+. ....++|.||||+++|||++|.+||....+-       ..+.         .++.+. 
T Consensus       577 wT---FcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpm-------ktYn---------~ILkGid  636 (732)
T KOG0614|consen  577 WT---FCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPM-------KTYN---------LILKGID  636 (732)
T ss_pred             ee---ecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchH-------HHHH---------HHHhhhh
Confidence            33   6899999999999877 6789999999999999999999998654321       1111         111111 


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCC
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPP  289 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  289 (356)
                      .-..+....+...+++++....+|.+|-.
T Consensus       637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            02334555667788889999999999965

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-35  Score=266.78  Aligned_cols=216  Identities=25%  Similarity=0.370  Sum_probs=178.5

Q ss_pred             eecHHHHhhhhccccccccccCceEEEEE-EeCCCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        15 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      ++.-+...+--|.-.+-||-|+||+|.++ +..+...||.|.+.+.  .......+.+.|-++|.....+.||++|..|.
T Consensus       620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ  699 (1034)
T KOG0608|consen  620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ  699 (1034)
T ss_pred             HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence            33444444555555788999999999999 4667888999988653  12233356788999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                      +++.+|+||+|++||++..+|. +.+-|.+..+..++.++..|+++.|.   .|+|||||||+|||||.+|++||.||||
T Consensus       700 DkdnLYFVMdYIPGGDmMSLLI-rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGL  775 (1034)
T KOG0608|consen  700 DKDNLYFVMDYIPGGDMMSLLI-RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGL  775 (1034)
T ss_pred             cCCceEEEEeccCCccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccc
Confidence            9999999999999999999884 45678999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccC---------CCCCee-------------------------------eeccCCCCCCCCCcccccCCCCCCccccc
Q 038199          172 AKLCD---------RNRSHV-------------------------------TISGYKGTPGYSAPEFLSGNYPITHKCDV  211 (356)
Q Consensus       172 ~~~~~---------~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv  211 (356)
                      +.-+.         ......                               .....+||..|+|||++... .++..+|.
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdw  854 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDW  854 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-Cccccchh
Confidence            87541         000000                               01135699999999999876 79999999


Q ss_pred             hhhHHHHHHHHhCCcccccCCCCc
Q 038199          212 YSFGMVLFEIVGRRRNAIVGSSES  235 (356)
Q Consensus       212 ~slGvvl~elltg~~p~~~~~~~~  235 (356)
                      ||.||+||||+.|+.||.......
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCCc
Confidence            999999999999999998766543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=229.67  Aligned_cols=207  Identities=25%  Similarity=0.337  Sum_probs=174.7

Q ss_pred             HHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCee
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~   96 (356)
                      +++......-...||+|++|.|-+-++ .+|+..|+|.+......+...++..|+++..+- .+|.+|.+||...+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            555556666678899999999988875 479999999998766667778889999988876 699999999999999899


Q ss_pred             eEEEeccCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           97 ALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ++.||.|+- ||+.+..   ..+..+++..+-+|+..++.||.|||+  +..++|||+||+|||++.+|+||+||||++-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999955 8887653   357889999999999999999999999  5889999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCC---CCCCccccchhhHHHHHHHHhCCcccccC
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVLFEIVGRRRNAIVG  231 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~Dv~slGvvl~elltg~~p~~~~  231 (356)
                      .+.+.-...   ...|-..|||||.+..+   ..|+.++||||||+.+.||.+++.|....
T Consensus       198 ~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            776543322   13366689999988532   26899999999999999999999886554

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-33  Score=245.21  Aligned_cols=132  Identities=27%  Similarity=0.381  Sum_probs=114.5

Q ss_pred             hhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-----CC---ceeeeeceEe-
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-----HI---NLVRLYGFCH-   91 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~---ni~~~~~~~~-   91 (356)
                      +..+|-+.++||-|-|++||++. ..+.+.||+|+.+..  +.-.+....|+.+|++++     |+   +||++++.|. 
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            44899999999999999999995 457889999999875  455577889999999984     32   6999999986 


Q ss_pred             ---cCCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE
Q 038199           92 ---DQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL  158 (356)
Q Consensus        92 ---~~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill  158 (356)
                         ++.+.|+|+|++ |.+|..++... -+.++...+.+|+.||+.||.|||.  ..+|||-||||+|||+
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence               567899999999 66888888654 4679999999999999999999998  4799999999999999

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.4e-33  Score=261.72  Aligned_cols=262  Identities=19%  Similarity=0.184  Sum_probs=176.9

Q ss_pred             hhhhccccccccccCceEEEEEEe-----------------CCCcEEEEEEeccccchh-------------hHHHHHHH
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-----------------PNGVKIAVKVLNRNLGRI-------------AEEQFMAE   71 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~E   71 (356)
                      ....|.+.++||+|+||+||+|..                 ..++.||||.+.......             ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            566889999999999999999953                 235679999986532111             11223446


Q ss_pred             HHHHccCCCCc-----eeeeeceEec--------CCeeeEEEeccCCCChhhhhhcCC----------------------
Q 038199           72 VGTIGRTYHIN-----LVRLYGFCHD--------QHMTALVYEYMENGSLDGYLFGKK----------------------  116 (356)
Q Consensus        72 ~~~l~~l~h~n-----i~~~~~~~~~--------~~~~~lV~e~~~~~sL~~~l~~~~----------------------  116 (356)
                      +..+.+++|.+     ++.+++++..        +...++||||+.+++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            67777776554     3667776643        346799999999999999885321                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCC
Q 038199          117 -RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA  195 (356)
Q Consensus       117 -~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~a  195 (356)
                       ..+++..+..++.|++.+|.|||+   .+++||||||+||+++.++.++|+|||++......... ......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence             234677899999999999999999   99999999999999999999999999999754332211 1111234789999


Q ss_pred             cccccCCC---------------------CCCccccchhhHHHHHHHHhCCc-ccccCCCCccc--c--chhhhHHHHhh
Q 038199          196 PEFLSGNY---------------------PITHKCDVYSFGMVLFEIVGRRR-NAIVGSSESLD--W--FPKHVWEEYEK  249 (356)
Q Consensus       196 PE~~~~~~---------------------~~~~~~Dv~slGvvl~elltg~~-p~~~~~~~~~~--~--~~~~~~~~~~~  249 (356)
                      ||.+....                     ....+.||||+||++++|++|.. |+.........  .  .....|..+..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99875321                     11235799999999999999875 43211100000  0  00001111111


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCC---CCCCCHHHHHH
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSP---EDRPPMSAVVK  295 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~Rps~~~v~~  295 (356)
                      ..        ..............+++.++|..+|   .+|+|++++++
T Consensus       459 ~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            00        0011122345678889999998766   68999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.9e-32  Score=230.85  Aligned_cols=212  Identities=37%  Similarity=0.610  Sum_probs=183.7

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCChhh
Q 038199           32 LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDG  110 (356)
Q Consensus        32 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL~~  110 (356)
                      ||+|++|.||++... +++.+++|++.........+.+.+|++.++.+.|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            799999999999875 4899999999875433245789999999999999999999999999899999999999899999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-CCceEEcccCCccccCCCCCeeeeccCCC
Q 038199          111 YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKG  189 (356)
Q Consensus       111 ~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g  189 (356)
                      ++......+++..+..++.+++.++.+||+   .+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            985444578999999999999999999999   99999999999999999 89999999999987654432  1222447


Q ss_pred             CCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHH
Q 038199          190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKA  269 (356)
Q Consensus       190 t~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (356)
                      ...|++||.+......+.++|+|++|++++++                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            78899999987643578899999999999998                                                


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          270 KRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       270 ~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ..+.+++.+|++.+|++||++.++++.
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            458889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=8.3e-34  Score=229.69  Aligned_cols=258  Identities=19%  Similarity=0.281  Sum_probs=198.0

Q ss_pred             hhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecC--Ceee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQ--HMTA   97 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~--~~~~   97 (356)
                      +..+|++.+++|+|.+++||.|. ..+++.++||++++    ...+.+.+|+.+|..|. ||||+.++++..+.  ..+.
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            55678889999999999999996 45789999999975    44567899999999997 99999999999875  4678


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-CceEEcccCCccccC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCD  176 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfgl~~~~~  176 (356)
                      +|+||+++.+...+.    ..++...+..++.+++.||.|+|+   +||.|||+||.|+++|.. -.++|+|+|++..+.
T Consensus       112 LiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            999999887776654    568888999999999999999999   999999999999999865 469999999999876


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .......   .+.+.-|--||.+..-..+...-|+|||||++..|+..+.||+-+.....+...  ...-....++..-+
T Consensus       185 p~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk--IakVLGt~el~~Yl  259 (338)
T KOG0668|consen  185 PGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK--IAKVLGTDELYAYL  259 (338)
T ss_pred             CCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH--HHHHhChHHHHHHH
Confidence            5543322   234556778999877667889999999999999999999999887664321100  00000011111111


Q ss_pred             H---------------hc-------CCC-chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 L---------------AC-------GIE-EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~---------------~~-------~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .               ..       .+. +.......+..+++.+.|..|-.+|+|++|.+.
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            0               00       011 111223477889999999999999999999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=270.48  Aligned_cols=241  Identities=24%  Similarity=0.359  Sum_probs=182.6

Q ss_pred             cccccccCceE-EEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEeccCCC
Q 038199           29 STRLGFGGFGE-VYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        29 ~~~iG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      .+.+|.|+-|+ ||+|.+ .|++||||.+-.    ...+...+|+..|+.- +||||+++|+.-.+.+..||..|.|.. 
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             HHHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            46789998876 899988 788999998754    3334567899999987 599999999999999999999999955 


Q ss_pred             ChhhhhhcC--CCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---C--CceEEcccCCccccCCC
Q 038199          107 SLDGYLFGK--KRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---N--FSPKVADFGLAKLCDRN  178 (356)
Q Consensus       107 sL~~~l~~~--~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~--~~~kl~Dfgl~~~~~~~  178 (356)
                      +|.+++...  ... ..-...+.++.|++.||++||+   .+||||||||.||||+.   +  ..++|+|||+++.....
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            999999663  111 1114567889999999999999   99999999999999965   3  46899999999987654


Q ss_pred             CCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhC-CcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          179 RSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR-RRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       179 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ... ....+..||.+|+|||++... ..+.+.|||||||++|+.++| ..||+..-...         .++..+....  
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---------~NIl~~~~~L--  732 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---------ANILTGNYTL--  732 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhh---------hhhhcCccce--
Confidence            333 334567799999999999876 457799999999999999987 45664321110         0000110000  


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       .. ..+. ...  +..+||.+|++++|..||++.+|+.
T Consensus       733 -~~-L~~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 -VH-LEPL-PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -ee-eccC-chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence             00 0011 111  6788999999999999999999985

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=228.93  Aligned_cols=279  Identities=19%  Similarity=0.244  Sum_probs=227.7

Q ss_pred             HhhhhccccccccccCceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeE
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~l   98 (356)
                      +....|.+.++||+|+||.+|.|. ..+|.+||||+.++..   .-.++..|..+.+.|+ -..|..+..++.++.+..+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            466789999999999999999996 4579999999998653   2346888999999997 5788888999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC---CceEEcccCCcccc
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLC  175 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~Dfgl~~~~  175 (356)
                      ||+++ |.||+++++-+.+.++..+++.++-|++.-++|+|.   ++++||||||+|+|+.-+   ..+.|+|||+++.+
T Consensus        89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999 889999998888999999999999999999999999   999999999999999644   46899999999987


Q ss_pred             CCCCCeee-----eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc
Q 038199          176 DRNRSHVT-----ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       176 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      .+..+...     ..+..||.+|.+-..+.+. ..+++.|+-|+|++++++..|..||..-.....    ...++.+   
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk----~QKyEkI---  236 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK----KQKYEKI---  236 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhH----HHHHHHH---
Confidence            65444332     2346699999999998876 689999999999999999999999865433211    2222222   


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCCCCCcccchhh
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLDLI  316 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~~~~~~~~~~  316 (356)
                        .+.-....+...+...|.++...+..|-...-++-|++..+.+.+..+...+...-.+-+.|..
T Consensus       237 --~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~  300 (341)
T KOG1163|consen  237 --SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTM  300 (341)
T ss_pred             --HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHH
Confidence              2223334445667778899999999999999999999999999888877776666655566543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-33  Score=229.86  Aligned_cols=252  Identities=18%  Similarity=0.287  Sum_probs=195.0

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeece-EecCCeeeEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF-CHDQHMTALV   99 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~-~~~~~~~~lV   99 (356)
                      ...|++.+.||+|.||.+-+++++ +++.+++|.+.+.  ......|.+|...--.|. |.||+..|++ |...+..+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            356889999999999999999876 5889999999875  455678999998887775 9999998875 5566788899


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc--CCCceEEcccCCccccCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~--~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||++.|+|.+-+  ....+.+.....++.|++.||.|+|+   +++||||||.+|||+-  +...+||+|||+.+..+.
T Consensus       101 qE~aP~gdL~snv--~~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  101 QEFAPRGDLRSNV--EAAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eccCccchhhhhc--CcccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            9999999999877  34678889999999999999999999   9999999999999993  345899999999875442


Q ss_pred             CCCeeeeccCCCCCCCCCccccc----CCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      .-     ....-+..|.+||...    +.....+.+|+|.||++++.++||..||........   +.+.|..|..+...
T Consensus       176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~~  247 (378)
T KOG1345|consen  176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKNP  247 (378)
T ss_pred             ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccCc
Confidence            21     1222455799999763    222467789999999999999999999986544333   34455556554433


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCC---CCHHHHHH
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDR---PPMSAVVK  295 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---ps~~~v~~  295 (356)
                            ..+.....++..+..+.++-+..++++|   .+++....
T Consensus       248 ------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  248 ------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             ------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence                  2233444456667778888999999999   44444443

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.98  E-value=3.8e-33  Score=249.41  Aligned_cols=271  Identities=21%  Similarity=0.283  Sum_probs=209.5

Q ss_pred             ceecHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC------CCceeee
Q 038199           14 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY------HINLVRL   86 (356)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~ni~~~   86 (356)
                      .++.-+++...+|.+....|+|-|++|..|.+. .|..||||+|.++  +.-.+.=..|+++|++|.      .-|++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            456778999999999999999999999999764 4889999999876  333345568999999995      3489999


Q ss_pred             eceEecCCeeeEEEeccCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-Cc
Q 038199           87 YGFCHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FS  163 (356)
Q Consensus        87 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~  163 (356)
                      +-.|.+.+++|||+|-+ ..+|.+.+.+.  +-.+....+..++.|++-||..|-.   .+|+|.||||+|||+++. ..
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcce
Confidence            99999999999999999 55999998654  4568889999999999999999998   999999999999999876 57


Q ss_pred             eEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCc-ccc----
Q 038199          164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES-LDW----  238 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~-~~~----  238 (356)
                      +||||||.|.......    ++.+.-+-.|.|||++.|- +|....|+||.||.||||.||+..|....... ..+    
T Consensus       576 LKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  576 LKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             eeeccCcccccccccc----ccHHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            8999999997655433    2333445689999999988 79999999999999999999987664332211 100    


Q ss_pred             chhhhHHHHhh-------------------------------------chhhHHHHhc-CCCchhHHHHHHHHHHHHhcc
Q 038199          239 FPKHVWEEYEK-------------------------------------SELDATILAC-GIEEKDKEKAKRLCMAALWCV  280 (356)
Q Consensus       239 ~~~~~~~~~~~-------------------------------------~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl  280 (356)
                      .+..+...+..                                     ..+...+... ..+...+.....+.+|+..||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            00111111111                                     1111111221 134455667788999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 038199          281 QDSPEDRPPMSAVVK  295 (356)
Q Consensus       281 ~~~p~~Rps~~~v~~  295 (356)
                      ..||++|.|..+.++
T Consensus       731 ~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  731 ILDPEKRITVNQALK  745 (752)
T ss_pred             ccChhhcCCHHHHhc
Confidence            999999999998875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=247.83  Aligned_cols=195  Identities=27%  Similarity=0.380  Sum_probs=166.9

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHH---------HHHHHHHHHccCC---CCceeeeeceE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEE---------QFMAEVGTIGRTY---HINLVRLYGFC   90 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---------~~~~E~~~l~~l~---h~ni~~~~~~~   90 (356)
                      ..|+..+.+|+|+||.|++|.++ +...|+||.+.+..  .-.+         ..-.|+.+|+.++   |+||++++++|
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeR--IL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKER--ILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhh--hhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            35777899999999999999765 57889999987542  1111         2346999999997   99999999999


Q ss_pred             ecCCeeeEEEecc-CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEccc
Q 038199           91 HDQHMTALVYEYM-ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  169 (356)
Q Consensus        91 ~~~~~~~lV~e~~-~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df  169 (356)
                      +++++.+|+||.. +|.+|.+++ .....+++..+..|+.|++.|+++||+   ++|||||||-+||.++.+|-+||+||
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeec
Confidence            9999999999986 456888988 456789999999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCccc
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNA  228 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~  228 (356)
                      |.+.....+..    ..++||..|.|||++.|..-....-|||++|+++|.++....|+
T Consensus       715 gsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  715 GSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99876544332    34679999999999999866788899999999999998777665

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-33  Score=234.58  Aligned_cols=267  Identities=22%  Similarity=0.328  Sum_probs=195.7

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC-----Ceee
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMTA   97 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-----~~~~   97 (356)
                      +.+-.+-||-|+||.||.++++ +|+.||+|.+..-. .-...+++.+|+.+|..++|.|++..+++..-.     +..|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4455788999999999999764 79999999887543 234447899999999999999999999887533     3567


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +|.|++.. +|..++ ...+.++...+.-+++||++||.|||+   .+|.||||||.|.|++.+-.+||+|||+++....
T Consensus       134 V~TELmQS-DLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  134 VLTELMQS-DLHKII-VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHh-hhhhee-ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence            89999954 898887 456788999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCc-cc----cchhhhHHHHh--hc
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES-LD----WFPKHVWEEYE--KS  250 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~-~~----~~~~~~~~~~~--~~  250 (356)
                      .... .++..+-|-.|.|||.+.|...|+.+.||||.||++.||+.++..|...++-. .+    .+.....+.+.  -+
T Consensus       209 d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 RDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            3332 23334457789999999998889999999999999999998776654433311 10    01111111111  11


Q ss_pred             hhhHHHHhcC-CCch---------hHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          251 ELDATILACG-IEEK---------DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       251 ~~~~~~~~~~-~~~~---------~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      .....+.... ..+.         +.....+-..++..++..||++|.+..+.+..+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            1111111111 1110         111223456677889999999999988887754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.7e-30  Score=222.91  Aligned_cols=201  Identities=35%  Similarity=0.515  Sum_probs=170.9

Q ss_pred             ccccccccccCceEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccC
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~  104 (356)
                      |.+.+.||+|++|.||++.... ++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5678899999999999997754 899999999865333256789999999999999999999999999899999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeee
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI  184 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  184 (356)
                      +++|.+++......+++..+..++.+++.++.+||+   .+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence            999999985443338999999999999999999999   89999999999999999999999999998876544311 11


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCccccc
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIV  230 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~  230 (356)
                      ....++..|++||.+.....++.++|+|+||+++++|++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2345778899999983333678899999999999999999998843

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-30  Score=232.85  Aligned_cols=262  Identities=20%  Similarity=0.242  Sum_probs=198.8

Q ss_pred             hccccccccccCceEEEEEEeCC--CcEEEEEEeccccchhhHHHHHHHHHHHccCCC----CceeeeeceE-ecCCeee
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFPN--GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH----INLVRLYGFC-HDQHMTA   97 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~ni~~~~~~~-~~~~~~~   97 (356)
                      .|.+.++||+|+||.||.+....  ...+|+|+.......... .+..|..++..+..    +++..+++.+ ....+.+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            89999999999999999997644  358999998764322222 67888888888862    6899999999 5788899


Q ss_pred             EEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-----CceEEcccCC
Q 038199           98 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-----FSPKVADFGL  171 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-----~~~kl~Dfgl  171 (356)
                      +||+.+ |.+|.++.... .+.++..+++.|+.|++.+|++||+   .|++||||||+|+++...     ..+.|.|||+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            999999 88999988544 4789999999999999999999999   999999999999999755     4699999999


Q ss_pred             cc--ccCCCCCe----e-e-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhh
Q 038199          172 AK--LCDRNRSH----V-T-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHV  243 (356)
Q Consensus       172 ~~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~  243 (356)
                      ++  .+......    . . .....||.+|++++.+.+. ..+++.|+||+++++.+++.|..||........       
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-------  245 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-------  245 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccch-------
Confidence            99  43222211    1 1 1345699999999999987 789999999999999999999988844332111       


Q ss_pred             HHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          244 WEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                           ....................+..+..++..+-..+..++|.+..+...|.......
T Consensus       246 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  246 -----KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -----HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                 00111111111111112223455666666677799999999999999987776554

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=3.4e-31  Score=232.06  Aligned_cols=266  Identities=23%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecC
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQ   93 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~   93 (356)
                      .-.....|....+||+|.|++||++.+.    .++.||+|.+...   ....++..|++.|..+. +.||+++.+++.++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t---s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT---SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc---cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            3345566788899999999999999643    4788999999763   33457899999999995 99999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-CCceEEcccCCc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLA  172 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfgl~  172 (356)
                      +..++|+||++.....++.    ..++...+..++..++.||.++|.   .|||||||||+|++.+. .+.-.|+|||++
T Consensus       108 d~v~ivlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             CeeEEEecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence            9999999999998888887    356788999999999999999999   99999999999999974 478899999998


Q ss_pred             cccCC---------------------------------CCC---------eeeeccCCCCCCCCCcccccCCCCCCcccc
Q 038199          173 KLCDR---------------------------------NRS---------HVTISGYKGTPGYSAPEFLSGNYPITHKCD  210 (356)
Q Consensus       173 ~~~~~---------------------------------~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  210 (356)
                      .....                                 ...         .....+..||++|.|||++......+.+.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            83210                                 000         000123459999999999988778899999


Q ss_pred             chhhHHHHHHHHhCCcccccCCCCccc------cchhh-------------hHHHHhhc-hhh-----------HHHHh-
Q 038199          211 VYSFGMVLFEIVGRRRNAIVGSSESLD------WFPKH-------------VWEEYEKS-ELD-----------ATILA-  258 (356)
Q Consensus       211 v~slGvvl~elltg~~p~~~~~~~~~~------~~~~~-------------~~~~~~~~-~~~-----------~~~~~-  258 (356)
                      |||.||+++-+++++.||.....+-..      .+...             .|+. ... .+.           +.... 
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~k-sn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQK-SNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecc-ccccccHHHHhchhccChhhcccc
Confidence            999999999999999999776554321      00000             1110 000 000           00000 


Q ss_pred             ----cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          259 ----CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       259 ----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          ........-.+..+++++.+|+..||.+|.|+++.++
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                0111111223457889999999999999999999986

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-32  Score=249.01  Aligned_cols=251  Identities=23%  Similarity=0.305  Sum_probs=199.8

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+|++.+++|+|.+|.||++++. +++..|+|+++-.. ..+..-+.+|+-+++.-+||||+.+++.+...+.+++.||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            357889999999999999999764 69999999997643 2344567789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      ||.||+|.+.. ....++++.++.......++|++|||+   ++=+|||||-.||++++.|.+|++|||.+..++..-.+
T Consensus        93 ycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   93 YCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             ecCCCccccee-eecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            99999999866 456789999999999999999999999   99999999999999999999999999998766543322


Q ss_pred             eeeccCCCCCCCCCcccc--cCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          182 VTISGYKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~--~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                        ..++.||+.|||||+.  .....|...+|||++|+...|+--.+.|.+          .-++.....     -+...+
T Consensus       169 --rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf----------dlhpmr~l~-----LmTkS~  231 (829)
T KOG0576|consen  169 --RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF----------DLHPMRALF-----LMTKSG  231 (829)
T ss_pred             --hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc----------ccchHHHHH-----HhhccC
Confidence              3457799999999975  233478999999999999999987776642          122211111     111111


Q ss_pred             ---CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 ---GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ---~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                         ............+.++++.|+.++|++||+++.++.
T Consensus       232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence               111222334566888999999999999999987654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=223.25  Aligned_cols=262  Identities=21%  Similarity=0.259  Sum_probs=192.3

Q ss_pred             hhhhccccccccccCceEEEEE-EeCCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC------
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------   93 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------   93 (356)
                      ...+|--.+-+|.|.- .|..+ +.-.++.||+|.+.... ......+..+|..++..+.|+||+.++.++.-.      
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3445555677899988 55566 33468999999886432 245557788999999999999999999998643      


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ...|+|||++.. +|...+.   -.++=.++..|+.|++.|+.|||+   .+|+||||||+||++..+..+|+.|||+++
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence            356899999965 8888774   346667899999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh---------hH
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH---------VW  244 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~---------~~  244 (356)
                      .....   ...+.+..|..|.|||++.+. .+.+.+||||+||++.||++|...|. +......|....         ..
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~-g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFP-GKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEec-CchHHHHHHHHHHHhcCCCHHHH
Confidence            65433   345667788899999999988 59999999999999999999987664 222222221100         00


Q ss_pred             HHHh--------------hchhhHHHHhcC---CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          245 EEYE--------------KSELDATILACG---IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       245 ~~~~--------------~~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ..+.              .........+..   ..+..+......++++.+||-.||++|.++++++..
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            0000              000000000000   011123445668889999999999999999999983

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.5e-29  Score=254.76  Aligned_cols=196  Identities=17%  Similarity=0.185  Sum_probs=137.4

Q ss_pred             cCCC-CceeeeeceE-------ecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 038199           77 RTYH-INLVRLYGFC-------HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH  148 (356)
Q Consensus        77 ~l~h-~ni~~~~~~~-------~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  148 (356)
                      .++| +||+.+++++       .+....++++|++ +++|.+++......+++..+..++.||+.||.|||+   ++|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence            3445 5777777776       2334567788987 559999996556679999999999999999999999   99999


Q ss_pred             cCCCCCcEEEcCC-------------------CceEEcccCCccccCCCCC--------------eeeeccCCCCCCCCC
Q 038199          149 YDIKPENVLLDAN-------------------FSPKVADFGLAKLCDRNRS--------------HVTISGYKGTPGYSA  195 (356)
Q Consensus       149 ~dikp~Nill~~~-------------------~~~kl~Dfgl~~~~~~~~~--------------~~~~~~~~gt~~y~a  195 (356)
                      |||||+||||+..                   +.+|++|||+++.......              ........||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999543                   4556666666653211000              000112457889999


Q ss_pred             cccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHH
Q 038199          196 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMA  275 (356)
Q Consensus       196 PE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  275 (356)
                      ||++.+. .++.++|||||||++|||++|..|+....         ......         .....+............+
T Consensus       184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~---------~~~~~~~~~~~~~~~~~~~  244 (793)
T PLN00181        184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSL---------RHRVLPPQILLNWPKEASF  244 (793)
T ss_pred             hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHH---------HHhhcChhhhhcCHHHHHH
Confidence            9999876 68999999999999999999876542110         000000         0001111111123345678


Q ss_pred             HHhcccCCCCCCCCHHHHHH
Q 038199          276 ALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       276 ~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +.+||+++|.+||++.++++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            88999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=9.3e-28  Score=198.45  Aligned_cols=167  Identities=20%  Similarity=0.208  Sum_probs=125.3

Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                      |+|.+++...+..+++.+++.|+.|++.||.|||+   .+      ||+||+++.++.+++  ||++.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence            68999996667789999999999999999999999   66      999999999999999  99987654321      


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                       ..||..|+|||++.+. .++.++|||||||++|||++|+.|+.......      .....+......   .........
T Consensus        64 -~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------~~~~~~~~~~~~---~~~~~~~~~  132 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELS------AILEILLNGMPA---DDPRDRSNL  132 (176)
T ss_pred             -CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhc------HHHHHHHHHhcc---CCccccccH
Confidence             2588999999999877 78999999999999999999999874432110      000000000000   000000122


Q ss_pred             HHHHH--HHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          266 KEKAK--RLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       266 ~~~~~--~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      .....  ++.+++.+||..+|.+||++.++++.+...
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            23333  699999999999999999999999987654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.4e-27  Score=213.16  Aligned_cols=167  Identities=22%  Similarity=0.186  Sum_probs=130.8

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC--CCcEEEEEEecccc----chhhHHHHHHHHHHHccCCCCceee-eeceEec
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP--NGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVR-LYGFCHD   92 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ni~~-~~~~~~~   92 (356)
                      -.....|.+.+.||+|+||+||+|.+.  +++.||||++....    .......+.+|++++++++|+|+++ ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            345678999999999999999999764  57788999875321    1233467999999999999999985 4432   


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCC-CCCcEEEcCCCceEEcccCC
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI-KPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~di-kp~Nill~~~~~~kl~Dfgl  171 (356)
                       ...++||||++|++|....  ..   .   ...++.|++.+|.|||+   +||+|||| ||+|||++.++.++|+|||+
T Consensus        91 -~~~~LVmE~~~G~~L~~~~--~~---~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLAR--PH---G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             -CCcEEEEEccCCCCHHHhC--cc---c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence             3579999999999996321  11   1   14678999999999999   99999999 99999999999999999999


Q ss_pred             ccccCCCCCeee------eccCCCCCCCCCcccccC
Q 038199          172 AKLCDRNRSHVT------ISGYKGTPGYSAPEFLSG  201 (356)
Q Consensus       172 ~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  201 (356)
                      ++.+........      .+...+++.|+|||.+..
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            997755432222      234568889999999863

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=4.5e-27  Score=225.77  Aligned_cols=256  Identities=19%  Similarity=0.183  Sum_probs=195.6

Q ss_pred             cccccccccCceEEEEEEe-CCCcEEEEEEec----cccchhhH-HHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           27 NYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLN----RNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        27 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~----~~~~~~~~-~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .....+|.|++|.|+.... ...+.++.|...    ........ ..+..|+-+-..++|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4578899999998887743 334444444332    22112222 23677888888999999999888887776666669


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |||++ +|..++ .....+....+..++.|++.|+.|+|+   .|+.|||+|++|+++..+|.+|++|||.+..+.....
T Consensus       401 E~~~~-Dlf~~~-~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLV-MSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHH-hcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 999988 334588999999999999999999999   9999999999999999999999999999988766555


Q ss_pred             e--eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          181 H--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       181 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .  ....+.+|+..|+|||++.+..-..+..||||.|+++..|.+|+.||.........+        ............
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~~~  547 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRNIF  547 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccccccc
Confidence            4  445667899999999999887555778999999999999999999998765543221        001111111111


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+........+.+.+.++.+||+.||.+|.|+++|++
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            2223345567788899999999999999999999987

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=9.1e-27  Score=193.58  Aligned_cols=254  Identities=20%  Similarity=0.325  Sum_probs=193.0

Q ss_pred             hhhhccccccccccCceEEEEEEeCCCcEEEEEEecc-ccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .-...++..+|.+.-.|+.|+|+++.+ .++.|+++. ..+...-..|..|.-.|+.+.||||+++++.|.....+.++.
T Consensus       188 d~~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  188 DVSSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             chhhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            334456778899999999999999544 566787763 222333357999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEc--ccCCccccCC
Q 038199          101 EYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA--DFGLAKLCDR  177 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~--Dfgl~~~~~~  177 (356)
                      .|++.|||+..++... --.+-.++.+++..+++|++|||+.. .-|.---|.+..|++|++.+.+|.  |--++-    
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf----  341 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF----  341 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee----
Confidence            9999999999996543 34677899999999999999999831 224444688999999999887764  211110    


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCC--CCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYP--ITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                           ...+..-.+.|++||.++..+.  --+++|+|||++++|||.|...||..-++-.          .     =...
T Consensus       342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme----------c-----gmki  401 (448)
T KOG0195|consen  342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME----------C-----GMKI  401 (448)
T ss_pred             -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh----------h-----hhhh
Confidence                 0111223678999999876532  3457999999999999999999986543311          0     0122


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      .+.+.+...++..+..+..++.-|++.||.+||.++.|+-.|+++.
T Consensus       402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            3444555667788888999999999999999999999999998764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=6.3e-24  Score=192.11  Aligned_cols=258  Identities=30%  Similarity=0.368  Sum_probs=197.5

Q ss_pred             ccccccccccCceEEEEEEeCCCcEEEEEEeccccchh--hHHHHHHHHHHHccCCCC-ceeeeeceEecCCeeeEEEec
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI--AEEQFMAEVGTIGRTYHI-NLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      |++.+.||.|+||.||++...  ..+++|.+.......  ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999875  789999998654443  367899999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-ceEEcccCCccccCCCC
Q 038199          103 MENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNR  179 (356)
Q Consensus       103 ~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfgl~~~~~~~~  179 (356)
                      +.++++.+++....  ..+.......+..|++.++.|+|+   .+++|||+||+||+++..+ .++++|||++.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997764333  279999999999999999999999   9999999999999999988 79999999998655443


Q ss_pred             Cee----eeccCCCCCCCCCcccccCC--CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          180 SHV----TISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       180 ~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ...    ......|+..|++||.+.+.  .......|+||+|++++++++|..|+......   ......+.........
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence            321    23456799999999999873  36889999999999999999999885433221   0001111111111100


Q ss_pred             HHHHhcCCCchh----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          254 ATILACGIEEKD----KEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       254 ~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                           .......    ......+.+++..++..+|..|.+.......
T Consensus       234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                 0000111    1223567889999999999999999887764

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=7.1e-26  Score=218.70  Aligned_cols=252  Identities=21%  Similarity=0.210  Sum_probs=184.1

Q ss_pred             hccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHH--HccCCCCceeeeeceEecCCeeeEEEec
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT--IGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+.+.+.||++.|-.|.+|++++|. |+|||+-+.........|.++++-  ...+++||++++.-+.......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677899999999999999998887 999998655434444445444433  4455899999999988888888999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC-CCCCe
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD-RNRSH  181 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~-~~~~~  181 (356)
                      ..+ +|++.+ ..+.-+...+..-|+.|++.||...|.   .||+|||||.+|||+..-+-+.|+||...+..- ..+..
T Consensus       103 vkh-nLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  103 VKH-NLYDRL-STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             Hhh-hhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            976 999988 334456777888899999999999999   999999999999999999999999998765431 11111


Q ss_pred             e----eeccCCCCCCCCCcccccCC----------CCCCccccchhhHHHHHHHHhC-CcccccCCCCccccchhhhHHH
Q 038199          182 V----TISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVLFEIVGR-RRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       182 ~----~~~~~~gt~~y~aPE~~~~~----------~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      .    .......-.+|.|||.+...          ...+++.||||+||++.||++- +++|...          .....
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----------QL~aY  247 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----------QLLAY  247 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----------HHHhH
Confidence            1    12223344579999987531          1268899999999999999985 5554321          11111


Q ss_pred             Hhh-chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          247 YEK-SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       247 ~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      ... ....+.++.. ++      ...+++++..|++.||++|-++++.++.-..
T Consensus       248 r~~~~~~~e~~Le~-Ie------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  248 RSGNADDPEQLLEK-IE------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             hccCccCHHHHHHh-Cc------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            111 1111222111 11      1258899999999999999999999987544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=4.9e-25  Score=183.45  Aligned_cols=140  Identities=16%  Similarity=0.164  Sum_probs=109.6

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEeccccch-hh------------------------HHHHHHHHHHHccCCCCce
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR-IA------------------------EEQFMAEVGTIGRTYHINL   83 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~E~~~l~~l~h~ni   83 (356)
                      ...||+|+||.||+|...+|+.||||+++..... ..                        ......|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            5789999999999998778999999999754211 01                        1123459999999987776


Q ss_pred             eeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCccccCCCCCcEEEcCCC
Q 038199           84 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL-HEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        84 ~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      .....+...  ..++||||++|+++..... ...+++...+..++.|++.+|.++ |+   .+++||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CC
Confidence            443332222  2389999999887765432 346789999999999999999999 68   8999999999999998 47


Q ss_pred             ceEEcccCCcccc
Q 038199          163 SPKVADFGLAKLC  175 (356)
Q Consensus       163 ~~kl~Dfgl~~~~  175 (356)
                      .++|+|||++...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2.3e-24  Score=181.50  Aligned_cols=175  Identities=14%  Similarity=0.113  Sum_probs=134.5

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhh--HHH------HHHHHHHHccCCCCceeeeeceE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA--EEQ------FMAEVGTIGRTYHINLVRLYGFC   90 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~------~~~E~~~l~~l~h~ni~~~~~~~   90 (356)
                      -++...+|...+.||.|+||.||+++. ++..+|||++........  ...      +.+|+..+.++.|++|..+.+++
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            356788999999999999999999866 567899999975432221  122      67999999999999999998886


Q ss_pred             ecC--------CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           91 HDQ--------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        91 ~~~--------~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      ...        ...++||||++|.+|.+..     .++.    ....+++.++..+|.   .|++|||++|+||+++.+|
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC
Confidence            533        3478999999999998764     2232    245699999999999   9999999999999999888


Q ss_pred             ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHH
Q 038199          163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV  222 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ell  222 (356)
                       ++|+|||...........              ..+.... .+..++|+|+||+.+.-+.
T Consensus       173 -i~liDfg~~~~~~e~~a~--------------d~~vler-~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK--------------DRIDLER-HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH--------------HHHHHHh-HhcccccccceeEeehHHH
Confidence             999999987644211100              0022223 5668999999999987665

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=2e-23  Score=204.85  Aligned_cols=201  Identities=20%  Similarity=0.204  Sum_probs=164.3

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC---CCceeeeeceEecC
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQ   93 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~~~~~~~   93 (356)
                      ...++....|.+.+.||+|+||+||+|...+|+.||+|+.+.......+    -=.+++.+|+   -+-|..+..++.-.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY----I~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY----ICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee----ehHHHHHhhchhhhcchHHHHHHHccC
Confidence            6678889999999999999999999998778999999998865333222    1122333333   35566666666666


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc-------CCCceEE
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-------ANFSPKV  166 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~-------~~~~~kl  166 (356)
                      +..++|+||.+.|+|.++++ ..+-+++..++.+..|++..++.||.   .+||||||||+|+||.       +...++|
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence            67789999999999999995 67789999999999999999999999   9999999999999992       2346899


Q ss_pred             cccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCc
Q 038199          167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR  226 (356)
Q Consensus       167 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~  226 (356)
                      +|||.+..+.--.........++|-.+-.+|+..|+ +++...|.|.|+-+++.||.|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHH
Confidence            999998776544333445566788899999999988 89999999999999999999873

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=5.8e-23  Score=171.58  Aligned_cols=142  Identities=18%  Similarity=0.205  Sum_probs=111.2

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEeccccch-------------------------hhHHHHHHHHHHHccCCCCce
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR-------------------------IAEEQFMAEVGTIGRTYHINL   83 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~l~h~ni   83 (356)
                      .+.||+|+||.||+|...+|+.||||+++.....                         .....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5789999999999998768999999998764211                         001234678999999998887


Q ss_pred             eeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc
Q 038199           84 VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  163 (356)
Q Consensus        84 ~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~  163 (356)
                      .....+...  ..++||||++|+++..... ....++...+..++.|++.++.++|+  ..|++||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCC
Confidence            444333332  2489999999876543321 34567888999999999999999997  37999999999999999 789


Q ss_pred             eEEcccCCccccC
Q 038199          164 PKVADFGLAKLCD  176 (356)
Q Consensus       164 ~kl~Dfgl~~~~~  176 (356)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999997544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=4.9e-23  Score=178.59  Aligned_cols=233  Identities=21%  Similarity=0.224  Sum_probs=152.9

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEec--cccchhhHHHHHHHHHHHccCCC----------CceeeeeceEe
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYH----------INLVRLYGFCH   91 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~h----------~ni~~~~~~~~   91 (356)
                      +...++.||.|+++.||.+++. +|+++|+|++.  ........+++++|......+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3445688999999999999765 59999999875  33344556788888877766432          12222222221


Q ss_pred             ---------cC---C-----eeeEEEeccCCCChhhhhhc---C---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 038199           92 ---------DQ---H-----MTALVYEYMENGSLDGYLFG---K---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH  148 (356)
Q Consensus        92 ---------~~---~-----~~~lV~e~~~~~sL~~~l~~---~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  148 (356)
                               ..   .     ..+++|+-+.+ +|.+++..   .   ...+.....+.+..|+++.+++||+   .|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence                     11   1     23678888854 88887631   1   1235566677788999999999999   99999


Q ss_pred             cCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccC-------CCCCCccccchhhHHHHHHH
Q 038199          149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-------NYPITHKCDVYSFGMVLFEI  221 (356)
Q Consensus       149 ~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Dv~slGvvl~el  221 (356)
                      +||+|+|++++.+|.++|+||+.....+..    ... ...+..|.+||....       ...++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999887654421    111 234577999997532       22578899999999999999


Q ss_pred             HhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCC
Q 038199          222 VGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDR  287 (356)
Q Consensus       222 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  287 (356)
                      .+|+.|+..........   +                 ...... +.++.+..||..+|+.||.+|
T Consensus       244 WC~~lPf~~~~~~~~~~---~-----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPE---W-----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSG---G-----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCcccccc---c-----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999987654322110   0                 112222 788889999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.5e-23  Score=181.58  Aligned_cols=199  Identities=22%  Similarity=0.249  Sum_probs=146.0

Q ss_pred             CCCceeeeeceEec---------------------------CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHH
Q 038199           79 YHINLVRLYGFCHD---------------------------QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT  131 (356)
Q Consensus        79 ~h~ni~~~~~~~~~---------------------------~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi  131 (356)
                      +||||+.+.++|.+                           ...+|+||..++. +|..++  .....+..+..-|+.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl--~~~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYL--WTRHRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHH--hcCCCchHHHHHHHHHH
Confidence            59999999987632                           3457899999966 999999  44566777888899999


Q ss_pred             HHHHHHHhhcCCCCccccCCCCCcEEE--cCCC--ceEEcccCCccccCCCCCe----eeeccCCCCCCCCCcccccCCC
Q 038199          132 AKGLVYLHEECQQRIIHYDIKPENVLL--DANF--SPKVADFGLAKLCDRNRSH----VTISGYKGTPGYSAPEFLSGNY  203 (356)
Q Consensus       132 ~~~l~~LH~~~~~~ivH~dikp~Nill--~~~~--~~kl~Dfgl~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~  203 (356)
                      ++|+.|||.   +|+.|||+|++|||+  ++|+  .+.++|||.+-......-.    ......-|...-||||+....+
T Consensus       351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999   999999999999999  4444  4789999987543221111    1112234777899999986432


Q ss_pred             C-----CCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHh
Q 038199          204 P-----ITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALW  278 (356)
Q Consensus       204 ~-----~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  278 (356)
                      .     .-.|+|.|+.|.+.||+++...||.....-..+               .+.......+..+..++..+++++..
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~---------------~r~Yqe~qLPalp~~vpp~~rqlV~~  492 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD---------------TRTYQESQLPALPSRVPPVARQLVFD  492 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheec---------------hhhhhhhhCCCCcccCChHHHHHHHH
Confidence            1     235899999999999999999898653221110               01122334456667777889999999


Q ss_pred             cccCCCCCCCCHHHHHHHHh
Q 038199          279 CVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       279 cl~~~p~~Rps~~~v~~~L~  298 (356)
                      .|+.||++|++..-....|.
T Consensus       493 lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HhcCCccccCCccHHHhHHH
Confidence            99999999999876665543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.9e-22  Score=166.39  Aligned_cols=190  Identities=17%  Similarity=0.050  Sum_probs=139.6

Q ss_pred             cccccccccCceEEEEEEeCCCcEEEEEEeccccc---hhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEEec
Q 038199           27 NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG---RIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        27 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .....|++|+||+||.+.. .+..++.+.+....-   ......+.+|+++|+++. |++++.++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999998866 677788777765422   122235889999999995 5889999886    346899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCC-CCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI-KPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~di-kp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      +.|.+|...+..        ....++.|++.+|.++|+   .||+|||| ||+|||++.++.++|+|||++.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998654311        123578899999999999   99999999 799999999999999999999865433221


Q ss_pred             ----ee-------eccCCCCCCCCCcccccCCCCCC-ccccchhhHHHHHHHHhCCcccccCC
Q 038199          182 ----VT-------ISGYKGTPGYSAPEFLSGNYPIT-HKCDVYSFGMVLFEIVGRRRNAIVGS  232 (356)
Q Consensus       182 ----~~-------~~~~~gt~~y~aPE~~~~~~~~~-~~~Dv~slGvvl~elltg~~p~~~~~  232 (356)
                          ..       ..-...++.|++|+...--...+ ...+.++-|+.+|.++|++.+...+.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                00       00122566778887543211122 56788999999999999998764443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.5e-23  Score=191.79  Aligned_cols=226  Identities=25%  Similarity=0.233  Sum_probs=184.4

Q ss_pred             cccccCceEEEEEE-e---CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEEeccC
Q 038199           31 RLGFGGFGEVYKGQ-F---PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        31 ~iG~G~~g~Vy~~~-~---~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~e~~~  104 (356)
                      .+|+|+||.|+++. .   ..|.-||.|+.+... ......+...|..++...+ ||.++.+...+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999999984 2   347789999886532 1122226677888888887 9999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeee
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI  184 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  184 (356)
                      ||.|...+ .....+.+.....+...++-+++++|.   .+++|||+|++||+++.+|++++.|||+++..-.....   
T Consensus        81 gg~lft~l-~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   81 GGDLFTRL-SKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             cchhhhcc-ccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence            99998877 345678888889999999999999999   99999999999999999999999999999876543322   


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCch
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEK  264 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (356)
                         +||..|||||++.+   ...++|.||||++.+||+||..||..                    +....+.. .....
T Consensus       154 ---cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~-~~~~~  206 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILK-AELEM  206 (612)
T ss_pred             ---ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhh-hccCC
Confidence               79999999999983   37789999999999999999988743                    12222221 12456


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCCH
Q 038199          265 DKEKAKRLCMAALWCVQDSPEDRPPM  290 (356)
Q Consensus       265 ~~~~~~~l~~l~~~cl~~~p~~Rps~  290 (356)
                      +........+++..++..+|..|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            77788888899999999999999755

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=5.7e-22  Score=182.55  Aligned_cols=214  Identities=24%  Similarity=0.357  Sum_probs=163.5

Q ss_pred             HccCCCCceeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCC
Q 038199           75 IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  154 (356)
Q Consensus        75 l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~  154 (356)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+......+++-....+...|+.||.|||.  +....||.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence            467889999999999999999999999999999999997778889999999999999999999998  233399999999


Q ss_pred             cEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCC--C----CCccccchhhHHHHHHHHhCCccc
Q 038199          155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY--P----ITHKCDVYSFGMVLFEIVGRRRNA  228 (356)
Q Consensus       155 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~----~~~~~Dv~slGvvl~elltg~~p~  228 (356)
                      |++++....+||+|||+.................-..-|.|||.+.+..  .    .+.+.||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987654311111111222345799999987631  1    477899999999999999999998


Q ss_pred             ccCCCCccccchhhhHHHHhhchhhHHHHh----cCCCchh--HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          229 IVGSSESLDWFPKHVWEEYEKSELDATILA----CGIEEKD--KEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~--~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .........            .++...+..    ..++...  .....++..++..||..+|.+||+++.|-..++.+..
T Consensus       159 ~~~~~~~~~------------~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  159 DLRNLVEDP------------DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccCCh------------HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            764432211            011111111    0111111  1344579999999999999999999999998877654

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=4.4e-21  Score=161.16  Aligned_cols=135  Identities=19%  Similarity=0.250  Sum_probs=104.7

Q ss_pred             ccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccC-----CCCceeeeeceEecCC---e-eeE
Q 038199           28 YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-----YHINLVRLYGFCHDQH---M-TAL   98 (356)
Q Consensus        28 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~ni~~~~~~~~~~~---~-~~l   98 (356)
                      =.+.||+|+||.||.  ++.....+||++.... ....+.+.+|+.+++.+     .||||+++++++.++.   . ..+
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            357899999999996  4432334799887532 23446799999999999     5799999999998874   3 337


Q ss_pred             EEec--cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCccccCCCCCcEEEcC----CCceEEcccCC
Q 038199           99 VYEY--MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL-VYLHEECQQRIIHYDIKPENVLLDA----NFSPKVADFGL  171 (356)
Q Consensus        99 V~e~--~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~~~ivH~dikp~Nill~~----~~~~kl~Dfgl  171 (356)
                      |+||  +.+++|.+++..  ..+++.  ..++.|++.++ +|||+   .+|+||||||+||+++.    ++.++|+||+.
T Consensus        83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  557999999943  345555  35677888777 99999   99999999999999964    34799999544


Q ss_pred             c
Q 038199          172 A  172 (356)
Q Consensus       172 ~  172 (356)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            4

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=5.8e-21  Score=164.32  Aligned_cols=142  Identities=18%  Similarity=0.167  Sum_probs=111.5

Q ss_pred             hccccccccccCceEEEEEE--eCCCcEEEEEEeccccch-----------------------hhHHHHHHHHHHHccCC
Q 038199           25 TSNYSTRLGFGGFGEVYKGQ--FPNGVKIAVKVLNRNLGR-----------------------IAEEQFMAEVGTIGRTY   79 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~   79 (356)
                      -|.+.+.||+|+||.||+|.  ..+|+.||||++......                       .....+..|+..++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            37788999999999999997  457999999998753210                       01123568999999997


Q ss_pred             CC--ceeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-ccccCCCCCcE
Q 038199           80 HI--NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIHYDIKPENV  156 (356)
Q Consensus        80 h~--ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~dikp~Ni  156 (356)
                      +.  .++.+++.   . ..++||||+.|.+|..... ....+....+..++.|++.++.+||+   .+ ++||||||+||
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence            53  34455543   2 3489999999988876542 23456667788999999999999999   99 99999999999


Q ss_pred             EEcCCCceEEcccCCcccc
Q 038199          157 LLDANFSPKVADFGLAKLC  175 (356)
Q Consensus       157 ll~~~~~~kl~Dfgl~~~~  175 (356)
                      +++ ++.++|+|||.+...
T Consensus       181 li~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCCEEEEEChhhhcc
Confidence            999 889999999998643

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.83  E-value=3.3e-20  Score=156.15  Aligned_cols=139  Identities=19%  Similarity=0.237  Sum_probs=110.3

Q ss_pred             hhccccccccccCceEEEEEEeCCCcEEEEEEeccccch---------------------hhHHHHHHHHHHHccCCCCc
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR---------------------IAEEQFMAEVGTIGRTYHIN   82 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~n   82 (356)
                      ..|.+.+.||+|+||.||++...+|+.||||++......                     .....+..|+.++..+.|++
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            347888999999999999998878999999987643210                     11123677899999887774


Q ss_pred             --eeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC
Q 038199           83 --LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA  160 (356)
Q Consensus        83 --i~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~  160 (356)
                        ++..++.    ...++||||++|++|......       .....++.+++.++.++|+   .+++||||+|+||+++.
T Consensus        95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence              4444432    345899999999998775421       3456788999999999999   99999999999999999


Q ss_pred             CCceEEcccCCccccC
Q 038199          161 NFSPKVADFGLAKLCD  176 (356)
Q Consensus       161 ~~~~kl~Dfgl~~~~~  176 (356)
                      ++.++|+|||++....
T Consensus       161 ~~~~~liDfg~~~~~~  176 (198)
T cd05144         161 DEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcEEEEECCccccCC
Confidence            9999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.2e-20  Score=156.64  Aligned_cols=135  Identities=24%  Similarity=0.297  Sum_probs=113.1

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccc-------hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      +.||+|++|.||+|.+ +|..+++|+......       ......+.+|++++..+.|+++.....++.+....++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 777899998654321       11224678899999999999988777777777788999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ++|++|.+.+....    . .+..++.+++.+|.++|+   .+++|||++|.||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999884322    2 888999999999999999   9999999999999999 78999999999863

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=2.9e-21  Score=174.91  Aligned_cols=175  Identities=22%  Similarity=0.332  Sum_probs=136.3

Q ss_pred             CeeeEEEeccCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           94 HMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                      .++++.|++|.-.+|.+.+.++  ....++.....++.|++.|+.|      ++.+|+|+||.||+...+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            4678999999999999999543  4567888999999999999999      7899999999999999999999999999


Q ss_pred             ccccCCCC----CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          172 AKLCDRNR----SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       172 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      ........    .....+...||.+||+||.+.++ .|+.++||||||++++||+.-                  .....
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~------------------f~T~~  463 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQ------------------FSTQF  463 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHH------------------hccHH
Confidence            87765444    22234557899999999999988 899999999999999999951                  11122


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAV  293 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v  293 (356)
                      ........+..+.+++.....-.+=+.++.+++.+.|.+||++.++
T Consensus       464 er~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  464 ERIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             HHHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence            2333344445555554333333445678999999999999954443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=8.6e-20  Score=153.86  Aligned_cols=131  Identities=23%  Similarity=0.307  Sum_probs=105.9

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEecccc-c------hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           31 RLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-G------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        31 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      .||+|+||.||+|.+ ++..+++|+..... .      .....++.+|+++++.+.|+++.....++.+....++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 67889999865321 1      112356788999999998887655555555666678999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      +|++|.+.+.....        .++.+++.+|.+||+   .+++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988733211        889999999999999   9999999999999999 78999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=3.3e-19  Score=171.98  Aligned_cols=134  Identities=20%  Similarity=0.259  Sum_probs=109.1

Q ss_pred             cccccccccCceEEEEEEeCCCcEEEEEEec-cccc------hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           27 NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLN-RNLG------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        27 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ...+.||+|+||+||+|.+..+ .+++|+.. ....      ....+++.+|+++++.++|++++....++.+....++|
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             CccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            4468899999999999987443 34444332 1111      12235688999999999999998877777777778999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      |||++|++|.+++.         ....++.|++.+|.+||+   .+++||||||+||++ .++.++|+|||+++.
T Consensus       415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999883         457899999999999999   999999999999999 577999999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=9.7e-20  Score=176.40  Aligned_cols=208  Identities=22%  Similarity=0.265  Sum_probs=145.1

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+++-++.|..|++|.||.++++ +.+++|+|+-+++   ..   +++   ++.....|.+|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---li---lRn---ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---LI---LRN---ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc---hh---hhc---cccccCCccee-----------------
Confidence            456777899999999999999876 4788998532221   11   111   22222333333                 


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                          |+-...+ +.-++++...        +.+++|||+   .+|+|||+||+|.+|..-|++|+.|||+++........
T Consensus       136 ----gDc~tll-k~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLL-KNIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhc-ccCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                3433434 2233444332        778999999   99999999999999999999999999998764221111


Q ss_pred             e-------------eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh
Q 038199          182 V-------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE  248 (356)
Q Consensus       182 ~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  248 (356)
                      .             .....+||+.|.|||++..+ .|....|.|++|+++||.+-|..||+.+..+..            
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeel------------  266 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------------  266 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------------
Confidence            1             12345799999999999877 799999999999999999999999876644211            


Q ss_pred             hchhhHHHH-hcCCCchhHHHHHHHHHHHHhcccCCCCCCC
Q 038199          249 KSELDATIL-ACGIEEKDKEKAKRLCMAALWCVQDSPEDRP  288 (356)
Q Consensus       249 ~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  288 (356)
                         +..++- ....++.+...+.+..+++.+.|+.+|..|-
T Consensus       267 ---fg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  267 ---FGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ---HhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence               111111 1112344566677889999999999999995

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=2.7e-18  Score=143.23  Aligned_cols=140  Identities=18%  Similarity=0.206  Sum_probs=98.4

Q ss_pred             ccccccccCceEEEEEEeCCCcEEEEEEeccccchh-hHHH----------------------HHHHHHHHccCCCC--c
Q 038199           28 YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI-AEEQ----------------------FMAEVGTIGRTYHI--N   82 (356)
Q Consensus        28 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~E~~~l~~l~h~--n   82 (356)
                      +.+.||+|+||+||+|...+++.||||++....... ....                      ...|...+..+.+.  .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            357899999999999987789999999987542111 1111                      13455555555433  2


Q ss_pred             eeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           83 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        83 i~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      +.+.+++    ...++||||++++.+........ ... ..+..++.+++.++.++|.  ..+++||||||+||+++ ++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence            4444443    23589999999854321110110 011 6678899999999999996  37899999999999999 88


Q ss_pred             ceEEcccCCccccC
Q 038199          163 SPKVADFGLAKLCD  176 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~  176 (356)
                      .++|+|||.+....
T Consensus       152 ~~~liDfg~a~~~~  165 (187)
T cd05119         152 KVYIIDVPQAVEID  165 (187)
T ss_pred             cEEEEECccccccc
Confidence            99999999997544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.75  E-value=1.5e-17  Score=133.44  Aligned_cols=135  Identities=20%  Similarity=0.160  Sum_probs=114.3

Q ss_pred             ccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCC--CceeeeeceEecCCeeeEEEeccCC
Q 038199           28 YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH--INLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        28 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      +.+.||+|.++.||++...+ ..+++|+......   ...+..|+..++.+++  .++++++++....+..+++|||+.|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35779999999999998744 7899999876432   4678899999999976  5899999888887889999999998


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..+..+        +......++.+++.++.+||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777643        5667788999999999999984334799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=3.3e-19  Score=171.69  Aligned_cols=259  Identities=22%  Similarity=0.227  Sum_probs=198.7

Q ss_pred             hhhhccccccccccCceEEEEEEeC--CCcEEEEEEecccc-chhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP--NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~   97 (356)
                      ....|.+.+.||+|+|+.|-.....  ....+|+|.+.... .....++...|..+-+.+. |+|++.+++...+.+..+
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            4667888899999999999988653  35556777665432 2333355666888877776 999999999999999999


Q ss_pred             EEEeccCCCChhhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCccccCCCCCcEEEcCCC-ceEEcccCCccc
Q 038199           98 LVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLH-EECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKL  174 (356)
Q Consensus        98 lV~e~~~~~sL~~~l-~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfgl~~~  174 (356)
                      ++.++..|+++.+.+ .......+....-.++.|+..++.|+| .   .++.|+||||+|.+++..+ ..++.|||++..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            999999999999888 444446777888899999999999999 7   9999999999999999999 999999999998


Q ss_pred             cCC-CCCeeeeccCCC-CCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          175 CDR-NRSHVTISGYKG-TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       175 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      +.. ..........+| ++.|+|||...+........|+||.|+++..+++|..||.........+.......   .  .
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~--~  249 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---G--R  249 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---c--c
Confidence            877 555555556778 99999999998753567889999999999999999999877655432211111000   0  0


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                             .....-.........++.+++..+|..|.+.+++-.
T Consensus       250 -------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 -------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence                   000111223344667778888899999999888764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=2.5e-17  Score=142.06  Aligned_cols=136  Identities=20%  Similarity=0.235  Sum_probs=105.0

Q ss_pred             ccccc-ccCceEEEEEEeCCCcEEEEEEecccc------------chhhHHHHHHHHHHHccCCCCce--eeeeceEecC
Q 038199           29 STRLG-FGGFGEVYKGQFPNGVKIAVKVLNRNL------------GRIAEEQFMAEVGTIGRTYHINL--VRLYGFCHDQ   93 (356)
Q Consensus        29 ~~~iG-~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--~~~~~~~~~~   93 (356)
                      ...|| .||.|+||.++. ++..++||.+....            ......++.+|++++.++.|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 899999999987 46789999875310            11233567889999999998774  6666654332


Q ss_pred             -C---eeeEEEeccCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcc
Q 038199           94 -H---MTALVYEYMEN-GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  168 (356)
Q Consensus        94 -~---~~~lV~e~~~~-~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D  168 (356)
                       .   ..++|||+++| .+|.+++..  ..++...    +.|++.+|.+||+   .||+||||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence             2   23599999997 689888732  3455443    5689999999999   9999999999999999988999999


Q ss_pred             cCCccc
Q 038199          169 FGLAKL  174 (356)
Q Consensus       169 fgl~~~  174 (356)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            999864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.65  E-value=8e-16  Score=143.90  Aligned_cols=141  Identities=16%  Similarity=0.189  Sum_probs=99.0

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhH---------------------------------------HHHHH
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAE---------------------------------------EQFMA   70 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------------------------------~~~~~   70 (356)
                      +.||.|++|.||+|++++|+.||||+...+......                                       -.|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            569999999999999989999999998765311110                                       02445


Q ss_pred             HHHHHccCC----CCceeeeeceEe-cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHH-HHHHHhhcCCC
Q 038199           71 EVGTIGRTY----HINLVRLYGFCH-DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK-GLVYLHEECQQ  144 (356)
Q Consensus        71 E~~~l~~l~----h~ni~~~~~~~~-~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~-~l~~LH~~~~~  144 (356)
                      |++.+.++.    +.+-+.+-.++. .....++||||++|++|.++.........   ...++.+++. .+..+|.   .
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~---~  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR---D  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh---C
Confidence            555555542    332233323332 23456899999999999887632222222   3445666655 4678898   9


Q ss_pred             CccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199          145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus       145 ~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      |++|+|++|.||+++.++.++++|||++....
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999999999987553

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=1.7e-15  Score=140.05  Aligned_cols=257  Identities=21%  Similarity=0.227  Sum_probs=194.2

Q ss_pred             cHHHHhhhhccccccccc--cCceEEEEEEe---CCCcEEEEEEeccccc-hhhHHHHHHHHHHHccCC-CCceeeeece
Q 038199           17 TSLQLNNFTSNYSTRLGF--GGFGEVYKGQF---PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTY-HINLVRLYGF   89 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni~~~~~~   89 (356)
                      +..++....+.+.+.+|.  |.+|.||.+..   .++..+|+|.-+...+ .....+=.+|+..-++++ |+|.++.+..
T Consensus       107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence            456777888888999999  99999999965   3588899997433221 223334466777777775 9999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCccccCCCCCcEEEcCC-Cce
Q 038199           90 CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK----GLVYLHEECQQRIIHYDIKPENVLLDAN-FSP  164 (356)
Q Consensus        90 ~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~  164 (356)
                      +...+.+++-.|+|. .+|..+.......++...++.++.+...    |+.++|+   .+++|-|+||.||++..+ ...
T Consensus       187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  187 WEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             cccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheeccccccee
Confidence            999999999999994 6888888666667888888999999988    9999999   999999999999999988 889


Q ss_pred             EEcccCCccccCCCCCeee---eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchh
Q 038199          165 KVADFGLAKLCDRNRSHVT---ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK  241 (356)
Q Consensus       165 kl~Dfgl~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~  241 (356)
                      +++|||+...+........   .....|...|++||..++-  ++..+|+|++|.++.+..++......+-..       
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------  333 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNS-------  333 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCC-------
Confidence            9999999988765542221   2233588899999999864  688999999999999999887654443211       


Q ss_pred             hhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          242 HVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       .|.......+.        .+....-..++...+.++++.+|-.|++...+..
T Consensus       334 -~W~~~r~~~ip--------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 -SWSQLRQGYIP--------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -CccccccccCc--------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             12222221111        1222233445666888899999999998777665

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.54  E-value=2.9e-14  Score=116.84  Aligned_cols=126  Identities=22%  Similarity=0.144  Sum_probs=94.7

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCce-eeeeceEecCCeeeEEEeccCCCCh
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      +.|+.|.++.||+++. .++.|++|+......  ....+..|+.+++.+.+.++ ++++.+..  ...++|||+++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEE-CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            5688999999999987 477899998765421  22346789999998865444 44554432  345799999999887


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----ccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          109 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-----IIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       109 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-----ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ....         .....++.+++.+|+.||+   .+     ++|||++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~~---------~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED---------FSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc---------ccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            6420         1123456789999999998   55     59999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.53  E-value=2.9e-14  Score=135.07  Aligned_cols=137  Identities=16%  Similarity=0.209  Sum_probs=91.6

Q ss_pred             ccccccCceEEEEEEeCC-CcEEEEEEeccccchh---------------------------------hHH------HHH
Q 038199           30 TRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRI---------------------------------AEE------QFM   69 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---------------------------------~~~------~~~   69 (356)
                      +-||+|++|.||+|++++ |+.||||++.++....                                 -.+      .+.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            679999999999999876 9999999997653111                                 001      133


Q ss_pred             HHHHHHccCC----CCceeeeeceEec-CCeeeEEEeccCCCChhhhhhcCCCC-----CCHHHHHHHHHHHHHHHHHHh
Q 038199           70 AEVGTIGRTY----HINLVRLYGFCHD-QHMTALVYEYMENGSLDGYLFGKKRA-----IEWEKLHEIAIGTAKGLVYLH  139 (356)
Q Consensus        70 ~E~~~l~~l~----h~ni~~~~~~~~~-~~~~~lV~e~~~~~sL~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~LH  139 (356)
                      +|+.-+.++.    +.+.+.+-.++.+ ....++||||++|+.+.++..-....     +....+..++.|+       .
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            4444444442    3333333333332 34567999999999998743111222     3333334444444       3


Q ss_pred             hcCCCCccccCCCCCcEEEcCCC----ceEEcccCCccccC
Q 038199          140 EECQQRIIHYDIKPENVLLDANF----SPKVADFGLAKLCD  176 (356)
Q Consensus       140 ~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfgl~~~~~  176 (356)
                      .   .|++|+|++|.||+++.+|    .++++|||+.....
T Consensus       278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            4   8999999999999999888    99999999987664

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=1.4e-14  Score=124.39  Aligned_cols=203  Identities=22%  Similarity=0.305  Sum_probs=137.0

Q ss_pred             HHHHHccCCCCceeeeeceEecCC-----eeeEEEeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038199           71 EVGTIGRTYHINLVRLYGFCHDQH-----MTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEEC  142 (356)
Q Consensus        71 E~~~l~~l~h~ni~~~~~~~~~~~-----~~~lV~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~  142 (356)
                      -+.-|-++.|.||++++.++.+..     ...++.||+..|+|..+|.+   ....+......+|+.||+.||.|||+ |
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~  195 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence            344455567999999999886553     46789999999999999964   34678999999999999999999998 5


Q ss_pred             CCCccccCCCCCcEEEcCCCceEEcccCCccccCC---CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHH
Q 038199          143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR---NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF  219 (356)
Q Consensus       143 ~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~  219 (356)
                      +.+++|+++..+.|++..+|-+|+.- +.......   ...........+.++|.+||.=.-. ..+.++|||+||...+
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCAL  273 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHH
Confidence            68899999999999999887777642 22111110   0001111224467899999986543 5688999999999999


Q ss_pred             HHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          220 EIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       220 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ||..|..-...+...            +...+....+..+....       .=+.++..|++..|..||+|..++.
T Consensus       274 emailEiq~tnseS~------------~~~ee~ia~~i~~len~-------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  274 EMAILEIQSTNSESK------------VEVEENIANVIIGLENG-------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHheeccCCCcce------------eehhhhhhhheeeccCc-------cccCcCcccccCCCCCCcchhhhhc
Confidence            998775321111100            00000000000000000       1234567799999999999998765

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.52  E-value=3.1e-13  Score=126.56  Aligned_cols=185  Identities=15%  Similarity=0.181  Sum_probs=136.2

Q ss_pred             hccccccccccCceEEEEE-EeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      -|++ ...+-++.+..-.| +..++.+|.|.+.+.... ...+...+-+..++.++||||++++..++.....|+|+|.+
T Consensus        14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV   91 (690)
T KOG1243|consen   14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV   91 (690)
T ss_pred             Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc
Confidence            3444 33444444422234 334688899998876543 44566788899999999999999999999999999999998


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      .  .|..++..    +....+...+.||+.||.+||.  +.+++|++|.-+.|+++..|..||++|.++.......... 
T Consensus        92 ~--Pl~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~-  162 (690)
T KOG1243|consen   92 R--PLETVLKE----LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA-  162 (690)
T ss_pred             c--cHHHHHHH----hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc-
Confidence            5  67776732    3366677788999999999996  4889999999999999999999999998876543322211 


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhC
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR  224 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg  224 (356)
                       ....---.|..|+.+...   .-..|.|.||++++|++.|
T Consensus       163 -~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  163 -KSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -ccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence             111122246677766433   2457999999999999998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.47  E-value=9.6e-13  Score=108.78  Aligned_cols=139  Identities=14%  Similarity=0.123  Sum_probs=100.4

Q ss_pred             cccccccCceEEEEEEeCC-------CcEEEEEEeccccc-----------h----------hhHHHHH----HHHHHHc
Q 038199           29 STRLGFGGFGEVYKGQFPN-------GVKIAVKVLNRNLG-----------R----------IAEEQFM----AEVGTIG   76 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-----------~----------~~~~~~~----~E~~~l~   76 (356)
                      ...||.|--+.||.|...+       +..+|||+.+....           .          .....+.    +|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999996432       47999998743210           0          0112233    7999999


Q ss_pred             cCC--CCceeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCccccCCCC
Q 038199           77 RTY--HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL-HEECQQRIIHYDIKP  153 (356)
Q Consensus        77 ~l~--h~ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~dikp  153 (356)
                      ++.  .-+++.++++    ...++||||+.+..+..... ....++......+..+++.+|..| |.   .++|||||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-kd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-KDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-hccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence            985  3567777765    34689999997654422111 223455566778889999999999 88   8999999999


Q ss_pred             CcEEEcCCCceEEcccCCccccC
Q 038199          154 ENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus       154 ~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      .||+++ ++.+.++|||.+....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999887544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.43  E-value=1.5e-12  Score=111.46  Aligned_cols=143  Identities=19%  Similarity=0.205  Sum_probs=111.4

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCC--CceeeeeceEecCC---eeeEEEeccC
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH--INLVRLYGFCHDQH---MTALVYEYME  104 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~~~~~~~~~~---~~~lV~e~~~  104 (356)
                      +.|+.|..+.||+++..+|+.+++|+............+..|+++++.+.+  .++.+++.+.....   ..++|||+++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999998766789999987654322234578899999999975  34677777766542   5689999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC------------------------------------------  142 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------  142 (356)
                      |.++...+.  ...++......++.+++++|..||+..                                          
T Consensus        84 G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            998877552  146778888888889999999998521                                          


Q ss_pred             -----------CCCccccCCCCCcEEEcC--CCceEEcccCCccc
Q 038199          143 -----------QQRIIHYDIKPENVLLDA--NFSPKVADFGLAKL  174 (356)
Q Consensus       143 -----------~~~ivH~dikp~Nill~~--~~~~kl~Dfgl~~~  174 (356)
                                 ...++|||+.|.||+++.  ++.+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       245799999999999988  66789999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=2.8e-12  Score=102.55  Aligned_cols=131  Identities=20%  Similarity=0.237  Sum_probs=96.5

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEecccc-------chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-------GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..+++|+-+.+|.+.+. |..+++|.-.+..       ..-...+-.+|+++++++.--.|...+=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46889999999999773 4446777543221       112224577899999998755544444444555566799999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      .+|..|.+++...        ...++..+-.-+.-||.   .+||||||.++||++..++ +.++||||+.
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            9999999888443        24455666666788999   9999999999999998775 9999999986

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.40  E-value=2.9e-12  Score=101.98  Aligned_cols=143  Identities=19%  Similarity=0.279  Sum_probs=105.9

Q ss_pred             ccccccccCceEEEEEEeCCCcEEEEEEecccc-------chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           28 YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-------GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        28 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ....|-||+-+.|+++.+ .|+.+.||--....       ......+..+|++++.++.--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            356788999999999988 67778888543221       1233356788999999987555554444555666678999


Q ss_pred             eccCC-CChhhhhhcCCCCCCH-HHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC---ceEEcccCCccc
Q 038199          101 EYMEN-GSLDGYLFGKKRAIEW-EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKL  174 (356)
Q Consensus       101 e~~~~-~sL~~~l~~~~~~~~~-~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~kl~Dfgl~~~  174 (356)
                      ||++| .++.+++......-.. ......+..|-..+.-||.   .+++||||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 5788888654333333 3337788888889999999   9999999999999996554   458999999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=2.9e-13  Score=125.50  Aligned_cols=246  Identities=19%  Similarity=0.193  Sum_probs=172.2

Q ss_pred             hhccccccccccCceEEEEEEe--CCCcEEEEEEeccccchhhHHH-HHHHHHHHccC-CCCceeeeeceEecCCeeeEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF--PNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      .++.+...||.|.|+.|+....  .++..|++|-..+.......+. -..|+-+...+ .|.|++..+..+......++=
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            4556678899999999999853  4688999998876654333332 34566666665 478888777666666666788


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-CceEEcccCCccccCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRN  178 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfgl~~~~~~~  178 (356)
                      -|||+++++.... .....+....++.+..|++.++.++|+   +.++|+|+||+||++..+ +.-++.|||....+...
T Consensus       345 ~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  345 LEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             hhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee
Confidence            9999998887655 334567788899999999999999999   999999999999999876 77889999988643211


Q ss_pred             CCeeeeccCCCCCCCC-CcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          179 RSHVTISGYKGTPGYS-APEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      .     ......-++. ..|.+.....+..+.|++|||.-+.+.+++..--..+..          |         ..+.
T Consensus       421 ~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~---------~~i~  476 (524)
T KOG0601|consen  421 S-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------S---------LTIR  476 (524)
T ss_pred             c-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------c---------eeee
Confidence            1     1122334555 256555555789999999999999999988642111100          0         0011


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      .+ ..+..+.....+..++.-+...++..||.+.++....+
T Consensus       477 ~~-~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  477 SG-DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             cc-cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            11 11222333355667777799999999999988776544

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.31  E-value=4.9e-11  Score=108.85  Aligned_cols=212  Identities=14%  Similarity=0.197  Sum_probs=148.7

Q ss_pred             ceEEEEEE-eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe----cCCeeeEEEeccCC-CChhh
Q 038199           37 FGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH----DQHMTALVYEYMEN-GSLDG  110 (356)
Q Consensus        37 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~----~~~~~~lV~e~~~~-~sL~~  110 (356)
                      -.+.|++. ..+|..|++|++.-+. ......-..-++.++++.|+|+|++..++.    .+..+++||+|+++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r-~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDR-DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeecccc-ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            36789995 4579999999994322 111122344678999999999999999887    34568899999876 57766


Q ss_pred             hhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199          111 YLFG--------------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus       111 ~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      +...              .+...++..+|.++.|+..||.++|+   .|+..+-|.+.+|+++.+.+++|..+|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            6531              23457889999999999999999999   999999999999999999999999888876543


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCccc-ccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNA-IVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ....                +.+.+    -.+-|.=.||.+++.|.||...- ..+..                   .  
T Consensus       445 ~d~~----------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~-------------------~--  483 (655)
T KOG3741|consen  445 EDPT----------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDST-------------------Q--  483 (655)
T ss_pred             CCCC----------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccch-------------------H--
Confidence            2220                12222    24678889999999999995321 00000                   0  


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                        .......-..++.++++++......++.+ -+..+++.+
T Consensus       484 --~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  484 --SSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             --HHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence              00011233456667777777777777776 455665554

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.21  E-value=1.3e-10  Score=95.71  Aligned_cols=126  Identities=24%  Similarity=0.336  Sum_probs=83.4

Q ss_pred             EEEEEEeCCCcEEEEEEeccccc-------------------------hhhHHHHHHHHHHHccCCCC--ceeeeeceEe
Q 038199           39 EVYKGQFPNGVKIAVKVLNRNLG-------------------------RIAEEQFMAEVGTIGRTYHI--NLVRLYGFCH   91 (356)
Q Consensus        39 ~Vy~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~~~E~~~l~~l~h~--ni~~~~~~~~   91 (356)
                      .||.|...+|..+|||+......                         ........+|++.|.++..-  +++.++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999888899999998743210                         11123466899999999755  567776553 


Q ss_pred             cCCeeeEEEeccC--CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCccccCCCCCcEEEcCCCceEEcc
Q 038199           92 DQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY-LHEECQQRIIHYDIKPENVLLDANFSPKVAD  168 (356)
Q Consensus        92 ~~~~~~lV~e~~~--~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~~~~ivH~dikp~Nill~~~~~~kl~D  168 (356)
                         ..++||||++  |..+..+...   .++......++.+++..+.. +|.   .|++|||+.+.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence               3479999998  6566554421   11134456677777775555 577   999999999999999988 999999


Q ss_pred             cCCcccc
Q 038199          169 FGLAKLC  175 (356)
Q Consensus       169 fgl~~~~  175 (356)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9988643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.20  E-value=3.3e-10  Score=98.91  Aligned_cols=140  Identities=14%  Similarity=0.006  Sum_probs=99.5

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchh----------hHHHHHHHHHHHccCCCCc--eeeeeceEec-----
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI----------AEEQFMAEVGTIGRTYHIN--LVRLYGFCHD-----   92 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~n--i~~~~~~~~~-----   92 (356)
                      +.+-.-....|++.++ +|+.|.||......-..          ....+.+|...+.++...+  .+..++++..     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3344333344667766 67889999764322111          1114778999988885333  3444555543     


Q ss_pred             CCeeeEEEeccCCC-ChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-------CCc
Q 038199           93 QHMTALVYEYMENG-SLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-------NFS  163 (356)
Q Consensus        93 ~~~~~lV~e~~~~~-sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-------~~~  163 (356)
                      ....++|+|++++. +|.+++... ....+......++.+++..+.-||.   .|++|||++++|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence            23468999999885 898887421 3456677788999999999999999   99999999999999975       468


Q ss_pred             eEEcccCCcc
Q 038199          164 PKVADFGLAK  173 (356)
Q Consensus       164 ~kl~Dfgl~~  173 (356)
                      +.|+||+.++
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999875

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.17  E-value=3e-10  Score=96.39  Aligned_cols=136  Identities=23%  Similarity=0.245  Sum_probs=101.3

Q ss_pred             ccccccccccCceEEEEEEeCCCcEEEEEEecccc-------------------c--hhhHHHHHHHHHHHccCCCC--c
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-------------------G--RIAEEQFMAEVGTIGRTYHI--N   82 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------------~--~~~~~~~~~E~~~l~~l~h~--n   82 (356)
                      ..++.+||-|--+.||.|..++|.++|||.=+-..                   +  ..+.....+|+++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            35678999999999999999899999999532111                   1  11223466899999999644  6


Q ss_pred             eeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           83 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        83 i~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      ++..+++-    ...+|||+++|-.|...-      ++......++..|+.-+..+-.   .|+||||+.+-||+++++|
T Consensus       173 VP~P~~~n----RHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAWN----RHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCccccc----cceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCC
Confidence            77777654    357999999997776533      1334444555566666665556   9999999999999999999


Q ss_pred             ceEEcccCCccc
Q 038199          163 SPKVADFGLAKL  174 (356)
Q Consensus       163 ~~kl~Dfgl~~~  174 (356)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999977653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.13  E-value=5.6e-09  Score=93.51  Aligned_cols=263  Identities=13%  Similarity=0.112  Sum_probs=162.0

Q ss_pred             hccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeece------EecC-Cee
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGF------CHDQ-HMT   96 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~------~~~~-~~~   96 (356)
                      -...+.-||+|+-+.+|-.-.-.+ . +-|+........ .   .+.+..|.+. .||-+-.-+.|      .-+. ...
T Consensus        12 ~i~~gr~LgqGgea~ly~l~e~~d-~-VAKIYh~Pppa~-~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          12 PIPPGRPLGQGGEADLYTLGEVRD-Q-VAKIYHAPPPAA-Q---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             ccCCCccccCCccceeeecchhhc-h-hheeecCCCchH-H---HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            345678899999999997732122 2 346665432111 1   1223344444 46644331221      1122 236


Q ss_pred             eEEEeccCCC-Chhhhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           97 ALVYEYMENG-SLDGYLF-----GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        97 ~lV~e~~~~~-sL~~~l~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      -+.|..+.|. ....++.     +......|...++.+..++.+.+.||.   .|.+-||++++|+|+++++.|.|.|-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccc
Confidence            6888888774 2222221     123458999999999999999999999   999999999999999999999999866


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCccccc-----CCCCCCccccchhhHHHHHHHHhC-CcccccCCCCccccchhhhH
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLS-----GNYPITHKCDVYSFGMVLFEIVGR-RRNAIVGSSESLDWFPKHVW  244 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~  244 (356)
                      ......+..   .....+|...|.+||...     +. .-+...|.|.||++++++|.| +.|+..-...+ ..  ..+.
T Consensus       163 sfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~-~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-~a--p~p~  235 (637)
T COG4248         163 SFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGF-ERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-DA--PNPL  235 (637)
T ss_pred             ceeeccCCc---eEecccCccccCCHHHhcccccccc-CCCccccchhHHHHHHHHHhcCCCCCCcccccC-CC--CCcc
Confidence            555443222   223356889999999764     22 457789999999999999987 56654311110 00  1111


Q ss_pred             H-HHhhchhhHH------HHhcCCCchhHHHHHHHHHHHHhcccC--CCCCCCCHHHHHHHHhccccC
Q 038199          245 E-EYEKSELDAT------ILACGIEEKDKEKAKRLCMAALWCVQD--SPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       245 ~-~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      + .+..+.+...      .....+.......+.++..+..+|+..  ++.-||+++..+..|..+...
T Consensus       236 E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         236 ETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             hhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            1 1111111111      111222222334556677777788753  367899999999888766543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.11  E-value=2.2e-11  Score=119.28  Aligned_cols=251  Identities=18%  Similarity=0.182  Sum_probs=169.4

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ....+.+.+-+-+|+++.++.+.-. .|...++|+.....  .....+....+-.++-..++|-++....-+.-....++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3444556678889999999988543 46666666554321  11112223333333333445666666555556677889


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC-
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR-  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~-  177 (356)
                      |++|+.+++|...++.. ...+.+........+.++++|||+   ..+.|+|++|.|.+...+++.++.|||....... 
T Consensus       882 ~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccc
Confidence            99999999999988443 355666667777888999999998   7799999999999999999999999984322110 


Q ss_pred             --------------------CC---Ce-----eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccc
Q 038199          178 --------------------NR---SH-----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAI  229 (356)
Q Consensus       178 --------------------~~---~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~  229 (356)
                                          ..   ..     .......||+.|.+||...+. .-...+|.|++|++++|.++|..|+.
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                                00   00     011235689999999999877 56788999999999999999998886


Q ss_pred             cCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHH
Q 038199          230 VGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMS  291 (356)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~  291 (356)
                      .....       ..++.+....+       .-+..+...+.+...++...+..+|.+|-.+.
T Consensus      1037 a~tpq-------~~f~ni~~~~~-------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQ-------QIFENILNRDI-------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchh-------hhhhccccCCC-------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            55432       22222222211       11223344455667777778899999998776

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.00  E-value=2.5e-09  Score=90.29  Aligned_cols=124  Identities=19%  Similarity=0.211  Sum_probs=91.6

Q ss_pred             CCcEEEEEEeccccch------hhHHHHHHHHHHHccCC--CCceeeeeceEecC----CeeeEEEeccCCC-Chhhhhh
Q 038199           47 NGVKIAVKVLNRNLGR------IAEEQFMAEVGTIGRTY--HINLVRLYGFCHDQ----HMTALVYEYMENG-SLDGYLF  113 (356)
Q Consensus        47 ~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~----~~~~lV~e~~~~~-sL~~~l~  113 (356)
                      .++.|-+|........      .......+|...+..+.  .-..+..+++....    ...++|+|.+++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            4667777754322111      23346778888888775  33455666666543    2457999999884 7998884


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC---ceEEcccCCccc
Q 038199          114 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKL  174 (356)
Q Consensus       114 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~kl~Dfgl~~~  174 (356)
                      .. ...+......++.+++..+.-||.   .|++|+|+++.|||++.++   .+.++||+.++.
T Consensus       111 ~~-~~~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QW-EQLDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hh-cccchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            32 226677788999999999999999   9999999999999998887   899999988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.00  E-value=1.1e-10  Score=110.25  Aligned_cols=152  Identities=21%  Similarity=0.349  Sum_probs=104.9

Q ss_pred             HHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee--e-----ccCCCCCCCCCcccccC
Q 038199          129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT--I-----SGYKGTPGYSAPEFLSG  201 (356)
Q Consensus       129 ~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~--~-----~~~~gt~~y~aPE~~~~  201 (356)
                      .+++.|+.|+|.  ..++||++|.|++|.++..+.+||+.|+.+...........  .     --......|.|||++.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999998  48899999999999999999999999998765433111100  0     01124557999999987


Q ss_pred             CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhccc
Q 038199          202 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQ  281 (356)
Q Consensus       202 ~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  281 (356)
                      . ..+.++|+||+|+++|.+..|+.+...........            ................+.+.++.+-+.+++.
T Consensus       184 ~-~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 T-TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY------------SFSRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             c-cccccccceeeeeEEEEEecCCcchhhccCCcchh------------hhhhcccccccccccccCcHHHHHHHHHHhc
Confidence            5 68999999999999999996665543332211100            0000111111112235667888899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 038199          282 DSPEDRPPMSAVVK  295 (356)
Q Consensus       282 ~~p~~Rps~~~v~~  295 (356)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998777654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.92  E-value=6.9e-09  Score=98.11  Aligned_cols=145  Identities=19%  Similarity=0.237  Sum_probs=95.1

Q ss_pred             ccc-ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHH---------------------------------------
Q 038199           27 NYS-TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE---------------------------------------   66 (356)
Q Consensus        27 ~~~-~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------------------------------------   66 (356)
                      +|. +-|+.++-|.||+|++++|+.||||+..++..+....                                       
T Consensus       127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El  206 (517)
T COG0661         127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL  206 (517)
T ss_pred             HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence            444 5699999999999999999999999997764211110                                       


Q ss_pred             HHHHHHHHHccCC----CCceeeeeceEe-cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038199           67 QFMAEVGTIGRTY----HINLVRLYGFCH-DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE  141 (356)
Q Consensus        67 ~~~~E~~~l~~l~----h~ni~~~~~~~~-~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  141 (356)
                      .+.+|+.-+.++.    ...-+.+=.++. -.....++|||++|-.+.+...-....++...+.....++.  +..+=. 
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~-  283 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR-  283 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh-
Confidence            1334444444432    111122222222 23456799999999999887533335555444444333322  222222 


Q ss_pred             CCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199          142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus       142 ~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                        .|++|.|..|.||+++.+|.+.+.|||+.....
T Consensus       284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             --cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence              789999999999999999999999999987654

>PRK09902 hypothetical protein; Provisional

Probab=98.88  E-value=5.2e-08  Score=80.93  Aligned_cols=140  Identities=15%  Similarity=0.061  Sum_probs=102.3

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEeccccc-----hhhHHHHHHHHHHHccCCC--CceeeeeceEec----CCeeeEE
Q 038199           31 RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-----RIAEEQFMAEVGTIGRTYH--INLVRLYGFCHD----QHMTALV   99 (356)
Q Consensus        31 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h--~ni~~~~~~~~~----~~~~~lV   99 (356)
                      .-|.||-+-|+...+ +|+.|-+|.-.....     ......|.+|+..+.++..  -.++++......    ....+||
T Consensus        25 N~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         25 NYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             CcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            356689999999887 445688887653221     2234679999999999853  234554422211    1245799


Q ss_pred             EeccCC-CChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc--eEEcccCCccc
Q 038199          100 YEYMEN-GSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--PKVADFGLAKL  174 (356)
Q Consensus       100 ~e~~~~-~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~--~kl~Dfgl~~~  174 (356)
                      +|-+.| .+|.+++... -.+.+......++.+++.++.-||+   .|+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997753 5888887332 2456788888999999999999999   99999999999999986666  99999976653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.78  E-value=1.4e-07  Score=78.71  Aligned_cols=139  Identities=16%  Similarity=0.149  Sum_probs=91.0

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHH---------HHHHHHHHccCC---CCceeeee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ---------FMAEVGTIGRTY---HINLVRLY   87 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~~E~~~l~~l~---h~ni~~~~   87 (356)
                      .+....|+..+++-......|.+.+. +|+.+++|....... .....         ..+.+..+.++.   -.....++
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y  104 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY  104 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence            45666777777777777777777766 678899998764321 11111         223333333332   23333333


Q ss_pred             ceEec-----CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           88 GFCHD-----QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        88 ~~~~~-----~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      .+...     ....++||||++|..|.+..     .++.    .+...+.+++..||.   .|++|||..|.|+++..+ 
T Consensus       105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-  171 (229)
T PF06176_consen  105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-  171 (229)
T ss_pred             eeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-
Confidence            33322     23456899999998887654     1222    244667788999999   999999999999999865 


Q ss_pred             ceEEcccCCcc
Q 038199          163 SPKVADFGLAK  173 (356)
Q Consensus       163 ~~kl~Dfgl~~  173 (356)
                      .++++||+..+
T Consensus       172 ~i~iID~~~k~  182 (229)
T PF06176_consen  172 GIRIIDTQGKR  182 (229)
T ss_pred             cEEEEECcccc
Confidence            49999997754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.77  E-value=9.5e-08  Score=81.77  Aligned_cols=137  Identities=18%  Similarity=0.241  Sum_probs=85.6

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCC--ceeeeeceEecCCeeeEEEeccCCCC
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--NLVRLYGFCHDQHMTALVYEYMENGS  107 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~~~~~~~~~~~~~lV~e~~~~~s  107 (356)
                      ..||+|..+.||+.   .+..+++|+.....   ......+|.++++.+..-  .+.+.+++..+.....+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984   24467889876532   334568899999988643  35777888877777889999999963


Q ss_pred             -hhhhh---------------------hcC-CCCCCHHHHHH-HHHH----------HHH-HHHHHhh-cCCCCccccCC
Q 038199          108 -LDGYL---------------------FGK-KRAIEWEKLHE-IAIG----------TAK-GLVYLHE-ECQQRIIHYDI  151 (356)
Q Consensus       108 -L~~~l---------------------~~~-~~~~~~~~~~~-i~~q----------i~~-~l~~LH~-~~~~~ivH~di  151 (356)
                       +...+                     +.- ........... +..+          +.. ...+|.. .....++|||+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             21111                     000 00111111100 1000          011 1222221 11345789999


Q ss_pred             CCCcEEEcCCCceEEcccCCcc
Q 038199          152 KPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       152 kp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      .|.||++++++ +.++||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999998874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.70  E-value=2.8e-07  Score=77.75  Aligned_cols=139  Identities=19%  Similarity=0.267  Sum_probs=92.0

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhH--------HH---------------HHHHHHHHccCC--CCcee
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAE--------EQ---------------FMAEVGTIGRTY--HINLV   84 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------~~---------------~~~E~~~l~~l~--h~ni~   84 (356)
                      ..|.+|--+.||+|...++..+|||+..........        .+               ...|+.-|+++.  +-.++
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            457788888999998778999999998654221111        00               224666666653  34445


Q ss_pred             eeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCce
Q 038199           85 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP  164 (356)
Q Consensus        85 ~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~  164 (356)
                      +.+++..    ..|||||+....+..-. -..-++.......+..++++.+.-|-.  ..++||+||..-|||+. ++.+
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~-LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPR-LKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCC-cccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeE
Confidence            5555443    46999999553211111 012233333567777788777777764  37899999999999999 7899


Q ss_pred             EEcccCCccccC
Q 038199          165 KVADFGLAKLCD  176 (356)
Q Consensus       165 kl~Dfgl~~~~~  176 (356)
                      .++|||-+....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999886543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.63  E-value=4e-07  Score=79.10  Aligned_cols=133  Identities=11%  Similarity=0.044  Sum_probs=82.9

Q ss_pred             CceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEEeccCCCChhhhhh-
Q 038199           36 GFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF-  113 (356)
Q Consensus        36 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~-  113 (356)
                      .-..||+.... +..+.||......    ...+.+|+++++.+. +--+++++++....+..++|||+++|.+|..... 
T Consensus        11 ~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~   85 (244)
T cd05150          11 SGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEE   85 (244)
T ss_pred             CcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcc
Confidence            44889999764 4678889876532    345677888888874 4456677887777667899999999987764320 


Q ss_pred             ------------------cCC---CCCCH--HHHHHHHH--------------------HHHHHHHHHhh----cCCCCc
Q 038199          114 ------------------GKK---RAIEW--EKLHEIAI--------------------GTAKGLVYLHE----ECQQRI  146 (356)
Q Consensus       114 ------------------~~~---~~~~~--~~~~~i~~--------------------qi~~~l~~LH~----~~~~~i  146 (356)
                                        ...   .++..  ........                    .+...+..|-.    .....+
T Consensus        86 ~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l  165 (244)
T cd05150          86 LEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVV  165 (244)
T ss_pred             cCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEE
Confidence                              000   01110  00000000                    01111222211    012458


Q ss_pred             cccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          147 IHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       147 vH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      +|+|+.|.||++++++.+.|+||+.+.
T Consensus       166 ~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         166 THGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ECCCCCCccEEEeCCcEEEEEEccccc
Confidence            999999999999998888999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.61  E-value=4.5e-07  Score=85.68  Aligned_cols=140  Identities=19%  Similarity=0.246  Sum_probs=92.5

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHH------------------------------------HHHHHHH
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE------------------------------------QFMAEVG   73 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~------------------------------------~~~~E~~   73 (356)
                      +-||..+.|.||+|+.++|+.|||||-+++.......                                    .|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5699999999999999999999999987664211100                                    1334443


Q ss_pred             HHcc----CCCCc------eeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038199           74 TIGR----TYHIN------LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ  143 (356)
Q Consensus        74 ~l~~----l~h~n------i~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  143 (356)
                      -..+    +.|-+      |++++--+  .....|+|||++|..+.+.-.-....++...+..-+.++..     +....
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~-----~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL-----EQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH-----HHHHh
Confidence            3333    23444      33333222  23457999999998887764334556666655444443322     22112


Q ss_pred             CCccccCCCCCcEEEc----CCCceEEcccCCccccC
Q 038199          144 QRIIHYDIKPENVLLD----ANFSPKVADFGLAKLCD  176 (356)
Q Consensus       144 ~~ivH~dikp~Nill~----~~~~~kl~Dfgl~~~~~  176 (356)
                      .|++|+|-.|.||++.    .++.+.+.|||+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            7899999999999998    36789999999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.60  E-value=7.4e-07  Score=76.64  Aligned_cols=140  Identities=21%  Similarity=0.182  Sum_probs=83.3

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCC--ceeeeeceEec---CCeeeEEEeccC
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--NLVRLYGFCHD---QHMTALVYEYME  104 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~~~~~~~~---~~~~~lV~e~~~  104 (356)
                      +.|+.|..+.||+....+ ..+++|+....   .....+..|..+++.+...  .+..++.....   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            568999999999998866 58999987653   4456778888888887532  35666664432   234689999999


Q ss_pred             CCChhh----------------hh---hcC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 038199          105 NGSLDG----------------YL---FGK---KRAIEWEK---------LHEI------------AIGTAK-GLVYLHE  140 (356)
Q Consensus       105 ~~sL~~----------------~l---~~~---~~~~~~~~---------~~~i------------~~qi~~-~l~~LH~  140 (356)
                      |..+..                .+   +..   ...+....         ....            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988777                11   011   11111100         0000            111222 3333432


Q ss_pred             c----CCCCccccCCCCCcEEEc-CCCceEEcccCCcc
Q 038199          141 E----CQQRIIHYDIKPENVLLD-ANFSPKVADFGLAK  173 (356)
Q Consensus       141 ~----~~~~ivH~dikp~Nill~-~~~~~kl~Dfgl~~  173 (356)
                      .    ....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            1    246799999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.54  E-value=1.1e-06  Score=89.34  Aligned_cols=146  Identities=16%  Similarity=0.233  Sum_probs=92.5

Q ss_pred             cccccccCceEEEEEEeCCC---cEEEEEEeccccchhhHHHHHHHHHHHccCC-CCce--eeeeceEecC---CeeeEE
Q 038199           29 STRLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINL--VRLYGFCHDQ---HMTALV   99 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--~~~~~~~~~~---~~~~lV   99 (356)
                      .+.|+.|.+..+|+.+..++   ..+++|+............+.+|+++++.+. |+++  ++++.++.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999976543   4688887654322223456889999999995 6654  7788877664   467899


Q ss_pred             EeccCCCChhhh-----------------------hhcCC----------CCCC--HHHHHHHHH---------------
Q 038199          100 YEYMENGSLDGY-----------------------LFGKK----------RAIE--WEKLHEIAI---------------  129 (356)
Q Consensus       100 ~e~~~~~sL~~~-----------------------l~~~~----------~~~~--~~~~~~i~~---------------  129 (356)
                      ||+++|..+.+.                       ++...          .+..  ..++..|..               
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999998654321                       01100          0001  112222211               


Q ss_pred             HHHHHHHHHhhcCC--------CCccccCCCCCcEEEcCC-C-ceEEcccCCccc
Q 038199          130 GTAKGLVYLHEECQ--------QRIIHYDIKPENVLLDAN-F-SPKVADFGLAKL  174 (356)
Q Consensus       130 qi~~~l~~LH~~~~--------~~ivH~dikp~Nill~~~-~-~~kl~Dfgl~~~  174 (356)
                      .+...+.+|....+        ..+||||+++.||+++.+ + .+-|.||.++..
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            12234566644222        359999999999999753 3 357999998765

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.53  E-value=8.8e-07  Score=70.79  Aligned_cols=128  Identities=20%  Similarity=0.283  Sum_probs=90.6

Q ss_pred             ccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCcee-eeeceEecCCeeeEEEeccC
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV-RLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~-~~~~~~~~~~~~~lV~e~~~  104 (356)
                      .+..+.||+|.+|.||++.+ .|.++|+|+-..+   .....+..|+++|..+.-.++. ++|.+..+    ++.|||++
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhhhcccccEEEEeec-cCceEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            34468899999999999999 4558999998775   4446788999999999766554 45554443    45699999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCC--CcEEEcCCCceEEcccCCcc
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP--ENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp--~Nill~~~~~~kl~Dfgl~~  173 (356)
                      |..|.+.....    +..+    ...++..-.-|-.   .||-|+.|.-  .||++.. +.+.|+||..+.
T Consensus        96 G~~L~~~~~~~----~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At  154 (201)
T COG2112          96 GRPLGKLEIGG----DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVND-RDVYIIDFDSAT  154 (201)
T ss_pred             Ccchhhhhhcc----cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecC-CcEEEEEccchh
Confidence            98887765211    2222    3344455444555   8999999875  5555544 499999998876

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.50  E-value=5e-08  Score=91.76  Aligned_cols=182  Identities=16%  Similarity=0.105  Sum_probs=132.1

Q ss_pred             ccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCc-eeeeeceEecCCeeeEEEeccCCC
Q 038199           28 YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        28 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +-..+++|+++.+++.+.-..+....+++...      ....-++++|.+++||| .+..++-+..+.+.+++++++.++
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            33557889999999997544455556766543      34566899999999999 666666667778889999999876


Q ss_pred             -ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeec
Q 038199          107 -SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS  185 (356)
Q Consensus       107 -sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  185 (356)
                       +.........-.+...+...+...-.+++++||+   ..=+|+|    ||+..+ +..+..||+....+....   ...
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~  388 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR  388 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence             3332221222334455556666777788999998   5568888    777655 689999999987766544   233


Q ss_pred             cCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcc
Q 038199          186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRN  227 (356)
Q Consensus       186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p  227 (356)
                      ...++..|+|||+...+ .+..+.|+|++|+-..++--|-.|
T Consensus       389 t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCC
Confidence            45689999999998877 688999999999877777666544

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.44  E-value=4.8e-06  Score=69.29  Aligned_cols=129  Identities=22%  Similarity=0.340  Sum_probs=89.5

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEecccc---------------chhhHHHHHHHHHHHccCC------CCceeeee
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL---------------GRIAEEQFMAEVGTIGRTY------HINLVRLY   87 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~E~~~l~~l~------h~ni~~~~   87 (356)
                      ...||+|+.-.||.-  ++....+||+.....               ......+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            467999999988875  344457899987654               1122345566666555554      88999999


Q ss_pred             ceEecCCeeeEEEeccCC------CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC
Q 038199           88 GFCHDQHMTALVYEYMEN------GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  161 (356)
Q Consensus        88 ~~~~~~~~~~lV~e~~~~------~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~  161 (356)
                      |+.+++..+.+|+|.+.+      .+|.+++  ....++. ...+.+.   +-..||-.   .+|+.+|++|.||++...
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l--~~~~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYL--KEGGLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHH--HcCCccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEEec
Confidence            999999889999998743      3677777  3344555 3333333   44556666   899999999999999432


Q ss_pred             ---C-ceEEcc
Q 038199          162 ---F-SPKVAD  168 (356)
Q Consensus       162 ---~-~~kl~D  168 (356)
                         . .+.|+|
T Consensus       155 ~~~~~~lvlID  165 (199)
T PF10707_consen  155 DSGEFRLVLID  165 (199)
T ss_pred             CCCceEEEEEe
Confidence               2 467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.37  E-value=1.2e-05  Score=66.54  Aligned_cols=103  Identities=21%  Similarity=0.180  Sum_probs=82.3

Q ss_pred             HHHHHHHccCCC-CceeeeeceEecCCeeeEEEeccCCCChhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038199           69 MAEVGTIGRTYH-INLVRLYGFCHDQHMTALVYEYMENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR  145 (356)
Q Consensus        69 ~~E~~~l~~l~h-~ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~  145 (356)
                      ..|..+++.+++ +++++++|.|-    .++|.|+...+++.....  ..-...+|..+.+|+.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888888875 69999999984    478999998766642210  11235799999999999999999999754456


Q ss_pred             ccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199          146 IIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus       146 ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      +.-.|++++|+-++++|++|++|.......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.36  E-value=3.1e-06  Score=73.14  Aligned_cols=73  Identities=15%  Similarity=0.127  Sum_probs=46.5

Q ss_pred             ccccccCce-EEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCC---ceeeeeceEecC---CeeeEEEec
Q 038199           30 TRLGFGGFG-EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI---NLVRLYGFCHDQ---HMTALVYEY  102 (356)
Q Consensus        30 ~~iG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---ni~~~~~~~~~~---~~~~lV~e~  102 (356)
                      +.|+.|+.. .||+.    +..+++|+....   .....+.+|.++++.+...   .+..+++.....   ...++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            457767666 48876    235778875442   2345788899999887522   344444443332   245889999


Q ss_pred             cCCCChh
Q 038199          103 MENGSLD  109 (356)
Q Consensus       103 ~~~~sL~  109 (356)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9997774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.33  E-value=1.2e-05  Score=71.89  Aligned_cols=78  Identities=9%  Similarity=0.054  Sum_probs=57.7

Q ss_pred             cccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCC---CceeeeeceEecC---CeeeEEE
Q 038199           27 NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH---INLVRLYGFCHDQ---HMTALVY  100 (356)
Q Consensus        27 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~ni~~~~~~~~~~---~~~~lV~  100 (356)
                      .-.+.||+|..+.||.....++ .+.+|+.+..   .....+..|++.++.+.-   -.++++++++...   +..++||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEeccc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            3356799999999999987556 4667875431   133578889999998852   4688888877543   5689999


Q ss_pred             eccCCCCh
Q 038199          101 EYMENGSL  108 (356)
Q Consensus       101 e~~~~~sL  108 (356)
                      |+++|.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.19  E-value=1.7e-05  Score=65.53  Aligned_cols=128  Identities=23%  Similarity=0.346  Sum_probs=90.0

Q ss_pred             hhhhccccccccccCc-eEEEEEEeCCCcEEEEEEecc---c--------cc--h-------hhHHHHHHHHHHHccCC-
Q 038199           22 NNFTSNYSTRLGFGGF-GEVYKGQFPNGVKIAVKVLNR---N--------LG--R-------IAEEQFMAEVGTIGRTY-   79 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~-g~Vy~~~~~~~~~vavK~~~~---~--------~~--~-------~~~~~~~~E~~~l~~l~-   79 (356)
                      ...++++.+.||.|.- |.||+++. +|+.||+|++..   .        ..  .       ...+-|..|-++..+|+ 
T Consensus        35 h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   35 HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            3378899999999999 99999998 778999999321   1        00  0       11135778888888875 


Q ss_pred             --CCce--eeeeceEecC------------------CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 038199           80 --HINL--VRLYGFCHDQ------------------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY  137 (356)
Q Consensus        80 --h~ni--~~~~~~~~~~------------------~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~  137 (356)
                        +.++  ++.+||..=.                  ....||.||.....          .+.    ..-+.++.+-+..
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHH
Confidence              4455  8888887311                  01236777664422          222    2335567777889


Q ss_pred             HhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199          138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus       138 LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      +|.   .||+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            999   99999999999988     4589999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.14  E-value=2.3e-05  Score=67.65  Aligned_cols=138  Identities=16%  Similarity=0.160  Sum_probs=80.9

Q ss_pred             ccccccCceEEEEEEeCC--CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCc-eeeeeceEecCCeeeEEEeccCCC
Q 038199           30 TRLGFGGFGEVYKGQFPN--GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +.|..|-...+|+....+  ++.|++|+......  ......+|+.+++.+...+ .+++++...    ..+||||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            457778889999998754  67899997654311  1123356888888885333 344444332    24899999997


Q ss_pred             Chhhh-------h----------hcCCC----------CCC-HHHHHHHHHH----------------------HHHHHH
Q 038199          107 SLDGY-------L----------FGKKR----------AIE-WEKLHEIAIG----------------------TAKGLV  136 (356)
Q Consensus       107 sL~~~-------l----------~~~~~----------~~~-~~~~~~i~~q----------------------i~~~l~  136 (356)
                      ++...       +          +....          ... +..+..+...                      +...+.
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            76321       0          01111          111 2222222111                      111111


Q ss_pred             HH----hhc-CCCCccccCCCCCcEEEcC-CCceEEcccCCcc
Q 038199          137 YL----HEE-CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAK  173 (356)
Q Consensus       137 ~L----H~~-~~~~ivH~dikp~Nill~~-~~~~kl~Dfgl~~  173 (356)
                      .|    -.. .+..++|+|+.+.||+++. ++.+.++||..+.
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            11    110 1356999999999999997 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.10  E-value=2e-05  Score=79.47  Aligned_cols=197  Identities=17%  Similarity=0.197  Sum_probs=133.7

Q ss_pred             HHHHHHHHccCCCCceeeeeceEecCCee----eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038199           68 FMAEVGTIGRTYHINLVRLYGFCHDQHMT----ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ  143 (356)
Q Consensus        68 ~~~E~~~l~~l~h~ni~~~~~~~~~~~~~----~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  143 (356)
                      ..-|+..+.+..|+|++.++.+.......    .+..++|..-++...+ ..-...+..+.+.+..++..||.|+|+   
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~~h~---  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAYLHS---  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHHHHH---
Confidence            44577777888999999999988755332    2456778887887777 345678999999999999999999999   


Q ss_pred             CCccccCCCCC---cEEEcCCCceEEc--ccCCccccCCCCCeeeeccCCCCCCCCCcccccCCC-CCCccccchhhHHH
Q 038199          144 QRIIHYDIKPE---NVLLDANFSPKVA--DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMV  217 (356)
Q Consensus       144 ~~ivH~dikp~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slGvv  217 (356)
                      ....|.-+..+   +...+..+.+...  ||+.+...........   ..-+..|.++|....+. ......|+|.+|..
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHHHH
Confidence            65555555544   4444566667766  8888876654332211   22344577888776542 23445799999999


Q ss_pred             HHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          218 LFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       218 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      ...+..|..+......                   ...+       .+......+......|+..++++|+++.+++...
T Consensus       382 ~~~~~~~~~i~~~~~~-------------------~~~~-------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAV-------------------PVSL-------LDVLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HhhhhhcCcccccccc-------------------hhhh-------hccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            9999987643211100                   0000       0011111467778889999999999999998754

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.02  E-value=3e-05  Score=69.40  Aligned_cols=140  Identities=16%  Similarity=0.129  Sum_probs=83.3

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCC--ceeeeece------EecCCeeeEEE
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--NLVRLYGF------CHDQHMTALVY  100 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~~~~~------~~~~~~~~lV~  100 (356)
                      .+.|..|....+|+....+ ..+++|+...    ...+.+..|++++..+.+.  .+++++..      ....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            3457778878999997644 4688898764    2234567778777777432  24444432      12234568999


Q ss_pred             eccCCCChhh----hh----------hc--C--CC------CCCHHHHH----------HHHHHHHHHHHHHhh----cC
Q 038199          101 EYMENGSLDG----YL----------FG--K--KR------AIEWEKLH----------EIAIGTAKGLVYLHE----EC  142 (356)
Q Consensus       101 e~~~~~sL~~----~l----------~~--~--~~------~~~~~~~~----------~i~~qi~~~l~~LH~----~~  142 (356)
                      ++++|..+..    ..          +.  .  ..      ...|....          .....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999977532    00          00  0  00      01111110          011112233444442    12


Q ss_pred             CCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       143 ~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      +.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3679999999999999998778899998864

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.02  E-value=4.8e-06  Score=72.96  Aligned_cols=136  Identities=15%  Similarity=0.112  Sum_probs=94.0

Q ss_pred             ccccccccccCceEEEEEEeCCCcEEEEEEecccc-------------------ch--hhHHHHHHHHHHHccCC-CC-c
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-------------------GR--IAEEQFMAEVGTIGRTY-HI-N   82 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------------~~--~~~~~~~~E~~~l~~l~-h~-n   82 (356)
                      +.++.+||-|.-+.+|.+-+.+|+++++|.=.-..                   ++  .+.-...+|+..|+.|. |- -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            35678999999999999999889999999431110                   00  11123557888888884 32 3


Q ss_pred             eeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           83 LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        83 i~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      +++.+++.    ..++|||++.|..|....+-    .+..++   ...+..-+--|..   .|+||||..-=||++++++
T Consensus       174 VPkpiD~~----RH~Vvmelv~g~Pl~~v~~v----~d~~~l---y~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  174 VPKPIDHN----RHCVVMELVDGYPLRQVRHV----EDPPTL---YDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCCccccc----ceeeHHHhhcccceeeeeec----CChHHH---HHHHHHHHHHHHH---cCceecccchheeEEecCC
Confidence            55555544    46899999999888654422    222232   2333334555666   9999999999999999999


Q ss_pred             ceEEcccCCcccc
Q 038199          163 SPKVADFGLAKLC  175 (356)
Q Consensus       163 ~~kl~Dfgl~~~~  175 (356)
                      .++++||.-....
T Consensus       240 ~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  240 KIVVIDFPQMVST  252 (465)
T ss_pred             CEEEeechHhhcc
Confidence            9999999765433

>PRK05231 homoserine kinase; Provisional

Probab=97.99  E-value=0.00017  Score=65.34  Aligned_cols=139  Identities=17%  Similarity=0.202  Sum_probs=75.3

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCC--ceeeeec------eEecCCeeeEEEe
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--NLVRLYG------FCHDQHMTALVYE  101 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~~~~------~~~~~~~~~lV~e  101 (356)
                      +.|+.|....+|+.+..+| .+++|+... ..   .+.+..|+.++..|...  .+.+++.      +....+..+++++
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~-~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFER-LT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEecc-CC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            4577788789999987555 688898752 11   22333344444444211  1333332      1122455789999


Q ss_pred             ccCCCChhh-----------hh---hcCCC----------CCCH-HHHHH------------HHHH-HHHHHHHHhhc--
Q 038199          102 YMENGSLDG-----------YL---FGKKR----------AIEW-EKLHE------------IAIG-TAKGLVYLHEE--  141 (356)
Q Consensus       102 ~~~~~sL~~-----------~l---~~~~~----------~~~~-~~~~~------------i~~q-i~~~l~~LH~~--  141 (356)
                      +++|..+..           .+   +....          .+.+ .....            .+.+ +...+..+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999975421           11   00000          1111 11111            1111 11122222211  


Q ss_pred             --CCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          142 --CQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       142 --~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                        .+.++||+|+.|.||+++.+....++||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              34689999999999999977666899998874

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.99  E-value=5.7e-05  Score=66.08  Aligned_cols=136  Identities=11%  Similarity=0.096  Sum_probs=78.7

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCce-eeeeceEecCCeeeEEEeccCCCChh
Q 038199           31 RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYMENGSLD  109 (356)
Q Consensus        31 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~~~~~~~~~lV~e~~~~~sL~  109 (356)
                      .+..|-.+.+|+.+. +++.+++|+......... ....+|.++++.+....+ .+++....    .++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            456688889999975 567888997654321110 135678888888864333 33444332    36899999987664


Q ss_pred             hh-------h----------hcC---CCCCCHH-HHHHHHHHH---------HHHHHHHhhc-----CCCCccccCCCCC
Q 038199          110 GY-------L----------FGK---KRAIEWE-KLHEIAIGT---------AKGLVYLHEE-----CQQRIIHYDIKPE  154 (356)
Q Consensus       110 ~~-------l----------~~~---~~~~~~~-~~~~i~~qi---------~~~l~~LH~~-----~~~~ivH~dikp~  154 (356)
                      ..       .          +..   ..+++.. .+..+..++         ...+..+-..     .+..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21       0          111   1122221 111221111         1112222110     1245899999999


Q ss_pred             cEEEcCCCceEEcccCCcc
Q 038199          155 NVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       155 Nill~~~~~~kl~Dfgl~~  173 (356)
                      ||++++++ +.++||..+.
T Consensus       157 Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC-CEEEeccccC
Confidence            99999876 7899998875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.85  E-value=0.00044  Score=63.92  Aligned_cols=76  Identities=13%  Similarity=0.183  Sum_probs=54.2

Q ss_pred             ccccccCceEEEEEEeCCC-cEEEEEEecccc-----c-hhhHHHHHHHHHHHccCC---CCceeeeeceEecCCeeeEE
Q 038199           30 TRLGFGGFGEVYKGQFPNG-VKIAVKVLNRNL-----G-RIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~-----~-~~~~~~~~~E~~~l~~l~---h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +.||.|.+..||++...+| +.++||.-....     . ....++...|.+.|+.+.   -.++++++.+.  .+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence            5689999999999988766 589999754211     0 134567788888888863   24577777763  3456899


Q ss_pred             EeccCCCC
Q 038199          100 YEYMENGS  107 (356)
Q Consensus       100 ~e~~~~~s  107 (356)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99997643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.78  E-value=0.00077  Score=60.68  Aligned_cols=141  Identities=18%  Similarity=0.168  Sum_probs=81.1

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCC--ceeeeeceE------ecCCeeeEEE
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--NLVRLYGFC------HDQHMTALVY  100 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~~~~~~------~~~~~~~lV~  100 (356)
                      .+.++.|....+|+.+..+| .+++|+.....   ..+.+..|.+++..|...  .+++++...      ...+..++|+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~---~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV---KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC---CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            35577777789999976455 57788765421   123445566666666322  233443321      1234578999


Q ss_pred             eccCCCChhhh----h----------hcCCCC-----------CCHHHHH------------HHHHHHHHHHHHHhh---
Q 038199          101 EYMENGSLDGY----L----------FGKKRA-----------IEWEKLH------------EIAIGTAKGLVYLHE---  140 (356)
Q Consensus       101 e~~~~~sL~~~----l----------~~~~~~-----------~~~~~~~------------~i~~qi~~~l~~LH~---  140 (356)
                      +|++|..+...    .          +.....           -.|....            .....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            99998654211    0          110000           1111100            001122334555532   


Q ss_pred             -cCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          141 -ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       141 -~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                       ..+.+++|+|+.+.||+++.++.+.++||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             234789999999999999988877899998874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.72  E-value=0.0002  Score=64.28  Aligned_cols=138  Identities=22%  Similarity=0.258  Sum_probs=81.9

Q ss_pred             ccccccCceEEEEEEeCC-------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCc-eeeeeceEecCCeeeEEEe
Q 038199           30 TRLGFGGFGEVYKGQFPN-------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~~~~~~~~~~~~~lV~e  101 (356)
                      +.|..|-...+|+....+       ++.|++|+.....  .......+|.++++.+...+ ..++++++.+    .+|++
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence            345567778899997654       5789999876542  22235677888888875333 3445555432    36899


Q ss_pred             ccCCCChhhhh-----------------hcCCCC--------CC--HHHHHH--------------------------HH
Q 038199          102 YMENGSLDGYL-----------------FGKKRA--------IE--WEKLHE--------------------------IA  128 (356)
Q Consensus       102 ~~~~~sL~~~l-----------------~~~~~~--------~~--~~~~~~--------------------------i~  128 (356)
                      |++|..+....                 +.....        .+  +..+..                          +.
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            99987764310                 010000        00  111111                          11


Q ss_pred             HHHHHHHHHHhh------cCCCCccccCCCCCcEEEcCC----CceEEcccCCcc
Q 038199          129 IGTAKGLVYLHE------ECQQRIIHYDIKPENVLLDAN----FSPKVADFGLAK  173 (356)
Q Consensus       129 ~qi~~~l~~LH~------~~~~~ivH~dikp~Nill~~~----~~~kl~Dfgl~~  173 (356)
                      ..+...+..|-.      ..+..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            122222334432      134679999999999999874    789999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.66  E-value=0.00072  Score=60.38  Aligned_cols=145  Identities=18%  Similarity=0.210  Sum_probs=83.8

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEecc-ccchhhHHHHHHHHHHHccCCC--CceeeeeceEecCC--eeeEEEeccC
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYH--INLVRLYGFCHDQH--MTALVYEYME  104 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h--~ni~~~~~~~~~~~--~~~lV~e~~~  104 (356)
                      +.+..|.--.+|..... ++.+++. .+. ...........+|+.+++.+.-  .-+...+++|.++.  ..|.||++++
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            34433433445555442 7788888 442 2223444567788888888742  34555667776665  7799999999


Q ss_pred             CCChhhhhhcCC-------------------------------CCCCHHHHHHHHHHH--------------HHHHHHHh
Q 038199          105 NGSLDGYLFGKK-------------------------------RAIEWEKLHEIAIGT--------------AKGLVYLH  139 (356)
Q Consensus       105 ~~sL~~~l~~~~-------------------------------~~~~~~~~~~i~~qi--------------~~~l~~LH  139 (356)
                      |..+.+......                               ......++..+..+.              .....+|+
T Consensus       109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~  188 (321)
T COG3173         109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE  188 (321)
T ss_pred             ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence            843322220000                               000111111111111              12233444


Q ss_pred             hcC-----CCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199          140 EEC-----QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus       140 ~~~-----~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ...     +..++|||+.+.|++++.++-+-++||+++..-+
T Consensus       189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            311     2459999999999999998889999999987543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.59  E-value=0.00071  Score=59.78  Aligned_cols=31  Identities=26%  Similarity=0.518  Sum_probs=25.5

Q ss_pred             CCccccCCCCCcEEEcCCCc-eEEcccCCccc
Q 038199          144 QRIIHYDIKPENVLLDANFS-PKVADFGLAKL  174 (356)
Q Consensus       144 ~~ivH~dikp~Nill~~~~~-~kl~Dfgl~~~  174 (356)
                      ..++|||+.|.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999987555 56999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.52  E-value=0.0015  Score=58.76  Aligned_cols=144  Identities=15%  Similarity=0.160  Sum_probs=95.5

Q ss_pred             cccccccccCceEEEEEEeCCCcEEEEEEecccc-c------------------------hhhHHHHHHHHHHHccCCCC
Q 038199           27 NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-G------------------------RIAEEQFMAEVGTIGRTYHI   81 (356)
Q Consensus        27 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~------------------------~~~~~~~~~E~~~l~~l~h~   81 (356)
                      ++...|..|--+.||.|...+|..+|||+.+... .                        ....-=...|++-|++++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4456688888899999988889999999875321 0                        00001133577777777544


Q ss_pred             ceeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC
Q 038199           82 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  161 (356)
Q Consensus        82 ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~  161 (356)
                      .|.-.--+...  ..+|||+++.......-. -.+..++...+..+-.|++.-+.-|..  ..++||.||.--|+|+.+ 
T Consensus       227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyhd-  300 (520)
T KOG2270|consen  227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYHD-  300 (520)
T ss_pred             CCCCCCceeee--cceEeeeeccCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEEC-
Confidence            43332222222  246999999543322211 134567777777777888888887776  378999999999999865 


Q ss_pred             CceEEcccCCccccC
Q 038199          162 FSPKVADFGLAKLCD  176 (356)
Q Consensus       162 ~~~kl~Dfgl~~~~~  176 (356)
                      |.+.++|.+-+....
T Consensus       301 G~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHD  315 (520)
T ss_pred             CEEEEEEccccccCC
Confidence            489999988776543

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.45  E-value=0.0019  Score=57.23  Aligned_cols=73  Identities=19%  Similarity=0.257  Sum_probs=48.0

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC---CCceeeeeceEecCCeeeEEEeccCC
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      .+.++.|....+|+.+. +++.+.||+-..    .....|..|++-|+.|.   --.+++++++....+..+|||||++.
T Consensus        22 ~~~v~GG~i~~a~~~~~-~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLDT-DGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEE--SSSSEEEEEET-TS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eEecCCCChhheEEEEC-CCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            46689899999999984 677899998763    22346778888888773   44688899998887778999999977


Q ss_pred             C
Q 038199          106 G  106 (356)
Q Consensus       106 ~  106 (356)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.29  E-value=0.0035  Score=58.73  Aligned_cols=48  Identities=21%  Similarity=0.221  Sum_probs=39.3

Q ss_pred             HHHHHHHHHHHccCCCCceeeeeceEecC-CeeeEEEeccCCCChhhhhh
Q 038199           65 EEQFMAEVGTIGRTYHINLVRLYGFCHDQ-HMTALVYEYMENGSLDGYLF  113 (356)
Q Consensus        65 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-~~~~lV~e~~~~~sL~~~l~  113 (356)
                      ..++...+..++.+.|+|+..++++.... ....+|||++ +.||++++.
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~   74 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK   74 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence            35678889999999999999999988755 3467899999 559999884

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.23  E-value=0.0055  Score=55.20  Aligned_cols=31  Identities=16%  Similarity=0.225  Sum_probs=28.0

Q ss_pred             CCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       143 ~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      +.+++|+|+.++||+++.++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            4689999999999999999999999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.21  E-value=0.0041  Score=56.49  Aligned_cols=73  Identities=19%  Similarity=0.165  Sum_probs=47.6

Q ss_pred             cccccCceEEEEEEeCCC-cEEEEEEeccc------cchhhHHHHHHHHHHHccCC--CC-ceeeeeceEecCCeeeEEE
Q 038199           31 RLGFGGFGEVYKGQFPNG-VKIAVKVLNRN------LGRIAEEQFMAEVGTIGRTY--HI-NLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        31 ~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~--h~-ni~~~~~~~~~~~~~~lV~  100 (356)
                      -||.|....||++..++| +.++||--..-      .-....++...|.+.|+...  -| ++++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999987654 68999954211      11334456677888887763  34 34444443  444556899


Q ss_pred             eccCC
Q 038199          101 EYMEN  105 (356)
Q Consensus       101 e~~~~  105 (356)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.12  E-value=0.003  Score=57.79  Aligned_cols=142  Identities=17%  Similarity=0.261  Sum_probs=83.2

Q ss_pred             hccccccccccCceEEEEEEeCC-----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCce-eeeeceEecCCeeeE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTAL   98 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~~~~~~~~~l   98 (356)
                      ..++. .|-.|-.-.+|++...+     ++.|++|+..... .... ...+|..+++.+...++ .++++.+.++    .
T Consensus        38 ~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~  110 (344)
T PLN02236         38 ALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----R  110 (344)
T ss_pred             cEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence            33444 44448888999997532     3689999876542 2222 23678888888854433 3455555432    5


Q ss_pred             EEeccCCCChhhh-----------------hhcCC----C-CCCHHHHHHHHHHH-----------------HHHHHHHh
Q 038199           99 VYEYMENGSLDGY-----------------LFGKK----R-AIEWEKLHEIAIGT-----------------AKGLVYLH  139 (356)
Q Consensus        99 V~e~~~~~sL~~~-----------------l~~~~----~-~~~~~~~~~i~~qi-----------------~~~l~~LH  139 (356)
                      |.+|+++.+|...                 ++...    . ...+.++.++..++                 ...+..|.
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            8999988776421                 01111    1 12233343443222                 11122222


Q ss_pred             ----h-cCCCCccccCCCCCcEEEcC-CCceEEcccCCcc
Q 038199          140 ----E-ECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAK  173 (356)
Q Consensus       140 ----~-~~~~~ivH~dikp~Nill~~-~~~~kl~Dfgl~~  173 (356)
                          . ..+..++|+|+++.||++++ ++.+.++||..+.
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence                1 11346899999999999976 4689999998775

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.90  E-value=0.0064  Score=50.93  Aligned_cols=137  Identities=18%  Similarity=0.196  Sum_probs=83.4

Q ss_pred             EEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHH
Q 038199           51 IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG  130 (356)
Q Consensus        51 vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~q  130 (356)
                      ..+|++..-.......-|..+.+++++++  .|+++..=  +....-++.|+|.....             ...-.|.++
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~N~i~ag  150 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NFSNFITAG  150 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------chhHHHHHh
Confidence            34555554333334456788899998874  45665521  33345588898843111             111122222


Q ss_pred             HHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCcccc
Q 038199          131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD  210 (356)
Q Consensus       131 i~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  210 (356)
                       +.+|.-+|+. ..+.+|||..|+||+-|..|-+||.|-+..-.  +            +.-|.--|+.    ..|.++.
T Consensus       151 -i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~------------~V~~vN~~Y~----~lT~~aE  210 (308)
T PF07387_consen  151 -IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N------------QVNMVNIEYE----SLTQEAE  210 (308)
T ss_pred             -HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--h------------eeeEEeeecc----ccChHHH
Confidence             3567888952 47899999999999999999999999765321  1            1123221221    4577788


Q ss_pred             chhhHHHHHHHHhC
Q 038199          211 VYSFGMVLFEIVGR  224 (356)
Q Consensus       211 v~slGvvl~elltg  224 (356)
                      +-+|-.-++++...
T Consensus       211 ~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  211 VKVFVKSCLKLVEK  224 (308)
T ss_pred             HHHHHHHHHHHHHH
Confidence            87776666666654

The function of this family is unknown.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.89  E-value=0.0098  Score=53.55  Aligned_cols=30  Identities=27%  Similarity=0.301  Sum_probs=25.8

Q ss_pred             CCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       143 ~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ..+++|||+.+.||+++. +.+.++||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            367899999999999987 578999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.84  E-value=0.024  Score=52.56  Aligned_cols=74  Identities=16%  Similarity=0.195  Sum_probs=51.6

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEecccc---ch---hhHHHHHHHHHHHccCC---CCceeeeeceEecCCeeeEE
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL---GR---IAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~---~~~~~~~~E~~~l~~l~---h~ni~~~~~~~~~~~~~~lV   99 (356)
                      .+.||.|....||+.... +..|+||.-....   +.   ...++-..|++.|+.+.   ..++++++.++.+.  .++|
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence            467899999999999874 4569999765211   11   23455566677777664   24788888888743  5789


Q ss_pred             EeccCC
Q 038199          100 YEYMEN  105 (356)
Q Consensus       100 ~e~~~~  105 (356)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.77  E-value=0.0086  Score=50.43  Aligned_cols=76  Identities=21%  Similarity=0.250  Sum_probs=54.5

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC---CCceeeeeceEecCCeeeEEEeccCC
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      .+.+-.|..-..|...+ ...+|-||+-..    .....|..|+.-|+.|.   .-.+.+++.+.......|+|+||++-
T Consensus        21 r~~v~gG~inea~~v~d-g~~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          21 REEVSGGDINEAWRLRD-GTDPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             ccccCCccccceeEeec-CCcceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            34555566666666655 456787886432    33456778888777774   35688899999999999999999988


Q ss_pred             CChh
Q 038199          106 GSLD  109 (356)
Q Consensus       106 ~sL~  109 (356)
                      +.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            7775

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.65  E-value=0.015  Score=52.95  Aligned_cols=142  Identities=14%  Similarity=0.174  Sum_probs=80.0

Q ss_pred             hccccccccccCceEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCce-eeeeceEecCCeeeEE
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALV   99 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~~~~~~~~~lV   99 (356)
                      ..++.. |..|-...+|+....+    +..|++|+......  ..-...+|..+++.+...++ +++++++.++    +|
T Consensus        16 ~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i   88 (330)
T PLN02421         16 DFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MI   88 (330)
T ss_pred             ceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCCc----Ee
Confidence            444444 4448888899986533    24789998765421  12234678888888865444 3455555322    58


Q ss_pred             EeccCCCChhhh-------h----------hcCC----C-CCCHHHHHHHHHHH----------------------HHHH
Q 038199          100 YEYMENGSLDGY-------L----------FGKK----R-AIEWEKLHEIAIGT----------------------AKGL  135 (356)
Q Consensus       100 ~e~~~~~sL~~~-------l----------~~~~----~-~~~~~~~~~i~~qi----------------------~~~l  135 (356)
                      .+|++|..|...       +          +...    . .-.+..+..+..++                      ..-+
T Consensus        89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  168 (330)
T PLN02421         89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI  168 (330)
T ss_pred             ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence            999988665321       1          1111    1 11233333332222                      1112


Q ss_pred             HHHhhc-----CCCCccccCCCCCcEEEcC-CCceEEcccCCcc
Q 038199          136 VYLHEE-----CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAK  173 (356)
Q Consensus       136 ~~LH~~-----~~~~ivH~dikp~Nill~~-~~~~kl~Dfgl~~  173 (356)
                      ..+...     .+.-++|+|+.+.||++++ ++.++++||..+.
T Consensus       169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            222110     1234899999999999974 5789999998774

>PRK06148 hypothetical protein; Provisional

Probab=96.62  E-value=0.038  Score=57.81  Aligned_cols=151  Identities=17%  Similarity=0.160  Sum_probs=83.3

Q ss_pred             HHHhhhhcccc---ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccC-------CCCceeeeec
Q 038199           19 LQLNNFTSNYS---TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-------YHINLVRLYG   88 (356)
Q Consensus        19 ~~~~~~~~~~~---~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~ni~~~~~   88 (356)
                      .++....|.+.   +.|+ |..-.+|+.+..+|+.|++|+.+...   .......|.+++..|       .-|.+++..+
T Consensus        17 ~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~---~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~   92 (1013)
T PRK06148         17 EALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE---PRVESDFQTAALDHLAAVAPDLPVPRLIPSLS   92 (1013)
T ss_pred             HHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc---chhHHHHHHHHHHHHHhhCCCCCcCeeeecCC
Confidence            34455556553   4575 45678899987778899999987642   222333444455433       2333333221


Q ss_pred             -----eEec-CC--eeeEEEeccCCCChhhhh-----------------h----c--C---CCCCCHH------------
Q 038199           89 -----FCHD-QH--MTALVYEYMENGSLDGYL-----------------F----G--K---KRAIEWE------------  122 (356)
Q Consensus        89 -----~~~~-~~--~~~lV~e~~~~~sL~~~l-----------------~----~--~---~~~~~~~------------  122 (356)
                           ...+ ..  ..+.+++|++|..|.+..                 +    .  .   ...+.|.            
T Consensus        93 G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~  172 (1013)
T PRK06148         93 GASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLH  172 (1013)
T ss_pred             CCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhh
Confidence                 1111 11  456789999997775410                 0    0  0   0112221            


Q ss_pred             -----HHHHHHHHHHHHHHH----HhhcCCCCccccCCCCCcEEEcCCC--ce-EEcccCCcc
Q 038199          123 -----KLHEIAIGTAKGLVY----LHEECQQRIIHYDIKPENVLLDANF--SP-KVADFGLAK  173 (356)
Q Consensus       123 -----~~~~i~~qi~~~l~~----LH~~~~~~ivH~dikp~Nill~~~~--~~-kl~Dfgl~~  173 (356)
                           ....++.+++....-    .-...+.++||+|+.+.||+++.++  .+ -|+|||-+.
T Consensus       173 ~i~d~~~r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        173 FIDDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             hcCCHHHHHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence                 111222233322221    1112357899999999999998775  44 499999875

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.59  E-value=0.0066  Score=51.36  Aligned_cols=120  Identities=18%  Similarity=0.231  Sum_probs=60.3

Q ss_pred             CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCce-eeeeceEecCCeeeEEEeccCCCChhh--hh------------
Q 038199           48 GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYMENGSLDG--YL------------  112 (356)
Q Consensus        48 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~~~~~~~~~lV~e~~~~~sL~~--~l------------  112 (356)
                      ++.|+|++....  .........|..+++.+...++ .++++.+.++    .|++|++|..|..  +.            
T Consensus         2 ~~~~~~Ri~g~~--t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l   75 (211)
T PF01633_consen    2 PEKYLVRIPGEG--TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLL   75 (211)
T ss_dssp             TSEEEEEEEESC--GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCC--cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHH
Confidence            467888888765  2333456778888888864444 4555555432    6779997766532  10            


Q ss_pred             ---h---c---CCCCCCHHHHHHH----------------------HHHHHHHHHHHhh-----cCCCCccccCCCCCcE
Q 038199          113 ---F---G---KKRAIEWEKLHEI----------------------AIGTAKGLVYLHE-----ECQQRIIHYDIKPENV  156 (356)
Q Consensus       113 ---~---~---~~~~~~~~~~~~i----------------------~~qi~~~l~~LH~-----~~~~~ivH~dikp~Ni  156 (356)
                         +   .   ....-.+..+..+                      ...+..-+..+..     ..+..++|+|+.+.||
T Consensus        76 ~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Ni  155 (211)
T PF01633_consen   76 AKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNI  155 (211)
T ss_dssp             HHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGE
T ss_pred             HHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccE
Confidence               0   0   0011112222222                      0111122222211     1125689999999999


Q ss_pred             EE-cCCCceEEcccCCcc
Q 038199          157 LL-DANFSPKVADFGLAK  173 (356)
Q Consensus       157 ll-~~~~~~kl~Dfgl~~  173 (356)
                      ++ +.++.++++||..+.
T Consensus       156 l~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  156 LINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EETSSSSCEEE--GTT-E
T ss_pred             EeccCCCeEEEecHHHHh
Confidence            99 888999999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.49  E-value=0.05  Score=49.39  Aligned_cols=72  Identities=14%  Similarity=0.124  Sum_probs=43.8

Q ss_pred             cCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCc--eeeee---c--eEecCCeeeEEEeccCCCC
Q 038199           35 GGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN--LVRLY---G--FCHDQHMTALVYEYMENGS  107 (356)
Q Consensus        35 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~~~---~--~~~~~~~~~lV~e~~~~~s  107 (356)
                      +.-..||+....++..+++|+....  .....++..|.+.+..|....  ++...   |  +..-++..+.|+++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~--~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPE--RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcc--cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            4456799998777888999987543  234456667777776653211  22211   1  1222345678999998864


Q ss_pred             h
Q 038199          108 L  108 (356)
Q Consensus       108 L  108 (356)
                      .
T Consensus       114 ~  114 (325)
T PRK11768        114 P  114 (325)
T ss_pred             C
Confidence            3

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.48  E-value=0.0096  Score=53.61  Aligned_cols=73  Identities=18%  Similarity=0.157  Sum_probs=59.7

Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ..+.|++|++. |+++..     .....+.++..++.+.+..++-+..  +-++-|||+.-.||+++ +|.+-|+||-++
T Consensus       298 ~~y~yl~~kdh-gt~is~-----ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-----IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceeee-----eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeee
Confidence            34667788886 556542     2355788999999999998888886  47799999999999999 899999999999


Q ss_pred             cc
Q 038199          173 KL  174 (356)
Q Consensus       173 ~~  174 (356)
                      +.
T Consensus       369 Rl  370 (488)
T COG5072         369 RL  370 (488)
T ss_pred             ec
Confidence            84

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.39  E-value=0.013  Score=53.54  Aligned_cols=59  Identities=20%  Similarity=0.239  Sum_probs=40.5

Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD  159 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~  159 (356)
                      .++=+|..|.++..++.  ....++..+..++.--++|+..+--  -.+++|.|+.|.||++-
T Consensus       321 vl~E~~~~Gl~v~~~v~--~~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVK--WKSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             eeeeeccccccHHhhhh--cccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence            46777888889998883  3334444555555555555544332  17899999999999993

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.22  E-value=0.12  Score=46.69  Aligned_cols=139  Identities=19%  Similarity=0.237  Sum_probs=80.7

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCc---eee---e----eceEecCCeeeEE
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN---LVR---L----YGFCHDQHMTALV   99 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n---i~~---~----~~~~~~~~~~~lV   99 (356)
                      +.|++ .-..+|+....+|+. ++|+....   ....++..|...+..|.-..   .++   .    +.......+.+-|
T Consensus        32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l  106 (331)
T COG2334          32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL  106 (331)
T ss_pred             ccccc-ccCceEEEEecCCCe-EEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence            33555 566789998867665 88988764   33455666777777663111   111   1    1111122367789


Q ss_pred             EeccCCCChhh-hh--------------h--cCC---------CCCCHHH-------------HHHHHHHHHHHHHHHhh
Q 038199          100 YEYMENGSLDG-YL--------------F--GKK---------RAIEWEK-------------LHEIAIGTAKGLVYLHE  140 (356)
Q Consensus       100 ~e~~~~~sL~~-~l--------------~--~~~---------~~~~~~~-------------~~~i~~qi~~~l~~LH~  140 (356)
                      ++|++|..+.. ..              +  .++         ....|..             -.....++...+..+.+
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99999988872 11              0  000         0122220             01122333344444443


Q ss_pred             ----cCCCC---ccccCCCCCcEEEcCCCc-eEEcccCCcc
Q 038199          141 ----ECQQR---IIHYDIKPENVLLDANFS-PKVADFGLAK  173 (356)
Q Consensus       141 ----~~~~~---ivH~dikp~Nill~~~~~-~kl~Dfgl~~  173 (356)
                          ..+..   +||+|+.|.||+++.+.. ..++||+-+.
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                22344   999999999999998874 8899998764

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.22  E-value=0.00024  Score=73.91  Aligned_cols=158  Identities=11%  Similarity=0.016  Sum_probs=106.4

Q ss_pred             HHHHHHHHccCCCCceeeeeceEec--CCeeeEEEeccCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038199           68 FMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYLHEEC  142 (356)
Q Consensus        68 ~~~E~~~l~~l~h~ni~~~~~~~~~--~~~~~lV~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~  142 (356)
                      ...|.+.++...|+++...+.=...  ....+.+++++.+|.+.+.+-+..   ..+...-+...-.+......-.|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4445556666789988776655443  345678999999999999885432   22333333332223244455555422


Q ss_pred             C--CCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHH
Q 038199          143 Q--QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE  220 (356)
Q Consensus       143 ~--~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~e  220 (356)
                      +  .--+|+++|+-|.++..+..+++.++|+.+......  .......+++-|++|+....- .++.++|+|..|+.+|+
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEI-KFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHHHHHHH
Confidence            2  337999999999999999999999999998322211  112334466677888877644 67888999999999999


Q ss_pred             HHhCCccc
Q 038199          221 IVGRRRNA  228 (356)
Q Consensus       221 lltg~~p~  228 (356)
                      ...|..++
T Consensus      1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred             HhcccHHH
Confidence            99887653

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=96.16  E-value=0.0021  Score=48.91  Aligned_cols=44  Identities=27%  Similarity=0.436  Sum_probs=34.9

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHcc
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR   77 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~   77 (356)
                      +-||.|+.|.||+|++++|+.||||+.+++.    .+.+..++.+++.
T Consensus        17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i----~~~i~~Dl~~l~~   60 (119)
T PF03109_consen   17 EPLASASIAQVHRARLKDGEEVAVKVQRPGI----EEQIEADLRILRR   60 (119)
T ss_pred             chhhheehhhheeeeecccchhhhhhcchHH----HHHHHHHHHHHHH
Confidence            5699999999999999899999999988643    3455556666554

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.15  E-value=0.024  Score=52.22  Aligned_cols=75  Identities=16%  Similarity=0.216  Sum_probs=49.5

Q ss_pred             cccccccCceEEEEEEeCC-CcEEEEEEec----cccc-hhhHHHHHHHHHHHccCC--CC-ceeeeeceEecCCeeeEE
Q 038199           29 STRLGFGGFGEVYKGQFPN-GVKIAVKVLN----RNLG-RIAEEQFMAEVGTIGRTY--HI-NLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~----~~~~-~~~~~~~~~E~~~l~~l~--h~-ni~~~~~~~~~~~~~~lV   99 (356)
                      .+.||-|.-.-||++...+ ++.|+||---    ...+ ....++..-|.+.|+.+.  -| ++++++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4568999999999998743 5679999532    1111 344467778888888764  45 45555543  33445688


Q ss_pred             EeccCC
Q 038199          100 YEYMEN  105 (356)
Q Consensus       100 ~e~~~~  105 (356)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888854

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	356
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-48
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-47
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-36
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-35
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-32
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-32
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-31
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-31
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-24
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-24
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-24
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-24
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-24
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-24
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-24
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-24
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-24
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-24
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-24
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-24
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-24
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-24
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-23
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-22
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-16
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-16
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-15
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-15
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-15
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-15
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-15
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-15
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
3soa_A	444	Full-Length Human Camkii Length = 444		2e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		8e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		9e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		7e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		8e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-05
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		8e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 117/296 (39%), Positives = 166/296 (56%), Gaps = 17/296 (5%)
Query: 15  RFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEV 72
           RF+  +L   + N+S +  LG GGFG+VYKG+  +G  +AVK L     +  E QF  EV
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 73  GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---IEWEKLHEIAI 129
             I    H NL+RL GFC       LVY YM NGS+   L  +  +   ++W K   IA+
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG 189
           G+A+GL YLH+ C  +IIH D+K  N+LLD  F   V DFGLAKL D    HV  +  +G
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRG 205
Query: 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRN---AIVGSSES---LDWFPKHV 243
           T G+ APE+LS     + K DV+ +G++L E++  +R    A + + +    LDW    +
Sbjct: 206 TIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 244 WEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG 299
            E+  ++ +D  +       KD E+ ++L   AL C Q SP +RP MS VV+MLEG
Sbjct: 265 KEKKLEALVDVDLQG---NYKD-EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 115/296 (38%), Positives = 164/296 (55%), Gaps = 17/296 (5%)
Query: 15  RFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEV 72
           RF+  +L   + N+  +  LG GGFG+VYKG+  +G  +AVK L     +  E QF  EV
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 73  GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---IEWEKLHEIAI 129
             I    H NL+RL GFC       LVY YM NGS+   L  +  +   ++W K   IA+
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG 189
           G+A+GL YLH+ C  +IIH D+K  N+LLD  F   V DFGLAKL D    HV  +  +G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRG 197
Query: 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRN---AIVGSSES---LDWFPKHV 243
             G+ APE+LS     + K DV+ +G++L E++  +R    A + + +    LDW    +
Sbjct: 198 XIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 244 WEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG 299
            E+  ++ +D  +       KD E+ ++L   AL C Q SP +RP MS VV+MLEG
Sbjct: 257 KEKKLEALVDVDLQG---NYKD-EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 103/291 (35%), Positives = 159/291 (54%), Gaps = 14/291 (4%)
Query: 15  RFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEV 72
           R   + L   T+N+  +  +G G FG+VYKG   +G K+A+K       +   E+F  E+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFETEI 86
Query: 73  GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAI 129
            T+    H +LV L GFC +++   L+Y+YMENG+L  +L+G      ++ WE+  EI I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL-CDRNRSHVTISGYK 188
           G A+GL YLH    + IIH D+K  N+LLD NF PK+ DFG++K   + +++H+     K
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV-VK 202
Query: 189 GTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY 247
           GT GY  PE F+ G   +T K DVYSFG+VLFE++  R   +      +    +   E +
Sbjct: 203 GTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
              +L+  +     ++   E  ++    A+ C+  S EDRP M  V+  LE
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 103/291 (35%), Positives = 158/291 (54%), Gaps = 14/291 (4%)
Query: 15  RFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEV 72
           R   + L   T+N+  +  +G G FG+VYKG   +G K+A+K       +   E+F  E+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFETEI 86
Query: 73  GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAI 129
            T+    H +LV L GFC +++   L+Y+YMENG+L  +L+G      ++ WE+  EI I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL-CDRNRSHVTISGYK 188
           G A+GL YLH    + IIH D+K  N+LLD NF PK+ DFG++K   +  ++H+     K
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV-VK 202
Query: 189 GTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY 247
           GT GY  PE F+ G   +T K DVYSFG+VLFE++  R   +      +    +   E +
Sbjct: 203 GTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
              +L+  +     ++   E  ++    A+ C+  S EDRP M  V+  LE
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 91/229 (39%), Positives = 118/229 (51%), Gaps = 19/229 (8%)
Query: 7   EIGREKPVRFTSLQLNNFTSNYSTR--------LGFGGFGEVYKGQFPNGVKIAVKVLNR 58
           E+   +   F+  +L N T+N+  R        +G GGFG VYKG + N   +AVK L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAA 64
Query: 59  NLGRIAEE---QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--F 113
            +    EE   QF  E+  + +  H NLV L GF  D     LVY YM NGSL   L   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 114 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173
                + W    +IA G A G+ +LHE      IH DIK  N+LLD  F+ K++DFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             ++    V  S   GT  Y APE L G   IT K D+YSFG+VL EI+
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 228

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 90/229 (39%), Positives = 117/229 (51%), Gaps = 19/229 (8%)
Query: 7   EIGREKPVRFTSLQLNNFTSNYSTR--------LGFGGFGEVYKGQFPNGVKIAVKVLNR 58
           E+   +   F+  +L N T+N+  R        +G GGFG VYKG + N   +AVK L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAA 64
Query: 59  NLGRIAEE---QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--F 113
            +    EE   QF  E+  + +  H NLV L GF  D     LVY YM NGSL   L   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 114 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173
                + W    +IA G A G+ +LHE      IH DIK  N+LLD  F+ K++DFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             ++    V      GT  Y APE L G   IT K D+YSFG+VL EI+
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 228

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/220 (40%), Positives = 114/220 (51%), Gaps = 19/220 (8%)
Query: 16  FTSLQLNNFTSNYSTR--------LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE- 66
           F+  +L N T+N+  R        +G GGFG VYKG + N   +AVK L   +    EE 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 67  --QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWE 122
             QF  E+  + +  H NLV L GF  D     LVY YM NGSL   L        + W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
              +IA G A G+ +LHE      IH DIK  N+LLD  F+ K++DFGLA+  ++    V
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
                 GT  Y APE L G   IT K D+YSFG+VL EI+
Sbjct: 185 MXXRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 222

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 89/220 (40%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 16  FTSLQLNNFTSNYSTR--------LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEE- 66
           F+  +L N T+N+  R         G GGFG VYKG + N   +AVK L   +    EE 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 67  --QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWE 122
             QF  E+    +  H NLV L GF  D     LVY Y  NGSL   L        + W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
              +IA G A G+ +LHE      IH DIK  N+LLD  F+ K++DFGLA+  ++    V
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             S   GT  Y APE L G   IT K D+YSFG+VL EI+
Sbjct: 182 XXSRIVGTTAYXAPEALRGE--ITPKSDIYSFGVVLLEII 219

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 111/200 (55%), Gaps = 15/200 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 84  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 137
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N  +    G K    ++APE +  NY   T
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAI--NYGTFT 194
Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K DV+SFG++L EIV   R
Sbjct: 195 IKSDVWSFGILLTEIVTHGR 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 111/200 (55%), Gaps = 15/200 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 83  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 136
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N  +    G K    ++APE +  NY   T
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAI--NYGTFT 193
Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K DV+SFG++L EIV   R
Sbjct: 194 IKSDVWSFGILLTEIVTHGR 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 132/272 (48%), Gaps = 30/272 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 88  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 141
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N  +    G K    ++APE +  NY   T
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAI--NYGTFT 198
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++L EIV   R    G +         V +  E+         C       
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYRMVRPDNC------- 245
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
              + L      C ++ PEDRP    +  +LE
Sbjct: 246 --PEELYQLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 111/200 (55%), Gaps = 15/200 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 131
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N  +    G K    ++APE +  NY   T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAI--NYGTFT 188
Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K DV+SFG++L EIV   R
Sbjct: 189 IKSDVWSFGILLTEIVTHGR 208

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 132/276 (47%), Gaps = 22/276 (7%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +   +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+L
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG C +Q    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL E C   +
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYS 180
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++++E+                   K  +E    SE+   I       K +
Sbjct: 181 SKSDVWSFGVLMWEVFSE---------------GKIPYENRSNSEVVEDISTGFRLYKPR 225
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
             +  +      C ++ PEDRP  S +++ L  + E
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 132/276 (47%), Gaps = 22/276 (7%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +   +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+L
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG C +Q    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL E C   +
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 124
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR-YS 182
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++++E+                   K  +E    SE+   I       K +
Sbjct: 183 SKSDVWSFGVLMWEVFSE---------------GKIPYENRSNSEVVEDISTGFRLYKPR 227
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
             +  +      C ++ PEDRP  S +++ L  + E
Sbjct: 228 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 132/276 (47%), Gaps = 22/276 (7%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +   +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+L
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQL 70
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG C +Q    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL E C   +
Sbjct: 71  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 127
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYS 185
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++++E+                   K  +E    SE+   I       K +
Sbjct: 186 SKSDVWSFGVLMWEVFSE---------------GKIPYENRSNSEVVEDISTGFRLYKPR 230
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
             +  +      C ++ PEDRP  S +++ L  + E
Sbjct: 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 136/272 (50%), Gaps = 30/272 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 73  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 126
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N  +    G K    ++APE +  NY   T
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAI--NYGTFT 183
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++L EIV   R    G +         V +  E+         C    ++ 
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYRMVRPDNC---PEEL 234
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 235 YQLMRLC----W--KERPEDRPTFDYLRSVLE 260

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 79  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 132
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N       G K    ++APE +  NY   T
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 189
Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K DV+SFG++L EIV   R
Sbjct: 190 IKSDVWSFGILLTEIVTHGR 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 80  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 133
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N       G K    ++APE +  NY   T
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 190
Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K DV+SFG++L EIV   R
Sbjct: 191 IKSDVWSFGILLTEIVTHGR 210

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 84  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 137
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N       G K    ++APE +  NY   T
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 194
Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K DV+SFG++L EIV   R
Sbjct: 195 IKSDVWSFGILLTEIVTHGR 214

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 131
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N       G K    ++APE +  NY   T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 188
Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K DV+SFG++L EIV   R
Sbjct: 189 IKSDVWSFGILLTEIVTHGR 208

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 86  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 139
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N       G K    ++APE +  NY   T
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 196
Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K DV+SFG++L EIV   R
Sbjct: 197 IKSDVWSFGILLTEIVTHGR 216

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 131
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N       G K    ++APE +  NY   T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 188
Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K DV+SFG++L EIV   R
Sbjct: 189 IKSDVWSFGILLTEIVTHGR 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 135/272 (49%), Gaps = 30/272 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 87  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 140
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + N       G K    ++APE +  NY   T
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAI--NYGTFT 197
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++L EIV   R    G +         V +  E+         C    ++ 
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYRMVRPDNC---PEEL 248
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 249 YQLMRLC----W--KERPEDRPTFDYLRSVLE 274

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 132/276 (47%), Gaps = 22/276 (7%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +   +G G FG V+ G + N  K+A+K +    G ++E+ F+ E   + +  H  LV+L
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKE--GSMSEDDFIEEAEVMMKLSHPKLVQL 87
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG C +Q    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL E C   +
Sbjct: 88  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR-YS 202
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++++E+                   K  +E    SE+   I       K +
Sbjct: 203 SKSDVWSFGVLMWEVFSE---------------GKIPYENRSNSEVVEDISTGFRLYKPR 247
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
             +  +      C ++ PEDRP  S +++ L  + E
Sbjct: 248 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 22/276 (7%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +   +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+L
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG C +Q    LV E+ME+G L  YL  ++     E L  + +   +G+ YL E C   +
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR-YS 183
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++++E+                   K  +E    SE+   I       K +
Sbjct: 184 SKSDVWSFGVLMWEVFSE---------------GKIPYENRSNSEVVEDISTGFRLYKPR 228
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
             +  +      C ++ PEDRP  S +++ L  + E
Sbjct: 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 91/272 (33%), Positives = 136/272 (50%), Gaps = 30/272 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 74  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 127
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H +++  N+L+    S K+ADFGLA+L + N  +    G K    ++APE +  NY   T
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAI--NYGTFT 184
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++L EIV   R    G +         V +  E+         C    ++ 
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYRMVRPDNC---PEEL 235
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            +  RLC    W  ++ PEDRP    +  +LE
Sbjct: 236 YQLMRLC----W--KERPEDRPTFDYLRSVLE 261

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 140/283 (49%), Gaps = 26/283 (9%)
Query: 29  STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMA---EVGTIGRTYHINLVR 85
           STR+G G FG VYKG++   V  AVK+L   +     EQF A   EV  + +T H+N++ 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDV--AVKILK--VVDPTPEQFQAFRNEVAVLRKTRHVNILL 96
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
             G+    ++ A+V ++ E  SL  +L  ++   +  +L +IA  TA+G+ YLH    + 
Sbjct: 97  FMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KN 152
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNY 203
           IIH D+K  N+ L    + K+ DFGLA +  R      +    G+  + APE   +  N 
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 204 PITHKCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE 262
           P + + DVYS+G+VL+E++ G    + + + + + +    V   Y   +L      C   
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM---VGRGYASPDLSKLYKNC--- 266
Query: 263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
               +  KRL      CV+   E+RP    ++  +E +   LP
Sbjct: 267 ---PKAMKRLVAD---CVKKVKEERPLFPQILSSIELLQHSLP 303

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 9/195 (4%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 19  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E +KL +IA  TA+G+ YLH +    IIH 
Sbjct: 77  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 132
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +  + P + 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 208 KCDVYSFGMVLFEIV 222
           + DVY+FG+VL+E++
Sbjct: 193 QSDVYAFGIVLYELM 207

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 136/286 (47%), Gaps = 26/286 (9%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVL-NRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           N   ++G G FG V++ ++ +G  +AVK+L  ++       +F+ EV  + R  H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
             G        ++V EY+  GSL   L   G +  ++  +   +A   AKG+ YLH    
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
             I+H ++K  N+L+D  ++ KV DFGL++L  +  + ++     GTP + APE L  + 
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLR-DE 214
Query: 204 PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI-LACGIE 262
           P   K DVYSFG++L+E+                   +  W     +++ A +   C   
Sbjct: 215 PSNEKSDVYSFGVILWELATL----------------QQPWGNLNPAQVVAAVGFKCKRL 258
Query: 263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE-VLPPP 307
           E  +    ++      C  + P  RP  + ++ +L  +++  +PPP
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 134/286 (46%), Gaps = 26/286 (9%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVL-NRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           N   ++G G FG V++ ++ +G  +AVK+L  ++       +F+ EV  + R  H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
             G        ++V EY+  GSL   L   G +  ++  +   +A   AKG+ YLH    
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
             I+H D+K  N+L+D  ++ KV DFGL++L  +    +      GTP + APE L  + 
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLR-DE 214
Query: 204 PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI-LACGIE 262
           P   K DVYSFG++L+E+                   +  W     +++ A +   C   
Sbjct: 215 PSNEKSDVYSFGVILWELATL----------------QQPWGNLNPAQVVAAVGFKCKRL 258
Query: 263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE-VLPPP 307
           E  +    ++      C  + P  RP  + ++ +L  +++  +PPP
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 130/274 (47%), Gaps = 22/274 (8%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +   +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+L
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG C +Q    LV+E+ME+G L  YL  ++     E L  + +   +G+ YL E     +
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ASV 124
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+   N L+  N   KV+DFG+ +    +  + + +G K    +++PE  S +   +
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR-YS 182
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV+SFG++++E+                   K  +E    SE+   I       K +
Sbjct: 183 SKSDVWSFGVLMWEVFSE---------------GKIPYENRSNSEVVEDISTGFRLYKPR 227
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
             +  +      C ++ PEDRP  S +++ L  +
Sbjct: 228 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 31  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E +KL +IA  TA+G+ YLH +    IIH 
Sbjct: 89  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE   +  + P + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 208 KCDVYSFGMVLFEIV 222
           + DVY+FG+VL+E++
Sbjct: 205 QSDVYAFGIVLYELM 219

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 22/279 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 17  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 75  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 130
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + DVY+FG+VL+E++ G+   + + + + + +    V   Y   +L      C       
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 240
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
            KA +  MA   C++   ++RP    ++  +E +   LP
Sbjct: 241 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 277

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 22/279 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 15  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + DVY+FG+VL+E++ G+   + + + + + +    V   Y   +L      C       
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 238
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
            KA +  MA   C++   ++RP    ++  +E +   LP
Sbjct: 239 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 22/279 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 20  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 133
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + DVY+FG+VL+E++ G+   + + + + + +    V   Y   +L      C       
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 243
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
            KA +  MA   C++   ++RP    ++  +E +   LP
Sbjct: 244 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 280

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 22/279 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 42  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 100 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 155
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + DVY+FG+VL+E++ G+   + + + + + +    V   Y   +L      C       
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 265
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
            KA +  MA   C++   ++RP    ++  +E +   LP
Sbjct: 266 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 302

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 22/279 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 20  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 133
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + DVY+FG+VL+E++ G+   + + + + + +    V   Y   +L      C       
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 243
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
            KA +  MA   C++   ++RP    ++  +E +   LP
Sbjct: 244 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 280

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 22/279 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 43  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 156
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + DVY+FG+VL+E++ G+   + + + + + +    V   Y   +L      C       
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 266
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
            KA +  MA   C++   ++RP    ++  +E +   LP
Sbjct: 267 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 303

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 31  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E +KL +IA  TA+G+ YLH +    IIH 
Sbjct: 89  STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE   +  + P + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 208 KCDVYSFGMVLFEIV 222
           + DVY+FG+VL+E++
Sbjct: 205 QSDVYAFGIVLYELM 219

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/200 (37%), Positives = 109/200 (54%), Gaps = 15/200 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G  GEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 91  HDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
             Q    ++ EYMENGSL  +L    G K  I   KL ++A   A+G+ ++ E   +  I
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEE---RNYI 131
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
           H D++  N+L+    S K+ADFGLA+L + +       G K    ++APE +  NY   T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTAPEAI--NYGTFT 188
Query: 207 HKCDVYSFGMVLFEIVGRRR 226
            K DV+SFG++L EIV   R
Sbjct: 189 IKSDVWSFGILLTEIVTHGR 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 22/279 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 15  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 73  STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE   +    P + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + DVY+FG+VL+E++ G+   + + + + + +    V   Y   +L      C       
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 238
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
            KA +  MA   C++   ++RP    ++  +E +   LP
Sbjct: 239 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 32  LGFGGFGEVYKGQFPNG-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           +G G FGEVYKG          V +A+K L           F+ E G +G+  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G         ++ EYMENG+LD +L  K       +L  +  G A G+ YL        
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNY 168
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +H D+   N+L+++N   KV+DFGL++ L D   +  T SG K    ++APE +S     
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KF 227
Query: 206 THKCDVYSFGMVLFEIV 222
           T   DV+SFG+V++E++
Sbjct: 228 TSASDVWSFGIVMWEVM 244

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 131/278 (47%), Gaps = 26/278 (9%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKP--GTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 91  HDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L  G+ RA++   L ++A   A G+ Y+    +   IH 
Sbjct: 74  SEEPIY-IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+      K+ADFGLA+L + N       G K    ++APE  L G + I  K
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGRFTI--K 186
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV+SFG++L E+V + R    G +       + V E+ E+         C I       
Sbjct: 187 SDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYRMPCPQDCPIS------ 234
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPP 306
              L    + C +  PE+RP    +   LE       P
Sbjct: 235 ---LHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEP 269

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 139/288 (48%), Gaps = 36/288 (12%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           +G G FG V K ++     +A+K +     R A   F+ E+  + R  H N+V+LYG C 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYGACL 72
Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA--IGTAKGLVYLHEECQQRIIHY 149
           +     LV EY E GSL   L G +    +   H ++  +  ++G+ YLH    + +IH 
Sbjct: 73  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 150 DIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-NYPITH 207
           D+KP N+LL A  +  K+ DFG A  CD  ++H+T    KG+  + APE   G NY  + 
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTA--CDI-QTHMT--NNKGSAAWMAPEVFEGSNY--SE 183
Query: 208 KCDVYSFGMVLFEIVGRRR--NAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD 265
           KCDV+S+G++L+E++ RR+  + I G +  + W                 I       K+
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW-------AVHNGTRPPLI-------KN 229
Query: 266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP-PPKPFRY 312
             K     M   W     P  RP M  +VK++  ++   P   +P +Y
Sbjct: 230 LPKPIESLMTRCW--SKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 275

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 139/288 (48%), Gaps = 36/288 (12%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           +G G FG V K ++     +A+K +     R A   F+ E+  + R  H N+V+LYG C 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYGACL 71
Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA--IGTAKGLVYLHEECQQRIIHY 149
           +     LV EY E GSL   L G +    +   H ++  +  ++G+ YLH    + +IH 
Sbjct: 72  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 150 DIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-NYPITH 207
           D+KP N+LL A  +  K+ DFG A  CD  ++H+T    KG+  + APE   G NY  + 
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTA--CDI-QTHMT--NNKGSAAWMAPEVFEGSNY--SE 182
Query: 208 KCDVYSFGMVLFEIVGRRR--NAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD 265
           KCDV+S+G++L+E++ RR+  + I G +  + W                 I       K+
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW-------AVHNGTRPPLI-------KN 228
Query: 266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP-PPKPFRY 312
             K     M   W     P  RP M  +VK++  ++   P   +P +Y
Sbjct: 229 LPKPIESLMTRCW--SKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 136/279 (48%), Gaps = 22/279 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 15  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE   +    P + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + DVY+FG+VL+E++ G+   + + + + + +    V   Y   +L      C       
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 238
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
            KA +  MA   C++   ++RP    ++  +E +   LP
Sbjct: 239 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 136/279 (48%), Gaps = 22/279 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 35  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 93  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 148
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE   +    P + 
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + DVY+FG+VL+E++ G+   + + + + + +    V   Y   +L      C       
Sbjct: 209 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 258
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
            KA +  MA   C++   ++RP    ++  +E +   LP
Sbjct: 259 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 295

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 136/279 (48%), Gaps = 22/279 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-FMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN       + Q F  EVG + +T H+N++   G+
Sbjct: 43  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH +    IIH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 156
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF--LSGNYPITH 207
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE   +    P + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + DVY+FG+VL+E++ G+   + + + + + +    V   Y   +L      C       
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLSKVRSNC------- 266
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
            KA +  MA   C++   ++RP    ++  +E +   LP
Sbjct: 267 PKAMKRLMAE--CLKKKRDERPLFPQILASIELLARSLP 303

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 10/194 (5%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G + N  K+AVK L    G ++ + F+ E   +    H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             +    ++ EYM  GSL  +L   +   +   KL + +   A+G+ Y+    ++  IH 
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 134
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPITHK 208
           D++  NVL+  +   K+ADFGLA++ + N  +    G K    ++APE ++ G + I  K
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPEAINFGCFTI--K 191
Query: 209 CDVYSFGMVLFEIV 222
            DV+SFG++L+EIV
Sbjct: 192 SDVWSFGILLYEIV 205

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 101/190 (53%), Gaps = 7/190 (3%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FG V  G++     +AVK++    G ++E++F  E  T+ +  H  LV+ YG C 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            ++   +V EY+ NG L  YL    + +E  +L E+     +G+ +L      + IH D+
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDL 130
Query: 152 KPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 211
              N L+D +   KV+DFG+ +    +  +V+  G K    +SAPE     +  + K DV
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFH-YFKYSSKSDV 188
Query: 212 YSFGMVLFEI 221
           ++FG++++E+
Sbjct: 189 WAFGILMWEV 198

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 113/211 (53%), Gaps = 13/211 (6%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 76  SEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  K
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI--K 188
Query: 209 CDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
            DV+SFG++L E+  + R    G  + E LD
Sbjct: 189 SDVWSFGILLTELTTKGRVPYPGMVNREVLD 219

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 112/211 (53%), Gaps = 13/211 (6%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 73  SEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   KVADFGLA+L + N       G K    ++APE  L G + I  K
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGRFTI--K 185
Query: 209 CDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
            DV+SFG++L E+  + R    G  + E LD
Sbjct: 186 SDVWSFGILLTELTTKGRVPYPGMVNREVLD 216

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 113/212 (53%), Gaps = 13/212 (6%)
Query: 30  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 15  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 73  VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 128
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI-- 185
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
           K DV+SFG++L E+  + R    G  + E LD
Sbjct: 186 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD 217

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 113/212 (53%), Gaps = 13/212 (6%)
Query: 30  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 13  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 71  VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI-- 183
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
           K DV+SFG++L E+  + R    G  + E LD
Sbjct: 184 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 113/212 (53%), Gaps = 13/212 (6%)
Query: 30  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
           K DV+SFG++L E+  + R    G  + E LD
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI--K 361
Query: 209 CDVYSFGMVLFEIVGRRR 226
            DV+SFG++L E+  + R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 102/196 (52%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K+LN   G  A  +FM E   +    H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C    +  LV + M +G L  Y+   K  I  + L    +  AKG++YL E   +R+
Sbjct: 106 LGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 161
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+ +    K+ DFGLA+L + +       G K    + A E +      T
Sbjct: 162 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FT 220
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 221 HQSDVWSYGVTIWELM 236

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI--K 361
Query: 209 CDVYSFGMVLFEIVGRRR 226
            DV+SFG++L E+  + R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 113/212 (53%), Gaps = 13/212 (6%)
Query: 30  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
           K DV+SFG++L E+  + R    G  + E LD
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 113/212 (53%), Gaps = 13/212 (6%)
Query: 30  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
           K DV+SFG++L E+  + R    G  + E LD
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 115/214 (53%), Gaps = 17/214 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G + N  K+AVK L    G ++ + F+ E   +    H  LVRLY   
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             +    ++ E+M  GSL  +L   +   +   KL + +   A+G+ Y+    ++  IH 
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 133
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPITHK 208
           D++  NVL+  +   K+ADFGLA++ + N  +    G K    ++APE ++ G + I  K
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGCFTI--K 190
Query: 209 CDVYSFGMVLFEIV--GR-----RRNAIVGSSES 235
            +V+SFG++L+EIV  G+     R NA V S+ S
Sbjct: 191 SNVWSFGILLYEIVTYGKIPYPGRTNADVMSALS 224

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 113/212 (53%), Gaps = 13/212 (6%)
Query: 30  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
           K DV+SFG++L E+  + R    G  + E LD
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 102/196 (52%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K+LN   G  A  +FM E   +    H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C    +  LV + M +G L  Y+   K  I  + L    +  AKG++YL E   +R+
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 138
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+ +    K+ DFGLA+L + +       G K    + A E +      T
Sbjct: 139 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FT 197
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 198 HQSDVWSYGVTIWELM 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 249 SEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI--K 361
Query: 209 CDVYSFGMVLFEIVGRRR 226
            DV+SFG++L E+  + R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 112/212 (52%), Gaps = 13/212 (6%)
Query: 30  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            D++  N+L+  N   KVADFGLA+L + N       G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGRFTI-- 194
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
           K DV+SFG++L E+  + R    G  + E LD
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 113/211 (53%), Gaps = 13/211 (6%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L +++   A G+ Y+    +   +H 
Sbjct: 80  SEEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI--K 192
Query: 209 CDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
            DV+SFG++L E+  + R    G  + E LD
Sbjct: 193 SDVWSFGILLTELTTKGRVPYPGMVNREVLD 223

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGLA+ L D   +  T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 229 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 268
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 332 SEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 444
Query: 209 CDVYSFGMVLFEIVGRRR 226
            DV+SFG++L E+  + R
Sbjct: 445 SDVWSFGILLTELTTKGR 462

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 112/212 (52%), Gaps = 13/212 (6%)
Query: 30  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            D+   N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
           K DV+SFG++L E+  + R    G  + E LD
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGFV 169
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 229 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 268
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 112/212 (52%), Gaps = 13/212 (6%)
Query: 30  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++ +  +V EYM  G L  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
           K DV+SFG++L E+  + R    G  + E LD
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 119/227 (52%), Gaps = 15/227 (6%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMA 70
           +KP    + ++   +     +LG G FGEV+   +    K+AVK +    G ++ E F+A
Sbjct: 2   QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLA 59
Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEI 127
           E   +    H  LV+L+     + +  ++ E+M  GSL  +L    G K+ +   KL + 
Sbjct: 60  EANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDF 116
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
           +   A+G+ ++    Q+  IH D++  N+L+ A+   K+ADFGLA++ + N  +    G 
Sbjct: 117 SAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAREGA 172
Query: 188 KGTPGYSAPEFLS-GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSS 233
           K    ++APE ++ G++ I  K DV+SFG++L EIV   R    G S
Sbjct: 173 KFPIKWTAPEAINFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMS 217

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 157
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 158 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 216
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 217 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 256
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 257 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 296

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 112/211 (53%), Gaps = 13/211 (6%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L +++   A G+ Y+    +   +H 
Sbjct: 80  SEEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   KVADFGLA+L + N       G K    ++APE  L G + I  K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDN-EWTARQGAKFPIKWTAPEAALYGRFTI--K 192
Query: 209 CDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
            DV+SFG++L E+  + R    G  + E LD
Sbjct: 193 SDVWSFGILLTELTTKGRVPYPGMVNREVLD 223

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 167
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 168 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 226
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 227 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 266
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 267 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 229 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 268
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 140
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 141 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 199
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 200 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 239
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 240 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 112/212 (52%), Gaps = 13/212 (6%)
Query: 30  TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY  
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++ +  +V EYM  G L  +L G+  + +   +L ++A   A G+ Y+    +   +H
Sbjct: 82  VSEEPIY-IVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
            D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE  L G + I  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI-- 194
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVG--SSESLD 237
           K DV+SFG++L E+  + R    G  + E LD
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 229 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 268
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 229 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 268
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 229 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 268
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GNMSPEAFLQEAQVMKKLRHEKLVQLYAVV 249
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 250 SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
           D++  N+L+  N   KVADFGL +L + N  +    G K    ++APE  L G + I  K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTI--K 362
Query: 209 CDVYSFGMVLFEIVGRRR 226
            DV+SFG++L E+  + R
Sbjct: 363 SDVWSFGILLTELTTKGR 380

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL + L D   +  T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 229 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 268
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G+        + +A+K L           F+ E   +G+  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EYMENGSLD +L          +L  +  G + G+ YL +      +
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSD---MGYV 146
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    ++APE ++     T
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR-KFT 205
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+V++E+V               +  +  WE   +  + A      +EE  +
Sbjct: 206 SASDVWSYGIVMWEVVS--------------YGERPYWEMTNQDVIKA------VEEGYR 245
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
             +   C AAL+     C Q     RP    +V ML+ ++
Sbjct: 246 LPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 119/227 (52%), Gaps = 15/227 (6%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMA 70
           +KP    + ++   +     +LG G FGEV+   +    K+AVK +    G ++ E F+A
Sbjct: 175 QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLA 232
Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEI 127
           E   +    H  LV+L+     + +  ++ E+M  GSL  +L    G K+ +   KL + 
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDF 289
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
           +   A+G+ ++    Q+  IH D++  N+L+ A+   K+ADFGLA++ + N  +    G 
Sbjct: 290 SAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGA 345
Query: 188 KGTPGYSAPEFLS-GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSS 233
           K    ++APE ++ G++ I  K DV+SFG++L EIV   R    G S
Sbjct: 346 KFPIKWTAPEAINFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMS 390

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 32  LGFGGFGEVYKGQFPNGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV +G+     K    +A+K L          +F++E   +G+  H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G   +     ++ E+MENG+LD +L          +L  +  G A G+ YL E      +
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE---MSYV 138
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS---GYKGTPGYSAPEFLSGNYP 204
           H D+   N+L+++N   KV+DFGL++  + N S  T +   G K    ++APE ++    
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR-K 197
Query: 205 ITHKCDVYSFGMVLFEIV 222
            T   D +S+G+V++E++
Sbjct: 198 FTSASDAWSYGIVMWEVM 215

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G FGEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLC--DRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
            D+   N L+  N   KVADFGL++L   D   +H   +G K    ++APE L+ N   +
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH---AGAKFPIKWTAPESLAYN-KFS 188
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV++FG++L+EI      A  G S      P  V+E  EK         C       
Sbjct: 189 IKSDVWAFGVLLWEI------ATYGMSPYPGIDPSQVYELLEKDYRMERPEGC------P 236
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
           EK   L  A   C Q +P DRP  + + +  E + +
Sbjct: 237 EKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V E MENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGAV 169
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA-YRKFT 228
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 229 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 268
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V E MENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 140
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 141 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 199
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 200 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 239
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 240 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G  + P+  +I+V +    +G   +++  F+ E   +G+  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V E MENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYV 169
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL++ L D   +  T  G K    +++PE ++     T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFT 228
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+VL+E+              + +  +  WE   +  + A      ++E  +
Sbjct: 229 SASDVWSYGIVLWEV--------------MSYGERPYWEMSNQDVIKA------VDEGYR 268
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
                 C AAL+     C Q    +RP    +V +L+ ++
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 32  LGFGGFGEVYKGQFPNGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV +G+     K    +A+K L          +F++E   +G+  H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G   +     ++ E+MENG+LD +L          +L  +  G A G+ YL E      +
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE---MSYV 140
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS---GYKGTPGYSAPEFLSGNYP 204
           H D+   N+L+++N   KV+DFGL++  + N S  T +   G K    ++APE ++    
Sbjct: 141 HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK- 199
Query: 205 ITHKCDVYSFGMVLFEIV 222
            T   D +S+G+V++E++
Sbjct: 200 FTSASDAWSYGIVMWEVM 217

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 32  LGFGGFGEVYKGQF----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G  GEV  G+        V +A+K L           F++E   +G+  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G      +  +V EYMENGSLD +L          +L  +  G   G+ YL +      +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   NVL+D+N   KV+DFGL++ L D   +  T +G K    ++APE ++     +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFR-TFS 232
Query: 207 HKCDVYSFGMVLFEIVG 223
              DV+SFG+V++E++ 
Sbjct: 233 SASDVWSFGVVMWEVLA 249

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 32  LGFGGFGEVYKGQF----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G  GEV  G+        V +A+K L           F++E   +G+  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G      +  +V EYMENGSLD +L          +L  +  G   G+ YL +      +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   NVL+D+N   KV+DFGL++ L D   +  T +G K    ++APE ++     +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFS 232
Query: 207 HKCDVYSFGMVLFEIVG 223
              DV+SFG+V++E++ 
Sbjct: 233 SASDVWSFGVVMWEVLA 249

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 130/276 (47%), Gaps = 28/276 (10%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLC--DRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
            D+   N L+  N   KVADFGL++L   D   +H   +G K    ++APE L+ N   +
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH---AGAKFPIKWTAPESLAYN-KFS 188
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV++FG++L+EI      A  G S      P  V+E  EK         C       
Sbjct: 189 IKSDVWAFGVLLWEI------ATYGMSPYPGIDPSQVYELLEKDYRMERPEGC------P 236
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
           EK   L  A   C Q +P DRP  + + +  E + +
Sbjct: 237 EKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 24/275 (8%)
Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G+        + +A+K L           F++E   +G+  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         ++ EYMENGSLD +L          +L  +  G   G+ YL +      +
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSAV 153
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFG+++ L D   +  T  G K    ++APE ++     T
Sbjct: 154 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA-YRKFT 212
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+V++E++        G     D   + V +  E+       + C I     
Sbjct: 213 SASDVWSYGIVMWEVMS------YGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIA---- 262
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV 301
                L    L C Q    DRP    +V ML+ ++
Sbjct: 263 -----LHQLMLDCWQKERSDRPKFGQIVNMLDKLI 292

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + +    +G K    ++APE L+ N   + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TFTAHAGAKFPIKWTAPESLAYN-KFSIK 190
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI      A  G S      P  V+E  EK         C       EK
Sbjct: 191 SDVWAFGVLLWEI------ATYGMSPYPGIDPSQVYELLEKDYRMERPEGC------PEK 238
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 239 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 24/275 (8%)
Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G+        + +A+K L           F++E   +G+  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         ++ EYMENGSLD +L          +L  +  G   G+ YL +      +
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYV 138
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFG+++ L D   +  T  G K    ++APE ++     T
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA-YRKFT 197
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+V++E++        G     D   + V +  E+       + C I     
Sbjct: 198 SASDVWSYGIVMWEVMS------YGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIA---- 247
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV 301
                L    L C Q    DRP    +V ML+ ++
Sbjct: 248 -----LHQLMLDCWQKERSDRPKFGQIVNMLDKLI 277

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 24/275 (8%)
Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G+        + +A+K L           F++E   +G+  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         ++ EYMENGSLD +L          +L  +  G   G+ YL +      +
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYV 132
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFG+++ L D   +  T  G K    ++APE ++     T
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFT 191
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+V++E++        G     D   + V +  E+       + C I     
Sbjct: 192 SASDVWSYGIVMWEVMS------YGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIA---- 241
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV 301
                L    L C Q    DRP    +V ML+ ++
Sbjct: 242 -----LHQLMLDCWQKERSDRPKFGQIVNMLDKLI 271

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 99/194 (51%), Gaps = 10/194 (5%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRLYG 88
           LG G FG+V  G+    G K+AVK+LNR   R  +   +   E+  +    H ++++LY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
                    +V EY+  G L  Y+    R  E E    +      G+ Y H   +  ++H
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-RRLFQQILSGVDYCH---RHMVVH 139
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+KPENVLLDA+ + K+ADFGL+ +         +    G+P Y+APE +SG      +
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRXSCGSPNYAAPEVISGRLYAGPE 196
Query: 209 CDVYSFGMVLFEIV 222
            D++S G++L+ ++
Sbjct: 197 VDIWSSGVILYALL 210

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 197
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 245
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 246 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 116/227 (51%), Gaps = 25/227 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMA 70
           +KP    + ++   +     +LG G FGEV+   +    K+AVK +    G ++ E F+A
Sbjct: 169 QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLA 226
Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEI 127
           E   +    H  LV+L+     + +  ++ E+M  GSL  +L    G K+ +   KL + 
Sbjct: 227 EANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDF 283
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
           +   A+G+ ++    Q+  IH D++  N+L+ A+   K+ADFGLA++           G 
Sbjct: 284 SAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV-----------GA 329
Query: 188 KGTPGYSAPEFLS-GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSS 233
           K    ++APE ++ G++ I  K DV+SFG++L EIV   R    G S
Sbjct: 330 KFPIKWTAPEAINFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMS 374

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 197
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 245
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 246 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYN-KFSIK 193
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 194 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 241
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 242 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 241 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYN-KFSIK 194
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 242
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 243 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 241 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 138
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 196
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 244
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 245 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 275

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 147
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 205
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 206 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 253
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 254 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 284

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 136/274 (49%), Gaps = 16/274 (5%)
Query: 16  FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 75
           + S +++     +   LG G FG V  G++     +A+K++    G ++E++F+ E   +
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVM 73
Query: 76  GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 135
               H  LV+LYG C  Q    ++ EYM NG L  YL   +   + ++L E+     + +
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGY 193
            YL     ++ +H D+   N L++     KV+DFGL++  L D   S V   G K    +
Sbjct: 134 EYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV---GSKFPVRW 187
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEI--VGRRRNAIVGSSESLDWFPK--HVWEEYEK 249
           S PE L  +   + K D+++FG++++EI  +G+       +SE+ +   +   ++  +  
Sbjct: 188 SPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 246
Query: 250 SELDATIL-ACGIEEKDKEKAKRLCMAALWCVQD 282
           SE   TI+ +C  E+ D+    ++ ++ +  V D
Sbjct: 247 SEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 197
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 245
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 246 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 241 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 241 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 28/276 (10%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLC--DRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
            D+   N L+  N   KVADFGL++L   D   +H   +G K    ++APE L+ N   +
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH---AGAKFPIKWTAPESLAYN-KFS 191
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV++FG++L+EI     +   G   S       V+E  EK         C       
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------P 239
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
           EK   L  A   C Q +P DRP  + + +  E + +
Sbjct: 240 EKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 241 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 24/270 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 192
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 240
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
              L  A   C Q +P DRP  + + +  E
Sbjct: 241 VYELMRA---CWQWNPSDRPSFAEIHQAFE 267

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 130/258 (50%), Gaps = 16/258 (6%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 126
Query: 152 KPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
              N L++     KV+DFGL++  L D   S V   G K    +S PE L  +   + K 
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLMYS-KFSSKS 182
Query: 210 DVYSFGMVLFEI--VGRRRNAIVGSSESLDWFPK--HVWEEYEKSELDATIL-ACGIEEK 264
           D+++FG++++EI  +G+       +SE+ +   +   ++  +  SE   TI+ +C  E+ 
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 242
Query: 265 DKEKAKRLCMAALWCVQD 282
           D+    ++ ++ +  V D
Sbjct: 243 DERPTFKILLSNILDVMD 260

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 194
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 242
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 243 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 194
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 242
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 243 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 28/276 (10%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLC--DRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
            D+   N L+  N   KVADFGL++L   D   +H   +G K    ++APE L+ N   +
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH---AGAKFPIKWTAPESLAYN-KFS 195
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
            K DV++FG++L+EI     +   G   S       V+E  EK         C       
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------P 243
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
           EK   L  A   C Q +P DRP  + + +  E + +
Sbjct: 244 EKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 100/192 (52%), Gaps = 11/192 (5%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 130
Query: 152 KPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
              N L++     KV+DFGL++  L D   S V   G K    +S PE L  +   + K 
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLMYS-KFSSKS 186
Query: 210 DVYSFGMVLFEI 221
           D+++FG++++EI
Sbjct: 187 DIWAFGVLMWEI 198

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 197
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI     +   G   S       V+E  EK         C       EK
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPEGC------PEK 245
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 246 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G+        V +A+K L           F+ E   +G+  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V E+MENG+LD +L          +L  +  G A G+ YL +      +
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLAD---MGYV 167
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPIT 206
           H D+   N+L+++N   KV+DFGL+++ + +   V T +G K    ++APE +      T
Sbjct: 168 HRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR-KFT 226
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+S+G+V++E+              + +  +  W+   +  + A      IEE  +
Sbjct: 227 SASDVWSYGIVMWEV--------------MSYGERPYWDMSNQDVIKA------IEEGYR 266
Query: 267 EKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVV 301
             A   C A L      C Q    +RP    +V +L+ ++
Sbjct: 267 LPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 129/256 (50%), Gaps = 12/256 (4%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 152 KPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDV 211
              N L++     KV+DFGL++    +  + +  G K    +S PE L  +   + K D+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSRGSKFPVRWSPPEVLMYS-KFSSKSDI 189
Query: 212 YSFGMVLFEI--VGRRRNAIVGSSESLDWFPK--HVWEEYEKSELDATIL-ACGIEEKDK 266
           ++FG++++EI  +G+       +SE+ +   +   ++  +  SE   TI+ +C  E+ D+
Sbjct: 190 WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADE 249
Query: 267 EKAKRLCMAALWCVQD 282
               ++ ++ +  V D
Sbjct: 250 RPTFKILLSNILDVMD 265

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 130/258 (50%), Gaps = 16/258 (6%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 152 KPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
              N L++     KV+DFGL++  L D   S V   G K    +S PE L  +   + K 
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLMYS-KFSSKS 187
Query: 210 DVYSFGMVLFEI--VGRRRNAIVGSSESLDWFPK--HVWEEYEKSELDATIL-ACGIEEK 264
           D+++FG++++EI  +G+       +SE+ +   +   ++  +  SE   TI+ +C  E+ 
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 247
Query: 265 DKEKAKRLCMAALWCVQD 282
           D+    ++ ++ +  V D
Sbjct: 248 DERPTFKILLSNILDVMD 265

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 130/258 (50%), Gaps = 16/258 (6%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 152 KPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
              N L++     KV+DFGL++  L D   S V   G K    +S PE L  +   + K 
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLMYS-KFSSKS 202
Query: 210 DVYSFGMVLFEI--VGRRRNAIVGSSESLDWFPK--HVWEEYEKSELDATIL-ACGIEEK 264
           D+++FG++++EI  +G+       +SE+ +   +   ++  +  SE   TI+ +C  E+ 
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 262
Query: 265 DKEKAKRLCMAALWCVQD 282
           D+    ++ ++ +  V D
Sbjct: 263 DERPTFKILLSNILDVMD 280

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 28  YSTRLGFGGFGEVY-KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           +  +LG G FG+V+   +  +G++  +K +N++  ++  EQ  AE+  +    H N++++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYLHEECQ 143
           +    D H   +V E  E G L   +   +   +A+    + E+       L Y H    
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---S 142
Query: 144 QRIIHYDIKPENVLLD--ANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
           Q ++H D+KPEN+L    +  SP K+ DFGLA+L  ++  H T +   GT  Y APE   
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHSTNAA--GTALYMAPEVFK 199
Query: 201 GNYPITHKCDVYSFGMVLF 219
            +  +T KCD++S G+V++
Sbjct: 200 RD--VTFKCDIWSAGVVMY 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 130/258 (50%), Gaps = 16/258 (6%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 92  DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
            Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D+
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 137
Query: 152 KPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
              N L++     KV+DFGL++  L D   S V   G K    +S PE L  +   + K 
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLMYS-KFSSKS 193
Query: 210 DVYSFGMVLFEI--VGRRRNAIVGSSESLDWFPK--HVWEEYEKSELDATIL-ACGIEEK 264
           D+++FG++++EI  +G+       +SE+ +   +   ++  +  SE   TI+ +C  E+ 
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 253
Query: 265 DKEKAKRLCMAALWCVQD 282
           D+    ++ ++ +  V D
Sbjct: 254 DERPTFKILLSNILDVMD 271

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G         + +A+K L           F++E   +G+  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         ++ E+MENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYV 157
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS---GYKGTPGYSAPEFLSGNYP 204
           H D+   N+L+++N   KV+DFGL++  + + S  T +   G K    ++APE +     
Sbjct: 158 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-K 216
Query: 205 ITHKCDVYSFGMVLFEIVG 223
            T   DV+S+G+V++E++ 
Sbjct: 217 FTSASDVWSYGIVMWEVMS 235

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG+V  G+    G K+AVK+LNR   R  +   +   E+  +    H ++++LY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 89  FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
                    +V EY+  G L  Y+   G+   +E  +L +  +       Y H   +  +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---YCH---RHMV 132
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+KPENVLLDA+ + K+ADFGL+ +        T     G+P Y+APE +SG     
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAG 189
Query: 207 HKCDVYSFGMVLFEIV 222
            + D++S G++L+ ++
Sbjct: 190 PEVDIWSCGVILYALL 205

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG+V  G+    G K+AVK+LNR   R  +   +   E+  +    H ++++LY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 89  FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
                    +V EY+  G L  Y+   G+   +E  +L +  +       Y H   +  +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---YCH---RHMV 132
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+KPENVLLDA+ + K+ADFGL+ +         +    G+P Y+APE +SG     
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRDSCGSPNYAAPEVISGRLYAG 189
Query: 207 HKCDVYSFGMVLFEIV 222
            + D++S G++L+ ++
Sbjct: 190 PEVDIWSCGVILYALL 205

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G FG+VYK Q     V  A KV++        E +M E+  +    H N+V+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
           + ++   ++ E+   G++D  +   +R +   ++  +   T   L YLH+    +IIH D
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRD 160
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNYPIT 206
           +K  N+L   +   K+ADFG++      R+      + GTP + APE +    S + P  
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 207 HKCDVYSFGMVLFEI 221
           +K DV+S G+ L E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 105/198 (53%), Gaps = 12/198 (6%)
Query: 30  TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V K Q  P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 22  SELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 81
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L   KR I  E L +++I   +GL YL E+ Q  I+H
Sbjct: 82  AFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLREKHQ--IMH 138
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y APE L G +  + 
Sbjct: 139 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMAPERLQGTH-YSV 192
Query: 208 KCDVYSFGMVLFEI-VGR 224
           + D++S G+ L E+ VGR
Sbjct: 193 QSDIWSMGLSLVELAVGR 210

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G FG+VYK Q     V  A KV++        E +M E+  +    H N+V+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
           + ++   ++ E+   G++D  +   +R +   ++  +   T   L YLH+    +IIH D
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRD 160
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNYPIT 206
           +K  N+L   +   K+ADFG++      R       + GTP + APE +    S + P  
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 207 HKCDVYSFGMVLFEI 221
           +K DV+S G+ L E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            ++   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 399
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI      A  G S         V+E  EK         C       EK
Sbjct: 400 SDVWAFGVLLWEI------ATYGMSPYPGIDLSQVYELLEKDYRMERPEGC------PEK 447
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 448 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 478

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL    ++  IH
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 380
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            ++   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 438
Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI      A  G S         V+E  EK         C       EK
Sbjct: 439 SDVWAFGVLLWEI------ATYGMSPYPGIDLSQVYELLEKDYRMERPEGC------PEK 486
Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
              L  A   C Q +P DRP  + + +  E + +
Sbjct: 487 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQ 517

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    +V EYM  G+L  YL    R  +    L  +A   +  + YL    ++  IH
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIH 153
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-TFSIK 211
Query: 209 CDVYSFGMVLFEIV 222
            DV++FG++L+EI 
Sbjct: 212 SDVWAFGVLLWEIA 225

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 131/289 (45%), Gaps = 31/289 (10%)
Query: 30  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 74  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 133
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 134 AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 190
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 191 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 244
Query: 208 KCDVYSFGMVLFEI-VGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + D++S G+ L E+ VGR               P    +E E       +  C +E    
Sbjct: 245 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 286
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLDL 315
           E   R             + RPPM A+ ++L+ +V   PP  P     L
Sbjct: 287 ETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLPSAVFSL 334

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G FG+VYK Q     V  A KV++        E +M E+  +    H N+V+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
           + ++   ++ E+   G++D  +   +R +   ++  +   T   L YLH+    +IIH D
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRD 160
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNYPIT 206
           +K  N+L   +   K+ADFG++      R       + GTP + APE +    S + P  
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 207 HKCDVYSFGMVLFEI 221
           +K DV+S G+ L E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 31/283 (10%)
Query: 30  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 182
Query: 208 KCDVYSFGMVLFEI-VGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + D++S G+ L E+ VGR               P    +E E       +  C +E    
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 224
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKP 309
           E   R             + RPPM A+ ++L+ +V   PP  P
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLP 266

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 35  GGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH 94
           G FG V+K Q  N   +AVK+      +  + ++  EV ++    H N+++  G   ++ 
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGA--EKR 89
Query: 95  MTA------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC------ 142
            T+      L+  + E GSL  +L  K   + W +L  IA   A+GL YLHE+       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 143 -QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
            +  I H DIK +NVLL  N +  +ADFGLA   +  +S     G  GT  Y APE L G
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 202 NYPITH----KCDVYSFGMVLFEIVGR 224
                     + D+Y+ G+VL+E+  R
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 31/283 (10%)
Query: 30  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 182
Query: 208 KCDVYSFGMVLFEI-VGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + D++S G+ L E+ VGR               P    +E E       +  C +E    
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 224
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKP 309
           E   R             + RPPM A+ ++L+ +V   PP  P
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLP 266

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 31/283 (10%)
Query: 30  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 182
Query: 208 KCDVYSFGMVLFEI-VGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + D++S G+ L E+ VGR               P    +E E       +  C +E    
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 224
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKP 309
           E   R             + RPPM A+ ++L+ +V   PP  P
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLP 266

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 31/283 (10%)
Query: 30  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 182
Query: 208 KCDVYSFGMVLFEI-VGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + D++S G+ L E+ VGR               P    +E E       +  C +E    
Sbjct: 183 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 224
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKP 309
           E   R             + RPPM A+ ++L+ +V   PP  P
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLP 266

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 31/283 (10%)
Query: 30  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 155
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 209
Query: 208 KCDVYSFGMVLFEI-VGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + D++S G+ L E+ VGR               P    +E E       +  C +E    
Sbjct: 210 QSDIWSMGLSLVEMAVGRYP------------IPPPDAKELE------LMFGCQVEGDAA 251
Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKP 309
           E   R         +   + RPPM A+ ++L+ +V   PP  P
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPM-AIFELLDYIVNEPPPKLP 293

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G         + +A+K L           F++E   +G+  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         ++ E+MENGSLD +L          +L  +  G A G+ YL +      +
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYV 131
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS---GYKGTPGYSAPEFLSGNYP 204
           H  +   N+L+++N   KV+DFGL++  + + S  T +   G K    ++APE +     
Sbjct: 132 HRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-K 190
Query: 205 ITHKCDVYSFGMVLFEIVG 223
            T   DV+S+G+V++E++ 
Sbjct: 191 FTSASDVWSYGIVMWEVMS 209

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 19/198 (9%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++A+K++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-QQRIIH 148
              +    L+ EY   G +  YL    R  E E     A    + +V   + C Q+RI+H
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE-----ARSKFRQIVSAVQYCHQKRIVH 134
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG----YKGTPGYSAPEFLSGNYP 204
            D+K EN+LLDA+ + K+ADFG +       +  T+ G    + G+P Y+APE   G   
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 205 ITHKCDVYSFGMVLFEIV 222
              + DV+S G++L+ +V
Sbjct: 188 DGPEVDVWSLGVILYTLV 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAE----EQFMAEVGTIGRTYHINLVRLY 87
           +G G FG VY G++ +  +  ++   ++L RI E    E F+ E   +    H N++ L 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 88  G-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           G     + +  ++  YM +G L  ++   +R    + L    +  A+G+ YL E   Q+ 
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKF 145
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTP-GYSAPEFLSGNYP 204
           +H D+   N +LD +F+ KVADFGLA+ + DR    V    +   P  ++A E L   Y 
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ-TYR 204
Query: 205 ITHKCDVYSFGMVLFEIVGR 224
            T K DV+SFG++L+E++ R
Sbjct: 205 FTTKSDVWSFGVLLWELLTR 224

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLYG 88
           LG G FG+  K       ++ V    + L R  EE    F+ EV  +    H N+++  G
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVM---KELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +       + EY++ G+L G +        W +    A   A G+ YLH      IIH
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLC----------------DRNRSHVTISGYKGTPG 192
            D+   N L+  N +  VADFGLA+L                 DR + +  +    G P 
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV----GNPY 187
Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
           + APE ++G      K DV+SFG+VL EI+GR
Sbjct: 188 WMAPEMINGR-SYDEKVDVFSFGIVLCEIIGR 218

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++A+K++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRI 146
              +    L+ EY   G +  YL    R  E E   K  +I       + Y H   Q+RI
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCH---QKRI 135
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG----YKGTPGYSAPEFLSGN 202
           +H D+K EN+LLDA+ + K+ADFG +       +  T+ G    + G P Y+APE   G 
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 203 YPITHKCDVYSFGMVLFEIV 222
                + DV+S G++L+ +V
Sbjct: 189 KYDGPEVDVWSLGVILYTLV 208

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 127/295 (43%), Gaps = 41/295 (13%)
Query: 32  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V+  +  N       + +AVK L ++    A + F  E   +    H ++V+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRAIEWE----KLHEIAIG 130
            YG C D     +V+EYM++G L+ +L            G+ R  + E    ++  IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            A G+VYL     Q  +H D+   N L+ AN   K+ DFG+++    +  +  + G+   
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRVGGHTML 197
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS 250
           P    P         T + DV+SFG++L+EI                 + K  W +   +
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------YGKQPWFQLSNT 242
Query: 251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
           E+   I    + E+ +   K +    L C Q  P+ R  +  + K+L  + +  P
Sbjct: 243 EVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKATP 297

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 12/213 (5%)
Query: 30  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 15  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 75  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 131
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D   +      + GT  Y +PE L G +  + 
Sbjct: 132 RDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE-----FVGTRSYMSPERLQGTH-YSV 185
Query: 208 KCDVYSFGMVLFEI-VGRRRNAIVGSSESLDWF 239
           + D++S G+ L E+ VGR     +   E LD+ 
Sbjct: 186 QSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYI 218

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 28  YSTRLGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAE----EQFMAEVGTIGRTYH 80
           Y  ++G GGFG V+KG+     + V I   +L  + G        ++F  EV  +    H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            N+V+LYG  H+     +V E++  G L   L  K   I+W     + +  A G+ Y+  
Sbjct: 83  PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 141 ECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           +    I+H D++  N+ L     +A    KVADFGL++     +S  ++SG  G   + A
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMA 194
Query: 196 PEFLSG-NYPITHKCDVYSFGMVLFEIV 222
           PE +       T K D YSF M+L+ I+
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 13  PVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQ 67
           P  F       F+  Y  +  LG G FGEV   +    G + AVKV+++     +  +E 
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 68  FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 127
            + EV  + +  H N+++LY F  D+    LV E    G L   +  +KR  E +    I
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-I 131
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNRSHV 182
                 G+ Y+H   + +I+H D+KPEN+LL     DAN   ++ DFGL+   + ++   
Sbjct: 132 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKK-- 184
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
            +    GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 185 -MKDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILY 218

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V+KG + P G    + + +KV+    GR + +     +  IG   H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C    +  LV +Y+  GSL  ++   + A+  + L    +  AKG+ YL E     +
Sbjct: 99  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGM 154
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPI 205
           +H ++   NVLL +    +VADFG+A L   +   +  S  K    + A E +  G Y  
Sbjct: 155 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY-- 212
Query: 206 THKCDVYSFGMVLFEIV 222
           TH+ DV+S+G+ ++E++
Sbjct: 213 THQSDVWSYGVTVWELM 229

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 30  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 182
Query: 208 KCDVYSFGMVLFEI-VGR 224
           + D++S G+ L E+ VGR
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLYG 88
           LG G FG+V        G K+A+K++N+ +   ++ Q     E+  +    H ++++LY 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RII 147
               +    +V EY  N   D Y+  + +  E E     A    + ++   E C + +I+
Sbjct: 82  VIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQE-----ARRFFQQIISAVEYCHRHKIV 135
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+KPEN+LLD + + K+ADFGL+  + D N    +     G+P Y+APE +SG     
Sbjct: 136 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKLYAG 191
Query: 207 HKCDVYSFGMVLFEIVGRR 225
            + DV+S G++L+ ++ RR
Sbjct: 192 PEVDVWSCGVILYVMLCRR 210

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 13  PVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQ 67
           P  F       F+  Y  +  LG G FGEV   +    G + AVKV+++     +  +E 
Sbjct: 19  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 78
Query: 68  FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 127
            + EV  + +  H N+++LY F  D+    LV E    G L   +  +KR  E +    I
Sbjct: 79  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-I 137
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNRSHV 182
                 G+ Y+H   + +I+H D+KPEN+LL     DAN   ++ DFGL+   + ++   
Sbjct: 138 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKK-- 190
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
            +    GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 191 -MKDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILY 224

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLYG 88
           LG G FG+V        G K+A+K++N+ +   ++ Q     E+  +    H ++++LY 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RII 147
               +    +V EY  N   D Y+  + +  E E     A    + ++   E C + +I+
Sbjct: 72  VIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQE-----ARRFFQQIISAVEYCHRHKIV 125
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+KPEN+LLD + + K+ADFGL+  + D N    +     G+P Y+APE +SG     
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKLYAG 181
Query: 207 HKCDVYSFGMVLFEIVGRR 225
            + DV+S G++L+ ++ RR
Sbjct: 182 PEVDVWSCGVILYVMLCRR 200

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLYG 88
           LG G FG+V        G K+A+K++N+ +   ++ Q     E+  +    H ++++LY 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RII 147
               +    +V EY  N   D Y+  + +  E E     A    + ++   E C + +I+
Sbjct: 81  VIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQE-----ARRFFQQIISAVEYCHRHKIV 134
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+KPEN+LLD + + K+ADFGL+  + D N    +     G+P Y+APE +SG     
Sbjct: 135 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKLYAG 190
Query: 207 HKCDVYSFGMVLFEIVGRR 225
            + DV+S G++L+ ++ RR
Sbjct: 191 PEVDVWSCGVILYVMLCRR 209

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V+KG + P G    + + +KV+    GR + +     +  IG   H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C    +  LV +Y+  GSL  ++   + A+  + L    +  AKG+ YL E     +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGM 136
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPI 205
           +H ++   NVLL +    +VADFG+A L   +   +  S  K    + A E +  G Y  
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY-- 194
Query: 206 THKCDVYSFGMVLFEIV 222
           TH+ DV+S+G+ ++E++
Sbjct: 195 THQSDVWSYGVTVWELM 211

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLYG 88
           LG G FG+V        G K+A+K++N+ +   ++ Q     E+  +    H ++++LY 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RII 147
               +    +V EY  N   D Y+  + +  E E     A    + ++   E C + +I+
Sbjct: 76  VIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQE-----ARRFFQQIISAVEYCHRHKIV 129
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           H D+KPEN+LLD + + K+ADFGL+  + D N    +     G+P Y+APE +SG     
Sbjct: 130 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKLYAG 185
Query: 207 HKCDVYSFGMVLFEIVGRR 225
            + DV+S G++L+ ++ RR
Sbjct: 186 PEVDVWSCGVILYVMLCRR 204

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 27  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 83
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 144 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 201 KWMALESLQ-TQKFTTKSDVWSFGVLLWELMTR 232

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 13  PVRFTSLQLNNFTSNYSTR--LGFGGFGEVY--KGQFPNGVKIAVKVLNRNL--GRIAEE 66
           P  F       F+  Y  +  LG G FGEV   K +   G + AVKV+++     +  +E
Sbjct: 36  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKE 94
Query: 67  QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 126
             + EV  + +  H N+++LY F  D+    LV E    G L   +  +KR  E +    
Sbjct: 95  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 153
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNRSH 181
           I      G+ Y+H   + +I+H D+KPEN+LL     DAN   ++ DFGL+   + ++  
Sbjct: 154 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKK- 207
Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
             +    GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 208 --MKDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILY 241

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +  VYKG     GV +A+K +  +         + E+  +    H N+VRLY  
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 90  CHDQHMTALVYEYMENG---SLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
            H ++   LV+E+M+N     +D    G   R +E   +        +GL + HE    +
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NK 128
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I+H D+KP+N+L++     K+ DFGLA+      +  T S    T  Y AP+ L G+   
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTY 186
Query: 206 THKCDVYSFGMVLFEIV 222
           +   D++S G +L E++
Sbjct: 187 STSIDIWSCGCILAEMI 203

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 13  PVRFTSLQLNNFTSNYSTR--LGFGGFGEVY--KGQFPNGVKIAVKVLNRNL--GRIAEE 66
           P  F       F+  Y  +  LG G FGEV   K +   G + AVKV+++     +  +E
Sbjct: 37  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKE 95
Query: 67  QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 126
             + EV  + +  H N+++LY F  D+    LV E    G L   +  +KR  E +    
Sbjct: 96  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 154
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNRSH 181
           I      G+ Y+H   + +I+H D+KPEN+LL     DAN   ++ DFGL+   + ++  
Sbjct: 155 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKK- 208
Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
             +    GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 209 --MKDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILY 242

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 31  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 84
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 130
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNY 203
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK-TR 189
Query: 204 PITHKCDVYSFGMVLFEI 221
             +H  D + FG+ L+E+
Sbjct: 190 TFSHASDTWMFGVTLWEM 207

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++AVK++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 148
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+K EN+LLDA+ + K+ADFG +           +  + G P Y+APE   G      +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 209 CDVYSFGMVLFEIVG 223
            DV+S G++L+ +V 
Sbjct: 194 VDVWSLGVILYTLVS 208

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQFMAE--VGTIGRTYHINLVRLYG 88
           LG G FG+V     +    K+A+K ++R L + ++     E  +  +    H ++++LY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE--KLHEIAIGTAKGLVYLHEECQQRI 146
                    +V EY   G L  Y+  KKR  E E  +  +  I   +   Y H   + +I
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIE---YCH---RHKI 129
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +H D+KPEN+LLD N + K+ADFGL+  + D N    +     G+P Y+APE ++G    
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGKLYA 185
Query: 206 THKCDVYSFGMVLF-EIVGR 224
             + DV+S G+VL+  +VGR
Sbjct: 186 GPEVDVWSCGIVLYVMLVGR 205

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 31  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 84
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 140
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNY 203
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK-TR 199
Query: 204 PITHKCDVYSFGMVLFEI 221
             +H  D + FG+ L+E+
Sbjct: 200 TFSHASDTWMFGVTLWEM 217

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR-IAE--EQFMAEVGTIGRTYHINLVRLYG 88
           +G GGFG+VY+  F  G ++AVK    +    I++  E    E        H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
            C  +    LV E+   G L+  L GK+  I  + L   A+  A+G+ YLH+E    IIH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 149 YDIKPENVLL--------DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
            D+K  N+L+         +N   K+ DFGLA+   R         Y     + APE + 
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAY----AWMAPEVIR 187
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
            +   +   DV+S+G++L+E++
Sbjct: 188 ASM-FSKGSDVWSYGVLLWELL 208

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++AVK++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 148
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+K EN+LLDA+ + K+ADFG +           +  + G+P Y+APE   G      +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 209 CDVYSFGMVLFEIVG 223
            DV+S G++L+ +V 
Sbjct: 194 VDVWSLGVILYTLVS 208

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++AVK++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 148
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+K EN+LLDA+ + K+ADFG + +    N+    +  + G+P Y+APE   G      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYDGP 192
Query: 208 KCDVYSFGMVLFEIVG 223
           + DV+S G++L+ +V 
Sbjct: 193 EVDVWSLGVILYTLVS 208

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 31  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 84
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 79  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 134
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNY 203
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TR 193
Query: 204 PITHKCDVYSFGMVLFEI 221
             +H  D + FG+ L+E+
Sbjct: 194 TFSHASDTWMFGVTLWEM 211

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 30  TRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           + LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG
Sbjct: 31  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     ++  E+M+ GSLD  L    R I  + L +++I   KGL YL E  + +I+H
Sbjct: 91  AFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 147
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+L+++    K+ DFG++ +L D        + + GT  Y +PE L G +  + 
Sbjct: 148 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 201
Query: 208 KCDVYSFGMVLFEI-VGR 224
           + D++S G+ L E+ VGR
Sbjct: 202 QSDIWSMGLSLVEMAVGR 219

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 31  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 84
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 130
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNY 203
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TR 189
Query: 204 PITHKCDVYSFGMVLFEI 221
             +H  D + FG+ L+E+
Sbjct: 190 TFSHASDTWMFGVTLWEM 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 31  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 84
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 130
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNY 203
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TR 189
Query: 204 PITHKCDVYSFGMVLFEI 221
             +H  D + FG+ L+E+
Sbjct: 190 TFSHASDTWMFGVTLWEM 207

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 31  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 84
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 134
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNY 203
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TR 193
Query: 204 PITHKCDVYSFGMVLFEI 221
             +H  D + FG+ L+E+
Sbjct: 194 TFSHASDTWMFGVTLWEM 211

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 31  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 84
           +LG G FG V +G++  P+G  V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 140
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNY 203
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P  + APE L    
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TR 199
Query: 204 PITHKCDVYSFGMVLFEI 221
             +H  D + FG+ L+E+
Sbjct: 200 TFSHASDTWMFGVTLWEM 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 104/200 (52%), Gaps = 21/200 (10%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-----FMAEVGTIGRTYHINLVR 85
           ++G G +G VYK +   G  +A+K +  +    AE++      + E+  +   +H N+V 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLD----AEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L    H +    LV+E+ME   L   L   K  ++  ++        +G+ + H   Q R
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHR 139
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           I+H D+KP+N+L++++ + K+ADFGLA+   +  R+ +H  ++ +     Y AP+ L G+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW-----YRAPDVLMGS 194
Query: 203 YPITHKCDVYSFGMVLFEIV 222
              +   D++S G +  E++
Sbjct: 195 KKYSTSVDIWSIGCIFAEMI 214

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 104/200 (52%), Gaps = 21/200 (10%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ-----FMAEVGTIGRTYHINLVR 85
           ++G G +G VYK +   G  +A+K +  +    AE++      + E+  +   +H N+V 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLD----AEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L    H +    LV+E+ME   L   L   K  ++  ++        +G+ + H   Q R
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHR 139
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           I+H D+KP+N+L++++ + K+ADFGLA+   +  R+ +H  ++ +     Y AP+ L G+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW-----YRAPDVLMGS 194
Query: 203 YPITHKCDVYSFGMVLFEIV 222
              +   D++S G +  E++
Sbjct: 195 KKYSTSVDIWSIGCIFAEMI 214

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 20  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 76
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 77  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 136
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 137 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 194 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 225

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 47  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 103
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 104 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 163
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 164 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 220
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 221 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 252

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 25  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 81
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 141
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 142 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 199 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 230

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 28  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 84
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 145 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 202 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 233

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 28  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 84
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 145 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 202 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 233

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 46  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 102
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 103 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 162
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 163 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 219
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 220 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 251

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 27  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 83
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 144 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 201 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 232

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++AV+++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 148
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+K EN+LLDA+ + K+ADFG + +    N+    +  + G+P Y+APE   G      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYDGP 192
Query: 208 KCDVYSFGMVLFEIVG 223
           + DV+S G++L+ +V 
Sbjct: 193 EVDVWSLGVILYTLVS 208

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 23  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 79
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 140 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 197 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 228

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 26  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 82
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ YL     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 143 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 200 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 231

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 28  YSTRLGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAE----EQFMAEVGTIGRTYH 80
           Y  ++G GGFG V+KG+     + V I   +L  + G        ++F  EV  +    H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            N+V+LYG  H+     +V E++  G L   L  K   I+W     + +  A G+ Y+  
Sbjct: 83  PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 141 ECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           +    I+H D++  N+ L     +A    KVADF L++     +S  ++SG  G   + A
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMA 194
Query: 196 PEFLSG-NYPITHKCDVYSFGMVLFEIV 222
           PE +       T K D YSF M+L+ I+
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 95/193 (49%), Gaps = 14/193 (7%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           LG G FGEV K +      + AVKV+N+   +  +    + EV  + +  H N+++L+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             D     +V E    G L   +  +KR  E +    I      G+ Y+H   +  I+H 
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMH---KHNIVHR 145
Query: 150 DIKPENVLLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           D+KPEN+LL++   +   K+ DFGL+    +N     +    GT  Y APE L G Y   
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRGTYD-- 200
Query: 207 HKCDVYSFGMVLF 219
            KCDV+S G++L+
Sbjct: 201 EKCDVWSAGVILY 213

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 28  YSTRLGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAE----EQFMAEVGTIGRTYH 80
           Y  ++G GGFG V+KG+     + V I   +L  + G        ++F  EV  +    H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            N+V+LYG  H+     +V E++  G L   L  K   I+W     + +  A G+ Y+  
Sbjct: 83  PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 141 ECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           +    I+H D++  N+ L     +A    KVADFG ++     +S  ++SG  G   + A
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMA 194
Query: 196 PEFLSG-NYPITHKCDVYSFGMVLFEIV 222
           PE +       T K D YSF M+L+ I+
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 29  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 85
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ +L     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 146 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 203 KWMALESLQ-TQKFTTKSDVWSFGVLLWELMTR 234

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 103
Query: 92  DQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 142
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 143 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPE 197
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 198 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGSSE 234
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 261

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 64
Query: 92  DQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 142
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 143 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPE 197
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 198 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGSSE 234
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 222

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++AV+++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 148
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+K EN+LLDA+ + K+ADFG +           +  + G+P Y+APE   G      +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 209 CDVYSFGMVLFEIVG 223
            DV+S G++L+ +V 
Sbjct: 194 VDVWSLGVILYTLVS 208

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 65
Query: 92  DQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 142
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 143 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPE 197
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 198 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGSSE 234
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 223

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 90
Query: 92  DQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 142
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 143 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPE 197
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 198 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGSSE 234
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 209 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 248

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 67
Query: 92  DQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 142
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 143 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPE 197
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 198 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGSSE 234
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 225

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG--VEHQLRREVEIQSHLRHPNILRL 77
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L    R  E ++        A  L Y H    +R+
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE-QRTATYITELANALSYCH---SKRV 133
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +N   K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMIEGRMH-D 188
Query: 207 HKCDVYSFGMVLFEIV 222
            K D++S G++ +E +
Sbjct: 189 EKVDLWSLGVLCYEFL 204

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 27  NYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLV 84
           N    LG G FGEV K +      + AVKV+N+   +  +    + EV  + +  H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +L+    D     +V E    G L   +  +KR  E +    I      G+ Y+H   + 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMH---KH 140
Query: 145 RIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
            I+H D+KPEN+LL++   +   K+ DFGL+    +N     +    GT  Y APE L G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG 197
Query: 202 NYPITHKCDVYSFGMVLF 219
            Y    KCDV+S G++L+
Sbjct: 198 TYD--EKCDVWSAGVILY 213

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           +G G FGEV++G++  G ++AVK+ +       EE+       I +T  +    + GF  
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA 70
Query: 92  DQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 142
             +          LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E   
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 143 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPE 197
              +  I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 198 FLSGNYPITH-----KCDVYSFGMVLFEIVGRRRNAIVGSSE 234
            L  +  + H     + D+Y+ G+V +EI   RR +I G  E
Sbjct: 189 VLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHE 228

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 32  LGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG V +G +      + +A+KVL +   +   E+ M E   + +  +  +VRL G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
            C  + +  LV E    G L  +L GK+  I    + E+    + G+ YL E   +  +H
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 133
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI-SGYKGTPGYSAPEFLSGNYPITH 207
            D+   NVLL      K++DFGL+K    + S+ T  S  K    + APE ++     + 
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSS 192
Query: 208 KCDVYSFGMVLFEIVG 223
           + DV+S+G+ ++E + 
Sbjct: 193 RSDVWSYGVTMWEALS 208

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 32  LGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG+V    +       G  +AVK L  + G      +  E+  +   YH ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 87  YGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            G C DQ   +L  V EY+  GSL  YL   + +I   +L   A    +G+ YLH    Q
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFLSGNY 203
             IH ++   NVLLD +   K+ DFGLAK       +  +     +P +  APE L   Y
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK-EY 195
Query: 204 PITHKCDVYSFGMVLFEIV 222
              +  DV+SFG+ L+E++
Sbjct: 196 KFYYASDVWSFGVTLYELL 214

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 27  NYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLV 84
           N    LG G FGEV K +      + AVKV+N+   +  +    + EV  + +  H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +L+    D     +V E    G L   +  +KR  E +    I      G+ Y+H   + 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMH---KH 140
Query: 145 RIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
            I+H D+KPEN+LL++   +   K+ DFGL+    +N     +    GT  Y APE L G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG 197
Query: 202 NYPITHKCDVYSFGMVLF 219
            Y    KCDV+S G++L+
Sbjct: 198 TYD--EKCDVWSAGVILY 213

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG--VEHQLRREVEIQSHLRHPNILRL 77
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L    R  E ++        A  L Y H    +R+
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE-QRTATYITELANALSYCH---SKRV 133
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +N   K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 188
Query: 207 HKCDVYSFGMVLFEIV 222
            K D++S G++ +E +
Sbjct: 189 EKVDLWSLGVLCYEFL 204

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 9/203 (4%)
Query: 21  LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 79
           LN+       ++G G FGEV+ G+   +   +AVK     L    + +F+ E   + +  
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+VRL G C  +    +V E ++ G    +L  +   +  + L ++    A G+ YL 
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEF 198
            +C    IH D+   N L+      K++DFG+++  + +  +    G +  P  ++APE 
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAPEA 286
Query: 199 LS-GNYPITHKCDVYSFGMVLFE 220
           L+ G Y  + + DV+SFG++L+E
Sbjct: 287 LNYGRY--SSESDVWSFGILLWE 307

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++AVK++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 148
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-----ARAKFRQIVSAVQYCHQKYIVH 137
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV--TISGYKGTPGYSAPEFLSGNYPIT 206
            D+K EN+LLD + + K+ADFG +     N   V   +  + G+P Y+APE   G     
Sbjct: 138 RDLKAENLLLDGDMNIKIADFGFS-----NEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 192
Query: 207 HKCDVYSFGMVLFEIVG 223
            + DV+S G++L+ +V 
Sbjct: 193 PEVDVWSLGVILYTLVS 209

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 11/194 (5%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++AVK++++  L   + ++   EV       H N+V+L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 148
              +    LV EY   G +  YL    R  E E     A    + +V   + C Q+ I+H
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKE-----ARAKFRQIVSAVQYCHQKFIVH 136
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+K EN+LLDA+ + K+ADFG +           +  + G P Y+APE   G      +
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 209 CDVYSFGMVLFEIV 222
            DV+S G++L+ +V
Sbjct: 194 VDVWSLGVILYTLV 207

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++AVK++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 148
              +    LV EY   G +  YL     A  W K  E A    + +V   + C Q+ I+H
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLV----AHGWMKEKE-ARAKFRQIVSAVQYCHQKFIVH 129
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+K EN+LLDA+ + K+ADFG +           +  + G+P Y+APE   G      +
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 209 CDVYSFGMVLFEIVG 223
            DV+S G++L+ +V 
Sbjct: 187 VDVWSLGVILYTLVS 201

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P+G    + +A+KVL  N    A ++ + E   +       + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       LV + M  G L  ++   +  +  + L    +  AKG+ YL +    R+
Sbjct: 85  LGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED---VRL 140
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+ +    K+ DFGLA+L D + +     G K    + A E +      T
Sbjct: 141 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR-FT 199
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 17/208 (8%)
Query: 27  NYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTIGRTY- 79
           +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I + + 
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GIIMKDFS 87
Query: 80  HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
           H N++ L G C     + LV   YM++G L  ++  +      + L    +  AKG+ +L
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 147
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTPGYSAP 196
                ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K    + A 
Sbjct: 148 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIVGR 224
           E L      T K DV+SFG++L+E++ R
Sbjct: 205 ESLQTQ-KFTTKSDVWSFGVLLWELMTR 231

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 13  PVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQ 67
           P  F       F+  Y  +  LG G FGEV   +    G + AVKV+++     +  +E 
Sbjct: 13  PGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 68  FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 127
            + EV  + +  H N+ +LY F  D+    LV E    G L   +  +KR  E +    I
Sbjct: 73  LLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-I 131
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNRSHV 182
                 G+ Y H   + +I+H D+KPEN+LL     DAN   ++ DFGL+   + ++   
Sbjct: 132 IRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKKX- 185
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
                 GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 186 --KDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILY 218

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 28  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 84
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ +L     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 145 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 202 KWMALESLQTQ-KFTTKSDVWSFGVLLWELMTR 233

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 17/208 (8%)
Query: 27  NYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTIGRTY- 79
           +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I + + 
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GIIMKDFS 90
Query: 80  HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
           H N++ L G C     + LV   YM++G L  ++  +      + L    +  AKG+ +L
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTPGYSAP 196
                ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K    + A 
Sbjct: 151 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIVGR 224
           E L      T K DV+SFG++L+E++ R
Sbjct: 208 ESLQTQ-KFTTKSDVWSFGVLLWELMTR 234

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 30/288 (10%)
Query: 27  NYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 81
            Y ++LG G FG V   ++       G  +AVK L  + G   +  F  E+  +   +  
Sbjct: 13  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSD 71
Query: 82  NLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
            +V+  G  +   +    LV EY+ +G L  +L   +  ++  +L   +    KG+ YL 
Sbjct: 72  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 131
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEF 198
               +R +H D+   N+L+++    K+ADFGLAKL   ++ +  +     +P +  APE 
Sbjct: 132 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 199 LSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA 258
           LS N   + + DV+SFG+VL+E+      +   S+E L             SE D   L+
Sbjct: 189 LSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM---------GSERDVPALS 238
Query: 259 ---CGIEEKDKEKAKRLCMAAL-----WCVQDSPEDRPPMSAVVKMLE 298
                +EE  +  A   C A +      C   SP+DRP  SA+   L+
Sbjct: 239 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 286

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 32  LGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG+V    +       G  +AVK L  + G      +  E+  +   YH ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 87  YGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            G C DQ   +L  V EY+  GSL  YL   + +I   +L   A    +G+ YLH    Q
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFLSGNY 203
             IH ++   NVLLD +   K+ DFGLAK       +  +     +P +  APE L   Y
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK-EY 195
Query: 204 PITHKCDVYSFGMVLFEIV 222
              +  DV+SFG+ L+E++
Sbjct: 196 KFYYASDVWSFGVTLYELL 214

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 17/208 (8%)
Query: 27  NYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTIGRTY- 79
           +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I + + 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GIIMKDFS 89
Query: 80  HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
           H N++ L G C     + LV   YM++G L  ++  +      + L    +  AKG+ +L
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTPGYSAP 196
                ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K    + A 
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIVGR 224
           E L      T K DV+SFG++L+E++ R
Sbjct: 207 ESLQTQ-KFTTKSDVWSFGVLLWELMTR 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 17/213 (7%)
Query: 22  NNFTSNYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTI 75
           ++   +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I
Sbjct: 87  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GII 143
Query: 76  GRTY-HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
            + + H N++ L G C     + LV   YM++G L  ++  +      + L    +  AK
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTP 191
           G+ +L     ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K   
Sbjct: 204 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
            + A E L      T K DV+SFG++L+E++ R
Sbjct: 261 KWMALESLQ-TQKFTTKSDVWSFGVLLWELMTR 292

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 17/208 (8%)
Query: 27  NYSTRLGFGGFGEVYKGQF--PNGVKI--AVKVLNR--NLGRIAEEQFMAEVGTIGRTY- 79
           +++  +G G FG VY G     +G KI  AVK LNR  ++G ++  QF+ E G I + + 
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTE-GIIMKDFS 94
Query: 80  HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
           H N++ L G C     + LV   YM++G L  ++  +      + L    +  AKG+ +L
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 154
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTPGYSAP 196
                ++ +H D+   N +LD  F+ KVADFGLA+ + D+    V   +G K    + A 
Sbjct: 155 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIVGR 224
           E L      T K DV+SFG++L+E++ R
Sbjct: 212 ESLQTQ-KFTTKSDVWSFGVLLWELMTR 238

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 21  LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 79
           LN+       ++G G FGEV+ G+   +   +AVK     L    + +F+ E   + +  
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+VRL G C  +    +V E ++ G    +L  +   +  + L ++    A G+ YL 
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEF 198
            +C    IH D+   N L+      K++DFG+++  + +       G +  P  ++APE 
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVXAASGGLRQVPVKWTAPEA 286
Query: 199 LS-GNYPITHKCDVYSFGMVLFE 220
           L+ G Y  + + DV+SFG++L+E
Sbjct: 287 LNYGRY--SSESDVWSFGILLWE 307

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 74
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 130
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R   T+S   GT  Y  PE + G     
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSCHAPSSR-RTTLS---GTLDYLPPEMIEGRMH-D 185
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 19/227 (8%)
Query: 8   IGREKPVRFTSLQLNNFTSNYSTR---LGFGGFGEV----YKGQFPN-GVKIAVKVLNRN 59
           +  +KP   T +   +F   +  R   LG G FG+V    Y  +  N G ++AVK L   
Sbjct: 4   VSEKKPA--TEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE 61
Query: 60  LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMTALVYEYMENGSLDGYLFGKKR 117
            G         E+  +   YH N+V+  G C +   +   L+ E++ +GSL  YL   K 
Sbjct: 62  SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 118 AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177
            I  ++  + A+   KG+ YL     ++ +H D+   NVL+++    K+ DFGL K  + 
Sbjct: 122 KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 178 NRSHVTISGYKGTPGY-SAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
           ++   T+   + +P +  APE  +   + I    DV+SFG+ L E++
Sbjct: 179 DKEXXTVKDDRDSPVFWYAPECLMQSKFYIA--SDVWSFGVTLHELL 223

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 78
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G +   L  K    + ++        A  L Y H    +R+
Sbjct: 79  YGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYCH---SKRV 134
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 189
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 190 EKVDLWSLGVLCYEFLVGK 208

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 32  LGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG+V    +       G  +AVK L  + G      +  E+  +   YH ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 87  YGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            G C D    +L  V EY+  GSL  YL   + +I   +L   A    +G+ YLH    Q
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFLSGNY 203
             IH D+   NVLLD +   K+ DFGLAK          +     +P +  APE L   Y
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK-EY 212
Query: 204 PITHKCDVYSFGMVLFEIV 222
              +  DV+SFG+ L+E++
Sbjct: 213 KFYYASDVWSFGVTLYELL 231

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 78
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G +   L  K    + ++        A  L Y H    +R+
Sbjct: 79  YGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYCH---SKRV 134
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPEMIEGRMH-D 189
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 190 EKVDLWSLGVLCYEFLVGK 208

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 110/246 (44%), Gaps = 30/246 (12%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 88
           LGFGG  EV+  +   +   +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 89  FCHDQH----MTALVYEYMENGSLDGYLFGK-----KRAIEWEKLHEIAIGTAKGLVYLH 139
               +     +  +V EY++  +L   +  +     KRAIE      +     + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 133
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEF 198
              Q  IIH D+KP N+++ A  + KV DFG+A+ + D   S    +   GT  Y +PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 199 LSGNYPITHKCDVYSFGMVLFEIV-------GRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
             G+  +  + DVYS G VL+E++       G   +++       D  P     E   ++
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSAD 249
Query: 252 LDATIL 257
           LDA +L
Sbjct: 250 LDAVVL 255

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 74
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 130
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMIEGRMH-D 185
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 31  RLGFGGFGEVYKGQFPNG-VKIAVKVL-------------NRNLGRIAEEQFMAEVGTIG 76
           +LG G +GEV   +  NG  + A+KV+             N+N+ +  EE +  E+  + 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY-NEISLLK 101
Query: 77  RTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLV 136
              H N+++L+    D+    LV E+ E G L   +  + +  E +  + I      G+ 
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN-IMKQILSGIC 160
Query: 137 YLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           YLH   +  I+H DIKPEN+LL+      + K+ DFGL+    ++     +    GT  Y
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYY 214
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLF 219
            APE L   Y    KCDV+S G++++
Sbjct: 215 IAPEVLKKKY--NEKCDVWSCGVIMY 238

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 90
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 91  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 146
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 147 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 201
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 202 EKVDLWSLGVLCYEFLVGK 220

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R     +   GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMH-D 184
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 187
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 99
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 155
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRM-HD 210
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 211 EKVDLWSLGVLCYEFLVGK 229

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 214
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 215 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 257
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 258 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 74
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 130
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R     +   GT  Y  PE + G     
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-D 185
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 32  LGFGGFGEV----YKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG+V    Y  +  N G ++AVK L    G         E+  +   YH N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 87  YGFCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            G C +   +   L+ E++ +GSL  YL   K  I  ++  + A+   KG+ YL     +
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPE-FLSGN 202
           + +H D+   NVL+++    K+ DFGL K  + ++   T+   + +P +  APE  +   
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 203 YPITHKCDVYSFGMVLFEIV 222
           + I    DV+SFG+ L E++
Sbjct: 194 FYIA--SDVWSFGVTLHELL 211

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R     +   GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-D 184
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R     +   GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMH-D 187
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R     +   GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-D 184
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 78
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 134
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 189
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 190 EKVDLWSLGVLCYEFLVGK 208

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 35  GGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF----C 90
           G FG V+K Q  N   +AVK+    L      Q   E+ +     H NL++         
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFP--LQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-------- 142
           + +    L+  + + GSL  YL G    I W +L  +A   ++GL YLHE+         
Sbjct: 83  NLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRGEGH 140
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           +  I H D K +NVLL ++ +  +ADFGLA   +  +      G  GT  Y APE L G 
Sbjct: 141 KPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGA 200
Query: 203 YPITH----KCDVYSFGMVLFEIVGRRRNA 228
                    + D+Y+ G+VL+E+V R + A
Sbjct: 201 INFQRDAFLRIDMYAMGLVLWELVSRCKAA 230

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 32  LGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG V +G +      + +A+KVL +   +   E+ M E   + +  +  +VRL G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
            C  + +  LV E    G L  +L GK+  I    + E+    + G+ YL E   +  +H
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 459
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI-SGYKGTPGYSAPEFLSGNYPITH 207
            ++   NVLL      K++DFGL+K    + S+ T  S  K    + APE ++     + 
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSS 518
Query: 208 KCDVYSFGMVLFEIVG 223
           + DV+S+G+ ++E + 
Sbjct: 519 RSDVWSYGVTMWEALS 534

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 72
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 73  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 128
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 129 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 183
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 184 EKVDLWSLGVLCYEFLVGK 202

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 30/288 (10%)
Query: 27  NYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 81
            Y ++LG G FG V   ++       G  +AVK L  + G   +  F  E+  +   +  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSD 84
Query: 82  NLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
            +V+  G  +   +    LV EY+ +G L  +L   +  ++  +L   +    KG+ YL 
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEF 198
               +R +H D+   N+L+++    K+ADFGLAKL   ++ +  +     +P +  APE 
Sbjct: 145 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 199 LSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA 258
           LS N   + + DV+SFG+VL+E+      +   S+E L              E D   L+
Sbjct: 202 LSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM---------GCERDVPALS 251
Query: 259 ---CGIEEKDKEKAKRLCMAAL-----WCVQDSPEDRPPMSAVVKMLE 298
                +EE  +  A   C A +      C   SP+DRP  SA+   L+
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 184
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 228
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 229 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 271
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 272 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 134/306 (43%), Gaps = 35/306 (11%)
Query: 9   GREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRI 63
           G + P  F    L      Y ++LG G FG V   ++       G  +AVK L  + G  
Sbjct: 1   GPQDPTIFEERHLK-----YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPD 54
Query: 64  AEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEW 121
            +  F  E+  +   +   +V+  G  +   +    LV EY+ +G L  +L   +  ++ 
Sbjct: 55  QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA 114
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
            +L   +    KG+ YL     +R +H D+   N+L+++    K+ADFGLAKL   ++ +
Sbjct: 115 SRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 171
Query: 182 VTISGYKGTPGY-SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
             +     +P +  APE LS N   + + DV+SFG+VL+E+      +   S+E L    
Sbjct: 172 YVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM- 229
Query: 241 KHVWEEYEKSELDATILA---CGIEEKDKEKAKRLCMAAL-----WCVQDSPEDRPPMSA 292
                     E D   L      +EE  +  A   C A +      C   SP+DRP  SA
Sbjct: 230 --------GCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSA 281
Query: 293 VVKMLE 298
           +   L+
Sbjct: 282 LGPQLD 287

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 187
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 75
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 131
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 132 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH-D 186
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 187 EKVDLWSLGVLCYEFLVGK 205

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 214
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 215 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 257
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 258 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 185 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMP 240
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 241 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 283
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 284 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 158 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 213
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 214 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 256
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 158 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 213
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 214 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 256
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 78
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 134
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R     +   GT  Y  PE + G     
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-D 189
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 190 EKVDLWSLGVLCYEFLVGK 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH-D 187
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 150 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 205
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 206 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 248
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 249 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 175 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 230
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 231 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 273
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 274 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIA--EEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG VY  +  N   I A+KVL +     A  E Q   EV       H N++RLYG
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           + HD     L+ EY   G++   L  K    + ++        A  L Y H    +++IH
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKKVIH 131
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            DIKPEN+LL +    K+ADFG +     +R     +   GT  Y  PE + G      K
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMH-DEK 186
Query: 209 CDVYSFGMVLFE-IVGR 224
            D++S G++ +E +VG+
Sbjct: 187 VDLWSLGVLCYEFLVGK 203

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 165 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 220
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 221 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 263
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 264 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 77
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 133
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 134 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 188
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 189 EKVDLWSLGVLCYEFLVGK 207

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYR-ASYYRKGGCAMLPVKWMP 214
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 215 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 257
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 258 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH-D 184
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 228
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 229 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 271
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 272 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 109/246 (44%), Gaps = 30/246 (12%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 88
           LGFGG  EV+  +   +   +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 89  FCHDQH----MTALVYEYMENGSLDGYLFGK-----KRAIEWEKLHEIAIGTAKGLVYLH 139
               +     +  +V EY++  +L   +  +     KRAIE      +     + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 133
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEF 198
              Q  IIH D+KP N+L+ A  + KV DFG+A+ + D   S    +   GT  Y +PE 
Sbjct: 134 ---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 199 LSGNYPITHKCDVYSFGMVLFEIV-------GRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
             G+  +  + DVYS G VL+E++       G    ++       D  P     E   ++
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 252 LDATIL 257
           LDA +L
Sbjct: 250 LDAVVL 255

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 99
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 155
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLDYLPPEMIEGRM-HD 210
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 211 EKVDLWSLGVLCYEFLVGK 229

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R     +   GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLDYLPPEMIEGRMH-D 184
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 73
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 129
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R     +   GT  Y  PE + G     
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLDYLPPEMIEGRMH-D 184
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R  S+    G    P  +  
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYRKGGCAMLPVKWMP 228
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 229 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 271
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 272 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 78
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 134
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEXIEGRXH-D 189
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 190 EKVDLWSLGVLCYEFLVGK 208

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 15/192 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 90
           +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G   
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++    +V EYM  GSL  YL  + R++   + L + ++   + + YL        +H 
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 126
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D+   NVL+  +   KV+DFGL K      +  T    K    ++APE L      + K 
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKS 180
Query: 210 DVYSFGMVLFEI 221
           DV+SFG++L+EI
Sbjct: 181 DVWSFGILLWEI 192

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 15/192 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 90
           +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G   
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++    +V EYM  GSL  YL  + R++   + L + ++   + + YL        +H 
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 132
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D+   NVL+  +   KV+DFGL K      +  T    K    ++APE L      + K 
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EAAFSTKS 186
Query: 210 DVYSFGMVLFEI 221
           DV+SFG++L+EI
Sbjct: 187 DVWSFGILLWEI 198

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLDYLPPEMIEGRMH-D 187
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 70
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 71  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 126
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+ADFG +     +R     +   GT  Y  PE + G     
Sbjct: 127 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH-D 181
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 182 EKVDLWSLGVLCYEFLVGK 200

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 109/246 (44%), Gaps = 30/246 (12%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 88
           LGFGG  EV+  +   +   +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 89  FCHDQH----MTALVYEYMENGSLDGYLFGK-----KRAIEWEKLHEIAIGTAKGLVYLH 139
               +     +  +V EY++  +L   +  +     KRAIE      +     + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 133
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEF 198
              Q  IIH D+KP N+++ A  + KV DFG+A+ + D   S    +   GT  Y +PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 199 LSGNYPITHKCDVYSFGMVLFEIV-------GRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
             G+  +  + DVYS G VL+E++       G    ++       D  P     E   ++
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 252 LDATIL 257
           LDA +L
Sbjct: 250 LDAVVL 255

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 14/194 (7%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +LG G +GEV   +     V+ A+K++ + ++   +  + + EV  +    H N+++LY 
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           F  D+    LV E  + G L   +  + +  E +    I      G+ YLH   +  I+H
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-IIKQVLSGVTYLH---KHNIVH 159
Query: 149 YDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KPEN+LL++       K+ DFGL+ + +  +    +    GT  Y APE L   Y  
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRKKYD- 215
Query: 206 THKCDVYSFGMVLF 219
             KCDV+S G++LF
Sbjct: 216 -EKCDVWSIGVILF 228

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 15/192 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 90
           +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G   
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++    +V EYM  GSL  YL  + R++   + L + ++   + + YL        +H 
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 141
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D+   NVL+  +   KV+DFGL K      +  T    K    ++APE L      + K 
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKS 195
Query: 210 DVYSFGMVLFEI 221
           DV+SFG++L+EI
Sbjct: 196 DVWSFGILLWEI 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 15/192 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 90
           +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G   
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAI-EWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++    +V EYM  GSL  YL  + R++   + L + ++   + + YL        +H 
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D+   NVL+  +   KV+DFGL K      +  T    K    ++APE L      + K 
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKS 367
Query: 210 DVYSFGMVLFEI 221
           DV+SFG++L+EI
Sbjct: 368 DVWSFGILLWEI 379

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAV-KVLNRNLGRIAEEQFM-AEVGTIGRTYHINLVRLYGF 89
           +G G +G   K +  +  KI V K L+      AE+Q + +EV  +    H N+VR Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 90  CHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-- 145
             D+  T L  V EY E G L   +    +  ++    E  +     L    +EC +R  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD-EEFVLRVMTQLTLALKECHRRSD 132
Query: 146 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
               ++H D+KP NV LD   + K+ DFGLA++ + + S      + GTP Y +PE ++ 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQMN- 189
Query: 202 NYPITHKCDVYSFGMVLFEI 221
                 K D++S G +L+E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL 209

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 31/217 (14%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG GGFG V++ +   +    A+K +      +A E+ M EV  + +  H  +VR +   
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 91  HDQHMT-------ALVYEYME-----NGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGL 135
            +++ T         VY Y++       +L  ++ G+    E E+   LH I +  A+ +
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH-IFLQIAEAV 131
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI----------S 185
            +LH    + ++H D+KP N+    +   KV DFGL    D++    T+          +
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           G  GT  Y +PE + GN   +HK D++S G++LFE++
Sbjct: 189 GQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELL 224

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 75
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 131
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+A+FG +     +R         GT  Y  PE + G     
Sbjct: 132 IHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 186
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 187 EKVDLWSLGVLCYEFLVGK 205

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 93  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 148
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 149 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 207
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 208 HQSDVWSYGVTVWELM 223

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 87  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 142
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 143 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 201
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 202 HQSDVWSYGVTVWELM 217

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 84  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 139
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 140 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 198
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 199 HQSDVWSYGVTVWELM 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C    +  L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 84  LGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 139
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 140 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 198
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 199 HQSDVWSYGVTVWELM 214

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 27  NYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 81
            Y ++LG G FG V   ++       G  +AVK L  + G   +  F  E+  +   +  
Sbjct: 10  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSD 68
Query: 82  NLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
            +V+  G  +   +    LV EY+ +G L  +L   +  ++  +L   +    KG+ YL 
Sbjct: 69  FIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 128
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEF 198
               +R +H D+   N+L+++    K+ADFGLAKL   ++    +     +P +  APE 
Sbjct: 129 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 199 LSGNYPITHKCDVYSFGMVLFEI 221
           LS N   + + DV+SFG+VL+E+
Sbjct: 186 LSDNI-FSRQSDVWSFGVVLYEL 207

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 86  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 141
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 200
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 201 HQSDVWSYGVTVWELM 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 85  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 140
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 86  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 141
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 200
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 201 HQSDVWSYGVTVWELM 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     + +F   +K+  K      G   E Q   EV       H N++RL
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRL 76
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           YG+ HD     L+ EY   G++   L  K    + ++        A  L Y H    +R+
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 132
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL +    K+A+FG +     +R         GT  Y  PE + G     
Sbjct: 133 IHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-D 187
Query: 207 HKCDVYSFGMVLFE-IVGR 224
            K D++S G++ +E +VG+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 77  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 132
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 191
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 192 HQSDVWSYGVTVWELM 207

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 86  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 141
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 200
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 201 HQSDVWSYGVTVWELM 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 86  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 141
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 200
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 201 HQSDVWSYGVTVWELM 216

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 117/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R   +    G    P  +  
Sbjct: 176 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-AGYYRKGGCAMLPVKWMP 231
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 232 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 274
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 275 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 85  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 140
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 117/284 (41%), Gaps = 38/284 (13%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FGEVY+GQ       P+ +++AVK L        E  F+ E   I +  H N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLH 139
             G         ++ E M  G L  +L        +  ++    L  +A   A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVA---DFGLAKLCDRNRSHVTISGYKGTP-GYSA 195
           E      IH DI   N LL      +VA   DFG+A+   R   +    G    P  +  
Sbjct: 199 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-AGYYRKGGCAMLPVKWMP 254
Query: 196 PE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           PE F+ G +  T K D +SFG++L+EI             SL + P   +      E+  
Sbjct: 255 PEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSKSNQEVLE 297
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            + + G  +  K     +      C Q  PEDRP  + +++ +E
Sbjct: 298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAV-KVLNRNLGRIAEEQFM-AEVGTIGRTYHINLVRLYGF 89
           +G G +G   K +  +  KI V K L+      AE+Q + +EV  +    H N+VR Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 90  CHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-- 145
             D+  T L  V EY E G L   +    +  ++    E  +     L    +EC +R  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD-EEFVLRVMTQLTLALKECHRRSD 132
Query: 146 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
               ++H D+KP NV LD   + K+ DFGLA++ + + S      + GTP Y +PE ++ 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTPYYMSPEQMN- 189
Query: 202 NYPITHKCDVYSFGMVLFEI 221
                 K D++S G +L+E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL 209

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 89  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 144
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 145 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 203
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 204 HQSDVWSYGVTVWELM 219

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 90  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 145
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 204
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 205 HQSDVWSYGVTVWELM 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 108 LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 163
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 164 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 222
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 223 HQSDVWSYGVTVWELM 238

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/334 (23%), Positives = 135/334 (40%), Gaps = 56/334 (16%)
Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN------GVKIAVK 54
           M+ F+Q I R   V                 LG G FG+V+  +  N       + +AVK
Sbjct: 3   MDTFVQHIKRHNIV-------------LKRELGEGAFGKVFLAECYNLCPEQDKILVAVK 49
Query: 55  VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL-- 112
            L ++    A + F  E   +    H ++V+ YG C +     +V+EYM++G L+ +L  
Sbjct: 50  TL-KDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRA 108
Query: 113 FGKKRAIEWE----------KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 162
            G    +  E          ++  IA   A G+VYL     Q  +H D+   N L+  N 
Sbjct: 109 HGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENL 165
Query: 163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             K+ DFG+++    +  +  + G+   P    P         T + DV+S G+VL+EI 
Sbjct: 166 LVKIGDFGMSRDV-YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224
Query: 223 GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQD 282
                           + K  W +   +E+   I    + ++ +   + +    L C Q 
Sbjct: 225 T---------------YGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQR 269
Query: 283 SPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLDLI 316
            P  R  +  +  +L+ + +  P      YLD++
Sbjct: 270 EPHMRKNIKGIHTLLQNLAKASPV-----YLDIL 298

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF- 89
           ++G G +GEV+ G++  G K+AVKV         EE        I +T  +    + GF 
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFF-----TTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 90  CHDQHMTA------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC- 142
             D   T       L+ +Y ENGSL  YL  K   ++ + + ++A  +  GL +LH E  
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 143 ----QQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAP 196
               +  I H D+K +N+L+  N +  +AD GLA   + D N   +  +   GT  Y  P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 197 EFLSGNYPITH-----KCDVYSFGMVLFEIVGR 224
           E L  +    H       D+YSFG++L+E+  R
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 30/246 (12%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 88
           LGFGG  EV+  +       +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 89  FCHDQH----MTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 139
               +     +  +V EY++  +L   +        KRAIE      +     + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 133
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEF 198
              Q  IIH D+KP N+++ A  + KV DFG+A+ + D   S    +   GT  Y +PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 199 LSGNYPITHKCDVYSFGMVLFEIV-------GRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
             G+  +  + DVYS G VL+E++       G    ++       D  P     E   ++
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 252 LDATIL 257
           LDA +L
Sbjct: 250 LDAVVL 255

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 23/202 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINLV 84
           ++G G +G VYK Q   G   A+K +     R+ +E        + E+  +    H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +LY   H +    LV+E+++   L   L   +  +E        +    G+ Y H+   +
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           R++H D+KP+N+L++     K+ADFGLA+   +  R  +H  ++ +     Y AP+ L G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW-----YRAPDVLMG 174
Query: 202 NYPITHKCDVYSFGMVLFEIVG 223
           +   +   D++S G +  E+V 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVN 196

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 23/202 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINLV 84
           ++G G +G VYK Q   G   A+K +     R+ +E        + E+  +    H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +LY   H +    LV+E+++   L   L   +  +E        +    G+ Y H+   +
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           R++H D+KP+N+L++     K+ADFGLA+   +  R  +H  ++ +     Y AP+ L G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW-----YRAPDVLMG 174
Query: 202 NYPITHKCDVYSFGMVLFEIVG 223
           +   +   D++S G +  E+V 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVN 196

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-------GRIAEEQFMAEVGTIGRTYHINL 83
           LG G FG V+  +   NG   A+KVL + +           +E+ M  + T     H  +
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-----HPFI 68
Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE-WEKLHEIAIGTAKGLVYLHEEC 142
           +R++G   D     ++ +Y+E G L   L   +R      K +   +  A  L YLH   
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA--LEYLH--- 123
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLS 200
            + II+ D+KPEN+LLD N   K+ DFG AK       +V    Y   GTP Y APE +S
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAK-------YVPDVTYXLCGTPDYIAPEVVS 176
Query: 201 GNYPITHKCDVYSFGMVLFEIVG 223
              P     D +SFG++++E++ 
Sbjct: 177 TK-PYNKSIDWWSFGILIYEMLA 198

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 23/202 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINLV 84
           ++G G +G VYK Q   G   A+K +     R+ +E        + E+  +    H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +LY   H +    LV+E+++   L   L   +  +E        +    G+ Y H+   +
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           R++H D+KP+N+L++     K+ADFGLA+   +  R  +H  ++ +     Y AP+ L G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW-----YRAPDVLMG 174
Query: 202 NYPITHKCDVYSFGMVLFEIVG 223
           +   +   D++S G +  E+V 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVN 196

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKV----LNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G K+ + V    L       A ++ + E   +    + ++ RL
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 117 LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 172
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 173 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 231
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 232 HQSDVWSYGVTVWELM 247

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 32  LGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG+V    +       G  +AVK L    G      +  E+  +   YH ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 87  YGFCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            G C DQ      LV EY+  GSL  YL   +  +   +L   A    +G+ YLH    Q
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 131
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFLSGNY 203
             IH  +   NVLLD +   K+ DFGLAK       +  +     +P +  APE L    
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK-EC 190
Query: 204 PITHKCDVYSFGMVLFEIV 222
              +  DV+SFG+ L+E++
Sbjct: 191 KFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 32  LGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG+V    +       G  +AVK L    G      +  E+  +   YH ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 87  YGFCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            G C DQ      LV EY+  GSL  YL   +  +   +L   A    +G+ YLH    Q
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 130
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFLSGNY 203
             IH  +   NVLLD +   K+ DFGLAK       +  +     +P +  APE L    
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK-EC 189
Query: 204 PITHKCDVYSFGMVLFEIV 222
              +  DV+SFG+ L+E++
Sbjct: 190 KFYYASDVWSFGVTLYELL 208

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 84
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 135
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGY 193
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG     +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 198
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
            APE L      T   D++SFG+VL+EI         G S           E+  K  +D
Sbjct: 199 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN----------EQVLKFVMD 247
Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                 G  ++     +R+      C Q +P+ RP    +V +L+
Sbjct: 248 G-----GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 30/246 (12%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 88
           LGFGG  EV+  +       +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 89  FCHDQH----MTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 139
               +     +  +V EY++  +L   +        KRAIE      +     + L + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 133
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEF 198
              Q  IIH D+KP N+++ A  + KV DFG+A+ + D   S    +   GT  Y +PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 199 LSGNYPITHKCDVYSFGMVLFEIV-------GRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
             G+  +  + DVYS G VL+E++       G    ++       D  P     E   ++
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 252 LDATIL 257
           LDA +L
Sbjct: 250 LDAVVL 255

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 14/216 (6%)
Query: 31  RLGFGGFGEVYKGQFPNGVK--IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           R+G G FGEVYKG   N  K  +A+K+++        E    E+  + +     + R +G
Sbjct: 26  RIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
                    ++ EY+  GS    L  K   +E   +  I     KGL YLH E   R IH
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE---RKIH 139
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            DIK  NVLL      K+ADFG+A +L D   + +  + + GTP + APE +  +     
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVIKQS-AYDF 195
Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKH 242
           K D++S G+   E+  G   N+ +     L   PK+
Sbjct: 196 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN 231

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 24  FTSNYSTRLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +T + +  LG G FG+V+K  +   G+K+A K++ +  G   +E+   E+  + +  H N
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKII-KTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           L++LY     ++   LV EY++ G L   +  +   +             +G+ ++H   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH--- 204
Query: 143 QQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
           Q  I+H D+KPEN+L    DA    K+ DFGLA+   R +    +    GTP + APE +
Sbjct: 205 QMYILHLDLKPENILCVNRDAK-QIKIIDFGLAR---RYKPREKLKVNFGTPEFLAPEVV 260
Query: 200 SGNYPITHKCDVYSFGMVLFEIVG 223
           + ++ ++   D++S G++ + ++ 
Sbjct: 261 NYDF-VSFPTDMWSVGVIAYMLLS 283

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 84
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 80
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 135
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGY 193
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG     +
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 195
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
            APE L      T   D++SFG+VL+EI         G S           E+  K  +D
Sbjct: 196 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN----------EQVLKFVMD 244
Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                 G  ++     +R+      C Q +P+ RP    +V +L+
Sbjct: 245 G-----GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 123/285 (43%), Gaps = 40/285 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 84
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 135
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGY 193
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG     +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 198
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
            APE L      T   D++SFG+VL+EI         G S           E+  K  +D
Sbjct: 199 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN----------EQVLKFVMD 247
Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                 G  ++     +R+      C Q +P  RP    +V +L+
Sbjct: 248 G-----GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  A+G+ YL +   +R+
Sbjct: 80  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLED---RRL 135
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 136 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 194
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 195 HQSDVWSYGVTVWELM 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 76
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 134
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 194 TES-KFSVASDVWSFGVVLYEL 214

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAV-KVLNRNLGRIAEEQFM-AEVGTIGRTYHINLVRLYGF 89
           +G G +G   K +  +  KI V K L+      AE+Q + +EV  +    H N+VR Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 90  CHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-- 145
             D+  T L  V EY E G L   +    +  ++    E  +     L    +EC +R  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD-EEFVLRVMTQLTLALKECHRRSD 132
Query: 146 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
               ++H D+KP NV LD   + K+ DFGLA++ + +        + GTP Y +PE ++ 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMN- 189
Query: 202 NYPITHKCDVYSFGMVLFEI 221
                 K D++S G +L+E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL 209

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 71
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 129
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 189 TES-KFSVASDVWSFGVVLYEL 209

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 75
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 193 TES-KFSVASDVWSFGVVLYEL 213

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 70
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 128
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 188 TES-KFSVASDVWSFGVVLYEL 208

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 72
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 190 TES-KFSVASDVWSFGVVLYEL 210

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 9   GREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRI 63
           G   P +F    L      +  +LG G FG V   ++       G  +AVK L  +    
Sbjct: 1   GSRDPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 55
Query: 64  AEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEW 121
             + F  E+  +    H N+V+  G C+   +    L+ EY+  GSL  YL   K  I+ 
Sbjct: 56  LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 114
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
            KL +      KG+ YL     +R IH ++   N+L++     K+ DFGL K+  +++ +
Sbjct: 115 IKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEY 171
Query: 182 VTISGYKGTPGY-SAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             +     +P +  APE L+ +   +   DV+SFG+VL+E+
Sbjct: 172 YKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYEL 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 77
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 135
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 195 TES-KFSVASDVWSFGVVLYEL 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           L  G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 108/246 (43%), Gaps = 30/246 (12%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 88
           LGFGG  EV+  +       +AVKVL  +L R      +F  E        H  +V +Y 
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 89  FCHDQH----MTALVYEYMENGSLDGYLFGK-----KRAIEWEKLHEIAIGTAKGLVYLH 139
               +     +  +V EY++  +L   +  +     KRAIE      +     + L + H
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSH 150
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEF 198
              Q  IIH D+KP N+++ A  + KV DFG+A+ + D   S    +   GT  Y +PE 
Sbjct: 151 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 207
Query: 199 LSGNYPITHKCDVYSFGMVLFEIV-------GRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
             G+  +  + DVYS G VL+E++       G    ++       D  P     E   ++
Sbjct: 208 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 266
Query: 252 LDATIL 257
           LDA +L
Sbjct: 267 LDAVVL 272

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           L  G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C    +  L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 145
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 204
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 205 HQSDVWSYGVTVWELM 220

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 87  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 142
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFG AKL           G K    + A E +      T
Sbjct: 143 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 201
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 202 HQSDVWSYGVTVWELM 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 103
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 221 TES-KFSVASDVWSFGVVLYEL 241

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 72
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 190 TES-KFSVASDVWSFGVVLYEL 210

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 85  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 140
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFG AKL           G K    + A E +      T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 85  LGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 140
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFG AKL           G K    + A E +      T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 78
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 136
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 196 TES-KFSVASDVWSFGVVLYEL 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 83  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 138
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFG AKL           G K    + A E +      T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           L  G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 90  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 145
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 204
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 205 HQSDVWSYGVTVWELM 220

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLYG 88
           LG G F  VY+ +    G+++A+K++++     A   ++   EV    +  H +++ LY 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           +  D +   LV E   NG ++ YL  + +     +          G++YLH      I+H
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILH 135
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+   N+LL  N + K+ADFGLA +L   +  H T+    GTP Y +PE  + +    H
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRS---AH 189
Query: 208 --KCDVYSFGMVLFE-IVGR 224
             + DV+S G + +  ++GR
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 72
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 190 TES-KFSVASDVWSFGVVLYEL 210

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 85  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 140
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFG AKL           G K    + A E +      T
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 79
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 137
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 197 TES-KFSVASDVWSFGVVLYEL 217

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 25/200 (12%)
Query: 31  RLGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRL 86
           +LG G +GEV   K +   G + A+K++ ++           + EV  + +  H N+++L
Sbjct: 11  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y F  D+    LV E    G L   +  +++  E +    I      G  YLH   +  I
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA-VIMKQVLSGTTYLH---KHNI 125
Query: 147 IHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYK----GTPGYSAPEFL 199
           +H D+KPEN+LL++       K+ DFGL+       +H  + G      GT  Y APE L
Sbjct: 126 VHRDLKPENLLLESKSRDALIKIVDFGLS-------AHFEVGGKMKERLGTAYYIAPEVL 178
Query: 200 SGNYPITHKCDVYSFGMVLF 219
              Y    KCDV+S G++L+
Sbjct: 179 RKKYD--EKCDVWSCGVILY 196

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 90
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 208 TES-KFSVASDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 90
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL   K  I+  KL +      KG+ YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 208 TES-KFSVASDVWSFGVVLYEL 228

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 32  LGFGGFGEVYKGQF-PNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG + P G    + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C       L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R+
Sbjct: 90  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 145
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFG AKL           G K    + A E +      T
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 204
Query: 207 HKCDVYSFGMVLFEIV 222
           H+ DV+S+G+ ++E++
Sbjct: 205 HQSDVWSYGVTVWELM 220

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 90
           LG G FG+VYK +      +A   +         E ++ E+  +    H  +V+L G + 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
           HD  +  ++ E+   G++D  +    R +   ++  +     + L +LH    +RIIH D
Sbjct: 87  HDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRD 142
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNYPIT 206
           +K  NVL+      ++ADFG++      ++      + GTP + APE +      + P  
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 200
Query: 207 HKCDVYSFGMVLFEI 221
           +K D++S G+ L E+
Sbjct: 201 YKADIWSLGITLIEM 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-FC 90
           LG G FG+VYK +      +A   +         E ++ E+  +    H  +V+L G + 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
           HD  +  ++ E+   G++D  +    R +   ++  +     + L +LH    +RIIH D
Sbjct: 79  HDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRD 134
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNYPIT 206
           +K  NVL+      ++ADFG++      ++      + GTP + APE +      + P  
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 192
Query: 207 HKCDVYSFGMVLFEI 221
           +K D++S G+ L E+
Sbjct: 193 YKADIWSLGITLIEM 207

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 84
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 135
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGY 193
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG     +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 198
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
            APE L      T   D++SFG+VL+EI         G S           E+  K  +D
Sbjct: 199 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN----------EQVLKFVMD 247
Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                 G  ++     +R+      C Q +P+ RP    +V +L+
Sbjct: 248 G-----GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 25/200 (12%)
Query: 31  RLGFGGFGEVY--KGQFPNGVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRL 86
           +LG G +GEV   K +   G + A+K++ ++           + EV  + +  H N+++L
Sbjct: 28  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y F  D+    LV E    G L   +  +++  E +    I      G  YLH   +  I
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA-AVIMKQVLSGTTYLH---KHNI 142
Query: 147 IHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYK----GTPGYSAPEFL 199
           +H D+KPEN+LL++       K+ DFGL+       +H  + G      GT  Y APE L
Sbjct: 143 VHRDLKPENLLLESKSRDALIKIVDFGLS-------AHFEVGGKMKERLGTAYYIAPEVL 195
Query: 200 SGNYPITHKCDVYSFGMVLF 219
              Y    KCDV+S G++L+
Sbjct: 196 RKKY--DEKCDVWSCGVILY 213

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 22  NNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGR 77
             F+ NY  +  LG G F  V +      G++ A K++N + L     ++   E     +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 137
             H N+VRL+    ++    LV++ +  G L   +  ++   E +  H I     + + Y
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAY 120
Query: 138 LHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLA-KLCDRNRSHVTISGYKGTPGY 193
            H      I+H ++KPEN+LL +     + K+ADFGLA ++ D    H    G+ GTPGY
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGY 173
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLF 219
            +PE L  + P +   D+++ G++L+
Sbjct: 174 LSPEVLKKD-PYSKPVDIWACGVILY 198

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 84
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 135
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGY 193
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG     +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETAYYRKGGKGLLPVRW 198
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
            APE L      T   D++SFG+VL+EI         G S           E+  K  +D
Sbjct: 199 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN----------EQVLKFVMD 247
Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                 G  ++     +R+      C Q +P+ RP    +V +L+
Sbjct: 248 G-----GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 15  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 74
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 75  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 134
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT--P 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 135 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPV 189
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 190 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 218

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 22  NNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGR 77
             F+ NY  +  LG G F  V +      G++ A K++N + L     ++   E     +
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 137
             H N+VRL+    ++    LV++ +  G L   +  ++   E +  H I     + + Y
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAY 119
Query: 138 LHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLA-KLCDRNRSHVTISGYKGTPGY 193
            H      I+H ++KPEN+LL +     + K+ADFGLA ++ D    H    G+ GTPGY
Sbjct: 120 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGY 172
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLF 219
            +PE L  + P +   D+++ G++L+
Sbjct: 173 LSPEVLKKD-PYSKPVDIWACGVILY 197

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 22  NNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGR 77
             F+ NY  +  LG G F  V +      G++ A K++N + L     ++   E     +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 137
             H N+VRL+    ++    LV++ +  G L   +  ++   E +  H I     + + Y
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAY 120
Query: 138 LHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLA-KLCDRNRSHVTISGYKGTPGY 193
            H      I+H ++KPEN+LL +     + K+ADFGLA ++ D    H    G+ GTPGY
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGY 173
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLF 219
            +PE L  + P +   D+++ G++L+
Sbjct: 174 LSPEVLKKD-PYSKPVDIWACGVILY 198

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 6   QEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLG 61
           Q++GR     F       F+ NY  +  LG G F  V +      G++ A K++N + L 
Sbjct: 11  QQMGRGS--EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS 68
Query: 62  RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEW 121
               ++   E     +  H N+VRL+    ++    LV++ +  G L   +  ++   E 
Sbjct: 69  ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA 128
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLA-KLCDR 177
           +  H I     + + Y H      I+H ++KPEN+LL +     + K+ADFGLA ++ D 
Sbjct: 129 DASHCIQ-QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
              H    G+ GTPGY +PE L  + P +   D+++ G++L+
Sbjct: 185 EAWH----GFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILY 221

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 13/220 (5%)
Query: 7   EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE 65
           E+ +E+P     L++ +F  +    LG G FG+V+  +F    +  A+K L +++  + +
Sbjct: 2   ELNKERPSLQIKLKIEDFILH--KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59
Query: 66  --EQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE 122
             E  M E   +   + H  L  ++     +     V EY+  G L  Y        +  
Sbjct: 60  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLS 118
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
           +    A     GL +LH    + I++ D+K +N+LLD +   K+ADFG+ K  +      
Sbjct: 119 RATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDA 173
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             + + GTP Y APE L G     H  D +SFG++L+E++
Sbjct: 174 KTNXFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEML 212

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 28  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 80
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            N+V L G C       ++ EY   G L  +L  K R +E +    IA  TA     LH 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 141 ECQ----------QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
             Q          +  IH D+   NVLL      K+ DFGLA+    + +++     +  
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             + APE +  +   T + DV+S+G++L+EI
Sbjct: 230 VKWMAPESIF-DCVYTVQSDVWSYGILLWEI 259

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 28  YSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +  +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDN 75
Query: 83  LVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           +V+  G C+   +    L+ EY+  GSL  YL      I+  KL +      KG+ YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL-- 133
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFL 199
              +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 200 SGNYPITHKCDVYSFGMVLFEI 221
           + +   +   DV+SFG+VL+E+
Sbjct: 193 TES-KFSVASDVWSFGVVLYEL 213

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 37/209 (17%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVL-------NRNLGRIAEEQFMAEVGTIGRTYHIN 82
           +LG GG   VY  +     +K+A+K +          L R     F  EV    +  H N
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-----FEREVHNSSQLSHQN 72
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA--------KG 134
           +V +     +     LV EY+E  +L  Y+         E    +++ TA         G
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---------ESHGPLSVDTAINFTNQILDG 123
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS 194
           + + H+    RI+H DIKP+N+L+D+N + K+ DFG+AK      S    +   GT  Y 
Sbjct: 124 IKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYF 179
Query: 195 APEFLSGNYPITHKC-DVYSFGMVLFEIV 222
           +PE   G    T +C D+YS G+VL+E++
Sbjct: 180 SPEQAKGEA--TDECTDIYSIGIVLYEML 206

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 35/225 (15%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH 91
           +G G +GEV++G + +G  +AVK+ +       +EQ       I  T  +    + GF  
Sbjct: 16  VGKGRYGEVWRGLW-HGESVAVKIFSSR-----DEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 92  DQHMTA--------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC- 142
              MT+        L+  Y E+GSL  Y F +++ +E      +A+  A GL +LH E  
Sbjct: 70  SD-MTSRNSSTQLWLITHYHEHGSL--YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 143 ----QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAP 196
               +  I H D K  NVL+ +N    +AD GLA +  +   ++ I      GT  Y AP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 197 EFLSGNYPITHKC-------DVYSFGMVLFEIVGRRRNAIVGSSE 234
           E L  +  I   C       D+++FG+VL+EI   RR  + G  E
Sbjct: 187 EVL--DEQIRTDCFESYKWTDIWAFGLVLWEIA--RRTIVNGIVE 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 84
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 82
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 135
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGY 193
            YL+    ++ +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG     +
Sbjct: 143 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 197
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
            APE L      T   D++SFG+VL+EI         G S           E+  K  +D
Sbjct: 198 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN----------EQVLKFVMD 246
Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                 G  ++     +R+      C Q +P+ RP    +V +L+
Sbjct: 247 G-----GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 24  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT--P 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 144 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPV 198
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 199 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 227

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 126/300 (42%), Gaps = 50/300 (16%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V K              +AVK+L  N         ++E   + +  H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------------------RAIEWE 122
           LYG C       L+ EY + GSL G+L   +                       RA+   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   ++G+ YL E    +++H D+   N+L+      K++DFGL++      S+V
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH 242
             S  +    + A E L  ++  T + DV+SFG++L+EIV    N   G        P+ 
Sbjct: 208 KRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP------PER 260
Query: 243 VWEEYEKSELDATILACGIE-EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV 301
           ++           +L  G   E+    ++ +    L C +  P+ RP  + + K LE ++
Sbjct: 261 LF----------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +       
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +       
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           RLG GGFG V +    + G ++A+K   + L     E++  E+  + +  H N+V     
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 90  CHDQHMTA------LVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
                  A      L  EY E G L  YL  F     ++   +  +    +  L YLHE 
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 142 CQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
              RIIH D+KPEN++L         K+ D G AK  D+       + + GT  Y APE 
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPEL 195
Query: 199 L-SGNYPITHKCDVYSFGMVLFEIV 222
           L    Y +T   D +SFG + FE +
Sbjct: 196 LEQKKYTVT--VDYWSFGTLAFECI 218

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 31  RLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N+V+
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 78
Query: 86  LYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
             G C+   +    L+ E++  GSL  YL   K  I+  KL +      KG+ YL     
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFLSGN 202
           +R IH D+   N+L++     K+ DFGL K+  +++    +     +P +  APE L+ +
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 203 YPITHKCDVYSFGMVLFEI 221
              +   DV+SFG+VL+E+
Sbjct: 196 -KFSVASDVWSFGVVLYEL 213

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 7/196 (3%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +  VYKG+       +A+K +       A    + EV  +    H N+V L+  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            H +    LV+EY++   L  YL      I    +        +GL Y H   +Q+++H 
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D+KP+N+L++     K+ADFGLA+   ++    T      T  Y  P+ L G+   + + 
Sbjct: 125 DLKPQNLLINERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI 182
Query: 210 DVYSFGMVLFEIVGRR 225
           D++  G + +E+   R
Sbjct: 183 DMWGVGCIFYEMATGR 198

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           RLG GGFG V +    + G ++A+K   + L     E++  E+  + +  H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 90  CHDQHMTA------LVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
                  A      L  EY E G L  YL  F     ++   +  +    +  L YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 142 CQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
              RIIH D+KPEN++L         K+ D G AK  D+       + + GT  Y APE 
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPEL 194
Query: 199 L-SGNYPITHKCDVYSFGMVLFEIV 222
           L    Y +T   D +SFG + FE +
Sbjct: 195 LEQKKYTVT--VDYWSFGTLAFECI 217

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 13/220 (5%)
Query: 7   EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE 65
           E+ +E+P     L++ +F       LG G FG+V+  +F    +  A+K L +++  + +
Sbjct: 3   ELNKERPSLQIKLKIEDF--ELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 60
Query: 66  --EQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE 122
             E  M E   +   + H  L  ++     +     V EY+  G L  Y        +  
Sbjct: 61  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLS 119
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
           +    A     GL +LH    + I++ D+K +N+LLD +   K+ADFG+ K  +      
Sbjct: 120 RATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDA 174
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             + + GTP Y APE L G     H  D +SFG++L+E++
Sbjct: 175 KTNEFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEML 213

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++     D         I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KPEN+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 127 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 181
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 13  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 123
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 184 AEPVDVWSCGIVLTAMLA 201

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 20/190 (10%)
Query: 47  NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--------NLVRLYGFCHDQHMTAL 98
            G + AVK++     R++ EQ         R  HI        +++ L           L
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177
Query: 99  VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL 158
           V++ M  G L  YL  +K A+  ++   I     + + +LH      I+H D+KPEN+LL
Sbjct: 178 VFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILL 233
Query: 159 DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH-----KCDVYS 213
           D N   +++DFG +   +       +    GTPGY APE L  +   TH     + D+++
Sbjct: 234 DDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA 290
Query: 214 FGMVLFEIVG 223
            G++LF ++ 
Sbjct: 291 CGVILFTLLA 300

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 145
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 146 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 205 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 262 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 298

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHINLVR 85
           LG G F  VYK +  N  +I V +    LG  +E +       + E+  +    H N++ 
Sbjct: 18  LGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 86  LY-GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           L   F H  +++ LV+++ME   L+  +      +    +    + T +GL YLH   Q 
Sbjct: 77  LLDAFGHKSNIS-LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 131
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEFLSG 201
            I+H D+KP N+LLD N   K+ADFGLAK     +R   H  ++ +     Y APE L G
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRW-----YRAPELLFG 186
Query: 202 NYPITHKCDVYSFGMVLFEIVGR 224
                   D+++ G +L E++ R
Sbjct: 187 ARMYGVGVDMWAVGCILAELLLR 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 86
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 87  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 146 LVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 203 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 239

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 125/300 (41%), Gaps = 50/300 (16%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V K              +AVK+L  N         ++E   + +  H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------------------RAIEWE 122
           LYG C       L+ EY + GSL G+L   +                       RA+   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   ++G+ YL E    +++H D+   N+L+      K++DFGL++      S V
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH 242
             S  +    + A E L  ++  T + DV+SFG++L+EIV    N   G        P+ 
Sbjct: 208 KRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP------PER 260
Query: 243 VWEEYEKSELDATILACGIE-EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV 301
           ++           +L  G   E+    ++ +    L C +  P+ RP  + + K LE ++
Sbjct: 261 LF----------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 131/306 (42%), Gaps = 60/306 (19%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLY 87
           +G G FG VY  +   N   +A+K ++ + G+ + E++   + EV  + +  H N ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    +H   LV EY   GS    L   K+ ++  ++  +  G  +GL YLH      +I
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMI 137
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNY 203
           H D+K  N+LL      K+ DFG A +          + + GTP + APE +     G Y
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQY 191
Query: 204 PITHKCDVYSFGMVLFEIVGRR-----RNAI-----VGSSESLDWFPKHVWEEYEKSELD 253
               K DV+S G+   E+  R+      NA+     +  +ES      H W EY ++ +D
Sbjct: 192 --DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH-WSEYFRNFVD 248
Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYL 313
           +                        C+Q  P+DRP    ++K       VL    P   +
Sbjct: 249 S------------------------CLQKIPQDRPTSEVLLKHR----FVLRERPPTVIM 280
Query: 314 DLIKMT 319
           DLI+ T
Sbjct: 281 DLIQRT 286

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 118/263 (44%), Gaps = 26/263 (9%)
Query: 46  PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN 105
           P   K+A+K +N    + + ++ + E+  + + +H N+V  Y     +    LV + +  
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 106 GSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL 158
           GS+   +         K   ++   +  I     +GL YLH+  Q   IH D+K  N+LL
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 149
Query: 159 DANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSF 214
             + S ++ADFG    LA   D  R+ V  + + GTP + APE +        K D++SF
Sbjct: 150 GEDGSVQIADFGVSAFLATGGDITRNKVRKT-FVGTPCWMAPEVMEQVRGYDFKADIWSF 208
Query: 215 GMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD--KEKAKRL 272
           G+   E+         G++    + P  V     ++  D   L  G+++K+  K+  K  
Sbjct: 209 GITAIELA-------TGAAPYHKYPPMKVLMLTLQN--DPPSLETGVQDKEMLKKYGKSF 259
Query: 273 CMAALWCVQDSPEDRPPMSAVVK 295
                 C+Q  PE RP  + +++
Sbjct: 260 RKMISLCLQKDPEKRPTAAELLR 282

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 131/306 (42%), Gaps = 60/306 (19%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLY 87
           +G G FG VY  +   N   +A+K ++ + G+ + E++   + EV  + +  H N ++  
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    +H   LV EY   GS    L   K+ ++  ++  +  G  +GL YLH      +I
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 176
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNY 203
           H D+K  N+LL      K+ DFG A +          + + GTP + APE +     G Y
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQY 230
Query: 204 PITHKCDVYSFGMVLFEIVGRR-----RNAI-----VGSSESLDWFPKHVWEEYEKSELD 253
               K DV+S G+   E+  R+      NA+     +  +ES      H W EY ++ +D
Sbjct: 231 --DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH-WSEYFRNFVD 287
Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYL 313
           +                        C+Q  P+DRP    ++K       VL    P   +
Sbjct: 288 S------------------------CLQKIPQDRPTSEVLLKHR----FVLRERPPTVIM 319
Query: 314 DLIKMT 319
           DLI+ T
Sbjct: 320 DLIQRT 325

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 108/270 (40%), Gaps = 41/270 (15%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLYG 88
           LG GGFGEV+  Q     K+              + +   M E   + + +   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 89  FCHDQHMTALVYEYMENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
               +    LV   M  G +         D   F + RAI +            GL +LH
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------TAQIVSGLEHLH 306
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
              Q+ II+ D+KPENVLLD + + +++D GLA   +         GY GTPG+ APE L
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELL 361
Query: 200 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC 259
            G        D ++ G+ L+E++  R               +   E+ E  EL   +L  
Sbjct: 362 LGE-EYDFSVDYFALGVTLYEMIAARGPF------------RARGEKVENKELKQRVLEQ 408
Query: 260 GIEEKDK--EKAKRLCMAALWCVQDSPEDR 287
            +   DK    +K  C A L   Q  PE R
Sbjct: 409 AVTYPDKFSPASKDFCEALL---QKDPEKR 435

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 118/263 (44%), Gaps = 26/263 (9%)
Query: 46  PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN 105
           P   K+A+K +N    + + ++ + E+  + + +H N+V  Y     +    LV + +  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 106 GSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL 158
           GS+   +         K   ++   +  I     +GL YLH+  Q   IH D+K  N+LL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 154
Query: 159 DANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSF 214
             + S ++ADFG    LA   D  R+ V  + + GTP + APE +        K D++SF
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKT-FVGTPCWMAPEVMEQVRGYDFKADIWSF 213
Query: 215 GMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD--KEKAKRL 272
           G+   E+         G++    + P  V     ++  D   L  G+++K+  K+  K  
Sbjct: 214 GITAIELA-------TGAAPYHKYPPMKVLMLTLQN--DPPSLETGVQDKEMLKKYGKSF 264
Query: 273 CMAALWCVQDSPEDRPPMSAVVK 295
                 C+Q  PE RP  + +++
Sbjct: 265 RKMISLCLQKDPEKRPTAAELLR 287

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V         K +    V +AVK+L  +         ++E + M  +G    
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK--- 99
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 + ++
Sbjct: 100 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 215 KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   ++ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 75  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ +N   K+ DFGL++  + + ++   S  K    + APE ++     T 
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 188
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 229

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ +N   K+ DFGL++  + + ++   S  K    + APE ++     T 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 191
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ +N   K+ DFGL++  + + ++   S  K    + APE ++     T 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 191
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 109/270 (40%), Gaps = 41/270 (15%)
Query: 32  LGFGGFGEVYKGQFPNGVKI---AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGFGEV+  Q     K+         R   R   +  M E   + + +   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 89  FCHDQHMTALVYEYMENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
               +    LV   M  G +         D   F + RAI +            GL +LH
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------TAQIVSGLEHLH 306
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
              Q+ II+ D+KPENVLLD + + +++D GLA   +         GY GTPG+ APE L
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELL 361
Query: 200 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC 259
            G        D ++ G+ L+E++  R               +   E+ E  EL   +L  
Sbjct: 362 LGE-EYDFSVDYFALGVTLYEMIAARGPF------------RARGEKVENKELKQRVLEQ 408
Query: 260 GIEEKDK--EKAKRLCMAALWCVQDSPEDR 287
            +   DK    +K  C A L   Q  PE R
Sbjct: 409 AVTYPDKFSPASKDFCEALL---QKDPEKR 435

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 91
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 92  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 151 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 208 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 244

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 50/225 (22%)
Query: 32  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 77
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 78  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H 
Sbjct: 136 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH- 187
Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            I  YK T        + APE L      TH+ DV+SFG++L+EI
Sbjct: 188 -IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 230

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 109/270 (40%), Gaps = 41/270 (15%)
Query: 32  LGFGGFGEVYKGQFPNGVKI---AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGFGEV+  Q     K+         R   R   +  M E   + + +   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 89  FCHDQHMTALVYEYMENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
               +    LV   M  G +         D   F + RAI +            GL +LH
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------TAQIVSGLEHLH 306
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
              Q+ II+ D+KPENVLLD + + +++D GLA   +         GY GTPG+ APE L
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELL 361
Query: 200 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC 259
            G        D ++ G+ L+E++  R               +   E+ E  EL   +L  
Sbjct: 362 LGE-EYDFSVDYFALGVTLYEMIAARGPF------------RARGEKVENKELKQRVLEQ 408
Query: 260 GIEEKDK--EKAKRLCMAALWCVQDSPEDR 287
            +   DK    +K  C A L   Q  PE R
Sbjct: 409 AVTYPDKFSPASKDFCEALL---QKDPEKR 435

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 15  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G +GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 80  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ +N   K+ DFGL++  + + ++   S  K    + APE ++     T 
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 193
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 194 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 234

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 50/225 (22%)
Query: 32  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 85
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 86  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H 
Sbjct: 144 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH- 195
Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            I  YK T        + APE L      TH+ DV+SFG++L+EI
Sbjct: 196 -IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 238

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 109/270 (40%), Gaps = 41/270 (15%)
Query: 32  LGFGGFGEVYKGQFPNGVKI---AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGFGEV+  Q     K+         R   R   +  M E   + + +   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 89  FCHDQHMTALVYEYMENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
               +    LV   M  G +         D   F + RAI +            GL +LH
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------TAQIVSGLEHLH 306
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
              Q+ II+ D+KPENVLLD + + +++D GLA   +         GY GTPG+ APE L
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELL 361
Query: 200 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC 259
            G        D ++ G+ L+E++  R               +   E+ E  EL   +L  
Sbjct: 362 LGE-EYDFSVDYFALGVTLYEMIAARGPF------------RARGEKVENKELKQRVLEQ 408
Query: 260 GIEEKDK--EKAKRLCMAALWCVQDSPEDR 287
            +   DK    +K  C A L   Q  PE R
Sbjct: 409 AVTYPDKFSPASKDFCEALL---QKDPEKR 435

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 88
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++ EY   G+L  YL  ++                 + ++ 
Sbjct: 89  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 148 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 205 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 241

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 81  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ +N   K+ DFGL++  + + ++   S  K    + APE ++     T 
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 194
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 195 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 235

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 50/225 (22%)
Query: 32  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 81
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 82  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H 
Sbjct: 140 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH- 191
Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            I  YK T        + APE L      TH+ DV+SFG++L+EI
Sbjct: 192 -IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 234

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 40/285 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 84
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 84
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 135
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGY 193
            YL+    ++ +H ++   N ++  +F+ K+ DFG+ +  D   +     G KG     +
Sbjct: 145 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 199
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
            APE L      T   D++SFG+VL+EI         G S           E+  K  +D
Sbjct: 200 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN----------EQVLKFVMD 248
Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                 G  ++     +R+      C Q +P  RP    +V +L+
Sbjct: 249 G-----GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 50/225 (22%)
Query: 32  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 92
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H 
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH- 202
Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            I  YK T        + APE L      TH+ DV+SFG++L+EI
Sbjct: 203 -IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TP 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 204
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 205 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 233

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI---------EWEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   + A+            K+ ++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TP 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 204
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 205 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 233

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 20  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 79
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI---------EWEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   + A+            K+ ++A   A 
Sbjct: 80  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 139
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT--P 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 140 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 194
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 195 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 223

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 50/225 (22%)
Query: 32  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 92
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H 
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH- 202
Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            I  YK T        + APE L      TH+ DV+SFG++L+EI
Sbjct: 203 -IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 40/285 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLV 84
           LG G FG VY+G   + +K      +AVK +N +       +F+ E   + G T H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 135
           RL G       T +V E M +G L  YL   +   E          +++ ++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGY 193
            YL+    ++ +H ++   N ++  +F+ K+ DFG+ +  D   +     G KG     +
Sbjct: 144 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 198
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD 253
            APE L      T   D++SFG+VL+EI         G S           E+  K  +D
Sbjct: 199 MAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN----------EQVLKFVMD 247
Query: 254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                 G  ++     +R+      C Q +P  RP    +V +L+
Sbjct: 248 G-----GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 21  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 80
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 81  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT--P 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 141 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 195
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 196 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 224

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 23  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT--P 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 143 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 197
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 198 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 23  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT--P 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 143 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 197
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 198 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 226

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 83  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ +N   K+ DFGL++  + + ++   S  K    + APE ++     T 
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 196
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 237

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G   +  +  ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ +N   K+ DFGL++  + + ++   S  K    + APE ++     T 
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 219
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 220 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 260

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 17  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT--P 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 137 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 191
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 192 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 220

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 50/225 (22%)
Query: 32  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 84
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 85  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H 
Sbjct: 143 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH- 194
Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            I  YK T        + APE L      TH+ DV+SFG++L+EI
Sbjct: 195 -IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 237

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 48/224 (21%)
Query: 32  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 92
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H+
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHHI 203
Query: 183 TISGYKGTPG-----YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
                K T G     + APE L      TH+ DV+SFG++L+EI
Sbjct: 204 DXXK-KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 22/224 (9%)
Query: 25  TSNYS--TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGR 77
           TS Y     +G G +G VYK + P +G  +A+K +    G     I+  + +A +  +  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 78  TYHINLVRLYGFCHDQHM-----TALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGT 131
             H N+VRL   C            LV+E+++   L  YL       +  E + ++    
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
            +GL +LH  C   I+H D+KPEN+L+ +  + K+ADFGLA++       + ++    T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALAPVVVTL 175
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES 235
            Y APE L  +   T   D++S G +  E+  RR+    G+SE+
Sbjct: 176 WYRAPEVLLQSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 217

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA---IGTAKGLVYLHEECQQR 145
             H ++   LV+E++   S+D   F    A+    L  I        +GL + H     R
Sbjct: 73  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHR 126
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           ++H D+KPEN+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G 
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGC 181
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
              +   D++S G +  E+V RR
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 28  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 80
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            N+V L G C       ++ EY   G L  +L  K R +E +    IA  T      LH 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 141 ECQ----------QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
             Q          +  IH D+   NVLL      K+ DFGLA+    + +++     +  
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             + APE +  +   T + DV+S+G++L+EI
Sbjct: 230 VKWMAPESIF-DCVYTVQSDVWSYGILLWEI 259

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 85
           LG G F  V K  +   G++ A K + +   R     +  E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 146 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEFVAPEIV-- 190
Query: 202 NY-PITHKCDVYSFGMVLF 219
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G FG+V K +   +    A+K +     +++    ++EV  +    H  +VR Y   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS--TILSEVMLLASLNHQYVVRYYAAW 71
Query: 91  HDQH-----MTA--------LVYEYMENGSLDGYL----FGKKRAIEWEKLHEIAIGTAK 133
            ++      MTA        +  EY ENG+L   +      ++R   W    +I     +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR------------SH 181
            L Y+H    Q IIH D+KP N+ +D + + K+ DFGLAK   R+             S 
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             ++   GT  Y A E L G      K D+YS G++ FE++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 121/307 (39%), Gaps = 54/307 (17%)
Query: 28  YSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI 81
           Y   +G G FG V++ + P  +       +AVK+L        +  F  E   +    + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--------------- 126
           N+V+L G C       L++EYM  G L+ +L            H                
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 127 --------IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
                   IA   A G+ YL E   ++ +H D+   N L+  N   K+ADFGL++    +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNI-YS 226
Query: 179 RSHVTISGYKGTP-GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD 237
             +    G    P  +  PE +  N   T + DV+++G+VL+EI           S  L 
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIF----------SYGLQ 275
Query: 238 WFPKHVWEEYEKSELDATILACGIEEKDKE--KAKRLCMAALWCVQDSPEDRPPMSAVVK 295
            +     EE      D  ILAC  E    E     RLC + L      P DRP   ++ +
Sbjct: 276 PYYGMAHEEVIYYVRDGNILACP-ENCPLELYNLMRLCWSKL------PADRPSFCSIHR 328
Query: 296 MLEGVVE 302
           +L+ + E
Sbjct: 329 ILQRMCE 335

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA---IGTAKGLVYLHEECQQR 145
             H ++   LV+E++   S+D   F    A+    L  I        +GL + H     R
Sbjct: 71  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHR 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           ++H D+KPEN+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGC 179
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
              +   D++S G +  E+V RR
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 24  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT--P 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 144 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 198
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 199 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 227

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPAFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V K              +AVK+L  N         ++E   + +  H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------------------RAIEWE 122
           LYG C       L+ EY + GSL G+L   +                       RA+   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   ++G+ YL E     ++H D+   N+L+      K++DFGL++      S V
Sbjct: 151 DLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             S  +    + A E L  ++  T + DV+SFG++L+EIV
Sbjct: 208 KRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIV 246

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ +N   K+ DFGL++  + + +    S  K    + APE ++     T 
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESINFRR-FTS 191
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 50/225 (22%)
Query: 32  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 92
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H 
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH- 202
Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            I  YK T        + APE L      TH+ DV+SFG++L+EI
Sbjct: 203 -IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 85
           LG G F  V K  +   G++ A K + +   R     ++ E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 146 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 202 NY-PITHKCDVYSFGMVLF 219
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 25  TSNYS--TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGR 77
           TS Y     +G G +G VYK + P +G  +A+K +    G     I+  + +A +  +  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 78  TYHINLVRLYGFCHDQHM-----TALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGT 131
             H N+VRL   C            LV+E+++   L  YL       +  E + ++    
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
            +GL +LH  C   I+H D+KPEN+L+ +  + K+ADFGLA++       + +     T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVVTL 175
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES 235
            Y APE L  +   T   D++S G +  E+  RR+    G+SE+
Sbjct: 176 WYRAPEVLLQSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 85
           LG G F  V K  +   G++ A K + +   R     ++ E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 146 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 202 NY-PITHKCDVYSFGMVLF 219
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 85
           LG G F  V K  +   G++ A K + +   R     ++ E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 146 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 202 NY-PITHKCDVYSFGMVLF 219
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 85
           LG G F  V K  +   G++ A K + +   R     ++ E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 146 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 202 NY-PITHKCDVYSFGMVLF 219
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++  Y   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 31/254 (12%)
Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G FG V++  +   G   A K +        +E    E+ T+    H  LV L+   
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
            D +   ++YE+M  G L   +  +   +  ++  E      KGL ++HE      +H D
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLD 174
Query: 151 IKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
           +KPEN++     S   K+ DFGL    D  +S   +    GT  ++APE   G  P+ + 
Sbjct: 175 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGK-PVGYY 230
Query: 209 CDVYSFGMVLFEIV-------GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI 261
            D++S G++ + ++       G   +  + + +S DW             +D +  + GI
Sbjct: 231 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------------NMDDSAFS-GI 277
Query: 262 EEKDKEKAKRLCMA 275
            E  K+  ++L +A
Sbjct: 278 SEDGKDFIRKLLLA 291

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 86/198 (43%), Gaps = 15/198 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVK---IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G  GEV      N V    +AVK+++        E    E+       H N+V+ YG
Sbjct: 14  LGEGAAGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              + ++  L  EY   G L   +    G          H++      G+VYLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 124
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L      
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV+S G+VL  ++ 
Sbjct: 185 AEPVDVWSCGIVLTAMLA 202

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ +N   K+ DFGL++  + + ++   S  K    + APE ++     T 
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 571
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++     D         I    +        +GL + H     R++H
Sbjct: 73  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 184
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++     D         I    +        +GL + H     R++H
Sbjct: 72  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 183
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ A    K+ DFGL++  + + ++   S  K    + APE ++     T 
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 191
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 232

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 120/294 (40%), Gaps = 44/294 (14%)
Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRL 86
           LG G FG V +G         +K+AVK +  +     E E+F++E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 87  YGFCHDQHMTAL-----VYEYMENGSLDGYLFGKK-----RAIEWEKLHEIAIGTAKGLV 136
            G C +     +     +  +M+ G L  YL   +     + I  + L +  +  A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
           YL     +  +H D+   N +L  + +  VADFGL+K       +      K    + A 
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI 256
           E L+     T K DV++FG+ ++EI  R      G          H   +Y         
Sbjct: 219 ESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQ-------NHEMYDY--------- 261
Query: 257 LACGIEEKDKEKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEVLP 305
           L  G   K  E     C+  L+     C +  P DRP  S +   LE ++E LP
Sbjct: 262 LLHGHRLKQPED----CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 52  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 111
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 112 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT--P 191
           G+ YL+     + +H D+   N ++  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 172 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 226
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 227 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 255

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVR 85
           LG G F  V K  +   G++ A K + +   R     ++ E+   EV  + +  H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L+    ++    L+ E +  G L  +L  +K ++  E+          G+ YLH    ++
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 146 IIHYDIKPENV-LLDANF---SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           I H+D+KPEN+ LLD N      K+ DFGLA   +     V      GTP + APE +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV-- 190
Query: 202 NY-PITHKCDVYSFGMVLF 219
           NY P+  + D++S G++ +
Sbjct: 191 NYEPLGLEADMWSIGVITY 209

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 31/254 (12%)
Query: 32  LGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G FG V++  +   G   A K +        +E    E+ T+    H  LV L+   
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
            D +   ++YE+M  G L   +  +   +  ++  E      KGL ++HE      +H D
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLD 280
Query: 151 IKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
           +KPEN++     S   K+ DFGL    D  +S   +    GT  ++APE   G  P+ + 
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGK-PVGYY 336
Query: 209 CDVYSFGMVLFEIV-------GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI 261
            D++S G++ + ++       G   +  + + +S DW             +D +  + GI
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------------NMDDSAFS-GI 383
Query: 262 EEKDKEKAKRLCMA 275
            E  K+  ++L +A
Sbjct: 384 SEDGKDFIRKLLLA 397

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 29  STRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN 82
           S  LG G FG VY+G     VK      +A+K +N         +F+ E   +      +
Sbjct: 17  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAK 133
           +VRL G       T ++ E M  G L  YL   +  +E           K+ ++A   A 
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT--P 191
           G+ YL+     + +H D+   N  +  +F+ K+ DFG+ +  D   +     G KG    
Sbjct: 137 GMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 191
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + +PE L      T+  DV+SFG+VL+EI
Sbjct: 192 RWMSPESLKDGVFTTY-SDVWSFGVVLWEI 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 32/232 (13%)
Query: 13  PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFM 69
           P  +  L  N+    +   +G G FG+V K +   +G+++  A+K +     +     F 
Sbjct: 16  PTIYPVLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73
Query: 70  AEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
            E+  + +  +H N++ L G C  +    L  EY  +G+L  +L  K R +E +    IA
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIA 132
Query: 129 IGTA----------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
             TA                +G+ YL    Q++ IH D+   N+L+  N+  K+ADFGL+
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS 189
Query: 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIVG 223
           +        V +    G          S NY + T   DV+S+G++L+EIV 
Sbjct: 190 R-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 32/232 (13%)
Query: 13  PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFM 69
           P  +  L  N+    +   +G G FG+V K +   +G+++  A+K +     +     F 
Sbjct: 6   PTIYPVLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 63
Query: 70  AEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
            E+  + +  +H N++ L G C  +    L  EY  +G+L  +L  K R +E +    IA
Sbjct: 64  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIA 122
Query: 129 IGTA----------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
             TA                +G+ YL    Q++ IH D+   N+L+  N+  K+ADFGL+
Sbjct: 123 NSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS 179
Query: 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIVG 223
           +        V +    G          S NY + T   DV+S+G++L+EIV 
Sbjct: 180 R-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 50/225 (22%)
Query: 32  LGFGGFGEVYKGQF-------PNGV-KIAVKVLNRNLGR------IAEEQFMAEVGTIGR 77
           LG G FG+V   +        PN V K+AVK+L  +         I+E + M  +G    
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--- 133
Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWE 122
             H N++ L G C       ++ EY   G+L  YL  ++                 +  +
Sbjct: 134 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA    R+  H 
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH- 243
Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            I  YK T        + APE L      TH+ DV+SFG++L+EI
Sbjct: 244 -IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 286

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 119
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 120 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 177 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 207

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 119
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 120 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 177 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 207

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 24  FTSNYST--RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY 79
           F  N+    ++G G +G VYK +    G  +A+K +  +          + E+  +    
Sbjct: 8   FMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+V+L    H ++   LV+E++               I    +        +GL + H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAP 196
                R++H D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y AP
Sbjct: 128 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 179
Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           E L G    +   D++S G +  E+V RR
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGF 89
           +G G +G+VYKG+    G   A+KV++  +    EE+   E+  + + ++H N+   YG 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 90  CHDQHMTA------LVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEEC 142
              ++         LV E+   GS+   +   K   ++ E +  I     +GL +LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 146
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-- 200
           Q ++IH DIK +NVLL  N   K+ DFG++   DR         + GTP + APE ++  
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACD 204
Query: 201 GNYPITH--KCDVYSFGMVLFEIV 222
            N   T+  K D++S G+   E+ 
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMA 228

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 32  LGFGGFGEVY--------KGQFPNGVKIAVKVLN-----RNLGRIAEEQFMAEVGTIGRT 78
           LG G FG+V         K +    V +AVK+L      ++L  +  E  M ++  IG+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 99
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEK 123
            H N++ L G C       ++  Y   G+L  YL  ++                 + ++ 
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
           L       A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+  +    +  
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            +  +    + APE L      TH+ DV+SFG++++EI
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGXKYY 181
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 25  TSNYS--TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGR 77
           TS Y     +G G +G VYK + P +G  +A+K +    G     I+  + +A +  +  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 78  TYHINLVRLYGFCHDQHM-----TALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGT 131
             H N+VRL   C            LV+E+++   L  YL       +  E + ++    
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
            +GL +LH  C   I+H D+KPEN+L+ +  + K+ADFGLA++     +   +     T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVV---VTL 175
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES 235
            Y APE L  +   T   D++S G +  E+  RR+    G+SE+
Sbjct: 176 WYRAPEVLLQSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 217

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G FGEV+KG      K+ A+K+++        E    E+  + +     + + YG 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 90  CHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 143
                   ++ EY+  GS LD         +E   L E  I T      KGL YLH E  
Sbjct: 89  YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 138
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            + IH DIK  NVLL  +   K+ADFG+A +L D   + +  + + GTP + APE +  +
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVIKQS 194
Query: 203 YPITHKCDVYSFGMVLFEIV 222
                K D++S G+   E+ 
Sbjct: 195 -AYDSKADIWSLGITAIELA 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 25/199 (12%)
Query: 30  TRLGFGGFGEVYK-----GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
           + LG G    VY+      Q P  +K+  K +++ + R        E+G + R  H N++
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR-------TEIGVLLRLSHPNII 111
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +L          +LV E +  G L   +  K    E +    +     + + YLHE    
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK-QILEAVAYLHE---N 167
Query: 145 RIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
            I+H D+KPEN LL A  +P    K+ADFGL+K+ +     V +    GTPGY APE L 
Sbjct: 168 GIVHRDLKPEN-LLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPEILR 223
Query: 201 GNYPITHKCDVYSFGMVLF 219
           G      + D++S G++ +
Sbjct: 224 GC-AYGPEVDMWSVGIITY 241

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KPEN+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 129 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 183
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 24  FTSNYST--RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY 79
           F  N+    ++G G +G VYK +    G  +A+K +  +          + E+  +    
Sbjct: 8   FMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+V+L    H ++   LV+E++               I    +        +GL + H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAP 196
                R++H D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y AP
Sbjct: 128 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAP 179
Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           E L G    +   D++S G +  E+V RR
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G FGEV+KG      K+ A+K+++        E    E+  + +     + + YG 
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 90  CHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 143
                   ++ EY+  GS LD         +E   L E  I T      KGL YLH E  
Sbjct: 74  YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 123
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            + IH DIK  NVLL  +   K+ADFG+A +L D   + +  + + GTP + APE +  +
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVIKQS 179
Query: 203 YPITHKCDVYSFGMVLFEIV 222
                K D++S G+   E+ 
Sbjct: 180 -AYDSKADIWSLGITAIELA 198

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G FGEV+KG      K+ A+K+++        E    E+  + +     + + YG 
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 90  CHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 143
                   ++ EY+  GS LD         +E   L E  I T      KGL YLH E  
Sbjct: 74  YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 123
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            + IH DIK  NVLL  +   K+ADFG+A +L D   + +  + + GTP + APE +  +
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIKQS 179
Query: 203 YPITHKCDVYSFGMVLFEIV 222
                K D++S G+   E+ 
Sbjct: 180 -AYDSKADIWSLGITAIELA 198

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G    ++   ++ E    G L  +L  +K +++   L   A   +  L YL     +R +
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   NVL+ A    K+ DFGL++  + + ++   S  K    + APE ++     T 
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR-FTS 571
Query: 208 KCDVYSFGMVLFEIV--------GRRRNAIVGSSESLDWFP 240
             DV+ FG+ ++EI+        G + N ++G  E+ +  P
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KPEN+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 128 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 182
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 149
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 181
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE L G    
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 180
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 155
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 216 SIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 145
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE L G    
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 180
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 181
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 130
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE L G    
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 185
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 186 STAVDIWSLGCIFAEMVTRR 205

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 145
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 152
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE L G    
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 182
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 153
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 214 SIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 144
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 205 SIDIWSVGCILAEMLSNR 222

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 167
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 17  TSLQLNNFTSNYST--RLGFGGFGEVYK-GQFPNGVKIAVKVLNRNLGR-----IAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K + +   +     ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
             EV  +    H N++ L+    ++    L+ E +  G L  +L  +K ++  E+  E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATEFL 120
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENV-LLDANFSP---KVADFGLAKLCDRNRSHVTI 184
                G+ YLH     +I H+D+KPEN+ LLD N      K+ DFGLA   D       I
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 185 SGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLF 219
               GTP + APE +  NY P+  + D++S G++ +
Sbjct: 178 F---GTPEFVAPEIV--NYEPLGLEADMWSIGVITY 208

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 16/196 (8%)
Query: 32  LGFGGFGEVY-----KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VY     K  F   +K+  K      G   E Q   E+      +H N++RL
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG--VEHQLRREIEIQAHLHHPNILRL 88
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y + +D+    L+ EY   G L   L  K    + ++   I    A  L+Y H    +++
Sbjct: 89  YNYFYDRRRIYLILEYAPRGELYKEL-QKSCTFDEQRTATIMEELADALMYCH---GKKV 144
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH DIKPEN+LL      K+ADFG +      R         GT  Y  PE + G     
Sbjct: 145 IHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC----GTLDYLPPEMIEGRMH-N 199
Query: 207 HKCDVYSFGMVLFEIV 222
            K D++  G++ +E++
Sbjct: 200 EKVDLWCIGVLCYELL 215

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG VY   +  N   +A+KVL ++       E Q   E+       H N++R+Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           + HD+    L+ E+   G L   L    R  E ++        A  L Y HE   +++IH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-QRSATFMEELADALHYCHE---RKVIH 137
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH- 207
            DIKPEN+L+      K+ADFG +      R         GT  Y  PE + G    TH 
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGK---THD 190
Query: 208 -KCDVYSFGMVLFEIV 222
            K D++  G++ +E +
Sbjct: 191 EKVDLWCAGVLCYEFL 206

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G FGEV+KG      K+ A+K+++        E    E+  + +     + + YG 
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 93
Query: 90  CHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 143
                   ++ EY+  GS LD         +E   L E  I T      KGL YLH E  
Sbjct: 94  YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 143
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            + IH DIK  NVLL  +   K+ADFG+A +L D   + +  + + GTP + APE +  +
Sbjct: 144 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIKQS 199
Query: 203 YPITHKCDVYSFGMVLFEIV 222
                K D++S G+   E+ 
Sbjct: 200 -AYDSKADIWSLGITAIELA 218

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH---SHRVLH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCKYY 181
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 31  RLGFGGFGEVYKGQFPNGVK--IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           R+G G FGEV+KG   N  +  +A+K+++        E    E+  + +     + + YG
Sbjct: 30  RIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYLHEECQ 143
                    ++ EY+  GS    L    RA  ++   E  I T      KGL YLH E  
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGLDYLHSE-- 139
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            + IH DIK  NVLL      K+ADFG+A +L D   + +  + + GTP + APE +  +
Sbjct: 140 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIQQS 195
Query: 203 YPITHKCDVYSFGMVLFEIV 222
                K D++S G+   E+ 
Sbjct: 196 -AYDSKADIWSLGITAIELA 214

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 31  RLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
           ++G G +G VYK      G+     KI +      +   A    + E+  +    H N+V
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA----IREISLLKELNHPNIV 65
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +L    H ++   LV+E++               I    +        +GL + H     
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SH 122
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           R++H D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE L G
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLG 177
Query: 202 NYPITHKCDVYSFGMVLFEIVGRR 225
               +   D++S G +  E+V RR
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 31  RLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
           ++G G +G VYK      G+     KI +      +   A    + E+  +    H N+V
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA----IREISLLKELNHPNIV 64
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +L    H ++   LV+E++               I    +        +GL + H     
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SH 121
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSG 201
           R++H D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE L G
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLG 176
Query: 202 NYPITHKCDVYSFGMVLFEIVGRR 225
               +   D++S G +  E+V RR
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG VY   +  N   +A+KVL ++       E Q   E+       H N++R+Y 
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           + HD+    L+ E+   G L   L    R  E ++        A  L Y HE   +++IH
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-QRSATFMEELADALHYCHE---RKVIH 138
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH- 207
            DIKPEN+L+      K+ADFG +      R         GT  Y  PE + G    TH 
Sbjct: 139 RDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGK---THD 191
Query: 208 -KCDVYSFGMVLFEIV 222
            K D++  G++ +E +
Sbjct: 192 EKVDLWCAGVLCYEFL 207

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 89  FCHDQHMTALVYE--------YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             H ++   LV+E        +M+  +L G      ++  ++ L        +GL + H 
Sbjct: 69  VIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLL--------QGLAFCH- 119
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPE 197
               R++H D+KP+N+L++   + K+ADFGLA+   +  R  +H  ++ +     Y APE
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPE 172
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            L G    +   D++S G +  E+V RR
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 28  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 80
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------RAIEWEKLHEIAIGT 131
            N+V L G C       ++ EY   G L  +L  K          R +E   L   +   
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A+G+ +L     +  IH D+   NVLL      K+ DFGLA+    + +++     +   
Sbjct: 162 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 231
            + APE +  +   T + DV+S+G++L+EI     N   G
Sbjct: 219 KWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 102/245 (41%), Gaps = 42/245 (17%)
Query: 18  SLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR 77
           SL L+N        +G G +G VYKG   +   +AVKV +      A  Q       I R
Sbjct: 9   SLDLDNL--KLLELIGRGRYGAVYKGSL-DERPVAVKVFS-----FANRQNFINEKNIYR 60
Query: 78  T---YHINLVRLYGFCHDQHMTA-------LVYEYMENGSLDGYLFGKKRAIEWEKLHEI 127
                H N+ R      D+ +TA       LV EY  NGSL  YL       +W     +
Sbjct: 61  VPLMEHDNIARF--IVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRL 116
Query: 128 AIGTAKGLVYLHEEC------QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR-- 179
           A    +GL YLH E       +  I H D+   NVL+  + +  ++DFGL+     NR  
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 180 -----SHVTISGYKGTPGYSAPEFLSGNYPITH------KCDVYSFGMVLFEIVGRRRNA 228
                 +  IS   GT  Y APE L G   +        + D+Y+ G++ +EI  R  + 
Sbjct: 177 RPGEEDNAAISEV-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 229 IVGSS 233
             G S
Sbjct: 236 FPGES 240

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 28  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 80
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------RAIEWEKLHEIAIGT 131
            N+V L G C       ++ EY   G L  +L  K          R +E   L   +   
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A+G+ +L     +  IH D+   NVLL      K+ DFGLA+    + +++     +   
Sbjct: 170 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            + APE +  +   T + DV+S+G++L+EI
Sbjct: 227 KWMAPESIF-DCVYTVQSDVWSYGILLWEI 255

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 181
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 25/227 (11%)
Query: 25  TSNYS--TRLGFGGFGEVYKGQFPNGVKI----AVKVLNRNLGR----IAEEQFMAEVGT 74
           TS Y     +G G +G VYK + P+        +V+V N   G     I+  + +A +  
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 75  IGRTYHINLVRLYGFCHDQHM-----TALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIA 128
           +    H N+VRL   C            LV+E+++   L  YL       +  E + ++ 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
               +GL +LH  C   I+H D+KPEN+L+ +  + K+ADFGLA++       + ++   
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALTPVV 180
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES 235
            T  Y APE L  +   T   D++S G +  E+  RR+    G+SE+
Sbjct: 181 VTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 181
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 183
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 181
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 180
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 91  HDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
            +  + A   E M++  L  +L G       K + +  + +        +GL Y+H    
Sbjct: 107 -NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 162
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGN 202
             ++H D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +
Sbjct: 163 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
              T   D++S G +L E++  R
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 184
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 183
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 180
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 117/236 (49%), Gaps = 20/236 (8%)
Query: 10  REKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAEEQF 68
           RE     +SL L +F  +    +G G + +V   +     +I A+KV+ + L  + +++ 
Sbjct: 8   RESGKASSSLGLQDF--DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL--VNDDED 63
Query: 69  MAEVGTIGRTY-----HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK 123
           +  V T    +     H  LV L+     +     V EY+  G L  +   ++R +  E 
Sbjct: 64  IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEH 122
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               +   +  L YLHE   + II+ D+K +NVLLD+    K+ D+G+ K  +  R   T
Sbjct: 123 ARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDT 177
Query: 184 ISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLFEIV-GRRRNAIVGSSESLD 237
            S + GTP Y APE L G +Y  +   D ++ G+++FE++ GR    IVGSS++ D
Sbjct: 178 TSXFCGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 231

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 130
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 185
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 186 STAVDIWSLGCIFAEMVTRR 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 182
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 73  VIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 184
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A++ ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 181
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 184
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 39/221 (17%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G FG+V K +   +    A+K +     +++    ++EV  +    H  +VR Y   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS--TILSEVMLLASLNHQYVVRYYAAW 71
Query: 91  HDQH-----MTA--------LVYEYMENGSLDGYL----FGKKRAIEWEKLHEIAIGTAK 133
            ++      MTA        +  EY EN +L   +      ++R   W    +I     +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR------------SH 181
            L Y+H    Q IIH D+KP N+ +D + + K+ DFGLAK   R+             S 
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             ++   GT  Y A E L G      K D+YS G++ FE++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTY-HINLVRLY 87
           +G G FG+V   +     V  AVKVL +   L +  E+  M+E   + +   H  LV L+
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
                      V +Y+  G L  Y   ++R     +    A   A  L YLH      I+
Sbjct: 106 FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIV 161
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPIT 206
           + D+KPEN+LLD+     + DFG   LC  N  H  T S + GTP Y APE L    P  
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFG---LCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYD 217
Query: 207 HKCDVYSFGMVLFEIV 222
              D +  G VL+E++
Sbjct: 218 RTVDWWCLGAVLYEML 233

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC- 90
           +G G +GEV++G +  G  +AVK+ +       +E+       +  T  +    + GF  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 91  ------HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 142
                 H      L+  Y E GSL  YL  +   ++      I +  A GL +LH E   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 143 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPE 197
              +  I H D+K +N+L+  N    +AD GLA +  ++ + + +      GT  Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 198 FLSGNYPIT-----HKCDVYSFGMVLFEIVGRR-RNAIV 230
            L     +       + D+++FG+VL+E+  R   N IV
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H     R++H
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 182
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           LG G FGEVY+G + N     + +AVK   ++     +E+FM+E   +    H ++V+L 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G   ++  T ++ E    G L  YL   K +++   L   ++   K + YL        +
Sbjct: 76  GIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 131
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   N+L+ +    K+ DFGL++  + +  +   S  +    + +PE ++     T 
Sbjct: 132 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRR-FTT 189
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
             DV+ F + ++EI+                F K  +   E  ++        +E+ D+ 
Sbjct: 190 ASDVWMFAVCMWEILS---------------FGKQPFFWLENKDVIGV-----LEKGDRL 229
Query: 268 KAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEV 303
               LC   L+     C    P DRP  + +V  L  V ++
Sbjct: 230 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 270

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC- 90
           +G G +GEV++G +  G  +AVK+ +       +E+       +  T  +    + GF  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 91  ------HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-- 142
                 H      L+  Y E GSL  YL  +   ++      I +  A GL +LH E   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 143 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPE 197
              +  I H D+K +N+L+  N    +AD GLA +  ++ + + +      GT  Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 198 FLSGNYPIT-----HKCDVYSFGMVLFEIVGRR-RNAIV 230
            L     +       + D+++FG+VL+E+  R   N IV
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 31  RLGFGGFGE-VYKGQFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G FG+ +      +G +  +K +N   +     E+   EV  +    H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 89  FCHDQHMTALVYEYMENGSL-------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
              +     +V +Y E G L        G LF + + ++W       +     L ++H+ 
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHD- 143
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
             ++I+H DIK +N+ L  + + ++ DFG+A++   N +        GTP Y +PE +  
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPE-ICE 198
Query: 202 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL 236
           N P  +K D+++ G VL+E+   +     GS ++L
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 32/232 (13%)
Query: 13  PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFM 69
           P  +  L  N+    +   +G G FG+V K +   +G+++  A+K +     +     F 
Sbjct: 13  PTIYPVLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 70
Query: 70  AEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIA 128
            E+  + +  +H N++ L G C  +    L  EY  +G+L  +L  K R +E +    IA
Sbjct: 71  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIA 129
Query: 129 IGTA----------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
             TA                +G+ YL    Q++ IH ++   N+L+  N+  K+ADFGL+
Sbjct: 130 NSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLS 186
Query: 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIVG 223
           +        V +    G          S NY + T   DV+S+G++L+EIV 
Sbjct: 187 R-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 15  RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAE 71
           +   LQ+     +    +G G FGEV   +     K+ A+K+L++   + R     F  E
Sbjct: 66  KIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEE 125
Query: 72  VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 131
              +       +V+L+    D     +V EYM  G L   +       +W K +     T
Sbjct: 126 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY-----T 180
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A+ ++ L       +IH D+KP+N+LLD +   K+ADFG     D     V      GTP
Sbjct: 181 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMVHCDTAVGTP 239
Query: 192 GYSAPEFL---SGNYPITHKCDVYSFGMVLFEIV 222
            Y +PE L    G+     +CD +S G+ LFE++
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E+++              I    +        +GL + H     R++H
Sbjct: 73  VIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 149 YDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KP+N+L++   + K+ADFGLA+   +  R   H  ++ +     Y APE L G    
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW-----YRAPEILLGCKYY 184
Query: 206 THKCDVYSFGMVLFEIVGRR 225
           +   D++S G +  E+V RR
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           LG G FGEVY+G + N     + +AVK   ++     +E+FM+E   +    H ++V+L 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G   ++  T ++ E    G L  YL   K +++   L   ++   K + YL        +
Sbjct: 92  GIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 147
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   N+L+ +    K+ DFGL++  + +  +   S  +    + +PE ++     T 
Sbjct: 148 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRR-FTT 205
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
             DV+ F + ++EI+                F K  +   E  ++        +E+ D+ 
Sbjct: 206 ASDVWMFAVCMWEILS---------------FGKQPFFWLENKDVIGV-----LEKGDRL 245
Query: 268 KAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEV 303
               LC   L+     C    P DRP  + +V  L  V ++
Sbjct: 246 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 286

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR---LYG 88
           +G G +GEV++G +  G  +AVK+ +       E+ +  E       Y+  ++R   + G
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRET----ELYNTVMLRHENILG 95
Query: 89  FC-------HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           F        H      L+  Y E GSL  YL  +   ++      I +  A GL +LH E
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIE 153
Query: 142 C-----QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYS 194
                 +  I H D+K +N+L+  N    +AD GLA +  ++ + + +      GT  Y 
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 195 APEFLSGNYPIT-----HKCDVYSFGMVLFEIVGRR-RNAIV 230
           APE L     +       + D+++FG+VL+E+  R   N IV
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 255

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 32  LGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           LG G FGEVY+G + N     + +AVK   ++     +E+FM+E   +    H ++V+L 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G   ++  T ++ E    G L  YL   K +++   L   ++   K + YL        +
Sbjct: 80  GIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DI   N+L+ +    K+ DFGL++  + +  +   S  +    + +PE ++     T 
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRR-FTT 193
Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
             DV+ F + ++EI+                F K  +   E  ++        +E+ D+ 
Sbjct: 194 ASDVWMFAVCMWEILS---------------FGKQPFFWLENKDVIGV-----LEKGDRL 233
Query: 268 KAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEV 303
               LC   L+     C    P DRP  + +V  L  V ++
Sbjct: 234 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 32  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 149
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPIT 206
           H D+   NVLL      K++DFGL+K    + ++     +   P  + APE ++  Y  +
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 208
Query: 207 HKCDVYSFGMVLFE 220
            K DV+SFG++++E
Sbjct: 209 SKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 32  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 149
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPIT 206
           H D+   NVLL      K++DFGL+K    + ++     +   P  + APE ++  Y  +
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 208
Query: 207 HKCDVYSFGMVLFE 220
            K DV+SFG++++E
Sbjct: 209 SKSDVWSFGVLMWE 222

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 30  TRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ------FMAEVGTIGRTYHIN 82
           T+LG G +GEVYK         +A+K +     R+  E+       + EV  +    H N
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           ++ L    H  H   L++EY EN  L  Y+  K   +    +         G+ + H   
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH--- 149
Query: 143 QQRIIHYDIKPENVLL---DANFSP--KVADFGLAK---LCDRNRSHVTISGYKGTPGYS 194
            +R +H D+KP+N+LL   DA+ +P  K+ DFGLA+   +  R  +H  I+ +     Y 
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW-----YR 204
Query: 195 APEFLSGNYPITHKCDVYSFGMVLFEIV 222
            PE L G+   +   D++S   +  E++
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 32  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 139
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPIT 206
           H D+   NVLL      K++DFGL+K    + ++     +   P  + APE ++  Y  +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 198
Query: 207 HKCDVYSFGMVLFE 220
            K DV+SFG++++E
Sbjct: 199 SKSDVWSFGVLMWE 212

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 32  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 147
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPIT 206
           H D+   NVLL      K++DFGL+K    + ++     +   P  + APE ++  Y  +
Sbjct: 148 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 206
Query: 207 HKCDVYSFGMVLFE 220
            K DV+SFG++++E
Sbjct: 207 SKSDVWSFGVLMWE 220

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 25/231 (10%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVL--NRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +LG G +G VYK      G  +A+K +    +L     ++ + E+  + +    ++V+ Y
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSPHVVKYY 90
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         +V EY   GS+   +  + + +  +++  I   T KGL YLH     R I
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKI 147
Query: 148 HYDIKPENVLLDANFSPKVADFGLA-KLCDR--NRSHVTISGYKGTPGYSAPEFLSGNYP 204
           H DIK  N+LL+     K+ADFG+A +L D    R+ V      GTP + APE +     
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-----GTPFWMAPEVIQ---E 199
Query: 205 ITHKC--DVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEKSEL 252
           I + C  D++S G+   E+  G+   A +    ++   P +    + K EL
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL 250

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 32  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 133
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPIT 206
           H D+   NVLL      K++DFGL+K    + ++     +   P  + APE ++  Y  +
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 192
Query: 207 HKCDVYSFGMVLFE 220
            K DV+SFG++++E
Sbjct: 193 SKSDVWSFGVLMWE 206

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 37/281 (13%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ---FMAEVGTIGRTYHINLVRLYG 88
           +G G FG+VY G++   V I +  + R+     E+Q   F  EV    +T H N+V   G
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERD----NEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
            C      A++    +  +L   +   K  ++  K  +IA    KG+ YLH +    I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILH 153
Query: 149 YDIKPENVLLDANFSPKVADFGL---AKLCDRNRSHVTISGYKGTPGYSAPEFL------ 199
            D+K +NV  D N    + DFGL   + +    R    +    G   + APE +      
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 200 --SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL 257
                 P +   DV++ G + +E+  R        +E++      +W+     + + + +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------IWQMGTGMKPNLSQI 266
Query: 258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
             G E  D           L+C     E+RP  + ++ MLE
Sbjct: 267 GMGKEISD---------ILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 32  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 133
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKL--CDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           H D+   NVLL      K++DFGL+K    D N       G K    + APE ++  Y  
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG-KWPVKWYAPECIN-YYKF 191
Query: 206 THKCDVYSFGMVLFE 220
           + K DV+SFG++++E
Sbjct: 192 SSKSDVWSFGVLMWE 206

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 32  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 129
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPIT 206
           H D+   NVLL      K++DFGL+K    + ++     +   P  + APE ++  Y  +
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 188
Query: 207 HKCDVYSFGMVLFE 220
            K DV+SFG++++E
Sbjct: 189 SKSDVWSFGVLMWE 202

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 32  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 127
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPIT 206
           H D+   NVLL      K++DFGL+K    + ++     +   P  + APE ++  Y  +
Sbjct: 128 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 186
Query: 207 HKCDVYSFGMVLFE 220
            K DV+SFG++++E
Sbjct: 187 SKSDVWSFGVLMWE 200

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H  LV L+     +     V EY+  G L  +   ++R +  E     +   +  L YLH
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
           E   + II+ D+K +NVLLD+    K+ D+G+ K  +  R   T S + GTP Y APE L
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 200 SG-NYPITHKCDVYSFGMVLFEIV-GRRRNAIVGSSESLD 237
            G +Y  +   D ++ G+++FE++ GR    IVGSS++ D
Sbjct: 226 RGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H  LV L+     +     V EY+  G L  +   ++R +  E     +   +  L YLH
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
           E   + II+ D+K +NVLLD+    K+ D+G+ K  +  R   T S + GTP Y APE L
Sbjct: 124 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEIL 178
Query: 200 SG-NYPITHKCDVYSFGMVLFEIV-GRRRNAIVGSSESLD 237
            G +Y  +   D ++ G+++FE++ GR    IVGSS++ D
Sbjct: 179 RGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 216

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H  LV L+     +     V EY+  G L  +   ++R +  E     +   +  L YLH
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
           E   + II+ D+K +NVLLD+    K+ D+G+ K  +  R   T S + GTP Y APE L
Sbjct: 128 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEIL 182
Query: 200 SG-NYPITHKCDVYSFGMVLFEIV-GRRRNAIVGSSESLD 237
            G +Y  +   D ++ G+++FE++ GR    IVGSS++ D
Sbjct: 183 RGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  +    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 149
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 19/189 (10%)
Query: 36  GFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM 95
           G G+ Y  +F     I  + L+ +   ++ E+   EV  +    H N++ L+    ++  
Sbjct: 35  GTGKEYAAKF-----IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 89
Query: 96  TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155
             L+ E +  G L  +L  +K ++  ++  +       G+ YLH    +RI H+D+KPEN
Sbjct: 90  VVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPEN 145
Query: 156 V-LLDANF-SP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCD 210
           + LLD N  +P  K+ DFG+A   +       I    GTP + APE +  NY P+  + D
Sbjct: 146 IMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIV--NYEPLGLEAD 200
Query: 211 VYSFGMVLF 219
           ++S G++ +
Sbjct: 201 MWSIGVITY 209

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 19/189 (10%)
Query: 36  GFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM 95
           G G+ Y  +F     I  + L+ +   ++ E+   EV  +    H N++ L+    ++  
Sbjct: 28  GTGKEYAAKF-----IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82
Query: 96  TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155
             L+ E +  G L  +L  +K ++  ++  +       G+ YLH    +RI H+D+KPEN
Sbjct: 83  VVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPEN 138
Query: 156 V-LLDANF-SP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCD 210
           + LLD N  +P  K+ DFG+A   +       I    GTP + APE +  NY P+  + D
Sbjct: 139 IMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIV--NYEPLGLEAD 193
Query: 211 VYSFGMVLF 219
           ++S G++ +
Sbjct: 194 MWSIGVITY 202

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 32  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 437 GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 491
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPIT 206
           H D+   NVLL      K++DFGL+K    + ++     +   P  + APE ++  Y  +
Sbjct: 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 550
Query: 207 HKCDVYSFGMVLFE 220
            K DV+SFG++++E
Sbjct: 551 SKSDVWSFGVLMWE 564

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 32  LGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIA-EEQFMAEVGTIGRTYHINLVRLY 87
           LG G FG V KG +        +AVK+L       A +++ +AE   + +  +  +VR+ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      +
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFV 492
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPIT 206
           H D+   NVLL      K++DFGL+K    + ++     +   P  + APE ++  Y  +
Sbjct: 493 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFS 551
Query: 207 HKCDVYSFGMVLFE 220
            K DV+SFG++++E
Sbjct: 552 SKSDVWSFGVLMWE 565

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 89
           LG G F  V +  + P G + A K++N       + Q +     I R   H N+VRL+  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ-QRIIH 148
             ++    LV++ +  G L   +  ++   E +  H I     + ++     C    I+H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI-----QQILESVNHCHLNGIVH 126
Query: 149 YDIKPENVLLDAN---FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KPEN+LL +     + K+ADFGLA   +         G+ GTPGY +PE L  + P 
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKD-PY 183
Query: 206 THKCDVYSFGMVLF 219
               D+++ G++L+
Sbjct: 184 GKPVDMWACGVILY 197

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  +    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 149
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y APE +  +   T 
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMA 70
           L +N+F+ +    +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M 
Sbjct: 186 LTMNDFSVHRI--IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 130
            + + G    I +   Y F H     + + + M  G L  Y   +        +   A  
Sbjct: 244 SLVSTGDCPFI-VCMSYAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAE 300
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
              GL ++H    + +++ D+KP N+LLD +   +++D GLA    + + H ++    GT
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 353
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            GY APE L          D +S G +LF+++
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMA 70
           L +N+F+ +    +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M 
Sbjct: 186 LTMNDFSVHRI--IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 130
            + + G    I +   Y F H     + + + M  G L  Y   +        +   A  
Sbjct: 244 SLVSTGDCPFI-VCMSYAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAE 300
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
              GL ++H    + +++ D+KP N+LLD +   +++D GLA    + + H ++    GT
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 353
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            GY APE L          D +S G +LF+++
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 89
           LG G F  V +  + P G + A K++N       + Q +     I R   H N+VRL+  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR-IIH 148
             ++    LV++ +  G L   +  ++   E +  H I     + ++     C    I+H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI-----QQILESVNHCHLNGIVH 126
Query: 149 YDIKPENVLLDAN---FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            D+KPEN+LL +     + K+ADFGLA   +         G+ GTPGY +PE L  + P 
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKD-PY 183
Query: 206 THKCDVYSFGMVLF 219
               D+++ G++L+
Sbjct: 184 GKPVDMWACGVILY 197

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           ++G G F EVY+     +GV +A+K +     +   A    + E+  + +  H N+++ Y
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 88  G-FCHDQHMTALVYEYMENGSLD---GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
             F  D  +  +V E  + G L     +   +KR I    + +  +     L ++H    
Sbjct: 99  ASFIEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSG 201
           +R++H DIKP NV + A    K+ D GL +      S  T + +   GTP Y +PE +  
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPERIHE 210
Query: 202 NYPITHKCDVYSFGMVLFEIVG 223
           N     K D++S G +L+E+  
Sbjct: 211 N-GYNFKSDIWSLGCLLYEMAA 231

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 27  NYSTRLGFGGFGEVYKG-QFPNGVKIA-VKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            +   +G G F  VYKG      V++A  ++ +R L +   ++F  E   +    H N+V
Sbjct: 29  KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIV 88
Query: 85  RLY----GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
           R Y         +    LV E   +G+L  YL  + +  + + L        KGL +LH 
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYL-KRFKVXKIKVLRSWCRQILKGLQFLHT 147
Query: 141 ECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
                IIH D+K +N+ +     S K+ D GLA L   + +   I    GTP + APE  
Sbjct: 148 RTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFXAPEXY 202
Query: 200 SGNYPITHKCDVYSFGMVLFE 220
              Y      DVY+FG    E
Sbjct: 203 EEKYD--ESVDVYAFGXCXLE 221

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMA 70
           L +N+F+ +    +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M 
Sbjct: 186 LTMNDFSVHRI--IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 130
            + + G    I +   Y F H     + + + M  G L  Y   +        +   A  
Sbjct: 244 SLVSTGDCPFI-VCMSYAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAE 300
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
              GL ++H    + +++ D+KP N+LLD +   +++D GLA    + + H ++    GT
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 353
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            GY APE L          D +S G +LF+++
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE-------EQFMA 70
           L +N+F+ +    +G GGFGEVY  +  +  K+ A+K L++   ++ +       E+ M 
Sbjct: 185 LTMNDFSVHRI--IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 130
            + + G    I +   Y F H     + + + M  G L  Y   +        +   A  
Sbjct: 243 SLVSTGDCPFI-VCMSYAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAE 299
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
              GL ++H    + +++ D+KP N+LLD +   +++D GLA    + + H ++    GT
Sbjct: 300 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 352
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            GY APE L          D +S G +LF+++
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGF 89
           LG G +G V K +  P+G  +AVK +   +    +++ + ++    RT      V  YG 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 90  CHDQHMTALVYEYMENGSLDGY---LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
              +    +  E M+  SLD +   +  K + I  + L +IA+   K L +LH +    +
Sbjct: 119 LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGYSAPEFLSGNYP 204
           IH D+KP NVL++A    K+ DFG++     + +    +G K    P    PE     Y 
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYS 235
Query: 205 ITHKCDVYSFGMVLFEIVGRR 225
           +  K D++S G+ + E+   R
Sbjct: 236 V--KSDIWSLGITMIELAILR 254

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 29  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRN---LGRIAEE----QFMAEVGTIGRTY 79
           S  LG G  GEV K  F      K+A+K++++    +G   E         E+  + +  
Sbjct: 15  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 138
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 130
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           HE     IIH D+KPENVLL +       K+ DFG +K+        T+    GTP Y A
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 184
Query: 196 PEFL--SGNYPITHKCDVYSFGMVLF 219
           PE L   G        D +S G++LF
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 29  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRN---LGRIAEE----QFMAEVGTIGRTY 79
           S  LG G  GEV K  F      K+A+K++++    +G   E         E+  + +  
Sbjct: 15  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 138
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 130
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           HE     IIH D+KPENVLL +       K+ DFG +K+        T+    GTP Y A
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 184
Query: 196 PEFL--SGNYPITHKCDVYSFGMVLF 219
           PE L   G        D +S G++LF
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 29  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRN---LGRIAEE----QFMAEVGTIGRTY 79
           S  LG G  GEV K  F      K+A+K++++    +G   E         E+  + +  
Sbjct: 15  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 138
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 130
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           HE     IIH D+KPENVLL +       K+ DFG +K+        T+    GTP Y A
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 184
Query: 196 PEFL--SGNYPITHKCDVYSFGMVLF 219
           PE L   G        D +S G++LF
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 126/310 (40%), Gaps = 55/310 (17%)
Query: 32  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V+  +  N       + +AVK L +     A + F  E   +    H ++VR
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 84
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRA---IEWEKLHEIAIGT 131
            +G C +     +V+EYM +G L+ +L            G+  A   +   +L  +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A G+VYL        +H D+   N L+      K+ DFG+++    +  +  + G    P
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLP 200
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
               P         T + DV+SFG+VL+EI                 + K  W +   +E
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT---------------YGKQPWYQLSNTE 245
Query: 252 LDATILACGIEEKDKEKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEVLPP 306
                + C  + ++ E+  R C   ++     C Q  P+ R  +  V   L+ + +  P 
Sbjct: 246 ----AIDCITQGRELER-PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 300
Query: 307 PKPFRYLDLI 316
                YLD++
Sbjct: 301 -----YLDVL 305

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   +     T  Y APE +  +   T 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 7/198 (3%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G +G V       N V++A+K ++    +   ++ + E+  + R  H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 91  HDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
               +  +  VY   +    D Y   K + +  + +        +GL Y+H      ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 152
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL+     K+ DFGLA++ D +  H   +     T  Y APE +  +   T 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 208 KCDVYSFGMVLFEIVGRR 225
             D++S G +L E++  R
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 29  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRN---LGRIAEE----QFMAEVGTIGRTY 79
           S  LG G  GEV K  F      K+A+K++++    +G   E         E+  + +  
Sbjct: 14  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 72
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 138
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 73  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 129
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           HE     IIH D+KPENVLL +       K+ DFG +K+        T+    GTP Y A
Sbjct: 130 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 183
Query: 196 PEFL--SGNYPITHKCDVYSFGMVLF 219
           PE L   G        D +S G++LF
Sbjct: 184 PEVLVSVGTAGYNRAVDCWSLGVILF 209

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 19/189 (10%)
Query: 36  GFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM 95
           G G+ Y  +F     I  + L  +   ++ E+   EV  +    H N++ L+    ++  
Sbjct: 49  GTGKEYAAKF-----IKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 103
Query: 96  TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155
             L+ E +  G L  +L  +K ++  ++  +       G+ YLH    +RI H+D+KPEN
Sbjct: 104 VVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPEN 159
Query: 156 V-LLDANF-SP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCD 210
           + LLD N  +P  K+ DFG+A   +       I    GTP + APE +  NY P+  + D
Sbjct: 160 IMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIV--NYEPLGLEAD 214
Query: 211 VYSFGMVLF 219
           ++S G++ +
Sbjct: 215 MWSIGVITY 223

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 32  LGFGGFGEVYKGQ-FPNGVK-IAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVR 85
           +G G +G+V+K +   NG + +A+K +    G     ++  + +A +  +    H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 86  LYGFC-----HDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLH 139
           L+  C       +    LV+E+++   L  YL    +  +  E + ++     +GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
                R++H D+KP+N+L+ ++   K+ADFGLA++       + ++    T  Y APE L
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVL 191
Query: 200 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
             +   T   D++S G +  E+  RR+    GSS+
Sbjct: 192 LQSSYAT-PVDLWSVGCIFAEMF-RRKPLFRGSSD 224

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 10/193 (5%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAV--KVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V K +  +  +I    K L  +  ++ ++  M E+  + +  H NLV L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 90  CHDQHMTALVYEYMENGSLDGY-LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    LV+E++++  LD   LF     ++++ + +       G+ + H      IIH
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCH---SHNIIH 147
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            DIKPEN+L+  +   K+ DFG A+                T  Y APE L G+      
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKA 205
Query: 209 CDVYSFGMVLFEI 221
            DV++ G ++ E+
Sbjct: 206 VDVWAIGCLVTEM 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 32  LGFGGFGEVYKGQ-FPNGVK-IAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVR 85
           +G G +G+V+K +   NG + +A+K +    G     ++  + +A +  +    H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 86  LYGFC-----HDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLH 139
           L+  C       +    LV+E+++   L  YL    +  +  E + ++     +GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
                R++H D+KP+N+L+ ++   K+ADFGLA++       + ++    T  Y APE L
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVL 191
Query: 200 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
             +   T   D++S G +  E+  RR+    GSS+
Sbjct: 192 LQSSYAT-PVDLWSVGCIFAEMF-RRKPLFRGSSD 224

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 15  RFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVG 73
           R+T LQ           +G G +G V          ++A+K ++    +   ++ + E+ 
Sbjct: 44  RYTQLQY----------IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQ 93
Query: 74  TIGRTYHINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 131
            + R  H N++ +        + A+  VY   +    D Y   K + +  + +       
Sbjct: 94  ILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQI 153
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGT 190
            +GL Y+H      ++H D+KP N+L++     K+ DFGLA++ D    H   ++    T
Sbjct: 154 LRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
             Y APE +  +   T   D++S G +L E++  R
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 126/310 (40%), Gaps = 55/310 (17%)
Query: 32  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V+  +  N       + +AVK L +     A + F  E   +    H ++VR
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 78
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRA---IEWEKLHEIAIGT 131
            +G C +     +V+EYM +G L+ +L            G+  A   +   +L  +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A G+VYL        +H D+   N L+      K+ DFG+++    +  +  + G    P
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLP 194
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
               P         T + DV+SFG+VL+EI                 + K  W +   +E
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT---------------YGKQPWYQLSNTE 239
Query: 252 LDATILACGIEEKDKEKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEVLPP 306
                + C  + ++ E+  R C   ++     C Q  P+ R  +  V   L+ + +  P 
Sbjct: 240 ----AIDCITQGRELER-PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 294
Query: 307 PKPFRYLDLI 316
                YLD++
Sbjct: 295 -----YLDVL 299

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 13/176 (7%)
Query: 51  IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDG 110
            AVK++++ +    +++  A     G   H N+V+L+   HDQ  T LV E +  G L  
Sbjct: 39  FAVKIISKRMEANTQKEITALKLCEG---HPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95
Query: 111 YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVA 167
            +  KK   E E  + I       + ++H+     ++H D+KPEN+L    + N   K+ 
Sbjct: 96  RIKKKKHFSETEASY-IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKII 151
Query: 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 223
           DFG A+L   +   +    +  T  Y+APE L+ N      CD++S G++L+ ++ 
Sbjct: 152 DFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQN-GYDESCDLWSLGVILYTMLS 204

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 29  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRN---LGRIAEE----QFMAEVGTIGRTY 79
           S  LG G  GEV K  F      K+A+K++++    +G   E         E+  + +  
Sbjct: 21  SKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 79
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 138
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 80  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 136
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           HE     IIH D+KPENVLL +       K+ DFG +K+        T+    GTP Y A
Sbjct: 137 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 190
Query: 196 PEFL--SGNYPITHKCDVYSFGMVLF 219
           PE L   G        D +S G++LF
Sbjct: 191 PEVLVSVGTAGYNRAVDCWSLGVILF 216

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 32  LGFGGFGEVYK----GQFPNGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLV 84
           LG G FG+V      G    GV I  AVK+L         E  M+E+  + +   H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKK----------------------RAIEWE 122
            L G C       L++EY   G L  YL  K+                        + +E
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
            L   A   AKG+ +L     +  +H D+   NVL+      K+ DFGLA+    + ++V
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 183 TISGYKGTPGYSAPEFL-SGNYPITHKCDVYSFGMVLFEI 221
                +    + APE L  G Y I  K DV+S+G++L+EI
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTI--KSDVWSYGILLWEI 267

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-- 88
           +G GGFG+V+K +   +G    +K +  N      E+   EV  + +  H+N+V   G  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 89  --FCHDQHMTA------------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI--GTA 132
             F +D   ++            +  E+ + G+L+ ++  K+R  + +K+  + +     
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQIT 132
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC----DRNRSHVTISGYK 188
           KG+ Y+H    +++I+ D+KP N+ L      K+ DFGL         R RS       K
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS-------K 182
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE 248
           GT  Y +PE +S       + D+Y+ G++L E++    +    + E+  +F         
Sbjct: 183 GTLRYMSPEQISSQ-DYGKEVDLYALGLILAELL----HVCDTAFETSKFF--------- 228
Query: 249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
            ++L   I++   ++K+K   ++L       +   PEDRP  S +++ L
Sbjct: 229 -TDLRDGIISDIFDKKEKTLLQKL-------LSKKPEDRPNTSEILRTL 269

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 32  LGFGGFGEVYKGQ-FPNGVK-IAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVR 85
           +G G +G+V+K +   NG + +A+K +    G     ++  + +A +  +    H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 86  LYGFC-----HDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLH 139
           L+  C       +    LV+E+++   L  YL    +  +  E + ++     +GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
                R++H D+KP+N+L+ ++   K+ADFGLA++       + ++    T  Y APE L
Sbjct: 138 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVL 191
Query: 200 SGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
             +   T   D++S G +  E+  RR+    GSS+
Sbjct: 192 LQSSYAT-PVDLWSVGCIFAEMF-RRKPLFRGSSD 224

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGF 89
           LG G +G V K +  P+G  +AVK +   +    +++ + ++    RT      V  YG 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 90  CHDQHMTALVYEYMENGSLDGY---LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
              +    +  E M+  SLD +   +  K + I  + L +IA+   K L +LH +    +
Sbjct: 75  LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGYSAPEFLSGNYP 204
           IH D+KP NVL++A    K+ DFG++     + +    +G K    P    PE     Y 
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191
Query: 205 ITHKCDVYSFGMVLFEIVGRR 225
           +  K D++S G+ + E+   R
Sbjct: 192 V--KSDIWSLGITMIELAILR 210

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 126/310 (40%), Gaps = 55/310 (17%)
Query: 32  LGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG G FG+V+  +  N       + +AVK L +     A + F  E   +    H ++VR
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 107
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRA---IEWEKLHEIAIGT 131
            +G C +     +V+EYM +G L+ +L            G+  A   +   +L  +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           A G+VYL        +H D+   N L+      K+ DFG+++    +  +  + G    P
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLP 223
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE 251
               P         T + DV+SFG+VL+EI                 + K  W +   +E
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT---------------YGKQPWYQLSNTE 268
Query: 252 LDATILACGIEEKDKEKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEVLPP 306
                + C  + ++ E+  R C   ++     C Q  P+ R  +  V   L+ + +  P 
Sbjct: 269 ----AIDCITQGRELER-PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323
Query: 307 PKPFRYLDLI 316
                YLD++
Sbjct: 324 -----YLDVL 328

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGF 89
           +G G +G V K    P+G  +AVK +   +    ++Q + ++  + R+     +V+ YG 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 90  CHDQHMTALVYEYMENGSLDG---YLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
              +    +  E M   S D    Y++      I  E L +I + T K L +L E    +
Sbjct: 90  LFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--K 146
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGN-- 202
           IIH DIKP N+LLD + + K+ DFG++ +L D     +  +   G   Y APE +  +  
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCRPYMAPERIDPSAS 202
Query: 203 ---YPITHKCDVYSFGMVLFEIVGRR 225
              Y +  + DV+S G+ L+E+   R
Sbjct: 203 RQGYDV--RSDVWSLGITLYELATGR 226

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 22  NNFTSNYST--RLGFGGFGEVYK--GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR 77
             FT +Y     LG G F  V +   + P   + A K++N       + Q +     I R
Sbjct: 27  TRFTDDYQLFEELGKGAFSVVRRCVKKTPTQ-EYAAKIINTKKLSARDHQKLEREARICR 85
Query: 78  TY-HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLV 136
              H N+VRL+    ++    LV++ +  G L   +  ++   E +  H I     + + 
Sbjct: 86  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH-QILESVN 144
Query: 137 YLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           ++H   Q  I+H D+KPEN+LL +     + K+ADFGLA   +         G+ GTPGY
Sbjct: 145 HIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGY 199
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLF 219
            +PE L  + P     D+++ G++L+
Sbjct: 200 LSPEVLRKD-PYGKPVDIWACGVILY 224

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 18  SLQLNNF--TSNYSTRLGFGGFGEVY-KGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT 74
           S+Q  N   T  +   LG G F EV+   Q   G   A+K + ++     +     E+  
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAV 59
Query: 75  IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKG 134
           + +  H N+V L           LV + +  G L   +   +R +  EK   + I     
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGVYTEKDASLVIQQVLS 117
Query: 135 LV-YLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            V YLHE     I+H D+KPEN+L    + N    + DFGL+K+      +  +S   GT
Sbjct: 118 AVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGT 170
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           PGY APE L+   P +   D +S G++ +
Sbjct: 171 PGYVAPEVLAQK-PYSKAVDCWSIGVITY 198

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           ++   LG G F EV   +     K +A+K + +      E     E+  + +  H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L           L+ + +  G L   +  K    E +    +       + YLH+     
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-SRLIFQVLDAVKYLHD---LG 136
Query: 146 IIHYDIKPENVL---LDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           I+H D+KPEN+L   LD +    ++DFGL+K+ D       +S   GTPGY APE L+  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK 193
Query: 203 YPITHKCDVYSFGMVLF 219
            P +   D +S G++ +
Sbjct: 194 -PYSKAVDCWSIGVIAY 209

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           ++   LG G F EV   +     K +A+K + +      E     E+  + +  H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L           L+ + +  G L   +  K    E +    +       + YLH+     
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-SRLIFQVLDAVKYLHD---LG 136
Query: 146 IIHYDIKPENVL---LDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           I+H D+KPEN+L   LD +    ++DFGL+K+ D       +S   GTPGY APE L+  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK 193
Query: 203 YPITHKCDVYSFGMVLF 219
            P +   D +S G++ +
Sbjct: 194 -PYSKAVDCWSIGVIAY 209

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           ++   LG G F EV   +     K +A+K + +      E     E+  + +  H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L           L+ + +  G L   +  K    E +    +       + YLH+     
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-SRLIFQVLDAVKYLHD---LG 136
Query: 146 IIHYDIKPENVL---LDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           I+H D+KPEN+L   LD +    ++DFGL+K+ D       +S   GTPGY APE L+  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK 193
Query: 203 YPITHKCDVYSFGMVLF 219
            P +   D +S G++ +
Sbjct: 194 -PYSKAVDCWSIGVIAY 209

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 24  FTSNYST--RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 79
           F S Y     LG G F  V +  +   G + A K++N       + Q +     I R   
Sbjct: 20  FQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLK 79
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+VRL+    ++    L+++ +  G L   +  ++   E +  H I     + +++ H
Sbjct: 80  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCH 138
Query: 140 EECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
              Q  ++H D+KPEN+LL +     + K+ADFGLA   +  +      G+ GTPGY +P
Sbjct: 139 ---QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSP 193
Query: 197 EFLSGNYPITHKCDVYSFGMVLF 219
           E L  + P     D+++ G++L+
Sbjct: 194 EVLRKD-PYGKPVDLWACGVILY 215

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           ++   LG G F EV   +     K +A+K + +      E     E+  + +  H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L           L+ + +  G L   +  K    E +    +       + YLH+     
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA-SRLIFQVLDAVKYLHD---LG 136
Query: 146 IIHYDIKPENVL---LDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           I+H D+KPEN+L   LD +    ++DFGL+K+ D       +S   GTPGY APE L+  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLA-Q 192
Query: 203 YPITHKCDVYSFGMVLF 219
            P +   D +S G++ +
Sbjct: 193 KPYSKAVDCWSIGVIAY 209

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FGEV   +  +  K+ A+K+L++   + R     F  E   +       +V+L+ 
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              D     +V EYM  G L   +       +W + +     TA+ ++ L        IH
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIH 196
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS---GNYPI 205
            D+KP+N+LLD +   K+ADFG     ++    V      GTP Y +PE L    G+   
Sbjct: 197 RDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQGGDGYY 255
Query: 206 THKCDVYSFGMVLFEIV 222
             +CD +S G+ L+E++
Sbjct: 256 GRECDWWSVGVFLYEML 272

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 27  NYSTRLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTY 79
           N    LG G FG+V +       +      +AVK+L            M+E+   I   +
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 80  HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGK-----------KRAIEWEKLHEI 127
           H+N+V L G C       +V  E+ + G+L  YL  K           K  +  E L   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
           +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
           +    + APE +      T + DV+SFG++L+EI
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 239

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FGEV   +  +  K+ A+K+L++   + R     F  E   +       +V+L+ 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              D     +V EYM  G L   +       +W + +     TA+ ++ L        IH
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIH 191
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS---GNYPI 205
            D+KP+N+LLD +   K+ADFG     ++    V      GTP Y +PE L    G+   
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250
Query: 206 THKCDVYSFGMVLFEIV 222
             +CD +S G+ L+E++
Sbjct: 251 GRECDWWSVGVFLYEML 267

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRT-Y 79
           ++   LG G FG+V +      +K      +AVK+L  +      E  M+E+  +     
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-------------- 125
           H+N+V L G C     T ++ EY   G L  +L  K+ +    K                
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 126 ---EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
                +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    + ++V
Sbjct: 162 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
                +    + APE +  N   T + DV+S+G+ L+E+
Sbjct: 219 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWEL 256

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FGEV   +  +  K+ A+K+L++   + R     F  E   +       +V+L+ 
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              D     +V EYM  G L   +       +W + +     TA+ ++ L        IH
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIH 196
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS---GNYPI 205
            D+KP+N+LLD +   K+ADFG     ++    V      GTP Y +PE L    G+   
Sbjct: 197 RDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQGGDGYY 255
Query: 206 THKCDVYSFGMVLFEIV 222
             +CD +S G+ L+E++
Sbjct: 256 GRECDWWSVGVFLYEML 272

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 7   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 65  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 121
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 122 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 176
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 177 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 2   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 60  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 171
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 172 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 33/233 (14%)
Query: 28  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 80
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 35  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK----------------------RA 118
            N+V L G C       ++ EY   G L  +L  K                       R 
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 119 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
           +E   L   +   A+G+ +L     +  IH D+   NVLL      K+ DFGLA+    +
Sbjct: 155 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 231
            +++     +    + APE +  +   T + DV+S+G++L+EI     N   G
Sbjct: 212 SNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRT-Y 79
           ++   LG G FG+V +      +K      +AVK+L  +      E  M+E+  +     
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-------------- 125
           H+N+V L G C     T ++ EY   G L  +L  K+ +    K                
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 126 ---EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
                +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    + ++V
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV 225
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
                +    + APE +  N   T + DV+S+G+ L+E+
Sbjct: 226 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWEL 263

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRT-Y 79
           ++   LG G FG+V +      +K      +AVK+L  +      E  M+E+  +     
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-------------- 125
           H+N+V L G C     T ++ EY   G L  +L  K+ +    K                
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 126 ---EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
                +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    + ++V
Sbjct: 164 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 220
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
                +    + APE +  N   T + DV+S+G+ L+E+
Sbjct: 221 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWEL 258

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 2   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 60  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 171
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 172 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRT-Y 79
           ++   LG G FG+V +      +K      +AVK+L  +      E  M+E+  +     
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-------------- 125
           H+N+V L G C     T ++ EY   G L  +L  K+ +    K                
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 126 ---EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
                +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    + ++V
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 225
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
                +    + APE +  N   T + DV+S+G+ L+E+
Sbjct: 226 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWEL 263

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 5   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 63  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 119
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 120 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 174
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 175 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 2   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 60  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 171
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 172 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 29  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRNLGRIAEEQ-------FMAEVGTIGRTY 79
           S  LG G  GEV K  F      K+A++++++    I   +          E+  + +  
Sbjct: 140 SKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 138
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 199 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 255
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           HE     IIH D+KPENVLL +       K+ DFG +K+        T+    GTP Y A
Sbjct: 256 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 309
Query: 196 PEFL--SGNYPITHKCDVYSFGMVLF 219
           PE L   G        D +S G++LF
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILF 335

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 24  FTSNYSTR--LGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAEE---------QFMAE 71
           ++  YST   LG G FG V+        K + VK + +   ++ E+         +   E
Sbjct: 22  YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKE--KVLEDCWIEDPKLGKVTLE 79
Query: 72  VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI---A 128
           +  + R  H N++++     +Q    LV E   +G LD + F  +     E L       
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
           + +A G + L +     IIH DIK EN+++  +F+ K+ DFG A   +R +   T   + 
Sbjct: 139 LVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FC 190
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           GT  Y APE L GN     + +++S G+ L+ +V
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 2   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 60  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 171
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 172 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 29  STRLGFGGFGEVYKGQFPNGV--KIAVKVLNRNLGRIAEEQ-------FMAEVGTIGRTY 79
           S  LG G  GEV K  F      K+A++++++    I   +          E+  + +  
Sbjct: 154 SKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 212
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE-KLHEIAIGTAKGLVYL 138
           H  ++++  F  D     +V E ME G L   + G KR  E   KL+   +  A  + YL
Sbjct: 213 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 269
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           HE     IIH D+KPENVLL +       K+ DFG +K+        T+    GTP Y A
Sbjct: 270 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLA 323
Query: 196 PEFL--SGNYPITHKCDVYSFGMVLF 219
           PE L   G        D +S G++LF
Sbjct: 324 PEVLVSVGTAGYNRAVDCWSLGVILF 349

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 27  NYSTRLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTY 79
           N    LG G FG+V +       +      +AVK+L            M+E+   I   +
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 80  HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGK-----------KRAIEWEKLHEI 127
           H+N+V L G C       +V  E+ + G+L  YL  K           K  +  E L   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
           +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
           +    + APE +      T + DV+SFG++L+EI
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 239

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIA----VKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           ++G G +G V+K +     +I     V++ + + G       + E+  +    H N+VRL
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELKHKNIVRL 66
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           +   H      LV+E+ +   L  Y       ++ E +        KGL + H    + +
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG---TPGYSAPEFLSGNY 203
           +H D+KP+N+L++ N   K+ADFGLA+        + +  Y     T  Y  P+ L G  
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLAR-----AFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 204 PITHKCDVYSFGMVLFEIVGRRRNAIVGSS 233
             +   D++S G +  E+    R    G+ 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGND 207

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 27  NYSTRLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRT-Y 79
           ++   LG G FG+V +      +K      +AVK+L  +      E  M+E+  +     
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-------------- 125
           H+N+V L G C     T ++ EY   G L  +L  K+ +    K                
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 126 ---EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
                +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    + ++V
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
                +    + APE +  N   T + DV+S+G+ L+E+
Sbjct: 203 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWEL 240

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N+F  +Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 2   VTMNDF--DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             T H  L  L Y F  HD+     V EY   G L  +L  ++R    E+          
Sbjct: 60  QNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH    + +++ DIK EN++LD +   K+ DFGL K  +      T+  + GTP Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 171
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 172 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 29  STRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRL 86
           S  LG G + +V       NG + AVK++ +  G  +  +   EV T+ +   + N++ L
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGH-SRSRVFREVETLYQCQGNKNILEL 76
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
             F  D     LV+E ++ GS+  ++  +K   E E    +    A  L +LH    + I
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREA-SRVVRDVAAALDFLH---TKGI 132
Query: 147 IHYDIKPENVLLDA--NFSP-KVADFGLAKLCDRNRSHVTISGYK-----GTPGYSAPE- 197
            H D+KPEN+L ++    SP K+ DF L      N S   I+  +     G+  Y APE 
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 198 ---FLSGNYPITHKCDVYSFGMVLF 219
              F         +CD++S G+VL+
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLY 217

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N F   Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 148 VTMNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 205
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             + H  L  L Y F  HD+     V EY   G L  +L  ++R    ++          
Sbjct: 206 QNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS 262
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH E  + +++ D+K EN++LD +   K+ DFGL K  +  +   T+  + GTP Y
Sbjct: 263 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 318
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 319 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N F   Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 145 VTMNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 202
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             + H  L  L Y F  HD+     V EY   G L  +L  ++R    ++          
Sbjct: 203 QNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS 259
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH E  + +++ D+K EN++LD +   K+ DFGL K  +  +   T+  + GTP Y
Sbjct: 260 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 315
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 316 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 32  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 84
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 85  RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK-------------KRAIEWEKLHEIAIG 130
            L G C       +V  E+ + G+L  YL  K             K  +  E L   +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V     +  
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             + APE +      T + DV+SFG++L+EI
Sbjct: 214 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 17  TSLQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVG 73
           + + +N F   Y   LG G FG+V    +   G   A+K+L + +    +E    + E  
Sbjct: 3   SRVTMNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 60
Query: 74  TIGRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 131
            +  + H  L  L Y F  HD+     V EY   G L  +L  ++R    ++        
Sbjct: 61  VLQNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEI 117
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
              L YLH E  + +++ D+K EN++LD +   K+ DFGL K  +  +   T+  + GTP
Sbjct: 118 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTP 173
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            Y APE L  N       D +  G+V++E++  R
Sbjct: 174 EYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 206

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FG+V   Q  +  K+ A+K +N+   + R        E+  +    H  LV L+ 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              D+    +V + +  G L  Y   +    + E +          L YL     QRIIH
Sbjct: 83  SFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIH 138
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI--T 206
            D+KP+N+LLD +    + DF +A +  R      I+   GT  Y APE  S       +
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAPEMFSSRKGAGYS 195
Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSES 235
              D +S G+  +E++  RR   + SS S
Sbjct: 196 FAVDWWSLGVTAYELLRGRRPYHIRSSTS 224

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G FG+V K +   +    A+K +     +++    ++EV  +    H  +VR Y   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS--TILSEVXLLASLNHQYVVRYYAAW 71
Query: 91  HDQH-----MTA--------LVYEYMENGSLDGYL----FGKKRAIEWEKLHEIAIGTAK 133
            ++       TA        +  EY EN +L   +      ++R   W    +I     +
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR------------SH 181
            L Y+H    Q IIH ++KP N+ +D + + K+ DFGLAK   R+             S 
Sbjct: 128 ALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             ++   GT  Y A E L G      K D YS G++ FE +
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N F   Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 7   VTMNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 64
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             + H  L  L Y F  HD+     V EY   G L  +L  ++R    ++          
Sbjct: 65  QNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS 121
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH E  + +++ D+K EN++LD +   K+ DFGL K  +  +   T+  + GTP Y
Sbjct: 122 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEY 177
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 178 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 16/216 (7%)
Query: 23  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 79
           N +S++  +  LG G +G V      P G  +A+K +      +   + + E+  +    
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 80  HINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 137
           H N++ ++             VY   E    D +     + +  + +      T + +  
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT--------ISGYKG 189
           LH      +IH D+KP N+L+++N   KV DFGLA++ D + +  +        ++ Y  
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           T  Y APE +  +   +   DV+S G +L E+  RR
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTI 75
           + +N F   Y   LG G FG+V    +   G   A+K+L + +    +E    + E   +
Sbjct: 6   VTMNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 63
Query: 76  GRTYHINLVRL-YGF-CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
             + H  L  L Y F  HD+     V EY   G L  +L  ++R    ++          
Sbjct: 64  QNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS 120
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
            L YLH E  + +++ D+K EN++LD +   K+ DFGL K  +  +   T+  + GTP Y
Sbjct: 121 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEY 176
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE L  N       D +  G+V++E++  R
Sbjct: 177 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 99/237 (41%), Gaps = 54/237 (22%)
Query: 32  LGFGGFGEVYKGQFPNGVKI--AVKVLNRNLGRIAE----EQFMAEVGTIGRTYHINLVR 85
           +G G +G V +    N  +   A+K++N+N  R       E+   EV  + + +H N+ R
Sbjct: 34  IGQGSYG-VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 86  LYGFCHDQHMTALVYEYMENGSL-----------------------------------DG 110
           LY    D+    LV E    G L                                   +G
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 111 YLFGKKRAIEW---EKL-HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN--FSP 164
            + G + ++++   EKL   I       L YLH    Q I H DIKPEN L   N  F  
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEI 209
Query: 165 KVADFGLAKLCDR--NRSHVTISGYKGTPGYSAPEFL-SGNYPITHKCDVYSFGMVL 218
           K+ DFGL+K   +  N  +  ++   GTP + APE L + N     KCD +S G++L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 132/298 (44%), Gaps = 66/298 (22%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG-- 88
           +G GGFG+V+K +   +G    ++ +  N      E+   EV  + +  H+N+V   G  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYN-----NEKAEREVKALAKLDHVNIVHYNGCW 74
Query: 89  --FCHDQHMTA-------------------------LVYEYMENGSLDGYLFGKKRAIEW 121
             F +D   +                          +  E+ + G+L+ ++  K+R  + 
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKL 133
Query: 122 EKLHEIAI--GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179
           +K+  + +     KG+ Y+H    +++IH D+KP N+ L      K+ DFGL     +N 
Sbjct: 134 DKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL-KND 189
Query: 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF 239
              T S  KGT  Y +PE +S       + D+Y+ G++L E++    +    + E+  +F
Sbjct: 190 GKRTRS--KGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELL----HVCDTAFETSKFF 242
Query: 240 PKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
                     ++L   I++   ++K+K   ++L       +   PEDRP  S +++ L
Sbjct: 243 ----------TDLRDGIISDIFDKKEKTLLQKL-------LSKKPEDRPNTSEILRTL 283

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+     +
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SAS 212
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 27  NYSTRLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTY 79
           N    LG G FG+V +       +      +AVK+L            M+E+   I   +
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 80  HINLVRLYGFCHDQHMTALV-YEYMENGSLDGYLFGK--------------KRAIEWEKL 124
           H+N+V L G C       +V  E+ + G+L  YL  K              K  +  E L
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184
              +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V  
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
              +    + APE +      T + DV+SFG++L+EI
Sbjct: 208 GDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 26/226 (11%)
Query: 28  YSTRLGFGGFGEVYK------GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YH 80
           +   LG G FG+V +      G+    +K+AVK+L        +E  M+E+  +     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLH 125
            N+V L G C       ++ EY   G L  +L  K+                 +    L 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 126 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185
             +   A+G+ +L     +  IH D+   NVLL      K+ DFGLA+    + +++   
Sbjct: 170 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 231
             +    + APE +  +   T + DV+S+G++L+EI     N   G
Sbjct: 227 NARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 151
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK-SAC 210
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 211 KSSDLWALGCIIYQLVA 227

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSH-VTISGYKGT 190
           +GL Y+H     ++IH D+KP N+L++ N   K+ DFG+A+ LC     H   ++ Y  T
Sbjct: 169 RGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 226
             Y APE +   +  T   D++S G +  E++ RR+
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSH-VTISGYKGT 190
           +GL Y+H     ++IH D+KP N+L++ N   K+ DFG+A+ LC     H   ++ Y  T
Sbjct: 170 RGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 226
             Y APE +   +  T   D++S G +  E++ RR+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 130
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 131 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 189
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 190 KSSDLWALGCIIYQLVA 206

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 16  FTSLQLNNFTSNYST--RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEV 72
             ++    FT  Y     LG G F  V +  +   G + A  ++N       + Q +   
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 73  GTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 131
             I R   H N+VRL+    ++    L+++ +  G L   +  ++   E +  H I    
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QI 119
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDRNRSHVTISGYK 188
            + +++ H   Q  ++H ++KPEN+LL +     + K+ADFGLA   +  +      G+ 
Sbjct: 120 LEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFA 174
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           GTPGY +PE L  + P     D+++ G++L+
Sbjct: 175 GTPGYLSPEVLRKD-PYGKPVDLWACGVILY 204

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 131
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 132 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 190
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 191 KSSDLWALGCIIYQLVA 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 12/196 (6%)
Query: 28  YSTRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           +   LG G F EV   +    G   AVK + +   +  E     E+  + +  H N+V L
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVAL 85
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
                  +   LV + +  G L   +  K    E +    +       + YLH   +  I
Sbjct: 86  EDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTE-KDASTLIRQVLDAVYYLH---RMGI 141
Query: 147 IHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
           +H D+KPEN+L    D      ++DFGL+K+  +      +S   GTPGY APE L+   
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYVAPEVLAQK- 197
Query: 204 PITHKCDVYSFGMVLF 219
           P +   D +S G++ +
Sbjct: 198 PYSKAVDCWSIGVIAY 213

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 129
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 188
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 189 KSSDLWALGCIIYQLVA 205

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 150
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SAC 209
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 210 KSSDLWALGCIIYQLVA 226

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 154
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SAC 213
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 214 KSSDLWALGCIIYQLVA 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 128
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 129 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 187
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 188 KSSDLWALGCIIYQLVA 204

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 34/234 (14%)
Query: 4   FLQEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLNRN 59
           + QE+ +   E P R+ +L          + +G G +G V       +G+KIAVK L+R 
Sbjct: 38  YRQELNKTIWEVPERYQTL----------SPVGSGAYGSVCSSYDVKSGLKIAVKKLSRP 87
Query: 60  LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 116
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 88  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPATSLEEFNDVYLVTHLMGADLN 143
Query: 117 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 144 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 200
Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           A+  D       ++GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 201 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 12/193 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 89
           +G G F  V +  +   G + A K++N       + Q +     I R   H N+VRL+  
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             ++    LV++ +  G L   +  ++   E +  H I     + +++ H   Q  ++H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCH---QMGVVHR 127
Query: 150 DIKPENVLLDANF---SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           D+KPEN+LL +     + K+ADFGLA     ++      G+ GTPGY +PE L       
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPEVLRKE-AYG 184
Query: 207 HKCDVYSFGMVLF 219
              D+++ G++L+
Sbjct: 185 KPVDIWACGVILY 197

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 135
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 194
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 195 KSSDLWALGCIIYQLVA 211

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 32  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 84
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 85  RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 128
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V     +
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
               + APE +      T + DV+SFG++L+EI
Sbjct: 212 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 158
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 217
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 218 KSSDLWALGCIIYQLVA 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 151
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 210
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 211 KSSDLWALGCIIYQLVA 227

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 32  LGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRL 86
           LG G FG V + Q        VK+AVK+L  ++   ++ E+F+ E   +    H ++ +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 87  YGFCHDQH------MTALVYEYMENGSLDGYLFGKKRA-----IEWEKLHEIAIGTAKGL 135
            G            +  ++  +M++G L  +L   +       +  + L    +  A G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
            YL     +  IH D+   N +L  + +  VADFGL++       +      K    + A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG 231
            E L+ N    H  DV++FG+ ++EI+ R +    G
Sbjct: 208 LESLADNLYTVHS-DVWAFGVTMWEIMTRGQTPYAG 242

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 212
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 212
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 151
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 210
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 211 KSSDLWALGCIIYQLVA 227

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 14/106 (13%)
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI-- 184
           I I  A+ + +LH    + ++H D+KP N+    +   KV DFGL    D++    T+  
Sbjct: 169 IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 185 --------SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
                    G  GT  Y +PE + GN   +HK D++S G++LFE++
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELL 270

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIAV--KVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G V+K +  +  +I    K L      + ++  + E+  + +  H NLV L  
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 89  FCHDQHMTALVYEYMENG---SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
               +    LV+EY ++     LD Y    +R +    +  I   T + + + H   +  
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCH---KHN 122
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
            IH D+KPEN+L+  +   K+ DFG A+L      +        T  Y +PE L G+   
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQY 180
Query: 206 THKCDVYSFGMVLFEIVG 223
               DV++ G V  E++ 
Sbjct: 181 GPPVDVWAIGCVFAELLS 198

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 32  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 84
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 85  RLYGFCHDQHMTALVY-EYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 128
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V     +
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
               + APE +      T + DV+SFG++L+EI
Sbjct: 203 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 234

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 32  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 84
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 85  RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 128
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V     +
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
               + APE +      T + DV+SFG++L+EI
Sbjct: 203 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 234

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 65/131 (49%), Gaps = 16/131 (12%)
Query: 98  LVYEYMENGSL---DGYLFGKKRA----IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
           ++YEYMEN S+   D Y F   +     I  + +  I         Y+H E  + I H D
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRD 177
Query: 151 IKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT-HK 208
           +KP N+L+D N   K++DFG ++ + D+      I G +GT  +  PEF S        K
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAK 232
Query: 209 CDVYSFGMVLF 219
            D++S G+ L+
Sbjct: 233 VDIWSLGICLY 243

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 150
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 209
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 210 KSSDLWALGCIIYQLVA 226

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 212
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 154
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 213
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 214 KSSDLWALGCIIYQLVA 230

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FGEV   +  N  K+ A+K+LN+   L R     F  E   +       +  L+ 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 89  FCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
              D +   LV +Y   G L   L  F  +   E  + +      A+ ++ +    Q   
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVHQLHY 196
Query: 147 IHYDIKPENVLLDANFSPKVADFG-LAKLCDRNRSHVTISGYKGTPGYSAPEFLS----G 201
           +H DIKP+N+L+D N   ++ADFG   KL +      +++   GTP Y +PE L     G
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEGG 254
Query: 202 NYPITHKCDVYSFGMVLFEIV 222
                 +CD +S G+ ++E++
Sbjct: 255 KGRYGPECDWWSLGVCMYEML 275

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 32  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 84
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 85  RLYGFCHDQHMTALVY-EYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 128
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
               + APE +      T + DV+SFG++L+EI
Sbjct: 203 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 234

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 32  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 84
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 85  RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 128
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
               + APE +      T + DV+SFG++L+EI
Sbjct: 212 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAX 212
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 153
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 212
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 213 KSSDLWALGCIIYQLVA 229

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 27  NYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
            +  RLG G FGEV++ +    G + AVK +   + R+  E+ +A  G         +V 
Sbjct: 75  THQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGL----SSPRIVP 128
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           LYG   +     +  E +E GSL G L  +   +  ++         +GL YLH    +R
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRR 184
Query: 146 IIHYDIKPENVLLDANFS-PKVADFGLAKLCDR----NRSHVTISGYKGTPGYSAPEFLS 200
           I+H D+K +NVLL ++ S   + DFG A LC +     +S +T     GT  + APE + 
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 243
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
           G  P   K D++S   ++  ++
Sbjct: 244 GK-PCDAKVDIWSSCCMMLHML 264

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+++L           LV++ M+ G L  YL  +K  +  ++  +I     + +  LH
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH 141
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF- 198
              +  I+H D+KPEN+LLD + + K+ DFG +   D      ++    GTP Y APE  
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC---GTPSYLAPEII 195
Query: 199 ---LSGNYP-ITHKCDVYSFGMVLFEIVG 223
              ++ N+P    + D++S G++++ ++ 
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGE-VYKGQFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F   V   +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 151
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 210
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 211 KSSDLWALGCIIYQLVA 227

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ----FMAEVGTIGRTYHINLVRL 86
           LG G F  V    +     + A+K+L +    I +E        E   + R  H   V+L
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y    D         Y +NG L  Y+  K  + +              L YLH    + I
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLH---GKGI 156
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           IH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+      
Sbjct: 157 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK-SAC 215
Query: 207 HKCDVYSFGMVLFEIVG 223
              D+++ G +++++V 
Sbjct: 216 KSSDLWALGCIIYQLVA 232

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 32  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 84
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 85  RLYGFCHDQHMTALVY-EYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 128
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
               + APE +      T + DV+SFG++L+EI
Sbjct: 203 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 234

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 32  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 84
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 85  RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 128
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
               + APE +      T + DV+SFG++L+EI
Sbjct: 214 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 245

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 91/181 (50%), Gaps = 19/181 (10%)
Query: 47  NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN 105
            G ++AVK ++ R   R   E    EV  +   +H N+V +Y          +V E++E 
Sbjct: 69  TGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEG 126
Query: 106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165
           G+L   +   +  +  E++  + +   + L YLH    Q +IH DIK +++LL ++   K
Sbjct: 127 GALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIK 181
Query: 166 VADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
           ++DFG    ++K   + +  V      GTP + APE +S   P   + D++S G+++ E+
Sbjct: 182 LSDFGFCAQVSKEVPKRKXLV------GTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEM 234
Query: 222 V 222
           +
Sbjct: 235 I 235

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTI--GRTYHINLVRL 86
           +G G FGEV   +  N  +I A+K+LN+   L R     F  E   +  G    I  +  
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH- 140
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           Y F  + H+  LV +Y   G L   L   +  +  E +    IG  + ++ +    Q   
Sbjct: 141 YAFQDENHLY-LVMDYYVGGDLLTLLSKFEDKLP-EDMARFYIG--EMVLAIDSIHQLHY 196
Query: 147 IHYDIKPENVLLDANFSPKVADFG-LAKLCDRNRSHVTISGYKGTPGYSAPEFL----SG 201
           +H DIKP+NVLLD N   ++ADFG   K+ D      +++   GTP Y +PE L     G
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA--VGTPDYISPEILQAMEDG 254
Query: 202 NYPITHKCDVYSFGMVLFEIV 222
                 +CD +S G+ ++E++
Sbjct: 255 MGKYGPECDWWSLGVCMYEML 275

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 32  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 84
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 85  RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 128
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
               + APE +      T + DV+SFG++L+EI
Sbjct: 249 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 280

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 107/259 (41%), Gaps = 31/259 (11%)
Query: 9   GREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAE 65
           GRE  + F  ++  +   NY  +  +G G +G VY     N  K +A+K +NR    + +
Sbjct: 10  GREN-LYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID 68
Query: 66  -EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL--VYEYMENGSLD-GYLFGKKRAIEW 121
            ++ + E+  + R     ++RLY       +     +Y  +E    D   LF     +  
Sbjct: 69  CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTE 128
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
           E +  I      G  ++HE     IIH D+KP N LL+ + S KV DFGLA+  +  +  
Sbjct: 129 EHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 182 VTISGYKGT--PG------------------YSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             ++  +    PG                  Y APE +      T   D++S G +  E+
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 222 VGRRRNAIVGSSESLDWFP 240
           +   ++ I   +     FP
Sbjct: 246 LNMLQSHINDPTNRFPLFP 264

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEK 123
           EQ   E+  + +  H N+V+L     D +   L  V+E +  G +      K  + +  +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
            +   +   KG+ YLH    Q+IIH DIKP N+L+  +   K+ADFG++   +   S   
Sbjct: 141 FYFQDL--IKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN--EFKGSDAL 193
Query: 184 ISGYKGTPGYSAPEFLSGNYPI--THKCDVYSFGMVLF 219
           +S   GTP + APE LS    I      DV++ G+ L+
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 31  RLGFGGFGEVYKGQFPNGVKIA----VKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           ++G G +G V+K +     +I     V++ + + G       + E+  +    H N+VRL
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELKHKNIVRL 66
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           +   H      LV+E+ +   L  Y       ++ E +        KGL + H    + +
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG---TPGYSAPEFLSGNY 203
           +H D+KP+N+L++ N   K+A+FGLA+        + +  Y     T  Y  P+ L G  
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLAR-----AFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 204 PITHKCDVYSFGMVLFEIVGRRRNAIVGSS 233
             +   D++S G +  E+    R    G+ 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGND 207

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNR--NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FGEV   +  N  +I A+K+LN+   L R     F  E   +       +  L+ 
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHY 157
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              D++   LV +Y   G L   L   +  +  E +    IG    ++ +    Q   +H
Sbjct: 158 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLP-EDMARFYIGEM--VLAIDSIHQLHYVH 214
Query: 149 YDIKPENVLLDANFSPKVADFG-LAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNY 203
            DIKP+NVLLD N   ++ADFG   K+ D      +++   GTP Y +PE L     G  
Sbjct: 215 RDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA--VGTPDYISPEILQAMEDGMG 272
Query: 204 PITHKCDVYSFGMVLFEIV 222
               +CD +S G+ ++E++
Sbjct: 273 KYGPECDWWSLGVCMYEML 291

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGF 89
           LG G +G V K +  P+G   AVK +   +    +++ + ++    RT      V  YG 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 90  CHDQHMTALVYEYMENGSLDGY---LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
              +    +  E + + SLD +   +  K + I  + L +IA+   K L +LH +    +
Sbjct: 102 LFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 158
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSGNYP 204
           IH D+KP NVL++A    K  DFG++     + +    +G K    P    PE     Y 
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYS 218
Query: 205 ITHKCDVYSFGMVLFEIVGRR 225
           +  K D++S G+   E+   R
Sbjct: 219 V--KSDIWSLGITXIELAILR 237

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 33/245 (13%)
Query: 26  SNYSTR--LGFGGFGEVYKGQFPNGVK-IAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHI 81
            NY  +  +G G +G VY     N  K +A+K +NR    + + ++ + E+  + R    
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 82  NLVRLYGFCHDQHMTAL--VYEYMENGSLD-GYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
            ++RL+     + +     +Y  +E    D   LF     +  + +  I      G  ++
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-HVT-------------- 183
           HE     IIH D+KP N LL+ + S K+ DFGLA+  + ++  H+               
Sbjct: 148 HESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 184 --------ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES 235
                   ++ +  T  Y APE +      T+  D++S G +  E++   ++ I   +  
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNR 264
Query: 236 LDWFP 240
              FP
Sbjct: 265 FPLFP 269

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 23/202 (11%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G +G VY G+   N V+IA+K +     R ++     E+       H N+V+  G  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGSF 88
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKL--HEIAIG-----TAKGLVYLHEECQ 143
            +     +  E +  GSL   L  K     W  L  +E  IG       +GL YLH+   
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSK-----WGPLKDNEQTIGFYTKQILEGLKYLHD--- 140
Query: 144 QRIIHYDIKPENVLLDA-NFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLS- 200
            +I+H DIK +NVL++  +   K++DFG +K L   N    T   + GT  Y APE +  
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQYMAPEIIDK 197
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
           G        D++S G  + E+ 
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMA 219

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 23  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 79
           N +S++  +  LG G +G V      P G  +A+K +      +   + + E+  +    
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 80  HINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 137
           H N++ ++             VY   E    D +     + +  + +      T + +  
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT--------ISGYKG 189
           LH      +IH D+KP N+L+++N   KV DFGLA++ D + +  +        +  +  
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           T  Y APE +  +   +   DV+S G +L E+  RR
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+++L           LV++ M+ G L  YL  +K  +  ++  +I     + +  LH
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH 128
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF- 198
              +  I+H D+KPEN+LLD + + K+ DFG +   D       +    GTP Y APE  
Sbjct: 129 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEII 182
Query: 199 ---LSGNYP-ITHKCDVYSFGMVLFEIVG 223
              ++ N+P    + D++S G++++ ++ 
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNA 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--------GRIAEEQFM 69
           ++L +F  N+   LG G FG+V   +     ++ AVK+L +++          + E++ +
Sbjct: 338 MKLTDF--NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 395
Query: 70  AEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI-- 127
           A  G         L +L+           V EY+  G L   ++  ++   +++ H +  
Sbjct: 396 ALPGKPPF-----LTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFY 447
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
           A   A GL +L     + II+ D+K +NV+LD+    K+ADFG+ K  +     VT   +
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXF 502
Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 223
            GTP Y APE ++   P     D ++FG++L+E++ 
Sbjct: 503 CGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLA 537

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 32  LGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINLV 84
           LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 85  RLYGFCHDQHMTALV-YEYMENGSLDGYLFGK---------------KRAIEWEKLHEIA 128
            L G C       +V  E+ + G+L  YL  K               K  +  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
              AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++   V     +
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
               + APE +      T + DV+SFG++L+EI
Sbjct: 212 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 7   EIGREKPVRFTSLQLNNFTSNYSTR------LGFGGFGEVYKG-QFPNGVKIAVKVLNRN 59
           E+ +E+P  F   +LN        R      +G G +G V        G+++AVK L+R 
Sbjct: 5   EMSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 63
Query: 60  LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 116
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 119
Query: 117 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 120 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 176
Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           A+  D       ++GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 177 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 7   EIGREKPVRFTSLQLNNFTSNYSTR------LGFGGFGEVYKG-QFPNGVKIAVKVLNRN 59
           E+ +E+P  F   +LN        R      +G G +G V        G+++AVK L+R 
Sbjct: 6   EMSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 64
Query: 60  LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 116
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 65  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 120
Query: 117 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 177
Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           A+  D       ++GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 178 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 27  NYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
            +  R+G G FGEV++ +    G + AVK +   + R+  E+ +A  G         +V 
Sbjct: 77  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGL----SSPRIVP 130
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           LYG   +     +  E +E GSL G L  +   +  ++         +GL YLH    +R
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRR 186
Query: 146 IIHYDIKPENVLLDANFS-PKVADFGLAKLCDR----NRSHVTISGYKGTPGYSAPEFLS 200
           I+H D+K +NVLL ++ S   + DFG A LC +     +S +T     GT  + APE + 
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 245
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
           G  P   K D++S   ++  ++
Sbjct: 246 GK-PCDAKVDIWSSCCMMLHML 266

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 27  NYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
            +  R+G G FGEV++ +    G + AVK +   + R+  E+ +A  G         +V 
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGL----SSPRIVP 114
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           LYG   +     +  E +E GSL G L  +   +  ++         +GL YLH    +R
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRR 170
Query: 146 IIHYDIKPENVLLDANFS-PKVADFGLAKLCDR----NRSHVTISGYKGTPGYSAPEFLS 200
           I+H D+K +NVLL ++ S   + DFG A LC +     +S +T     GT  + APE + 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
           G  P   K D++S   ++  ++
Sbjct: 230 GK-PCDAKVDIWSSCCMMLHML 250

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--------GRIAEEQFM 69
           ++L +F  N+   LG G FG+V   +     ++ AVK+L +++          + E++ +
Sbjct: 17  MKLTDF--NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 74
Query: 70  AEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI-- 127
           A  G         L +L+           V EY+  G L   ++  ++   +++ H +  
Sbjct: 75  ALPGKPPF-----LTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFY 126
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
           A   A GL +L     + II+ D+K +NV+LD+    K+ADFG+ K  +     VT   +
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXF 181
Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 223
            GTP Y APE ++   P     D ++FG++L+E++ 
Sbjct: 182 CGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLA 216

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G       K + +  + +  +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 103/232 (44%), Gaps = 31/232 (13%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMA--EVGTIGRTYHINLVRLYG 88
           LG GGFGEV   Q    G   A K L +   +  + + MA  E   + +     +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 89  FCHDQHMTALVYEYMENGSLDGYL-------FGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
               +    LV   M  G L  ++       F + RA+ +      A     GL  LH E
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY------AAEICCGLEDLHRE 305
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
              RI++ D+KPEN+LLD +   +++D GLA      +   TI G  GT GY APE +  
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVK- 358
Query: 202 NYPITHKCDVYSFGMVLFEIVG------RRRNAIVGSSESLDWFPKHVWEEY 247
           N   T   D ++ G +L+E++       +R+  I    E ++   K V EEY
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVPEEY 408

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+++L           LV++ M+ G L  YL  +K  +  ++  +I     + +  LH
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH 141
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF- 198
              +  I+H D+KPEN+LLD + + K+ DFG +   D       +    GTP Y APE  
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEII 195
Query: 199 ---LSGNYP-ITHKCDVYSFGMVLFEIVG 223
              ++ N+P    + D++S G++++ ++ 
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 7   EIGREKPVRFTSLQLNNFTSNYSTR------LGFGGFGEVYKG-QFPNGVKIAVKVLNRN 59
           E+ +E+P  F   +LN        R      +G G +G V        G+++AVK L+R 
Sbjct: 6   EMSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 64
Query: 60  LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 116
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 65  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 120
Query: 117 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGL 177
Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           A+  D       ++GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 178 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 92
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 93  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 147
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 148 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 202
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 7   EIGREKPVRFTSLQLNNFTSNYSTR------LGFGGFGEVYKG-QFPNGVKIAVKVLNRN 59
           E+ +E+P  F   +LN        R      +G G +G V        G+++AVK L+R 
Sbjct: 23  EMSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 81
Query: 60  LGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--K 116
              I   ++   E+  +    H N++ L     D    A   E   +  L  +L G    
Sbjct: 82  FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 137
Query: 117 RAIEWEKLHE-----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
             ++ +KL +     +     +GL Y+H      IIH D+KP N+ ++ +   K+ DFGL
Sbjct: 138 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 194
Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           A+  D       ++GY  T  Y APE +          D++S G ++ E++  R
Sbjct: 195 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 23  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 79
           N +S++  +  LG G +G V      P G  +A+K +      +   + + E+  +    
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 80  HINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVY 137
           H N++ ++             VY   E    D +     + +  + +      T + +  
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT--------ISGYKG 189
           LH      +IH D+KP N+L+++N   KV DFGLA++ D + +  +        ++    
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           T  Y APE +  +   +   DV+S G +L E+  RR
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 26  SNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
           + +  RLG G FGEV++ +    G + AVK +   + R   E+ MA  G         +V
Sbjct: 95  ATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA--EELMACAGLTS----PRIV 148
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            LYG   +     +  E +E GSL G L  ++  +  ++         +GL YLH    +
Sbjct: 149 PLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLH---SR 204
Query: 145 RIIHYDIKPENVLLDANFS-PKVADFGLAKLCDRN---RSHVTISGYKGTPGYSAPEFLS 200
           RI+H D+K +NVLL ++ S   + DFG A     +   +S +T     GT  + APE + 
Sbjct: 205 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL 264
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
           G      K DV+S   ++  ++
Sbjct: 265 GRS-CDAKVDVWSSCCMMLHML 285

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 102/232 (43%), Gaps = 31/232 (13%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMA--EVGTIGRTYHINLVRLYG 88
           LG GGFGEV   Q    G   A K L +   +  + + MA  E   + +     +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC------ 142
               +    LV   M  G L  +++          + +     A+ + Y  E C      
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIY---------HMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 143 -QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
            ++RI++ D+KPEN+LLD +   +++D GLA      +   TI G  GT GY APE +  
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVK- 358
Query: 202 NYPITHKCDVYSFGMVLFEIVG------RRRNAIVGSSESLDWFPKHVWEEY 247
           N   T   D ++ G +L+E++       +R+  I    E ++   K V EEY
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVPEEY 408

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G       K + +  + +  +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 92
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 93  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 147
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 148 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 202
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 23/202 (11%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G +G VY G+   N V+IA+K +     R ++     E+       H N+V+  G  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGSF 74
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKL--HEIAIG-----TAKGLVYLHEECQ 143
            +     +  E +  GSL   L  K     W  L  +E  IG       +GL YLH+   
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSK-----WGPLKDNEQTIGFYTKQILEGLKYLHD--- 126
Query: 144 QRIIHYDIKPENVLLDA-NFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLS- 200
            +I+H DIK +NVL++  +   K++DFG +K L   N    T   + GT  Y APE +  
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQYMAPEIIDK 183
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
           G        D++S G  + E+ 
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMA 205

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 19  LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN--LGRIAEEQFMAE--VG 73
           L ++NF   +   LG G FG+V   +    G   AVKVL ++  L     E  M E  + 
Sbjct: 20  LGIDNF--EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRIL 77
Query: 74  TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
           ++ R  H  L +L+           V E++  G L  +   K R  +  +    A     
Sbjct: 78  SLARN-HPFLTQLFCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAAEIIS 135
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTP 191
            L++LH+   + II+ D+K +NVLLD     K+ADFG+ K  +C    + VT + + GTP
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC----NGVTTATFCGTP 188
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            Y APE L          D ++ G++L+E++
Sbjct: 189 DYIAPEILQ-EMLYGPAVDWWAMGVLLYEML 218

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 94
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 95  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 204
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 92
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 93  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 147
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 148 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 202
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 86
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 87  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 141
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 142 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 196
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 89
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 90  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 199
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 98
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 99  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 153
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 154 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 208
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 89
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 90  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 199
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + Y+    +  ++ A KV+ ++  L    +E+   E+       + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           F  D     +V E     SL   L  +++A+   +       T +G+ YLH     R+IH
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIH 165
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-----GTPGYSAPEFL--SG 201
            D+K  N+ L+ +   K+ DFGLA       + +   G +     GTP Y APE L   G
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 202 NYPITHKCDVYSFGMVLFEIV 222
           +   + + D++S G +L+ ++
Sbjct: 219 H---SFEVDIWSLGCILYTLL 236

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 145
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 159
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLC--DRNRSHVTISGYKGTPGYSAPEFLSGNY 203
           +IH D+K  N+ L+ +   K+ DFGLA     D  R  V      GTP Y APE LS   
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVLSKKG 215
Query: 204 PITHKCDVYSFGMVLFEIV 222
             + + DV+S G +++ ++
Sbjct: 216 H-SFEVDVWSIGCIMYTLL 233

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 89
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 90  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 199
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + Y+    +  ++ A KV+ ++  L    +E+   E+       + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           F  D     +V E     SL   L  +++A+   +       T +G+ YLH     R+IH
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIH 165
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-----GTPGYSAPEFL--SG 201
            D+K  N+ L+ +   K+ DFGLA       + +   G +     GTP Y APE L   G
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 202 NYPITHKCDVYSFGMVLFEIV 222
           +   + + D++S G +L+ ++
Sbjct: 219 H---SFEVDIWSLGCILYTLL 236

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 84
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 85  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 139
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 140 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 194
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + Y+    +  ++ A KV+ ++  L    +E+   E+       + ++V  +G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           F  D     +V E     SL   L  +++A+   +       T +G+ YLH     R+IH
Sbjct: 94  FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIH 149
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-----GTPGYSAPEFL--SG 201
            D+K  N+ L+ +   K+ DFGLA       + +   G +     GTP Y APE L   G
Sbjct: 150 RDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 202 NYPITHKCDVYSFGMVLFEIV 222
           +   + + D++S G +L+ ++
Sbjct: 203 H---SFEVDIWSLGCILYTLL 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + Y+    +  ++ A KV+ ++  L    +E+   E+       + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           F  D     +V E     SL   L  +++A+   +       T +G+ YLH     R+IH
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIH 165
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-----GTPGYSAPEFL--SG 201
            D+K  N+ L+ +   K+ DFGLA       + +   G +     GTP Y APE L   G
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 202 NYPITHKCDVYSFGMVLFEIV 222
           +   + + D++S G +L+ ++
Sbjct: 219 H---SFEVDIWSLGCILYTLL 236

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 89
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 90  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 145 SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 199
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 98
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 99  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 153
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 154 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 208
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 93
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 94  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 148
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 203
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTYHINLV 84
           +LG G +G V+K      G  +AVK +     N    +    + M      G    +NL+
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEEC 142
            +    +D+ +  LV++YME       L    RA   E +H+  +     K + YLH   
Sbjct: 76  NVLRADNDRDV-YLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKL---CDRNRSHVTIS-------------- 185
              ++H D+KP N+LL+A    KVADFGL++      R  +++ +S              
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 186 --GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
              Y  T  Y APE L G+   T   D++S G +L EI+
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 83
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 84  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 193
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 145
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 135
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLC--DRNRSHVTISGYKGTPGYSAPEFLSGNY 203
           +IH D+K  N+ L+ +   K+ DFGLA     D  R  V      GTP Y APE LS   
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVLSKKG 191
Query: 204 PITHKCDVYSFGMVLFEIV 222
             + + DV+S G +++ ++
Sbjct: 192 H-SFEVDVWSIGCIMYTLL 209

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 145
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 161
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLC--DRNRSHVTISGYKGTPGYSAPEFLSGNY 203
           +IH D+K  N+ L+ +   K+ DFGLA     D  R  V      GTP Y APE LS   
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVLSKKG 217
Query: 204 PITHKCDVYSFGMVLFEIV 222
             + + DV+S G +++ ++
Sbjct: 218 -HSFEVDVWSIGCIMYTLL 235

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 84
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 85  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 139
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 140 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 194
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 94
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   Y  +  Y APE
Sbjct: 152 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 205
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T   DV+S G VL E++
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 99
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 100 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 154
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 209
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 99
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 100 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 154
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 209
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 106
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 107 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 161
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 162 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 216
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 86
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   Y  +  Y APE
Sbjct: 144 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 197
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T   DV+S G VL E++
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 85
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 86  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 141
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 142 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 195
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   Y  +  Y APE
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 192
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T   DV+S G VL E++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 115
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   Y  +  Y APE
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 226
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T   DV+S G VL E++
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 107
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 108 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 162
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 217
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 21  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 79
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 33  LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 86
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 87  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 144
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSA 195
               Q +IH DIK +++LL  +   K++DFG    ++K   R +  V      GTP + A
Sbjct: 145 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 195
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE +S   P   + D++S G+++ E+V
Sbjct: 196 PELIS-RLPYGPEVDIWSLGIMVIEMV 221

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 117
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   Y  +  Y APE
Sbjct: 175 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 228
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T   DV+S G VL E++
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 109
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   Y  +  Y APE
Sbjct: 167 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 220
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T   DV+S G VL E++
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 21  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 79
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 31  LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 84
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 85  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 142
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSA 195
               Q +IH DIK +++LL  +   K++DFG    ++K   R +  V      GTP + A
Sbjct: 143 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 193
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE +S   P   + D++S G+++ E+V
Sbjct: 194 PELIS-RLPYGPEVDIWSLGIMVIEMV 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 21  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 79
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 22  LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 75
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 76  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 133
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSA 195
               Q +IH DIK +++LL  +   K++DFG    ++K   R +  V      GTP + A
Sbjct: 134 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 184
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE +S   P   + D++S G+++ E+V
Sbjct: 185 PELIS-RLPYGPEVDIWSLGIMVIEMV 210

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   Y  +  Y APE
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 192
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T   DV+S G VL E++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 119
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   Y  +  Y APE
Sbjct: 177 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 230
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T   DV+S G VL E++
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   Y  +  Y APE
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 192
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T   DV+S G VL E++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 160
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   Y  +  Y APE
Sbjct: 218 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPE 271
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            + G    T   DV+S G VL E++
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 21  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 79
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 153 LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 206
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 207 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 264
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSA 195
               Q +IH DIK +++LL  +   K++DFG    ++K   R +  V      GTP + A
Sbjct: 265 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 315
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE +S   P   + D++S G+++ E+V
Sbjct: 316 PELIS-RLPYGPEVDIWSLGIMVIEMV 341

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 93/236 (39%), Gaps = 29/236 (12%)
Query: 8   IGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLG 61
           I + K  +   + L+     +   LG   FG+VYKG             +A+K L     
Sbjct: 12  INQHKQAKLKEISLS--AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 62  RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK------ 115
               E+F  E     R  H N+V L G        ++++ Y  +G L  +L  +      
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 116 ---------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV 166
                    K A+E      +    A G+ YL       ++H D+   NVL+    + K+
Sbjct: 130 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKI 186
Query: 167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 221
           +D GL +       +  +        + APE  + G + I    D++S+G+VL+E+
Sbjct: 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSI--DSDIWSYGVVLWEV 240

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 25/202 (12%)
Query: 32  LGFGGFGEV---YKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G +G V   Y  +     K+AVK L+R     I   +   E+  +    H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHE 140
               D    A   E      L   L G       K +A+  E +  +     +GL Y+H 
Sbjct: 94  ----DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
                IIH D+KP NV ++ +   ++ DFGLA+  D       ++GY  T  Y APE + 
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPEIML 201
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
                    D++S G ++ E++
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELL 223

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 37/286 (12%)
Query: 28  YSTRLGFGGFGEVYKG---------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT 78
           ++  LG G F +++KG         Q  +  ++ +KVL++   R   E F      + + 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQL-HETEVLLKVLDK-AHRNYSESFFEAASMMSKL 69
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
            H +LV  YG C       LV E+++ GSLD YL   K  I      E+A   A  + +L
Sbjct: 70  SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFL 129
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG--YKGTPGYSAP 196
            E     +IH ++  +N+LL      K  +    KL D   S   +     +    +  P
Sbjct: 130 EE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           E +     +    D +SFG  L+EI   G +  + + S   L ++        ++ +L A
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-------DRHQLPA 239
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
                        KA  L      C+   P+ RP   A+++ L  +
Sbjct: 240 P------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 37/286 (12%)
Query: 28  YSTRLGFGGFGEVYKG---------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT 78
           ++  LG G F +++KG         Q  +  ++ +KVL++   R   E F      + + 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQL-HETEVLLKVLDK-AHRNYSESFFEAASMMSKL 69
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
            H +LV  YG C       LV E+++ GSLD YL   K  I      E+A   A  + +L
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG--YKGTPGYSAP 196
            E     +IH ++  +N+LL      K  +    KL D   S   +     +    +  P
Sbjct: 130 EE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           E +     +    D +SFG  L+EI   G +  + + S   L ++        ++ +L A
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-------DRHQLPA 239
Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
                        KA  L      C+   P+ RP   A+++ L  +
Sbjct: 240 P------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 21  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 79
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 26  LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 79
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 80  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 137
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSA 195
               Q +IH DIK +++LL  +   K++DFG    ++K   R +  V      GTP + A
Sbjct: 138 ---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 188
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE +S   P   + D++S G+++ E+V
Sbjct: 189 PELIS-RLPYGPEVDIWSLGIMVIEMV 214

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 110
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 111 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 165
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       + GY  T  Y APE +   
Sbjct: 166 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRWYRAPEIMLNW 220
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 47  NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMEN 105
           +G ++AVK+++  L +    + +     I R Y H N+V +Y          ++ E+++ 
Sbjct: 69  SGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126
Query: 106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165
           G+L   +   +  +  E++  +     + L YLH    Q +IH DIK +++LL  +   K
Sbjct: 127 GALTDIV--SQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVK 181
Query: 166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           ++DFG      ++          GTP + APE +S +   T + D++S G+++ E+V
Sbjct: 182 LSDFGFCAQISKDVPKR--KXLVGTPYWMAPEVISRSLYAT-EVDIWSLGIMVIEMV 235

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 21  LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY- 79
           L+NF      ++G G  G V      +  K+ V V   +L +    + +     I R Y 
Sbjct: 76  LDNFI-----KIGEGSTGIVCIATVRSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQ 129
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H N+V +Y          +V E++E G+L   +   +  +  E++  + +   + L  LH
Sbjct: 130 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH 187
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSA 195
               Q +IH DIK +++LL  +   K++DFG    ++K   R +  V      GTP + A
Sbjct: 188 A---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMA 238
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE +S   P   + D++S G+++ E+V
Sbjct: 239 PELIS-RLPYGPEVDIWSLGIMVIEMV 264

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G       K + +  + +  +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGL +  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 32  LGFGGFGEVY---KGQFPN-GVKIAVKVLNRNLGRIAEE-QFMAEVGTIGRTYHINLVRL 86
           LG G FG+V+   K   P+ G   A+KVL +   ++ +  +   E   +    H  +V+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           +     +    L+ +++  G L   L  K+     E +       A GL +LH      I
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLDHLHSLG---I 151
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I+ D+KPEN+LLD     K+ DFGL+K   D  +   +   + GT  Y APE ++     
Sbjct: 152 IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS---FCGTVEYMAPEVVN-RQGH 207
Query: 206 THKCDVYSFGMVLFEIV 222
           +H  D +S+G+++FE++
Sbjct: 208 SHSADWWSYGVLMFEML 224

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ D+GLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 26/202 (12%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 145
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 137
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-----GTPGYSAPEFLS 200
           +IH D+K  N+ L+ +   K+ DFGLA       + V   G +     GTP Y APE LS
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKTLCGTPNYIAPEVLS 190
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
                + + DV+S G +++ ++
Sbjct: 191 KKGH-SFEVDVWSIGCIMYTLL 211

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 20/226 (8%)
Query: 7   EIGREKPVRFTSLQ-LNNFTSNYSTRLGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRI 63
           ++G E  + F S++  NNF    S  LG G F  V +      G + A K L  R  G+ 
Sbjct: 12  DLGTEN-LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD 70
Query: 64  AEEQFMAEVGTIGRTYHI-NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK-KRAIEW 121
              + + E+  +        ++ L+    +     L+ EY   G +      +    +  
Sbjct: 71  CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE 130
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDRN 178
             +  +     +G+ YLH   Q  I+H D+KP+N+LL + +     K+ DFG++    R 
Sbjct: 131 NDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS----RK 183
Query: 179 RSHVT-ISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIV 222
             H   +    GTP Y APE L  NY PIT   D+++ G++ + ++
Sbjct: 184 IGHACELREIMGTPEYLAPEIL--NYDPITTATDMWNIGIIAYMLL 227

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 26  SNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
           + +  RLG G FGEV++ +    G + AVK +   + R   E+ MA  G         +V
Sbjct: 76  ATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA--EELMACAGLTS----PRIV 129
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            LYG   +     +  E +E GSL G L  ++  +  ++         +GL YLH    +
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLH---SR 185
Query: 145 RIIHYDIKPENVLLDANFS-PKVADFGLAKLCDRN---RSHVTISGYKGTPGYSAPEFLS 200
           RI+H D+K +NVLL ++ S   + DFG A     +   +  +T     GT  + APE + 
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
           G      K DV+S   ++  ++
Sbjct: 246 GRS-CDAKVDVWSSCCMMLHML 266

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 115
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 224
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L++    I   ++   E+  +    H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 99
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 100 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 154
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 209
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 26/202 (12%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 145
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 137
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-----GTPGYSAPEFLS 200
           +IH D+K  N+ L+ +   K+ DFGLA       + V   G +     GTP Y APE LS
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKTLCGTPNYIAPEVLS 190
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
                + + DV+S G +++ ++
Sbjct: 191 KKGH-SFEVDVWSIGCIMYTLL 211

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 52/238 (21%)
Query: 10  REKPVR-FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRN-------- 59
           R++P      ++L +F  N+   LG G FG+V         ++ A+K+L ++        
Sbjct: 6   RKQPSNNLDRVKLTDF--NFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDV 63
Query: 60  ---------LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDG 110
                    L  + +  F+ ++ +  +T    + RLY           V EY+  G L  
Sbjct: 64  ECTMVEKRVLALLDKPPFLTQLHSCFQT----VDRLY----------FVMEYVNGGDLMY 109
Query: 111 YL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165
           ++     F + +A+ +    EI+IG    L +LH   ++ II+ D+K +NV+LD+    K
Sbjct: 110 HIQQVGKFKEPQAVFYAA--EISIG----LFFLH---KRGIIYRDLKLDNVMLDSEGHIK 160
Query: 166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 223
           +ADFG+ K  +     VT   + GTP Y APE ++   P     D +++G++L+E++ 
Sbjct: 161 IADFGMCK--EHMMDGVTTREFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLA 215

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 89
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 147 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 198
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 26/202 (12%)
Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + ++    +  ++ A K++ ++L       E+   E+       H ++V  +G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEECQQR 145
           F  D     +V E     SL      +K   E E    L +I +G      YLH   + R
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLH---RNR 141
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-----GTPGYSAPEFLS 200
           +IH D+K  N+ L+ +   K+ DFGLA       + V   G +     GTP Y APE LS
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKTLCGTPNYIAPEVLS 194
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
                + + DV+S G +++ ++
Sbjct: 195 KKGH-SFEVDVWSIGCIMYTLL 215

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 100
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 158 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 209
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 93
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 202
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 97
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 98  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 152
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 153 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 207
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 82
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 140 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 191
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 192 PELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 30/203 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKV---LNRNLGRIAE------EQFMAEVGTIGRTYHIN 82
           +G G +GEV         KIAV+    + R   +I +      ++F  E+  +    H N
Sbjct: 17  IGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           ++RLY    D     LV E    G L   +   KR         I       + Y H   
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 143 QQRIIHYDIKPENVLL--DANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
           +  + H D+KPEN L   D+  SP K+ DFGLA    R +    +    GTP Y +P+ L
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL 180
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
            G Y    +CD +S G++++ ++
Sbjct: 181 EGLY--GPECDEWSAGVMMYVLL 201

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 93
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 202
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 83
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 84  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 193
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 106
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 107 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 161
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 162 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 216
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 107
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 108 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 162
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 217
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 93
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 94  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 148
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 203
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 25/202 (12%)
Query: 32  LGFGGFGEV---YKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G +G V   Y  +     K+AVK L+R     I   +   E+  +    H N++ L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHE 140
               D    A   E      L   L G       K +A+  E +  +     +GL Y+H 
Sbjct: 86  ----DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
                IIH D+KP NV ++ +   ++ DFGLA+  D       ++GY  T  Y APE + 
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRWYRAPEIML 193
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
                    D++S G ++ E++
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELL 215

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 85
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 143 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 194
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 42/224 (18%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 89
           LG+G  G V ++G F  G  +AVK +  +   IA    + E+  +  +  H N++R Y  
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 75
Query: 90  CHDQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHE------IAIGTAKGLVYLHEE 141
           C +      +Y  +E  N +L   +  K  + E  KL +      +    A G+ +LH  
Sbjct: 76  CSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 142 CQQRIIHYDIKPENVLLDA-------------NFSPKVADFGLAKLCDRNRS--HVTISG 186
              +IIH D+KP+N+L+               N    ++DFGL K  D  +S     ++ 
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 187 YKGTPGYSAPEFL--SGNYP----ITHKCDVYSFGMVLFEIVGR 224
             GT G+ APE L  S N      +T   D++S G V + I+ +
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 30/203 (14%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVKV---LNRNLGRIAE------EQFMAEVGTIGRTYHIN 82
           +G G +GEV         KIAV+    + R   +I +      ++F  E+  +    H N
Sbjct: 34  IGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           ++RLY    D     LV E    G L   +   KR         I       + Y H   
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 143 QQRIIHYDIKPENVLL--DANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
           +  + H D+KPEN L   D+  SP K+ DFGLA    R +    +    GTP Y +P+ L
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL 197
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
            G Y    +CD +S G++++ ++
Sbjct: 198 EGLY--GPECDEWSAGVMMYVLL 218

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 27/212 (12%)
Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           LG   FG+VYKG             +A+K L         E+F  E     R  H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIG 130
           L G        ++++ Y  +G L  +L  +               K A+E      +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            A G+ YL       ++H D+   NVL+    + K++D GL +       +  +      
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 191 PGYSAPE-FLSGNYPITHKCDVYSFGMVLFEI 221
             + APE  + G + I    D++S+G+VL+E+
Sbjct: 194 IRWMAPEAIMYGKFSI--DSDIWSYGVVLWEV 223

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 25/202 (12%)
Query: 32  LGFGGFGEV---YKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G +G V   Y  +     K+AVK L+R     I   +   E+  +    H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHE 140
               D    A   E      L   L G       K +A+  E +  +     +GL Y+H 
Sbjct: 94  ----DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
                IIH D+KP NV ++ +   ++ DFGLA+  D       ++GY  T  Y APE + 
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPEIML 201
Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
                    D++S G ++ E++
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELL 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 26/204 (12%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGF 89
           +G G  G+V+K +F   G  IAVK + R+  +   ++ + ++  + +++    +V+ +G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKR---AIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
                   +  E M  G+    L  KKR    I    L ++ +   K L YL E  +  +
Sbjct: 93  FITNTDVFIAMELM--GTCAEKL--KKRMQGPIPERILGKMTVAIVKALYYLKE--KHGV 146
Query: 147 IHYDIKPENVLLDANFSPKVADFGLA-KLCD---RNRSHVTISGYKGTPGYSAPEFLSGN 202
           IH D+KP N+LLD     K+ DFG++ +L D   ++RS        G   Y APE +   
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS-------AGCAAYMAPERIDPP 199
Query: 203 YPITH----KCDVYSFGMVLFEIV 222
            P       + DV+S G+ L E+ 
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELA 223

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 94
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 95  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+      +   ++GY  T  Y APE +   
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNW 204
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 94
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 95  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+      +   ++GY  T  Y APE +   
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNW 204
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 94
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 95  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+      +   ++GY  T  Y APE +   
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNW 204
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 89
           LG+G  G V ++G F  G  +AVK +  +   IA    + E+  +  +  H N++R Y  
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 93
Query: 90  CHDQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHE------IAIGTAKGLVYLHEE 141
           C +      +Y  +E  N +L   +  K  + E  KL +      +    A G+ +LH  
Sbjct: 94  CSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 150
Query: 142 CQQRIIHYDIKPENVLLDA-------------NFSPKVADFGLAKLCDRNRS--HVTISG 186
              +IIH D+KP+N+L+               N    ++DFGL K  D  +      ++ 
Sbjct: 151 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 187 YKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGR 224
             GT G+ APE L  S    +T   D++S G V + I+ +
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D+    LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 89
           LG+G  G V ++G F  G  +AVK +  +   IA    + E+  +  +  H N++R Y  
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 93
Query: 90  CHDQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHE------IAIGTAKGLVYLHEE 141
           C +      +Y  +E  N +L   +  K  + E  KL +      +    A G+ +LH  
Sbjct: 94  CSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 150
Query: 142 CQQRIIHYDIKPENVLLDA-------------NFSPKVADFGLAKLCDRNRS--HVTISG 186
              +IIH D+KP+N+L+               N    ++DFGL K  D  +      ++ 
Sbjct: 151 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 187 YKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGR 224
             GT G+ APE L  S    +T   D++S G V + I+ +
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G FG V++  +   G     K +N     + +     E+  + + +H  L+ L+   
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
            D++   L+ E++  G L   +  +   +   ++        +GL ++HE     I+H D
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLD 174
Query: 151 IKPENVLLDAN--FSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           IKPEN++ +     S K+ DFGLA KL       VT +    T  ++APE +    P+  
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA----TAEFAAPEIVDRE-PVGF 229
Query: 208 KCDVYSFGMV 217
             D+++ G++
Sbjct: 230 YTDMWAIGVL 239

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 30  TRLGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
            ++G G FGEV+K +    G K+A+K VL  N         + E+  +    H N+V L 
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 88  GFCHDQHM--------TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
             C  +            LV+++ E+  L G L          ++  +      GL Y+H
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNRSHVTISGYKGTPGYSAPE 197
              + +I+H D+K  NVL+  +   K+ADFGLA+     +N           T  Y  PE
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIVGR 224
            L G        D++  G ++ E+  R
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 30  TRLGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
            ++G G FGEV+K +    G K+A+K VL  N         + E+  +    H N+V L 
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 88  GFCHDQHM--------TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
             C  +            LV+++ E+  L G L          ++  +      GL Y+H
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNRSHVTISGYKGTPGYSAPE 197
              + +I+H D+K  NVL+  +   K+ADFGLA+     +N           T  Y  PE
Sbjct: 142 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 198
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIVGR 224
            L G        D++  G ++ E+  R
Sbjct: 199 LLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 30  TRLGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
            ++G G FGEV+K +    G K+A+K VL  N         + E+  +    H N+V L 
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 88  GFCHDQHM--------TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
             C  +            LV+++ E+  L G L          ++  +      GL Y+H
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNRSHVTISGYKGTPGYSAPE 197
              + +I+H D+K  NVL+  +   K+ADFGLA+     +N           T  Y  PE
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIVGR 224
            L G        D++  G ++ E+  R
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 30  TRLGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
            ++G G FGEV+K +    G K+A+K VL  N         + E+  +    H N+V L 
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 88  GFCHDQHM--------TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
             C  +            LV+++ E+  L G L          ++  +      GL Y+H
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNRSHVTISGYKGTPGYSAPE 197
              + +I+H D+K  NVL+  +   K+ADFGLA+     +N           T  Y  PE
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIVGR 224
            L G        D++  G ++ E+  R
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 30  TRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLY 87
           T +G G +G V       +G K+A+K L+R     I  ++   E+  +    H N++ L 
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEW--EKLHEIAIGTAKGLVYLHEECQQR 145
                       Y++            K   +E+  EK+  +     KGL Y+H      
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG--- 164
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           ++H D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +      
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYRAPEVILSWMHY 219
Query: 206 THKCDVYSFGMVLFEIV 222
               D++S G ++ E++
Sbjct: 220 NQTVDIWSVGCIMAEML 236

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 83
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++  KL +     +     +GL Y+H   
Sbjct: 84  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +   
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 193
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++G   T  Y APE +   
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+  FGLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ D GLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 109/259 (42%), Gaps = 33/259 (12%)
Query: 32  LGFGGFGE-VYKGQFPNGVKIAVKVLNRNLGRIA--EEQFMAEVGTIGRTYHINLVRLYG 88
           LG G  G  VY+G F N   +AVK +       A  E Q + E        H N++R + 
Sbjct: 32  LGHGAEGTIVYRGMFDNR-DVAVKRILPECFSFADREVQLLRESDE-----HPNVIRYFC 85
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
              D+    +  E +   +L  Y+  K  A    +   +   T  GL +LH      I+H
Sbjct: 86  TEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVH 141
Query: 149 YDIKPENVLLD-----ANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            D+KP N+L+            ++DFGL  KL     S    SG  GT G+ APE LS +
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 203 YP--ITHKCDVYSFGMVLFEIVG-----------RRRNAIVGSSESLDWFPKHVWEEYEK 249
                T+  D++S G V + ++            R+ N ++G+  SLD       E+   
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC-SLDCLHPEKHEDVIA 260
Query: 250 SELDATILACGIEEKDKEK 268
            EL   ++A   +++   K
Sbjct: 261 RELIEKMIAMDPQKRPSAK 279

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++G+  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++G+  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 33/207 (15%)
Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG VY+ +   +G  +A+K VL     +  E Q M ++       H N+VRL  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 81
Query: 90  CH------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-----KGLVYL 138
            +      D     LV +Y+       Y   +  +   + L  I +        + L Y+
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
           H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y A
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRA 190
Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIV 222
           PE + G    T   DV+S G VL E++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 24  FTSNYSTR--LGFGGFGE----VYKGQFPNGVKIAVKVLNRNLGRIAEE-QFMAEVGTIG 76
           F+  Y  +  +G G + E    V+K      ++ AVKV++++    +EE + +   G   
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDPSEEIEILLRYGQ-- 79
Query: 77  RTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAK 133
              H N++ L     D     LV E M  G L   +  +K   E E    LH I     K
Sbjct: 80  ---HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG----K 132
Query: 134 GLVYLHEECQQRIIHYDIKPENVL-LDANFSP---KVADFGLAKLCDRNRSHVTISGYKG 189
            + YLH    Q ++H D+KP N+L +D + +P   ++ DFG AK        +    Y  
Sbjct: 133 TVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-- 187
Query: 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 223
           T  + APE L         CD++S G++L+ ++ 
Sbjct: 188 TANFVAPEVLK-RQGYDEGCDIWSLGILLYTMLA 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ D GLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 30  TRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLY 87
           T +G G +G V       +G K+A+K L+R     I  ++   E+  +    H N++ L 
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 88  GF------CHDQHMTALVYEYMENG--SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
                     + +   LV  +M+     + G  F +      EK+  +     KGL Y+H
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE------EKIQYLVYQMLKGLKYIH 143
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
                 ++H D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y APE +
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYRAPEVI 195
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
                     D++S G ++ E++
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEML 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 83
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 84  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       ++G+  T  Y APE +   
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNW 193
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 24  FTSNYSTR--LGFGGFGE----VYKGQFPNGVKIAVKVLNRNLGRIAEE-QFMAEVGTIG 76
           F+  Y  +  +G G + E    V+K      ++ AVKV++++    +EE + +   G   
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDPSEEIEILLRYGQ-- 79
Query: 77  RTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAK 133
              H N++ L     D     LV E M  G L   +  +K   E E    LH I     K
Sbjct: 80  ---HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG----K 132
Query: 134 GLVYLHEECQQRIIHYDIKPENVL-LDANFSP---KVADFGLAKLCDRNRSHVTISGYKG 189
            + YLH    Q ++H D+KP N+L +D + +P   ++ DFG AK        +    Y  
Sbjct: 133 TVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-- 187
Query: 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 223
           T  + APE L         CD++S G++L+ ++ 
Sbjct: 188 TANFVAPEVLK-RQGYDEGCDIWSLGILLYTMLA 220

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G+++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ D GLA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG- 88
           +G G +G V        G K+A+K L R     +  ++   E+  +    H N++ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 89  FCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
           F  D+ +       LV  +M  G+  G L   ++  E +++  +     KGL Y+H    
Sbjct: 93  FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE-DRIQFLVYQMLKGLRYIHAAG- 148
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
             IIH D+KP N+ ++ +   K+ DFGLA+  D       + G   T  Y APE +    
Sbjct: 149 --IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVTRWYRAPEVILNWM 201
Query: 204 PITHKCDVYSFGMVLFEIV 222
             T   D++S G ++ E++
Sbjct: 202 RYTQTVDIWSVGCIMAEMI 220

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 29/205 (14%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLN----RNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           +G G F  V +      G + AVK+++     +   ++ E    E        H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 87  YGFCHDQHMTALVYEYMENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVY 137
                   M  +V+E+M+   L          G+++ +  A  + +         + L Y
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR------QILEALRY 145
Query: 138 LHEECQQRIIHYDIKPENVLLDA--NFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYS 194
            H+     IIH D+KPENVLL +  N +P K+ DFG+A       S +   G  GTP + 
Sbjct: 146 CHD---NNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHFM 200
Query: 195 APEFLSGNYPITHKCDVYSFGMVLF 219
           APE +    P     DV+  G++LF
Sbjct: 201 APEVVKRE-PYGKPVDVWGCGVILF 224

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 30  TRLGFGGFGEVYKGQFP-NGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRL 86
           +RLG G +GEV+K +   +G   AVK  ++   G     + +AEVG+  +   H   VRL
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
                +  +  L  E +   SL  +      ++   ++      T   L +LH    Q +
Sbjct: 123 EQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGL 178
Query: 147 IHYDIKPENVLLDANFSPKVADFG-LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +H D+KP N+ L      K+ DFG L +L       V     +G P Y APE L G+Y  
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPELLQGSYGT 234
Query: 206 THKCDVYSFGMVLFEIV 222
               DV+S G+ + E+ 
Sbjct: 235 A--ADVFSLGLTILEVA 249

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 81/192 (42%), Gaps = 14/192 (7%)
Query: 32  LGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG   + + +  N + +AVK + R  G   +E    E+       H N+VR    
Sbjct: 27  IGAGNFGVARLMRDKQANEL-VAVKYIER--GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                  A+V EY   G L   +    R  E E           G+ Y H     ++ H 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYAH---AMQVAHR 139
Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           D+K EN LLD + +P  K+ADFG +K    +  H       GTP Y APE L        
Sbjct: 140 DLKLENTLLDGSPAPRLKIADFGYSKA---SVLHSQPKSAVGTPAYIAPEVLLKKEYDGK 196
Query: 208 KCDVYSFGMVLF 219
             DV+S G+ L+
Sbjct: 197 VADVWSCGVTLY 208

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 42/224 (18%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGF 89
           LG+G  G V ++G F  G  +AVK +  +   IA    + E+  +  +  H N++R Y  
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 75
Query: 90  CHDQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHE------IAIGTAKGLVYLHEE 141
           C +      +Y  +E  N +L   +  K  + E  KL +      +    A G+ +LH  
Sbjct: 76  CSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 142 CQQRIIHYDIKPENVLLDA-------------NFSPKVADFGLAKLCDRNRS--HVTISG 186
              +IIH D+KP+N+L+               N    ++DFGL K  D  +      ++ 
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 187 YKGTPGYSAPEFL--SGNYP----ITHKCDVYSFGMVLFEIVGR 224
             GT G+ APE L  S N      +T   D++S G V + I+ +
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 81/197 (41%), Gaps = 14/197 (7%)
Query: 27  NYSTRLGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
           ++   +G G FG   + + +    + +AVK + R  G   +E    E+       H N+V
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIER--GAAIDENVQREIINHRSLRHPNIV 79
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           R           A++ EY   G L   +    R  E E           G+ Y H     
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLSGVSYCH---SM 135
Query: 145 RIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           +I H D+K EN LLD + +P  K+ DFG +K    +  H       GTP Y APE L   
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 203 YPITHKCDVYSFGMVLF 219
                  DV+S G+ L+
Sbjct: 193 EYDGKIADVWSCGVTLY 209

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 84
Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 85  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 137
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +IH DIK +N+LL  + S K+ DFG        +S    S   GTP + APE ++     
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVT-RKAY 194
Query: 206 THKCDVYSFGMVLFEIV 222
             K D++S G++  E++
Sbjct: 195 GPKVDIWSLGIMAIEMI 211

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 83
Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 84  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +IH DIK +N+LL  + S K+ DFG        +S    S   GTP + APE ++     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT-RKAY 193
Query: 206 THKCDVYSFGMVLFEIV 222
             K D++S G++  E++
Sbjct: 194 GPKVDIWSLGIMAIEMI 210

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVK-VLN-----RNLGR 62
           E  +R    +L+   S Y+ +  +  G +G V  G    G+ +A+K V N     R +  
Sbjct: 7   EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 63  IAE----EQFMAEVGTIGRTYHINLVRLYG-FCHDQ----HMTALVYEYMENGSLDGYLF 113
           +++    ++ + E+  +   +H N++ L   F H +    H   LV E M    L   + 
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH 125
Query: 114 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173
            ++  I  + +         GL  LHE     ++H D+ P N+LL  N    + DF LA+
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 174 --LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
               D N++H     Y     Y APE +      T   D++S G V+ E+  R+
Sbjct: 183 EDTADANKTH-----YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 83
Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 84  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +IH DIK +N+LL  + S K+ DFG        +S    S   GTP + APE ++     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVT-RKAY 193
Query: 206 THKCDVYSFGMVLFEIV 222
             K D++S G++  E++
Sbjct: 194 GPKVDIWSLGIMAIEMI 210

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVKI----AVKVLNRNLGRIAEE-QFMAEVGTIGRTYHINLVRL 86
           LG G FG+V+  +  +G       A+KVL +   ++ +  +   E   +    H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           +     +    L+ +++  G L   L  K+     E +       A  L +LH      I
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLG---I 147
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I+ D+KPEN+LLD     K+ DFGL+K   D  +   +   + GT  Y APE ++     
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGTVEYMAPEVVN-RRGH 203
Query: 206 THKCDVYSFGMVLFEIV 222
           T   D +SFG+++FE++
Sbjct: 204 TQSADWWSFGVLMFEML 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 87
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 88  --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DF LA+  D       ++GY  T  Y APE +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAPEIMLNW 197
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVKI----AVKVLNRNLGRIAEE-QFMAEVGTIGRTYHINLVRL 86
           LG G FG+V+  +  +G       A+KVL +   ++ +  +   E   +    H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           +     +    L+ +++  G L   L  K+     E +       A  L +LH      I
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLG---I 148
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I+ D+KPEN+LLD     K+ DFGL+K   D  +   +   + GT  Y APE ++     
Sbjct: 149 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGTVEYMAPEVVN-RRGH 204
Query: 206 THKCDVYSFGMVLFEIV 222
           T   D +SFG+++FE++
Sbjct: 205 TQSADWWSFGVLMFEML 221

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 83
Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 84  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +IH DIK +N+LL  + S K+ DFG        +S    S   GTP + APE ++     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVT-RKAY 193
Query: 206 THKCDVYSFGMVLFEIV 222
             K D++S G++  E++
Sbjct: 194 GPKVDIWSLGIMAIEMI 210

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVK-VLN-----RNLGR 62
           E  +R    +L+   S Y+ +  +  G +G V  G    G+ +A+K V N     R +  
Sbjct: 7   EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 63  IAE----EQFMAEVGTIGRTYHINLVRLYG-FCHDQ----HMTALVYEYMENGSLDGYLF 113
           +++    ++ + E+  +   +H N++ L   F H +    H   LV E M    L   + 
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH 125
Query: 114 GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173
            ++  I  + +         GL  LHE     ++H D+ P N+LL  N    + DF LA+
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 174 --LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
               D N++H     Y     Y APE +      T   D++S G V+ E+  R+
Sbjct: 183 EDTADANKTH-----YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 32  LGFGGFGEVYKGQFPNGVKI----AVKVLNRNLGRIAEE-QFMAEVGTIGRTYHINLVRL 86
           LG G FG+V+  +  +G       A+KVL +   ++ +  +   E   +    H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           +     +    L+ +++  G L   L  K+     E +       A  L +LH      I
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLG---I 147
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           I+ D+KPEN+LLD     K+ DFGL+K   D  +   +   + GT  Y APE ++     
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGTVEYMAPEVVN-RRGH 203
Query: 206 THKCDVYSFGMVLFEIV 222
           T   D +SFG+++FE++
Sbjct: 204 TQSADWWSFGVLMFEML 220

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEV---GTIGRTYHINLVR 85
           ++G G FG V+K  +  +G   A+K   + L G + E+  + EV     +G+  H+  VR
Sbjct: 14  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV--VR 71
Query: 86  LY-GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEE 141
            +  +  D HM  +  EY   GSL   +    R + + K   L ++ +   +GL Y+H  
Sbjct: 72  YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 128
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVA-------DFGLAKLCDR--NRSHVT-ISG---YK 188
               ++H DIKP N+ +     P  A       D+   K+  +  +  HVT IS     +
Sbjct: 129 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 187
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 223
           G   + A E L  NY    K D+++  + +    G
Sbjct: 188 GDSRFLANEVLQENYTHLPKADIFALALTVVXAAG 222

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V        G ++AVK L+R    I   ++   E+  +    H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 107
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHE-----IAIGTAKGLVYLHEEC 142
             D    A   E   +  L  +L G      ++ +KL +     +     +GL Y+H   
Sbjct: 108 --DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 162
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
              IIH D+KP N+ ++ +   K+ DFGLA+  D       + G   T  Y APE +   
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRAPEIMLNW 217
Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E++  R
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNRN--LGRIA---------EEQFMAEVGTIGRTY 79
           LG GGFG V+ G +  + +++A+KV+ RN  LG            E   + +VG  G   
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG-- 96
Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           H  ++RL  +   Q    LV E       D + +  ++    E       G     +   
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQ-DLFDYITEKGPLGEGPSRCFFGQVVAAI--- 152
Query: 140 EECQQR-IIHYDIKPENVLLDANFS-PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           + C  R ++H DIK EN+L+D      K+ DFG   L          + + GT  YS PE
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPE 208
Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
           ++S +        V+S G++L+++V
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMV 233

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 32  LGFGGFGEVYK----GQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HIN--- 82
           LG G +G+V+          G   A+KVL +    I ++    E     R    HI    
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKK--ATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 83  -LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
            LV L+     +    L+ +Y+  G L  +L  ++R  E    HE+ I   + ++ L   
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIVLALEHL 175
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
            +  II+ DIK EN+LLD+N    + DFGL+K    + +      + GT  Y AP+ + G
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRG 234
Query: 202 NYPITHKC-DVYSFGMVLFEIV 222
                 K  D +S G++++E++
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELL 256

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 11/134 (8%)
Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           GF  D+ ++    +  E    DG+    K  I  E L   +   A+G+ +L     ++ I
Sbjct: 172 GFQEDKSLS----DVEEEEDSDGFY---KEPITMEDLISYSFQVARGMEFLS---SRKCI 221
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H D+   N+LL  N   K+ DFGLA+   +N  +V     +    + APE +      T 
Sbjct: 222 HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST- 280
Query: 208 KCDVYSFGMVLFEI 221
           K DV+S+G++L+EI
Sbjct: 281 KSDVWSYGVLLWEI 294

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 80/192 (41%), Gaps = 14/192 (7%)
Query: 32  LGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG   + + +  N + +AVK + R  G   +E    E+       H N+VR    
Sbjct: 26  IGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIDENVKREIINHRSLRHPNIVRFKEV 82
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                  A+V EY   G L   +    R  E E           G+ Y H     ++ H 
Sbjct: 83  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCH---AMQVCHR 138
Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           D+K EN LLD + +P  K+ DFG +K    +  H       GTP Y APE L        
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 208 KCDVYSFGMVLF 219
             DV+S G+ L+
Sbjct: 196 VADVWSCGVTLY 207

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEV---GTIGRTYHINLVR 85
           ++G G FG V+K  +  +G   A+K   + L G + E+  + EV     +G+  H+  VR
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV--VR 73
Query: 86  LY-GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEE 141
            +  +  D HM  +  EY   GSL   +    R + + K   L ++ +   +GL Y+H  
Sbjct: 74  YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 130
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVA-------DFGLAKLCDR--NRSHVT-ISG---YK 188
               ++H DIKP N+ +     P  A       D+   K+  +  +  HVT IS     +
Sbjct: 131 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 189
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 223
           G   + A E L  NY    K D+++  + +    G
Sbjct: 190 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 6/162 (3%)
Query: 64  AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEW 121
            E     E+  + R  H N+++L    +++    +  V EY   G  +      ++    
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV 108
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
            + H        GL YLH    Q I+H DIKP N+LL    + K++  G+A+      + 
Sbjct: 109 CQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 182 VTISGYKGTPGYSAPEFLSGNYPIT-HKCDVYSFGMVLFEIV 222
            T    +G+P +  PE  +G    +  K D++S G+ L+ I 
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNIT 207

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEV---GTIGRTYHINLVR 85
           ++G G FG V+K  +  +G   A+K   + L G + E+  + EV     +G+  H+  VR
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV--VR 73
Query: 86  LY-GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEE 141
            +  +  D HM  +  EY   GSL   +    R + + K   L ++ +   +GL Y+H  
Sbjct: 74  YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 130
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVA-------DFGLAKLCDR--NRSHVT-ISG---YK 188
               ++H DIKP N+ +     P  A       D+   K+  +  +  HVT IS     +
Sbjct: 131 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 189
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 223
           G   + A E L  NY    K D+++  + +    G
Sbjct: 190 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 224

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 192
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 193 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 248
Query: 214 FGMVLF 219
            G++++
Sbjct: 249 LGVIMY 254

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 20/226 (8%)
Query: 5   LQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLG 61
           +Q +G    V+        FT  Y  +  +G G +    +       ++ AVK+++++  
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60
Query: 62  RIAEE-QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
              EE + +   G      H N++ L     D     +V E M+ G L   +  +K   E
Sbjct: 61  DPTEEIEILLRYGQ-----HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL-LDANFSP---KVADFGLAKLCD 176
            E    +     K + YLH    Q ++H D+KP N+L +D + +P   ++ DFG AK   
Sbjct: 116 REA-SAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
                +    Y  T  + APE L         CD++S G++L+ ++
Sbjct: 172 AENGLLMTPCY--TANFVAPEVLE-RQGYDAACDIWSLGVLLYTML 214

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 97  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 153
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 154 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 209
Query: 214 FGMVLF 219
            G++++
Sbjct: 210 LGVIMY 215

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 91  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 147
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 148 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 203
Query: 214 FGMVLF 219
            G++++
Sbjct: 204 LGVIMY 209

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 90  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 146
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 147 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 202
Query: 214 FGMVLF 219
            G++++
Sbjct: 203 LGVIMY 208

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 142 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 198
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 199 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 254
Query: 214 FGMVLF 219
            G++++
Sbjct: 255 LGVIMY 260

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 96  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 152
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 153 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 208
Query: 214 FGMVLF 219
            G++++
Sbjct: 209 LGVIMY 214

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 148
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 149 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 204
Query: 214 FGMVLF 219
            G++++
Sbjct: 205 LGVIMY 210

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 84
Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
             D ++      +V EY+  GSL   +   +  ++  ++  +     + L +LH     +
Sbjct: 85  --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 137
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +IH +IK +N+LL  + S K+ DFG        +S    S   GTP + APE ++     
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT-RKAY 194
Query: 206 THKCDVYSFGMVLFEIV 222
             K D++S G++  E++
Sbjct: 195 GPKVDIWSLGIMAIEMI 211

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 98  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 154
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 155 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 210
Query: 214 FGMVLF 219
            G++++
Sbjct: 211 LGVIMY 216

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNL-GRIAEEQFMAEV---GTIGRTYHINLVR 85
           ++G G FG V+K  +  +G   A+K   + L G + E+  + EV     +G+  H+  VR
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV--VR 75
Query: 86  LY-GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK---LHEIAIGTAKGLVYLHEE 141
            +  +  D HM  +  EY   GSL   +    R + + K   L ++ +   +GL Y+H  
Sbjct: 76  YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 132
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVA-------DFGLAKLCDR--NRSHVT-ISG---YK 188
               ++H DIKP N+ +     P  A       D+   K+  +  +  HVT IS     +
Sbjct: 133 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG 223
           G   + A E L  NY    K D+++  + +    G
Sbjct: 192 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 148
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 149 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 204
Query: 214 FGMVLF 219
            G++++
Sbjct: 205 LGVIMY 210

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 36/209 (17%)
Query: 32  LGFGGFGEVYKGQFPNGVK----IAVKVLN-----RNLGRIAEEQFMAEVGTIGRTYHIN 82
           LG GG+G+V++ +   G       A+KVL      RN    A  +  AE   +    H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK--AERNILEEVKHPF 82
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIAIGTAKGLVY 137
           +V L           L+ EY+  G L  ++  ++  I  E      L EI++     L +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA----LGH 136
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSA 195
           LH   Q+ II+ D+KPEN++L+     K+ DFGL K  + D   +H     + GT  Y A
Sbjct: 137 LH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT----FCGTIEYMA 189
Query: 196 PEFL--SGNYPITHKCDVYSFGMVLFEIV 222
           PE L  SG+       D +S G ++++++
Sbjct: 190 PEILMRSGH---NRAVDWWSLGALMYDML 215

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 106 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 162
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 163 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWS 218
Query: 214 FGMVLF 219
            G++++
Sbjct: 219 LGVIMY 224

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 90  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENL 146
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD++S
Sbjct: 147 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYVAPEVL-GPEKYDKSCDMWS 202
Query: 214 FGMVLF 219
            G++++
Sbjct: 203 LGVIMY 208

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           +G G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EYM  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     KVADFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           +G G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EYM  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     KVADFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 36/209 (17%)
Query: 32  LGFGGFGEVYKGQFPNGVK----IAVKVLN-----RNLGRIAEEQFMAEVGTIGRTYHIN 82
           LG GG+G+V++ +   G       A+KVL      RN    A  +  AE   +    H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK--AERNILEEVKHPF 82
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIAIGTAKGLVY 137
           +V L           L+ EY+  G L  ++  ++  I  E      L EI++     L +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA----LGH 136
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSA 195
           LH   Q+ II+ D+KPEN++L+     K+ DFGL K  + D   +H     + GT  Y A
Sbjct: 137 LH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHX----FCGTIEYMA 189
Query: 196 PEFL--SGNYPITHKCDVYSFGMVLFEIV 222
           PE L  SG+       D +S G ++++++
Sbjct: 190 PEILMRSGH---NRAVDWWSLGALMYDML 215

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 73
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E ME    D + F  +R    E+L           V    
Sbjct: 74  -GVIRLLDWFERPDSFVLILERMEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 132 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 185
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMV 208

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 32  LGFGGFGEVYKGQFPNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G FG V++ +     ++A+K VL     +  E Q M  V       H N+V L  F 
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK------HPNVVDLKAFF 101
Query: 91  H------DQHMTALVYEYM-ENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           +      D+    LV EY+ E        + K K+ +    +        + L Y+H   
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 143 QQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTI--SGYKGTPGYSAPEFL 199
              I H DIKP+N+LLD      K+ DFG AK+      +V+   S Y     Y APE +
Sbjct: 162 ---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-----YRAPELI 213
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
            G    T   D++S G V+ E++
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELM 236

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 21/221 (9%)
Query: 14  VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNR--NLGRIAEEQFMA 70
           VR   ++L          +G G F EV   +    G   A+K++N+   L R     F  
Sbjct: 51  VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 71  EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHEIA 128
           E   +       + +L+    D++   LV EY   G L   L  FG++   E  + +   
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY- 187
           I  A   V+     +   +H DIKP+N+LLD     ++ADFG    C + R+  T+    
Sbjct: 171 IVMAIDSVH-----RLGYVHRDIKPDNILLDRCGHIRLADFG---SCLKLRADGTVRSLV 222
Query: 188 -KGTPGYSAPEFLSG------NYPITHKCDVYSFGMVLFEI 221
             GTP Y +PE L              +CD ++ G+  +E+
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 59/126 (46%), Gaps = 11/126 (8%)
Query: 98  LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156
           +V E ++ G L   +  +  +A    +  EI     + + YLH      I H D+KPEN+
Sbjct: 136 IVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH---SINIAHRDVKPENL 192
Query: 157 LLDA---NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
           L  +   N   K+ DFG AK      SH +++    TP Y APE L G       CD +S
Sbjct: 193 LYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDXWS 248
Query: 214 FGMVLF 219
            G++ +
Sbjct: 249 LGVIXY 254

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 79/192 (41%), Gaps = 14/192 (7%)
Query: 32  LGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG   + + +  N + +AVK + R  G   +E    E+       H N+VR    
Sbjct: 27  IGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                  A+V EY   G L   +    R  E E           G+ Y H     ++ H 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCH---AMQVCHR 139
Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           D+K EN LLD + +P  K+  FG +K    +  H       GTP Y APE L        
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 208 KCDVYSFGMVLF 219
             DV+S G+ L+
Sbjct: 197 VADVWSCGVTLY 208

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN-LGRIAE-EQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG V        G   A+K+L++  + ++ E E  + E   +       LV+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRI 146
              D     +V EY   G +  +L   +R   + + H    A        YLH      +
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDL 162
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPI 205
           I+ D+KPEN+++D     KV DFGLAK   + R+        GTP Y APE  LS  Y  
Sbjct: 163 IYRDLKPENLMIDQQGYIKVTDFGLAKRV-KGRTWXLC----GTPEYLAPEIILSKGY-- 215
Query: 206 THKCDVYSFGMVLFEIVG 223
               D ++ G++++E+  
Sbjct: 216 NKAVDWWALGVLIYEMAA 233

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 78/192 (40%), Gaps = 14/192 (7%)
Query: 32  LGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG   + + +  N + +AVK + R  G         E+       H N+VR    
Sbjct: 27  IGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIAANVKREIINHRSLRHPNIVRFKEV 83
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                  A+V EY   G L   +    R  E E           G+ Y H     ++ H 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCH---AMQVCHR 139
Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           D+K EN LLD + +P  K+ DFG +K    +  H       GTP Y APE L        
Sbjct: 140 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 208 KCDVYSFGMVLF 219
             DV+S G+ L+
Sbjct: 197 VADVWSCGVTLY 208

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           +G G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     KVADFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 79/192 (41%), Gaps = 14/192 (7%)
Query: 32  LGFGGFG--EVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG   + + +  N + +AVK + R  G   +E    E+       H N+VR    
Sbjct: 27  IGSGNFGVARLMRDKQSNEL-VAVKYIER--GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                  A+V EY   G L   +    R  E E           G+ Y H     ++ H 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCH---AMQVCHR 139
Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           D+K EN LLD + +P  K+  FG +K    +  H       GTP Y APE L        
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 208 KCDVYSFGMVLF 219
             DV+S G+ L+
Sbjct: 197 VADVWSCGVTLY 208

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 46/229 (20%)
Query: 31  RLGFGGFGEVY--KGQFPNGV--KIAVKVL--NRNLGRIAEE-QFMAEVGTIGRTYHINL 83
           ++G G F  VY    Q   G   KIA+K L    +  RIA E Q +   G       +  
Sbjct: 28  KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVK- 86
Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
              Y F  + H+  +   Y+E+ S    L     ++ ++++ E  +   K L  +H   Q
Sbjct: 87  ---YCFRKNDHVV-IAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIH---Q 135
Query: 144 QRIIHYDIKPENVLLDANFSP-KVADFGLAK--------------------LCDRNRSHV 182
             I+H D+KP N L +       + DFGLA+                     C +N+  +
Sbjct: 136 FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSI 195
Query: 183 TISGYK------GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            +S  +      GTPG+ APE L+     T   D++S G++   ++  R
Sbjct: 196 CLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 49/95 (51%), Gaps = 14/95 (14%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSP------KVADFGLAKLCDRNRSHVTISGY 187
           GL Y+H  C   IIH DIKPENVL++   SP      K+AD G A   D    H T S  
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNS-- 195
Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             T  Y +PE L G  P     D++S   ++FE++
Sbjct: 196 IQTREYRSPEVLLGA-PWGCGADIWSTACLIFELI 229

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 48  GVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG-FCHDQHMTALVYEYMEN 105
           G+ +AVK L+R    +   ++   E+  +    H N++ L   F   + +      Y+  
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 106 GSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164
             +D  L       ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + 
Sbjct: 107 ELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 163
Query: 165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR 224
           K+ DFGLA+    N     ++ Y  T  Y APE + G        D++S G ++ E+V  
Sbjct: 164 KILDFGLARTASTN---FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELV-- 217
Query: 225 RRNAIVGSSESLDWFPK 241
           + + I   ++ +D + K
Sbjct: 218 KGSVIFQGTDHIDQWNK 234

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 49/95 (51%), Gaps = 14/95 (14%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSP------KVADFGLAKLCDRNRSHVTISGY 187
           GL Y+H  C   IIH DIKPENVL++   SP      K+AD G A   D + ++      
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI---- 196
Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
             T  Y +PE L G  P     D++S   ++FE++
Sbjct: 197 -QTREYRSPEVLLGA-PWGCGADIWSTACLIFELI 229

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 79/180 (43%), Gaps = 16/180 (8%)
Query: 52  AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGY 111
           AVK++ +  G I    F           H N++ L  F  ++    LV+E M  GS+  +
Sbjct: 42  AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH 101
Query: 112 LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSP-KVAD 168
           +  ++   E E    +    A  L +LH    + I H D+KPEN+L +     SP K+ D
Sbjct: 102 IHKRRHFNELEA-SVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICD 157
Query: 169 FGLAKLCDRNRSHVTISGYK-----GTPGYSAPE----FLSGNYPITHKCDVYSFGMVLF 219
           FGL      N     IS  +     G+  Y APE    F         +CD++S G++L+
Sbjct: 158 FGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK     R    
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 195 TWXLXGTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK     R    
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 195 TWXLAGTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN-LGRIAE-EQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG V        G   A+K+L++  + ++ E E  + E   +       LV+L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQRI 146
              D     +V EY   G +  +L   +R   + + H    A        YLH      +
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDL 162
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPI 205
           I+ D+KPEN+++D     +V DFGLAK   + R+        GTP Y APE  LS  Y  
Sbjct: 163 IYRDLKPENLMIDQQGYIQVTDFGLAKRV-KGRTWXLC----GTPEYLAPEIILSKGY-- 215
Query: 206 THKCDVYSFGMVLFEIVG 223
               D ++ G++++E+  
Sbjct: 216 NKAVDWWALGVLIYEMAA 233

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 92
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 93  EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 146
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 147 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTLC----GTPEYLAPEIILSKGY 201
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 202 --NKAVDWWALGVLIYEMAA 219

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 74
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 75  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 132
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 133 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 26  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 80
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 81  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPH 137
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 138 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 193
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 194 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 228

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 57/233 (24%)
Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVL-----NRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           L  GGF  VY+ Q   +G + A+K L      +N   I E  FM ++     + H N+V+
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL-----SGHPNIVQ 90
Query: 86  LYGFCHDQHMTA----------LVYEYMENGSLDGYL--FGKKRAIEWEKLHEIAIGTAK 133
              FC    +            L+   +  G L  +L     +  +  + + +I   T +
Sbjct: 91  ---FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY------ 187
            + ++H + +  IIH D+K EN+LL    + K+ DFG         S  TIS Y      
Sbjct: 148 AVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFG---------SATTISHYPDYSWS 197
Query: 188 -------------KGTPGYSAPEF--LSGNYPITHKCDVYSFGMVLFEIVGRR 225
                          TP Y  PE   L  N+PI  K D+++ G +L+ +  R+
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 161
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTLC----GTPEYLAPEIILSKGY 216
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 217 --NKAVDWWALGVLIYEMAA 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 18  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 72
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 73  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 129
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 130 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV-KGRTWXL 185
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 186 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 220

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 88
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 89  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 147 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 200
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMV 223

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 72
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 73  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 130
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 131 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 184
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMV 207

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 12/133 (9%)
Query: 91  HDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
           H +    ++ E ME G L   +  +  +A    +  EI       + +LH      I H 
Sbjct: 96  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHR 152
Query: 150 DIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           D+KPEN+L    + +   K+ DFG AK   +N           TP Y APE L G     
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYVAPEVL-GPEKYD 207
Query: 207 HKCDVYSFGMVLF 219
             CD++S G++++
Sbjct: 208 KSCDMWSLGVIMY 220

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 74
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 75  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 132
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 133 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMV 209

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 101
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 102 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 160 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 213
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMV 236

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 73
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 74  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 132 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 185
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMV 208

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 88
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 89  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 147 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 200
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMV 223

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 32  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 86
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 87  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 143
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 144 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 199
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 200 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 234

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 12/133 (9%)
Query: 91  HDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
           H +    ++ E ME G L   +  +  +A    +  EI       + +LH      I H 
Sbjct: 77  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHR 133
Query: 150 DIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           D+KPEN+L    + +   K+ DFG AK   +N           TP Y APE L G     
Sbjct: 134 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYVAPEVL-GPEKYD 188
Query: 207 HKCDVYSFGMVLF 219
             CD++S G++++
Sbjct: 189 KSCDMWSLGVIMY 201

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 52  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 106
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 107 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 163
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK     R    
Sbjct: 164 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGA 215
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 216 TWTLCGTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 254

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 116
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 117 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 175 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 228
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 69
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 70  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 128 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 82/178 (46%), Gaps = 10/178 (5%)
Query: 48  GVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG-FCHDQHMTALVYEYMEN 105
           G+ +AVK L+R    +   ++   E+  +    H N++ L   F   + +      Y+  
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 106 GSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164
             +D  L       ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + 
Sbjct: 109 ELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 165
Query: 165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
           K+ DFGLA+    N     ++ Y  T  Y APE + G        D++S G ++ E+V
Sbjct: 166 KILDFGLARTACTN---FMMTPYVVTRYYRAPEVILG-MGYAANVDIWSVGCIMGELV 219

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 101
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 102 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 160 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 213
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMV 236

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 89
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 90  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 148 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 102
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 103 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 161 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 214
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 74
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 75  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 132
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 133 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMV 209

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 89
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 90  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 148 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 102
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 103 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 161 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 214
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 101
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 102 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 160 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 213
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMV 236

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 102
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 103 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 161 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 214
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 16/144 (11%)
Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHE 140
           LV+L     D     +V EY   G +  +L   +R   + + H    A        YLH 
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH- 159
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FL 199
                +I+ D+KPEN+L+D     KVADFG AK   + R+        GTP Y APE  L
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTWXLC----GTPEYLAPEIIL 212
Query: 200 SGNYPITHKCDVYSFGMVLFEIVG 223
           S  Y      D ++ G++++E+  
Sbjct: 213 SKGY--NKAVDWWALGVLIYEMAA 234

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 102
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 103 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 161 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 214
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 101
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 102 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 160 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 213
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMV 236

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 52  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 106
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 107 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPH 163
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 164 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 219
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 220 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 254

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 89
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 90  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 148 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMV 224

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFAEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 69
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 70  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 128 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMV 204

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 161
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 217 --NKAVDWWALGVLIYEMAA 234

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 23  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEE-QFMAEVGTIGRT 78
            FT  Y  +  +G G +    +        + AVK+++++     EE + +   G     
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQ---- 74
Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
            H N++ L     D     +V E  + G L   +  +K   E E    +     K + YL
Sbjct: 75  -HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREA-SAVLFTITKTVEYL 132
Query: 139 HEECQQRIIHYDIKPENVL-LDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYS 194
           H    Q ++H D+KP N+L +D + +P   ++ DFG AK        +    Y  T  + 
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY--TANFV 187
Query: 195 APEFLSGNYPITHKCDVYSFGMVLF 219
           APE L         CD++S G++L+
Sbjct: 188 APEVLE-RQGYDAACDIWSLGVLLY 211

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 116
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 117 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 175 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 228
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMV 251

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY   G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+++D     KV DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 121
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 122 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 179
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 180 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 233
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMV 256

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 108
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 109 -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 167 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 220
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMV 243

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SL 161
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 217 --NKAVDWWALGVLIYEMAA 234

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 42/218 (19%)
Query: 32  LGFGGFGEVYK--GQFPNGVKIAVKVLNRNLGRIAEE-----QFMAEVGTIGRTYHINLV 84
           LG G FG+V +       G  +AVK++ +N+ R  E      Q +  + T         V
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI---EWEKLHEIAIGTAKGLVYLHEE 141
           ++  +        +V+E +    L  Y F K+        + + ++A    K + +LH  
Sbjct: 81  QMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH-- 135
Query: 142 CQQRIIHYDIKPENVLLDAN-----FSP--------------KVADFGLAKLCDRNRSHV 182
              ++ H D+KPEN+L   +     ++P              KV DFG A   D + S +
Sbjct: 136 -SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL 194
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
                  T  Y APE +      +  CDV+S G +L E
Sbjct: 195 V-----STRHYRAPEVILA-LGWSQPCDVWSIGCILIE 226

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 96
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
             ++RL  +        L+ E  E    D + F  +R    E+L           V    
Sbjct: 97  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 154
Query: 141 ECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
            C   ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE++
Sbjct: 155 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 208
Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
             +        V+S G++L+++V
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMV 231

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 29/164 (17%)
Query: 80  HINLVRLYGFCHDQ----HMTALVYEYMENGSL--------DGYLFGKKRAIEWEKLHEI 127
           H N++RL  +C  +    H   L+  + + G+L        D   F  +  I W     +
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW-----L 139
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG-LAKLC---DRNRSHVT 183
            +G  +GL  +H    +   H D+KP N+LL     P + D G + + C   + +R  +T
Sbjct: 140 LLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 184 ISGY---KGTPGYSAPEFLS--GNYPITHKCDVYSFGMVLFEIV 222
           +  +   + T  Y APE  S   +  I  + DV+S G VL+ ++
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY   G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+++D     KV DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      +   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            APE + G        D++S G+++ E++
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGVIMGEMI 219

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 119 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-- 177
Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            +   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 178 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 119 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-- 170
Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            +   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 171 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 161
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 217 --NKAVDWWALGVLIYEMAA 234

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      +   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            APE + G        D++S G+++ E++
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGVIMGEMI 219

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 99
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 153
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 154 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 208
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 209 --NKAVDWWALGVLIYEMAA 226

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 161
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 217 --NKAVDWWALGVLIYEMAA 234

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 119 IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
           ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-- 177
Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            +   ++ Y  T  Y APE + G        D++S G ++ E+V  +
Sbjct: 178 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 161
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 217 --NKAVDWWALGVLIYEMAA 234

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 32  LGFGGFGEVYKG-QFPNGVKIAVKVLNR----------NLGRIAEEQFMAEVGTIGRTYH 80
           LG GGFG VY G +  + + +A+K + +          N  R+  E  + +  + G +  
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 69
Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLH 139
             ++RL  +        L+ E  E    D + F  +R A++ E          + + + H
Sbjct: 70  -GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 140 EECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
                 ++H DIK EN+L+D N    K+ DFG   L          + + GT  YS PE+
Sbjct: 128 NXG---VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEW 180
Query: 199 LSGNYPITHKCDVYSFGMVLFEIV 222
           +  +        V+S G++L+++V
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 127
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 128 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 181
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 182 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 236
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 237 --NKAVDWWALGVLIYEMAA 254

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY   G +  +L   +R   + + H    A        YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 161
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+++D     KV DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 217 --NKAVDWWALGVLIYEMAA 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  LS  Y      D ++ G++++++  
Sbjct: 199 C----GTPEYLAPEIILSKGY--NKAVDWWALGVLIYQMAA 233

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V   +    G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 99
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY+  G +  +L   +R   + + H    A        YLH     
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SL 153
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+L+D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 154 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 208
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 209 --NKAVDWWALGVLIYEMAA 226

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 28/189 (14%)
Query: 47  NGVKIAVKVLN----RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY 102
            G + AVK+++     +   ++ E    E        H ++V L        M  +V+E+
Sbjct: 50  TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF 109
Query: 103 MENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153
           M+   L          G+++ +  A  + +         + L Y H+     IIH D+KP
Sbjct: 110 MDGADLCFEIVKRADAGFVYSEAVASHYMR------QILEALRYCHD---NNIIHRDVKP 160
Query: 154 ENVLLDA--NFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD 210
             VLL +  N +P K+  FG+A       S +   G  GTP + APE +    P     D
Sbjct: 161 HCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHFMAPEVVK-REPYGKPVD 217
Query: 211 VYSFGMVLF 219
           V+  G++LF
Sbjct: 218 VWGCGVILF 226

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 28/189 (14%)
Query: 47  NGVKIAVKVLN----RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY 102
            G + AVK+++     +   ++ E    E        H ++V L        M  +V+E+
Sbjct: 48  TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF 107
Query: 103 MENGSL---------DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153
           M+   L          G+++ +  A  + +         + L Y H+     IIH D+KP
Sbjct: 108 MDGADLCFEIVKRADAGFVYSEAVASHYMR------QILEALRYCHD---NNIIHRDVKP 158
Query: 154 ENVLLDA--NFSP-KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD 210
             VLL +  N +P K+  FG+A       S +   G  GTP + APE +    P     D
Sbjct: 159 HCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVD 215
Query: 211 VYSFGMVLF 219
           V+  G++LF
Sbjct: 216 VWGCGVILF 224

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      +   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE + G        D++S G ++ E+V  +
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 16/180 (8%)
Query: 52  AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGY 111
           AVK++ +  G I    F           H N++ L  F  ++    LV+E M  GS+  +
Sbjct: 42  AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH 101
Query: 112 LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSP-KVAD 168
           +  ++   E E    +    A  L +LH    + I H D+KPEN+L +     SP K+ D
Sbjct: 102 IHKRRHFNELEA-SVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICD 157
Query: 169 FGLAKLCDRNRSHVTISGYK-----GTPGYSAPE----FLSGNYPITHKCDVYSFGMVLF 219
           F L      N     IS  +     G+  Y APE    F         +CD++S G++L+
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       LV+L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKL 106
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY   G +  +L   +R   + + H    A        YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+++D     +V DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 161 DLIYRDLKPENLMIDQQGYIQVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 215
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 216 --NKAVDWWALGVLIYEMAA 233

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      +   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE + G        D++S G ++ E+V  +
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 4/78 (5%)
Query: 146 IIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
           + H DIKP NVL++ A+ + K+ DFG AK    +  +V    Y  +  Y APE + GN  
Sbjct: 152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQH 208
Query: 205 ITHKCDVYSFGMVLFEIV 222
            T   D++S G +  E++
Sbjct: 209 YTTAVDIWSVGCIFAEMM 226

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 93/239 (38%), Gaps = 33/239 (13%)
Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G +G V +   +    V    K+L      I  ++ + E+  + R  H ++V++   
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 90  CHDQHMTAL--VYEYMENGSLD-GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
              + +     +Y  +E    D   LF     +    +  +      G+ Y+H      I
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---I 177
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCD---RNRSHVTIS------------------ 185
           +H D+KP N L++ + S KV DFGLA+  D      S + IS                  
Sbjct: 178 LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
Query: 186 ----GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP 240
               G+  T  Y APE +      T   DV+S G +  E++   +  +   ++    FP
Sbjct: 238 RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFP 296

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+++D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y APE  +S  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPEIIISKGY--NKAVDWWALGVLIYEMAA 233

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       L +L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLTKL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY   G +  +L   +R   + + H    A        YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 161
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+++D     KV DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 217 --NKAVDWWALGVLIYEMAA 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       L +L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLTKL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY   G +  +L   +R   + + H    A        YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SL 161
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+++D     KV DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 217 --NKAVDWWALGVLIYEMAA 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      +   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            APE + G        D++S G ++ E++
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMI 219

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 11  EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN----LGRIAE 65
           E P + T+ QL+ F  +    LG G FG V   +   +G   A+K+L++     L +I  
Sbjct: 31  ETPSQNTA-QLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-- 85
Query: 66  EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH 125
           E  + E   +       LV+L     D     +V EY+  G +  +L   +R   + + H
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH 142
Query: 126 E--IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
               A        YLH      +I+ D+KPEN+L+D     +V DFG AK   + R+   
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXL 198
Query: 184 ISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVG 223
                GTP Y AP   LS  Y      D ++ G++++E+  
Sbjct: 199 C----GTPEYLAPAIILSKGY--NKAVDWWALGVLIYEMAA 233

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +  
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             + APE +      T + DV+SFG++L+EI
Sbjct: 264 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 293

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 42/218 (19%)
Query: 32  LGFGGFGEVYK--GQFPNGVKIAVKVLNRNLGRIAEE-----QFMAEVGTIGRTYHINLV 84
           LG G FG+V +       G  +AVK++ +N+ R  E      Q +  + T         V
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAI---EWEKLHEIAIGTAKGLVYLHEE 141
           ++  +        +V+E +    L  Y F K+        + + ++A    K + +LH  
Sbjct: 81  QMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH-- 135
Query: 142 CQQRIIHYDIKPENVLLDAN-----FSP--------------KVADFGLAKLCDRNRSHV 182
              ++ H D+KPEN+L   +     ++P              KV DFG A   D + S +
Sbjct: 136 -SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL 194
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
               +     Y APE +      +  CDV+S G +L E
Sbjct: 195 VXXRH-----YRAPEVILA-LGWSQPCDVWSIGCILIE 226

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+      +   ++ Y  T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            APE + G        D++S G ++ E++
Sbjct: 192 RAPEVILG-MGYKENVDIWSVGCIMGEMI 219

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +  
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             + APE +      T + DV+SFG++L+EI
Sbjct: 259 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +  
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             + APE +      T + DV+SFG++L+EI
Sbjct: 266 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     +  
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
             + APE +      T + DV+SFG++L+EI
Sbjct: 257 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 286

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 23/200 (11%)
Query: 32  LGFGGFGEV-YKGQFPNGVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG V        G   A+K+L++     L +I  E  + E   +       L +L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLTKL 107
Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE--IAIGTAKGLVYLHEECQQ 144
                D     +V EY   G +  +L   +R   + + H    A        YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLH---SL 161
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNY 203
            +I+ D+KPEN+++D     KV DFG AK   + R+        GTP Y APE  LS  Y
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GTPEYLAPEIILSKGY 216
Query: 204 PITHKCDVYSFGMVLFEIVG 223
                 D ++ G++++E+  
Sbjct: 217 --NKAVDWWALGVLIYEMAA 234
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	356
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-111
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-98
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-96
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-75
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-61
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-38
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-32
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-32
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-31
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-29
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-29
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-28
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-28
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-26
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-18
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-13
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-12
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-11
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-06

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  326 bits (837), Expect = e-111
 Identities = 117/305 (38%), Positives = 170/305 (55%), Gaps = 19/305 (6%)

Query: 7   EIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA 64
           E+   +  RF+  +L   + N+S +  LG GGFG+VYKG+  +G  +AVK L     +  
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70

Query: 65  EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---IEW 121
           E QF  EV  I    H NL+RL GFC       LVY YM NGS+   L  +  +   ++W
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130

Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
            K   IA+G+A+GL YLH+ C  +IIH D+K  N+LLD  F   V DFGLAKL D   +H
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190

Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES------ 235
           VT +  +GT G+ APE+LS     + K DV+ +G++L E++  +R   +    +      
Sbjct: 191 VT-TAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248

Query: 236 LDWFPKHVWEEYEKSELDATILACGIEEK-DKEKAKRLCMAALWCVQDSPEDRPPMSAVV 294
           LDW    V    ++ +L+A ++   ++     E+ ++L   AL C Q SP +RP MS VV
Sbjct: 249 LDW----VKGLLKEKKLEA-LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303

Query: 295 KMLEG 299
           +MLEG
Sbjct: 304 RMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  291 bits (748), Expect = 8e-98
 Identities = 109/304 (35%), Positives = 161/304 (52%), Gaps = 30/304 (9%)

Query: 15  RFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEV 72
           R   + L   T+N+  +  +G G FG+VYKG   +G K+A+K           E+F  E+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86

Query: 73  GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---WEKLHEIAI 129
            T+    H +LV L GFC +++   L+Y+YMENG+L  +L+G         WE+  EI I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC-DRNRSHVTISGYK 188
           G A+GL YLH      IIH D+K  N+LLD NF PK+ DFG++K   + +++H++ +  K
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-TVVK 202

Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV-GRRRNAIVGSSES-----LDWFPKH 242
           GT GY  PE+      +T K DVYSFG+VLFE++  R   AIV S         +W    
Sbjct: 203 GTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARS--AIVQSLPREMVNLAEW---- 255

Query: 243 VWEEYEKSELDATI---LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG 299
             E +   +L+  +   LA  I     E  ++    A+ C+  S EDRP M  V+  LE 
Sbjct: 256 AVESHNNGQLEQIVDPNLADKI---RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

Query: 300 VVEV 303
            + +
Sbjct: 313 ALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  287 bits (737), Expect = 3e-96
 Identities = 100/305 (32%), Positives = 145/305 (47%), Gaps = 31/305 (10%)

Query: 15  RFTSLQLNNFTSNYSTR--------LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA-- 64
            F+  +L N T+N+  R        +G GGFG VYKG   N   +AVK L   +      
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72

Query: 65  -EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR--AIEW 121
            ++QF  E+  + +  H NLV L GF  D     LVY YM NGSL   L        + W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN-RS 180
               +IA G A G+ +LHE      IH DIK  N+LLD  F+ K++DFGLA+  ++  ++
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES--LDW 238
            +T S   GT  Y APE L G   IT K D+YSFG+VL EI+               LD 
Sbjct: 190 VMT-SRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246

Query: 239 FPKHVWEEYEKSE--LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM 296
             + + +E +  E  +D       + + D    + +   A  C+ +    RP +  V ++
Sbjct: 247 K-EEIEDEEKTIEDYIDKK-----MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

Query: 297 LEGVV 301
           L+ + 
Sbjct: 301 LQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  233 bits (597), Expect = 4e-75
 Identities = 74/292 (25%), Positives = 116/292 (39%), Gaps = 26/292 (8%)

Query: 28  YSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
                  G FG V+K Q      +AVK+           Q   EV ++    H N+++  
Sbjct: 28  LLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFI 84

Query: 88  GFCHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE-- 141
           G             L+  + E GSL  +L  K   + W +L  IA   A+GL YLHE+  
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIP 142

Query: 142 -----CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
                 +  I H DIK +NVLL  N +  +ADFGLA   +  +S     G  GT  Y AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202

Query: 197 EFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL 252
           E L G          + D+Y+ G+VL+E+  R   A     E +  F + + +     ++
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262

Query: 253 DATILACG----IEEKDKEKAKRLCMAAL--WCVQDSPEDRPPMSAVVKMLE 298
              ++       + +  ++ A    +      C     E R     V + + 
Sbjct: 263 QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  201 bits (512), Expect = 3e-62
 Identities = 75/325 (23%), Positives = 114/325 (35%), Gaps = 43/325 (13%)

Query: 18  SLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAE--VGTI 75
           SL L+N        +G G +G VYKG   +   +AVKV +        + F+ E  +  +
Sbjct: 9   SLDLDNLK--LLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRV 61

Query: 76  GRTYHINLVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 130
               H N+ R                 LV EY  NGSL  YL       +W     +A  
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHS 119

Query: 131 TAKGLVYLHEE------CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR----- 179
             +GL YLH E       +  I H D+   NVL+  + +  ++DFGL+     NR     
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 180 -SHVTISGYKGTPGYSAPEFLSGNY------PITHKCDVYSFGMVLFEIVGRRRNAIVGS 232
                     GT  Y APE L G            + D+Y+ G++ +EI  R  +   G 
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239

Query: 233 SESLDWFPKHVWEEYEKSELDATILACG------IEEKDKEKAKRLC-MAAL--WCVQDS 283
           S                +  D  +L           E  KE +  +  +      C    
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299

Query: 284 PEDRPPMSAVVKMLEGVVEVLPPPK 308
            E R       + +  ++ +    K
Sbjct: 300 AEARLTAQXAEERMAELMMIWERNK 324

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (502), Expect = 6e-61
 Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 44/291 (15%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G FG V++ ++ +G  +AVK+L   +       +F+ EV  + R  H N+V   G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
                  ++V EY+  GSL   L     +  ++  +   +A   AKG+ YLH      I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H ++K  N+L+D  ++ KV DFGL++L  +  + ++     GTP + APE L    P   
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE-PSNE 218

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
           K DVYSFG++L+E+   ++             P      +    L+   +   +  K   
Sbjct: 219 KSDVYSFGVILWELATLQQ-------------P------WG--NLNPAQVVAAVGFKC-- 255

Query: 268 KAKRL-----CMAAL-----WCVQDSPEDRPPMSAVVKMLEGVV-EVLPPP 307
             KRL         +      C  + P  RP  + ++ +L  ++   +PPP
Sbjct: 256 --KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  194 bits (494), Expect = 7e-60
 Identities = 75/296 (25%), Positives = 123/296 (41%), Gaps = 50/296 (16%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            +G G FG V K ++     +A+K +         + F+ E+  + R  H N+V+LYG C
Sbjct: 15  VVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIE--WEKLHEIAIGTAKGLVYLHEECQQRIIH 148
            +     LV EY E GSL   L G +              +  ++G+ YLH    + +IH
Sbjct: 71  LNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 149 YDIKPENVLLDANFS-PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            D+KP N+LL A  +  K+ DFG A           ++  KG+  + APE   G+   + 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGS-NYSE 182

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
           KCDV+S+G++L+E++ RR+             P   ++E                     
Sbjct: 183 KCDVFSWGIILWEVITRRK-------------P---FDEIGGPAFRIMWAV--------H 218

Query: 268 KAKRL-----CMAAL-----WCVQDSPEDRPPMSAVVKMLEGVVEVLP-PPKPFRY 312
              R          +      C    P  RP M  +VK++  ++   P   +P +Y
Sbjct: 219 NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  191 bits (488), Expect = 4e-59
 Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 36/279 (12%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN         + F  EVG + +T H+N++   G+
Sbjct: 31  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E +KL +IA  TA+G+ YLH    + IIH 
Sbjct: 89  STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG--NYPITH 207
           D+K  N+ L  + + K+ DFGLA    R           G+  + APE +    + P + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 208 KCDVYSFGMVLFEIVGRR--------RNAIVGSSESLDWFPKHVWEEYEKSELDATILAC 259
           + DVY+FG+VL+E++  +        R+ I+            V       +L      C
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM----------VGRGSLSPDLSKVRSNC 254

Query: 260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
                  ++ KRL      C++   ++RP    ++  +E
Sbjct: 255 P------KRMKRLMAE---CLKKKRDERPSFPRILAEIE 284

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (484), Expect = 2e-58
 Identities = 75/291 (25%), Positives = 119/291 (40%), Gaps = 54/291 (18%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVL------NRNLGRIAEEQFMAEVGTIGRTYHINL 83
           ++G GGFG V+KG+   +   +A+K L               ++F  EV  +    H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
           V+LYG  H+     +V E++  G L   L  K   I+W     + +  A G+ Y+     
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQN 142

Query: 144 QRIIHYDIKPENVLLD-----ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
             I+H D++  N+ L      A    KVADFGL++      S  ++SG  G   + APE 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPET 197

Query: 199 LSG-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL 257
           +       T K D YSF M+L+ I+                 P   ++EY   ++    +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEG-------------P---FDEYSYGKIKFINM 241

Query: 258 ACGIEEKDKEKAKRL-----C---MAAL--WCVQDSPEDRPPMSAVVKMLE 298
                    E+  R      C   +  +   C    P+ RP  S +VK L 
Sbjct: 242 IR-------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  187 bits (476), Expect = 5e-57
 Identities = 71/302 (23%), Positives = 107/302 (35%), Gaps = 52/302 (17%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            LG G FG+  K      G  + +K L        +  F+ EV  +    H N+++  G 
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            +       + EY++ G+L G +        W +    A   A G+ YLH      IIH 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK------------GTPGYSAPE 197
           D+   N L+  N +  VADFGLA+L    ++                    G P + APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192

Query: 198 FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL 257
            ++G      K DV+SFG+VL EI+GR                     +Y    +D  + 
Sbjct: 193 MINGR-SYDEKVDVFSFGIVLCEIIGRVN----------------ADPDYLPRTMDFGL- 234

Query: 258 ACGIEEKDKEKAKRLCMA----------ALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPP 307
                  +                     + C    PE RP    +   LE +   L   
Sbjct: 235 -------NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287

Query: 308 KP 309
            P
Sbjct: 288 LP 289

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  184 bits (470), Expect = 1e-56
 Identities = 70/290 (24%), Positives = 112/290 (38%), Gaps = 56/290 (19%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNR---NLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
            +G GGFG+VY+  +  G ++AVK              E    E        H N++ L 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G C  +    LV E+   G L+  L GK+  I  + L   A+  A+G+ YLH+E    II
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPII 130

Query: 148 HYDIKPENVLLDANFSP--------KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
           H D+K  N+L+              K+ DFGLA    R     T     G   + APE +
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVI 186

Query: 200 SGNYPITHKCDVYSFGMVLFEIVGRRR-----------NAIVGSSESLDWFPKHVWEEYE 248
             +   +   DV+S+G++L+E++                 +  +  +L   P    E + 
Sbjct: 187 RAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-IPSTCPEPF- 243

Query: 249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            ++L   +  C                  W     P  RP  + ++  L 
Sbjct: 244 -AKL---MEDC------------------W--NPDPHSRPSFTNILDQLT 269

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  185 bits (472), Expect = 3e-56
 Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 38/295 (12%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           ++G G +GEV+ G++  G K+AVKV        A      E+       H N++      
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAAD 100

Query: 91  HDQHMT----ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR- 145
                +     L+ +Y ENGSL  YL  K   ++ + + ++A  +  GL +LH E     
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 146 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS--GYKGTPGYSAPEFL 199
               I H D+K +N+L+  N +  +AD GLA     + + V I      GT  Y  PE L
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 200 SG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
                  ++      D+YSFG++L+E+   RR    G  E      +  + +   S+   
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVA--RRCVSGGIVEEY----QLPYHDLVPSDPSY 272

Query: 255 TILACGIEEKD------KEKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLE 298
             +   +  K          +   C+  +      C   +P  R     V K L 
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (464), Expect = 3e-55
 Identities = 63/287 (21%), Positives = 112/287 (39%), Gaps = 47/287 (16%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            +G G FG+VY G++   V  A+++++         + F  EV    +T H N+V   G 
Sbjct: 40  LIGKGRFGQVYHGRWHGEV--AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
           C      A++    +  +L   +   K  ++  K  +IA    KG+ YLH    + I+H 
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154

Query: 150 DIKPENVLLDANFSPKVADFGLAKL---CDRNRSHVTISGYKGTPGYSAPEFLSGNYPI- 205
           D+K +NV  D N    + DFGL  +       R    +    G   + APE +    P  
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213

Query: 206 -------THKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA 258
                  +   DV++ G + +E+  R              +P      ++    +A I  
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHARE-------------WP------FKTQPAEAIIWQ 254

Query: 259 CG-------IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            G        +    ++   + +    C     E+RP  + ++ MLE
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLF---CWAFEQEERPTFTKLMDMLE 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  178 bits (455), Expect = 2e-54
 Identities = 61/307 (19%), Positives = 115/307 (37%), Gaps = 57/307 (18%)

Query: 8   IGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLN-RNLGRIAEE 66
           + +   + F  L          T+L     GE++KG++  G  I VKVL  R+       
Sbjct: 1   MNKHSGIDFKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR 52

Query: 67  QFMAEVGTIGRTYHINLVRLYGFCHDQHMT--ALVYEYMENGSLDGYLF-GKKRAIEWEK 123
            F  E   +    H N++ + G C         L+  +M  GSL   L  G    ++  +
Sbjct: 53  DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQ 112

Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
             + A+  A+G+ +LH   +  I  + +   +V++D + + +++   +        S  +
Sbjct: 113 AVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQS 165

Query: 184 ISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK 241
             G    P + APE L            D++SF ++L+E+V R               P 
Sbjct: 166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV-------------P- 210

Query: 242 HVWEEYEKSELDATILACGIEEKDKEKAKRL-----C---MAAL--WCVQDSPEDRPPMS 291
             + +    E+   +           +  R          ++ L   C+ + P  RP   
Sbjct: 211 --FADLSNMEIGMKVA---------LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFD 259

Query: 292 AVVKMLE 298
            +V +LE
Sbjct: 260 MIVPILE 266

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  180 bits (459), Expect = 3e-54
 Identities = 72/290 (24%), Positives = 121/290 (41%), Gaps = 28/290 (9%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            +G G FGEV++G++  G ++AVK+ +            AE+       H N++      
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAAD 105

Query: 91  HDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR- 145
           +  + T     LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E     
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 146 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS--GYKGTPGYSAPEFL 199
               I H D+K +N+L+  N +  +AD GLA   D     + I+     GT  Y APE L
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 200 SG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
                  ++    + D+Y+ G+V +EI  R     +     L ++   V  +    E+  
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVPSDPSVEEMRK 282

Query: 255 TILACG----IEEKDKEKAKRLCMAAL--WCVQDSPEDRPPMSAVVKMLE 298
            +        I  + +       MA +   C   +   R     + K L 
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  174 bits (442), Expect = 4e-52
 Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 38/295 (12%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            +G G +GEV++G +  G  +AVK+ +             E+       H N++      
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASD 71

Query: 91  HDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE----- 141
                ++    L+  Y E GSL  YL  +   ++      I +  A GL +LH E     
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS--GYKGTPGYSAPEFL 199
            +  I H D+K +N+L+  N    +AD GLA +  ++ + + +      GT  Y APE L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189

Query: 200 SG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
                   +    + D+++FG+VL+E+   RR    G  E      K  + +   ++   
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDY----KPPFYDVVPNDPSF 243

Query: 255 TILACGIEEKD------KEKAKRLCMAALW-----CVQDSPEDRPPMSAVVKMLE 298
             +   +                  + +L      C   +P  R     + K L 
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  151 bits (383), Expect = 1e-42
 Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 9/195 (4%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G FGEV+ G+   +   +AVK     L    + +F+ E   + +  H N+VRL G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
           C  +    +V E ++ G    +L  +   +  + L ++    A G+ YL     +  IH 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPE-FLSGNYPITH 207
           D+   N L+      K++DFG+++       +    G +  P  ++APE    G Y  + 
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEALNYGRY--SS 294

Query: 208 KCDVYSFGMVLFEIV 222
           + DV+SFG++L+E  
Sbjct: 295 ESDVWSFGILLWETF 309

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  147 bits (374), Expect = 8e-42
 Identities = 75/304 (24%), Positives = 123/304 (40%), Gaps = 58/304 (19%)

Query: 31  RLGFGGFGEVYKGQFPNG-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
            LG G FG VYKG +        + +A+K L       A ++ + E   +    + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L G C    +  L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R
Sbjct: 82  LLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RR 137

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPE-FLSGNY 203
           ++H D+   NVL+      K+ DFGLAKL           G K  P  + A E  L   Y
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-VPIKWMALESILHRIY 196

Query: 204 PITHKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI 261
             TH+ DV+S+G+ ++E++  G +              P   ++    SE+ + +     
Sbjct: 197 --THQSDVWSYGVTVWELMTFGSK--------------P---YDGIPASEISSIL----- 232

Query: 262 EEKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFR 311
                EK +RL     C   ++     C     + RP    ++     +        P R
Sbjct: 233 -----EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR-----DPQR 282

Query: 312 YLDL 315
           YL +
Sbjct: 283 YLVI 286

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  144 bits (366), Expect = 6e-41
 Identities = 63/298 (21%), Positives = 115/298 (38%), Gaps = 49/298 (16%)

Query: 31  RLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
            LG G FG+V   ++       G ++AVK L    G         E+  +   YH N+V+
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 86  LYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
             G C +       L+ E++ +GSL  YL   K  I  ++  + A+   KG+ YL     
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS--- 144

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE 197
           ++ +H D+   NVL+++    K+ DFGL K  + ++ +     Y           + APE
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY-----YTVKDDRDSPVFWYAPE 199

Query: 198 FLSGNYPI-THKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
                        DV+SFG+ L E++      ++ +     +                  
Sbjct: 200 --CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL- 256

Query: 255 TILACGIEEKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLEGVVE 302
                       ++ KRL     C   ++     C +  P +R     +++  E +++
Sbjct: 257 ------------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  142 bits (360), Expect = 6e-40
 Identities = 77/304 (25%), Positives = 117/304 (38%), Gaps = 49/304 (16%)

Query: 31  RLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
            LG G FG+V    +       G  +AVK L  + G      +  E+  +   YH ++++
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 86  LYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
             G C D    +  LV EY+  GSL  YL   + +I   +L   A    +G+ YLH    
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLHA--- 152

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS-----APEF 198
           Q  IH D+   NVLLD +   K+ DFGLAK       +          G S     APE 
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAPE- 207

Query: 199 LSGNYPI-THKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT 255
                    +  DV+SFG+ L+E++       +       L    +        +EL   
Sbjct: 208 -CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL-- 264

Query: 256 ILACGIEEKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEVLP 305
                      E+ +RL     C A ++     C +     RP    ++ +L+ V E   
Sbjct: 265 -----------ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313

Query: 306 PPKP 309
              P
Sbjct: 314 GQAP 317

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  140 bits (356), Expect = 1e-39
 Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 62/300 (20%)

Query: 30  TRLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
             LG G FG V +G +      + +A+KVL +   +   E+ M E   + +  +  +VRL
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 87  YGFC-HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
            G C  +  M  LV E    G L  +L GK+  I    + E+    + G+ YL E   + 
Sbjct: 76  IGVCQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KN 130

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-F 198
            +H D+   NVLL      K++DFGL+K    + S+     Y           + APE  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----YTARSAGKWPLKWYAPECI 185

Query: 199 LSGNYPITHKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI 256
               +  + + DV+S+G+ ++E +  G++              P   +++ +  E+ A I
Sbjct: 186 NFRKF--SSRSDVWSYGVTMWEALSYGQK--------------P---YKKMKGPEVMAFI 226

Query: 257 LACGIEEKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEVLPP 306
                     E+ KR+     C   L+     C     EDRP    V + +      L  
Sbjct: 227 ----------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  141 bits (358), Expect = 2e-39
 Identities = 75/324 (23%), Positives = 131/324 (40%), Gaps = 56/324 (17%)

Query: 31  RLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
            LG G FG V+KG +        + + +KV+    GR + +     +  IG   H ++VR
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L G C    +  LV +Y+  GSL  ++   + A+  + L    +  AKG+ YL E     
Sbjct: 80  LLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HG 135

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           ++H ++   NVLL +    +VADFG+A L   +   +  S  K    + A E  S ++  
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE--SIHFGK 193

Query: 206 -THKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE 262
            TH+ DV+S+G+ ++E++  G                P   +     +E+   +      
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE--------------P---YAGLRLAEVPDLL------ 230

Query: 263 EKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRY 312
               EK +RL     C   ++     C       RP    +      +        P RY
Sbjct: 231 ----EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR-----DPPRY 281

Query: 313 LDLIKMTGLKSLESSDGSNSSNRS 336
           L + + +G       +    +N+ 
Sbjct: 282 LVIKRESGPGIAPGPEPHGLTNKK 305

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  141 bits (358), Expect = 2e-39
 Identities = 76/329 (23%), Positives = 129/329 (39%), Gaps = 59/329 (17%)

Query: 31  RLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
            LG G FG VYKG +        + +A+K L       A ++ + E   +    + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L G C    +  L+ + M  G L  Y+   K  I  + L    +  AKG+ YL +   +R
Sbjct: 82  LLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RR 137

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           ++H D+   NVL+      K+ DFGLAKL           G K    + A E  S  + I
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRI 195

Query: 206 -THKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE 262
            TH+ DV+S+G+ ++E++  G +              P   ++    SE+ + +      
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK--------------P---YDGIPASEISSIL------ 232

Query: 263 EKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRY 312
               EK +RL     C   ++     C     + RP    ++     +        P RY
Sbjct: 233 ----EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR-----DPQRY 283

Query: 313 LDL---IKMTGLKSLESSDGSNSSNRSRW 338
           L +    +M      +S+      +    
Sbjct: 284 LVIQGDERMHLPSPTDSNFYRALMDEEDM 312

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  143 bits (363), Expect = 3e-39
 Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 9/193 (4%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 91  HDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L     + +   +L ++A   A G+ Y+        +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE        T K 
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGR-FTIKS 362

Query: 210 DVYSFGMVLFEIV 222
           DV+SFG++L E+ 
Sbjct: 363 DVWSFGILLTELT 375

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  142 bits (361), Expect = 6e-39
 Identities = 60/193 (31%), Positives = 103/193 (53%), Gaps = 9/193 (4%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+   +    K+AVK +    G ++ E F+AE   +    H  LV+L+   
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 91  HDQHMTALVYEYMENGSLDGYLF-GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             + +  ++ E+M  GSL  +L   +       KL + +   A+G+ ++ +   +  IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 308

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D++  N+L+ A+   K+ADFGLA++ + N  +    G K    ++APE ++     T K 
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPEAINFG-SFTIKS 366

Query: 210 DVYSFGMVLFEIV 222
           DV+SFG++L EIV
Sbjct: 367 DVWSFGILLMEIV 379

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (350), Expect = 6e-39
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 23/204 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            LG G FG V  G++     +AVK++    G ++E++F  E  T+ +  H  LV+ YG C
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
             ++   +V EY+ NG L  YL    + +E  +L E+     +G+ +L      + IH D
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRD 129

Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-FLSGNY 203
           +   N L+D +   KV+DFG+ +    +        Y  + G      +SAPE F    Y
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDD-------QYVSSVGTKFPVKWSAPEVFHYFKY 182

Query: 204 PITHKCDVYSFGMVLFEIV--GRR 225
             + K DV++FG++++E+   G+ 
Sbjct: 183 --SSKSDVWAFGILMWEVFSLGKM 204

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  144 bits (364), Expect = 7e-39
 Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 9/193 (4%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L    G ++ E F+ E   + +  H  LV+LY   
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 91  HDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L     + +   +L ++A   A G+ Y+        +H 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D++  N+L+  N   KVADFGLA+L + N  +    G K    ++APE        T K 
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGR-FTIKS 445

Query: 210 DVYSFGMVLFEIV 222
           DV+SFG++L E+ 
Sbjct: 446 DVWSFGILLTELT 458

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  138 bits (351), Expect = 9e-39
 Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 45/292 (15%)

Query: 31  RLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N+V+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 75

Query: 86  LYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
             G C+        L+ EY+  GSL  YL   K  I+  KL +      KG+ YL     
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT--- 132

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE 197
           +R IH D+   N+L++     K+ DFGL K+  +++       +K          + APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF-----FKVKEPGESPIFWYAPE 187

Query: 198 FLSGNYPI-THKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI 256
             S      +   DV+SFG+VL+E+      +    +E +         +     L   +
Sbjct: 188 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 257 LACGIEEKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLE 298
                     +   RL     C   ++     C  ++   RP    +   ++
Sbjct: 246 ----------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  137 bits (347), Expect = 2e-38
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 23/204 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+LYG C
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
            +Q    LV E+ME+G L  YL  ++     E L  + +   +G+ YL E     +IH D
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 129

Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-FLSGNY 203
           +   N L+  N   KV+DFG+ +    ++       Y  + G      +++PE F    Y
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQ-------YTSSTGTKFPVKWASPEVFSFSRY 182

Query: 204 PITHKCDVYSFGMVLFEIV--GRR 225
             + K DV+SFG++++E+   G+ 
Sbjct: 183 --SSKSDVWSFGVLMWEVFSEGKI 204

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  142 bits (359), Expect = 2e-38
 Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 40/278 (14%)

Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L      +  E+F+ E   +    H NLV+L G 
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 90  CHDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL +   +  IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 341

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            ++   N L+  N   KVADFGL++L   + ++   +G K    ++APE L+ N   + K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 399

Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE-YEKSELDATILACGIEEKDKE 267
            DV++FG++L+EI           +  +  +P     + YE            +E+  + 
Sbjct: 400 SDVWAFGVLLWEIA----------TYGMSPYPGIDLSQVYEL-----------LEKDYRM 438

Query: 268 KAKRLC-------MAALWCVQDSPEDRPPMSAVVKMLE 298
           +    C       M    C Q +P DRP  + + +  E
Sbjct: 439 ERPEGCPEKVYELM--RACWQWNPSDRPSFAEIHQAFE 474

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  136 bits (346), Expect = 3e-38
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 23/204 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
             Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 145

Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-FLSGNY 203
           +   N L++     KV+DFGL++    +        Y  + G      +S PE  +   +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDE-------YTSSVGSKFPVRWSPPEVLMYSKF 198

Query: 204 PITHKCDVYSFGMVLFEIV--GRR 225
             + K D+++FG++++EI   G+ 
Sbjct: 199 --SSKSDIWAFGVLMWEIYSLGKM 220

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  138 bits (349), Expect = 3e-38
 Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 35/287 (12%)

Query: 31  RLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           +LG G FG V   ++       G  +AVK L  +      + F  E+  +    H N+V+
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 106

Query: 86  LYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
             G C+        L+ EY+  GSL  YL   K  I+  KL +      KG+ YL     
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT--- 163

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGN 202
           +R IH D+   N+L++     K+ DFGL K+  +++ +  +     +P  + APE  S  
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE--SLT 221

Query: 203 YPI-THKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI 261
               +   DV+SFG+VL+E+      +    +E +         +     L   +     
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL----- 276

Query: 262 EEKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLE 298
                +   RL     C   ++     C  ++   RP    +   ++
Sbjct: 277 -----KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (343), Expect = 1e-37
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 26/210 (12%)

Query: 31  RLGFGGFGEVYKGQF--PNG--VKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLV 84
           +LG G FG V +G++  P+G  V +AVK L  ++     A + F+ EV  +    H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 85  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 140

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE- 197
           R IH D+   N+LL      K+ DFGL +   +N  H     Y           + APE 
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-----YVMQEHRKVPFAWCAPES 195

Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV--GRR 225
             +  +  +H  D + FG+ L+E+   G+ 
Sbjct: 196 LKTRTF--SHASDTWMFGVTLWEMFTYGQE 223

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  135 bits (341), Expect = 2e-37
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 22/202 (10%)

Query: 31  RLGFGGFGEVYKGQF--PNGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            LG G FGEVY+G +    G KI  AVK   ++     +E+FM+E   +    H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G   ++  T ++ E    G L  YL   K +++   L   ++   K + YL        
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INC 134

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPEFLSG 201
           +H DI   N+L+ +    K+ DFGL++  +          YK +       + +PE  S 
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTRLPIKWMSPE--SI 186

Query: 202 NYPI-THKCDVYSFGMVLFEIV 222
           N+   T   DV+ F + ++EI+
Sbjct: 187 NFRRFTTASDVWMFAVCMWEIL 208

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (338), Expect = 5e-37
 Identities = 71/200 (35%), Positives = 109/200 (54%), Gaps = 23/200 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 91  HDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             + +  ++ EYMENGSL  +L       +   KL ++A   A+G+ ++ E   +  IH 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLS-GN 202
           D++  N+L+    S K+ADFGLA+L + N        Y    G      ++APE ++ G 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE-------YTAREGAKFPIKWTAPEAINYGT 186

Query: 203 YPITHKCDVYSFGMVLFEIV 222
           +  T K DV+SFG++L EIV
Sbjct: 187 F--TIKSDVWSFGILLTEIV 204

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (341), Expect = 5e-37
 Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 27/234 (11%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF--PNG---VKIAVKV 55
           + +F  EI          +            +G G FGEVYKG     +G   V +A+K 
Sbjct: 34  VLKFTTEIHPS------CVTRQK-------VIGAGEFGEVYKGMLKTSSGKKEVPVAIKT 80

Query: 56  LNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK 115
           L           F+ E G +G+  H N++RL G         ++ EYMENG+LD +L  K
Sbjct: 81  LKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK 140

Query: 116 KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
                  +L  +  G A G+ YL        +H D+   N+L+++N   KV+DFGL+++ 
Sbjct: 141 DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197

Query: 176 -DRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIV--GRR 225
            D   +  T SG K    ++APE      +  T   DV+SFG+V++E++  G R
Sbjct: 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKF--TSASDVWSFGIVMWEVMTYGER 249

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  134 bits (340), Expect = 6e-37
 Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 40/289 (13%)

Query: 31  RLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           +LG G FG V   ++       G  +AVK L ++ G   +  F  E+  +   +   +V+
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 86  LYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
             G  +     +  LV EY+ +G L  +L   +  ++  +L   +    KG+ YL     
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS--- 145

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGN 202
           +R +H D+   N+L+++    K+ADFGLAKL   ++ +  +     +P  + APE  S +
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE--SLS 203

Query: 203 YPI-THKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC 259
             I + + DV+SFG+VL+E+     +              P   +      E D   L+ 
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS-----------CSPSAEFLRMMGCERDVPALSR 252

Query: 260 GIEEKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLE 298
            +E    E+ +RL     C A +      C   SP+DRP  SA+   L+
Sbjct: 253 LLEL--LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (349), Expect = 1e-36
 Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 50/286 (17%)

Query: 30  TRLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
             LG G FG V +G +      + +A+KVL +   +   E+ M E   + +  +  +VRL
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C  + +  LV E    G L  +L GK+  I    + E+    + G+ YL E   +  
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 457

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPI 205
           +H ++   NVLL      K++DFGL+K    + S+ T       P  + APE    N+  
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE--CINFRK 515

Query: 206 -THKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE 262
            + + DV+S+G+ ++E +  G++              P   +++ +  E+ A I      
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK--------------P---YKKMKGPEVMAFI------ 552

Query: 263 EKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLE 298
               E+ KR+     C   L+     C     EDRP    V + + 
Sbjct: 553 ----EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  132 bits (335), Expect = 1e-36
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 31  RLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G   +  +  ++ E    G L  +L  +K +++   L   A   +  L YL     +R 
Sbjct: 82  IGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 137

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPE-FLS 200
           +H DI   NVL+ +N   K+ DFGL++  + +      + YK + G     + APE    
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAPESINF 191

Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
             +  T   DV+ FG+ ++EI+
Sbjct: 192 RRF--TSASDVWMFGVCMWEIL 211

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  136 bits (344), Expect = 1e-36
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 29/201 (14%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G  
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 91  -HDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++    +V EYM  GSL  YL  + R  +  + L + ++   + + YL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLSGN 202
            D+   NVL+  +   KV+DFGL K                         ++APE L   
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEAL--R 359

Query: 203 YPI-THKCDVYSFGMVLFEIV 222
               + K DV+SFG++L+EI 
Sbjct: 360 EKKFSTKSDVWSFGILLWEIY 380

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  132 bits (335), Expect = 3e-36
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 31  RLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +G G  GEV  G+        V +A+K L           F++E   +G+  H N++RL
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G      +  +V EYMENGSLD +L          +L  +  G   G+ YL +      
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGY 172

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-FL 199
           +H D+   NVL+D+N   KV+DFGL+++ + +           T G      ++APE   
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-----PDAAYTTTGGKIPIRWTAPEAIA 227

Query: 200 SGNYPITHKCDVYSFGMVLFEIV--GRR 225
              +  +   DV+SFG+V++E++  G R
Sbjct: 228 FRTF--SSASDVWSFGVVMWEVLAYGER 253

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  131 bits (332), Expect = 5e-36
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 33/225 (14%)

Query: 24  FTSNYST--RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH 80
           + S++     LG G FG+V K +   +    A+K +            ++EV  +    H
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNH 61

Query: 81  INLVRLYG-FCHDQHMTA------------LVYEYMENGSLDGYLFGKKRAIEWEKLHEI 127
             +VR Y  +   ++               +  EY ENG+L   +  +    + ++   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
                + L Y+H    Q IIH D+KP N+ +D + + K+ DFGLAK   R+   + +   
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 188 K------------GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
                        GT  Y A E L G      K D+YS G++ FE
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  132 bits (334), Expect = 1e-35
 Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 26/233 (11%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNG----VKIAVKVL 56
           +  F +E+         ++ ++         +G G FGEV  G+        + +A+K L
Sbjct: 35  VHEFAKELDAT------NISIDK-------VVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81

Query: 57  NRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK 116
                      F+ E   +G+  H N++RL G         +V EYMENGSLD +L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141

Query: 117 RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LC 175
                 +L  +  G A G+ YL +      +H D+   N+L+++N   KV+DFGL + L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198

Query: 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIV--GRR 225
           D   +  T  G K    +++PE  +  Y   T   DV+S+G+VL+E++  G R
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPE--AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  130 bits (328), Expect = 2e-35
 Identities = 74/291 (25%), Positives = 123/291 (42%), Gaps = 62/291 (21%)

Query: 31  RLGFGGFGEVYKGQFPNG---VKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRL 86
            LG G FG V KG +        +AVK+L         +++ +AE   + +  +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL E      
Sbjct: 84  IGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 138

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLS 200
           +H D+   NVLL      K++DFGL+K    + ++     YK          + APE   
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-----YKAQTHGKWPVKWYAPE--C 191

Query: 201 GNYPI-THKCDVYSFGMVLFEIV--GRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL 257
            NY   + K DV+SFG++++E    G++              P   +   + SE+ A + 
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK--------------P---YRGMKGSEVTAML- 233

Query: 258 ACGIEEKDKEKAKRL-----CMAALW-----CVQDSPEDRPPMSAVVKMLE 298
                    EK +R+     C   ++     C     E+RP  +AV   L 
Sbjct: 234 ---------EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  129 bits (327), Expect = 2e-35
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 32  LGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG VY G   +     +  AVK LNR        QF+ E   +    H N++ L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92

Query: 88  GFCHDQHMTAL-VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           G C     + L V  YM++G L  ++  +      + L    +  AKG+ YL     ++ 
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKF 149

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRN---RSHVTISG---YKGTPGYSAPE-FL 199
           +H D+   N +LD  F+ KVADFGLA+          H         K      A E   
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALESLQ 205

Query: 200 SGNYPITHKCDVYSFGMVLFEIV 222
           +  +  T K DV+SFG++L+E++
Sbjct: 206 TQKF--TTKSDVWSFGVLLWELM 226

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (332), Expect = 2e-35
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 19/202 (9%)

Query: 32  LGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG VY G   +     +  AVK LNR        QF+ E   +    H N++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 88  GFCHDQHMTAL-VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           G C     + L V  YM++G L  ++  +      + L    +  AKG+ +L     ++ 
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKF 213

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPEFLSG 201
           +H D+   N +LD  F+ KVADFGLA+             +  T       + A E  S 
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMALE--SL 268

Query: 202 NYPI-THKCDVYSFGMVLFEIV 222
                T K DV+SFG++L+E++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELM 290

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  129 bits (327), Expect = 3e-35
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)

Query: 31  RLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +G G FG VY G++ +     ++ A+K L+R       E F+ E   +    H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 87  YGFCHDQHMTAL-VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
            G           +  YM +G L  ++   +R    + L    +  A+G+ YL E   Q+
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QK 144

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPEFLS 200
            +H D+   N +LD +F+ KVADFGLA+       +   S  +         ++A E  S
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYY---SVQQHRHARLPVKWTALE--S 199

Query: 201 GNYPI-THKCDVYSFGMVLFEIV 222
                 T K DV+SFG++L+E++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELL 222

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  129 bits (326), Expect = 3e-35
 Identities = 55/234 (23%), Positives = 87/234 (37%), Gaps = 39/234 (16%)

Query: 5   LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF--------PNGVKIAVKVL 56
             +I  E       L  N         LG G F +++KG           +  ++ +KVL
Sbjct: 2   FHKIRNE------DLIFNE-------SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL 48

Query: 57  NRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK 116
                R   E F      + +  H +LV  YG C       LV E+++ GSLD YL   K
Sbjct: 49  -DKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK 107

Query: 117 RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP--------KVAD 168
             I      E+A   A  + +L E     +IH ++  +N+LL              K++D
Sbjct: 108 NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164

Query: 169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            G++               +    +  PE +     +    D +SFG  L+EI 
Sbjct: 165 PGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  128 bits (324), Expect = 6e-35
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 23/201 (11%)

Query: 31  RLGFGGFGEVYKGQFPNG-VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L      +  E+F+ E   +    H NLV+L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 90  CHDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    ++ +    L  +A   +  + YL +   +  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 134

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLS-G 201
            D+   N L+  N   KVADFGL++L       +T   Y    G      ++APE L+  
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL-------MTGDTYTAHAGAKFPIKWTAPESLAYN 187

Query: 202 NYPITHKCDVYSFGMVLFEIV 222
            +  + K DV++FG++L+EI 
Sbjct: 188 KF--SIKSDVWAFGVLLWEIA 206

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  128 bits (325), Expect = 6e-35
 Identities = 56/265 (21%), Positives = 102/265 (38%), Gaps = 42/265 (15%)

Query: 9   GREKPVRFTSLQLNNFTSNYST--RLGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAE 65
              + + F S+ +      YS   ++G GG  +V++         A+K +N         
Sbjct: 13  LGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 70

Query: 66  EQFMAEVGTIGRTYHINL--VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE- 122
           + +  E+  + +    +   +RLY +        +V E   N  L+ +L  KK    WE 
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWER 129

Query: 123 --KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
                 +     + +  +H   Q  I+H D+KP N L+  +   K+ DFG+A     + +
Sbjct: 130 KSYWKNML----EAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181

Query: 181 HVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVLFE-IVGR----- 224
            V      GT  Y  PE +               I+ K DV+S G +L+    G+     
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

Query: 225 ------RRNAIVGSSESLDWFPKHV 243
                 + +AI+  +  ++ FP   
Sbjct: 242 IINQISKLHAIIDPNHEIE-FPDIP 265

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  128 bits (323), Expect = 1e-34
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 21/202 (10%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + ++          A K++ ++  L     E+   E+       H ++V  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQR 145
           F  D     +V E     SL      +K   E E    L +I      G  YLH   + R
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RNR 135

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-HVTISGYKGTPGYSAPEFLSGN-Y 203
           +IH D+K  N+ L+ +   K+ DFGLA   + +      +    GTP Y APE LS   +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH 192

Query: 204 PITHKCDVYSFGMVLFE-IVGR 224
             + + DV+S G +++  +VG+
Sbjct: 193 --SFEVDVWSIGCIMYTLLVGK 212

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  127 bits (322), Expect = 1e-34
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 29/201 (14%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G  
Sbjct: 28  TIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 91  -HDQHMTALVYEYMENGSLDGYL-FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++    +V EYM  GSL  YL    +  +  + L + ++   + + YL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLSGN 202
            D+   NVL+  +   KV+DFGL K                         ++APE L   
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEAL--R 187

Query: 203 YPI-THKCDVYSFGMVLFEIV 222
               + K DV+SFG++L+EI 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIY 208

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  128 bits (324), Expect = 1e-34
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 21/202 (10%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG GGF + ++          A K++ ++  L     E+   E+       H ++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQR 145
           F  D     +V E     SL      +K   E E    L +I      G  YLH   + R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RNR 161

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-HVTISGYKGTPGYSAPEFLSGN-Y 203
           +IH D+K  N+ L+ +   K+ DFGLA   + +      +    GTP Y APE LS   +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH 218

Query: 204 PITHKCDVYSFGMVLFE-IVGR 224
             + + DV+S G +++  +VG+
Sbjct: 219 --SFEVDVWSIGCIMYTLLVGK 238

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  132 bits (333), Expect = 3e-34
 Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 22/202 (10%)

Query: 31  RLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G   +  +  ++ E    G L  +L  +K +++   L   A   +  L YL     +R 
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRF 512

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPEFLS- 200
           +H DI   NVL+ +N   K+ DFGL++  + +      + YK + G     + APE ++ 
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAPESINF 566

Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
             +  T   DV+ FG+ ++EI+
Sbjct: 567 RRF--TSASDVWMFGVCMWEIL 586

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  126 bits (318), Expect = 4e-34
 Identities = 64/197 (32%), Positives = 91/197 (46%), Gaps = 13/197 (6%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG VY  +   +   +A+KVL +        E Q   EV       H N++RLYG
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           + HD     L+ EY   G++   L    +  E      I    A  L Y H    +R+IH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCH---SKRVIH 132

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G      K
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR-MHDEK 187

Query: 209 CDVYSFGMVLFE-IVGR 224
            D++S G++ +E +VG+
Sbjct: 188 VDLWSLGVLCYEFLVGK 204

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (320), Expect = 6e-34
 Identities = 63/345 (18%), Positives = 124/345 (35%), Gaps = 51/345 (14%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINL--VRLYG 88
           +G GG  +V++         A+K +N         + +  E+  + +    +   +RLY 
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQR 145
           +        +V E   N  L+ +L  KK    WE       +     + +  +H   Q  
Sbjct: 77  YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIH---QHG 128

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG---- 201
           I+H D+KP N L+  +   K+ DFG+A     + + V      GT  Y  PE +      
Sbjct: 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 202 ------NYPITHKCDVYSFGMVLFE-IVGR-----------RRNAIVGSSESLDWFPKHV 243
                    I+ K DV+S G +L+    G+           + +AI+  +  ++ FP   
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FPDIP 246

Query: 244 WEEYEKSELDATILACGIEEKDKEKAKRLCMAAL----WCVQDSPEDRPPMSAVVKMLEG 299
                + +L   +  C      ++  +R+ +  L    +    +           + ++ 
Sbjct: 247 -----EKDLQDVLKCCLK----RDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 297

Query: 300 VVEVLPPPKPFRYLDLIKMTGLKSLESSDGSNSSNRSRWYKETTP 344
           V+  L        +     T  +     +  NSS+   + K+   
Sbjct: 298 VLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGK 342

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  125 bits (316), Expect = 7e-34
 Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 19/200 (9%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG VY  +   N   +A+KVL ++       E Q   E+       H N++R+Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQR 145
           + HD+    L+ E+   G L   L    R  E      + E+A      L Y H   +++
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA----DALHYCH---ERK 134

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +IH DIKPEN+L+      K+ADFG +      R         GT  Y  PE + G    
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEGK-TH 189

Query: 206 THKCDVYSFGMVLFE-IVGR 224
             K D++  G++ +E +VG 
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  130 bits (329), Expect = 1e-33
 Identities = 65/208 (31%), Positives = 88/208 (42%), Gaps = 27/208 (12%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY-- 87
           RLG GGFG V +      G ++A+K   + L     E++  E+  + +  H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 88  ----GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKGLVYL 138
                      +  L  EY E G L  YL   +       L E  I T     +  L YL
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYL 137

Query: 139 HEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           HE    RIIH D+KPEN++L         K+ D G AK  D+         + GT  Y A
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTLQYLA 191

Query: 196 PEFLSG-NYPITHKCDVYSFGMVLFEIV 222
           PE L    Y  T   D +SFG + FE +
Sbjct: 192 PELLEQKKY--TVTVDYWSFGTLAFECI 217

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  124 bits (314), Expect = 2e-33
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 15/202 (7%)

Query: 28  YSTRLGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           +   +G G F  VYKG      V++A   L  R L +   ++F  E   +    H N+VR
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 86  LYGFCHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
            Y              LV E M +G+L  YL  + + ++ + L        KGL +LH  
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 142 CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
               IIH D+K +N+ +     S K+ D GLA L   + +        GTP + APE   
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYE 203

Query: 201 GNYPITHKCDVYSFGMVLFEIV 222
             Y      DVY+FGM + E+ 
Sbjct: 204 EKY--DESVDVYAFGMCMLEMA 223

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  124 bits (312), Expect = 4e-33
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            LG GGFG V++ +   +    A+K +      +A E+ M EV  + +  H  +VR +  
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 90  CHD---------QHMTALVY---EYMENGSLDGYLFGKKRA--IEWEKLHEIAIGTAKGL 135
             +               +Y   +     +L  ++ G+      E      I +  A+ +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI----------S 185
            +LH    + ++H D+KP N+    +   KV DFGL    D++    T+          +
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
           G  GT  Y +PE + GN   +HK D++S G++LFE+
Sbjct: 189 GQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFEL 223

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  126 bits (319), Expect = 4e-33
 Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 19/200 (9%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA--EEQFMAEVGTIGRTYHINLVRLYGF 89
           LG G  G +      +   +AVK +       A  E Q + E        H N++R +  
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRES-----DEHPNVIRYFCT 86

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             D+    +  E     +L  Y+  K  A    +   +   T  GL +LH      I+H 
Sbjct: 87  EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHR 142

Query: 150 DIKPENVLL-----DANFSPKVADFGLAKLCDRNRSHVTI-SGYKGTPGYSAPEFLSGNY 203
           D+KP N+L+            ++DFGL K     R   +  SG  GT G+ APE LS + 
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202

Query: 204 --PITHKCDVYSFGMVLFEI 221
               T+  D++S G V + +
Sbjct: 203 KENPTYTVDIFSAGCVFYYV 222

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  125 bits (316), Expect = 4e-33
 Identities = 46/207 (22%), Positives = 81/207 (39%), Gaps = 25/207 (12%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINL--VRLYG 88
           +G GG  +V++         A+K +N         + +  E+  + +    +   +RLY 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQR 145
           +        +V E   N  L+ +L  KK    WE       +     + +  +H   Q  
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIH---QHG 175

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG---- 201
           I+H D+KP N L+  +   K+ DFG+A     + + V      G   Y  PE +      
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 202 ------NYPITHKCDVYSFGMVLFEIV 222
                    I+ K DV+S G +L+ + 
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMT 261

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  123 bits (310), Expect = 5e-33
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 24/204 (11%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G F  VY+ +    G+++A+K++++         ++   EV    +  H +++ LY 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAI-EWE---KLHEIAIGTAKGLVYLHEECQQ 144
           +  D +   LV E   NG ++ YL  + +   E E    +H+I      G++YLH     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLH---SH 131

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-HVTISGYKGTPGYSAPEFLSGNY 203
            I+H D+   N+LL  N + K+ADFGLA         H T+    GTP Y +PE  + + 
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRSA 188

Query: 204 PITH--KCDVYSFGMVLFE-IVGR 224
              H  + DV+S G + +  ++GR
Sbjct: 189 ---HGLESDVWSLGCMFYTLLIGR 209

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  122 bits (309), Expect = 1e-32
 Identities = 48/211 (22%), Positives = 77/211 (36%), Gaps = 28/211 (13%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            LG G    V++G+    G   A+KV N        +  M E   + +  H N+V+L+  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 90  --CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKGLVYLHEEC 142
                     L+ E+   GSL   L     A     L E            G+ +L E  
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE-- 130

Query: 143 QQRIIHYDIKPENVLL----DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
              I+H +IKP N++     D     K+ DFG A+  + +   V++    GT  Y  P+ 
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDM 186

Query: 199 LSGNYPI-------THKCDVYSFGMVLFEIV 222
                             D++S G+  +   
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  122 bits (308), Expect = 1e-32
 Identities = 62/295 (21%), Positives = 117/295 (39%), Gaps = 53/295 (17%)

Query: 23  NFTSNYST--RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 79
            F  ++     +G GGFG+V+K +   +G    +K +     +   E+   EV  + +  
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLD 62

Query: 80  HINLVRLYGFCHDQHMTA----------------LVYEYMENGSLDGYLFGKK-RAIEWE 122
           H+N+V   G                         +  E+ + G+L+ ++  ++   ++  
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
              E+     KG+ Y+H    +++I+ D+KP N+ L      K+ DFGL      +    
Sbjct: 123 LALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH 242
                KGT  Y +PE +S       + D+Y+ G++L E++     A              
Sbjct: 180 RS---KGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTA-------------- 221

Query: 243 VWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML 297
               +E S+    +    I +   +K K L       +   PEDRP  S +++ L
Sbjct: 222 ----FETSKFFTDLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILRTL 269

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  123 bits (310), Expect = 2e-32
 Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 33/283 (11%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            LG G  G V+K    P+G+ +A K+++  +      Q + E+  +       +V  YG 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            +     ++  E+M+ GSLD  +  K   I  + L +++I   KGL YL E+   +I+H 
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHR 156

Query: 150 DIKPENVLLDANFSPKVADFGLA-KLCDRNR-SHVTISGYKGTPGYSAPEFLSGNYPITH 207
           D+KP N+L+++    K+ DFG++ +L D    S V      GT  Y +PE L G    + 
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT-HYSV 209

Query: 208 KCDVYSFGMVLFEI-VGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           + D++S G+ L E+ VGR              +P    +  E   +          E D 
Sbjct: 210 QSDIWSMGLSLVEMAVGR--------------YPIPPPDAKELELMFGC-----QVEGDA 250

Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKP 309
            +           +     D  P  A+ ++L+ +V   PP  P
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  125 bits (316), Expect = 2e-32
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 16/215 (7%)

Query: 12  KPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQ 67
            P  F + +  + +  Y     LG G +GEV   +     V+ A+K++   ++   +  +
Sbjct: 23  TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82

Query: 68  FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI 127
            + EV  +    H N+++LY F  D+    LV E  + G L   +  + +  E      I
Sbjct: 83  LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE-VDAAVI 141

Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTI 184
                 G+ YLH   +  I+H D+KPEN+LL   + +   K+ DFGL+ + +  +     
Sbjct: 142 IKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198

Query: 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
               GT  Y APE L   Y    KCDV+S G++LF
Sbjct: 199 L---GTAYYIAPEVLRKKY--DEKCDVWSIGVILF 228

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  122 bits (308), Expect = 2e-32
 Identities = 81/308 (26%), Positives = 118/308 (38%), Gaps = 53/308 (17%)

Query: 31  RLGFGGFGEVYKGQFPNG------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            LG G FGEVY+GQ          +++AVK L        E  F+ E   I +  H N+V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYL------FGKKRAIEWEKLHEIAIGTAKGLVYL 138
           R  G         ++ E M  G L  +L        +  ++    L  +A   A G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 139 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNRSHVTISGY--KGTPGY 193
            E      IH DI   N LL         K+ DFG+A+   R         Y  KG    
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-------SYYRKGGCAM 206

Query: 194 S-----APE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY 247
                  PE F+ G +  T K D +SFG++L+EI             SL + P   +   
Sbjct: 207 LPVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSK 249

Query: 248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV---EVL 304
              E+   + + G  +  K     +      C Q  PEDRP  + +++ +E      +V+
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309

Query: 305 PPPKPFRY 312
               P  Y
Sbjct: 310 NTALPIEY 317

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  123 bits (310), Expect = 4e-32
 Identities = 48/210 (22%), Positives = 77/210 (36%), Gaps = 28/210 (13%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF- 89
           LG G    V++G+    G   A+KV N        +  M E   + +  H N+V+L+   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 90  -CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKGLVYLHEECQ 143
                    L+ E+   GSL   L     A     L E            G+ +L E   
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE--- 130

Query: 144 QRIIHYDIKPENVLL----DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
             I+H +IKP N++     D     K+ DFG A+  + +   V++    GT  Y  P+  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMY 187

Query: 200 SGNYPI-------THKCDVYSFGMVLFEIV 222
                            D++S G+  +   
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (313), Expect = 5e-32
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 17/216 (7%)

Query: 12  KPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEE 66
            P  F       F+  Y  +  LG G FGEV   +    G + AVKV+++     +  +E
Sbjct: 12  TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71

Query: 67  QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 126
             + EV  + +  H N+++LY F  D+    LV E    G L   +  +KR  E      
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE-VDAAR 130

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVT 183
           I      G+ Y+H   + +I+H D+KPEN+LL     + + ++ DFGL+   + ++    
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187

Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
                GT  Y APE L G Y    KCDV+S G++L+
Sbjct: 188 KI---GTAYYIAPEVLHGTY--DEKCDVWSTGVILY 218

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  120 bits (303), Expect = 5e-32
 Identities = 51/237 (21%), Positives = 82/237 (34%), Gaps = 46/237 (19%)

Query: 23  NFTSNYSTR------LGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGT 74
              S Y+T       +G G FG V+K     +G   A+K   +   G + E+  + EV  
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63

Query: 75  IGRTY-HINLVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT- 131
                 H ++VR +  +  D HM  +  EY   GSL   +   +         E  +   
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHML-IQNEYCNGGSLADAI--SENYRIMSYFKEAELKDL 120

Query: 132 ----AKGLVYLHEECQQRIIHYDIKPENVLLDANFSP-------------------KVAD 168
                +GL Y+H      ++H DIKP N+ +     P                   K+ D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            G        +         G   + A E L  NY    K D+++  + +    G  
Sbjct: 178 LGHVTRISSPQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (304), Expect = 6e-32
 Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 18/197 (9%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTY-HINLVRLY 87
           RLG G +GEV+K +   +G   AVK       G     + +AEVG+  +   H   VRL 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 88  G-FCHDQHMTALVYEYME--NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
             +     +    Y   E    SL  +      ++   ++      T   L +LH    Q
Sbjct: 124 QAWEEGGIL----YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---Q 176

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
            ++H D+KP N+ L      K+ DFGL        +       +G P Y APE L G+Y 
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGSY- 232

Query: 205 ITHKCDVYSFGMVLFEI 221
                DV+S G+ + E+
Sbjct: 233 -GTAADVFSLGLTILEV 248

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  123 bits (310), Expect = 6e-32
 Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 38/219 (17%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA--EEQFMAEVGTIGRTYHINLVRLYGF 89
           LG+G  G V       G  +AVK +  +   IA  E + + E        H N++R Y  
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-----DDHPNVIRYYCS 77

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH------EIAIGTAKGLVYLHEECQ 143
                   +  E     +L   +  K  + E  KL        +    A G+ +LH    
Sbjct: 78  ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133

Query: 144 QRIIHYDIKPENVLLD-------------ANFSPKVADFGLAKLCDRNRS--HVTISGYK 188
            +IIH D+KP+N+L+               N    ++DFGL K  D  +S     ++   
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 189 GTPGYSAPEFLSGNY------PITHKCDVYSFGMVLFEI 221
           GT G+ APE L  +        +T   D++S G V + I
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  121 bits (306), Expect = 8e-32
 Identities = 45/198 (22%), Positives = 92/198 (46%), Gaps = 9/198 (4%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G FG+    +   +G +  +K +N   +     E+   EV  +    H N+V+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             +     +V +Y E G L   +  +K    + +++ +  +     L ++H+   ++I+H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILH 148

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            DIK +N+ L  + + ++ DFG+A++ +            GTP Y +PE      P  +K
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACIGTPYYLSPEICENK-PYNNK 205

Query: 209 CDVYSFGMVLFEIVGRRR 226
            D+++ G VL+E+   + 
Sbjct: 206 SDIWALGCVLYELCTLKH 223

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  120 bits (302), Expect = 2e-31
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 35/215 (16%)

Query: 31  RLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            LG G FG VY+G     VK      +A+K +N         +F+ E   +      ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYL---------FGKKRAIEWEKLHEIAIGTAKGL 135
           RL G       T ++ E M  G L  YL                   K+ ++A   A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY--KGTPGY 193
            YL+     + +H D+   N ++  +F+ K+ DFG+ +             Y  KG  G 
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-------DYYRKGGKGL 201

Query: 194 -----SAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
                 +PE    G +  T   DV+SFG+VL+EI 
Sbjct: 202 LPVRWMSPESLKDGVF--TTYSDVWSFGVVLWEIA 234

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  119 bits (301), Expect = 2e-31
 Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 12/200 (6%)

Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 87
            +G GG G+VY+ +       +A+K+++  L        +   E  T GR    ++V ++
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
            F        +    +    L   L  ++  +   +   I       L   H        
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGAT 156

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-GTPGYSAPEFLSGNYPIT 206
           H D+KPEN+L+ A+    + DFG+A         +T  G   GT  Y APE  S +   T
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSES-HAT 213

Query: 207 HKCDVYSFGMVLFEIV-GRR 225
           ++ D+Y+   VL+E + G  
Sbjct: 214 YRADIYALTCVLYECLTGSP 233

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  119 bits (301), Expect = 2e-31
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 44/220 (20%)

Query: 31  RLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFMAEV---GTIGRTYHINLV 84
            +G G FG+V K +       +  A+K +     +     F  E+     +G   H N++
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNII 89

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKLHEIAI 129
            L G C  +    L  EY  +G+L  +L                     +  ++L   A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG 189
             A+G+ YL +   ++ IH D+   N+L+  N+  K+ADFGL++  +          Y  
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE---------VYVK 197

Query: 190 TPG------YSAPEFLSGNYPI-THKCDVYSFGMVLFEIV 222
                    + A E L  NY + T   DV+S+G++L+EIV
Sbjct: 198 KTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 235

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (297), Expect = 5e-31
 Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 39/220 (17%)

Query: 31  RLGFGGFGEVYKGQFPNG------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            LG   FG+VYKG             +A+K L         E+F  E     R  H N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKLHEIAI 129
            L G        ++++ Y  +G L  +L                  K A+E      +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG 189
             A G+ YL       ++H D+   NVL+    + K++D GL +             YK 
Sbjct: 136 QIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA------DYYKL 186

Query: 190 TPG------YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
                    + APE  + G +  +   D++S+G+VL+E+ 
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKF--SIDSDIWSYGVVLWEVF 224

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  117 bits (296), Expect = 6e-31
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 29/232 (12%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLN 57
           M          + + F           +  +  LG G FG+V+  +   +G++  +K +N
Sbjct: 1   MHHHHHHSSGRENLYFQG----TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN 56

Query: 58  RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK-- 115
           ++  ++  EQ  AE+  +    H N+++++    D H   +V E  E G L      +  
Sbjct: 57  KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----LERIV 112

Query: 116 KRAIEWEKLHEIAIGT-----AKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVA 167
                 + L E  +          L Y H    Q ++H D+KPEN+L      +   K+ 
Sbjct: 113 SAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKII 169

Query: 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           DFGLA+L   +      +   GT  Y APE    +   T KCD++S G+V++
Sbjct: 170 DFGLAELFKSDEHSTNAA---GTALYMAPEVFKRDV--TFKCDIWSAGVVMY 216

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  118 bits (297), Expect = 6e-31
 Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 25/211 (11%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG GGF  V   +   +G   A+K +  +  +   E+   E        H N++RL  +
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHE-----IAIGTAKGLVYLHE 140
           C  +        L+  + + G+L   +  ++   +   L E     + +G  +GL  +H 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN-RSHVTISG------YKGTPGY 193
              +   H D+KP N+LL     P + D G       +                + T  Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 194 SAPEFLSG--NYPITHKCDVYSFGMVLFEIV 222
            APE  S   +  I  + DV+S G VL+ ++
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  117 bits (296), Expect = 7e-31
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 12/200 (6%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 87
           +LG GG   VY  +     +K+A+K +        E  ++F  EV    +  H N+V + 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
               +     LV EY+E  +L  Y+      +  +           G+ + H     RI+
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-GTPGYSAPEFLSGNYPIT 206
           H DIKP+N+L+D+N + K+ DFG+AK    + + +T + +  GT  Y +PE   G     
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGE-ATD 190

Query: 207 HKCDVYSFGMVLFEIV-GRR 225
              D+YS G+VL+E++ G  
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP 210

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  119 bits (300), Expect = 7e-31
 Identities = 81/308 (26%), Positives = 120/308 (38%), Gaps = 53/308 (17%)

Query: 31  RLGFGGFGEVYKGQFPNG------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            LG G FGEVY+GQ          +++AVK L        E  F+ E   I +  H N+V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYL------FGKKRAIEWEKLHEIAIGTAKGLVYL 138
           R  G         ++ E M  G L  +L        +  ++    L  +A   A G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 139 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNRSHVTISGY--KGTPGY 193
            E      IH DI   N LL         K+ DFG+A+        +  +GY  KG    
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD-------IYRAGYYRKGGCAM 247

Query: 194 S-----APE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY 247
                  PE F+ G +  T K D +SFG++L+EI             SL + P   +   
Sbjct: 248 LPVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSK 290

Query: 248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV---EVL 304
              E+   + + G  +  K     +      C Q  PEDRP  + +++ +E      +V+
Sbjct: 291 SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350

Query: 305 PPPKPFRY 312
               P  Y
Sbjct: 351 NTALPIEY 358

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  117 bits (295), Expect = 1e-30
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 42/221 (19%)

Query: 31  RLGFGGFGEVYKGQFPNG------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            LG G FG+V+  +  N       + +AVK L       A + F  E   +    H ++V
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTNLQHEHIV 80

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKLHEIAI 129
           + YG C D     +V+EYM++G L+ +L                  K  +   ++  IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY-- 187
             A G+VYL     Q  +H D+   N L+ AN   K+ DFG++    R+   V  + Y  
Sbjct: 141 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMS----RD---VYSTDYYR 190

Query: 188 KGTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
            G        +  PE  +   +  T + DV+SFG++L+EI 
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIF 229

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  118 bits (297), Expect = 1e-30
 Identities = 44/218 (20%), Positives = 80/218 (36%), Gaps = 32/218 (14%)

Query: 32  LGFGGFGEVYKGQFPNGVKIAVKVLNRN----------------LGRIAEEQFMAEVGTI 75
           L  G F ++   +  +    A+K   ++                  +   + F  E+  I
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 76  GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEKLHE-----IA 128
               +   +   G   +     ++YEYMEN S+  +   F          +       I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
                   Y+H   ++ I H D+KP N+L+D N   K++DFG ++     +   +    +
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS----R 211

Query: 189 GTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFE-IVGR 224
           GT  +  PEF S        K D++S G+ L+      
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  116 bits (293), Expect = 1e-30
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 12/205 (5%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
            +G G +G   K +   +G  +  K L+  ++    ++  ++EV  +    H N+VR Y 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 89  FCHDQHMTAL--VYEYMENGSLDGYLFGKKRA---IEWEKLHEIAIGTAKGLVYLHE--E 141
              D+  T L  V EY E G L   +    +    ++ E +  +       L   H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
               ++H D+KP NV LD   + K+ DFGLA++ + + S      + GTP Y +PE ++ 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFVGTPYYMSPEQMNR 190

Query: 202 NYPITHKCDVYSFGMVLFEIVGRRR 226
                 K D++S G +L+E+     
Sbjct: 191 M-SYNEKSDIWSLGCLLYELCALMP 214

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  120 bits (303), Expect = 1e-30
 Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 23  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRT 78
            F   Y+    LG G FGEV K +      + AVKV+N  +         + EV  + + 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
            H N+++L+    D     +V E    G L   +  +KR  E      I      G+ Y+
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYM 137

Query: 139 HEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
           H   +  I+H D+KPEN+LL   + +   K+ DFGL+    +N          GT  Y A
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIA 191

Query: 196 PEFLSGNYPITHKCDVYSFGMVLF 219
           PE L G Y    KCDV+S G++L+
Sbjct: 192 PEVLRGTY--DEKCDVWSAGVILY 213

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  117 bits (295), Expect = 2e-30
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 33/214 (15%)

Query: 31  RLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVR 85
            LG G FG V +G         +K+AVK +  +     E E+F++E   +    H N++R
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 86  LYGFCHDQHMTA-----LVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGL 135
           L G C +          ++  +M+ G L  YL         + I  + L +  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY-KGTPG-- 192
            YL     +  +H D+   N +L  + +  VADFGL+K             Y +G     
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG------DYYRQGRIAKM 211

Query: 193 ---YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
              + A E      Y  T K DV++FG+ ++EI 
Sbjct: 212 PVKWIAIESLADRVY--TSKSDVWAFGVTMWEIA 243

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  116 bits (292), Expect = 2e-30
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)

Query: 23  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRT 78
            F   Y+    LG G FGEV K +      + AVKV+N  +         + EV  + + 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AK 133
            H N+++L+    D     +V E    G     LF     I+ ++  E            
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGE----LF--DEIIKRKRFSEHDAARIIKQVFS 132

Query: 134 GLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
           G+ Y+H   +  I+H D+KPEN+LL   + +   K+ DFGL+    +N          GT
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GT 186

Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
             Y APE L G Y    KCDV+S G++L+
Sbjct: 187 AYYIAPEVLRGTY--DEKCDVWSAGVILY 213

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  117 bits (294), Expect = 2e-30
 Identities = 72/314 (22%), Positives = 120/314 (38%), Gaps = 61/314 (19%)

Query: 31  RLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            LG G FG+V+  +  N +       +AVK L       A + F  E   +    H ++V
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-ARQDFQREAELLTMLQHQHIV 106

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYL--------------FGKKRAIEWEKLHEIAIG 130
           R +G C +     +V+EYM +G L+ +L                    +   +L  +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY--K 188
            A G+VYL        +H D+   N L+      K+ DFG++    R+   +  + Y   
Sbjct: 167 VAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMS----RD---IYSTDYYRV 216

Query: 189 GTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH 242
           G        +  PE  L   +  T + DV+SFG+VL+EI             +    P  
Sbjct: 217 GGRTMLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIF------------TYGKQP-- 260

Query: 243 VWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
            W +   +E    I      E+ +     +      C Q  P+ R  +  V   L+ + +
Sbjct: 261 -WYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319

Query: 303 VLPPPKPFRYLDLI 316
             P      YLD++
Sbjct: 320 APPV-----YLDVL 328

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  117 bits (294), Expect = 3e-30
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 34/215 (15%)

Query: 31  RLGFGGFGEVYKGQFPNG----VKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVR 85
            LG G FG V + Q        VK+AVK+L  ++   ++ E+F+ E   +    H ++ +
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 86  LYGFCHDQHMTA------LVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKG 134
           L G               ++  +M++G L  +L           +  + L    +  A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY-KGTPG- 192
           + YL     +  IH D+   N +L  + +  VADFGL+      R   +   Y +G    
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLS------RKIYSGDYYRQGCASK 200

Query: 193 ----YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
               + A E      Y  T   DV++FG+ ++EI+
Sbjct: 201 LPVKWLALESLADNLY--TVHSDVWAFGVTMWEIM 233

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (293), Expect = 3e-30
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 14/204 (6%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 87
            LGFGG  EV+  +   +   +AVKVL  +L R      +F  E        H  +V +Y
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 88  GFCHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
                +        +V EY++  +L   +   +  +  ++  E+     + L + H+   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQ--- 134

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-GTPGYSAPEFLSGN 202
             IIH D+KP N+++ A  + KV DFG+A+    + + VT +    GT  Y +PE   G+
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194

Query: 203 YPITHKCDVYSFGMVLFEIV-GRR 225
             +  + DVYS G VL+E++ G  
Sbjct: 195 -SVDARSDVYSLGCVLYEVLTGEP 217

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  115 bits (291), Expect = 5e-30
 Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 46/225 (20%)

Query: 31  RLGFGGFGEVYKGQ------FPNGVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRTYHI 81
            LG G FG+V +            + +AVK+L  +      E  M+E+     +G   H+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HM 87

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLDGYL-----------------FGKKRAIEWEKL 124
           N+V L G C     T ++ EY   G L  +L                    + A++ E L
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184
              +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA      R     
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA------RDIKND 198

Query: 185 SGYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
           S Y           + APE   +  Y  T + DV+S+G+ L+E+ 
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELF 241

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  115 bits (290), Expect = 5e-30
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 14/199 (7%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG 88
            LG G +G V K +  P+G  +AVK +   +    +++ + ++    RT      V  YG
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 89  FCHDQHMTALVYEYMENGSLDGYL---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
               +    +  E M + SLD +      K + I  + L +IA+   K L +LH +    
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LS 130

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +IH D+KP NVL++A    K+ DFG++     + +        G   Y APE ++     
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI---DAGCKPYMAPERINPELNQ 187

Query: 206 ---THKCDVYSFGMVLFEI 221
              + K D++S G+ + E+
Sbjct: 188 KGYSVKSDIWSLGITMIEL 206

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  115 bits (291), Expect = 8e-30
 Identities = 65/245 (26%), Positives = 97/245 (39%), Gaps = 55/245 (22%)

Query: 7   EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKG------QFPNGVKIAVKVLNRNL 60
           E  R        LQ           LG G FG+V +       +    +K+AVK+L    
Sbjct: 42  EFPRNN------LQFGK-------TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88

Query: 61  GRIAEEQFMAEVG---TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR 117
               +E  M+E+     +G+  H N+V L G C       ++ EY   G L  +L  K R
Sbjct: 89  HADEKEALMSELKIMSHLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146

Query: 118 AIEWEK-------------LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164
            +E +              L   +   A+G+ +L     +  IH D+   NVLL      
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVA 203

Query: 165 KVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMV 217
           K+ DFGLA      R  +  S Y           + APE      Y  T + DV+S+G++
Sbjct: 204 KIGDFGLA------RDIMNDSNYIVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGIL 255

Query: 218 LFEIV 222
           L+EI 
Sbjct: 256 LWEIF 260

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (290), Expect = 9e-30
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 15/200 (7%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG 88
            +G G +G V K    P+G  +AVK +   +    ++Q + ++  + R+     +V+ YG
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
               +    +  E M       Y +        I  E L +I + T K L +L E    +
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LK 146

Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
           IIH DIKP N+LLD + + K+ DFG+  +L D            G   Y APE +  +  
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPERIDPSAS 202

Query: 205 I---THKCDVYSFGMVLFEI 221
                 + DV+S G+ L+E+
Sbjct: 203 RQGYDVRSDVWSLGITLYEL 222

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  115 bits (290), Expect = 1e-29
 Identities = 40/213 (18%), Positives = 73/213 (34%), Gaps = 30/213 (14%)

Query: 32  LGFGGFGEVYKGQF------PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLV 84
           LG G F +VY+          N  K  +KV    N         + E   +  +     +
Sbjct: 73  LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER--LKPSMQHMFM 130

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-----IAIGTAKGLVYLH 139
           + Y     Q+ + LV E    G+L   +    +    + + +      A+     +  +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAI-NLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189

Query: 140 EECQQRIIHYDIKPENVLL-----------DANFSPKVADFGLAKLCDRNRSHVTISGYK 188
           +     IIH DIKP+N +L           D +    + D G +            +   
Sbjct: 190 D---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246

Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEI 221
            T G+   E LS   P  ++ D +     ++ +
Sbjct: 247 ETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCM 278

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  113 bits (285), Expect = 2e-29
 Identities = 52/208 (25%), Positives = 83/208 (39%), Gaps = 26/208 (12%)

Query: 23  NFTSNYST--RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 79
           +    Y+    +G G +GEV         ++ A K + +       ++F  E+  +    
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLD 64

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKG 134
           H N++RLY    D     LV E    G L    F  +R +      E             
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGEL----F--ERVVHKRVFRESDAARIMKDVLSA 118

Query: 135 LVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           + Y H   +  + H D+KPEN L      +   K+ DFGLA      +   T  G   TP
Sbjct: 119 VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG---TP 172

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLF 219
            Y +P+ L G Y    +CD +S G++++
Sbjct: 173 YYVSPQVLEGLY--GPECDEWSAGVMMY 198

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  114 bits (287), Expect = 2e-29
 Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 16/197 (8%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G F EVY+     +GV +A+K +     +   A    + E+  + +  H N+++ Y 
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKGLVYLHEECQ 143
              + +   +V E  + G L   +  K    +   + E  +          L ++H    
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
           +R++H DIKP NV + A    K+ D GL +      +        GTP Y +PE +  N 
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHEN- 211

Query: 204 PITHKCDVYSFGMVLFE 220
               K D++S G +L+E
Sbjct: 212 GYNFKSDIWSLGCLLYE 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (287), Expect = 2e-29
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 14/198 (7%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYG 88
            +G G  G+V+K +F   G  IAVK + R+  +   ++ + ++  + ++     +V+ +G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
                    +  E M   +       +    E   L ++ +   K L YL E+    +IH
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPE-RILGKMTVAIVKALYYLKEK--HGVIH 148

Query: 149 YDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI-- 205
            D+KP N+LLD     K+ DFG+  +L D      +     G   Y APE +    P   
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA----GCAAYMAPERIDPPDPTKP 204

Query: 206 --THKCDVYSFGMVLFEI 221
               + DV+S G+ L E+
Sbjct: 205 DYDIRADVWSLGISLVEL 222

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  117 bits (294), Expect = 3e-29
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 37/231 (16%)

Query: 12  KPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRN--------- 59
            P  +   +      +Y     LG G +GEV   +      + A+KV+ ++         
Sbjct: 22  NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81

Query: 60  ---LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK 116
                    E+   E+  +    H N+++L+    D+    LV E+ E G L    F  +
Sbjct: 82  DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----F--E 135

Query: 117 RAIEWEKLHEIAIGT-----AKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVAD 168
           + I   K  E            G+ YLH   +  I+H DIKPEN+LL   ++  + K+ D
Sbjct: 136 QIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVD 192

Query: 169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           FGL+    ++          GT  Y APE L   Y    KCDV+S G++++
Sbjct: 193 FGLSSFFSKDYKLRDRL---GTAYYIAPEVLKKKY--NEKCDVWSCGVIMY 238

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (288), Expect = 3e-29
 Identities = 28/250 (11%), Positives = 60/250 (24%), Gaps = 46/250 (18%)

Query: 10  REKPVRFTSLQLNNFTSNYST--RLGFGGFGEVYKG-QFPNGVKIAVKVLNRN--LGRIA 64
           +       SL L+           L  G    V+           A+KV        R  
Sbjct: 47  QNAETTVDSL-LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105

Query: 65  EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA--------------------------L 98
            E+         R    +             +                           L
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165

Query: 99  VYEYM-----ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153
           +            S   +++  +       LH +     +    L     + ++H    P
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTP 222

Query: 154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVY 212
           +N+ +  +    + D              +         Y+  EFL+ +    TH  + +
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAW 277

Query: 213 SFGMVLFEIV 222
             G+ ++ + 
Sbjct: 278 QLGLSIYRVW 287

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  113 bits (286), Expect = 4e-29
 Identities = 79/319 (24%), Positives = 123/319 (38%), Gaps = 66/319 (20%)

Query: 31  RLGFGGFGEVYKG--------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRTY 79
            LG G FG+V           +    V +AVK+L  +         ++E+     IG+  
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-- 99

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKL 124
           H N++ L G C       ++ EY   G+L  YL                  +  + ++ L
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184
                  A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+        +  
Sbjct: 160 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARD-------INN 209

Query: 185 SGY--KGTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL 236
             Y  K T G     + APE      Y  TH+ DV+SFG++++EI             +L
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIF------------TL 255

Query: 237 DWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM 296
              P   +      EL   +      +K       L M    C    P  RP    +V+ 
Sbjct: 256 GGSP---YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

Query: 297 LEGVVEVLPPPKPFRYLDL 315
           L+ ++ +    +   YLDL
Sbjct: 313 LDRILTLTTNEE---YLDL 328

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  113 bits (285), Expect = 4e-29
 Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 15/196 (7%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +G G F +V   +    G ++A+K++++  L   + ++   EV  +    H N+V+L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRI 146
              +    L+ EY   G +  YL    R  E E   K  +I       + Y H   Q+RI
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCH---QKRI 135

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+K EN+LLDA+ + K+ADFG +           +  + G P Y+APE   G     
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDG 192

Query: 207 HKCDVYSFGMVLFEIV 222
            + DV+S G++L+ +V
Sbjct: 193 PEVDVWSLGVILYTLV 208

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  112 bits (283), Expect = 5e-29
 Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 19/198 (9%)

Query: 32  LGFGGFGEVYKG-QFPNGVKIAVK-VLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           LG G +G VY G    N V+IA+K +  R+      +    E+       H N+V+  G 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS--QPLHEEIALHKHLKHKNIVQYLGS 87

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEW-EKLHEIAIGTA---KGLVYLHEECQQR 145
             +     +  E +  GSL   L  K   ++  E+   I   T    +GL YLH+    +
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT--IGFYTKQILEGLKYLHD---NQ 142

Query: 146 IIHYDIKPENVLLDA-NFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
           I+H DIK +NVL++  +   K++DFG +K L   N    T     GT  Y APE +    
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEIIDKGP 199

Query: 204 P-ITHKCDVYSFGMVLFE 220
                  D++S G  + E
Sbjct: 200 RGYGKAADIWSLGCTIIE 217

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  116 bits (292), Expect = 9e-29
 Identities = 46/203 (22%), Positives = 79/203 (38%), Gaps = 22/203 (10%)

Query: 31  RLGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY- 87
            +  GG G +Y    +  NG  + +K L  +    A+   MAE   +    H ++V+++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 88  -GFCHDQHMTALVY---EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
                D+H   + Y   EY+   SL        + +   +     +     L YLH    
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS--- 200

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
             +++ D+KPEN++L      K+ D G     +            GTPG+ APE +    
Sbjct: 201 IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY------GTPGFQAPEIVRTG- 252

Query: 204 PITHKCDVYSFGMVLFEIVGRRR 226
             T   D+Y+ G  L  +     
Sbjct: 253 -PTVATDIYTVGRTLAALTLDLP 274

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  113 bits (285), Expect = 1e-28
 Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 48/226 (21%)

Query: 31  RLGFGGFGEVYKG--------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRTY 79
            LG G FG+V           +    V +AVK+L  +         ++E+     IG+  
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-- 145

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRAIEWEKL 124
           H N++ L G C       ++ EY   G+L  YL                  +  + ++ L
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184
                  A+G+ YL     Q+ IH D+   NVL+  N   K+ADFGLA+        +  
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARD-------INN 255

Query: 185 SGY--KGTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
             Y  K T G     + APE      Y  TH+ DV+SFG++++EI 
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIF 299

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (283), Expect = 1e-28
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 22/198 (11%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           R+G G FGEV++ +    G + AVK +        E   + E+          +V LYG 
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGA 118

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA---KGLVYLHEECQQRI 146
             +     +  E +E GSL   +  K+     E             +GL YLH    +RI
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDR--ALYYLGQALEGLEYLHT---RRI 171

Query: 147 IHYDIKPENVLLDANFSP-KVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           +H D+K +NVLL ++ S   + DFG A         +S +T     GT  + APE + G 
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 203 YPITHKCDVYSFGMVLFE 220
            P   K D++S   ++  
Sbjct: 232 -PCDAKVDIWSSCCMMLH 248

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  110 bits (278), Expect = 2e-28
 Identities = 58/192 (30%), Positives = 82/192 (42%), Gaps = 11/192 (5%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G +GEV           +AVK+++        E    E+       H N+V+ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRII 147
            + ++  L  EY   G L   +       E +     H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGIT 127

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L        
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

Query: 208 KCDVYSFGMVLF 219
             DV+S G+VL 
Sbjct: 188 PVDVWSCGIVLT 199

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (282), Expect = 3e-28
 Identities = 66/250 (26%), Positives = 102/250 (40%), Gaps = 61/250 (24%)

Query: 7   EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN--------GVKIAVKVLNR 58
           E+ R++      L L          LG G FG+V   +             K+AVK+L  
Sbjct: 65  ELPRDR------LVLGK-------PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 111

Query: 59  NLGRIAEEQFMAEVG---TIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--- 112
           +         ++E+     IG+  H N++ L G C       ++ EY   G+L  YL   
Sbjct: 112 DATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 169

Query: 113 ------------FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA 160
                          +  +  + L   A   A+G+ YL     ++ IH D+   NVL+  
Sbjct: 170 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE 226

Query: 161 NFSPKVADFGLAKLCDRNRSHVTISGY--KGTPG-----YSAPE-FLSGNYPITHKCDVY 212
           +   K+ADFGLA+        +    Y  K T G     + APE      Y  TH+ DV+
Sbjct: 227 DNVMKIADFGLARD-------IHHIDYYKKTTNGRLPVKWMAPEALFDRIY--THQSDVW 277

Query: 213 SFGMVLFEIV 222
           SFG++L+EI 
Sbjct: 278 SFGVLLWEIF 287

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  110 bits (278), Expect = 3e-28
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)

Query: 22  NNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIA--------EEQFMA 70
           + F  NY  +  LG G    V +    P   + AVK+++   G            E  + 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72

Query: 71  EVGTIGR-TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI 129
           EV  + + + H N+++L           LV++ M+ G L  YL  K    E ++  +I  
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE-KETRKIMR 131

Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG 189
              + +  LH+     I+H D+KPEN+LLD + + K+ DFG +   D       +    G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---G 185

Query: 190 TPGYSAPEFLSGNYPITHK-----CDVYSFGMVLF 219
           TP Y APE +  +    H       D++S G++++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  110 bits (277), Expect = 5e-28
 Identities = 59/224 (26%), Positives = 89/224 (39%), Gaps = 45/224 (20%)

Query: 31  RLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRTYHI 81
            LG G FG+V +              +AVK+L            M+E+     IG   H+
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HL 91

Query: 82  NLVRLYGFCHDQHM-TALVYEYMENGSLDGYL---------------FGKKRAIEWEKLH 125
           N+V L G C        ++ E+ + G+L  YL                  K  +  E L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 126 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185
             +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+  D  +      
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPD--- 203

Query: 186 GYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
            Y           + APE      Y  T + DV+SFG++L+EI 
Sbjct: 204 -YVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIF 244

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  110 bits (278), Expect = 5e-28
 Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 49/229 (21%)

Query: 31  RLGFGGFGEVYKGQFPNGVK------IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            +G G FG V++ + P  +       +AVK+L        +  F  E   +    + N+V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYL-----------------------FGKKRAIEW 121
           +L G C       L++EYM  G L+ +L                             +  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
            +   IA   A G+ YL E   ++ +H D+   N L+  N   K+ADFGL+    RN   
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS----RN--- 223

Query: 182 VTISGY--KGTPGY-----SAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
           +  + Y               PE      Y  T + DV+++G+VL+EI 
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIF 270

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  110 bits (278), Expect = 7e-28
 Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 23/214 (10%)

Query: 22  NNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR- 77
             F   Y  +  +G G    V +      G + AVK++     R++ EQ         R 
Sbjct: 90  KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149

Query: 78  -------TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG 130
                    H +++ L           LV++ M  G L  YL  K    E ++   I   
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE-KETRSIMRS 208

Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
             + + +LH      I+H D+KPEN+LLD N   +++DFG +   +       +    GT
Sbjct: 209 LLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GT 262

Query: 191 PGYSAPEFLSGNYPITHK-----CDVYSFGMVLF 219
           PGY APE L  +   TH       D+++ G++LF
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  109 bits (275), Expect = 1e-27
 Identities = 58/192 (30%), Positives = 82/192 (42%), Gaps = 11/192 (5%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           LG G +GEV           +AVK+++        E    E+       H N+V+ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRII 147
            + ++  L  EY   G L   +       E +     H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGIT 127

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L        
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

Query: 208 KCDVYSFGMVLF 219
             DV+S G+VL 
Sbjct: 188 PVDVWSCGIVLT 199

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  109 bits (274), Expect = 2e-27
 Identities = 61/270 (22%), Positives = 94/270 (34%), Gaps = 54/270 (20%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN 57
           M          + + F    L      Y  +  +G G +G V    +       A+K++N
Sbjct: 1   MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 58  R----NLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLF 113
           +     +     E+   EV  + + +H N+ RLY    D+    LV E    G L   L 
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120

Query: 114 GKKRAIEWEKLHEIAIGTAK---------------------------------------G 134
                   +   ++                                              
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 135 LVYLHEECQQRIIHYDIKPENVLL--DANFSPKVADFGLAKLCDRNRSH--VTISGYKGT 190
           L YLH    Q I H DIKPEN L   + +F  K+ DFGL+K   +  +     ++   GT
Sbjct: 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

Query: 191 PGYSAPEFLSG-NYPITHKCDVYSFGMVLF 219
           P + APE L+  N     KCD +S G++L 
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (271), Expect = 2e-27
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 23  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRT 78
            F+ NY  +  LG G F  V +      G++ A K++N + L     ++   E     + 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62

Query: 79  YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-----IAIGTAK 133
            H N+VRL+    ++    LV++ +  G L    F  +  +  E   E           +
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGEL----F--EDIVAREFYSEADASHCIQQILE 116

Query: 134 GLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
            + Y H      I+H ++KPEN+LL       + K+ADFGLA   + + +    +   GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GT 170

Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           PGY +PE L  + P +   D+++ G++L+
Sbjct: 171 PGYLSPEVLKKD-PYSKPVDIWACGVILY 198

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  108 bits (272), Expect = 2e-27
 Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 47/228 (20%)

Query: 31  RLGFGGFGEVYKGQ------FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            LG G FG+V K              +AVK+L  N         ++E   + +  H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYL-----------------------FGKKRAIEW 121
           +LYG C       L+ EY + GSL G+L                          +RA+  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
             L   A   ++G+ YL E    +++H D+   N+L+      K++DFGL++  D     
Sbjct: 150 GDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYEED 204

Query: 182 VTISGY-KGTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
                Y K + G     + A E      Y  T + DV+SFG++L+EIV
Sbjct: 205 S----YVKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIV 246

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (274), Expect = 3e-27
 Identities = 28/237 (11%), Positives = 66/237 (27%), Gaps = 54/237 (22%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-------LGRIAEE---------------- 66
            LG        +      G    V V           + ++ EE                
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 67  ----QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM----ENGSLDGYLFG---K 115
               +F+     +       ++R+     D  + +  + Y        +    L      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 116 KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
            +++      ++ +   + L  LH      ++H  ++P +++LD      +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 176 DRNRSHVTISGYKGTPGYSAPEFLS----------GNYPITHKCDVYSFGMVLFEIV 222
                         + G+  PE  +              +T   D ++ G+V++ I 
Sbjct: 257 GARVVSS------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  108 bits (271), Expect = 5e-27
 Identities = 62/230 (26%), Positives = 90/230 (39%), Gaps = 51/230 (22%)

Query: 31  RLGFGGFGEVYKGQ------FPNGVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRTYHI 81
            LG G FG+V              +++AVK+L         E  M+E+     +G   H 
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HE 109

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLDGYL----------------------FGKKRAI 119
           N+V L G C       L++EY   G L  YL                            +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 120 EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179
            +E L   A   AKG+ +L     +  +H D+   NVL+      K+ DFGLA      R
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA------R 220

Query: 180 SHVTISGYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVLFEIV 222
             ++ S Y           + APE    G Y  T K DV+S+G++L+EI 
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIF 268

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  108 bits (271), Expect = 8e-27
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 25/220 (11%)

Query: 12  KPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQ 67
           +   F       F+ NY  +  LG G F  V +      G++ A K++N + L     ++
Sbjct: 15  RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK 74

Query: 68  FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE- 126
              E     +  H N+VRL+    ++    LV++ +  G L    F  +  +  E   E 
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----F--EDIVAREFYSEA 128

Query: 127 ----IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSP-KVADFGLAKLCDRNR 179
                     + + Y H      I+H ++KPEN+LL   A  +  K+ADFGLA   + + 
Sbjct: 129 DASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185

Query: 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           +    +   GTPGY +PE L  + P +   D+++ G++L+
Sbjct: 186 AWHGFA---GTPGYLSPEVLKKD-PYSKPVDIWACGVILY 221

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  107 bits (268), Expect = 1e-26
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 30/208 (14%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-----------TY 79
           LG GGFG V+ G    + +++A+KV+ RN  R+     +++  T                
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRN--RVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWE---KLHEIAIGTAKGL 135
           H  ++RL  +   Q    LV E       L  Y+  K    E        ++       +
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAI 152

Query: 136 VYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS 194
            + H    + ++H DIK EN+L+D      K+ DFG   L              GT  YS
Sbjct: 153 QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----GTRVYS 205

Query: 195 APEFLSGNYPITHKCDVYSFGMVLFEIV 222
            PE++S +        V+S G++L+++V
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMV 233

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  107 bits (270), Expect = 1e-26
 Identities = 47/230 (20%), Positives = 100/230 (43%), Gaps = 27/230 (11%)

Query: 2   ERFLQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN- 57
           ++F ++I ++   +   ++  +    Y     LG G FG V++  +   G     K +N 
Sbjct: 27  DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86

Query: 58  RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL------DGY 111
                        E+  + + +H  L+ L+    D++   L+ E++  G L      + Y
Sbjct: 87  PYPLDK--YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY 144

Query: 112 LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADF 169
              +   I +  + +      +GL ++H   +  I+H DIKPEN++ +   +   K+ DF
Sbjct: 145 KMSEAEVINY--MRQAC----EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDF 195

Query: 170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           GLA   + +      +    T  ++APE +    P+    D+++ G++ +
Sbjct: 196 GLATKLNPDEIVKVTT---ATAEFAAPEIVDRE-PVGFYTDMWAIGVLGY 241

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (271), Expect = 1e-26
 Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 33/218 (15%)

Query: 22  NNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRN-------LGRIAEEQFMAE 71
                 Y     LG G  GEV    +     K+A++++++                   E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 72  VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE----- 126
           +  + +  H  ++++  F   +    +V E ME G L    F   + +  ++L E     
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL----F--DKVVGNKRLKEATCKL 243

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVT 183
                   + YLHE     IIH D+KPENVLL   + +   K+ DFG +K+        T
Sbjct: 244 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300

Query: 184 ISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLF 219
           +    GTP Y APE L            D +S G++LF
Sbjct: 301 LC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  105 bits (264), Expect = 3e-26
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 22/206 (10%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 88
            +G G    V      P   K+A+K +N    + + ++ + E+  + + +H N+V  Y  
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 89  FCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEK-LHEIAIG-----TAKGLVYLHEE 141
           F     +  LV + +  GS+ D       +       L E  I        +GL YLH+ 
Sbjct: 82  FVVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCD-----RNRSHVTISGYKGTPGYSA 195
                IH D+K  N+LL  + S ++ADFG+ A L       RN+   T     GTP + A
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV---GTPCWMA 194

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEI 221
           PE +        K D++SFG+   E+
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIEL 220

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  107 bits (268), Expect = 3e-26
 Identities = 39/324 (12%), Positives = 83/324 (25%), Gaps = 74/324 (22%)

Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLN-------RNLGRIAEE---------------- 66
            LG        +      G    V V           + ++ EE                
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 67  ----QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV----YEYMENGSLDGYLFGKKR- 117
               +F+     +       ++R+     D  + +             +    L      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 118 --AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
             ++      ++ +   + L  LH      ++H  ++P +++LD      +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYP----ITHKCDVYSFGMVLFEIV-GR---RRN 227
             +       G+   P  +A   L         +T   D ++ G+ ++ I         +
Sbjct: 262 GASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320

Query: 228 AIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDR 287
           A +G SE                +                  + L    L   +   EDR
Sbjct: 321 AALGGSE------WIFRSCKNIPQP----------------VRALLEGFL---RYPKEDR 355

Query: 288 PPMSAVVK--MLEGVVEVLPPPKP 309
                 ++    E +   L    P
Sbjct: 356 LLPLQAMETPEYEQLRTELSAALP 379

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  105 bits (263), Expect = 5e-26
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 25/211 (11%)

Query: 23  NFTSNYSTR---LGFGGFGEVYKG-QFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGR 77
           NF + Y      LG G F  V +      G + A K L  R  G+    + + E+  +  
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84

Query: 78  TYHI-NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-IAIGTAK-- 133
                 ++ L+    +     L+ EY   G +    F        E + E   I   K  
Sbjct: 85  AKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQI 140

Query: 134 --GLVYLHEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYK 188
             G+ YLH+     I+H D+KP+N+LL + +     K+ DFG+++          I    
Sbjct: 141 LEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--- 194

Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           GTP Y APE L+ + PIT   D+++ G++ +
Sbjct: 195 GTPEYLAPEILNYD-PITTATDMWNIGIIAY 224

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (264), Expect = 7e-26
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 27/220 (12%)

Query: 13  PVRFTSLQLNNFTSNYS----TRLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQ 67
             R  + +     S Y+      LG G FG+V+K  +   G+K+A K++    G   +E+
Sbjct: 74  DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEE 132

Query: 68  FMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL------DGYLFGKKRAIEW 121
              E+  + +  H NL++LY     ++   LV EY++ G L      + Y   +   I +
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNR 179
             + +I     +G+ ++H   Q  I+H D+KPEN+L     +   K+ DFGLA+      
Sbjct: 193 --MKQIC----EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243

Query: 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
                    GTP + APE ++ ++ ++   D++S G++ +
Sbjct: 244 KLKVNF---GTPEFLAPEVVNYDF-VSFPTDMWSVGVIAY 279

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  105 bits (264), Expect = 7e-26
 Identities = 48/301 (15%), Positives = 90/301 (29%), Gaps = 55/301 (18%)

Query: 33  GFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQF---MAEVGTIGRTYHINLVRLYG 88
           GF     V   ++ P G  + V+ +N  L   + E       E+       H N+V    
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRIN--LEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93

Query: 89  -FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG-----TAKGLVYLHEEC 142
            F  D  +  +V  +M  GS    +         + ++E+AI        K L Y+H   
Sbjct: 94  TFIADNEL-WVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQGVLKALDYIH--- 145

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFG-LAKLCD----RNRSHVTISGYKGTPGYSAPE 197
               +H  +K  ++L+  +    ++       +      +   H           + +PE
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205

Query: 198 FLSGN-YPITHKCDVYSFG------------------M-VLFEIVGRRRNAIVGSSESLD 237
            L  N      K D+YS G                    +L E +      ++ +S    
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA 265

Query: 238 WFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALW----------CVQDSPEDR 287
                       +   +  L           +        +          C+Q +P+ R
Sbjct: 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR 325

Query: 288 P 288
           P
Sbjct: 326 P 326

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  105 bits (264), Expect = 7e-26
 Identities = 54/194 (27%), Positives = 78/194 (40%), Gaps = 18/194 (9%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G FG     +       +AVK + R  G   +E    E+       H N+VR     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQQRII 147
                 A++ EY   G L   +    R  E E      ++  G +    Y H     +I 
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YCH---SMQIC 138

Query: 148 HYDIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           H D+K EN LLD + +P  K+ DFG +K    +    +     GTP Y APE L      
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEYD 195

Query: 206 THKCDVYSFGMVLF 219
               DV+S G+ L+
Sbjct: 196 GKIADVWSCGVTLY 209

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  104 bits (261), Expect = 9e-26
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 30/214 (14%)

Query: 23  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAE-----EQFMAEVGT 74
                Y     LG G F  V K  +   G++ A K + +   R +      E+   EV  
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 75  IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI-AIGTAK 133
           + +  H N++ L+    ++    L+ E +  G     LF      + E L E  A    K
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGE----LF--DFLAQKESLSEEEATSFIK 122

Query: 134 ----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNRSHVTIS 185
               G+ YLH    ++I H+D+KPEN++L     P    K+ DFGLA   +       I 
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
              GTP + APE ++   P+  + D++S G++ +
Sbjct: 180 ---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 209

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  104 bits (261), Expect = 1e-25
 Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 28/206 (13%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--------- 81
           LG GGFG VY G    + + +A+K + ++  RI++   +     +     +         
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKD--RISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 82  NLVRLYGFCHDQHMTALVYEYMEN-GSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVY 137
            ++RL  +        L+ E  E    L  ++  +    E        ++     + + +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVRH 164

Query: 138 LHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
            H      ++H DIK EN+L+D N    K+ DFG   L              GT  YS P
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPP 217

Query: 197 EFLSGNYPITHKCDVYSFGMVLFEIV 222
           E++  +        V+S G++L+++V
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMV 243

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  103 bits (260), Expect = 1e-25
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 22/204 (10%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-LGRIA--EEQFMAEVGTIGRTYHINLVRLY 87
           LG G +G+V +        + AVK+L +  L RI   E     E+  + R  H N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 88  GFCHDQHMTA--LVYEYMENGSLDGYLFG---KKRAIEWE---KLHEIAIGTAKGLVYLH 139
              +++      +V EY   G  +  +     +KR    +      ++  G      YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
               Q I+H DIKP N+LL    + K++  G+A+      +  T    +G+P +  PE  
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183

Query: 200 SGNYPIT-HKCDVYSFGMVLFEIV 222
           +G    +  K D++S G+ L+ I 
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNIT 207

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (259), Expect = 1e-25
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 32/215 (14%)

Query: 23  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKV-----LNRNLGRIAEEQFMAEVGT 74
               +Y     LG G F  V K  Q   G + A K      L+ +   ++ E+   EV  
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 75  IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEI-AIGTA 132
           +    H N++ L+    ++    L+ E +  G L D          E E L E  A    
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFD-------FLAEKESLTEDEATQFL 114

Query: 133 K----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNRSHVTI 184
           K    G+ YLH    +RI H+D+KPEN++L     P    K+ DFG+A   +       I
Sbjct: 115 KQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171

Query: 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
               GTP + APE ++   P+  + D++S G++ +
Sbjct: 172 F---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 202

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  104 bits (262), Expect = 1e-25
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 30/220 (13%)

Query: 17  TSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNR-----NLGRIAEEQF 68
            + +       Y     LG G F  V K  +   G++ A K + +     +   +  E+ 
Sbjct: 3   ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62

Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI- 127
             EV  + +  H N++ L+    ++    L+ E +  G     LF      + E L E  
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGE----LF--DFLAQKESLSEEE 116

Query: 128 AIGTAK----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNR 179
           A    K    G+ YLH    ++I H+D+KPEN++L     P    K+ DFGLA   +   
Sbjct: 117 ATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173

Query: 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
               I    GTP + APE ++   P+  + D++S G++ +
Sbjct: 174 EFKNIF---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 209

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  103 bits (258), Expect = 1e-25
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 20/199 (10%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMA----EVGTIGRTYHINLVRL 86
           LG G FG+V  G+    G K+AVK+LNR   +I     +     E+  +    H ++++L
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQ--KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQ 143
           Y          +V EY+  G L  Y+    R  E E      +I         Y H   +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---R 129

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
             ++H D+KPENVLLDA+ + K+ADFGL+ +        T     G+P Y+APE +SG  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 186

Query: 204 PITHKCDVYSFGMVLFEIV 222
               + D++S G++L+ ++
Sbjct: 187 YAGPEVDIWSCGVILYALL 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  103 bits (259), Expect = 2e-25
 Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 28/214 (13%)

Query: 18  SLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT 74
           S+Q  N    +     LG G F EV+   Q   G   A+K + ++     +     E+  
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAV 59

Query: 75  IGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHE-----IA 128
           + +  H N+V L           LV + +  G L D       R +E     E     + 
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD-------RILERGVYTEKDASLVI 112

Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTIS 185
                 + YLHE     I+H D+KPEN+L    + N    + DFGL+K+           
Sbjct: 113 QQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC- 168

Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
              GTPGY APE L+   P +   D +S G++ +
Sbjct: 169 ---GTPGYVAPEVLAQK-PYSKAVDCWSIGVITY 198

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  104 bits (260), Expect = 2e-25
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 31/217 (14%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGF 89
           L  GGF  VY+ Q   +G + A+K L  N         + EV  + + + H N+V+    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 90  CH--DQHMTALVYEY---ME--NGSLDGYLFGKKRAIEWEKLHE-----IAIGTAKGLVY 137
                +       E+    E   G L  +L   K+      L       I   T + + +
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFL---KKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--------- 188
           +H   +  IIH D+K EN+LL    + K+ DFG A        +   +  +         
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 189 -GTPGYSAPEF--LSGNYPITHKCDVYSFGMVLFEIV 222
             TP Y  PE   L  N+PI  K D+++ G +L+ + 
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  103 bits (258), Expect = 2e-25
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 21/198 (10%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 88
           ++G G FGEV+KG        +A+K+++        E    E+  + +     + + YG 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI---GTAKGLVYLHEECQQR 145
           +  D  +  ++ EY+  GS    L  +   ++ E   +IA       KGL YLH    ++
Sbjct: 89  YLKDTKL-WIIMEYLGGGSALDLL--EPGPLD-ET--QIATILREILKGLDYLHS---EK 139

Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNY 203
            IH DIK  NVLL  +   K+ADFG+  +L D      T   + GTP + APE +    Y
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAY 196

Query: 204 PITHKCDVYSFGMVLFEI 221
               K D++S G+   E+
Sbjct: 197 --DSKADIWSLGITAIEL 212

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  103 bits (259), Expect = 3e-25
 Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 28/227 (12%)

Query: 5   LQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLG 61
           +Q +G    V+        FT  Y  +  +G G +    +       ++ AVK+++++  
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60

Query: 62  RIAEE-QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE 120
              EE + +   G      H N++ L     D     +V E M+ G L   +  +K   E
Sbjct: 61  DPTEEIEILLRYGQ-----HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115

Query: 121 WE---KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSP-KVADFGLAK 173
            E    L  I     K + YLH    Q ++H D+KP N+L      N    ++ DFG AK
Sbjct: 116 REASAVLFTIT----KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLF 219
                     +     T  + APE L    Y     CD++S G++L+
Sbjct: 169 QLRAENG--LLMTPCYTANFVAPEVLERQGY--DAACDIWSLGVLLY 211

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  102 bits (257), Expect = 3e-25
 Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 28/217 (12%)

Query: 23  NFTSNYSTR---LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR- 77
            F   Y  +   LG G    V          + AVK++ +  G     +   EV  + + 
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQC 67

Query: 78  TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKG 134
             H N++ L  F  ++    LV+E M  GS+  ++  ++   E E    + ++    A  
Sbjct: 68  QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV----ASA 123

Query: 135 LVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYK--- 188
           L +LH    + I H D+KPEN+L    +     K+ DF L      N     IS  +   
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 189 --GTPGYSAPEFLSGNYPITH----KCDVYSFGMVLF 219
             G+  Y APE +            +CD++S G++L+
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  102 bits (257), Expect = 4e-25
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 26/205 (12%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMA---------EVGTIGRTYHI 81
           LG G FG V+         ++ VK + +   ++ E+ ++          E+  + R  H 
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKE--KVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGS-LDGYLFGKKRAIEWE---KLHEIAIGTAKGLVY 137
           N++++     +Q    LV E   +G  L  ++    R  E        ++         Y
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----Y 145

Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
           L     + IIH DIK EN+++  +F+ K+ DFG A   +R +   T   + GT  Y APE
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPE 199

Query: 198 FLSGNYPITHKCDVYSFGMVLFEIV 222
            L GN     + +++S G+ L+ +V
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLV 224

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  102 bits (257), Expect = 4e-25
 Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 41/221 (18%)

Query: 23  NFTSNYST--RLGFGGFGEVYKG-QFPNGVKIAVKVLNRN-------LGRIAEEQFMAEV 72
                Y     LG G  GEV    +     K+A+K++++                   E+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 73  GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAIGT 131
             + +  H  ++++  F   +    +V E ME G L D       + +  ++L E    T
Sbjct: 67  EILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFD-------KVVGNKRLKE---AT 115

Query: 132 AKGLV--------YLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRS 180
            K           YLHE     IIH D+KPENVLL   + +   K+ DFG +K+      
Sbjct: 116 CKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

Query: 181 HVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLF 219
             T+    GTP Y APE L            D +S G++LF
Sbjct: 173 MRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (261), Expect = 4e-25
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 24/215 (11%)

Query: 17  TSLQLNNFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEV 72
            ++    FT  Y     LG G F  V +      G + A  ++N + L     ++   E 
Sbjct: 2   ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61

Query: 73  GTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-----I 127
                  H N+VRL+    ++    L+++ +  G L    F  +  +  E   E      
Sbjct: 62  RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----F--EDIVAREYYSEADASHC 115

Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTI 184
                + +++ H+     ++H ++KPEN+LL       + K+ADFGLA   +  +     
Sbjct: 116 IQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AW 170

Query: 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
            G+ GTPGY +PE L  + P     D+++ G++L+
Sbjct: 171 FGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILY 204

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  101 bits (254), Expect = 6e-25
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 25/202 (12%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 88
            LG G FG+VYK +    G   A KV+         E ++ E+  +    H  +V+L G 
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI---GTAKGLVYLHEECQQR 145
           + HD  +  ++ E+   G++D  +    R +  E   +I +      + L +LH    +R
Sbjct: 85  YYHDGKLW-IMIEFCPGGAVDAIMLELDRGLT-EP--QIQVVCRQMLEALNFLH---SKR 137

Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPE------F 198
           IIH D+K  NVL+      ++ADFG+ AK     +   +   + GTP + APE       
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETM 194

Query: 199 LSGNYPITHKCDVYSFGMVLFE 220
               Y   +K D++S G+ L E
Sbjct: 195 KDTPY--DYKADIWSLGITLIE 214

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (256), Expect = 6e-25
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 30/220 (13%)

Query: 17  TSLQLNNFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKV-----LNRNLGRIAEEQF 68
           T  +  N    Y T   LG G F  V K  +   G++ A K         +   ++ E  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61

Query: 69  MAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEI- 127
             EV  +    H N++ L+    ++    L+ E +  G L    F      E E L E  
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----F--DFLAEKESLTEEE 115

Query: 128 AIGTAK----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNR 179
           A    K    G+ YLH     +I H+D+KPEN++L     P    K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

Query: 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
               I    GTP + APE ++   P+  + D++S G++ +
Sbjct: 173 EFKNIF---GTPEFVAPEIVNYE-PLGLEADMWSIGVITY 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (255), Expect = 9e-25
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)

Query: 23  NFTSNYSTR--LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 79
             +  +     LG G    VY+ +        A+KVL +    + ++    E+G + R  
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK---TVDKKIVRTEIGVLLRLS 106

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE-----IAIGTAKG 134
           H N+++L          +LV E +  G L    F   R +E     E           + 
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGEL----F--DRIVEKGYYSERDAADAVKQILEA 160

Query: 135 LVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
           + YLHE     I+H D+KPEN+L      +   K+ADFGL+K+ +      T+    GTP
Sbjct: 161 VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTP 214

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           GY APE L G      + D++S G++ +
Sbjct: 215 GYCAPEILRGC-AYGPEVDMWSVGIITY 241

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  101 bits (254), Expect = 1e-24
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 27/214 (12%)

Query: 23  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLN----RNLGRIAEEQFMAEVGTI 75
            F   Y     +G G F  V +      G + AVK+++     +   ++ E    E    
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 76  GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEW--EK-----LHEIA 128
               H ++V L        M  +V+E+M+   L   +  +  A     E      + +I 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSP-KVADFGLAKLCDRNRSHVTIS 185
               + L Y H+     IIH D+KP  VLL    N +P K+  FG+A     +   +   
Sbjct: 141 ----EALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAG 191

Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           G  GTP + APE +    P     DV+  G++LF
Sbjct: 192 GRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILF 224

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (252), Expect = 2e-24
 Identities = 37/208 (17%), Positives = 81/208 (38%), Gaps = 26/208 (12%)

Query: 23  NFTSNYSTR--LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY 79
                Y     LG G FG V++  +  +      K +        +     E+  +    
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR 59

Query: 80  HINLVRLYGFCHDQHMTALVYEYMENGSL------DGYLFGKKRAIEWEKLHEIAIGTAK 133
           H N++ L+          +++E++    +        +   ++  + +  +H++     +
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--VHQVC----E 113

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTP 191
            L +LH      I H+DI+PEN++     S   K+ +FG A+      +   +      P
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAP 167

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLF 219
            Y APE    +  ++   D++S G +++
Sbjct: 168 EYYAPEVHQHD-VVSTATDMWSLGTLVY 194

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  102 bits (256), Expect = 3e-24
 Identities = 55/229 (24%), Positives = 101/229 (44%), Gaps = 25/229 (10%)

Query: 2   ERFLQEIGREKPVRFTSLQLNNFTSNYST--RLGFGGFGEVYKGQF-PNGVKIAVKVLN- 57
           + ++ +I ++   +   ++ ++   +Y     LG G FG V++      G   A K +  
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192

Query: 58  RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR 117
            +      E    E+ T+    H  LV L+    D +   ++YE+M  G L   +  +  
Sbjct: 193 PHESDK--ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH- 249

Query: 118 AIEWEKLHEI-AIGTAK----GLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADFG 170
                K+ E  A+   +    GL ++HE      +H D+KPEN++     S   K+ DFG
Sbjct: 250 ----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFG 302

Query: 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
           L    D  +S    +   GT  ++APE   G  P+ +  D++S G++ +
Sbjct: 303 LTAHLDPKQSVKVTT---GTAEFAAPEVAEGK-PVGYYTDMWSVGVLSY 347

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  100 bits (250), Expect = 3e-24
 Identities = 36/132 (27%), Positives = 60/132 (45%), Gaps = 16/132 (12%)

Query: 101 EYMENGSLDGYLFGKKRA--IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL 158
           +     +L  ++  +      E      I I  A+ + +LH    + ++H D+KP N+  
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197

Query: 159 DANFSPKVADFGLAKLCDRNRSHVTIS----------GYKGTPGYSAPEFLSGNYPITHK 208
             +   KV DFGL    D++    T+           G  GT  Y +PE + GN   +HK
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYSHK 256

Query: 209 CDVYSFGMVLFE 220
            D++S G++LFE
Sbjct: 257 VDIFSLGLILFE 268

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  102 bits (255), Expect = 3e-24
 Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 20/199 (10%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMA----EVGTIGRTYHINLVRL 86
           LG G FG+V  G+    G K+AVK+LNR   +I     +     E+  +    H ++++L
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQ--KIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQ 143
           Y          +V EY+  G L  Y+    R  E E      +I  G      Y H   +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---R 134

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
             ++H D+KPENVLLDA+ + K+ADFGL+ +        T     G+P Y+APE +SG  
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 191

Query: 204 PITHKCDVYSFGMVLFEIV 222
               + D++S G++L+ ++
Sbjct: 192 YAGPEVDIWSSGVILYALL 210

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 99.8 bits (249), Expect = 5e-24
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 29/203 (14%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEE--QFMAEVGTIGRTYHINLVRLY 87
            +G G FG VY  +   N   +A+K ++ +  +  E+    + EV  + +  H N ++  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 88  G-FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI---GTAKGLVYLHEECQ 143
           G +  +     LV EY    + D     KK   E     EIA    G  +GL YLH    
Sbjct: 121 GCYLREHTA-WLVMEYCLGSASDLLEVHKKPLQE----VEIAAVTHGALQGLAYLHS--- 172

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPE----F 198
             +IH D+K  N+LL      K+ DFG  + +   N S V      GTP + APE     
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-SFV------GTPYWMAPEVILAM 225

Query: 199 LSGNYPITHKCDVYSFGMVLFEI 221
             G Y    K DV+S G+   E+
Sbjct: 226 DEGQY--DGKVDVWSLGITCIEL 246

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 47/195 (24%), Positives = 92/195 (47%), Gaps = 14/195 (7%)

Query: 31  RLGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 88
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           +     +  +V EY+  GSL   +   +  ++  ++  +     + L +LH     ++IH
Sbjct: 86  YLVGDELW-VVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139

Query: 149 YDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
            DIK +N+LL  + S K+ DFG  A++        T+    GTP + APE ++       
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRK-AYGP 195

Query: 208 KCDVYSFGMVLFEIV 222
           K D++S G++  E++
Sbjct: 196 KVDIWSLGIMAIEMI 210

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 50/200 (25%), Positives = 97/200 (48%), Gaps = 24/200 (12%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG- 88
           ++G G  G V   +   +G ++AVK+++    +   E    EV  +    H N+V +Y  
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG-----TAKGLVYLHEECQ 143
           +   + +  ++ E+++ G+L          +   +L+E  I        + L YLH    
Sbjct: 111 YLVGEELW-VLMEFLQGGALTD-------IVSQVRLNEEQIATVCEAVLQALAYLH---A 159

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           Q +IH DIK +++LL  +   K++DFG  A++        ++    GTP + APE +S +
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEVISRS 216

Query: 203 YPITHKCDVYSFGMVLFEIV 222
                + D++S G+++ E+V
Sbjct: 217 -LYATEVDIWSLGIMVIEMV 235

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  100 bits (251), Expect = 2e-23
 Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 27/235 (11%)

Query: 2   ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLN--R 58
           ++F +    +       L +N+F  +    +G GGFGEVY  +  +  K+ A+K L+  R
Sbjct: 169 DKFTRFCQWKNVELNIHLTMNDF--SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226

Query: 59  NLGRIAEEQFMAE---VGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL--- 112
              +  E   + E   +  +       +V +    H     + + + M  G L  +L   
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH 286

Query: 113 --FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 170
             F +     +    EI +G    L ++H    + +++ D+KP N+LLD +   +++D G
Sbjct: 287 GVFSEADMRFY--AAEIILG----LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE-IVGR 224
           LA    + + H       GT GY APE L          D +S G +LF+ + G 
Sbjct: 338 LACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 18/196 (9%)

Query: 30  TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
            +LG G +G VYK      G  +A+K +         ++ + E+  + +    ++V+ YG
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYG 91

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI---GTAKGLVYLHEECQQR 145
                    +V EY   GS+   +  + + +  E   EIA     T KGL YLH     R
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT-ED--EIATILQSTLKGLEYLH---FMR 145

Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
            IH DIK  N+LL+     K+ADFG+  +L D      T+    GTP + APE +     
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI---GTPFWMAPEVIQEI-G 201

Query: 205 ITHKCDVYSFGMVLFE 220
                D++S G+   E
Sbjct: 202 YNCVADIWSLGITAIE 217

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 23/200 (11%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMA----EVGTIGRTYHINLVRL 86
           LG G FG+V     +    K+A+K ++R    + +         E+  +    H ++++L
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIAIGTAKGLVYLHEECQ 143
           Y          +V EY   G L  Y+  KKR  E E      +I         Y H   +
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH---R 126

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKL-CDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            +I+H D+KPEN+LLD N + K+ADFGL+ +  D N    +     G+P Y+APE ++G 
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGK 182

Query: 203 YPITHKCDVYSFGMVLFEIV 222
                + DV+S G+VL+ ++
Sbjct: 183 LYAGPEVDVWSCGIVLYVML 202

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 43/221 (19%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRN---------------LGRIAEEQFMAEVGTI 75
           +G G +G V       +    A+KVL++                  R A    +   G I
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 76  GRTY----------HINLVRLYGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRAIEWE- 122
            + Y          H N+V+L     D +   L  V+E +  G +       K   E + 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQA 139

Query: 123 --KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
                ++     KG+ YLH    Q+IIH DIKP N+L+  +   K+ADFG++     + +
Sbjct: 140 RFYFQDLI----KGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITH--KCDVYSFGMVLF 219
            ++ +   GTP + APE LS    I      DV++ G+ L+
Sbjct: 193 LLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 38/213 (17%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGR----IAEEQFMAEVGTIGRTYHINLVR 85
            +G G +G+VYKG+    G   A+KV++           E   + +        H N+  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-----HRNIAT 85

Query: 86  LYG-FCHDQHMTA-----LVYEYMENGSL-DGYLFGKKRAIEWEKLHEIAI---GTAKGL 135
            YG F             LV E+   GS+ D     K   ++ E+   IA       +GL
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EE--WIAYICREILRGL 142

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYS 194
            +LH+    ++IH DIK +NVLL  N   K+ DFG+ A+L        T     GTP + 
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWM 196

Query: 195 APE------FLSGNYPITHKCDVYSFGMVLFEI 221
           APE           Y    K D++S G+   E+
Sbjct: 197 APEVIACDENPDATY--DFKSDLWSLGITAIEM 227

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 35/215 (16%)

Query: 22  NNFTSNY---STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR 77
              T +Y      LG G  G+V +      G K A+K+L  +     E     +      
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG--- 80

Query: 78  TYHINLVRLYGFCHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEK-----LHEIA 128
               ++V +     + H       ++ E ME G L   +  +      E+     + +I 
Sbjct: 81  --GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138

Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTIS 185
                 + +LH      I H D+KPEN+L    + +   K+ DFG AK   +N       
Sbjct: 139 ----TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC- 190

Query: 186 GYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLF 219
               TP Y APE L    Y     CD++S G++++
Sbjct: 191 ---YTPYYVAPEVLGPEKY--DKSCDMWSLGVIMY 220

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 29/215 (13%)

Query: 19  LQLNNFTSNYSTR-----LGFGGFGEVYKG-QFPNGVKIAVKVLNRNLGRIAEEQFMAEV 72
           ++ + F  +Y        LG G F    K     +    AVK++++      E     E+
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEI 56

Query: 73  GTIGR-TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWE---KLHEIA 128
             +     H N+V+L+   HDQ  T LV E +  G L   +  KK   E E    + ++ 
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL- 115

Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAK-LCDRNRSHVTI 184
                 + ++H+     ++H D+KPEN+L    + N   K+ DFG A+     N+   T 
Sbjct: 116 ---VSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169

Query: 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
                T  Y+APE L+ N      CD++S G++L+
Sbjct: 170 C---FTLHYAAPELLNQN-GYDESCDLWSLGVILY 200

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.8 bits (234), Expect = 5e-22
 Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 22/199 (11%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G F  V   +     +  A+K+L +   +          E   + R  H   V+LY 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 89  FCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIGTAKGLVYLHEE 141
              D         Y +NG L  Y+     F +       + +  EI       L YLH  
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT----RFYTAEIVSA----LEYLHG- 148

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
             + IIH D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+ 
Sbjct: 149 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 202 NYPITHKCDVYSFGMVLFE 220
                   D+++ G ++++
Sbjct: 207 K-SACKSSDLWALGCIIYQ 224

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 94.3 bits (235), Expect = 9e-22
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 25/206 (12%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRL-Y 87
           +G G FG+V   Q  +  K+ A+K +N+   + R        E+  +    H  LV L Y
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
            F  ++ M  +V + +  G L  +L     F ++    +  + E+ +     L YL    
Sbjct: 83  SFQDEEDMF-MVVDLLLGGDLRYHLQQNVHFKEETVKLF--ICELVMA----LDYLQN-- 133

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            QRIIH D+KP+N+LLD +    + DF +A +  R     T++   GT  Y APE  S  
Sbjct: 134 -QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSSR 189

Query: 203 YPITHKCDV--YSFGMVLFE-IVGRR 225
               +   V  +S G+  +E + GRR
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRR 215

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 72/236 (30%), Positives = 99/236 (41%), Gaps = 32/236 (13%)

Query: 1   MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLN-- 57
             RFLQ     K +    +  N F       LG GGFGEV   Q     K+ A K L   
Sbjct: 167 FNRFLQW----KWLERQPVTKNTF--RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220

Query: 58  RNLGRIAEEQFMAEVGTIGRTYHINLVRL-YGFCHDQHMTALVYEYMENGSL-------D 109
           R   R  E   + E   + +     +V L Y +     +  LV   M  G L        
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL-CLVLTLMNGGDLKFHIYHMG 279

Query: 110 GYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF 169
              F + RA+ +    EI  G    L  LH    +RI++ D+KPEN+LLD +   +++D 
Sbjct: 280 QAGFPEARAVFY--AAEICCG----LEDLHR---ERIVYRDLKPENILLDDHGHIRISDL 330

Query: 170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE-IVGR 224
           GLA          TI G  GT GY APE +      T   D ++ G +L+E I G+
Sbjct: 331 GLAV---HVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQ 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 92.9 bits (231), Expect = 6e-21
 Identities = 75/239 (31%), Positives = 107/239 (44%), Gaps = 37/239 (15%)

Query: 2   ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLN--R 58
            RFLQ     K +    +  + F       LG GGFGEV+  Q     K+ A K LN  R
Sbjct: 169 LRFLQW----KWLEAQPMGEDWF--LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR 222

Query: 59  NLGRIAEEQFMAEVGTIGRTYHINLVRL-YGFCHDQHMTAL--VYEYMENGSL------- 108
              R   +  M E   + + +   +V L Y F   +  T L  V   M  G +       
Sbjct: 223 LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF---ETKTDLCLVMTIMNGGDIRYHIYNV 279

Query: 109 --DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV 166
             D   F + RAI +    +I  G    L +LH+   + II+ D+KPENVLLD + + ++
Sbjct: 280 DEDNPGFQEPRAIFY--TAQIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRI 330

Query: 167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE-IVGR 224
           +D GLA      ++     GY GTPG+ APE L G        D ++ G+ L+E I  R
Sbjct: 331 SDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAAR 386

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 55/233 (23%), Positives = 88/233 (37%), Gaps = 38/233 (16%)

Query: 6   QEIGREKPVRFTSLQLNNFTSNYSTR---LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG 61
           Q+  +        ++ N    +Y      LG G  G+V +        K A+K+L     
Sbjct: 41  QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK 100

Query: 62  RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA----LVYEYMENGSL-------DG 110
              E +              ++VR+     + +       +V E ++ G L         
Sbjct: 101 ARREVELHWRASQ-----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 155

Query: 111 YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVA 167
             F ++ A E   +  I     + + YLH      I H D+KPEN+L      N   K+ 
Sbjct: 156 QAFTEREASEI--MKSIG----EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206

Query: 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPITHKCDVYSFGMVLF 219
           DFG AK    + S  T      TP Y APE L    Y     CD++S G++++
Sbjct: 207 DFGFAKETTSHNSLTTPC---YTPYYVAPEVLGPEKY--DKSCDMWSLGVIMY 254

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 88.3 bits (219), Expect = 3e-20
 Identities = 31/284 (10%), Positives = 73/284 (25%), Gaps = 54/284 (19%)

Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQ--FMAEVGTIGRTYHINLVRLY 87
             G     + ++        ++A+  ++       +     ++    + R     + R+ 
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
              H +    +V E++  GSL         +             A      H   +  + 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH---RAGVA 151

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
                P  V         V+  G   L                P                
Sbjct: 152 LSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA--------NP 181

Query: 208 KCDVYSFGMVLFEIV-GRRRNAIVGSSESLDWFPKHVWEEYEK-SELDATILACGIEEKD 265
           + D+   G  L+ ++  R      G    L    +    +  + +++D  I    I    
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF-QISA-- 238

Query: 266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKP 309
                 +   ++   Q     R   S ++ +++    V    + 
Sbjct: 239 ------VAARSV---QGDGGIRSA-STLLNLMQQATAVADRTEV 272

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FGEV   +  +  K+ A+K+L++   + R     F  E   +       +V+L+ 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEK--LHEIAIGTAKGLVYLHEECQQRI 146
              D     +V EYM  G L   +       +W +    E+ +     L  +H       
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA----LDAIH---SMGF 189

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS---GNY 203
           IH D+KP+N+LLD +   K+ADFG     ++       +   GTP Y +PE L    G+ 
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 248

Query: 204 PITHKCDVYSFGMVLFE 220
               +CD +S G+ L+E
Sbjct: 249 YYGRECDWWSVGVFLYE 265

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 19/200 (9%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           +G G FGEV   +  N  K+ A+K+LN+   L R     F  E   +       +  L+ 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAI--EWEK--LHEIAIGTAKGLVYLHEECQQ 144
              D +   LV +Y   G L   L   +  +  E  +  L E+ I     +  +H   Q 
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA----IDSVH---QL 194

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
             +H DIKP+N+L+D N   ++ADFG       + +  +     GTP Y +PE L     
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEG 253

Query: 205 ITHK----CDVYSFGMVLFE 220
              +    CD +S G+ ++E
Sbjct: 254 GKGRYGPECDWWSLGVCMYE 273

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 23/203 (11%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRL-Y 87
           +G G F EV   +     ++ A+K++N+   L R     F  E   +       + +L +
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL--FGKKRAIEWEK--LHEIAIGTAKGLVYLHEECQ 143
            F  D++   LV EY   G L   L  FG++   E  +  L EI +     +  +H   +
Sbjct: 129 AF-QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVH---R 180

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL---- 199
              +H DIKP+N+LLD     ++ADFG       + +  ++    GTP Y +PE L    
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVG 239

Query: 200 --SGNYPITHKCDVYSFGMVLFE 220
              G      +CD ++ G+  +E
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYE 262

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 36/207 (17%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--------TYHIN 82
           +G G FG+V K         +A+K++ RN  R    Q   E+  +          T ++ 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHR-QAAEEIRILEHLRKQDKDNTMNV- 161

Query: 83  LVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYL 138
            + +   F    H+  + +E +   S++ Y   KK   +      + + A    + L  L
Sbjct: 162 -IHMLENFTFRNHI-CMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 139 HEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTI--SGYKGTPGYS 194
           H   + RIIH D+KPEN+LL        KV DFG +  C  ++   T   S +     Y 
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRF-----YR 266

Query: 195 APEFLSGNYPITHKCDVYSFGMVLFEI 221
           APE + G        D++S G +L E+
Sbjct: 267 APEVILG-ARYGMPIDMWSLGCILAEL 292

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 23/204 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ----FMA--EVGTIGRTYHINLV 84
           ++G G +G VYK +   G  +A+K +     R+  E       A  E+  +   +H N+V
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRI-----RLDAEDEGIPSTAIREISLLKELHHPNIV 82

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            L    H +    LV+E+ME   L   L   K  ++  ++        +G+ + H   Q 
Sbjct: 83  SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QH 138

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEFLSG 201
           RI+H D+KP+N+L++++ + K+ADFGLA+      R+ +H  +     T  Y AP+ L G
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-----TLWYRAPDVLMG 193

Query: 202 NYPITHKCDVYSFGMVLFEIVGRR 225
           +   +   D++S G +  E++  +
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 41/214 (19%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVK-VLN--RNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FG VY+ +   +G  +A+K VL   R   R  E Q M ++       H N+VRL 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--ELQIMRKLD------HCNIVRLR 113

Query: 88  GFCHDQHMTA------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG-----TAKGLV 136
            F +            LV +Y+       Y   +  +   + L  I +        + L 
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGY 193
           Y+H      I H DIKP+N+LLD + +  K+ DFG AK   R   +V+   S Y     Y
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----Y 222

Query: 194 SAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRR 225
            APE + G  +Y  T   DV+S G VL E++  +
Sbjct: 223 RAPELIFGATDY--TSSIDVWSAGCVLAELLLGQ 254

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.5 bits (197), Expect = 5e-17
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 24/214 (11%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ----FMA--EVGTIGRTYHINL 83
           ++G G +G V+K +       +A+K +     R+ ++       A  E+  +    H N+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
           VRL+   H      LV+E+ +   L  Y       ++ E +        KGL + H    
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---S 119

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEFLS 200
           + ++H D+KP+N+L++ N   K+A+FGLA+      R  S   +     T  Y  P+ L 
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLF 174

Query: 201 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE 234
           G    +   D++S G +  E+    R    G+  
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 80.5 bits (199), Expect = 5e-17
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 40/217 (18%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTI-----------GRTY 79
           LG+G F  V+  +   N   +A+K++ R      E     E+  +               
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 84

Query: 80  HINLVRLYG-FCH----DQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGT 131
             ++++L   F H      H+  +V+E +     +     KK   R I    + +I+   
Sbjct: 85  ANHILKLLDHFNHKGPNGVHV-VMVFEVL---GENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSP------KVADFGLAKLCDRNRSHVTIS 185
             GL Y+H  C   IIH DIKPENVL++   SP      K+AD G A  C  +      +
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE---HYT 193

Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
               T  Y +PE L G  P     D++S   ++FE++
Sbjct: 194 NSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELI 229

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 79.5 bits (197), Expect = 5e-17
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 40/213 (18%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ------FMA--EVGTIGRTYHI 81
           ++G G +G V+K +    G  +A+K       +  E +       +A  E+  + +  H 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIK-------KFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           NLV L      +    LV+EY ++ ++   L   +R +    +  I   T + + + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSH--VTISGYKGTPGYSAP 196
            +   IH D+KPEN+L+  +   K+ DFG A+L             T         Y +P
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-------WYRSP 171

Query: 197 EFLSG--NY--PITHKCDVYSFGMVLFEIVGRR 225
           E L G   Y  P+    DV++ G V  E++   
Sbjct: 172 ELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 57/237 (24%), Positives = 94/237 (39%), Gaps = 39/237 (16%)

Query: 6   QEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVK-VLNRNLGRI 63
            E  R++  RF   +            G G FG V  G+    G+ +A+K V+     R 
Sbjct: 15  DERSRKEMDRFQVER----------MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN 64

Query: 64  AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA-------LVYEYMENGSLDGYLFGKK 116
            E Q M +   +   +H N+V+L  + +             +V EY+       +   + 
Sbjct: 65  RELQIMQD---LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRN 118

Query: 117 RAIEWEKLHEIAIG-----TAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFG 170
                     I I        + +  LH      + H DIKP NVL++ A+ + K+ DFG
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFG 177

Query: 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRR 225
            AK    +  +V    Y  +  Y APE + G  +Y  T   D++S G +  E++   
Sbjct: 178 SAKKLSPSEPNV---AYICSRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGE 229

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 54/204 (26%), Positives = 83/204 (40%), Gaps = 30/204 (14%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--------TYHIN 82
           +G G FG+V K         +A+K++ +N       Q   EV  +           Y+I 
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLN-QAQIEVRLLELMNKHDTEMKYYI- 118

Query: 83  LVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYL 138
            V L   F    H+  LV+E +   S + Y   +    R +      + A      L++L
Sbjct: 119 -VHLKRHFMFRNHL-CLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173

Query: 139 HEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
               +  IIH D+KPEN+LL        K+ DFG +  C   +       Y  +  Y +P
Sbjct: 174 ATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQ---YIQSRFYRSP 227

Query: 197 EFLSGNYPITHKCDVYSFGMVLFE 220
           E L G  P     D++S G +L E
Sbjct: 228 EVLLG-MPYDLAIDMWSLGCILVE 250

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 78.7 bits (195), Expect = 7e-17
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQ----FMA--EVGTIGRTYHINLV 84
           ++G G +G VYK Q   G   A+K +     R+ +E          E+  +    H N+V
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +LY   H +    LV+E+++   L   L   +  +E        +    G+ Y H    +
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEFLSG 201
           R++H D+KP+N+L++     K+ADFGLA+      R  +H  +     T  Y AP+ L G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAPDVLMG 174

Query: 202 NYPITHKCDVYSFGMVLFEIVGRR 225
           +   +   D++S G +  E+V   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 80.1 bits (198), Expect = 7e-17
 Identities = 64/238 (26%), Positives = 100/238 (42%), Gaps = 50/238 (21%)

Query: 7   EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVK-VLN--RNLGRI 63
           + G ++ + +T+ +           +G G FG V++ +     ++A+K VL   R   R 
Sbjct: 33  KTGEQREIAYTNCK----------VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR- 81

Query: 64  AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA------LVYEYMENGSLDGYLFGKKR 117
            E Q M  V       H N+V L  F +            LV EY+       Y   +  
Sbjct: 82  -ELQIMRIVK------HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHY 131

Query: 118 AIEWEKLHEIAIG-----TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP-KVADFGL 171
           A   + +  + I        + L Y+H      I H DIKP+N+LLD      K+ DFG 
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188

Query: 172 AKLCDRNRSHVT--ISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRR 225
           AK+      +V+   S Y     Y APE + G  NY  T   D++S G V+ E++  +
Sbjct: 189 AKILIAGEPNVSYICSRY-----YRAPELIFGATNY--TTNIDIWSTGCVMAELMQGQ 239

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 32/209 (15%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQ------FMA--EVGTIGRTYHI 81
            +G G +G V K +    G  +A+K       +  E         +A  E+  + +  H 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIK-------KFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
           NLV L   C  +    LV+E++++ ++   L      ++++ + +       G+ + H  
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-- 141

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLS 200
               IIH DIKPEN+L+  +   K+ DFG A+ L               T  Y APE L 
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYDDEVATRWYRAPELLV 197

Query: 201 G--NY--PITHKCDVYSFGMVLFEIVGRR 225
           G   Y   +    DV++ G ++ E+    
Sbjct: 198 GDVKYGKAV----DVWAIGCLVTEMFMGE 222

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 49/231 (21%)

Query: 10  REKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE--- 65
           + +     + QL+ F  +    LG G FG V   +        A+K+L++   ++ +   
Sbjct: 29  KWETPSQNTAQLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQ 84

Query: 66  -EQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAI 119
            E  + E   +       LV+L     D     +V EY+  G +  +L     F +  A 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA- 143

Query: 120 EWEKLH--EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---- 173
              + +  +I +       YLH      +I+ D+KPEN+L+D     +V DFG AK    
Sbjct: 144 ---RFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

Query: 174 ----LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
               LC             GTP   APE +          D ++ G++++E
Sbjct: 194 RTWTLC-------------GTPEALAPEIILSK-GYNKAVDWWALGVLIYE 230

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 77.2 bits (191), Expect = 4e-16
 Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 47/209 (22%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRNLGRIAE----EQFMAEVGTIGRTYHINLVRL 86
           LG G FG V+  +  +  +  A+KVL +    +      E    E   +    H  ++R+
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKE--IVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIGTAKGLVYLH 139
           +G   D     ++ +Y+E G L   L     F    A    K +  E+ +     L YLH
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA----KFYAAEVCLA----LEYLH 123

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--------LCDRNRSHVTISGYKGTP 191
               + II+ D+KPEN+LLD N   K+ DFG AK        LC             GTP
Sbjct: 124 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-------------GTP 167

Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
            Y APE +S   P     D +SFG++++E
Sbjct: 168 DYIAPEVVSTK-PYNKSIDWWSFGILIYE 195

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 27/206 (13%)

Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRI---AEEQF----MAEVGTIGRTYHIN 82
           +LG G +  VYKG+       +A+K        I    EE      + EV  +    H N
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALK-------EIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           +V L+   H +    LV+EY++   L  YL      I    +        +GL Y H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEFL 199
           +Q+++H D+KP+N+L++     K+ADFGLA+      +   +  +     T  Y  P+ L
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-----TLWYRPPDIL 172

Query: 200 SGNYPITHKCDVYSFGMVLFEIVGRR 225
            G+   + + D++  G + +E+   R
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 45/216 (20%), Positives = 73/216 (33%), Gaps = 57/216 (26%)

Query: 22  NNFTSNYSTR---LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR 77
           N    +Y      LG G  G+V +        K A+K+L        E +          
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ--- 69

Query: 78  TYHINLVRLYGFCHDQHMTA----LVYEYMENGSL-------DGYLFGKKRAIEWEKLHE 126
               ++VR+     + +       +V E ++ G L           F ++ A E   +  
Sbjct: 70  --CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--MKS 125

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVT 183
           I     + + YLH      I H D+KPEN+L      N   K+ DFG             
Sbjct: 126 IG----EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF------------ 166

Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF 219
                      A E     Y     CD++S G++++
Sbjct: 167 -----------AKETTGEKY--DKSCDMWSLGVIMY 189

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 38/210 (18%)

Query: 32  LGFGGFGEVY---KGQFPNGVKI-AVKVLNRNLGRIAE-----EQFMAEVGTIGRTYHIN 82
           LG G +G+V+   K    +  K+ A+KVL +    I +     E    E   +       
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA--TIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 83  -LVRL-YGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIGT 131
            LV L Y F   Q  T L  + +Y+  G L  +L     F +       +++  EI +  
Sbjct: 120 FLVTLHYAF---QTETKLHLILDYINGGELFTHLSQRERFTEHEV----QIYVGEIVLA- 171

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
              L +LH+     II+ DIK EN+LLD+N    + DFGL+K    + +      + GT 
Sbjct: 172 ---LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTI 224

Query: 192 GYSAPEFLSGN-YPITHKCDVYSFGMVLFE 220
            Y AP+ + G         D +S G++++E
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 38/214 (17%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF----MAEVGTIGRTYHINLVR 85
           +LG G +  VYKG     GV +A+K +  +    +EE      + E+  +    H N+VR
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLD----SEEGTPSTAIREISLMKELKHENIVR 67

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT-----AKGLVYLHE 140
           LY   H ++   LV+E+M+N  L  Y+  +        L    +        +GL + H 
Sbjct: 68  LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH- 125

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSH--VTISGYKGTPGYSA 195
             + +I+H D+KP+N+L++     K+ DFGLA+         S   VT+        Y A
Sbjct: 126 --ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL-------WYRA 176

Query: 196 PEFLSG--NY--PITHKCDVYSFGMVLFEIVGRR 225
           P+ L G   Y   I    D++S G +L E++  +
Sbjct: 177 PDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 25/207 (12%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF--MA--EVGTIGRTYHINLVR 85
            LG G F  VYK +       +A+K +       A++     A  E+  +    H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 86  LYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
           L      +   +LV+++ME   L+  +      +    +    + T +GL YLH   Q  
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 132

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSH--VTISGYKGTPGYSAPEFLS 200
           I+H D+KP N+LLD N   K+ADFGLAK     +R  +H  VT         Y APE L 
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-------WYRAPELLF 185

Query: 201 G--NYPITHKCDVYSFGMVLFEIVGRR 225
           G   Y      D+++ G +L E++ R 
Sbjct: 186 GARMY--GVGVDMWAVGCILAELLLRV 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 22/203 (10%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRL-Y 87
           LG G FG+V   +     +  A+K+L +   + +      + E   +  + H  L  L Y
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 88  GFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
            F     +   V EY   G L  +L     F + RA  +    EI       L YLH E 
Sbjct: 216 SFQTHDRL-CFVMEYANGGELFFHLSRERVFSEDRARFY--GAEIVSA----LDYLHSE- 267

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
            + +++ D+K EN++LD +   K+ DFGL K   ++ +  T+  + GTP Y APE L  N
Sbjct: 268 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDN 324

Query: 203 YPITHKCDVYSFGMVLFE-IVGR 224
                  D +  G+V++E + GR
Sbjct: 325 -DYGRAVDWWGLGVVMYEMMCGR 346

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 73.4 bits (181), Expect = 6e-15
 Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 46/221 (20%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQF----MAEVGT---IGRTYHIN 82
            +G G +G VYK +   +G  +A+K +    G           + EV     +    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 83  LVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA----- 132
           +VRL   C            LV+E+++   L  YL         +K     +        
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---------DKAPPPGLPAETIKDL 125

Query: 133 -----KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR--SHVTIS 185
                +GL +LH      I+H D+KPEN+L+ +  + K+ADFGLA++       + V + 
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV- 181

Query: 186 GYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLFEIVGRR 225
               T  Y APE L    Y      D++S G +  E+  R+
Sbjct: 182 ----TLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFRRK 216

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.4 bits (181), Expect = 7e-15
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 36/206 (17%)

Query: 32  LGFGGFGEVY---KGQFPNGVKI-AVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG+V+   K    +  ++ A+KVL    L      +   E   +    H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 87  -YGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIGTAKGLV 136
            Y F   Q    L  + +++  G L   L     F ++      K +  E+A+     L 
Sbjct: 92  HYAF---QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV----KFYLAELALA----LD 140

Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYS 194
           +LH      II+ D+KPEN+LLD     K+ DFGL+K  +    +++ +     GT  Y 
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFC---GTVEYM 193

Query: 195 APEFLSGNYPITHKCDVYSFGMVLFE 220
           APE ++     T   D +SFG+++FE
Sbjct: 194 APEVVNRR-GHTQSADWWSFGVLMFE 218

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 74.1 bits (182), Expect = 7e-15
 Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 47/224 (20%)

Query: 31  RLGFGGFGEVYKGQ---FPNGVKIAVKVLNRNLGRIAEEQF----MAEVGTIGRTYHINL 83
           ++G G +G VYK +     +    A+K       +I           E+  +    H N+
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALK-------QIEGTGISMSACREIALLRELKHPNV 80

Query: 84  VRLYGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK-------- 133
           + L             L+++Y E+  L   +   + +   +K  ++  G  K        
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLC---DRNRSH----- 181
           G+ YLH      ++H D+KP N+L+          K+AD G A+L     +  +      
Sbjct: 140 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           VT         Y APE L G    T   D+++ G +  E++   
Sbjct: 197 VTF-------WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.3 bits (181), Expect = 8e-15
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 38/208 (18%)

Query: 32  LGFGGFGEVY---KGQFPNGVKI-AVKVLNRN--LGRIAE-EQFMAEVGTIGRTYHINLV 84
           LG GG+G+V+   K    N  KI A+KVL +   +    +     AE   +    H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 85  RL-YGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRAIEWEKLH--EIAIGTAKG 134
            L Y F   Q    L  + EY+  G L   L     F +  A      +  EI++     
Sbjct: 85  DLIYAF---QTGGKLYLILEYLSGGELFMQLEREGIFMEDTA----CFYLAEISMA---- 133

Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPG 192
           L +LH+   + II+ D+KPEN++L+     K+ DFGL K  + D   +H T     GT  
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH-TFC---GTIE 186

Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVLFE 220
           Y APE L  +       D +S G ++++
Sbjct: 187 YMAPEILMRS-GHNRAVDWWSLGALMYD 213

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 50/220 (22%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ----FMA--EVGTIGRTYHINL 83
           +LG G +GEVYK         +A+K +     R+  E+      A  EV  +    H N+
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK--------GL 135
           + L    H  H   L++EY EN  L  Y+         +K  ++++   K        G+
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEN-DLKKYM---------DKNPDVSMRVIKSFLYQLINGV 145

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSP-----KVADFGLAKLC---DRNRSH--VTIS 185
            + H    +R +H D+KP+N+LL  + +      K+ DFGLA+      R  +H  +T+ 
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL- 201

Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
                  Y  PE L G+   +   D++S   +  E++ + 
Sbjct: 202 ------WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 30/231 (12%)

Query: 7   EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRI 63
           E+ +E+P     L++ +F       LG G FG+V+  +F    +  A+K L ++  L   
Sbjct: 2   ELNKERPSLQIKLKIEDF--ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59

Query: 64  AEEQFMAE---VGTIGRTYHINLVRL-YGFCHDQHMTALVYEYMENGSLDGYL-----FG 114
             E  M E   +       H  L  +   F   +++   V EY+  G L  ++     F 
Sbjct: 60  DVECTMVEKRVLSLAWE--HPFLTHMFCTFQTKENLF-FVMEYLNGGDLMYHIQSCHKFD 116

Query: 115 KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174
             RA  +    EI +G    L +LH    + I++ D+K +N+LLD +   K+ADFG+ K 
Sbjct: 117 LSRATFY--AAEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167

Query: 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE-IVGR 224
            +      T + + GTP Y APE L G     H  D +SFG++L+E ++G+
Sbjct: 168 -NMLGDAKTNT-FCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQ 215

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 50/238 (21%), Positives = 84/238 (35%), Gaps = 28/238 (11%)

Query: 9   GREKPVRFTSLQLNN----FTSNYS--TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR 62
           G +         L        S Y+    +  G +G V  G    G+ +A+K +   +  
Sbjct: 1   GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60

Query: 63  IAEEQFMAEVGTIGRTY----------HINLVRLYGFCHDQHMTA-----LVYEYMENGS 107
                 +++     R            H N++ L          A     LV E M    
Sbjct: 61  GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-D 119

Query: 108 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA 167
           L   +  ++  I  + +         GL  LHE     ++H D+ P N+LL  N    + 
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITIC 176

Query: 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           DF LA+    + +    + Y     Y APE +      T   D++S G V+ E+  R+
Sbjct: 177 DFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 61/202 (30%), Positives = 88/202 (43%), Gaps = 30/202 (14%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRL-Y 87
           LG G FG+V   +     +  A+K+L +   + +      + E   +  T H  L  L Y
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 88  GFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            F   Q    L  V EY   G L  +L     F ++RA  +    EI       L YLH 
Sbjct: 73  AF---QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSA----LEYLHS 123

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEF 198
              + +++ DIK EN++LD +   K+ DFGL K  + D      T     GTP Y APE 
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFC---GTPEYLAPEV 176

Query: 199 LSGNYPITHKCDVYSFGMVLFE 220
           L  N       D +  G+V++E
Sbjct: 177 LEDN-DYGRAVDWWGLGVVMYE 197

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 45/214 (21%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNR-NLGRIAEE----QFMAEVGTIGRTYHINLV 84
           +LG G + EV++     N  K+ VK+L      +I  E    + +            N++
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG--------GPNII 94

Query: 85  RLYGFCHDQH--MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAI-----GTAKGLVY 137
            L     D      ALV+E++ N                + L +  I        K L Y
Sbjct: 95  TLADIVKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDY 145

Query: 138 LHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
            H      I+H D+KP NV++D  +   ++ D+GLA+     + +   +    +  +  P
Sbjct: 146 CH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGP 199

Query: 197 EFLSG----NYPITHKCDVYSFGMVLFEIVGRRR 226
           E L      +Y +    D++S G +L  ++ R+ 
Sbjct: 200 ELLVDYQMYDYSL----DMWSLGCMLASMIFRKE 229

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 32/208 (15%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAE---VGTIGRTYHINLVR 85
           LG G FG+V   +     ++ AVK+L ++  +     E  M E   +   G+     L +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--PPFLTQ 406

Query: 86  L-YGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           L   F     +   V EY+  G L  ++     F +  A+ +    EIAIG    L +L 
Sbjct: 407 LHSCFQTMDRLY-FVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIG----LFFLQ 459

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPE 197
               + II+ D+K +NV+LD+    K+ADFG+ K  + D   +  T     GTP Y APE
Sbjct: 460 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFC---GTPDYIAPE 512

Query: 198 FLSGNYPITHKCDVYSFGMVLFE-IVGR 224
            ++   P     D ++FG++L+E + G+
Sbjct: 513 IIAYQ-PYGKSVDWWAFGVLLYEMLAGQ 539

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 70.3 bits (173), Expect = 9e-14
 Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 54/224 (24%)

Query: 31  RLGFGGFGEVYKGQ--FPNGVKIAVKVLNRNLGR-------IAEEQFMAEVGTIGRTYHI 81
            +G G +G+V+K +     G  +A+K +    G        I E   +     +    H 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH---LETFEHP 74

Query: 82  NLVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA---- 132
           N+VRL+  C            LV+E+++   L  YL         +K+ E  + T     
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---------DKVPEPGVPTETIKD 124

Query: 133 ------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR--SHVTI 184
                 +GL +LH     R++H D+KP+N+L+ ++   K+ADFGLA++       + V +
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query: 185 SGYKGTPGYSAPEFLSG-NY--PITHKCDVYSFGMVLFEIVGRR 225
                T  Y APE L   +Y  P+    D++S G +  E+  R+
Sbjct: 182 -----TLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 70.3 bits (173), Expect = 9e-14
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 40/219 (18%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ----FMA--EVGTIGRTYHINL 83
           ++G G FGEV+K +    G K+A+K +      +  E+      A  E+  +    H N+
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALREIKILQLLKHENV 78

Query: 84  VRLYGFCHDQHMTA--------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 135
           V L   C  +            LV+++ E+  L G L          ++  +      GL
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG--- 192
            Y+H   + +I+H D+K  NVL+  +   K+ADFGLA+     ++    + Y  T     
Sbjct: 138 YYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP-NRY--TNRVVT 191

Query: 193 --YSAPEFLSG--NY--PITHKCDVYSFGMVLFEIVGRR 225
             Y  PE L G  +Y  PI    D++  G ++ E+  R 
Sbjct: 192 LWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 31/203 (15%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAE---VGTIGRTYHINLVR 85
           LG G FG+V   +     ++ AVK+L ++  +     E  M E   +   G+     L +
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--PPFLTQ 85

Query: 86  L-YGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           L   F     +   V EY+  G L  ++     F +  A+ +    EIAIG    L +L 
Sbjct: 86  LHSCFQTMDRLY-FVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIG----LFFLQ 138

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPE 197
               + II+ D+K +NV+LD+    K+ADFG+ K  + D   +  T     GTP Y APE
Sbjct: 139 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFC---GTPDYIAPE 191

Query: 198 FLSGNYPITHKCDVYSFGMVLFE 220
            ++   P     D ++FG++L+E
Sbjct: 192 IIAYQ-PYGKSVDWWAFGVLLYE 213

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 43/216 (19%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY----------H 80
           +G G +G V       N V++A+K ++       E Q   +     RT           H
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISP-----FEHQTYCQ-----RTLREIKILLRFRH 84

Query: 81  INLVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG----- 130
            N++ +        +       +V + ME    D Y     + ++ + L    I      
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET---DLY-----KLLKTQHLSNDHICYFLYQ 136

Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI-SGYKG 189
             +GL Y+H      ++H D+KP N+LL+     K+ DFGLA++ D +  H    + Y  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           T  Y APE +  +   T   D++S G +L E++  R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 32/208 (15%)

Query: 32  LGFGGFGEVYKGQFPNGVKI-AVKVLNRN--LGRIAEEQFMAE---VGTIGRTYHINLVR 85
           LG G FG+V   +      + AVKVL ++  L     E  M E   +       H  L +
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 88

Query: 86  L-YGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           L   F     +   V E++  G L  ++     F + RA  +    EI       L++LH
Sbjct: 89  LFCCFQTPDRLF-FVMEFVNGGDLMFHIQKSRRFDEARARFY--AAEIISA----LMFLH 141

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPE 197
           +   + II+ D+K +NVLLD     K+ADFG+ K  +C+   +  T     GTP Y APE
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-TFC---GTPDYIAPE 194

Query: 198 FLSGNYPITHKCDVYSFGMVLFE-IVGR 224
            L          D ++ G++L+E + G 
Sbjct: 195 ILQEM-LYGPAVDWWAMGVLLYEMLCGH 221

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 33/233 (14%)

Query: 2   ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKI-AVKVLNRN- 59
           E       RE     +SL L +F  +    +G G + +V   +     +I A++V+ +  
Sbjct: 32  EEKEAMNTRESGKASSSLGLQDF--DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL 89

Query: 60  -LGRIAEEQFMAE---VGTIGRTYHINLVRL-YGFCHDQHMTALVYEYMENGSLDGYL-- 112
                  +    E           H  LV L   F  +  +   V EY+  G L  ++  
Sbjct: 90  VNDDEDIDWVQTEKHVFEQASN--HPFLVGLHSCFQTESRLF-FVIEYVNGGDLMFHMQR 146

Query: 113 ---FGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF 169
                ++ A  +    EI++     L YLHE   + II+ D+K +NVLLD+    K+ D+
Sbjct: 147 QRKLPEEHARFY--SAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDY 197

Query: 170 GLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
           G+ K  L   + +  T     GTP Y APE L G        D ++ G+++FE
Sbjct: 198 GMCKEGLRPGDTTS-TFC---GTPNYIAPEILRGE-DYGFSVDWWALGVLMFE 245

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 54/234 (23%), Positives = 90/234 (38%), Gaps = 44/234 (18%)

Query: 15  RFTSLQLNN----FTSNYS--TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ 67
            F    +N         Y   T +G G +G V       +G K+A+K     L R  + +
Sbjct: 9   GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSE 64

Query: 68  FMAEVGTIGRTY----------HINLVRLYGFCHDQHMTA------LVYEYMENGSLDGY 111
             A+     R Y          H N++ L                 LV  +M+   L   
Sbjct: 65  IFAK-----RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKI 118

Query: 112 LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
           +         EK+  +     KGL Y+H      ++H D+KP N+ ++ +   K+ DFGL
Sbjct: 119 M---GLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172

Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           A+  D       ++GY  T  Y APE +          D++S G ++ E++  +
Sbjct: 173 ARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 36/97 (37%), Positives = 47/97 (48%), Gaps = 14/97 (14%)

Query: 126 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVT 183
           EIA      L YLH      I++ D+KPEN+LLD+     + DFGL K  +   + +  T
Sbjct: 147 EIASA----LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS-T 198

Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
                GTP Y APE L    P     D +  G VL+E
Sbjct: 199 FC---GTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYE 231

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 14/97 (14%)

Query: 126 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVT 183
           EI++     L YLHE   + II+ D+K +NVLLD+    K+ D+G+ K  L   + +  T
Sbjct: 118 EISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-T 169

Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
                GTP Y APE L G        D ++ G+++FE
Sbjct: 170 FC---GTPNYIAPEILRGE-DYGFSVDWWALGVLMFE 202

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 37/212 (17%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---------- 79
            +G G +G V        G K+A+K     L R  + +  A+     R Y          
Sbjct: 32  PVGSGAYGAVCSAVDGRTGAKVAIK----KLYRPFQSELFAK-----RAYRELRLLKHMR 82

Query: 80  HINLVRLYGFCHDQHMTA------LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK 133
           H N++ L                 LV  +M     D     K   +  +++  +     K
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKLGEDRIQFLVYQMLK 139

Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           GL Y+H      IIH D+KP N+ ++ +   K+ DFGLA+  D       ++GY  T  Y
Sbjct: 140 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWY 191

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
            APE +      T   D++S G ++ E++  +
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
            G+ +LH      IIH D+KP N+++ ++ + K+ DFGLA+    +     ++ Y  T  
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRY 191

Query: 193 YSAPEF-LSGNYPITHKCDVYSFGMVLFEIVGRR 225
           Y APE  L   Y      D++S G ++ E++   
Sbjct: 192 YRAPEVILGMGY--KENVDIWSVGCIMGEMIKGG 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 11/96 (11%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISGYKGTP 191
           + + ++H      I H DIKP+N+L+++  +  K+ DFG AK    +   V    Y  + 
Sbjct: 152 RAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSR 205

Query: 192 GYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRR 225
            Y APE +  +  Y  T   D++S G V  E++  +
Sbjct: 206 FYRAPELMLGATEY--TPSIDLWSIGCVFGELILGK 239

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 54/224 (24%)

Query: 32  LGFGGFGEVYKG--QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--------TYHI 81
           LG G FG+V +         ++A+K++ RN+G+  E     E+  + +         +  
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKII-RNVGKYRE-AARLEINVLKKIKEKDKENKFLC 84

Query: 82  NLVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVY 137
             V +   F    HM  + +E +     + + F K+   +      +  +A      L +
Sbjct: 85  --VLMSDWFNFHGHM-CIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138

Query: 138 LHEECQQRIIHYDIKPENVLLDANFSP-------------------KVADFGLAKLCDRN 178
           LHE    ++ H D+KPEN+L   +                      +VADFG A     +
Sbjct: 139 LHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDH 193

Query: 179 RSHVTI--SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
             H TI  + +     Y  PE +         CDV+S G +LFE
Sbjct: 194 EHHTTIVATRH-----YRPPEVILE-LGWAQPCDVWSIGCILFE 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 45/235 (19%)

Query: 15  RFTSLQLNN----FTSNYS--TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQ 67
           +F S+++ +        Y     +G G  G V           +A+K     L R  + Q
Sbjct: 47  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK----KLSRPFQNQ 102

Query: 68  FMAEVGTIGRTY----------HINLVRLYGFCHDQHMTA------LVYEYMENGSLDGY 111
             A+     R Y          H N++ L      Q          LV E M+  +L   
Sbjct: 103 THAK-----RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQV 156

Query: 112 LFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
           +   +  ++ E++  +      G+ +LH      IIH D+KP N+++ ++ + K+ DFGL
Sbjct: 157 I---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210

Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVLFEIVGRR 225
           A+    +     ++ Y  T  Y APE  L   Y      D++S G ++ E+V  +
Sbjct: 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGY--KENVDIWSVGCIMGEMVRHK 260

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 59/253 (23%), Positives = 95/253 (37%), Gaps = 54/253 (21%)

Query: 1   MERFLQEIGREKPVRFTSLQLNN----FTSNYS--TRLGFGGFGEVYKGQ-FPNGVKIAV 53
           M        +E+P  F   +LN         Y   + +G G +G V        G+++AV
Sbjct: 1   MAHHHHHHSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 59

Query: 54  KVLNRNLGRIAEEQFMAEVGTIGRTY----------HINLVRLYGFCHDQHMTA------ 97
           K     L R  +    A+     RTY          H N++ L                 
Sbjct: 60  K----KLSRPFQSIIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110

Query: 98  LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIG-----TAKGLVYLHEECQQRIIHYDIK 152
           LV   M     D         ++ +KL +  +        +GL Y+H      IIH D+K
Sbjct: 111 LVTHLMGA---DLN-----NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLK 159

Query: 153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVY 212
           P N+ ++ +   K+ DFGLA+          ++GY  T  Y APE +          D++
Sbjct: 160 PSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

Query: 213 SFGMVLFEIVGRR 225
           S G ++ E++  R
Sbjct: 215 SVGCIMAELLTGR 227

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 54/224 (24%)

Query: 32  LGFGGFGEVYKGQ--FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--------TYHI 81
           LG G FG+V +       G  +AVK++ +N+ R  E    +E+  +          T+  
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCE-AARSEIQVLEHLNTTDPNSTFRC 79

Query: 82  NLVRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVY 137
             V++   F H  H+  +V+E +    L  Y F K+        + + ++A    K + +
Sbjct: 80  --VQMLEWFEHHGHI-CIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133

Query: 138 LHEECQQRIIHYDIKPENVLLDANFSP-------------------KVADFGLAKLCDRN 178
           LH     ++ H D+KPEN+L   +                      KV DFG A     +
Sbjct: 134 LHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDD 188

Query: 179 RSHVTI--SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
             H T+  + +     Y APE +      +  CDV+S G +L E
Sbjct: 189 EHHSTLVSTRH-----YRAPEVILA-LGWSQPCDVWSIGCILIE 226

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 5/95 (5%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTI-SGYKGT 190
           +GL Y+H      ++H D+KP N+ ++  +   K+ DFGLA++ D + SH    S    T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187

Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR 225
             Y +P  L      T   D+++ G +  E++  +
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 57/228 (25%), Positives = 83/228 (36%), Gaps = 58/228 (25%)

Query: 32  LGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVG---TIGRT----YHINL 83
           +G G FG V   Q   N    AVKV+ RN+ +        E      I        +I  
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTR-SAKIEADILKKIQNDDINNNNI-- 98

Query: 84  VRLYG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYLH 139
           V+ +G F +  HM  L++E +       Y    +        E +    I   K L YL 
Sbjct: 99  VKYHGKFMYYDHM-CLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154

Query: 140 EECQQRIIHYDIKPENVLLDANFSP-------------------------KVADFGLAKL 174
           +     + H D+KPEN+LLD  +                           K+ DFG A  
Sbjct: 155 KM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-- 209

Query: 175 CDRNRSHVTI--SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFE 220
             ++  H +I  +       Y APE +          D++SFG VL E
Sbjct: 210 TFKSDYHGSIINTRQ-----YRAPEVILN-LGWDVSSDMWSFGCVLAE 251

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 6/108 (5%)

Query: 116 KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
           K  +  E L   +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+  
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVLFEIV 222
            ++  +V     +    + APE  +    + T + DV+SFG++L+EI 
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIF 289

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.2 bits (125), Expect = 9e-08
 Identities = 34/151 (22%), Positives = 57/151 (37%), Gaps = 16/151 (10%)

Query: 31  RLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT-IGRTYHINL 83
            LG G FG+V +       +      +AVK+L            M+E+   I   +H+N+
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 84  VRLYGFC-HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           V L G C        ++ E+ + G+L  YL          K +E      KG  +   + 
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSKRNEFVPYKTKGARFRQGKD 140

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK 173
               I  D+K     + ++ S   + F   K
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 15/103 (14%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT--------I 184
           + +  LH      +IH D+KP N+L+++N   KV DFGLA++ D + +  +        +
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 185 SGYKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRR 225
             +  T  Y APE +  S  Y  +   DV+S G +L E+  RR
Sbjct: 180 VEFVATRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLRR 220

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 61/372 (16%), Positives = 108/372 (29%), Gaps = 127/372 (34%)

Query: 23  NFTSNYS--TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN-------------LGRIAEE 66
            F   Y    +LG+G F  V+          +A+KV+                L  +   
Sbjct: 34  LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN- 92

Query: 67  QFMAEVGTIGRTYHINLVRLYG-FCHD----QHMTALVYEYMENG-SLDGYLFG-KKRAI 119
              ++     R     +V+L   F        H+  +V+E +  G  L  ++     + +
Sbjct: 93  ---SDPNDPNREM---VVQLLDDFKISGVNGTHI-CMVFEVL--GHHLLKWIIKSNYQGL 143

Query: 120 EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL--------------------- 158
               + +I     +GL YLH +C+  IIH DIKPEN+LL                     
Sbjct: 144 PLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201

Query: 159 ----------------------------DANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
                                             K+AD G A    ++ +   I     T
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED-IQ----T 256

Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR--NAIVGSSESLDW---------- 238
             Y + E L G+       D++S   + FE+           G   + D           
Sbjct: 257 RQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315

Query: 239 --FPKHVWEEYEKSE--------------------LDATILACGIEEKDKEKAKRLCMAA 276
              P+ +    + S+                     +  +      +++        +  
Sbjct: 316 GKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPM 375

Query: 277 LWCVQDSPEDRP 288
           L  +   PE R 
Sbjct: 376 LELI---PEKRA 384

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 34/114 (29%), Positives = 47/114 (41%), Gaps = 26/114 (22%)

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
           K + YLH      ++H D+KP N+LL+A    KVADFGL++     R             
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 193 -------------------YSAPEFL--SGNYPITHKCDVYSFGMVLFEIVGRR 225
                              Y APE L  S  Y  T   D++S G +L EI+  +
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKY--TKGIDMWSLGCILGEILCGK 228

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 46/263 (17%), Positives = 84/263 (31%), Gaps = 91/263 (34%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---------- 79
            +G G +G V +         +A+K     + R+ E+    +     R            
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIK----KILRVFEDLIDCK-----RILREIAILNRLN 110

Query: 80  HINLVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-- 132
           H ++V++      + +       +V E  +    D                ++   T   
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SD--------------FKKL-FRTPVY 152

Query: 133 --------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
                          G+ Y+H      I+H D+KP N L++ + S KV DFGLA+  D  
Sbjct: 153 LTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209

Query: 179 RSHVTISGYKGTPG-------------------------YSAPEFL--SGNYPITHKCDV 211
            +  +                                  Y APE +    NY  T   DV
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDV 267

Query: 212 YSFGMVLFEIVGRRRNAIVGSSE 234
           +S G +  E++   +  +   ++
Sbjct: 268 WSIGCIFAELLNMIKENVAYHAD 290

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.8 bits (136), Expect = 3e-09
 Identities = 37/269 (13%), Positives = 69/269 (25%), Gaps = 67/269 (24%)

Query: 5   LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIA 64
           + E  ++ PV F+   L         ++G G FGEV++    +   +A+K++      + 
Sbjct: 2   MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIADHT-PVAIKIIAIEGPDLV 59

Query: 65  E-------EQFMAEV---------GTIGRTYHINLVRLYGFCHDQ--------------- 93
                   E+ + E+                    + L      Q               
Sbjct: 60  NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119

Query: 94  ---------------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYL 138
                              +V E+   G     +  K           I       L   
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLS--SLATAKSILHQLTASLAVA 177

Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK------------LCDRNRSHVTISG 186
               +    H D+   NVLL      K+      K            + D   S +   G
Sbjct: 178 EASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235

Query: 187 -YKGTPGYSAPEFLSGNYPITHKCDVYSF 214
                      +  +G+    ++ D+Y  
Sbjct: 236 IVVFCDVSMDEDLFTGDG--DYQFDIYRL 262

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 50/262 (19%), Positives = 86/262 (32%), Gaps = 82/262 (31%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---------- 79
            +G G +G VY          +A+K     + R+ E+    +     R            
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIK----KVNRMFEDLIDCK-----RILREITILNRLK 83

Query: 80  HINLVRLYGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA-- 132
              ++RLY       +       +V E  ++   D              L ++   T   
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADS---D--------------LKKL-FKTPIF 125

Query: 133 --------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
                          G  ++HE     IIH D+KP N LL+ + S KV DFGLA+  +  
Sbjct: 126 LTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

Query: 179 RSHVTISGYKGTPG--------------------YSAPEFLSGNYPITHKCDVYSFGMVL 218
           +    ++  +                        Y APE +      T   D++S G + 
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242

Query: 219 FEIVGRRRNAIVGSSESLDWFP 240
            E++   ++ I   +     FP
Sbjct: 243 AELLNMLQSHINDPTNRFPLFP 264

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 39/201 (19%), Positives = 70/201 (34%), Gaps = 31/201 (15%)

Query: 31  RLGFGGFGEVYKGQ---------FPNGVKIAVKVLNRN---------LGRIAEEQFMAEV 72
                  G +Y+            P   K ++K+  ++           R A+   + + 
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 73  GTIGRTYHINLVRLYGF-CHDQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKL-HEIAI 129
             +  T  + +    GF  H      LV   +  G SL   L    + +  E+   ++A 
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVAC 166

Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV--ADFGLAKLCDRNRSHVTISGY 187
                L +LHE      +H ++  EN+ +D     +V  A +G A     +  HV     
Sbjct: 167 RLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223

Query: 188 KGTPGYSAPEFLSGNYPITHK 208
             +P     EF+S +    HK
Sbjct: 224 SRSPHEGDLEFISMD---LHK 241

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 44/189 (23%), Positives = 71/189 (37%), Gaps = 32/189 (16%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIA---VKVLNRNLGRIAEE----QFMAEVGTIGRTYHIN 82
           ++G GGFG +Y         K A   VKV  +  G +  E    Q +A+   I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 83  LVRLYGFCH----------DQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGT 131
            +   G              +    +V E +  G  L   + G+    +   + ++ I  
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ-KISGQNGTFKKSTVLQLGIRM 160

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV--ADFGLAKLCDRNRSHVTI----- 184
              L Y+HE      +H DIK  N+LL      +V  AD+GL+     N +H        
Sbjct: 161 LDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217

Query: 185 SGYKGTPGY 193
            G+ GT  +
Sbjct: 218 KGHNGTIEF 226

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 38/201 (18%), Positives = 66/201 (32%), Gaps = 31/201 (15%)

Query: 31  RLGFGGFGEVYKGQFPNG------VKIAVKVLNRNLGRIAEE----QFMAEVGTIGRTYH 80
            +G GGFG +Y     +           VKV   + G +  E    Q  A+   I +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 81  INLVRLYGFCH----------DQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAI 129
              ++  G              +    ++ +    G  L        +    + + ++++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV--ADFGLAKLCDRNRSHVTISGY 187
                L Y+HE      +H DIK  N+LL+     +V   D+GLA        H   +  
Sbjct: 160 RILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 188 KGTPGYSAPEFLSGNYPITHK 208
                    EF S +    H 
Sbjct: 217 PKRCHDGTIEFTSID---AHN 234

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 42/180 (23%), Positives = 67/180 (37%), Gaps = 29/180 (16%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI-----NLV 84
           ++G G FGE+  G+       +A+K+           Q   E     R Y        + 
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEY----RFYKQLGSGDGIP 68

Query: 85  RLYGFCHDQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
           ++Y F       A+V E +  G SL+       R    + +  IAI     + Y+H +  
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125

Query: 144 QRIIHYDIKPENVLLDANFSPK-----VADFGLAKLCDRNRSHVTIS-----GYKGTPGY 193
             +I+ D+KPEN L+    +       + DF LAK      +   I         GT  Y
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 27/179 (15%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGR---IAEEQFMAEV-GTIGRTYHINLVR 85
           R+G G FG +++G    N  ++A+K   R         E +    + G  G      +  
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG------IPN 70

Query: 86  LYGFCHDQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           +Y F  +     LV + +  G SL+  L    R    + +   A      +  +HE   +
Sbjct: 71  VYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 125

Query: 145 RIIHYDIKPENVLLDANFSPK-----VADFGLAKLCDRNRSHVTIS-----GYKGTPGY 193
            +++ DIKP+N L+    S       V DFG+ K      +   I         GT  Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 41/178 (23%), Positives = 69/178 (38%), Gaps = 27/178 (15%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI-----NLV 84
           ++G G FGE+Y G       ++A+K+ N         Q + E     + Y I      + 
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLLYES----KIYRILQGGTGIP 66

Query: 85  RLYGFCHDQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
            +  F  +     LV + +  G SL+       R +  + +  +A      + ++H +  
Sbjct: 67  NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123

Query: 144 QRIIHYDIKPENVLLDANFSPK---VADFGLAKLCDRNRSHVTIS-----GYKGTPGY 193
              +H DIKP+N L+          + DFGLAK      +H  I         GT  Y
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 40/178 (22%), Positives = 67/178 (37%), Gaps = 27/178 (15%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI-----NLV 84
           ++G G FG++Y G     G ++A+K+           Q   E     + Y +      + 
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIES----KIYKMMQGGVGIP 68

Query: 85  RLYGFCHDQHMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
            +     +     +V E +  G SL+       R    + +  +A      + Y+H    
Sbjct: 69  TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS--- 123

Query: 144 QRIIHYDIKPENVLLDANFSPK---VADFGLAKLCDRNRSHVTI-----SGYKGTPGY 193
           +  IH D+KP+N L+          + DFGLAK     R+H  I         GT  Y
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	356
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.82
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.44
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.37
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.16
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.03
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.83
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.8
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.8
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.73
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.68
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.47
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.43
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.36
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.09
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.98
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.92
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.91
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.89
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.86
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.85
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.84
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.84
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.66
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.56
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.42
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.12
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.78
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.85
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.42
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.74
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.99

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.7e-62  Score=431.99  Aligned_cols=273  Identities=27%  Similarity=0.416  Sum_probs=215.8

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ..|++...++++.++||+|+||+||+|++.+  .||||+++.. ......+.|.+|+.++++++|||||++++++.+ +.
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~  105 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN  105 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence            3477888889999999999999999998743  5999999743 334556789999999999999999999998865 45


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .+||||||+||+|.+++......+++.++..|+.||+.||+|||+   ++||||||||+|||+++++.+||+|||+|+..
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            799999999999999997777789999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCC--CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ............+||+.|||||++.+.  ..++.++|||||||++|||+||+.||......      ..........   
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~---  253 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRG---  253 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTT---
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcC---
Confidence            544444444557899999999998643  25899999999999999999999998543221      0001111000   


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCC
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPP  306 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~  306 (356)
                        ............++.++.+++.+||+.||++|||+.+|++.|+.+....|.
T Consensus       254 --~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          254 --YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             --CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             --CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence              000111223445678899999999999999999999999999988766543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.4e-62  Score=437.25  Aligned_cols=263  Identities=21%  Similarity=0.317  Sum_probs=221.5

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      .++...+++|.++||+|+||+||+|.+.      +++.||||+++........++|.+|+.++++++|||||+++|++.+
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            4566678899999999999999999862      4688999999865555566789999999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEE
Q 038199           93 QHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL  157 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nil  157 (356)
                      ....++|||||++|+|.+++...               ...+++..++.|+.||+.||+|||+   ++||||||||+|||
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NIL  177 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVL  177 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceE
Confidence            99999999999999999999543               2458999999999999999999999   99999999999999


Q ss_pred             EcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCcc
Q 038199          158 LDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESL  236 (356)
Q Consensus       158 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~  236 (356)
                      +++++.+||+|||+++...............||++|||||++.+. .++.++|||||||++|||+| |..||....    
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~----  252 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----  252 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCC----
T ss_pred             ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCC----
Confidence            999999999999999876544333334456799999999999877 79999999999999999998 788874322    


Q ss_pred             ccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          237 DWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                                  ..++...+..+...+.+..++.++.+++.+||+.||++|||+++|++.|+...
T Consensus       253 ------------~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          253 ------------NQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             ------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ------------HHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence                        12223334444555566677889999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.1e-62  Score=433.29  Aligned_cols=263  Identities=24%  Similarity=0.380  Sum_probs=220.0

Q ss_pred             HhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      +...+|.+.++||+|+||+||+|++.      +++.||||+++.. .....++|.+|++++++++|||||++++++.+++
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            34467889999999999999999763      4778999999754 3455678999999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           95 MTALVYEYMENGSLDGYLFGK------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      ..++|||||++|+|.+++...            ...+++.+++.|+.||+.||.|||+   ++||||||||+|||+++++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCC
Confidence            999999999999999999543            2479999999999999999999999   9999999999999999999


Q ss_pred             ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchh
Q 038199          163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPK  241 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~  241 (356)
                      .+||+|||+++...............||++|||||++.+. .++.++|||||||++|||+| |+.||...+         
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---------  235 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLS---------  235 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---------
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------
Confidence            9999999999876544433333345689999999999877 79999999999999999999 888874322         


Q ss_pred             hhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          242 HVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                             ..++...+..+.....+..++.++.+++.+||+.||++|||+++|++.|+.+....
T Consensus       236 -------~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          236 -------NNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             -------HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             -------HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                   12223334444445556677889999999999999999999999999999876653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.6e-61  Score=433.54  Aligned_cols=262  Identities=24%  Similarity=0.359  Sum_probs=212.3

Q ss_pred             HhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      +...++.+.++||+|+||+||+|++.      +++.||||+++.. .....++|.+|++++++++|||||++++++.+..
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            44567788899999999999999863      4788999999754 3455678999999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC
Q 038199           95 MTALVYEYMENGSLDGYLFGK--------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA  160 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~  160 (356)
                      ..+||||||++|+|.+++...              ..++++.+++.|+.||+.||+|||+   ++||||||||+|||+++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECC
Confidence            999999999999999998543              2469999999999999999999999   99999999999999999


Q ss_pred             CCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccc
Q 038199          161 NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWF  239 (356)
Q Consensus       161 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~  239 (356)
                      ++.+||+|||+++...............||+.|||||++.+. .++.++|||||||++|||+| |+.||.....      
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------  266 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------  266 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCH------
Confidence            999999999999876544433334456799999999999877 79999999999999999999 8888754321      


Q ss_pred             hhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          240 PKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                                .++...+..+...+.+..++.++.+++.+||+.||++|||+++|++.|+.+...
T Consensus       267 ----------~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          267 ----------TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ----------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----------HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                      112223333444455566788899999999999999999999999999988764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.6e-60  Score=427.56  Aligned_cols=268  Identities=24%  Similarity=0.345  Sum_probs=224.4

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeec
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYG   88 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~   88 (356)
                      ...|++...+|++.++||+|+||+||+|.+.      +++.||||++.........+.|.+|+.+++++. |||||++++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            3457888889999999999999999999753      246899999987665666678999999999996 599999999


Q ss_pred             eEec-CCeeeEEEeccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCC
Q 038199           89 FCHD-QHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK  152 (356)
Q Consensus        89 ~~~~-~~~~~lV~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dik  152 (356)
                      +|.+ +..+++|||||++|+|.+++...               ...+++..++.|+.||+.||+|||+   ++|||||||
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK  212 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA  212 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccC
Confidence            9876 45789999999999999999542               2458999999999999999999999   999999999


Q ss_pred             CCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccC
Q 038199          153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVG  231 (356)
Q Consensus       153 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~  231 (356)
                      |+|||+++++.+||+|||+|+..............+||+.|||||++.+. .++.++|||||||++|||+| |+.||...
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999977655554455566799999999999877 79999999999999999998 88887543


Q ss_pred             CCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          232 SSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ...               ..+...+..+.....+..++.++.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       292 ~~~---------------~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          292 KID---------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CCS---------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHH---------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            221               11222333444445555677889999999999999999999999999988754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.9e-59  Score=422.77  Aligned_cols=250  Identities=21%  Similarity=0.345  Sum_probs=205.8

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .+|++.++||+|+||+||+|++. +|+.||||++... ......+.+.+|++++++++||||+++++++.+.+..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            47999999999999999999764 6999999999754 334556789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          102 YMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+||+|.+++... ...+++..++.|+.||+.||.|||+   ++||||||||+|||++.+|.+||+|||+++...... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            99999999999654 4568999999999999999999999   999999999999999999999999999998654221 


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                       ......+||+.|||||++.+. .++.++|||||||++|||++|+.||.....                ..+...+....
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~----------------~~~~~~i~~~~  241 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSM----------------KNLVLKIISGS  241 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHHHHHHHHTC
T ss_pred             -ccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHHHcCC
Confidence             112345799999999999887 799999999999999999999999854321                11112222333


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+......+.++.+++.+||++||++|||++++++
T Consensus       242 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            34445566788999999999999999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.2e-59  Score=413.26  Aligned_cols=251  Identities=21%  Similarity=0.291  Sum_probs=211.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ..+|++.+.||+|+||+||+|++. +|+.||||++....  .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            357999999999999999999764 69999999997532  233456799999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      ||||+||+|.+++. ..+.+++..+..|+.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+.+....
T Consensus       111 mEy~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          111 LSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             ECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999994 35689999999999999999999999   999999999999999999999999999999876554


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      ........+||+.|||||++.+. .++.++|||||||++|||++|..||...+..       ....         .+...
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~---------~i~~~  249 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------LIFA---------KIIKL  249 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH---------HHHHT
T ss_pred             CcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHH---------HHHcC
Confidence            44445567899999999999877 7899999999999999999999998543211       1111         11111


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      . ...+...+.++.+++.+||++||++|||++|++.
T Consensus       250 ~-~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          250 E-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             C-CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             C-CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            1 1223345677899999999999999999998743

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-57  Score=402.86  Aligned_cols=245  Identities=25%  Similarity=0.390  Sum_probs=199.4

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEec----CCeeeEE
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHMTALV   99 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~----~~~~~lV   99 (356)
                      |.+.++||+|+||+||+|.+. +++.||||++... ......+.|.+|++++++++|||||++++++.+    ....+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            478889999999999999764 6899999999643 344556789999999999999999999999865    3567999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ccccCCCCCcEEEcC-CCceEEcccCCccccC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDA-NFSPKVADFGLAKLCD  176 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dikp~Nill~~-~~~~kl~Dfgl~~~~~  176 (356)
                      ||||+||+|.+++. ....+++..+..|+.||+.||+|||+   ++  ||||||||+|||++. +|.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999994 45689999999999999999999998   77  999999999999974 7899999999998644


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ...    ....+||+.|||||++.+  .++.++|||||||++|||+||+.||......      ..         +...+
T Consensus       184 ~~~----~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~---------~~~~i  242 (290)
T 3fpq_A          184 ASF----AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQ---------IYRRV  242 (290)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HH---------HHHHH
T ss_pred             CCc----cCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HH---------HHHHH
Confidence            322    234579999999999875  5899999999999999999999998543221      11         11111


Q ss_pred             HhcCCC-chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LACGIE-EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....+ ..+...+.++.+++.+||+.||++|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111 222334567899999999999999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.6e-58  Score=413.10  Aligned_cols=247  Identities=22%  Similarity=0.286  Sum_probs=207.4

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|++.++||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            45888999999999999999765 69999999996432 23345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      |+||+|.+++..  ..+++..+..|+.||+.||+|||+   ++||||||||+|||++.+|.+||+|||+++.......  
T Consensus       153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--  225 (346)
T 4fih_A          153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  225 (346)
T ss_dssp             CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence            999999999843  579999999999999999999999   9999999999999999999999999999987654332  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC--
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG--  260 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  260 (356)
                      .....+||+.|+|||++.+. .|+.++|||||||++|||++|..||......          +      ....+....  
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----------~------~~~~i~~~~~~  288 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----------K------AMKMIRDNLPP  288 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------H------HHHHHHHSSCC
T ss_pred             cccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------H------HHHHHHcCCCC
Confidence            23456899999999999877 7999999999999999999999998543210          0      111111111  


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........+.++.+++.+||+.||++|||++|+++
T Consensus       289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            12233456778999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3e-58  Score=413.11  Aligned_cols=253  Identities=23%  Similarity=0.239  Sum_probs=206.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...|++.++||+|+||+||+|++. +|+.||||+++....      ..+|+.++++++|||||++++++.++..+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            345788899999999999999764 699999999975421      2469999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-ceEEcccCCccccCCCCC
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+||+|.+++. ..+.+++..+..|+.||+.||+|||+   ++||||||||+|||++.+| .+||+|||+++.......
T Consensus       131 y~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          131 LLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             ccCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            999999999994 34679999999999999999999999   9999999999999999887 699999999987654322


Q ss_pred             ee---eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          181 HV---TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       181 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ..   .....+||+.|||||++.+. .++.++|||||||++|||+||+.||........                ...+.
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------------~~~i~  269 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----------------CLKIA  269 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----------------HHHHH
T ss_pred             ccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----------------HHHHH
Confidence            21   22345799999999999987 799999999999999999999999865433211                11111


Q ss_pred             hcCC--CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          258 ACGI--EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       258 ~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ....  ...++..+.++.+++.+||++||++|||+.||++.|.....
T Consensus       270 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          270 SEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             HSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            1111  12334567789999999999999999999999998876544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.7e-58  Score=410.83  Aligned_cols=273  Identities=25%  Similarity=0.324  Sum_probs=203.9

Q ss_pred             hhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC----eeeEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----MTALV   99 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~----~~~lV   99 (356)
                      .+|.+.++||+|+||+||+|++ +|+.||||+++..  ......+..|+..+.+++||||+++++++.+..    ..+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~--~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            4688999999999999999988 6899999999753  222233445666777889999999999998653    57999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-----QQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ||||++|+|.+++.  ..++++..+.+++.|++.||+|||+.+     ..+||||||||+|||++.++++||+|||+++.
T Consensus        80 ~Ey~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           80 SDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHH--HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCcHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999999994  357999999999999999999999721     23999999999999999999999999999987


Q ss_pred             cCCCCCeee--eccCCCCCCCCCcccccCCC-----CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          175 CDRNRSHVT--ISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       175 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      .........  ....+||++|+|||++.+..     .++.++|||||||++|||+||..|+.........+...... ..
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~-~~  236 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS-DP  236 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS-SC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc-cc
Confidence            755443322  23457999999999987542     36779999999999999999988775543322221110000 00


Q ss_pred             hhchhhHHHHhcC-CCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          248 EKSELDATILACG-IEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       248 ~~~~~~~~~~~~~-~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ........+.... .+.     .....+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0001111111111 111     123466789999999999999999999999999988754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.4e-57  Score=397.27  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=192.7

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .+|++.+.||+|+||+||+|.+. +|+.||||+++...  ......++.+|++++++++||||+++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999764 69999999997542  2233467999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||| +|+|.+++.. .+.+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 6799998843 5679999999999999999999999   999999999999999999999999999998654332 


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                        .....+||+.|+|||++.+...++.++|||||||++|||+||+.||...+.       ......         +....
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~~~~~---------i~~~~  228 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PVLFKN---------ISNGV  228 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH---------HHHTC
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHH---------HHcCC
Confidence              223467999999999998874456899999999999999999999854321       111111         11111


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       ...+...+.++.+++.+||+.||++|||++++++
T Consensus       229 -~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 -YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             2233445678899999999999999999999987

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.2e-57  Score=414.58  Aligned_cols=247  Identities=22%  Similarity=0.288  Sum_probs=207.2

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|++.++||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            45899999999999999999764 69999999997532 23345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      |+||+|.+++.  ...+++..+..|+.||+.||+|||+   ++||||||||+||||+.+|.+||+|||+++.+.....  
T Consensus       230 ~~gG~L~~~i~--~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          230 LEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             CTTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             CCCCcHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            99999999984  3569999999999999999999999   9999999999999999999999999999987654332  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC--
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG--  260 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  260 (356)
                      .....+||+.|||||++.+. .|+.++|||||||++|||++|..||......                .....+....  
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----------------~~~~~i~~~~~~  365 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----------------KAMKMIRDNLPP  365 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSCCC
T ss_pred             cccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHHHHHHcCCCC
Confidence            23456799999999999877 7999999999999999999999998543211                0111111111  


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........+.++.+|+.+||..||++|||++|+++
T Consensus       366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11223445678999999999999999999999986

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.3e-56  Score=395.75  Aligned_cols=249  Identities=23%  Similarity=0.370  Sum_probs=193.3

Q ss_pred             hccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC---------
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH---------   94 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~---------   94 (356)
                      +|++.+.||+|+||+||+|++. +|+.||||+++........+.+.+|+.++++++||||+++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5889999999999999999764 699999999976545556678999999999999999999999987544         


Q ss_pred             ---eeeEEEeccCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEccc
Q 038199           95 ---MTALVYEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  169 (356)
Q Consensus        95 ---~~~lV~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df  169 (356)
                         ..|+|||||+||+|.+++....  ....+..++.|+.||+.||+|||+   ++|+||||||+|||++.++.+||+||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence               3689999999999999996543  245677899999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCCee----------eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc
Q 038199          170 GLAKLCDRNRSHV----------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF  239 (356)
Q Consensus       170 gl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~  239 (356)
                      |+++.........          .....+||+.|||||++.+. .++.++|||||||++|||++   ||...        
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--------  230 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--------  230 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--------
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--------
Confidence            9998765432211          12346799999999999887 79999999999999999996   44210        


Q ss_pred             hhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          240 PKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          .   ........+.....++........+.+++.+||+.||++|||+.++++
T Consensus       231 ----~---~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          231 ----M---ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ----H---HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----c---HHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                0   011111122333444555556667888999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.5e-57  Score=401.45  Aligned_cols=249  Identities=23%  Similarity=0.234  Sum_probs=198.1

Q ss_pred             hhhccccccccccCceEEEEEEeC----CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      ..+|++.+.||+|+||+||+|+..    +++.||||+++... ......++.+|++++++++||||+++++++.+.+..|
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            357999999999999999999652    47899999997532 2233346889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +|||||+||+|.+++. ..+.+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+....
T Consensus       103 ivmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEECCCTTCEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEcCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            9999999999999994 34679999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ...  .....+||+.|||||++.+. .++.++|||||||++|||+||+.||...+..                .....+.
T Consensus       179 ~~~--~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~----------------~~~~~i~  239 (304)
T 3ubd_A          179 HEK--KAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRK----------------ETMTMIL  239 (304)
T ss_dssp             --C--CCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHH
T ss_pred             CCc--cccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHH----------------HHHHHHH
Confidence            322  22346799999999999877 7999999999999999999999998543211                1111111


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPM-----SAVVK  295 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~~v~~  295 (356)
                      ... ...+...+.++.+++.+||++||++|||+     +++++
T Consensus       240 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          240 KAK-LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             cCC-CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            211 22334567789999999999999999985     56654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-53  Score=388.23  Aligned_cols=267  Identities=19%  Similarity=0.254  Sum_probs=201.9

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEec------CCe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------QHM   95 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~------~~~   95 (356)
                      .+|++.++||+|+||+||+|.+. +|+.||||+++... .....+++.+|+.+|++++||||+++++++..      ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            46999999999999999999764 69999999997543 23445678899999999999999999998764      357


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .|||||||+ |+|.+++. ..+.+++..+..|+.||+.||.|||+   ++||||||||+|||++.++.+||+|||+++.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 57999884 46789999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCC--eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc--------chhhhHH
Q 038199          176 DRNRS--HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW--------FPKHVWE  245 (356)
Q Consensus       176 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~  245 (356)
                      .....  .......+||+.|+|||++.+...++.++||||+||++|||++|+.||...+....-.        .....+.
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            43321  1223457899999999998876567999999999999999999999985433211000        0000000


Q ss_pred             HHhhchhhHHHHhcC-CCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          246 EYEKSELDATILACG-IEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       246 ~~~~~~~~~~~~~~~-~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ............... ...     ..+..+.++.+|+.+||..||++|||++++++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000011110000 000     01123567889999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-52  Score=380.56  Aligned_cols=201  Identities=23%  Similarity=0.340  Sum_probs=173.0

Q ss_pred             hhhccccccccccCceEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   97 (356)
                      ...|++.++||+|+||+||+|+.+    +++.||||++...   ....++.+|+++++.+ +||||+++++++.+.+..+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            467999999999999999999642    4788999998754   3345688999999998 6999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-CceEEcccCCccccC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCD  176 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfgl~~~~~  176 (356)
                      +||||++|++|.+++    +.+++..+..++.||+.||+|||+   ++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus        97 lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           97 IAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             EEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            999999999999998    358999999999999999999999   999999999999999876 899999999998654


Q ss_pred             CCCCe--------------------------eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCccccc
Q 038199          177 RNRSH--------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIV  230 (356)
Q Consensus       177 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~  230 (356)
                      .....                          ......+||+.|+|||++.+...++.++||||+||++|||++|+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            32111                          1123457999999999998765689999999999999999999999976


Q ss_pred             CCC
Q 038199          231 GSS  233 (356)
Q Consensus       231 ~~~  233 (356)
                      +..
T Consensus       250 ~~~  252 (361)
T 4f9c_A          250 ASD  252 (361)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.4e-51  Score=394.73  Aligned_cols=251  Identities=22%  Similarity=0.257  Sum_probs=202.5

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHH---HHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEE---QFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~---~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ..+|++.++||+|+||+||+|+.. +|+.||||++....  ......   ....++.+++.++||||+++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            356899999999999999999765 69999999996431  111112   234457778888999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      |+|||||+||+|.+++. ..+.+++..+..|+.||+.||+|||+   ++||||||||+|||++.+|++||+|||+|+...
T Consensus       268 ylVmEy~~GGdL~~~l~-~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999994 34679999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ...    ....+||+.|||||++.+...++.++|+|||||++|||++|..||........       .      .+....
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-------~------~i~~~i  406 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------H------EIDRMT  406 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-------H------HHHHHH
T ss_pred             CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-------H------HHHHhh
Confidence            432    23467999999999997544789999999999999999999999854322110       0      011111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      .... ...+...+.++.+++.+||++||.+|++     +++|++
T Consensus       407 ~~~~-~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          407 LTMA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHCC-CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             cCCC-CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1111 2233456778999999999999999998     677765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.3e-50  Score=391.02  Aligned_cols=248  Identities=22%  Similarity=0.304  Sum_probs=209.3

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|++.+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+...+++||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            57999999999999999999764 69999999997542 34557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC--CceEEcccCCccccCCCCC
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN--FSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~--~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+||+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.+  +.+||+|||+++.+.....
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            99999999996666789999999999999999999999   999999999999999754  8999999999998764433


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                      .   ...+||+.|+|||++.+. .++.++|||||||++|||++|..||......                .....+....
T Consensus       313 ~---~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~----------------~~~~~i~~~~  372 (573)
T 3uto_A          313 V---KVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDD----------------ETLRNVKSCD  372 (573)
T ss_dssp             E---EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHHHHHHTTC
T ss_pred             e---eeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHHHHHHhCC
Confidence            2   335799999999999987 7999999999999999999999998543221                1111111111


Q ss_pred             ---CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 ---IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                         ........+.++.+|+.+||+.||.+|||+.++++
T Consensus       373 ~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          373 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               12223445678899999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.1e-50  Score=360.93  Aligned_cols=277  Identities=35%  Similarity=0.568  Sum_probs=224.5

Q ss_pred             hhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ....|++.+.||+|+||+||+|.+.+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            446788899999999999999998889999999987543 3455789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199          102 YMENGSLDGYLFGKK---RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      |+++++|.+++....   ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999985432   359999999999999999999999   99999999999999999999999999999865433


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      ..........||..|+|||.+.+. .++.++||||||+++|||++|+.|+.............+................
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            333223345589999999998766 6899999999999999999999998765443322222222222222222222222


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      ..........+..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            233345678889999999999999999999999999999887653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.5e-50  Score=371.04  Aligned_cols=265  Identities=25%  Similarity=0.367  Sum_probs=219.8

Q ss_pred             HHHhhhhccccccccccCceEEEEEEe--------CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeece
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQF--------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGF   89 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~   89 (356)
                      +++...+|++.+.||+|+||+||+|.+        .++..||||+++........+.+.+|+.+++++ +||||++++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            445667899999999999999999975        235679999998765566667899999999999 89999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCC
Q 038199           90 CHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  154 (356)
Q Consensus        90 ~~~~~~~~lV~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~  154 (356)
                      +.+....++||||+++|+|.+++....               ..+++..++.++.||+.||.|||+   ++|+||||||+
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~  232 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAAR  232 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGG
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchh
Confidence            999999999999999999999986432               358999999999999999999999   99999999999


Q ss_pred             cEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCC
Q 038199          155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSS  233 (356)
Q Consensus       155 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~  233 (356)
                      |||++.++.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|||++ |..|+.....
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999999876544333233344577899999999876 78999999999999999999 8888744321


Q ss_pred             CccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          234 ESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                                      ......+........+..++.++.+++.+||+.||++||++.++++.|+.+...
T Consensus       312 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          312 ----------------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             ----------------GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                            111222233333444556677899999999999999999999999999987643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.5e-50  Score=362.19  Aligned_cols=272  Identities=26%  Similarity=0.442  Sum_probs=209.9

Q ss_pred             cceecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           13 PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      +.....+++...+|++.++||+|+||+||+|++ +|+.||||++.... .....+.+.+|+.++++++||||+++++++.
T Consensus        26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             ------CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            344456677788999999999999999999987 68899999987543 3444567999999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ccccCCCCCcEEEcCCCceEEc
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFSPKVA  167 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dikp~Nill~~~~~~kl~  167 (356)
                      +....++||||+++++|.+++....  ..+++..++.++.|++.||+|||+   .+  ++||||||+||+++.++.+||+
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEEC
Confidence            9999999999999999999996543  249999999999999999999999   88  9999999999999999999999


Q ss_pred             ccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       168 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      |||+++.......  ......||..|+|||++.+. .++.++||||||+++|+|++|..||......             
T Consensus       182 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------------  245 (309)
T 3p86_A          182 DFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPA-------------  245 (309)
T ss_dssp             CCC-------------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------------
T ss_pred             CCCCCcccccccc--ccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------
Confidence            9999975443221  12345689999999999877 6899999999999999999999998543211             


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCC
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPP  306 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~  306 (356)
                        ...............+...+.++.+++.+||+.||.+|||+.+|++.|+.+.....+
T Consensus       246 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          246 --QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             --HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             --HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence              001111112222334455677899999999999999999999999999998776444

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.9e-50  Score=364.38  Aligned_cols=266  Identities=26%  Similarity=0.415  Sum_probs=219.6

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ++...+|.+.+.||+|+||+||+|.+.    .+..||||++.........+.+.+|+.++++++||||+++++++.+...
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            456778999999999999999999864    3456999999876556667789999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++++|.+++......+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+++..
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            999999999999999997667789999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          176 DRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       176 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ...... .......+|..|+|||++.+. .++.++||||||+++|||++ |..||.....                ....
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~----------------~~~~  264 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTN----------------RDVI  264 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----------------HHHH
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----------------HHHH
Confidence            543322 222334567789999999866 68999999999999999999 8888743221                1122


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                      ..+........+..++..+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus       265 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          265 SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            2222333334455667789999999999999999999999999999876533

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.9e-51  Score=376.32  Aligned_cols=268  Identities=22%  Similarity=0.314  Sum_probs=220.8

Q ss_pred             eecHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        15 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      ....|++...+|.+.++||+|+||+||+|.+. +++.||||++.........+.+.+|++++++++||||+++++++.+.
T Consensus       105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            34567788889999999999999999999875 68999999998655455556789999999999999999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ...++||||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            99999999999999999996656679999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ...............++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....                ...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~----------------~~~  324 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSN----------------QQT  324 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----------------HHH
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------------HHH
Confidence            64432211111112346679999999866 68999999999999999998 8877643221                112


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ...+........+..++.++.+++.+||+.||++|||+++|++.|+.+..
T Consensus       325 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          325 REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            22233333334445567789999999999999999999999999988753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.5e-50  Score=360.66  Aligned_cols=256  Identities=24%  Similarity=0.282  Sum_probs=207.0

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+|++.+.||+|+||+||+|.+. +++.||||++.........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            357899999999999999999765 6999999999754333444678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++++|.+++ .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..+......
T Consensus        86 ~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999998 345679999999999999999999999   99999999999999999999999999999876544333


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                      .......||..|+|||++.+....+.++||||||+++|+|++|..||........      .+..+..        ....
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~--------~~~~  227 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKE--------KKTY  227 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH------HHHHHHT--------TCTT
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHhc--------cccc
Confidence            3344567999999999998763457899999999999999999999865433211      1111111        1111


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .......+..+.+++.+||+.||++|||++++++.
T Consensus       228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            12223456678899999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.9e-50  Score=370.03  Aligned_cols=264  Identities=27%  Similarity=0.435  Sum_probs=206.0

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC----CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ++....|++.+.||+|+||+||+|++.    ++..||||+++........+.+.+|+.++++++||||+++++++.+...
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            345568899999999999999999764    4778999999876555666789999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++++|.+++......+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999999997767789999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCee-eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          176 DRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       176 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ....... ......++..|+|||++.+. .++.++||||||+++|||++ |..|+.....                ....
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----------------~~~~  260 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------------QDVI  260 (373)
T ss_dssp             ----------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----------------HHHH
T ss_pred             ccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHH
Confidence            5432221 12223457789999999876 78999999999999999998 8888743321                1111


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      ..+........+..++..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            11222222223345667899999999999999999999999999887653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.7e-50  Score=362.66  Aligned_cols=278  Identities=27%  Similarity=0.364  Sum_probs=215.0

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC--
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH--   94 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~--   94 (356)
                      +.+.+...+|++.++||+|+||+||+|++ .++.||||++...  ......+..|+.++++++||||+++++++.+..  
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cccccchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            34456778899999999999999999987 4789999999754  334455677999999999999999999998754  


Q ss_pred             --eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC----------CccccCCCCCcEEEcCCC
Q 038199           95 --MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ----------RIIHYDIKPENVLLDANF  162 (356)
Q Consensus        95 --~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~----------~ivH~dikp~Nill~~~~  162 (356)
                        ..++||||+++++|.+++..  ..+++..+..++.|++.||.|||+   .          +++||||||+|||++.++
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCC
Confidence              36999999999999999943  459999999999999999999998   7          999999999999999999


Q ss_pred             ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCC----CCCCccccchhhHHHHHHHHhCCcccccCCCCcccc
Q 038199          163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW  238 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~  238 (356)
                      .+||+|||+++...............||..|+|||++.+.    ..++.++|||||||++|||++|+.||..........
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            9999999999877655444344456799999999998763    245678899999999999999999986544322111


Q ss_pred             chhhhHHHHhhchhhHHHHhcCCCc------hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          239 FPKHVWEEYEKSELDATILACGIEE------KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      +.......................+      .....+.++.+++.+||+.||++|||+++|++.|+.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1100000000111111111111111      123456779999999999999999999999999998754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.2e-50  Score=361.95  Aligned_cols=285  Identities=38%  Similarity=0.609  Sum_probs=223.1

Q ss_pred             ceecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           14 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      ..+...++...+|.+.+.||+|+||+||+|.+.+|+.||||++...........+.+|+.++++++||||+++++++.+.
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   99 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP   99 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence            34566777888999999999999999999988789999999997654333334789999999999999999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           94 HMTALVYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      ...++||||+.+++|.+++...   ...+++..+..++.|++.||.|||+.+..+++||||||+||+++.++.+||+|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  179 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG  179 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred             CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence            9999999999999999999654   2359999999999999999999999211299999999999999999999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCc--cccchhhhHHHHh
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES--LDWFPKHVWEEYE  248 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~  248 (356)
                      ++......... ......||..|+|||.+.+. .++.++||||||+++|+|++|..||.......  ......+......
T Consensus       180 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          180 LAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             SCEECCSSSSC-EECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             cccccCccccc-ccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            99876544332 23445699999999999766 68999999999999999999999985321100  0000011111111


Q ss_pred             hchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ....................+..+.+++.+||+.||.+|||+++|++.|+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            1111222222223345677889999999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=367.60  Aligned_cols=272  Identities=25%  Similarity=0.340  Sum_probs=225.9

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeee
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRL   86 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~   86 (356)
                      .+.+++...+|.+.++||+|+||+||+|.+.        .+..||||++..........++.+|+++++++ +||||+++
T Consensus        61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            3557788899999999999999999999752        24679999998766666668899999999999 89999999


Q ss_pred             eceEecCCeeeEEEeccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCC
Q 038199           87 YGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI  151 (356)
Q Consensus        87 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~di  151 (356)
                      ++++.+....++||||+++++|.+++....               ..+++..++.|+.||+.||.|||+   .+++||||
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dl  217 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDL  217 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCC
Confidence            999999999999999999999999996543               459999999999999999999999   99999999


Q ss_pred             CCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCccccc
Q 038199          152 KPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIV  230 (356)
Q Consensus       152 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~  230 (356)
                      ||+|||++.++.+||+|||+++...............+|..|+|||++.+. .++.++||||||+++|+|++ |..|+..
T Consensus       218 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             CGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999876554433333445678899999999876 78999999999999999999 8888743


Q ss_pred             CCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCCC
Q 038199          231 GSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPP  307 (356)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~  307 (356)
                      ...                ......+........+..++.++.+++.+||+.||++|||+++|++.|+.+.......
T Consensus       297 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          297 VPV----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             CCH----------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             CCH----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            221                1122222233333344456778999999999999999999999999999987655443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.3e-50  Score=360.33  Aligned_cols=266  Identities=26%  Similarity=0.389  Sum_probs=216.3

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      +...+|.+.++||+|+||+||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+....++|
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            45678999999999999999999764 6999999988653 345667899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+++++|.+++......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            99999999999997767889999999999999999999999   999999999999999999999999999998764332


Q ss_pred             Ceee------------eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          180 SHVT------------ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       180 ~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      ....            .....||+.|+|||++.+. .++.++||||||+++|||++|..|+............       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-------  234 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-------  234 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-------
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-------
Confidence            2211            1145699999999999876 7899999999999999999999887554332211100       


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                         ........ .   .+..++..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       235 ---~~~~~~~~-~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          235 ---NVRGFLDR-Y---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             ---CHHHHHHH-T---CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---hhhccccc-c---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence               00011110 0   122344568899999999999999999999999998876543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.8e-50  Score=367.31  Aligned_cols=273  Identities=24%  Similarity=0.353  Sum_probs=223.8

Q ss_pred             CCcceecHHHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCce
Q 038199           11 EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINL   83 (356)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni   83 (356)
                      ..|.....|++...+|.+.++||+|+||.||+|++      .+++.||||++.........+.+.+|+.+++++ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            44566678888999999999999999999999963      246899999998765556667899999999999 79999


Q ss_pred             eeeeceEecCC-eeeEEEeccCCCChhhhhhcCCC---------------------------------------------
Q 038199           84 VRLYGFCHDQH-MTALVYEYMENGSLDGYLFGKKR---------------------------------------------  117 (356)
Q Consensus        84 ~~~~~~~~~~~-~~~lV~e~~~~~sL~~~l~~~~~---------------------------------------------  117 (356)
                      +++++++.+.. ..++||||+++|+|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            99999988754 48999999999999999965422                                             


Q ss_pred             --------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199          118 --------------------AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       118 --------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                                          .+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                                18999999999999999999999   9999999999999999999999999999987655


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ...........||..|+|||++.+. .++.++||||||+++|||++ |..||......               .......
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------------~~~~~~~  309 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---------------EEFCRRL  309 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---------------HHHHHHH
T ss_pred             cccchhccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchh---------------HHHHHHH
Confidence            4444444556688999999999866 78999999999999999998 88887543321               1111222


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ........+...+.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       310 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            2222333344456779999999999999999999999999988754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-49  Score=349.23  Aligned_cols=262  Identities=25%  Similarity=0.437  Sum_probs=218.2

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      +++...+|++.+.||+|+||+||+|++.++..||+|++...  ....+++.+|+.++++++||||+++++++.+....++
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG--SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT--TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC--CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence            35677899999999999999999999888889999999764  2344679999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||+++++|.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            999999999999996666679999999999999999999999   99999999999999999999999999999876544


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ... ......+|..|+|||.+.+. .++.++||||||+++|+|++ |..||.....                ........
T Consensus       158 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~~~~~~  219 (268)
T 3sxs_A          158 QYV-SSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----------------SEVVLKVS  219 (268)
T ss_dssp             CEE-ECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----------------HHHHHHHH
T ss_pred             hhh-cccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccCh----------------HHHHHHHH
Confidence            322 22344567789999999876 68999999999999999999 8888743321                11111122


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      .......+...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       220 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          220 QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            2222233344566799999999999999999999999999988653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-49  Score=350.78  Aligned_cols=261  Identities=28%  Similarity=0.468  Sum_probs=217.4

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      |.+...+|++.+.||+|+||+||+|.+.+++.||+|++....  ...+.+.+|+.++++++||||+++++++.+....++
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence            445678899999999999999999998888899999998653  334679999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            999999999999997777789999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.....                ......+.
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----------------~~~~~~~~  221 (269)
T 4hcu_A          160 QYT-SSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------SEVVEDIS  221 (269)
T ss_dssp             HHH-STTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHHHHH
T ss_pred             ccc-cccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----------------HHHHHHHh
Confidence            211 12234467789999999866 68999999999999999999 8888744321                11111222


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .......+...+..+.+++.+||+.||++||+++++++.|+.+.+
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          222 TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            222233344456779999999999999999999999999988754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.2e-50  Score=359.20  Aligned_cols=280  Identities=24%  Similarity=0.352  Sum_probs=215.3

Q ss_pred             HHHhhhhccccccccccCceEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      .++...+|++.++||+|+||+||+|++     .+++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            456788999999999999999999974     25889999999754 244457899999999999999999999998643


Q ss_pred             --CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           94 --HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        94 --~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                        ...++||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence              56899999999999999997666679999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCee-eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc
Q 038199          172 AKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       172 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      +.......... ......++..|+|||.+.+. .++.++||||||+++|||++|..|+......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            98765433221 12234467789999999876 78999999999999999999988764321100000000000001111


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      ..............+..++.++.+++.+||+.||++|||+++|++.|+.+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            22223333444445566778899999999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.5e-49  Score=354.47  Aligned_cols=276  Identities=23%  Similarity=0.332  Sum_probs=225.9

Q ss_pred             hcCCcceecHHHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCC
Q 038199            9 GREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHI   81 (356)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~   81 (356)
                      ++.....-..+++...+|.+.+.||+|+||+||+|.+      .+++.||||++.........+.+.+|+.+++++ +||
T Consensus         8 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~   87 (313)
T 1t46_A            8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM   87 (313)
T ss_dssp             CTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred             ccccCCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCC
Confidence            3344434456778888999999999999999999974      347899999998665555667899999999999 899


Q ss_pred             ceeeeeceEecCCeeeEEEeccCCCChhhhhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038199           82 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR-----------------AIEWEKLHEIAIGTAKGLVYLHEECQQ  144 (356)
Q Consensus        82 ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~  144 (356)
                      ||+++++++.+....++||||+++++|.+++.....                 .+++..++.++.|++.||.|||+   .
T Consensus        88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~  164 (313)
T 1t46_A           88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---K  164 (313)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---C
Confidence            999999999999999999999999999999865432                 48999999999999999999999   9


Q ss_pred             CccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-
Q 038199          145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-  223 (356)
Q Consensus       145 ~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-  223 (356)
                      +++||||||+||+++.++.+||+|||++................+|..|+|||.+.+. .++.++||||||+++|+|++ 
T Consensus       165 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~  243 (313)
T 1t46_A          165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSL  243 (313)
T ss_dssp             TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTT
T ss_pred             CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999877655444444445578899999998766 78999999999999999999 


Q ss_pred             CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          224 RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       224 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      |..|+.......               ..............+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       244 g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          244 GSSPYPGMPVDS---------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             TCCSSTTCCSSH---------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCcccchh---------------HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            888875433210               11111112222233345567899999999999999999999999999887654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.1e-49  Score=354.29  Aligned_cols=271  Identities=26%  Similarity=0.369  Sum_probs=223.6

Q ss_pred             CcceecHHHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceee
Q 038199           12 KPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR   85 (356)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~   85 (356)
                      +....+.+++...+|.+.+.||+|+||.||+|.+      .+++.||||++.........+.+.+|+.++++++||||++
T Consensus        11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~   90 (314)
T 2ivs_A           11 KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK   90 (314)
T ss_dssp             ---CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             eccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceee
Confidence            3444566777889999999999999999999975      2358899999987655566678999999999999999999


Q ss_pred             eeceEecCCeeeEEEeccCCCChhhhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038199           86 LYGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------------------RAIEWEKLHEIAIGTAKGLVYLHEEC  142 (356)
Q Consensus        86 ~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~  142 (356)
                      +++++.+....++||||+++++|.+++....                       ..+++..++.++.|++.||.|||+  
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--  168 (314)
T 2ivs_A           91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--  168 (314)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--
T ss_pred             EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--
Confidence            9999999999999999999999999986432                       348999999999999999999999  


Q ss_pred             CCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHH
Q 038199          143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIV  222 (356)
Q Consensus       143 ~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ell  222 (356)
                       .+++||||||+||+++.++.++|+|||++................++..|+|||.+.+. .++.++||||||+++|||+
T Consensus       169 -~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~  246 (314)
T 2ivs_A          169 -MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIV  246 (314)
T ss_dssp             -TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHH
T ss_pred             -CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHH
Confidence             99999999999999999999999999999877655444333445578889999999876 6899999999999999999


Q ss_pred             h-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          223 G-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       223 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      + |..|+.....                ......+........+...+.++.+++.+||+.||++||++.+|++.|+++.
T Consensus       247 t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          247 TLGGNPYPGIPP----------------ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             TTSCCSSTTCCG----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hCCCCCCCCCCH----------------HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            9 8888754322                1112222222233344556778999999999999999999999999998875


Q ss_pred             c
Q 038199          302 E  302 (356)
Q Consensus       302 ~  302 (356)
                      .
T Consensus       311 ~  311 (314)
T 2ivs_A          311 V  311 (314)
T ss_dssp             H
T ss_pred             h
Confidence            4

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.5e-49  Score=356.36  Aligned_cols=275  Identities=17%  Similarity=0.177  Sum_probs=216.9

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ....|++.+.||+|+||+||+|.. .+|+.||||++....   ..+.+.+|+.+++++ +||||+++++++.+....++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            346799999999999999999975 579999999987542   224588999999999 899999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc-----eEEcccCCccc
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-----PKVADFGLAKL  174 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~-----~kl~Dfgl~~~  174 (356)
                      |||+ +++|.+++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.     +||+|||+++.
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999 899999997667789999999999999999999999   99999999999999998887     99999999987


Q ss_pred             cCCCCCee-----eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          175 CDRNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       175 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      ........     ......||..|+|||++.+. .++.++|||||||++|||++|..||.........    .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~----~~~~~i~~  234 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK----ERYQKIGD  234 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH----HHHHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHH----HHHHHHHh
Confidence            65443321     12346799999999999876 7899999999999999999999998664332110    00111100


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCCCCCcccch
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLD  314 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~~~~~~~~  314 (356)
                      .     .............+ ++.+++.+||+.||.+||++++|.+.|+.+...........+.+
T Consensus       235 ~-----~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  293 (330)
T 2izr_A          235 T-----KRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW  293 (330)
T ss_dssp             H-----HHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred             h-----hccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence            0     00000001111233 79999999999999999999999999998877655443333333

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.1e-49  Score=349.89  Aligned_cols=265  Identities=23%  Similarity=0.410  Sum_probs=217.3

Q ss_pred             eecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        15 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      .+..+++...+|++.+.||+|+||+||++++.++..||||++....  ...+++.+|+.++++++||||+++++++.+..
T Consensus        15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            4566788889999999999999999999998888899999998652  33467899999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccc
Confidence            9999999999999999997656789999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ....... ......+|..|+|||.+.+. .++.++||||||+++|+|++ |..||.....                ....
T Consensus       170 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----------------~~~~  231 (283)
T 3gen_A          170 VLDDEYT-SSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----------------SETA  231 (283)
T ss_dssp             BCCHHHH-STTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----------------HHHH
T ss_pred             ccccccc-cccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccCh----------------hHHH
Confidence            5432211 12234467789999999866 68999999999999999998 8888744221                1111


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ..+........+...+..+.+++.+||+.||++|||++++++.|..+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          232 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            2222222233334456779999999999999999999999999987754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-49  Score=359.00  Aligned_cols=266  Identities=25%  Similarity=0.366  Sum_probs=218.4

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      .+++...+|++.+.||+|+||.||+|.+.      +++.||||++.........+.+.+|+.++++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34556788999999999999999999763      348899999987655556678999999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKK-----------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH  148 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  148 (356)
                      +....++||||+++++|.+++....                       ..+++..++.++.||+.||.|||+   .+++|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence            9999999999999999999986432                       579999999999999999999999   99999


Q ss_pred             cCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcc
Q 038199          149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRN  227 (356)
Q Consensus       149 ~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p  227 (356)
                      |||||+||+++.++.+||+|||++................+|..|+|||.+.+. .++.++||||||+++|||++ |..|
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999866433322223345678899999998866 68999999999999999999 8888


Q ss_pred             cccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          228 AIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      |.....                ......+........+..++.++.+++.+||+.||++||++.+|++.|+.+...
T Consensus       277 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          277 YYGMAH----------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TTTSCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCCCCh----------------HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            743221                111122222333334455677899999999999999999999999999987654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.3e-49  Score=357.05  Aligned_cols=269  Identities=25%  Similarity=0.362  Sum_probs=222.6

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeee
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLY   87 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~   87 (356)
                      +.+++...+|++.+.||+|+||+||+|.+.        +++.||||++...........+.+|+.+++++ +||||++++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            567788899999999999999999999752        46789999998765566667899999999999 899999999


Q ss_pred             ceEecCCeeeEEEeccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCC
Q 038199           88 GFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK  152 (356)
Q Consensus        88 ~~~~~~~~~~lV~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dik  152 (356)
                      +++.+....++||||+++++|.+++....               ..+++..++.++.||+.||.|||+   .+++|||||
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlk  184 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLA  184 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCS
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCc
Confidence            99999999999999999999999996542               248999999999999999999999   999999999


Q ss_pred             CCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccC
Q 038199          153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVG  231 (356)
Q Consensus       153 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~  231 (356)
                      |+||+++.++.+||+|||++................++..|+|||++.+. .++.++||||||+++|+|++ |..|+...
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            99999999999999999999877654443333445578889999998766 68999999999999999999 88887432


Q ss_pred             CCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          232 SSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                      ..                ......+........+..++.++..++.+||+.||.+||++.++++.|+.+....+
T Consensus       264 ~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          264 PV----------------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             CH----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CH----------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            21                11112222222333445566789999999999999999999999999998876543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-49  Score=358.96  Aligned_cols=268  Identities=24%  Similarity=0.324  Sum_probs=216.4

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceE
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC   90 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~   90 (356)
                      .+++...+|++.+.||+|+||+||+|.+      .+++.||||++.........+.+.+|+.+++++ +||||+++++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4667778999999999999999999975      246789999998654445557899999999999 899999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGKKR----------------------AIEWEKLHEIAIGTAKGLVYLHEECQQRIIH  148 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  148 (356)
                      .+....++||||+++++|.+++.....                      .+++..++.++.||+.||.|||+   .+++|
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH  195 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVH  195 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence            999999999999999999999965432                      37999999999999999999999   99999


Q ss_pred             cCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcc
Q 038199          149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRN  227 (356)
Q Consensus       149 ~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p  227 (356)
                      |||||+||+++.++.++|+|||++................||+.|+|||.+.+. .++.++||||||+++|+|+| |..|
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999876554444444445678899999998766 68999999999999999998 8888


Q ss_pred             cccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          228 AIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      |.......               ..............+...+.++.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       275 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          275 YPGIPVDA---------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             STTCCCSH---------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cccCCcHH---------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            75443210               111112222223334455678999999999999999999999999999876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.4e-49  Score=355.54  Aligned_cols=261  Identities=25%  Similarity=0.361  Sum_probs=208.9

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcE----EEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      +...+|++.++||+|+||+||+|.+. +++.    ||+|.+...........+.+|+.++++++||||+++++++.+.. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            45678999999999999999999754 4544    58888765444455678999999999999999999999998765 


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++|++++.+++|.+++......+++..++.|+.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            689999999999999997777889999999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      .............+|..|+|||.+.+. .++.++||||||+++|||++ |..||.....                .....
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------------~~~~~  230 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----------------SEISS  230 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----------------GGHHH
T ss_pred             cCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCH----------------HHHHH
Confidence            655544444445678899999999876 78999999999999999999 8888754322                12222


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .+........+...+.++..++.+||+.||.+||++.+|++.|+.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            233333334455567789999999999999999999999999988754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6e-49  Score=371.45  Aligned_cols=267  Identities=26%  Similarity=0.400  Sum_probs=220.2

Q ss_pred             ceecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           14 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      .....+++...+|++.++||+|+||+||+|.+.++..||||+++...  ...+.+.+|+.++++++||||+++++++. .
T Consensus       178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            33466788889999999999999999999998888899999998642  44678999999999999999999999986 5


Q ss_pred             CeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           94 HMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ...++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+   ++++||||||+|||++.++.+||+|||++
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            5789999999999999999543 2478999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhch
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      +........ ......++..|+|||++... .++.++||||||+++|||++ |+.|+.....                ..
T Consensus       332 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----------------~~  393 (454)
T 1qcf_A          332 RVIEDNEYT-AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----------------PE  393 (454)
T ss_dssp             GGBCCHHHH-TTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------HH
T ss_pred             eEcCCCcee-ccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----------------HH
Confidence            875432111 11223467789999999866 68999999999999999999 8888743211                11


Q ss_pred             hhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      ....+......+.+..++.++.+++.+||+.||++|||+++|++.|+.+....
T Consensus       394 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          394 VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            22222333334445567788999999999999999999999999999886543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.4e-48  Score=346.45  Aligned_cols=250  Identities=20%  Similarity=0.294  Sum_probs=207.7

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ...+|++.++||+|+||+||+|.+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            356899999999999999999975 469999999987542 234567899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||++|++|.+++..  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            99999999999843  469999999999999999999999   9999999999999999999999999999987654332


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH-hc
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL-AC  259 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  259 (356)
                      .  .....||+.|+|||.+.+. .++.++||||||+++|||++|..||......          ..     ...... ..
T Consensus       172 ~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------~~-----~~~~~~~~~  233 (297)
T 3fxz_A          172 K--RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------RA-----LYLIATNGT  233 (297)
T ss_dssp             C--BCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------HH-----HHHHHHHCS
T ss_pred             c--cCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----------HH-----HHHHHhCCC
Confidence            2  2345699999999999877 7899999999999999999999998543211          00     000011 11


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....+...+..+.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            112234456777999999999999999999999987

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.7e-48  Score=351.56  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=208.6

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ....|.+.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            456799999999999999999976 579999999997542 344557789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999999999843 4579999999999999999999999   999999999999999999999999999998765432


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                         .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.....                ......+...
T Consensus       169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------------~~~~~~i~~~  229 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----------------KELRERVLRG  229 (328)
T ss_dssp             ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHC
T ss_pred             ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhC
Confidence               234467999999999998774446899999999999999999999854321                1111111111


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      . ...+...+.++.+++.+||+.||.+|||++++++.
T Consensus       230 ~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          230 K-YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             C-CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             C-CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1 12233456778999999999999999999999873

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-48  Score=346.97  Aligned_cols=273  Identities=27%  Similarity=0.445  Sum_probs=203.6

Q ss_pred             cceecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           13 PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      +..++.+++...+|++.++||+|+||+||+|.+..  .||||++.... .....+.+.+|+.++++++||||++++++. 
T Consensus        13 ~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-   89 (289)
T 3og7_A           13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-   89 (289)
T ss_dssp             -----CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred             CCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence            45667789999999999999999999999998633  59999997543 345557899999999999999999999965 


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                      .....++||||+++++|.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEcccee
Confidence            4556799999999999999997677789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      +................||..|+|||.+..  ...++.++||||||+++|+|++|..||......      ....+....
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~  240 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGR  240 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHH
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcc
Confidence            986654333333344569999999999862  226788999999999999999999998543321      011111111


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ..     ...........++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       241 ~~-----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          241 GS-----LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TS-----CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cc-----cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            00     0011112233556789999999999999999999999999988753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=363.60  Aligned_cols=263  Identities=27%  Similarity=0.356  Sum_probs=215.2

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      ++...+|++.++||+|+||+||+|.+.      +++.||||++...........+.+|+.++++++||||+++++++.+.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            455678899999999999999999842      46789999997665566667899999999999999999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC---ce
Q 038199           94 HMTALVYEYMENGSLDGYLFGKK------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SP  164 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~  164 (356)
                      ...++||||+++++|.+++....      ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++   .+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceE
Confidence            99999999999999999985432      459999999999999999999999   9999999999999998555   59


Q ss_pred             EEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhh
Q 038199          165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHV  243 (356)
Q Consensus       165 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~  243 (356)
                      ||+|||+++...............||..|+|||++.+. .++.++|||||||++|||++ |..||.....          
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~----------  292 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------  292 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----------
Confidence            99999999765322222222334578899999999776 78999999999999999998 8888744321          


Q ss_pred             HHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          244 WEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                            ......+........+..++..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus       293 ------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          293 ------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             ------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence                  11222233333334445567789999999999999999999999999988754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-48  Score=349.39  Aligned_cols=286  Identities=22%  Similarity=0.329  Sum_probs=222.8

Q ss_pred             CCcceecHHHHhhhhccccccccccCceEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceee
Q 038199           11 EKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR   85 (356)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~   85 (356)
                      +.+..+....+....|++.++||+|+||.||+|.+     .+++.||||++.........+.+.+|+.++++++||||++
T Consensus         8 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   87 (302)
T 4e5w_A            8 KPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK   87 (302)
T ss_dssp             CCCCCCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CcceecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeee
Confidence            34445667777888899999999999999999983     3689999999986544555678999999999999999999


Q ss_pred             eeceEecC--CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc
Q 038199           86 LYGFCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  163 (356)
Q Consensus        86 ~~~~~~~~--~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~  163 (356)
                      +++++.+.  ...++||||+++++|.+++......+++..++.++.|++.||+|||+   .+++||||||+||+++.++.
T Consensus        88 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~  164 (302)
T 4e5w_A           88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQ  164 (302)
T ss_dssp             EEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTE
T ss_pred             eeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCC
Confidence            99999876  66899999999999999996666789999999999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCee-eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh
Q 038199          164 PKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH  242 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~  242 (356)
                      ++|+|||++.......... ......||..|+|||.+.+. .++.++||||||+++|+|++|..|+............ .
T Consensus       165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~  242 (302)
T 4e5w_A          165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG-P  242 (302)
T ss_dssp             EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC-S
T ss_pred             EEECcccccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccC-C
Confidence            9999999998776554332 22345678889999999876 6889999999999999999998875321100000000 0


Q ss_pred             hHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          243 VWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      ......................+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          243 THGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00001111222223333334445566788999999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-48  Score=345.90  Aligned_cols=263  Identities=22%  Similarity=0.315  Sum_probs=206.1

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      .+++...+|++.+.||+|+||+||+|.+..    +..||+|++.........+.+.+|+.++++++||||+++++++. .
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            456778899999999999999999997632    45799999886555566678999999999999999999999985 4


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ...++||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccc
Confidence            56789999999999999997666789999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ........ ......+++.|+|||.+.+. .++.++||||||+++|||++ |..||......                ..
T Consensus       165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----------------~~  226 (281)
T 1mp8_A          165 YMEDSTYY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----------------DV  226 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------GH
T ss_pred             ccCccccc-ccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----------------HH
Confidence            76543221 12223467789999999866 68999999999999999997 88887543221                11


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ...+........+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       227 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          227 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11222222333445567789999999999999999999999999987653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.8e-47  Score=339.49  Aligned_cols=282  Identities=34%  Similarity=0.526  Sum_probs=225.1

Q ss_pred             cceecHHHHhhhhcccc--------ccccccCceEEEEEEeCCCcEEEEEEecccc---chhhHHHHHHHHHHHccCCCC
Q 038199           13 PVRFTSLQLNNFTSNYS--------TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRTYHI   81 (356)
Q Consensus        13 ~~~~~~~~~~~~~~~~~--------~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~   81 (356)
                      .-.|...++...+.+|.        ++||+|+||+||+|.+ +++.||||++....   .....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            34667777777776664        5699999999999987 68899999987532   234457899999999999999


Q ss_pred             ceeeeeceEecCCeeeEEEeccCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc
Q 038199           82 NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK--KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD  159 (356)
Q Consensus        82 ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~  159 (356)
                      ||+++++++.+....++||||+++++|.+++...  ...+++..++.++.|++.||.|||+   .+++||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998543  4569999999999999999999999   9999999999999999


Q ss_pred             CCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc
Q 038199          160 ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF  239 (356)
Q Consensus       160 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~  239 (356)
                      .++.++|+|||++................||..|+|||.+.+  .++.++||||||+++|+|++|..|+........  .
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~  243 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L  243 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence            999999999999987665444434445679999999999875  478899999999999999999999865443221  1


Q ss_pred             hhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          240 PKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .............................+..+.+++.+||+.||.+|||+++|++.|+.+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            111111111111111222233344567788899999999999999999999999999988643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-48  Score=352.23  Aligned_cols=262  Identities=25%  Similarity=0.351  Sum_probs=208.8

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcE----EEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      +...+|++.++||+|+||+||+|.+. +++.    ||+|.+...........+.+|+.++++++||||+++++++.+.. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            45678999999999999999999754 4554    57777765544556678999999999999999999999998765 


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++|++++.+++|.+++......+++..++.|+.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            789999999999999997777889999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      .............+|..|+|||.+.+. .++.++||||||+++|||++ |..||.....                .....
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~----------------~~~~~  230 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----------------SEISS  230 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----------------GGHHH
T ss_pred             cCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCH----------------HHHHH
Confidence            554444334445578889999999876 78999999999999999999 8888754322                11222


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      .+........+...+.++.+++.+||+.||.+||++.++++.|+.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            2333333444555677899999999999999999999999999988653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-48  Score=352.01  Aligned_cols=264  Identities=28%  Similarity=0.448  Sum_probs=211.0

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCC-----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      ++...+|++.+.||+|+||+||+|.+..     +..||||++...........+.+|+.++++++||||+++++++.+..
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            5566788889999999999999997532     24599999987655566678999999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+++++|.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            9999999999999999997667789999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCee-eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchh
Q 038199          175 CDRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       175 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ........ ......+|..|+|||.+.+. .++.++||||||+++|||++ |..||.....                ...
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~----------------~~~  259 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HEV  259 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHH
T ss_pred             hccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCH----------------HHH
Confidence            65432221 12223467789999999876 78999999999999999999 8888743221                111


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      ...+........+...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          260 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            122222222333445677899999999999999999999999999887653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-48  Score=353.70  Aligned_cols=266  Identities=23%  Similarity=0.349  Sum_probs=219.9

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceE
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC   90 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~   90 (356)
                      ..+++...+|++.+.||+|+||+||+|.+.      +++.||||++...........+.+|+.++++++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            567788889999999999999999999653      37889999998665555667899999999999999999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGK---------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  161 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~  161 (356)
                      .+....++||||+++++|.+++...         ...+++..++.++.|++.||.|||+   .+++||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence            9999999999999999999998532         1467999999999999999999999   999999999999999999


Q ss_pred             CceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccch
Q 038199          162 FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFP  240 (356)
Q Consensus       162 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~  240 (356)
                      +.+||+|||++................+|..|+|||.+.+. .++.++||||||+++|+|++ |..|+.....       
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------  246 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------  246 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCH-------
Confidence            99999999999866443332222334568899999999866 68999999999999999999 7777643211       


Q ss_pred             hhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                               ......+........+...+..+.+++.+||+.||.+|||+.++++.|+....
T Consensus       247 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          247 ---------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ---------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                     11122222233334445567789999999999999999999999999998765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.8e-49  Score=355.49  Aligned_cols=260  Identities=24%  Similarity=0.329  Sum_probs=209.6

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcE----EEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVK----IAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ...+|++.++||+|+||+||+|.+. +++.    ||+|++...........+.+|+.++++++||||+++++++.+ ...
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   89 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL   89 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence            4568899999999999999999764 4554    788887654333334567889999999999999999999864 568


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+.+++|.+++......+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            89999999999999997666789999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ............|+..|+|||.+.+. .++.++||||||+++|+|++ |..||......                .....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~  229 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----------------EVPDL  229 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----------------HHHHH
T ss_pred             cccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHH----------------HHHHH
Confidence            55444344455688899999999866 68999999999999999999 98887543321                11122


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      +........+...+.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          230 LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             HHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            22222223333455678899999999999999999999999988754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.5e-47  Score=345.73  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=204.1

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC-------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-------   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-------   94 (356)
                      ..+|++.+.||+|+||.||+|.+. +|+.||||++.........+.+.+|+.++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467899999999999999999875 799999999976544556678999999999999999999999986543       


Q ss_pred             --------------------------------------------------eeeEEEeccCCCChhhhhhcCC--CCCCHH
Q 038199           95 --------------------------------------------------MTALVYEYMENGSLDGYLFGKK--RAIEWE  122 (356)
Q Consensus        95 --------------------------------------------------~~~lV~e~~~~~sL~~~l~~~~--~~~~~~  122 (356)
                                                                        ..++||||+++++|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3789999999999999996543  346777


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe----------eeeccCCCCCC
Q 038199          123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH----------VTISGYKGTPG  192 (356)
Q Consensus       123 ~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~----------~~~~~~~gt~~  192 (356)
                      .++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            899999999999999999   99999999999999999999999999999877654321          11233569999


Q ss_pred             CCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHH
Q 038199          193 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRL  272 (356)
Q Consensus       193 y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  272 (356)
                      |+|||.+.+. .++.++||||||+++|||++|..|+.                  ..............+......+.++
T Consensus       242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~  302 (332)
T 3qd2_B          242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM------------------ERVRIITDVRNLKFPLLFTQKYPQE  302 (332)
T ss_dssp             GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH------------------HHHHHHHHHHTTCCCHHHHHHCHHH
T ss_pred             ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh------------------HHHHHHHHhhccCCCcccccCChhH
Confidence            9999999876 78999999999999999999865421                  0111122223334455556677888


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHH
Q 038199          273 CMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       273 ~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+++.+||+.||++|||++++++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCCCcCCCHHHHhh
Confidence            99999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-47  Score=343.06  Aligned_cols=264  Identities=27%  Similarity=0.401  Sum_probs=211.7

Q ss_pred             hhhhccccccccccCceEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe-cCCee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH-DQHMT   96 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~-~~~~~   96 (356)
                      ...+|++.++||+|+||+||+|.+.+    ...+|+|++.........+.+.+|+.++++++||||+++++++. .+...
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            45678889999999999999997532    33689999987655566678999999999999999999999864 55678


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccc
Confidence            99999999999999997767789999999999999999999999   999999999999999999999999999998664


Q ss_pred             CCCCe--eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          177 RNRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       177 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      .....  .......+|..|+|||.+.+. .++.++||||||+++|+|++|..|+......               .....
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---------------~~~~~  243 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---------------FDITV  243 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---------------TTHHH
T ss_pred             ccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCH---------------HHHHH
Confidence            43221  122334577889999999876 6899999999999999999966554333221               11111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      ..........+...+..+.+++.+||+.||++|||++++++.|+.+....
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            22222223334445677999999999999999999999999999887643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.5e-48  Score=350.06  Aligned_cols=272  Identities=24%  Similarity=0.354  Sum_probs=222.0

Q ss_pred             CcceecHHHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCcee
Q 038199           12 KPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLV   84 (356)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~   84 (356)
                      -|.....+++...+|++.+.||+|+||+||+|.+      .+++.||||++...........+.+|+.+++++ +||||+
T Consensus        15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv   94 (316)
T 2xir_A           15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   94 (316)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence            3445566778889999999999999999999963      347899999998765555667899999999999 699999


Q ss_pred             eeeceEecCC-eeeEEEeccCCCChhhhhhcCCC---------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 038199           85 RLYGFCHDQH-MTALVYEYMENGSLDGYLFGKKR---------------AIEWEKLHEIAIGTAKGLVYLHEECQQRIIH  148 (356)
Q Consensus        85 ~~~~~~~~~~-~~~lV~e~~~~~sL~~~l~~~~~---------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  148 (356)
                      ++++++.+.. ..++||||+++++|.+++.....               .+++..+..++.|++.||.|||+   .+++|
T Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H  171 (316)
T 2xir_A           95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIH  171 (316)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence            9999987654 58999999999999999965432               28999999999999999999999   99999


Q ss_pred             cCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcc
Q 038199          149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRN  227 (356)
Q Consensus       149 ~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p  227 (356)
                      |||||+||+++.++.+||+|||+++...............||..|+|||++.+. .++.++||||||+++|+|++ |..|
T Consensus       172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p  250 (316)
T 2xir_A          172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASP  250 (316)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999876555444444455678899999999876 68999999999999999998 8888


Q ss_pred             cccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          228 AIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      +......               ......+........+...+.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       251 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          251 YPGVKID---------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             STTCCCS---------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Ccccchh---------------HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            7543321               01111122222223334456779999999999999999999999999988754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.1e-47  Score=338.38  Aligned_cols=262  Identities=23%  Similarity=0.327  Sum_probs=208.9

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      +...+|++.+.||+|+||+||+|.+. +++.||+|++....  .....+.+.+|+.++++++||||+++++++.+....+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            45678999999999999999999764 68999999985432  3344578999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||++|++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        88 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999999843 4579999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      .... ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||......      ......          .
T Consensus       164 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~----------~  225 (294)
T 4eqm_A          164 TSLT-QTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKH----------I  225 (294)
T ss_dssp             ------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHH----------H
T ss_pred             cccc-ccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHH----------h
Confidence            3222 22335689999999999876 6899999999999999999999998543221      000011          1


Q ss_pred             hcCCCc----hhHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhccccCC
Q 038199          258 ACGIEE----KDKEKAKRLCMAALWCVQDSPEDRP-PMSAVVKMLEGVVEVL  304 (356)
Q Consensus       258 ~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~v~~~L~~~~~~~  304 (356)
                      ....+.    .....+..+.+++.+||+.||.+|| +++++.+.|+.+....
T Consensus       226 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          226 QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             SSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             hccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            111111    1223457799999999999999999 9999999998876543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-47  Score=342.69  Aligned_cols=249  Identities=16%  Similarity=0.217  Sum_probs=207.7

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+|.+.+.||+|+||+||+|.+. +++.||+|++...  ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            467899999999999999999765 6899999999754  3455678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC--CCceEEcccCCccccCCCC
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA--NFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~--~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |++|++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.  ++.+||+|||++.......
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            999999999996666689999999999999999999999   99999999999999987  7899999999998775443


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      ..   ....||+.|+|||++.+. .++.++||||||+++|+|++|..||......                .....+...
T Consensus       159 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~i~~~  218 (321)
T 1tki_A          159 NF---RLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQ----------------QIIENIMNA  218 (321)
T ss_dssp             EE---EEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHHT
T ss_pred             cc---ccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----------------HHHHHHHcC
Confidence            22   234589999999999876 6899999999999999999999998543211                111111111


Q ss_pred             CCCc---hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          260 GIEE---KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       260 ~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ....   .....+.++.+++.+||..||.+|||+.++++.
T Consensus       219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111   112456789999999999999999999999983

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.4e-48  Score=364.98  Aligned_cols=255  Identities=26%  Similarity=0.385  Sum_probs=211.9

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC-eee
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH-MTA   97 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-~~~   97 (356)
                      |++....|++.++||+|+||+||+|.+ +|+.||||+++..   ...+.+.+|+.++++++||||+++++++.+.. ..+
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSC---TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCc---hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            456678889999999999999999988 5789999999864   24467999999999999999999999987665 789


Q ss_pred             EEEeccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           98 LVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      +||||+++|+|.+++..... .+++..++.++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++...
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            99999999999999965443 47999999999999999999999   999999999999999999999999999998543


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ...     ....++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....                ......
T Consensus       341 ~~~-----~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----------------~~~~~~  398 (450)
T 1k9a_A          341 STQ-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----------------KDVVPR  398 (450)
T ss_dssp             -----------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT----------------TTHHHH
T ss_pred             ccc-----cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence            221     123578899999999876 78999999999999999998 8888754322                112222


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      +..+.....+..++..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       399 i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          399 VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            22333344455677889999999999999999999999999988754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.3e-48  Score=347.32  Aligned_cols=276  Identities=25%  Similarity=0.336  Sum_probs=218.2

Q ss_pred             hhhccccccccccCceEEEEEEeC-----CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC--Ce
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HM   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~   95 (356)
                      ...|++.++||+|+||+||++.+.     +++.||||++.........+.+.+|++++++++||||+++++++.+.  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            334499999999999999988642     58899999998765556677899999999999999999999999874  67


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++++|.+++..  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus       110 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            8999999999999999943  459999999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ........ .....+|..|+|||.+.+. .++.++||||||+++|+|++|..|+.......... ...............
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMTVLRLTE  262 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchhHHHHHH
Confidence            65443322 2334578889999999876 68899999999999999999998874321110000 000001111222333


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                      .+........+..++.++.+++.+||+.||++|||++++++.|+.+.+...
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            333444445556677889999999999999999999999999998866443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-48  Score=341.05  Aligned_cols=260  Identities=28%  Similarity=0.463  Sum_probs=215.4

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      .+...+|++.+.||+|+||.||+|.+.+++.||+|++....  ...+.+.+|++++++++||||+++++++.+....++|
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence            35567899999999999999999998888899999998653  3346799999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            99999999999997666789999999999999999999999   999999999999999999999999999998654321


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      . .......++..|+|||.+.+. .++.++||||||+++|+|++ |..|+.....                ......+..
T Consensus       159 ~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~~~~i~~  220 (267)
T 3t9t_A          159 Y-TSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------SEVVEDIST  220 (267)
T ss_dssp             H-HSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHHHHHT
T ss_pred             c-cccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCH----------------HHHHHHHhc
Confidence            1 111234567789999999866 68999999999999999999 7877643321                111111222


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ......+...+..+.+++.+||+.||++||++.++++.|+.+.+
T Consensus       221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          221 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            22223334456779999999999999999999999999988754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.5e-48  Score=350.43  Aligned_cols=269  Identities=22%  Similarity=0.347  Sum_probs=201.7

Q ss_pred             eecHHHHhhhhccccccccccCceEEEEEEeCC-C---cEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeece
Q 038199           15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-G---VKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGF   89 (356)
Q Consensus        15 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~   89 (356)
                      .+....+...+|++.+.||+|+||+||+|.+.. +   ..||||++.... .....+.+.+|+.++++++||||++++++
T Consensus        14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   93 (323)
T 3qup_A           14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV   93 (323)
T ss_dssp             --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred             HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence            445566677889999999999999999998653 3   279999997542 33455789999999999999999999999


Q ss_pred             EecCCee------eEEEeccCCCChhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE
Q 038199           90 CHDQHMT------ALVYEYMENGSLDGYLFGK-----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL  158 (356)
Q Consensus        90 ~~~~~~~------~lV~e~~~~~sL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill  158 (356)
                      +.+....      ++||||+.+++|.+++...     ...+++..++.++.|++.||.|||+   .+++||||||+||++
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli  170 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCML  170 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEE
Confidence            9877655      8999999999999988432     2269999999999999999999999   999999999999999


Q ss_pred             cCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccc
Q 038199          159 DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLD  237 (356)
Q Consensus       159 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~  237 (356)
                      +.++.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|+|++ |..||.....    
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~----  245 (323)
T 3qup_A          171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN----  245 (323)
T ss_dssp             CTTSCEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----
T ss_pred             cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccCh----
Confidence            99999999999999876544333333344577889999999876 68999999999999999999 7877754322    


Q ss_pred             cchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          238 WFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                                  ...............+...+.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       246 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          246 ------------AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             ------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------------HHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                        112222222333344455667899999999999999999999999999988764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-47  Score=341.63  Aligned_cols=265  Identities=25%  Similarity=0.347  Sum_probs=214.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-C---CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee-e
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-N---GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT-A   97 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~-~   97 (356)
                      ...|.++++||+|+||+||+|.+. +   +..||+|++.........+.+.+|+.++++++||||+++++++.+.+.. +
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            345666799999999999999753 2   3379999998755556667899999999999999999999999876554 8


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+.+++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999997767889999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCCe--eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          178 NRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       178 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ....  .......++..|+|||.+.+. .++.++||||||+++|+|++|..|+.....               .......
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~---------------~~~~~~~  240 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHID---------------PFDLTHF  240 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---------------GGGHHHH
T ss_pred             CcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCC---------------HHHHHHH
Confidence            2211  122334578899999999876 789999999999999999997766543322               1112222


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCC
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPP  306 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~  306 (356)
                      .........+...+..+.+++.+||+.||.+|||++++++.|+.+......
T Consensus       241 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          241 LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             hhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            222223334445567899999999999999999999999999988765543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.1e-48  Score=366.22  Aligned_cols=267  Identities=28%  Similarity=0.408  Sum_probs=214.9

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ...|++....|++.++||+|+||+||+|.+.++..||||+++...  ...+.+.+|+.++++++||||+++++++.+ ..
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            355778888999999999999999999998777889999998643  345689999999999999999999999876 66


Q ss_pred             eeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           96 TALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      .++||||+++|+|.+++... ...+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++.
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            89999999999999999542 3569999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ....... ......++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....                ....
T Consensus       330 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----------------~~~~  391 (452)
T 1fmk_A          330 IEDNEYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVL  391 (452)
T ss_dssp             --------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHH
T ss_pred             cCCCcee-cccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCH----------------HHHH
Confidence            6432211 12234467889999998866 78999999999999999999 8877643211                1112


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCC
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPP  306 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~  306 (356)
                      ..+..+.....+..++..+.+++.+||+.||++|||+++|++.|+.+.....+
T Consensus       392 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          392 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence            22223333344556778899999999999999999999999999988765433

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.7e-47  Score=341.82  Aligned_cols=270  Identities=18%  Similarity=0.204  Sum_probs=216.9

Q ss_pred             HHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   97 (356)
                      ++...+|++.+.||+|+||+||+|.+ .+++.||||++....   ....+.+|+.+++++ +|+|++.+++++.+....+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            34567899999999999999999975 579999999987542   234578899999999 7999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc-----eEEcccCCc
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-----PKVADFGLA  172 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~-----~kl~Dfgl~  172 (356)
                      +||||+ +++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.     ++|+|||++
T Consensus        83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999 899999997667789999999999999999999999   99999999999999987766     999999999


Q ss_pred             cccCCCCCee-----eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          173 KLCDRNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       173 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      +.........     ......||..|+|||.+.+. .++.++||||||+++|||++|+.||.........    ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~~~~~~  233 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----QKYERI  233 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----HHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccH----HHHHHH
Confidence            8765443321     12345699999999999876 6899999999999999999999998664332111    111111


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCC
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPP  306 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~  306 (356)
                      ..     ..............+.++.+++.+||+.||++||++++|++.|+.+......
T Consensus       234 ~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          234 GE-----KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             HH-----HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             Hh-----hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            10     0011111112224567899999999999999999999999999998765543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-47  Score=346.43  Aligned_cols=251  Identities=25%  Similarity=0.311  Sum_probs=206.7

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ...+|++.+.||+|+||+||+|+.. +|+.||||++....  .......+.+|+.++++++||||+++++++.+....++
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            3468999999999999999999765 69999999997532  22344678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||++||+|..++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus        83 v~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           83 VMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EEECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999999884 34679999999999999999999999   99999999999999999999999999999864322


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      ..  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||......       ....         .+..
T Consensus       159 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~---------~i~~  219 (337)
T 1o6l_A          159 GA--TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFE---------LILM  219 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH---------HHHH
T ss_pred             CC--cccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHH-------HHHH---------HHHc
Confidence            21  22345699999999999876 7899999999999999999999998543211       1111         1111


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVKM  296 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~  296 (356)
                      .. ...+...+.++.+++.+||+.||++||     ++++|++.
T Consensus       220 ~~-~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          220 EE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC-CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            11 122334567899999999999999999     89999873

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=341.66  Aligned_cols=259  Identities=28%  Similarity=0.478  Sum_probs=205.7

Q ss_pred             hhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...+|++.+.||+|+||+||+|++ .++.||||++...   ...+.+.+|+.++++++||||+++++++.+  ..++|||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence            456889999999999999999988 5788999999753   445789999999999999999999998874  4789999


Q ss_pred             ccCCCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc-eEEcccCCccccCCC
Q 038199          102 YMENGSLDGYLFGKKR--AIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-PKVADFGLAKLCDRN  178 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~-~kl~Dfgl~~~~~~~  178 (356)
                      |+++++|.+++.....  .+++..++.++.|++.||.|||+...++++||||||+||+++.++. +||+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999999965432  4789999999999999999999844468999999999999988876 799999999755422


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                           .....||..|+|||++.+. .++.++||||||+++|||++|+.||........              ........
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------------~~~~~~~~  219 (307)
T 2eva_A          160 -----MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--------------RIMWAVHN  219 (307)
T ss_dssp             ----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--------------HHHHHHHT
T ss_pred             -----cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--------------HHHHHHhc
Confidence                 1234589999999999876 789999999999999999999999854322110              00111122


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCC
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPP  306 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~  306 (356)
                      ..........+..+.+++.+||+.||++|||++++++.|+.+....+.
T Consensus       220 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            223334455667899999999999999999999999999998766544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4e-48  Score=369.25  Aligned_cols=264  Identities=26%  Similarity=0.404  Sum_probs=220.3

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      +..|++...+|++.++||+|+||+||+|.+.. +..||||++....  ...+.+.+|+.++++++||||+++++++.+..
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            45578888899999999999999999998754 8899999997652  34578999999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           95 MTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ..++||||+.+++|.+++... ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccce
Confidence            999999999999999999653 4569999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ...... ........++..|+|||++.+. .++.++|||||||++|||++ |..|+.....                ..+
T Consensus       367 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~----------------~~~  428 (495)
T 1opk_A          367 LMTGDT-YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQV  428 (495)
T ss_dssp             CCTTCC-EECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG----------------GGH
T ss_pred             eccCCc-eeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH----------------HHH
Confidence            764332 2222334567789999999866 68999999999999999999 7777643221                111


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ...+........+..++..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       429 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            22222233334445667789999999999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.3e-47  Score=340.96  Aligned_cols=269  Identities=20%  Similarity=0.232  Sum_probs=207.1

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ..+-...+|++.++||+|+||+||+|.+.+|+.||+|++.... .......+.+|+.++++++||||+++++++.+....
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            3444567899999999999999999998889999999997542 223346788999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+++ +|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus        95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            999999975 8888886667789999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh-------
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK-------  249 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------  249 (356)
                      .....  .....||..|+|||++.+...++.++|||||||++|+|++|+.||........  . .........       
T Consensus       171 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~-~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          171 IPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--L-PKIFSILGTPNPREWP  245 (311)
T ss_dssp             SCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--H-HHHHHHHCCCCTTTSG
T ss_pred             CCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHHCCCChHHhh
Confidence            33222  23356899999999987755689999999999999999999999865433211  0 000000000       


Q ss_pred             -chhhHHHHhc--------CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 -SELDATILAC--------GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 -~~~~~~~~~~--------~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       ..........        ......+..+.++.+++.+||+.||++|||++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             0000000000        000111224567889999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-47  Score=342.72  Aligned_cols=272  Identities=18%  Similarity=0.197  Sum_probs=213.1

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC--eee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH--MTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~--~~~   97 (356)
                      +...+|.+.++||+|+||+||+|.+. +++.||||++.........+.+.+|++++++++||||+++++++.+..  ..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            45678999999999999999999765 599999999986544455677889999999999999999999998655  779


Q ss_pred             EEEeccCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE----cCCCceEEcccCC
Q 038199           98 LVYEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGL  171 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill----~~~~~~kl~Dfgl  171 (356)
                      +||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+++||||||+||++    +.++.+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999999999996543  349999999999999999999999   999999999999999    7788899999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccC-------CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhH
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSG-------NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVW  244 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~  244 (356)
                      ++........   ....||..|+|||++..       ...++.++|||||||++|||++|..||.........  .....
T Consensus       163 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~  237 (319)
T 4euu_A          163 ARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMY  237 (319)
T ss_dssp             CEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHH
T ss_pred             ceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHH
Confidence            9876544322   23568999999998752       236899999999999999999999998654332111  01111


Q ss_pred             HHHhhchhh---HH-------H----HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          245 EEYEKSELD---AT-------I----LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       245 ~~~~~~~~~---~~-------~----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      .........   ..       .    ............+..+.+++.+||+.||++|||++++++.....
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            111000000   00       0    00011134467888899999999999999999999999987654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.4e-47  Score=345.80  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=205.9

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccch-----hhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ....|++.+.||+|+||+||+|... +|+.||+|++......     ...+.+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3467999999999999999999765 6999999999754321     235679999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC----ceEEcccCC
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGL  171 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfgl  171 (356)
                      .++||||++|++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+||+++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           90 VVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999999994 45679999999999999999999999   9999999999999998776    799999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      +........   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......       ....      
T Consensus       166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------~~~~------  228 (361)
T 2yab_A          166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLA------  228 (361)
T ss_dssp             CEECCTTCC---CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHH------
T ss_pred             ceEcCCCCc---cccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHH------
Confidence            987654322   2345699999999999876 7899999999999999999999998543211       0111      


Q ss_pred             hhHHHHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          252 LDATILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       252 ~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                         .+......   ......+..+.+++.+||..||.+|||+.++++
T Consensus       229 ---~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          229 ---NITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ---HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               11111111   111234567899999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.5e-48  Score=352.86  Aligned_cols=266  Identities=23%  Similarity=0.326  Sum_probs=217.4

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCC-C-----cEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeece
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN-G-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGF   89 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~   89 (356)
                      ..+++....|.+.+.||+|+||+||+|.+.. +     +.||+|++.........+.+.+|+.+++++ +||||++++++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            3567778889999999999999999997632 3     479999998765555667899999999999 89999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcE
Q 038199           90 CHDQHMTALVYEYMENGSLDGYLFGK-------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV  156 (356)
Q Consensus        90 ~~~~~~~~lV~e~~~~~sL~~~l~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Ni  156 (356)
                      +.+....++||||+++++|.+++...             ...+++..++.++.|++.||.|||+   .+++||||||+||
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNV  195 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGC
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceE
Confidence            99999999999999999999998532             3468999999999999999999999   9999999999999


Q ss_pred             EEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCc
Q 038199          157 LLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSES  235 (356)
Q Consensus       157 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~  235 (356)
                      +++.++.++|+|||++................+|..|+|||.+.+. .++.++||||||+++|||++ |..|+...... 
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-  273 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-  273 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchh-
Confidence            9999999999999999876544443333445578899999998866 68999999999999999998 77777543221 


Q ss_pred             cccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          236 LDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                                    ...............+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       274 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          274 --------------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             --------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence                          0111111222222233345677999999999999999999999999998764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.3e-48  Score=340.77  Aligned_cols=265  Identities=31%  Similarity=0.449  Sum_probs=216.5

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      -..|++...+|++.+.||+|+||+||+|.+.+++.||||++....  ...+.+.+|++++++++||||+++++++.++ .
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~   81 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-P   81 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC-C
Confidence            356778889999999999999999999998788899999997642  3456899999999999999999999998754 5


Q ss_pred             eeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           96 TALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      .++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            799999999999999994432 379999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ....... ......++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....                ....
T Consensus       159 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~----------------~~~~  220 (279)
T 1qpc_A          159 IEDNEYT-AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------PEVI  220 (279)
T ss_dssp             CSSSCEE-CCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHH
T ss_pred             ccCcccc-cccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCH----------------HHHH
Confidence            6543221 22334577899999999765 68899999999999999999 7877643221                0111


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      ..+........+...+..+.+++.+||+.||++|||++++++.|+.+....
T Consensus       221 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            112222222333455678999999999999999999999999999876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.3e-47  Score=338.31  Aligned_cols=258  Identities=28%  Similarity=0.433  Sum_probs=209.1

Q ss_pred             HHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhH------HHHHHHHHHHccCCCCceeeeeceEec
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAE------EQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      .+...+|++.+.||+|+||+||+|.+ .+++.||||++.........      +.+.+|+.++++++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            45668899999999999999999976 46999999998653322111      578999999999999999999999976


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ccccCCCCCcEEEcCCCc-----eE
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFS-----PK  165 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dikp~Nill~~~~~-----~k  165 (356)
                      ..  ++||||+++++|.+++......+++..+..++.|++.||+|||+   .+  ++||||||+||+++.++.     +|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence            65  69999999999999887777889999999999999999999999   88  999999999999988776     99


Q ss_pred             EcccCCccccCCCCCeeeeccCCCCCCCCCcccccC-CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhH
Q 038199          166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVW  244 (356)
Q Consensus       166 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~  244 (356)
                      |+|||+++.....     .....||..|+|||.+.+ ...++.++||||||+++|+|++|..||.........       
T Consensus       170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------  237 (287)
T 4f0f_A          170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-------  237 (287)
T ss_dssp             ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-------
T ss_pred             eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-------
Confidence            9999999754321     234568999999999843 225788999999999999999999998654332110       


Q ss_pred             HHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          245 EEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                            ..............+...+.++.+++.+||+.||.+|||++++++.|+.+
T Consensus       238 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          238 ------FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ------HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ------HHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                  00111112222334455677899999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.2e-48  Score=341.96  Aligned_cols=265  Identities=26%  Similarity=0.405  Sum_probs=221.8

Q ss_pred             eecHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        15 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      .+..+++...+|++.++||+|+||+||+|.+. +++.||+|++..+  ....+.+.+|+.++++++||||+++++++.+.
T Consensus         4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            45678889999999999999999999999865 4889999999764  34557899999999999999999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           94 HMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ...++||||+++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccc
Confidence            9999999999999999999653 4569999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhch
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      ......... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..|+.....                ..
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~----------------~~  220 (288)
T 3kfa_A          159 RLMTGDTYT-AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQ  220 (288)
T ss_dssp             GTSCSSSSE-EETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----------------GG
T ss_pred             eeccCCccc-cccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------------HH
Confidence            876544332 23344578889999999876 68999999999999999999 8777644321                11


Q ss_pred             hhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ....+........+...+..+.+++.+||+.||.+|||++++++.|+.+..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          221 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            122222222333445566789999999999999999999999999987754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-47  Score=338.73  Aligned_cols=262  Identities=27%  Similarity=0.368  Sum_probs=216.2

Q ss_pred             Hhhhhccccc-cccccCceEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           21 LNNFTSNYST-RLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        21 ~~~~~~~~~~-~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      +...+|.+.+ .||+|+||+||+|.+.   +++.||||++.........+.+.+|+.++++++||||+++++++. ....
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   84 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEAL   84 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSE
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCc
Confidence            3456677765 8999999999999753   578899999987655566778999999999999999999999994 5568


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            99999999999999997666789999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          177 RNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       177 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ....... .....+|..|+|||.+.+. .++.++||||||+++|+|++ |..||......                ....
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~  224 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------------EVMA  224 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----------------HHHH
T ss_pred             cCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----------------HHHH
Confidence            4433222 2234568899999999766 68999999999999999998 99887543221                1112


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      .+........+...+.++.+++.+||+.||++||++.++++.|+.+...
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          225 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            2222333344456678899999999999999999999999999987654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-47  Score=353.11  Aligned_cols=263  Identities=26%  Similarity=0.388  Sum_probs=202.1

Q ss_pred             hhhccccccccccCceEEEEEEeC--C--CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec-CCeee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP--N--GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTA   97 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~-~~~~~   97 (356)
                      ...|.+.+.||+|+||+||+|.+.  +  +..||||++.........+++.+|+.++++++||||+++++++.+ ....+
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            345677899999999999999753  2  246899998765555666789999999999999999999998754 56789


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+++++|.+++......+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            9999999999999997777789999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCCee--eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhC-CcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          178 NRSHV--TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGR-RRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       178 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      .....  ......++..|+|||.+.+. .++.++||||||+++|||++| ..|+......                ....
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~----------------~~~~  307 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----------------DITV  307 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS----------------CHHH
T ss_pred             cccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH----------------HHHH
Confidence            32211  12234577889999999876 789999999999999999995 4454332211                1111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                      .+........+..++..+.+++.+||+.||++||+++++++.|+.+.....
T Consensus       308 ~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          308 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            222222233344566789999999999999999999999999998876544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=351.55  Aligned_cols=257  Identities=25%  Similarity=0.304  Sum_probs=209.6

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      ..++...+|++.+.||+|+||.||+|.+. +++.||+|++....  .......+.+|+.+++.++||||+++++++.+..
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            34556788999999999999999999764 58999999986532  2234467889999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+.||+|..++. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.+|.+||+|||++..
T Consensus        89 ~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeee
Confidence            9999999999999999984 45679999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCC--CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      .....   .....+||+.|+|||++.+.  ..++.++|||||||++|||++|..||.........             ..
T Consensus       165 ~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-------------~~  228 (384)
T 4fr4_A          165 LPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-------------EI  228 (384)
T ss_dssp             CCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH-------------HH
T ss_pred             ccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH-------------HH
Confidence            65332   23446799999999998642  25899999999999999999999998654332110             00


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP-MSAVVK  295 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~v~~  295 (356)
                      ..... ......+...+..+.+++.+||+.||.+||+ +++|++
T Consensus       229 ~~~~~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          229 VHTFE-TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHH-HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHh-hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            01111 1122233445678999999999999999998 677665

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-47  Score=351.62  Aligned_cols=277  Identities=13%  Similarity=0.179  Sum_probs=210.0

Q ss_pred             hhhhccccccccccCceEEEEEEeCC------CcEEEEEEeccccchhh----------HHHHHHHHHHHccCCCCceee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIA----------EEQFMAEVGTIGRTYHINLVR   85 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~ni~~   85 (356)
                      ...+|.+.++||+|+||+||+|.+.+      ++.||||++........          ...+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34589999999999999999997754      47899999876432111          123445677788899999999


Q ss_pred             eeceEecC----CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc--
Q 038199           86 LYGFCHDQ----HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--  159 (356)
Q Consensus        86 ~~~~~~~~----~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~--  159 (356)
                      +++++.+.    ...++||||+ |++|.+++......+++..++.|+.||+.||.|||+   .+|+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence            99998764    5589999999 999999997767889999999999999999999999   9999999999999998  


Q ss_pred             CCCceEEcccCCccccCCCCCee-----eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCC
Q 038199          160 ANFSPKVADFGLAKLCDRNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE  234 (356)
Q Consensus       160 ~~~~~kl~Dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~  234 (356)
                      .++.+||+|||+++.+.......     ......||..|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            88999999999998764322111     11234599999999999877 6899999999999999999999998643221


Q ss_pred             ccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCCCCC
Q 038199          235 SLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKP  309 (356)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~~~  309 (356)
                      ..  ......... ..........+..   ....+.++.+++..||+.||.+||++++|++.|+.+.........
T Consensus       268 ~~--~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~  336 (364)
T 3op5_A          268 PK--YVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD  336 (364)
T ss_dssp             HH--HHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred             HH--HHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence            10  000001011 1111111111110   123356799999999999999999999999999988776554443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6e-47  Score=338.74  Aligned_cols=259  Identities=24%  Similarity=0.340  Sum_probs=201.6

Q ss_pred             HhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHcc--CCCCceeeeeceEec----CC
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--TYHINLVRLYGFCHD----QH   94 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~~~~~~~~----~~   94 (356)
                      +...+|++.+.||+|+||+||+|++ +++.||||++...    ....+..|.+++..  ++||||+++++++.+    ..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            3567899999999999999999988 7899999998753    23455566666665  789999999998654    35


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCccccCCCCCcEEEcCCCceEE
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH--------EECQQRIIHYDIKPENVLLDANFSPKV  166 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~dikp~Nill~~~~~~kl  166 (356)
                      ..++||||+++++|.+++  ....+++..++.++.|++.||.|||        +   .+++||||||+|||++.++.+||
T Consensus        80 ~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEEEECCCTTCBHHHHH--TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEE
T ss_pred             eeEEehhhccCCCHHHHH--hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEE
Confidence            688999999999999999  4567999999999999999999999        7   99999999999999999999999


Q ss_pred             cccCCccccCCCCCeee--eccCCCCCCCCCcccccCCC-----CCCccccchhhHHHHHHHHhC----------Ccccc
Q 038199          167 ADFGLAKLCDRNRSHVT--ISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGR----------RRNAI  229 (356)
Q Consensus       167 ~Dfgl~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dv~slGvvl~elltg----------~~p~~  229 (356)
                      +|||+++..........  .....||..|+|||++.+..     .++.++||||||+++|||++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            99999987655444322  22346999999999987652     234689999999999999999          55543


Q ss_pred             cCCCCccccchhhhHHHHhhchhhHHHH-hcCCC-----chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          230 VGSSESLDWFPKHVWEEYEKSELDATIL-ACGIE-----EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ........      +....     .... ....+     ......+..+.+++.+||+.||++|||+++|++.|+++
T Consensus       235 ~~~~~~~~------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPS------FEDMR-----KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCC------HHHHH-----HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcc------hhhhh-----HHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            32221110      11110     0010 01111     12345778899999999999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1e-46  Score=333.12  Aligned_cols=255  Identities=24%  Similarity=0.283  Sum_probs=209.2

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++.........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999765 6899999999754444556789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        86 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            999999999883 45679999999999999999999999   99999999999999999999999999999866433332


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                      .......|+..|+|||.+.+....+.++||||||+++|+|++|..||........      .+..+..        ....
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~--------~~~~  227 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKE--------KKTY  227 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHHHT--------TCTT
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHhhh--------cccc
Confidence            2334466899999999998763347899999999999999999999865433211      1111111        0111


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .......+..+.+++.+||+.||++|||++++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            1122345667899999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-47  Score=338.07  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=197.6

Q ss_pred             HhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccc---hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG---RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      +...+|++.++||+|+||+||+|.+ +++.||||++.....   ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             cchhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            3457899999999999999999987 588999999875422   223467899999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC---ccccCCCCCcEEEcC--------CCceEE
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR---IIHYDIKPENVLLDA--------NFSPKV  166 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~---ivH~dikp~Nill~~--------~~~~kl  166 (356)
                      +||||+++++|.+++  ....+++..+..++.|++.||.|||+   .+   ++||||||+||+++.        ++.++|
T Consensus        83 lv~e~~~~~~L~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           83 LVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             EEEECCTTEEHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             EEEEcCCCCCHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            999999999999998  45689999999999999999999999   77   999999999999986        678999


Q ss_pred             cccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH
Q 038199          167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       167 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      +|||++........    ....||..|+|||.+.+. .++.++||||||+++|+|++|+.||......            
T Consensus       158 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------  220 (271)
T 3dtc_A          158 TDFGLAREWHRTTK----MSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------------  220 (271)
T ss_dssp             CCCCC-----------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------------
T ss_pred             ccCCcccccccccc----cCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------
Confidence            99999986543322    234689999999999876 6899999999999999999999997543211            


Q ss_pred             HhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                         ...............+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       221 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          221 ---AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence               000111111122233445567899999999999999999999999999764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-47  Score=338.61  Aligned_cols=252  Identities=23%  Similarity=0.280  Sum_probs=199.4

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccch-------------------------hhHHHHHHHHHH
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-------------------------IAEEQFMAEVGT   74 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~   74 (356)
                      +...+|++.+.||+|+||+||+|.+. +++.||||++......                         ...+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            34568999999999999999999764 6899999998653211                         123568899999


Q ss_pred             HccCCCCceeeeeceEec--CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCC
Q 038199           75 IGRTYHINLVRLYGFCHD--QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK  152 (356)
Q Consensus        75 l~~l~h~ni~~~~~~~~~--~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dik  152 (356)
                      +++++||||+++++++.+  ....++||||+++++|.+++  ....+++..+..++.|++.||.|||+   .+++|||||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk  164 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIK  164 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCC
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCC
Confidence            999999999999999986  56889999999999998876  45689999999999999999999999   999999999


Q ss_pred             CCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCC--CCccccchhhHHHHHHHHhCCccccc
Q 038199          153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP--ITHKCDVYSFGMVLFEIVGRRRNAIV  230 (356)
Q Consensus       153 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~Dv~slGvvl~elltg~~p~~~  230 (356)
                      |+||+++.++.+||+|||++........  ......||..|+|||.+.+...  .+.++||||||+++|+|++|..||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987654332  2334579999999999976532  47789999999999999999999854


Q ss_pred             CCCCccccchhhhHHHHhhchhhHHHHhc-CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          231 GSSESLDWFPKHVWEEYEKSELDATILAC-GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ....       ...         ..+... ...+.....+.++.+++.+||+.||++||+++++++
T Consensus       243 ~~~~-------~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIM-------CLH---------SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHH-------HHH---------HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHH-------HHH---------HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            3210       000         111111 111222345677999999999999999999999875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-46  Score=339.67  Aligned_cols=246  Identities=21%  Similarity=0.321  Sum_probs=203.9

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccC
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYME  104 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~  104 (356)
                      |.+.++||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++......++||||++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            666789999999999999875 69999999997543 3445678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeee
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI  184 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  184 (356)
                      +++|.+++.  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.........  .
T Consensus       126 ~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~  198 (321)
T 2c30_A          126 GGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--R  198 (321)
T ss_dssp             SCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--B
T ss_pred             CCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--c
Confidence            999999983  4579999999999999999999999   99999999999999999999999999999876543222  2


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC--C
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI--E  262 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  262 (356)
                      ....||..|+|||++.+. .++.++||||||+++|||++|+.||......       ...         ..+.....  .
T Consensus       199 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-------~~~---------~~~~~~~~~~~  261 (321)
T 2c30_A          199 KSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAM---------KRLRDSPPPKL  261 (321)
T ss_dssp             CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHH---------HHHHHSSCCCC
T ss_pred             ccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH---------HHHhcCCCCCc
Confidence            345699999999999876 7899999999999999999999998543211       001         11111111  1


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ......+..+.+++.+||+.||++|||++++++.
T Consensus       262 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2233456678999999999999999999999974

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.6e-47  Score=337.67  Aligned_cols=263  Identities=21%  Similarity=0.262  Sum_probs=201.9

Q ss_pred             hhccccccccccCceEEEEEEeCCCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|++.++||+|+||+||+|.+.+|+.||+|++..... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46889999999999999999887799999999975432 22336788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.+ +|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........  
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence            976 9999887667789999999999999999999999   9999999999999999999999999999987643222  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch---hhHH----
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE---LDAT----  255 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~----  255 (356)
                      ......||..|+|||++.+...++.++||||||+++|||++|..||........  . ...........   ....    
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--L-MRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCCTTTSTTGGGST
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHHCCCChhhchhhhccc
Confidence            123346899999999997654689999999999999999999999854322100  0 00000000000   0000    


Q ss_pred             -HHh-------cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 -ILA-------CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 -~~~-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       ...       ..........+.++.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             000       0000111234567889999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-46  Score=345.49  Aligned_cols=253  Identities=21%  Similarity=0.324  Sum_probs=207.4

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      ......|++.+.||+|+||.||+|.+. +|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+....+
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            344678999999999999999999764 68999999997542 3445577899999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC---CceEEcccCCccc
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKL  174 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~Dfgl~~~  174 (356)
                      +||||+.|++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.+   +.+||+|||++..
T Consensus       105 lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             EEECCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999999884 45679999999999999999999999   999999999999999765   4599999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ......   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.....       ...+.         
T Consensus       181 ~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~---------  240 (362)
T 2bdw_A          181 VNDSEA---WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYA---------  240 (362)
T ss_dssp             CTTCCS---CCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH---------
T ss_pred             ecCCcc---cccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHH---------
Confidence            654322   2345799999999999876 789999999999999999999999854321       11111         


Q ss_pred             HHHhcCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          255 TILACGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       255 ~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .+.....   .......+.++.+++.+||+.||++||++.++++.
T Consensus       241 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          241 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111111   11223456779999999999999999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=339.73  Aligned_cols=250  Identities=23%  Similarity=0.352  Sum_probs=205.7

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccch-----hhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ....|++.+.||+|+||+||+|.+. +|+.||+|++......     ...+.+.+|+.++++++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3467999999999999999999765 6999999999754221     245789999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC----ceEEcccCC
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGL  171 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfgl  171 (356)
                      .++||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++    .+||+|||+
T Consensus        89 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           89 VILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999999984 45679999999999999999999999   9999999999999998887    799999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      +........   .....||+.|+|||++.+. .++.++||||||+++|+|++|..||......       .....     
T Consensus       165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~-----  228 (326)
T 2y0a_A          165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLAN-----  228 (326)
T ss_dssp             CEECCTTSC---CCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHH-----
T ss_pred             CeECCCCCc---cccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHH-----
Confidence            987653322   2335699999999999876 7899999999999999999999998543211       00111     


Q ss_pred             hhHHHHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          252 LDATILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       252 ~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          +......   ......+..+.+++.+||+.||++|||+.++++
T Consensus       229 ----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          229 ----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             ----HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----HHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                1111111   111234567889999999999999999999997

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.8e-47  Score=334.75  Aligned_cols=257  Identities=21%  Similarity=0.323  Sum_probs=209.9

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC--Cee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ--HMT   96 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~--~~~   96 (356)
                      ++...+|++.++||+|+||+||+|.+ +++.||||++.... .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            44567899999999999999999998 58899999997542 345557899999999999999999999999877  788


Q ss_pred             eEEEeccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCC--ccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           97 ALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ++||||+++++|.+++..... .+++..++.++.|++.||.|||+   .+  ++||||||+||+++.++.++|.|||++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEecccee
Confidence            999999999999999965443 59999999999999999999998   88  9999999999999999999999998875


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCC--CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      ....       ....||+.|+|||.+.+..  .++.++||||||+++|||++|..||......               ..
T Consensus       162 ~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~~  219 (271)
T 3kmu_A          162 SFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM---------------EI  219 (271)
T ss_dssp             TTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH---------------HH
T ss_pred             eecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH---------------HH
Confidence            4322       2245789999999987652  2334799999999999999999987533211               01


Q ss_pred             hhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .............+...+.++.+++.+||+.||++|||++++++.|+.+.+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          220 GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            111122222334445567789999999999999999999999999988753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.8e-47  Score=336.17  Aligned_cols=264  Identities=20%  Similarity=0.260  Sum_probs=205.1

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .+|++.++||+|+||+||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46899999999999999999765 68999999997543 33444678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++ +|.+.+......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9976 6666665667789999999999999999999999   99999999999999999999999999999876433222


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc---hhhHHH--
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS---ELDATI--  256 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--  256 (356)
                        .....||..|+|||++.+...++.++|||||||++|+|++|..|+..+......  ...........   ......  
T Consensus       158 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGS
T ss_pred             --ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChhhhhhhccc
Confidence              234568999999999987645899999999999999999999887554332110  00000000000   000000  


Q ss_pred             ----------HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 ----------LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ----------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                                .........+..+.++.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                      000011122345677899999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.2e-47  Score=338.41  Aligned_cols=262  Identities=23%  Similarity=0.330  Sum_probs=211.7

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      +.+...+|.+.+.||+|+||+||+|.+.+    +..||+|++.........+.+.+|+.++++++||||+++++++.++ 
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-   85 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence            45567889999999999999999997532    3469999998765556668899999999999999999999998755 


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+.+++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            4689999999999999997666779999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |+.||......                ...
T Consensus       163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~----------------~~~  224 (281)
T 3cc6_A          163 IEDEDYY-KASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENK----------------DVI  224 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG----------------GHH
T ss_pred             ccccccc-ccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChH----------------HHH
Confidence            6543221 12334567889999999766 68999999999999999998 99887543221                111


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ..+........+...+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus       225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          225 GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            1222222233334456779999999999999999999999999987653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=341.32  Aligned_cols=249  Identities=24%  Similarity=0.305  Sum_probs=198.7

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~   96 (356)
                      ++...+|++.++||+|+||+||+|.+. +|+.||||++.... .......+..|+..+.++ +||||+++++++.++...
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            445578999999999999999999875 69999999986532 233344556666666555 899999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+ +++|.+++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            9999999 669999887667789999999999999999999999   999999999999999999999999999988764


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ....   .....||+.|+|||++.+  .++.++|||||||++|||++|..++..          ...+..+.....    
T Consensus       209 ~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~----------~~~~~~~~~~~~----  269 (311)
T 3p1a_A          209 TAGA---GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHG----------GEGWQQLRQGYL----  269 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSS----------HHHHHHHTTTCC----
T ss_pred             cCCC---CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCC----------ccHHHHHhccCC----
Confidence            3322   233568999999999876  589999999999999999999765422          111222221111    


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          ........+.++.+++.+||+.||++|||++++++
T Consensus       270 ----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 ----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                11122335678999999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.4e-47  Score=342.22  Aligned_cols=267  Identities=24%  Similarity=0.347  Sum_probs=201.8

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCe---
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM---   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~---   95 (356)
                      ...+|++.+.||+|+||+||+|.+ .+++.||||++....  .......+.+|+.++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            457899999999999999999976 579999999997643  23344678999999999999999999999876543   


Q ss_pred             -eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           96 -TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        96 -~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                       .++||||++|++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             ccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence             4999999999999999843 4579999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          175 CDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       175 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ....... .......||..|+|||.+.+. .++.++||||||+++|+|++|+.||......      ...+..       
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~-------  231 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQH-------  231 (311)
T ss_dssp             ----------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHH-------
T ss_pred             ccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHH-------
Confidence            6543222 222335689999999999877 7899999999999999999999998543221      111111       


Q ss_pred             HHHHhcCCCc--hhHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHhccccCCCCCC
Q 038199          254 ATILACGIEE--KDKEKAKRLCMAALWCVQDSPEDRPPMSAVV-KMLEGVVEVLPPPK  308 (356)
Q Consensus       254 ~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~-~~L~~~~~~~~~~~  308 (356)
                        ........  .....+.++.+++.+||+.||++||++.+++ ..|.......++..
T Consensus       232 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~  287 (311)
T 3ork_A          232 --VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA  287 (311)
T ss_dssp             --HHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSS
T ss_pred             --hcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCC
Confidence              11111111  1123567799999999999999999666555 45666555444433

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=347.97  Aligned_cols=281  Identities=23%  Similarity=0.348  Sum_probs=216.3

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      ...++....|++.+.||+|+||.||+|.+     .+++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            34455677899999999999999999973     35899999999764 2345578999999999999999999999987


Q ss_pred             cCC--eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEccc
Q 038199           92 DQH--MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF  169 (356)
Q Consensus        92 ~~~--~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Df  169 (356)
                      ...  ..++||||+++++|.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+||
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Df  189 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDF  189 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecC
Confidence            643  7899999999999999997766789999999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh
Q 038199          170 GLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE  248 (356)
Q Consensus       170 gl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  248 (356)
                      |++........... .....++..|+|||.+.+. .++.++||||||+++|+|++|..|+....................
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  268 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence            99987765443322 2234567789999999866 688999999999999999999887643110000000000000000


Q ss_pred             hchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ...+...+........+..++.++.+++.+||+.||++||++.+|++.|+.+.+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            111222223333334445567889999999999999999999999999988753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.7e-48  Score=341.98  Aligned_cols=257  Identities=24%  Similarity=0.343  Sum_probs=207.3

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CC-------cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NG-------VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      ++...+|.+.+.||+|+||+||+|.+. ++       ..||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            345778999999999999999999754 34       579999997542 345578999999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc--------
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--------  163 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~--------  163 (356)
                      +....++||||+++++|.+++......+++..+..++.|++.||.|||+   ++++||||||+||+++.++.        
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccce
Confidence            9999999999999999999997666669999999999999999999999   99999999999999988877        


Q ss_pred             eEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhh
Q 038199          164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHV  243 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~  243 (356)
                      ++|+|||++......      ....||..|+|||.+.+...++.++||||||+++|||++|..|+......         
T Consensus       160 ~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---------  224 (289)
T 4fvq_A          160 IKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---------  224 (289)
T ss_dssp             EEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---------
T ss_pred             eeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---------
Confidence            999999998754322      12347889999999987446899999999999999999976554332211         


Q ss_pred             HHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          244 WEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                            .........  ....+...+.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       225 ------~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          225 ------QRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             ------HHHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             ------HHHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                  000000000  1111222345688999999999999999999999999988764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-47  Score=342.79  Aligned_cols=271  Identities=25%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccC--CCCceeeeeceEecC-
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT--YHINLVRLYGFCHDQ-   93 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~ni~~~~~~~~~~-   93 (356)
                      ........+|++.++||+|+||+||+|++ +++.||||++...    ....+..|.+++..+  +||||+++++++.+. 
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            34555678999999999999999999988 4899999998643    233455566666554  899999999999877 


Q ss_pred             ---CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC--------CccccCCCCCcEEEcCCC
Q 038199           94 ---HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ--------RIIHYDIKPENVLLDANF  162 (356)
Q Consensus        94 ---~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~--------~ivH~dikp~Nill~~~~  162 (356)
                         ...++||||+++++|.+++..  ..+++..++.++.|++.||.|||+   .        +++||||||+||+++.++
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCC
Confidence               678999999999999999943  479999999999999999999998   6        999999999999999999


Q ss_pred             ceEEcccCCccccCCCCCeee--eccCCCCCCCCCcccccCCCCCCcc------ccchhhHHHHHHHHhCCcccccCCCC
Q 038199          163 SPKVADFGLAKLCDRNRSHVT--ISGYKGTPGYSAPEFLSGNYPITHK------CDVYSFGMVLFEIVGRRRNAIVGSSE  234 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~------~Dv~slGvvl~elltg~~p~~~~~~~  234 (356)
                      .+||+|||++...........  .....||..|+|||++.+. ..+..      +|||||||++|||++|..|+......
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999977654332221  2245699999999999765 33443      99999999999999995554332222


Q ss_pred             ccccchh----hhHHHHhhchhhHHHHh-cCCCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          235 SLDWFPK----HVWEEYEKSELDATILA-CGIEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       235 ~~~~~~~----~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      ...|...    ..+....     ..... ...+.     ....++.++.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus       259 ~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMR-----EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHH-----HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccHhhhcCCCCchhhhH-----HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            1111100    0011111     11111 11111     1236788899999999999999999999999999988664

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.2e-47  Score=341.26  Aligned_cols=271  Identities=25%  Similarity=0.372  Sum_probs=207.2

Q ss_pred             eecHHHHhhhhccccccccccCceEEEEEEeC----CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeece
Q 038199           15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGF   89 (356)
Q Consensus        15 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~   89 (356)
                      .+....+...+|.+.+.||+|+||+||+|.+.    +++.||||++.... .....+.+.+|+.++++++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            34556667789999999999999999999653    35589999997542 34445779999999999999999999999


Q ss_pred             EecCC-----eeeEEEeccCCCChhhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc
Q 038199           90 CHDQH-----MTALVYEYMENGSLDGYLFG-----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD  159 (356)
Q Consensus        90 ~~~~~-----~~~lV~e~~~~~sL~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~  159 (356)
                      +.+..     ..++||||+++++|.+++..     ....+++..++.++.|++.||.|||+   .+++||||||+||+++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~  181 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLR  181 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEEC
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEc
Confidence            98654     35899999999999998842     34679999999999999999999999   9999999999999999


Q ss_pred             CCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCcccc
Q 038199          160 ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDW  238 (356)
Q Consensus       160 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~  238 (356)
                      .++.+||+|||++................++..|+|||.+.+. .++.++||||||+++|+|++ |..|+.....     
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----  255 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----  255 (313)
T ss_dssp             TTSCEEECSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----
T ss_pred             CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCH-----
Confidence            9999999999999876543322222334578899999999876 78999999999999999999 7777644322     


Q ss_pred             chhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          239 FPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                                 ...............+...+..+.+++.+||..||.+||++.++++.|+.+....|
T Consensus       256 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          256 -----------HEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             -----------GGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -----------HHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                       11112222233334455567789999999999999999999999999998876543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.6e-47  Score=350.26  Aligned_cols=262  Identities=23%  Similarity=0.269  Sum_probs=204.8

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCC
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQH   94 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~   94 (356)
                      ..+...+|++.++||+|+||+||+|++. +++.||+|+++...  .....+.+..|..++.++ +||||+++++++.+..
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            3456678999999999999999999865 58899999997542  122234678899999887 7999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||++||+|..++. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.+|.+||+|||+++.
T Consensus       127 ~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEEcCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            9999999999999999884 34679999999999999999999999   9999999999999999999999999999985


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ......  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........       ........
T Consensus       203 ~~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~~~~~~  272 (396)
T 4dc2_A          203 GLRPGD--TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLFQ  272 (396)
T ss_dssp             CCCTTC--CBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHHHH
T ss_pred             cccCCC--ccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhHHHHHH
Confidence            332221  23446799999999999877 789999999999999999999999864322111000       00001111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPM------SAVVK  295 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~------~~v~~  295 (356)
                      .+... ....+...+.++.+++.+||+.||.+||++      ++|++
T Consensus       273 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          273 VILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             HHHHC-CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             HHhcc-ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            11111 122334466789999999999999999996      56655

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=351.54  Aligned_cols=252  Identities=20%  Similarity=0.265  Sum_probs=205.7

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ....|++.+.||+|+||+||+|.+ .+|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            457899999999999999999975 469999999997543 334456789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc---CCCceEEcccCCccccC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCD  176 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~---~~~~~kl~Dfgl~~~~~  176 (356)
                      |||+.||+|.+.+.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||++....
T Consensus        89 ~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999998854 4679999999999999999999999   9999999999999998   56789999999998765


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      .....  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.....       ...+.         .+
T Consensus       165 ~~~~~--~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~~---------~i  225 (444)
T 3soa_A          165 GEQQA--WFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLYQ---------QI  225 (444)
T ss_dssp             TTCCB--CCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHH---------HH
T ss_pred             CCCce--eecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHHH---------HH
Confidence            43222  2345799999999999876 789999999999999999999999854321       11111         11


Q ss_pred             HhcCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          257 LACGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       257 ~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .....   .+.....+.++.+++.+||+.||++|||+.++++.
T Consensus       226 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          226 KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             HHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11111   11123456779999999999999999999999983

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=348.52  Aligned_cols=253  Identities=26%  Similarity=0.290  Sum_probs=200.9

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCC
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQH   94 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~   94 (356)
                      ..+...+|++.++||+|+||+||+|++. +|+.||||++....  .....+.+..|..+++.+ +||||+++++++.+..
T Consensus        18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            3456678999999999999999999765 68999999997532  233446788999999988 6999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||++||+|..++. ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999999884 34679999999999999999999999   9999999999999999999999999999985


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      .....  ......+||+.|+|||++.+. .++.++|||||||++|||++|..||......       .         ...
T Consensus       174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~---------~~~  234 (353)
T 3txo_A          174 GICNG--VTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------D---------LFE  234 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H---------HHH
T ss_pred             cccCC--ccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------H---------HHH
Confidence            43222  123346799999999999876 6899999999999999999999998543221       1         111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPM------SAVVK  295 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~------~~v~~  295 (356)
                      .+.... ...+...+.++.+++.+||+.||.+||++      +++++
T Consensus       235 ~i~~~~-~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          235 AILNDE-VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHcCC-CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            111111 12233456678999999999999999998      77766

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=338.28  Aligned_cols=247  Identities=26%  Similarity=0.316  Sum_probs=205.6

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ...+|++.+.||+|+||+||+|+.. +|+.||+|++....  .....+.+.+|..+++.++||||+++++++.+....++
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            3467899999999999999999765 69999999997532  12334678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||++|++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+||+++.+|.+||+|||+++.....
T Consensus        84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            9999999999999853 4679999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                           ....+||+.|+|||++.+. .++.++|||||||++|||++|..||.....       ...+.         .+..
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~---------~i~~  217 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYE---------KILN  217 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH---------HHHH
T ss_pred             -----cccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHH---------HHHh
Confidence                 2335699999999999876 789999999999999999999999854321       01111         1111


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      .. ...+...+.++.+++.+||+.||++||     +++++++
T Consensus       218 ~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          218 AE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            11 122334567799999999999999999     8888886

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.2e-47  Score=342.47  Aligned_cols=278  Identities=26%  Similarity=0.339  Sum_probs=217.6

Q ss_pred             HhhhhccccccccccCceEEEEEEe-----CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe--cC
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF-----PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH--DQ   93 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~--~~   93 (356)
                      ++..+|++.+.||+|+||+||+|++     .+++.||||++... .....+.+.+|++++++++||||+++++++.  +.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            3567899999999999999999983     35889999999764 2344567999999999999999999999886  45


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ...++||||+++++|.+++......+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccce
Confidence            67899999999999999996656679999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          174 LCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       174 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      .......... .....||..|+|||.+.+. .++.++||||||+++|+|++|..|+............ ...........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~  253 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRL  253 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHH
Confidence            7755443322 2334578889999999876 6899999999999999999999887542211000000 00000001122


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      ............+..++..+.+++.+||+.||++|||++++++.|+.+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            2223333344455667788999999999999999999999999999886543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=346.30  Aligned_cols=256  Identities=21%  Similarity=0.283  Sum_probs=199.6

Q ss_pred             HhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCC--CceeeeeceEecCCeee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYH--INLVRLYGFCHDQHMTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h--~ni~~~~~~~~~~~~~~   97 (356)
                      +....|++.+.||+|+||+||++.+.+++.||||++... ......+.+.+|+.++++++|  |||+++++++.+....+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            456789999999999999999998888999999998743 234455789999999999976  99999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +|||+ .+++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++ ++.+||+|||+++....
T Consensus        86 lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99995 57799999854 5679999999999999999999999   9999999999999997 57899999999987654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccC----------CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSG----------NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      ...........||+.|+|||++.+          ...++.++|||||||++|||++|+.||......             
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------------  226 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------------  226 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------------
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------------
Confidence            443333345679999999999853          136789999999999999999999998532211             


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                       ................+...+.++.+++.+||+.||.+|||+.++++.
T Consensus       227 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          227 -ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence             000111111111122223334578899999999999999999999974

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.4e-47  Score=368.38  Aligned_cols=251  Identities=27%  Similarity=0.386  Sum_probs=205.2

Q ss_pred             cccccCceEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCC
Q 038199           31 RLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGS  107 (356)
Q Consensus        31 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~s  107 (356)
                      +||+|+||.||+|.+.   ++..||||+++........+.+.+|++++++++||||+++++++.+ +..++||||+.+|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999753   4677999999876555567889999999999999999999999976 45899999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee-eecc
Q 038199          108 LDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISG  186 (356)
Q Consensus       108 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~  186 (356)
                      |.+++......+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++......... ....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            999997667789999999999999999999999   999999999999999999999999999998764332221 1122


Q ss_pred             CCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchh
Q 038199          187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD  265 (356)
Q Consensus       187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (356)
                      ..++..|+|||++.+. .++.++|||||||++|||++ |+.||.....                ......+..+.....+
T Consensus       499 ~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----------------~~~~~~i~~~~~~~~p  561 (613)
T 2ozo_A          499 GKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----------------PEVMAFIEQGKRMECP  561 (613)
T ss_dssp             ---CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS----------------HHHHHHHHTTCCCCCC
T ss_pred             CCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH----------------HHHHHHHHcCCCCCCC
Confidence            3467899999999866 78999999999999999998 9888754322                1122233333334455


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ..++.++.+++.+||+.||++||++.+|++.|+.+..
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            5677889999999999999999999999999988654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.8e-46  Score=343.03  Aligned_cols=251  Identities=20%  Similarity=0.243  Sum_probs=204.3

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc----chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ....|++.+.||+|+||+||+|.+. +|+.||||++....    .....+.+.+|+.++++++||||+++++++.+....
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4568999999999999999999764 69999999986421    122457899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc---eEEcccC
Q 038199           97 ALVYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFG  170 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~---~kl~Dfg  170 (356)
                      ++||||++|++|.+.+...   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999998877432   3468999999999999999999999   99999999999999976654   9999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      ++........  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||....        ..        
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~--------  239 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK--------ER--------  239 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HH--------
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HH--------
Confidence            9987654322  22345699999999999876 68999999999999999999999985421        00        


Q ss_pred             hhhHHHHhcCCCch---hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          251 ELDATILACGIEEK---DKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       251 ~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       ....+........   ....+.++.+++.+||+.||++|||+.++++
T Consensus       240 -~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          240 -LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             -HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             1111111111111   1234678999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-47  Score=368.63  Aligned_cols=266  Identities=27%  Similarity=0.400  Sum_probs=218.3

Q ss_pred             ecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           16 FTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        16 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ...|++...+|++.++||+|+||+||+|.+.++..||||++....  ...+.|.+|+.++++++||||+++++++.+ ..
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            355778889999999999999999999998777889999998643  345689999999999999999999999876 66


Q ss_pred             eeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           96 TALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      .++||||+.+++|.+++... ...+++..++.|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence            89999999999999999542 3569999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ...... .......++..|+|||++.+. .++.++|||||||++|||++ |..|+.....                .+..
T Consensus       413 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----------------~~~~  474 (535)
T 2h8h_A          413 IEDNEY-TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVL  474 (535)
T ss_dssp             CCCHHH-HTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----------------HHHH
T ss_pred             cCCCce-ecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHH
Confidence            542211 111223467789999998866 68999999999999999999 8877643211                1112


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                      ..+........+..++..+.+++.+||+.||++|||+++|++.|+.+.....
T Consensus       475 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          475 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            2222333333445667789999999999999999999999999998876543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.2e-47  Score=344.03  Aligned_cols=264  Identities=27%  Similarity=0.366  Sum_probs=211.4

Q ss_pred             HHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      .++...+|++.+.||+|+||+||+|.+      .+++.||||++..........++.+|+.++++++||||+++++++.+
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            345678999999999999999999974      24778999999765556666789999999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---CCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKK------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFS  163 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~  163 (356)
                      ....++||||+++++|.+++....      ..+++..++.++.|++.||.|||+   .+++||||||+||+++.   +..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcce
Confidence            999999999999999999996543      458999999999999999999999   99999999999999984   446


Q ss_pred             eEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhh
Q 038199          164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKH  242 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~  242 (356)
                      ++|+|||++................|+..|+|||.+.+. .++.++||||||+++|+|++ |..|+.....         
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~---------  251 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---------  251 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---------
Confidence            999999999865443333333345578899999998766 68999999999999999998 8777743321         


Q ss_pred             hHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          243 VWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                             ......+........+...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       252 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          252 -------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             -------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence                   11112222222333444566789999999999999999999999999987754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.3e-46  Score=339.30  Aligned_cols=260  Identities=25%  Similarity=0.370  Sum_probs=190.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ..+|++.++||+|+||+||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457899999999999999999764 6899999999765444445678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199          102 YMENGSLDGYLFGK-----KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus       102 ~~~~~sL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      |+++ +|.+++...     ...+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            9975 998887532     2469999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh--------
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE--------  248 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  248 (356)
                      ....  ......||..|+|||++.+...++.++|||||||++|||++|+.||........   .........        
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhh
Confidence            3322  123356899999999998654689999999999999999999999854332100   000000000        


Q ss_pred             ---h-------------chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          249 ---K-------------SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       249 ---~-------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                         .             .........    ......+.++.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQP----HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGG----GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcc----cccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence               0             000000000    001123567899999999999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.5e-47  Score=346.06  Aligned_cols=255  Identities=21%  Similarity=0.238  Sum_probs=194.8

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ...+|++.++||+|+||+||++... +++.||||++....  ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            4678999999999999999999765 69999999997642  33356889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc--eEEcccCCccccCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--PKVADFGLAKLCDRN  178 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~--~kl~Dfgl~~~~~~~  178 (356)
                      ||+.+++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.  +||+|||+++.....
T Consensus        96 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           96 EYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999998843 4579999999999999999999999   99999999999999987765  999999998743322


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .   ......||+.|+|||++.+....+.++|||||||++|+|++|+.||........  +..         ........
T Consensus       172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~---------~~~~~~~~  237 (361)
T 3uc3_A          172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRK---------TIQRILSV  237 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHH---------HHHHHHTT
T ss_pred             C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHH---------HHHHHhcC
Confidence            2   123356999999999998763334559999999999999999999865432211  000         00011111


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ....+.....+.++.+++.+||+.||++|||+.++++.
T Consensus       238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            11111222345678999999999999999999999984

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5e-47  Score=345.17  Aligned_cols=253  Identities=24%  Similarity=0.308  Sum_probs=204.6

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCC
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQH   94 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~   94 (356)
                      ..+...+|++.+.||+|+||.||+|++. +|+.||||+++...  .......+..|..+++.+ +||||+++++++.+..
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            4567789999999999999999999865 68999999997532  123345688899999876 8999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||++||+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++.
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999999843 4579999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ......  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..+..        
T Consensus       168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~--------  229 (345)
T 1xjd_A          168 NMLGDA--KTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHS--------  229 (345)
T ss_dssp             CCCTTC--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH--------
T ss_pred             cccCCC--cccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHHH--------
Confidence            432221  23446799999999999876 7899999999999999999999998543211       11111        


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMS-AVVK  295 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-~v~~  295 (356)
                       +... ....+...+.++.+++.+||+.||++||++. +|++
T Consensus       230 -i~~~-~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          230 -IRMD-NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             -HHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -HHhC-CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence             1111 1222334567799999999999999999997 6654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-46  Score=344.39  Aligned_cols=253  Identities=19%  Similarity=0.256  Sum_probs=207.0

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...|++.+.||+|+||+||+|.+. +|+.||+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            357999999999999999999764 68999999997543 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC--CCceEEcccCCccccCCCC
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA--NFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~--~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |+.|++|.+++......+++..+..++.||+.||.|||+   .+++||||||+|||++.  ++.+||+|||++.......
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999999996666689999999999999999999999   99999999999999974  4789999999998765443


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      ..   ....||..|+|||++.+. .++.++|||||||++|||++|..||......       .....+....      ..
T Consensus       206 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~i~~~~------~~  268 (387)
T 1kob_A          206 IV---KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCD------WE  268 (387)
T ss_dssp             CE---EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCC------CC
T ss_pred             ce---eeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC------CC
Confidence            22   223689999999999876 7899999999999999999999998543210       0011110000      00


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .........+.++.+++.+||+.||++|||+.++++.
T Consensus       269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1112223456779999999999999999999999974

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-46  Score=340.80  Aligned_cols=259  Identities=23%  Similarity=0.265  Sum_probs=205.4

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   97 (356)
                      ...+|++.+.||+|+||.||+|++. +++.||||++....  .....+.+.+|..+++++ +||||+++++++.+....+
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   86 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF   86 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence            3467899999999999999999865 58999999997542  234456788999999988 8999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||++|++|..++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        87 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999998843 4579999999999999999999999   9999999999999999999999999999986432


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ...  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........       .........+.
T Consensus       163 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~~~~~~~~i~  232 (345)
T 3a8x_A          163 PGD--TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLFQVIL  232 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHHHHHHH
T ss_pred             CCC--cccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------ccHHHHHHHHH
Confidence            221  23446799999999999876 789999999999999999999999854322111000       00001111111


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPM------SAVVK  295 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~------~~v~~  295 (356)
                      .. ....+...+.++.+++.+||+.||.+||++      +++++
T Consensus       233 ~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          233 EK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             HC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             cC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            11 122334566789999999999999999996      56654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.9e-47  Score=344.03  Aligned_cols=249  Identities=23%  Similarity=0.314  Sum_probs=203.2

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ..+|.+.+.||+|+||+||+|.+ .+++.||||++.....  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46799999999999999999976 5799999999875321  12235788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+ +|+|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 6788888743 4579999999999999999999999   999999999999999999999999999998765432


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      .   ....+||+.|+|||++.+....+.++|||||||++|+|++|..||..........                .+. .
T Consensus       163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i~-~  222 (336)
T 3h4j_B          163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KVN-S  222 (336)
T ss_dssp             T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CCC-S
T ss_pred             c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HHH-c
Confidence            2   2335699999999999876434789999999999999999999986543221100                000 0


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .....+...+.++.+++.+||+.||.+|||++++++.
T Consensus       223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            0111223345678899999999999999999999873

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.1e-46  Score=341.98  Aligned_cols=247  Identities=21%  Similarity=0.225  Sum_probs=205.7

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ...+|++.+.||+|+||.||+|++. +|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3468899999999999999999865 69999999996532  12344678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||++|++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.+|.+||+|||+++.....
T Consensus       119 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            9999999999999853 3579999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .     ...+||+.|+|||++.+. .++.++|||||||++|||++|..||.....       ...+.         .+..
T Consensus       195 ~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~---------~i~~  252 (350)
T 1rdq_E          195 T-----WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYE---------KIVS  252 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH---------HHHH
T ss_pred             c-----ccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHH---------HHHc
Confidence            2     234689999999999876 789999999999999999999999854321       11111         1111


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      .. ...+...+.++.+++.+||+.||.+||+     +++|++
T Consensus       253 ~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          253 GK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC-CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            11 1223345678999999999999999998     888876

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.8e-46  Score=339.84  Aligned_cols=254  Identities=21%  Similarity=0.244  Sum_probs=197.3

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHHccCCCCceeeeeceE
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRTYHINLVRLYGFC   90 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~   90 (356)
                      ...+...+|++.+.||+|+||.||+++.    .+|+.||+|++....   .......+.+|+.++++++||||+++++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            3445678899999999999999999976    468999999997542   123345688999999999999999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      .+....++||||++|++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCC
Confidence            99999999999999999999884 34578999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      +++.......  ......||+.|+|||++.+. .++.++||||||+++|+|++|..||......       ...      
T Consensus       167 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~------  230 (327)
T 3a62_A          167 LCKESIHDGT--VTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------KTI------  230 (327)
T ss_dssp             CC------------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHH------
T ss_pred             cccccccCCc--cccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------HHH------
Confidence            9875432221  22345799999999999876 6899999999999999999999998543211       001      


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                         ..+.... ...+...+.++.+++.+||+.||.+||     ++.++++
T Consensus       231 ---~~i~~~~-~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          231 ---DKILKCK-LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---HHHHHTC-CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---HHHHhCC-CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence               1111111 122334567799999999999999999     7778876

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.7e-46  Score=335.20  Aligned_cols=265  Identities=23%  Similarity=0.371  Sum_probs=203.4

Q ss_pred             HhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      ....+|++.+.||+|+||.||+|.. .+|+.||||++...  ........+.+|+.++++++||||+++++++.+....+
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            3456799999999999999999975 47999999999742  23445577899999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           98 LVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      +||||+++++|.+++..   ....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            99999999999998853   35679999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ......  ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||.......              .....
T Consensus       186 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~  248 (310)
T 2wqm_A          186 FSSKTT--AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------------YSLCK  248 (310)
T ss_dssp             ---------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCH--------------HHHHH
T ss_pred             ecCCCc--cccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhH--------------HHHHH
Confidence            543322  12234689999999999876 78999999999999999999999875432210              00111


Q ss_pred             HHHhcCCCc-hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          255 TILACGIEE-KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       255 ~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                      .+.....+. .....+.++.+++.+||+.||++||++.+|++.|+++.+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          249 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             HHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            111111111 123456779999999999999999999999999999876543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=340.99  Aligned_cols=251  Identities=23%  Similarity=0.318  Sum_probs=190.2

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ....|++.+.||+|+||+||+|.+. +++.||||++...   ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc---hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            4566899999999999999999875 5889999999764   33467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---CCceEEcccCCccccCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDR  177 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfgl~~~~~~  177 (356)
                      ||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.   ++.+||+|||+++....
T Consensus       128 e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          128 ELVTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCCSCBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            9999999999884 45679999999999999999999999   99999999999999975   88999999999986543


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ..   ......||..|+|||++.+. .++.++|||||||++|||++|..||......      ......+.....     
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~-----  268 (349)
T 2w4o_A          204 QV---LMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEY-----  268 (349)
T ss_dssp             ------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCC-----
T ss_pred             cc---ccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCC-----
Confidence            22   12335689999999999876 6899999999999999999999998543321      001111111000     


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       ..........+.++.+++.+||+.||++|||+.++++
T Consensus       269 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          269 -YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0011222345677999999999999999999999997

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.9e-46  Score=347.44  Aligned_cols=254  Identities=21%  Similarity=0.273  Sum_probs=198.5

Q ss_pred             hhhccccccccccCceEEEEEEeCCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCC--CCceeeeeceEecCCeeeEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTY--HINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ...|.+.+.||+|+||+||+|.+.+++.||||++... ......+.+.+|+.+++++.  ||||+++++++......++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3459999999999999999998878999999999753 23455578999999999996  59999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      || +.+++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++......
T Consensus       135 ~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             Ee-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            99 557899999854 4578999999999999999999999   9999999999999995 5799999999998765443


Q ss_pred             CeeeeccCCCCCCCCCcccccCC----------CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      .........||+.|+|||++.+.          ..++.++|||||||++|||++|..||......         .     
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---------~-----  274 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------I-----  274 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---------H-----
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---------H-----
Confidence            33333456799999999998641          25789999999999999999999998532211         0     


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ..+............+...+.++.+++.+||+.||.+||++.++++.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            00111111111111222235678899999999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-46  Score=332.52  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=200.3

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ...+|.+.++||+|+||+||+|... +++.||+|++.........+.+.+|++++++++||||+++++++.+....++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            4468999999999999999999764 689999999986655556678999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE---cCCCceEEcccCCccc
Q 038199          101 EYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKL  174 (356)
Q Consensus       101 e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfgl~~~  174 (356)
                      ||+++++|.+++...   ...+++..+..++.|++.||.|||+   .+++||||||+||++   +.++.++|+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999988432   4679999999999999999999999   999999999999999   4567899999999976


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ......   .....||..|+|||.+.+  .++.++||||||+++|+|++|..||......       .......      
T Consensus       177 ~~~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-------~~~~~~~------  238 (285)
T 3is5_A          177 FKSDEH---STNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-------EVQQKAT------  238 (285)
T ss_dssp             -------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHH------
T ss_pred             cCCccc---CcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHH-------HHHhhhc------
Confidence            543322   233568999999999864  5789999999999999999999998543211       0000000      


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       .............+.++.+++.+||+.||++|||+.++++
T Consensus       239 -~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          239 -YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -HCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -cCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0001111111224567889999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.8e-47  Score=355.06  Aligned_cols=260  Identities=20%  Similarity=0.210  Sum_probs=208.2

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      +...+|++.++||+|+||+||+|++. +++.||+|++....  .......+.+|..++..++||||+++++++.+....+
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            34568899999999999999999875 58899999997521  1122234889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+.||+|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence            9999999999999997667789999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCeeeeccCCCCCCCCCccccc----CCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      .... .....+||+.|+|||++.    +...++.++|||||||++|||++|+.||......       ..+..+..    
T Consensus       228 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~----  295 (437)
T 4aw2_A          228 DGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMN----  295 (437)
T ss_dssp             TSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHT----
T ss_pred             CCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-------HHHHhhhh----
Confidence            3322 233467999999999986    2336899999999999999999999998643221       11111110    


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPED--RPPMSAVVKM  296 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~  296 (356)
                       .......+......+.++.+++.+||..+|++  ||+++++++.
T Consensus       296 -~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          296 -HKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             -HHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             -ccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence             00111222222345677899999999888888  9999999873

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.3e-46  Score=331.81  Aligned_cols=268  Identities=19%  Similarity=0.233  Sum_probs=210.6

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceE-ecCCeeeEEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC-HDQHMTALVY  100 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~-~~~~~~~lV~  100 (356)
                      ..+|++.+.||+|+||+||+|.+ .+|+.||||++....   ..+.+.+|+.+++.++|++++..+..+ .+....++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            46799999999999999999976 579999999987542   224688999999999987766555544 6677889999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE---cCCCceEEcccCCccccCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||+ +++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||++   +.++.+||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999 889999997667789999999999999999999999   999999999999999   4888999999999987655


Q ss_pred             CCCee-----eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          178 NRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       178 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      .....     ......||..|+|||.+.+. .++.++||||||+++|+|++|+.||...........    .......  
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~--  233 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK----YERISEK--  233 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH----HHHHHHH--
T ss_pred             cccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh----hhhhccc--
Confidence            43321     12345699999999999877 689999999999999999999999876433221110    1111110  


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCCC
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPP  307 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~  307 (356)
                         .............+.++.+++.+||+.||++||++++|++.|+.+.......
T Consensus       234 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          234 ---KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             ---HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ---ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence               0011111112334577999999999999999999999999999887655443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.7e-46  Score=351.20  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=208.2

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      .+....|.+.+.||+|+||.||+|.+. +|+.||||++....  .......+.+|+.+++.++||||+++++++.+....
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            345678999999999999999999865 79999999997532  112346789999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||++|++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++....
T Consensus        92 ~lv~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           92 FMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EEEEECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999999984 45679999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ....   ....+||+.|+|||++.+....+.++|||||||++|+|++|..||......       .....+         
T Consensus       168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i---------  228 (476)
T 2y94_A          168 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------TLFKKI---------  228 (476)
T ss_dssp             TTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------HHHHHH---------
T ss_pred             cccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------HHHHHH---------
Confidence            4322   234579999999999987643478999999999999999999998543221       111111         


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ... ....+...+.++.+++.+||+.||.+|||++++++
T Consensus       229 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          229 CDG-IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HTT-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcC-CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            111 11222334567899999999999999999999997

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.5e-46  Score=340.68  Aligned_cols=252  Identities=24%  Similarity=0.288  Sum_probs=204.3

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCe
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHM   95 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~   95 (356)
                      .+...+|++.+.||+|+||+||+|+.. +|+.||||++....  .....+.+..|..+++.+ +||||+++++++.+...
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            355678999999999999999999875 48899999997532  223446788999999988 79999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||++||+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.+|.+||+|||+++..
T Consensus        96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999999843 4579999999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      .....  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||......                .....
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~~~~  232 (353)
T 2i0e_A          172 IWDGV--TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------------ELFQS  232 (353)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHH
T ss_pred             ccCCc--ccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHH----------------HHHHH
Confidence            32221  23346799999999999876 7899999999999999999999998543211                11111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      +.... ...+...+.++.+++.+||+.||.+||+     +++|++
T Consensus       233 i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          233 IMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHCC-CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHhCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            11111 1233456678999999999999999995     466665

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.4e-46  Score=333.43  Aligned_cols=262  Identities=25%  Similarity=0.345  Sum_probs=210.3

Q ss_pred             HHhhhhccccc-cccccCceEEEEEEe---CCCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           20 QLNNFTSNYST-RLGFGGFGEVYKGQF---PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        20 ~~~~~~~~~~~-~iG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      .+...+|.+.+ .||+|+||+||+|.+   .+++.||||++..... ....+.+.+|+.++++++||||+++++++ +..
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            34567888887 999999999999953   2478999999975432 33357899999999999999999999999 556


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            78999999999999999954 4579999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchh
Q 038199          175 CDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       175 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ......... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.....                ...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~  229 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEV  229 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHH
T ss_pred             eccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----------------HHH
Confidence            655443322 2223467889999999766 68899999999999999999 9888754321                111


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      ...+........+...+..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          230 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            222222333344456677899999999999999999999999999987643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.1e-46  Score=338.34  Aligned_cols=261  Identities=24%  Similarity=0.383  Sum_probs=208.0

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEE--EEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKI--AVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~   96 (356)
                      +...+|++.+.||+|+||.||+|.+. ++..+  |||.+...........+.+|+++++++ +||||+++++++.+....
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            44578899999999999999999754 56644  999987654445556799999999999 899999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC
Q 038199           97 ALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  161 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~  161 (356)
                      ++||||+++++|.+++....               ..+++..++.++.||+.||.|||+   .+++||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCC
Confidence            99999999999999996543               479999999999999999999999   999999999999999999


Q ss_pred             CceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccch
Q 038199          162 FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFP  240 (356)
Q Consensus       162 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~  240 (356)
                      +.+||+|||+++......   ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.....       
T Consensus       179 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------  247 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------  247 (327)
T ss_dssp             GCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------
T ss_pred             CeEEEcccCcCccccccc---cccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------
Confidence            999999999987432211   11223468899999999766 68999999999999999998 9888744321       


Q ss_pred             hhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                               ......+........+...+.++.+++.+||..||.+|||++++++.|+.+....
T Consensus       248 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          248 ---------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             ---------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ---------HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence                     0111112222223334455678999999999999999999999999999876643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=340.40  Aligned_cols=269  Identities=22%  Similarity=0.259  Sum_probs=199.1

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|.+.++||+|+||+||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46899999999999999999765 68999999997543222223456799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++ +|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........  
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--  155 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  155 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--
Confidence            975 9999887777789999999999999999999999   9999999999999999999999999999976543222  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH--------hhchhhH
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY--------EKSELDA  254 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~  254 (356)
                      ......||..|+|||++.+...++.++||||||+++|+|++|+.||.........   .......        .......
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcch
Confidence            2233468999999999987557899999999999999999999998553321100   0000000        0000000


Q ss_pred             HHHh----cCC----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhccc
Q 038199          255 TILA----CGI----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK--MLEGVV  301 (356)
Q Consensus       255 ~~~~----~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~~  301 (356)
                      ....    ...    ....+..+.++.+++.+||+.||++|||++++++  .+..+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            0000    000    0111234567889999999999999999999998  344443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=336.80  Aligned_cols=271  Identities=21%  Similarity=0.264  Sum_probs=210.5

Q ss_pred             HHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe----cC
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH----DQ   93 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~----~~   93 (356)
                      ..+...+|++.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.    ..
T Consensus        24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            445678899999999999999999976 57999999998653 2455678999999999999999999999987    34


Q ss_pred             CeeeEEEeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           94 HMTALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      ...++||||+.+++|.+++..   ....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecC
Confidence            578899999999999998854   35679999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCee-------eeccCCCCCCCCCcccccCCC--CCCccccchhhHHHHHHHHhCCcccccCCCCccccchh
Q 038199          171 LAKLCDRNRSHV-------TISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK  241 (356)
Q Consensus       171 l~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~  241 (356)
                      ++..........       ......||..|+|||.+.+..  .++.++||||||+++|+|++|..||.....        
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------  251 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ--------  251 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH--------
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc--------
Confidence            987543211000       001234789999999987542  368899999999999999999988732100        


Q ss_pred             hhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCCC
Q 038199          242 HVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPP  307 (356)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~  307 (356)
                            ...............+.....+..+.+++.+||+.||.+||+++++++.|+.+....+.+
T Consensus       252 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          252 ------KGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             ------TTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             ------ccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence                  001111111111112223445678999999999999999999999999999887654443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.7e-47  Score=334.09  Aligned_cols=256  Identities=26%  Similarity=0.375  Sum_probs=203.9

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC-Cee
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-HMT   96 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-~~~   96 (356)
                      .+.+...+|++.+.||+|+||+||++++ +|+.||||++...   ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus        15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           15 GWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cccCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            3456778999999999999999999988 5889999999764   3456789999999999999999999987654 478


Q ss_pred             eEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           97 ALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      ++||||+++++|.+++.... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            99999999999999985432 238999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ....     ....++..|+|||.+.+. .++.++||||||+++|+|++ |..|+......                ....
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----------------~~~~  225 (278)
T 1byg_A          168 SSTQ-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVP  225 (278)
T ss_dssp             -------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----------------GHHH
T ss_pred             cccc-----cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHH
Confidence            4322     123478899999999766 68999999999999999998 88887443211                1111


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .+........+...+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            122222233344567789999999999999999999999999988753

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.4e-47  Score=343.56  Aligned_cols=274  Identities=24%  Similarity=0.338  Sum_probs=202.9

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHH--HccCCCCceeeeeceEec----
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGT--IGRTYHINLVRLYGFCHD----   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~ni~~~~~~~~~----   92 (356)
                      ..+...+|++.+.||+|+||+||+|++ +++.||||++...    ....+..|.++  ++.++||||+++++.+..    
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            345677899999999999999999987 7899999999753    22334444444  455899999999985532    


Q ss_pred             -CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC---------CccccCCCCCcEEEcCCC
Q 038199           93 -QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ---------RIIHYDIKPENVLLDANF  162 (356)
Q Consensus        93 -~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~---------~ivH~dikp~Nill~~~~  162 (356)
                       ....++||||+++++|.+++..  ...++..+..++.||+.||.|||+   .         +|+||||||+|||++.++
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             CCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCC
Confidence             3356899999999999999943  345899999999999999999998   7         999999999999999999


Q ss_pred             ceEEcccCCccccCCCCC------eeeeccCCCCCCCCCcccccCC------CCCCccccchhhHHHHHHHHhCCccccc
Q 038199          163 SPKVADFGLAKLCDRNRS------HVTISGYKGTPGYSAPEFLSGN------YPITHKCDVYSFGMVLFEIVGRRRNAIV  230 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~Dv~slGvvl~elltg~~p~~~  230 (356)
                      .+||+|||++........      ........||..|+|||++.+.      ..++.++|||||||++|||++|..|+..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            999999999987653321      1122345699999999998762      2456789999999999999999888766


Q ss_pred             CCCCccccchhhhHHHHhh----chhhHHHHhc-CCC------chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          231 GSSESLDWFPKHVWEEYEK----SELDATILAC-GIE------EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-~~~------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      +.........  .......    .......... ..+      ......+.++.+++.+||+.||++|||++++++.|+.
T Consensus       238 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          238 GESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             TSCCCCCCCT--THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccchhHHHHh--hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            5443221100  0000000    0000001000 011      1123467789999999999999999999999999999


Q ss_pred             cccCC
Q 038199          300 VVEVL  304 (356)
Q Consensus       300 ~~~~~  304 (356)
                      +....
T Consensus       316 ll~~~  320 (336)
T 3g2f_A          316 LMMIW  320 (336)
T ss_dssp             HHHCC
T ss_pred             HHHHH
Confidence            87654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.3e-46  Score=333.09  Aligned_cols=267  Identities=19%  Similarity=0.235  Sum_probs=206.7

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceE-ecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC-HDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~-~~~~~~~lV   99 (356)
                      ...+|++.+.||+|+||+||+|.+ .+++.||||++....   ....+.+|+.+++.++|++++..+..+ .+....++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            356899999999999999999975 579999999876532   223578899999999877766655554 677788999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE---cCCCceEEcccCCccccC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCD  176 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfgl~~~~~  176 (356)
                      |||+ +++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||++   +.++.+||+|||+++...
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 889999997667789999999999999999999999   999999999999999   788999999999998765


Q ss_pred             CCCCee-----eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          177 RNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       177 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      ......     ......||..|+|||.+.+. .++.++|||||||++|+|++|+.||...........    ....... 
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~-  233 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK----YERISEK-  233 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH----HHHHHHH-
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh----hhhhhcc-
Confidence            443321     12345689999999999877 689999999999999999999999866443222111    1111000 


Q ss_pred             hhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                          .............+.++.+++.+||+.||++||++++|++.|+.+.....
T Consensus       234 ----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          234 ----KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             ----HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             ----cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence                00111111112345679999999999999999999999999998876543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.8e-46  Score=336.65  Aligned_cols=252  Identities=23%  Similarity=0.280  Sum_probs=183.3

Q ss_pred             hhcccc---ccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeE
Q 038199           24 FTSNYS---TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        24 ~~~~~~---~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~l   98 (356)
                      ..|++.   +.||+|+||+||+|.+. +++.||||++...    ....+.+|+.+++++. ||||+++++++.+....++
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            445553   78999999999999764 6899999999653    3456788999999997 9999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC---ceEEcccCCcccc
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLC  175 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~kl~Dfgl~~~~  175 (356)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++   .+||+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           84 VMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            9999999999999854 4679999999999999999999999   9999999999999997765   8999999999865


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      .....  ......||..|+|||++.+. .++.++||||||+++|+|++|..||...........         .......
T Consensus       160 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---------~~~~~~~  227 (325)
T 3kn6_A          160 PPDNQ--PLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS---------AVEIMKK  227 (325)
T ss_dssp             CC------------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC---------HHHHHHH
T ss_pred             CCCCC--cccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc---------HHHHHHH
Confidence            43322  22345689999999999876 789999999999999999999999865432111000         0011111


Q ss_pred             HHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +......   ......+.++.+++.+||+.||.+|||++++++
T Consensus       228 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          228 IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1111111   122345778999999999999999999999885

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.4e-46  Score=338.59  Aligned_cols=268  Identities=25%  Similarity=0.341  Sum_probs=210.4

Q ss_pred             eecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHcc--CCCCceeeeeceEec
Q 038199           15 RFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR--TYHINLVRLYGFCHD   92 (356)
Q Consensus        15 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~~~~~~~~   92 (356)
                      .+...+....+|.+.+.||+|+||+||+|++ +|+.||||++...    ....+.+|.+++..  ++||||+++++++.+
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            3444667788999999999999999999988 6899999999643    34567788888887  689999999999987


Q ss_pred             CC----eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCccccCCCCCcEEEcC
Q 038199           93 QH----MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH--------EECQQRIIHYDIKPENVLLDA  160 (356)
Q Consensus        93 ~~----~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~dikp~Nill~~  160 (356)
                      ..    ..++||||+++++|.+++..  ..+++..++.++.|++.||.|||        +   .+++||||||+||+++.
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKK  182 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECT
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECC
Confidence            75    78999999999999999943  47999999999999999999999        7   89999999999999999


Q ss_pred             CCceEEcccCCccccCCCCCee--eeccCCCCCCCCCcccccCCCC-----CCccccchhhHHHHHHHHhC---------
Q 038199          161 NFSPKVADFGLAKLCDRNRSHV--TISGYKGTPGYSAPEFLSGNYP-----ITHKCDVYSFGMVLFEIVGR---------  224 (356)
Q Consensus       161 ~~~~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-----~~~~~Dv~slGvvl~elltg---------  224 (356)
                      ++.+||+|||++..........  ......||..|+|||.+.+...     ++.++||||||+++|||++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            9999999999998766544332  1234568999999999876522     23689999999999999999         


Q ss_pred             -CcccccCCCCccccchhhhHHHHhhchhhHHHHhcC-CCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          225 -RRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG-IEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       225 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                       ..||.........      ...     ....+.... .+.     .....+..+.+++.+||+.||++|||+.+|++.|
T Consensus       263 ~~~p~~~~~~~~~~------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          263 YQLPYYDLVPSDPS------VEE-----MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             CCCTTTTTSCSSCC------HHH-----HHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             cccCccccCcCccc------HHH-----HHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence             4444332111000      000     111111111 111     1236678899999999999999999999999999


Q ss_pred             hccccC
Q 038199          298 EGVVEV  303 (356)
Q Consensus       298 ~~~~~~  303 (356)
                      +.+...
T Consensus       332 ~~i~~~  337 (342)
T 1b6c_B          332 SQLSQQ  337 (342)
T ss_dssp             HHHHHT
T ss_pred             HHHHHH
Confidence            987543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=348.26  Aligned_cols=274  Identities=18%  Similarity=0.194  Sum_probs=213.9

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC--eee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH--MTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~--~~~   97 (356)
                      ....+|.+.++||+|+||+||+|.+. +|+.||||++.........+.+.+|++++++++||||+++++++.+..  ..+
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            45678999999999999999999765 599999999986544455677889999999999999999999998655  679


Q ss_pred             EEEeccCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE----cCCCceEEcccCC
Q 038199           98 LVYEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGL  171 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill----~~~~~~kl~Dfgl  171 (356)
                      +||||+++++|.+++....  ..+++..++.++.||+.||.|||+   .+|+||||||+||++    +.++.+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999995432  339999999999999999999999   999999999999999    7778899999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCC-------CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhH
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-------YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVW  244 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~  244 (356)
                      ++.......   .....||..|+|||++.+.       ..++.++|||||||++|||++|+.||.........  .....
T Consensus       163 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~  237 (396)
T 4eut_A          163 ARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMY  237 (396)
T ss_dssp             CEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHH
T ss_pred             ceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHH
Confidence            987654322   2335699999999998641       25688999999999999999999998654332111  01111


Q ss_pred             HHHhhchhhHH-----H---------HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          245 EEYEKSELDAT-----I---------LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       245 ~~~~~~~~~~~-----~---------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ...........     .         ............+..+.+++.+||+.||++||+++++++.+..+..
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            11110000000     0         0000112346778889999999999999999999999999888765

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.9e-46  Score=341.20  Aligned_cols=248  Identities=21%  Similarity=0.299  Sum_probs=198.7

Q ss_pred             hccc--cccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           25 TSNY--STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        25 ~~~~--~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .|.+  .+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E  166 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME  166 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3444  57899999999999976 469999999997642 3455789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE--cCCCceEEcccCCccccCCCC
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL--DANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill--~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |+++++|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||+  +.++.+||+|||+++......
T Consensus       167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            999999999886666789999999999999999999999   999999999999999  567899999999998765433


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      .   .....||+.|+|||++.+. .++.++|||||||++|||++|..||......       .....        .....
T Consensus       244 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~--------i~~~~  304 (373)
T 2x4f_A          244 K---LKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNN--------ILACR  304 (373)
T ss_dssp             B---CCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHH--------HHHTC
T ss_pred             c---cccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH--------HHhcc
Confidence            2   2234699999999999866 6899999999999999999999998543221       00111        11111


Q ss_pred             --CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 --GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 --~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                        .........+.++.+++.+||+.||.+||++.++++
T Consensus       305 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          305 WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              011222345678999999999999999999999997

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=342.26  Aligned_cols=271  Identities=18%  Similarity=0.218  Sum_probs=201.5

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC----CCcEEEEEEeccccchh----------hHHHHHHHHHHHccCCCCceee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRI----------AEEQFMAEVGTIGRTYHINLVR   85 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~ni~~   85 (356)
                      ++...+|.+.+.||+|+||+||+|.+.    ++..||||++.......          ....+.+|+..++.++||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            345678999999999999999999764    57889999987543211          1124668889999999999999


Q ss_pred             eeceEec----CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC
Q 038199           86 LYGFCHD----QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  161 (356)
Q Consensus        86 ~~~~~~~----~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~  161 (356)
                      +++++.+    ....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+   .+++||||||+||+++.+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG-GGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence            9999987    67899999999 9999999843 3489999999999999999999999   999999999999999887


Q ss_pred             C--ceEEcccCCccccCCCCCe-----eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCC
Q 038199          162 F--SPKVADFGLAKLCDRNRSH-----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSE  234 (356)
Q Consensus       162 ~--~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~  234 (356)
                      +  .+||+|||+++........     .......||..|+|||++.+. .++.++|||||||++|||++|..||......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            7  9999999999876432211     111345699999999999876 7899999999999999999999998542221


Q ss_pred             ccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          235 SLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ....  ........ ...........   .....+.++.+++.+||..||++||++++|++.|+.+.-
T Consensus       267 ~~~~--~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          267 PVAV--QTAKTNLL-DELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHH--HHHHHHHH-HTTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cHHH--HHHHHhhc-ccccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1000  00000000 00000000000   001345679999999999999999999999999987654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.5e-46  Score=348.06  Aligned_cols=273  Identities=22%  Similarity=0.289  Sum_probs=202.5

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC-----Ce
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HM   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-----~~   95 (356)
                      ..+|.+.+.||+|+||+||+|.+. +++.||||++.... ......++.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            568999999999999999999764 68999999997542 334557899999999999999999999999766     56


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+. ++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 49999884 45679999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCe--------------------eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCc
Q 038199          176 DRNRSH--------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSES  235 (356)
Q Consensus       176 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~  235 (356)
                      ......                    .......||.+|+|||++.....++.++|||||||++|||++|..|+.......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            543221                    123456799999999987555479999999999999999998755544332222


Q ss_pred             cccchhh---------------------------------h---HHHHhhchhhHHHHhcCC-Cc-----hhHHHHHHHH
Q 038199          236 LDWFPKH---------------------------------V---WEEYEKSELDATILACGI-EE-----KDKEKAKRLC  273 (356)
Q Consensus       236 ~~~~~~~---------------------------------~---~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~l~  273 (356)
                      ..+++..                                 .   +..+........+..... ..     ..+..+.++.
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  339 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI  339 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence            1111100                                 0   000000011111111000 00     0123567889


Q ss_pred             HHHHhcccCCCCCCCCHHHHHH--HHhcc
Q 038199          274 MAALWCVQDSPEDRPPMSAVVK--MLEGV  300 (356)
Q Consensus       274 ~l~~~cl~~~p~~Rps~~~v~~--~L~~~  300 (356)
                      +++.+||+.||++|||++++++  .+..+
T Consensus       340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          340 NLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             HHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            9999999999999999999998  35444

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4e-46  Score=340.14  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=202.7

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ..|.+.+.||+|+||+||+|.. .+|+.||||++....  .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999975 579999999997532  2334467899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+. |+|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 58888876566789999999999999999999999   99999999999999999999999999999765432  


Q ss_pred             eeeeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          181 HVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                          ....||+.|+|||++.+  ...++.++|||||||++|||++|..|+......      ..         .......
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~---------~~~~~~~  268 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA---------LYHIAQN  268 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HH---------HHHHHHS
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HH---------HHHHHhc
Confidence                23468999999999852  236899999999999999999999987543211      00         0111111


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      ..........+..+.+++.+||+.||++|||++++++..
T Consensus       269 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          269 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            111122234566789999999999999999999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-45  Score=338.08  Aligned_cols=272  Identities=24%  Similarity=0.235  Sum_probs=209.6

Q ss_pred             CcceecHHHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-----CCceee
Q 038199           12 KPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-----HINLVR   85 (356)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni~~   85 (356)
                      ...++..+++...+|.+.++||+|+||+||+|.+ .+++.||||++...  ......+..|+.+++.+.     ||||++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            4456677788889999999999999999999976 46899999999753  344567788999999886     999999


Q ss_pred             eeceEecCCeeeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC----
Q 038199           86 LYGFCHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----  160 (356)
Q Consensus        86 ~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~----  160 (356)
                      +++++......++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 889999986543 469999999999999999999999   99999999999999975    


Q ss_pred             ---------------------CCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHH
Q 038199          161 ---------------------NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF  219 (356)
Q Consensus       161 ---------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~  219 (356)
                                           ++.+||+|||++.......     ....||..|+|||++.+. .++.++|||||||++|
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~  250 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC-CCCCccchHHHHHHHH
Confidence                                 7899999999998654322     235689999999999877 7899999999999999


Q ss_pred             HHHhCCcccccCCCCccc--------cchhhhHHHHhhchhhH---------------------HHHhcCCCchhHHHHH
Q 038199          220 EIVGRRRNAIVGSSESLD--------WFPKHVWEEYEKSELDA---------------------TILACGIEEKDKEKAK  270 (356)
Q Consensus       220 elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~  270 (356)
                      +|++|+.||.........        -.+...+..........                     .......+........
T Consensus       251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            999999998653321100        00000000000000000                     0000001111111236


Q ss_pred             HHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          271 RLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       271 ~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+.+++.+||+.||++|||++++++
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhc
Confidence            6889999999999999999999985

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-45  Score=342.40  Aligned_cols=278  Identities=15%  Similarity=0.153  Sum_probs=209.8

Q ss_pred             HHHHhhhhcccccccccc--CceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           18 SLQLNNFTSNYSTRLGFG--GFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      .+-....+|++.++||+|  +||+||+|.+. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus        19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            334567889999999999  99999999865 69999999997543 234456788999999999999999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           94 HMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ...++||||+++++|.+++... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence            9999999999999999998654 4679999999999999999999999   99999999999999999999999999988


Q ss_pred             cccCCCCCe-----eeeccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH
Q 038199          173 KLCDRNRSH-----VTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       173 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      .........     .......||..|+|||++.+. ..++.++|||||||++|||++|+.||.........  .......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~  253 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGT  253 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC----
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCC
Confidence            654322111     111224688999999999863 36899999999999999999999998654332110  0000000


Q ss_pred             Hh----------------------hchhhHHH---------HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          247 YE----------------------KSELDATI---------LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       247 ~~----------------------~~~~~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..                      ........         ............+..+.+++.+||+.||++|||++++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00                      00000000         000011123345677999999999999999999999987


Q ss_pred             H--Hhcc
Q 038199          296 M--LEGV  300 (356)
Q Consensus       296 ~--L~~~  300 (356)
                      .  +..+
T Consensus       334 hp~f~~~  340 (389)
T 3gni_B          334 HSFFKQI  340 (389)
T ss_dssp             SGGGGGC
T ss_pred             CHHHHHH
Confidence            4  4443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=350.09  Aligned_cols=260  Identities=21%  Similarity=0.196  Sum_probs=206.6

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      .+...+|++.++||+|+||+||+|+.. +|+.||||+++...  .......+.+|..++.+++||||+++++++.+....
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            345678999999999999999999864 69999999997531  122234588999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||++||+|.+++...+..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++...
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            99999999999999996655689999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccC------CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSG------NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      ..... .....+||+.|+|||++.+      ...++.++|||||||++|||++|+.||......       ..+..+.. 
T Consensus       214 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~-  284 (412)
T 2vd5_A          214 ADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------ETYGKIVH-  284 (412)
T ss_dssp             TTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHT-
T ss_pred             CCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-
Confidence            43322 2234579999999999862      225899999999999999999999998543221       11111110 


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHH
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDR---PPMSAVVKM  296 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---ps~~~v~~~  296 (356)
                          .......+......+.++.+++.+||. +|.+|   |++++|++.
T Consensus       285 ----~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          285 ----YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ----HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ----cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                001111222234566789999999999 99998   589998873

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.5e-45  Score=331.53  Aligned_cols=250  Identities=22%  Similarity=0.350  Sum_probs=205.9

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccch-----hhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ....|++.+.||+|+||.||+|.+. +|+.||||++......     ...+.+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3567999999999999999999765 6999999999754321     235789999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC----ceEEcccCC
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGL  171 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfgl  171 (356)
                      .++||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++    .++|+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            999999999999999994 45679999999999999999999999   9999999999999999887    799999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      +........   .....||..|+|||.+.+. .++.++||||||+++|+|++|..||......       .....     
T Consensus       166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~-----  229 (321)
T 2a2a_A          166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLAN-----  229 (321)
T ss_dssp             CEECCTTCC---CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHH-----
T ss_pred             ceecCcccc---ccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------HHHHH-----
Confidence            987654322   2335689999999999876 7899999999999999999999998543211       00111     


Q ss_pred             hhHHHHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          252 LDATILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       252 ~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          +......   ......+..+.+++.+||+.||++|||+.++++
T Consensus       230 ----i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          230 ----ITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             ----HHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ----HHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                1111111   111234567899999999999999999999997

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-45  Score=347.65  Aligned_cols=198  Identities=23%  Similarity=0.323  Sum_probs=156.5

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEec-----CCe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-----QHM   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~-----~~~   95 (356)
                      ..+|++.++||+|+||+||+|.+. +++.||||++.... .....+++.+|+.++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999764 69999999987542 33455789999999999999999999999843     356


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .|+||||+ +++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       132 ~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 469998884 45679999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCe-------------------------eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCC
Q 038199          176 DRNRSH-------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR  225 (356)
Q Consensus       176 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~  225 (356)
                      ......                         ......+||..|+|||++.....++.++|||||||++|||++|.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            432211                         12344678999999998755447999999999999999999953

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.7e-46  Score=333.34  Aligned_cols=267  Identities=20%  Similarity=0.249  Sum_probs=200.5

Q ss_pred             hhhccc-cccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEE
Q 038199           23 NFTSNY-STRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        23 ~~~~~~-~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ...|.+ .+.||+|+||+||+|.+. +++.||||++.... ......+.+|++++.++ +||||+++++++.+....++|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            356777 478999999999999754 69999999997543 34456789999999985 799999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc---eEEcccCCccccC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGLAKLCD  176 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~---~kl~Dfgl~~~~~  176 (356)
                      |||+++++|.+++.. ...+++..+..++.||+.||.|||+   .+++||||||+||+++.++.   +||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           90 FEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999999999853 4579999999999999999999999   99999999999999988765   9999999987654


Q ss_pred             CCCCe-----eeeccCCCCCCCCCcccccCC----CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          177 RNRSH-----VTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       177 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      .....     .......||..|+|||++.+.    ..++.++||||||+++|+|++|..||.........|.........
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            22111     112234589999999998641    247889999999999999999999997665443333211110000


Q ss_pred             hhchhhHHHHhcCCCchh---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILACGIEEKD---KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      . ......+.........   ...+..+.+++.+||+.||++|||+.++++
T Consensus       246 ~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          246 Q-NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             H-HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H-HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0 0111112222211111   234677999999999999999999999997

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.1e-46  Score=331.56  Aligned_cols=256  Identities=22%  Similarity=0.303  Sum_probs=192.5

Q ss_pred             HHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhH-HHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      +++...+|++.++||+|+||+||+|.+ .+|+.||||++......... ..+..+...++.++||||+++++++.+....
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            356678999999999999999999976 47999999999765333333 3445556668888999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           97 ALVYEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ++||||+++ +|.+++..   ....+++..+..++.|++.||.|||+   . +++||||||+||+++.++.+||+|||++
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence            999999975 88777643   46789999999999999999999999   7 9999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCccccc---CCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLS---GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      .........   ....||..|+|||.+.   ....++.++||||||+++|+|++|..|+......         .     
T Consensus       158 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~-----  220 (290)
T 3fme_A          158 GYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---------F-----  220 (290)
T ss_dssp             ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---------H-----
T ss_pred             ccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch---------H-----
Confidence            866443222   2246899999999962   2336889999999999999999999998543221         0     


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...................+.++.+++.+||+.||++|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          221 QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            0111111112222223345677999999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-45  Score=349.50  Aligned_cols=264  Identities=20%  Similarity=0.265  Sum_probs=210.6

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCC-CceeeeeceEecCCeeeEEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH-INLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ..+|.+.++||+|+||.||+|.+ .+++.||||++.....   ..++..|+++++.+.| +++..+..++.+....++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            46899999999999999999976 4699999999875422   2357889999999976 66777777777888999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE---cCCCceEEcccCCccccCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||+ +++|.+++......+++..++.|+.||+.||.|||+   .+|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999 889999997667889999999999999999999999   999999999999999   6889999999999987765


Q ss_pred             CCCee-----eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          178 NRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       178 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      .....     ......||..|+|||++.+. .++.++|||||||++|||++|..||........    ...+..+.... 
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~----~~~~~~i~~~~-  232 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK----KQKYEKISEKK-  232 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH----HHHHHHHHHHH-
T ss_pred             CccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhH----HHHHHHHhhcc-
Confidence            43321     12246799999999999877 789999999999999999999999865433211    11111111111 


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                          ...........++.++.+++.+||+.+|++||++++|++.|+.+...
T Consensus       233 ----~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          233 ----VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             ----HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence                11111122234467899999999999999999999999999887543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.2e-45  Score=323.77  Aligned_cols=248  Identities=22%  Similarity=0.298  Sum_probs=204.5

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ...+|.+.++||+|+||+||+|.+. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            3567999999999999999999765 58899999987543 234578999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE---cCCCceEEcccCCccccCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||++   +.++.++|+|||++.....
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999998843 4569999999999999999999999   999999999999999   7888999999999987654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ...   .....||..|+|||.+.+.  ++.++||||||+++|+|++|..||......                .....+.
T Consensus       162 ~~~---~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~  220 (277)
T 3f3z_A          162 GKM---MRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDS----------------EVMLKIR  220 (277)
T ss_dssp             TSC---BCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHH
T ss_pred             ccc---hhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHH
Confidence            332   2335689999999998754  799999999999999999999998543211                1111111


Q ss_pred             hcCCCchh---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          258 ACGIEEKD---KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       258 ~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........   ...+..+.+++.+||+.||++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          221 EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22111111   135678999999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.3e-46  Score=335.19  Aligned_cols=264  Identities=20%  Similarity=0.323  Sum_probs=209.5

Q ss_pred             cceecHHHHhhhhcccc-ccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCC-CCceeeeec
Q 038199           13 PVRFTSLQLNNFTSNYS-TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY-HINLVRLYG   88 (356)
Q Consensus        13 ~~~~~~~~~~~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~   88 (356)
                      .+.|...+.....|.+. +.||+|+||+||+|.+. +++.||||++.... .......+.+|+.+++++. ||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34667778888888887 88999999999999765 69999999987532 2334567899999999995 799999999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---CCce
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSP  164 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~  164 (356)
                      ++.+....++||||+.+++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.   ++.+
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence            999999999999999999999998543 4679999999999999999999999   99999999999999987   7899


Q ss_pred             EEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhH
Q 038199          165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVW  244 (356)
Q Consensus       165 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~  244 (356)
                      ||+|||+++.......   .....||+.|+|||++.+. .++.++||||||+++|+|++|..||......       ...
T Consensus       174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~  242 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ETY  242 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHH
T ss_pred             EEeeCccccccCCccc---cccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHH
Confidence            9999999987653322   2335689999999999876 7899999999999999999999998543221       000


Q ss_pred             HHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          245 EEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .....      .............+..+.+++.+||+.||++|||++++++.
T Consensus       243 ~~i~~------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          243 LNISQ------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHH------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHHh------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            00000      00111122234456779999999999999999999999863

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-45  Score=326.87  Aligned_cols=249  Identities=26%  Similarity=0.341  Sum_probs=201.7

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ...+|++.+.||+|+||+||+|.+. +++.||||++....  .......+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            4567999999999999999999764 58899999986532  12234678999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999998843 4579999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .    .....|+..|+|||.+.+. .++.++||||||+++|+|++|..||......       ......         ..
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~---------~~  221 (279)
T 3fdn_A          163 R----RTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRI---------SR  221 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHH---------HH
T ss_pred             c----ccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHH-------HHHHHH---------Hh
Confidence            2    2334689999999999876 6889999999999999999999997543210       011111         11


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                       .....+...+..+.+++.+||+.||.+||+++++++.
T Consensus       222 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 -VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             1112233456678999999999999999999999983

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=326.77  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=186.3

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ..+|++.+.||+|+||.||+|.. .+|+.||||++....  .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35789999999999999999976 479999999996432  112246789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            99999999999997666789999999999999999999999   999999999999999999999999999998764332


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      ..  .....||..|+|||.+.+. .++.++||||||+++|+|++|..|+........       ......          
T Consensus       167 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~----------  226 (278)
T 3cok_A          167 EK--HYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------LNKVVL----------  226 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCS----------
T ss_pred             Cc--ceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------HHHHhh----------
Confidence            21  1234689999999999876 689999999999999999999999865432110       000000          


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....+...+.++.+++.+||+.||++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          227 ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            001122234567899999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-46  Score=350.23  Aligned_cols=259  Identities=22%  Similarity=0.254  Sum_probs=206.7

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ..+...+|++.++||+|+||+||+|++. +++.||+|++....  .......+.+|..+++.++||||+++++++.+...
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3345678999999999999999999865 58999999996521  11222357899999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||++||+|.+++..  ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.+|.+||+|||+++..
T Consensus       144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            9999999999999999843  468999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCC---CCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYP---ITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ..... ......+||+.|+|||++.+...   ++.++|||||||++|||++|..||......       ..+..+...  
T Consensus       219 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~--  288 (410)
T 3v8s_A          219 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNH--  288 (410)
T ss_dssp             CTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTH--
T ss_pred             ccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------hHHHHHHhc--
Confidence            54322 22345679999999999876521   788999999999999999999998643221       111111110  


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPED--RPPMSAVVKM  296 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~  296 (356)
                         ... ...+.....+.++.+++.+||..+|.+  ||++++|++.
T Consensus       289 ---~~~-~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          289 ---KNS-LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ---HHH-CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ---ccc-ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence               000 111122235677899999999999988  9999999984

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.8e-45  Score=329.73  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=209.0

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...|++.+.||+|+||+||+|.+ .+++.||||++.........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            45688899999999999999975 46899999999765445556789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++++|.+++  ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........ 
T Consensus       101 ~~~~~~L~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          101 YLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             CCTTEEHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred             eCCCCcHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence            99999999998  34679999999999999999999999   9999999999999999999999999999987654322 


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                       ......|+..|+|||.+.+. .++.++||||||+++|+|++|..|+......                .....+.....
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~  236 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPM----------------KVLFLIPKNNP  236 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSCC
T ss_pred             -ccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHH----------------HHHHHhhcCCC
Confidence             12345689999999999876 7899999999999999999999887432210                01111122222


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKML  297 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L  297 (356)
                      .......+..+.+++.+||+.||.+|||+.++++..
T Consensus       237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            333344567799999999999999999999998743

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.4e-46  Score=341.24  Aligned_cols=250  Identities=26%  Similarity=0.300  Sum_probs=194.4

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHH-HccCCCCceeeeeceEecCCee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGT-IGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~-l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      +...+|++.+.||+|+||.||+|++. +++.||||++....  .......+..|..+ ++.++||||+++++++.+....
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            45578999999999999999999865 58999999997542  12333556777776 5678999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||++||+|.+++.. ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+++...
T Consensus       115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999998843 4678999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ....  .....+||+.|+|||++.+. .++.++|+|||||++|||++|..||.....       ...+.         .+
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~---------~i  251 (373)
T 2r5t_A          191 EHNS--TTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYD---------NI  251 (373)
T ss_dssp             CCCC--CCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HHHHH---------HH
T ss_pred             cCCC--ccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHH---------HH
Confidence            3221  23346799999999999876 789999999999999999999999854321       11111         11


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVV  294 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~  294 (356)
                      .... ...+...+..+.+++.+||+.||.+||++.+.+
T Consensus       252 ~~~~-~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          252 LNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             HHSC-CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             Hhcc-cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            1111 122234567789999999999999999985433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-46  Score=334.08  Aligned_cols=266  Identities=20%  Similarity=0.269  Sum_probs=199.7

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .+|++.++||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            46899999999999999999765 59999999986543 23345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+++++|..++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           83 YCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             CCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            999999988873 45679999999999999999999999   99999999999999999999999999999876533222


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch--------hhhHHHHhhchhh
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP--------KHVWEEYEKSELD  253 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~  253 (356)
                        .....||..|+|||.+.+...++.++||||||+++|+|++|..||............        ......+......
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          159 --YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             --cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence              233468999999999987557899999999999999999999998554321100000        0000000000000


Q ss_pred             HHH-Hhc--CCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATI-LAC--GIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~-~~~--~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ... ...  ...   ...+..+.++.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000 000  000   001234567899999999999999999999996

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.7e-46  Score=340.77  Aligned_cols=257  Identities=17%  Similarity=0.165  Sum_probs=208.1

Q ss_pred             HHHHhhhhccccccccccCceEEEEEE------eCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC---CCceeeeec
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQ------FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYG   88 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~~   88 (356)
                      .+++...+|.+.++||+|+||+||+|.      ..+++.||||++...    ....+..|+++++.++   |+||+.+++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            345667889999999999999999993      346899999999754    2345777888887776   999999999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC----
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFG----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----  160 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~----  160 (356)
                      ++...+..++||||+++|+|.+++..    ....+++..++.|+.||+.||+|||+   .+|+||||||+|||++.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence            99999999999999999999999954    35679999999999999999999999   99999999999999988    


Q ss_pred             -------CCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCC
Q 038199          161 -------NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSS  233 (356)
Q Consensus       161 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~  233 (356)
                             ++.+||+|||+++...............||..|+|||++.+. .++.++|||||||++|||++|+.|+.....
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                   899999999999866543344445667899999999999887 689999999999999999999998754322


Q ss_pred             CccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHHhccccC
Q 038199          234 ESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDR-PPMSAVVKMLEGVVEV  303 (356)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-ps~~~v~~~L~~~~~~  303 (356)
                      ....              .     .......  .....+.+++..|++.+|.+| |+++++.+.|+.....
T Consensus       291 ~~~~--------------~-----~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          291 GECK--------------P-----EGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             TEEE--------------E-----CSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             Ccee--------------e-----chhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            1100              0     0000000  124457788899999999999 5788888888877654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.6e-46  Score=342.37  Aligned_cols=268  Identities=24%  Similarity=0.321  Sum_probs=209.4

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      .++...+|++.++||+|+||+||+|.+. +++.||+|++.........+.+.+|+.++++++||||+++++++.+....+
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            3456788999999999999999999765 699999999987655666678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      +||||+++++|.+++.. ...+++..+..++.|++.||.|||+   . +++||||||+||+++.++.++|+|||++....
T Consensus       108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            99999999999999843 4579999999999999999999998   6 89999999999999999999999999987553


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch----------------
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP----------------  240 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~----------------  240 (356)
                      ...    .....||..|+|||++.+. .++.++||||||+++|+|++|..||............                
T Consensus       184 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          184 DSM----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHC--------CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             ccc----ccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            221    2234689999999999876 7899999999999999999999998654321110000                


Q ss_pred             -------hhhHHHHh---hchhhHHHHhcCCC-chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          241 -------KHVWEEYE---KSELDATILACGIE-EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       241 -------~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                             ........   .............. ......+.++.+++.+||+.||++|||++++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                   00000000   00011111111111 112234667999999999999999999999997

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-46  Score=336.57  Aligned_cols=269  Identities=21%  Similarity=0.290  Sum_probs=187.9

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ..+.+...+|++.+.||+|+||+||+|.+. +++.||||++.........+.+.+|+.++++++||||+++++++.....
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            457788899999999999999999999764 6899999998755434455678899999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcc
Q 038199           96 TALVYEYMENGSLDGYLFG-------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  168 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D  168 (356)
                      .++||||+++++|.+++..       ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEe
Confidence            9999999999999999853       24569999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCCe---eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHH
Q 038199          169 FGLAKLCDRNRSH---VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWE  245 (356)
Q Consensus       169 fgl~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~  245 (356)
                      ||++.........   .......||..|+|||.+.+...++.++||||||+++|+|++|..||.......      ....
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~  238 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLML  238 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHH
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHH
Confidence            9998765433211   112335689999999998753367899999999999999999999985543211      0000


Q ss_pred             HHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          246 EYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...... ................+.++.+++.+||+.||.+||++.++++
T Consensus       239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          239 TLQNDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHTSSC-CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhccCC-CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            000000 0000000001111234567899999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-45  Score=329.23  Aligned_cols=262  Identities=19%  Similarity=0.219  Sum_probs=201.4

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ...+|.+.+.||+|+||.||+|.+. +++.||||++.....  ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3467999999999999999999865 689999999975432  2334678999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus       112 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999999999843 4579999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      ... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||......                ........
T Consensus       188 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------------~~~~~~~~  249 (309)
T 2h34_A          188 KLT-QLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS----------------VMGAHINQ  249 (309)
T ss_dssp             ----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----------------HHHHHHHS
T ss_pred             ccc-cccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH----------------HHHHHhcc
Confidence            221 22345689999999999876 7899999999999999999999987542110                00111111


Q ss_pred             cCC--CchhHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhccccCCC
Q 038199          259 CGI--EEKDKEKAKRLCMAALWCVQDSPEDRP-PMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       259 ~~~--~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~v~~~L~~~~~~~~  305 (356)
                      ...  .......+.++.+++.+||+.||++|| +++++++.|+.......
T Consensus       250 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          250 AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            110  122344566799999999999999999 99999999998766543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-45  Score=342.24  Aligned_cols=268  Identities=24%  Similarity=0.292  Sum_probs=192.7

Q ss_pred             HhhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCC-CCceeeeeceEecC--Ce
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQ--HM   95 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~--~~   95 (356)
                      ....+|++.+.||+|+||+||+|.+ .+|+.||||++.... ......++.+|+.+++.+. ||||+++++++...  ..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3456899999999999999999976 469999999986432 3455567889999999997 99999999999754  36


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++ +|..++..  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            8999999974 89988843  579999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCC-------------------CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc
Q 038199          176 DRNR-------------------SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL  236 (356)
Q Consensus       176 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~  236 (356)
                      ....                   ........+||..|+|||++.+...++.++|||||||++|||++|+.||........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            4311                   111233467999999999998755789999999999999999999999854332110


Q ss_pred             ccchhhh-------HHHHh---hchhhHH---HH------hcCCCchh-------------HHHHHHHHHHHHhcccCCC
Q 038199          237 DWFPKHV-------WEEYE---KSELDAT---IL------ACGIEEKD-------------KEKAKRLCMAALWCVQDSP  284 (356)
Q Consensus       237 ~~~~~~~-------~~~~~---~~~~~~~---~~------~~~~~~~~-------------~~~~~~l~~l~~~cl~~~p  284 (356)
                        +....       .+.+.   .......   ..      ........             ...+.++.+++.+||+.||
T Consensus       240 --~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          240 --LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             --HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             --HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence              00000       00000   0000000   00      00000000             0235678999999999999


Q ss_pred             CCCCCHHHHHHH
Q 038199          285 EDRPPMSAVVKM  296 (356)
Q Consensus       285 ~~Rps~~~v~~~  296 (356)
                      ++|||++++++.
T Consensus       318 ~~R~t~~e~l~H  329 (388)
T 3oz6_A          318 NKRISANDALKH  329 (388)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             ccCCCHHHHhCC
Confidence            999999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-45  Score=335.60  Aligned_cols=257  Identities=23%  Similarity=0.246  Sum_probs=201.8

Q ss_pred             HHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc----chhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      .-...+|++.+.||+|+||+||+|.+ .+++.||+|++....    .....+.+.+|+.++++++||||+++++++.+..
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            34567899999999999999999976 468999999986431    2344578999999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcC---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 038199           95 MTALVYEYMENGSLDGYLFGK---------------------------------------KRAIEWEKLHEIAIGTAKGL  135 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~~l  135 (356)
                      ..++||||++|++|.+++...                                       ...+++..+..++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999988410                                       12346788999999999999


Q ss_pred             HHHhhcCCCCccccCCCCCcEEEcCCC--ceEEcccCCccccCCCCCe--eeeccCCCCCCCCCcccccCC-CCCCcccc
Q 038199          136 VYLHEECQQRIIHYDIKPENVLLDANF--SPKVADFGLAKLCDRNRSH--VTISGYKGTPGYSAPEFLSGN-YPITHKCD  210 (356)
Q Consensus       136 ~~LH~~~~~~ivH~dikp~Nill~~~~--~~kl~Dfgl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~D  210 (356)
                      .|||+   .+++||||||+||+++.++  .+||+|||++.........  .......||+.|+|||.+.+. ..++.++|
T Consensus       182 ~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            99999   9999999999999998776  8999999999876432221  123345699999999998652 36889999


Q ss_pred             chhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC---CchhHHHHHHHHHHHHhcccCCCCCC
Q 038199          211 VYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI---EEKDKEKAKRLCMAALWCVQDSPEDR  287 (356)
Q Consensus       211 v~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~R  287 (356)
                      |||||+++|||++|+.||......                .....+.....   .+.....+..+.+++.+||+.||.+|
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDA----------------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChH----------------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence            999999999999999998543221                00111111111   12222356789999999999999999


Q ss_pred             CCHHHHHH
Q 038199          288 PPMSAVVK  295 (356)
Q Consensus       288 ps~~~v~~  295 (356)
                      |++.++++
T Consensus       323 ps~~~~l~  330 (345)
T 3hko_A          323 FDAMRALQ  330 (345)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhc
Confidence            99999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=329.60  Aligned_cols=267  Identities=23%  Similarity=0.300  Sum_probs=196.0

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc----hhhHHHHHHHHHHHccC---CCCceeeeece
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG----RIAEEQFMAEVGTIGRT---YHINLVRLYGF   89 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l---~h~ni~~~~~~   89 (356)
                      .+++...+|++.++||+|+||+||+|.+ .+++.||||++.....    ......+.+|+.+++++   +||||++++++
T Consensus         3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            3566778999999999999999999986 4699999999864221    11124566777777766   49999999999


Q ss_pred             EecCC-----eeeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc
Q 038199           90 CHDQH-----MTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  163 (356)
Q Consensus        90 ~~~~~-----~~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~  163 (356)
                      +....     ..++|||++.+ +|.+++.... ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred             eeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence            98754     57899999974 9999986543 349999999999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhh
Q 038199          164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHV  243 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~  243 (356)
                      +||+|||+++.......   .....||..|+|||++.+. .++.++|||||||++|+|++|..||........   ....
T Consensus       159 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i  231 (308)
T 3g33_A          159 VKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKI  231 (308)
T ss_dssp             EEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHH
T ss_pred             EEEeeCccccccCCCcc---cCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence            99999999986643322   2345689999999999876 689999999999999999999999854332110   0000


Q ss_pred             HHHHhhch---------hhHHHHhcCC----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          244 WEEYEKSE---------LDATILACGI----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       244 ~~~~~~~~---------~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ........         ..........    ....+..+..+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00000000         0000000000    0011234567899999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.6e-46  Score=351.06  Aligned_cols=252  Identities=23%  Similarity=0.299  Sum_probs=196.5

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      +...+|++.++||+|+||.||+|... +|+.||||++....  .......+.+|+.++++++||||+++++++.+.+..+
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            34567999999999999999999764 69999999997531  2333456788999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+++++|.+++. ....+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.+||+|||+++....
T Consensus       225 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          225 FVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEECCCSSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEeeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999999884 34679999999999999999999995  27899999999999999999999999999975432


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ..  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......                .....+.
T Consensus       302 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----------------~~~~~i~  362 (446)
T 4ejn_A          302 DG--ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELIL  362 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHH
T ss_pred             CC--cccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHH----------------HHHHHHH
Confidence            22  223446799999999999876 7899999999999999999999998543211                1111111


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      ... ...+...+.++.+++.+||+.||.+||     +++++++
T Consensus       363 ~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          363 MEE-IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             hCC-CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            111 122334567799999999999999999     9999987

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.8e-45  Score=333.13  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=207.2

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      ....+|.+.+.||+|+||.||++.+. +++.||+|++....  .....+.+.+|+.++++++||||+++++++.+....+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            34568999999999999999999765 58899999987542  2345577899999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus       118 lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          118 VVLELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             EEECCCTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCCCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999999999884 34679999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ....  .....||..|+|||++.+. .++.++||||||+++|+|++|..||......       ..+...         .
T Consensus       194 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~---------~  254 (335)
T 2owb_A          194 DGER--KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRI---------K  254 (335)
T ss_dssp             TTCC--BCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHH---------H
T ss_pred             Cccc--ccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHH---------h
Confidence            3221  2335689999999999876 6899999999999999999999988543210       011111         1


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .. ....+...+..+.+++.+||+.||++||+++++++.
T Consensus       255 ~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          255 KN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HT-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cC-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11 111223445678899999999999999999999973

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.9e-45  Score=324.37  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=204.6

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ..+|++.+.||+|+||+||+|.+. +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            567999999999999999999764 58999999997532 3445577889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc---eEEcccCCccccCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGLAKLCDR  177 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~---~kl~Dfgl~~~~~~  177 (356)
                      ||+.+++|.+.+.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.   ++|+|||++.....
T Consensus        85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999888843 4679999999999999999999999   99999999999999976654   99999999976654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ...   .....||..|+|||.+.+. .++.++||||||+++|+|++|..||......       ...........     
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-----  224 (284)
T 3kk8_A          161 SEA---WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAY-----  224 (284)
T ss_dssp             SCB---CCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC-----
T ss_pred             Ccc---ccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHHHHHhccc-----
Confidence            332   2335689999999999876 7899999999999999999999998543211       11111111000     


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       ..........+.++.+++.+||+.||++|||+.++++
T Consensus       225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          225 -DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             0011112345677999999999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5e-45  Score=324.73  Aligned_cols=249  Identities=25%  Similarity=0.389  Sum_probs=200.4

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEec----CCe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~----~~~   95 (356)
                      ....|.+.+.||+|+||+||+|.+. ++..||+|++... ......+.+.+|+.++++++||||+++++++..    ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            4556888999999999999999764 6889999998743 234556789999999999999999999998865    456


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ccccCCCCCcEEEc-CCCceEEcccCCc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLD-ANFSPKVADFGLA  172 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dikp~Nill~-~~~~~kl~Dfgl~  172 (356)
                      .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+  ++||||||+||+++ .++.++|+|||++
T Consensus       104 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            8999999999999999943 4679999999999999999999999   88  99999999999997 7899999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ........    ....||..|+|||.+.+  .++.++||||||+++|+|++|..||......      ......      
T Consensus       180 ~~~~~~~~----~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~------  241 (290)
T 1t4h_A          180 TLKRASFA----KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRR------  241 (290)
T ss_dssp             GGCCTTSB----EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHH------
T ss_pred             cccccccc----ccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHH------
Confidence            76543322    23468999999999874  4799999999999999999999998543221      011111      


Q ss_pred             hHHHHhcCC-CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 DATILACGI-EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 ~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                         ...... .......+.++.+++.+||+.||.+|||+.++++
T Consensus       242 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          242 ---VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---HhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               111111 1122233467999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=341.61  Aligned_cols=261  Identities=16%  Similarity=0.159  Sum_probs=205.0

Q ss_pred             hhhccccccccccCceEEEEEEeCC---------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceee--------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPN---------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVR--------   85 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~--------   85 (356)
                      ..+|.+.+.||+|+||+||+|.+..         ++.||||++...      ..+.+|++++++++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            5789999999999999999997653         789999998753      35788999999999999987        


Q ss_pred             -------eeceEec-CCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcE
Q 038199           86 -------LYGFCHD-QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV  156 (356)
Q Consensus        86 -------~~~~~~~-~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Ni  156 (356)
                             +++++.. +...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+   .+++||||||+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI  190 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI  190 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence                   5666665 67889999999 99999999654 4689999999999999999999999   9999999999999


Q ss_pred             EEcCCC--ceEEcccCCccccCCCCCee-----eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccc
Q 038199          157 LLDANF--SPKVADFGLAKLCDRNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAI  229 (356)
Q Consensus       157 ll~~~~--~~kl~Dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~  229 (356)
                      +++.++  .+||+|||+++.........     ......||..|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            999998  89999999998764322111     11234699999999999876 78999999999999999999999986


Q ss_pred             cCCCCccccchhhhHHHHhhchhhHHHHhcCCCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          230 VGSSESLDWFPKHVWEEYEKSELDATILACGIEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      .......         ....  ............     .....+.++.+++.+||+.||++||++++|++.|+.+....
T Consensus       270 ~~~~~~~---------~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          270 NCLPNTE---------DIMK--QKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             GGTTCHH---------HHHH--HHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cCCcCHH---------HHHH--HHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            5432110         0000  000001111100     01123577999999999999999999999999999887654


Q ss_pred             C
Q 038199          305 P  305 (356)
Q Consensus       305 ~  305 (356)
                      .
T Consensus       339 ~  339 (352)
T 2jii_A          339 R  339 (352)
T ss_dssp             T
T ss_pred             C
Confidence            3

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-45  Score=326.73  Aligned_cols=246  Identities=23%  Similarity=0.367  Sum_probs=202.4

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ...+|++.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+..+.++ +||||+++++++.+....++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3567999999999999999999765 69999999997542 234456788999999999 89999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC--------------
Q 038199           99 VYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN--------------  161 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~--------------  161 (356)
                      ||||+++++|.+++...   ...+++..+..++.||+.||.|||+   .+++||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999998543   2679999999999999999999999   999999999999999844              


Q ss_pred             -----CceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc
Q 038199          162 -----FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL  236 (356)
Q Consensus       162 -----~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~  236 (356)
                           ..++|+|||++.......      ...||..|+|||.+.+...++.++||||||+++|+|++|..++...     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----  234 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----  234 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence                 479999999998765432      2348999999999987656778999999999999999998654221     


Q ss_pred             ccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          237 DWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                           ..+..         +.....+..+...+.++.+++.+||+.||++|||+.++++
T Consensus       235 -----~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          235 -----DQWHE---------IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -----HHHHH---------HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----hHHHH---------HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                 11111         1222233344456678999999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7e-46  Score=336.92  Aligned_cols=245  Identities=23%  Similarity=0.300  Sum_probs=202.0

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc-------hhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      ...+|++.+.||+|+||+||+|.+ .+++.||||++.....       ......+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            356899999999999999999975 4699999999975421       11334577899999999999999999999999


Q ss_pred             CeeeEEEeccCCC-ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           94 HMTALVYEYMENG-SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        94 ~~~~lV~e~~~~~-sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ...++||||+.+| +|.+++. ....+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999998766 9999884 45579999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      .........   ....||..|+|||++.+....+.++||||||+++|+|++|..||......                  
T Consensus       178 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------  236 (335)
T 3dls_A          178 AYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------  236 (335)
T ss_dssp             EECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred             eECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence            876544322   22468999999999987733488999999999999999999997431110                  


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                         ...  ....+...+.++.+++.+||+.||++|||++++++.
T Consensus       237 ---~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ---VEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---TTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---Hhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000  011122245678999999999999999999999984

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.3e-45  Score=325.25  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=207.3

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      ....+|.+.+.||+|+||+||++.+. +++.||+|++....  .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            35578999999999999999999765 58899999987542  2345577899999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        92 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           92 VVLELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEEECCTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999999884 34579999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ....  .....||..|+|||.+.+. .++.++||||||+++|+|++|..|+......       ..+...         .
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~---------~  228 (294)
T 2rku_A          168 DGER--KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRI---------K  228 (294)
T ss_dssp             TTCC--BCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHH---------H
T ss_pred             Cccc--cccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHH---------h
Confidence            3222  2335689999999999876 6899999999999999999999987543211       011111         1


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .. ....+...+..+.+++.+||+.||++|||++++++.
T Consensus       229 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          229 KN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             TT-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hc-cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11 112223445678999999999999999999999984

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.2e-45  Score=339.98  Aligned_cols=253  Identities=23%  Similarity=0.273  Sum_probs=193.5

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-------hhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      ......|.+.++||+|+||+||+|.+. +++.||||++.....       ......+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345678999999999999999999764 689999999875321       111235789999999999999999999986


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC---CceEEcc
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVAD  168 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~D  168 (356)
                      .+ ..++||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.+   +.+||+|
T Consensus       211 ~~-~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          211 AE-DYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SS-EEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             cC-ceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence            54 5789999999999999883 45679999999999999999999999   999999999999999654   4599999


Q ss_pred             cCCccccCCCCCeeeeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH
Q 038199          169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       169 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      ||+++......   ......||+.|+|||++.+  ...++.++|||||||++|+|++|..||.......           
T Consensus       286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-----------  351 (419)
T 3i6u_A          286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-----------  351 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-----------
T ss_pred             cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-----------
Confidence            99998765332   2234569999999999863  2367889999999999999999999986533211           


Q ss_pred             HhhchhhHHHHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          247 YEKSELDATILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          .....+......   ......+..+.+++.+||+.||++||+++++++
T Consensus       352 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          352 ----SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             ----CHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----HHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                011111111111   111234677999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.6e-46  Score=331.41  Aligned_cols=264  Identities=26%  Similarity=0.373  Sum_probs=203.3

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC--CCc--EEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP--NGV--KIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      ..+...+|++.+.||+|+||+||+|.+.  +++  .||||++....  .....+.+.+|+.++++++||||+++++++.+
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            3456778999999999999999999752  333  68999987542  23445789999999999999999999999987


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      .. .++||||+.+++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~  168 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLM  168 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccc
Confidence            65 789999999999999996656779999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhc
Q 038199          173 KLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       173 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      ........... .....+|..|+|||.+.+. .++.++||||||+++|+|++ |..||......       ...      
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~------  234 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QIL------  234 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHH------
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-------HHH------
Confidence            87755443322 2234577789999999866 68899999999999999999 88887543211       000      


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                        ............+...+.++.+++.+||+.||++||++.++++.|+.+..
T Consensus       235 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          235 --HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             --HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             --HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence              11111112223344567789999999999999999999999999987654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.1e-46  Score=336.13  Aligned_cols=265  Identities=24%  Similarity=0.313  Sum_probs=193.0

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEe---
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCH---   91 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~---   91 (356)
                      ...++...+|++.++||+|+||.||+|.+. +++.||||++... .......+.+|+.+++++. ||||+++++++.   
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            345566778999999999999999999764 6899999998654 2344567899999999996 999999999984   


Q ss_pred             -----cCCeeeEEEeccCCCChhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ccccCCCCCcEEEcCCC
Q 038199           92 -----DQHMTALVYEYMENGSLDGYLFG--KKRAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANF  162 (356)
Q Consensus        92 -----~~~~~~lV~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dikp~Nill~~~~  162 (356)
                           .....++||||+. |+|.+++..  ....+++..++.++.||+.||.|||+   .+  ++||||||+||+++.++
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTS
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCC
Confidence                 3445789999996 589888754  35679999999999999999999999   88  99999999999999999


Q ss_pred             ceEEcccCCccccCCCCCee----------eeccCCCCCCCCCccccc--CCCCCCccccchhhHHHHHHHHhCCccccc
Q 038199          163 SPKVADFGLAKLCDRNRSHV----------TISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVLFEIVGRRRNAIV  230 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~--~~~~~~~~~Dv~slGvvl~elltg~~p~~~  230 (356)
                      .+||+|||++..........          ......||..|+|||++.  ....++.++||||||+++|+|++|..||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            99999999998765432211          111345899999999983  223688999999999999999999999753


Q ss_pred             CCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          231 GSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                      .....                   ..............+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus       256 ~~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          256 GAKLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             hhHHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            32210                   000000111112223457889999999999999999999999998876543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.3e-46  Score=328.59  Aligned_cols=255  Identities=22%  Similarity=0.308  Sum_probs=206.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEe--cCCeeeE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCH--DQHMTAL   98 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~--~~~~~~l   98 (356)
                      ..+|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++.  +....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467899999999999999999765 68999999997542 3455578999999999999999999999875  4568899


Q ss_pred             EEeccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----ccccCCCCCcEEEcCCCceEEcccC
Q 038199           99 VYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQR-----IIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-----ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||+   .+     ++||||||+||+++.++.++|+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998542   3459999999999999999999999   77     9999999999999999999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      ++.........  .....|+..|+|||.+.+. .++.++||||||+++|+|++|..|+.....                .
T Consensus       162 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~  222 (279)
T 2w5a_A          162 LARILNHDTSF--AKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQ----------------K  222 (279)
T ss_dssp             HHHHC---CHH--HHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------H
T ss_pred             hheeecccccc--ccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCH----------------H
Confidence            99865433211  1234589999999999876 689999999999999999999988754321                1


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEG  299 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~  299 (356)
                      .....+........+...+.++.+++.+||+.||++||++.+|++.+..
T Consensus       223 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          223 ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            1112222333333444567789999999999999999999999986654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.5e-45  Score=337.73  Aligned_cols=247  Identities=22%  Similarity=0.301  Sum_probs=190.2

Q ss_pred             hcccc-ccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHcc-CCCCceeeeeceEec----CCeee
Q 038199           25 TSNYS-TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGFCHD----QHMTA   97 (356)
Q Consensus        25 ~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~ni~~~~~~~~~----~~~~~   97 (356)
                      .|.+. +.||+|+||+||+|.+. +|+.||||++...      ..+.+|+.++.+ .+||||+++++++..    ....+
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            45554 78999999999999764 6899999999642      346678888744 589999999999875    56789


Q ss_pred             EEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---CCceEEcccCCcc
Q 038199           98 LVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAK  173 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfgl~~  173 (356)
                      +||||++||+|.+++.... ..+++..+..|+.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999996543 469999999999999999999999   99999999999999987   7899999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ......   .....+||..|+|||++.+. .++.++|||||||++|||++|..||..........            ...
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------------~~~  276 (400)
T 1nxk_A          213 ETTSHN---SLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------GMK  276 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC------------SHH
T ss_pred             ccCCCC---ccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH------------HHH
Confidence            654322   22345689999999999876 78999999999999999999999986543321100            001


Q ss_pred             HHHHhcCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          254 ATILACGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       254 ~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      ..+.....   .......+.++.+++.+||+.||++|||+.++++.
T Consensus       277 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          277 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11111111   11113456779999999999999999999999984

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.2e-45  Score=325.71  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=205.9

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec------
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------   92 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~------   92 (356)
                      .....+|++.+.||+|+||.||+|.+. +++.||+|++....     +.+.+|+.++++++||||+++++++..      
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            445678999999999999999999875 69999999997542     246789999999999999999998864      


Q ss_pred             ----------CCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC
Q 038199           93 ----------QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  161 (356)
Q Consensus        93 ----------~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~  161 (356)
                                ....++||||+++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEET
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCC
Confidence                      44578999999999999999643 4679999999999999999999999   999999999999999999


Q ss_pred             CceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchh
Q 038199          162 FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK  241 (356)
Q Consensus       162 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~  241 (356)
                      +.++|+|||++........   .....|+..|+|||.+.+. .++.++||||||+++|+|++|..|+...          
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~----------  224 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFET----------  224 (284)
T ss_dssp             TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHH----------
T ss_pred             CCEEECcchhheecccccc---ccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhH----------
Confidence            9999999999987654332   2234689999999999876 6899999999999999999998764210          


Q ss_pred             hhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          242 HVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                              ............   ....+..+.+++.+||+.||.+||++.++++.|..+....
T Consensus       225 --------~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          225 --------SKFFTDLRDGII---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             --------HHHHHHHHTTCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             --------HHHHHHhhcccc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                    001111111111   1234566889999999999999999999999998876543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6e-45  Score=330.44  Aligned_cols=268  Identities=22%  Similarity=0.304  Sum_probs=201.3

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ...+|++.+.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            3467889999999999999999765 59999999986442 234456788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||+++++|..++ .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus       103 ~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          103 FEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EECCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EecCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            9999999888876 345679999999999999999999999   999999999999999999999999999997654332


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc--------chhhhHHHHhhch
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW--------FPKHVWEEYEKSE  251 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~  251 (356)
                      .  ......||..|+|||.+.+...++.++||||||+++|+|++|..||..........        ........+....
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            2  22335689999999999876568999999999999999999999886543211000        0000000000000


Q ss_pred             hhHHH-HhcCC-----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          252 LDATI-LACGI-----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       252 ~~~~~-~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..... .....     ....+..+..+.+++.+||+.||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000 00000     0011234678999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-44  Score=342.60  Aligned_cols=263  Identities=21%  Similarity=0.220  Sum_probs=194.7

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC------C
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------H   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------~   94 (356)
                      ..+|++.++||+|+||+||+|.+. +|+.||||++.... ......++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467888999999999999999754 69999999997542 344557789999999999999999999999654      3


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+++ +|.+.+.   ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            56999999976 5666662   358999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cchhhhHHHHhh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WFPKHVWEEYEK  249 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~  249 (356)
                      .....   ......||..|+|||++.+. .++.++|||||||++|||++|+.||........-     .+.....+.+..
T Consensus       214 ~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          214 AGTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ---CC---CC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cCCCc---ccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            65332   22345799999999999887 7999999999999999999999998543211000     000000000000


Q ss_pred             c--hhhHHHHhc------------------CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          250 S--ELDATILAC------------------GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       250 ~--~~~~~~~~~------------------~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .  .........                  .........+.++.+++.+||+.||++|||++++++.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0  000000000                  0011122336789999999999999999999999984

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-45  Score=333.62  Aligned_cols=266  Identities=23%  Similarity=0.259  Sum_probs=198.6

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchh----hHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRI----AEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ...+|++.+.||+|+||+||+|.+. +|+.||||++.......    ....+.+|+.++++++||||+++++++.+....
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4567999999999999999999865 58999999997532111    124678999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+++ +|..++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999999976 8988886666789999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh---
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD---  253 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  253 (356)
                      ....  ......||..|+|||++.+...++.++|||||||++|+|++|..|+........  + ...++........   
T Consensus       164 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~-~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          164 SPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--L-TRIFETLGTPTEEQWP  238 (346)
T ss_dssp             SCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCTTTSS
T ss_pred             CCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--H-HHHHHHcCCCChhhhh
Confidence            3322  223456899999999997654689999999999999999999887654322100  0 0000000000000   


Q ss_pred             ------HHHHhcCCCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          254 ------ATILACGIEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       254 ------~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                            ........+.     .....+.++.+++.+||+.||++|||++++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                  0000000000     012345779999999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-45  Score=360.27  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=202.1

Q ss_pred             ccccccCceEEEEEEe---CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEeccCC
Q 038199           30 TRLGFGGFGEVYKGQF---PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMEN  105 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~  105 (356)
                      ++||+|+||+||+|.+   .+++.||||+++... .....+++.+|+.++++++||||+++++++.++ ..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence            4799999999999954   246889999997543 234457899999999999999999999999754 57899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe-eee
Q 038199          106 GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH-VTI  184 (356)
Q Consensus       106 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~  184 (356)
                      ++|.+++. ....+++..+..|+.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++........ ...
T Consensus       454 g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999994 45679999999999999999999999   99999999999999999999999999999876543322 122


Q ss_pred             ccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCc
Q 038199          185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEE  263 (356)
Q Consensus       185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (356)
                      ....+|..|+|||++.+. .++.++|||||||++|||++ |+.||.....                ......+.......
T Consensus       530 ~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----------------~~~~~~i~~~~~~~  592 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEVTAMLEKGERMG  592 (635)
T ss_dssp             -----CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHHHTTCCCC
T ss_pred             cCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHcCCCCC
Confidence            234467889999999876 78999999999999999998 9888744321                12223333333444


Q ss_pred             hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          264 KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      .+..++.++.+++.+||+.||++||++++|++.|+.+.
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            55567788999999999999999999999999998764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.5e-45  Score=324.30  Aligned_cols=254  Identities=24%  Similarity=0.372  Sum_probs=199.1

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ..+...+|.+.+.||+|+||.||+|.+. +|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+...
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            3445678999999999999999999875 69999999986532  12334678999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus        86 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            9999999999999999843 3578999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      .....   .....|+..|+|||.+.+....+.++||||||+++|+|++|..|+.....       ......         
T Consensus       162 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~---------  222 (276)
T 2h6d_A          162 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKK---------  222 (276)
T ss_dssp             CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH---------
T ss_pred             CCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHH---------
Confidence            54321   22346899999999998764447899999999999999999998754221       011111         


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      +... ....+...+..+.+++.+||+.||++|||+.++++.
T Consensus       223 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          223 IRGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hhcC-cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1111 112223345678999999999999999999999983

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-45  Score=333.57  Aligned_cols=266  Identities=20%  Similarity=0.242  Sum_probs=194.2

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      ........+|++.++||+|+||+||+|.+ .+++.||||++..... ......+.+|+.++++++||||+++++++.+..
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            44556677899999999999999999975 4699999999975432 233456789999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc-----CCCceEEccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-----ANFSPKVADF  169 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~-----~~~~~kl~Df  169 (356)
                      ..++||||+++ +|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++     .++.+||+||
T Consensus       107 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          107 RLHLIFEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEEEEECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEEEEecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            99999999975 99998843 4569999999999999999999999   9999999999999994     4556999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      |++........  ......||..|+|||++.+...++.++|||||||++|||++|..||.......      ........
T Consensus       182 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~  253 (329)
T 3gbz_A          182 GLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID------QLFKIFEV  253 (329)
T ss_dssp             THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHH
T ss_pred             CCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH------HHHHHHHH
Confidence            99987653322  22334689999999999876468999999999999999999999985432210      00000000


Q ss_pred             c------hhhHH--------HHhcCCCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 S------ELDAT--------ILACGIEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 ~------~~~~~--------~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .      .....        ........     .....+.++.+++.+||+.||++|||++++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0      00000        00000000     01113567889999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.2e-45  Score=324.78  Aligned_cols=254  Identities=21%  Similarity=0.325  Sum_probs=203.0

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-----hhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-----RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      +...+|++.+.||+|+||+||+|.+. +|+.||+|++.....     ....+.+.+|+.++++++||||+++++++.+..
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT   81 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence            34578999999999999999999875 699999999875421     123578999999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC----ceEEcccC
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFG  170 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfg  170 (356)
                      ..++||||+++++|.+++. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++    .++|+|||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLA-EKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             eEEEEEeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999999984 34579999999999999999999999   9999999999999998877    89999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      ++........   .....|+..|+|||.+.+. .++.++||||||+++|+|++|..||......       .....+...
T Consensus       158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~  226 (283)
T 3bhy_A          158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQ-------ETLTNISAV  226 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTT
T ss_pred             cceeccCCCc---ccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------HHHHHhHhc
Confidence            9987643322   2234589999999999876 6899999999999999999999987543211       011111100


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..      ..........+..+.+++.+||+.||++||++.++++
T Consensus       227 ~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          227 NY------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00      0001112234567899999999999999999999997

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.1e-45  Score=324.32  Aligned_cols=251  Identities=25%  Similarity=0.307  Sum_probs=205.9

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ..+...+|++.+.||+|+||+||+|.+. +++.||||++....  .......+.+|++++++++||||+++++++.+...
T Consensus         9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (284)
T 2vgo_A            9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR   88 (284)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence            3445678999999999999999999765 58899999986432  12234678999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus        89 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            9999999999999998843 3579999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ....    .....|+..|+|||.+.+. .++.++||||||+++|+|++|..||......       ....         .
T Consensus       165 ~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~---------~  223 (284)
T 2vgo_A          165 PSLR----RRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ETHR---------R  223 (284)
T ss_dssp             SSSC----BCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHH---------H
T ss_pred             cccc----cccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HHHH---------H
Confidence            4322    2235689999999999876 6899999999999999999999998543211       0011         1


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +.. .....+...+..+.+++.+||+.||.+||+++++++
T Consensus       224 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          224 IVN-VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHT-TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Hhc-cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            111 111223345677899999999999999999999997

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.3e-45  Score=351.97  Aligned_cols=255  Identities=25%  Similarity=0.306  Sum_probs=208.4

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      +...+|++.+.||+|+||.||+|.+. +|+.||||++....  .......+.+|+.++++++||||+++++++.+....+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            34567888999999999999999764 69999999996531  1233456889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           98 LVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      +||||++||+|.+++.... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.+|.+||+|||+++...
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999999886543 459999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ....   ....+||+.|+|||++.+. .++.++|||||||++|||++|..||........            ...+...+
T Consensus       338 ~~~~---~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~------------~~~i~~~i  401 (576)
T 2acx_A          338 EGQT---IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK------------REEVERLV  401 (576)
T ss_dssp             TTCC---EECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC------------HHHHHHHH
T ss_pred             cCcc---ccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchh------------HHHHHHHh
Confidence            4332   2335799999999999876 689999999999999999999999865432111            01111111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                      ... ....+...+.++.+++.+||+.||.+||     ++++|++
T Consensus       402 ~~~-~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          402 KEV-PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             hcc-cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            111 1223344567899999999999999999     7788876

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.3e-45  Score=339.93  Aligned_cols=267  Identities=24%  Similarity=0.255  Sum_probs=205.2

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCC--------CCceeeee
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--------HINLVRLY   87 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~ni~~~~   87 (356)
                      ...++...+|.+.++||+|+||+||+|.+ .+++.||||++...  ....+.+.+|+.+++.++        |+||++++
T Consensus        30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            44556678999999999999999999975 46899999999754  445577889999999985        78899999


Q ss_pred             ceEe----cCCeeeEEEeccCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CccccCCCCCcEEEcCC
Q 038199           88 GFCH----DQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDAN  161 (356)
Q Consensus        88 ~~~~----~~~~~~lV~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dikp~Nill~~~  161 (356)
                      +++.    +....++||||+.+ +|.+.+.. ....+++..+..++.||+.||.|||+   + +|+||||||+|||++.+
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~  183 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVN  183 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCC
T ss_pred             cceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEecc
Confidence            9987    56788999999955 55555533 34679999999999999999999999   8 99999999999999877


Q ss_pred             C-------------------------------------------------ceEEcccCCccccCCCCCeeeeccCCCCCC
Q 038199          162 F-------------------------------------------------SPKVADFGLAKLCDRNRSHVTISGYKGTPG  192 (356)
Q Consensus       162 ~-------------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~  192 (356)
                      +                                                 .+||+|||++......     .....||..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~  258 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQ  258 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGG
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCc
Confidence            5                                                 7999999999876432     233468999


Q ss_pred             CCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh--hchhhHHHHhc-----------
Q 038199          193 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE--KSELDATILAC-----------  259 (356)
Q Consensus       193 y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----------  259 (356)
                      |+|||++.+. .++.++|||||||++|||++|+.||....................  ...........           
T Consensus       259 y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  337 (397)
T 1wak_A          259 YRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG  337 (397)
T ss_dssp             GCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred             ccCChhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence            9999999877 689999999999999999999999976544321100000000000  00000000000           


Q ss_pred             ------------------CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          260 ------------------GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       260 ------------------~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                                        .........+..+.+++.+||+.||++|||++++++
T Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                              001234667788999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-45  Score=360.59  Aligned_cols=263  Identities=22%  Similarity=0.314  Sum_probs=212.9

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      .+++...+|++.+.||+|+||+||+|.+..    +..||||++.........+.+.+|+.++++++||||+++++++.+ 
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            455667788999999999999999997632    567999998765555666789999999999999999999999854 


Q ss_pred             CeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           94 HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ...++||||+++++|.+++......+++..++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            56899999999999999997666789999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ........ ......+|..|+|||.+.+. .++.++||||||+++|||++ |..||.....                ...
T Consensus       540 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----------------~~~  601 (656)
T 2j0j_A          540 YMEDSTYY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKN----------------NDV  601 (656)
T ss_dssp             SCCC-----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHH
T ss_pred             ecCCCcce-eccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----------------HHH
Confidence            76543222 12234467889999999866 78999999999999999997 8777643221                111


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ...+........+..++..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus       602 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          602 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            12222333334455667789999999999999999999999999987653

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=337.58  Aligned_cols=269  Identities=22%  Similarity=0.333  Sum_probs=207.7

Q ss_pred             ceecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           14 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      .....+++...+|++.+.||+|+||+||+|.+.+  .+|+|++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            4456778888999999999999999999998743  49999987532 22233567889999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ....++||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++ ++.++|+|||++
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCc
Confidence            999999999999999999996666689999999999999999999999   9999999999999998 679999999998


Q ss_pred             cccCCCCCe---eeeccCCCCCCCCCcccccC--------CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchh
Q 038199          173 KLCDRNRSH---VTISGYKGTPGYSAPEFLSG--------NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK  241 (356)
Q Consensus       173 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~  241 (356)
                      .........   .......|+..|+|||.+.+        ...++.++||||||+++|||++|..||......       
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------  249 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------  249 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------
Confidence            765322111   11223458899999999864        225788999999999999999999998543221       


Q ss_pred             hhHHHHhhchhhHHHHhcCCC-chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          242 HVWEEYEKSELDATILACGIE-EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      .         ..........+ ......+.++.+++.+||..||++|||+.++++.|+.+....
T Consensus       250 ~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          250 A---------IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             H---------HHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             H---------HHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            0         00111111111 111234567899999999999999999999999999887654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.8e-45  Score=332.30  Aligned_cols=270  Identities=21%  Similarity=0.274  Sum_probs=202.5

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEec--------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--------   92 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~--------   92 (356)
                      ..+|++.++||+|+||+||+|.+ .+|+.||||++.... .......+.+|+.++++++||||+++++++.+        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999976 469999999986442 22334578899999999999999999999986        


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ....++||||+++ +|.+.+......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3468999999976 7877776666789999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCe--eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc--------chhh
Q 038199          173 KLCDRNRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW--------FPKH  242 (356)
Q Consensus       173 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~--------~~~~  242 (356)
                      +........  .......||..|+|||++.+...++.++|||||||++|+|++|..||..........        ....
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            876532221  223445689999999999876568999999999999999999999886533211000        0000


Q ss_pred             hHHHHhhchhhHHH--HhcCCCchhH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          243 VWEEYEKSELDATI--LACGIEEKDK-----EKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       243 ~~~~~~~~~~~~~~--~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .|............  ..........     ..+..+.+++.+||+.||++|||++++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00000000000000  0000000000     114568899999999999999999999973

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-44  Score=327.36  Aligned_cols=257  Identities=19%  Similarity=0.242  Sum_probs=202.1

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEec--CCeeeE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHD--QHMTAL   98 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~--~~~~~l   98 (356)
                      ..+|++.++||+|+||+||+|.+ .+++.||||++...    ..+.+.+|+.++++++ ||||+++++++.+  ....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            46789999999999999999975 56999999999753    2467899999999997 9999999999987  667899


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-ceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfgl~~~~~~  177 (356)
                      ||||+.+++|.+++.    .+++..+..++.|++.||.|||+   .+++||||||+|||++.++ .+||+|||+++....
T Consensus       111 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999999999999883    48999999999999999999999   9999999999999999776 899999999987654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ...   .....|+..|+|||.+.+...++.++|||||||++|+|++|..||..+.......  .................
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l--~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHHHHCHHHHHHHHH
T ss_pred             CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH--HHHHHhcCCchhhhHHH
Confidence            332   2334689999999999875478999999999999999999999986554321110  00000011111111111


Q ss_pred             hcC-----------------------CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          258 ACG-----------------------IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       258 ~~~-----------------------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...                       ........+.++.+++.+||+.||++|||++++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            100                       01112225678999999999999999999999997

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.6e-45  Score=332.89  Aligned_cols=249  Identities=20%  Similarity=0.290  Sum_probs=200.1

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ....|++.+.||+|+||+||+|.+. +|+.||||++.....     ...+|++++.++ +||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            3567999999999999999999765 689999999976422     235688888887 799999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC----CceEEcccCCcccc
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN----FSPKVADFGLAKLC  175 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~----~~~kl~Dfgl~~~~  175 (356)
                      |||++||+|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+||++.++    +.+||+|||++...
T Consensus        95 ~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           95 TELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             ECCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             EeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999999884 45679999999999999999999999   999999999999998433    35999999999876


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      .....  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||........    ..         +...
T Consensus       171 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~---------~~~~  234 (342)
T 2qr7_A          171 RAENG--LLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP----EE---------ILAR  234 (342)
T ss_dssp             BCTTC--CBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH----HH---------HHHH
T ss_pred             cCCCC--ceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH----HH---------HHHH
Confidence            54332  22345789999999999865 588999999999999999999999865322110    11         1111


Q ss_pred             HHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          256 ILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       256 ~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      +......   ......+.++.+++.+||..||++||++.++++
T Consensus       235 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111111   112345677999999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.9e-45  Score=334.73  Aligned_cols=267  Identities=20%  Similarity=0.258  Sum_probs=203.5

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC-----Cee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMT   96 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-----~~~   96 (356)
                      ..+|++.+.||+|+||+||+|.+. +++.||||++...........+.+|+.++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            368999999999999999999764 68899999998654455567899999999999999999999998754     368


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++|||++.+ +|.+++.  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus       106 ~iv~e~~~~-~L~~~l~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLK--TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCSE-EHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccCc-CHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            999999975 9998884  3569999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCCee-eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc-----chhhhHHHHh--
Q 038199          177 RNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW-----FPKHVWEEYE--  248 (356)
Q Consensus       177 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~-----~~~~~~~~~~--  248 (356)
                      ...... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||..........     ......+.+.  
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            332221 12335789999999987665468999999999999999999999985543221000     0000000000  


Q ss_pred             -hchhhHHHHhcCC------CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          249 -KSELDATILACGI------EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       249 -~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       .............      ....+..+.++.+++.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0000000000000      0011234567899999999999999999999997

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-44  Score=345.71  Aligned_cols=255  Identities=25%  Similarity=0.325  Sum_probs=207.0

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ...+|.+.+.||+|+||.||+|++. +|+.||||++....  .......+.+|+.++++++||||+++++++.+....++
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            3467888899999999999999875 69999999997532  12334678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           99 VYEYMENGSLDGYLFGK---KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      ||||++||+|..++...   ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.+|.+||+|||+++..
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999988543   3479999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ......  ....+||+.|+|||++.+. .++.++|||||||++|||++|..||........            ...+...
T Consensus       340 ~~~~~~--~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~------------~~~~~~~  404 (543)
T 3c4z_A          340 KAGQTK--TKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE------------NKELKQR  404 (543)
T ss_dssp             CTTCCC--BCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC------------HHHHHHH
T ss_pred             cCCCcc--cccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchh------------HHHHHHH
Confidence            543322  2345799999999999876 789999999999999999999999865432111            0011111


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPM-----SAVVK  295 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~~v~~  295 (356)
                      +... ....+...+..+.+++.+||+.||.+||++     ++|++
T Consensus       405 i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          405 VLEQ-AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             Hhhc-ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            1111 122334566789999999999999999975     56654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.9e-45  Score=331.10  Aligned_cols=263  Identities=21%  Similarity=0.280  Sum_probs=203.0

Q ss_pred             ceecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCC--CCceeeeeceE
Q 038199           14 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTY--HINLVRLYGFC   90 (356)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~   90 (356)
                      ..++..++...+|++.+.||+|+||.||++.+.+++.||||++... ......+.+.+|+.++++++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            3456677788899999999999999999999888999999999653 23455578999999999997  59999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      .+....++||| +.+++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||++++ +.+||+|||
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecc
Confidence            99999999999 557899999854 4678999999999999999999999   99999999999999965 799999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCC----------CCCCccccchhhHHHHHHHHhCCcccccCCCCccccch
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP  240 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~  240 (356)
                      ++................|+..|+|||.+.+.          ..++.++||||||+++|+|++|..||.......     
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----  246 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----  246 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----
Confidence            99876544333233345689999999998651          257889999999999999999999985432210     


Q ss_pred             hhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          241 KHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                          .     ..............+...+.++.+++.+||+.||.+||++.++++.
T Consensus       247 ----~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          247 ----S-----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ----H-----HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----H-----HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                0     0111111111112222335678999999999999999999999973

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=338.00  Aligned_cols=259  Identities=22%  Similarity=0.249  Sum_probs=205.5

Q ss_pred             HhhhhccccccccccCceEEEEEEe----CCCcEEEEEEecccc---chhhHHHHHHHHHHHccC-CCCceeeeeceEec
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF----PNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD   92 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~   92 (356)
                      +...+|++.++||+|+||+||+|+.    .+++.||||+++...   .....+.+.+|+.+++++ +||||+++++++.+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            3457899999999999999999976    368999999987432   122335677899999999 69999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999999843 4579999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      +........ ......||..|+|||++.+. ..++.++|||||||++|||++|..||.........       .     .
T Consensus       207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------~-----~  273 (355)
T 1vzo_A          207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-------A-----E  273 (355)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-------H-----H
T ss_pred             eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-------H-----H
Confidence            865432221 12335699999999999853 25789999999999999999999998654332110       0     0


Q ss_pred             hhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 038199          252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVKML  297 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~L  297 (356)
                      +..... ......+...+..+.+++.+||..||.+||     +++++++..
T Consensus       274 ~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          274 ISRRIL-KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHHHHh-ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            011111 112233445567789999999999999999     999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.8e-45  Score=327.11  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=201.2

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      +....+|++.+.||+|+||.||+|.+. +|+.||||++...   .....+.+|+.++++++||||+++++++.+....++
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            445667899999999999999999765 5999999999764   234678999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999999986556789999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      ...  .....|+..|+|||.+.+. .++.++||||||+++|+|++|..||......          ...      .....
T Consensus       179 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~------~~~~~  239 (314)
T 3com_A          179 MAK--RNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPM----------RAI------FMIPT  239 (314)
T ss_dssp             BSC--BCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----------HHH------HHHHH
T ss_pred             ccc--cCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChH----------HHH------HHHhc
Confidence            221  2335689999999999876 6899999999999999999999987532210          000      00111


Q ss_pred             c--CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          259 C--GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       259 ~--~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .  .....+...+..+.+++.+||..||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          240 NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1  111223345677999999999999999999999987

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.4e-44  Score=343.38  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=201.6

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccch------------hhHHHHHHHHHHHccCCCCceeeeec
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGR------------IAEEQFMAEVGTIGRTYHINLVRLYG   88 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~ni~~~~~   88 (356)
                      ...+|.+.++||+|+||+||+|.+. +++.||||++......            ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4567999999999999999999765 5899999999753211            33467899999999999999999999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC---ceE
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPK  165 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~---~~k  165 (356)
                      ++.+....++|||||+|++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999999988843 4679999999999999999999999   9999999999999998776   699


Q ss_pred             EcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHH
Q 038199          166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWE  245 (356)
Q Consensus       166 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~  245 (356)
                      |+|||++........   .....||+.|+|||++.+  .++.++|||||||++|+|++|..||......           
T Consensus       190 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------  253 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-----------  253 (504)
T ss_dssp             ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------
T ss_pred             EEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----------
Confidence            999999987654322   234569999999999874  5899999999999999999999998543221           


Q ss_pred             HHhhchhhHHHHhcCCCc---hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          246 EYEKSELDATILACGIEE---KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                           .....+.......   .....+.++.+++.+||+.||.+|||++++++
T Consensus       254 -----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          254 -----DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             -----HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----HHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 1111112221111   11234677999999999999999999999987

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=321.84  Aligned_cols=253  Identities=22%  Similarity=0.246  Sum_probs=201.0

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc---chhhHHHHHHHHHHHccCCCCceeeeeceEe--cCCee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRTYHINLVRLYGFCH--DQHMT   96 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~--~~~~~   96 (356)
                      ..+|.+.+.||+|+||.||++.+. +++.||+|++....   .......+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            357999999999999999999864 68999999997532   1234567999999999999999999999984  45678


Q ss_pred             eEEEeccCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           97 ALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      ++||||+.++ |.+++.. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 6666643 35679999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCC-CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      .............||..|+|||++.+.. ..+.++||||||+++|+|++|..|+.....       ......        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~--------  224 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFEN--------  224 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHH--------
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHH--------
Confidence            5444443445567999999999987642 247799999999999999999999854321       111111        


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                       +... ....+...+..+.+++.+||+.||.+|||++++++.
T Consensus       225 -i~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          225 -IGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -HHHC-CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -HhcC-CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             1111 112233456678999999999999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=331.87  Aligned_cols=268  Identities=20%  Similarity=0.268  Sum_probs=199.1

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~------   94 (356)
                      ..+|++.+.||+|+||+||+|.+ .+|+.||||++.... .....+++.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            45788899999999999999976 469999999996532 3444577899999999999999999999997653      


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+ +++|.+++..  ..+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 7899999854  579999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc--------cchhhhHHH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD--------WFPKHVWEE  246 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~  246 (356)
                      ....     .....||..|+|||++.+...++.++|||||||+++||++|+.||........-        ..+...+..
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            5432     234568999999999887447899999999999999999999998543221000        000000000


Q ss_pred             HhhchhhHHHHhc------CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhccc
Q 038199          247 YEKSELDATILAC------GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK--MLEGVV  301 (356)
Q Consensus       247 ~~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~~  301 (356)
                      +............      .........+..+.+++.+||..||.+|||++++++  .+..+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            0000011111100      001112334677899999999999999999999998  354443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.6e-44  Score=322.96  Aligned_cols=250  Identities=25%  Similarity=0.354  Sum_probs=195.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec---------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD---------   92 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~---------   92 (356)
                      ..+|++.+.||+|+||+||+|.+. +++.||||++...  ....+.+.+|+.++++++||||+++++++.+         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            457899999999999999999864 6999999999653  4455789999999999999999999998764         


Q ss_pred             ----CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcc
Q 038199           93 ----QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  168 (356)
Q Consensus        93 ----~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D  168 (356)
                          ....++||||+++++|.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence                456789999999999999997667788999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCC------------eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc
Q 038199          169 FGLAKLCDRNRS------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL  236 (356)
Q Consensus       169 fgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~  236 (356)
                      ||++........            ........||..|+|||.+.+...++.++||||||+++|+|+++   +...     
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p---~~~~-----  231 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTG-----  231 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC---CSSH-----
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc---cCCc-----
Confidence            999986543211            11223456899999999998655689999999999999999983   2111     


Q ss_pred             ccchhhhHHHHhhchhhHHHHh---cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          237 DWFPKHVWEEYEKSELDATILA---CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                           ..     .......+..   ..........+..+.+++.+||+.||.+|||+.++++
T Consensus       232 -----~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 -----ME-----RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -----HH-----HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----hh-----HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                 00     0001111111   1112233445567899999999999999999999997

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.1e-44  Score=327.52  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=203.4

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-------hhhHHHHHHHHHHHccC-CCCceeeeeceEec
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD   92 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~   92 (356)
                      ...+|++.+.||+|+||.||+|.+. +|+.||||++.....       ....+.+.+|+.+++++ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            3467888999999999999999875 699999999875431       12235688999999999 79999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ....++||||++|++|.+++. ....+++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~  247 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLT-EKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS  247 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCEEEEEEEeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence            999999999999999999984 34679999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCC-----CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGN-----YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      ........   .....||+.|+|||++.+.     ..++.++|||||||++|+|++|..||......             
T Consensus       248 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------------  311 (365)
T 2y7j_A          248 CHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-------------  311 (365)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred             cccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-------------
Confidence            87654332   2345699999999988532     25788999999999999999999998543210             


Q ss_pred             hhchhhHHHHhcCCCchh---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILACGIEEKD---KEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                         .....+.........   ...+..+.+++.+||+.||++||++.++++
T Consensus       312 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 ---LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ---HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               011111111111111   134567899999999999999999999987

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.2e-44  Score=343.26  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=204.1

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ...+|++.++||+|+||+||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4578999999999999999999765 69999999986421 233456789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc---CCCceEEcccCCccccC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCD  176 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~---~~~~~kl~Dfgl~~~~~  176 (356)
                      |||+.+++|.+.+.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||+++...
T Consensus       100 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999988843 4679999999999999999999999   9999999999999995   45679999999998665


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ...   ......||+.|+|||++.+  .++.++|||||||++|+|++|..||......                .....+
T Consensus       176 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~i  234 (486)
T 3mwu_A          176 QNT---KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----------------DILKRV  234 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHH
T ss_pred             CCC---ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHH
Confidence            432   2234569999999999976  4899999999999999999999998543210                111111


Q ss_pred             HhcCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          257 LACGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       257 ~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      .....   .+.....+.++.+++.+||+.||.+|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11111   12223456789999999999999999999999984

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.4e-44  Score=343.58  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=199.7

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ....|.+.++||+|+||+||+|.+. +++.||||++.... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3457999999999999999999865 68999999997542 233346789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---CCceEEcccCCccccC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCD  176 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfgl~~~~~  176 (356)
                      |||+.+++|.+.+. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||++....
T Consensus       115 ~e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          115 MECYKGGELFDEII-HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            99999999998884 34679999999999999999999999   99999999999999976   4559999999998765


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ...   ......||+.|+|||++.+  .++.++|||||||++|+|++|..||......                .....+
T Consensus       191 ~~~---~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~i  249 (494)
T 3lij_A          191 NQK---KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ----------------EILRKV  249 (494)
T ss_dssp             TTB---CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHH
T ss_pred             CCc---cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHH
Confidence            432   2234569999999999864  5899999999999999999999998543221                111111


Q ss_pred             HhcCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LACGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....   .+.....+..+.+++.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          250 EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            11111   1222345677999999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-44  Score=356.12  Aligned_cols=251  Identities=24%  Similarity=0.286  Sum_probs=205.6

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~   96 (356)
                      +...+|++.++||+|+||+||+|++. +++.||||++....  .....+.+..|..++..+ +||||+.+++++.+.+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            45567899999999999999999765 58899999997532  223346788999999988 699999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||++||+|..++.. ...+++..+..|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       418 ~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999999853 3579999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ....  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.....                ..+...+
T Consensus       494 ~~~~--~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~----------------~~~~~~i  554 (674)
T 3pfq_A          494 WDGV--TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----------------DELFQSI  554 (674)
T ss_dssp             CTTC--CBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHH
T ss_pred             cCCc--ccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCH----------------HHHHHHH
Confidence            3222  23456799999999999877 799999999999999999999999854321                1111111


Q ss_pred             HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 038199          257 LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPM-----SAVVK  295 (356)
Q Consensus       257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~~v~~  295 (356)
                      .... ...+...+.++.+++.+||+.||++||++     ++|++
T Consensus       555 ~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          555 MEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HSSC-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HhCC-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            1111 22334567789999999999999999998     66665

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-44  Score=331.53  Aligned_cols=269  Identities=19%  Similarity=0.223  Sum_probs=198.8

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccc----------hhhHHHHHHHHHHHccCCCCceeee
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG----------RIAEEQFMAEVGTIGRTYHINLVRL   86 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~E~~~l~~l~h~ni~~~   86 (356)
                      ........+|.+.+.||+|+||+||+|.+.+|+.||||++.....          ....+.+.+|+.++++++||||+++
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            445566789999999999999999999887899999999864321          1223679999999999999999999


Q ss_pred             eceEec-----CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC
Q 038199           87 YGFCHD-----QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN  161 (356)
Q Consensus        87 ~~~~~~-----~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~  161 (356)
                      ++++..     ....++||||+. ++|.+++......+++..+..++.||+.||.|||+   .+++||||||+||+++.+
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~  170 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADN  170 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTT
T ss_pred             eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCC
Confidence            999853     346799999997 58888887667789999999999999999999999   999999999999999999


Q ss_pred             CceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchh
Q 038199          162 FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK  241 (356)
Q Consensus       162 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~  241 (356)
                      +.+||+|||++........   .....||..|+|||++.+...++.++|||||||++|+|++|+.||........  . .
T Consensus       171 ~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~  244 (362)
T 3pg1_A          171 NDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ--L-N  244 (362)
T ss_dssp             CCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-H
T ss_pred             CCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH--H-H
Confidence            9999999999975433222   23346889999999988744789999999999999999999999865332100  0 0


Q ss_pred             hhHHHHhh-----------chhhHHHHhcC--C-----CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          242 HVWEEYEK-----------SELDATILACG--I-----EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       242 ~~~~~~~~-----------~~~~~~~~~~~--~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...+....           ...........  .     ....+..+..+.+++.+||+.||++|||+.++++
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            00000000           00000000000  0     0111223567899999999999999999999997

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-44  Score=344.74  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=207.7

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      .+...+|++.++||+|+||+||+|... +|+.||||++....  .....+.+.+|+.++++++||||+++++++.+....
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            345678999999999999999999765 79999999986432  234567899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE---cCCCceEEcccCCcc
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAK  173 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfgl~~  173 (356)
                      ++||||+.+++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+||++   +.++.+||+|||++.
T Consensus       102 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EEEECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999999884 45679999999999999999999999   999999999999999   567899999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      .......   .....||+.|+|||++.+  .++.++|||||||++|+|++|..||......                ...
T Consensus       178 ~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~  236 (484)
T 3nyv_A          178 HFEASKK---MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEY----------------DIL  236 (484)
T ss_dssp             HBCCCCS---HHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHH
T ss_pred             Ecccccc---cccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH----------------HHH
Confidence            7654332   233468999999999976  4789999999999999999999998543211                111


Q ss_pred             HHHHhcCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILACGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+.....   .+.....+.++.+++.+||+.||.+|||+.++++
T Consensus       237 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          237 KKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            11112111   1222345678999999999999999999999997

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.7e-44  Score=322.20  Aligned_cols=248  Identities=22%  Similarity=0.324  Sum_probs=201.9

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ...+|.+.+.||+|+||+||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            4568999999999999999999764 69999999997542 233457889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE---cCCCceEEcccCCccccCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDR  177 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill---~~~~~~kl~Dfgl~~~~~~  177 (356)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||++   +.++.++|+|||++.....
T Consensus        86 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           86 QLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             EcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999999998843 4579999999999999999999999   999999999999999   7788999999999875432


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ..    .....||..|+|||.+.+. .++.++||||||+++|+|++|..||......       ....         .+.
T Consensus       162 ~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~---------~i~  220 (304)
T 2jam_A          162 GI----MSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFE---------KIK  220 (304)
T ss_dssp             BT----THHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHH---------HHH
T ss_pred             Cc----cccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHH---------HHH
Confidence            21    1224589999999999876 7899999999999999999999987543210       1111         111


Q ss_pred             hcC---CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          258 ACG---IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       258 ~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...   ........+..+.+++.+||..||++||+++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          221 EGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111   11222345677999999999999999999999997

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=321.99  Aligned_cols=256  Identities=23%  Similarity=0.305  Sum_probs=200.8

Q ss_pred             HHhhhhccccc-----cccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC
Q 038199           20 QLNNFTSNYST-----RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ   93 (356)
Q Consensus        20 ~~~~~~~~~~~-----~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   93 (356)
                      ++....|.+.+     .||+|+||+||+|.+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus        13 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   91 (295)
T 2clq_A           13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN   91 (295)
T ss_dssp             -CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence            34444555544     899999999999976 468999999987542 34456789999999999999999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-CCceEEcccC
Q 038199           94 HMTALVYEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFG  170 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfg  170 (356)
                      ...++||||+++++|.+++....  ..+++..+..++.|++.||.|||+   .+++||||||+||+++. ++.++|+|||
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg  168 (295)
T 2clq_A           92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFG  168 (295)
T ss_dssp             TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred             CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecc
Confidence            99999999999999999986543  356799999999999999999999   99999999999999987 8999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      ++........  ......|+..|+|||++.+. ..++.++||||||+++|+|++|..||.......        .     
T Consensus       169 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~-----  233 (295)
T 2clq_A          169 TSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--------A-----  233 (295)
T ss_dssp             TCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--------H-----
T ss_pred             cccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--------H-----
Confidence            9987643221  12345689999999998654 137899999999999999999999875322110        0     


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       ...........+..+...+.++.+++.+||+.||++||++.++++
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          234 -AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -HHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -HHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             000111112223334456678999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.7e-44  Score=322.74  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=198.1

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc-------hhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      ....+|.+.+.||+|+||.||+|.+. +++.||||++.....       ......+.+|+.++++++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            34578999999999999999999764 689999999865321       1222458899999999999999999999877


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc---eEEccc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADF  169 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~---~kl~Df  169 (356)
                      .. .++||||+++++|.+++. ....+++..+..++.||+.||.|||+   .+++||||||+||+++.++.   +||+||
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             Cc-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            65 799999999999999883 45689999999999999999999999   99999999999999987654   999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCccccc--CCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      |++.......   ......||..|+|||++.  +...++.++||||||+++|+|++|..||........           
T Consensus       162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------  227 (322)
T 2ycf_A          162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-----------  227 (322)
T ss_dssp             TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-----------
T ss_pred             ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-----------
Confidence            9998764322   112345899999999974  233688999999999999999999999865432210           


Q ss_pred             hhchhhHHHHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          ....+......   ......+..+.+++.+||+.||++||++.++++
T Consensus       228 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 ----LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             ----HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                11111111111   112234677999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.8e-45  Score=326.07  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=200.3

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            4578999999999999999999875 58999999987542 344578899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+++++|.+++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            9999999999986656789999999999999999999999   9999999999999999999999999998754321110


Q ss_pred             eeeeccCCCCCCCCCccccc----CCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          181 HVTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                        ......||..|+|||.+.    ....++.++||||||+++|+|++|..|+......       ...        ....
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~--------~~~~  235 (302)
T 2j7t_A          173 --KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVL--------LKIA  235 (302)
T ss_dssp             --C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHH--------HHHH
T ss_pred             --ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHH--------HHHh
Confidence              112345899999999883    2336889999999999999999999987543210       000        0001


Q ss_pred             Hh-cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LA-CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .. ......+...+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          236 KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            01 1111223445677999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.9e-44  Score=329.23  Aligned_cols=266  Identities=20%  Similarity=0.258  Sum_probs=207.7

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchh----------------hHHHHHHHHHHHccCCC
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRI----------------AEEQFMAEVGTIGRTYH   80 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~E~~~l~~l~h   80 (356)
                      ...++...+|++.+.||+|+||.||+|.+ +|+.||||++.......                ..+.+.+|+.++++++|
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  102 (348)
T 2pml_X           24 KEKDKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN  102 (348)
T ss_dssp             SSSCEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred             hhcccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence            34445567899999999999999999988 99999999986432111                11689999999999999


Q ss_pred             CceeeeeceEecCCeeeEEEeccCCCChhhh------hhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCC
Q 038199           81 INLVRLYGFCHDQHMTALVYEYMENGSLDGY------LFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP  153 (356)
Q Consensus        81 ~ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~------l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp  153 (356)
                      |||+++++++.+.+..++||||+++++|.++      +... ...+++..+..++.|++.||.|||+  ..+++||||||
T Consensus       103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p  180 (348)
T 2pml_X          103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKP  180 (348)
T ss_dssp             TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCG
T ss_pred             CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCCh
Confidence            9999999999999999999999999999998      5332 5689999999999999999999996  37999999999


Q ss_pred             CcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCc-cccchhhHHHHHHHHhCCcccccCC
Q 038199          154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH-KCDVYSFGMVLFEIVGRRRNAIVGS  232 (356)
Q Consensus       154 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~Dv~slGvvl~elltg~~p~~~~~  232 (356)
                      +||+++.++.++|+|||++......    ......|+..|+|||.+.+...++. ++||||||+++|+|++|..||....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999876443    2344668999999999987644555 9999999999999999999986543


Q ss_pred             CCccccchhhhHHHHhhchhhHH---------HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          233 SESLDWFPKHVWEEYEKSELDAT---------ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..      ......+........         .............+.++.+++.+||+.||.+||++.++++
T Consensus       257 ~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          257 SL------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CS------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cH------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            31      011111111100000         0000000011445678999999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.3e-44  Score=330.68  Aligned_cols=263  Identities=19%  Similarity=0.246  Sum_probs=184.7

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC------C
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------H   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------~   94 (356)
                      ..+|++.+.||+|+||.||+|.+ .+|+.||||++.... ......++.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46788999999999999999975 469999999997542 334557888999999999999999999998654      5


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++|+|++ +++|.+++.  ...+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            579999999 679999883  3679999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-c----ch---hhhHHH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-W----FP---KHVWEE  246 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-~----~~---~~~~~~  246 (356)
                      ....     .....||..|+|||++.+...++.++|||||||++|||++|+.||........- .    ..   ...+..
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            5432     234568999999999987547899999999999999999999998543321000 0    00   000000


Q ss_pred             HhhchhhHHHHhcC-CCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          247 YEKSELDATILACG-IEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       247 ~~~~~~~~~~~~~~-~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                      +............. .+.     .....+..+.+++.+||..||++|||+.++++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00000011111000 000     011235678999999999999999999999973

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-43  Score=326.25  Aligned_cols=262  Identities=20%  Similarity=0.205  Sum_probs=192.7

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~------   94 (356)
                      ..+|++.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467899999999999999999754 68999999997542 3344567889999999999999999999997654      


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+++ +|.+.+.   ..+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            67999999975 7888773   458999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccc-----cchhhhHHHHhh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLD-----WFPKHVWEEYEK  249 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~  249 (356)
                      .....   ......||..|+|||++.+. .++.++|||||||++|+|++|+.||.........     .......+.+..
T Consensus       177 ~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          177 AGTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ----------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             ccccc---ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            54322   22335689999999999876 7899999999999999999999998543321000     000000000000


Q ss_pred             --chhhHHHH------------------hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 --SELDATIL------------------ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 --~~~~~~~~------------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                        ........                  ...........+.++.+++.+||..||++|||++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence              00000000                  00011122345778999999999999999999999998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-44  Score=331.92  Aligned_cols=258  Identities=19%  Similarity=0.222  Sum_probs=195.3

Q ss_pred             HHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec------
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------   92 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~------   92 (356)
                      +....+|++.+.||+|+||+||+|.+ .+|+.||||++..+...     ..+|+.+++.++||||+++++++..      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            45667899999999999999999975 57999999998754222     2469999999999999999999843      


Q ss_pred             --------------------------------CCeeeEEEeccCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHH
Q 038199           93 --------------------------------QHMTALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVY  137 (356)
Q Consensus        93 --------------------------------~~~~~lV~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~  137 (356)
                                                      ....++||||+++ +|.+.+.   ..+..+++..+..++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3458899999975 8777664   246789999999999999999999


Q ss_pred             HhhcCCCCccccCCCCCcEEEc-CCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHH
Q 038199          138 LHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM  216 (356)
Q Consensus       138 LH~~~~~~ivH~dikp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGv  216 (356)
                      ||+   .+|+||||||+||+++ .++.+||+|||+++........   ....||..|+|||.+.+...++.++|||||||
T Consensus       157 LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          157 IHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            999   9999999999999997 6889999999999876443322   23568999999999887656899999999999


Q ss_pred             HHHHHHhCCcccccCCCCccccchhhhHHHHh--hchhhHHHHh-----------cC-CC----chhHHHHHHHHHHHHh
Q 038199          217 VLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE--KSELDATILA-----------CG-IE----EKDKEKAKRLCMAALW  278 (356)
Q Consensus       217 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-----------~~-~~----~~~~~~~~~l~~l~~~  278 (356)
                      ++|||++|+.||.......      .......  ..........           .. ..    ..+...+.++.+++.+
T Consensus       231 il~ell~g~~pf~~~~~~~------~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  304 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSID------QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ  304 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCChHH------HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence            9999999999986433211      0000000  0000000000           00 00    0112245678999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 038199          279 CVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       279 cl~~~p~~Rps~~~v~~  295 (356)
                      ||+.||.+|||+.++++
T Consensus       305 ~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          305 ILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HCCSSGGGSCCHHHHHT
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.7e-44  Score=333.24  Aligned_cols=199  Identities=23%  Similarity=0.300  Sum_probs=170.7

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccC------CCCceeeeeceEecC
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT------YHINLVRLYGFCHDQ   93 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~ni~~~~~~~~~~   93 (356)
                      ....+|++.++||+|+||+||+|.+. +++.||||++...  ......+.+|+.+++.+      .|+||+.+++++...
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            34567999999999999999999764 5899999999764  34445677788877776      577999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc--eEEcccC
Q 038199           94 HMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--PKVADFG  170 (356)
Q Consensus        94 ~~~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~--~kl~Dfg  170 (356)
                      ...++||||+. ++|.+++.... ..+++..+..|+.||+.||+|||+   .+|+||||||+|||++.++.  +||+|||
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999999996 58988886543 469999999999999999999999   99999999999999999887  9999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccC
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG  231 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  231 (356)
                      ++......     .....||..|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus       248 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          248 SSCYEHQR-----VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceecCCc-----ccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99764432     2235689999999999877 6899999999999999999999887543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-45  Score=338.55  Aligned_cols=242  Identities=15%  Similarity=0.114  Sum_probs=187.5

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccc--cchhhHHHHHHHH---HHHccCCCCceeeee-------ce
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEV---GTIGRTYHINLVRLY-------GF   89 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~---~~l~~l~h~ni~~~~-------~~   89 (356)
                      ..+|.+.+.||+|+||+||+|.+ .+|+.||||++...  ......+.+.+|+   ..+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35678889999999999999986 46999999998743  2334557899999   555556799999998       55


Q ss_pred             EecCC-----------------eeeEEEeccCCCChhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 038199           90 CHDQH-----------------MTALVYEYMENGSLDGYLFGKK------RAIEWEKLHEIAIGTAKGLVYLHEECQQRI  146 (356)
Q Consensus        90 ~~~~~-----------------~~~lV~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  146 (356)
                      +.+.+                 ..++||||+ +|+|.+++....      ..+++..++.|+.||+.||+|||+   .+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            55443                 278999999 579999985421      234468899999999999999999   999


Q ss_pred             cccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCC----------CCCCccccchhhHH
Q 038199          147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGM  216 (356)
Q Consensus       147 vH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~Dv~slGv  216 (356)
                      +||||||+|||++.++.+||+|||+++....     ......| ..|+|||++.+.          ..++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985332     2234567 999999998754          25799999999999


Q ss_pred             HHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          217 VLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       217 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ++|||++|+.||........                .......     ....+.++.+++.+||+.||++||++.++++
T Consensus       302 il~elltg~~Pf~~~~~~~~----------------~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG----------------SEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CC----------------SGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccc----------------hhhhhhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999854332111                0000010     1233567889999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=324.80  Aligned_cols=253  Identities=25%  Similarity=0.337  Sum_probs=196.6

Q ss_pred             HhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEec------
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHD------   92 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~------   92 (356)
                      .....|++.+.||+|+||.||+|.+ .+|+.||||++....  ...+.+.+|+.+++++ +||||+++++++..      
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            3566789999999999999999976 468999999997542  3346789999999998 79999999999976      


Q ss_pred             CCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           93 QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                      ....++||||+++++|.+++... ...+++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            46789999999999999999654 3579999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      +........  ......|+..|+|||.+.+    ...++.++||||||+++|+|++|..|+......          .. 
T Consensus       176 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~-  242 (326)
T 2x7f_A          176 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----------RA-  242 (326)
T ss_dssp             TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----------HH-
T ss_pred             ceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----------HH-
Confidence            886543221  1223468999999999862    226889999999999999999999987432210          00 


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          .................+..+.+++.+||..||.+||++.++++
T Consensus       243 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          243 ----LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ----HHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----HHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                00011111111122334567999999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.6e-45  Score=337.05  Aligned_cols=256  Identities=11%  Similarity=0.002  Sum_probs=183.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccC--CCCceeeee-------ceE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRT--YHINLVRLY-------GFC   90 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l--~h~ni~~~~-------~~~   90 (356)
                      ..+|.+.+.||+|+||+||+|.+. +|+.||||++....  .....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            445888999999999999999864 69999999998643  234446677885444444  699988755       344


Q ss_pred             ecC-----------------CeeeEEEeccCCCChhhhhhcCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCCcc
Q 038199           91 HDQ-----------------HMTALVYEYMENGSLDGYLFGKKRAIEWEKL------HEIAIGTAKGLVYLHEECQQRII  147 (356)
Q Consensus        91 ~~~-----------------~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~~~~iv  147 (356)
                      ...                 ...++||||++ ++|.+++...+..+.+..+      ..++.||+.||+|||+   ++|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence            322                 33799999998 7999999655555566666      7888999999999999   9999


Q ss_pred             ccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCC-CCCCccccchhhHHHHHHHHhCCc
Q 038199          148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVLFEIVGRRR  226 (356)
Q Consensus       148 H~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slGvvl~elltg~~  226 (356)
                      ||||||+|||++.++.+||+|||+++.....     .....+|..|+|||++.+. ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999865421     1134567999999999761 268999999999999999999999


Q ss_pred             ccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          227 NAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       227 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ||............        ....................+..+.+++.+||+.||++|||+.++++
T Consensus       292 Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            98765332111000        00000000001111122345677999999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=335.10  Aligned_cols=267  Identities=19%  Similarity=0.245  Sum_probs=183.4

Q ss_pred             hhhccc-cccccccCceEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe--cCCee
Q 038199           23 NFTSNY-STRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH--DQHMT   96 (356)
Q Consensus        23 ~~~~~~-~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~--~~~~~   96 (356)
                      ...|++ +++||+|+||+||+|.+.   +++.||||++...   .....+.+|+.++++++||||+++++++.  .....
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            345666 568999999999999864   5789999999754   22246789999999999999999999995  46788


Q ss_pred             eEEEeccCCCChhhhhhc--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE----cCCCce
Q 038199           97 ALVYEYMENGSLDGYLFG--------KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSP  164 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill----~~~~~~  164 (356)
                      ++||||+.+ +|.+++..        ....+++..+..|+.||+.||.|||+   .+|+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcE
Confidence            999999965 78777632        12359999999999999999999999   999999999999999    677899


Q ss_pred             EEcccCCccccCCCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc---h
Q 038199          165 KVADFGLAKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF---P  240 (356)
Q Consensus       165 kl~Dfgl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~---~  240 (356)
                      ||+|||+++........ .......||..|+|||++.+...++.++|||||||++|||++|..||...........   .
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            99999999876543221 2233467899999999998754689999999999999999999999865433211000   0


Q ss_pred             hhh--------------HHHHhhchhhHHHHhcC----C--Cchh-------HHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 038199          241 KHV--------------WEEYEKSELDATILACG----I--EEKD-------KEKAKRLCMAALWCVQDSPEDRPPMSAV  293 (356)
Q Consensus       241 ~~~--------------~~~~~~~~~~~~~~~~~----~--~~~~-------~~~~~~l~~l~~~cl~~~p~~Rps~~~v  293 (356)
                      ...              |..+.............    .  ....       ...+..+.+|+.+||+.||.+|||++++
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            000              00000000000000000    0  0000       0014568899999999999999999999


Q ss_pred             HHH
Q 038199          294 VKM  296 (356)
Q Consensus       294 ~~~  296 (356)
                      ++.
T Consensus       332 L~h  334 (405)
T 3rgf_A          332 MQD  334 (405)
T ss_dssp             HTS
T ss_pred             hcC
Confidence            984

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.1e-44  Score=327.64  Aligned_cols=264  Identities=19%  Similarity=0.245  Sum_probs=201.1

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC-----Cee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HMT   96 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-----~~~   96 (356)
                      ..+|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467899999999999999999765 69999999997654455567788999999999999999999988754     678


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++||||+. ++|.+++..  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 489988843  579999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCee--------eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH-
Q 038199          177 RNRSHV--------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY-  247 (356)
Q Consensus       177 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-  247 (356)
                      ......        ......||..|+|||++.+...++.++|||||||++|+|++|..||.........   ....... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~  240 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFGIIG  240 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhC
Confidence            332211        1223568999999998865447899999999999999999999998643311000   0000000 


Q ss_pred             -----------hhchhhHHHHhcC---C---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 -----------EKSELDATILACG---I---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 -----------~~~~~~~~~~~~~---~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                                 .............   .   ....+..+.++.+++.+||+.||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                       0000000000000   0   0111245677899999999999999999999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-43  Score=326.01  Aligned_cols=259  Identities=20%  Similarity=0.278  Sum_probs=196.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee----
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT----   96 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~----   96 (356)
                      ..+|.+.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            357888899999999999999764 69999999997543 334457889999999999999999999999877654    


Q ss_pred             --eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           97 --ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        97 --~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                        ++||||+. ++|.+++   ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 5888777   3459999999999999999999999   9999999999999999999999999999986


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh----------hH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH----------VW  244 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~----------~~  244 (356)
                      ....     .....||..|+|||++.+...++.++|||||||++|+|++|..||........  +...          .+
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFV  266 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCcHHHH
Confidence            5432     23456899999999998744789999999999999999999999854321100  0000          00


Q ss_pred             HHHhhchhhHHHHhc---CCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          245 EEYEKSELDATILAC---GIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       245 ~~~~~~~~~~~~~~~---~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+............   ...   ......+..+.+++.+||+.||++|||++++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            000000000000000   000   011234678999999999999999999999987

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-43  Score=322.34  Aligned_cols=267  Identities=22%  Similarity=0.282  Sum_probs=204.8

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEe-C-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCc------eeeeec
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQF-P-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN------LVRLYG   88 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------i~~~~~   88 (356)
                      ...++...+|++.+.||+|+||+||+|.+ . +++.||||++...  ....+.+.+|+.+++.++|+|      ++++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            44556678999999999999999999975 3 6889999999754  344567889999999887654      999999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-------
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-------  160 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-------  160 (356)
                      ++.+....++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+   .+++||||||+||+++.       
T Consensus        85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEE
T ss_pred             ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEecccccccc
Confidence            999999999999999 789999886543 478999999999999999999999   99999999999999987       


Q ss_pred             ------------CCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCccc
Q 038199          161 ------------NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNA  228 (356)
Q Consensus       161 ------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~  228 (356)
                                  ++.+||+|||++.......     ....||..|+|||++.+. .++.++||||||+++|||++|..||
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf  234 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVF  234 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCC
Confidence                        6689999999998654322     234689999999999876 7899999999999999999999998


Q ss_pred             ccCCCCcccc--------chhhhHHHHhhc--------------hhhHHHHh-----cCCCchhHHHHHHHHHHHHhccc
Q 038199          229 IVGSSESLDW--------FPKHVWEEYEKS--------------ELDATILA-----CGIEEKDKEKAKRLCMAALWCVQ  281 (356)
Q Consensus       229 ~~~~~~~~~~--------~~~~~~~~~~~~--------------~~~~~~~~-----~~~~~~~~~~~~~l~~l~~~cl~  281 (356)
                      ..........        .+...+......              ........     ..........+.++.+++.+||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            6543211000        000000000000              00000000     00011233457789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 038199          282 DSPEDRPPMSAVVK  295 (356)
Q Consensus       282 ~~p~~Rps~~~v~~  295 (356)
                      .||.+|||+.++++
T Consensus       315 ~dP~~Rpt~~ell~  328 (339)
T 1z57_A          315 YDPAKRITLREALK  328 (339)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             cCcccccCHHHHhc
Confidence            99999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.9e-44  Score=317.47  Aligned_cols=254  Identities=21%  Similarity=0.278  Sum_probs=204.5

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc--------hhhHHHHHHHHHHHccCC-CCceeeeec
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--------RIAEEQFMAEVGTIGRTY-HINLVRLYG   88 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~ni~~~~~   88 (356)
                      ..-...+|++.+.||+|+||.||+|.+. +|+.||||++.....        ....+.+.+|+.+++++. ||||+++++
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (298)
T 1phk_A           12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   91 (298)
T ss_dssp             ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence            3345678999999999999999999765 689999999964321        123457889999999995 999999999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcc
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  168 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D  168 (356)
                      ++.+....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           92 TYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEec
Confidence            99999999999999999999999843 4679999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCCeeeeccCCCCCCCCCccccc-----CCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhh
Q 038199          169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-----GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHV  243 (356)
Q Consensus       169 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~  243 (356)
                      ||++........   .....|+..|+|||++.     ....++.++||||||+++|+|++|..|+......       . 
T Consensus       168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-  236 (298)
T 1phk_A          168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------L-  236 (298)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-
T ss_pred             ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-------H-
Confidence            999987654322   23356899999999875     2336789999999999999999999987543210       0 


Q ss_pred             HHHHhhchhhHHHHhcCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          244 WEEYEKSELDATILACGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                              ....+.....   .+.....+..+.+++.+||+.||.+|||+.++++
T Consensus       237 --------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          237 --------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --------HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --------HHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                    1111111111   1222356678999999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=317.94  Aligned_cols=265  Identities=21%  Similarity=0.245  Sum_probs=193.4

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe----------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH----------   91 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~----------   91 (356)
                      ..+|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            467899999999999999999765 5999999998754 2445578899999999999999999998873          


Q ss_pred             ----cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc-CCCceEE
Q 038199           92 ----DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKV  166 (356)
Q Consensus        92 ----~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~kl  166 (356)
                          +....++||||+. ++|.+++  ....+++..+..++.|++.||+|||+   .+++||||||+||+++ .++.+||
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVL--EQGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHh--hcCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence                4467899999997 5999998  34679999999999999999999999   9999999999999997 5679999


Q ss_pred             cccCCccccCCCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc-------
Q 038199          167 ADFGLAKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW-------  238 (356)
Q Consensus       167 ~Dfgl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~-------  238 (356)
                      +|||+++........ .......++..|+|||.+.+...++.++||||||+++|||++|+.||..........       
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999876432221 112334578999999988764478999999999999999999999986543211000       


Q ss_pred             -chhhhHHHHhhchhhHHHHhc---CCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          239 -FPKHVWEEYEKSELDATILAC---GIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       239 -~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       .....+..... .........   ...   ......+.++.+++.+||+.||++|||++++++
T Consensus       243 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          243 VVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCHHHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence             00000000000 000000000   000   111235678999999999999999999999987

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.5e-44  Score=329.88  Aligned_cols=261  Identities=21%  Similarity=0.235  Sum_probs=196.0

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC----
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----   94 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~----   94 (356)
                      .+....+|++.++||+|+||+||+|++..+..||+|++..+...     ..+|+.+++.++||||+++++++....    
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~  109 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD  109 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence            34456689999999999999999999877667999988654221     236999999999999999999985433    


Q ss_pred             --eeeEEEeccCCCChhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc-CCCceEEccc
Q 038199           95 --MTALVYEYMENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADF  169 (356)
Q Consensus        95 --~~~lV~e~~~~~sL~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~kl~Df  169 (356)
                        ..++||||+.++.+.....  .....+++..+..++.||+.||.|||+   .+|+||||||+|||++ .++.+||+||
T Consensus       110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence              3789999998754433321  236789999999999999999999999   9999999999999998 7899999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh-
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE-  248 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  248 (356)
                      |+++........   ....||..|+|||++.+...++.++|||||||++|||++|+.||.......      ....... 
T Consensus       187 G~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~------~l~~i~~~  257 (394)
T 4e7w_A          187 GSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID------QLVEIIKV  257 (394)
T ss_dssp             TTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHH
T ss_pred             CCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHH
Confidence            999876443322   235689999999999776568999999999999999999999986543210      0000000 


Q ss_pred             -hchhhHHH-------HhcCC---C--c----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          249 -KSELDATI-------LACGI---E--E----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       249 -~~~~~~~~-------~~~~~---~--~----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                       .......+       .....   .  .    .....+.++.+++.+||+.||.+|||+.++++.
T Consensus       258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence             00000000       00000   0  0    011245679999999999999999999999973

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-43  Score=332.07  Aligned_cols=260  Identities=23%  Similarity=0.259  Sum_probs=195.3

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecC------Ce
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ------HM   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~------~~   95 (356)
                      ..+|++.+.||+|+||+||+|.+. +|+.||||++..+..     ...+|++++++++||||+++++++...      .+
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            446899999999999999999875 699999999875421     234699999999999999999988532      24


Q ss_pred             eeEEEeccCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-CceEEcccCC
Q 038199           96 TALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGL  171 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-~~~kl~Dfgl  171 (356)
                      .++||||+.+ +|.+.+.   .....+++..+..++.||+.||.|||+   .+|+||||||+|||++.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchh
Confidence            6799999976 6665553   246789999999999999999999999   999999999999999955 6789999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh--
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK--  249 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  249 (356)
                      ++.......   .....||..|+|||++.+...++.++|||||||++|||++|+.||.......      ...+....  
T Consensus       204 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~------~l~~i~~~lg  274 (420)
T 1j1b_A          204 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD------QLVEIIKVLG  274 (420)
T ss_dssp             CEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHC
T ss_pred             hhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhC
Confidence            987644322   2335689999999998765578999999999999999999999986533210      00000000  


Q ss_pred             chhhHHH---Hhc----CCC-----c----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcc
Q 038199          250 SELDATI---LAC----GIE-----E----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK--MLEGV  300 (356)
Q Consensus       250 ~~~~~~~---~~~----~~~-----~----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~  300 (356)
                      ......+   ...    ..+     .    .....+.++.+|+.+||..||.+||++.++++  .+..+
T Consensus       275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            0000000   000    000     0    11234567999999999999999999999987  34444

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-43  Score=324.52  Aligned_cols=268  Identities=21%  Similarity=0.219  Sum_probs=189.1

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe--
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM--   95 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~--   95 (356)
                      ......+|++.+.||+|+||+||+|.+. +|+.||||++..+.  .....+.+++..++.++||||+++++++.....  
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            4556678999999999999999999864 68999999986542  223456778888899999999999999865432  


Q ss_pred             -----eeEEEeccCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCccccCCCCCcEEEcC-CCce
Q 038199           96 -----TALVYEYMENGSLDGYLF---GKKRAIEWEKLHEIAIGTAKGLVYLH--EECQQRIIHYDIKPENVLLDA-NFSP  164 (356)
Q Consensus        96 -----~~lV~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~~ivH~dikp~Nill~~-~~~~  164 (356)
                           .++||||+.+ +|...+.   .....+++..+..++.|++.||.|||  +   .+|+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcE
Confidence                 7899999987 5544332   34667999999999999999999999  8   99999999999999996 8999


Q ss_pred             EEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc-----
Q 038199          165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF-----  239 (356)
Q Consensus       165 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~-----  239 (356)
                      ||+|||+++.......   .....||..|+|||++.+...++.++|||||||++|+|++|..||...........     
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            9999999987654332   23356899999999987665689999999999999999999999865432110000     


Q ss_pred             ---hhhhHHHHhhchhhHHHHhc-------CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          240 ---PKHVWEEYEKSELDATILAC-------GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       240 ---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                         ....+..+............       .........+.++.+++.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence               00000000000000000000       001111224678999999999999999999999997

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.2e-44  Score=323.64  Aligned_cols=260  Identities=23%  Similarity=0.293  Sum_probs=184.4

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHH-HHccCCCCceeeeeceEecCCe
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVG-TIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      .+++...+|++.+.||+|+||.||+|.+. +|+.||||++..........++..|+. +++.++||||+++++++.+.+.
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            45566788999999999999999999764 699999999976544444556666666 7777899999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CccccCCCCCcEEEcCCCceEEcccC
Q 038199           96 TALVYEYMENGSLDGYLFG----KKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      .++||||+.+ +|.+++..    ....+++..+..++.|++.||.|||+   . +++||||||+||+++.++.+||+|||
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            9999999976 88777642    35689999999999999999999999   8 99999999999999999999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCccccc---CCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLS---GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      ++........   .....||..|+|||.+.   ....++.++||||||+++|+|++|..||........         ..
T Consensus       172 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~  239 (327)
T 3aln_A          172 ISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QL  239 (327)
T ss_dssp             SSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------
T ss_pred             Cceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HH
Confidence            9986643322   12235899999999984   222688999999999999999999999854321100         00


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ... .. ..............+..+.+++.+||+.||++||++.++++
T Consensus       240 ~~~-~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          240 TQV-VK-GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCC-CC-SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHH-hc-CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            000 00 00000001111234567999999999999999999999987

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.7e-43  Score=313.11  Aligned_cols=252  Identities=24%  Similarity=0.313  Sum_probs=204.7

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ......+|++.+.||+|+||+||+|... +++.||||++.... .....+.+.+|+.++++++||||+++++++.+....
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            4456678999999999999999999765 68999999986532 234557899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC---CceEEcccCCcc
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAK  173 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~---~~~kl~Dfgl~~  173 (356)
                      ++|||++.+++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.+   +.+||+|||++.
T Consensus        97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999999888843 4579999999999999999999999   999999999999999654   479999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ........   ....|+..|+|||.+.+.  ++.++||||||+++|+|++|..||......       .         ..
T Consensus       173 ~~~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~---------~~  231 (287)
T 2wei_A          173 CFQQNTKM---KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEY-------D---------IL  231 (287)
T ss_dssp             TBCCCSSC---SCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H---------HH
T ss_pred             eecCCCcc---ccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------H---------HH
Confidence            66433221   223478899999998764  789999999999999999999987543211       0         11


Q ss_pred             HHHHhcCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 ATILACGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+.....   .+.....+.++.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            11111111   1122345678999999999999999999999997

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=320.67  Aligned_cols=259  Identities=20%  Similarity=0.279  Sum_probs=197.4

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCe-----
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM-----   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~-----   95 (356)
                      ..+|.+.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467899999999999999999764 69999999997543 33445678999999999999999999999987654     


Q ss_pred             -eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           96 -TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        96 -~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                       .++||||+. ++|.+++   ...+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 4888877   2359999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh----------hH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH----------VW  244 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~----------~~  244 (356)
                      ....     .....||..|+|||.+.+...++.++||||||+++|+|++|..||........  +...          .+
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFV  248 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHHHH
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHH
Confidence            5432     23356899999999988744789999999999999999999999865432100  0000          00


Q ss_pred             HHHhhchhhHHHHh------cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          245 EEYEKSELDATILA------CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       245 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..+...........      ..........+.++.+++.+||+.||++|||++++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000000000000      0011122345678999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.7e-43  Score=324.52  Aligned_cols=262  Identities=23%  Similarity=0.319  Sum_probs=200.5

Q ss_pred             HhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-----------CCceeeeec
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-----------HINLVRLYG   88 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni~~~~~   88 (356)
                      +...+|++.+.||+|+||+||+|.+ .+++.||||++...  ....+.+.+|+.+++++.           ||||+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            3567899999999999999999976 46999999999754  344567889999999886           899999999


Q ss_pred             eEecCC----eeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CccccCCCCCcEEEc---
Q 038199           89 FCHDQH----MTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLD---  159 (356)
Q Consensus        89 ~~~~~~----~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dikp~Nill~---  159 (356)
                      ++....    ..++|||++ +++|.+++... ...+++..+..++.||+.||.|||+   + +|+||||||+|||++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccC
Confidence            998654    789999999 88999998653 4569999999999999999999999   8 999999999999994   


Q ss_pred             ---CCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcc
Q 038199          160 ---ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESL  236 (356)
Q Consensus       160 ---~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~  236 (356)
                         ..+.+||+|||++.......     ....||..|+|||++.+. .++.++||||||+++|||++|..||........
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence               34489999999998764322     234689999999999876 689999999999999999999999875443211


Q ss_pred             ccchhhhHHHH-----------hhchhh---------------------HHHHhcCCCchhHHHHHHHHHHHHhcccCCC
Q 038199          237 DWFPKHVWEEY-----------EKSELD---------------------ATILACGIEEKDKEKAKRLCMAALWCVQDSP  284 (356)
Q Consensus       237 ~~~~~~~~~~~-----------~~~~~~---------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p  284 (356)
                      ...........           ......                     ..... .....+...+.++.+++.+||+.||
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT-EKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH-HTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh-hcccCCcchHHHHHHHHHHHhccCc
Confidence            10000000000           000000                     00000 0112346778899999999999999


Q ss_pred             CCCCCHHHHHH
Q 038199          285 EDRPPMSAVVK  295 (356)
Q Consensus       285 ~~Rps~~~v~~  295 (356)
                      ++|||++++++
T Consensus       323 ~~Rpt~~ell~  333 (373)
T 1q8y_A          323 RKRADAGGLVN  333 (373)
T ss_dssp             TTCBCHHHHHT
T ss_pred             cccCCHHHHhh
Confidence            99999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.1e-43  Score=322.20  Aligned_cols=203  Identities=25%  Similarity=0.299  Sum_probs=171.4

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CC-----ceeeeeceEe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HI-----NLVRLYGFCH   91 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----ni~~~~~~~~   91 (356)
                      .+....+|++.+.||+|+||+||+|.+. +++.||||++...  .....++..|+.+++.+. |+     +|+.+++++.
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            4445678999999999999999999764 6889999999754  344567778888888774 44     5999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc--CCCceEEcc
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVAD  168 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~--~~~~~kl~D  168 (356)
                      .....++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|
T Consensus       127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            99999999999965 9999886543 5699999999999999999999941 27899999999999994  577899999


Q ss_pred             cCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccC
Q 038199          169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVG  231 (356)
Q Consensus       169 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  231 (356)
                      ||+++.....     .....||..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CTTCEETTCC-----CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCceecccc-----cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999876432     2235689999999999877 6899999999999999999999998654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=315.52  Aligned_cols=257  Identities=21%  Similarity=0.254  Sum_probs=187.2

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhH-HHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAE-EQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      ..++....+|++.+.||+|+||.||+|.+. +|+.||||++......... ..+..+..+++.++||||+++++++.+..
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            334556678899999999999999999875 6999999999765333333 34455556788889999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ..++||||+ ++.+..+.......+++..+..++.|++.||.|||+   . +++||||||+||+++.++.+||+|||++.
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            999999999 556766664446789999999999999999999998   6 99999999999999999999999999997


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      .......   .....|+..|+|||.+.+    ...++.++||||||+++|+|++|..||......      ..       
T Consensus       174 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-------  237 (318)
T 2dyl_A          174 RLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FE-------  237 (318)
T ss_dssp             ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HH-------
T ss_pred             hccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HH-------
Confidence            6543322   223468999999999852    236788999999999999999999988543221      00       


Q ss_pred             chhhHHHHhcCC--CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 SELDATILACGI--EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 ~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                        ..........  .+.....+.++.+++.+||+.||.+||+++++++
T Consensus       238 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          238 --VLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             --HHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --HHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              0111111111  1111235567999999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.6e-43  Score=317.87  Aligned_cols=262  Identities=23%  Similarity=0.347  Sum_probs=196.9

Q ss_pred             hhhccccccccccCceEEEEEEe--CCCcEEEEEEeccccc-hhhHHHHHHHHHHHccC---CCCceeeeeceEe-----
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF--PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRT---YHINLVRLYGFCH-----   91 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~ni~~~~~~~~-----   91 (356)
                      ..+|++.+.||+|+||+||+|.+  .+|+.||||++..... ......+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            46799999999999999999986  3588999999864321 11123456777777665   8999999999987     


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                      .....++||||+. ++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCc
Confidence            5667899999997 5999988654 3459999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh-
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK-  249 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  249 (356)
                      ++.......   ......||..|+|||++.+. .++.++||||||+++|+|++|..||........  . ......... 
T Consensus       166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~-~~i~~~~~~~  238 (326)
T 1blx_A          166 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--L-GKILDVIGLP  238 (326)
T ss_dssp             SCCCCCGGG---GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCC
T ss_pred             ccccccCCC---CccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--H-HHHHHHcCCC
Confidence            997654222   22335689999999999876 689999999999999999999999864332100  0 000000000 


Q ss_pred             --chh------hHHHH----hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 --SEL------DATIL----ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 --~~~------~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                        ...      .....    ...........+..+.+++.+||+.||++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              000      00000    00001112335667899999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6e-43  Score=319.82  Aligned_cols=267  Identities=20%  Similarity=0.260  Sum_probs=201.7

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeC-CC-cEEEEEEeccccchhhHHHHHHHHHHHccCCCCc------eeeeec
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NG-VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN------LVRLYG   88 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------i~~~~~   88 (356)
                      ...++...+|++.+.||+|+||+||+|.+. ++ +.||||++...  ....+.+.+|+.++++++|++      ++.+++
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            445566789999999999999999999764 44 78999999754  345567889999999987665      899999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEE---------
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---------  158 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill---------  158 (356)
                      ++......++||||+ +++|.+++... ...+++..+..++.||+.||.|||+   .+|+||||||+|||+         
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccc
Confidence            999999999999999 55666666443 4579999999999999999999999   999999999999999         


Q ss_pred             ----------cCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCccc
Q 038199          159 ----------DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNA  228 (356)
Q Consensus       159 ----------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~  228 (356)
                                +.++.+||+|||++.......     ....||..|+|||++.+. .++.++||||||+++|||++|..||
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf  239 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLF  239 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCC
Confidence                      567899999999998644322     234689999999999876 7899999999999999999999998


Q ss_pred             ccCCCCcccc--------chhhhHHHHhhch--------------hhHHHHh-c----CCCchhHHHHHHHHHHHHhccc
Q 038199          229 IVGSSESLDW--------FPKHVWEEYEKSE--------------LDATILA-C----GIEEKDKEKAKRLCMAALWCVQ  281 (356)
Q Consensus       229 ~~~~~~~~~~--------~~~~~~~~~~~~~--------------~~~~~~~-~----~~~~~~~~~~~~l~~l~~~cl~  281 (356)
                      ..........        .+...+.......              ....... .    .........+.++.+++.+||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            6543211000        0000000000000              0000000 0    0011223446689999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 038199          282 DSPEDRPPMSAVVK  295 (356)
Q Consensus       282 ~~p~~Rps~~~v~~  295 (356)
                      .||++|||+.++++
T Consensus       320 ~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          320 FDPAQRITLAEALL  333 (355)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.1e-44  Score=322.79  Aligned_cols=248  Identities=21%  Similarity=0.307  Sum_probs=200.1

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccch-----hhHHHHHHHHHHHccCC--CCceeeeec
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRTY--HINLVRLYG   88 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~ni~~~~~   88 (356)
                      ...+....+|++.+.||+|+||+||+|.+ .+++.||||++......     .....+.+|+.+++++.  |+||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            44566788899999999999999999975 46899999999754211     12245678999999996  599999999


Q ss_pred             eEecCCeeeEEEeccCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc-CCCceEE
Q 038199           89 FCHDQHMTALVYEYMEN-GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKV  166 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~-~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~kl  166 (356)
                      ++.+....++|||++.+ ++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++ .++.+||
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEE
Confidence            99999999999999976 899998843 4679999999999999999999999   9999999999999998 7899999


Q ss_pred             cccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH
Q 038199          167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       167 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      +|||++.......    .....||..|+|||++.+....+.++||||||+++|||++|+.||....             .
T Consensus       192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~  254 (320)
T 3a99_A          192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------E  254 (320)
T ss_dssp             CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------H
T ss_pred             eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------h
Confidence            9999998765332    2335689999999998766344788999999999999999998874210             0


Q ss_pred             HhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .         ... ........+.++.+++.+||+.||++|||+++|++
T Consensus       255 ~---------~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 I---------IRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             H---------HHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             h---------hcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0         000 01122234567899999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=318.40  Aligned_cols=249  Identities=23%  Similarity=0.323  Sum_probs=191.4

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccch-----hhHHHHHHHHHHHccC----CCCceeee
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGR-----IAEEQFMAEVGTIGRT----YHINLVRL   86 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~ni~~~   86 (356)
                      ...+....+|++.+.||+|+||.||+|.+ .+++.||||++......     .....+.+|+.+++++    +||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            44566778899999999999999999976 46899999999754211     1223456788988888    89999999


Q ss_pred             eceEecCCeeeEEEec-cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc-CCCce
Q 038199           87 YGFCHDQHMTALVYEY-MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSP  164 (356)
Q Consensus        87 ~~~~~~~~~~~lV~e~-~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~-~~~~~  164 (356)
                      ++++.+.+..++|||+ +.+++|.+++.. ...+++..++.++.|++.||.|||+   .+++||||||+||+++ .++.+
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeE
Confidence            9999999999999999 788999999854 4579999999999999999999999   9999999999999999 88999


Q ss_pred             EEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhH
Q 038199          165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVW  244 (356)
Q Consensus       165 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~  244 (356)
                      +|+|||++.......    .....|+..|+|||++.+....+.++||||||+++|+|++|+.||....            
T Consensus       180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------  243 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------  243 (312)
T ss_dssp             EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred             EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------
Confidence            999999998765432    2335689999999998765334568999999999999999998874210            


Q ss_pred             HHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          245 EEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                       ..        . . .....+...+.++.+++.+||+.||++||+++++++.
T Consensus       244 -~~--------~-~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 -EI--------L-E-AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -HH--------H-H-TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -HH--------h-h-hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00        0 0 0111223456678999999999999999999999973

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=330.03  Aligned_cols=254  Identities=22%  Similarity=0.254  Sum_probs=189.8

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeE
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~l   98 (356)
                      .+...+|.+.++||+|+||+|+.....+|+.||||++.....    ..+.+|+.+++++ +||||+++++++.+....++
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            345567888899999999997655555889999999975322    2356799999999 79999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---C--CceEEcccCCcc
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---N--FSPKVADFGLAK  173 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~--~~~kl~Dfgl~~  173 (356)
                      ||||+. ++|.+++...........+..++.||+.||.|||+   .+|+||||||+|||++.   +  ..++|+|||+++
T Consensus        96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            999996 49999997666566666778999999999999999   99999999999999953   2  357899999998


Q ss_pred             ccCCCCCe-eeeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhh
Q 038199          174 LCDRNRSH-VTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       174 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      ........ .......||+.|+|||++.+  ...++.++|||||||++|||++ |..|+......       . ......
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~-~~~~~~  243 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------Q-ANILLG  243 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------H-HHHHTT
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------H-HHHHhc
Confidence            76543221 22344679999999999974  2257889999999999999999 77777432111       0 000000


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..      ..............+.+++.+||+.||.+|||+++|++
T Consensus       244 ~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 AC------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CC------CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cC------CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00      00011122344566889999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-42  Score=316.17  Aligned_cols=257  Identities=20%  Similarity=0.261  Sum_probs=175.8

Q ss_pred             hhhhcccc-ccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec----CCe
Q 038199           22 NNFTSNYS-TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHM   95 (356)
Q Consensus        22 ~~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~----~~~   95 (356)
                      ...+|.+. +.||+|+||+||+|.+. +|+.||||++...  ...   .......++.+.||||+++++++..    +..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            45678875 56999999999999765 6999999999653  121   2223334566789999999999876    456


Q ss_pred             eeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---CCceEEcccCC
Q 038199           96 TALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGL  171 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfgl  171 (356)
                      .++||||++|++|.+++.... ..+++..++.++.|++.||.|||+   .+++||||||+||+++.   ++.+||+|||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            899999999999999996553 479999999999999999999999   99999999999999976   45699999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      +.......    .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.........       ...... 
T Consensus       178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~-  244 (336)
T 3fhr_A          178 AKETTQNA----LQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-------PGMKRR-  244 (336)
T ss_dssp             CEEC--------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             ceeccccc----cccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-------hhHHHh-
Confidence            98654322    2234689999999999766 6899999999999999999999998554322110       000000 


Q ss_pred             hhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcc
Q 038199          252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK--MLEGV  300 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~  300 (356)
                      ... .............+.++.+++.+||+.||.+|||++++++  .+...
T Consensus       245 ~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          245 IRL-GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             hhc-cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            000 0000011112345677999999999999999999999998  44443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-42  Score=326.41  Aligned_cols=252  Identities=22%  Similarity=0.284  Sum_probs=186.5

Q ss_pred             hhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|...+.||+|+||+||.+...+|+.||||++...    ..+.+.+|+.+++++ +||||+++++++.+....++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            344557889999999998776668999999998653    234678899999876 899999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCC------CCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC-------------Cc
Q 038199          103 MENGSLDGYLFGKKRA------IEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-------------FS  163 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~-------------~~  163 (356)
                      +. ++|.+++......      .++..++.++.||+.||.|||+   .+|+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceE
Confidence            96 5999999644221      1333567899999999999999   999999999999999654             48


Q ss_pred             eEEcccCCccccCCCCCee--eeccCCCCCCCCCcccccC------CCCCCccccchhhHHHHHHHHh-CCcccccCCCC
Q 038199          164 PKVADFGLAKLCDRNRSHV--TISGYKGTPGYSAPEFLSG------NYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSE  234 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~  234 (356)
                      +||+|||+++.........  ......||+.|+|||++.+      ...++.++|||||||++|||++ |..|+......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998765433221  1234569999999999865      2368999999999999999999 88887432211


Q ss_pred             ccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          235 SLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .         ..+......   ............+.++.+++.+||+.||.+|||+.+|++
T Consensus       247 ~---------~~i~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 E---------SNIIRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H---------HHHHHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---------HHHhcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            0         000000000   000111224567788999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.9e-42  Score=304.70  Aligned_cols=244  Identities=12%  Similarity=0.031  Sum_probs=191.8

Q ss_pred             cceecHHH-HhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCCCceeeeec
Q 038199           13 PVRFTSLQ-LNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYHINLVRLYG   88 (356)
Q Consensus        13 ~~~~~~~~-~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~   88 (356)
                      +..+..++ +...+|++.+.||+|+||.||+|.+. +++.||||++.....  ......+.+|+.++++++||||+++++
T Consensus        19 ~~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~   98 (286)
T 3uqc_A           19 DVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD   98 (286)
T ss_dssp             -CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeE
Confidence            44555566 67788999999999999999999765 599999999976532  334478999999999999999999999


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcc
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  168 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D  168 (356)
                      ++.+.+..|+||||++|++|.+++..  . .....+..|+.|++.||.|||+   ++|+||||||+||+++.+|.++|++
T Consensus        99 ~~~~~~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~  172 (286)
T 3uqc_A           99 VVHTRAGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAY  172 (286)
T ss_dssp             EEEETTEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECS
T ss_pred             EEEECCcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEe
Confidence            99999999999999999999999832  2 4566789999999999999999   9999999999999999999999974


Q ss_pred             cCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh
Q 038199          169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE  248 (356)
Q Consensus       169 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  248 (356)
                      +|                      |++        .++.++||||||+++|||++|+.||.............   ....
T Consensus       173 ~~----------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~  219 (286)
T 3uqc_A          173 PA----------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTA  219 (286)
T ss_dssp             CC----------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTT
T ss_pred             cc----------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhc
Confidence            43                      332        36889999999999999999999987654322100000   0000


Q ss_pred             hchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          249 KSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      .....       ........+.++.+++.+||+.||++| |+.++++.|+.+...
T Consensus       220 ~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          220 GQPIE-------PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             SCBCC-------HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             cCCCC-------hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            00000       001122345678999999999999999 999999999987654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-42  Score=340.48  Aligned_cols=245  Identities=21%  Similarity=0.261  Sum_probs=197.9

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC--CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP--NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ..++...+|++.+.||+|+||+||+|.+.  +|+.||||++...........+.+|+.++++++||||+++++++.+...
T Consensus        74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            34566689999999999999999999764  5899999998765444556788999999999999999999999987655


Q ss_pred             -----eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccC
Q 038199           96 -----TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG  170 (356)
Q Consensus        96 -----~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfg  170 (356)
                           .|+||||++|++|.+++.   ..+++..++.|+.||+.||.|||+   ++|+||||||+|||++.+ .+||+|||
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             CCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecc
Confidence                 699999999999998773   279999999999999999999999   999999999999999886 89999999


Q ss_pred             CccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhc
Q 038199          171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKS  250 (356)
Q Consensus       171 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (356)
                      +++.....      ....||+.|+|||++.+.  .+.++|||||||++|+|++|..|+........              
T Consensus       227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------  284 (681)
T 2pzi_A          227 AVSRINSF------GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------  284 (681)
T ss_dssp             TCEETTCC------SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------
T ss_pred             cchhcccC------CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccccc--------------
Confidence            99876533      334689999999998765  48899999999999999999877543111000              


Q ss_pred             hhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHhcc
Q 038199          251 ELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP-MSAVVKMLEGV  300 (356)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~v~~~L~~~  300 (356)
                               .........+..+.+++.+||+.||.+||+ ++++...|..+
T Consensus       285 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          285 ---------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             ---------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                     001122234467889999999999999994 66666666554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.8e-42  Score=334.05  Aligned_cols=263  Identities=26%  Similarity=0.331  Sum_probs=198.3

Q ss_pred             hhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec------CC
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------QH   94 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~------~~   94 (356)
                      ...+|++.++||+|+||+||+|.+ .+|+.||||++.........+.+.+|+.++++++||||+++++++..      +.
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            347899999999999999999976 46899999999876556667889999999999999999999998765      67


Q ss_pred             eeeEEEeccCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc---eEEccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKK--RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADF  169 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~---~kl~Df  169 (356)
                      ..++||||++|++|.+++....  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.   ++|+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            7899999999999999996533  369999999999999999999999   99999999999999987664   999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      |++........   .....||..|+|||.+.+. .++.++||||||+++|+|++|..||....... .|...........
T Consensus       169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-~~~~~i~~~~~~~  243 (676)
T 3qa8_A          169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-QWHGKVREKSNEH  243 (676)
T ss_dssp             CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-HSSTTCC------
T ss_pred             ccccccccccc---cccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchh-hhhhhhhcccchh
Confidence            99987654332   2345689999999999876 78999999999999999999999986532110 0000000000000


Q ss_pred             ch----hhHHH----HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 038199          250 SE----LDATI----LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSA  292 (356)
Q Consensus       250 ~~----~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~  292 (356)
                      ..    .....    ............+..+.+++.+||..||++|||+.+
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            00    00000    000011233456788999999999999999999977

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.4e-41  Score=305.62  Aligned_cols=244  Identities=14%  Similarity=0.123  Sum_probs=185.5

Q ss_pred             HHhhhhccccccccccCceEEEEEEeCCCcEEEEEEecccc-------chhhHHHHHHHHHHHccCC---------C---
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-------GRIAEEQFMAEVGTIGRTY---------H---   80 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---------h---   80 (356)
                      .+...+|++.++||+|+||+||+|++ +|+.||||++....       .....+.+.+|+.+++.++         |   
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             HSCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             hcccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            35668899999999999999999988 78999999997542       2233467888988888875         4   


Q ss_pred             --------------CceeeeeceEec-------------CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHH
Q 038199           81 --------------INLVRLYGFCHD-------------QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAK  133 (356)
Q Consensus        81 --------------~ni~~~~~~~~~-------------~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~  133 (356)
                                    |||+++++++.+             ....++||||+++|++.+.+  ....+++..+..++.||+.
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~--~~~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM--RTKLSSLATAKSILHQLTA  172 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGG--TTTCCCHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHH--HhcCCCHHHHHHHHHHHHH
Confidence                          555555555544             67899999999999766666  2367899999999999999


Q ss_pred             HHHHHh-hcCCCCccccCCCCCcEEEcCCC--------------------ceEEcccCCccccCCCCCeeeeccCCCCCC
Q 038199          134 GLVYLH-EECQQRIIHYDIKPENVLLDANF--------------------SPKVADFGLAKLCDRNRSHVTISGYKGTPG  192 (356)
Q Consensus       134 ~l~~LH-~~~~~~ivH~dikp~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~  192 (356)
                      ||.||| +   .+|+||||||+|||++.++                    .+||+|||+++.....       ...||..
T Consensus       173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred             HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence            999999 8   9999999999999999887                    8999999999876532       2358999


Q ss_pred             CCCcccccCCCCCCccccchhhHHH-HHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH-H-HhcCCCchhHHHH
Q 038199          193 YSAPEFLSGNYPITHKCDVYSFGMV-LFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT-I-LACGIEEKDKEKA  269 (356)
Q Consensus       193 y~aPE~~~~~~~~~~~~Dv~slGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~  269 (356)
                      |+|||++.+..  +.++||||||++ .+++++|..|+.           ...|........... . ............+
T Consensus       243 y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  309 (336)
T 2vuw_A          243 SMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYS-----------NVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK  309 (336)
T ss_dssp             TTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHH-----------HHHHHHHHHHHHHHTCCCSSCCCSHHHHHHH
T ss_pred             ccChhhhcCCC--ccceehhhhhCCCCcccccccCCCc-----------chhhhhHHHHhhhhhhccCcccchhhhhhcC
Confidence            99999998763  889999998777 677888877752           111111111111100 0 0111223456788


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHH
Q 038199          270 KRLCMAALWCVQDSPEDRPPMSAVV  294 (356)
Q Consensus       270 ~~l~~l~~~cl~~~p~~Rps~~~v~  294 (356)
                      .++.+++.+||+.|     |+++++
T Consensus       310 ~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          310 RKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHHhccC-----CHHHHH
Confidence            99999999999976     888888

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.5e-41  Score=313.70  Aligned_cols=240  Identities=15%  Similarity=0.098  Sum_probs=178.8

Q ss_pred             hccccccccccCceEEEEEEe-CCCcEEEEEEeccccc--hhhHHHHHHHHHHHccCCC-Cceeee--------------
Q 038199           25 TSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTYH-INLVRL--------------   86 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h-~ni~~~--------------   86 (356)
                      ++.+++.||+|+||+||+|.+ .+|+.||||++.....  ....+.+.+|+.+++.+.| +|...+              
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            366778999999999999975 4699999999874322  2334679999999999976 321111              


Q ss_pred             -------eceEec-----CCeeeEEEeccCCCChhhhhh------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 038199           87 -------YGFCHD-----QHMTALVYEYMENGSLDGYLF------GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH  148 (356)
Q Consensus        87 -------~~~~~~-----~~~~~lV~e~~~~~sL~~~l~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  148 (356)
                             +.++..     ....+++|+++ +++|.+++.      .....+++..++.++.|++.||.|||+   ++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence                   111111     12456778876 569998883      235568899999999999999999999   99999


Q ss_pred             cCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCccccc---------CCCCCCccccchhhHHHHH
Q 038199          149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS---------GNYPITHKCDVYSFGMVLF  219 (356)
Q Consensus       149 ~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~Dv~slGvvl~  219 (356)
                      |||||+|||++.++.+||+|||+++.....     .....| ..|+|||++.         ....++.++|||||||++|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999998764422     344567 9999999983         2225788999999999999


Q ss_pred             HHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          220 EIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       220 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ||++|+.||........                ........     ...+.++.+++.+||+.||++||++.++++
T Consensus       309 elltg~~Pf~~~~~~~~----------------~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGG----------------SEWIFRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHSSCCCCTTGGGSC----------------SGGGGSSC-----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHCCCCCCCcchhhh----------------HHHHHhhc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999854322110                00111110     123467999999999999999999877754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.2e-40  Score=293.70  Aligned_cols=231  Identities=22%  Similarity=0.302  Sum_probs=178.6

Q ss_pred             HHHhhhhccc-cccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHH-ccCCCCceeeeeceEec---
Q 038199           19 LQLNNFTSNY-STRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTI-GRTYHINLVRLYGFCHD---   92 (356)
Q Consensus        19 ~~~~~~~~~~-~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~ni~~~~~~~~~---   92 (356)
                      .++.. .|.+ .+.||+|+||.||+|.+ .+++.||||++...      ..+.+|+.++ +..+||||+++++++.+   
T Consensus        13 ~~~~~-~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           13 NAIID-DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             SCGGG-TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccc-chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            34433 3444 48899999999999976 46899999999642      3467788887 55689999999999886   


Q ss_pred             -CCeeeEEEeccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---CCceEEc
Q 038199           93 -QHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVA  167 (356)
Q Consensus        93 -~~~~~lV~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~  167 (356)
                       ....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.   ++.++|+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence             677899999999999999996543 479999999999999999999999   99999999999999988   7899999


Q ss_pred             ccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       168 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      |||++....                        +. .++.++||||||+++|||++|..||.........          
T Consensus       163 Dfg~a~~~~------------------------~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------  207 (299)
T 3m2w_A          163 DFGFAKETT------------------------GE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------  207 (299)
T ss_dssp             CCTTCEECT------------------------TC-GGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------
T ss_pred             ccccccccc------------------------cc-cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------
Confidence            999986432                        12 4688999999999999999999998543221100          


Q ss_pred             hhchhhHHHHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          248 EKSELDATILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                        .............   ......+.++.+++.+||+.||.+|||+.++++.
T Consensus       208 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          208 --PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             --CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              0000000000000   0112346779999999999999999999999983

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.8e-35  Score=281.33  Aligned_cols=187  Identities=17%  Similarity=0.128  Sum_probs=132.9

Q ss_pred             ccccccCceEEEEEE-eCCCcEEEEEEecccc---------chhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeE
Q 038199           30 TRLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNL---------GRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ..++.|++|.+..++ ...|+.||+|++....         .+...++|.+|+++|+++ +|+||++++++++++...||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            346778888777763 4468999999997542         234446799999999999 69999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||++|++|.+++. ..++++..   +|+.||+.||+|+|+   +|||||||||+|||++.+|.+||+|||+++.....
T Consensus       320 VMEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          320 VMEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999994 45567654   588999999999999   99999999999999999999999999999876543


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcc
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRN  227 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p  227 (356)
                      ..  .....+||+.|+|||++.+.  +..++|+||+|++++++.++..+
T Consensus       393 ~~--~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CS--WPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -C--CSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             Cc--cccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence            22  22345699999999999875  56789999999999888776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=5.4e-30  Score=245.85  Aligned_cols=183  Identities=16%  Similarity=0.203  Sum_probs=142.6

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEeccccc-------hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-------RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .+.||+|+||+||+|.. .++.+++|+......       ....+++.+|++++++++||||+.+..++.+....++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            56899999999999965 678899998653211       1123568999999999999999966666667777899999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |++|++|.+++..         +..++.|++.||.|||+   ++|+||||||+|||++.  .+||+|||+++........
T Consensus       420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            9999999999843         67899999999999999   99999999999999998  9999999999876543221


Q ss_pred             e-----eeccCCCCCCCCCcccccC--CCCCCccccchhhHHHHHHHHhCCcc
Q 038199          182 V-----TISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVLFEIVGRRRN  227 (356)
Q Consensus       182 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slGvvl~elltg~~p  227 (356)
                      .     ......||+.|+|||++.+  . .|+..+|+|+..+-.++-+.++.+
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~-~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLE-GYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHH-HHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHH-HHHHHHhHHHHHHHHHHHHHhccc
Confidence            1     1124569999999999975  3 578889999998888887766543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=7.3e-27  Score=206.22  Aligned_cols=144  Identities=15%  Similarity=0.069  Sum_probs=116.9

Q ss_pred             ccccccccccCceEEEEEEeCCCcEEEEEEeccccch-----------------hhHHHHHHHHHHHccCCCCceeeeec
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGR-----------------IAEEQFMAEVGTIGRTYHINLVRLYG   88 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~ni~~~~~   88 (356)
                      |.+++.||+|+||.||+|.+.+|+.||||+++.....                 .....+.+|+.++++++  | +++.+
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            3456999999999999998877999999999643211                 13467899999999998  5 66666


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcc
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  168 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D  168 (356)
                      ++.. +..++||||++|++|.+ +..       .....++.|++.||.|||+   .+++||||||+|||++ ++.++|+|
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred             EEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence            5544 45699999999999988 411       2345799999999999999   9999999999999999 99999999


Q ss_pred             cCCccccCCCCCeeeeccCCCCCCCCCccccc
Q 038199          169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS  200 (356)
Q Consensus       169 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  200 (356)
                      ||+++.               +..+.|||.+.
T Consensus       236 FG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             CTTCEE---------------TTSTTHHHHHH
T ss_pred             CCCCeE---------------CCCCCHHHHHH
Confidence            999863               33578898874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=4.4e-23  Score=179.82  Aligned_cols=137  Identities=15%  Similarity=0.148  Sum_probs=106.3

Q ss_pred             ccccccccccCceEEEEEEe-CCCcE--EEEEEeccccch-----------------------hhHHHHHHHHHHHccCC
Q 038199           26 SNYSTRLGFGGFGEVYKGQF-PNGVK--IAVKVLNRNLGR-----------------------IAEEQFMAEVGTIGRTY   79 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~   79 (356)
                      |.+.+.||+|+||.||+|.+ .+|+.  ||||+++.....                       .....+.+|+..++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56789999999999999987 67888  999997543111                       11236789999999998


Q ss_pred             CCce--eeeeceEecCCeeeEEEeccCC-C----ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCccccCC
Q 038199           80 HINL--VRLYGFCHDQHMTALVYEYMEN-G----SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH-EECQQRIIHYDI  151 (356)
Q Consensus        80 h~ni--~~~~~~~~~~~~~~lV~e~~~~-~----sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~di  151 (356)
                      |+++  +.++++    ...++||||+.+ |    +|.+...    ..++..+..++.|++.+|.||| +   .+|+||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQE---AELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence            8754  344432    356899999942 3    5665542    1234567889999999999999 8   99999999


Q ss_pred             CCCcEEEcCCCceEEcccCCcccc
Q 038199          152 KPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus       152 kp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      ||+|||++.  .++|+|||++...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999988  9999999999653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.82  E-value=7.6e-21  Score=172.38  Aligned_cols=138  Identities=12%  Similarity=0.095  Sum_probs=98.5

Q ss_pred             ccccccccccCceEEEEEEeCCCcEEEEEEeccccc-------------hhhHHH--------HHHHHHHHccCCCCcee
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-------------RIAEEQ--------FMAEVGTIGRTYHINLV   84 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~--------~~~E~~~l~~l~h~ni~   84 (356)
                      |.++++||+|+||.||+|...+|+.||||+++....             ......        ...|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            788999999999999999988899999998753210             001111        23455555555433322


Q ss_pred             eeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC--
Q 038199           85 RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF--  162 (356)
Q Consensus        85 ~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~--  162 (356)
                      -..-+..  ...++||||++|++|..+...       .....++.|++.+|.+||.   .|||||||||.|||+++++  
T Consensus       177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CCCEEEE--ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECS
T ss_pred             CCeeeec--cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCc
Confidence            1111111  124799999999888765421       1345688999999999999   9999999999999998776  


Q ss_pred             --------ceEEcccCCcccc
Q 038199          163 --------SPKVADFGLAKLC  175 (356)
Q Consensus       163 --------~~kl~Dfgl~~~~  175 (356)
                              .+.|+||+-+...
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEET
T ss_pred             ccccccccceEEEEeCCcccC
Confidence                    3899999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=1.1e-13  Score=120.58  Aligned_cols=142  Identities=11%  Similarity=0.000  Sum_probs=111.6

Q ss_pred             hhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|++...++.|+.+.||++.. +++.+++|+...... .....+.+|+++++.+. +.+++++++++.+....++|||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            3577888899999999999986 467899999875321 12235888999999884 67788999999988899999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC----------------------------------------  142 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------  142 (356)
                      ++|.+|.+.+.      +......++.+++++|..||+..                                        
T Consensus        92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            99999987541      11223477889999999999811                                        


Q ss_pred             ----------------CCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          143 ----------------QQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       143 ----------------~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                                      +..++|||++|.||++++++.+.|+||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                            1448999999999999876667799998874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.44  E-value=2.4e-13  Score=117.98  Aligned_cols=135  Identities=12%  Similarity=0.007  Sum_probs=100.2

Q ss_pred             ccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCc--eeeeeceEecCCeeeEEEecc
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN--LVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~~~~~~~~~~~~~lV~e~~  103 (356)
                      +.+....+.|..+.||++...+|+.+++|+....    ....+..|+.+++.+.+.+  +++++++..+.+..++|||++
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            3443444566679999998767888999997653    1245778999998885434  566888888877889999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-----------------------------------------  142 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----------------------------------------  142 (356)
                      +|.+|.  ...    ..   ...++.+++..|..||+..                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  311    11   2356778888888888721                                         


Q ss_pred             --------------CCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          143 --------------QQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       143 --------------~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                                    +..++|||++|.||++++++.+.|+||+.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                          1129999999999999877667799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.37  E-value=3.4e-12  Score=116.25  Aligned_cols=142  Identities=13%  Similarity=0.170  Sum_probs=107.1

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEec--cccchhhHHHHHHHHHHHccCC--CCceeeeeceEecC---CeeeEEEe
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLN--RNLGRIAEEQFMAEVGTIGRTY--HINLVRLYGFCHDQ---HMTALVYE  101 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~---~~~~lV~e  101 (356)
                      .+.|+.|.++.||+.+..+ ..+++|+..  ..........+.+|+.+++.+.  +..+++++.++.+.   ...|+|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4678999999999998744 678889876  3321223356888999999986  45688888888776   45789999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC---------------------------------------  142 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------  142 (356)
                      +++|..+.+..   -..++......++.+++..|..||+..                                       
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99998875422   235778888999999999999999731                                       


Q ss_pred             ----------------CCCccccCCCCCcEEEcCCCc--eEEcccCCccc
Q 038199          143 ----------------QQRIIHYDIKPENVLLDANFS--PKVADFGLAKL  174 (356)
Q Consensus       143 ----------------~~~ivH~dikp~Nill~~~~~--~kl~Dfgl~~~  174 (356)
                                      ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            256999999999999987653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.16  E-value=1.4e-11  Score=109.57  Aligned_cols=184  Identities=17%  Similarity=0.166  Sum_probs=122.5

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCc--eeeeeceEecCC---eeeEEEec
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HIN--LVRLYGFCHDQH---MTALVYEY  102 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--i~~~~~~~~~~~---~~~lV~e~  102 (356)
                      .+.++.|....||++.    ..+++|+-...   .....+.+|+++++.+. +..  +..++.......   ..|+||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            3558999999999874    46889986542   34567899999998873 333  445555443333   45899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC----------------------------------------  142 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------  142 (356)
                      ++|.+|.....   ..++..+...++.+++..+..||+..                                        
T Consensus        98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            99988875331   35677788888899999999888611                                        


Q ss_pred             ---------------CCCccccCCCCCcEEEcC--CCceEEcccCCccccCCCCCeeeeccCCCCCCC---CCccccc--
Q 038199          143 ---------------QQRIIHYDIKPENVLLDA--NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY---SAPEFLS--  200 (356)
Q Consensus       143 ---------------~~~ivH~dikp~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~--  200 (356)
                                     ...++|||++|.||+++.  ++.+.++||+.+..........      ....+   ..|+...  
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------SLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------TTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------HHHhhccccCHHHHHHH
Confidence                           134799999999999988  5568899999886532211000      00111   2222111  


Q ss_pred             ----CCC-------CCCccccchhhHHHHHHHHhCCccc
Q 038199          201 ----GNY-------PITHKCDVYSFGMVLFEIVGRRRNA  228 (356)
Q Consensus       201 ----~~~-------~~~~~~Dv~slGvvl~elltg~~p~  228 (356)
                          +..       ......+.|+++.++|++.+|..++
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                000       0112258999999999999997553

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.83  E-value=3.5e-08  Score=87.53  Aligned_cols=136  Identities=15%  Similarity=0.122  Sum_probs=95.8

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCC---ceeeeeceEe-cCCeeeEEEeccC
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI---NLVRLYGFCH-DQHMTALVYEYME  104 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---ni~~~~~~~~-~~~~~~lV~e~~~  104 (356)
                      .+.++.|....||+.    |..+++|+-..   ......+..|+++++.+.+.   .+..++.++. ..+..++||++++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            355788988899998    56788898432   33456789999999998642   3566666664 4456789999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 038199          105 NGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE-------------------------------------------  141 (356)
Q Consensus       105 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-------------------------------------------  141 (356)
                      |.+|.....   ..++......++.++...|..||+.                                           
T Consensus        97 G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           97 GQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             SEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            988875321   2334555556666666666666642                                           


Q ss_pred             --------------CCCCccccCCCCCcEEEcC---CCc-eEEcccCCccc
Q 038199          142 --------------CQQRIIHYDIKPENVLLDA---NFS-PKVADFGLAKL  174 (356)
Q Consensus       142 --------------~~~~ivH~dikp~Nill~~---~~~-~kl~Dfgl~~~  174 (356)
                                    .+..++|||+.|.||+++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          1235699999999999987   355 58999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.80  E-value=4.3e-08  Score=85.24  Aligned_cols=133  Identities=16%  Similarity=0.064  Sum_probs=95.1

Q ss_pred             ccccCce-EEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEEeccCCCCh
Q 038199           32 LGFGGFG-EVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        32 iG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      +..|..| .||+.... ++..+++|+-..    .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            3344444 69998764 467899998654    23456888999998874 44578889999988999999999999887


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 038199          109 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC----------------------------------------------  142 (356)
Q Consensus       109 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------------  142 (356)
                      .+.....     ......+..+++..|..||+..                                              
T Consensus       108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            7654211     1223345556666666666421                                              


Q ss_pred             ---------CCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          143 ---------QQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       143 ---------~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                               ...++|||+.+.||+++.++.+-|+||+.+.
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     1137999999999999988777899999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.68  E-value=2.9e-08  Score=90.04  Aligned_cols=82  Identities=10%  Similarity=-0.014  Sum_probs=56.7

Q ss_pred             cccc-cccCceEEEEEEeC-------CCcEEEEEEeccccc--hhhHHHHHHHHHHHccCC-C--CceeeeeceEecC--
Q 038199           29 STRL-GFGGFGEVYKGQFP-------NGVKIAVKVLNRNLG--RIAEEQFMAEVGTIGRTY-H--INLVRLYGFCHDQ--   93 (356)
Q Consensus        29 ~~~i-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~ni~~~~~~~~~~--   93 (356)
                      .+.| +.|....+|+....       +++.+++|+......  ......+.+|+.+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88989999998753       267899998654320  001235678888888874 3  3577788877655  


Q ss_pred             -CeeeEEEeccCCCChhh
Q 038199           94 -HMTALVYEYMENGSLDG  110 (356)
Q Consensus        94 -~~~~lV~e~~~~~sL~~  110 (356)
                       ...++|||+++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999977654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.47  E-value=5.7e-07  Score=82.72  Aligned_cols=76  Identities=14%  Similarity=0.099  Sum_probs=49.6

Q ss_pred             cccccccCceEEEEEEeC-CCcEEEEEEeccccc------hhhHHHHHHHHHHHccCCC--C-ceeeeeceEecCCeeeE
Q 038199           29 STRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLG------RIAEEQFMAEVGTIGRTYH--I-NLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~-ni~~~~~~~~~~~~~~l   98 (356)
                      .+.||.|.++.||++... +++.++||.......      ....+++..|.++++.+..  + .++.++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            357999999999999754 468899998653211      0123456778888887632  3 34455543  3445689


Q ss_pred             EEeccCCC
Q 038199           99 VYEYMENG  106 (356)
Q Consensus        99 V~e~~~~~  106 (356)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.43  E-value=1.6e-06  Score=77.73  Aligned_cols=138  Identities=14%  Similarity=0.146  Sum_probs=78.5

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC--CCceeeeec------eEecCCeeeEEEe
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HINLVRLYG------FCHDQHMTALVYE  101 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~------~~~~~~~~~lV~e  101 (356)
                      +.|+.|..+.||++...+| .+++|+....  .   ..+..|..+++.+.  .-.++.++.      +....+..++||+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP--E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC--H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC--H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3466678899999987555 5899988753  1   23334555555442  112333332      1234566789999


Q ss_pred             ccCCCChhh-----------h---hhc--CCC--C---------CCHHHH------------------------------
Q 038199          102 YMENGSLDG-----------Y---LFG--KKR--A---------IEWEKL------------------------------  124 (356)
Q Consensus       102 ~~~~~sL~~-----------~---l~~--~~~--~---------~~~~~~------------------------------  124 (356)
                      +++|..+..           .   ++.  ...  +         ..|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            999865530           0   110  000  0         122110                              


Q ss_pred             -HHHHHHHHHHHHHHhh----------cCCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          125 -HEIAIGTAKGLVYLHE----------ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       125 -~~i~~qi~~~l~~LH~----------~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                       ..+..++..++.+|+.          ..+..++|||+.+.||+++.++.+.++||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             1111223345666652          124789999999999999888899999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.36  E-value=3.7e-06  Score=74.42  Aligned_cols=74  Identities=22%  Similarity=0.251  Sum_probs=60.1

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC---CCceeeeeceEecCCeeeEEEeccCCC
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY---HINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +.|+.|....+|+... ++..+++|+....    ....+..|++.|+.+.   ...+++++.++......++|||+++|.
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            5689999999999987 5678889987642    3467888999988884   356888898888778899999999997


Q ss_pred             Ch
Q 038199          107 SL  108 (356)
Q Consensus       107 sL  108 (356)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            65

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.09  E-value=1.5e-05  Score=73.70  Aligned_cols=80  Identities=13%  Similarity=0.046  Sum_probs=45.9

Q ss_pred             CCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee-eccCCCCCCCCCcccccCCC--CCCccccchhhHHHHH
Q 038199          143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVLF  219 (356)
Q Consensus       143 ~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slGvvl~  219 (356)
                      ...++|||++|.||+++.++ ++++||+.+........-.. ...  -...|.+|+......  .-....++.+....+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            37899999999999998876 99999998864321100000 000  011244554442110  1122345557777777


Q ss_pred             HHHhCC
Q 038199          220 EIVGRR  225 (356)
Q Consensus       220 elltg~  225 (356)
                      +.+++.
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.98  E-value=3.3e-05  Score=67.54  Aligned_cols=78  Identities=15%  Similarity=0.177  Sum_probs=55.3

Q ss_pred             ccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-C--CceeeeeceEecCCeeeEEEec
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-H--INLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h--~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..-.+.+|.|..+.||+.+..+|+.|.+|+-.... ......|..|++.|+.+. .  -.+++++++.    ..++|||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            33357789999999999999899999999876432 122245788998888774 2  2345555543    24789999


Q ss_pred             cCCCCh
Q 038199          103 MENGSL  108 (356)
Q Consensus       103 ~~~~sL  108 (356)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.92  E-value=4.1e-05  Score=70.99  Aligned_cols=72  Identities=19%  Similarity=0.253  Sum_probs=49.3

Q ss_pred             ccccccCceEEEEEEeCC--------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCce-eeeeceEecCCeeeEEE
Q 038199           30 TRLGFGGFGEVYKGQFPN--------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVY  100 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~~~~~~~~~lV~  100 (356)
                      +.|+.|....||++...+        ++.+++|+....   ...+.+..|..+++.+...++ +++++.+.+    .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            567888889999998653        578999987432   112345578888888753333 566665543    3899


Q ss_pred             eccCCCCh
Q 038199          101 EYMENGSL  108 (356)
Q Consensus       101 e~~~~~sL  108 (356)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.91  E-value=6.9e-05  Score=66.67  Aligned_cols=139  Identities=14%  Similarity=0.149  Sum_probs=80.5

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCC--ceeeeece-----EecCCeeeEEEecc
Q 038199           31 RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHI--NLVRLYGF-----CHDQHMTALVYEYM  103 (356)
Q Consensus        31 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~~~~~-----~~~~~~~~lV~e~~  103 (356)
                      .|+ |....||+....+|+.+++|+.....  .....+..|..+++.+...  .++.++..     ....+..++||+++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            466 88889999977677789999986431  2334566788777776421  23444443     12234567899999


Q ss_pred             CCCChhh-----h---------hhc--C------CCCCCHHHH----HHH---------------HHHHHHHHHHHhhc-
Q 038199          104 ENGSLDG-----Y---------LFG--K------KRAIEWEKL----HEI---------------AIGTAKGLVYLHEE-  141 (356)
Q Consensus       104 ~~~sL~~-----~---------l~~--~------~~~~~~~~~----~~i---------------~~qi~~~l~~LH~~-  141 (356)
                      +|..+..     +         ++.  .      ....++...    ..+               ...+-..+..+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8854421     0         000  0      011222211    001               00111122333221 


Q ss_pred             ---CCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199          142 ---CQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus       142 ---~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                         .+..++|||+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               236689999999999999 4 899999988753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.89  E-value=0.0001  Score=65.41  Aligned_cols=140  Identities=12%  Similarity=0.107  Sum_probs=78.2

Q ss_pred             ccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCc--eeeeece------EecCCeeeEEEe
Q 038199           30 TRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN--LVRLYGF------CHDQHMTALVYE  101 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~~~~~------~~~~~~~~lV~e  101 (356)
                      +.|+.|....+|+....+| .+++|+.....   ..+.+..|+.+++.+...+  +..++..      ....+..++|++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            4577788899999987555 68899887521   1234556777766653212  3333321      122345689999


Q ss_pred             ccCCCChhhh--------------hhc--CC--CC----C---CHHHHHH------------HHHHHHHHHHHHhhc---
Q 038199          102 YMENGSLDGY--------------LFG--KK--RA----I---EWEKLHE------------IAIGTAKGLVYLHEE---  141 (356)
Q Consensus       102 ~~~~~sL~~~--------------l~~--~~--~~----~---~~~~~~~------------i~~qi~~~l~~LH~~---  141 (356)
                      +++|..+...              ++.  ..  .+    .   .|.....            +...+...+..++..   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            9998654210              110  00  00    1   1211100            001133445555531   


Q ss_pred             -CCCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          142 -CQQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       142 -~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                       .+..++|+|+.+.||+++.++.+.++||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             23579999999999999987666899998774

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.86  E-value=5.7e-05  Score=62.10  Aligned_cols=98  Identities=13%  Similarity=0.097  Sum_probs=67.2

Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeeeecc
Q 038199          107 SLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG  186 (356)
Q Consensus       107 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  186 (356)
                      ||.++|...+.++++++++.++.|.+.+|.-+-..  ..-..+=+.|..|++..+|.|.+.+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            78999988899999999999999999998776220  1111233457999999999998764 1111             


Q ss_pred             CCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh
Q 038199          187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG  223 (356)
Q Consensus       187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt  223 (356)
                       .....+.+||....  ..+.+.=|||||+++|.-+-
T Consensus        98 -~~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGYS--QCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSSS--SSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhccc--cchHHHHHHHHHHHHHHHhh
Confidence             01224678887642  45788999999999998884

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.85  E-value=3.8e-05  Score=67.58  Aligned_cols=72  Identities=7%  Similarity=0.033  Sum_probs=44.6

Q ss_pred             cccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCce-eeeeceEecCCeeeEEEecc-CCC
Q 038199           29 STRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYM-ENG  106 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~~~~~~~~~lV~e~~-~~~  106 (356)
                      .+.|+.|....+|+.     +.+++|+-......  .....+|+.+++.+...++ .+++++.  .+.-++|+||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            567888999999999     56888987653111  1123457777776642222 4555443  33457899999 765


Q ss_pred             Chh
Q 038199          107 SLD  109 (356)
Q Consensus       107 sL~  109 (356)
                      +|.
T Consensus        94 ~l~   96 (301)
T 3dxq_A           94 TMS   96 (301)
T ss_dssp             ECC
T ss_pred             cCC
Confidence            553

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.84  E-value=5.1e-05  Score=67.77  Aligned_cols=139  Identities=18%  Similarity=0.122  Sum_probs=71.7

Q ss_pred             ccccccCceE-EEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC--CCceeeeeceEecCCeeeEEEeccCCC
Q 038199           30 TRLGFGGFGE-VYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HINLVRLYGFCHDQHMTALVYEYMENG  106 (356)
Q Consensus        30 ~~iG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~~~~~lV~e~~~~~  106 (356)
                      +.|+.|+... +|+....+|+.+++|.......    ..+..|+.+++.+.  .-.+.+++.+..+.  .++|||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence            4565554443 6787764467788886544210    22345666666553  12355666654333  37899999776


Q ss_pred             Chhhhhhc---------------------C----CCCCCHHHHH-------HHH-------------HHHHHHHHHHh--
Q 038199          107 SLDGYLFG---------------------K----KRAIEWEKLH-------EIA-------------IGTAKGLVYLH--  139 (356)
Q Consensus       107 sL~~~l~~---------------------~----~~~~~~~~~~-------~i~-------------~qi~~~l~~LH--  139 (356)
                      .+.+.+..                     .    -..++.....       .+.             ..+...+..+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            65432211                     0    0112221110       000             01112222221  


Q ss_pred             -hcCCCCccccCCCCCcEEEcCC----CceEEcccCCccc
Q 038199          140 -EECQQRIIHYDIKPENVLLDAN----FSPKVADFGLAKL  174 (356)
Q Consensus       140 -~~~~~~ivH~dikp~Nill~~~----~~~kl~Dfgl~~~  174 (356)
                       ...+..++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1123679999999999999874    6899999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.84  E-value=6.6e-05  Score=68.20  Aligned_cols=138  Identities=14%  Similarity=0.171  Sum_probs=84.0

Q ss_pred             ccccccCceEEEEEEeC--------CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEE
Q 038199           30 TRLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      +.|..|-...+|++...        +++.|++|+....  ......+.+|.++++.+. +.-..++++++.+    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            45766888899999864        2478999986332  123455678999998875 3223566666654    2899


Q ss_pred             eccCCCChhhh-----------------hhcC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 038199          101 EYMENGSLDGY-----------------LFGK----KRAIE--WEKLHEIAIGTAK-------------------GLVYL  138 (356)
Q Consensus       101 e~~~~~sL~~~-----------------l~~~----~~~~~--~~~~~~i~~qi~~-------------------~l~~L  138 (356)
                      ||++|..|..-                 ++..    .+...  +.++.++..++-.                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665321                 0111    12222  4566666655422                   23333


Q ss_pred             hh-----cCCCCccccCCCCCcEEEcCC----CceEEcccCCcc
Q 038199          139 HE-----ECQQRIIHYDIKPENVLLDAN----FSPKVADFGLAK  173 (356)
Q Consensus       139 H~-----~~~~~ivH~dikp~Nill~~~----~~~kl~Dfgl~~  173 (356)
                      ..     ..+..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            32     113469999999999999876    789999998875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.66  E-value=0.00017  Score=67.16  Aligned_cols=73  Identities=16%  Similarity=0.148  Sum_probs=47.4

Q ss_pred             ccccccCceEEEEEEeCC-CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCce-eeeeceEecCCeeeEEEeccCCCC
Q 038199           30 TRLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL-VRLYGFCHDQHMTALVYEYMENGS  107 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~~~~~~~~~lV~e~~~~~s  107 (356)
                      +.|+.|-...+|++...+ +..+++|+........  ....+|..+++.|...++ +++++++.+    .+||||++|.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~--idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI--INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC--SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh--cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            568888889999998754 5789999875432111  112578888888864444 566776632    35999998855


Q ss_pred             h
Q 038199          108 L  108 (356)
Q Consensus       108 L  108 (356)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.56  E-value=0.00016  Score=65.59  Aligned_cols=73  Identities=7%  Similarity=0.130  Sum_probs=43.8

Q ss_pred             ccccccCceEEEEEEeCC---------CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCc-eeeeeceEecCCeeeEE
Q 038199           30 TRLGFGGFGEVYKGQFPN---------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALV   99 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~~~~~~~~~~~~~lV   99 (356)
                      +.|+.|....+|+....+         ++.+++|+.......  ......|..+++.+...+ ..++++..  .  .++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            567888889999997643         268889987543211  112356777777774333 44555543  2  3689


Q ss_pred             EeccCCCCh
Q 038199          100 YEYMENGSL  108 (356)
Q Consensus       100 ~e~~~~~sL  108 (356)
                      |+|++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.42  E-value=0.002  Score=57.51  Aligned_cols=31  Identities=29%  Similarity=0.313  Sum_probs=27.6

Q ss_pred             CCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199          144 QRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus       144 ~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            5799999999999999888899999987753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.78  E-value=0.0034  Score=57.72  Aligned_cols=138  Identities=11%  Similarity=0.114  Sum_probs=83.7

Q ss_pred             ccccccCceEEEEEEeCC--------CcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEE
Q 038199           30 TRLGFGGFGEVYKGQFPN--------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      +.|..|-...+|+....+        ++.|++++.....  .......+|..+++.+. +.-..++++.+.    .++||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            456778889999998753        5789999865432  11112356888887774 222445554332    37899


Q ss_pred             eccCCCChhhh-------h----------h---c---------CCCCCCHHHHHHHHHHHH-------------------
Q 038199          101 EYMENGSLDGY-------L----------F---G---------KKRAIEWEKLHEIAIGTA-------------------  132 (356)
Q Consensus       101 e~~~~~sL~~~-------l----------~---~---------~~~~~~~~~~~~i~~qi~-------------------  132 (356)
                      +|++|..|..-       .          +   .         ...+..+.++..+..++-                   
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998664210       0          0   0         011123455555543332                   


Q ss_pred             HHHHHHhh---------------------cCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199          133 KGLVYLHE---------------------ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus       133 ~~l~~LH~---------------------~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..+..|..                     ..+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     11346899999999999 7888999999988753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.85  E-value=0.0042  Score=56.86  Aligned_cols=30  Identities=23%  Similarity=0.328  Sum_probs=25.0

Q ss_pred             CccccCCCCCcEEE------cCCCceEEcccCCccc
Q 038199          145 RIIHYDIKPENVLL------DANFSPKVADFGLAKL  174 (356)
Q Consensus       145 ~ivH~dikp~Nill------~~~~~~kl~Dfgl~~~  174 (356)
                      .++|+|+.+.||++      ++++.+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999988753

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.42  E-value=0.026  Score=52.55  Aligned_cols=62  Identities=3%  Similarity=0.017  Sum_probs=19.4

Q ss_pred             cccccccccCceEEEEEEeCC-CcEEEE------EEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           27 NYSTRLGFGGFGEVYKGQFPN-GVKIAV------KVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        27 ~~~~~iG~G~~g~Vy~~~~~~-~~~vav------K~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      .+.++||   ||+||+|.+.. ..+|||      |..... ........+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            5678887   99999998753 467888      665432 22233346888999999999999999988764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.74  E-value=0.74  Score=37.65  Aligned_cols=91  Identities=5%  Similarity=0.042  Sum_probs=63.9

Q ss_pred             HHHHHccCCCCceeeeeceEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccC
Q 038199           71 EVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD  150 (356)
Q Consensus        71 E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~d  150 (356)
                      |+.+|.. .||++++. .+-.+.+...+.++.-.  +...+-  .-+.++....++++.+|+....++++     -+|--
T Consensus        36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~  104 (215)
T 4ann_A           36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD--NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFV  104 (215)
T ss_dssp             GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG--GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECC
T ss_pred             HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH--HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEE
Confidence            3444433 57888876 56666676666666543  222222  23578889999999999987755553     47778


Q ss_pred             CCCCcEEEcCCCceEEcccCCc
Q 038199          151 IKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus       151 ikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      |.|+|++++.++.+++.-.|+-
T Consensus       105 L~P~NL~f~~~~~p~i~~RGik  126 (215)
T 4ann_A          105 LAPDELFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             CSGGGEEECTTSCEEESCCEET
T ss_pred             EecceEEEcCCCCEEEEEccCc
Confidence            9999999999999999877664

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.99  E-value=1.3  Score=36.32  Aligned_cols=82  Identities=11%  Similarity=0.099  Sum_probs=59.7

Q ss_pred             CCCceeeeeceEecCCeeeEEEeccCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCccccCCCCCcE
Q 038199           79 YHINLVRLYGFCHDQHMTALVYEYMEN-GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLV-YLHEECQQRIIHYDIKPENV  156 (356)
Q Consensus        79 ~h~ni~~~~~~~~~~~~~~lV~e~~~~-~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~~~~ivH~dikp~Ni  156 (356)
                      .||++  -..+-.+.+...+.++.-++ .++...     ..++....++++.+|+.... +++.     -+|--|.|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence            47877  34444667777777776532 344432     46888999999999988766 5543     57778899999


Q ss_pred             EEcCCCceEEcccCCc
Q 038199          157 LLDANFSPKVADFGLA  172 (356)
Q Consensus       157 ll~~~~~~kl~Dfgl~  172 (356)
                      +++.++.+++.-.|+-
T Consensus       116 ~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          116 MFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EECTTCCEEESCCEET
T ss_pred             EEeCCCcEEEEEcCCc
Confidence            9999999999877764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	356
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-72
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-57
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-57
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-21

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 6e-72
 Identities = 80/278 (28%), Positives = 131/278 (47%), Gaps = 20/278 (7%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           R+G G FG VYKG++   V  AVK+LN         + F  EVG + +T H+N++   G+
Sbjct: 15  RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                + A+V ++ E  SL  +L   +   E  KL +IA  TA+G+ YLH    + IIH 
Sbjct: 73  STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG--NYPITH 207
           D+K  N+ L  + + K+ DFGLA +  R           G+  + APE +      P + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
           + DVY+FG+VL+E++  +      +  + D     V   Y   +L        +     +
Sbjct: 189 QSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSK------VRSNCPK 240

Query: 268 KAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP 305
             KRL      C++   ++RP    ++  +E +   LP
Sbjct: 241 AMKRL---MAECLKKKRDERPLFPQILASIELLARSLP 275

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 1e-63
 Identities = 73/272 (26%), Positives = 127/272 (46%), Gaps = 22/272 (8%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            +G G FG V+ G + N  K+A+K +    G ++EE F+ E   + +  H  LV+LYG C
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
            +Q    LV+E+ME+G L  YL  ++     E L  + +   +G   +    +  +IH D
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVIHRD 126

Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD 210
           +   N L+  N   KV+DFG+ +    ++   +  G K    +++PE  S +   + K D
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFS-RYSSKSD 184

Query: 211 VYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAK 270
           V+SFG++++E+                   K  +E    SE+   I       K +  + 
Sbjct: 185 VWSFGVLMWEVFSEG---------------KIPYENRSNSEVVEDISTGFRLYKPRLAST 229

Query: 271 RLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
            +      C ++ PEDRP  S +++ L  + E
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 4e-63
 Identities = 62/268 (23%), Positives = 119/268 (44%), Gaps = 22/268 (8%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            LG G FG V  G++     +A+K++    G ++E++F+ E   +    H  LV+LYG C
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
             Q    ++ EYM NG L  YL   +   + ++L E+     + + YL     ++ +H D
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125

Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD 210
           +   N L++     KV+DFGL++    +    +  G K    +S PE L  +   + K D
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMYS-KFSSKSD 183

Query: 211 VYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAK 270
           +++FG++++EI    +                 +E +  SE    I       +    ++
Sbjct: 184 IWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYRPHLASE 228

Query: 271 RLCMAALWCVQDSPEDRPPMSAVVKMLE 298
           ++      C  +  ++RP    ++  + 
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 5e-62
 Identities = 70/294 (23%), Positives = 122/294 (41%), Gaps = 28/294 (9%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            +G G FGEV++G++  G ++AVK+ +    R       AE+       H N++      
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAAD 66

Query: 91  HDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC---- 142
           +  + T     LV +Y E+GSL  YL   +  +  E + ++A+ TA GL +LH E     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 143 -QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI--SGYKGTPGYSAPEFL 199
            +  I H D+K +N+L+  N +  +AD GLA   D     + I  +   GT  Y APE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 200 SG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
                  ++    + D+Y+ G+V +EI  R         +    +   V  +    E+  
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 255 TILACGI------EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
            +    +        +  E  + +      C   +   R     + K L  + +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 2e-61
 Identities = 74/279 (26%), Positives = 121/279 (43%), Gaps = 24/279 (8%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +LG G FGEV+ G +    ++A+K L      ++ E F+ E   + +  H  LV+LY   
Sbjct: 24  KLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            ++ +  +V EYM  GSL  +L G+  + +   +L ++A   A G+ Y+    +   +H 
Sbjct: 82  SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D++  N+L+  N   KVADFGLA+L + N       G K    ++APE        T K 
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYG-RFTIKS 195

Query: 210 DVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKA 269
           DV+SFG++L E+  + R                 +      E+   +          E  
Sbjct: 196 DVWSFGILLTELTTKGR---------------VPYPGMVNREVLDQVERGYRMPCPPECP 240

Query: 270 KRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPK 308
           + L      C +  PE+RP    +   LE       P  
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 4e-61
 Identities = 81/269 (30%), Positives = 126/269 (46%), Gaps = 24/269 (8%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           RLG G FGEV+ G +    K+AVK L +  G ++ + F+AE   + +  H  LVRLY   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 91  HDQHMTALVYEYMENGSLDGYLFGKKRA-IEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             + +  ++ EYMENGSL  +L       +   KL ++A   A+G+ ++ E      IH 
Sbjct: 78  TQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D++  N+L+    S K+ADFGLA+L + N       G K    ++APE ++     T K 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYG-TFTIKS 191

Query: 210 DVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKA 269
           DV+SFG++L EIV   R                 +      E+   +       +     
Sbjct: 192 DVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVRPDNCP 236

Query: 270 KRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
           + L      C ++ PEDRP    +  +LE
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (491), Expect = 5e-60
 Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 26/278 (9%)

Query: 32  LGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLY 87
           +G G FGEV  G         + +A+K L           F++E   +G+  H N++ L 
Sbjct: 34  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 93

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G         ++ E+MENGSLD +L          +L  +  G A G+ YL        +
Sbjct: 94  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYV 150

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS---GYKGTPGYSAPEFLSGNYP 204
           H D+   N+L+++N   KV+DFGL++  + + S  T +   G K    ++APE +     
Sbjct: 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-K 209

Query: 205 ITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEK 264
            T   DV+S+G+V++E++                  +  + +    ++   I        
Sbjct: 210 FTSASDVWSYGIVMWEVMSYG---------------ERPYWDMTNQDVINAIEQDYRLPP 254

Query: 265 DKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
             +    L    L C Q     RP    +V  L+ ++ 
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-59
 Identities = 68/271 (25%), Positives = 116/271 (42%), Gaps = 24/271 (8%)

Query: 32  LGFGGFGEVYKGQF---PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           LG G FG V +G +      + +A+KVL +   +   E+ M E   + +  +  +VRL G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
            C  + +  LV E    G L  +L GK+  I    + E+    + G+ YL    ++  +H
Sbjct: 77  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 132

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI-SGYKGTPGYSAPEFLSGNYPITH 207
            D+   NVLL      K++DFGL+K    + S+ T  S  K    + APE ++     + 
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSS 191

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
           + DV+S+G+ ++E +   +                 +++ +  E+ A I      E   E
Sbjct: 192 RSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEVMAFIEQGKRMECPPE 236

Query: 268 KAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
               L      C     EDRP    V + + 
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 1e-57
 Identities = 73/307 (23%), Positives = 132/307 (42%), Gaps = 36/307 (11%)

Query: 19  LQLNNFTSNYST--RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTI 75
           ++L +   ++     LG G  G V+K    P+G+ +A K+++  +      Q + E+  +
Sbjct: 1   MELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 76  GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 135
                  +V  YG  +     ++  E+M+ GSLD  L    R I  + L +++I   KGL
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
            YL E+   +I+H D+KP N+L+++    K+ DFG++     + ++     + GT  Y +
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMS 171

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT 255
           PE L G    + + D++S G+ L E+   R              P         ++    
Sbjct: 172 PERLQGT-HYSVQSDIWSMGLSLVEMAVGRY----------PIPPP-------DAKELEL 213

Query: 256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYL-- 313
           +  C +E    E   R             + RPPM A+ ++L+ +V   PP  P      
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLPSGVFSL 272

Query: 314 ---DLIK 317
              D + 
Sbjct: 273 EFQDFVN 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 2e-57
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 26/298 (8%)

Query: 12  KPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQ 67
           + V+   +  ++   +++  +G G FG VY G   +     +  AVK LNR        Q
Sbjct: 15  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 74

Query: 68  FMAEVGTIGRTYHINLVRLYGFC-HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 126
           F+ E   +    H N++ L G C   +    +V  YM++G L  ++  +      + L  
Sbjct: 75  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN--RSHVTI 184
             +  AKG+        ++ +H D+   N +LD  F+ KVADFGLA+        S    
Sbjct: 135 FGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

Query: 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVW 244
           +G K    + A E L      T K DV+SFG++L+E++ R                   +
Sbjct: 192 TGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGA---------------PPY 235

Query: 245 EEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
            +    ++   +L      + +     L    L C     E RP  S +V  +  +  
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (469), Expect = 9e-57
 Identities = 62/301 (20%), Positives = 107/301 (35%), Gaps = 48/301 (15%)

Query: 31  RLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            +G G FG V++ + P          +AVK+L        +  F  E   +    + N+V
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR-----------------------AIEW 121
           +L G C       L++EYM  G L+ +L                             +  
Sbjct: 80  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139

Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
            +   IA   A G+ YL E   ++ +H D+   N L+  N   K+ADFGL++       +
Sbjct: 140 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196

Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK 241
                      +  PE +      T + DV+++G+VL+EI                    
Sbjct: 197 KADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGL--------------- 240

Query: 242 HVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV 301
             +      E+   +    I    +     L      C    P DRP   ++ ++L+ + 
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300

Query: 302 E 302
           E
Sbjct: 301 E 301

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-56
 Identities = 67/297 (22%), Positives = 109/297 (36%), Gaps = 47/297 (15%)

Query: 31  RLGFGGFGEVYKGQFPN------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINL 83
            LG G FG+V              +++AVK+L         E  M+E+  + +   H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR----------------------AIEW 121
           V L G C       L++EY   G L  YL  K+                        + +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
           E L   A   AKG+ +L     +  +H D+   NVL+      K+ DFGLA+    + ++
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPK 241
           V     +    + APE L      T K DV+S+G++L+EI     N   G       F K
Sbjct: 221 VVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-ANFYK 278

Query: 242 HVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
            +   ++              ++     + + +    C       RP    +   L 
Sbjct: 279 LIQNGFK-------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 66/306 (21%), Positives = 119/306 (38%), Gaps = 28/306 (9%)

Query: 32  LGFGGFGEVYKGQFPN-----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G FG VYKG +        + +A+K L       A ++ + E   +    + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C    +  L+ + M  G L  Y+   K  I  + L    +  AKG+ YL     +R+
Sbjct: 77  LGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRL 132

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+   NVL+      K+ DFGLAKL           G K    + A E +      T
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYT 191

Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           H+ DV+S+G+ ++E++                     ++    SE+ + +       +  
Sbjct: 192 HQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKGERLPQPP 236

Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPFRYLDLIKMTGLKSLES 326
                + M  + C     + RP    ++       ++   P+ +  +   +   L S   
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQGDERMHLPSPTD 293

Query: 327 SDGSNS 332
           S+   +
Sbjct: 294 SNFYRA 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-56
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 25/285 (8%)

Query: 32  LGFGGFGEVYKGQFPNG-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
           +G G FGEVYKG          V +A+K L           F+ E G +G+  H N++RL
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G         ++ EYMENG+LD +L  K       +L  +  G A G+ YL        
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNY 131

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPI 205
           +H D+   N+L+++N   KV+DFGL+++ + +     T SG K    ++APE +S     
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KF 190

Query: 206 THKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD 265
           T   DV+SFG+V++E++                     + E    E+   I         
Sbjct: 191 TSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVMKAINDGFRLPTP 235

Query: 266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPPPKPF 310
            +    +    + C Q     RP  + +V +L+ ++      K  
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-55
 Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 42/296 (14%)

Query: 31  RLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINL 83
            LG G FG+V +            + +AVK+L  +      E  M+E+  +     H+N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 84  VRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKR-----------------AIEWEKLHE 126
           V L G C     T ++ EY   G L  +L  K+                  A++ E L  
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
            +   AKG+ +L     +  IH D+   N+LL      K+ DFGLA+    + ++V    
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE 246
            +    + APE +      T + DV+S+G+ L+E+     +   G       F K + E 
Sbjct: 207 ARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMIKEG 264

Query: 247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
           +               E    +   +      C    P  RP    +V+++E  + 
Sbjct: 265 FRML----------SPEHAPAEMYDI---MKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-55
 Identities = 69/275 (25%), Positives = 109/275 (39%), Gaps = 26/275 (9%)

Query: 31  RLGFGGFGEVYKGQFP----NGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLV 84
           +LG G FG V +G++       V +AVK L  ++    E  + F+ EV  +    H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
           RLYG      M  +V E    GSL   L   +       L   A+  A+G+ YL     +
Sbjct: 75  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 130

Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
           R IH D+   N+LL      K+ DFGL +   +N  H  +  ++  P             
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190

Query: 205 ITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE-E 263
            +H  D + FG+ L+E+    +                 W     S++   I   G    
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQ---------------EPWIGLNGSQILHKIDKEGERLP 235

Query: 264 KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
           + ++  + +    + C    PEDRP   A+   L 
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-55
 Identities = 65/272 (23%), Positives = 109/272 (40%), Gaps = 30/272 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
            +G G FG+V  G +  G K+AVK +  +      + F+AE   + +  H NLV+L G  
Sbjct: 14  TIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 91  -HDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             ++    +V EYM  GSL  YL  + R  +  + L + ++   + + YL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   NVL+  +   KV+DFGL K     +        K    ++APE L      + K
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREK-KFSTK 180

Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV+SFG++L+EI    R                 +      ++   +      +     
Sbjct: 181 SDVWSFGILLWEIYSFGR---------------VPYPRIPLKDVVPRVEKGYKMDAPDGC 225

Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV 300
              +      C       RP    + + LE +
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 1e-54
 Identities = 59/274 (21%), Positives = 108/274 (39%), Gaps = 28/274 (10%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
            +G G +G   K +   +G  +  K L+  ++    ++  ++EV  +    H N+VR Y 
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 89  FCHDQHMTAL--VYEYMENGSLDGYLFGKKR---AIEWEKLHEIAIGTAKGLVYLHE--E 141
              D+  T L  V EY E G L   +    +    ++ E +  +       L   H   +
Sbjct: 71  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130

Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
               ++H D+KP NV LD   + K+ DFGLA++ + + S      + GTP Y +PE ++ 
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTPYYMSPEQMNR 188

Query: 202 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI 261
                 K D++S G +L+E+                      +  + + EL   I     
Sbjct: 189 M-SYNEKSDIWSLGCLLYEL----------------CALMPPFTAFSQKELAGKIREGKF 231

Query: 262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
                  +  L       +      RP +  +++
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-54
 Identities = 66/275 (24%), Positives = 111/275 (40%), Gaps = 29/275 (10%)

Query: 28  YSTRLGFGGFGEVYKGQFP-NGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVR 85
           +   +G G F  VYKG      V++A   L  R L +   ++F  E   +    H N+VR
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 86  LYGFCHD----QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE 141
            Y         +    LV E M +G+L  YL  + + ++ + L        KGL +LH  
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 142 CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
               IIH D+K +N+ +     S K+ D GLA L   + +   I    GTP + APE   
Sbjct: 132 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYE 186

Query: 201 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG 260
             Y      DVY+FGM + E+            ++     + V    + +  D   +   
Sbjct: 187 EKY--DESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAI--- 239

Query: 261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
                  + K +      C++ + ++R  +  ++ 
Sbjct: 240 ------PEVKEIIE---GCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 2e-54
 Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 26/273 (9%)

Query: 31  RLGFGGFGEVYKGQFPN---GVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRL 86
            LG G FG V KG +        +AVK+L         +++ +AE   + +  +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G C  +    LV E  E G L+ YL  + R ++ + + E+    + G+ YL    +   
Sbjct: 74  IGICEAESW-MLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE---ESNF 128

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS-GYKGTPGYSAPEFLSGNYPI 205
           +H D+   NVLL      K++DFGL+K    + ++       K    + APE ++     
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KF 187

Query: 206 THKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD 265
           + K DV+SFG++++E     +                 +   + SE+ A +         
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMGCP 232

Query: 266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
               + +      C     E+RP  +AV   L 
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (451), Expect = 3e-54
 Identities = 71/274 (25%), Positives = 125/274 (45%), Gaps = 24/274 (8%)

Query: 31  RLGFGGFGEVYKGQFPN-GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG G +GEVY+G +    + +AVK L  +   +  E+F+ E   +    H NLV+L G 
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKR-AIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +    ++ E+M  G+L  YL    R  +    L  +A   +  + YL    ++  IH
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 138

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+   N L+  N   KVADFGL++L   +      +G K    ++APE L+ N   + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYN-KFSIK 196

Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEK 268
            DV++FG++L+EI                      +   + S++   +      E+ +  
Sbjct: 197 SDVWAFGVLLWEIATYG---------------MSPYPGIDLSQVYELLEKDYRMERPEGC 241

Query: 269 AKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
            +++      C Q +P DRP  + + +  E + +
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-54
 Identities = 65/309 (21%), Positives = 121/309 (39%), Gaps = 43/309 (13%)

Query: 13  PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNG---VKIAVKVLNRNLGRIAEEQFM 69
           P  +  L  N+    +   +G G FG+V K +       +  A+K +     +     F 
Sbjct: 1   PTIYPVLDWNDIK--FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58

Query: 70  AEVGTIGR-TYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGK------------- 115
            E+  + +  +H N++ L G C  +    L  EY  +G+L  +L                
Sbjct: 59  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118

Query: 116 --KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173
                +  ++L   A   A+G+ YL    Q++ IH D+   N+L+  N+  K+ADFGL++
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 175

Query: 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSS 233
             +           +    + A E L+ +   T   DV+S+G++L+EIV           
Sbjct: 176 GQEVYVKKTMG---RLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGG------- 224

Query: 234 ESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAV 293
                     +     +EL   +      EK       +      C ++ P +RP  + +
Sbjct: 225 --------TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276

Query: 294 VKMLEGVVE 302
           +  L  ++E
Sbjct: 277 LVSLNRMLE 285

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (449), Expect = 1e-53
 Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 32/281 (11%)

Query: 22  NNFTSNYST--RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIG 76
           ++    +S    +G G FG VY  +   N   +A+K ++ +  +  E  +  + EV  + 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 77  RTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLV 136
           +  H N ++  G    +H   LV EY    + D     KK  ++  ++  +  G  +GL 
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLA 129

Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
           YLH      +IH D+K  N+LL      K+ DFG A +     S V      GTP + AP
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAP 180

Query: 197 EFLSGNY--PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA 254
           E +          K DV+S G+   E+  R+    + +  ++         E    +   
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKP--PLFNMNAMSALYHIAQNESPALQ--- 235

Query: 255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
                       E  +        C+Q  P+DRP    ++K
Sbjct: 236 -------SGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 2e-53
 Identities = 62/270 (22%), Positives = 108/270 (40%), Gaps = 25/270 (9%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            LG G FG+VYK Q     V  A KV++        E +M E+  +    H N+V+L   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            + ++   ++ E+   G++D  +   +R +   ++  +   T   L YLH+    +IIH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHR 134

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY----PI 205
           D+K  N+L   +   K+ADFG++    R         + GTP + APE +        P 
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD--SFIGTPYWMAPEVVMCETSKDRPY 192

Query: 206 THKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKD 265
            +K DV+S G+ L E+              +    K    E       +           
Sbjct: 193 DYKADVWSLGITLIEMAEIEP--PHHELNPMRVLLKIAKSEPPTLAQPSRW--------- 241

Query: 266 KEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
               K        C++ + + R   S +++
Sbjct: 242 SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-53
 Identities = 65/275 (23%), Positives = 101/275 (36%), Gaps = 21/275 (7%)

Query: 24  FTSNYS--TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYH 80
           F  ++     LG G +GEV           +AVK+++        E    E+       H
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 81  INLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            N+V+ YG   + ++  L  EY   G L   +      +              G+VYLH 
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
                I H DIKPEN+LLD   + K++DFGLA +   N     ++   GT  Y APE L 
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 201 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG 260
                    DV+S G+VL  ++                + +      E S+         
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGEL-----------PWDQPSDSCQEYSDWKEKKTYLN 227

Query: 261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
             +K       L       + ++P  R  +  + K
Sbjct: 228 PWKKIDSAPLALLH---KILVENPSARITIPDIKK 259

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-52
 Identities = 59/276 (21%), Positives = 113/276 (40%), Gaps = 25/276 (9%)

Query: 31  RLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL 86
            +G G FG+V++G + +     + +A+K           E+F+ E  T+ +  H ++V+L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
            G   +  +  ++ E    G L  +L  +K +++   L   A   +  L YL     +R 
Sbjct: 74  IGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 129

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H DI   NVL+ +N   K+ DFGL++  + +  +    G K    + APE ++     T
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESINFR-RFT 187

Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
              DV+ FG+ ++EI+                     ++  + +++   I          
Sbjct: 188 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 232

Query: 267 EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
                L      C    P  RP  + +   L  ++E
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 1e-51
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 29/268 (10%)

Query: 31  RLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLY 87
            LG G FG VY  +   +   +A+KVL +        E Q   EV       H N++RLY
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G+ HD     L+ EY   G++   L    +  + ++        A  L Y H    +R+I
Sbjct: 73  GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS---KRVI 128

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H DIKPEN+LL +    K+ADFG +     +R         GT  Y  PE + G      
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMIEGR-MHDE 183

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
           K D++S G++ +E +  +      ++   + + +    E+               +   E
Sbjct: 184 KVDLWSLGVLCYEFLVGKP--PFEANTYQETYKRISRVEFT------------FPDFVTE 229

Query: 268 KAKRLCMAALWCVQDSPEDRPPMSAVVK 295
            A+ L       ++ +P  RP +  V++
Sbjct: 230 GARDLIS---RLLKHNPSQRPMLREVLE 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-51
 Identities = 61/287 (21%), Positives = 112/287 (39%), Gaps = 34/287 (11%)

Query: 31  RLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLV 84
            LG G FG VY+G      +     ++A+K +N         +F+ E   +      ++V
Sbjct: 27  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIE---------WEKLHEIAIGTAKGL 135
           RL G       T ++ E M  G L  YL   + A+            K+ ++A   A G+
Sbjct: 87  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
            YL      + +H D+   N ++  +F+ K+ DFG+ +       +           + +
Sbjct: 147 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT 255
           PE L      T   DV+SFG+VL+EI                   +  ++     ++   
Sbjct: 204 PESLKDG-VFTTYSDVWSFGVVLWEIA---------------TLAEQPYQGLSNEQVLRF 247

Query: 256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
           ++  G+ +K       L      C Q +P+ RP    ++  ++  +E
Sbjct: 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-50
 Identities = 68/297 (22%), Positives = 112/297 (37%), Gaps = 43/297 (14%)

Query: 31  RLGFGGFGEVYKGQFP--------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHI 81
            LG G FG+V   +             K+AVK+L  +         ++E+  +     H 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHE 126
           N++ L G C       ++ EY   G+L  YL  ++                 +  + L  
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
            A   A+G+ YL     ++ IH D+   NVL+  +   K+ADFGLA+       +   + 
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE 246
            +    + APE L      TH+ DV+SFG++L+EI                      +  
Sbjct: 197 GRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGG---------------SPYPG 240

Query: 247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV 303
               EL   +      +K       L M    C    P  RP    +V+ L+ +V +
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-47
 Identities = 67/295 (22%), Positives = 116/295 (39%), Gaps = 41/295 (13%)

Query: 31  RLGFGGFGEVYKG------QFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINL 83
            LG G FG+V +       +      +AVK+L            M+E+  +    +H+N+
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 84  VRLYGFC-HDQHMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEI 127
           V L G C        ++ E+ + G+L  YL  K               K  +  E L   
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
           +   AKG+ +L     ++ IH D+   N+LL      K+ DFGLA+   ++  +V     
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY 247
           +    + APE +      T + DV+SFG++L+EI     +   G     + F + + E  
Sbjct: 197 RLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGT 254

Query: 248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE 302
                          +    +  +     L C    P  RP  S +V+ L  +++
Sbjct: 255 RMR----------APDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  157 bits (399), Expect = 6e-46
 Identities = 64/324 (19%), Positives = 116/324 (35%), Gaps = 31/324 (9%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            LG G FG V++      G   A K +        +E    E+ T+    H  LV L+  
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             D +   ++YE+M  G L   +  +   +  ++  E      KGL ++HE      +H 
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHL 148

Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           D+KPEN++     S   K+ DFGL    D  +S        GT  ++APE   G  P+ +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGK-PVGY 204

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
             D++S G++ + ++        G     +        ++   +   + ++        E
Sbjct: 205 YTDMWSVGVLSYILLSGLS--PFGGENDDETLRNVKSCDWNMDDSAFSGIS--------E 254

Query: 268 KAKRLCMAALWCVQDSPEDRPPMSAVVKM-------LEGVVEVLPPPKPFRYLDLIKMTG 320
             K         +   P  R  +   ++          G    +P  +  +  D IK   
Sbjct: 255 DGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKY 311

Query: 321 LKSLESSDGSNSSNRSRWYKETTP 344
               E        +     ++  P
Sbjct: 312 DAWPEPLPPLGRISNYSSLRKHRP 335

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 1e-45
 Identities = 50/266 (18%), Positives = 101/266 (37%), Gaps = 24/266 (9%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G  G VY       G ++A++ +N    +  +E  + E+  +    + N+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                   +V EY+  GSL   +   +  ++  ++  +     + L +LH     ++IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 140

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           DIK +N+LL  + S K+ DFG        +S  +     GTP + APE ++       K 
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRK-AYGPKV 197

Query: 210 DVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKA 269
           D++S G++  E++         +   L            + +    +             
Sbjct: 198 DIWSLGIMAIEMIEGEP--PYLNENPLRALYLIATNGTPELQNPEKL---------SAIF 246

Query: 270 KRLCMAALWCVQDSPEDRPPMSAVVK 295
           +        C+    E R     +++
Sbjct: 247 RDFLN---RCLDMDVEKRGSAKELLQ 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-44
 Identities = 54/273 (19%), Positives = 95/273 (34%), Gaps = 29/273 (10%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRN--LGRIAEEQFMAEVGTIGRTYHINLVRLY 87
            LG G F  V   +      + A+K+L +   +          E   + R  H   V+LY
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
               D         Y +NG L  Y+       E          TA+ +  L     + II
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTAEIVSALEYLHGKGII 130

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           H D+KPEN+LL+ +   ++ DFG AK+          + + GT  Y +PE L+       
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACK 189

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK- 266
             D+++ G +++++V                     +    +  +   I+    +  +K 
Sbjct: 190 SSDLWALGCIIYQLV----------------AGLPPFRAGNEYLIFQKIIKLEYDFPEKF 233

Query: 267 -EKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
             KA+ L       +      R     +     
Sbjct: 234 FPKARDLVE---KLLVLDATKRLGCEEMEGYGP 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-43
 Identities = 50/338 (14%), Positives = 113/338 (33%), Gaps = 46/338 (13%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            LG G FG V++     +      K +        +     E+  +    H N++ L+  
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHES 69

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                   +++E++    +   +      +   ++        + L +LH      I H+
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126

Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           DI+PEN++     S   K+ +FG A+      +          P Y APE    +  ++ 
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDV-VST 182

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK- 266
             D++S G +++ ++                   + +      ++   I+       ++ 
Sbjct: 183 ATDMWSLGTLVYVLL----------------SGINPFLAETNQQIIENIMNAEYTFDEEA 226

Query: 267 -----EKAKRLCMAALWCVQDSPEDRPPMSAVV------KMLEGV-VEVLPPPKPFRYLD 314
                 +A          +    + R   S  +      + +E V  +V+   K  RY  
Sbjct: 227 FKEISIEAMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYH 283

Query: 315 LIKMTGLKSLESSDGSNSSNRSRWYKETTPIMAKHEIQ 352
            +    L  + S+   +     R   +    +AK ++ 
Sbjct: 284 TLIKKDLNMVVSAARISCGGAIR--SQKGVSVAKVKVA 319

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  151 bits (382), Expect = 3e-43
 Identities = 56/276 (20%), Positives = 105/276 (38%), Gaps = 30/276 (10%)

Query: 19  LQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTI 75
           L +N+F+      +G GGFGEVY  +    G   A+K L++     +  E   + E   +
Sbjct: 1   LTMNDFS--VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58

Query: 76  ---GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTA 132
                     +V +    H     + + + M  G L  +L       E + +   A    
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD-MRFYAAEII 117

Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
            GL ++H    + +++ D+KP N+LLD +   +++D GLA    + + H ++    GT G
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 170

Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL 252
           Y APE L          D +S G +LF+++          ++      +       +   
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--- 227

Query: 253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRP 288
                   + +    + + L       +Q     R 
Sbjct: 228 --------LPDSFSPELRSLLE---GLLQRDVNRRL 252

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  148 bits (374), Expect = 4e-42
 Identities = 56/292 (19%), Positives = 112/292 (38%), Gaps = 26/292 (8%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            LG G FG V++      G     K +N     + +     E+  + + +H  L+ L+  
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
             D++   L+ E++  G L   +  +   +   ++        +GL ++HE     I+H 
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 151

Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           DIKPEN++ +   +   K+ DFGLA   + +           T  ++APE +    P+  
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDRE-PVGF 207

Query: 208 KCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKE 267
             D+++ G++ + ++           + L+        ++E  E                
Sbjct: 208 YTDMWAIGVLGYVLLSGLS--PFAGEDDLETLQNVKRCDWEFDE--------DAFSSVSP 257

Query: 268 KAKRLCMAALWCVQDSPEDRPPMSAVVKM--LEGVVEVLPPPKPFRYLDLIK 317
           +AK         +Q  P  R  +   ++   L+G    L    P    + I+
Sbjct: 258 EAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIR 306

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  143 bits (362), Expect = 4e-41
 Identities = 59/289 (20%), Positives = 110/289 (38%), Gaps = 37/289 (12%)

Query: 24  FTSNYST--RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--------RIAEEQFMAEV 72
           F  NY     LG G    V +    P   + AVK+++   G        +   E  + EV
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 73  GTIGRT-YHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGT 131
             + +   H N+++L           LV++ M+ G L  YL  +K  +  ++  +I    
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRAL 119

Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
            + +  LH+     I+H D+KPEN+LLD + + K+ DFG +   D            GTP
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTP 173

Query: 192 GYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE 246
            Y APE +  +          + D++S G++++ ++           + +      +   
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP--PFWHRKQMLMLRMIMSGN 231

Query: 247 YEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
           Y+    +    +        +  K L       +   P+ R      + 
Sbjct: 232 YQFGSPEWDDYS--------DTVKDLVS---RFLVVQPQKRYTAEEALA 269

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 5e-41
 Identities = 57/299 (19%), Positives = 116/299 (38%), Gaps = 29/299 (9%)

Query: 20  QLNNFTSNYST--RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIG 76
           Q+ +    Y+    +G G +G V       N V++A+K ++    +   ++ + E+  + 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 77  RTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFG--KKRAIEWEKLHEIAIGTAKG 134
           R  H N++ +        +  +   Y+    +   L+   K + +  + +        +G
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGY 193
           L Y+H      ++H D+KP N+LL+     K+ DFGLA++ D +  H   ++ Y  T  Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIVGRR--------RNAIVGSSESLDWFPKHVWE 245
            APE +  +   T   D++S G +L E++  R         + +      L    +    
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 246 EYEKSELDATILACGIEEKDK---------EKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
                +    +L+   + K            KA  L       +  +P  R  +   + 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (359), Expect = 2e-40
 Identities = 52/266 (19%), Positives = 90/266 (33%), Gaps = 19/266 (7%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
            LG G F EV   +       +A+K + +      E     E+  + +  H N+V L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
                   L+ + +  G L   +  K           +       + YLH+         
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLK 134

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
                   LD +    ++DFGL+K+ D       +S   GTPGY APE L+   P +   
Sbjct: 135 PENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK-PYSKAV 190

Query: 210 DVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKA 269
           D +S G++ + ++                F + +  EYE              +   + A
Sbjct: 191 DCWSIGVIAYILLCGYP--PFYDENDAKLFEQILKAEYEFDSP--------YWDDISDSA 240

Query: 270 KRLCMAALWCVQDSPEDRPPMSAVVK 295
           K         ++  PE R      ++
Sbjct: 241 KDFIR---HLMEKDPEKRFTCEQALQ 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  141 bits (356), Expect = 3e-40
 Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 27/279 (9%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 87
            LGFGG  EV+  +       +AVKVL  +L R      +F  E        H  +V +Y
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 88  GFCHDQHMTA----LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQ 143
                +        +V EY++  +L   +  +   +  ++  E+     + L + H+   
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQ--- 129

Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG-YKGTPGYSAPEFLSGN 202
             IIH D+KP N+++ A  + KV DFG+A+    + + VT +    GT  Y +PE   G+
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189

Query: 203 YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE 262
             +  + DVYS G VL+E++             +    +HV E+          L+    
Sbjct: 190 -SVDARSDVYSLGCVLYEVLTGEP--PFTGDSPVSVAYQHVREDPIPPSARHEGLS---- 242

Query: 263 EKDKEKAKRLCMAALWCVQDSPEDRPP-MSAVVKMLEGV 300
                    + +     +  +PE+R    + +   L  V
Sbjct: 243 ----ADLDAVVL---KALAKNPENRYQTAAEMRADLVRV 274

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-40
 Identities = 65/284 (22%), Positives = 103/284 (36%), Gaps = 28/284 (9%)

Query: 32  LGFGGFGEVYKGQFPN-GVKIAVKVLNRN----LGRIAEEQFMAEVGTIGRTYHINLVRL 86
           LG G F  VYK +  N    +A+K +                + E+  +    H N++ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
                 +   +LV+++ME       +      +    +    + T +GL YLH+     I
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---I 121

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           +H D+KP N+LLD N   K+ADFGLAK         T      T  Y APE L G     
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--QVVTRWYRAPELLFGARMYG 179

Query: 207 HKCDVYSFGMVLFEIVGRRR--------------NAIVGSSESLDWFPKHVWEEYEKSEL 252
              D+++ G +L E++ R                   +G+     W       +Y   + 
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM 296
              I    I     +    L          +P  R   +  +KM
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-39
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 32/271 (11%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTY-HINLVRL 86
            LG G FG+V+  +F       A+K L +++  + +  E  M E   +   + H  L  +
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 87  YGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
           +     +     V EY+  G L  ++    +  +  +    A     GL +LH    + I
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHS---KGI 124

Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
           ++ D+K +N+LLD +   K+ADFG+ K      +      + GTP Y APE L G     
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN--TFCGTPDYIAPEILLGQ-KYN 181

Query: 207 HKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDK 266
           H  D +SFG++L+E++                  +  +   ++ EL  +I          
Sbjct: 182 HSVDWWSFGVLLYEML----------------IGQSPFHGQDEEELFHSIRMDNPFYPRW 225

Query: 267 --EKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
             ++AK L +         PE R  +   ++
Sbjct: 226 LEKEAKDLLV---KLFVREPEKRLGVRGDIR 253

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 7e-39
 Identities = 57/274 (20%), Positives = 103/274 (37%), Gaps = 39/274 (14%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEE-----QFMAEVGTIGR--TYHIN 82
            LG GGFG VY G    + + +A+K + ++      E     +   EV  + +  +    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           ++RL  +        L+ E  E          ++ A++ E          + + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128

Query: 143 QQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
              ++H DIK EN+L+D N    K+ DFG   L            + GT  YS PE++  
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRY 183

Query: 202 NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI 261
           +        V+S G++L+++V                 P    EE  + ++         
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGD-------------IPFEHDEEIIRGQVF-------F 223

Query: 262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
            ++   + + L     WC+   P DRP    +  
Sbjct: 224 RQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  137 bits (345), Expect = 1e-38
 Identities = 55/278 (19%), Positives = 104/278 (37%), Gaps = 19/278 (6%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G +G VYK Q   G   A+K +             + E+  +    H N+V+LY  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 90  CHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
            H +    LV+E+++          +   +E        +    G+ Y H+   +R++H 
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD---RRVLHR 124

Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
           D+KP+N+L++     K+ADFGLA+           +    T  Y AP+ L G+   +   
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 210 DVYSFGMVLFEIVGRR--------RNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI 261
           D++S G +  E+V            + ++     L       W    +            
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 262 EEKDKEKAKRLCMAAL----WCVQDSPEDRPPMSAVVK 295
               +   K L  + +      ++  P  R      ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  136 bits (342), Expect = 4e-38
 Identities = 49/280 (17%), Positives = 92/280 (32%), Gaps = 29/280 (10%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYG 88
           R+G G FG +++G    N  ++A+K   R   R    Q   E  T         +  +Y 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPR---RSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           F  +     LV + +     D  L    R    + +   A      +  +H   ++ +++
Sbjct: 69  FGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124

Query: 149 YDIKPENVLLDANFSP-----KVADFGLAKLCDRNRSHVTI-----SGYKGTPGYSAPEF 198
            DIKP+N L+    S       V DFG+ K      +   I         GT  Y +   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 199 LSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA 258
             G    + + D+ + G V           + GS            ++YE+  +     +
Sbjct: 185 HLGR-EQSRRDDLEALGHVFMYF-------LRGSLPWQGLKAATNKQKYER--IGEKKQS 234

Query: 259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
             + E      +       +    + +  P    +  +  
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 5e-38
 Identities = 59/291 (20%), Positives = 106/291 (36%), Gaps = 21/291 (7%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G VYK +    G  +A+K +  +          + E+  +    H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H ++   LV+E++               I    +        +GL + H      ++H
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLH 125

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+KP+N+L++   + K+ADFGLA+         T      T  Y APE L G    +  
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVTLWYRAPEILLGCKYYSTA 183

Query: 209 CDVYSFGMVLFEIVGRRR--------NAIVGSSESLDWFPKHVWEEYEKSELDATILACG 260
            D++S G +  E+V RR         + +     +L    + VW                
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243

Query: 261 IEEKDKEKAKRLCMAAL----WCVQDSPEDRPPMSAVVKM--LEGVVEVLP 305
             +   +    L           +   P  R    A +     + V + +P
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  135 bits (340), Expect = 1e-37
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 13/199 (6%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAE--EQFMAEVGTIGRTYHINLVRLY 87
            LG G FG V+  +   NG   A+KVL + +    +  E    E   +    H  ++R++
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 88  GFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRII 147
           G   D     ++ +Y+E G L   L   +R          A       + L     + II
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----CLALEYLHSKDII 126

Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
           + D+KPEN+LLD N   K+ DFG AK               GTP Y APE +S   P   
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVSTK-PYNK 180

Query: 208 KCDVYSFGMVLFEIVGRRR 226
             D +SFG++++E++    
Sbjct: 181 SIDWWSFGILIYEMLAGYT 199

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 1e-37
 Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 33/279 (11%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC 90
           +G G FG VY+ +   +G  +A+K + ++     +     E+  + +  H N+VRL  F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82

Query: 91  H------DQHMTALVYEYMENGSLDGYLFG--KKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           +      D+    LV +Y+              K+ +    +        + L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--- 139

Query: 143 QQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
              I H DIKP+N+LLD +    K+ DFG AK   R   +V+   Y  +  Y APE + G
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIFG 196

Query: 202 NYPITHKCDVYSFGMVLFEIVGRRR--------NAIVGSSESLDWFPKHVWEEYEKSELD 253
               T   DV+S G VL E++  +         + +V   + L    +    E   +  +
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 254 ATILACGIEEKDKEKAKRLCMAAL----WCVQDSPEDRP 288
                       K    R    A+      ++ +P  R 
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (338), Expect = 1e-37
 Identities = 55/278 (19%), Positives = 99/278 (35%), Gaps = 27/278 (9%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           ++G G FG++Y G     G ++A+K+      +    Q   E            +    +
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 90  C-HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
           C  +     +V E +     D + F  ++    + +  +A      + Y+H    +  IH
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHS---KNFIH 126

Query: 149 YDIKPENVL---LDANFSPKVADFGLAKLCDRNRSHVTI-----SGYKGTPGYSAPEFLS 200
            D+KP+N L           + DFGLAK     R+H  I         GT  Y++     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 201 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG 260
           G    + + D+ S G VL           +GS            ++YE+       ++  
Sbjct: 187 GI-EQSRRDDLESLGYVLMYF-------NLGSLPWQGLKAATKRQKYERISEK--KMSTP 236

Query: 261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE 298
           IE   K           +C     +D+P  S + ++  
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 2e-37
 Identities = 62/292 (21%), Positives = 108/292 (36%), Gaps = 31/292 (10%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLN-RNLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G FGEV+K +    G K+A+K +   N         + E+  +    H N+V L  
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 89  FCHDQ--------HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHE 140
            C  +            LV+++ E+    G L          ++  +      GL   + 
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGL---YY 132

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS--HVTISGYKGTPGYSAPEF 198
             + +I+H D+K  NVL+  +   K+ADFGLA+     ++      +    T  Y  PE 
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 199 LSGNYPITHKCDVYSFGMVLFEIVGRRR--------NAIVGSSESLDWFPKHVWEEYEKS 250
           L G        D++  G ++ E+  R          + +   S+        VW   +  
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252

Query: 251 ELDATILACGIEE---KDKEKAKRLCMAAL----WCVQDSPEDRPPMSAVVK 295
           EL   +     ++   KD+ KA      AL      +   P  R      + 
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 3e-37
 Identities = 59/290 (20%), Positives = 116/290 (40%), Gaps = 36/290 (12%)

Query: 31  RLGFGGFGEVYKGQF--PNGVKIAVKVLNRNLG----RIAEEQFMAEVGTIGRTYHINLV 84
            +G G +G+V+K +     G  +A+K +    G     ++  + +A +  +    H N+V
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 85  RLYGFCHDQH-----MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLH 139
           RL+  C            LV+E+++           +  +  E + ++     +GL +LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
                R++H D+KP+N+L+ ++   K+ADFGLA++     +  +      T  Y APE L
Sbjct: 134 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVTLWYRAPEVL 187

Query: 200 SGNYPITHKCDVYSFGMVLFEIVGRRR--------------NAIVGSSESLDWFPKHVWE 245
             +       D++S G +  E+  R+                 ++G     DW       
Sbjct: 188 LQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 246 EYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
                   A  +   + + D+   K L +    C+  +P  R    + + 
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDEL-GKDLLL---KCLTFNPAKRISAYSALS 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 5e-35
 Identities = 59/281 (20%), Positives = 108/281 (38%), Gaps = 43/281 (15%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-----GRIAEEQFMAEVGTIGRTYHINLV 84
            LG G F  V K +    G++ A K + +         ++ E    EV  +    H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 85  RLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
            L+    ++    L+ E +  G L  +   +K ++  E+  E       G   ++     
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNG---VYYLHSL 132

Query: 145 RIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
           +I H+D+KPEN++L     P    K+ DFGLA   D            GTP + APE ++
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 189

Query: 201 GNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG 260
              P+  + D++S G++ + ++                     +    K E  A + A  
Sbjct: 190 YE-PLGLEADMWSIGVITYILL----------------SGASPFLGDTKQETLANVSAVN 232

Query: 261 IEEKDK------EKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
            E +D+        AK         +   P+ R  +   ++
Sbjct: 233 YEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-35
 Identities = 49/280 (17%), Positives = 95/280 (33%), Gaps = 21/280 (7%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNR-NLGRIAEEQFMAEVGTIGRTYHINLVRLYG 88
           ++G G +G V+K +       +A+K +   +         + E+  +    H N+VRL+ 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 89  FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
             H      LV+E+ +      +               +     + L  L     + ++H
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRNVLH 124

Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
            D+KP+N+L++ N   K+A+FGLA+         +      T  Y  P+ L G    +  
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTS 182

Query: 209 CDVYSFGMVLFEIVGRRRNAIVGSSES---------LDWFPKHVWEEYEKSELDATILAC 259
            D++S G +  E+    R    G+            L    +  W    K          
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242

Query: 260 GIEEKDKEKAKRLCMAAL----WCVQDSPEDRPPMSAVVK 295
                      +L           ++ +P  R      ++
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 7e-35
 Identities = 60/276 (21%), Positives = 107/276 (38%), Gaps = 36/276 (13%)

Query: 32  LGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGF 89
           LG G  G+V +        K A+K+L          +   EV    R +   ++VR+   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDV 73

Query: 90  CHDQHMTA----LVYEYMENGSLDGYLFGKK-RAIEWEKLHEIAIGTAKGLVYLHEECQQ 144
             + +       +V E ++ G L   +  +  +A    +  EI     + + YLH     
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 145 RIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
            I H D+KPEN+L  +       K+ DFG AK    + S  T      TP Y APE L  
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGP 187

Query: 202 NYPITHKCDVYSFGMVLFEIVGRRR--NAIVGSSESLDWFPKHVWEEYEKSELDATILAC 259
                  CD++S G++++ ++       +  G + S     +    +YE    + + ++ 
Sbjct: 188 E-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS- 245

Query: 260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK 295
                  E+ K L       ++  P  R  ++  + 
Sbjct: 246 -------EEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 6e-34
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 12/211 (5%)

Query: 19  LQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRN--LGRIAEEQFMAEVGTI 75
           + +N+F   Y   LG G FG+V   +    G   A+K+L +   + +      + E   +
Sbjct: 2   VTMNDFD--YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59

Query: 76  GRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGL 135
             T H  L  L            V EY   G L  +L  ++   E           A+ +
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER----ARFYGAEIV 115

Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
             L     + +++ DIK EN++LD +   K+ DFGL K    + +  T+  + GTP Y A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLA 173

Query: 196 PEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 226
           PE L  N       D +  G+V++E++  R 
Sbjct: 174 PEVLEDN-DYGRAVDWWGLGVVMYEMMCGRL 203

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (302), Expect = 6e-32
 Identities = 51/220 (23%), Positives = 84/220 (38%), Gaps = 15/220 (6%)

Query: 10  REKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAE--E 66
           + +     + QL+ F       LG G FG V   +   +G   A+K+L++      +  E
Sbjct: 29  KWETPSQNTAQLDQFD--RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86

Query: 67  QFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHE 126
             + E   +       LV+L     D     +V EY+  G +  +L  +           
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARF 145

Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
            A        YLH      +I+ D+KPEN+L+D     +V DFG AK             
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----- 197

Query: 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR 226
             GTP   APE +          D ++ G++++E+     
Sbjct: 198 LCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYP 236

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 4e-31
 Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 13/200 (6%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
            +G G +G V        G K+A+K L R     +  ++   E+  +    H N++ L  
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 89  FCHDQHMTALVYEY---MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
                       ++   M     D     K   +  +++  +     KGL Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           IIH D+KP N+ ++ +   K+ DFGLA+  D        +GY  T  Y APE +      
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRY 196

Query: 206 THKCDVYSFGMVLFEIVGRR 225
           T   D++S G ++ E++  +
Sbjct: 197 TQTVDIWSVGCIMAEMITGK 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  117 bits (294), Expect = 5e-31
 Identities = 43/201 (21%), Positives = 84/201 (41%), Gaps = 19/201 (9%)

Query: 31  RLGFGGFGEVYKGQ-FPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYG 88
           +LG G + EV++     N  K+ VK+L      + +++   E+  +       N++ L  
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLAD 97

Query: 89  FCHDQ--HMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRI 146
              D      ALV+E++ N           + +    +        K L Y H      I
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGI 150

Query: 147 IHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           +H D+KP NV++D  +   ++ D+GLA+     + +   +    +  +  PE L      
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMY 207

Query: 206 THKCDVYSFGMVLFEIVGRRR 226
            +  D++S G +L  ++ R+ 
Sbjct: 208 DYSLDMWSLGCMLASMIFRKE 228

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 9e-31
 Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 12/204 (5%)

Query: 31  RLGFGGFGEVYKGQ----FPNGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRTYHI-N 82
            LG G +G+V+  +       G   A+KVL +          E    E   +        
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 83  LVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
           LV L+     +    L+ +Y+  G L  +L  ++R  E E    + I   + ++ L    
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----VQIYVGEIVLALEHLH 146

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
           +  II+ DIK EN+LLD+N    + DFGL+K    + +             +      G+
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206

Query: 203 YPITHKCDVYSFGMVLFEIVGRRR 226
                  D +S G++++E++    
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGAS 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 6e-27
 Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 19/203 (9%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
            +G G  G V           +A+K L+R    +   ++   E+  +    H N++ L  
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 89  FCHDQHMT------ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC 142
               Q          LV E M+           +  ++ E++  +      G+ +LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 139

Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
               IH D+KP N+++ ++ + K+ DFGLA+    +      + Y  T  Y APE + G 
Sbjct: 140 I---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILG- 192

Query: 203 YPITHKCDVYSFGMVLFEIVGRR 225
                  D++S G ++ E+V  +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 7e-27
 Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 13/200 (6%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYG 88
            +G G +G V        G+++AVK L+R     I  ++   E+  +    H N++ L  
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 89  FCHDQHMTA---LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR 145
                        VY        D     K + +  + +  +     +GL Y+H      
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141

Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
           IIH D+KP N+ ++ +   K+ DFGLA+  D   +      Y  T  Y APE +      
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-----YVATRWYRAPEIMLNWMHY 196

Query: 206 THKCDVYSFGMVLFEIVGRR 225
               D++S G ++ E++  R
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (259), Expect = 7e-26
 Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 22/209 (10%)

Query: 31  RLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGF 89
           +LG+G F  V+  +   N   +A+K++  +  ++  E    E+  + R    +  +    
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 90  CH---------------DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKG 134
                            +     +V+E +    L      + R I    + +I+     G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 135 LVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
           L Y+H   +  IIH DIKPENVL++       +    +A L +        +    T  Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 194 SAPEFLSGNYPITHKCDVYSFGMVLFEIV 222
            +PE L G  P     D++S   ++FE++
Sbjct: 196 RSPEVLLGA-PWGCGADIWSTACLIFELI 223

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.9 bits (217), Expect = 3e-21
 Identities = 23/160 (14%), Positives = 42/160 (26%), Gaps = 19/160 (11%)

Query: 31  RLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG---------RIAEEQFMAEVGTIGRTYHI 81
            +G G    V+        +  VK                   +  F        R    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 82  NLVRLYGFCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLH-EIAIGTAKGLVYLHE 140
            L +L G    +      Y +  N  L   +  K+      +   E+     + +   + 
Sbjct: 67  ALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
                I+H D+   NVL+       + DF  +        
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	356
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.73
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.5
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.99
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.72
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.89

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-59  Score=410.34  Aligned_cols=258  Identities=29%  Similarity=0.480  Sum_probs=208.5

Q ss_pred             hhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ...|++.++||+|+||+||+|.+.+++.||||+++.+  ....++|.+|++++++++||||+++++++.+.+..++||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            4578999999999999999999888889999999764  34456899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++|+|.+++......+++..+..|+.||+.||.|||+   ++|+||||||+|||+++++.+||+|||+++........ 
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            99999999997777889999999999999999999999   99999999999999999999999999999876543322 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                      ......||..|+|||++.+. .++.++|||||||++|||+|++.|+.....               ...+...+..+...
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---------------~~~~~~~i~~~~~~  221 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------------NSEVVEDISTGFRL  221 (263)
T ss_dssp             -------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---------------HHHHHHHHHHTCCC
T ss_pred             eecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCC---------------HHHHHHHHHhcCCC
Confidence            22335689999999999877 799999999999999999997655433222               11122223333334


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ..+..++.++.+++.+||+.||++|||+++|++.|+++.+
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            4455567789999999999999999999999999998754

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-59  Score=411.50  Aligned_cols=270  Identities=27%  Similarity=0.435  Sum_probs=212.6

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      |++....|++.++||+|+||+||+|++.  ..||||+++.. ......+.|.+|+.++++++||||+++++++.+ ...+
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence            5677788999999999999999999863  35999999743 234556789999999999999999999998765 4579


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +|||||++|+|.+++...+..+++..+..|+.||+.||+|||+   ++||||||||+|||++.++.+||+|||+++....
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            9999999999999997777789999999999999999999999   9999999999999999999999999999987665


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCC--CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ...........||+.|+|||++.+.  ..++.++|||||||++|||+||+.||......      ...........    
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~----  226 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRGY----  226 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHTS----
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCC----
Confidence            4444444556799999999998643  25789999999999999999999998543221      00111111100    


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCC
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLP  305 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~  305 (356)
                       ...........++.++.+++.+||+.||++|||+++|++.|+.+....|
T Consensus       227 -~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         227 -LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             -CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence             0001112234456789999999999999999999999999998876544

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-59  Score=414.83  Aligned_cols=272  Identities=26%  Similarity=0.427  Sum_probs=228.8

Q ss_pred             hhcCCcceecHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeee
Q 038199            8 IGREKPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRL   86 (356)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~   86 (356)
                      |++.+| .+..|++...+|++.++||+|+||+||+|.+. +|+.||||+++.+.  ...++|.+|++++++++||||+++
T Consensus         2 ~~p~~p-~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~   78 (287)
T d1opja_           2 MDPSSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQL   78 (287)
T ss_dssp             CCTTST-TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCCCCC-CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecC
Confidence            456666 45678899999999999999999999999875 58999999997653  445689999999999999999999


Q ss_pred             eceEecCCeeeEEEeccCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceE
Q 038199           87 YGFCHDQHMTALVYEYMENGSLDGYLFG-KKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK  165 (356)
Q Consensus        87 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~k  165 (356)
                      ++++.++...++|||||++|+|.+++.. ....+++..+..|+.||+.||.|||+   ++|+||||||+|||++.++.+|
T Consensus        79 ~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~K  155 (287)
T d1opja_          79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVK  155 (287)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred             CccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEE
Confidence            9999999999999999999999999864 35689999999999999999999999   9999999999999999999999


Q ss_pred             EcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHH
Q 038199          166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWE  245 (356)
Q Consensus       166 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~  245 (356)
                      |+|||+++........ ......|+..|+|||++.+. .++.++|||||||++|||++|..|+..+...           
T Consensus       156 l~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-----------  222 (287)
T d1opja_         156 VADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------  222 (287)
T ss_dssp             ECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------
T ss_pred             EccccceeecCCCCce-eeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchH-----------
Confidence            9999999876544332 33445688999999999876 7899999999999999999988776544321           


Q ss_pred             HHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          246 EYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                          ..+...+........+...+.++.+++.+||+.||++|||+++|++.|+.+..
T Consensus       223 ----~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         223 ----SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ----HHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                11222233333444555677889999999999999999999999999987643

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-59  Score=406.92  Aligned_cols=254  Identities=24%  Similarity=0.281  Sum_probs=207.1

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|++.++||+|+||+||+|.+. +|+.||||++.........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            46899999999999999999864 69999999997654344456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      |+||+|.+++ .....+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++.........
T Consensus        85 ~~gg~L~~~l-~~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          85 CSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999998 455689999999999999999999999   999999999999999999999999999998775544443


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGIE  262 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (356)
                      .....+||+.|+|||++.+...++.++|||||||++|||++|+.||........      .+...        .......
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~~~--------~~~~~~~  226 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDW--------KEKKTYL  226 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH------HHHHH--------HTTCTTS
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH------HHHHH--------hcCCCCC
Confidence            445578999999999998763357889999999999999999999865433211      01111        1111112


Q ss_pred             chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          263 EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ......+.++.+++.+||+.||++|||++++++
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            223345677889999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-59  Score=406.48  Aligned_cols=266  Identities=31%  Similarity=0.474  Sum_probs=220.3

Q ss_pred             cceecHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           13 PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      |..-..|++...+|++.++||+|+||+||+|.+++++.||||+++.+  ....+.|.+|+.++++++||||+++++++.+
T Consensus         2 p~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~   79 (272)
T d1qpca_           2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ   79 (272)
T ss_dssp             CTTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence            44446678888899999999999999999999888889999999764  3445689999999999999999999998865


Q ss_pred             CCeeeEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           93 QHMTALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                      + ..++||||+++|+|.+++... ...+++..++.|+.||+.||.|||+   ++|+||||||+|||+++++.+||+|||+
T Consensus        80 ~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGl  155 (272)
T d1qpca_          80 E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGL  155 (272)
T ss_dssp             S-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             C-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccc
Confidence            4 568999999999999987443 3469999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhch
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSE  251 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  251 (356)
                      ++....... .......||+.|+|||++.+. .++.++|||||||++|||+||..|+......               ..
T Consensus       156 a~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~---------------~~  218 (272)
T d1qpca_         156 ARLIEDNEY-TAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---------------PE  218 (272)
T ss_dssp             CEECSSSCE-ECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------------HH
T ss_pred             eEEccCCcc-ccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH---------------HH
Confidence            987654322 223446789999999999866 6899999999999999999977665433221               11


Q ss_pred             hhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          252 LDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      ....+..+.....+...+.++.+++.+||+.||++|||+++|++.|+.+.
T Consensus       219 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         219 VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            22223333344445567788999999999999999999999999998653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-58  Score=408.17  Aligned_cols=262  Identities=26%  Similarity=0.420  Sum_probs=208.7

Q ss_pred             HhhhhccccccccccCceEEEEEEeC-CC---cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFP-NG---VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      +...+|++.++||+|+||+||+|.+. ++   ..||||++.........++|.+|+.++++++||||+++++++.+....
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            34567888999999999999999864 23   358999988766666677899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      ++|||||++|+|.+++......+++.++..|+.||+.||.|||+   ++++||||||+|||++.++++||+|||+++...
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            99999999999999987777789999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCeee---eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchh
Q 038199          177 RNRSHVT---ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       177 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      .......   .....||+.|+|||.+.+. .++.++|||||||++|||+| |..||.....                ..+
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----------------~~~  242 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTN----------------QDV  242 (299)
T ss_dssp             ----------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHH
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCH----------------HHH
Confidence            4333222   2234578999999999876 78999999999999999998 7878743221                112


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ...+......+.+..++.++.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       243 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         243 INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            22333344445556677889999999999999999999999999988754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-58  Score=402.59  Aligned_cols=264  Identities=28%  Similarity=0.445  Sum_probs=213.9

Q ss_pred             HhhhhccccccccccCceEEEEEEeCC-C----cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           21 LNNFTSNYSTRLGFGGFGEVYKGQFPN-G----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        21 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      +...+|++.++||+|+||+||+|.+.+ +    ..||||++..........+|.+|+.++++++||||+++++++.+...
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            344578899999999999999997643 2    46999999876666666789999999999999999999999999999


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+.+++|.+++......+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence            999999999999999887777889999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ...... .......||..|+|||++.+. .++.++|||||||++|||++|..|+......               ..+..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---------------~~~~~  224 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN---------------HEVMK  224 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------------HHHHH
T ss_pred             cCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCH---------------HHHHH
Confidence            543222 223345689999999999877 7899999999999999999987765443221               12223


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      .+..+...+.+...+.++.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            3334444555566778899999999999999999999999999887653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=395.13  Aligned_cols=255  Identities=24%  Similarity=0.408  Sum_probs=218.0

Q ss_pred             hhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..+|++.++||+|+||+||+|++++++.||||+++..  ....+.|.+|+.++++++||||+++++++.++...++||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            4578999999999999999999988889999999865  34457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +++|+|..++......+++..+.+++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++........ 
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            99999999987777889999999999999999999999   99999999999999999999999999999876543322 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHhcCC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACGI  261 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (356)
                      ......||..|+|||.+.+. .++.++||||||+++|||+| |+.||....                ..++...+..+..
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~----------------~~~~~~~i~~~~~  219 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFT----------------NSETAEHIAQGLR  219 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----------------HHHHHHHHHTTCC
T ss_pred             eecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCC----------------HHHHHHHHHhCCC
Confidence            33446789999999999876 78999999999999999998 677764332                1222233334444


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      ...+...+.++.+++.+||+.||++|||+++|++.|..+
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            445556678899999999999999999999999998653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=399.32  Aligned_cols=259  Identities=27%  Similarity=0.375  Sum_probs=216.8

Q ss_pred             hhhhccccc-cccccCceEEEEEEeC---CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           22 NNFTSNYST-RLGFGGFGEVYKGQFP---NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        22 ~~~~~~~~~-~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      ....+.+.+ +||+|+||+||+|.+.   ++..||||+++........++|.+|++++++++||||+++++++.++ ..+
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~   84 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM   84 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence            345667777 4999999999999764   35579999998766666678899999999999999999999998754 578


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +||||+++|+|.+++...+..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            9999999999999986667789999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          178 NRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       178 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ...... .....||+.|+|||++.+. .++.++|||||||++|||+| |..||.....                .++...
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----------------~~~~~~  224 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----------------PEVMAF  224 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----------------HHHHHH
T ss_pred             cccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence            443322 2345689999999999876 78999999999999999998 8888754322                112223


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      +..+...+.+..++.++.+++.+||+.||++|||+.+|++.|+...
T Consensus       225 i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            3344445556677889999999999999999999999999997653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=408.64  Aligned_cols=261  Identities=25%  Similarity=0.341  Sum_probs=214.5

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCC-C-----cEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEe
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPN-G-----VKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCH   91 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~   91 (356)
                      |++...+|++.++||+|+||+||+|++.. +     ..||||++...........+.+|+.+++++ +||||+++++++.
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            56677889999999999999999997532 2     369999987654455557899999999998 8999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKK----------------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY  149 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  149 (356)
                      +.+..++|||||++|+|.+++....                      ..+++..++.|+.||+.||+|||+   ++||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeec
Confidence            9999999999999999999996542                      348999999999999999999999   999999


Q ss_pred             CCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCccc
Q 038199          150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNA  228 (356)
Q Consensus       150 dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~  228 (356)
                      ||||+||+++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||+| |..||
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCC
Confidence            99999999999999999999999877665555555566789999999999876 78999999999999999998 78887


Q ss_pred             ccCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 038199          229 IVGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLE  298 (356)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~  298 (356)
                      ......               ..+...+......+.+...+.++.+++.+||+.||++|||+++|++.|.
T Consensus       268 ~~~~~~---------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         268 PGIPVD---------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TTCCCS---------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCHH---------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            543321               1112222233334455567788999999999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=399.17  Aligned_cols=267  Identities=28%  Similarity=0.437  Sum_probs=215.8

Q ss_pred             cHHHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           17 TSLQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        17 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ..|++...+|++.+.||+|+||+||+|.+++++.||||+++..  ....+.|.+|+.++++++||||+++++++.++ ..
T Consensus        10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~   86 (285)
T d1fmka3          10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PI   86 (285)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEecC-Ce
Confidence            4567778899999999999999999999888888999999765  34457899999999999999999999998654 57


Q ss_pred             eEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           97 ALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      ++||||+++|+|..++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++++||+|||+++..
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhc
Confidence            8999999999999888543 4569999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|||++|..|+......               ......
T Consensus       164 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~---------------~~~~~~  226 (285)
T d1fmka3         164 EDNEYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------------REVLDQ  226 (285)
T ss_dssp             -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------------HHHHHH
T ss_pred             cCCCce-eeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH---------------HHHHHH
Confidence            433222 22345689999999999876 7899999999999999999987776544321               111222


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCCCC
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVLPP  306 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~  306 (356)
                      +......+.+...+.++.+++.+||+.||++||++++|++.|+.......|
T Consensus       227 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         227 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence            223333445566778899999999999999999999999999987665444

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=390.28  Aligned_cols=246  Identities=26%  Similarity=0.362  Sum_probs=206.2

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .+|++.+.||+|+||+||+|.+. +++.||||++....  .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57899999999999999999875 68999999986432  1234467899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |||++|+|.+++. ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus        86 Ey~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~  161 (263)
T d2j4za1          86 EYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  161 (263)
T ss_dssp             ECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred             eecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence            9999999999984 34679999999999999999999999   9999999999999999999999999999986554322


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                          ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....       ...+..+         ... 
T Consensus       162 ----~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i---------~~~-  219 (263)
T d2j4za1         162 ----TTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRI---------SRV-  219 (263)
T ss_dssp             ----EETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHH---------HTT-
T ss_pred             ----cccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHH---------HcC-
Confidence                235699999999999987 789999999999999999999999853321       1111111         111 


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ....+...+.++.+++.+||+.||++|||++++++
T Consensus       220 ~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            11223345678999999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-56  Score=393.66  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=207.4

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|++.++||+|+||+||+|.+ .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4799999999999999999976 469999999987542 23456799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      |+||+|.+++.  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++.......  
T Consensus        99 ~~gg~L~~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--  171 (293)
T d1yhwa1          99 LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (293)
T ss_dssp             CTTCBHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             cCCCcHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence            99999999884  3579999999999999999999999   9999999999999999999999999999987654332  


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc-CC
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC-GI  261 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  261 (356)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......               .......... ..
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---------------~~~~~~~~~~~~~  235 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---------------RALYLIATNGTPE  235 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------HHHHHHHHHCSCC
T ss_pred             cccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHH---------------HHHHHHHhCCCCC
Confidence            22446799999999999876 7899999999999999999999998533210               0011111111 11


Q ss_pred             CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          262 EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...+...+.++.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2334556778999999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=392.35  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=197.1

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEec--CCeeeEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--QHMTALV   99 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~--~~~~~lV   99 (356)
                      .+|++.+.||+|+||+||+|++. +|+.||||++... ..+...+.+.+|++++++++||||+++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57899999999999999999764 6999999999754 244555779999999999999999999999865  4568999


Q ss_pred             EeccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199          100 YEYMENGSLDGYLFG---KKRAIEWEKLHEIAIGTAKGLVYLHEEC--QQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ||||+||+|.+++..   .+..+++..++.++.||+.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999853   3567999999999999999999999821  12499999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...+.                ..+..
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----------------~~~~~  224 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQ----------------KELAG  224 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHHHH
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCH----------------HHHHH
Confidence            654322  22346799999999999876 789999999999999999999999853221                11122


Q ss_pred             HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          255 TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .+........+...+.++.+++.+||+.||.+|||++++++
T Consensus       225 ~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         225 KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            23333334444566788999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=395.03  Aligned_cols=250  Identities=21%  Similarity=0.295  Sum_probs=204.9

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .+|++.+.||+|+||+||+|.+. +|+.||||++....  .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999764 69999999997432  2334467999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |||+||+|.+++. ..+.+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+++.......
T Consensus        88 Ey~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999884 45689999999999999999999999   9999999999999999999999999999988765544


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                      ........||+.|+|||++.+. .++.++|||||||++|||++|..||.....       ......         +....
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~---------i~~~~  226 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQK---------IIKLE  226 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH---------HHTTC
T ss_pred             ccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCH-------HHHHHH---------HHcCC
Confidence            4444556799999999999877 789999999999999999999999854321       111111         11111


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                       ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       227 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence             1223345677999999999999999999999754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=393.35  Aligned_cols=250  Identities=24%  Similarity=0.334  Sum_probs=206.9

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      ..|++.++||+|+||+||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            35899999999999999999764 69999999997542 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      |+||+|.+++....+.+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~  165 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  165 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence            99999999986666789999999999999999999999   999999999999999999999999999997543221  1


Q ss_pred             eeccCCCCCCCCCcccccC----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          183 TISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      ......||+.|+|||++..    ...++.++|||||||++|||++|+.||......                .....+..
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----------------~~~~~i~~  229 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM----------------RVLLKIAK  229 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG----------------GHHHHHHH
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH----------------HHHHHHHc
Confidence            1234679999999999842    225789999999999999999999998543221                01111111


Q ss_pred             c--CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          259 C--GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       259 ~--~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .  .....+...+.++.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1  122334556788999999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=402.37  Aligned_cols=268  Identities=23%  Similarity=0.322  Sum_probs=209.7

Q ss_pred             HHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           20 QLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        20 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      |+...+|++.++||+|+||+||+|.+. +|+.||+|+++.........++.+|+.++++++||||+++++++.+....++
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456788999999999999999999764 6999999999866555666789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||||++||+|.+++.+ ...+++..+..++.|++.||.|||+.  ++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        82 VmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            9999999999999853 45799999999999999999999971  48999999999999999999999999999876432


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhh----------HHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHV----------WEEYE  248 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~  248 (356)
                      .    ....+||..|+|||++.+. .++.++||||+||++|||++|+.||...............          .....
T Consensus       159 ~----~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         159 M----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             T----C---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             c----cccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            2    2335799999999999987 7999999999999999999999999765432110000000          00000


Q ss_pred             -------------hc---hhhHHHHhcCCC-chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          249 -------------KS---ELDATILACGIE-EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       249 -------------~~---~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                                   ..   ...........+ ......+.++.+++.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                         00   000000000000 011123467899999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-56  Score=389.83  Aligned_cols=253  Identities=26%  Similarity=0.366  Sum_probs=205.1

Q ss_pred             cccc-ccccccCceEEEEEEeC---CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           26 SNYS-TRLGFGGFGEVYKGQFP---NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        26 ~~~~-~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      +.+. ++||+|+||+||+|.+.   .++.||||+++... .....+++.+|+.++++++||||+++++++.++ ..++||
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvm   86 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVM   86 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEE
Confidence            3444 57999999999999753   35789999997543 234456899999999999999999999999654 568999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+++|+|.+++. ....+++..++.|+.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        87 E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          87 EMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             ECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EcCCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            9999999999984 45679999999999999999999999   9999999999999999999999999999987765444


Q ss_pred             eee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          181 HVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       181 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      ... .....||+.|+|||.+.+. .++.++|||||||++|||+| |+.||....                ..++...+..
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----------------~~~~~~~i~~  225 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----------------GSEVTAMLEK  225 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----------------HHHHHHHHHT
T ss_pred             ccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCC----------------HHHHHHHHHc
Confidence            332 2345689999999999876 68999999999999999998 788875322                1122233334


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      +...+.+..++.++.+++.+||+.||++|||+++|++.|+..
T Consensus       226 ~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            444555566788899999999999999999999999988753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=383.87  Aligned_cols=245  Identities=25%  Similarity=0.402  Sum_probs=198.8

Q ss_pred             ccccccccccCceEEEEEEeC-CCcEEEEEEeccc-cchhhHHHHHHHHHHHccCCCCceeeeeceEec----CCeeeEE
Q 038199           26 SNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRN-LGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD----QHMTALV   99 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~----~~~~~lV   99 (356)
                      |++.++||+|+||+||+|.+. +++.||+|++... ......+.+.+|++++++++||||+++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            478899999999999999764 6899999998753 234555789999999999999999999999865    3467899


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ccccCCCCCcEEEc-CCCceEEcccCCccccC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLD-ANFSPKVADFGLAKLCD  176 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dikp~Nill~-~~~~~kl~Dfgl~~~~~  176 (356)
                      |||+++|+|.+++. ....+++..+..|+.||+.||+|||+   ++  |+||||||+|||++ .++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHh-ccccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999984 34679999999999999999999998   77  99999999999996 57899999999998654


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATI  256 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (356)
                      ....    ....||+.|+|||++.+  .++.++|||||||++|||++|+.||......      ...+         ..+
T Consensus       167 ~~~~----~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~---------~~i  225 (270)
T d1t4ha_         167 ASFA----KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIY---------RRV  225 (270)
T ss_dssp             TTSB----EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHH---------HHH
T ss_pred             CCcc----CCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHH---------HHH
Confidence            3322    23579999999999875  4899999999999999999999998533221      1111         111


Q ss_pred             HhcCCC-chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          257 LACGIE-EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       257 ~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....+ ..+...+.++.+++.+||+.||++|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111111 223334567899999999999999999999985

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-56  Score=389.59  Aligned_cols=261  Identities=22%  Similarity=0.313  Sum_probs=207.9

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCC----CcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPN----GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH   94 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   94 (356)
                      |++...+|++.+.||+|+||+||+|.+..    +..||||+++........+.+.+|+.++++++||||+++++++.+ .
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~   80 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N   80 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            45667889999999999999999997642    356899998766556666789999999999999999999999964 5


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+++|+|.+++......+++..++.++.||+.||.|||+   ++++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhee
Confidence            6899999999999999887777889999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ....... ......||+.|+|||++.+. .++.++|||||||++|||++ |..|+.....                ..+.
T Consensus       158 ~~~~~~~-~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~----------------~~~~  219 (273)
T d1mp8a_         158 MEDSTYY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKN----------------NDVI  219 (273)
T ss_dssp             --------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----------------GGHH
T ss_pred             ccCCcce-eccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCH----------------HHHH
Confidence            6543222 22345689999999999876 78999999999999999998 6777644322                1222


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      ..+..+...+.+...+.++.+++.+||+.||++|||+++|++.|+.+.
T Consensus       220 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         220 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            233334444556667788999999999999999999999999998764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-56  Score=395.61  Aligned_cols=264  Identities=25%  Similarity=0.379  Sum_probs=218.1

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD   92 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~   92 (356)
                      +|+....|++.+.||+|+||+||+|++.      +++.||||+++........++|.+|+.++++++||||+++++++.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            4444567899999999999999999753      3578999999876555566789999999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGK-----------------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHY  149 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  149 (356)
                      ....++||||+.+|+|.+++...                       ...+++..++.|+.|++.||+|||+   +++|||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEee
Confidence            99999999999999999998532                       2348999999999999999999999   999999


Q ss_pred             CCCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccc
Q 038199          150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAI  229 (356)
Q Consensus       150 dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~  229 (356)
                      ||||+|||++.++.+||+|||+++...............|++.|+|||.+.+. .++.++|||||||++|||++|..|..
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999876544433344456788999999999877 79999999999999999999975432


Q ss_pred             cCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          230 VGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      .+..               ..++...+.....++.+...+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus       244 ~~~~---------------~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMA---------------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSC---------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCC---------------HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            2221               12222334444455556667788999999999999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-55  Score=391.25  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=191.5

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      ...|++.+.||+|+||+||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++.++...++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            456999999999999999999765 6899999999765434445678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc---CCCceEEcccCCccccCCC
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~---~~~~~kl~Dfgl~~~~~~~  178 (356)
                      ||+||+|.+++. ....+++..+..++.||+.||+|||+   ++|+||||||+||++.   +++.+||+|||+++.....
T Consensus        88 ~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999994 45689999999999999999999999   9999999999999994   5789999999999865433


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                      .   .....+||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..+         ..+..
T Consensus       164 ~---~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~---------~~i~~  223 (307)
T d1a06a_         164 S---VLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLF---------EQILK  223 (307)
T ss_dssp             ------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHH---------HHHHT
T ss_pred             C---eeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------HHH---------HHHhc
Confidence            2   22345799999999999877 7899999999999999999999998543211       111         11111


Q ss_pred             cCC---CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          259 CGI---EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       259 ~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ...   .+.....+.++.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111   1223456678999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-56  Score=394.45  Aligned_cols=270  Identities=24%  Similarity=0.342  Sum_probs=210.4

Q ss_pred             ceecHHHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeee
Q 038199           14 VRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRL   86 (356)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~   86 (356)
                      .+...|++...+|++.++||+|+||+||+|.+.      +++.||||+++........+.+.+|...+.++ +|+||+.+
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            344567788889999999999999999999752      35689999998665556667788888888887 68999999


Q ss_pred             eceEecC-CeeeEEEeccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccC
Q 038199           87 YGFCHDQ-HMTALVYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD  150 (356)
Q Consensus        87 ~~~~~~~-~~~~lV~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~d  150 (356)
                      ++++.+. ...++|||||++|+|.+++...               ...+++..+..++.||+.||.|||+   ++|+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCc
Confidence            9987654 5689999999999999998543               2358999999999999999999999   9999999


Q ss_pred             CCCCcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCc-ccc
Q 038199          151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRR-NAI  229 (356)
Q Consensus       151 ikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~-p~~  229 (356)
                      |||+|||++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||+||.. |+.
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999876555444444556799999999999876 78999999999999999999865 443


Q ss_pred             cCCCCccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          230 VGSSESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .....               ..+...+..+.....+...+.++.+++.+||+.||++|||+++|++.|+.+..
T Consensus       239 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         239 GVKID---------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             TCCCS---------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHH---------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            22211               11122223333444455567789999999999999999999999999987753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-54  Score=393.52  Aligned_cols=264  Identities=20%  Similarity=0.289  Sum_probs=216.1

Q ss_pred             CcceecHHHHhhhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceE
Q 038199           12 KPVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFC   90 (356)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~   90 (356)
                      +|+....+.+ ...|++.+.||+|+||+||+|.+ .+|+.||||+++... ......+.+|+.++++++||||+++++++
T Consensus        18 ~p~~~~~~~~-~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   95 (352)
T d1koba_          18 QPVEVKQGSV-YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAF   95 (352)
T ss_dssp             CCCCCBCSCG-GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred             CCccCCCCCc-ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3555544444 35799999999999999999976 479999999997643 34456788999999999999999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc--CCCceEEcc
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVAD  168 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~--~~~~~kl~D  168 (356)
                      .++...++|||||+||+|.+++.....++++..+..|+.||+.||.|||+   ++|+||||||+|||++  .++.+||+|
T Consensus        96 ~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~D  172 (352)
T d1koba_          96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIID  172 (352)
T ss_dssp             ECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             EECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEee
Confidence            99999999999999999998886666789999999999999999999999   9999999999999997  678999999


Q ss_pred             cCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh
Q 038199          169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE  248 (356)
Q Consensus       169 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  248 (356)
                      ||++.........   ....||+.|+|||++.+. .++.++|||||||++|||+||..||......              
T Consensus       173 FGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------------  234 (352)
T d1koba_         173 FGLATKLNPDEIV---KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------------  234 (352)
T ss_dssp             CTTCEECCTTSCE---EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------------
T ss_pred             cccceecCCCCce---eeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------------
Confidence            9999887654333   234589999999999877 7999999999999999999999998543211              


Q ss_pred             hchhhHHHHhcC---CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhcc
Q 038199          249 KSELDATILACG---IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM--LEGV  300 (356)
Q Consensus       249 ~~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~--L~~~  300 (356)
                        .....+....   ........+.++.+++.+||+.||.+|||++++++.  +...
T Consensus       235 --~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         235 --ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             --HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             --HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence              0111111111   122334567789999999999999999999999873  5443

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-55  Score=390.84  Aligned_cols=247  Identities=24%  Similarity=0.329  Sum_probs=203.2

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      ..|+..++||+|+||+||+|.+ .+|+.||||++....  .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4588899999999999999976 468999999997543  2344467899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |||.+|+|..++ ....++++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  
T Consensus        95 E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          95 EYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             ECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            999999987665 345689999999999999999999999   99999999999999999999999999999865432  


Q ss_pred             eeeeccCCCCCCCCCcccccCC--CCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHh
Q 038199          181 HVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILA  258 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (356)
                          ....||+.|+|||++.+.  ..++.++|||||||++|||++|..||......          +     ........
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----------~-----~~~~i~~~  229 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------S-----ALYHIAQN  229 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------H-----HHHHHHHS
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH----------H-----HHHHHHhC
Confidence                235699999999998642  25889999999999999999999997532210          0     01111111


Q ss_pred             cCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          259 CGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..........+.++.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1112223345678999999999999999999999987

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-54  Score=391.86  Aligned_cols=259  Identities=22%  Similarity=0.301  Sum_probs=213.9

Q ss_pred             cceecHHHHhhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           13 PVRFTSLQLNNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      |..+....+. .+|++.+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.
T Consensus        16 p~~l~~~~il-~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   93 (350)
T d1koaa2          16 PVEIKHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFE   93 (350)
T ss_dssp             CCCCBCSCGG-GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CCcCCCCCCc-cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4455444433 57999999999999999999764 69999999997543 345578999999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEc--CCCceEEccc
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADF  169 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~--~~~~~kl~Df  169 (356)
                      +.+..++|||||+||+|.+++......+++..+..|+.||+.||.|||+   +++|||||||+|||++  .++.+||+||
T Consensus        94 ~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DF  170 (350)
T d1koaa2          94 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDF  170 (350)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeec
Confidence            9999999999999999999996666789999999999999999999999   9999999999999995  4578999999


Q ss_pred             CCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       170 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      |+++........   ....||+.|+|||++.+. .++.++|||||||++|||++|..||......       ...     
T Consensus       171 G~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~-----  234 (350)
T d1koaa2         171 GLTAHLDPKQSV---KVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETL-----  234 (350)
T ss_dssp             TTCEECCTTSCE---EEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHH-----
T ss_pred             chheeccccccc---ceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-------HHH-----
Confidence            999877654433   235689999999999877 7899999999999999999999998543211       011     


Q ss_pred             chhhHHHHhcC---CCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          250 SELDATILACG---IEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       250 ~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                          ..+....   ........+.++.+++.+||+.||++|||++++++.
T Consensus       235 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         235 ----RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ----HHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ----HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                1111111   122334556789999999999999999999999984

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-55  Score=391.37  Aligned_cols=258  Identities=24%  Similarity=0.351  Sum_probs=209.6

Q ss_pred             hhccccccccccCceEEEEEEeC-CCc----EEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGV----KIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~l   98 (356)
                      .+|++.++||+|+||+||+|.+. +|+    .||+|++.........+++.+|+.++++++||||+++++++.++. .++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            46899999999999999999764 454    588998876555566678999999999999999999999998764 578


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      +++++.+++|.+++......+++..++.|+.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            889999999999887778899999999999999999999999   99999999999999999999999999999987655


Q ss_pred             CCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ..........||+.|+|||++.+. .++.++|||||||++|||+| |..|+....                ...+...+.
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~----------------~~~~~~~i~  227 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------------ASEISSILE  227 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----------------GGGHHHHHH
T ss_pred             cccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCC----------------HHHHHHHHH
Confidence            544444556789999999999877 78999999999999999999 566653221                222333344


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .+...+.+..++.++.+++.+||+.||++|||+.+|++.|..+..
T Consensus       228 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            444455566677889999999999999999999999999887643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=390.58  Aligned_cols=267  Identities=24%  Similarity=0.368  Sum_probs=224.8

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEe------CCCcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceE
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQF------PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFC   90 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~   90 (356)
                      .|++...+|+++++||+|+||.||+|++      .+++.||||+++..........+.+|+.+++++ +||||+++++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            4788889999999999999999999974      246789999998765566667899999999999 699999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCC
Q 038199           91 HDQHMTALVYEYMENGSLDGYLFGK-----------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP  153 (356)
Q Consensus        91 ~~~~~~~lV~e~~~~~sL~~~l~~~-----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp  153 (356)
                      .+....++|||||++|+|.+++...                 ...+++..+..++.||+.||+|||+   ++++||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccc
Confidence            9999999999999999999998543                 2358999999999999999999999   9999999999


Q ss_pred             CcEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCC
Q 038199          154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSS  233 (356)
Q Consensus       154 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~  233 (356)
                      +||+++.++.++++|||+++...............||+.|+|||.+.+. .++.++|||||||++|||+|++.|+.....
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987766555555667899999999999876 789999999999999999996666544332


Q ss_pred             CccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          234 ESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      .              ...+...+..+..+..+...+.++.+|+.+||+.||.+|||+++|+++|++...
T Consensus       253 ~--------------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         253 V--------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             S--------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H--------------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            2              111222333334444455567889999999999999999999999999987543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=382.92  Aligned_cols=254  Identities=26%  Similarity=0.381  Sum_probs=204.8

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec-CCeee
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTA   97 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~-~~~~~   97 (356)
                      |++...+|++.++||+|+||.||+|++ +|+.||||+++.+   ...+.+.+|++++++++||||++++|++.+ ....+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            456677899999999999999999998 5789999999764   345679999999999999999999999865 45679


Q ss_pred             EEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccC
Q 038199           98 LVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD  176 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~  176 (356)
                      +||||+++|+|.+++... ...+++..++.|+.||+.||.|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecC
Confidence            999999999999999543 3459999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      ...     ....+|..|+|||++.+. .++.++||||||+++|||+| |..|+....                ...+...
T Consensus       155 ~~~-----~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~----------------~~~~~~~  212 (262)
T d1byga_         155 STQ-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIP----------------LKDVVPR  212 (262)
T ss_dssp             ------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----------------GGGHHHH
T ss_pred             CCC-----ccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCC----------------HHHHHHH
Confidence            322     223578999999999876 78999999999999999998 555543221                1122223


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVV  301 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~  301 (356)
                      +..+..++.+...+.++.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       213 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            3334445566667788999999999999999999999999998764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=385.59  Aligned_cols=262  Identities=27%  Similarity=0.409  Sum_probs=215.1

Q ss_pred             hhhccccccccccCceEEEEEEeCC--C--cEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec-CCeee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPN--G--VKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD-QHMTA   97 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~-~~~~~   97 (356)
                      ..+++|.++||+|+||+||+|.+.+  +  ..||||+++........++|.+|++++++++||||++++|++.+ +...+
T Consensus        26 ~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             HceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            4455678899999999999998643  2  35899999865556667889999999999999999999999875 45789


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +|||||++++|.+++......+++..+++++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            9999999999999997777889999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCee--eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHH
Q 038199          178 NRSHV--TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDAT  255 (356)
Q Consensus       178 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (356)
                      .....  ......||..|+|||.+.+. .++.++||||||+++|||+||+.|+......               ......
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---------------~~~~~~  246 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---------------FDITVY  246 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC---------------------CHHH
T ss_pred             cccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCH---------------HHHHHH
Confidence            33221  22345689999999998876 7899999999999999999988876543221               112222


Q ss_pred             HHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          256 ILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                      +..+.....+...+.++.+++.+||+.||++||++.+|++.|+++...
T Consensus       247 i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            333334444455677899999999999999999999999999988754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-55  Score=388.70  Aligned_cols=264  Identities=26%  Similarity=0.357  Sum_probs=218.3

Q ss_pred             HHHhhhhccccccccccCceEEEEEEeCC--------CcEEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeece
Q 038199           19 LQLNNFTSNYSTRLGFGGFGEVYKGQFPN--------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGF   89 (356)
Q Consensus        19 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~   89 (356)
                      |++....|++++.||+|+||.||+|+...        +..||||+++.+........+.+|...+.++ +||||++++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            77888999999999999999999997522        2479999998877667778899999999988 79999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCC
Q 038199           90 CHDQHMTALVYEYMENGSLDGYLFGKK---------------RAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE  154 (356)
Q Consensus        90 ~~~~~~~~lV~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~  154 (356)
                      +.++...++||||+++|+|.+++....               ..+++.+++.++.||+.||+|||+   .++|||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccc
Confidence            999999999999999999999995442               458999999999999999999999   99999999999


Q ss_pred             cEEEcCCCceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCC
Q 038199          155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSS  233 (356)
Q Consensus       155 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~  233 (356)
                      |||++.++.+||+|||+++...............||+.|+|||.+.+. .++.++|||||||++|||++ |..|+.....
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            999999999999999999987655554445556789999999999876 79999999999999999998 5656532211


Q ss_pred             CccccchhhhHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          234 ESLDWFPKHVWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                                      ..+...+..+.....+...+.++.+++.+||+.||++|||+.+|++.|+++..
T Consensus       244 ----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 ----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ----------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                            11222333444455556677889999999999999999999999999988754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=387.54  Aligned_cols=266  Identities=24%  Similarity=0.364  Sum_probs=222.9

Q ss_pred             HHHHhhhhccccccccccCceEEEEEEeC------CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEe
Q 038199           18 SLQLNNFTSNYSTRLGFGGFGEVYKGQFP------NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCH   91 (356)
Q Consensus        18 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   91 (356)
                      -|++...+|++.++||+|+||+||+|.+.      +++.||||+++..........+.+|+.++++++||||+++++++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            36778889999999999999999999752      257899999986655666678999999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC
Q 038199           92 DQHMTALVYEYMENGSLDGYLFGK---------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF  162 (356)
Q Consensus        92 ~~~~~~lV~e~~~~~sL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~  162 (356)
                      .....++||||+.+|+|.+++...         ...+++..+..++.|++.||.|||+   ++|+||||||+|||+++++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCc
Confidence            999999999999999999988432         2457999999999999999999999   9999999999999999999


Q ss_pred             ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh
Q 038199          163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH  242 (356)
Q Consensus       163 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~  242 (356)
                      ++||+|||+++...............||+.|+|||.+.+. .++.++||||||+++|||+||..++..+..         
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---------  240 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------  240 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---------
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCC---------
Confidence            9999999999877655444444556789999999999877 789999999999999999998644322211         


Q ss_pred             hHHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          243 VWEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                            ..+....+..+...+.+..++..+.+++.+||+.||++|||+++|++.|++..+
T Consensus       241 ------~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         241 ------NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ------HHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                  122223333444555556677889999999999999999999999999987644

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=377.34  Aligned_cols=249  Identities=23%  Similarity=0.350  Sum_probs=206.0

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-----chhhHHHHHHHHHHHccCCCCceeeeeceEecCCee
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-----GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMT   96 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   96 (356)
                      ..+|++.+.||+|+||+||+|.+ .+|+.||||++....     .....+.+.+|+.++++++||||+++++++.+....
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999986 469999999986432     123457899999999999999999999999999999


Q ss_pred             eEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC----ceEEcccCCc
Q 038199           97 ALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLA  172 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----~~kl~Dfgl~  172 (356)
                      ++|||||+||+|.+++.. .+.+++..+..++.|++.||+|||+   .+|+||||||+||+++.++    .+||+|||++
T Consensus        89 ~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999843 4579999999999999999999999   9999999999999998776    4999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      ........   .....||+.|+|||++.+. .++.++|||||||++|||++|..||......       ..+.       
T Consensus       165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~-------  226 (293)
T d1jksa_         165 HKIDFGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLA-------  226 (293)
T ss_dssp             EECTTSCB---CSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH-------
T ss_pred             hhcCCCcc---ccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------HHHH-------
Confidence            87654332   2345689999999999876 7899999999999999999999998543211       1111       


Q ss_pred             hHHHHhcCCC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 DATILACGIE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 ~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                        .+......   ......+.++.+++.+||+.||++|||++++++
T Consensus       227 --~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         227 --NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --HHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --HHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              11111111   122345677899999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=380.75  Aligned_cols=259  Identities=27%  Similarity=0.386  Sum_probs=202.0

Q ss_pred             hhhhccccccccccCceEEEEEEeC--CC--cEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCe
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP--NG--VKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHM   95 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   95 (356)
                      ...+|++.+.||+|+||+||+|++.  ++  ..||||+++...  .....+.|.+|+.++++++||||+++++++.+. .
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~   84 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P   84 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence            3567999999999999999999752  23  478999987542  234446899999999999999999999999765 5


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++||||+++++|.+++......+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            789999999999999887667789999999999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCCeee-eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHh-CCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          176 DRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVG-RRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       176 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ........ .....|+..|+|||.+.+. .++.++||||||+++|||+| |..||......               ....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---------------~~~~  225 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------------QILH  225 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------------HHHH
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---------------HHHH
Confidence            65544332 2334578899999999876 78999999999999999998 78886432210               0111


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGV  300 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~  300 (356)
                      .........+.+...+.++.+++.+||+.||++|||+.+|++.|+..
T Consensus       226 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         226 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11222333444556678899999999999999999999999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=381.66  Aligned_cols=249  Identities=25%  Similarity=0.301  Sum_probs=207.8

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      -.+|++.+.||+|+||.||+|++ .+|+.||||++++..  .....+++.+|+.++++++||||+++++++.+....++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            35799999999999999999976 479999999997532  223456789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      ||||+||+|..++. ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+++......
T Consensus        84 ~ey~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999884 45679999999999999999999999   999999999999999999999999999998654332


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      .  .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||......                .+.......
T Consensus       160 ~--~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----------------~~~~~i~~~  220 (337)
T d1o6la_         160 A--TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------RLFELILME  220 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHC
T ss_pred             c--ccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHH----------------HHHHHHhcC
Confidence            2  23446799999999999887 7999999999999999999999998643321                111111121


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      . ...+...+.++.+++.+||++||.+||+     ++++++
T Consensus       221 ~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         221 E-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C-CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1 2334456778899999999999999995     778876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-54  Score=383.06  Aligned_cols=259  Identities=24%  Similarity=0.384  Sum_probs=208.5

Q ss_pred             hhhccccccccccCceEEEEEEeC-CCc--EEEEEEeccccchhhHHHHHHHHHHHccC-CCCceeeeeceEecCCeeeE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFP-NGV--KIAVKVLNRNLGRIAEEQFMAEVGTIGRT-YHINLVRLYGFCHDQHMTAL   98 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~l   98 (356)
                      ...|++.++||+|+||+||+|.+. +|.  .||||.+.........+.+.+|+++++++ +||||+++++++.++...++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            367888999999999999999764 444  47888876544445556899999999998 79999999999999999999


Q ss_pred             EEeccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCc
Q 038199           99 VYEYMENGSLDGYLFGK---------------KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS  163 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~  163 (356)
                      ||||+++|+|.+++...               ...+++..+..++.||+.||.|||+   ++++||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence            99999999999998543               3679999999999999999999999   99999999999999999999


Q ss_pred             eEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhh
Q 038199          164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHV  243 (356)
Q Consensus       164 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~  243 (356)
                      +||+|||+++.......   .....||..|+|||.+.+. .++.++|||||||++|||++|..|+..+..          
T Consensus       166 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~----------  231 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----------  231 (309)
T ss_dssp             EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCC----------
T ss_pred             eEEcccccccccccccc---ccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCC----------
Confidence            99999999975442222   1234589999999999876 789999999999999999998764332221          


Q ss_pred             HHHHhhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccC
Q 038199          244 WEEYEKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEV  303 (356)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~  303 (356)
                           ...+...+..+.....+...+.++.+++.+||+.||++|||+++|++.|+++...
T Consensus       232 -----~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         232 -----CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             -----HHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -----HHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                 1122222333334455556778899999999999999999999999999988653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.7e-53  Score=377.41  Aligned_cols=245  Identities=26%  Similarity=0.315  Sum_probs=205.8

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .+|++.+.||+|+||+||+|++. +|+.||||+++...  .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46899999999999999999864 69999999997532  2234567899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |||.||+|..++ .....+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+++...... 
T Consensus        84 E~~~gg~l~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-  158 (316)
T d1fota_          84 DYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-  158 (316)
T ss_dssp             CCCCSCBHHHHH-HHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred             eecCCccccccc-cccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence            999999999888 355678999999999999999999999   999999999999999999999999999998765432 


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                          ...+||+.|+|||++.+. .++.++|||||||++|||++|+.||......                .....+....
T Consensus       159 ----~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~~~~i~~~~  217 (316)
T d1fota_         159 ----YTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------KTYEKILNAE  217 (316)
T ss_dssp             ----CCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHHCC
T ss_pred             ----ccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHH----------------HHHHHHHcCC
Confidence                345799999999999877 7899999999999999999999998543211                1111111211


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                       ...+...+.++.+++.+||..||.+|+     |++++++
T Consensus       218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence             223345567799999999999999996     8999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.3e-53  Score=373.75  Aligned_cols=259  Identities=24%  Similarity=0.345  Sum_probs=202.9

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCC----e
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----M   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~----~   95 (356)
                      ..+|++.+.||+|+||+||+|.+ .+|+.||||+++...  ......++.+|+.++++++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999976 479999999997543  2344567999999999999999999999987643    4


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .|+||||++|++|..++. ..+.+++.++..|+.||+.||+|||+   ++|+||||||+|||++.++.++++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999998884 34679999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhH
Q 038199          176 DRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDA  254 (356)
Q Consensus       176 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (356)
                      ...... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||......      ...+         .
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~---------~  225 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAY---------Q  225 (277)
T ss_dssp             C----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH---------H
T ss_pred             ccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHH---------H
Confidence            433322 223446799999999999876 7899999999999999999999998543211      1111         1


Q ss_pred             HHHhcCCC--chhHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhccc
Q 038199          255 TILACGIE--EKDKEKAKRLCMAALWCVQDSPEDRP-PMSAVVKMLEGVV  301 (356)
Q Consensus       255 ~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~v~~~L~~~~  301 (356)
                      .+......  ......+.++.+++.+||+.||++|| |++++++.|.++.
T Consensus       226 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         226 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            11111111  12234567899999999999999999 8999999887764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=375.11  Aligned_cols=247  Identities=16%  Similarity=0.231  Sum_probs=205.8

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|++.+.||+|+||+||+|.+. +|+.||||+++..  ......+.+|+++|++++||||+++++++.+.+..|+||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            56899999999999999999764 6899999999865  34445788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCC--CceEEcccCCccccCCCCC
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN--FSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~--~~~kl~Dfgl~~~~~~~~~  180 (356)
                      |+|++|.+++...+..+++.++..|+.||+.||+|||+   .+|+||||||+|||++.+  +.+||+|||+++.......
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            99999999996666689999999999999999999999   999999999999999754  5899999999987654332


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                      .   ....||+.|+|||.+.+. .++.++|||||||++|+|++|..||......                .....+....
T Consensus       160 ~---~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~----------------~~~~~i~~~~  219 (321)
T d1tkia_         160 F---RLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQ----------------QIIENIMNAE  219 (321)
T ss_dssp             E---EEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHHTC
T ss_pred             c---cccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCC
Confidence            2   234589999999999877 7899999999999999999999998543221                1111111111


Q ss_pred             CC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          261 IE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       261 ~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..   ......+.++.+++.+||..||++|||++++++
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11   111235677899999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=377.08  Aligned_cols=274  Identities=25%  Similarity=0.319  Sum_probs=204.4

Q ss_pred             hhhccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC----eeeE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----MTAL   98 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~----~~~l   98 (356)
                      ..+|.+.++||+|+||+||+|++ +|+.||||+++..  .........|+..+.+++||||+++++++.+..    ..++
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~--~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            35788899999999999999987 7889999999753  222222334555666789999999999998653    5789


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-----QQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ||||+++|+|.+++++  .++++..+++++.|++.||.|||+..     .++|+||||||+|||++.++.+||+|||+++
T Consensus        79 v~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999999999999954  47999999999999999999999621     2699999999999999999999999999998


Q ss_pred             ccCCCCCee--eeccCCCCCCCCCcccccCCC-----CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH
Q 038199          174 LCDRNRSHV--TISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE  246 (356)
Q Consensus       174 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  246 (356)
                      .........  ......||+.|+|||++.+..     .++.++|||||||++|||+||..|+.........+...... .
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~-~  235 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS-D  235 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS-S
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc-c
Confidence            876544332  233467999999999987542     25778999999999999999988876544332221110000 0


Q ss_pred             HhhchhhHHHHhcCC------CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          247 YEKSELDATILACGI------EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ...............      .......+..+.+++.+||+.||++|||+.+|++.|+++..
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            000011111111111      11234466779999999999999999999999999987753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-52  Score=377.10  Aligned_cols=245  Identities=21%  Similarity=0.230  Sum_probs=205.4

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      .+|++.++||+|+||+||+|.+. +|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999764 69999999986432  2233467899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCC
Q 038199          101 EYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS  180 (356)
Q Consensus       101 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~  180 (356)
                      ||+.||+|..++. ..+.+++..+..++.||+.||.|||+   ++||||||||+|||++.+|.+||+|||+++...... 
T Consensus       121 e~~~~g~l~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             ECCTTCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             ccccccchhhhHh-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence            9999999999884 34579999999999999999999999   999999999999999999999999999998765332 


Q ss_pred             eeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhcC
Q 038199          181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILACG  260 (356)
Q Consensus       181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (356)
                          ....||+.|+|||++.+. .++.++|||||||++|||+||..||.....       ....         ..+....
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~---------~~i~~~~  254 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIY---------EKIVSGK  254 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH---------HHHHHCC
T ss_pred             ----ccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHH---------HHHhcCC
Confidence                235699999999999877 789999999999999999999999854321       1111         1111111


Q ss_pred             CCchhHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038199          261 IEEKDKEKAKRLCMAALWCVQDSPEDRP-----PMSAVVK  295 (356)
Q Consensus       261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~  295 (356)
                       ...+...+.++.+++.+||+.||.+|+     |++++++
T Consensus       255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence             223345667899999999999999994     8999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-52  Score=368.05  Aligned_cols=253  Identities=21%  Similarity=0.274  Sum_probs=206.5

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc--------hhhHHHHHHHHHHHccCC-CCceeeeeceEec
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG--------RIAEEQFMAEVGTIGRTY-HINLVRLYGFCHD   92 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~   92 (356)
                      ..+|++.+.||+|+||+||+|++ .+|+.||||++.....        ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            35799999999999999999976 4699999999865321        122346889999999997 9999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ++..|+||||++||+|.+++.. ...+++.++..++.||+.||+|||+   ++|+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence            9999999999999999999953 5689999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccC-----CCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSG-----NYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY  247 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  247 (356)
                      +.......   .....||..|+|||.+.+     ...++.++||||+||++|||++|+.||......       .....+
T Consensus       158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~i  227 (277)
T d1phka_         158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMI  227 (277)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHH
T ss_pred             eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHHH
Confidence            87654332   234579999999998752     335788999999999999999999998543211       111111


Q ss_pred             hhchhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 EKSELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .....      ..........+.++.+++.+||+.||++|||+++|++
T Consensus       228 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 MSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11100      0112233467788999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-52  Score=380.99  Aligned_cols=250  Identities=22%  Similarity=0.248  Sum_probs=201.7

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHH---HHHHHHHccCCCCceeeeeceEecCCeee
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQF---MAEVGTIGRTYHINLVRLYGFCHDQHMTA   97 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~---~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   97 (356)
                      .+|++.+.||+|+||+||+|++. +|+.||||++....  .......+   ..++.+++.++||||+++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999764 69999999986431  11112223   34577888889999999999999999999


Q ss_pred             EEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCC
Q 038199           98 LVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR  177 (356)
Q Consensus        98 lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~  177 (356)
                      +|||||+||+|.+++. ....+++..+..++.||+.||+|||+   +++|||||||+|||++.+|.+||+|||+++....
T Consensus        84 ivmE~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHH-hcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            9999999999999984 35678999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHH
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATIL  257 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (356)
                      ..    .....||+.|+|||++.+...++.++|||||||++|||+||..||.........       .      ..... 
T Consensus       160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~------~~~~~-  221 (364)
T d1omwa3         160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------E------IDRMT-  221 (364)
T ss_dssp             SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-------H------HHHHS-
T ss_pred             Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-------H------HHHhc-
Confidence            32    234579999999999976547899999999999999999999998654332110       0      00000 


Q ss_pred             hcCCCchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          258 ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      .......+...+.++.+++.+||+.||++|||     ++++++
T Consensus       222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         222 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11112233346678999999999999999999     688876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=374.05  Aligned_cols=248  Identities=24%  Similarity=0.304  Sum_probs=203.9

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc--chhhHHHHHHHHHHHc-cCCCCceeeeeceEecCCeeeEE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL--GRIAEEQFMAEVGTIG-RTYHINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~ni~~~~~~~~~~~~~~lV   99 (356)
                      .+|++.+.||+|+||+||+|++. +|+.||||++..+.  .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46899999999999999999764 69999999997532  2233456677777765 68999999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCC
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR  179 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~  179 (356)
                      |||++||+|.+++. ....+++..+..++.||+.||+|||+   ++++||||||+|||++.++.+||+|||+++......
T Consensus        82 mEy~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999984 45679999999999999999999999   999999999999999999999999999998655433


Q ss_pred             CeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhhHHHHhc
Q 038199          180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELDATILAC  259 (356)
Q Consensus       180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (356)
                      .  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......       ..+.         .+...
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~---------~i~~~  218 (320)
T d1xjda_         158 A--KTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFH---------SIRMD  218 (320)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH---------HHHHC
T ss_pred             c--cccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHH---------HHHcC
Confidence            2  23446799999999999987 7999999999999999999999998543221       1111         11111


Q ss_pred             CCCchhHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 038199          260 GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMS-AVVK  295 (356)
Q Consensus       260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-~v~~  295 (356)
                       ....+...+.++.+++.+||..||++||++. ++++
T Consensus       219 -~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 -NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence             1233445677899999999999999999996 6754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=368.35  Aligned_cols=258  Identities=23%  Similarity=0.250  Sum_probs=194.8

Q ss_pred             cccccccCceEEEEEEeC-CCcEEEEEEeccccchhh----HHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEecc
Q 038199           29 STRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIA----EEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        29 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      .++||+|+||+||+|.+. +|+.||||+++.......    ...+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999864 699999999975422111    246889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCeee
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT  183 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  183 (356)
                      .++++..+. .....+++..+..++.||+.||+|||+   ++++||||||+|||++.++.+||+|||+++........  
T Consensus        83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--  156 (299)
T d1ua2a_          83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--  156 (299)
T ss_dssp             SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--
T ss_pred             cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc--
Confidence            887776655 556789999999999999999999999   99999999999999999999999999999876543322  


Q ss_pred             eccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh---chhh------H
Q 038199          184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK---SELD------A  254 (356)
Q Consensus       184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~------~  254 (356)
                      .....||+.|+|||++.+...++.++|||||||++|||++|..||........  + ....+....   ....      .
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l-~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--L-TRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--H-HHHHHhcCCCChhhccchhccch
Confidence            23457999999999987665789999999999999999999988754322100  0 000000000   0000      0


Q ss_pred             HHHhcCCCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          255 TILACGIEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       255 ~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .......+.     .....+.++.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000000000     11233567899999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=364.89  Aligned_cols=266  Identities=21%  Similarity=0.266  Sum_probs=202.9

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc-hhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .+|++.++||+|+||+||+|.+ .+|+.||||+++.... ....+++.+|++++++++||||+++++++.++...++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4788999999999999999976 5699999999975422 2234678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      |+.++.+..........+++..+..++.|++.||.|||+   ++||||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence            997755544444456789999999999999999999999   9999999999999999999999999999987654332 


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHh------hchhhHH
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYE------KSELDAT  255 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  255 (356)
                       ......||+.|+|||.+.....++.++|||||||++|+|++|+.||.......      ..+....      .......
T Consensus       158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~------~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID------QLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCTTTSTTG
T ss_pred             -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH------HHHHHHHhcCCCchhhcccc
Confidence             22345699999999998776567899999999999999999999985432110      0000000      0000000


Q ss_pred             H--------HhcC-CC---chhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhcc
Q 038199          256 I--------LACG-IE---EKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM--LEGV  300 (356)
Q Consensus       256 ~--------~~~~-~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~--L~~~  300 (356)
                      .        .... ..   ......+.++.+++.+||+.||++|||++++++.  ++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            0        0000 00   0112334678899999999999999999999984  5444

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=369.37  Aligned_cols=250  Identities=22%  Similarity=0.275  Sum_probs=197.9

Q ss_pred             hhcccc-ccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHcc-CCCCceeeeeceEec----CCee
Q 038199           24 FTSNYS-TRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGR-TYHINLVRLYGFCHD----QHMT   96 (356)
Q Consensus        24 ~~~~~~-~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~ni~~~~~~~~~----~~~~   96 (356)
                      ..|.+. +.||+|+||+||+|.+ .+++.||||+++..      ..+.+|+.++.+ .+||||+++++++.+    ....
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            467775 5699999999999976 57999999999642      356789988765 489999999999875    4678


Q ss_pred             eEEEeccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---CCceEEcccCCc
Q 038199           97 ALVYEYMENGSLDGYLFGK-KRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLA  172 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfgl~  172 (356)
                      |+|||||+||+|.+++... ...+++..+..|+.||+.||.|||+   ++|+||||||+|||++.   .+.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence            9999999999999999654 3579999999999999999999999   99999999999999975   567999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      +.......   .....||+.|+|||++.+. .++.++|||||||++|+|+||+.||..........   .......... 
T Consensus       162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~-  233 (335)
T d2ozaa1         162 KETTSHNS---LTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQ-  233 (335)
T ss_dssp             EECCCCCC---CCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS-
T ss_pred             eeccCCCc---cccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCC-
Confidence            87654432   2345799999999999877 79999999999999999999999986543321100   0000000000 


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                           ...........+.++.+++.+||+.||++|||+.++++
T Consensus       234 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 -----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 00011223456778999999999999999999999988

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.4e-51  Score=359.51  Aligned_cols=263  Identities=21%  Similarity=0.256  Sum_probs=202.0

Q ss_pred             hhccccccccccCceEEEEEEeCCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEec
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYEY  102 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e~  102 (356)
                      .+|++.++||+|+||+||+|++++|+.||||++.... .....+++.+|+.++++++||||+++++++.+.+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            3789999999999999999998889999999997543 233346899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCee
Q 038199          103 MENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV  182 (356)
Q Consensus       103 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  182 (356)
                      +.++.+..+. ...+.+++..+..++.||+.||+|||+   .+||||||||+|||++.++.+||+|||++......... 
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  156 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-  156 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc-
Confidence            9876665554 566789999999999999999999999   99999999999999999999999999999876543322 


Q ss_pred             eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh---------chhh
Q 038199          183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK---------SELD  253 (356)
Q Consensus       183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~  253 (356)
                       .....|++.|+|||.+.+...++.++|||||||++|||++|+.||........  + ...+.....         ....
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~-~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--L-MRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCCTTTSTTGGGST
T ss_pred             -cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--H-HHHHHhhCCCChhhccchhhhh
Confidence             23345899999999998765789999999999999999999999854321100  0 000000000         0000


Q ss_pred             HH---H---HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          254 AT---I---LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       254 ~~---~---~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..   .   ............+.++.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   0   000001112334567889999999999999999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-52  Score=362.41  Aligned_cols=242  Identities=22%  Similarity=0.325  Sum_probs=196.9

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccc-----hhhHHHHHHHHHHHccCC--CCceeeeeceEecCC
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLG-----RIAEEQFMAEVGTIGRTY--HINLVRLYGFCHDQH   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~~   94 (356)
                      ..+|++++.||+|+||+||+|.+ .+|+.||||++.....     .....++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            45799999999999999999976 4799999999864321     111234678999999986  899999999999999


Q ss_pred             eeeEEEeccCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-CCceEEcccCCc
Q 038199           95 MTALVYEYMEN-GSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLA  172 (356)
Q Consensus        95 ~~~lV~e~~~~-~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-~~~~kl~Dfgl~  172 (356)
                      ..++|||++.+ +++.+++. ....+++..+..++.||+.||+|||+   ++|+||||||+|||++. ++.+||+|||++
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 57777763 45679999999999999999999999   99999999999999985 479999999999


Q ss_pred             cccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchh
Q 038199          173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSEL  252 (356)
Q Consensus       173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  252 (356)
                      +......    .....||+.|+|||++.+...++.++|||||||++|||++|+.||...             +..     
T Consensus       159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------------~~i-----  216 (273)
T d1xwsa_         159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------------EEI-----  216 (273)
T ss_dssp             EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------------HHH-----
T ss_pred             eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------------hHH-----
Confidence            8654332    234579999999999986644577899999999999999999997421             000     


Q ss_pred             hHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          253 DATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          ... ....+...+.++.+++.+||+.||++|||++++++
T Consensus       217 ----~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         217 ----IRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ----HHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----hhc-ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                011 11122345677899999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-50  Score=357.71  Aligned_cols=266  Identities=18%  Similarity=0.204  Sum_probs=212.0

Q ss_pred             hhhhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEE
Q 038199           22 NNFTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        22 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV   99 (356)
                      ...+|++.++||+|+||+||+|++. +|+.||||+++...   ....+.+|++.++.+. |+|++.+++++.++...++|
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            3467999999999999999999764 69999999986542   2245778999999996 48999999999999999999


Q ss_pred             EeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC-----CCceEEcccCCccc
Q 038199          100 YEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-----NFSPKVADFGLAKL  174 (356)
Q Consensus       100 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~-----~~~~kl~Dfgl~~~  174 (356)
                      |||+ +++|.+++......++..++..++.|++.||+|||+   ++|+||||||+|||++.     ++.++|+|||+++.
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9999 679999987777889999999999999999999999   99999999999999964     57899999999988


Q ss_pred             cCCCCCee-----eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh
Q 038199          175 CDRNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK  249 (356)
Q Consensus       175 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  249 (356)
                      +.......     ......||+.|+|||++.+. .++.++|||||||++|||++|..||.........    .....+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~----~~~~~i~~  230 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----QKYERIGE  230 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----HHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH----HHHHHHHh
Confidence            65433221     22345799999999999877 7999999999999999999999999654432211    11111110


Q ss_pred             chhhHHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccccCC
Q 038199          250 SELDATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVEVL  304 (356)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~  304 (356)
                      .     .............++++..++..|+..+|++||+++.+.+.|+.+....
T Consensus       231 ~-----~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         231 K-----KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             H-----HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             c-----cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            0     0111111222345677999999999999999999999999988876544

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-50  Score=355.95  Aligned_cols=262  Identities=19%  Similarity=0.215  Sum_probs=203.6

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCc-eeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHIN-LVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~~~~~~~~~~~~~lV~e  101 (356)
                      .+|++.++||+|+||+||+|.+ .+|+.||||++....   ...++..|++++++++|+| |+.+.+++.+....++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4799999999999999999976 469999999987542   2245788999999997665 5566667778888999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcC---CCceEEcccCCccccCCC
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRN  178 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~---~~~~kl~Dfgl~~~~~~~  178 (356)
                      |+ +++|...+......+++..+..++.|++.||+|||+   ++|+||||||+|||++.   +..++|+|||+++.....
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99 557777776677889999999999999999999999   99999999999999853   457999999999987544


Q ss_pred             CCee-----eeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          179 RSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       179 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      ....     ......||+.|+|||.+.+. .++.++|||||||++|||++|..||................         
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~---------  229 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---------  229 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH---------
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh---------
Confidence            3221     22345799999999999887 68999999999999999999999986654432211100000         


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccc
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKMLEGVVE  302 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~  302 (356)
                      ........+.....++.++.+++.+||+.+|++||+++++.+.|+.+..
T Consensus       230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            0011111112223456779999999999999999999999998887644

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-50  Score=355.62  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=196.9

Q ss_pred             hhhccccccccccCceEEEEEEe-CC-CcEEEEEEeccccc-hhhHHHHHHHHHHHccC---CCCceeeeeceEec----
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PN-GVKIAVKVLNRNLG-RIAEEQFMAEVGTIGRT---YHINLVRLYGFCHD----   92 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~ni~~~~~~~~~----   92 (356)
                      ..+|++.++||+|+||+||+|.+ .+ ++.||||+++.... ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            56899999999999999999976 44 67799999864322 22223456777776665   79999999999853    


Q ss_pred             -CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCC
Q 038199           93 -QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL  171 (356)
Q Consensus        93 -~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl  171 (356)
                       ....+++||++.++++..........+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence             346789999999887766665667789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHH----
Q 038199          172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEY----  247 (356)
Q Consensus       172 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----  247 (356)
                      ++......   ......||+.|+|||++.+. .++.++||||+||++|||++|..||........  + .......    
T Consensus       163 ~~~~~~~~---~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~-~~i~~~~~~~~  235 (305)
T d1blxa_         163 ARIYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--L-GKILDVIGLPG  235 (305)
T ss_dssp             CCCCCGGG---GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCC
T ss_pred             hhhhcccc---cCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--H-HHHHHhhCCCc
Confidence            87543222   23446799999999999877 799999999999999999999999854322100  0 0000000    


Q ss_pred             ----hhc-hhhHHHH----hcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          248 ----EKS-ELDATIL----ACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       248 ----~~~-~~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                          ... .......    ...........+..+.+|+.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                000 0000000    00001112234567889999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=354.49  Aligned_cols=268  Identities=19%  Similarity=0.219  Sum_probs=197.7

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEecCC----eeeE
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH----MTAL   98 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~----~~~l   98 (356)
                      .+|++.++||+|+||+||+|.+ .+|+.||||++.........+++.+|+.+|++++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4689999999999999999975 5799999999976544555678999999999999999999999987543    2344


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN  178 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~  178 (356)
                      +++++.+++|.+++.  ...+++..+..++.|++.||+|||+   ++||||||||+|||++.++.+||+|||++......
T Consensus        88 l~~~~~~g~L~~~l~--~~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          88 LVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEEECCCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEeecCCchhhhhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            555666899999984  3479999999999999999999999   99999999999999999999999999999876443


Q ss_pred             CCe-eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh-----hHHHHhhc--
Q 038199          179 RSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH-----VWEEYEKS--  250 (356)
Q Consensus       179 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~-----~~~~~~~~--  250 (356)
                      ... .......||+.|+|||++.....++.++||||+||++|||++|..||.........+....     ........  
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            222 1223456899999999986665789999999999999999999999854432111000000     00000000  


Q ss_pred             -hhhHHHHhcC---CCc---hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          251 -ELDATILACG---IEE---KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       251 -~~~~~~~~~~---~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                       ..........   ..+   ..+..+.++.+++.+||+.||++|||++++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0000000000   000   111234578899999999999999999999973

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-49  Score=356.08  Aligned_cols=268  Identities=20%  Similarity=0.264  Sum_probs=198.6

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCC------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQH------   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~------   94 (356)
                      ..+|++.++||+|+||+||+|.+ .+|+.||||+++... .....+.+.+|+.+|++++||||+++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46788999999999999999976 469999999997543 3444568899999999999999999999997654      


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+ +.+|..+..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence            469999999 668887763  4579999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCcccc--------chhhhHHH
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDW--------FPKHVWEE  246 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~  246 (356)
                      .....     ....||+.|+|||++.+...++.++||||+||++|+|++|+.||..........        .+...+..
T Consensus       171 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         171 ADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            65432     345699999999998876568999999999999999999999985543211000        00000000


Q ss_pred             HhhchhhHHHHhc------CCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhccc
Q 038199          247 YEKSELDATILAC------GIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVKM--LEGVV  301 (356)
Q Consensus       247 ~~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~--L~~~~  301 (356)
                      .............      .........+.++.+|+.+||..||++|||++++++.  ++.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0000000000000      0011122345678899999999999999999999983  55443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=353.23  Aligned_cols=263  Identities=22%  Similarity=0.248  Sum_probs=196.7

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCceeeeeceEec------CCee
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------QHMT   96 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~------~~~~   96 (356)
                      .+|+..++||+|+||+||+|++. +|+.||||++..+..     .+.+|++++++++||||+++++++..      ..+.
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            47888999999999999999864 699999999976432     23479999999999999999999853      3357


Q ss_pred             eEEEeccCCCChhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-ceEEcccCCcc
Q 038199           97 ALVYEYMENGSLDGYLF--GKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAK  173 (356)
Q Consensus        97 ~lV~e~~~~~sL~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfgl~~  173 (356)
                      ++|||||+++.+..+..  .....+++..+..|+.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+++
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchh
Confidence            89999998754443332  346689999999999999999999999   9999999999999999775 89999999998


Q ss_pred             ccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhh-------hHHH
Q 038199          174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKH-------VWEE  246 (356)
Q Consensus       174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~-------~~~~  246 (356)
                      .......   .....||..|+|||.+.+...++.++||||+||++|||++|..||........  +...       ..+.
T Consensus       172 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~  246 (350)
T d1q5ka_         172 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQ  246 (350)
T ss_dssp             ECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred             hccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHh
Confidence            7654332   23356899999999987665789999999999999999999999854432110  0000       0000


Q ss_pred             HhhchhhHHHHhcCC---------CchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhccc
Q 038199          247 YEKSELDATILACGI---------EEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK--MLEGVV  301 (356)
Q Consensus       247 ~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~~  301 (356)
                      +.... .. ......         .......+.++.+|+.+||+.||++|||+.|+++  .++.+.
T Consensus       247 ~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         247 IREMN-PN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHHC-C----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhc-cc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            00000 00 000000         0111234567899999999999999999999997  344443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-48  Score=351.61  Aligned_cols=259  Identities=19%  Similarity=0.263  Sum_probs=199.9

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEec--CCeeeE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHD--QHMTAL   98 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~--~~~~~l   98 (356)
                      ..+|++.++||+|+||+||+|++ .+|+.||||+++..    ..+++.+|+++|++++ ||||+++++++..  ....++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            45799999999999999999976 46999999999753    2457889999999995 9999999999974  456899


Q ss_pred             EEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC-ceEEcccCCccccCC
Q 038199           99 VYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDR  177 (356)
Q Consensus        99 V~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~-~~kl~Dfgl~~~~~~  177 (356)
                      |||||.+++|..+.    +.+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+|||+++....
T Consensus       110 v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         110 VFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence            99999999997754    579999999999999999999999   9999999999999998655 699999999987654


Q ss_pred             CCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch-------hhhHHHHhhc
Q 038199          178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP-------KHVWEEYEKS  250 (356)
Q Consensus       178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~  250 (356)
                      ...   .....||..|+|||.+.+...++.++||||+||+++||++|+.||.........+..       ...+......
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            332   234568999999999887656899999999999999999999998765442211000       0000000000


Q ss_pred             hh--hHHH------------HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          251 EL--DATI------------LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       251 ~~--~~~~------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      ..  ....            ............+.++.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  0000            000111122334567899999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-49  Score=347.79  Aligned_cols=264  Identities=19%  Similarity=0.239  Sum_probs=207.1

Q ss_pred             hhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecCCeeeEEEe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQHMTALVYE  101 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lV~e  101 (356)
                      .+|++.++||+|+||+||+|++ .+|+.||||+++... ......++.+|+.+++.++||||+++++++.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            3789999999999999999976 478999999996543 33455789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccccCCCCCe
Q 038199          102 YMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH  181 (356)
Q Consensus       102 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  181 (356)
                      ++.+++|..++ ...+.+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||.++........
T Consensus        82 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          82 FCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             CCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             ecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            99998888776 456788999999999999999999999   99999999999999999999999999999876544332


Q ss_pred             eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhh---chh---hH-
Q 038199          182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEK---SEL---DA-  254 (356)
Q Consensus       182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~---~~-  254 (356)
                      .  ....++..|+|||.+.+...++.++|||||||++|||++|+.|+..+...... +.. .......   ...   .. 
T Consensus       158 ~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         158 Y--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKR-IFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             C--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHH-HHHHHCCCCTTTCTTGGGS
T ss_pred             c--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH-HHH-HHhhcCCCChhhhhhhhhc
Confidence            2  22347788999999887656799999999999999999999998654432110 000 0000000   000   00 


Q ss_pred             --------HHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          255 --------TILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       255 --------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                              ..............+..+.+++.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    00011112223344567889999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=349.34  Aligned_cols=267  Identities=20%  Similarity=0.220  Sum_probs=195.9

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEec--------
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD--------   92 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~--------   92 (356)
                      ..+|++.++||+|+||+||+|.+ .+|+.||||++.... ......++.+|+.++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999976 479999999986432 23344678899999999999999999998854        


Q ss_pred             CCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCc
Q 038199           93 QHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA  172 (356)
Q Consensus        93 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~  172 (356)
                      ....++|||++.++.+.... .....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence            34578999999876655443 556789999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCe--eeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHH----
Q 038199          173 KLCDRNRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEE----  246 (356)
Q Consensus       173 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----  246 (356)
                      +........  .......||..|+|||++.+...++.++|||||||++|||++|+.||........   .......    
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~~~~  241 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSI  241 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhcCCC
Confidence            876533222  1223356999999999988765789999999999999999999999853221100   0000000    


Q ss_pred             -------HhhchhhHHHHhcCC-Cchh------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038199          247 -------YEKSELDATILACGI-EEKD------KEKAKRLCMAALWCVQDSPEDRPPMSAVVKM  296 (356)
Q Consensus       247 -------~~~~~~~~~~~~~~~-~~~~------~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~  296 (356)
                             ............... ....      ......+.+|+.+||+.||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence                   000000000000000 0001      1123467789999999999999999999973

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=349.56  Aligned_cols=255  Identities=21%  Similarity=0.231  Sum_probs=203.4

Q ss_pred             hhhccccccccccCceEEEEEEe---C-CCcEEEEEEecccc---chhhHHHHHHHHHHHccCCC-CceeeeeceEecCC
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF---P-NGVKIAVKVLNRNL---GRIAEEQFMAEVGTIGRTYH-INLVRLYGFCHDQH   94 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~---~-~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~ni~~~~~~~~~~~   94 (356)
                      -.+|++.++||+|+||+||+|..   + +|+.||||+++...   .....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            36699999999999999999964   2 48899999986432   12334568899999999965 89999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCccc
Q 038199           95 MTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL  174 (356)
Q Consensus        95 ~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~  174 (356)
                      ..++||||+.+++|.+++. ..+.+++..+..++.||+.||+|||+   ++++||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~~v~e~~~~~~L~~~i~-~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ceeeeeecccccHHHHHHH-hcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999999984 44567889999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCeeeeccCCCCCCCCCcccccCCC-CCCccccchhhHHHHHHHHhCCcccccCCCCccccchhhhHHHHhhchhh
Q 038199          175 CDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFPKHVWEEYEKSELD  253 (356)
Q Consensus       175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (356)
                      +....... .....|++.|+|||.+.+.. .++.++|||||||++|||++|..||.........   ....         
T Consensus       179 ~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~---------  245 (322)
T d1vzoa_         179 FVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEIS---------  245 (322)
T ss_dssp             CCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHH---------
T ss_pred             hccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH---------
Confidence            64333222 23456999999999987542 4788999999999999999999998665443211   0000         


Q ss_pred             HHHHhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038199          254 ATILACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP-----MSAVVK  295 (356)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~  295 (356)
                      ... .......+...+.++.+++.+||+.||++|||     ++|+++
T Consensus       246 ~~~-~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         246 RRI-LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHH-HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             Hhc-ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            001 11122334456788999999999999999994     788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=345.33  Aligned_cols=268  Identities=18%  Similarity=0.244  Sum_probs=198.0

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEecC-----Ce
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHDQ-----HM   95 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-----~~   95 (356)
                      ..+|++.++||+|+||+||+|.+ .+|+.||||+++... .....+++.+|+.++++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            45799999999999999999975 579999999997543 334556789999999999999999999998633     33


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .++|++++.|++|.+++  ..+.+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||++...
T Consensus        97 ~~~i~~~~~gg~L~~~~--~~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence            46677788899999998  44579999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc--------hhhhHHHH
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF--------PKHVWEEY  247 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~--------~~~~~~~~  247 (356)
                      ...     .....|+..|+|||.+.+...++.++|||||||++|+|++|..||...........        ....+...
T Consensus       172 ~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         172 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             TGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             Ccc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            322     23356888999999987765678999999999999999999999854332110000        00000000


Q ss_pred             hhchhhHHHHhc-CCCc-----hhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcc
Q 038199          248 EKSELDATILAC-GIEE-----KDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK--MLEGV  300 (356)
Q Consensus       248 ~~~~~~~~~~~~-~~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~  300 (356)
                      ............ ....     .....+.++.+|+.+||+.||.+|||++|+++  .+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            000000000000 0000     01123567889999999999999999999997  35444

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=340.03  Aligned_cols=261  Identities=21%  Similarity=0.221  Sum_probs=190.8

Q ss_pred             hhccccccccccCceEEEEEEeC-CCcEEEEEEecccc-chhhHHHHHHHHHHHccCCCCceeeeeceEec------CCe
Q 038199           24 FTSNYSTRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL-GRIAEEQFMAEVGTIGRTYHINLVRLYGFCHD------QHM   95 (356)
Q Consensus        24 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~------~~~   95 (356)
                      .+|++.++||+|+||+||+|.+. +|+.||||++.... ......++.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            46889999999999999999765 69999999997543 23444678999999999999999999999963      467


Q ss_pred             eeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcccCCcccc
Q 038199           96 TALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC  175 (356)
Q Consensus        96 ~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~~~  175 (356)
                      .|+|||||.++.+. .+   ...+++..+..++.||+.||.|||+   +||+||||||+|||++.++.++++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~~-~~---~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VI---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHH-HH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHH-hh---hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence            89999999775554 44   3468999999999999999999999   99999999999999999999999999998865


Q ss_pred             CCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccc-----hhhhHHHHhhc
Q 038199          176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWF-----PKHVWEEYEKS  250 (356)
Q Consensus       176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~-----~~~~~~~~~~~  250 (356)
                      ....   ......||..|+|||++.+. .++.++||||+||++++|++|+.||...+.......     .....+.+...
T Consensus       170 ~~~~---~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         170 GTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             --------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             cccc---ccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            5432   22345689999999999876 789999999999999999999998854322110000     00000000000


Q ss_pred             h--hhHHH------------------HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038199          251 E--LDATI------------------LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPPMSAVVK  295 (356)
Q Consensus       251 ~--~~~~~------------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~  295 (356)
                      .  .....                  ............+.++.+|+.+||..||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0  00000                  011112234456788999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.6e-42  Score=313.05  Aligned_cols=263  Identities=22%  Similarity=0.264  Sum_probs=189.4

Q ss_pred             hhhccccccccccCceEEEEEEe-CCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-----------CCceeeeeceE
Q 038199           23 NFTSNYSTRLGFGGFGEVYKGQF-PNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-----------HINLVRLYGFC   90 (356)
Q Consensus        23 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni~~~~~~~   90 (356)
                      +.+|++.++||+|+||+||+|++ .+|+.||||+++.+  ....+.+.+|+.+++.++           |+||+++++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            45799999999999999999976 47999999999865  334467788988888775           57899999888


Q ss_pred             ecC--CeeeEEEeccCCCChhh--hhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCC----
Q 038199           91 HDQ--HMTALVYEYMENGSLDG--YLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----  162 (356)
Q Consensus        91 ~~~--~~~~lV~e~~~~~sL~~--~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~----  162 (356)
                      ...  ...+++++++..+....  ........+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++    
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence            643  45566666664443322  222346789999999999999999999996  37899999999999997655    


Q ss_pred             --ceEEcccCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHHHHHhCCcccccCCCCccccch
Q 038199          163 --SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLFEIVGRRRNAIVGSSESLDWFP  240 (356)
Q Consensus       163 --~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~  240 (356)
                        .++++|||.+.......     ....||..|+|||++.+. .++.++||||+||++++|++|+.||............
T Consensus       168 ~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             EEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cceeeEeeccccccccccc-----ccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence              39999999998654322     335689999999999876 7899999999999999999999998664332111000


Q ss_pred             hhh-----------HHHHhhchhhHHH--------------------HhcCCCchhHHHHHHHHHHHHhcccCCCCCCCC
Q 038199          241 KHV-----------WEEYEKSELDATI--------------------LACGIEEKDKEKAKRLCMAALWCVQDSPEDRPP  289 (356)
Q Consensus       241 ~~~-----------~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  289 (356)
                      ...           .+...........                    ............+.++.+|+.+||..||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            000           0000000000000                    000011234567788999999999999999999


Q ss_pred             HHHHHH
Q 038199          290 MSAVVK  295 (356)
Q Consensus       290 ~~~v~~  295 (356)
                      ++|+++
T Consensus       322 a~e~L~  327 (362)
T d1q8ya_         322 AGGLVN  327 (362)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=1.6e-27  Score=196.43  Aligned_cols=172  Identities=14%  Similarity=0.110  Sum_probs=122.7

Q ss_pred             ccccccccccCceEEEEEEeCCCcEEEEEEeccccc-----------------hhhHHHHHHHHHHHccCCCCceeeeec
Q 038199           26 SNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLG-----------------RIAEEQFMAEVGTIGRTYHINLVRLYG   88 (356)
Q Consensus        26 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~E~~~l~~l~h~ni~~~~~   88 (356)
                      +.++++||+|+||+||+|.+.+|+.||||++.....                 .........|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            457899999999999999888899999998753211                 111234557889999999999998876


Q ss_pred             eEecCCeeeEEEeccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCccccCCCCCcEEEcCCCceEEcc
Q 038199           89 FCHDQHMTALVYEYMENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD  168 (356)
Q Consensus        89 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dikp~Nill~~~~~~kl~D  168 (356)
                      +..    .++|||++++..+..        ++...+..++.|++.+++|||+   .+|+||||||+|||++++ .++|+|
T Consensus        82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred             ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence            542    479999998865543        3344467899999999999999   999999999999999865 589999


Q ss_pred             cCCccccCCCCCeeeeccCCCCCCCCCcccccCCCCCCccccchhhHHHHH
Q 038199          169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVLF  219 (356)
Q Consensus       169 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slGvvl~  219 (356)
                      ||++.....+.........+.   . -.+.+. + .++.++|+||+.--++
T Consensus       146 FG~a~~~~~~~~~~~l~rd~~---~-~~~~f~-r-~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWREILERDVR---N-IITYFS-R-TYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHHHHHHHHHH---H-HHHHHH-H-HHCCCCCHHHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHHHHHH---H-HHHHHc-C-CCCCcccHHHHHHHHh
Confidence            999976543322110000000   0 001121 2 5788999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.73  E-value=2.4e-08  Score=84.27  Aligned_cols=141  Identities=11%  Similarity=0.014  Sum_probs=94.8

Q ss_pred             hccccccccccCceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEEecc
Q 038199           25 TSNYSTRLGFGGFGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVYEYM  103 (356)
Q Consensus        25 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~e~~  103 (356)
                      .|.+.+..+.++.+.||+... +++.+++|+..... ......+.+|...++.+. +--+.+++.+..+++..++||+++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            445555555566678999876 55667888876432 122335677888877664 444677888888888899999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 038199          104 ENGSLDGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEEC-----------------------------------------  142 (356)
Q Consensus       104 ~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----------------------------------------  142 (356)
                      +|.++.+....   ...   ...++.+++..+..||+..                                         
T Consensus        93 ~G~~~~~~~~~---~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T d1j7la_          93 DGVLCSEEYED---EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SSEEHHHHTTT---CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred             ccccccccccc---ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence            99887654411   111   2223445555555555411                                         


Q ss_pred             ---------------CCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          143 ---------------QQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       143 ---------------~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                                     ...++|+|+.|.||++++++.+.|+||+.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                           1237999999999999987777899998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.50  E-value=2.2e-07  Score=77.79  Aligned_cols=129  Identities=12%  Similarity=0.030  Sum_probs=84.7

Q ss_pred             ccccC-ceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCC--CCceeeeeceEecCCeeeEEEeccCCCCh
Q 038199           32 LGFGG-FGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY--HINLVRLYGFCHDQHMTALVYEYMENGSL  108 (356)
Q Consensus        32 iG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~~~~~lV~e~~~~~sL  108 (356)
                      +..|. -+.||+....++..+++|.-....    ...+..|...++.+.  .-.+.+++.+..+.+..++||++++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            34444 468999988778889999876432    224566777777663  33467788888888889999999998766


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc-----------------------------------------------
Q 038199          109 DGYLFGKKRAIEWEKLHEIAIGTAKGLVYLHEE-----------------------------------------------  141 (356)
Q Consensus       109 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------------------------------------------  141 (356)
                      ....      ...   ..++.++...|..||+.                                               
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            4321      111   11122233333333321                                               


Q ss_pred             ----C----CCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          142 ----C----QQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       142 ----~----~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                          .    +..++|+|+.|.||+++.+..+.|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                0    1237999999999999987777899998874

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.99  E-value=1e-05  Score=71.98  Aligned_cols=77  Identities=16%  Similarity=0.123  Sum_probs=48.9

Q ss_pred             ccccccCceEEEEEEeC-CCcEEEEEEecccc------chhhHHHHHHHHHHHccCC-C--CceeeeeceEecCCeeeEE
Q 038199           30 TRLGFGGFGEVYKGQFP-NGVKIAVKVLNRNL------GRIAEEQFMAEVGTIGRTY-H--INLVRLYGFCHDQHMTALV   99 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~-h--~ni~~~~~~~~~~~~~~lV   99 (356)
                      +.||.|....||++... +++.|+||.-....      -....++...|.+.++.+. +  ..+++++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            46899999999999865 47789999643211      0122345667888887663 2  345556544  44556799


Q ss_pred             EeccCCCCh
Q 038199          100 YEYMENGSL  108 (356)
Q Consensus       100 ~e~~~~~sL  108 (356)
                      ||++.+..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.72  E-value=4.3e-05  Score=65.94  Aligned_cols=133  Identities=14%  Similarity=0.120  Sum_probs=77.2

Q ss_pred             ceEEEEEEeCCCcEEEEEEeccccchhhHHHHHHHHHHHccCCCCce--eeee-----ceEecCCeeeEEEeccCCCChh
Q 038199           37 FGEVYKGQFPNGVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTYHINL--VRLY-----GFCHDQHMTALVYEYMENGSLD  109 (356)
Q Consensus        37 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--~~~~-----~~~~~~~~~~lV~e~~~~~sL~  109 (356)
                      --.||+++..+|+.|++|+-...  ....+++..|...+..|...++  +..+     ..+..+...+.+++++.|..+.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~--~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE--RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT--TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC--CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            35799999889999999998654  3345667788888877642222  1111     1223455678899999874432


Q ss_pred             h-----hh-------------hc----CCCCCCHH----------------------HHHHHHHHHHHHHHHH-hhcCCC
Q 038199          110 G-----YL-------------FG----KKRAIEWE----------------------KLHEIAIGTAKGLVYL-HEECQQ  144 (356)
Q Consensus       110 ~-----~l-------------~~----~~~~~~~~----------------------~~~~i~~qi~~~l~~L-H~~~~~  144 (356)
                      .     +.             ..    .....+..                      .....+.++...+.-+ .+..+.
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            1     00             00    00111111                      1222222232222222 122246


Q ss_pred             CccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          145 RIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       145 ~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      ++||+|+.+.|||++++  ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhcc
Confidence            79999999999999743  4589998875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.26  E-value=0.00068  Score=59.82  Aligned_cols=73  Identities=18%  Similarity=0.210  Sum_probs=49.6

Q ss_pred             ccccccCceEEEEEEeCC--------CcEEEEEEeccccchhhHHHHHHHHHHHccCC-CCceeeeeceEecCCeeeEEE
Q 038199           30 TRLGFGGFGEVYKGQFPN--------GVKIAVKVLNRNLGRIAEEQFMAEVGTIGRTY-HINLVRLYGFCHDQHMTALVY  100 (356)
Q Consensus        30 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~lV~  100 (356)
                      +.|+.|-.-.+|++...+        .+.|.+++....  . ......+|..+++.+. +.-.+++++++.+    .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            568889899999998643        356777776532  1 2234567888888885 3334567777653    6899


Q ss_pred             eccCCCChh
Q 038199          101 EYMENGSLD  109 (356)
Q Consensus       101 e~~~~~sL~  109 (356)
                      ||++|..|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999885553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.89  E-value=0.0037  Score=52.89  Aligned_cols=31  Identities=26%  Similarity=0.321  Sum_probs=27.9

Q ss_pred             CCCccccCCCCCcEEEcCCCceEEcccCCcc
Q 038199          143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK  173 (356)
Q Consensus       143 ~~~ivH~dikp~Nill~~~~~~kl~Dfgl~~  173 (356)
                      +.++||+|+.++||+++.+...-++||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            5789999999999999988777899999874